<SEC-DOCUMENT>0000927066-22-000012.txt : 20220211
<SEC-HEADER>0000927066-22-000012.hdr.sgml : 20220211
<ACCEPTANCE-DATETIME>20220211160749
ACCESSION NUMBER:		0000927066-22-000012
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		144
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220211
DATE AS OF CHANGE:		20220211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DAVITA INC.
		CENTRAL INDEX KEY:			0000927066
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				510354549
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14106
		FILM NUMBER:		22620833

	BUSINESS ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202
		BUSINESS PHONE:		310-536-2668

	MAIL ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA HEALTHCARE PARTNERS INC.
		DATE OF NAME CHANGE:	20121107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA INC
		DATE OF NAME CHANGE:	20001005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TOTAL RENAL CARE HOLDINGS INC
		DATE OF NAME CHANGE:	19950524
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>dva-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:1726f308-1cc7-4a47-a8e3-a7d089a83ae3,g:ca3879f3-8750-4d94-926a-aa4c6036a270,d:916f7af890114e55a87e260476560c60--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:dva="http://www.davita.com/20211231" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dva-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF80L2ZyYWc6OGIwNWVkNDI3ODNhNGEwOTg4YzU4NjBkMWU3MDUxOTYvdGFibGU6ZTY0NWZiMmM1NzAzNDQ2OWFkZjYyZjdiNzdmZTc5YTYvdGFibGVyYW5nZTplNjQ1ZmIyYzU3MDM0NDY5YWRmNjJmN2I3N2ZlNzlhNl8yLTEtMS0xLTgzMDc4_891e2656-60f3-48ce-b832-549cca2ad37b">false</ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF80L2ZyYWc6OGIwNWVkNDI3ODNhNGEwOTg4YzU4NjBkMWU3MDUxOTYvdGFibGU6ZTY0NWZiMmM1NzAzNDQ2OWFkZjYyZjdiNzdmZTc5YTYvdGFibGVyYW5nZTplNjQ1ZmIyYzU3MDM0NDY5YWRmNjJmN2I3N2ZlNzlhNl8zLTEtMS0xLTgzMDc4_a6d48c05-f0a7-4dc4-8b95-dc8ae99e3442">2021</ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF80L2ZyYWc6OGIwNWVkNDI3ODNhNGEwOTg4YzU4NjBkMWU3MDUxOTYvdGFibGU6ZTY0NWZiMmM1NzAzNDQ2OWFkZjYyZjdiNzdmZTc5YTYvdGFibGVyYW5nZTplNjQ1ZmIyYzU3MDM0NDY5YWRmNjJmN2I3N2ZlNzlhNl80LTEtMS0xLTgzMDc4_c9d9fc59-981a-4b43-8f8d-6e9cb2dfbb85">FY</ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF80L2ZyYWc6OGIwNWVkNDI3ODNhNGEwOTg4YzU4NjBkMWU3MDUxOTYvdGFibGU6ZTY0NWZiMmM1NzAzNDQ2OWFkZjYyZjdiNzdmZTc5YTYvdGFibGVyYW5nZTplNjQ1ZmIyYzU3MDM0NDY5YWRmNjJmN2I3N2ZlNzlhNl81LTEtMS0xLTgzMDc4_6994346f-3d46-41cd-a415-72c9a380d623">0000927066</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzItMi0xLTEtODMwNzg_b371d3e8-c01f-416c-a06b-8e5e5028ffdb">0.001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzMtMi0xLTEtODMwNzg_f46b216e-38b8-4cec-ae5f-c66103c23bea">5,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzQtMi0xLTEtODMwNzg_d0b0a4f7-ed24-4fdb-a89d-0b61e0048ef4">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzUtMi0xLTEtODMwNzg_fe89440e-2131-47ef-ab6f-f159a2af3973">0.001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzYtMi0xLTEtODMwNzg_e809e663-68ea-4b15-9424-618835163983">450,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzgtMS0xLTEtODMwNzg_e764459e-49db-4e01-8abe-ff0882fdfb10">97,289</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzgtMi0xLTEtODMwNzg_a3c84f97-d2d7-45f3-9daf-12d8d46b9cee">109,933</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i70ca4b5a53254c4ea41168999c345602_D20200101-20201231" decimals="INF" name="dva:NumberOfConcentrationRiskCustomers" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTQvZnJhZzo4ZjgyNDJkYjI0OGM0MDI3YWI4ZWRlNmMzYTJlYTU3OS90ZXh0cmVnaW9uOjhmODI0MmRiMjQ4YzQwMjdhYjhlZGU2YzNhMmVhNTc5XzE0_277a7ff7-f8b9-4648-952b-996078570924">No</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i70ca4b5a53254c4ea41168999c345602_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTQvZnJhZzo4ZjgyNDJkYjI0OGM0MDI3YWI4ZWRlNmMzYTJlYTU3OS90ZXh0cmVnaW9uOjhmODI0MmRiMjQ4YzQwMjdhYjhlZGU2YzNhMmVhNTc5Xzcw_0a8e5c63-d016-45c3-a6fd-1ab87ae420c4">10</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzUvZnJhZzphYTYxZTA1ZDE1OGQ0ZTMwYjlkMjRlYWZlNDBlYTllNy90ZXh0cmVnaW9uOmFhNjFlMDVkMTU4ZDRlMzBiOWQyNGVhZmU0MGVhOWU3XzY2_5b0a9fe8-dbb3-420d-80ca-e2ad93c7f25a">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzUvZnJhZzphYTYxZTA1ZDE1OGQ0ZTMwYjlkMjRlYWZlNDBlYTllNy90ZXh0cmVnaW9uOmFhNjFlMDVkMTU4ZDRlMzBiOWQyNGVhZmU0MGVhOWU3XzE5Ng_0380a00c-b1e7-4ff5-8c00-3ec7c8ede187">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDEvZnJhZzo5N2RiNDA1YmNlZDQ0ZjA5YjQzMjY0NjE5ZWEwNTQ2Ni90ZXh0cmVnaW9uOjk3ZGI0MDViY2VkNDRmMDliNDMyNjQ2MTllYTA1NDY2XzE2_ca773252-3dbf-4e3d-87e1-0147649ab86d">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDEvZnJhZzo5N2RiNDA1YmNlZDQ0ZjA5YjQzMjY0NjE5ZWEwNTQ2Ni90ZXh0cmVnaW9uOjk3ZGI0MDViY2VkNDRmMDliNDMyNjQ2MTllYTA1NDY2XzE0Ng_86eb2266-3d86-4a90-b08b-63cedfba6bda">no</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="4" name="dva:PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDcvZnJhZzpkZjg0N2I1NjIxMzY0YmRiYjFjZGRlMjZkYzMwZWY4Mi90ZXh0cmVnaW9uOmRmODQ3YjU2MjEzNjRiZGJiMWNkZGUyNmRjMzBlZjgyXzgz_72f0a86b-90e9-476b-9192-b02765177436">1.00</ix:nonFraction><ix:nonNumeric contextRef="ie9bff082b91346b1a64d99905758b26e_D20210101-20211231" name="us-gaap:OperatingLossCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTYvZnJhZzo0Yjg3OWJmNTY4NTU0ZmY1YjJjMDI3OTdkOTZkNGI1Mi90ZXh0cmVnaW9uOjRiODc5YmY1Njg1NTRmZjViMmMwMjc5N2Q5NmQ0YjUyXzY1_d9b1b4f6-c1b0-47d1-b80a-04c108d06b02">2036-12-31</ix:nonNumeric><ix:nonNumeric contextRef="iece01fa01730408186a67affd6c9484d_D20210101-20211231" name="us-gaap:OperatingLossCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTYvZnJhZzo0Yjg3OWJmNTY4NTU0ZmY1YjJjMDI3OTdkOTZkNGI1Mi90ZXh0cmVnaW9uOjRiODc5YmY1Njg1NTRmZjViMmMwMjc5N2Q5NmQ0YjUyXzEwOQ_e514b8c5-7a7f-4152-a6e5-f6f06eec5dfb">2029-12-31</ix:nonNumeric><ix:nonNumeric contextRef="i62817899f49f4b0d9b02387e82cb91f9_D20210101-20211231" name="us-gaap:OperatingLossCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTYvZnJhZzo0Yjg3OWJmNTY4NTU0ZmY1YjJjMDI3OTdkOTZkNGI1Mi90ZXh0cmVnaW9uOjRiODc5YmY1Njg1NTRmZjViMmMwMjc5N2Q5NmQ0YjUyXzE3OQ_4680b45c-fca4-40cd-8eb5-02c4fb932735">2041-12-31</ix:nonNumeric><ix:nonNumeric contextRef="i72a8de58066e4a4a806a5dfa92b2e593_D20210101-20211231" name="us-gaap:OperatingLossCarryforwardsExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTYvZnJhZzo0Yjg3OWJmNTY4NTU0ZmY1YjJjMDI3OTdkOTZkNGI1Mi90ZXh0cmVnaW9uOjRiODc5YmY1Njg1NTRmZjViMmMwMjc5N2Q5NmQ0YjUyXzI1MQ_475cbfec-26e1-4138-8f9a-56369995a43b">2022-12-31</ix:nonNumeric><ix:nonNumeric contextRef="icaa1d23ca55b42bc9d292cd4c74005e2_D20210101-20211231" name="us-gaap:TaxCreditCarryforwardExpirationDate" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTYvZnJhZzo0Yjg3OWJmNTY4NTU0ZmY1YjJjMDI3OTdkOTZkNGI1Mi90ZXh0cmVnaW9uOjRiODc5YmY1Njg1NTRmZjViMmMwMjc5N2Q5NmQ0YjUyXzM2Mg_694922a1-3763-497f-9b05-9e78038bc3da">2024-12-31</ix:nonNumeric><ix:nonNumeric contextRef="i2be3f954e5f14213b4903797ad633c44_D20210101-20211231" name="dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzEvZnJhZzowNjViNDQxZGUwYzE0MTUzYjM0OGRmYmU3ODI5NWE4Yy90ZXh0cmVnaW9uOjA2NWI0NDFkZTBjMTQxNTNiMzQ4ZGZiZTc4Mjk1YThjXzky_d161914e-1eac-4576-8b48-3898615e3629">1</ix:nonNumeric><ix:nonNumeric contextRef="ife16d51280fb452d8a63ec87d4093b0f_D20210101-20211231" name="dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzEvZnJhZzowNjViNDQxZGUwYzE0MTUzYjM0OGRmYmU3ODI5NWE4Yy90ZXh0cmVnaW9uOjA2NWI0NDFkZTBjMTQxNTNiMzQ4ZGZiZTc4Mjk1YThjXzk4_d220be28-9980-494e-bc63-f3bfb734a392">2</ix:nonNumeric><ix:nonNumeric contextRef="i2be3f954e5f14213b4903797ad633c44_D20210101-20211231" name="dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzEvZnJhZzowNjViNDQxZGUwYzE0MTUzYjM0OGRmYmU3ODI5NWE4Yy90ZXh0cmVnaW9uOjA2NWI0NDFkZTBjMTQxNTNiMzQ4ZGZiZTc4Mjk1YThjXzE2Mw_d36a0e12-4ef5-4297-b44f-31c8097e23ed">3</ix:nonNumeric><ix:nonNumeric contextRef="ife16d51280fb452d8a63ec87d4093b0f_D20210101-20211231" name="dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzEvZnJhZzowNjViNDQxZGUwYzE0MTUzYjM0OGRmYmU3ODI5NWE4Yy90ZXh0cmVnaW9uOjA2NWI0NDFkZTBjMTQxNTNiMzQ4ZGZiZTc4Mjk1YThjXzE2OQ_beeb74a2-aaeb-4175-a226-86fcc6beeee6">4</ix:nonNumeric><ix:nonNumeric contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231" name="dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzk4_1165aa38-f883-4968-8d88-16163128f92a">0</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="i803f99ff64c84ab393254741b3910d99_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzMtMS0xLTEtODMwNzg_9314496a-a768-41b5-8504-c9612a3546b4">50.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i803f99ff64c84ab393254741b3910d99_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzMtMi0xLTEtODMwNzg_d627fc49-bdcd-4e29-9b94-f115f0f52434">60.00</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i2767101ebdd54c7faa2d837388057e78_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzQtMS0xLTEtODMwNzg_be86db7d-5a3e-4fcd-8bbe-196ebb3506b7">60.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i2767101ebdd54c7faa2d837388057e78_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzQtMi0xLTEtODMwNzg_ee2e0ae3-ea64-483c-a351-23a22761ce97">70.00</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ie84513b046464781864c4f5c126a57c1_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzUtMS0xLTEtODMwNzg_4a5ac597-8540-4470-bdab-01b90074a9d8">70.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ie84513b046464781864c4f5c126a57c1_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzUtMi0xLTEtODMwNzg_00ae1b95-d675-41c3-86ba-8bb49639591e">80.00</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ic0e79d8201f24669b11431997b178ed7_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzYtMS0xLTEtMTU2NTE5_b07d2e2c-f2d5-4446-933c-fd387232fac2">100.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ic0e79d8201f24669b11431997b178ed7_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzYtMi0xLTEtMTU2NTIx_8f920ace-bf94-4f8d-888c-6cc364e05697">110.00</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i3a011ba985114d35aac38e038221e94d_D20191104-20191104" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzEyNQ_56a5ebf9-97b1-4341-aa78-f3d2bca12549">50</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="icd9f925115cc4474bf68992371fa2ba6_D20210701-20210701" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzIzNA_102e738b-2a20-4629-82e7-49e22d20df5d">100</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="INF" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzQxOQ_e90b9fd4-6129-470a-b38b-bda78261151f">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="INF" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzU3NA_04dff9db-9b59-4739-8521-0fd66af4a80c">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="INF" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzYyMQ_1aba7357-ef40-46ca-b7db-9928602effcb">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="INF" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzYzNQ_617ecb7e-65a4-408c-b620-d09d44c3d645">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="INF" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzY1MA_687b57d4-7df9-4385-bd02-c1cf796bd651">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i8128ed8de2d8431a8be4d9736d9eb22a_I20201210" decimals="-3" name="dva:TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODkvZnJhZzpiN2ZiMThjMzZkZTc0ZDVlOTk0YjMyN2NlMWRkZWE0ZC90ZXh0cmVnaW9uOmI3ZmIxOGMzNmRlNzRkNWU5OTRiMzI3Y2UxZGRlYTRkXzI3Ng_71329a35-1a7d-4ef6-bee1-18ed705bd14a">329,302</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i518c74e1af094a8bbc78df6c4a5e0e05_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODkvZnJhZzpiN2ZiMThjMzZkZTc0ZDVlOTk0YjMyN2NlMWRkZWE0ZC90ZXh0cmVnaW9uOmI3ZmIxOGMzNmRlNzRkNWU5OTRiMzI3Y2UxZGRlYTRkXzQzNQ_7383caec-d3c6-45ad-8410-96e8f331f16b">13,877</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i8d5b598835d84508b6ec3b7ee400fa41_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODkvZnJhZzpiN2ZiMThjMzZkZTc0ZDVlOTk0YjMyN2NlMWRkZWE0ZC90ZXh0cmVnaW9uOmI3ZmIxOGMzNmRlNzRkNWU5OTRiMzI3Y2UxZGRlYTRkXzQ0Mg_18c48c80-d974-47c6-8c9c-5b1acc3b9ab9">16,477</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dva-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6946ea686e7c41b3a8aa82ffda6fb966_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i50c3ae2124374b73a5fb91701224c115_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i94e3a04a958345dca335a60cee3d8130_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d3dd21038464c23a62a67a39190a154_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e07643e57f74006b5bcc05f2f454af3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63999090b4ba4b888b7f56a9059c5fe0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0acb94239c44493880ec3eb2ccd8e937_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fe0fe3dc214439e993ff7b2ef6840b7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b6e5fa072d7489db4ab12e204b38a35_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07d5f8524b0847c08febc20a18ec3e47_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bca572e906b49798cc07308d3e4bfc0_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i050ebae691a14d39a71068a4d4ddb981_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88726c7f90b243d4adcbf6e341fa9adc_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e3632fb440c4f8b987b9e68d47870e0_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dd50a980cda4949863e518248043db7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c551774ede47b9a8a31720f6c90ba1_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b898106fe1a419ca926f1ea86e57923_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia217ce5b5094494d94eaad3451dec57d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb2ad82533ae4593ad0e4a15e9fed8e1_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i750133c9d44946099dfeb64f0ff3dda6_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i944596afcbc042b0b7e8ae7c9ea00e76_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2f800f0bf6140faaf3bda87332ad8ca_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if648bd429f9e4b07af2e909f55c08369_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i583e6028240a4d259061cd7bbc80a527_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15f02743c68844acade340aa85cc54cd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88c33ce611c94db9b64610be315aa469_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5a1a9dd763f490c88b2409ea91246ed_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06d01a2b80634e908567ea9c88abdc8f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1b9156dde5743f4b33b9826bbf418bb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62f1cb2b785248a3b90677c8293c94df_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b6aab96951d446ab5be207620dd6ff7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i996169fbe8c44228b5349d69256e805e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i838fbf8cfb7d4a6cb6315c5d14ce207e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b4abd021662426781fb847359853689_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifae2538458cc41c69083e653352c94de_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e5cea8acd3342e28c6385ed6cb5ccd2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide8b363308b74e509b2de9b4dec149b4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i757f5d8cb16b4caeb7c0303e2e952d94_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d5b598835d84508b6ec3b7ee400fa41_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia00e3841c62b4348bd05c6b2d0b4d596_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60ae2bbc50a5435997c99adc86408164_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4654e2a535af44d68cb85bf0e223c161_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36a1b963ab624f408820e5a7b1cda4ef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dd9625df77a4aa09aad592fdc4607db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31cbff30dba64d4c9bbe2eb87db6524c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ebd4f5dd6634fdda4f23120f166d49b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife7743b6788a41e5b36480f00efcdabe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i350dba809a5e474b83a7ae6fd0ebf067_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27ce758ca09a46018cfdba537eef12e3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7cd4ee4e9ce4fc7b8372541703a718f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i518c74e1af094a8bbc78df6c4a5e0e05_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9e84e755ba249e59a9b6aa205496944_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3715810153a34e87aa3d4a8555b92c56_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia58cacd8bb944663919470f872cd9f54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e3c3810c47a4c88b525c4a096aec7af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7e9c24fd093462cb7636796ea413cc3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3013c0642fb54553a6a63393504e9d22_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32f5b12383e04ff68c813ea6c09f8e5d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9418d8475e0410d982f26661945c8cf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32582f828b954718823b2edb03b73ce7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="clinic"><xbrli:measure>dva:clinic</xbrli:measure></xbrli:unit><xbrli:unit id="state"><xbrli:measure>dva:state</xbrli:measure></xbrli:unit><xbrli:context id="ie9c338e435f04dd6bb9e00a239820984_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="patient"><xbrli:measure>dva:patient</xbrli:measure></xbrli:unit><xbrli:context id="idcc6cfbc476149a0b92d93b432177548_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dva:InternationalOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34062f45d55f4583ba09a038767a205e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dva:InternationalOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="country"><xbrli:measure>dva:country</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="entity"><xbrli:measure>dva:entity</xbrli:measure></xbrli:unit><xbrli:context id="i7ec096dcca304113bc6030ce985e8e87_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f47d0696ecb4ceea5e3dae2b3f56bbf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i844334ff13de4b30b4c03942a019ecc3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib840efffa3b94830990c3a92b56374e2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eb5b1eefc8d41fd800f8c1f52603ba0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90c6f2e663a84d45ba6b27262a653a05_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic04011b05a72411caa75091e3801f7de_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5041e4e8c2184140828efaa001bdd25e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94e0c5744d944b2b9bd9e8a2915c8453_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c40460b5c5b441db56d0568eb1241d1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43f279672ea545869037ea2802282d14_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33d553b0e327490488f4d8edbe627ee0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3fd96e606364586af971c83948be72a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cdf7cce3e8f4dd797d01eb3c13004e6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05351ca6b9d14e4db0eabbbe9c54574c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0a25508bcb746169dec8366c15ed07a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05cf3e1772d6444ea76bd84771ac5085_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8c57a5b75b1450db44db406dbe6cbb1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d275721d92143bf8c330f70d27cb62f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcf3ecd2542b42dbafe63b11f52a5f01_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibde88c91df984f719e7c6e7ac45ff483_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i308c251f3409431ba2ce96afe16e5595_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5aed74fb770d4a2699f1ddada95c657a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i304d4d375e0f48c0ab470af39fbd5154_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f79711127304e7698b87e1bd094348f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73c74d19584d454fa34768055ba7f8dc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4a725d0f7e941a989ed5bb796119840_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec92bd4bff18494083abb72a297d1750_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic08ccea9be2442a6ab45a04b8ae8f5f2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1db402b2e17c4fdeabe30ffd0d4e606e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9c4a257e0bd4952bb2f643a893d32b0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20c733ee69934ecb9b5772eec12a55aa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf215d79e0d04757b9564cfbcda02f3a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06141d893bb4422fa657c1f835bd0f2b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i295d3ce315bf4c489968d63c7ba4628f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i867fc66d86b045b5b0590e89915a412c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i527765f1b1c747358b403c1ee2d8bd10_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i046bac9a5f584086bb2c35f87b6a1468_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3875776099b146e2b6fff08d3a03da84_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i409fa2d900b448c8827e86526a38779c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i520c14418180468ba0ed3e50cc99d1cf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0b031a2280648889e03675a2160e4f9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2e7eff1c5284135b2912c47d643c653_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6465f4788ca4b3baa87609dbf71f52f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1db70badf9c4be0b0e0fc9f772301e6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7778dcdd0e944f4a8815e82230ee02f2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5da5750bb2a24b08979a8ec810b8c815_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d3fb78c0dc54d1587b96b694d859948_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icab03bd4111342188781a60000b67316_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3959cde560fe4d70a411b92be2612071_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58155ca3f13343d5a0780d211b521c24_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0063865a3f1a46df9d125b3ec015e2eb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i095a32d1f5934a57968454e6e538c10b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba5967b32fb4416ab78a1b0e0114069a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54f8e1940aa343e29817e02300203cc7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f1b74b97d41414b9d610ad1be460b97_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b7c2045c16f477c9b93026d6c4bfcca_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">us-gaap:ThirdPartyPayorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70683478a02f41b494c6217a76fe90ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c61506ae168449c8f430ff4e7720a1b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28b42af03e324f849e1bb33d2bda90ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i208729e6625e496e9dca88ea4de1c200_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i264dc38d90f840d89c8f00122dc94dda_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70ca4b5a53254c4ea41168999c345602_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">us-gaap:ThirdPartyPayorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37e77621419b4554a580d5c9a5c257e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic186c5f3dfeb4441b6f677670d000585_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19bdab5e4fc54c39bb5f779d936b5427_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ccecfd286b84522bff1dcdb23b998d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47b17801eff8471da78a0721b8cde413_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0e8651392b14a558028cc674241e13e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b12e4ffb329474094355b4068bcdcd8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61f69079b45d4915928d89956cfa6568_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c28d59a6d30456dbaefa29fc86e6c27_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08588920534148a6a55bbac6aa980054_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5f7e68c3398415a8874d0a8dd8fc0c4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56bb88494d0e4f3eaa70062661dfec9c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:SupplierRebatesAndOtherNonTradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca143f3c4b747dfa1c18ed1ce48c40f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:SupplierRebatesAndOtherNonTradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0991372c81b2467aa534d7228b96ce3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib12ac6055b314dc9aafc2ab60037e0dd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05ba62c8cdc74b429954ac9b69ac970f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i837096e088984a8bb905c6961208d97e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3346ac383fd4263ba845f553e8518d0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ef4a9f5101d466cb9f802a38be35ea5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2aaedfe7b774b2182eb25476a91fc19_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7602e286b8e94ab9a142a5146dae00c4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f73dfca446c431ca0404970955b23db_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd2fb3df258c442a8587eff3039100b2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a4806c6b06944568dbe93e7f5881e70_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ff02df8087d45659dea2988089fd145_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id31eb9b4ab454ab0bd1eb2e6df77f27c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a6af38324324be6933f6bddc285dac3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9573fac1bfc4444783c0b158169c7afc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:DeconsolidatedNoncontrollingEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc608d996b8446e4980e0cc9b39bf059_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:DeconsolidatedNoncontrollingEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d64f38aa44e457487bb0f100b1f8548_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:OtherOwnershipInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie883ccd9687a49048607db5fe42301ac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:OtherOwnershipInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46dab217b75644dabc035f91f7fe782d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9be08d57aed4fe3b4db3144e1d9ad04_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib628323096c74e788c6d7a961b4d57af_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d9240c1eab54582a445c05ab20d0f19_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2265c5d8f9c40e9b91c40988cbafd40_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i586e32d477c142e5b161872b638df89f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e74dde23e17402298e90d199d2fe1a4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84431a6770414fe28573bbddc636eae2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2538a02f3c984fcab3ed760d226d516f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34e4090bf4484176976adbed8bae6da2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee6f5fabba1c4c0b9cb21463c121a0ef_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icce7de8cdc8f44f5a250fb8c150e4e1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8a66dcc0dd948fbb741fd4e292faf13_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3967c55184a84f96ba8812e7748f5793_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32b056464d244f37914b806833c01276_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c41f79e5ca947d0a2bcc3fd59da587b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d14633c017d4293acaf92b67376ea7e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b36f25a93464b258c27c7f22e113088_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>dva:segment</xbrli:measure></xbrli:unit><xbrli:context id="i70ab78105894454bb3a4d66a58c9ce87_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">dva:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4bdcb9f103f4aaeb04d4e05c9d4ad58_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">dva:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id251067d050c44fe8c0736b4e398bced_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec2c1892554643868b5366813ed68ed8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83a7731ed6494f868aa4389a7de35e85_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9d939dcfcda400d965c56313d937123_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9046f56523ce431bbd0d602da2e2fead_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eda909ed98c425386284bc3c9809bd2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i600487b6cfcc42429d3cde02ae5b6e4c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">dva:IndefiniteLifeNetOperatingLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c646949f7af4e90ac555e2e74c3848f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">dva:PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0110ff4724f848ca85d3284f225e5fb5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9bff082b91346b1a64d99905758b26e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iece01fa01730408186a67affd6c9484d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">dva:TaxYear2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62817899f49f4b0d9b02387e82cb91f9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72a8de58066e4a4a806a5dfa92b2e593_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaa1d23ca55b42bc9d292cd4c74005e2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1db4cfcf189544c5ae3f2c2607ab9bf3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e9bc16804444b71ac99a4f60e9d5c12_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04f7923e726c44b5a317209e10a39819_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib46d077db6cc4fc5ba1ee2fbd6eac6fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4715240e08ce4789b224f11378f56cf4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5327139cdd234a31b8cc0934bc70b68b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i600b97f9f2a649adb54ed6ff94464b99_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie199cda3ed26463fafa480e81f60a090_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c69871249f9445c9b595c58151ff7cb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ec717b426f84c228c0d4292f6059e35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22e611f57b324bf78f55d029bc529436_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12da2441415248babcb9af6aa29feb11_D20210226-20210226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-26</xbrli:startDate><xbrli:endDate>2021-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i890855c7c3d64bd8ab0ed0292f35e955_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a9bcb8cc67b428099ac387fd810b3ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ee95b0a63934b3fab601bf43c7befac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f95c3f7ea894940b533361538fc95dd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe46e390006b4b0db6ef499531f4433a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44e756811d3a4db48b9f947147694905_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i773db74022044af6886373bcbb94b346_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida3ce71f441045c4b651feea14f7ae6b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib96d977216a04df8a88cb6db54969996_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46b324066b524a409692e8df3f51de03_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11aa03bc52b94636a23c6f74a4cfed25_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">dva:GroundLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icabbc5daf3b5479cbbc15782e1d08326_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5c90a9b4f6e4bc8ac5981725f5f1a56_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1edafa8b823d47d6aee45f343d6d4dab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4a422541b9c4b1d89d6f0b455e51179_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ba1dad9a06d4586808260f76a47066d_I20210226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i483ab4301786474fb072fbdef5442d37_D20200609-20200609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-09</xbrli:startDate><xbrli:endDate>2020-06-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee77e0f66a124be69818c3fe1f9d91bb_I20200609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8442b0b05e984872893ac93049fee22e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95df5bcea102459b914d1085942b9258_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie83cf4a097b643ee9745264ab855ca7b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i214ffb0410c04addafdd70da53f31176_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82b6dd5b3eea468885f8236cc977ca08_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaeebf4414172413da3e7139927c5aba9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i387548dbf53e458f864bbbc27c03ff99_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic78e16c835d34203a6c659d6e08d50e5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cd53a26306b4722840092750230a681_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0e0782bc40d453b86948be43d51725e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23e9c0b63c2e405182c0cf2802b5eca3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84fde8e60f5a4538937fd23d973e3361_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7258618967043f9bcfd1acc842da238_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cda5450900646759ef0009b9d20a3d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae4fd45d48224399bcab66769793c52a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i263db25331b246e78a22100f6d1d1509_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f9ca0e521b646668df9e2106ef3225f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if350164cad7147d78b7f10200a640f14_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad35108069fd45b89fe53b05bbe9c30d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bd72b308e7b468186e6b9b780fa5baf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecb8fa3387954169853ce5d7b54cb5f5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88356036cde840bc8b51ec086349bd93_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbc2e076ebb1492187444b939215b5ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">dva:OperatingLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c510942daa4f38b0c113fc3987e2b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06ff6a03ae0d445a88f8a814027ab039_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">dva:OperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad36adbebb114059971bb24c387fa559_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">dva:OperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab5a10e4b11d48bf88b5d0ee68ea283b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">dva:OperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife16d51280fb452d8a63ec87d4093b0f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80a65d71492d461c921f03cd2f80cb2f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e2d65ac940341779a7bb92437611d0e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaeb01d7a6b7545c59b03e80288b089bb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fa45997abe546d1b852b96a64b33d64_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib37522dd4fa04db58a48b42468502952_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">dva:AllTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab1bf5046e4745aa8d595dc07340685c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">dva:AllTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2be3f954e5f14213b4903797ad633c44_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if21f5702256f425495741fad20cc492f_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd5bad9eacc4435abc4605158f6eb4f0_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:IncrementalCashPortionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0c63c6719e446e98d499e8b261b5511_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:CashPaidForPortionPreviouslyRefundedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5bfd09272294ace935620050b39f2f8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">dva:EpogenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64d9f8f9c7f64715b2760f70c13f5222_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">dva:EpogenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafc102d9c4e84b66827b02448eb62b33_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:CommitmentsToProvideOperatingCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic622bc7776774482b0a75f8b50b90c1b_I20200611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cd5dd9a955e4f3595a1f2ea57f1dd2a_I20200611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35c0745d14cd45a6967e0f7b75a5a9d2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e9c2f87088c43fb9b9ca96464a7c38f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib351125c6c8e42c092e5fa01eb01c2c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b85e310c2ac454bb82196389edfda90_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i945bf94544c1438d8e7ef2556b93e671_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4579481a1deb4e84842b772212d72988_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8af02ad747e04ed092ad98eca4b0cece_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f4abca32687438c9db55fe5ab0adc1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84101fbfd0514880a929fe88d9382ec5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4d14e355b8248a1b1ab9ddb2b5f20bc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic595c1af14b94764aab706a16639ebc2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i827e2371cbd94ca1a2c25ee147f4a6bf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0917584175d94759b1facacb37055db9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8276ca374b541099daef28f0d1b9d96_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i501bc5f3ffe44653996610d022c113bd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79b0c0d86d8e45d790c2ff8423f37743_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c8c2a2e98ec40d79e375f2a9fffd77c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97843a20897047b5a1130cbd153c19f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia27684d4183a41acb4b535601396cbc2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b0097cc1b5e467d90993d8c00830861_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockSettledStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id524f2487e4c4b6b8d6dfc8130802d34_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockSettledStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42692d9f0c4245ddb37f1c5457eb7288_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockSettledStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a9414d6f3884602bb28983144590fd6_D20191104-20191104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-04</xbrli:startDate><xbrli:endDate>2019-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie576d2314dda4f0ebf4d0fcfd81bff38_I20191104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3aa0d7d04018489e86afb5c88077307b_D20191104-20191104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-04</xbrli:startDate><xbrli:endDate>2019-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a011ba985114d35aac38e038221e94d_D20191104-20191104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-04</xbrli:startDate><xbrli:endDate>2019-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43f1797df61c4bada947140a55076305_D20210101-20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41c89f4e64064444ab4288488f07ab8a_D20211231-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabef7cbe53f54aab89ff94790caaaed4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i380e810ddcd14e7bab4d2d061f0adab0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10d2c3b34a424e5d8a056079072420d1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie566e44321f64f1aa0fcc5e21f1a0e7c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dd1cc1bae74476ba5ac3d8c45f6fd36_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee68ddd110f44f1ab19b2eecfcc796b2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic32b93908745434ba82e999a75ecc6c1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i069396e3d9b14202820b9db352b5ab69_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i803f99ff64c84ab393254741b3910d99_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2767101ebdd54c7faa2d837388057e78_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie84513b046464781864c4f5c126a57c1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0e79d8201f24669b11431997b178ed7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd9f925115cc4474bf68992371fa2ba6_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccf688ffd7124bc6aff7a41fd8083119_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i684fe46545c247fab8d3ef0b725b99a6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba8fa87bf6254cb286350207ba622d6f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88d2ab8df3834c2f925e018980a4b615_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:TenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c74357cd2654da2ab5263e5e1505e1a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:TenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d53d30fe41e4561a3d660180e6b98d1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:TenderOfferMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f0cb06103bb48559ef92bd1d85fb047_D20220101-20220209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-02-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8128ed8de2d8431a8be4d9736d9eb22a_I20201210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea987dbdc7b04a8d9e5cc739bde1bfa9_I20211217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee586c56506f498d9a9bab33ee7558dd_I20220209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d67a2844f2a4c2c9c90e44bd33843a0_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eaadc9608cb41a185326a3a4f0c59f4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11a5e338ac8c41b4ba17536e1b30f48d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i274989deb10a476caf0af271f7ed680c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idadb367715dc4267900964561174325e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84ad34d2722493ca0102f68dc85910c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24b7a5a0b9454a6596459b76ca8a77fd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a368aff679b44b39b1d63b92999f915_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99108034d2554d938cf6bbf6690251eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifea37fe88f5b44c18e322f6488b835ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40dcb33a068e49c5873ade196d5fa5e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id404b91855424fc799a056cf6f4b718b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85c3913492e84060812eb8467e8fd210_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bf0294b716341479fe2709f0bed1d2b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d3d4f666d7c449b92c0699610606f26_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4a2d038875f4494931bdd14b3909f34_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f41405ceef34baa8b52e118cd782f5d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f9f2f3219c543598584da510ed53480_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i274782ed156b4160aac90d9ee2a76efb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i621a25eea7db4a01974ef60b2432c93e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="clinic2"><xbrli:measure>dva:Clinic</xbrli:measure></xbrli:unit><xbrli:context id="i2245b27c94104effb35180d14351a3fd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76921e5033604a8fabf20815d5b64089_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6a746b4356448749bd18ee02e4a5e7a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied9a0e0050574260b26da48baf596e12_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib46805457f7f4d4eae7bb7b5aaa08d10_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3508cbe980914e3d84c8b1cdebe10249_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8e3b5c936ba4ca59945d40967ade470_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14dc4deb3c484a63bee7e80f59d2a7f8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1950b3dc9ab941c69beba84eed98aa3e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a29a18c5e154226819a3fce4b9d0866_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31ffbb8892c441dea9a0c3e595b43682_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa2fdc006ca3477fbbe827fe56dcb2a6_D20200501-20200501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:RMSLifelineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b812c94400f4e9f93e3edc28560ca7d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97ebc821f8af433693f363565139ae7a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15c23a9ed8c74ad88b0b718d8dcbce70_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c26b75f552e487080d6ca8af0cbfbb2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34268660f8994614945e3a3ac73ae27c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94e70ca9077e4db8b762a4fcc4bfbd6f_D20190619-20190619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-19</xbrli:startDate><xbrli:endDate>2019-06-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aba66ad0dad46008b9826b26fef8363_D20171205-20171205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-05</xbrli:startDate><xbrli:endDate>2017-12-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7458081d2436470ea923b7c4156197b2_D20190619-20190619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-19</xbrli:startDate><xbrli:endDate>2019-06-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfd8f32feed247c2a24b065aa98482f1_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafda8ba2e67442e6935e3adfbd191cc1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dva:CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54d86d8eabc947b9afbe06d0abb8af86_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icedbf892c351473882af74862a207224_D20190101-20190618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DMGAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia96df5cbacd84affb90640475c11f0a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd41fb8f57d94a9c8174ee4a26733781_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fef43c972784c6a8dbdf6403215466d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica05fdb7be334adbaa11280e81f266cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6864393609014579b808f5a4cacfb46d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i418c9ec9c3c24e6f814f5127bfb19718_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83a052e9006844f196962f56a7a3ab82_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98fc6e3377174560b321ac0cda63f05d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3d558bed55f41d99d2f76f5a51d8b45_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab0bdb00a98b44d1b298eba644850e38_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i094bcb864f7f45e4b54429ab104ba86e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc5f11c3daa745e5a80d9f58e885601d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6488a2f4b17b4b85a4d7bf553c12175e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fa251283e0a4f088eb92843005d890b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i123069f4eb5a4ab69f8ac7158c7ce2a4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05d3a24424f8420b8fe59106d9cca3c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3aa693ad0da4e16b1fa0ce0a7ea10b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i773b082f96934fbdb2cc112ef35d5bcf_D20201231-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-31</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a546c754ebc4cf29073750fe342c98d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e14e13c061a41a69e38812da9f0c694_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i544de1e9a45e4dbaaf258e405bc34603_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a20be04098a43a2ad690daf6b43b6a9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i489433a3b5c64d6d8c71dff895bfc7c5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib875d6317d544b89a9327b5a6ee456e1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d18a39a07e04a829dc76a948808fea5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i341a3fbdfb3a478c8c3956fb1de4ca5a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0c557cfe8294cbea0ed6640742174a4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i740db58e2be94545b0d469bbda135eed_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30278d11df6d4599be4d253d8771c646_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02fff1f443d0417a9b5ea14a7887642f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f996697630f4114b1fe31268ca70cfb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6915b80d9b3f460f8e299e65e92465a5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if07da703894f46ff923b52cd1974f85e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaff1da3cd4af4158afb2f7ced0775c70_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2abab19ce64643c5b1ead781e19bc5d4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53d5102250e24aa5bd036affff061811_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic74654e344444142a656506ce7f98032_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i769c9942acbc457e9f36b28d6dc6bcff_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5869a8167684e6e92336d2061353dd0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id95aa5b653c348f3afacdc11aed8c324_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f1ee4e1cd744091960584e2d8db83ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8020fe2d892b43739f987d0c488736a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7ce08c39f814ce99981d4545611fa84_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i149a050b3c4645829b359c2948b066e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c153efa63664c3e9cd75b33af39db2a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91556d981c14455d82d1dc87f6ab398c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69bac113d5d84b4b85c181e2fd5a277c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a475d47d0d042098ff362c229c4796b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i916f7af890114e55a87e260476560c60_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.138%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTk0_ca1cd68f-e765-4e5c-abb1-58347ce28639">10-K</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6NTM1ZDUyMDA5MDRlNDM5ODk2Zjk2ZjIxOTNjNjRlNjYvdGFibGVyYW5nZTo1MzVkNTIwMDkwNGU0Mzk4OTZmOTZmMjE5M2M2NGU2Nl8wLTAtMS0xLTgzMDc4_5d511243-5c59-4e5b-b65a-76ff8f521828">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the Fiscal Year Ended <ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8xOTc5MTIwOTMwMjk4Ng_f1e2c504-4a3f-45d5-923d-3756352023d3"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8xOTc5MTIwOTMwMjk4Ng_e913ee63-57cc-440d-9062-4a4090f0c1d1">December&#160;31</ix:nonNumeric>, 2021</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">or</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6ODM5NGI3OTcxYjQ2NDQ3MDg3NzcxYTJiNTViNzRjYjMvdGFibGVyYW5nZTo4Mzk0Yjc5NzFiNDY0NDcwODc3NzFhMmI1NWI3NGNiM18wLTAtMS0xLTgzMDc4_fc1ce468-f677-4e6a-94e3-fab7e8a216e5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from ___________ to ___________</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTg5_468e0ca7-bc84-4cad-a191-5b9e95bb3e0f">1-14106</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><img src="dva-20211231_g1.gif" alt="dva-20211231_g1.gif" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:112px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTk1_2cc2b28e-93d1-4c27-8add-5181c4c85d8f">DAVITA INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:244.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:16.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:244.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6Mzc4OTk4NGYyNGRlNDZmY2FiNjY0ZDkyMWNiOTAwODQvdGFibGVyYW5nZTozNzg5OTg0ZjI0ZGU0NmZjYWI2NjRkOTIxY2I5MDA4NF8wLTAtMS0xLTgzMDc4_f8cf1898-397e-4e65-9378-47eae4435525">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6Mzc4OTk4NGYyNGRlNDZmY2FiNjY0ZDkyMWNiOTAwODQvdGFibGVyYW5nZTozNzg5OTg0ZjI0ZGU0NmZjYWI2NjRkOTIxY2I5MDA4NF8wLTItMS0xLTgzMDc4_b167a71a-20e6-43a0-a88e-263bf08e513e">51-0354549</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.50pt"><tr><td style="width:1.0pt"></td><td style="width:39.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:19.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:30.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6YWQ5M2ZiYWE0ZjBkNDRkNmJiMzRhYzU3ZTAwOTZkZjUvdGFibGVyYW5nZTphZDkzZmJhYTRmMGQ0NGQ2YmIzNGFjNTdlMDA5NmRmNV8wLTAtMS0xLTgzMDc4_fe9bdfba-b2b7-4c55-8e05-88863c16aee7">2000 16th Street</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6YWQ5M2ZiYWE0ZjBkNDRkNmJiMzRhYzU3ZTAwOTZkZjUvdGFibGVyYW5nZTphZDkzZmJhYTRmMGQ0NGQ2YmIzNGFjNTdlMDA5NmRmNV8xLTAtMS0xLTgzMDc4_82f00f97-425e-4eeb-9ddd-cfb60264a76b">Denver,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6YWQ5M2ZiYWE0ZjBkNDRkNmJiMzRhYzU3ZTAwOTZkZjUvdGFibGVyYW5nZTphZDkzZmJhYTRmMGQ0NGQ2YmIzNGFjNTdlMDA5NmRmNV8xLTEtMS0xLTgzMDc4_1d0c2638-8a4d-4a35-8c09-27ed86f91a31">CO</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6YWQ5M2ZiYWE0ZjBkNDRkNmJiMzRhYzU3ZTAwOTZkZjUvdGFibGVyYW5nZTphZDkzZmJhYTRmMGQ0NGQ2YmIzNGFjNTdlMDA5NmRmNV8xLTItMS0xLTgzMDc4_ab3c9404-3099-40bd-806d-589ea4d54ca9">80202</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Telephone number (<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTk2_ef4966d3-3a05-4224-9fb9-6c4171380e55">720</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTkw_d2e0cf2b-27d4-49ae-a816-b2c0df48b284">631-2100</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:159.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:30.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:115.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:6.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:190.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading symbol(s):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered:</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6M2RjMTQzMjIwMGQ1NDI4MWEyYTZkZGY2YTA4NzU1YTQvdGFibGVyYW5nZTozZGMxNDMyMjAwZDU0MjgxYTJhNmRkZjZhMDg3NTVhNF8xLTAtMS0xLTgzMDc4_ac35f1fe-6e68-4037-9f18-32d0c48f8c8f">Common Stock, $0.001 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6M2RjMTQzMjIwMGQ1NDI4MWEyYTZkZGY2YTA4NzU1YTQvdGFibGVyYW5nZTozZGMxNDMyMjAwZDU0MjgxYTJhNmRkZjZhMDg3NTVhNF8xLTItMS0xLTgzMDc4_9ce9b5d6-35be-47d4-8cde-826151c451cb">DVA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6M2RjMTQzMjIwMGQ1NDI4MWEyYTZkZGY2YTA4NzU1YTQvdGFibGVyYW5nZTozZGMxNDMyMjAwZDU0MjgxYTJhNmRkZjZhMDg3NTVhNF8xLTQtMS0xLTgzMDc4_024f4979-4a33-4c30-b10b-e53ec7036c3e">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(g) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">None</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTkx_e1dfe802-cf8a-4c45-85c5-35918c9be41d">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;&#9744;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTky_77c010ea-3b36-488d-832a-d1d0d9e43750">No</ix:nonNumeric>&#160;&#160;&#9746;</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTk3_2f020416-502f-4c76-8cc0-3a19a807fbb5">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTg3_6283efbf-54c9-4ba5-804c-37fa942d558a">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:495.00pt"><tr><td style="width:1.0pt"></td><td style="width:85.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:102.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:145.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:127.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6ZDNhYTlmNjY1ZjA2NDBjYWE0YzI1YzFiOTQyZGJmOWYvdGFibGVyYW5nZTpkM2FhOWY2NjVmMDY0MGNhYTRjMjVjMWI5NDJkYmY5Zl8wLTAtMS0xLTgzMDc4_7b5d7af0-ccff-4b45-be46-92e680cdc66b">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6ZDNhYTlmNjY1ZjA2NDBjYWE0YzI1YzFiOTQyZGJmOWYvdGFibGVyYW5nZTpkM2FhOWY2NjVmMDY0MGNhYTRjMjVjMWI5NDJkYmY5Zl8xLTUtMS0xLTgzMDc4_f3188848-74db-4e0d-b921-75e62a0456ae">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6ZDNhYTlmNjY1ZjA2NDBjYWE0YzI1YzFiOTQyZGJmOWYvdGFibGVyYW5nZTpkM2FhOWY2NjVmMDY0MGNhYTRjMjVjMWI5NDJkYmY5Zl8yLTUtMS0xLTgzMDc4_d58956be-e033-4478-9863-18101effb162">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;&#9744;</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its final report.     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTkz_1420f6ea-a682-4fdd-84ef-5f47455721f2">&#9746;</ix:nonNumeric></span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTg4_6f797e7e-3769-4d15-bd0f-d7fcd4600670">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the aggregate market value of the registrant's common stock outstanding held by non-affiliates based upon the closing price on the New York Stock Exchange was approximately $<ix:nonFraction unitRef="usd" contextRef="i6946ea686e7c41b3a8aa82ffda6fb966_I20210630" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV82MDQ3MzEzOTU2MTQ1_1c832f59-52df-4ad3-bdf0-eaefcbfad6f8">12.7</ix:nonFraction> billion.</span></div><div style="margin-top:4pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As of January&#160;31, 2022, the number of shares of the registrant&#8217;s common stock outstanding was approximately <ix:nonFraction unitRef="shares" contextRef="i50c3ae2124374b73a5fb91701224c115_I20220131" decimals="-5" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yNzk0_5b941a75-e376-43c9-ba68-112acb1b6b38">96.3</ix:nonFraction> million shares.</span></div><div style="margin-top:6pt;text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yNDE4OTI1NTgxNDQzNw_23bf5ca6-2cf1-4dfc-9e3b-69525c6fcb91">KPMG LLP</ix:nonNumeric> (<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yNDE4OTI1NTgxNDQ0MA_5a45ab61-88a1-43d5-8733-51f82f69019c">185</ix:nonNumeric>), <ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yNDE4OTI1NTgxNDQ0NA_bf9d3b75-58ea-46f8-b1fd-0786eeedfc8a">Seattle, WA, USA</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Documents incorporated by reference</span></div><div style="margin-top:2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s proxy statement for its 2022 annual meeting of stockholders are incorporated by reference in Part III of this Form 10-K.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i916f7af890114e55a87e260476560c60_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.230%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.248%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page&#160;No.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_13">Business</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_58">Risk Factors</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_58">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_67">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_67">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_70">Properties</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_70">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_73">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_73">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_76">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_76">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_82">Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_82">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_85">Selected Financial Data</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_85">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_88">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_88">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_136">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_136">77</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_139">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_139">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_142">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_142">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_145">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_145">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_148">Other Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_148">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_7146825583238">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_7146825583238">78</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART III.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_154">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_154">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_157">Executive Compensation</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_157">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_160">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_160">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_163">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_163">80</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_166">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_166">80</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART IV.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_172">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_172">81</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_175">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_175">81</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_316">Exhibit Index</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_316">1 of 4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_319">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_319">S-1</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i916f7af890114e55a87e260476560c60_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i916f7af890114e55a87e260476560c60_13"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Business</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless otherwise indicated in this report "DaVita", "the Company" "we", "us", "our" and other similar terms refer to DaVita Inc. and its consolidated subsidiaries. Our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, are made available free of charge through our website, located at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">http://www.davita.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, as soon as reasonably practicable after the reports are filed with or furnished to the Securities and Exchange Commission (SEC). The SEC also maintains a website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">http://www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> where these reports and other information about us can be obtained. The contents of our website are not incorporated by reference into this report.</span></div><div id="i916f7af890114e55a87e260476560c60_16"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of DaVita Inc.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DaVita is a leading healthcare provider focused on transforming care delivery to improve quality of life for patients globally. We are one of the largest providers of kidney care services in the U.S. and have been a leader in clinical quality and innovation for over 20 years. DaVita is committed to bold, patient-centric care models, implementing the latest technologies and advancing integrated care offerings. Over the years, we have established a value-based culture with a philosophy of caring that is focused on both our patients and teammates. This culture and philosophy fuel our continuous drive toward achieving our mission "to be the provider, partner and employer of choice" and fulfilling our vision "to build the greatest healthcare community the world has ever seen".</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of kidney function is normally irreversible. Kidney failure is typically caused by Type I and Type II diabetes, hypertension, polycystic kidney disease, long-term autoimmune attack on the kidneys and prolonged urinary tract obstruction. End stage renal disease or end stage kidney disease (ESRD or ESKD) is the stage of advanced kidney impairment that requires continued dialysis treatments or a kidney transplant to sustain life. Dialysis is the removal of toxins, fluids and salt from the blood of patients by artificial means. Patients suffering from ESKD generally require dialysis at least three times a week for the rest of their lives or until they receive a kidney transplant. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, ESRD or ESKD, in the United States, and is our largest line of business. As of December&#160;31, 2021, we provided dialysis and administrative services and related laboratory services throughout the U.S. via a network of 2,815 outpatient dialysis centers and home programs in 46 states and the District of Columbia, serving a total of approximately 203,100 patients, and have contracts to provide hospital inpatient dialysis services in approximately 850 hospitals. Our robust platform to deliver kidney care services also includes established nephrology and payor relationships. In addition, as of December&#160;31, 2021, our international operations provided dialysis and administrative services to a total of 339 outpatient dialysis centers located in ten countries outside of the U.S., serving approximately 39,900 patients. Finally, our U.S ancillary services and strategic initiatives provided integrated care and disease management services to 16,000 patients in risk-based integrated care arrangements and to an additional 7,000 patients in other integrated care arrangements as of December&#160;31, 2021. Most of the patients served by our integrated care business are also our dialysis patients. We refer to our U.S. ancillary services and strategic initiatives and our international operations as, collectively, our "ancillary services". We also have a separate corporate administrative support function that supports our U.S. dialysis business and these ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our patient-centric care model leverages our platform of kidney care services to maximize patient choice in both models and modalities of care. We believe that the flexibility we offer coupled with a focus on comprehensive kidney care supports our commitments to help improve clinical outcomes and quality of life for our patients. According to the most recently published data, for eight consecutive years, we are an industry leader in the Centers for Medicare &amp; Medicaid Services&#8217; (CMS) Quality Incentive Program (QIP), which promotes high quality services in outpatient dialysis facilities treating patients with ESKD. In addition, according to the most recently published data, for seven consecutive years, we are also an industry leader under CMS&#8217; Five-Star Quality Rating system, which rates eligible dialysis centers based on the quality of outcomes to help patients, their families, and caregivers make more informed decisions about where patients receive care. According to the most recently collected data from Nephrology News and Issues, we are an industry leader for the total number of patients in home-based dialysis services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quality clinical outcomes are driven by our experienced and knowledgeable teammates. We employ registered nurses, licensed practical or vocational nurses, patient care technicians, social workers, registered dietitians, biomedical technicians and other administrative and support teammates who strive to achieve superior clinical outcomes at our dialysis facilities. In addition to our teammates at our dialysis facilities, as of December&#160;31, 2021, our domestic Chief Medical Officer lead a team of 24 senior nephrologists in our physician leadership team as part of our domestic Office of the Chief Medical Officer (OCMO). Our international Chief Medical Officer lead a team of 11 senior nephrologists in our physician leadership team as part of our international OCMO as of December&#160;31, 2021. Our OCMO teammates represent a variety of academic, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clinical practice, and clinical research backgrounds. We also have a Physician Council that serves as an advisory body to senior management, which was composed of eight physicians with extensive experience in clinical practice and seven Group Medical Directors as of December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2019, we completed the sale of our prior DaVita Medical Group (DMG) business, a patient and physician-focused integrated healthcare delivery and management company, to Collaborative Care Holdings, LLC, a subsidiary of UnitedHealth Group Inc. As a result, the DMG business has been classified as discontinued operations and its results of operations are reported as discontinued operations for all periods presented in the consolidated financial statements included in this report. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial information about DMG, see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Note 22 to the consolidated financial statements included in this report.</span></div><div id="i916f7af890114e55a87e260476560c60_19"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 and its impact on our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a caregiving organization, we continue to be impacted by the effects of the novel coronavirus (COVID-19) pandemic. DaVita&#8217;s caregiving teammates continue to be on the front lines of the ongoing COVID-19 pandemic providing critical, life-sustaining care for our patients. We continue to closely monitor the impact on our business of the pandemic and the resulting economic and political environment, including the various impacts on our patients, teammates, physician partners, suppliers, vendors and business partners. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During this time of great and continued challenge, our top priorities continue to be the health, safety and well-being of our patients, teammates and physician partners and helping to ensure that our patients have the ability to maintain continuity of care throughout this crisis, whether in the hospital, outpatient or home setting. To that end, we have dedicated and continue to dedicate substantial resources in response to COVID-19, including the implementation of additional protocols and initiatives to help safely maintain continuity of care for our patients and help protect our caregivers. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the ultimate impact of this public health crisis on the Company will depend on future developments that are highly uncertain and difficult to predict. For additional discussion of the COVID-19 pandemic and our response, including its impact on us and related risks and uncertainties, please see the discussion below under the heading "&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">", the risk factor in Item 1A. Risk Factors under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, many of which may have a material adverse impact on us,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and the discussion under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 and its impact on our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Part II, Item 7. "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div id="i916f7af890114e55a87e260476560c60_22"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. dialysis business</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis business is a leading provider of kidney dialysis services for patients suffering from ESKD. As of December&#160;31, 2021, we provided dialysis and administrative services in the U.S. through a network of 2,815 outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 203,100 patients. We also have contracts to provide hospital inpatient dialysis services in approximately 850 hospitals and related laboratory services throughout the U.S. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the United States Renal Data System (USRDS), there were over 569,000 ESKD dialysis patients in the U.S. in 2019. Based on the most recent 2021 annual data report from the USRDS, the underlying ESKD dialysis patient population has grown at an approximate compound rate of 3.5% from 2009 to 2019 and a compound rate of 3.1% from 2014 to 2019, which suggests that the rate of growth of the ESKD patient population is declining relative to long term trends. A number of factors may impact ESKD growth rates, including, among others, the aging of the U.S. population, transplant rates, incidence rates for diseases that cause kidney failure such as diabetes and hypertension, mortality rates for dialysis patients and growth rates of minority populations with higher than average incidence rates of ESKD. Certain of these factors, in particular mortality rates for dialysis patients, have been impacted by the COVID-19 pandemic.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treatment options for ESKD</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treatment options for ESKD are dialysis and kidney transplantation.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis options</span></div><div style="margin-top:9pt;padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hemodialysis</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hemodialysis, the most common form of ESKD treatment, is usually performed at a freestanding outpatient dialysis center, at a hospital-based outpatient center, or at the patient&#8217;s home. The hemodialysis machine uses an artificial kidney, called a dialyzer, to remove toxins, fluids and salt from the patient&#8217;s blood. The dialysis process occurs across a semi-permeable membrane that divides the dialyzer into two distinct chambers. While blood is circulated through one chamber, a pre-mixed </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fluid is circulated through the other chamber. The toxins, salt and excess fluids from the blood cross the membrane into the fluid, allowing cleansed blood to return back into the patient&#8217;s body. Each hemodialysis treatment that occurs in the outpatient dialysis centers typically lasts approximately three and one-half hours and is usually performed three times per week.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hospital inpatient hemodialysis services are required for patients with acute kidney failure primarily resulting from trauma, patients in early stages of ESKD and ESKD patients who require hospitalization for other reasons. Hospital inpatient hemodialysis is generally performed at the patient&#8217;s bedside or in a dedicated treatment room in the hospital, as needed.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some ESKD patients who are healthier and more independent may perform hemodialysis in their home or residence through the use of a hemodialysis machine designed specifically for home therapy that is portable, smaller and easier to use. Patients receive training, support and monitoring from registered nurses, usually in our outpatient dialysis centers, in connection with their home hemodialysis treatment. Home hemodialysis is typically performed with greater frequency than dialysis treatments performed in outpatient dialysis centers and on varying schedules.</span></div><div style="margin-top:9pt;padding-left:38.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Peritoneal dialysis</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Peritoneal dialysis uses the patient&#8217;s peritoneal or abdominal cavity to eliminate fluid and toxins and is typically performed at home. The most common methods of peritoneal dialysis are continuous ambulatory peritoneal dialysis (CAPD) and continuous cycling peritoneal dialysis (CCPD). Because it does not involve going to an outpatient dialysis center three times a week for treatment, peritoneal dialysis is generally an alternative to hemodialysis for patients who are healthier, more independent and desire more flexibility in their lifestyle. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CAPD introduces dialysis solution into the patient&#8217;s peritoneal cavity through a surgically placed catheter. Toxins in the blood continuously cross the peritoneal membrane into the dialysis solution. After several hours, the patient drains the used dialysis solution and replaces it with fresh solution. This procedure is usually repeated four times per day.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CCPD is performed in a manner similar to CAPD, but uses a mechanical device to cycle dialysis solution through the patient&#8217;s peritoneal cavity while the patient is sleeping or at rest.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kidney transplantation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although kidney transplantation, when successful, is generally the most desirable form of therapeutic intervention, the shortage of suitable donors, side effects of immunosuppressive pharmaceuticals given to transplant recipients and dangers associated with transplant surgery for some patient populations have generally limited the use of this treatment option. An executive order signed in July 2019 (the 2019 Executive Order) directed HHS to develop policies addressing, among other things, the goal of making more kidneys available for transplant. As directed by the 2019 Executive Order, the CMS, through its Center for Medicare and Medicaid Innovation (CMMI), subsequently released the framework for certain proposed voluntary payment models that would adjust payment incentives to encourage kidney transplants. For more information regarding the 2019 Executive Order and these payment models, please see the discussion below under the heading "&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Integrated Kidney Care and Medicare and Medicaid program reforms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div id="i916f7af890114e55a87e260476560c60_25"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. dialysis services we provide</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Outpatient hemodialysis services </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition of our enrollment in Medicare for the provision of dialysis services, we contract with a nephrologist or a group of associated nephrologists to provide medical director services at each of our dialysis centers. In addition, other nephrologists may apply for practice privileges to treat their patients at our centers. Each center has an administrator, typically a registered nurse, who supervises the day-to-day operations of the center and its staff. The staff of each center typically consists of registered nurses, licensed practical or vocational nurses, patient care technicians, a social worker, a registered dietician, biomedical technician support and other administrative and support personnel.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total patient turnover at centers we consolidate, which is based upon all causes, averaged approximately 27% in 2021 and 25% in 2020. The overall number of patients to whom we provided services in the U.S. in 2021 decreased by approximately 0.5% from 2020, primarily due to an increase in mortality rates, which have been impacted by the COVID-19 pandemic. This was partially offset by new dialysis patients who started treating at our centers acquired during the year.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hospital inpatient hemodialysis services </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we have contracts to provide hospital inpatient hemodialysis services, excluding physician services, to patients in approximately 850 hospitals throughout the U.S. We render these services based on a contracted per-</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">treatment fee that is individually negotiated with each hospital. When a hospital requests our services, we typically administer the dialysis treatment at the patient&#8217;s bedside or in a dedicated treatment room in the hospital, as needed. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Home-based dialysis services </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Home-based dialysis services includes home hemodialysis and peritoneal dialysis. Many of our outpatient dialysis centers offer certain support services for dialysis patients who prefer and are able to perform either home hemodialysis or peritoneal dialysis in their homes. Home-based hemodialysis support services consist of providing equipment and supplies, training, patient monitoring, on-call support services and follow-up assistance. Registered nurses train patients and their families or other caregivers to perform either home hemodialysis or peritoneal dialysis. The 2019 Executive Order and related HHS guidance described above also included a stated goal of increasing the relative number of new ESKD patients that receive dialysis at home.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the most recent 2021 annual data report from the USRDS, in 2019 approximately 13% of ESKD dialysis patients in the U.S. perform home-based dialysis.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treatments and revenues by modality:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph summarizes our U.S. dialysis treatments by modality and U.S. dialysis patient services revenues by modality for the year ended December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><img src="dva-20211231_g2.jpg" alt="dva-20211231_g2.jpg" style="height:172px;margin-bottom:5pt;vertical-align:text-bottom;width:625px"/></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ESKD laboratory services </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate a separately licensed and highly automated clinical laboratory which specializes in ESKD patient testing. This specialized laboratory provides routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESKD patients which are integral components of the services we provide. Our laboratory provides these tests predominantly for our ESKD patients throughout the U.S. These tests are performed to monitor a patient&#8217;s ESKD condition, including the adequacy of dialysis, as well as other medical conditions of the patient. Our laboratory utilizes information systems which provide information to certain members of the dialysis centers&#8217; staff and medical directors regarding critical outcome indicators. In 2021, our laboratory performed COVID-19 testing for our patients and teammates. </span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management services </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate or provide management and administrative services pursuant to management and administrative services agreements to 57 outpatient dialysis centers located in the U.S. in which we either own a noncontrolling interest or which are wholly-owned by third parties. Management fees are established by contract and are recognized as earned typically based on a percentage of revenues or cash collections generated by the outpatient dialysis centers.</span></div><div id="i916f7af890114e55a87e260476560c60_28"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of revenue&#8212;concentrations and risks</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis revenues represent approximately 91% of our consolidated revenues for the year ended December&#160;31, 2021. Our U.S. dialysis revenues are derived primarily from our core business of providing dialysis services and related laboratory services and, to a lesser extent, the administration of pharmaceuticals and management fees generated from providing management and administrative services to certain outpatient dialysis centers, as discussed above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sources of our U.S. dialysis revenues are principally from government-based programs, including Medicare and Medicare Advantage plans, Medicaid and managed Medicaid plans and commercial insurance plans. The following table </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">summarizes our U.S. dialysis revenues by payor source for U.S. dialysis patient services revenues the year ended December&#160;31, 2021:</span></div><div style="margin-top:9pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.309%"><tr><td style="width:1.0%"></td><td style="width:75.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and managed Medicaid plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government-based programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total government-based programs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial (including hospital dialysis services)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare revenue</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare ESRD revenue</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 1972, the federal government has provided healthcare coverage for ESRD patients under the Medicare ESRD program regardless of age or financial circumstances. ESRD is the first and only disease state eligible for Medicare coverage both for dialysis and dialysis-related services and for all benefits available under the Medicare program. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government dialysis related payment rates in the U.S. are principally determined by federal Medicare and state Medicaid policy. For patients with Medicare coverage, all ESRD payments for dialysis treatments are made under a single bundled payment rate which provides a fixed payment rate to encompass all goods and services provided during the dialysis treatment that are related to the dialysis treatment, including certain pharmaceuticals, such as erythropoiesis-stimulating agents (ESAs), calcimimetics, vitamin D analogs and iron supplements, irrespective of the level of pharmaceuticals administered to the patient or additional services performed. Most lab services are also included in the bundled payment.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Medicare reimbursement limits the allowable charge per treatment, it provides industry participants with a relatively predictable and recurring revenue stream for dialysis services provided to patients without commercial insurance. For the year ended December&#160;31, 2021, approximately 90% of our total dialysis patients were covered under some form of government-based program, with approximately 75% of our dialysis patients covered under Medicare and Medicare Advantage plans.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under this ESRD Prospective Payment System (PPS), the bundled payments to a dialysis facility may be reduced by as much as 2% based on the facility&#8217;s performance in specified quality measures set annually by CMS through its QIP. CMS established QIP through the Medicare Improvements for Patients and Providers Act of 2008 to promote high quality services in outpatient dialysis facilities treating patients with ESRD. QIP associates a portion of Medicare reimbursement directly with a facility&#8217;s performance on quality of care measures. Reductions in Medicare reimbursement result when a facility&#8217;s overall score on applicable measures does not meet established standards. Due to the ongoing COVID-19 pandemic, CMS is not applying QIP payment reductions to facilities in 2022. The bundled payment rate is also adjusted for certain patient characteristics, a geographic usage index and certain other factors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertainty about future payment rates remains a material risk to our business, as well as the potential implementation of or changes in coverage determinations or other rules or regulations by CMS or Medicare Administrative Contractors that may impact reimbursement. An important provision in the Medicare ESRD statute is an annual adjustment, or market basket update, to the ESRD PPS base rate. Absent action by Congress, the ESRD PPS base rate is automatically updated annually by a formulaic inflation adjustment. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 18, 2020, pursuant to the 2019 Executive Order, CMS, through CMMI, published the final ESRD Treatment Choices mandatory payment model (ETC). The ETC launched on January 1, 2021, administered through CMMI in approximately 20% of our dialysis clinics across the country. There was no material impact to us during 2021 related to the ETC. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 29, 2021, CMS issued a final rule to update the ESRD PPS payment rate and policies. Among other things, the rule updates payment rates under the ESRD PPS for renal dialysis services furnished to beneficiaries on or after January 1, 2022, finalizes updates to the Acute Kidney Injury (AKI) dialysis payment rate for dialysis services furnished by ESRD facilities and finalizes modifications to the ETC model policies. CMS estimates the final rule will affect ESRD facilities' average reimbursement by a productivity-adjusted market basket increase of 1.9% in 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Budget Control Act of 2011 (BCA) and subsequent activity in Congress, a $1.2 trillion sequester (across-the-board spending cuts) in discretionary programs took effect in 2013 reducing Medicare payments by 2%, which was </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subsequently extended through fiscal year 2027. Federal COVID-19 relief legislation suspended the 2% Medicare sequestration from May 1, 2020 through December 31, 2021. The Protecting Medicare and American Farmers from Sequester Cuts Act, signed into law on December 10, 2021, extended the suspension of the 2% Medicare sequestration from December 31, 2021 through March 31, 2022, with 1% Medicare sequestration beginning April 1, 2022 through June 30, 2022 and 2% Medicare sequestration beginning July 1, 2022. In the years ended December 31, 2021 and 2020, our revenues significantly increased due to this suspension and we expect that this suspension will continue to significantly increase our revenues while it remains in effect. When the temporary suspension is no longer in effect, we expect that the across-the-board spending cuts of the BCA will, once again, adversely affect our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ESRD patients receiving dialysis services become eligible for primary Medicare coverage at various times, depending on their age or disability status, as well as whether they are covered by a commercial insurance plan. Generally, for a patient not covered by a commercial insurance plan, Medicare becomes the primary payor for ESRD patients receiving dialysis services either immediately or after a three-month waiting period. For a patient covered by a commercial insurance plan, Medicare generally becomes the primary payor after 33 months, which includes the three-month waiting period, or earlier if the patient&#8217;s commercial insurance plan coverage terminates. When Medicare becomes the primary payor, the payment rates we receive for that patient shift from the commercial insurance plan rates to Medicare payment rates, which are on average significantly lower than commercial insurance rates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare pays 80% of the amount set by the Medicare system for each covered dialysis treatment. The patient is responsible for the remaining 20%. In most cases, a secondary payor, such as Medicare supplemental insurance, a state Medicaid program or a commercial health plan, covers all or part of these balances. Some patients who do not qualify for Medicaid, but otherwise cannot afford secondary insurance in the form of a Medicare Supplement Plan, can apply for premium payment assistance from charitable organizations to obtain secondary coverage. If a patient does not have secondary insurance coverage, we are generally unsuccessful in our efforts to collect from the patient the remaining 20% portion of the ESRD composite rate that Medicare does not pay. However, we are able to recover some portion of this unpaid patient balance from Medicare through an established cost reporting process by identifying these Medicare bad debts on each center&#8217;s Medicare cost report.</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Advantage revenue</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Advantage (MA, managed Medicare or Medicare Part C) plans are offered by private health insurers who contract with CMS to provide their members with Medicare Part A, Part B and/or Part D benefits. These MA plans include health maintenance organizations, preferred provider organizations, private fee-for-service (FFS) organizations, special needs plans (SNPs) or Medicare medical savings account plans. The 21st Century Cures Act (the Cures Act) included a provision that, effective January 1, 2021, allows Medicare-eligible beneficiaries with ESRD to choose coverage under an MA plan. Prior to the Cures Act, MA plans were only available to ESRD patients if the patient was remaining on an MA plan that they had enrolled in prior to being diagnosed with ESRD, or in certain other limited situations such as a SNP. As a result, this provision under the Cures Act has broadened access for Medicare ESRD patients to certain enhanced benefits offered by MA plans. MA plans usually provide reimbursement to us at a negotiated rate that is generally higher than Medicare FFS rates.</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicaid revenue</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid programs are state-administered programs partially funded by the federal government. These programs are intended to provide health coverage for patients whose income and assets fall below state-defined levels and who are otherwise uninsured. These programs also serve as supplemental insurance programs for co-insurance payments due from Medicaid-eligible patients with primary coverage under the Medicare program. Some Medicaid programs also pay for additional services, including some oral medications that are not covered by Medicare. We are enrolled in the Medicaid programs in the states in which we conduct our business.</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial revenue</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before a patient becomes eligible to elect to have Medicare as their primary payor for dialysis services, a patient&#8217;s commercial insurance plan, if any, is generally responsible for payment of such dialysis services for up to the first 33 months, as discussed above. Although commercial payment rates vary, average commercial payment rates established under commercial contracts are generally significantly higher than Medicare rates. The payments we receive from commercial payors generate nearly all of our profits and all of our non-hospital dialysis profits come from commercial payors. Payment methods from commercial payors can include a single lump-sum per treatment, referred to as bundled rates, or in other cases separate payments for dialysis treatments and pharmaceuticals, if used as part of the treatment, referred to as FFS rates. Commercial payment rates are the result of negotiations between us and insurers or third-party administrators. Our out-of-network payment rates are on average higher than in-network commercial contract payment rates. Some of our commercial contracts pay us under a single bundled payment rate for all dialysis services provided to covered patients. However, some of our commercial contracts </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also pay us for certain other services and pharmaceuticals in addition to the bundled payment. Our commercial contracts typically contain annual price escalator provisions. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 25% of our U.S. dialysis patient services revenues and approximately 10% of our U.S. dialysis patients are associated with non-hospital commercial payors for the year ended December&#160;31, 2021. Non-hospital commercial patients as a percentage of our total U.S. dialysis patients for 2021 were relatively flat compared to 2020. Less than 1% of our U.S. dialysis revenues are due directly from patients. No single commercial payor accounted for more than 10% of total U.S. dialysis revenues for the year ended December&#160;31, 2021. See Note 2 to the consolidated financial statements included in this report for disclosure on our concentration related to our commercial payors on a total consolidated revenue basis.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both the number of our patients under commercial plans and the rates under these commercial plans are subject to change based on a number of factors. For additional detail on these factors and other risks associated with on our commercial revenue, see the risk factors in Item 1A. Risk Factors under the headings "</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex series of governmental laws, regulations and requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation"; "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows"; "If the number or percentage of patients with higher-paying commercial insurance declines, if the average rates that commercial payors pay us decline, if patients in commercial plans are subject to restriction in plan designs, or if we are unable to maintain contracts with payors with competitive terms, including, without limitation, reimbursement rates, scope and duration of coverage and in-network benefits, it could have a material adverse effect on our business, results of operations, financial condition and cash flows</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "We face various risks related to the dynamic and evolving novel coronavirus pandemic, many of which may have a material adverse impact on us." </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from other pharmaceuticals</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2021, both oral and intravenous forms of calcimimetics, a drug class taken by many patients with ESRD to treat mineral bone disorder, were added to the ESRD PPS bundled payment, and as a result we expect our operating income from calcimimetics to be more stable in the future as compared to the year ended December&#160;31, 2020 under the transitional drug add-on payment adjustment (TDAPA) model. For the year ended December 31, 2020, the oral and intravenous forms of calcimimetics were separately reimbursed through a TDAPA model based on a pass-through rate of the average sales price plus 0%, before sequestration.</span></div><div id="i916f7af890114e55a87e260476560c60_31"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician relationships</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joint venture partners</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own and operate certain of our dialysis centers through entities that are structured as joint ventures. We generally hold controlling interests in these joint ventures, with nephrologists, hospitals, management services organizations, and/or other healthcare providers holding minority equity interests. These joint ventures are typically formed as limited liability companies. For the year ended December&#160;31, 2021, revenues from joint ventures in which we have a controlling interest represented approximately 28% of our U.S. dialysis revenues. We expect to continue to enter into new U.S. dialysis-related joint ventures in the ordinary course of business.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Community physicians</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An ESKD patient generally seeks treatment or support for their home treatment at an outpatient dialysis center near their home where their treating nephrologist has practice privileges. Our relationships with local nephrologists and our ability to provide quality dialysis services and to meet the needs of their patients are key factors in the success of our dialysis operations. Over 5,400 nephrologists currently refer patients to our outpatient dialysis centers.&#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical directors</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participation in the Medicare ESRD program requires that dialysis services at an outpatient dialysis center be under the general supervision of a medical director.&#160;Per these requirements, this individual is usually a board certified nephrologist. We engage physicians or groups of physicians to serve as medical directors for each of our outpatient dialysis centers. At some outpatient dialysis centers, we also separately contract with one or more other physicians or groups to serve as assistant or associate medical directors over other modalities such as home dialysis. We have over 1,000 individual physicians and physician groups under contract to provide medical director services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical directors for our dialysis centers enter into written contracts with us that specify their duties and fix their compensation generally for periods of ten years. The compensation of our medical directors is the result of arm&#8217;s length </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">negotiations, consistent with fair market value, and generally depends upon an analysis of various factors such as the physician&#8217;s duties, responsibilities, professional qualifications and experience, as well as the time and effort required to provide such services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our medical director contracts and joint venture operating agreements generally include covenants not to compete or own interests in dialysis centers operated by other providers within a defined geographic area for various time periods, as applicable. These non-compete agreements do not restrict or limit the physicians from practicing medicine or prohibit the physicians from referring patients to any outpatient dialysis center, including dialysis centers operated by other providers. </span></div><div id="i916f7af890114e55a87e260476560c60_34"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Location of our U.S. dialysis centers</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operated 2,815 outpatient dialysis centers in the U.S. as of December&#160;31, 2021 and 2,758 of these centers are consolidated in our financial statements. Of the remaining 57 nonconsolidated U.S. outpatient dialysis centers, we own a noncontrolling interest in 55 centers and provide management and administrative services to two centers that are wholly-owned by third parties. The locations of the 2,758 U.S. outpatient dialysis centers consolidated in our financial statements at December&#160;31, 2021, were as follows:</span></div><div style="margin-top:9pt"><img src="dva-20211231_g3.jpg" alt="dva-20211231_g3.jpg" style="height:372px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div id="i916f7af890114e55a87e260476560c60_37"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ancillary services, including our international operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our ancillary services relate primarily to our core business of providing kidney care services. As of December&#160;31, 2021, these consisted primarily of our integrated kidney care services, our physician services supporting integrated kidney care and our kidney care initiatives outside of dialysis, our clinical research programs, and our transplant software business as well as our international operations.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Ancillary services</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made and continue to make investments in building our integrated care capabilities, including the operation of certain strategic business initiatives that are intended to integrate care among healthcare participants across the renal care continuum from CKD to ESKD to kidney transplant. Through improved technology and data sharing, as well as an increasing focus on value-based contracting and care, these initiatives seek to bring together physicians, nurses, dieticians, pharmacists, hospitals, dialysis clinics, transplant centers and payors with a view towards improving clinical outcomes for our patients and reducing the overall cost of comprehensive kidney care.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Integrated Kidney Care services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;VillageHealth DM, LLC, also doing business as DaVita Integrated Kidney Care (DaVita IKC), provides advanced integrated care management services to health plans and government programs for members/beneficiaries diagnosed with ESKD, CKD and/or poly-comorbid conditions. Through a combination of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">health monitoring, clinical coordination, innovative interventions, predictive analytics, medical claims analysis and information technology, we endeavor to assist our health plan and government program customers and patients in obtaining superior renal healthcare and improved clinical outcomes, as well as helping to reduce overall medical costs. Integrated kidney care management revenues from commercial and Medicare Advantage insurers can be based upon either an established contract fee recognized as earned for services provided over the contract period, or related to the operation of risk-based and value-based programs, including shared savings, pay for performance, and capitation contracts. DaVita IKC also contracts with payors to operate Medicare Advantage ESKD special needs plans to provide ESKD patients full service healthcare. DaVita IKC supported our ESKD seamless care organizations (ESCO) joint venture programs until their completion in 2021, and DaVita IKC has commenced participation in certain of the payment models administered by CMMI. As further described below under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Government regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CMMI Payment Models</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">", the Company has invested resources, and expects to continue to invest substantial resources in these models as part of the Company's overall plan to grow its integrated kidney care business and value-based care initiatives. See Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenue, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the Company's consolidated financial statements for more information on how the Company accounts for its integrated care arrangements.</span></div><div style="margin-top:9pt;padding-left:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also developing, and has entered into, various forms of technology-based, administrative, financial and other collaboration and incentive arrangements with physician partners and other providers in support of our innovative, developing and expanding integrated kidney care programs and arrangements.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Physician services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Nephrology Practice Solutions (NPS) is an independent business that partners with physicians committed to providing outstanding clinical and integrated care to patients. NPS provides nephrologist recruitment and staffing services in select markets which are billed on a per search basis. NPS also offers physician practice management services to nephrologists under administrative services agreements. These services include physician practice management, billing and collections, credentialing, coding and other support services that enable physician practices to increase efficiency and manage their administrative needs. Additionally, NPS owns and operates nephrology practices in multiple states. Fees generated from these services are recognized as earned typically based upon flat fees or cash collections generated by the physician practice.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Clinical research programs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;DaVita Clinical Research (DCR) is a provider-based specialty clinical research organization with a full spectrum of services for clinical drug research and device development. DCR uses its extensive, applied database and real-world healthcare experience to assist in the design, recruitment and completion of retrospective and prospective pragmatic and clinical trials. Revenues are based upon an established fee per study, as determined by contract with drug companies and other sponsors and are recognized as earned according to the contract terms.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Transplant software business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;DaVita's new transplant software business, MedSleuth, which was acquired on December 31, 2021, works with transplant centers across the U.S. to provide greater connectivity among transplant candidates, transplant centers, physicians and care teams to help improve the experience and outcomes for kidney and liver transplant patients.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional discussion of our ancillary services, see Part II, Item 7, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International dialysis operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we operated or provided administrative services to a total of 339 outpatient dialysis centers, which includes consolidated and nonconsolidated centers located in ten countries outside of the U.S., serving approximately 39,900 patients. Our international dialysis operations have continued to grow steadily and expand as a result of acquiring and developing outpatient dialysis centers in various strategic markets. Our international operations are included in our ancillary services. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the locations of our international outpatient dialysis centers were as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.409%"><tr><td style="width:1.0%"></td><td style="width:67.237%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.563%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Malaysia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Colombia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Saudi Arabia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portugal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Singapore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes centers that are operated or managed by our Asia Pacific joint venture (APAC JV).</span></div><div id="i916f7af890114e55a87e260476560c60_40"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate administrative support</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate administrative support consists primarily of labor, benefits and long-term incentive compensation costs and professional fees for departments which provide support to all of our different operating lines of business. These expenses are included in our consolidated general and administrative expenses.</span></div><div id="i916f7af890114e55a87e260476560c60_43"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government regulation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a complex regulatory environment with an extensive and evolving set of federal, state and local governmental laws, regulations and other requirements. These laws, regulations and other requirements are promulgated and overseen by a number of different legislative, regulatory, administrative and quasi-regulatory bodies, each of which may have varying interpretations, judgments or related guidance. As such, we utilize considerable resources on an ongoing basis to monitor, assess and respond to applicable legislative, regulatory and administrative requirements, but there is no guarantee that we will be successful in our efforts to adhere to all of these requirements. Additional discussion on certain of these laws, regulations and other requirements is set forth below in this section.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our personnel, representatives or operations are alleged to have violated these or other laws, regulations or requirements, we could experience material harm to our reputation and stock price, and it could impact our relationships and/or contracts related to our business, among other things. If any of our personnel, representatives, or operations are found to violate these or other laws, regulations or requirements, we could suffer additional severe consequences that could have a material adverse effect on our business, results of operations, financial condition and cash flows, including, among others:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of required certifications, suspension or exclusion from or termination of our participation in government programs (including, without limitation, Medicare, Medicaid and CMMI demonstration programs);</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Refunds of amounts received in violation of law or applicable payment program requirements dating back to the applicable statute of limitation periods;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of licenses required to operate healthcare facilities or administer pharmaceuticals in the states in which we operate;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reductions in payment rates or coverage for dialysis and ancillary services and pharmaceuticals;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Criminal or civil liability, fines, damages or monetary penalties;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Imposition of corporate integrity agreements, corrective action plans or consent agreements;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enforcement actions, investigations, or audits by governmental agencies and/or state law claims for monetary damages by patients who believe their protected health information (PHI) has been used, disclosed or not properly safeguarded in violation of federal or state patient privacy laws, including, among others, the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Privacy Act of 1974; </span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enforcement actions, investigations or audits by government agencies and/or initiated by qui tam relators related to interoperability and related data sharing and access requirements and regulations; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mandated changes to our practices or procedures that significantly increase operating expenses that could subject us to ongoing audits and reporting requirements as well as increased scrutiny of our billing and business practices, which could lead to potential fines, among other things;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Termination of various relationships and/or contracts related to our business, such as joint venture arrangements, medical director agreements, hospital services and skilled nursing home agreements, real estate leases, value based arrangements, clinical incentive programs, payor contracts and consulting or participating provider agreements with physicians, among others; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Harm to our reputation which could negatively impact our business relationships and stock price, our ability to attract and retain patients, physicians and teammates, our ability to obtain financing and our access to new business opportunities, among other things.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our industry will continue to be subject to extensive and complex regulation, the scope and effect of which are difficult to predict. We are currently subject to various legal proceedings, such as lawsuits, investigations, audits and inquiries by various government and regulatory agencies, as further described in Note 16 to the consolidated financial statements, and our operations and activities could be reviewed or challenged by regulatory authorities at any time in the future. For additional detail on risks related to each of the foregoing, see the discussion in Item 1A. Risk Factors under the headings, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm stock price, and in some circumstances, could materially harm our reputation;" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "We are, and may in the future be, a party to various lawsuits, demands, claims, qui tam suits, governmental investigations and audits and other legal matters, any of which could result in, among other things, substantial financial penalties or awards against us, mandated refunds, substantial payments made by us, required changes to our business practices, exclusion from future participation in Medicare, Medicaid and other healthcare programs and possible criminal penalties, any of which could have a material adverse effect on our business, results of operations, financial condition, cash flows, reputation and stock price."</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licensure and Certification</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our dialysis centers are certified by CMS, as required for the receipt of Medicare payments. Certain of our payor contracts also condition payment on Medicare certification. In some states, our outpatient dialysis centers also are required to secure additional state licenses and permits. Governmental authorities, primarily state departments of health, periodically inspect our centers to determine if we satisfy applicable federal and state standards and requirements, including the conditions for coverage in the Medicare ESRD program.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced some delays in obtaining Medicare certifications from CMS, though recent changes by CMS in the prioritizing of dialysis providers as well as legislation allowing private entities to perform initial dialysis facility surveys for certification has helped to decrease or limit certain delays.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in September 2019, CMS finalized updates to the Provider Enrollment Rule creating onerous disclosure obligations for all providers enrolling in Medicare, Medicaid and the Children&#8217;s Health Insurance Plan (CHIP). The final rule provides CMS with stronger revocation authority, increases the bar for re-enrollment, and permits CMS to impose a Medicare reapplication bar where a prospective provider's Medicare enrollment application is denied because the provider submitted incomplete, false, or misleading information for providers who are terminated from the Medicare program. CMS may also deny enrollment to providers who have affiliations with other providers that CMS has determined pose undue risk of fraud, waste or abuse. If we fail to comply with these and other applicable requirements on our licensure and certification programs, particularly in light of increased penalties that include a 10-year bar to Medicare re-enrollment, under certain circumstances it could have a material adverse impact on our business, results of operations, financial condition, cash flows and reputation.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Anti-Kickback Statute</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Anti-Kickback Statute prohibits, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration, directly or indirectly, in cash or kind, to induce or reward either the referral of an individual for, or the purchase, or order or recommendation of, any good or service, for which payment may be made under federal and state healthcare programs such as Medicare and Medicaid.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal criminal penalties for the violation of the federal Anti-Kickback Statute include imprisonment, fines and exclusion of the provider from future participation in the federal healthcare programs, including Medicare and Medicaid. Violations of the federal Anti-Kickback Statute are punishable by imprisonment for up to ten years and statutory fines of up to $100,000 or both. Larger criminal fines can be imposed under the provisions of the U.S. Sentencing Guidelines and the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alternate Fines Statute. Individuals and entities convicted of violating the federal Anti-Kickback Statute are subject to mandatory exclusion from participation in Medicare, Medicaid and other federal healthcare programs for a minimum of five years. Civil penalties for violation of this law include statutory amounts of up to $100,000 (adjusted for inflation) in monetary penalties per violation, assessments of up to three times the total payments between the parties to the arrangement, and permissive exclusion from participation in the federal healthcare programs or suspension from future participation in Medicare and Medicaid. The ACA amended the federal Anti-Kickback Statute to clarify that the defendant may not need to have actual knowledge of the federal Anti-Kickback Statute or have the specific intent to violate it. In addition, the ACA amended the federal Anti-Kickback Statute to provide that any claims for items or services resulting from a violation of the federal Anti-Kickback Statute are considered false or fraudulent for purposes of the False Claims Act (FCA) and can result in treble damages and other penalties under the FCA.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Anti-Kickback Statute includes statutory exceptions and regulatory safe harbors that protect certain arrangements. Business transactions and arrangements that are structured fully within an applicable safe harbor do not violate the federal Anti-Kickback Statute. When an arrangement is not structured fully within a safe harbor, the arrangement must be evaluated on a case-by-case basis in light of the parties&#8217; intent and the arrangement&#8217;s potential for abuse, and may be subject to greater scrutiny by enforcement agencies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2020, HHS' Office of Inspector General (OIG) and CMS released a final rule implementing modifications to the Federal Anti-Kickback Statute and Civil Monetary Penalties Statute that are intended to promote value-based and coordinated care arrangements as well as reduce other regulatory burdens. The changes implemented by the final rules went into effect on January 19, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business operations, DaVita and its ancillary businesses and subsidiaries enter into numerous arrangements with physicians and other potential referral sources, that potentially implicate the Anti-Kickback Statute. Examples of such arrangements include, among other things, medical director agreements, joint ventures, leases and subleases with entities in which physicians, hospitals or medical groups hold ownership interests, consulting agreements, hospital services agreements, discharge planning services agreements, acute dialysis services agreements, value based care arrangements, employment and coverage agreements, and incentive performance arrangements. In addition, some referring physicians may own our common stock in reliance on the Anti-Kickback Statute safe harbor for investment interests in large publicly traded companies. Furthermore, our dialysis centers and subsidiaries sometimes enter into certain rebate, pricing, or other contracts to acquire certain discounted items and services that may be reimbursed by a federal healthcare program.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreements do not need to fit within a relevant federal Anti-Kickback Statute safe harbor provision to be permissible; however, we generally endeavor to structure our arrangements within applicable safe harbors. Some of our arrangements are not structured fully within a safe harbor. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our business transactions or arrangements, including but not limited to those described above, were found to violate the federal Anti-Kickback Statute, we, among other things, could face criminal, civil or administrative sanctions, including possible exclusion from participation in Medicare, Medicaid and other state and federal healthcare programs. Any findings that we have violated these laws could have a material adverse impact on our business, results of operations, financial condition, cash flows, reputation and stock price.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stark Law</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stark Law is a strict liability civil law that prohibits a physician who has a financial relationship, or who has an immediate family member who has a financial relationship, with entities providing Designated Health Services (DHS), from referring Medicare and Medicaid patients to such entities for the furnishing of DHS, unless an exception applies. The types of financial arrangements between a physician and a DHS entity that trigger the self-referral prohibitions of the Stark Law are broad and include direct and indirect ownership and investment interests and compensation arrangements. The Stark Law also prohibits the DHS entity receiving a prohibited referral from presenting, or causing to be presented, a claim or billing for the services arising out of the prohibited referral. If the Stark Law is implicated, the financial relationship must fully satisfy a Stark Law exception. If an exception to the Stark Law is not satisfied, then the parties to the arrangement could be subject to sanctions. Sanctions for violation of the Stark Law include denial of payment for claims for services provided in violation of the prohibition, refunds of amounts collected in violation of the prohibition, a civil penalty of up to $15,000 (adjusted for inflation) for each service arising out of the prohibited referral, a statutory civil penalty of up to $100,000 (adjusted for inflation) against parties that enter into a scheme to circumvent the Stark Law prohibition, civil assessment of up to three times the amount claimed, and potential exclusion from the federal healthcare programs, including Medicare and Medicaid. Amounts collected for prohibited claims must be reported and refunded generally within 60 days after the date on which the overpayment was identified. Furthermore, Stark Law violations and failure to return overpayments timely can form the basis for FCA liability as discussed below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2020, CMS released a final rule implementing modifications to the Stark Law. The purpose of these modifications is to promote value-based and coordinated care arrangements as well as reduce other regulatory burdens. Most changes implemented by the final rule went into effect on January 19, 2021. We continue to assess the anticipated impact of these modifications on our business, results of operations and financial condition.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The definition of DHS under the Stark Law excludes services paid under a composite rate, even if some of the components bundled in the composite rate are DHS. Although the ESRD bundled payment system is no longer titled a composite rate, we believe that the former composite rate payment system and the current bundled system are both composite systems excluded from the Stark Law. Since most services furnished to Medicare beneficiaries provided in our dialysis centers are reimbursed through a bundled rate, we believe that the services performed in our facilities generally are not DHS. Certain separately billable drugs (drugs furnished to an ESRD patient that are not for the treatment of ESRD that CMS allows our centers to bill for using the so-called AY modifier) may be considered DHS. However, we have implemented certain billing controls designed to limit DHS being billed out of our dialysis clinics. Likewise, the definition of inpatient hospital services, for purposes of the Stark Law, also excludes inpatient dialysis performed in hospitals that are not certified to provide ESRD services. Consequently, we believe that our arrangements with such hospitals for the provision of dialysis services to hospital inpatients should not trigger the Stark Law referral prohibition.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, although prescription drugs are DHS, there is an exception in the Stark Law for calcimimetics, EPO and other specifically enumerated dialysis drugs when furnished in or by an ESRD facility such that the arrangement for the furnishing of the drugs does not violate the Stark Law. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business operations, DaVita and its ancillary businesses and subsidiaries have many different types of financial arrangements with referring physicians that potentially implicate the Stark Law, including, but not limited to, medical director agreements, joint ventures, leases and subleases with entities in which physicians, hospitals or medical groups hold ownership interest, consulting agreements, hospital services agreements, discharge planning services agreements, acute dialysis services agreements, value based care arrangements, employment agreements and incentive performance arrangements. In addition, some referring physicians may own our common stock in reliance on the Stark Law exception for investment interests in large publicly traded companies. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our interpretation of the applicability of the Stark Law to our operations is incorrect, the controls we have implemented fail, an arrangement is entered into outside of our processes, or we were to fail to satisfy an applicable exception to the Stark Law, we could be found to be in violation of the Stark Law and required to change our practices, face civil penalties, pay substantial fines, return certain payments received from Medicare and beneficiaries or otherwise experience a material adverse effect.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition, it might be necessary to restructure existing compensation agreements with our medical directors and to repurchase or to request the sale of ownership interests in subsidiaries and partnerships held by referring physicians or, alternatively, to refuse to accept referrals for DHS from these physicians, or take other actions to modify our operations. Any finding by CMS or other regulatory or enforcement authorities that we have violated the Stark Law or related penalties and restructuring or other required actions could have a material adverse effect on our business, results of operations, financial condition, cash flows, stock price and reputation.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">False Claims Act</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal FCA is a means of policing false bills or false requests for payment in the healthcare delivery system. In part, the FCA authorizes the imposition of up to three times the government&#8217;s damages and civil penalties, plus up to approximately $23,000 per claim, on any person who, among other acts:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Knowingly presents or causes to be presented to the federal government, a false or fraudulent claim for payment or approval;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Knowingly makes, uses or causes to be made or used, a false record or statement material to a false or fraudulent claim;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Knowingly makes, uses, or causes to be made or used, a false record or statement material to an obligation to pay the government, or knowingly conceals or knowingly and improperly, avoids or decreases an obligation to pay or transmit money or property to the federal government; or</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conspires to commit the above acts.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, amendments to the FCA impose severe penalties for the knowing and improper retention of overpayments collected from government payors. Under these provisions, within 60 days of identifying and quantifying an overpayment, a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provider is required to follow certain notification and repayment processes. An overpayment impermissibly retained could subject us to liability under the FCA, exclusion from government healthcare programs, and penalties under the federal Civil Monetary Penalty statute. As a result of these provisions, our procedures for identifying and processing overpayments may be subject to greater scrutiny.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal government has used the FCA to prosecute a wide variety of alleged false claims and fraud allegedly perpetrated against Medicare and state healthcare programs, including coding errors, billing for services not rendered, the submission of false cost reports, billing for services at a higher payment rate than appropriate, billing under a comprehensive code as well as under one or more component codes included in the comprehensive code and billing for care that is not considered medically necessary. The ACA provides that claims tainted by a violation of the federal Anti-Kickback Statute are false for purposes of the FCA. Some courts have held that filing claims or failing to refund amounts collected in violation of the Stark Law can form the basis for liability under the FCA. In addition to the provisions of the FCA, which provide for civil enforcement, the federal government can use several criminal statutes to prosecute persons who are alleged to have submitted false or fraudulent claims for payment to the federal government. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fraud and abuse under state law</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states in which we operate dialysis centers have laws prohibiting physicians from holding financial interests in various types of medical facilities to which they refer patients. Some of these laws could potentially be interpreted broadly as prohibiting physicians who hold shares of our publicly traded stock or are physician owners from referring patients to our dialysis centers if the centers use our laboratory subsidiary to perform laboratory services for their patients or do not otherwise satisfy an exception to the law. States also have laws similar to or stricter than the federal Anti-Kickback Statute that may affect our ability to receive referrals from physicians with whom we have financial relationships, such as our medical directors. Some state anti-kickback laws also include civil and criminal penalties. Some of these laws include exemptions that may be applicable to our medical directors and other physician relationships or for financial interests limited to shares of publicly traded stock. Some, however, may include no explicit exemption for certain types of agreements and/or relationships entered into with physicians. If these laws are interpreted to apply to referring physicians with whom we contract for items or services, including medical directors, or to referring physicians with whom we hold joint ownership interests or to referring physicians who hold interests in DaVita Inc. limited solely to our publicly traded stock, and for which no applicable exception exists, we may be required to terminate or restructure our relationships with or refuse referrals from these referring physicians and could be subject to criminal, civil and administrative sanctions, refund requirements and exclusions from government healthcare programs, including Medicare and Medicaid, which could have a material adverse effect on our business, results of operations, financial condition, cash flows, reputation and stock price.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Practice of Medicine and Fee-Splitting</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are states in which we operate that have laws that prohibit business entities not owned by health care providers, such as our Company and our subsidiaries, from practicing medicine, employing physicians and other health care providers providing certain clinical services or exercising control over medical or clinical decisions by physicians and potentially other types of health care providers (known collectively as the corporate practice of medicine). These states may also prohibit entities from engaging in certain financial arrangements, such as fee-splitting, with physicians and potentially other types of health care providers. Violations of the corporate practice of medicine, fee-splitting and related laws vary by state and may result in physicians and potentially other types of health care providers being subject to disciplinary action, as well as to forfeiture of revenues from payors for services rendered. Violations may also bring both civil and, in more extreme cases, criminal liability for engaging in medical practice without a license and violating the corporate practice of medicine, fee-splitting and related laws. Some of the relevant laws, regulations, and agency interpretations in states with corporate practice of medicine restrictions have been subject to limited judicial and regulatory interpretation. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Civil Monetary Penalties Statute</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Civil Monetary Penalties Statute, 42 U.S.C. &#167; 1320a-7a, authorizes the imposition of civil money penalties, assessments, and exclusion against an individual or entity based on a variety of prohibited conduct, including, but not limited to:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Presenting, or causing to be presented, claims for payment to Medicare, Medicaid, or other third-party payors that the individual or entity knows or should know are for an item or service that was not provided as claimed or is false or fraudulent; </span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Offering remuneration to a federal healthcare program beneficiary that the individual or entity knows or should know is likely to influence the beneficiary to order or receive healthcare items or services from a particular provider;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Arranging contracts with an entity or individual excluded from participation in the federal healthcare programs;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Violating the federal Anti-Kickback Statute;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Making, using, or causing to be made or used, a false record or statement material to a false or fraudulent claim for payment for items and services furnished under a federal healthcare program;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Making, using, or causing to be made any false statement, omission, or misrepresentation of a material fact in any application, bid, or contract to participate or enroll as a provider of services or a supplier under a federal healthcare program; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failing to report and return an overpayment owed to the federal government.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantial civil monetary penalties may be imposed under the federal Civil Monetary Penalty Statute and vary, depending on the underlying violation. In addition, an assessment of not more than three times the total amount claimed for each item or service may also apply, and a violator may be subject to exclusion from federal and state healthcare programs.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Corrupt Practices Act</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the provisions of the Foreign Corrupt Practices Act (FCPA) in the United States and similar laws in other countries, which generally prohibit companies and those acting on their behalf from making improper payments to foreign government officials and others for the purpose of obtaining or retaining business. A violation of the FCPA or other similar laws by us and/or our agents or representatives could result in, among other things, the imposition of fines and penalties, changes to our business practices, the termination of or other adverse impacts under our contracts or debarment from bidding on contracts, and/or harm to our reputation, any of which could have a material adverse effect on our business, results of operations, financial condition, cash flows and stock price.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Privacy and Security</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Insurance Portability and Accountability Act of 1996 and its implementing privacy and security regulations, as amended by the federal Health Information Technology for Economic and Clinical Health Act (HITECH Act) (collectively referred to as HIPAA), require us to provide certain protections to patients and their health information. The HIPAA privacy and security regulations extensively regulate the use and disclosure of PHI and require covered entities, which include healthcare providers, to implement and maintain administrative, physical and technical safeguards to protect the security of such information. Additional security requirements apply to electronic PHI. These regulations also provide patients with substantive rights with respect to their health information.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The HIPAA privacy and security regulations also require us to enter into written agreements with certain contractors, known as business associates, to whom we disclose PHI. Covered entities may be subject to penalties for, among other activities, failing to enter into a business associate agreement where required by law or as a result of a business associate violating HIPAA if the business associate is found to be an agent of the covered entity and acting within the scope of the agency. Business associates are also directly subject to liability under the HIPAA privacy and security regulations. In instances where we act as a business associate to a covered entity, there is the potential for additional liability beyond our status as a covered entity.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covered entities must report breaches of unsecured PHI to affected individuals without unreasonable delay but not to exceed 60 days of discovery of the breach by a covered entity or its agents. Notification must also be made to the HHS and, for breaches of unsecured PHI involving more than 500 residents of a state or jurisdiction, to the media. All non-permitted uses or disclosures of unsecured PHI are presumed to be breaches unless the covered entity or business associate establishes that there is a low probability the information has been compromised. Various state laws and regulations may also require us to notify affected individuals, and U.S. state attorneys general, or other regulators or law enforcement, in the event of a data breach involving individually identifiable information without regard to whether there is a low probability of the information being compromised.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Penalties for impermissible use or disclosure of PHI were increased by the HITECH Act by imposing tiered penalties of more than $50,000 per violation and up to $1.5&#160;million per year for identical violations. In addition, HIPAA provides for criminal penalties of up to $250,000 and ten years in prison, with the severest penalties for obtaining and disclosing PHI with the intent to sell, transfer or use such information for commercial advantage, personal gain or malicious harm. Further, state attorneys general may bring civil actions seeking either injunction or damages in response to violations of the HIPAA privacy and security regulations that threaten the privacy of state residents.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the protection of PHI, healthcare companies must meet privacy and security requirements applicable to other categories of personal information. Companies may process consumer information in conjunction with website and corporate operations. They may also handle employee information, including Social Security Numbers, payroll information, and other categories of sensitive information, to further their employment practices. In processing this additional information, companies must comply with the applicable privacy and security requirements of comprehensive privacy and data protection laws, consumer protection laws, labor and employment laws, and its publicly-available notices.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Data protection laws and regulations are evolving globally, and may continue to add additional compliance costs and legal risks to our international operations. In the European Union, the General Data Protection Regulation (EU GDPR) imposes a comprehensive data protection regime with the potential for regulatory fines as well as data breach litigation by impacted data subjects. Under the EU GDPR, regulatory penalties may be passed by data protection authorities for up to the greater of 4% of worldwide turnover or &#8364;20 million. The United Kingdom has implemented similar legislation (UK GDPR) that may carry similar compliance and operational costs as the EU GDPR, and non-compliance with which carries potential fines of up to the greater of &#163;17.5 million or 4% of global turnover. The costs of compliance with, and other burdens imposed by, the EU GDPR, UK GDPR and other new laws, regulations and policies implementing the EU GDPR and UK GDPR may impact our European and United Kingdom operations and may limit the ways in which we can provide services or use personal data collected while providing services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Privacy and data protection laws are also evolving nationally, providing for enhanced state privacy rights that are broader than the current federal privacy rights, and may add additional compliance costs and legal risks to our U.S. operations. For example, the California Consumer Protection Act (CCPA), which became effective January 1, 2020, requires certain companies doing business in California to enhance privacy disclosures regarding the collection, use and sharing of a consumer's personal data. The CCPA also permits the imposition of civil penalties, grants enforcement authority to the state Attorney General and provides a private right of action for consumers where certain personal information is breached due to unreasonable information security practices.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the California Privacy Rights Act (CPRA), which is expected to take effect in January 2023, significantly expands the data protection obligations imposed by the CCPA on companies doing business in California, including additional consumer rights processes, limitations on data uses, and opt outs for certain uses of sensitive data. It will also create a new California data protection agency to enforce the law, and require certain businesses with higher risk privacy and security practices to submit annual audits to the agency on a regular basis. The CPRA will likely result in broader increased regulatory scrutiny in California of businesses&#8217; privacy and security practices, could lead to a further rise in data protection litigation, and will require additional compliance investment and potential business process changes in the meantime. In addition to California, other states have passed similar privacy laws, such as the Colorado Privacy Act and the Virginia Consumer Data Protection Act.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the breach reporting requirements under HIPAA, companies are subject to state breach notification laws. Each state enforces a law requiring companies to provide notice of a breach of certain categories of sensitive personal information, e.g. Social Security Number, financial account information, or username and password. A company impacted by a breach must notify affected individuals, attorney&#8217;s general or other agencies within a certain time frame. If a company does not provide timely notice with the required content, it may be subject to civil penalties brought by attorney&#8217;s generals or affected individuals. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companies must also safeguard personal information in accordance with federal and state data security laws and requirements. These requirements are akin to the HIPAA requirements to safeguard PHI, described above. The Federal Trade Commission, for example, requires companies to implement reasonable data security measures relative to its operations and the volume and complexity of the information it processes. Also, various state data security laws require companies to safeguard data with technical security controls and underlying policies and processes. Due to the constant changes in the data security space, companies must continuously review and update data security practices to mitigate any potential operational or legal liabilities stemming from data security risks. If we fail to comply with applicable privacy and security laws, regulations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and standards, including with respect to third-party service providers that utilize sensitive personal information, including PHI,</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on our behalf, properly maintain the integrity of our data, protect our proprietary rights, or defend against cybersecurity attacks,</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">it could materially harm our reputation and/or have a material adverse effect on our business, results of operations, financial</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Integrated Kidney Care and Medicare and Medicaid program reforms</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory framework of the healthcare marketplace continues to evolve as a result of executive, legislative, regulatory and administrative developments and judicial proceedings. These changes shape the landscape for our current dialysis business as well as for emerging comprehensive and integrated kidney care programs. The following discussion describes certain of these changes in further detail.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CMMI Payment Models:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> An executive order issued in July 2019 (the 2019 Executive Order) directed CMS to create payment models through CMMI to evaluate the effects of creating payment incentives for the greater use of home-based dialysis and kidney transplants for those already on dialysis, improve quality of care for kidney patients and reduce expenditures. The first of these, the ESRD Treatment Choices (ETC) mandatory payment model launched in approximately 30% of dialysis clinics across the country on January 1, 2021. In November 2021, CMS revised the ETC model to include an additional positive payment adjustment for significant improvement in the home dialysis rate or the transplant waitlist rate among ESRD patients with lower socioeconomic status. CMS will also stratify the achievement benchmarks for geographies with 50 percent or more patients who are dual-eligible or received a Low Income Subsidy (LIS) to account for socioeconomic factors that may impact the ability to receive home-based dialysis or gain placement on a transplant waitlist. CMS also announced the Global and Professional Direct Contracting (GPDC) Model to reduce the cost and improve the quality of care for Medicare fee-for-service patients. The Company, via its wholly owned subsidiary Vively Health, began participating in the GPDC Model at the start of the first performance year on April 1, 2021. CMS also announced the implementation of two voluntary kidney care payment models, Kidney Care First (KCF) and Comprehensive Kidney Care Contracting (CKCC), with the stated goal of helping healthcare providers reduce the cost and improve the quality of care for patients with late-stage chronic kidney disease and ESRD. CMS has stated these payment models are aimed to prevent or delay the need for dialysis and encourage kidney transplantation. Certain of these payment models, such as the First Performance Period for the Kidney Care Choices Model CKCC Options (the CKCC Model) commenced on January 1, 2022. As described above, the Company has invested substantial resources, and expects to continue to invest substantial resources in these models as part of the Company's overall plan to grow its integrated kidney care business and value-based care initiatives.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the aforementioned new models of care, federal bipartisan legislation related to full capitation demonstration for ESRD was introduced in Congress in August 2021 as the BETTER Kidney Care Act. This proposed legislation would build on prior coordinated care models, such as the Comprehensive ESRD Care (CEC) Model, and would establish a demonstration program for the provision of integrated care to Medicare fee-for-service dialysis and transplant patients. As noted above, we have made and continue to make substantial investments in value based care and building our integrated care capabilities, but there can be no assurances that initiatives such as this or any other legislation that aligns with our strategy and investments will be passed into law, and the ongoing COVID-19 pandemic may delay the progress of any such initiatives. Irrespective of whether such laws are passed, there can be no assurances that we will be able to successfully execute on the required strategic initiatives that would allow us to provide a competitive and successful integrated care program on the broad scale, and in the desired time frame. Additionally, the ultimate terms and conditions of any such potential legislation remain unclear. For example, our costs of care could exceed our associated reimbursement rates under such legislation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional details on the risks related to integrated kidney care and Medicare and Medicaid program reforms, see the discussion in Item 1A. Risk Factors under the headings "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If we are not able to successfully implement our strategy with respect to our integrated kidney care and value-based care initiatives, including maintaining our existing business and further developing our capabilities in a complex and highly regulated environment, it could result in a loss of our investments and have a material adverse effect on our growth strategy, could adversely impact our business, results of operations, financial condition and cash flows, and could materially harm our reputation;" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "If we are unable to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and developing and maintaining relationships with physicians and hospitals, it could materially adversely affect our business, results of operations, financial condition and cash flows."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ACA and related regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The ACA regulatory framework of the healthcare marketplace continues to evolve as a result of executive, legislative, regulatory and administrative developments and judicial proceedings. For example, the expanded access to healthcare developed under the ACA has been both positively and negatively impacted over time by subsequent legal, regulatory and judicial action. In 2021, the American Rescue Plan included several provisions designed to expand health coverage during the COVID-19 pandemic, including the expansion of premium tax credits that assist consumers who purchase health insurance on marketplaces developed under the ACA and temporarily offering incentives to expand Medicaid coverage for states that have not yet done so. Our revenue and operating income levels are highly sensitive to the percentage of our patients with higher-paying commercial health insurance and any legislative, regulatory or other changes that decrease the accessibility and availability, including the duration, of commercial insurance is likely to have a material adverse impact on our business. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to the political environment may increase the likelihood of legislative or regulatory changes that would impact us, such as changes to the healthcare regulatory landscape. Examples of such potential changes also could include, among other things, legislative developments or administrative decisions such as moving to a universal health insurance or "single payor" system whereby health insurance is provided to all Americans by the government, the availability of a "public health insurance option" similar to Medicare, government programs that impact access to Medicaid expansion or impact funding provided to families to purchase plans through the health insurance exchanges or changes to the eligibility age for Medicare beneficiaries. Some of these or other changes could in turn impact the percentage of our patients with higher-paying commercial health </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance, impact the scope or terms of coverage under commercial health plans and/or increase our expenses, among other things. The timing of legislative or executive action related to these potential initiatives, if any, remains uncertain, particularly in light of the ongoing COVID-19 pandemic, and as such, considerable uncertainty exists surrounding the continued development of the ACA and related regulations, programs and models, as well as similar healthcare reform measures and/or other potential changes at the federal and/or state level to laws, regulations and other requirements that govern our business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Century Cures Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cures Act included a provision that, effective January 1, 2021, allows Medicare eligible beneficiaries with ESRD to choose coverage under a MA managed care plan. This provision has broadened patient access to certain enhanced benefits offered by MA plans. MA plans usually provide reimbursement to us at a negotiated rate that is generally higher than Medicare FFS rates. This change in benefit eligibility has increased the percentage of our patients on MA plans as compared to Medicare Part B plans, though it is unclear how many eligible ESRD patients will continue to seek to enroll in MA plans for their ESRD benefits over time. This uncertainty may be heightened by a provision in the Cures Act that, among other things, removes the objective time and distance standards relating to network adequacy for outpatient dialysis centers for MA plans. The removal of these standards could result in MA plans seeking to limit provider networks available to dialysis patients. If MA plans attempt to use this revision to the rules to limit or restrict their networks, this may adversely impact the number of ESRD patients that select MA plans and also may result in the Company not being an in-network provider for significant MA plans. For details on the risks associated with these provisions of the Cures Act, see the risk factors in Item 1A. Risk Factors under the headings,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation;" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "If the number or percentage of patients with higher-paying commercial insurance declines, if the average rates that commercial payors pay us decline, if patients in commercial plans are subject to restriction in plan designs, or if we are unable to maintain contracts with payors with competitive terms, including, without limitation, reimbursement rates, scope and duration of coverage and in-network benefits, it could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cures Act also includes provisions related to data interoperability, information blocking, and patient access. CMS and the Office of the National Coordinator for Health Information Technology (ONC) issued final rules related to these provisions, which include, among other things, requirements surrounding information blocking, changes to ONC's Health IT Certification Program and requirements that CMS-regulated payors make relevant claims/care data and provider directory information available through standardized patient access and provider directory application programming interfaces (APIs) that connect to provider electronic health records. We have made and continue to make investments in building data interoperability capabilities, including as part of building on our integrated care capabilities as noted above, and continue to monitor guidance from ONC on the rule.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Price Transparency Rules</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In addition, recent price transparency regulations require most group health plans, and health insurance issuers in the group and individual markets, to make certain pricing and patient responsibility information publicly available. For plan years that start on or after January 1, 2022, and with enforcement beginning on July 1, 2022, any such plan or issuer must publish monthly machine-readable files that include negotiated rates between the plan or issuer and in-network providers, and allowed amounts paid and/or billed charges for out-of-network providers, for all covered items and services. For plan years that begin on or after January 1, 2023, most group health plans, and health insurance issuers in the group and individual markets, must provide enrollees with out-of-pocket cost and underlying provider negotiated rate information in a consumer-friendly format for an initial list of 500 designated services (which do not include dialysis). A plan or issuer may choose to include more than these 500 services, and for plan years that begin on or after January 1, 2024, most group health plans, and health insurance issuers in the group and individual markets, must provide enrollees with this information for all covered items and services. Additionally, CMS released regulations associated with "surprise billing" which necessitate, among other requirements, that certain providers provide patients with information regarding patient financial accountability and costs of services in advance of care being provided.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the ultimate impact of these regulations remains uncertain, any changes by group health plans, health insurance issuers in the group and individual markets, or consumer choices resulting from these regulations could have a material adverse impact on our business, financial condition and results of operations, and could materially harm our reputation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Response</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 2021, President Biden directed federal agencies to develop rules and take action related to COVID-19 vaccination requirements, including rules that may impact employers with 100 or more employees as well as workers in the dialysis and other healthcare settings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On November 4, 2021, OSHA released the COVID-19 vaccine emergency temporary standard (ETS), but withdrew the rule effective January 26, 2022 after legal challenges. On November 5, 2021, CMS also issued an Interim Final Rule (IFR) requiring that, as a condition of participation in Medicare and Medicaid, various providers and suppliers, including ESRD facilities, implement policies and procedures for COVID-19 vaccination of all staff who provide care, treatment, or other services for the provider or its patients. Several legal challenges have been filed </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">against the IFR, but the U.S. Supreme Court lifted the injunction against the IFR while the legal challenges proceed in the lower courts such that all healthcare workers at the providers and suppliers noted above are to be fully vaccinated or receive an approved medical or religious accommodation by February 28, 2022, in accordance with federal employment law. In addition, on September 9, 2021, President Biden issued Executive Order 14042, referred to as the federal contractor vaccine mandate, to require all U.S. based employees working on or in connection with covered federal government contracts and all other employees who share workplaces with or come into contact with employees working on or in connection with covered federal government contracts, to be fully vaccinated, or have an approved medical or religious accommodation, by January 18, 2022. In December 2021 a federal court enjoined the federal contractor vaccine mandate. A number of of other courts have enjoined the federal contractor vaccine mandate. At this time, several other state vaccine mandates have been legally challenged and are under review by the applicable courts. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The uncertainty associated with the legal standing of these mandates and the cumulative impact of those mandates, that have already gone into effect, contributes to the volatility and uncertainty in the current labor market and may ultimately exacerbate the risk and impact of labor shortages on our business. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on the risks to our business associated with COVID-19 and labor market conditions, see the risk factors in Item 1A. Risk Factors under the headings, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, many of which may have a material adverse impact on us;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is labor intensive and if our labor costs continue to rise, including due to shortages, changes in certification requirements and/or higher than normal turnover rates in skilled clinical personnel; or currently pending or future governmental laws, rules, regulations or initiatives impose additional requirements or limitations on our operations or profitability; or, if we are unable to attract and retain employees; or if union organizing activities or legislative or other changes result in significant increases in our operating costs or decreases in productivity, we may experience disruptions in our business operations and increases in operating expenses, among other things, any of which could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, many of which may have a material adverse impact on us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain state and federal agencies, including OSHA and CMS, have released requirements, or are considering or are in the process of modifying existing requirements associated with the continued protection of employees as it relates to COVID-19. These requirements may result in increased costs related to, among other things, PPE, fit-testing, and paid time off, mandated surveillance testing of our teammates for COVID-19 and other increased obligations with which we must comply. Compliance with COVID-19-related safety rules and regulations is generally enforced with sanctions and/or fines, and non-compliance also has the potential for negative publicity or reputational impact. As these requirements are continuing to evolve and develop, at this time we cannot predict the ultimate impact they might have on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other regulations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis and related lab services operations are subject to various state hazardous waste and non-hazardous medical waste disposal laws. These laws do not classify as hazardous most of the waste produced from dialysis services. OSHA regulations require employers to provide workers who are occupationally subject to blood or other potentially infectious materials with prescribed protections. These regulatory requirements apply to all healthcare facilities, including dialysis centers, and require employers to make a determination as to which employees may be exposed to blood or other potentially infectious materials and to have in effect a written exposure control plan. In addition, employers are required to provide or employ hepatitis B vaccinations, personal protective equipment and other safety devices, infection control training, post-exposure evaluation and follow-up, waste disposal techniques and procedures and work practice controls. Employers are also required to comply with various record-keeping requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a few states in which we do business have certificate of need programs regulating the establishment or expansion of healthcare facilities, including dialysis centers.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State initiatives</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been several state initiatives to limit payments to dialysis providers or impose other burdensome operational requirements, which, if passed, could have a material adverse impact on our business, results of operation, financial condition and cash flows. For instance, in 2020, voters in California considered a statewide ballot initiative proposed by the Service Employees International Union - United Healthcare Workers West (SEIU) that sought to impose certain regulatory requirements on dialysis clinics, including requirements related to physician staffing levels, clinical reporting, clinical treatment options and limitations on the ability to make decisions on closing or reducing services for dialysis clinics. While voters rejected this ballot initiative in 2020, we incurred substantial costs to oppose it. On August 25, 2021, SEIU again proposed a California statewide ballot initiative with similar provisions. In the event this proposal becomes eligible for the November 2022 election, we expect to again incur substantial costs to oppose it. We may face ballot initiatives or other proposed regulations or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">legislation in California or other states in future years, which may require us to incur further substantial costs and which, if passed, could have a material adverse impact on our business, results of operations, financial condition and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolving proposed or issued laws, requirements, rules and guidance that impact our business, including without limitation as may be described above, and any failure on our part to adequately adjust to any resulting marketplace developments could have a material adverse effect on our business, results of operations, financial condition and cash flows. For additional discussion on the risks associated with the evolving payment and regulatory landscape for kidney care, see the discussion in Item 1A. Risk Factors, including the discussion under the heading,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "Our business is subject to a complex set of governmental laws, regulations and requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation;" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows."</span></div><div id="i916f7af890114e55a87e260476560c60_46"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate compliance program</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has designed and implemented a corporate compliance program as part of our commitment to comply fully with applicable criminal, civil and administrative laws and regulations and to maintain the high standards of conduct we expect from all of our teammates. We continuously review this program and work to enhance it as appropriate. The primary purposes of the program include:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assessing and identifying health care regulatory risks for existing and new businesses;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Training and educating our teammates and affiliated professionals to promote awareness of legal and regulatory requirements, a culture of compliance, and the necessity of complying with all applicable laws, regulations and requirements;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Developing and implementing compliance policies and procedures and creating controls to support compliance with applicable laws, regulations and requirements and our policies and procedures;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Auditing and monitoring the activities of our operating units and business support functions to identify and mitigate risks and potential instances of noncompliance in a timely manner; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ensuring that we promptly take steps to resolve any instances of noncompliance and address areas of weakness or potential noncompliance.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a code of conduct that each of our teammates, members of our Board of Directors, affiliated professionals and certain third parties must follow, and we have an anonymous compliance hotline for teammates and patients to report potential instances of noncompliance that is managed by a third party. Our Chief Compliance Officer administers the compliance program. The Chief Compliance Officer reports directly to our Chief Executive Officer (CEO) and the Chair of the Compliance and Quality Committee of our Board of Directors (Board).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any future penalties, sanctions or other consequences could be more severe in certain circumstances if the OIG or a similar regulatory authority determines that we knowingly or repeatedly failed to comply with applicable laws, regulations or requirements, including substantial penalties and exclusion from participation in federal healthcare programs that could have a material adverse effect on our business, results of operations, financial condition and cash flows, reputation and stock price.</span></div><div id="i916f7af890114e55a87e260476560c60_49"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. dialysis industry has experienced consolidation over the last 20 years, but remains highly competitive. In our U.S. dialysis business, we continue to face intense competition from large and medium-sized providers, among others, which compete directly with us for limited acquisition targets, for individual patients who may choose to dialyze with us and to engage physicians qualified to provide required medical director services. Competition for growth in existing and expanding geographies or areas is intense and is not limited to only those large dialysis providers with substantial financial resources or established participants in the dialysis space. We also compete with new dialysis providers, individual nephrologists, former medical directors or physicians that have opened their own dialysis units or facilities. Moreover, as we continue our international dialysis expansion into various international markets, we face competition from large and medium-sized providers, among others, for acquisition targets as well as physician relationships. We also experience competitive pressures from other dialysis and healthcare providers in recruiting and retaining qualified skilled clinical personnel as well as in connection with negotiating contracts with commercial healthcare payors and inpatient dialysis service agreements with hospitals. Acquisitions, developing new outpatient dialysis centers, patient retention and referrals, and physician relationships are significant components of our growth strategy and our business could be adversely affected if we are not able to continue to make dialysis </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acquisitions on reasonable and acceptable terms, continue to develop new outpatient dialysis centers, maintain or establish new relationships with physicians or if we experience significant patient attrition or lack of new patient growth relative to our competitors. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our largest competitor, Fresenius Medical Group (FMC), manufactures a full line of dialysis supplies and equipment in addition to owning and operating outpatient dialysis centers worldwide. This may, among other things, give FMC cost advantages over us because of its ability to manufacture its own products. Additionally, FMC has been one of our largest suppliers of dialysis products and equipment over the last several years. In January 2021, upon the expiration of our prior agreement with FMC on December 31, 2020, we entered into and subsequently extended a new agreement with FMC to purchase a certain amount of dialysis equipment, parts and supplies from FMC which extends through December&#160;31, 2024. The amount of purchases from FMC over the remaining term of this agreement will depend upon a number of factors, including the operating requirements of our centers, the number of centers we acquire, and growth of our existing centers.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to traditional dialysis providers, there have been a number of announcements, initiatives and capital raises by non-traditional dialysis providers and others along the full continuum of kidney care from CKD to dialysis to transplant. These providers, certain of which command considerable resources and capital, may increasingly compete with us in the integrated kidney care market as we seek to grow in that space, or they may focus their efforts on the development of more conventional dialysis competition or the commencement of other new business activities or the development of innovative technologies that could be transformative to the industry. For additional discussion on these developments and associated risks, see the risk factor in Item 1A. Risk Factors under the heading, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If we are unable to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and developing and maintaining relationships with physicians and hospitals, it could materially adversely affect our business, results of operations, financial condition and cash flows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div id="i916f7af890114e55a87e260476560c60_52"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are predominantly self-insured with respect to professional and general liability and workers' compensation risks through wholly-owned captive insurance companies.&#160;We are also predominantly self-insured with respect to employee medical and other health benefits. We also maintain insurance, excess coverage, or reinsurance for property and general liability, professional liability, directors&#8217; and officers&#8217; liability, workers' compensation, cybersecurity and other coverage in amounts and on terms deemed appropriate by management, based on our actual claims experience and expectations for future claims. Future claims could, however, exceed our applicable insurance coverage. Physicians practicing at our dialysis centers are required to maintain their own malpractice insurance, and our medical directors are required to maintain coverage for their individual private medical practices. Our liability policies cover our medical directors for the performance of their duties as medical directors at our outpatient dialysis centers.</span></div><div id="i916f7af890114e55a87e260476560c60_55"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human capital management</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At DaVita, we are guided by our Mission&#8212;to be the provider, partner and employer of choice&#8212;and a set of Core Values&#8212;Service Excellence, Integrity, Team, Continuous Improvement, Accountability, Fulfillment and Fun&#8212;which are reinforced at all levels of the organization. Our teammates share a common passion for improving patients' lives and are the cornerstone for the health of DaVita.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strive to be a community first and a company second, and affectionately call ourselves a Village. To be a healthy Village, we need to attract, retain and develop highly qualified and diverse teammates. To do so, we have implemented strategies that support our mission to be the employer of choice, such as: </span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Designing programs and processes to cultivate a diverse talent pipeline that can allow us to hire ahead of needs;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Providing development and professional growth opportunities; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Offering a robust and competitive total rewards program. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These efforts are underpinned by a foundational focus on diversity and belonging that starts at the top with our Board and executive leadership and permeates through our Village as further described below. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that this intentional investment of time and resources fosters a special community of teammates that, in turn, inspires the Village to take better care of our patients and better care of the communities in which we live.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oversight &amp; Management</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board provides oversight on human capital matters, receiving regular updates from our Chief People Officer about People Services&#8217; activities, strategies and initiatives, and through the Board&#8217;s annual work with our CEO on management development and succession planning. Among other things, our Board and/or its committees also receive reports related to pay equity, risks and trends related to labor and human capital management issues and general issues pertaining to our teammates. The Board, in conjunction with its committees, also oversees the Company's activities, policies and programs related to corporate environmental and social responsibility, including considering the impact of such activities, policies and programs on the Company, teammates, patients and communities, among others.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These reports and recommendations to the Board and its committees are part of our broader People Services leadership and oversight framework, which includes guidance from various stakeholders across the business and benefits from the broad participation of senior leadership. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity &amp; Belonging</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment in our teammates is underscored by our commitment to Diversity &amp; Belonging (D&amp;B). We published our first D&amp;B Report in March 2021, which disclosed our diversity metrics and roadmap for delivering our vision of cultivating "a diverse Village where everyone belongs." Our 3,154 dialysis centers operate in communities large and small, in nearly every state in the U.S. as well as ten other countries. Our Village's diversity is inherent in the teammates who work in our centers, the patients we care for, the physicians with whom we partner, and the communities where we serve.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To help achieve this vision, we empower all leaders and teammates to cultivate D&amp;B in their centers and on their teams. One way we do this is by sharing tools and resources like our Belonging Teammate and Belonging Leader Guides, which encourage teammates to connect with each other to learn about individual experiences with belonging and better understand the impact of unconscious bias. Based on our most recent internal surveys, 84% of teammates indicated that they feel a sense of belonging within the DaVita community. We also launched our second annual Week of Belonging in 2021, engaging approximately 69,000 teammates globally with activities and education designed to further create a sense of belonging.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We take a collaborative, leader-led approach to building our D&amp;B program. Everyone from our front-line patient care technicians (PCTs) and nurses to our divisional vice presidents, our CEO and our Board has a role in implementing our strategy. It truly does take a Village to bring our vision to life. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the past several years, our D&amp;B efforts have focused primarily on supporting strong representation of women and people of color in our Company and ensuring that we are creating a welcoming, open environment where all teammates, patients, physicians and care partners belong. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, our Village in the U.S. was comprised of 78% women and 55% people of color. We are proud of the fact that in the U.S. as of December&#160;31, 2021, 73% of our managers and 57% of our directors are women and that leaders with profit and loss responsibility are 54% women and 25% people of color. We also are proud that our Board is comprised of 44% women and 33% people of color. With respect to Board leadership positions, we are one of the few companies in the S&amp;P 500 to have a woman serving as the Chair of the Board. We are also one of the few S&amp;P 500 companies to have a person of color serve as our CEO. We publish our demographic data in our EEO-1 Report, which is included in our Sustainability Accounting Standards Board (SASB) Report.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Talent Pipeline and Career Development</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We understand that a key component of developing strong representation of women and people of color in leadership is to have recruiting practices focused on diversity. Some of our practices include: </span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diverse Sourcing: Our recruiters are trained on how to source for diverse candidates to ensure we have a robust pipeline at all levels of the organization.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diverse Partnerships: We have external partnerships with organizations like Forte Foundation and Management Leadership for Tomorrow to help create equal opportunities for diverse candidates.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Redwoods Leadership: We partner closely with diverse student body organizations at colleges and universities to source applicants for our Redwoods leadership development programs. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helping teammates reach the next stage in their career and increasing their earnings potential is one of our passions. We have several career development programs that support teammates to further their careers. To help ensure that teammates have the support needed to succeed in their current roles, and grow their careers, we have invested in an end-to-end career </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development pipeline that includes programs and initiatives that provide financial, academic and social support to our clinical and operations personnel to help achieve their higher education and leadership goals. We are proud of our Clinical Ladders program that ties performance and career progression. This program is designed to clarify for teammates what is expected in order to move to the next level on the ladder and help provide them with the tools to do so. Predominately all of our teammates are clinical field/operations personnel, and we have programs in place to help guide their potential journey at DaVita. Beginning with programs that cover certification fees for PCTs to coaching and tuition programs that help guide PCTs to becoming registered nurses (RNs) to programs that help develop high potential nurses, clinical coordinators and clinic nurse managers into operational managers and ultimately to programs that prepare and coach operational managers for potential regional operations director roles, our goal is to make resources available to teammates at each step of a possible career path. We are proud of the work we have done in this area, with approximately 64% of our Facility Administrators and managers having been promoted internally, as of December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total Rewards Program and Pay Equity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pay philosophy and practices are designed to be competitive in the local market and to reward strong team and individual performance. We believe merit-driven pay encourages teammates to do their best work, including in caring for our patients, and we strive to link pay to performance so we can continue to incentivize the provision of extraordinary care to our patients and grow our Village.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To help our teammates reach their full potential, we offer a total rewards package. More than just pay, our comprehensive compensation package connects teammates to robust health care coverage, resources for retirement planning and savings, opportunities for career development, and well-being resources for every stage of life. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer family support programs to our teammates and their families that include family care programs for back-up child and elder care, parental support and parental leave programs. We also offer a number of scholarships for teammates' children and grandchildren.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To support our teammates in maintaining strong physical and mental health, we offer a variety of physical and mental health benefits programs, including, among other things:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Teammate Assistance Program that offers counseling sessions annually to all teammates and their household members, along with work/life resources and tools that include telephonic or face to face legal consultation and expert financial planning/consultation. Each household member has access to ten free sessions per life event.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Free access to Headspace application for digital meditation and mindfulness and referrals/consultations on everyday issues such as dependent care, auto repair, pet care and home improvement.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vitality Points, a voluntary wellness incentive program that encourages teammates and their spouses/domestic partners to engage with their provider to manage their overall health. In addition, it allows participating teammates and spouses/domestic partners to earn credits toward their medical premium for getting a biometric screening with a primary care provider.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Short &amp; Long term disability for full time teammates and Life/AD&amp;D coverage at both the basic and supplemental levels.</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our DaVita Village Network, which provides financial support to eligible teammates experiencing a specific tragedy or hardship and helps cover additional costs that local fundraising and insurance do not fully cover.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer a robust suite of financial well-being programs for eligible teammates including, among others, a 401(k) program with company match, an employee stock purchase plan, health savings account funding for certain high deductible health plans and a deferred compensation plan. We also offer DailyPay, a service that provides teammates with financial flexibility by allowing them to access earned but unpaid wages before payday for a nominal fee. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pay Equity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At DaVita, we are committed to equal pay for equal work; meaning, teammates in the same position, performing at the same level, and in similar geographies, are paid fairly relative to one another, regardless of their gender, race or ethnicity. We believe that equitable pay is a critical component of establishing a fair work environment where all teammates are valued and feel like they belong. Fair pay is essential to our ability to attract and motivate the highly qualified, and diverse, teammates who are at the center of our current and future success.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Agile Response, Teammate Feedback and Responding to the Public Health Crisis</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has continued to test our ability to respond to external developments and care for our teammates in real time. One of our key goals during the pandemic has been to maintain frequent communication and engagement with teammates, including "town hall" and Q&amp;A calls, emails and more. We continued this practice in 2021, and as the pandemic continues to evolve, the scope of our teammate communications program has expanded to include COVID-19 testing, treatments, therapies, vaccines and boosters, as well as associated government actions and mandates. As the pandemic has persisted and in response to the hardship imposed by the pandemic on our teammates, and in recognition of their dedication and commitment to our patients&#8217; health, we provided financial support to teammates and we also continue to provide essential relief programs to support teammates, including backup childcare, modified sick policies and certain increased overtime pay for front-line positions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most importantly, the health and safety of our teammates, physician partners and their families remains a top priority throughout this ongoing pandemic. We implemented guidance early in the pandemic to help mitigate health and safety risks imposed by COVID-19, including, among other things:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Securing necessary supplies of personal protective equipment;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restricting visitors to our centers;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Screening teammates, patients and visitors for signs and symptoms of, or exposure to, COVID-19, before allowing entry into our clinics or business offices;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Implementing an early universal masking policy; </span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Educating teammates and patients on the benefits of the COVID-19 vaccines and boosters, and facilitating the administration of these to our teammates and patients; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Providing guidance on staying safe outside of our centers.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also converted our live, in-person teammate and leadership development programs to virtual delivery, to help ensure that our teammates across our global Village could continue to grow personally and professionally and have access to career development resources despite the ongoing pandemic.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our ability to engage with teammates and respond to these developments has helped us to better care for them. By caring for our teammates, we have been generally able to maintain continuity of care for our patients and support the broader healthcare community throughout this unprecedented public health crisis.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we employed approximately 69,000 teammates, including our international teammates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information about certain risks associated with our human capital management and our response to the COVID-19 pandemic, see the risk factors in Item 1A. Risk Factors under the headings, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is labor intensive and if our labor costs continue to rise, including due to shortages, changes in certification requirements and/or higher than normal turnover rates in skilled clinical personnel; or currently pending or future governmental laws, rules, regulations or initiatives impose additional requirements or limitations on our operations or profitability; or, if we are unable to attract and retain employees; or if union organizing activities or legislative or other changes result in significant increases in our operating costs or decreases in productivity, we may experience disruptions in our business operations and increases in operating expenses, among other things, any of which could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, many of which may have a material adverse impact on us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also encourage you to visit our website at www.davita.com/communitycare for more detailed information regarding certain aspects of our human capital and ESG related programs and initiatives described herein, including our D&amp;B Report, SASB Report and Policy on Fair and Equitable Pay, as well as our efforts to care for our patients, our community and our world. Nothing on our website, sections thereof or documents linked thereto, shall be deemed incorporated by reference into this report.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A.&#160;&#160;&#160;&#160;Risk Factors</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Annual Report on Form 10-K contains forward-looking statements within the meaning of the federal securities laws. Please read the cautionary notice regarding forward-looking statements in Item 7 of Part II of this Annual Report on Form 10-K under the heading "Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations." These forward-looking statements involve risks and uncertainties, including those discussed below, which could have a material adverse effect on our business, cash flows, financial condition, results of operations and/or reputation. The risks and uncertainties discussed below are not the only ones facing our business. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial could also have a material adverse effect on our business, cash flows, financial condition, results of operations and/or reputation.</span></div><div id="i916f7af890114e55a87e260476560c60_61"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary Risk Factors</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the principal risks and uncertainties that could adversely affect our business, cash flows, financial condition and/or results of operations, and these adverse impacts may be material. This summary is qualified in its entirety by reference to the more detailed descriptions of the risks and uncertainties included in this Item 1A. below and you should read this summary together with those more detailed descriptions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These principal risk and uncertainties relate to, among other things: </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Related to the Operation of our Business</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2773">the dynamic and evolving novel coronavirus pandemic</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2768">the complex set of governmental laws, regulations and other requirements that impact us, including potential changes thereto</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2763">the various lawsuits, demands, claims, </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2763">qui tam</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2763"> suits, governmental investigations and audits and other legal matters that we may be subject to from time to time</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2753">the number o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2753">r p</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2753">ercentage of patients with higher-paying </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2753">commer</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2753">cial insurance,</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2753"> the average rates that commercial payors pay us, any restrictions in plan designs or other contractual terms, including, without limitation, the scope and duration of coverage and in-network benefits</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2897">our ability to successfully implement our strategy with respect to</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2897"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2897">integrated ki</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2897">d</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2897">ney</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2897"> care, value-bas</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2897">ed care and</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2897"> home-based dialysis</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2748">changes in the structure of and payment rates under government-based programs</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2802">increases in labor costs, including, without limitation, due to shortages, changes in certification requirements and/or higher than normal turnover rates in skilled clinical personnel; currently pending or future governmental laws, rules, regulations or initiatives; our ability to attract and retain key leadership talent or employees; or union organizing activities or other legislative or other changes</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2758">our ability to comply with complex privacy and information security laws that impact us and/or our ability to properly maintain the integrity of our data, protect our proprietary rights to our systems or defend against cybersecurity attacks</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2728">our ability to establish and maintain supply relationships that meet our needs at cost-effective prices or at prices that allow for adequate reimbursement as applicable, as well as our ability to access new technology or superior products in a cost-effective manner</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2743">changes in clinical practices, payment rates or regulations impacting pharmaceuticals</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2738">our ability to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and physicians willing to serve as medical directors</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2723">our </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2723">U.S. </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2723">ancillary services and strategic initiatives</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2723"> and</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2723"> our international operations </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2723">and our ability to expand within markets or to new markets, or invest in new products or services</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2797">our ability to effectively maintain, operate or upgrade our information systems or those of third-party service providers upon which we rely, including, without limitation, our clinical, billing and collections systems</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2797">, and our ability </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2797">to adhere to federal and state data sharing and access requirements and regulations</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2733">our acquisitions, mergers, joint ventures or dispositions</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2792">our aspirations, goals and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2792">disclosures</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2792"> relat</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2792">ed to environment</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2792">al</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2792">, soc</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2792">ial and governance (ESG) matters</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2807">our ability to appropriately estimate the amount of dialysis revenues and related refund liabilities</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General Risks</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2859">our current or future level of indebtedness, including, without limitation, our ability to generate cash to service our indebtedness and for other intended purposes and our ability to maintain compliance with debt covenan</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2859">ts</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2885">changes in tax laws, regulations and interpretations or challenges to our tax positions</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2870">deterioration in economic conditions, general inflationary pressures, disruptions in the financial markets or the effects of natural or other disasters, political instability, public health crises or adverse weather events such as hurricanes, earthquakes, fires or flooding, including as such events may be impacted by the effects of climate change</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2880">liability claims for damages and other expenses that are not covered by insurance or exceed our existing insurance coverage</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2875">our ability to successfully maintain an effective internal control over financial reporting</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; and</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_2865">provisions in our organizational documents, our compensation programs and policies and certain requirements under Delaware law that may deter changes of control or make it more difficult for our stockholders to change the composition of our Board of Directors and take other corporate actions that our stockholders would otherwise determine to be in their best interests</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div id="i916f7af890114e55a87e260476560c60_64"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Operation of our Business</span></div><div id="i916f7af890114e55a87e260476560c60_2773"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, many of which may have a material adverse impact on us.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disease caused by the novel coronavirus (COVID-19) is impacting the world and our business in many different ways. The ultimate impact of COVID-19 on us will depend on future developments that are highly uncertain and difficult to predict, including among other things, the severity and duration of the pandemic; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus such as the Delta and Omicron variants; COVID-19's impact on the chronic kidney disease (CKD) patient population and our patient population including on the mortality of these patients; the availability, acceptance, impact and efficacy of COVID-19 vaccines, treatments and therapies; the pandemic&#8217;s continuing impact on our revenue and non-acquired growth due to lower treatment volumes, the U.S. and global economies, unemployment, labor market conditions, inflation and monetary policies; the potential negative impact on our commercial mix or the number of patients covered by commercial insurance plans; continued increased COVID-related costs; supply chain challenges and disruptions, including with respect to our clinical supplies; the responses of our competitors to the pandemic and related changes in the marketplace; the timing, scope and effectiveness of federal, state and local government responses; and any potential changes to the extensive set of federal, state and local laws, regulations and requirements that govern our business. The impact could come in many forms, including but not limited to those described below.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have experienced and expect to continue to experience a negative impact on revenue and non-acquired growth from COVID-19 due to lower treatment volumes, including from the negative impact of COVID-19 on the mortality rates of our patients, which has in turn impacted our patient census. Because ESKD patients may be older and generally have comorbidities, several of which are risk factors for COVID-19, we believe the mortality rate of infected patients has been higher in the dialysis population than in the general population, and COVID-19 also could impact the CKD population differently. Over the longer term, we believe that changes in mortality in both the CKD and ESKD populations due to COVID-19 will continue to depend primarily on the infection rate, case fatality rate, the age and health status of affected patients, and access to and continued efficacy of vaccinations or other treatments or therapies, particularly as it relates to variants of the virus, as well as willingness to be vaccinated. We expect that the impact of COVID-19 is likely to continue to negatively impact our revenue and non-acquired growth for a period of time even as the pandemic subsides due to the compounding impact of mortalities, among other things. However, determining the extent to which these impacts should be directly attributable to COVID-19 is difficult due to testing and reporting limitations, and other factors that may drive treatment volumes and new admissions over time, such as the number of transplants or deferred admissions. Depending on the ultimate severity and duration of the pandemic, the magnitude of these cumulative impacts could have a material adverse impact on our results of operations, financial condition and cash flows.</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business is labor intensive and our financial and operating results have been and continue to be sensitive to variations in labor-related costs and productivity. We have historically faced and expect to continue to face costs and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">difficulties in hiring and retaining caregivers due to a nationwide shortage of skilled clinical personnel. These challenges have been heightened by the increased demand for and demand upon such personnel by the ongoing pandemic.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The labor market is challenging and continues to experience volatility, uncertainty and labor supply shortages, particularly in healthcare. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, federal and state agencies have announced or released rules relating to COVID-19 vaccination requirements that may impact our teammates, provider and patients.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cumulative impact of these requirements, some of which have already gone into effect and some of which remain subject to legal challenge, as further described in Part I, Item 1. Business of this Form 10-K under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation&#8212;COVID-19 Response"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, contributes further to the volatility and uncertainty in the labor market and may ultimately further exacerbate labor shortages. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hese conditions have adversely impacted, and may continue to adversely impact, our ability to attract and retain employees, particularly clinical personnel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our continuing efforts in this highly competitive market, we have provided our teammates with additional compensation, among other things. In 2022, we expect to provide our teammates with higher than usual wage increases, which will put additional pressure on our cost structure going forward. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced staffing shortages and disruptions as a result of current labor market conditions and the current Omicron surge, and further staffing shortages or disruptions, if material, could lead to the unplanned closures of certain centers or adversely impact clinical operations, and may otherwise have a material adverse impact on our ability to provide dialysis services or the cost of providing those services, among other things. Prolonged volatility, uncertainty, labor supply shortages and other challenging labor market conditions, including, among other things, due to inflationary pressures or evolving monetary policies, could have an adverse impact on our ability to execute on our strategic initiatives, and ultimately could have a material adverse impact on our labor costs, results of operations, financial condition and cash flows.</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The COVID-19 pandemic and efforts to contain the virus have impacted the global economy, resulting in, among other things, volatility and uncertainty in labor market conditions as discussed in more detail above. These impacts could ultimately result in a materially reduced share of our patients being covered by commercial insurance plans, with more patients being covered by lower-paying government insurance programs or being uninsured. These effects may persist after the pandemic subsides as, among other things, our patients could experience permanent changes in their insurance coverage as a result of changes to their employment status. In the event such a material reduction occurs in the share of our patients covered by commercial insurance plans, it would have a material adverse impact on our business, results of operations, financial condition and cash flows. The extent of these effects will depend upon, among other things, the extent and duration of the increased unemployment levels for our patient population, any economic deterioration or potential recession; the timing and scope of federal, state and local governmental responses to the ongoing pandemic; and patients&#8217; ability to retain existing insurance and their individual choices with respect to their coverage, all of which are highly uncertain and difficult to predict.</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have dedicated and continue to dedicate substantial resources in response to COVID-19. We have incurred costs, and expect to continue to incur extended costs in the future in connection with our response to COVID-19, and the cumulative impact of these costs could be material. Among other things, our response to COVID-19 has resulted in higher salary and wage expense, and we have provided, and may provide in the future, substantial financial support to our teammates, which may include relief reimbursement. Additionally, the steps we have taken designed to help safely maintain continuity of care for our patients and help protect our caregivers, such as our policies to implement dedicated care shifts for patients with confirmed or suspected COVID-19 and other enhanced clinical practices, have increased our expenses and use of personal protective equipment (PPE). These efforts are part of a wider Prepare, Prevent, Respond and Recover protocol that includes operational initiatives such as the redistribution of teammates, machines and supplies across the country as needed, increased investment in and utilization of telehealth capabilities and administration of COVID-19 vaccines. These initiatives have increased our expenses and operational complexity, and also may involve execution and compliance risks. </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effort and cost needed to procure certain of our equipment and clinical supplies, including PPE, have substantially increased, and we expect these increased costs will continue. Certain of these increased costs may persist due to the overall challenges and disruptions of global supply chains. These global supply chain challenges have impacted the availability of certain of our equipment and clinical supplies. Prolonged strain on global supply chains may result in additional equipment and clinical supply shortages, disruptions, delays or associated price increases that could impact our ability to provide dialysis services or the cost of providing those services, among other things. </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rulemaking responses to COVID-19 by certain state and federal agencies, including without limitation OSHA and CMS, have also impacted our costs and operations and generated certain compliance risks. These regulations, described in detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Part I, Item 1. Business of this Form 10-K under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation&#8212;COVID-19 Response"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have resulted in increased costs related to, among other things, PPE, fit-testing, paid time off, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">surveillance testing of our teammates for COVID-19 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and other increased obligations with which we must comply.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As these requirements are continuing to evolve and develop, at this time we cannot predict the ultimate impact they may </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have on our business, results of operations, financial condition and cash flows. Compliance with COVID-19-related safety rules and regulations is enforced with sanctions and/or fines, and non-compliance also has the potential for negative publicity or reputational impact. If the pandemic requires us to maintain certain restrictive operational protocols for an extended period of time, it may adversely impact our strategic initiatives, such as our strategy to continue to build our abilities to offer home dialysis options and expanding our integrated care capabilities. </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We operate in a complex and highly regulated environment, and the novel nature of our COVID-19 response, including, among other things, with respect to waivers of certain regulatory requirements, temporary clinical and operational changes and administration of COVID-19 vaccines, some of which are currently available under emergency use authorizations, as well as our efforts to comply with related evolving rules and regulations may increase our exposure to legal, regulatory and clinical risks. In addition, in the event any of our temporary clinical and operational changes in response to COVID-19 become permanent, it could have an adverse impact on our business to the extent such changes result in increased costs or otherwise negatively impact our operations.</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we experience a failure of the fitness of our clinical laboratory, dialysis centers and related operations and/or other facilities as a result of the COVID-19 pandemic or otherwise, or another event or occurrence adversely impacts the safety of our caregivers or patients (or is alleged to have done so), we could face adverse consequences, including without limitation, material negative impact on our brand, increased litigation, compliance or regulatory investigations, teammate unrest, work stoppages or other workforce disruptions. Any governmental investigations or legal actions brought by patients, teammates, caregivers or others relating to the safety of our caregivers or patients or alleged exposure to COVID-19 at our facilities or by our caregivers may involve significant demands and require substantial legal defense costs, which may not be adequately covered by our professional and general liability insurance, and may materially harm our reputation.</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">State and local social distancing restrictions and guidance have required us to significantly increase the use of remote arrangements for our teammates and telehealth technology for our dialysis patients, which broadens our technology footprint for where and how protected health information is used or disclosed, and in turn increases our exposure to the various privacy and information security risks we face, such as the risk of "phishing" and other cybersecurity attacks and the risk of unauthorized dissemination of sensitive personal, proprietary or confidential information. </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our need, ability and willingness to use and retain any provider relief or other funds or assistance from the government, the consequences of our decisions with respect thereto, our ability to operate within any restrictions on our business or operations that may be imposed as a condition to participation in any government assistance programs, and the impact of any such programs on our competitors, all will depend, among other things, on the magnitude, timing and nature of COVID-19&#8217;s impact on the Company as well as the requirements of any such programs, which are uncertain. There can be no assurance that financial or other assistance will be available from the government if we have a need for such assistance in the future. </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If general economic conditions deteriorate further or remain uncertain for an extended period of time, we may incur future charges to recognize impairment in the carrying amount of our goodwill and other intangible assets. We may experience an increased need for additional liquidity funded by accessing existing credit facilities, raising new debt in the capital markets, or other sources, and we may seek to refinance existing debt, which may be more difficult or costly as a result of the pandemic&#8217;s impact on capital markets or on us. Furthermore, any extended billing or collection cycles, or deterioration in collectability of accounts receivable, will adversely impact our results of operations and cash flows. </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our value-based care and other programs where we assume financial accountability for total patient cost, an increase in COVID-19 rates among patients could have an impact on total cost of care. This increase may in turn impact the profitability of those programs relative to their respective funding.</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The global nature of the pandemic may have varying impacts on our ongoing operations outside the United States, and may impact our ability to expand our operations into other parts of the world.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing and other continued impacts and disruptions to our business in connection with the COVID-19 pandemic could have a material adverse impact on our patients, teammates, physician partners, suppliers, business, operations, reputation, financial condition, results of operations, cash flows and/or liquidity. In addition, the COVID-19 pandemic heightens many of the other risks and uncertainties discussed herein, and in many cases, may lead to impacts that persist even after the pandemic subsides. For additional information related to COVID-19 and its impact on our business, see the discussion in Part I, Item 1. Business of this Form 10-K under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and in Part II, Item 7. "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_2768"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a complex regulatory environment with an extensive and evolving set of federal, state and local governmental laws, regulations and other requirements that apply to us. These laws, regulations and other requirements are promulgated and overseen by a number of different legislative, regulatory, administrative, and quasi-regulatory bodies, each of which may have varying interpretations, judgments or related guidance. As such, we utilize considerable resources on an ongoing basis to monitor, assess and respond to applicable legislative, regulatory and administrative requirements, but there is no guarantee that we will be successful in our efforts to adhere to all of these requirements. Laws, regulations and other requirements that apply to or impact our business include, but are not limited to:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare and Medicaid reimbursement statutes, rules and regulations (including, but not limited to, manual provisions, local coverage determinations, national coverage determinations, payment schedules and agency guidance); </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare and Medicaid provider requirements, including, but not limited to, requirements associated with providing and updating certain information about the Medicare or Medicaid entity, as applicable, and its direct and indirect affiliates; </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Section 1115A of the Social Security Act, which, among other things, authorizes the Center for Medicare and Medicaid Innovation (CMMI) to test certain innovation models;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fraud waste and abuse laws;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the 21st Century Cures Act (the Cures Act);</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal Acquisition Regulations;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Foreign Corrupt Practices Act (FCPA) and similar laws and regulations; </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">antitrust and competition laws and regulations;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws and regulations related to the corporate practice of medicine;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws and regulations regarding the collection, use and disclosure of patient health information (e.g., Health Insurance Portability and Accountability Act of 1996 (HIPAA)); </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws and regulations regarding the storage, handling, shipment, disposal and/or dispensing of pharmaceuticals and blood products and other biological materials; and</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">individualized state laws and regulations associated with the operation of our business. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our personnel, representatives or operations are alleged to have violated these or other laws, regulations or requirements, we could experience material harm to our reputation and stock price, and it could impact our relationships and/or contracts related to our business, among other things. If any of our personnel, representatives, or operations are found to violate these or other laws, regulations or requirements, we could suffer additional severe consequences that could have a material adverse effect on our business, results of operations, financial condition and cash flows, including, among others:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of required certifications or suspension or exclusion from or termination of our participation in government programs (including, without limitation, Medicare, Medicaid and CMMI demonstration programs); </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Refunds of amounts received in violation of law or applicable payment program requirements dating back to the applicable statute of limitation periods; </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of licenses required to operate healthcare facilities or administer pharmaceuticals in the states in which we operate; </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reductions in payment rates or coverage for dialysis and ancillary services and pharmaceuticals; </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Criminal or civil liability, fines, damages or monetary penalties; </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Imposition of corporate integrity agreements, corrective action plans or consent agreements; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enforcement actions, investigations, or audits by governmental agencies and/or state law claims for monetary damages by patients who believe their protected health information (PHI) has been used, disclosed or not properly safeguarded in violation of federal or state patient privacy laws, including, among others, HIPAA and the Privacy Act of 1974; </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enforcement actions, investigations, or audits by government agencies related to interoperability and related data sharing and access requirements and regulations;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mandated changes to our practices or procedures that significantly increase operating expenses that could subject us to ongoing audits and reporting requirements as well as increased scrutiny of our billing and business practices which could lead to potential fines, among other things;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Termination of various relationships and/or contracts related to our business, such as joint venture arrangements, medical director agreements, hospital services and skilled nursing home agreements, real estate leases, value-based care arrangements, clinical incentive programs, payor contracts and consulting or participating provider agreements with physicians, among others; and </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Harm to our reputation, which could negatively impact our business relationships and stock price, our ability to attract and retain patients, physicians and teammates, our ability to obtain financing and our access to new business opportunities, among other things.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any future penalties, sanctions or other consequences could be more severe in certain circumstances if the OIG or a similar regulatory authority determines that we knowingly or repeatedly failed to comply with laws, regulations or requirements that apply to our business. Additionally, the healthcare sector, including the dialysis industry, is regularly subject to negative publicity, including as a result of governmental investigations, adverse media coverage and political debate surrounding the U.S. healthcare system, among other things. Negative publicity, regardless of merit, regarding the dialysis industry generally, the U.S. healthcare system or DaVita in particular may adversely affect us. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 16 to the consolidated financial statements included in this report for further details regarding certain pending legal proceedings and regulatory matters to which we are or may be subject from time to time, any of which may include allegations of violations of applicable laws, regulations and requirements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the laws, regulations and other requirements that govern our business may continue to change over time, and there is no assurance that we will be able to accurately predict the nature, timing or extent of such changes or the impact of such changes on the markets in which we conduct business or on the other participants that operate in those markets.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, the regulatory framework of the healthcare marketplace continues to evolve as a result of executive, legislative, regulatory and administrative developments and judicial proceedings. These changes shape the landscape for our current dialysis and ancillary businesses as well as for emerging comprehensive and integrated kidney care markets. For example, we have made substantial investments in and dedicated resources to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our integrated care business, value-based care initiatives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and home-based dialysis business to address the executive order issued in July 2019 (the 2019 Executive Order) that directed CMS to create payment models through CMMI to evaluate the effects of creating payment incentives for the greater use of home-based dialysis and kidney transplants for those already on dialysis, improve quality of care for kidney patients and reduce expenditures. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the expanded access to healthcare developed under the Patient Protection and Affordable Care Act and the Health Care Reconciliation Act of 2010, as amended (collectively, the ACA) has been both positively and negatively impacted over time by subsequent legal, regulatory and judicial action. If the ACA is significantly altered or if other reforms limiting access to healthcare are enacted in the future, such changes could impact our business in a number of ways, some of which may be material. For example, any change in CMMI&#8217;s authority to implement innovative payment models, as enacted by the ACA, could cause us to lose the substantial investments and resources we have dedicated to those programs. In addition, the ACA's health insurance exchanges, which provide a marketplace for eligible individuals and small employers to purchase health insurance, initially increased the accessibility and availability of commercial insurance. In the event the exchange markets are significantly impaired as a result of legislative developments or other changes, it may adversely impact the percentage of our patients with higher-paying commercial health insurance, particularly if patients become unemployed due to factors related to the COVID-19 pandemic or otherwise and are unable to turn to the exchanges as an alternative to employer-based coverage. For additional information on the impact of the COVID-19 pandemic on our share of patients covered by commercial insurance plans, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, many of which may have a material adverse impact on us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" Because our revenue and operating income levels are </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">highly sensitive to the percentage and number of our patients with higher-paying commercial health insurance, any legislative, regulatory or other changes that decrease the accessibility and availability, including the duration, of commercial insurance is likely to have a material adverse impact on our business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to the political environment may increase the likelihood of regulatory or legislative changes that would impact us, such as changes to the healthcare regulatory landscape or to the federal corporate tax rate. Examples of such potential changes are described in more detail in Part I, Item 1. Business of this Form 10-K under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Some of these and other related changes could in turn impact the percentage of our patients with higher-paying commercial health insurance, impact the scope or terms of coverage under commercial health plans and/or increase our expenses, among other things. The timing of any legislative or executive action related to these potential initiatives remains uncertain, particularly in light of the ongoing COVID-19 pandemic, and as such, considerable uncertainty exists surrounding the continued development of the ACA and related regulations, programs and models, as well as similar healthcare reform measures and/or other changes that may be enacted at the federal and/or state level to laws, regulations and other requirements that govern our business. Although we cannot predict the short- or long-term effects of legislative or regulatory changes, future market changes could result in, among other things, more restrictive commercial plans with lower reimbursement rates or higher deductibles and co-payments that patients may not be able to pay. In addition, to the extent that monetary policies or other factors contribute to an increase in inflationary pressures, this may in turn increase our labor and supply costs at a rate that outpaces the Medicare or any other rate increases we may receive. For additional information on the impact of economic conditions or legislative or regulatory changes on the coverage and rates for our services and the percentage or number of our patients with commercial insurance, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If the number or percentage of patients with higher-paying commercial insurance declines, if the average rates that commercial payors pay us decline, if patients in commercial plans are subject to restriction in plan designs, or if we are unable to maintain contracts with payors with competitive terms, including, without limitation, reimbursement rates, scope and duration of coverage and in-network benefits, it could have a material adverse effect on our business, results of operations, financial condition and cash flows."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to the continuously evolving healthcare regulatory landscape may also have the potential to generate opportunities with relative ease of entry for certain smaller and/or non-traditional providers and we may be competing with them for patients in an asymmetrical environment with respect to data and/or regulatory requirements given our status as an ESRD service provider. For additional detail on our evolving competitive environment, see the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"If we are unable to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and developing and maintaining relationships with physicians and hospitals, it could materially adversely affect our business, results of operations, financial condition and cash flows." </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have also been several state initiatives to limit payments to dialysis providers or impose other burdensome operational requirements, which, if passed, could have a material adverse impact on our business, results of operation, financial condition and cash flow. For instance, in 2020, voters in California considered a statewide ballot initiative proposed by </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Service Employees International Union - United Healthcare Workers West (SEIU) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that sought to impose certain regulatory requirements on dialysis clinics, including requirements related to physician staffing levels, clinical reporting, clinical treatment options and limitations on the ability to make decisions on closing or reducing services for dialysis clinics. While voters rejected this ballot initiative in 2020, we incurred substantial costs to oppose it. On August 25, 2021, SEIU again </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proposed a California statewide ballot initiative with similar provisions. In the event this proposal becomes eligible for the November 2022 election, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we expect to again incur substantial costs to oppose it. We may face ballot initiatives or other proposed regulations or legislation in California or other states in future years, which may require us to incur further substantial costs and which, if passed, could have a material adverse impact on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, there have </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> been rule making and legislative efforts at both the federal and state level regarding the use of charitable premium assistance for ESRD patients that may establish new conditions for coverage standards for dialysis facilities. For example, on October 13, 2019, a California bill (AB 290) was signed into law that limits the amount of reimbursement paid to certain providers for services provided to patients with commercial insurance who receive charitable premium assistance. The American Kidney Fund (AKF), an organization that provides charitable premium assistance, announced that it would be withdrawing from California as a result of AB 290. The implementation of AB 290 has been stayed pending resolution of legal challenges, but in the event AB 290 becomes effective and the AKF withdraws from California, it may cause other organizations that provide charitable premium assistance to withdraw from California, and we would expect an adverse impact on the ability of patients to afford Medicare premiums and Medicare supplemental and commercial coverage. We expect that such an adverse impact will in turn adversely impact our business, results of operations, financial condition and cash flows. Bills similar to AB 290 were introduced in other states, but have not been successfully passed to date. If these or similar bills are introduced and implemented in other jurisdictions, and organizations that provide charitable premium assistance in those jurisdictions are similarly impacted, it could in the aggregate have a material adverse impact on our business, results of operations, financial condition and cash flows. For additional information on risks associated with charitable premium assistance for ESRD patients and the potential impact of decreases to the percentage or number of our patients with commercial </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance, see the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"If the number or percentage of patients with higher-paying commercial insurance declines, if the average rates that commercial payors pay us decline, if patients in commercial plans are subject to restriction in plan designs, or if we are unable to maintain contracts with payors with competitive terms, including, without limitation, reimbursement rates, scope and duration of coverage and in-network benefits, it could have a material adverse effect on our business, results of operations, financial condition and cash flows."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, legislation, regulations, regulatory guidance, ballot initiatives and any similar initiatives could result in a reduction in the percentage of our patients with commercial insurance; limit the scope or nature of coverage through the exchanges or other health insurance programs or otherwise reduce reimbursement rates for our services from commercial and/or government payors; restrict or prohibit the ability of patients with access to alternative coverage from selecting a marketplace plan on or off exchange; limit the amount of revenue that a dialysis provider can retain for caring for patients with commercial insurance; impose burdensome operational requirements; affect payments made to providers for services provided to patients who receive charitable premium assistance and/or otherwise restrict or prohibit the use of charitable premium assistance; or reduce the standards for network adequacy or require disclosure of certain pricing and patient responsibility information. In turn, these potential impacts could cause us to incur substantial costs to oppose any such proposed requirements or measures, impact our dialysis center development plans, and if passed and/or implemented, could materially reduce our revenues and increase our operating and other costs, adversely impact dialysis centers across the U.S. making certain centers economically unviable, lead to the closure of certain centers, restrict the ability of dialysis patients to obtain and maintain optimal insurance coverage and reduce the number of patients that select commercial insurance plans or MA plans for their dialysis care, among other things. The healthcare legislative and regulatory environment is dynamic and evolving, and any such proposed or issued laws, requirements, rules and guidance could impact our business, including as may be described above, and any failure on our part to adequately adjust to any resulting marketplace developments or regulatory compliance requirements, may, among other things, erode our patient base or reimbursement rates and could otherwise have a material adverse effect on our business, results of operations, financial condition and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that the information above describes statutory and regulatory provisions, it is qualified in its entirety by reference to the particular statutory and regulatory provisions that are referenced. For additional information related to the laws, rules and other regulations described above, please see Part I, Item 1. Business of this Form 10-K under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div id="i916f7af890114e55a87e260476560c60_2763"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are, and may in the future be, a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> suits, governmental investigations and audits and other legal matters, any of which could result in, among other things, substantial financial penalties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or awards against us, mandated refunds, substantial payments made by us, required changes to our business practices, exclusion from future participation in Medicare, Medicaid and other healthcare programs and possible criminal penalties, any of which could have a material adverse effect on our business, results of operations, financial condition, cash flows, reputation and stock price.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are, and may in the future be, subject to investigations and audits by governmental agencies and/or private civil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by relators and other lawsuits, demands, claims, legal proceedings and/or other actions, including, without limitation, investigations or other actions resulting from our obligation to self-report certain suspected violations of law. Any allegations against us, our personnel or our representatives in such matters may among other things harm our reputation, stock price, and our various business relationships and/or contracts related to our business, and these impacts may be material.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Responding to subpoenas, investigations and other lawsuits, claims and legal proceedings, as well as defending ourselves in such matters, will continue to require management's attention and cause us to incur significant legal expense. Negative developments, findings or terms and conditions that we might agree to accept as part of a negotiated resolution of pending or future legal or regulatory matters could result in, among other things, harm to our reputation, substantial financial penalties or awards against us, substantial payments made by us, required changes to our business practices, impacts on our various relationships and/or contracts related to our business, exclusion from future participation in Medicare, Medicaid and other healthcare programs and, in certain cases, criminal penalties, any of which could have a material adverse effect on us. It is possible that criminal proceedings may be initiated against us and/or individuals in our business in connection with governmental investigations. In that regard, as further described in Note 16 to the consolidated financial statements included in this report, in the U.S. District Court, District of Colorado in 2021, a grand jury returned an indictment against the Company and its former chief executive officer in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. v. DaVita Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., alleging that purported agreements entered into by DaVita's former chief executive officer not to solicit senior-level employees violate Section 1 of the Sherman Act. Other than as may be described in Note 16 to the consolidated financial statements included in this report, we cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which we are or may be subject from time to time, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on our business, results of operations, financial condition, cash flows, reputation and stock price. See Note 16 to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the consolidated financial statements included in this report for further details regarding these and other legal proceedings and regulatory matters.</span></div><div id="i916f7af890114e55a87e260476560c60_2753"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If the number or percentage of patients with higher-paying commercial insurance declines, if the average rates that commercial payors pay us decline, if patients in commercial plans are subject to restriction in plan designs, if we are unable to maintain contracts with payors with competitive terms, including, without limitation, reimbursement rates, scope and duration of coverage and in-network benefits, it could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of our U.S. dialysis net patient services revenues for the year ended December 31, 2021 was generated from patients who have commercial payors (including hospital dialysis services) as their primary payor. The majority of these patients have insurance policies that pay us on terms and at rates that are generally significantly higher than Medicare rates, and as such our revenue and net income levels are sensitive to the number of our patients with higher-paying commercial insurance coverage and the percentage of our patients under higher-paying commercial plans relative to government-based programs. The payments we receive from commercial payors generate nearly all of our profit and all of our nonacute dialysis profits come from commercial payors. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When Medicare becomes the primary payor for a patient, the payment rate we receive for that patient decreases from the employer group health plan or commercial plan rate to the lower Medicare payment rate. If the number of our patients who have Medicare or another government-based program as their primary payor increases, it could negatively impact the percentage of our patients covered under commercial insurance plans. There are a number of factors that could drive a decline in the number or percentage of our patients covered under commercial insurance plans, including, among others, a continued decline in the rate of growth of the ESRD patient population, improved mortality, changes in the patient's or a family member's employment status, reduced availability of commercial health plans or reduced coverage by such plans through the ACA exchanges or otherwise due to changes to the marketplace, healthcare regulatory system or otherwise. Commercial payors could also cease paying in the primary position after providing 30 months of coverage resulting in potentially material reductions in payment as the patient moves to Medicare primary. Declining macroeconomic conditions, such as, for example, those resulting from the ongoing COVID-19 pandemic, could also negatively impact the percentage of our patients covered under commercial insurance plans. To the extent there are sustained or increased job losses in the U.S., we could experience a decrease in the number of patients covered under commercial plans and/or an increase in uninsured and underinsured patients independent of whether general economic conditions improve. If we experience higher numbers of uninsured or underinsured patients, it also would result in an increase in uncollectible accounts. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our arrangements and negotiations with payors also impact the number or percentage of patients with higher-paying commercial insurance. We continuously are in the process of negotiating existing and potential new agreements with commercial payors who aggressively negotiate terms with us, and we can make no assurances about the ultimate results of these negotiations or the timing of any potential rate changes resulting from these negotiations. Sometimes many significant agreements are being renegotiated at the same time. A material portion of our commercial revenue is concentrated with a limited number of commercial payors, and any changes impacting our highest paying commercial payors or our relationships with these payors will have a disproportionate impact on us. We believe payor consolidations have significantly increased the negotiating leverage of commercial payors, and ongoing consolidations may continue to increase this leverage in the future. We continue to experience downward pressure on some of our commercial payment rates as a result of these and other general conditions in the market, including, among other things, as employers shift to less expensive options for medical services, as commercial payors dedicate increased focus on dialysis services. In addition, our agreements and rates with commercial payors may be impacted by new business activities of these commercial payors as well as steps that these commercial payors have taken and may continue to take to control the cost of and/or the eligibility for access to the services that we provide, including, without limitation, relative to products on and off the healthcare exchanges. These efforts could impact the number of our patients who are eligible to enroll in commercial insurance plans, and remain on the plans, including plans offered through healthcare exchanges. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our negotiations with commercial payors may relate to commercial fee-for-service contracts, value-based care (VBC) contracts in which we share risk with commercial payors, as well as contracts to provide dialysis services to Medicare Part C Medicare Advantage (MA) patients. If we fail to maintain contracts with payors and other healthcare providers with competitive or favorable terms, either with respect to commercial plans, commercial VBC contracts, MA plans or otherwise, including, without limitation, with respect to reimbursement rates, scope and duration of coverage and in-network benefits, contract term or termination rights, or if we fail to accurately estimate the price for and manage our medical costs in an effective manner, whether due to inflationary pressures or otherwise, such that the profitability of our commercial or other value-based products are negatively impacted, it could have a material adverse effect on our business, results of operations, financial condition and cash flows. The ultimate result of our negotiations with payors cannot be predicted as they occur in a highly competitive environment and are influenced by those aforementioned marketplace dynamics. Among other things, these </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">negotiations may result in termination or non-renewals of existing agreements, decreases in contracted rates, and reduction in the number of our patients that are covered by commercial plans, and we may not be able to enter into new agreements on competitive terms or at all. In the event that our ongoing negotiations result in overall commercial rate reductions in excess of overall commercial rate increases, the cumulative effect could have a material adverse effect on our business, results of operations, financial condition and cash flows. In addition, to the extent that these negotiations result in a reduction in the number of our patients covered by commercial plans, it could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain payors have been attempting to design and implement plans that restrict access to ESRD coverage both in the commercial and individual market. Among other things, these restrictive plan designs seek to limit the duration and/or the breadth of ESRD benefits, limit the number of in-network providers, set arbitrary provider reimbursement rates, or otherwise restrict access to care, all of which may result in a decrease in the number of patients covered by commercial insurance. Payors have also disputed the scope and duration of ESRD benefit coverage under their plans, and, among other things, have required patients to seek Medicare coverage for ESRD treatments. The U.S. Supreme Court has accepted review of a case evaluating the scope and impact of the Medicare as Secondary Payor Act (MSPA). For additional information on the appeal, see Note 16 to the consolidated financial statements included in this report. If the Court declines to uphold the protections of the MSPA such that more plans seek to implement plan designs that discourage patients from retaining their commercial coverage, it may lead to a significant decrease in the number of patients with commercial plans, the duration of benefits for patients under commercial plans and/or a significant decrease in the payment rates we receive, any of which would have a material adverse effect on our business, results of operations, financial condition and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, some commercial payors are pursuing or have incorporated policies into their provider manuals limiting or refusing to accept charitable premium assistance from non-profit organizations, such as the American Kidney Fund, which may impact the number of patients who are able to afford commercial plans. Paying for coverage is a significant financial burden for many patients, and ESRD disproportionately affects the low-income population. Charitable premium assistance supports continuity of coverage and access to care for patients, many of whom are unable to continue working full-time as a result of their severe health condition. Many patients with commercial and government insurance also rely on financial assistance from charitable organizations, such as the American Kidney Fund. Certain payors have challenged our patients' and other providers' patients' ability to utilize assistance from charitable organizations for the payment of premiums, including, without limitation, through litigation and other legal proceedings. The use of charitable premium assistance for ESRD patients has also faced challenges and inquiries from legislators, regulators and other governmental authorities, and this may continue. In addition, CMS or another regulatory agency or legislative authority may issue a new rule or guidance that challenges or restricts charitable premium assistance. If any of these challenges to kidney patients' use of premium assistance is successful or restrictions are imposed on the use of financial assistance from such charitable organizations or if organizations providing such assistance are no longer available such that kidney patients are unable to obtain, or continue to receive or receive for a limited duration, such financial assistance, it may restrict the ability of dialysis patients to obtain and maintain optimal insurance coverage and could have a material adverse effect on our business, results of operations, financial condition and cash flows. In addition, if our assumptions about how kidney patients will respond to any change in financial assistance from charitable organizations are incorrect, it could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our negotiations and relationships with payors may also be impacted by legislative or regulatory developments and associated legal rulings. For example, the final rules for the Cures Act, which are described in detail in Part I, Item 1. Business of this Form 10-K under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation&#8212;21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Century Cures Act,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">broadened ESRD patient access to certain enhanced benefits offered by MA plans. While these rules increased our MA plan enrollment for ESRD benefits in their first year, the potential ultimate impact of this change in benefit eligibility remains subject to change as market participants continue to adjust to this new regulatory environment. As an example, the removal of objective time and distance standards relating to network adequacy for outpatient dialysis centers for MA plans that was included in the final rules may adversely impact the number of ESRD patients that select MA plans and also may result in the Company not being an in-network provider for significant MA plans in the event MA plans attempt to use this revision to the rules to limit or restrict their networks. If kidney patients choose not to enroll in MA plans or choose to leave MA plans, whether due to network adequacy standards or otherwise, or if we fail to provide education to kidney patients in the manner specified by CMS, we could be subject to certain clinical, operational, financial and legal risks, which could have a material adverse effect on our business, results of operations, financial condition and cash flows. In addition, recent price transparency regulations require most group health plans and health insurance issuers in the group and individual markets to make certain pricing and patient responsibility information publicly available. For further detail on these regulations see the discussion in Part I, Item 1. Business of this Form 10-K under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation&#8212;Price Transparency Rules.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" While the ultimate impact of these requirements remains uncertain, any changes by group health plans, health insurance issuers in the group and individual markets, or consumer choices resulting from these requirements could have a material adverse impact on our business, results of operations, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and financial condition, and our reputation could be materially harmed. We could also experience a further decrease in the payments we receive for services if changes to the marketplace or the healthcare regulatory system result in fewer patients covered under commercial plans or an increase of patients covered under more restrictive commercial plans with lower reimbursement rates, among other things. For additional details regarding potential legislative or regulatory changes, the specific risks we face in connection with any decrease in payments we receive for services due to, for example, fewer patients being covered under commercial plans or an increase of patients covered under more restrictive commercial plans with lower reimbursement rates, please see Part I, Item 1. Business of this Form 10-K under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the discussion in the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted, the foregoing dynamics of our arrangements and negotiations with commercial payors each may have an impact on, among other things, our ability to enter into and maintain contracts with payors with competitive terms, including, without limitation, reimbursement rates, scope and duration of coverage and in-network benefits as well as the number or percentage of our patients with higher-paying commercial insurance. If, as a result of these or other dynamics, we experience a decline in the average rates that commercial payors pay us or a reduction in the number of patients with ESRD coverage under higher-paying commercial plans either in total or relative to the number of patients under government-based programs that pay at lower rates or an increase in the number of patients that are uninsured or underinsured, it could have a material adverse effect on our business, results of operations, financial condition and cash flows. </span></div><div id="i916f7af890114e55a87e260476560c60_2897"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are not able to successfully implement our strategy with respect to our integrated kidney care and value-based care initiatives, including maintaining our existing business and further developing our capabilities in a complex and highly regulated environment, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">it could result in a loss of our investments and have a material adverse effect on our growth strategy, could adversely impact our business, results of operations, financial condition and cash flows, and could materially harm our reputation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our integrated kidney care business manages patients and coordinates their care through value-based care arrangements with commercial payors and through government programs. We have continued to grow this portion of our business both with commercial payors, including as Medicare Advantage has expanded, and with government programs as CMS and CMMI implement new payment models focused on comprehensive and integrated kidney care. A</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s part of our growth strategy, we have invested and expect to continue to invest substantial resources in the further development of our integrated care business and value-based care initiatives. There can be no assurances that we will be able to successfully implement our strategies with respect to integrated kidney care and value-based care in a complex, evolving and highly competitive and regulated environment, including, among other things, maintaining our existing business; recovering our investments; entering into agreements with payors, physicians, third party vendors and others on competitive terms, as appropriate, that prove actuarially sound; structuring these agreements and arrangements to comply with evolving rules and regulations, including, among other things, rules and regulations related to fraud and abuse and the use of protected health information; and further developing our operational, IT and other capabilities to enable us to provide competitive programs at scale. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New entrants are aggressively pursuing opportunities to participate in the new CMMI payment models, and with increasing investment and funding, these new entrants may adopt strategies that increase our costs to participate in these payment models and/or adversely impact our ability to enter into competitive arrangements. For additional detail on our evolving competitive environment, see the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"If we are unable to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and developing and maintaining relationships with physicians and hospitals, it could materially adversely affect our business, results of operations, financial condition and cash flows." </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of these or other of our integrated kidney care and value-based care initiatives are unsuccessful, it could result in a loss of our investments and have a material adverse effect on our growth strategy, could adversely impact our business, results of operations, financial condition and cash flows, and could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, future legislative or regulatory action related to, among other things, integrated kidney care and/or full capitation demonstration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for ESRD may impact our ability to provide a competitive and successful integrated care program at scale. There can be no assurances that any other legislation or regulation that aligns with our strategy and investments will be passed into law or enacted, and the ongoing COVID-19 pandemic may delay the progress of such initiatives. Additionally, the ultimate terms and conditions of any such potential legislative or regulatory action remain unclear. For example, our costs of care could exceed our associated reimbursement rates under such legislation. Irrespective of whether such laws are passed, there can be no assurances that we will be able to successfully execute on the required strategic initiatives that would allow us to provide a competitive and successful integrated care program on a broad scale, and in the desired time frame. Any failure on our part to adequately implement strategic initiatives to adjust to any marketplace developments resulting from executive, legislative, regulatory or administrative changes could have a material adverse impact on our business. For additional detail on risks associated with operating in a highly regulated environment, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition to the above risks, certain risks inherent to implementation of our strategies with respect to integrated kidney care and value-based care initiatives will increase as we work to expand these offerings, including risks related to developing our operational, IT, billing and telehealth systems, among others. For additional detail on risks associated with information systems and new technology generally, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Failing to effectively maintain, operate or upgrade our information systems or those of third-party service providers upon which we rely, including, without limitation, our clinical, billing and collections systems, or failure to adhere to federal and state data sharing and access requirements and regulations, could materially adversely affect our business, results of operations, financial condition, cash flows and reputation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are not able to successfully implement our strategy with respect to home-based dialysis, including maintaining our existing business and further developing our capabilities in a complex and highly regulated environment, it could have a material adverse effect on our business, results of operations, financial condition and cash flows, and could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our home-based dialysis services, which include home hemodialysis and peritoneal dialysis (PD), represented approximately 18% of our U.S. dialysis patient services revenues for the year ended December 31, 2021, and have increasingly become an important part of our overall strategy. In addition, home-based dialysis recently has been the subject of increased political and industry focus. For example, in connection with the 2019 Executive Order, HHS set out specific goals related to home dialysis and CMMI&#8217;s ESRD Treatment Choices (ETC) mandatory payment model and voluntary payment models included new incentives to encourage dialysis at home. More recently, CMS finalized changes to the ETC model and other regulations to encourage dialysis facilities and healthcare providers to seek to decrease disparities in health equity across racial and socioeconomic status in rates of home dialysis and kidney transplants among ESRD patients. We are a leader in home-based dialysis and have made investments in processes and infrastructure to continue to grow this modality. There are, however, risks associated with this growth, including, among other things, financial, legal and operational risks related to our ability to design and develop infrastructure and to plan for capacity in a modality that is part of an evolving marketplace. We may also be subject to associated risks related to our ability to successfully manage related operational initiatives, find, train and retain appropriate staff, contract with payors for appropriate reimbursement, and maintain processes to adhere to the complex regulatory and legal requirements, including without limitation those associated with billing Medicare. For additional detail on risks associated with operating in a highly regulated environment, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition to the above risks, certain risks inherent to home-based dialysis will increase as we expand our home-based dialysis offerings, including risks related to managing transitions between in-center and home-based dialysis, billing and telehealth systems, among others. For additional detail on risks associated with information systems and new technology generally, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Failing to effectively maintain, operate or upgrade our information systems or those of third-party service providers upon which we rely, including, without limitation, our clinical, billing and collections systems, or failure to adhere to federal and state data sharing and access requirements and regulations, could materially adversely affect our business, results of operations, financial condition, cash flows and reputation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An increased focus on home-based dialysis is also indicative of the generally evolving market for kidney care. This developing market may create additional opportunities for competition with relative ease of entry, and if we are unable to successfully adapt to these or other marketplace developments, which, among other things, may include regulatory changes with respect to conditions of coverage, in a timely and compliant manner, we may experience a material adverse impact on our growth in home-based dialysis or a reduction in our overall number of patients, among other things. Our response to the COVID-19 pandemic has also required us to impose certain operational restrictions that may adversely impact certain home-based dialysis initiatives, and the extent of this impact may depend on the severity or duration of the pandemic, among other things. For additional detail on the competitive landscape in kidney care, see the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"If we are unable to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and developing and maintaining relationships with physicians and hospitals, it could materially adversely affect our business, results of operations, financial condition and cash flows."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and for additional detail on the impact of COVID-19 on our home-based dialysis business, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, many of which may have a material adverse impact on us."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If we are not able to successfully implement our strategy with respect to home-based dialysis, including maintaining our existing business and further developing our capabilities in a complex and highly regulated environment, it could have a material adverse effect on our business, results of operations, financial condition and cash flows, and could materially harm our reputation.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_2748"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in the structure of and payment rates under the Medicare ESRD program or changes in state Medicaid or other non-Medicare government-based programs or payment rates could have a material adverse effect on our business, results of operations, financial condition and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of our dialysis revenues are generated from patients who have Medicare as their primary payor. For patients with Medicare coverage, all ESRD payments for dialysis treatments are currently made under a single bundled payment rate which provides a fixed payment rate to encompass all goods and services provided during the dialysis treatment that are related to the treatment of dialysis, subject to certain adjustments as described below. Most lab services are also included in the bundled payment. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the ESRD Prospective Payment System (PPS), bundled payments to a dialysis facility may be reduced by as much as 2% based on the facility's performance in specified quality measures set annually by CMS through the ESRD Quality Incentive Program, which was established by the Medicare Improvements for Patients and Providers Act of 2008. The bundled payment rate is also adjusted for certain patient characteristics, a geographic usage index and certain other factors. In addition, the ESRD PPS is subject to rebasing, which can have a positive financial effect, or a negative one if the government fails to rebase in a manner that adequately addresses the costs borne by dialysis facilities. Similarly, as new drugs, services or labs are added to the ESRD bundle, CMS' failure to adequately calculate or fund the costs associated with the drugs, services or labs could have a material adverse effect on our business, results of operations, financial condition and cash flows. In certain instances, new injectable, intravenous or oral products may be reimbursed separately from the bundled payment for a defined period of time through a transitional drug add-on payment adjustment (TDAPA). For a discussion of certain risks associated with this transitional pricing process, see the risk factor under the heading, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in clinical practices, payment rates or regulations impacting pharmaceuticals could have a material adverse effect on our business, results of operations, financial condition, and cash flows and negatively impact our ability to care for patients."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current bundled payment system presents certain operating, clinical and financial risks, which include, without limitation:</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk that our rates are reduced by CMS. CMS publishes a final rule for the ESRD PPS each year and uncertainty about future payment rates remains a material risk to our business.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk that CMS, on its own or through its contracted Medicare Administrative Contractors (MACs) or otherwise, implements Local Coverage Determinations (LCDs) or implements payment provisions, policy or regulatory mandates, including changes to the existing or future PPS, that limit our ability to either be paid for covered dialysis services or bill for treatments or other drugs and services or other rules that may impact reimbursement. Such payment rules and regulations and coverage determinations or related decisions could have an adverse impact on our operations and revenue. There is also risk that commercial insurers could seek to incorporate the requirements or limitations associated with such LCDs or CMS guidance into their contracted terms with dialysis providers, which could have an adverse impact on our revenue. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk that a MAC, or multiple MACs, change their interpretations of existing regulations, manual provisions and/or guidance, or seek to implement or enforce new interpretations that are inconsistent with how we have interpreted existing regulations, manual provisions and/or guidance.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk that CMS implements data and related reporting requirements that result in decreased reimbursement and/or increased technology and operational costs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk that increases in our operating costs will outpace the Medicare rate increases we receive. We expect operating costs to continue to increase due to inflationary factors, such as increases in labor and supply costs, including, without limitation, increases in maintenance costs and capital expenditures to improve, renovate and maintain our facilities, equipment and information technology to meet changing regulatory requirements and business needs, regardless of whether there is a compensating inflation-based increase in Medicare payment rates or in payments under the bundled payment rate system. </span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk of continued federal budget sequestration cuts or other disruptions in federal government operations and funding. As a result of the Budget Control Act of 2011, the Bipartisan Budget Act (BBA) and the CARES Act, an annual 2% reduction to Medicare payments took effect on April 1, 2013, and has been extended through 2030 (though the reduction was temporarily suspended from May 1, 2020 through March 31, 2022 in connection with COVID-19 relief related legislation; from April 2022 through June 2022 a 1% sequester cut will be in effect, with a full 2% reduction resuming thereafter). These across-the-board spending cuts have affected and will continue to adversely affect our business, results of operations, financial condition and cash flows. Any extended disruption in federal government operations and funding, including an extended government shutdown, U.S. government debt default and/or failure of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the U.S. government to enact annual appropriations could have a material adverse effect on our business, results of operations, financial condition and cash flows. Additionally, disruptions in federal government operations may delay or negatively impact regulatory approvals and guidance that are important to our operations, and create uncertainty about the pace of upcoming regulatory developments.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk that failure to adequately develop and maintain our clinical systems or failure of our clinical systems to operate effectively could have a material adverse effect on our business, results of operations, financial condition and cash flows. For example, in connection with claims for which at least part of the government's payments to us is based on clinical performance or patient outcomes or co-morbidities, if our clinical systems fail to accurately capture the data we report to CMS or we otherwise have data integrity issues with respect to the reported information, we might be over-reimbursed by the government, which could, among other things, subject us to liability exclusion from participation in federal healthcare programs and penalties under the federal Civil Monetary Penalty statute, and could adversely impact our reputation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to similar risks for services billed separately from the ESRD bundled payment, including, without limitation, the risk that a MAC, or multiple MACs, change their interpretations of existing regulations, manual provisions and/or guidance; or seek to implement or enforce new interpretations that are inconsistent with how we have interpreted existing regulations, manual provisions and/or guidance.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above risks under the current Medicare ESRD program, changing legislation and other regulatory and executive developments have led and may continue to lead to the emergence of new models of care and other initiatives in both the government and private sector that, among other things, may impact the structure of, and payment rates under, the Medicare ESRD program. Moreover, the number of our patients with primary Medicare coverage may be subject to change, particularly with the effectiveness of the Cures Act, which allows Medicare-eligible individuals with ESRD to enroll in Medicare Part C MA managed care plans. For additional details regarding the risks we face for failing to adhere to our Medicare and Medicaid regulatory compliance obligations or failing to adequately implement strategic initiatives to adjust to marketplace developments, see the risk factors above under the headings "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation;" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Primary coverage for a significant number of our patients also comes from state Medicaid programs partially funded by the federal government as well as other non-Medicare government-based programs, such as coverage through the Department of Veterans Affairs (VA). As state governments and other governmental organizations face increasing financial hardship and budgetary pressure, including as a result of the COVID-19 pandemic, we may in turn face reductions in payment rates, delays in the receipt of payments, limitations on enrollee eligibility or other changes to the applicable programs. For example, certain state Medicaid programs and the VA have recently considered, proposed or implemented payment rate reductions, such as the VA's adoption of Medicare's bundled PPS pricing methodology for any veterans receiving treatment from non-VA providers under a national contracting initiative. Since we are a non-VA provider, these reimbursements are tied to a percentage of Medicare reimbursement, and we have exposure to any dialysis reimbursement changes made by CMS. Approximately 3% of our U.S. dialysis patient services revenues for the year ended December 31, 2021 were generated by the VA. In addition, in 2019, we entered into a Nationwide Dialysis Services contract with the VA that includes five separate one-year renewal periods throughout the term of the contract. The term structure is similar to our prior five-year agreement with the VA, and is consistent with VA practice for similar provider agreements. With this contract award, the VA has agreed to keep our percentage of Medicare reimbursement consistent with that under our prior agreement with the VA during the term of the contract. As with that prior agreement, this agreement provides the VA with the right to terminate the agreements without cause on short notice, among other things. Should the VA renegotiate, not renew or cancel these agreements for any reason, we may cease accepting patients under this program and may be forced to close centers or experience lower reimbursement rates, which could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State Medicaid programs are increasingly adopting Medicare-like bundled payment systems, but sometimes these payment systems are poorly defined and are implemented without any claims processing infrastructure, or patient or facility adjusters. If these payment systems are implemented without any adjusters and claims processing infrastructure, Medicaid payments will be substantially reduced and the costs to submit such claims may increase, which will have a negative impact on our business, results of operations, financial condition and cash flows. In addition, some state Medicaid program eligibility requirements mandate that citizen enrollees in such programs provide documented proof of citizenship. If our patients cannot meet these proof of citizenship documentation requirements, they may be denied coverage under these programs, resulting in decreased patient volumes and revenue. These Medicaid payment and enrollment changes, along with similar changes to other </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">non-Medicare government programs, could reduce the rates paid by these programs for dialysis and related services, delay the receipt of payment for services provided and further limit eligibility for coverage which could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div id="i916f7af890114e55a87e260476560c60_2802"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business is labor intensive and if our labor costs continue to rise, including due to shortages, changes in certification requirements and/or higher than normal turnover rates in skilled clinical personnel; or currently pending or future governmental laws, rules, regulations or initiatives impose additional requirements or limitations on our operations or profitability; or, if we are unable to attract and retain employees; or if union organizing activities or legislative or other changes result in significant increases in our operating costs or decreases in productivity, we may experience disruptions in our business operations and increases in operating expenses, among other things, any of which could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face increasing labor costs generally, and in particular, we continue to face increased labor costs and difficulties in hiring nurses due to a nationwide shortage of skilled clinical personnel that has been exacerbated by the ongoing COVID-19 pandemic and recent developments in the labor market. As referenced above, the current labor market is challenging and continues to experience volatility, uncertainty and labor supply shortages, particularly in healthcare. Our business is labor intensive, and our financial and operating results have been and continue to be sensitive to variations in labor-related costs, productivity and the number of pending or potential claims against us related to labor and employment practices. We have incurred and expect to continue to incur increased labor costs and experience staffing challenges, including without limitation those related to COVID-19, the extent of which will depend on the severity and duration of the pandemic and ancillary impacts on the economy and labor market, among other things. For additional discussion of the risks facing us related to COVID-19, including, among other things, risks related to the potential impact of vaccine mandates and other pandemic related requirements on us, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, many of which may have a material adverse impact on us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, to the extent that general inflationary pressures continue or further increase, this may in turn increase our labor and supply costs at a rate that outpaces the Medicare or any other rate increases we may receive. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete for nurses with hospitals and other healthcare providers. The ongoing nursing shortage may limit our ability to expand our operations. Furthermore, changes in certification requirements can impact our ability to maintain sufficient staff levels, including to the extent our teammates are not able to meet new requirements, among other things. In addition, if we experience a higher than normal turnover rate for our skilled clinical personnel, our operations and treatment growth may be negatively impacted, which could adversely affect our business, results of operations, financial condition and cash flows. We also face competition in attracting and retaining talent for key leadership positions. If we are unable to attract and retain qualified individuals, we may experience disruptions in our business operations, including, without limitation, our ability to achieve strategic goals, which could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Political or other efforts at the national or local level could result in actions or proposals that increase the likelihood of success of union organizing activities at our facilities and ongoing union organizing activities at our facilities could continue or increase for other reasons. We could experience an upward trend in wages and benefits and labor and employment claims, including, without limitation, the filing of class action suits, or adverse outcomes of such claims, or face work stoppages. In addition, we are and may continue to be subject to targeted corporate campaigns by union organizers in response to which we have been and expect to continue to be required to expend substantial resources, both time and financial. Any of these events or circumstances could have a material adverse effect on our employee relations, treatment growth, productivity, business, results of operations, financial condition, cash flows and reputation.</span></div><div id="i916f7af890114e55a87e260476560c60_2758"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Privacy and information security laws are complex, and if we fail to comply with applicable laws, regulations and standards, including with respect to third-party service providers that utilize sensitive personal information on our behalf, or if we fail to properly maintain the integrity of our data, protect our proprietary rights to our systems or defend against cybersecurity attacks, we may be subject to government or private actions due to privacy and security breaches or suffer losses to our data and information technology assets, any of which could have a material adverse effect on our business, results of operations, financial condition and cash flows or materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must comply with numerous federal and state laws and regulations in both the U.S. and the foreign jurisdictions in which we operate governing the collection, dissemination, access, use, security and privacy of PHI, including, without limitation, HIPAA and its implementing privacy, security, and related regulations, as amended by the federal Health Information Technology for Economic and Clinical Health Act (HITECH) and collectively referred to as HIPAA. We are also required to report known breaches of PHI and other certain personal information consistent with applicable breach reporting requirements set forth in applicable laws and regulations. From time to time, we may be subject to both federal and state inquiries or audits related to HIPAA, HITECH and other state privacy laws associated with complaints, desk audits, and data </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">breaches. Requirements under HIPAA also continue to evolve. If we fail to comply with applicable privacy and security laws, regulations and standards, including with respect to third-party service providers that utilize sensitive personal information, including PHI, on our behalf, properly maintain the integrity of our data, protect our proprietary rights, or defend against cybersecurity attacks, it could materially harm our reputation and/or have a material adverse effect on our business, results of operations, financial condition and cash flows. These risks may be intensified to the extent that the laws change or to the extent that we increase our use of third-party service providers that utilize sensitive personal information, including PHI, on our behalf.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Data protection laws are evolving globally, and may continue to add additional compliance costs and legal risks to our international operations. In the European Union, the General Data Protection Regulation (EU GDPR) imposes a comprehensive data protection regime with the potential for regulatory fines as well as data breach litigation by impacted data subjects. Under the EU GDPR, regulatory penalties may be assessed by data protection authorities for up to the greater of 4% of worldwide turnover or &#8364;20 million. The United Kingdom has implemented similar legislation (UK GDPR) that may carry similar compliance and operational costs as the EU GDPR, and non-compliance with which carries potential fines of up to the greater of &#163;17.5 million or 4% of global turnover. The costs of compliance with, and other burdens imposed by, the EU GDPR, UK GDPR and other new laws, regulations and policies implementing the EU GDPR and UK GDPR may impact our European and United Kingdom operations and may limit the ways in which we can provide services or use personal data collected while providing services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Privacy and data protection laws are also evolving nationally, providing for enhanced state privacy rights that are broader than the current federal privacy rights, and may add additional compliance costs and legal risks to our U.S. operations. The costs of compliance with, and the burdens imposed by, these and other new federal and state laws, regulations or policies may impact our operations and/or limit the ways in which we can provide services or use personal data collected while providing services. If we fail to comply with the requirements of these and other new laws, regulations or policies, we could be subject to penalties that, in some cases, would have a material adverse impact on our business, results of operations, financial condition and cash flows. For more details on the privacy and other regulations affecting our business, see Part I, Item 1. Business of this Form 10-K under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Scrutiny over cybersecurity standards in the health sector is also increasing, and ongoing developments in this area may cause us to invest additional resources in technology, personnel and programmatic cybersecurity controls as the cybersecurity risks we face continue to evolve.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information security risks have significantly increased in recent years in part because of the proliferation of new technologies, the increasing use of the Internet and telecommunications technologies to conduct our operations, and the increased sophistication and activities of organized crime, hackers, terrorists and other external parties, including, among others, foreign state agents. Our business and operations rely on the secure and continuous processing, transmission and storage of confidential, proprietary and other information in our computer systems and networks, including sensitive personal information, such as PHI, social security numbers, and/or credit card information of our patients, teammates, physicians, business partners and others. Our business and operations also rely on certain critical IT vendors that support such processing, transmission and storage (which have become more relevant and important given the information security issues and risks that are intensified through remote work arrangements).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly review, monitor and implement multiple layers of security measures through technology, processes and our people. We utilize security technologies designed to protect and maintain the integrity of our information systems and data, and our defenses are monitored and routinely tested internally and by external parties. Despite these efforts, our facilities and systems and those of our third-party service providers may be vulnerable to privacy and security incidents; security attacks and breaches; acts of vandalism or theft; computer viruses and other malicious code; coordinated attacks by a variety of actors, including, among others, activist entities or state sponsored cyberattacks; emerging cybersecurity risks; cyber risk related to connected devices; misplaced or lost data; programming and/or human errors; or other similar events that could impact the security, reliability and availability of our systems. Internal or external parties have attempted to, and will continue to attempt to, circumvent our security systems, and we have in the past, and expect that we will in the future, defend against, experience, and respond to attacks on our network including, without limitation, reconnaissance probes, denial of service attempts, malicious software attacks including ransomware or other attacks intended to render our internal operating systems or data unavailable, and phishing attacks or business email compromise. Cybersecurity requires ongoing investment and diligence against evolving threats. Emerging and advanced security threats, including, without limitation, coordinated attacks, require additional layers of security which may disrupt or impact efficiency of operations. As with any security program, there always exists the risk that employees will violate our policies despite our compliance efforts or that certain attacks may be beyond the ability of our security and other systems to detect. There can be no assurance that investments, diligence and/or our internal controls will be sufficient to prevent or timely discover an attack.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any security breach involving the misappropriation, loss or other unauthorized disclosure or use of confidential information, including, among others, PHI, financial data, competitively sensitive information, or other proprietary data, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">whether by us or a third party, could have a material adverse effect on our business, results of operations, financial condition, and cash flows and materially harm our reputation. We may be required to expend significant additional resources to modify our protective measures, to investigate and remediate vulnerabilities or other exposures, or to make required notifications. The occurrence of any of these events could, among other things, result in interruptions, delays, the loss or corruption of data, cessations in the availability of systems and liability under privacy and security laws, all of which could have a material adverse effect on our business, results of operations, financial condition and cash flows, or materially harm our reputation and trigger regulatory actions and private party litigation. If we are unable to protect the physical and electronic security and privacy of our databases and transactions, we could be subject to potential liability and regulatory action, our reputation and relationships with our patients, physicians, vendors and other business partners would be harmed, and our business, results of operations, financial condition and cash flows could be materially and adversely affected. Failure to adequately protect and maintain the integrity of our information systems (including our networks) and data, or to defend against cybersecurity attacks, could subject us to monetary fines, civil suits, civil penalties or criminal sanctions and requirements to disclose the breach publicly, and could further result in a material adverse effect on our business, results of operations, financial condition and cash flows or harm our reputation. As malicious cyber activity escalates, including activity that originates outside of the U.S., and as our COVID-19 response has increased our remote work arrangements and broadened our technology footprint, the risks we face relating to transmission of data and our use of service providers outside of our network, as well as the storing or processing of data within our network, have intensified. There have been increased international, federal and state and other privacy, data protection and security enforcement efforts and we expect this trend to continue. While we plan to maintain cyber liability insurance, there can be no assurance that we will successfully be able to obtain such insurance on terms and conditions that are favorable to us or at all. Additionally, any cyber liability insurance may not cover us for all types of losses or harms and may not be sufficient to protect us against the amount of all losses.</span></div><div id="i916f7af890114e55a87e260476560c60_2728"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If certain of our suppliers do not meet our needs, if there are material price increases on supplies, if we are not reimbursed or adequately reimbursed for drugs we purchase or if we are unable to effectively access new technology or superior products, it could negatively impact our ability to effectively provide the services we offer and could have a material adverse effect on our business, results of operations, financial condition, cash flows and could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant suppliers, with a substantial portion of our total vendor spend concentrated with a limited number of third party suppliers. These third party suppliers include, without limitation, suppliers of pharmaceuticals or clinical products that may be the primary source of products critical to the services we provide, or to which we have committed obligations to make purchases, sometimes at particular prices. We and other dialysis providers have experienced supply chain shortages with respect to certain of our equipment and clinical supplies, such as dialysate, which is the fluid solution used in hemodialysis to filter toxins and fluid from the blood, and we have had to make significant operational changes in response. Separately, the ongoing COVID-19 pandemic also has resulted in global supply chain challenges and has materially impacted global supply chain reliability, as further described in the risk factor under the heading, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, many of which may have a material adverse impact on us</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our suppliers do not meet our needs for the products they supply, including, without limitation, in the event of COVID-19 related global supply chain challenges, a product recall, other shortage or dispute, and we are not able to find adequate alternative sources at competitive prices; if we experience material price increases from these suppliers or otherwise in connection with our actions to secure needed products that we are unable to mitigate; if some of the drugs that we purchase from our suppliers are not reimbursed or not adequately reimbursed by commercial or government payors; or if we are unable to secure products, including pharmaceuticals at competitive rates and within the desired time frame; it could negatively impact our ability to effectively provide the services we offer, have a material adverse impact on our business, results of operations, financial condition and cash flows, and could materially harm our reputation. In addition, the technology related to the products critical to the services we provide is subject to new developments which may result in superior products. If we are not able to access superior products on a cost-effective basis, either due to competitive conditions in the marketplace or otherwise, or if suppliers are not able to fulfill our requirements for such products, we could face patient attrition and other negative consequences which could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div id="i916f7af890114e55a87e260476560c60_2743"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in clinical practices, payment rates or regulations impacting pharmaceuticals could have a material adverse effect on our business, results of operations, financial condition, and cash flows and negatively impact our ability to care for patients.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare bundles certain pharmaceuticals into the ESRD PPS payment rate at industry average doses and prices. Variations above the industry average may be subject to partial reimbursement through the PPS outlier reimbursement policy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to industry averages, which can be caused by, among other things, changes in physician prescribing practices, including in response to the introduction of new drugs, treatments or technologies, changes in best and/or accepted clinical </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">practice, changes in private or governmental payment criteria regarding pharmaceuticals, or the introduction of administration policies may negatively impact our ability to obtain sufficient reimbursement levels for the care we provide, which could have a material adverse effect on our business, results of operations, financial condition and cash flows. Physician practice patterns, including their independent determinations as to appropriate pharmaceuticals and dosing, are subject to change, including, for example, as a result of changes in labeling of pharmaceuticals or the introduction of new pharmaceuticals. Additionally, commercial payors have increasingly examined their administration policies for pharmaceuticals and, in some cases, have modified those policies. If such policy and practice trends or other changes to private and governmental payment criteria make it more difficult to preserve our margins per treatment, it could have a material adverse effect on our business, results of operations, financial condition and cash flows. Further, increased utilization of certain pharmaceuticals whose costs are included in a bundled reimbursement rate, or decreases in reimbursement for pharmaceuticals whose costs are not included in a bundled reimbursement rate, could also have a material adverse effect on our business, results of operation, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulations and processes impacting reimbursement for pharmaceuticals and any changes thereto could similarly affect our operating results. Among other things, as new kidney care drugs, treatments or technologies are introduced over time, we expect that the use of transitional payment adjustments to incorporate certain of these new drugs, treatments or technologies as defined by the CMS policy into the bundled Medicare Part B ESRD payment may lead to fluctuations in associated levels of operating income and risk that the reimbursement levels of such drugs, treatments or technologies may not adequately cover our cost to obtain the drug or other associated costs. Drivers of these risks include, among other things, the risk that CMS may not provide adequate funding in the Medicare Part B ESRD payment in the post-transitional period or such items are not covered by transitional add on pricing, in which case there may be less clarity on the reimbursement, either of which may in turn materially adversely impact our business, results of operations, financial condition and cash flows. For example, in the event that a hypoxia-inducible factor (HIF) product is approved by the FDA we expect that HIF products will be subject to a TDAPA period prior to being incorporated into the payment bundle. We are developing operational and clinical processes designed to provide the drug as may be required under the applicable regulations and as may be prescribed by physicians and also are working to contract with manufacturers of drug(s) to establish terms and access to the product, as well as payors, as applicable, for reimbursement and/or administration of the drug. While the timing and details of a potential approval, including the contents of the applicable FDA label, remain uncertain, if HIF products are approved, we could experience significant fluctuations in our associated levels of operating income and could be subject to material financial, operational and/or legal risk if we are not adequately reimbursed for the cost of the drug, if we are unable to implement effective and appropriate operational measures to distribute the drug, if we fail to implement appropriate storage and diversion controls or if we cannot obtain competitive pricing for the HIF, the aggregate impact of these risks could have a material adverse effect on our business, results of operation, financial condition and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar operating and clinical rigor and appropriate processes will be needed for other potential new drugs, treatments or technologies that are approved and come onto the market, including, among others a new medication that may assist with uraemic pruritus in dialysis patients that was approved in 2021 and may be available to providers and for reimbursement in 2022. Any failure to successfully contract with manufacturers for competitive pricing, failure to successfully contract with the government or other payors for appropriate reimbursement, or failure to prepare, develop and implement processes that provide for appropriate availability and use in our clinics in compliance with applicable laws, including those related to controlled substances, could have a material adverse impact on our business, results of operations, financial condition and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also be subject to increased inquiries or audits from a variety of governmental bodies or claims by third parties related to pharmaceuticals, which would require management's attention and could result in significant legal expense. Any negative findings could result in, among other things, substantial financial penalties or repayment obligations, the imposition of certain obligations on and changes to our practices and procedures as well as the attendant financial burden on us to comply with the obligations, or exclusion from future participation in the Medicare and Medicaid programs, and could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation. For additional details, see the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation."</span></div><div id="i916f7af890114e55a87e260476560c60_2738"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are unable to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and developing and maintaining relationships with physicians and hospitals, it could materially adversely affect our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a highly competitive and continuously evolving environment across the spectrum of kidney care, and operating in this market requires us to successfully execute on strategic initiatives which, among other things, build or retain </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our patient population through acquisition or referrals, or that develop and maintain our relationships with physicians and hospitals in both the dialysis and pre-dialysis space. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition for relationships with certain referral sources, including nephrologists and hospitals, in existing and expanding geographies or areas is intense, and we continue to face intense competition from large and medium-sized providers, among others, which compete directly with us for physicians qualified to serve as medical directors, for limited acquisition targets and for individual patients. Competition in existing and expanding geographies or areas is intense, and is not limited to large competitors with substantial financial resources or to established participants in the dialysis space. We also compete with individual nephrologists who have opened their own dialysis units or facilities, for example. Our largest competitor, Fresenius Medical Group, manufactures a full line of dialysis supplies and equipment in addition to owning and operating dialysis centers, which may, among other things, give it cost advantages over us because of its ability to manufacture its own products. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, there is significant competition for maintaining or developing relationships with physicians that can serve as medical directors at our centers. Physicians, including medical directors, choose where they refer their patients, and neither of our current nor former medical directors have an obligation to refer their patients to our centers. Certain physicians prefer to have their patients treated at dialysis centers where they or other members of their practice supervise the overall care provided as medical director of the center. As a result, referral sources for many of our centers include the physician or physician group providing medical director services to the center. Moreover, because Medicare regulations require medical directors for each of our Medicare certified dialysis centers, our ability to operate our centers depends in part on our ability to secure medical director agreements with a sufficient number of nephrologists. Our medical director contracts are for fixed periods, generally ten years, and at any given time a large number of them could be up for renewal at the same time. Medical directors have no obligation to extend their agreements with us and, under certain circumstances, our former medical directors may choose to provide medical director services for competing providers or establish their own dialysis centers in competition with ours. If we are unable to contract with nephrologists to provide medical director services, then we may be unable to satisfy the federal Medicare requirements associated with medical directors and to operate our centers. The aging of the nephrologist population and opportunities presented by our competitors may negatively impact a medical director's decision to enter into or extend his or her agreement with us. In addition, if the terms of any existing agreement are found to violate applicable laws, there can be no assurances that we would be successful in restructuring the relationship, which would lead to the early termination of the agreement. If we are unable to obtain qualified medical directors to provide supervision of the operations and care provided at our dialysis centers, it could affect not only our ability to operate the center and for other physicians to feel confident in referring patients to our dialysis centers. If a significant number of physicians were to cease referring patients to our dialysis centers, whether due to law, rule or regulation, new competition, a perceived decrease in the quality of service levels at our centers or other reasons, it would have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as we continue to expand our offerings across the kidney care continuum, our ability to enter into and maintain integrated kidney care relationships with payors, physicians and other providers may have an impact on dialysis patient retention and the continued referrals of patients from referral sources such as hospitals and nephrologists. This environment is highly competitive and has been evolving. For example, there have been a number of announcements, initiatives and capital raises by non-traditional dialysis providers and others, which relate to entry into the dialysis and pre-dialysis space, the development of innovative technologies, or the commencement of new business activities that could be transformative to the industry. Some of these new entrants have considerable financial resources. Although these and other potential competitors may face operational or financial challenges, the evolving nature of the dialysis and pre-dialysis marketplaces have presented some opportunities for relative ease of entry for these and other potential competitors. As a result, we may compete with these smaller or non-traditional providers or others in an asymmetrical environment with respect to data and regulatory requirements that we face as an ESRD service provider, thereby negatively impacting our ability to effectively compete. These and other factors have continued to drive change in the dialysis and pre-dialysis space, and if we are unable to successfully adapt to these dynamics, it could have a material adverse impact on our business, results of operations, financial condition and cash flows. As an example, new entrants are aggressively pursuing opportunities to participate in the new CMMI payment models, and increasing investment in and availability of funding to new entrants in the dialysis and pre-dialysis marketplace that are not subject to the same regulatory restrictions as the Company, could adversely impact our ability to enter into competitive arrangements. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the aforementioned competitive pressures and related risks may be impacted by a continued decline in the rate of growth of the ESRD patient population, higher mortality rates for dialysis patients or other reductions in demand for dialysis treatments, whether due to the development of innovative technologies or otherwise. The recent 2020 annual data report from the United States Renal Data System (USRDS) suggests that the rate of growth of the ESRD patient population is declining relative to long term trends. A number of factors may impact ESRD growth rates, including, without limitation, the aging of the U.S. population, incidence rates for diseases that cause kidney failure such as diabetes and hypertension, transplant rates, mortality rates for dialysis patients and growth rates of minority populations with higher than average incidence rates of ESRD. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of these factors, in particular the mortality rates for dialysis patients, have been impacted by the COVID-19 pandemic. The magnitude of these cumulative COVID-19 related impacts on our patient census and treatment volumes has been substantial and depending on the ultimate severity and duration of the pandemic, could be material. While we have continued efforts to seek growth opportunities, such as by expanding our business into various international markets, we face ongoing competition from large and medium-sized providers, among others, for acquisition targets in those markets. Any failure on our part to appropriately adjust our business and operations in light of these complicated marketplace dynamics could have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to effectively compete in the markets in which we operate, including by implementing our growth strategy, effectively adjusting our business and operations in light of evolving marketplace dynamics, building or retaining our patient population, maintaining and developing relationships with nephrologists and hospitals, particularly medical director relationships, or making acquisitions at the desired pace or at all; if we are not able to continue to maintain the expected or desired level of non-acquired growth; or if we experience significant patient attrition either as a result of new business activities in the dialysis or pre-dialysis space by our existing competitors, other market participants, new entrants, new technology or other forms of competition, or as a result of reductions in demand for dialysis treatments, including, without limitation, due to increased mortality rates for dialysis patients resulting from COVID-19 or otherwise, reduced prevalence of ESRD, the development of innovative technologies or an increase in the number of kidney transplants, it could materially adversely affect our business, results of operations, financial condition and cash flows.</span></div><div id="i916f7af890114e55a87e260476560c60_2723"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The U.S. ancillary services and strategic initiatives and international operations that we operate or invest in now or in the future may generate losses and may ultimately be unsuccessful. In the event that one or more of these activities is unsuccessful, our business, results of operations, financial condition and cash flows may be negatively impacted and we may have to write off our investment and incur other exit costs.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ancillary services and strategic initiatives are subject to many of the same risks, regulations and laws, as described in the risk factors related to our dialysis business set forth in this Part I, Item 1A., and are also subject to additional risks, regulations and laws specific to the nature of the particular strategic initiative. We have added, and expect to continue to add additional service offerings to our business and pursue additional strategic initiatives in the future as circumstances warrant, which could include healthcare services not directly related to dialysis. Many of these initiatives require or would require investments of both management and financial resources and can generate significant losses for a substantial period of time and may not become profitable in the expected timeframe or at all. There can be no assurance that any such strategic initiative will ultimately be successful. Any significant change in market conditions or business performance, including, without limitation, as a result of the COVID-19 pandemic, or in the political, legislative or regulatory environment, may impact the performance or economic viability of any of these strategic initiatives. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our ancillary services, strategic initiatives or international operations are unsuccessful, it may have a negative impact on our business, results of operations, financial condition and cash flows, and if we determine to exit that line of business we may incur significant termination costs. For discussion of risks and potential impacts specific to our integrated kidney care business and related growth strategy, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If we are not able to successfully implement our strategy with respect to our integrated kidney care and value-based care initiatives, including maintaining our existing business and further developing our capabilities in a complex and highly regulated environment, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">it could result in a loss of our investments and have a material adverse effect on our growth strategy, could adversely impact our business, results of operations, financial condition and cash flows, and could materially harm our reputation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may incur a material write-off or an impairment of our investment, including, without limitation, goodwill or other assets, in one or more of our ancillary services or strategic initiatives or international operations. In that regard, we have taken, and may in the future take, impairment and restructuring charges in addition to those described above related to our ancillary services and strategic initiatives and international operations, including, without limitation, in our prior pharmacy businesses. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expansion of our operations to and offering our services in markets outside of the U.S. subjects us to political, economic, legal, operational and other risks that could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuing to expand our operations by offering our services and entering new lines of business in certain markets outside of the U.S., which increases our exposure to the inherent risks of doing business in international markets. Depending on the market, these risks include those relating to:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the local economic environment including, among other things, labor cost increases and other general inflationary pressures;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political instability, armed conflicts or terrorism;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">public health crises, such as pandemics or epidemics, including the COVID-19 pandemic;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">social changes;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">intellectual property legal protections and remedies;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trade regulations;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">procedures and actions affecting approval, production, pricing, reimbursement and marketing of products and services;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">foreign currency;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additional U.S. and foreign taxes;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">export controls;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">antitrust and competition laws and regulations;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of reliable legal systems which may affect our ability to enforce contractual rights;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in local laws or regulations, or interpretation or enforcement thereof;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potentially longer ramp-up times for starting up new operations and for payment and collection cycles;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">financial and operational, and information technology systems integration;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to comply with U.S. laws, such as the FCPA, or local laws that prohibit us, our partners, or our partners' or our agents or intermediaries from making improper payments to foreign officials or any third party for the purpose of obtaining or retaining business; and</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">data and privacy restrictions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issues relating to the failure to comply with applicable non-U.S. laws, requirements or restrictions may also impact our domestic business and/or raise scrutiny on our domestic practices.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, some factors that will be critical to the success of our international business and operations will be different than those affecting our domestic business and operations. For example, conducting international operations requires us to devote significant management resources to implement our controls and systems in new markets, to comply with local laws and regulations, including to fulfill financial reporting and records retention requirements among other things, and to overcome the numerous new challenges inherent in managing international operations, including, without limitation, challenges based on differing languages and cultures, challenges related to establishing clinical operations in differing regulatory and compliance environments, and challenges related to the timely hiring, integration and retention of a sufficient number of skilled personnel to carry out operations in an environment with which we are not familiar.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any expansion of our international operations through acquisitions or through organic growth could increase these risks. Additionally, while we may invest material amounts of capital and incur significant costs in connection with the growth and development of our international operations, including to start up or acquire new operations, we may not be able to operate them profitably on the anticipated timeline, or at all.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks could have a material adverse effect on our business, results of operations, financial condition, cash flows and could materially harm our reputation.</span></div><div id="i916f7af890114e55a87e260476560c60_2797"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failing to effectively maintain, operate or upgrade our information systems or those of third-party service providers upon which we rely, including, without limitation, our clinical, billing and collections systems, or failure to adhere to federal and state data sharing and access requirements and regulations could materially adversely affect our business, results of operations, financial condition, cash flows and reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business depends significantly on effective information systems. Our information systems require an ongoing commitment of significant resources to maintain, upgrade and enhance existing systems and develop or contract for new systems in order to keep pace with continuing changes in information processing technology, emerging cybersecurity risks and threats, evolving industry, legal and regulatory standards and requirements, new models of care, and other changes in our business, among other things. For example, the provisions related to data interoperability, information blocking, and patient access in the Cures Act include, among other things, changes to the Office of the National Coordinator for Health Information </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Technology&#8217;s (ONC's) Health IT Certification Program and requirements that CMS-regulated payors make relevant claims/care data and provider directory information available through standardized patient access and provider directory application programming interfaces (APIs) that connect to provider electronic health records. We have made and expect to continue to make significant investments in updating and integrating our clinical IT systems and in building our data interoperability capabilities. Any failure to adequately comply with these rules may, among other things, result in fines and sanctions, adversely impact our Medicare business, our ability to scale our integrated care business and our ability to compete with certain smaller and/or non-traditional providers taking advantage of an asymmetrical environment with respect to data and/or regulatory requirements given our status as an ESRD service provider; or otherwise have a material adverse effect on our business, financial condition, results of operations and cash flows. There can be no assurances that the implementation of planned enhancements to our systems, such as our implementation of these data interoperability provisions or our other ongoing efforts to upgrade and better integrate our clinical systems, will be successful or that we will ultimately realize anticipated benefits from investments in new or existing information systems. In addition, we may from time to time obtain significant portions of our systems-related support, technology or other services from independent third parties, which may make our operations vulnerable if such third parties fail to perform adequately.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to successfully implement, operate and maintain effective and efficient information systems with adequate technological capabilities, deficiencies or defects in the systems and related technology, or our failure to efficiently and effectively implement ongoing system upgrades or consolidate our information systems to eliminate redundant or obsolete applications, could result in increased legal and compliance risks and competitive disadvantages, among other things, which could have a material adverse effect on our business, financial condition, results of operations and reputation. For additional information on the risks we face in a highly competitive market, see the risk factor under the heading, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"If we are unable to compete successfully, including, without limitation, implementing our growth strategy and/or retaining patients and developing and maintaining relationships with physicians and hospitals, it could materially adversely affect our business, results of operations, financial condition and cash flows." </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the information we rely upon to run our business was found to be inaccurate or unreliable or if we or third parties on which we rely fail to adequately maintain information systems and data integrity effectively, whether due to software deficiencies, human coding or implementation error or otherwise, we could experience difficulty meeting clinical outcome goals, face regulatory problems, including sanctions and penalties, incur increases in operating expenses or suffer other adverse consequences, any of which could be material. Moreover, failure to adequately protect and maintain the integrity of our information systems (including our networks) and data, or information systems and data hosted by third parties upon which we rely, could subject us to severe consequences as described in the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Privacy and information security laws are complex, and if we fail to comply with applicable laws, regulations and standards, including with respect to third-party service providers that utilize sensitive personal information on our behalf, or if we fail to properly maintain the integrity of our data, protect our proprietary rights to our systems or defend against cybersecurity attacks, we may be subject to government or private actions due to privacy and security breaches or suffer losses to our data and information technology assets, any of which could have a material adverse effect on our business, results of operations, financial condition and cash flows or materially harm our reputation."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our billing systems, among others, are critical to our billing operations. This includes our systems for our dialysis clinics as well as our systems for our ancillary businesses including hospital services. If there are defects in our billing systems, or billing systems or services of third parties upon which we rely, we may experience difficulties in our ability to successfully bill and collect for services rendered, including, without limitation, a delay in collections, a reduction in the amounts collected, increased risk of retractions from and refunds to commercial and government payors, an increase in our provision for uncollectible accounts receivable and noncompliance with reimbursement laws and related requirements, any or all of which could materially adversely affect our results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the clinical environment, a failure of our clinical systems, or the systems of our third-party service providers, to operate effectively could have a material adverse effect on our business, the clinical care provided to patients, results of operations, financial condition and cash flows. For example, in connection with claims for which at least part of the government's payments to us is based on clinical performance or patient outcomes or co-morbidities, if relevant clinical systems fail to accurately capture the data we report to CMS or we otherwise have data integrity issues with respect to the reported information, this could impact our payments from government payors as well as our ability to retain funds paid to us based on the inaccurate information.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we expect the highly competitive environment in which we operate to become increasingly more competitive as the market evolves and new technologies are introduced. This dynamic environment requires continuous investment in new technologies and clinical applications. Machine learning and artificial intelligence are increasingly driving innovations in technology, and parts of our operations may employ robotics. If these technologies or applications fail to operate as anticipated or do not perform as specified, including due to potential design defects and defects in the development of algorithms or other technologies, human error or otherwise, our clinical operations, business and reputation may be harmed. If we are unable to successfully maintain, enhance or operate our information systems, including through the implementation of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such technologies or applications in our clinical operations and laboratory, we may be, among other things, unable to efficiently adapt to evolving laws and requirements, unable to remain competitive with others who successfully implement and advance this technology, subject to increased risk under existing laws, regulations and requirements that apply to our business, and our patients' safety may be adversely impacted, any of which could have a material adverse impact on our business, results of operations and financial condition and could materially harm our reputation. For additional detail, see the discussion in the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation."</span></div><div id="i916f7af890114e55a87e260476560c60_2733"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may engage in acquisitions, mergers, joint ventures or dispositions, which may materially affect our results of operations, debt-to-capital ratio, capital expenditures or other aspects of our business, and, under certain circumstances, could have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business strategy includes growth through acquisitions of dialysis centers and other businesses, as well as through entry into joint ventures. We may engage in acquisitions, mergers, joint ventures or dispositions or expand into new business lines or models, which may affect our results of operations, debt-to-capital ratio, capital expenditures or other aspects of our business. There can be no assurance that we will be able to identify suitable acquisition targets or merger partners or buyers for dispositions or that, if identified, we will be able to agree to terms with merger partners, acquire these targets or make these dispositions on acceptable terms or on the desired timetable. There can also be no assurance that we will be successful in completing any acquisitions, mergers or dispositions that we announce, executing new business lines or models or integrating any acquired business into our overall operations. There is no guarantee that we will be able to operate acquired businesses successfully as stand-alone businesses, or that any such acquired business will operate profitably or will not otherwise have a material adverse effect on our business, results of operations, financial condition and cash flows or materially harm our reputation. In addition, acquisition, merger or joint venture activity conducted as part of our overall growth strategy is subject to antitrust and competition laws, and antitrust regulators can investigate future (or pending) and consummated transactions. These laws could impact our ability to pursue these transactions, and under certain circumstances, could result in mandated divestitures, among other things. If a proposed transaction or series of transactions is subject to challenge under antitrust or competition laws, we may incur substantial legal costs, management&#8217;s attention and resources may be diverted, and if we are found to have violated these or other related laws, regulations or requirements, we could suffer severe consequences that could have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation and stock price. For additional detail, see the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Further, we cannot be certain that key talented individuals at the business being acquired will continue to work for us after the acquisition or that they will be able to continue to successfully manage or have adequate resources to successfully operate any acquired business. In addition, certain of our acquired dialysis centers and facilities have been in service for many years, which may result in a higher level of maintenance costs. Further, our facilities, equipment and information technology may need to be improved or renovated to maintain or increase operational efficiency, compete for patients and medical directors, or meet changing regulatory requirements. Increases in maintenance costs and/or capital expenditures could have, under certain circumstances, a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Businesses we acquire may have unknown or contingent liabilities or liabilities that are in excess of the amounts that we originally estimated, and may have other issues, including, without limitation, those related to internal control over financial reporting or issues that could affect our ability to comply with healthcare laws and regulations and other laws applicable to our expanded business, which could harm our reputation. As a result, we cannot make any assurances that the acquisitions we consummate will be successful. Although we generally seek indemnification from the sellers of businesses we acquire for matters that are not properly disclosed to us, we are not always successful. In addition, even in cases where we are able to obtain indemnification, we may discover liabilities greater than the contractual limits, the amounts held in escrow for our benefit (if any), or the financial resources of the indemnifying party. In the event that we are responsible for liabilities substantially in excess of any amounts recovered through rights to indemnification or alternative remedies that might be available to us, or any applicable insurance, we could suffer severe consequences that would have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the terms of the equity purchase agreement for the DMG sale (the DMG sale agreement), we agreed to certain indemnification obligations, including with respect to claims for breaches of our representations and warranties regarding compliance with law, litigation, absence of undisclosed liabilities, employee benefit matters, labor matters, or taxes, among others, and other claims for which we provided the buyer with a special indemnity. As a result, we may become </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">obligated to make payments to the buyer relating to our previous ownership and operation of the DMG business. Any such post-closing liabilities and required payments under the DMG sale agreement, or otherwise, or in connection with any other past or future disposition of material assets or businesses could individually or in the aggregate have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, joint ventures, including, without limitation, our Asia Pacific joint venture, and minority investments inherently involve a lesser degree of control over business operations, thereby potentially increasing the financial, legal, operational and/or compliance risks associated with the joint venture or minority investment. In addition, we may be dependent on joint venture partners, controlling shareholders or management who may have business interests, strategies or goals that are inconsistent with ours. Business decisions or other actions or omissions of the joint venture partner, controlling shareholders or management may require us to make capital contributions or necessitate other payments, result in litigation or regulatory action against us, result in reputational harm to us or adversely affect the value of our investment or partnership, among other things. In addition, we have potential obligations to purchase the interests held by third parties in many of our joint ventures as a result of put provisions that are exercisable at the third party's discretion within specified time periods, pursuant to the applicable agreement. If these put provisions were exercised, we would be required to purchase the third party owner's equity interest, generally at the appraised market value. There can be no assurances that these joint ventures and/or minority investments, including, without limitation, our Asia Pacific joint venture, ultimately will be successful.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If our joint ventures were found to violate the law, we could suffer severe consequences that would have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we owned a controlling interest in numerous dialysis-related joint ventures, which represented approximately 28% of our U.S. dialysis revenues for the year ended December 31, 2021. In addition, we also owned noncontrolling equity investments in several other dialysis related joint ventures. We expect to continue to increase the number of our joint ventures. Many of our joint ventures with physicians or physician groups also have certain physician owners providing medical director services to centers we own and operate. Because our relationships with physicians are governed by the federal and state anti-kickback statutes, we have sought to structure our joint venture arrangements to satisfy as many federal safe harbor requirements as we believe are commercially reasonable. Our joint venture arrangements do not satisfy all of the elements of any safe harbor under the federal Anti-Kickback Statute, however, and therefore are susceptible to government scrutiny. Additionally, our joint ventures and minority investments inherently involve a lesser degree of control over business operations, thereby potentially increasing the financial, legal, operational and/or compliance risks associated with the joint venture or minority investment. If our joint ventures are found to violate applicable laws or regulations, we could suffer severe consequences that would have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation. For additional information on these risks, see the risk factors under the headings "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We may engage in acquisitions, mergers, joint ventures or dispositions, which may materially affect our results of operations, debt-to-capital ratio, capital expenditures or other aspects of our business, and, under certain circumstances, could have a material adverse effect on our business, results of operations, financial condition and cash flows and could materially harm our reputation."</span></div><div id="i916f7af890114e55a87e260476560c60_2792"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our aspirations, goals and disclosures related to environmental, social and governance (ESG) matters expose us to numerous risks, including without limitation risks to our reputation and stock price.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a longstanding ESG program and have engaged with key stakeholders to develop ESG focus areas and to set ESG-related goals, many of which are aspirational. We have set and disclosed these focus areas, goals and related objectives as part of our continued commitment to ESG matters, but our goals and objectives reflect our current plans and aspirations and are not guarantees that we will be able to achieve them. Our efforts to accomplish and accurately report on these goals and objectives present numerous operational, reputational, financial, legal and other risks, certain of which are outside of our control, and could have, under certain circumstances, a material adverse impact on us, including on our reputation and stock price. Examples of such risks include, among others: the availability and cost of low- or non-carbon-based energy sources and technologies for us and our vendors, evolving regulatory requirements affecting ESG standards, frameworks and disclosures, including evolving standards for measuring and reporting on related metrics, the availability of suppliers that can meet our sustainability and other standards, our ability to recruit, develop and retain diverse talent in our labor markets, and our ability to grow our home based dialysis business. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our ESG practices do not meet evolving investor or other stakeholder expectations and standards, then our reputation, our ability to attract or retain employees and our attractiveness as an investment, business partner or acquiror could be </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">negatively impacted. Similarly, our failure or perceived failure to adequately pursue or fulfill our goals and objectives or to satisfy various reporting standards within the timelines we announce, or at all, could also have similar negative impacts and expose us to other risks, which under certain circumstances could be material. If we are not able to adequately recognize and respond to the rapid and ongoing developments and governmental and social expectations relating to ESG matters, this failure could result in missed corporate opportunities, additional regulatory, social or other scrutiny of us, the imposition of unexpected costs, or damage to our reputation with governments, patients, teammates, third parties and the communities in which we operate, which in turn could have a material adverse effect on our business, financial condition, cash flows and results of operations and could cause the market value of our common stock to decline.</span></div><div id="i916f7af890114e55a87e260476560c60_2807"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">There are significant risks associated with estimating the amount of dialysis revenues and related refund liabilities that we recognize, and if our estimates of revenues and related refund liabilities are materially inaccurate, it could impact the timing and the amount of our revenues recognition or have a material adverse effect on our business,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are significant risks associated with estimating the amount of U.S. dialysis net patient services revenues and related refund liabilities that we recognize in a reporting period. The billing and collection process is complex due to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, such as ensuring appropriate documentation. Determining applicable primary and secondary coverage for approximately 203,100 U.S. patients at any point in time, together with the changes in patient coverage that occur each month, requires complex, resource-intensive processes. Errors in determining the correct coordination of benefits may result in refunds to payors. Revenues associated with Medicare and Medicaid programs are also subject to estimating risk related to the amounts not paid by the primary government payor that will ultimately be collectible from other government programs paying secondary coverage, the patient's commercial health plan secondary coverage or the patient. Collections, refunds and payor retractions typically continue to occur for up to three years and longer after services are provided. We generally expect our range of U.S. dialysis patient services revenues estimating risk to be within 1% of revenues for the segment. If our estimates of U.S. dialysis patient services revenues and related refund liabilities are materially inaccurate, it could impact the timing and the amount of our revenues recognition and have a material adverse impact on our business, results of operations, financial condition and cash flows.</span></div><div id="i916f7af890114e55a87e260476560c60_2852"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div id="i916f7af890114e55a87e260476560c60_2859"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The level of our current and future debt could have an adverse impact on our business, and our ability to generate cash to service our indebtedness and for other intended purposes and our ability to maintain compliance with debt covenants depends on many factors beyond our control.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a substantial amount of indebtedness outstanding and we may incur substantial additional indebtedness in the future, including indebtedness incurred to finance repurchases of our common stock pursuant to our share repurchase authorization discussed under "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Repurchases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" in Part II, Item 7. "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." As described in Note 13 to the consolidated financial statements included in this report, we are party to a senior secured credit agreement (the Credit Agreement), which consists of a secured term loan A facility, a secured term loan B-1 facility and a secured revolving line of credit in the aggregate principal amount of $1 billion. Our long-term indebtedness also includes $4.250 billion aggregate principal amount of senior notes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior secured credit facilities bear, and other indebtedness we may incur in the future may bear, interest at a variable rate. As a result, at any given time interest rates on the senior secured credit facilities and any other variable rate debt could be higher or lower than current levels. If interest rates increase, our debt service obligations on our variable rate indebtedness will increase even though the amount borrowed remains the same, and therefore net income and associated cash flows, including cash available for servicing our indebtedness, will correspondingly decrease.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our indebtedness levels and the required payments on such indebtedness may also be impacted by reforms related to LIBOR. The variable interest rates payable under our senior secured credit facilities are linked to LIBOR as the benchmark for establishing such rates. The LIBOR benchmark has been the subject of recent national, international and other regulatory guidance and reform proposals. The reforms may cause LIBOR to perform differently from the past and LIBOR may ultimately cease to exist after 2023. The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of, among other entities, large U.S. financial institutions, has recommended that U.S. dollar LIBOR be replaced with a new index that measures the cost of borrowing cash overnight, backed by U.S. Treasury securities (SOFR). Whether or not SOFR or any other potential alternative reference rate attains market traction as a LIBOR replacement rate remains in question. Our senior secured credit facilities include mechanics to facilitate the adoption by us and our lenders of an alternative benchmark rate for use in place of LIBOR; however, no assurance can be made that we and our lenders will agree on </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such an alternative rate and, even if agreed upon, such alternative rate may not perform in a manner similar to LIBOR and may result in interest rates that are higher or lower than those that would have resulted had LIBOR remained in effect.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to make payments on our indebtedness, to fund planned capital expenditures and expansion efforts, including, without limitation, any strategic acquisitions or investments we may make in the future, to repurchase our stock at the levels intended or announced and to meet our other liquidity needs such as for working capital or capital expenditures, will depend on our ability to generate cash. This depends not only on the success of our business but is also subject to economic, financial, competitive, regulatory and other factors that are beyond our control. We cannot provide assurances that our business will generate sufficient cash flows from operations in the future or that future borrowings will be available to us in amounts sufficient to enable us to service our indebtedness or to fund our working capital and other liquidity needs, including those described above. If we are unable to generate sufficient funds to service our outstanding indebtedness or to meet our working capital or other liquidity needs, including those described above, we would be required to refinance, restructure, or otherwise amend some or all of such indebtedness, sell assets, change or reduce our intended or announced uses or strategy for capital deployment, including, without limitation, for stock repurchases, reduce capital expenditures, planned expansions or other strategic initiatives, or raise additional cash through the sale of our equity or equity-related securities. We cannot make any assurances that any such refinancing, restructurings, amendments, sales of assets, or issuances of equity or equity-related securities can be accomplished or, if accomplished, will be on favorable terms or would raise sufficient funds to meet these obligations or our other liquidity needs. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may continue to incur indebtedness in the future, and the amount of that additional indebtedness may be substantial. Although the Credit Agreement includes covenants that could limit our indebtedness, we currently have, and expect to continue to have, the ability to incur substantial additional debt. The risks described in this risk factor could intensify as new debt is added to current debt levels or if we incur any new debt obligations that subject us to restrictive covenants that limit our financial and operational flexibility. Any breach or failure to comply with any of these covenants could result in a default under our indebtedness. Other risks related to our ability to generate sufficient cash to service our indebtedness and for other intended purposes, include, for example:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase our vulnerability to general adverse economic and industry conditions;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our flexibility in planning for, or reacting to, changes in our business and the markets in which we operate;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expose us to interest rate volatility that could adversely affect our business, results of operations, financial condition and cash flows, and our ability to service our indebtedness;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">place us at a competitive disadvantage compared to our competitors that have less debt; and</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our ability to borrow additional funds, or to refinance existing debt on favorable terms when otherwise available or at all.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure to pay any of our indebtedness when due or any other default under our credit facilities or our other indebtedness could have a material adverse effect on our business, results of operations, financial condition and cash flows, and could trigger cross default or cross acceleration provisions in our other debt instruments, thereby permitting the holders of that other indebtedness to demand immediate repayment or cease to make future extensions of credit, and, in the case of secured indebtedness, to take possession of and sell the collateral securing such indebtedness to satisfy our obligations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowings under our senior secured credit facilities and senior indentures are guaranteed by certain of our domestic subsidiaries, and borrowings under our senior secured credit facilities are secured by substantially all of our and certain of our domestic subsidiaries' assets. Such guarantees and the fact that we have pledged such assets may make it more difficult and expensive for us to make, or under certain circumstances could effectively prevent us from making, additional secured and unsecured borrowings.</span></div><div id="i916f7af890114e55a87e260476560c60_2885"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We could be subject to adverse changes in tax laws, regulations and interpretations or challenges to our tax positions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to tax laws and regulations of the U.S. federal, state and local governments as well as various foreign jurisdictions. We compute our income tax provision based on enacted tax rates in the jurisdictions in which we operate. As the tax rates vary among jurisdictions, a change in earnings attributable to the various jurisdictions in which we operate could result in an unfavorable or favorable change in our overall tax provision.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in tax laws or regulations may be proposed or enacted that could adversely affect our overall tax liability. There can be no assurance that changes in tax laws or regulations, both within the U.S. and the other jurisdictions in which we operate, will not materially and adversely affect our effective tax rate, tax payments, results of operations, financial condition and cash flows. For example, there are ongoing discussions domestically regarding tax reforms that could potentially have a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">material adverse impact on our results of operations and financial condition. Similarly, changes in tax laws and regulations that impact our patients, business partners and counterparties or the economy generally may also impact our results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, tax laws and regulations are complex and subject to varying interpretations, and any significant failure to comply with applicable tax laws and regulations in all relevant jurisdictions could give rise to material penalties and liabilities. We are regularly subject to audits by various tax authorities. For example, our current audits include an audit by the Internal Revenue Service for the years 2014&#8211;2017, and it is possible that the final determination of this and any other tax audits and any related litigation could be materially different from our historical income tax provisions and accruals. Any changes in enacted tax laws, rules or regulatory or judicial interpretations; any adverse development or outcome in connection with tax audits in any jurisdiction; or any change in the pronouncements relating to accounting for income taxes could materially and adversely impact our effective tax rate, tax payments, results of operations, financial condition and cash flows.</span></div><div id="i916f7af890114e55a87e260476560c60_2870"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deterioration in economic conditions, general inflationary pressures, disruptions in the financial markets or the effects of natural or other disasters, political instability, public health crises or adverse weather events such as hurricanes, earthquakes, fires or flooding could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deterioration in economic conditions and general inflationary pressures, whether in connection with the COVID-19 pandemic or otherwise, could have a material adverse effect on our business, results of operations, financial condition and cash flows. Among other things, the potential decline in federal and state revenues that may result from a deterioration in economic conditions may create additional pressures to contain or reduce reimbursements for our services from Medicare, Medicaid and other government sponsored programs. Increases in job losses in the U.S. as a result of adverse economic conditions, including economic deterioration due to the ongoing COVID-19 pandemic, could result in a smaller percentage of our patients being covered by an employer group health plan and a larger percentage being covered by lower paying Medicare and Medicaid programs. Employers may also select more restrictive commercial plans with lower reimbursement rates. To the extent that payors are negatively impacted by a decline in the economy, we may experience further pressure on commercial rates, a slowdown in collections and a reduction in the amounts we expect to collect. In addition, uncertainty in the financial markets could adversely affect the variable interest rates payable under our credit facilities or could make it more difficult to obtain or renew such facilities or to obtain other forms of financing in the future, if at all. For additional information regarding the risks presented by the COVID-19 pandemic, see the discussion in the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, many of which may have a material adverse impact on us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" For additional information regarding the risks related to our indebtedness, see the discussion in the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"The level of our current and future debt could have an adverse impact on our business, and our ability to generate cash to service our indebtedness and for other intended purposes and our ability to maintain compliance with debt covenants depends on many factors beyond our control.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" In addition, to the extent that monetary policies or other factors contribute to an increase in inflationary pressures, this may in turn increase our labor and supply costs at a rate that outpaces the Medicare or any other rate increases we may receive. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, as of December 31, 2021, we had approximately $7.046 billion of goodwill recorded on our consolidated balance sheet. We account for impairments of goodwill in accordance with the provisions of applicable accounting guidance, and record impairment charges when and to the extent a reporting unit's carrying amount is determined to exceed its estimated fair value. We use a variety of factors to assess changes in the financial condition, future prospects and other circumstances concerning our businesses and to estimate their fair value when applicable. These assessments and the related valuations can involve significant uncertainties and require significant judgment on various matters.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should our revenues and financial results be materially, unfavorably impacted due to, among other things, a worsening of the economic and employment conditions in the United States that negatively impacts reimbursement rates or the availability of insurance coverage for our patients, we may incur future charges to recognize impairment in the carrying amount of our goodwill and other intangible assets, which could have a material adverse effect on our business, results of operation and financial condition.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, some of our operations, including our clinical laboratory, dialysis centers and other facilities, may be adversely impacted by the effects of natural or other disasters, political instability, public health crises such as global pandemics or epidemics, including the COVID-19 pandemic, or adverse weather events such as hurricanes, earthquakes, fires or flooding. Each of these effects and risks may be further intensified by the increasing impact of climate change on a global scale. In addition, these risks are particularly heightened for our patients in part because individuals with chronic illness may be more susceptible to the adverse effects of epidemics or other public health crises and also because any natural or other disaster, political instability or adverse weather event that disrupts or limits the operation of any of our centers or other facilities or services may delay or otherwise impact the critical services we provide to dialysis patients. Further, any such event or other </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">occurrence that results in a failure of the fitness of our clinical laboratory, dialysis centers and related operations and/or other facilities or otherwise adversely impacts the safety of our teammates or patients at any of those locations could lead us to face adverse consequences, including, without limitation, the potential loss of data, including PHI or PII, compliance or regulatory investigations, any of which could materially impact our business, results of operation and financial condition, and could materially harm our reputation. For example, our clinical laboratory is located in Florida, a state that has in the past experienced and may in the future experience hurricanes. Natural or other disasters or adverse weather events could significantly damage or destroy our facilities, disrupt operations, increase our costs to maintain operations and require substantial expenditures and recovery time to fully resume operations. In addition, as the effects of climate change progressively surface, such as through potential increases in the frequency and intensity of natural or other disasters or adverse weather events or through laws or regulations adopted in response, we may face increased costs associated with operating our clinics, including, without limitation, with respect to supplies of water or energy costs.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our presence in markets outside the U.S. may increase our exposure to these and similar risks related to natural disasters, public health crises, political instability, climate change or other catastrophic events outside our control. For additional information regarding the risks related to our international business, see the discussion in the risk factor under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expansion of our operations to and offering our services in markets outside of the U.S. subjects us to political, economic, legal, operational and other risks that could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any or all of these factors, as well as other consequences of these events, none of which we can currently predict, could have a material adverse effect on our business, results of operations, financial condition and cash flows or materially harm our reputation.</span></div><div id="i916f7af890114e55a87e260476560c60_2880"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be subject to liability claims for damages and other expenses that are not covered by insurance or exceed our existing insurance coverage that could have a material adverse effect on our business, results of operations, financial condition, cash flows and could materially harm our reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and how we manage our business may subject us, as well as our officers and directors to whom we owe certain defense and indemnity obligations, to litigation and liability. Our business, profitability and growth prospects could suffer if we face negative publicity or we pay damages or defense costs in connection with a claim that is outside the scope or limits of coverage of any applicable insurance coverage, including, without limitation, claims related to adverse patient events, cybersecurity incidents, contractual disputes, antitrust and competition laws and regulations, professional and general liability and directors' and officers' duties. In addition, we have received notices of claims from commercial payors and other third parties, as well as subpoenas and civil investigative demands from the federal government, related to our business practices, including, without limitation, our historical billing practices and the historical billing practices of acquired businesses. Although the ultimate outcome of these claims cannot be predicted, an adverse result with respect to one or more of these claims could have a material adverse effect on our business, results of operations, financial condition and cash flows, and could materially harm our reputation. We maintain insurance coverage for those risks we deem are appropriate to insure against and make determinations about whether to self-insure as to other risks or layers of coverage. However, a successful claim, including, without limitation, a professional liability, malpractice or negligence claim or a claim related to antitrust and competition laws or a cybersecurity incident, which is in excess of any applicable insurance coverage, that is outside the scope or limits of any applicable insurance coverage, or that is subject to our self-insurance retentions, could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if our costs of insurance and claims increase, then our earnings could decline. Market rates for insurance premiums and deductibles have been steadily increasing. Our business, results of operations, financial condition and cash flows could be materially and adversely affected by any of the following:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the collapse or insolvency of our insurance carriers;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">further increases in premiums and deductibles;</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases in the number of liability claims against us or the cost of settling or trying cases related to those claims; </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining insurance with exclusions for things such as communicable diseases; or</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an inability to obtain one or more types of insurance on acceptable terms, if at all.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_2875"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to successfully maintain an effective internal control over financial reporting, the integrity of our financial reporting could be compromised, which could have a material adverse effect on our ability to accurately report our financial results, the market's perception of our business and our stock price.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The integration of acquisitions and addition of new business lines into our internal control over financial reporting has required and will continue to require significant time and resources from our management and other personnel and has increased, and is expected to continue to increase, our compliance costs. Failure to maintain an effective internal control environment could have a material adverse effect on our ability to accurately report our financial results, the market's perception of our business and our stock price. In addition, we could be required to restate our financial results in the event of a significant failure of our internal control over financial reporting or in the event of inappropriate application of accounting principles.</span></div><div id="i916f7af890114e55a87e260476560c60_2865"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provisions in our organizational documents, our compensation programs and policies and certain requirements under Delaware law may deter changes of control and may make it more difficult for our stockholders to change the composition of our Board of Directors and take other corporate actions that our stockholders would otherwise determine to be in their best interests.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our organizational documents include provisions that may deter hostile takeovers, delay or prevent changes of control or changes in our management, or limit the ability of our stockholders to approve transactions that they may otherwise determine to be in their best interests. These include provisions prohibiting our stockholders from acting by written consent, advance notice requirements for director nominations and stockholder proposals and granting our Board of Directors the authority to issue preferred stock and to determine the rights and preferences of the preferred stock without the need for further stockholder approval.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our outstanding employee stock-based compensation awards include a provision accelerating the vesting of the awards in the event of a change of control. These and any other change of control provisions may affect the price an acquirer would be willing to pay for our Company.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to Section 203 of the Delaware General Corporation Law that, subject to exceptions, prohibits us from engaging in any business combinations with any interested stockholder, as defined in that section, for a period of three years following the date on which that stockholder became an interested stockholder.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions described above may discourage, delay or prevent an acquisition of our Company at a price that our stockholders may find attractive. These provisions could also make it more difficult for our stockholders to elect directors and take other corporate actions and could limit the price that investors might be willing to pay for shares of our common stock.</span></div><div id="i916f7af890114e55a87e260476560c60_67"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1B.&#160;&#160;&#160;&#160;Unresolved Staff Comments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i916f7af890114e55a87e260476560c60_70"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Properties.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters are located in Denver, Colorado, consisting of one owned 240,000 square foot building and one leased 345,900 square foot location. Our headquarters are occupied by teammates engaged in management, finance, marketing, strategy, legal, compliance and other administrative functions. We lease five business offices located in California, Pennsylvania, Tennessee and Washington, and own one business office in Washington in the U.S. In addition, our international headquarters is located in the United Kingdom and consists of one leased business office. Our laboratory is based in Florida where we operate our lab services out of one leased building. We also lease other administrative offices in the U.S. and worldwide. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our U.S. dialysis business we own the land and buildings for five outpatient dialysis centers. We also own 16 properties for development, including operating outpatient dialysis centers and properties we hold for sale. Our remaining outpatient dialysis centers are located on premises that we lease.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our leases for our U.S. dialysis business cover periods from five years to 15 years and typically contain renewal options of five years to ten years at the fair rental value at the time of renewal. Our leases are generally subject to periodic consumer price index increases, or contain fixed escalation clauses. Our outpatient dialysis centers range in size from approximately 1,000 to 33,000 square feet, with an average size of approximately 7,800 square feet. Our international leases generally range from one to ten years.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our outpatient dialysis centers are operating at or near capacity. However, we believe that we have adequate capacity within most of our existing dialysis centers to accommodate additional patient volume through increased hours and/or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">days of operation, or, if additional space is available within an existing facility, by adding dialysis stations. We can usually relocate existing centers to larger facilities or open new centers if existing centers reach capacity. With respect to relocating centers or building new centers, we believe that we can generally lease space at economically reasonable rates in the areas planned for each of these centers, although there can be no assurances in this regard. Expansion of existing centers or relocation of our dialysis centers is subject to review for compliance with conditions relating to participation in the Medicare ESRD program, among other things. In states that require a certificate of need or center license, additional approvals would generally be necessary for expansion or relocation.</span></div><div id="i916f7af890114e55a87e260476560c60_73"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Legal Proceedings.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Part I, Item&#160;3&#160;is incorporated herein by reference to the information set forth under the caption "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 16 to the consolidated financial statements included in this report.</span></div><div id="i916f7af890114e55a87e260476560c60_76"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mine Safety Disclosures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i916f7af890114e55a87e260476560c60_82"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the New York Stock Exchange under the symbol DVA. The closing price of our common stock on January&#160;31, 2022 was $108.37 per share. According to Computershare, our registrar and transfer agent, as of January&#160;31, 2022, there were 7,232 holders of record of our common stock. This figure does not include the indeterminate number of beneficial holders whose shares are held of record by brokerage firms and clearing agencies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our initial public offering was in 1994, and we have not declared or paid cash dividends to holders of our common stock since going public. We have no current plans to pay cash dividends and there are certain limitations on our ability to pay dividends under the terms of our senior secured credit facilities. See "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and capital resources"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under Item 7. "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the notes to the consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our repurchases of our common stock during the fourth quarter of 2021:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:500.25pt"><tr><td style="width:1.0pt"></td><td style="width:156.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:66.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:93.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:97.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:32pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total number<br/>of shares<br/>purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average price<br/>paid per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total number of shares purchased as part of publicly announced plans or programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Approximate dollar value<br/>of shares that may yet be purchased under the plans or programs</span></td></tr><tr style="height:11pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars and shares in thousands, except per share data)</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 1-31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">890,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 1-30, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">738,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 1-31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,383,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.52&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our repurchases of our common stock during 2021:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:30.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.693%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total number<br/>of shares<br/>purchased</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average price<br/>paid per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total number of shares purchased as part of publicly announced plans or programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Approximate dollar value<br/>of shares that may yet be purchased under the plans or programs</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars and shares in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 1 - March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,607,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 1 - June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,366,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 1 - September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,030,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 1 - December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,383,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.41&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on December 10, 2020, the Board terminated all remaining prior share repurchase authorizations available to us and approved a new share repurchase authorization of $2.0 billion. Effective on December 17, 2021, the Board increased the Company's existing authorization by $2.0 billion in additional share repurchasing authority. We are authorized to make purchases from time to time in the open market or in privately negotiated transactions, including without limitation, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing, depending upon market conditions and other considerations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;9, 2022, we have a total of $2.225 billion available under the current repurchase authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, we remain subject to share repurchase limitations, including under the terms of our senior secured credit facilities.</span></div><div id="i916f7af890114e55a87e260476560c60_85"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Selected Financial Data.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This item is no longer required as the Company has adopted the changes to Item 301 of Regulation S-K contained in the Securities and Exchange Commission's Release No. 33-10890.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div id="i916f7af890114e55a87e260476560c60_91"></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-looking statements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Annual Report on Form 10-K, including this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, contains statements that are forward-looking statements within the meaning of the federal securities laws and as such are intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. These forward-looking statements could include, among other things, DaVita's response to and the expected future impacts of the novel coronavirus (COVID-19), including statements about our balance sheet and liquidity, our expenses and expense offsets, revenues, billings and collections, potential need, ability or willingness to use any funds under government relief programs, availability or cost of supplies, treatment volumes, mix expectation, such as the percentage or number of patients under commercial insurance, the availability, acceptance, impact, administration and efficacy of COVID-19 vaccines, treatments and therapies, the continuing impact on the U.S. and global economies, unemployment and labor market conditions, and overall impact on our patients and teammates, as well as other statements regarding our future operations, financial condition and prospects, expenses, strategic initiatives, government and commercial payment rates, expectations related to value-based care, integrated kidney care and Medicare Advantage plan enrollment and our ongoing stock repurchase program. All statements in this report, other than statements of historical fact, are forward-looking statements. Without limiting the foregoing, statements including the words "expect," "intend," "will," "could," "plan," "anticipate," "believe," and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on DaVita's current expectations and are based solely on information available as of the date of this report. DaVita undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of changed circumstances, new information, future events or otherwise, except as may be required by law. Actual future events and results could differ materially from any forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the continuing impact of the dynamic and evolving COVID-19 pandemic, including, without limitation, on our patients, teammates, physician partners, suppliers, business, operations, reputation, financial condition and results of operations; the government&#8217;s response to the COVID-19 pandemic, including, among other things, federal, state and local vaccine mandates or surveillance testing requirements and the extent to which they may ultimately be applicable to us; the pandemic's continuing impact on the U.S. and global economies, unemployment, labor market conditions, inflation and evolving monetary policies; the availability, acceptance, impact and efficacy of COVID-19 vaccines, treatments and therapies; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus, such as the Delta and Omicron variants; the continuing impact of the pandemic on our revenue and non-acquired growth due to lower treatment volumes; COVID-19's impact on the chronic kidney disease (CKD) population and our patient population including on the mortality of these patients; any potential negative impact on our commercial mix or the number of our patients covered by commercial insurance plans; continued increased COVID-19-related costs; supply chain challenges and disruptions, including with respect to our clinical supplies; and higher salary and wage expense driven in part by labor market conditions and a high demand for our clinical personnel, any of which may also have the effect of heightening many of the other risks and uncertainties discussed below, and in many cases, lead to impacts that persist even after the pandemic subsides; </span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which the ongoing implementation of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof or related litigation result in a reduction in coverage or reimbursement rates for our services, a reduction in the number of patients enrolled in higher-paying commercial plans or that are enrolled in or select Medicare Advantage plans or other material impacts to our business or operations; or our making incorrect assumptions about how our patients will respond to any such developments;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">risks arising from potential changes in laws, regulations or requirements applicable to us, such as potential and proposed federal and/or state legislation, regulation, ballot, executive action or other initiatives, including without limitation those related to healthcare and/or labor matters, such as AB 290 in California;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the political environment and related developments on the current healthcare marketplace and on our business, including with respect to the Affordable Care Act, the exchanges and many other core aspects of the current healthcare marketplace, as well as the composition of the U.S. Supreme Court and the current presidential administration and congressional majority;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">legal and compliance risks, such as our continued compliance with complex, and at times, evolving government regulations and requirements;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">noncompliance by us or our business associates with any privacy or security laws or any security breach by us or a third party involving the misappropriation, loss or other unauthorized use or disclosure of confidential information;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the concentration of profits generated by higher-paying commercial payor plans for which there is continued downward pressure on average realized payment rates, and a reduction in the number or percentage of our patients under such plans, including, without limitation, as a result of restrictive plan designs, restrictions or prohibitions on the use and/or availability of charitable premium assistance, which may result in the loss of revenues or patients, or our making incorrect assumptions about how our patients will respond to any change in financial assistance from charitable organizations;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully implement our strategies with respect to integrated kidney care and value-based care initiatives and home based dialysis in the desired time frame and in a complex, dynamic and highly regulated environment, including, among other things, maintaining our existing business; meeting growth expectations; recovering our investments; entering into agreements with payors, third party vendors and others on terms that are competitive and, as appropriate, prove actuarially sound; structuring operations, agreements and arrangements to comply with evolving rules and regulations; finding, training and retaining appropriate staff; and further developing our integrated care and other capabilities to provide competitive programs at scale; </span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">a reduction in government payment rates under the Medicare End Stage Renal Disease program, state Medicaid or other government-based programs and the impact of the Medicare Advantage benchmark structure;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">changes in pharmaceutical practice patterns, reimbursement and payment policies and processes, or pharmaceutical pricing, including with respect to hypoxia inducible factors, among other things;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop and maintain relationships with physicians and hospitals, changing affiliation models for physicians, and the emergence of new models of care or other initiatives introduced by the government or private sector that, among other things, may erode our patient base and impact reimbursement rates;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to complete acquisitions, mergers, dispositions, joint ventures or other strategic transactions that we might announce or be considering, on terms favorable to us or at all, or to integrate and successfully operate any business we may acquire or have acquired, or to successfully expand our operations and services in markets outside the United States, or to businesses outside of dialysis;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract, retain and motivate teammates and our ability to manage operating cost increases or productivity decreases whether due to union organizing activities, legislative or other changes, demand for labor, volatility and uncertainty in the labor market, the current challenging labor market conditions, or other reasons;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our aspirations, goals and disclosures related to environmental, social and governance (ESG) matters, including evolving regulatory requirements affecting ESG standards, measurements and reporting requirements; the availability of suppliers that can meet our sustainability standards; and our ability to recruit, develop and retain diverse talent in our labor markets;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">continued increased competition from dialysis providers and others, and other potential marketplace changes, including increased investment in and availability of funding to new entrants in the dialysis and pre-dialysis marketplace;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the variability of our cash flows, including without limitation any extended billing or collections cycles; the risk that we may not be able to generate or access sufficient cash in the future to service our indebtedness or to fund our other liquidity needs; and the risk that we may not be able to refinance our indebtedness as it becomes due, on terms favorable to us or at all;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">factors that may impact our ability to repurchase stock under our stock repurchase program and the timing of any such stock repurchases, as well as our use of a considerable amount of available funds to repurchase stock;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">risks arising from the use of accounting estimates, judgments and interpretations in our financial statements;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">impairment of our goodwill, investments or other assets; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the other risk factors, trends and uncertainties set forth in Part I, Item 1A. of this Annual Report on Form 10-K, and the other risks and uncertainties discussed in any subsequent reports that we file or furnish with the SEC from time to time.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following should be read in conjunction with our consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company overview</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal business is to provide dialysis and related lab services to patients in the United States, which we refer to as our U.S. dialysis business. We also operate our U.S. ancillary services and strategic initiatives and our international operations, which we collectively refer to as our ancillary services, as well as our corporate administrative support. Our U.S. dialysis business is a leading provider of kidney dialysis services in the U.S. for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD) or end stage kidney disease (ESKD).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;19, 2019, we completed the sale of our prior DaVita Medical Group (DMG) business to Collaborative Care Holdings, LLC, a subsidiary of UnitedHealth Group Inc. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented and DMG is not included below in this Management's Discussion and Analysis.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the challenges of responding to the novel coronavirus pandemic (COVID-19), our year-over-year overall financial performance in 2021 benefited from increased revenue, which was primarily due to higher average revenue per treatment in our U.S. dialysis business and acquired growth in our international business. In addition our 2021 financial performance benefited from lower pharmaceutical unit costs and intensity, advocacy costs and COVID-19-related compensation expenses as compared to the prior year. These benefits were partially offset by a decline in treatment volume and increases in compensation expense, including labor costs (both operating and overhead) and health benefits expense. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Drivers of our financial performance in 2021 included the following:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">improved certain key clinical outcomes in our U.S. dialysis business, including exceeding our pre-pandemic level of patients receiving kidney transplants;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">revenue growth of 0.1% in U.S. dialysis and 19.9% in international operations;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating income growth of 3.0% in U.S. dialysis and 82.6% in international operations;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net increase of 18 international dialysis centers;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provision of integrated kidney care to </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patients in risk-based integrated care arrangements and an additional 7,000 patients in other integrated care arrangements;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating cash flows of $1.931 billion from continuing operations;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">repurchase of 13,877,193 shares of our common stock for aggregate consideration of $1.546 billion, and reduction of our share count by 11.5% year-over-year;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">completion of an unregistered add-on offering of $1 billion aggregate principal amount to the existing 4.625% senior notes due June&#160;1, 2030 (the Additional 2030 Notes); and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impact of COVID-19 as further discussed in Part I. Item 1 "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 and its impact on our business" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we expect that COVID-19 will continue to impact our business and financial performance though the magnitude of these impacts remains difficult to predict and subject to significant uncertainty due to a number of factors, as described in further detail below </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 and its impact on our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On treatment volume, we continue to face pressure primarily driven by the impact of COVID-19 on mortality rates for dialysis patients due to recent surges of infections, which may be further compounded by any future surges, if such surges occur. We anticipate that this pressure also will be magnified by continued slowing industry growth and continued competitive activity in 2022. On reimbursement rate, we expect growth in aggregate, primarily due to the expected net market basket update for Medicare treatments as well as a continuing increase in anticipated Medicare Advantage enrollment due to the 21st Century Cures Act, albeit less than what we experienced in 2021, partially offset by the scheduled resumption of Medicare sequestration later in 2022. On cost, we continue to expect increasing inflationary pressure on wage rates and other costs, increased costs due to the challenging labor market conditions, and an increase in depreciation expenses due to the general release of our new clinical IT platform in 2022, partially offset by continued anticipated savings on pharmaceutical costs. We expect to incur elevated advocacy costs in 2022, in-line with our advocacy costs incurred in 2018 and 2020, respectively. We also expect to continue making investments to expand our ability to offer home-based dialysis service options and further advance our integrated care and value-based care initiatives in 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, considerable uncertainty exists surrounding the continued development of the various governmental laws, regulations and other requirements that impact our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion below includes analysis of our financial condition and results of operations for the years ended December&#160;31, 2021 compared to December&#160;31, 2020. Our Annual Report on Form 10-K for the year ended December&#160;31, 2020, includes a discussion and analysis of our financial condition and results of operations for the year ended December&#160;31, 2019, in its Part II, Item 7, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">".</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References to the "Notes" in the discussion below refer to the notes to the Company's consolidated financial statements included in this Annual Report on Form 10-K at Item 15, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits, Financial Statement Schedules</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as referred from Part II Item 8, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements and Supplementary Data.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div id="i916f7af890114e55a87e260476560c60_97"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 and its impact on our business</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, the continued impacts and disruptions to our business in connection with of the COVID-19 pandemic could have a material adverse impact on our patients, teammates, physician partners, suppliers, business, operations, reputation, financial condition, results of operations, cash flows and/or liquidity. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operational and Financial Impacts</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During this time of great and continued challenge, we continue our focus on the health, safety and well-being of our patients, teammates and physician partners and helping to ensure that our patients have the ability to maintain continuity of care throughout this crisis, whether in the hospital, outpatient or home setting. To that end, we have dedicated and continue to dedicate substantial resources in response to COVID-19, including the implementation of additional protocols and initiatives to help safely maintain continuity of care for our patients and help protect our caregivers. For example, we implemented dedicated care shifts for patients with confirmed or suspected COVID-19 and other enhanced clinical practices, including procuring additional equipment and clinical supplies, such as personal protective equipment (PPE). These efforts are part of a wider Prepare, Prevent, Respond and Recover program that we have implemented in connection with the pandemic, which also includes operational protocols such as the redistribution of teammates, machines and supplies across the country as needed and continued investment in and utilization of telehealth capabilities and the administration of COVID-19 vaccines. We also have maintained business process continuity during the pandemic by enabling most back office teammates to work remotely. We carefully monitor the efficacy of our response protocols and their impact on our operations and strategic priorities as the pandemic continues. Certain temporary changes made in response to the COVID-19 pandemic could become permanent, which could have an adverse impact on our business. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due in part to these protocols and initiatives, we have incurred costs related to COVID-19 in 2021, and we expect to continue to incur extended costs in the future in connection with our response to COVID-19, and the cumulative impact of these costs could be material. Among other things, our response to COVID-19 has resulted in higher salary and wage expense, and we have provided, and may provide in the future, substantial financial support to our teammates, which may include relief reimbursement. We also continued to experience significant cost inflation on PPE in 2021, though certain other costs related to our COVID-19 response have decreased since the peak of the COVID-19 surge in the fourth quarter of 2020. We believe that the cost of these medical supplies will remain elevated and as our COVID-19 response continues, we expect to continue to incur extended and significant additional costs for these supplies, and we expect that certain of these increased costs may persist due to the overall challenges and disruptions of global supply chains. These global supply chain challenges have impacted the availability of certain of our equipment and clinical supplies. Prolonged strain on global supply chains may result in additional equipment and clinical supply shortages, disruptions, delays or associated price increases that could impact our ability to provide dialysis services or the cost of providing those services, among other things. On the other hand, our COVID-19 response has reduced certain other expenses, such as those related to teammate travel, though it remains uncertain how much of these reductions, if any, will persist after the pandemic subsides and more teammates return to their respective office locations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is labor intensive and our financial and operating results have been and continue to be sensitive to variations in labor-related costs and productivity. We have historically faced and expect to continue to face costs and difficulties in hiring and retaining caregivers due to a nationwide shortage of skilled clinical personnel. These challenges have been heightened by the increased demand for and demand upon such personnel attributed to the ongoing pandemic. As referenced above, the labor market is challenging and continues to experience volatility, uncertainty and labor supply shortages, particularly in healthcare. In addition, federal and state agencies have announced or released rules relating to COVID-19 vaccination requirements that relate to our teammates, providers and patients. Certain of these regulations are subject to ongoing legal challenge as further described in Part I, Item 1. Business of this Form 10-K under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation&#8212;COVID-19 Response"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The cumulative impact of these mandates, some of which have already gone into effect, contributes further to the volatility and uncertainty in the labor market and may ultimately further exacerbate labor shortages. These conditions have adversely impacted, and may continue to adversely impact, our ability to attract and retain employees, particularly clinical personnel. As part of our efforts in this highly competitive market, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we have provid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ed o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ur teammates with additional compensation, among other things. In 2022, we expect to provide our teammates with higher than usual wage </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increases, which will put additional pressure on our cost structure going forward</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have experienced staffing shortages and disruptions as a result of current labor market conditions and the current Omicron surge, and further staffing shortages or disruptions, if material, could lead to the unplanned closures of certain centers or adversely impact clinical operations, and may otherwise have a material adverse impact on our ability to provide dialysis services or the cost of providing those services, among other things. Prolonged volatility, uncertainty, labor supply shortages and other challenging labor market conditions, including, among other things, due to inflationary pressures or evolving monetary policies, could also have an adverse impact on our ability to execute on our strategic initiatives, and ultimately could have a material adverse impact on our labor costs, results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, treatment volumes reflected continued pressure primarily driven by the ongoing impact of COVID-19 on mortality rates for dialysis patients which has had a negative impact on our patient census. Because ESKD patients may be older than the average American and generally have comorbidities, several of which are risk factors for COVID-19, we believe the mortality rate of infected patients has been higher in the dialysis population than in the general population, and COVID-19 also could impact the CKD population differently. The recent surges associated with the Delta and Omicron variants led to a significant increase in COVID&#8209;19 cases in our patient population. At the peak of the most recent surge in January 2022, the new case count was more than two times as high as the peak from winter 2020. While the mortality rate associated with this latest surge preliminarily appears to be lower than in prior surges, it is too early to provide a comprehensive assessment. The fourth quarter of 2021 saw a slight decrease in incremental mortality on an absolute basis compared to the third quarter of 2021. Over the longer term, we believe that changes in mortality in both the CKD and ESKD populations due to COVID-19 will continue to depend primarily on the infection rate, case fatality rate, the age and health status of affected patients, and access to and continued efficacy of vaccinations or other treatments or therapies, as well as willingness to be vaccinated. We expect that the impact of COVID-19 is likely to continue to negatively impact our revenue and non-acquired growth for a period of time even as the pandemic subsides due to the compounding impact of mortalities, among other things. However, determining the extent to which these impacts should be directly attributable to COVID-19 is difficult due to testing and reporting limitations, and other factors that may drive treatment volumes and new admissions over time, such as the number of transplants or deferred admissions. Depending on the ultimate severity and duration of the pandemic, the magnitude of these cumulative impacts could have a material adverse impact on our results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the COVID-19 pandemic and efforts to contain the virus have impacted the global economy, resulting in, among other things, volatility and uncertainty in labor market conditions as noted above. These impacts could ultimately result in a materially reduced share of our patients being covered by commercial insurance plans, with more patients being covered by lower-paying government insurance programs or being uninsured. These effects may persist after the pandemic subsides as, among other things, our patients could experience permanent changes in their insurance coverage as a result of changes to their employment status. In the event such a material reduction occurs in the share of our patients covered by commercial insurance plans, it would have a material adverse impact on our business, results of operations, financial condition and cash flows. Despite the broader economic conditions in the U.S. for the year ended December 31, 2021, our commercial mix in 2021 slightly improved as compared to our commercial mix in 2020. The ultimate impact of COVID-19 on our commercial mix will depend on future developments that are highly uncertain and difficult to predict.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal, State and Local Government Response</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The government response to COVID-19 has been wide-ranging and will continue to develop over time. As a result, we may not be able to accurately predict the nature, timing or extent of the impact of such changes on the markets in which we conduct business or on the other participants that operate in those markets, or any potential changes to the extensive set of federal, state and local laws, regulations and requirements that govern our business, including for example, the COVID-19 vaccine mandates and similar state and local mandates referenced above. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have worked with certain government agencies to respond to the COVID-19 pandemic, and in certain cases have sought waivers of regulatory requirements. We have also contracted with the federal government to provide direct administration of COVID-19 vaccines to our patients and teammates at our clinics. Approximately 73% of our patients have received at least one dose of the COVID-19 vaccine and nearly all of our clinical teammates are fully vaccinated or have an exemption. Certain of these vaccines are currently available under emergency use authorizations, and there can be no assurance that our patients and caregivers will choose to receive a COVID-19 vaccine or that the vaccines will prove to be as safe and effective as currently understood by the scientific community, particularly as it may relate to variants of the virus. In addition, we may encounter difficulties with the availability and storage of the vaccines, or experience other complications related to administering the vaccines, some of which have multiple dose requirements, or may include the administration of "boosters". As of December&#160;31, 2021, we had administered approximately 217,000 COVID-19 vaccines and boosters due in part to the state and federal vaccine allocations to dialysis providers.</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain state and federal agencies, including the Occupational Safety and Health Administration (OSHA) and CMS, have released requirements, or are in the process of modifying existing requirements associated with the continued protection of employees as it relates to COVID-19. These requirements related to, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">among other things, initial and booster vaccines, PPE, fit-testing, surveillance testing of our teammates for COVID-19 and other increased obligations with which we must comply may further impact our costs, create operational challenges, negatively impact our ability to attract and retain employees and create a risk of non-compliance if we are not able to successfully implement such requirements. We operate in a complex and highly regulated environment, and the novel nature of our COVID-19 response, including, for example, with respect to regulatory waivers, our administration of the COVID-19 vaccines, and our efforts to comply with evolving rules and regulations, may increase our exposure to legal, regulatory and clinical risks.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, federal COVID-19 relief legislation suspended the 2% Medicare sequestration from May 1, 2020 through December 31, 2021. The Protecting Medicare and American Farmers from Sequester Cuts Act, signed into law on December 10, 2021, extended the suspension of the 2% Medicare sequestration from December 31, 2021 through March 31, 2022, with 1% Medicare sequestration beginning April 1, 2022 through June 30, 2022 and 2% Medicare sequestration beginning July 1, 2022. While in effect, the suspension of sequestration has significantly increased, and will continue to significantly increase, our revenues.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the ultimate impact of this public health crisis on the Company will depend on future developments that are highly uncertain and difficult to predict, including among others the ultimate severity and duration of the pandemic; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus, such as the Delta and Omicron variants; COVID-19's impact on the chronic kidney disease (CKD) patient population and our patient population, including on the mortality of these patients; the availability, acceptance, impact and efficacy of COVID-19 vaccines, treatments and therapies; the pandemic&#8217;s continuing impact on our revenue and non-acquired growth due to lower treatment volumes, the U.S. and global economies, unemployment, labor market conditions, inflation and monetary policies; the potential negative impact on our commercial mix or the number of patients covered by commercial insurance plans; continued increased COVID-related costs; supply chain challenges and disruptions; the responses of our competitors to the pandemic and related changes in the marketplace; the timing, scope and effectiveness of federal, state and local government responses to the continuing pandemic; and any potential changes to the extensive set of federal, state and local laws, regulations and requirements that govern our business. In many cases, the impact of the pandemic on us may persist even after the pandemic subsidies. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional discussion of the COVID-19 pandemic and our response, including its impact on us and related risks and uncertainties, please see the discussion in Part I Item 1. Business under the headings, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 and its impact on our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as well as the risk factor in Part I Item 1A. Risk Factors under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, many of which may have a material adverse impact on us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated results of operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our revenues, operating income and adjusted operating income by line of business. See the discussion of our results for each line of business following this table. When multiple drivers are identified in the following discussion of results, they are listed in order of magnitude: </span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.795%"><tr><td style="width:1.0%"></td><td style="width:46.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total consolidated revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted operating income (loss):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,797&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating income (loss) by reportable segment, see the "Reconciliations of non-GAAP measures" section below. </span></div><div id="i916f7af890114e55a87e260476560c60_103"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. dialysis business</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, our U.S. dialysis business is a leading provider of kidney dialysis services, operating 2,815 outpatient dialysis centers serving a total of approximately 203,100 patients, and contracted to provide hospital inpatient dialysis services in approximately 850 hospitals. We estimate that we have approximately a 36% share of the U.S. dialysis market based upon the number of patients we serve. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 91% of our 2021 consolidated revenues were derived directly from our U.S. dialysis business. The principal drivers of our U.S. dialysis revenues include&#160;&#160;&#160;&#160;:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our number of treatments, which is primarily a function of the number of chronic patients requiring approximately three in-center treatments per week as well as, to a lesser extent, the number of treatments for home-based dialysis and hospital inpatient dialysis; and</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our average dialysis patient service revenue per treatment, including the mix of patients with commercial plans and government programs as primary payor.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our U.S. dialysis business, our home-based dialysis and hospital inpatient dialysis services are operationally integrated with our outpatient dialysis centers and related laboratory services. Our outpatient, home-based and hospital inpatient dialysis services comprise approximately 76%, 18% and 6% of our U.S. dialysis revenues, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., government dialysis-related payment rates are principally determined by federal Medicare and state Medicaid policy. For 2021, approximately 68% of our total U.S. dialysis patient services revenues were generated from government-based programs for services to approximately 90% of our total U.S. patients. These government-based programs are principally Medicare and Medicare Advantage, Medicaid and managed Medicaid plans, and other government plans, representing approximately 58%, 7% and 3% of our U.S. dialysis patient services revenues, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 29, 2021, CMS issued a final rule to update the ESRD PPS payment rate and policies, as described further above. CMS estimates the final rule will affect ESRD facilities' average reimbursement by a productivity-adjusted market </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">basket increase of 1.9% in 2022. In addition, the Protecting Medicare and American Farmers from Sequester Cuts Act extended the suspension of the 2% Medicare sequestration from December 31, 2021 through March 31, 2022, with 1% Medicare sequestration beginning April 1, 2022 through June 30, 2022 and 2% Medicare sequestration beginning July 1, 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dialysis payment rates from commercial payors vary and a major portion of our commercial rates are set at contracted amounts with payors and are subject to intense negotiation pressure. On average, dialysis-related payment rates from contracted commercial payors are significantly higher than Medicare, Medicaid and other government program payment rates, and therefore the percentage of commercial patients in relation to total patients represents a significant driver of our total average dialysis patient service revenue per treatment. Commercial payors (including hospital dialysis services) represent approximately 32% of U.S. dialysis patient services revenues.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For discussion of government reimbursement, the Medicare ESRD bundled payment system, Medicare Advantage and commercial reimbursement, see the discussion in Part I. Item 1. Business under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. dialysis business &#8211; Sources of revenue-concentrations and risks."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For a discussion of operational, clinical and financial risks and uncertainties that we face in connection with the Medicare ESRD bundled payment system, see the risk factor in Part I. Item 1A. Risk Factors under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business is subject to a complex set of governmental laws, regulations and other requirements and any failure to adhere to those requirements, or any changes in those requirements, could have a material adverse effect on our business, results of operations, financial condition and cash flows, could materially harm our stock price, and in some circumstances, could materially harm our reputation."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For a discussion of operational, clinical and financial risks and uncertainties that we face in connection with commercial payors, see the risk factor in Item 1A. Risk Factors under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If the number or percentage of patients with higher-paying commercial insurance declines, if the average rates that commercial payors pay us decline, if patients in commercial plans are subject to restriction in plan designs, if we are unable to maintain contracts with payors with competitive terms, including, without limitation, reimbursement rates, scope and duration of coverage and in-network benefits, it could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2021, both oral and intravenous forms of calcimimetics were added to the ESRD PPS bundled payment, and as a result our operating income from calcimimetics was more stable in 2021 and will continue to be in the future as compared to the year ended December&#160;31, 2020 under the transitional drug add-on payment adjustment (TDAPA) model. For the year ended December 31, 2020, the oral and intravenous forms of calcimimetics were separately reimbursed through a TDAPA model based on a pass-through rate of the average sales price plus 0%, before sequestration.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 1% and 4% of our total U.S. dialysis patient services revenues for the years 2021 and 2020, respectively, were associated with the administration of separately-billable physician-prescribed pharmaceuticals, the majority of which relate to the administration of calcimimetics. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that we will continue to experience increases in our operating costs in 2022 that may outpace any net Medicare, commercial or other rate increases that we may receive, which could significantly impact our operating results.&#160;In particular, we expect to continue experiencing increases in operating costs that are subject to inflation, such as labor and supply costs, including increases in maintenance costs, regardless of whether there is a compensating inflation-based increase in Medicare, commercial or other payor payment rates. We also continue to expect to incur additional COVID-19-related costs while the pandemic continues. In addition, we expect to continue to incur capital expenditures and associated depreciation and amortization to improve, renovate and maintain our facilities, equipment and information technology to meet evolving regulatory requirements and otherwise.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis patient care costs are those costs directly associated with operating and supporting our dialysis centers, home-based dialysis programs and hospital inpatient dialysis programs, and consist principally of labor, benefits, pharmaceuticals, medical supplies and other operating costs of the dialysis centers. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal drivers of our U.S. dialysis patient care costs include:</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical hours per treatment, labor rates and benefit costs;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">vendor pricing and utilization levels of pharmaceuticals;</span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business infrastructure costs, which include the operating costs of our dialysis centers; and </span></div><div style="margin-top:9pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">medical supply costs. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other cost categories that can present significant variability include insurance costs and professional fees. In addition, proposed ballot initiatives or referendums, legislation, regulations or policy changes could cause us to incur substantial costs to prepare for, or implement changes required. Any such changes could result in, among other things, increases in our labor costs </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or limitations on the amount of revenue that we can retain. For additional information on risks associated with potential and proposed ballot initiatives, referendums, legislation, regulations or policy changes, see the risk factor in Item 1A. Risk Factors under the heading, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in federal and state healthcare legislation or regulations could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our average clinical hours per treatment were relatively flat in 2021 compared to 2020. We are always striving for improved productivity levels, however, changes in things such as federal and state policies or regulatory billing requirements can lead to increased labor costs. In 2021, the demand for skilled clinical personnel continued, exacerbated by the nationwide shortage caused by the continuing COVID-19 pandemic on these resources. In 2021 and 2020, we experienced an increase in our clinical labor rates of approximately 3.9% and 3.0%, respectively, consistent with general industry trends. We expect to continue to see higher clinical labor rates in 2022 due to the labor market conditions and the continued competition for skilled clinical personnel. In 2021, our overall clinical teammate retention declined from 2020. We also continue to experience increases in the infrastructure and operating costs of our dialysis centers and general increases in rent and repairs and maintenance. In 2021, we continued to implement certain cost control initiatives to help manage our overall operating costs, including labor productivity and utilities expense, and we expect to continue these initiatives in 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis general and administrative expenses represented 8.7% and 9.0% of our U.S. dialysis revenues in 2021 and 2020, respectively. Increases in general and administrative expenses over the last several years were primarily related to strengthening our dialysis business and related compliance and operational processes, responding to certain legal and compliance matters, professional fees associated with enhancing our information technology systems and more recent advocacy costs in 2020 related to countering union policy efforts. We expect that these levels of general and administrative expenses will be impacted by higher advocacy costs in 2022 compared to 2021, continued investment in developing our capabilities and executing on our strategic priorities, among other things.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. dialysis results of operations</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treatment volume:&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"><tr><td style="width:1.0%"></td><td style="width:47.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dialysis treatments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,622,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,314,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(692,431)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average treatments per day</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,027)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treatment days</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Normalized non-acquired treatment growth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.9)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:13.5pt;padding-right:13.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Normalized non-acquired treatment growth reflects year over year growth in treatment volume, adjusted to exclude acquisitions and other similar transactions, and further adjusted to normalize for the number and mix of treatment days in a given period versus the prior period.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis treatment volume is directly correlated with our operating revenues and expenses. The decrease in our U.S. dialysis treatments was driven by approximately (0.6) fewer treatment days in 2021 compared to 2020 and a decrease in non-acquired treatments, partially offset by acquired treatment growth. Treatment volume in 2021 was negatively impacted by higher mortality and missed treatments than in 2020. We believe the increased mortality rate is largely attributable to the impact of COVID-19 on our patient population.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues:&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;padding-left:63pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"><tr><td style="width:1.0%"></td><td style="width:47.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average patient service revenue per treatment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">359.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:31.5pt;padding-right:31.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis revenues were positively impacted by an increase in our average patient service revenue per treatment driven by favorable changes in government mix due to shifts to Medicare Advantage plans, favorable changes in government rate related to increased Medicare base rates in 2021 and the temporary suspension of Medicare sequestration, as well as an increase in commercial mix and hospital inpatient dialysis services revenue per treatment. This was partially offset by changes in our treatment volume, as described above.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses and charges:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.479%"><tr><td style="width:1.0%"></td><td style="width:47.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient care costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses and charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient care costs per treatment</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241.47&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.24&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.23&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers</span></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">General and administrative expenses for the year ended December 31, 2020 included advocacy costs of approximately $67 million incurred to counter union policy efforts, including a California ballot initiative.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient care costs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis patient care costs are those costs directly associated with operating and supporting our dialysis centers and consist principally of compensation expenses including labor and benefits, pharmaceuticals, medical supplies and other operating costs of the dialysis centers. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis patient care costs per treatment increased primarily due to increases in compensation expenses related to increased wages and health benefit expenses due to lower than normal claims volume in 2020 due to COVID-19, other direct operating expenses associated with our dialysis centers, medical supply expense and insurance expense. These increases were partially offset by decreases in pharmaceutical unit costs and intensity and COVID-19-related compensation expenses, utilities expense driven by our virtual power purchase arrangements and professional fees.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis general and administrative expenses decreased primarily due to decreases in advocacy costs and contributions to our charitable foundation, partially offset by increases in compensation expenses related to labor costs, health benefit expenses and payroll taxes, as well as increases in professional fees and long-term incentive compensation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and amortization. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense is directly impacted by the number of dialysis centers and the information technology we develop and acquire. U.S. dialysis depreciation and amortization expense increased primarily due to the development of new centers and renovation of existing centers as well as accelerated depreciation for expected center closures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity investment income. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis equity investment income decreased primarily due to a decline in profitability at our nonconsolidated joint ventures due to growth in development of new centers.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income and adjusted operating income</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.017%"><tr><td style="width:1.0%"></td><td style="width:46.493%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted operating income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:13.5pt;padding-right:13.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating income by reportable segment, see the "Reconciliations of non-GAAP measures" section below. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis operating income and adjusted operating income increased compared to 2020 primarily due to an increase in our average patient service revenue per treatment and decreases in pharmaceutical unit costs and intensity, COVID-19-related compensation expenses, advocacy costs, utilities expense, as described above, and contributions to our charitable foundation. These increases to operating income were partially offset by a decrease in dialysis treatments and increases in compensation expense, as described above, other direct operating expenses associated with our dialysis centers, medical supply expense, insurance expense and long-term incentive compensation.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other - Ancillary services</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our other operations include ancillary services that are primarily aligned with our core business of providing dialysis services to our network of patients. As of December&#160;31, 2021, these consisted primarily of our U.S. integrated care and disease management business (DaVita IKC), physician services, and clinical research programs (DaVita Clinical Research), as well as our international operations. These ancillary services, including our international operations, generated revenues of approximately $1.047 billion in 2021, representing approximately 9% of our consolidated revenues.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, DaVita IKC provided integrated care and disease management services to approximately </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patients in risk-based integrated care arrangements and to an additional 7,000 patients in other integrated care arrangements. We also expect to add additional service offerings to our business and pursue additional strategic initiatives in the future as circumstances warrant, which could include, among other things, healthcare services not related to dialysis.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in the risk factor in Item 1A. Risk Factors under the heading, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The ancillary services and strategic initiatives and international operations that we operate or invest in now or in the future may generate losses and may ultimately be unsuccessful. In the event that one or more of these activities is unsuccessful, our business, results of operations, financial condition and cash flows may be negatively impacted and we may have to write off our investment and incur other exit costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," if any of our ancillary services, strategic initiatives or our international operations are unsuccessful, it may have a negative impact on our business, results of operations, financial condition and cash flows, and if we determine to exit that line of business we may incur significant termination costs. For discussion of risks and potential impacts specific to our integrated kidney care business and related growth strategy, see the risk factor under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"If we are not able to successfully implement our strategy with respect to our integrated kidney care and value-based care initiatives, including maintaining our existing business and further developing our capabilities in a complex and highly regulated environment, it could result in a loss of our investments and have a material adverse effect on our growth strategy, could adversely impact our business, results of operations, financial condition and cash flows, and could materially harm our reputation." </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have in the past and may in the future incur material write-offs or impairments of our investments, including goodwill, in one or more of these ancillary services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, our international dialysis business owned or operated 339 outpatient dialysis centers located in ten countries outside of the U.S. For 2021, total revenues generated from our international operations were approximately 6% of our consolidated revenues.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ancillary services results of operations</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.333%"><tr><td style="width:1.0%"></td><td style="width:45.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.531%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.531%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.531%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. ancillary</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating (loss) income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. ancillary</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total ancillary services loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted operating (loss) income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. ancillary</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total adjusted operating loss:</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The reported operating income and adjusted operating income for the years ended December&#160;31, 2021 and December&#160;31, 2020, includes foreign currency gains (losses) embedded in equity method income recognized from our APAC joint venture of approximately $3 million and $(3) million, respectively.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating (loss) income by reportable segment, see the "Reconciliations of non-GAAP measures" section below. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. ancillary services revenues decreased due to a decrease in revenues at our integrated care and disease management business primarily due to a reduction in members in our special needs plans, as well as a decrease in revenues related to completion of our ESCO programs in the first quarter of 2021 and decreased revenues related to the sale of our vascular access business, RMS Lifeline, Inc. (Lifeline), as described below, partially offset by an increase in revenues in our physician services business. Our international revenues increased primarily as a result of acquired treatment growth as we continue to expand our international business.</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charges impacting operating income: </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on changes in ownership interests, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We sold 100% of the stock of Lifeline, our vascular access business, effective May 1, 2020 and recognized a loss of approximately $16 million on this transaction.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating loss and adjusted operating loss:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. ancillary services operating loss and adjusted operating loss were impacted by the sale of Lifeline, as described above. These losses were also impacted by a decline in operating results at our integrated care and disease management business due to increased investments to build up our integrated care support function, partially offset by a one-time non-recurring benefit received in the fourth quarter, improved performance at our physicians services business and decreased expenses in our clinical research business. International operating results increased primarily due to acquisition-related growth in our international business.</span></div><div id="i916f7af890114e55a87e260476560c60_109"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate administrative support</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate administrative support consists primarily of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">labor, benefits and long-term incentive compensation expense, as well as professional fees for departments which provide support to all of our various operating lines of business. In 2020, corporate support also included an accrual for legal matters. Corporate administrative support expenses are included in general and administrative expenses on our consolidated income statement. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accruals for legal matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During 2020, we recorded a net charge for legal matters of $35 million.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate administrative support expenses decreased $35 million primarily driven by accruals for legal matters, as described above, as well as a decrease in severance accruals associated with our senior executive leadership transition in 2020, partially offset by increased legal fees in 2021.</span></div><div id="i916f7af890114e55a87e260476560c60_112"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate-level charges</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt prepayment, refinancing and redemption charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate from continuing operations attributable to DaVita Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of our effective income tax rate from continuing operations attributable to DaVita Inc., see the "Reconciliations of non-GAAP measures" section below. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt expense</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt expense decreased primarily due to a decrease in our overall weighted average effective interest rate on our debt, including a reduction in the LIBOR component of the interest rate on debt under our senior secured credit facilities and the repricing of our Term Loan B-1 as well as the refinancing our 5.125% senior notes and 5.0% senior notes with lower cost debt, partially offset by additional debt expense associated with the Additional 2030 Notes offering completed in February 2021. Our overall weighted average effective interest rate in 2021 was 3.28% compared to 3.59% in 2020. See Note 13 to the consolidated financial statements for further information on the components of our debt and changes in them since 2020. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt prepayment, refinancing and redemption charges</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt prepayment, refinancing and redemption charges were $89 million in 2020 as a result of the redemption in full of both our $1.75 billion aggregate principal amount outstanding of 5.125% senior notes and our $1.50 billion aggregate principal amount outstanding of 5.0% senior notes. These 2020 charges represented debt redemption premium charges and deferred financing cost write-offs associated with our prior senior note debt that was paid in full. These charges recognized in 2020 also included $3 million of refinancing charges comprised partially of fees incurred on the repricing of our Term Loan B and partially of deferred financing costs written off for the portion of this debt considered extinguished and reborrowed. See further discussion of our 2020 debt prepayment, refinancing and redemption charges in Note 13 to the consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income consists primarily of interest income on cash and cash equivalents and short- and long-term investments, realized and unrealized gains and losses recognized on investments, and foreign currency transaction gains and losses. Other income decreased primarily due to losses on certain investments that began trading in public markets during the second quarter of 2021 and a decrease in interest income on our holdings of cash and cash equivalents in 2021. These decreases were partially offset by a reduction in foreign currency transaction losses. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provision for income taxes&#160;</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate and effective income tax rate from continuing operations attributable to DaVita Inc. decreased in 2021 primarily due to an increase in tax benefits from stock-based compensation deductions, reductions in nondeductible advocacy spending in 2021 and deferred tax benefits recognized with respect to our foreign provision which were partially offset by re-measurement of our federal deferred taxes in 2021. Additionally we recognized a benefit for a favorable settlement reached with state tax authorities which was partially offset by an accrual for our federal uncertain tax positions.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in income attributable to noncontrolling interests in 2021 compared to 2020 was due to improved earnings at certain U.S. dialysis partnerships.</span></div><div id="i916f7af890114e55a87e260476560c60_115"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts receivable</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated accounts receivable balances at December&#160;31, 2021 and December&#160;31, 2020 were $1.958 billion and $1.824 billion, respectively, representing approximately 62 days and 59 days of revenue (DSO), respectively. The increase in consolidated DSO was primarily due to an increase of two days of DSO in our U.S. dialysis business primarily due to temporary billing holds.&#160;Our DSO calculation is based on the most recent quarter&#8217;s average revenues per day. There were no significant changes during 2021 from 2020 in the carrying amount of accounts receivable outstanding over one year old or in the amounts pending approval from third-party payors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, our patient services accounts receivable balances that are more than six months old represents approximately 16% and 17%, respectively of our total accounts receivable balances outstanding. Substantially all revenue realized is from government and commercial payors, as discussed above. Less than 1% of our revenues in both periods were classified as patient pay.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts pending approval from third-party payors associated with Medicare bad debt claims as of December&#160;31, 2021 and 2020, other than the standard monthly billing, consisted of approximately $133 million and $154 million, respectively, and are classified as other receivables. A significant portion of our Medicare bad debt claims are typically paid to us before the Medicare fiscal intermediary audits the claims but are subject to subsequent adjustment based upon the actual results of those audits. Such audits typically occur one to four years after the claims are filed.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and capital resources</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our major sources and uses of cash, cash equivalents and restricted cash:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:53.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.964%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Annual change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash items in net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other working capital changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,931&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,979&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Routine maintenance/IT/other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(399)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Development and relocations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of self-developed properties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DMG post-closing sale proceeds adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt issuances (payments), net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,278.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing and debt redemption costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award exercises and other share issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,900.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,539)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(112.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,083)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,847)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,877,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,477,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,600,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Free cash flow</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:2pt;padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:2pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of our free cash flow, see the "Reconciliations of Non-GAAP measures" section below.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated cash flows</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated cash flows from operating activities for 2021 and 2020 were $1,931 million and $1,979 million, respectively. The decrease in cash flow from continuing operations was primarily driven by an increase in total DSO of approximately three days for 2021 compared to an increase of one day in 2020, combined with the net legal settlement payment partially offset by a decrease in cash interest paid.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows used for investing activities in 2021 decreased $40 million compared to 2020 primarily due to the final settlement payment made for the DMG sale in 2020, as well as a decrease in capital expenditures related to development partially offset by a reduction in proceeds from sale of assets. See below for additional information regarding the growth in our dialysis centers.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows used in financing activities decreased $764 million in 2021 compared to 2020. Significant sources of cash during 2021 included proceeds from the issuance of $1,000 million in aggregate principal amount of the Additional 2030 Notes as an add-on offering to our 4.625% senior notes due 2030 that were issued at an offering price of 101.750% of face amount in February 2021. Significant uses of cash during 2021 primarily consisted of the repayment in full of borrowings under our revolving line of credit, net payments of regularly scheduled mandatory principal payments under our senior secured credit facilities totaling approximately $88 million on Term Loan A and $27 million on Term Loan B-1 and additional required principal payments under other debt arrangements. In addition, we incurred bond issuance costs of approximately $9 million. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See further discussion in Note 13 to the consolidated financial statements related to debt financing activities. In addition, during the year ended December&#160;31, 2021 we used cash to repurchase 13,877,193 shares of our common stock.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By comparison, in 2020 debt activity primarily consisted of issuances of $1,500 million in aggregate principal amount of 3.75% senior notes due 2031 in August 2020 and $1,750 million in aggregate principal amount of 4.625% senior notes due 2030 in June 2020, as well as a net draw of $75 million on our revolving line of credit. Significant uses of cash during 2020 included the subsequent redemptions in full of $1,500 million in aggregate principal amount of 5.0% senior notes due 2025 in August 2020 and $1,750 million in aggregate principal amount of 5.125% senior notes due 2024 in July 2020. Other net payments during 2020 primarily consisted of regularly scheduled mandatory principal payments under our senior secured credit facilities totaling approximately $55 million on Term Loan A and $27 million on Term Loan B-1 and additional required principal payments under other debt arrangements. In addition, we incurred bond issuance costs of approximately $38 million, debt redemption premium charges related to the redemption of our senior notes due in 2024 and 2025 of approximately $67 million and costs of repricing our Term Loan B of approximately $3 million. See further discussion in Note 13 to the consolidated financial statements related to debt financing activities. For the year ended December&#160;31, 2020 we used cash to repurchase 16,477,378 shares of our common stock. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis center capacity and growth</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are typically able to increase our capacity by extending hours at our existing dialysis centers, expanding our existing dialysis centers, relocating our dialysis centers, developing new dialysis centers and by acquiring dialysis centers. The development of a typical new outpatient dialysis center generally requires approximately $2.3 million for leasehold improvements and other capital expenditures. Based on our experience, a new outpatient dialysis center typically opens within a year after the property lease is signed, normally achieves operating profitability in the second year after Medicare certification, and normally reaches maturity within three to five years. Acquiring an existing outpatient dialysis center requires a substantially greater initial investment, but profitability and cash flows are generally accelerated and more predictable. To a limited extent, we enter into agreements to provide management and administrative services to outpatient dialysis centers in which we own a noncontrolling interest or which are wholly-owned by third parties in return for management fees.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the growth in our dialysis operations by number of dialysis centers owned or operated:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of centers operated at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquired centers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed centers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net change in non-owned managed or administered centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sold and closed centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closed centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of centers operated at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,815&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers which we manage or provide administrative services to but in which we own a noncontrolling equity interest or which are wholly-owned by third parties, including our Asia Pacific joint venture centers.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers that were sold and/or closed for which the majority of patients were not retained.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers that were closed for which the majority of patients were retained and transferred to one of our other existing outpatient dialysis centers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our common stock repurchases during the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-top:6pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.152%"><tr><td style="width:1.0%"></td><td style="width:40.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.443%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions and shares in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Open market repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tender offer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The aggregate amounts paid for shares repurchased pursuant to our tender offer for our shares during the year ended December&#160;31, 2020, include its clearing price of $88.00 per share plus related fees and expenses of $2.5 million.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2021, we have repurchased 1,437,107 shares of our common stock for $159 million at an average cost of $110.73 per share through February&#160;9, 2022. We retired all shares of common stock held in treasury effective December&#160;31, 2021 and December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See further discussion of our share repurchase activity and authorizations in Note 19 to the consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available liquidity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, our cash balance was $462 million and we held approximately $22 million in short-term investments. At that time we also had an undrawn $1.0 billion revolving line of credit under our senior secured credit facilities. Credit available under this revolving line of credit is reduced by the amount of any letters of credit outstanding thereunder, of which there were none as of December&#160;31, 2021. As of December&#160;31, 2021 we separately had approximately $69 million in letters of credit outstanding under a separate bilateral secured letter of credit facility.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13 to the consolidated financial statements for components of our long-term debt and their interest rates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and efforts to prevent its spread have dramatically reduced global economic activity and driven increased volatility in the financial markets. We have maintained business process continuity during the COVID-19 pandemic by enabling most back office teammates to work remotely, and as of the date of this report, we have not experienced a material deterioration in our liquidity position as a result of the COVID-19 crisis. The ultimate impact of the pandemic will depend on future developments that are highly uncertain and difficult to predict.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash flow from operations and other sources of liquidity, including from amounts available under our senior secured credit facilities and our access to the capital markets, will be sufficient to fund our scheduled debt service under the terms of our debt agreements and other obligations for the foreseeable future, including the next 12 months. Our primary recurrent sources of liquidity are cash from operations and cash from borrowings, which are subject to general, economic, financial, competitive, regulatory and other factors that are beyond our control, as described in Item 1A. Risk Factors under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The level of our current and future debt could have an adverse impact on our business, and our ability to generate cash to service our indebtedness and for other intended purposes and our ability to maintain compliance with debt covenants depends on many factors beyond our control.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliations of non-GAAP measures</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide reconciliations of adjusted operating income (loss) to operating income (loss) as presented on a U.S. generally accepted accounting principles (GAAP) basis for our U.S. dialysis reportable segment as well as for our U.S. ancillary services, our international business, and for our total ancillary services which combines them and is disclosed as our other segments category. These non-GAAP or "adjusted" measures are presented because management believes these measures are useful adjuncts to, but not alternatives for, our GAAP results.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, management uses adjusted operating income (loss) to compare and evaluate our performance period over period and relative to competitors, to analyze the underlying trends in our business, to establish operational budgets and forecasts and for incentive compensation purposes. We believe this non-GAAP measure is also useful to investors and analysts in evaluating our performance over time and relative to competitors, as well as in analyzing the underlying trends in our business. We also believe this presentation enhances a user's understanding of our normal operating income by excluding certain items which we do not believe are indicative of our ordinary results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our effective income tax rate on income from continuing operations attributable to DaVita Inc. excludes noncontrolling owners' income, which primarily relates to non-tax paying entities. We believe this adjusted effective income tax rate is useful to management, investors and analysts in evaluating our performance and establishing expectations for income taxes incurred on our ordinary results attributable to DaVita Inc.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, our free cash flow from continuing operations represents net cash provided by operating activities from continuing operations less distributions to noncontrolling interests and all capital expenditures (including development capital expenditures, routine maintenance and information technology), plus contributions from noncontrolling interests and proceeds from the sale of self-developed properties. Management uses this measure to assess our ability to fund acquisitions and meet our debt service obligations and we believe this measure is equally useful to investors and analysts as an adjunct to cash flows from operating activities from continuing operations and other measures under GAAP.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is important to bear in mind that these non-GAAP "adjusted" measures are not measures of financial performance under GAAP and should not be considered in isolation from, nor as substitutes for, their most comparable GAAP measures.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. <br/>dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate <br/>administration</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,975&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,797&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. <br/>dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate <br/>administration</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on changes in ownership interests, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accruals for legal matters</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:74.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Noncontrolling owners&#8217; income primarily attributable to non-tax paying entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(222)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense for continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense from continuing operations attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate on income from continuing operations attributable to DaVita Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:65.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.336%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.337%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net cash provided by continuing operating <br/>&#160;activities to free cash flow from continuing operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenditures for routine maintenance and information technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(399)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenditures for development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of self-developed properties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Free cash flow</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div id="i916f7af890114e55a87e260476560c60_124"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-balance sheet arrangements and aggregate contractual obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the debt obligations and operating lease liabilities reflected on our balance sheet, we have commitments associated with letters of credit, as well as certain working capital funding obligations associated with our equity investments in nonconsolidated dialysis ventures that we manage and some we manage that are wholly-owned by third parties.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have potential obligations to purchase the noncontrolling interests held by third parties in many of our majority-owned dialysis partnerships and other nonconsolidated entities. These obligations are in the form of put provisions that are exercisable at the third-party owners&#8217; discretion within specified periods as outlined in each specific put provision. For additional information see Note 17 to the consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of these cash contractual obligations and commitments as of December&#160;31, 2021:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:50.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023-2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025-2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt and leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest payments on credit facilities and senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases, including imputed interest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Partnership interests subject to put provisions:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">On-balance sheet:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Off-balance sheet:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-owned and minority owned put provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,267&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">See Note 13 to the consolidated financial statements for components of our long-term debt and related interest rates. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">See Note 14 to the consolidated financial statements for components of our leases and related interest rates. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents amounts for which we are contractually committed, should the outside partner exercise its put option.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 we have outstanding letters of credit in the aggregate amount of $69 million under a separate bilateral secured letter of credit facility.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, we entered into a Sourcing and Supply Agreement with Amgen USA Inc. (Amgen) that expires on December&#160;31, 2022. Under the terms of the agreement, we will purchase EPO from Amgen in amounts necessary to meet no less than 90% of its requirements for erythropoiesis-stimulating agents (ESAs) through the expiration of the contract. The actual amount of EPO that we will purchase will depend upon the amount of EPO administered during dialysis as prescribed by physicians and the overall number of patients that we serve.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 we have outstanding purchase agreements with various suppliers to purchase set amounts of dialysis equipment, parts, and supplies. If we fail to meet the minimum purchase commitments under these contracts during any year, we are required to pay the difference to the supplier. For additional information see Note 17 to the consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated dialysis businesses that we manage and in which we own a noncontrolling equity interest or which are wholly-owned by third parties. For additional information see Note 17 to the consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we expect our 2022 capital expenditures to be in alignment with 2021 capital expenditures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have approximately $88 million of existing income tax liabilities for unrecognized tax benefits, including interest, penalties and other long-term tax liabilities. We expect a significant portion of these settlements to be paid in 2022. </span></div><div id="i916f7af890114e55a87e260476560c60_127"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in Note 16 to the consolidated financial statements included in this report is incorporated by reference in response to this item.</span></div><div id="i916f7af890114e55a87e260476560c60_130"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting policies, estimates and judgments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements and accompanying notes are prepared in accordance with United States generally accepted accounting principles. These accounting principles require us to make estimates, judgments and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions (redeemable equity interests). All significant estimates, judgments and assumptions are developed based on the best information available to us at the time made and are regularly reviewed and updated when necessary. Actual results will generally differ from these estimates, and such differences may be material. Changes in estimates are reflected in our financial statements in the period of change based upon on-going actual experience trends or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies. Certain accounting estimates, including those concerning revenue recognition and accounts receivable, fair value estimates for goodwill and noncontrolling interests, accounting for income taxes, and loss contingencies are considered to be critical to evaluating and understanding our financial results because they involve inherently uncertain matters and their application requires the most difficult and complex judgments and estimates. For additional information, see Part II Item 15, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits, Financial Statement Schedules" &#8211; Note 1 &#8211; "Organization and summary of significant accounting policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as referred from Part II Item 8, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements and Supplementary Data</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. dialysis revenue recognition and accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. There are significant estimating risks associated with the amount of U.S. dialysis revenue that we recognize in a given reporting period. Payment rates are often subject to significant uncertainties related to wide variations in the coverage terms of the commercial healthcare plans under which we receive payments. In addition, ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage, and other payor issues complicate the billing and collection process. The measurement and recognition of revenue requires the use of estimates of the amounts that will ultimately be realized considering, among other items, retroactive adjustments that may be associated with regulatory reviews, audits, billing reviews and other matters.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with Medicare and Medicaid programs are recognized based on (a)&#160;the payment rates that are established by statute or regulation for the portion of the payment rates paid by the government payor (e.g., 80% for Medicare patients) and (b)&#160;for the portion not paid by the primary government payor, the estimated amounts that will ultimately be collectible from other government programs providing secondary coverage (e.g., Medicaid secondary coverage), the patient&#8217;s commercial health plan secondary coverage, or the patient. Our dialysis related reimbursements from Medicare are subject to certain variations under Medicare&#8217;s single bundled payment rate system whereby our reimbursements can be adjusted for </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain patient characteristics and other variable factors. Our revenue recognition depends upon our ability to effectively capture, document and bill for Medicare&#8217;s base payment rate and these other factors. In addition, as a result of the potential range of variations that can occur in our dialysis-related reimbursements from Medicare under the single bundled payment rate system, our revenue recognition is subject to a greater degree of estimating risk.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial healthcare plans, including contracted managed-care payors, are billed at our usual and customary rates; however, revenue is recognized based on estimated net realizable revenue for the services provided. Net realizable revenue is estimated based on contractual terms for the patients covered under commercial healthcare plans with which we have formal agreements, non-contracted commercial healthcare plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in our billing and collection processes that can result in denied claims for payments, the estimated timing of collections, changes in our expectations of the amounts that we expect to collect and regulatory compliance matters. Determining applicable primary and secondary coverage for our approximately 203,100 U.S. dialysis patients at any point in time, together with the changes in patient coverages that occur each month, requires complex, resource-intensive processes. Collections, refunds and payor retractions typically continue to occur for up to three years or longer after services are provided.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally expect the range of our U.S. dialysis revenue estimating risk to be within 1% of revenue, which can represent as much as approximately 5% of our U.S. dialysis business&#8217;s adjusted operating income. Changes in estimates are reflected in the then-current financial statements based on on-going actual experience trends, or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies. Changes in revenue estimates for prior periods are separately disclosed and reported if material to the current reporting period and longer term trend analyses, and have not been significant.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for laboratory services, which are integrally related to our dialysis services, are recognized in the period services are provided at the estimated net realizable amounts to be received.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain fair value estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair value measurements and estimates affect, or potentially affect, a variety of elements in the Company's financial statements. Two of the elements most significantly impacted by fair value estimates are the Company's goodwill impairment assessments and remeasurements of its noncontrolling interests subject to put provisions balance.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is not amortized, but is assessed for impairment when changes in circumstances warrant and at least annually. An impairment charge is recorded when and to the extent a reporting unit's carrying amount is determined to exceed its estimated fair value. Changes in circumstance that may trigger a goodwill impairment assessment for one of our business units can include, among others, changes in the legal environment, addressable market, business strategy, development or business plans, reimbursement structure, operating performance, future prospects, relationships with partners, and/or market value indications for the subject business. We use a variety of factors to assess changes in the financial condition, future prospects and other circumstances for businesses subject to goodwill impairment assessment. However, these assessments and the related valuations can involve significant uncertainties and require significant judgment on various matters. See Note 10 to the consolidated financial statements for a sensitivity summary on the Company's reporting units considered at risk of goodwill impairment as of December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also required to remeasure its noncontrolling interests subject to put provisions to estimated fair value each reporting period. These estimates also require substantive judgment on meaningful uncertainties concerning this significant balance. See Notes 17 and 24 to the consolidated financial statements for a summary of the Company's approach to these valuations, the variables and uncertainties involved, and the sensitivity of these valuations to changes in a primary aggregate valuation metric.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our income tax expense, deferred tax assets and liabilities, and liabilities for unrecognized tax benefits reflect management&#8217;s best assessment of estimated current and future taxes to be paid. We are subject to income taxes in the United States and numerous state and foreign jurisdictions, and changes in tax laws or regulations may be proposed or enacted that could adversely affect our overall tax liability. The actual impact of any such laws or regulations could be materially different from our current estimates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgments and estimates are required in determining our consolidated income tax expense. Deferred income taxes arise from temporary differences between the tax basis of assets and liabilities and their reported amounts in the financial statements, which will result in taxable or deductible amounts in the future. In evaluating our ability to recover our deferred tax assets within the jurisdictions from which they arise, we consider all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, results of recent operations, and assumptions about the amount of future federal, state, and foreign pre-tax operating income adjusted for items that do not have tax consequences. The assumptions about future taxable income require significant judgments and are consistent with the plans and estimates we use to manage the underlying businesses. To the extent that recovery is not likely, a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valuation allowance is established. The allowance is regularly reviewed and updated for changes in circumstances that would cause a change in judgment about the realizability of the related deferred tax assets.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss contingencies.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Notes 1 and 16 to the consolidated financial statements, we operate in a highly regulated industry and are party to various lawsuits, claims, qui tam suits, governmental investigations and audits (including, without limitation, investigations or other actions resulting from our obligation to self-report suspected violations of law), contract disputes and other legal proceedings.&#160;Assessments of such matters can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. We record accruals for loss contingencies on such matters to the extent that we determine an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. See Note 16 to the consolidated financial statements included in this report for further discussion.</span></div><div id="i916f7af890114e55a87e260476560c60_133"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant new accounting standards</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 to the consolidated financial statements included in this report for information regarding certain recent financial accounting standards that have been issued by the FASB.</span></div><div id="i916f7af890114e55a87e260476560c60_136"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7A.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest rate sensitivity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below provide information about our financial instruments that are sensitive to changes in interest rates. The first table below presents principal repayments and current weighted average interest rates on our debt obligations as of December&#160;31, 2021. The variable rates presented reflect the weighted average LIBOR rates in effect for all debt tranches plus interest rate margins in effect as of December&#160;31, 2021. The Term Loan A interest rate margin in effect at December&#160;31, 2021, was 1.50%. At December&#160;31, 2021, the Term Loan B-1 interest rate margin in effect was 1.75%. The interest rates in effect on our Term Loan A and revolving line of credit are subject to adjustment depending upon changes in our leverage ratio.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.974%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expected maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average<br/>interest<br/>rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair&#160;value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="51" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed rate</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents the fair value of our long-term debt excluding financing leases.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:23.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.737%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Contract maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Receive variable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 interest rate cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR above 2.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a further discussion of our debt, see Note 13 to our consolidated financial statements at Part II Item 15, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits, Financial Statement Schedules" &#8211; Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as referred from Part II Item 8, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements and Supplementary Data.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash flow from operations and other sources of liquidity, including from amounts available under our current credit facilities and our access to the capital markets, will be sufficient to fund our scheduled debt service under the terms of our debt agreements and other obligations for the foreseeable future, including the next 12 months. Our primary recurrent sources of liquidity are cash from operations and cash from borrowings.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One means of assessing exposure to debt-related interest rate changes is a duration-based analysis that measures the potential loss in net income resulting from a hypothetical increase in interest rates of 100 basis points across all variable rate maturities (referred to as a parallel shift in the yield curve). Under this model, with all else constant, it is estimated that such an increase would have reduced net income by approximately $33.8 million, $34.8 million, and $32.4 million, net of tax, for the years ended December&#160;31, 2021, 2020, and 2019, respectively.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exchange rate sensitivity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our business is predominantly conducted in the U.S., we have developing operations in ten other countries as well. For financial reporting purposes, the U.S. dollar is our reporting currency. However, the functional currencies of our operating businesses in other countries are typically those of the countries in which they operate. Therefore, changes in the rate of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exchange between the U.S. dollar and the local currencies in which our international operations are conducted affect our results of operations and financial position as reported in our consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have consolidated the balance sheets of our non-U.S. dollar denominated operations into U.S. dollars at the exchange rates prevailing at the balance sheet dates and have translated their revenues and expense at average exchange rates during each period.&#160;Additionally, our individual subsidiaries are exposed to transactional risks mainly resulting from intercompany transactions between and among subsidiaries with different functional currencies. This exposes the subsidiaries to fluctuations in the rate of exchange between the invoicing or obligation currencies and the currency in which their local operations are conducted.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our exposure to foreign exchange risk through the judgment of our international and corporate management teams.&#160;Through 2021, our international operations have remained fairly small relative to the size of our consolidated financial statements, constituting approximately 9% of our consolidated assets and approximately 6% of our consolidated revenues for the year ended December&#160;31, 2021, with no single country constituting more than 3% of consolidated assets.&#160;In addition, our unrealized foreign currency translation losses were approximately 5%, 0.4%, and 1% of our consolidated operating income for the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the relatively small size of our international operations, management does not consider our exposure to foreign exchange risk to be significant to the consolidated enterprise.&#160;As such, through December&#160;31, 2021, we have not engaged in transactions to hedge the exposure of our international transactions or net investments to foreign currency risk.&#160;</span></div><div id="i916f7af890114e55a87e260476560c60_139"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial Statements and Supplementary Data.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the Index to Financial Statements and Index to Financial Statement Schedules included at Item 15, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits, Financial Statement Schedules."</span></div><div id="i916f7af890114e55a87e260476560c60_142"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i916f7af890114e55a87e260476560c60_145"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9A.&#160;&#160;&#160;&#160;Controls and Procedures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has established and maintains disclosure controls and procedures designed to ensure that information required to be disclosed in the reports that it files or submits pursuant to the Securities Exchange Act of 1934 (Exchange Act) as amended is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management including our Chief Executive Officer (CEO) and Chief Financial Officer (CFO) as appropriate to allow for timely decisions regarding required disclosures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our CEO and CFO, of the effectiveness of the design and operation of the Company's disclosure controls and procedures in accordance with the Exchange Act requirements as of December 31, 2021. Based upon that evaluation, the CEO and CFO concluded that the Company's disclosure controls and procedures were effective as required by the Exchange Act as of such date for our Exchange Act reports, including this report. Management recognizes that these controls and procedures can provide only reasonable assurance of desired outcomes, and that estimates and judgments are still inherent in the process of maintaining effective controls and procedures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in the Company's internal control over financial reporting that was identified during the evaluation that occurred during the fourth fiscal quarter of 2021 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.</span></div><div id="i916f7af890114e55a87e260476560c60_148"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9B.&#160;&#160;&#160;&#160;Other Information.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i916f7af890114e55a87e260476560c60_7146825583238"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9C.&#160;&#160;&#160;&#160;Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i916f7af890114e55a87e260476560c60_154"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Directors, Executive Officers and Corporate Governance.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to disclose any amendments or waivers to the Code of Ethics applicable to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions, on our website located at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http://www.davita.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In 2002, we adopted a Corporate Governance Code of Ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, and to all of our financial accounting and legal professionals who are directly or indirectly involved in the preparation, reporting and fair presentation of our financial statements and Exchange Act reports. The Code of Ethics is posted on our website, located at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http://www.davita.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We also maintain a Corporate Code of Conduct that applies to all of our employees, officers and directors, which is posted on our website.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Corporate Governance Guidelines all Board Committees including the Audit Committee, Nominating and Governance Committee and the Compensation Committee, which are comprised solely of independent directors as defined within the listing standards of the New York Stock Exchange, have written charters that outline the committee&#8217;s purpose, goals, membership requirements and responsibilities. These charters are regularly reviewed and updated as necessary by our Board of Directors. All Board Committee charters as well as the Corporate Governance Guidelines are posted on our website located at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http://www.davita.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The other information required to be disclosed by this item will appear in, and is incorporated by reference from, the sections entitled "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proposal 1 Election of Directors"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Governance"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Security Ownership of Certain Beneficial Owners and Management"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be included in our definitive proxy statement relating to our 2022 annual stockholder meeting.</span></div><div id="i916f7af890114e55a87e260476560c60_157"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Executive Compensation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will appear in, and is incorporated by reference from, the sections entitled "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">", "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pay Ratio Disclosure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">", "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation of Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Committee Interlocks and Insider Participation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" included in our definitive proxy statement relating to our 2022 annual stockholder meeting. The information required by Item&#160;407(e)(5) of Regulation S-K will appear in and is incorporated by reference from the section entitled "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Committee Report"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be included in our definitive proxy statement relating to our 2022 annual stockholder meeting; however, this information shall not be deemed to be filed.</span></div><div id="i916f7af890114e55a87e260476560c60_160"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about our common stock that may be issued upon the exercise of stock-settled stock appreciation rights, restricted stock units and other rights under all of our existing equity compensation plans as of December&#160;31, 2021, which consist of our 2020 Incentive Award Plan, 2011 Incentive Award Plan and our Employee Stock Purchase Plan. The material terms of these plans are described in Note 18 to the consolidated financial statements.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:40.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.691%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.887%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Plan category (shares in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">shares&#160;to&#160;be issued upon&#160;exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">of outstanding options, warrants and rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted average exercise price of outstanding options, warrants and rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of shares remaining<br/>available&#160;for future issuance under&#160;equity<br/>compensation plans&#160;(excluding securities reflected&#160;in<br/>column&#160;(a))</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total of shares reflected in columns (a) and (c)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">(d)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity compensation plans approved by shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity compensation plans not requiring shareholder<br/>&#160;approval</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.66&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,658&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Includes 829 shares of common stock reserved for issuance in connection with performance share units at the maximum number of shares issuable thereunder.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;This weighted average excludes full value awards such as restricted stock units and performance share units.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information required to be disclosed by Item&#160;12 will appear in, and is incorporated by reference from, the section entitled "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Security Ownership of Certain Beneficial Owners and Management"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be included in our definitive proxy statement relating to our 2022 annual stockholder meeting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Certain Relationships and Related Transactions, and Director Independence.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will appear in, and is incorporated by reference from, the section entitled "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Relationships and Related Transactions"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the section entitled "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Governance"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be included in our definitive proxy statement relating to our 2022 annual stockholder meeting.</span></div><div id="i916f7af890114e55a87e260476560c60_166"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Principal Accounting Fees and Services.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will appear in, and is incorporated by reference from, the section entitled "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proposal 2 Ratification of the Appointment of our Independent Registered Public Accounting Firm"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be included in our definitive proxy statement relating to our 2022 annual stockholder meeting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i916f7af890114e55a87e260476560c60_172"></div><div style="-sec-extract:summary;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits, Financial Statement Schedules.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a) Documents filed as part of this Report:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1)&#160;Index to Financial Statements:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:87.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_178">Management&#8217;s Report on Internal Control Over Financial Reporting</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_178">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_181">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_181">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_184">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_184">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_187">Consolidated Statements of Income for the years ended December&#160;31, 2021, 2020, and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_187">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_190">Consolidated Statements of Comprehensive Income for the years ended December&#160;31, 2021, 2020, and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_190">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_193">Consolidated Balance Sheets as of December&#160;31, 2021, and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_193">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_199">Consolidated Statements of Cash Flow for the years ended December&#160;31, 2021, 2020, and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_199">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_202">Consolidated Statements of Equity for the years ended December&#160;31, 2021, 2020, and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_202">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_205">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_205">11</a></span></div></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(2)&#160;Index to Financial Statement Schedules:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:87.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_322">Schedule II&#8212;Valuation and Qualifying Accounts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i916f7af890114e55a87e260476560c60_322">S-</a>3</span></div></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(3)&#160;Exhibits</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is set forth in the Exhibit Index that precedes the signature pages of this Annual Report on Form 10-K.</span></div><div id="i916f7af890114e55a87e260476560c60_175"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form 10-K Summary.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining an adequate system of internal control over financial reporting designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles and which includes those policies and procedures that (i)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii)&#160;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the last fiscal year, the Company conducted an evaluation, under the oversight of the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company&#8217;s internal control over financial reporting. This evaluation was completed based on the criteria established in the report titled "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control&#8212;Integrated Framework (2013)"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon our evaluation under the COSO framework, we have concluded that the Company&#8217;s internal control over financial reporting was effective as of December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s independent registered public accounting firm, KPMG LLP, has issued an attestation report on the Company&#8217;s internal control over financial reporting, which report is included in this Annual Report.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_181"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and Board of Directors</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DaVita Inc.:</span></div><div><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opinion on the Consolidated Financial Statements</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of DaVita Inc. and subsidiaries (the Company) as of December 31, 2021 and 2020, the related consolidated statements of income, comprehensive income, equity, and cash flow for each of the years in the three-year period ended December 31, 2021, and the related notes and financial statement Schedule II - Valuation and Qualifying Accounts (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 11, 2022 expressed an unqualified opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matters</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. dialysis patient service revenue recognition</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Notes 1 and 2 to the consolidated financial statements, the Company recognized $10,642 million in U.S. dialysis patient service revenue for the year ended December 31, 2021. There are uncertainties associated with estimating U.S. dialysis patient service revenue, which generally take several years to resolve. As these estimates are refined over time, both positive and negative adjustments are recognized in the current period. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the recognition of the transaction price the Company expects to collect as a result of satisfying its performance obligations related to U.S. dialysis patient service revenue as a critical audit matter because it involves estimation that requires complex auditor judgment. The key assumptions and inputs used to estimate the transaction price relate to ongoing insurance coverage changes, differing interpretations of contract coverage, determination of applicable primary and secondary coverage, coordination of benefits, and varying patient characteristics impacting Medicare reimbursements. Changes to the key assumptions and inputs used in the application of the methodology may have a significant effect on the Company&#8217;s determination of the estimate. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company&#8217;s U.S. dialysis patient service revenue recognition process, including controls related to the application of the methodology used to estimate the transaction price, and the key assumptions and inputs. We evaluated the Company&#8217;s key assumptions and inputs to estimate the transaction price the Company expects to collect as a result of satisfying its performance obligations by comparing key assumptions to historical collection experience, trends of refunds and payor payment adjustments, delays in the Company&#8217;s billing and collection process and regulatory compliance matters. Additionally, we compared U.S. dialysis patient service revenue related to the transaction price estimates recognized in prior periods to actual cash collections related to performance obligations satisfied in prior periods to analyze the Company&#8217;s ability to estimate the transaction price the Company expects to collect as a result of satisfying its performance obligations. We developed an estimate of U.S. dialysis patient service revenue based on actual and expected cash collections and compared the estimate to U.S. dialysis patient service revenue recorded by the Company for the year ended December 31, 2021.</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of legal proceedings and regulatory matters</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 16 to the consolidated financial statements, the Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits, governmental investigations and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings. The Company records accruals for certain legal proceedings and regulatory matters to the extent an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the evaluation of legal proceedings and regulatory matters as a critical audit matter. Due to the nature of the legal proceedings and regulatory matters, a high degree of subjectivity was required in evaluating the completeness of the Company&#8217;s population of legal proceedings and regulatory matters. Additionally, complex auditor judgment was required in evaluating the Company&#8217;s probability of outcome assessment, and related disclosures. </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company&#8217;s legal proceedings and regulatory matters process. This includes controls over the Company&#8217;s determination of the completeness of the population of legal proceedings and regulatory matters, as well as controls over the Company&#8217;s probability of outcome assessment, and related disclosures. We tested existing legal proceedings and regulatory matters by reading certain written correspondence received from outside parties as well as reading certain written responses provided to outside parties. We read letters received directly from the Company&#8217;s external and internal legal counsel that described certain legal proceedings and regulatory matters. We involved forensic professionals with specialized skills and knowledge who inspected the Company&#8217;s compliance case log. Additionally, we assessed the completeness of the population of legal proceedings and regulatory matters and related disclosures by 1) inquiring of certain key executives and directors and 2) evaluating information received through procedures described above and through publicly available information about the Company, its competitors, and the industry. </span></div><div><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ KPMG LLP</span></div><div style="margin-bottom:10pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2000. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seattle, Washington</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;11, 2022</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_184"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and Board of Directors</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DaVita Inc.:</span></div><div><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opinion on Internal Control Over Financial Reporting</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited DaVita Inc. and subsidiaries' (the Company) internal control over financial reporting as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated statements of income, comprehensive income, equity, and cash flow for each of the years in the three-year period ended December 31, 2021, and the related notes and financial statement Schedule II - Valuation and Qualifying Accounts (collectively, the consolidated financial statements), and our report dated February 11, 2022 expressed an unqualified opinion on those consolidated financial statements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ KPMG LLP</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seattle, Washington</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;11, 2022</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_187"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQtMS0xLTEtODMwNzg_34dc1dff-8dfd-4bb6-9784-574a8eb65a7d">11,213,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQtMy0xLTEtODMwNzg_61a73ed2-98dd-434c-805c-2036b3e07971">11,026,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQtNS0xLTEtODMwNzg_6f1519ca-b024-49ec-a3e3-73e63c33cdba">10,896,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzUtMS0xLTEtODMwNzg_bf4d4461-8524-49ed-847f-93519eb03561">405,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzUtMy0xLTEtODMwNzg_b05045f6-dfa7-4648-acbb-8bc07ce9352d">524,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzUtNS0xLTEtODMwNzg_334f1a94-5060-4144-8abe-07be58f4128d">491,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzYtMS0xLTEtODMwNzg_9d0bd332-77ca-480b-8766-f117dd6c02ca">11,618,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzYtMy0xLTEtODMwNzg_3a9cbd25-b58a-4ccd-ad3d-6e946a501ba2">11,550,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzYtNS0xLTEtODMwNzg_da77ac14-ac5f-4879-bd03-d71693cba037">11,388,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient care costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="dva:PatientCareCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzgtMS0xLTEtODMwNzg_38a3b5cb-6e3b-433e-aeb1-985640b16035">7,972,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="dva:PatientCareCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzgtMy0xLTEtODMwNzg_a438d508-8426-49b3-8d95-810ea98287ef">7,988,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="dva:PatientCareCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzgtNS0xLTEtODMwNzg_a4c1e8cf-5bda-4430-85a3-e58b35dad529">7,914,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzktMS0xLTEtODMwNzg_fb4e304a-5281-438a-b887-438fb71cfb45">1,195,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzktMy0xLTEtODMwNzg_78ba6653-fc6e-455c-bec8-d485335f1ebd">1,247,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzktNS0xLTEtODMwNzg_ea045008-5465-4a0a-9b01-e870c4cce7e4">1,103,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzEwLTEtMS0xLTgzMDc4_ff28cb03-ac4d-45bb-875c-24e5285f2f85">680,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzEwLTMtMS0xLTgzMDc4_3ba77570-cc57-49f2-9f71-0d2cd8755f70">630,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzEwLTUtMS0xLTgzMDc4_41484694-34b5-4af3-a387-be1ec61f5e5c">615,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investment income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzEyLTEtMS0xLTgzMDc4_d50fc5a2-8315-4e39-854d-8b87f2e1f836">26,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzEyLTMtMS0xLTgzMDc4_a79533f8-ca21-487e-b819-b5f35f462200">26,916</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzEyLTUtMS0xLTgzMDc4_6a167cea-c8fd-4f1b-b6c5-1b6a1ba292b8">12,679</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE0LTEtMS0xLTgzMDc4_4f629c1a-18c7-4c6a-a982-ee072fc24be3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE0LTMtMS0xLTgzMDc4_b0e6e513-1920-4bab-a5d3-9f18fb63aafb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE0LTUtMS0xLTgzMDc4_ce71496e-7bf5-42af-bc7d-817a2eced9eb">124,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on changes in ownership interest, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE1LTEtMS0xLTgzMDc4_b16a742a-0aa6-4caa-9a65-437669b9d7bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE1LTMtMS0xLTgzMDc4_a47655f8-6e75-4961-ac5f-d58aaa3ef559">16,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE1LTUtMS0xLTgzMDc4_f4025a74-f38b-4704-ac16-c0c24a0709fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE3LTEtMS0xLTgzMDc4_0fc0ef8b-e240-4522-a8e4-7470a146bd19">9,821,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE3LTMtMS0xLTgzMDc4_aef82c38-71b5-4387-94da-bc54208041da">9,855,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE3LTUtMS0xLTgzMDc4_9210bc80-e82f-4057-a05a-d6c4f50e7849">9,745,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE4LTEtMS0xLTgzMDc4_ecb82bfe-c9c3-4dac-a892-882b233fb17b">1,797,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE4LTMtMS0xLTgzMDc4_6c013cb1-e03e-4117-8f5b-9d457215d79a">1,694,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE4LTUtMS0xLTgzMDc4_cdbe8135-3c4d-4a66-b536-4f01e43de998">1,643,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE5LTEtMS0xLTgzMDc4_27d7ab4c-78f0-4dbd-b3d0-4c73ba93652d">285,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE5LTMtMS0xLTgzMDc4_bcd788fd-9781-4542-984e-815756eb296c">304,111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE5LTUtMS0xLTgzMDc4_ece863b4-8e5d-4ea7-a8ea-fa26154f11f3">443,824</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt prepayment, refinancing and redemption charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="dva:DebtPrepaymentRefinancingRedemptionCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIwLTEtMS0xLTgzMDc4_06044dfc-b232-48c9-8e20-1cc318fb956e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="dva:DebtPrepaymentRefinancingRedemptionCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIwLTMtMS0xLTgzMDc4_ce8a1c9a-eefe-4e96-b944-6482389e43b7">89,022</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="dva:DebtPrepaymentRefinancingRedemptionCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIwLTUtMS0xLTgzMDc4_fea3d737-c4dc-4b5a-8bf0-be1d2f0f437b">33,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIxLTEtMS0xLTgzMDc4_e482f775-1382-40f4-bc1e-9256ae99f1af">6,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIxLTMtMS0xLTgzMDc4_e2308e51-4fb4-40f3-b0e0-27b6f71609b9">16,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIxLTUtMS0xLTgzMDc4_ca01b7fe-32d7-4ed2-9072-d7b4861dd3e2">29,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIyLTEtMS0xLTgzMDc4_427781df-3998-4e11-be89-67507795746b">1,518,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIyLTMtMS0xLTgzMDc4_8c748163-9a03-45ef-b468-e6e67921214f">1,318,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIyLTUtMS0xLTgzMDc4_cab4b61b-4d66-4ace-9894-8c9b038cf71d">1,195,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIzLTEtMS0xLTgzMDc4_163583e2-3f94-45b0-8e4e-8c24684d7ae6">306,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIzLTMtMS0xLTgzMDc4_e6019912-2c97-44a3-9a1f-88daffec974d">313,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIzLTUtMS0xLTgzMDc4_417c64ae-535f-49d9-b6fa-204d1e696a7c">279,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI0LTEtMS0xLTgzMDc4_f76fd6c7-cb0e-416c-a642-0c6f701dfcd9">1,211,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI0LTMtMS0xLTgzMDc4_414f935e-178a-4ac4-b511-6bad8349ddf9">1,004,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI0LTUtMS0xLTgzMDc4_84296cca-c816-4c1b-80f6-4c1a53e130ae">915,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI1LTEtMS0xLTgzMDc4_232d0f00-d14b-4c21-88cd-bb93e09b5566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI1LTMtMS0xLTgzMDc4_d6784983-719c-4f74-bd26-d300afbdee5e">9,653</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI1LTUtMS0xLTgzMDc4_05e5c20e-e632-4d45-8870-dd01cdb9e155">105,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI2LTEtMS0xLTgzMDc4_70f38360-358d-4522-a128-ec9b3f407fdf">1,211,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI2LTMtMS0xLTgzMDc4_7464d982-1292-45bc-97df-ecea5c54e6a5">994,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI2LTUtMS0xLTgzMDc4_439be468-8f76-454c-8761-50ed2b73127f">1,021,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI3LTEtMS0xLTgzMDc4_0a6f5d21-bd78-4687-88b2-bb0238aaef7a">233,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI3LTMtMS0xLTgzMDc4_06fa904c-ce42-47ba-b57e-9025c548cda7">221,035</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI3LTUtMS0xLTgzMDc4_3a57d806-a4e0-4fde-adcd-09b2f16730bc">210,313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI4LTEtMS0xLTgzMDc4_3e447174-152f-4c60-8d38-d6b5b2974f40">978,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI4LTMtMS0xLTgzMDc4_1cba2dc0-e94b-485f-bae9-b565006b1e85">773,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI4LTUtMS0xLTgzMDc4_a3ab5b17-08d8-4bf1-a14e-a0acde01fc6c">810,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMxLTEtMS0xLTgzMDc4_8686b3a8-f052-4d93-aa5c-016a630197af">9.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMxLTMtMS0xLTgzMDc4_2546d20a-62fb-499f-91af-b3a61b094a55">6.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMxLTUtMS0xLTgzMDc4_9aedb01d-5093-462c-aa63-74bfb988fdde">4.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMyLTEtMS0xLTgzMDc4_afb1ef5f-e727-4437-b2ed-a15eb7e1349b">9.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMyLTMtMS0xLTgzMDc4_fe6c9913-0810-437d-aa99-f8101bb93d65">6.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMyLTUtMS0xLTgzMDc4_f3a082a4-4806-4739-a19f-d4fee201d649">5.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income from continuing operations</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMzLTEtMS0xLTgzMDc4_8a5bc7ff-59ee-485c-b5e6-6f05ae22de78">8.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMzLTMtMS0xLTgzMDc4_d3f9e8f3-f24f-4d5e-a3fa-8ee5192d9a3a">6.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMzLTUtMS0xLTgzMDc4_96fa8cf1-7ffa-4e53-a02f-7a6d2fa54864">4.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM0LTEtMS0xLTgzMDc4_1161471c-a5a4-43e8-acd6-50eb7ad271f3">8.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM0LTMtMS0xLTgzMDc4_bda76ea7-d68c-4425-b2c9-9111289cf4c6">6.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM0LTUtMS0xLTgzMDc4_3ac5453d-f042-4556-b344-6f4b7e97e3ff">5.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average shares for earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM3LTEtMS0xLTgzMDc4_af20c6e5-cbbd-4592-9a97-045ae934044a">105,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM3LTMtMS0xLTgzMDc4_48a44102-6487-4857-a49d-397ce15efc7a">119,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM3LTUtMS0xLTgzMDc4_97664f7b-169f-44a8-bc77-c07a947050a2">153,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM4LTEtMS0xLTgzMDc4_5415fd43-f5bd-4d7b-abe6-f1e63d1793ea">109,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM4LTMtMS0xLTgzMDc4_a17f231f-323a-4f68-a1f1-3bd0d110b878">122,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM4LTUtMS0xLTgzMDc4_2de14e14-c8cf-4185-b755-7fd1a839ea87">153,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQxLTEtMS0xLTgzMDc4_6c5b67f2-43ae-4f19-8091-c5fcf88b10df">978,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQxLTMtMS0xLTgzMDc4_776b7d19-f2d0-4068-8a5d-f994d4c2453f">783,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQxLTUtMS0xLTgzMDc4_cc77980e-b331-4892-981b-eb5b5669f38f">706,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQyLTEtMS0xLTgzMDc4_37365ad7-c463-437a-8506-9ad9b3165a74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQyLTMtMS0xLTgzMDc4_ce335e8d-3555-4734-ac83-df9d973e7bd9">9,653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQyLTUtMS0xLTgzMDc4_0ceb222f-4961-4fca-9efb-b5281f6c5500">104,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQzLTEtMS0xLTgzMDc4_f8547aec-4d56-4864-a562-cd9313e7f4d0">978,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQzLTMtMS0xLTgzMDc4_9be0b152-8b6d-4e36-98fc-c0bd9b51fb86">773,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQzLTUtMS0xLTgzMDc4_f49f9da5-4442-49be-9b85-64628606b70c">810,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;See notes to consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_190"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars in thousands)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzItMS0xLTEtODMwNzg_70f38360-358d-4522-a128-ec9b3f407fdf">1,211,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzItMy0xLTEtODMwNzg_7464d982-1292-45bc-97df-ecea5c54e6a5">994,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzItNS0xLTEtODMwNzg_439be468-8f76-454c-8761-50ed2b73127f">1,021,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses) on interest rate cap agreements:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzUtMS0xLTEtODMwNzg_0392d728-4345-4ecf-8a9d-73f6a7ed728b">7,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzUtMy0xLTEtODMwNzg_78062ecd-f061-4868-ade2-6bdf357ab59a">16,346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzUtNS0xLTEtODMwNzg_84b28537-3d19-4523-a0b4-4427d62a4e50">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzYtMS0xLTEtODMwNzg_a11d24e9-7baa-4c40-8d4a-b42f8a6ce993">4,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzYtMy0xLTEtODMwNzg_c5612083-b912-438a-ba25-ac3fec41cd53">5,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzYtNS0xLTEtODMwNzg_186ca5ed-7e75-4369-ba2c-4ca2f54b6a53">6,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized losses on foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzctMS0xLTEtODMwNzg_d7fdb29b-26d8-4853-84f1-c85c14ff5292">84,381</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzctMy0xLTEtODMwNzg_a50e5c68-196a-4ebf-bc63-c8e21123062d">7,623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzctNS0xLTEtODMwNzg_2cfe7553-ce79-4efd-9f3a-6b1ce2beeb11">20,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzgtMS0xLTEtODMwNzg_7b863b42-6583-48bf-9f70-da5096716622">73,093</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzgtMy0xLTEtODMwNzg_22e4e6c7-23fa-49a9-942f-a4a7ad91b736">18,656</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzgtNS0xLTEtODMwNzg_50498ebc-4b50-419c-932b-447840293da1">12,574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzktMS0xLTEtODMwNzg_540df694-c28f-41a3-b2d9-fd02dcf6d5bf">1,138,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzktMy0xLTEtODMwNzg_5c3cbbf7-ca4a-4f2e-9b51-d0bb293cbc83">976,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzktNS0xLTEtODMwNzg_220deafb-d96f-4724-bd72-26d6a512884e">1,008,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzEwLTEtMS0xLTgzMDc4_e4d5d808-654f-49e4-8bda-68f944e3d7c5">233,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzEwLTMtMS0xLTgzMDc4_f3c862e5-7427-4005-ac9d-24bbf45479b5">221,035</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzEwLTUtMS0xLTgzMDc4_94f7704f-5a42-466d-b0df-9b501e1a8af2">210,313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzExLTEtMS0xLTgzMDc4_214ef793-c0a0-4b2b-87e0-b272c8441fc9">905,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzExLTMtMS0xLTgzMDc4_de687ad8-7ae6-4e58-acaa-e78669ff516c">754,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzExLTUtMS0xLTgzMDc4_fbfbc30b-13ad-4850-a30f-e7d7b63d47ad">798,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;See notes to consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_193"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:74.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.760%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzItMS0xLTEtODMwNzg_418cefab-f43a-4005-9e9d-6a69dad862fc">461,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzItMy0xLTEtODMwNzg_fb3a50b1-c194-4caa-961c-f1938de04dbe">324,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMtMS0xLTEtODMwNzg_ad3877c4-8747-4473-b5a1-9e102061a67c">93,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMtMy0xLTEtODMwNzg_27b198df-b030-455f-b36c-bccd0f7f55c2">176,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQtMS0xLTEtODMwNzg_7cf65ef6-13b7-40aa-9464-38e67075eeff">22,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQtMy0xLTEtODMwNzg_89a5da46-ed08-4f3e-a7b7-b5861f208e18">20,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzUtMS0xLTEtODMwNzg_e1d2c79f-8a73-4c22-ad78-bc9d60dbc42d">1,957,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzUtMy0xLTEtODMwNzg_aa4ef263-bdf0-41b7-af94-04bc95192d23">1,824,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzYtMS0xLTEtODMwNzg_5164c3ef-a7aa-4c42-8f8f-488e48a22c5d">107,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzYtMy0xLTEtODMwNzg_c6301b1c-0a8b-498b-a4fe-9bfe296d4d22">111,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzctMS0xLTEtODMwNzg_366972f1-bda0-43ea-a206-76c2e007229f">427,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzctMy0xLTEtODMwNzg_22026333-d00e-4933-b1e8-a49d7cc4ae55">544,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzgtMS0xLTEtODMwNzg_4bf02661-7346-49a3-b67d-f6260247ff53">72,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzgtMy0xLTEtODMwNzg_84e6fef2-2f6c-47b2-a3e0-7131541a3b62">76,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzktMS0xLTEtODMwNzg_ba200e94-935c-413f-b005-a443bc039ba8">25,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzktMy0xLTEtODMwNzg_bd78cf5c-b352-4b5e-8547-8fb250b023e6">70,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzEwLTEtMS0xLTgzMDc4_7709e174-0216-477d-a763-1347341e671a">3,167,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzEwLTMtMS0xLTgzMDc4_2f0cb0e0-e70d-46ed-bda1-c7cf07c69de7">3,148,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net of accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzExLTEtMS0xLTgzMDc4_196f439c-12e8-4f25-b758-d86da767b464">3,479,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzExLTMtMS0xLTgzMDc4_8858fe50-b811-4989-a1ca-79cf8303341d">3,521,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzEyLTEtMS0xLTgzMDc4_31531771-90e9-4d1b-b4db-451f5133ae79">2,824,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzEyLTMtMS0xLTgzMDc4_c0267bad-1ea3-40c4-9ccf-5a67c7e8ca3d">2,863,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net of accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzEzLTEtMS0xLTgzMDc4_75348b1a-3550-43ed-a9b1-767592cd9ce7">177,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzEzLTMtMS0xLTgzMDc4_e7c8ac22-eb33-4dcd-b905-1872feee0fe2">166,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method and other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE0LTEtMS0xLTgzMDc4_e00c1910-132e-4092-b4d7-5be4fd885c21">238,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE0LTMtMS0xLTgzMDc4_d18b4e18-99d9-4c5e-b248-de912146ecd4">257,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE1LTEtMS0xLTgzMDc4_54a6ca26-959c-4d86-87b2-6650fa051165">49,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE1LTMtMS0xLTgzMDc4_d921d98e-783c-4190-a983-0daa132d7977">32,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE2LTEtMS0xLTgzMDc4_a0defcbb-cabf-4d91-9713-09178bede6fc">136,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE2LTMtMS0xLTgzMDc4_713a483b-7ded-42f6-bea8-1f193d0549f0">79,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE3LTEtMS0xLTgzMDc4_a472a893-25d4-498d-9542-daaee97bfca0">7,046,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE3LTMtMS0xLTgzMDc4_d7da35bc-4409-400c-8dca-e9a10a18658c">6,919,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE4LTEtMS0xLTgzMDc4_08ed0c5c-30ba-4bc6-b2b7-5cc82d5a21d0">17,121,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE4LTMtMS0xLTgzMDc4_7443c507-0252-47db-853e-1db917bae3d4">16,988,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIwLTEtMS0xLTgzMDc4_f96a9e5c-447b-45a3-864e-d1d6d07cac39">402,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIwLTMtMS0xLTgzMDc4_1a1866b0-9ae5-4878-ae2d-2f36e4377249">434,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIxLTEtMS0xLTgzMDc4_2da532ea-4933-460a-ab13-b61ffa06b091">709,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIxLTMtMS0xLTgzMDc4_f8473eea-a0a6-48f8-8e8c-d588bb8610de">810,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIyLTEtMS0xLTgzMDc4_be68afb3-8764-4887-8d4e-ce197925146e">659,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIyLTMtMS0xLTgzMDc4_687045b9-7bb1-4e72-891f-c33d9e0d8905">685,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIzLTEtMS0xLTgzMDc4_d56681fe-2ef6-4301-9dd5-2e3a7cd36c8f">394,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIzLTMtMS0xLTgzMDc4_cfdf3bcd-03d0-470c-9d1d-202156f44ab8">369,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI0LTEtMS0xLTgzMDc4_23272319-c4c2-4a2c-a554-5b8a78c9d1e6">179,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI0LTMtMS0xLTgzMDc4_9386b79c-f0ac-4971-baf1-c6daedb259eb">168,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI1LTEtMS0xLTgzMDc4_dddf6e0f-bf16-4c00-bd80-411210a861ce">53,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI1LTMtMS0xLTgzMDc4_cc73f326-851e-4bd4-8049-ef1b86d5c7c9">7,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI2LTEtMS0xLTgzMDc4_38dcdef1-92a9-41ff-b79b-3d1ff87c61af">2,398,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI2LTMtMS0xLTgzMDc4_ce01b789-9ae2-41d6-8415-3dbd58ce51ee">2,476,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI3LTEtMS0xLTgzMDc4_b1f4bc8e-a2b7-438b-9b6a-e96f3d6f2d3e">2,672,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI3LTMtMS0xLTgzMDc4_9b7e17f9-6219-4673-85ac-4e04434a846b">2,738,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI4LTEtMS0xLTgzMDc4_0b21345e-3466-4ad2-927a-3c283dbfeb49">8,729,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI4LTMtMS0xLTgzMDc4_4d8be9f7-7a72-4c29-98c8-85305b263e99">7,917,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI5LTEtMS0xLTgzMDc4_4dd42b0c-4559-411e-911e-843ae6c5b513">119,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI5LTMtMS0xLTgzMDc4_7f66a3c9-2a72-4a13-b89d-805ba5681c44">150,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMwLTEtMS0xLTgzMDc4_ab4ed086-a94c-4d30-8e14-5978ec03ff04">830,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMwLTMtMS0xLTgzMDc4_e7704de6-6e50-46d8-bd95-d5439f81b8f3">809,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMxLTEtMS0xLTgzMDc4_c801a5c0-0120-4537-b74d-fef3d90659bf">14,750,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMxLTMtMS0xLTgzMDc4_f927353f-b062-4dc5-9a20-17d8152dbca0">14,091,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMzLTEtMS0xLTgzMDc4_c8b20a15-8902-46ca-b7e0-18d79c1f89af">1,434,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMzLTMtMS0xLTgzMDc4_64654a95-79f7-4e50-bb4b-8851c2936c8f">1,330,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM1LTAtMS0xLTgzMDc4L3RleHRyZWdpb246ZjdjZTk3NzhlMTgwNDJiMjk4MjhhYjdmNTE3MjcxNGZfNDk0NzgwMjMyNTA3NQ_92b4d727-0d5f-41bc-8354-decb0984a45c">0.001</ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM1LTAtMS0xLTgzMDc4L3RleHRyZWdpb246ZjdjZTk3NzhlMTgwNDJiMjk4MjhhYjdmNTE3MjcxNGZfNDk0NzgwMjMyNTA4NQ_11c47a24-3455-44a3-accb-7ed5d7361144">5,000</ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM1LTAtMS0xLTgzMDc4L3RleHRyZWdpb246ZjdjZTk3NzhlMTgwNDJiMjk4MjhhYjdmNTE3MjcxNGZfNDk0NzgwMjMyNTA5Mg_2cf10ed4-6c52-4f30-a984-2a7e236c343c">none</ix:nonFraction> issued)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#cceeff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM1LTEtMS0xLTgzMDc4_a83eac43-b355-4af9-923d-739b1f0da225">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#cceeff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM1LTMtMS0xLTgzMDc4_574556e8-85e6-49bb-8a21-e1233c994230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM2LTAtMS0xLTgzMDc4L3RleHRyZWdpb246Mzg4MTE3ZmU5MWMxNDg4OGFjYmYzNzYzNGVmY2FmNGNfNDk0NzgwMjMyNTE5Mw_5445d31a-34c0-47f4-b558-988af13a3562">0.001</ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM2LTAtMS0xLTgzMDc4L3RleHRyZWdpb246Mzg4MTE3ZmU5MWMxNDg4OGFjYmYzNzYzNGVmY2FmNGNfNDk0NzgwMjMyNTIwNA_d59f38e1-87bf-4382-9215-b5d9a974850c">450,000</ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM2LTAtMS0xLTgzMDc4L3RleHRyZWdpb246Mzg4MTE3ZmU5MWMxNDg4OGFjYmYzNzYzNGVmY2FmNGNfNDk0NzgwMjMyNTIwOA_c1bf6c15-97ff-45b5-aef5-dc4d320d7db7">97,289</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM2LTAtMS0xLTgzMDc4L3RleHRyZWdpb246Mzg4MTE3ZmU5MWMxNDg4OGFjYmYzNzYzNGVmY2FmNGNfNDk0NzgwMjMyNTI3Mg_25b2ad24-66ff-4662-b728-2bcfd45ede73">109,933</ix:nonFraction> shares issued</span></div><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">and outstanding at December&#160;31, 2021, and 2020, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM2LTEtMS0xLTgzMDc4_5d3a5f25-fe4c-4415-a086-9c7af8c4d558">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM2LTMtMS0xLTgzMDc4_9d27e2d9-6d73-4c4e-a790-b5a78854ae73">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM3LTEtMS0xLTgzMDc4_1a576f13-6e8f-4c84-9f8d-ec18704ff4b7">540,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM3LTMtMS0xLTgzMDc4_b6047fee-e10e-4da6-8756-7e07b0f10434">597,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM4LTEtMS0xLTgzMDc4_e20517e9-67a5-4400-a8ac-e7dac3cdc546">354,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM4LTMtMS0xLTgzMDc4_20ed74ef-82e9-4f23-ba2e-d30afa58f8f6">852,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM5LTEtMS0xLTgzMDc4_c63c157a-2de6-40fa-a523-03b948f5cff9">139,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM5LTMtMS0xLTgzMDc4_11c854cd-9188-4541-9c11-8c9403f51569">66,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total DaVita Inc. shareholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQwLTEtMS0xLTgzMDc4_203341f5-0afe-4d92-a1d9-e0c63515bc92">755,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQwLTMtMS0xLTgzMDc4_a446b2fb-8670-4abc-a902-3d8620f6c1e2">1,383,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests not subject to put provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQxLTEtMS0xLTgzMDc4_f78f6392-4356-4214-9672-e3558445f2df">180,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQxLTMtMS0xLTgzMDc4_c92be1eb-dab4-49de-893c-34da347ce9b6">183,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQyLTEtMS0xLTgzMDc4_d9561d9f-6283-4067-9057-5841ff606bf0">936,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQyLTMtMS0xLTgzMDc4_84b5e1fd-80a5-43df-8542-70d263ecba05">1,566,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQzLTEtMS0xLTgzMDc4_36ecc5b2-7f0f-4e83-bb85-8533095f2ee7">17,121,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQzLTMtMS0xLTgzMDc4_b46231c2-a807-4eca-b9dd-75b32c6323cc">16,988,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_199"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOW</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars in thousands)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMtMS0xLTEtODMwNzg_988081fc-bdf0-4482-a188-5fbb87d905de">1,211,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMtMy0xLTEtODMwNzg_36dd4cf9-6f0d-42f4-8fa1-8644bc260f6b">994,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMtNS0xLTEtODMwNzg_c10fb8a6-952b-46cb-a684-55c806058c1c">1,021,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAmortizationAndAccretionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUtMS0xLTEtODMwNzg_f81932cd-210b-456d-95ec-2eaec449b406">680,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAmortizationAndAccretionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUtMy0xLTEtODMwNzg_2a3cc6bc-9ef7-4d13-aa66-f67b3e4da517">630,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAmortizationAndAccretionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUtNS0xLTEtODMwNzg_3672032b-ba26-4ddc-8f93-d36ca2d86263">615,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzYtMS0xLTEtODMwNzg_9d44de93-3df0-45a9-9e64-d41f0d86c235">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzYtMy0xLTEtODMwNzg_b92eb72e-9c7f-479e-a7ef-e5718223df27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzYtNS0xLTEtODMwNzg_57eb8b5d-91ce-4785-92b8-51331da644d6">124,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt prepayment, refinancing and redemption charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="dva:DebtRefinancingCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzgtMS0xLTEtODMwNzg_5c28ba79-814b-4ef8-a036-e2ccf14a2da4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="dva:DebtRefinancingCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzgtMy0xLTEtODMwNzg_ca531cf0-f503-4463-b158-eb558b5a9c8f">86,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="dva:DebtRefinancingCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzgtNS0xLTEtODMwNzg_62b3d499-5381-4a0e-aed5-26eb2b9b2fdc">33,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzktMS0xLTEtODMwNzg_ad02580a-1e87-42a4-a0ac-6635c8ea1335">102,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzktMy0xLTEtODMwNzg_b75b359b-2d78-4585-b2ea-e5a180fc00dc">91,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzktNS0xLTEtODMwNzg_fa326d2e-874e-4b5a-b2d7-0faf36498698">67,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEwLTEtMS0xLTgzMDc4_da9eb3f1-3c05-49d1-b411-373e6313053a">60,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEwLTMtMS0xLTgzMDc4_84fa430e-1872-4e6b-adae-26274cefc5b5">240,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEwLTUtMS0xLTgzMDc4_e6e381df-61d6-4f34-bce9-37fccbd10ad5">41,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investment loss, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="dva:AdjustmentIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzExLTEtMS0xLTgzMDc4_6dc8ad1d-e489-4076-b6a7-4eb79edec6e7">5,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="dva:AdjustmentIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzExLTMtMS0xLTgzMDc4_b7b630a2-4c99-4fdf-b113-c41a26a849ab">13,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="dva:AdjustmentIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzExLTUtMS0xLTgzMDc4_b8075d3b-9c1a-4fc6-95bd-a67059b702d6">8,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sales of business interests, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="dva:LossGainOnDispositionOfBusinessInterestsBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEyLTEtMS0xLTgzMDc4_13f65314-02d3-4bf3-a4d4-3903a2335b93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="dva:LossGainOnDispositionOfBusinessInterestsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEyLTMtMS0xLTgzMDc4_98c188b3-cafe-4ce7-818b-84e30c2b42c5">24,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="dva:LossGainOnDispositionOfBusinessInterestsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEyLTUtMS0xLTgzMDc4_9f8aef7a-7bbc-4ee0-8a26-8d78f4e77f94">23,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEzLTEtMS0xLTgzMDc4_5c7982d6-9a20-4322-9a85-aefa6f6cdbcc">11,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEzLTMtMS0xLTgzMDc4_249be201-7740-4ed1-ae18-2d7f5c0e821b">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEzLTUtMS0xLTgzMDc4_fbc65ddc-0eb3-4431-bb58-0d393ddffbe9">49,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE1LTEtMS0xLTgzMDc4_6dd11063-9a03-407b-ab43-c45cfcc7c897">138,140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE1LTMtMS0xLTgzMDc4_c94150ea-7448-440c-80cb-9c604a5ede3d">21,087</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE1LTUtMS0xLTgzMDc4_c1b8b0bd-66d3-4f73-a6b9-3f250cbddc3f">79,957</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE2LTEtMS0xLTgzMDc4_050385a8-7d05-4855-9048-859f0736b100">5,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE2LTMtMS0xLTgzMDc4_da8d0af8-ea13-4694-9bc3-7bf37ed74cfa">12,349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE2LTUtMS0xLTgzMDc4_a4ac5f08-511e-4f3a-941b-b795851b310b">10,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables and prepaid and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE3LTEtMS0xLTgzMDc4_f2468f3f-8559-484c-bbb9-fd0d7f5a886a">128,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE3LTMtMS0xLTgzMDc4_9fad129e-77c5-45ff-a21b-416687162160">79,277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE3LTUtMS0xLTgzMDc4_c97c2b56-4c94-4e62-a595-11fb6fb69490">2,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE4LTEtMS0xLTgzMDc4_bf2ec4ef-376e-4a90-8b16-857179bb1dff">26,387</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE4LTMtMS0xLTgzMDc4_c6ef8d25-1784-49c4-996b-5fcd693e6999">6,123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE4LTUtMS0xLTgzMDc4_3330fefc-eaf8-4b09-a044-8ba0d7df5af9">6,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE5LTEtMS0xLTgzMDc4_8b9b1bc0-9d70-4716-9d57-3968a4351eed">30,320</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE5LTMtMS0xLTgzMDc4_863031d3-8921-4f8f-aa1a-89d8c17a329a">37,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE5LTUtMS0xLTgzMDc4_70bc6660-c747-461b-b1c9-96fcdadc20ba">84,539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIwLTEtMS0xLTgzMDc4_575aa354-5a9d-4519-a648-7251150e5bb6">16,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIwLTMtMS0xLTgzMDc4_8fe204bd-e14d-47f5-820c-1def95bd2ab4">20,931</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIwLTUtMS0xLTgzMDc4_bff5e8eb-dafc-4be7-a88f-be9fc621e579">14,697</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIxLTEtMS0xLTgzMDc4_bebbb470-5296-4a9b-8e3a-97547fa1b32a">93,645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIxLTMtMS0xLTgzMDc4_4676348c-7322-4533-b068-a33b3df9537a">105,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIxLTUtMS0xLTgzMDc4_cd1035a0-6df5-4a69-ab8b-2f3302ec6568">181,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIyLTEtMS0xLTgzMDc4_316f439f-2811-4f9e-84bf-16179777d0d8">36,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIyLTMtMS0xLTgzMDc4_f3d46083-661b-4e78-8283-a163de07f6d7">87,391</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIyLTUtMS0xLTgzMDc4_b1886544-1483-44a5-8eae-bd37f6183f47">95,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIzLTEtMS0xLTgzMDc4_aa7227d9-14c9-43df-b59b-6c2dbc21124f">6,732</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIzLTMtMS0xLTgzMDc4_33de82d3-756f-4c89-8826-613468ef95bb">19,851</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIzLTUtMS0xLTgzMDc4_2e9488d3-2d0b-4a04-afd3-27fc13cb5647">31,446</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI0LTEtMS0xLTgzMDc4_98daf5a7-9701-4ee6-950a-0b14091e0dc5">1,930,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI0LTMtMS0xLTgzMDc4_3e1b4a9d-7837-452d-b84e-2371e2927a2e">1,979,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI0LTUtMS0xLTgzMDc4_0c7d6c30-dc0b-4c04-8a80-0476e24e7ed9">2,072,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI2LTEtMS0xLTgzMDc4_a14a3f7b-4e10-4bf1-af73-db40c6747a35">641,465</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI2LTMtMS0xLTgzMDc4_6f6a5cd4-472f-4331-966d-0f90bf79f075">674,541</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI2LTUtMS0xLTgzMDc4_77db6437-20b8-4b57-8077-0571982cc685">766,546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI3LTEtMS0xLTgzMDc4_736a5327-16a9-4f30-af0c-af06a0833155">187,050</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI3LTMtMS0xLTgzMDc4_f263149b-bf7c-4e50-a796-d7e6857c4db5">182,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI3LTUtMS0xLTgzMDc4_07130225-d2f1-4204-b4df-5217526416bc">100,861</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from asset and business sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI4LTEtMS0xLTgzMDc4_17ce4442-9452-44a8-8dbc-ab8cc0167e77">61,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI4LTMtMS0xLTgzMDc4_09a6a9aa-4192-487b-95ee-ad0f456962ef">50,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI4LTUtMS0xLTgzMDc4_9ad40c44-03c4-4a23-810a-d115c1dacb5e">3,877,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of debt investments held-to-maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI5LTEtMS0xLTgzMDc4_83047c97-4b3d-44ba-8ea3-a5c40d41a842">30,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI5LTMtMS0xLTgzMDc4_2477b532-3a0c-4519-9c64-2d758837929f">150,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI5LTUtMS0xLTgzMDc4_7632c024-1f65-4b0b-81ce-e7e9d7688325">101,462</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of other debt and equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="dva:PaymentsToAcquireOtherDebtAndEquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMwLTEtMS0xLTgzMDc4_013ce77e-d21a-47a4-85be-ddf745884024">2,987</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="dva:PaymentsToAcquireOtherDebtAndEquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMwLTMtMS0xLTgzMDc4_ae02466a-abad-462d-be9f-8cb309db452b">3,757</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="dva:PaymentsToAcquireOtherDebtAndEquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMwLTUtMS0xLTgzMDc4_f8e974af-5b44-4158-8c6d-540d87fec808">5,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from debt investments held-to-maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMxLTEtMS0xLTgzMDc4_ad09a92f-3d80-4287-9010-eecca657b35c">15,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMxLTMtMS0xLTgzMDc4_fb4e9cd3-25e8-4420-8657-bb193ede9eb9">151,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMxLTUtMS0xLTgzMDc4_5c8db413-0a4a-47cd-92b9-3feacf0bc15b">95,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of other debt and equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMyLTEtMS0xLTgzMDc4_92524e77-bd39-4eda-aef4-0f4527b71999">12,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMyLTMtMS0xLTgzMDc4_92653cf3-e0e9-4072-a107-6b722aa2a0b0">3,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMyLTUtMS0xLTgzMDc4_abeeca54-915e-4caa-9ec8-58e67f4359a8">3,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMzLTEtMS0xLTgzMDc4_e1c5d787-0e64-4303-aaf3-c23c8a4946a8">13,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMzLTMtMS0xLTgzMDc4_6beedd16-663f-4a42-aeef-6f8f12aef5df">22,341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMzLTUtMS0xLTgzMDc4_146891fb-a603-4e43-a23f-047dcc129969">9,366</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM0LTEtMS0xLTgzMDc4_4770c1fa-866b-4edc-9a6c-f3256acffe99">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM0LTMtMS0xLTgzMDc4_ddebb90b-bb8f-4ffc-8af3-14cd10824f18">3,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM0LTUtMS0xLTgzMDc4_786f31ea-e264-48f7-9030-6f50eeaa56ea">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM1LTEtMS0xLTE3MTUwMQ_bd45e669-193e-434d-81b9-1ac90ef5a577">745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM1LTMtMS0xLTE3MTUwMQ_4a048bf1-a016-44cb-8463-5251e881896c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM1LTUtMS0xLTE3MTUwMQ_4d8b8932-b76a-4819-904a-d2082bb31a76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM1LTEtMS0xLTgzMDc4_11a94e68-b4fd-4066-aa09-0145ffd84954">784,733</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM1LTMtMS0xLTgzMDc4_ea6ff6c4-2cab-4dfe-96b9-a3cf1d711bf2">825,371</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM1LTUtMS0xLTgzMDc4_69ec032b-fa87-47e9-8673-2014e7a29949">2,995,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM3LTEtMS0xLTgzMDc4_4567d159-6186-476a-9aeb-89c519a3de31">1,615,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM3LTMtMS0xLTgzMDc4_efdd1a11-25f9-4dfc-bc81-bc6740dfb1f9">4,046,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM3LTUtMS0xLTgzMDc4_e67d0a16-a7f9-46d9-b2b6-2be9fc104e58">38,525,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM4LTEtMS0xLTgzMDc4_441c2ac9-f9dc-4d4a-99bd-28ea34ad07b6">861,115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM4LTMtMS0xLTgzMDc4_c106d4e9-73e3-420a-9ad7-8e4541e9e4e7">4,110,304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM4LTUtMS0xLTgzMDc4_796f9a9e-e7b2-4ba8-84bc-ed02ca05cfe9">40,520,722</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing and debt redemption costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="dva:DebtFinancingAndDebtRedemptionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM5LTEtMS0xLTgzMDc4_423d74e5-e58b-41e8-8aa9-f943c95b01b8">9,091</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="dva:DebtFinancingAndDebtRedemptionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM5LTMtMS0xLTgzMDc4_999ba41b-e19f-4d45-820c-a3d124f05e95">105,848</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="dva:DebtFinancingAndDebtRedemptionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM5LTUtMS0xLTgzMDc4_1d4df886-72ba-4e61-a0ff-3756474fe162">85,319</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQwLTEtMS0xLTgzMDc4_185098d0-b4cc-4863-8efd-d2bae8fd14d3">1,538,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQwLTMtMS0xLTgzMDc4_d8e7f078-8af7-4368-9b6e-3f9d14c6b724">1,458,442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQwLTUtMS0xLTgzMDc4_98f1dc38-2ff4-4301-86df-cde9dbb27f81">2,383,816</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDistributionsToAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQxLTEtMS0xLTgzMDc4_976e351d-85ce-4dc0-a33a-ad4bc0758d84">244,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDistributionsToAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQxLTMtMS0xLTgzMDc4_90bb8795-d893-4821-94b9-11ac4f767e13">253,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsOfDistributionsToAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQxLTUtMS0xLTgzMDc4_9a04622e-cc98-48f2-ba09-c21072b93b9c">233,123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net payments related to stock purchases and awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="dva:PaymentsRelatedToStockPurchasesAndAwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQyLTEtMS0xLTgzMDc4_d39dc41e-ecce-4409-933d-7067ee82d25b">60,001</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="dva:PaymentsRelatedToStockPurchasesAndAwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQyLTMtMS0xLTgzMDc4_823e06ce-29d1-4159-9884-b29fa5b094d5">975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQyLTUtMS0xLTgzMDc4_3ad3a7e9-1d61-490b-823c-115cf50aa924">11,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQzLTEtMS0xLTgzMDc4_ad107878-1546-40d0-88f3-3e2c772d42c9">31,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQzLTMtMS0xLTgzMDc4_e73a3582-ea28-436e-ad51-663009a6a4aa">42,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQzLTUtMS0xLTgzMDc4_97f8d4eb-ec51-4db6-a471-5a9f34874f72">57,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of additional noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ0LTEtMS0xLTgzMDc4_b6dedd97-77c5-4d92-a1fc-434346521826">2,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ0LTMtMS0xLTgzMDc4_482eb8e2-5189-44a8-bf7d-7c9c4eb29191">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ0LTUtMS0xLTgzMDc4_015cc210-1f22-4bce-979d-e9b3b43aac79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ1LTEtMS0xLTgzMDc4_9c6127af-23f3-4c88-977c-3f00bb81b42f">20,104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ1LTMtMS0xLTgzMDc4_d30eb1b5-f9ea-4f35-90d1-c5c481ae22ea">7,831</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ1LTUtMS0xLTgzMDc4_5051b5f8-e6e5-451f-b609-25dca865ea21">68,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ2LTEtMS0xLTgzMDc4_def554a3-1052-4c49-bce2-9b84fa32ee92">1,082,966</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ2LTMtMS0xLTgzMDc4_1e5fe817-545d-4abd-84fa-9260e47858a1">1,846,777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ2LTUtMS0xLTgzMDc4_78ba8b9b-11fa-439a-a45b-e6c8d28886a1">4,696,450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ3LTEtMS0xLTgzMDc4_0bcd8231-6e53-43fd-aff4-3003f39cdca0">10,007</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ3LTMtMS0xLTgzMDc4_9a7086ea-a1b3-4498-9e55-ce6a762fa456">13,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ3LTUtMS0xLTgzMDc4_44f49ff8-5b30-41e8-b638-08a181904b25">1,760</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ4LTEtMS0xLTgzMDc4_0175e290-8a39-49b1-a91d-95790601fca2">53,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ4LTMtMS0xLTgzMDc4_15b65ffb-9c20-47cd-bd76-5443a3470774">706,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ4LTUtMS0xLTgzMDc4_9b349f16-b100-478d-a2b5-f7ac78f69864">369,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net decrease in cash, cash equivalents and restricted cash from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3dd21038464c23a62a67a39190a154_D20210101-20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ5LTEtMS0xLTgzMDc4_11350493-d398-479d-ae9a-fe03eaab89f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e07643e57f74006b5bcc05f2f454af3_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ5LTMtMS0xLTgzMDc4_dfb2dbe5-fec7-4879-910d-038ef16c9766">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63999090b4ba4b888b7f56a9059c5fe0_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ5LTUtMS0xLTgzMDc4_45aa5101-ab6c-469b-8c9b-1a2bc448842d">423,813</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash from continuing<br/>&#160;operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0acb94239c44493880ec3eb2ccd8e937_D20210101-20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUwLTEtMS0xLTgzMDc4_bb587eb9-938a-4ac9-be40-c9d94e5fb860">53,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fe0fe3dc214439e993ff7b2ef6840b7_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUwLTMtMS0xLTgzMDc4_1e7625b2-a08c-46b7-ae2b-8040367631e3">706,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b6e5fa072d7489db4ab12e204b38a35_D20190101-20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUwLTUtMS0xLTgzMDc4_799cec1c-7ab1-4b20-8371-c3be69eccd42">793,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash of continuing operations at beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUxLTEtMS0xLTgzMDc4_e1b132df-a81f-40e7-9c64-aaee2894a613">501,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUxLTMtMS0xLTgzMDc4_179d15e2-5ce4-488c-9244-06aedb5a1421">1,208,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bca572e906b49798cc07308d3e4bfc0_I20181231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUxLTUtMS0xLTgzMDc4_c52e3b43-8f13-452b-8776-249efce55c8e">415,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash of continuing operations at end of the year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUyLTEtMS0xLTgzMDc4_065e8932-56fd-45ab-abe8-85672b264026">554,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUyLTMtMS0xLTgzMDc4_7525ddf9-7f45-4aaa-998d-7822f1c28326">501,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUyLTUtMS0xLTgzMDc4_4bac4945-9313-4463-90d0-b2903cdda445">1,208,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_202"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands)</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.048%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.182%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.863%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.049%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Non-controlling<br/>interests<br/>subject to put<br/>provisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">DaVita Inc. Shareholders' Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Non-controlling interests not<br/>subject to<br/>put provisions</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Retained<br/>earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>income (loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i050ebae691a14d39a71068a4d4ddb981_I20181231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMS0xLTEtODMwNzg_faa9297e-a096-413f-9dc8-6973eef31d4b">1,124,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88726c7f90b243d4adcbf6e341fa9adc_I20181231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMy0xLTEtODMwNzg_c8a84fc4-56fe-4697-b4c6-1c78f03a19e0">166,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88726c7f90b243d4adcbf6e341fa9adc_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtNS0xLTEtODMwNzg_13b1fa97-c103-412a-83d9-baf674dc5a8e">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e3632fb440c4f8b987b9e68d47870e0_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtNy0xLTEtODMwNzg_2afc4c51-6db1-44b0-ae45-0fa0fdb9a7e0">995,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd50a980cda4949863e518248043db7_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtOS0xLTEtODMwNzg_290e1039-f353-43a0-84d6-373baf4fec79">2,743,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1c551774ede47b9a8a31720f6c90ba1_I20181231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMTEtMS0xLTgzMDc4_cf5bfa68-0bcd-4989-b681-306decbcbd00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c551774ede47b9a8a31720f6c90ba1_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMTMtMS0xLTgzMDc4_96575f62-32d6-4fa9-a79b-0ee5889ea8bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b898106fe1a419ca926f1ea86e57923_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMTUtMS0xLTgzMDc4_fe24d732-e3ea-4b42-b60c-b0ba4919a67c">34,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia217ce5b5094494d94eaad3451dec57d_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMTctMS0xLTgzMDc4_60e4eb13-6d33-4e97-b34f-34ad9a24099f">3,703,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb2ad82533ae4593ad0e4a15e9fed8e1_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMTktMS0xLTgzMDc4_468a8e3e-6c3b-4fcd-a09d-7ea1b787eea8">204,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative effect of change<br/>&#160;in accounting principle</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i750133c9d44946099dfeb64f0ff3dda6_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzUtMS0xLTEtMTA2NjQ1_dba9052d-87be-40a5-810a-8b2134c3f8f5">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i944596afcbc042b0b7e8ae7c9ea00e76_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzUtOS0xLTEtODMwNzg_ad67165e-2a3f-47f5-b6a5-9848558f5abf">39,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f800f0bf6140faaf3bda87332ad8ca_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzUtMTctMS0xLTgzMDc4_fb3fc21e-3846-4c03-b318-1f2c12abffcf">39,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if648bd429f9e4b07af2e909f55c08369_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzUtMTktMS0xLTEwNjY2OQ_66001557-94cd-4c96-ba87-bf4e1b1b9234">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzctMS0xLTEtODMwNzg_2f35745c-87eb-4956-a6bd-541aca790164">143,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i583e6028240a4d259061cd7bbc80a527_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzctOS0xLTEtODMwNzg_f7df7e17-fbcd-4a1c-9a1e-a71f90af191c">810,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzctMTctMS0xLTgzMDc4_761a4453-ab07-4719-a3ce-492b9e89a81f">810,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f02743c68844acade340aa85cc54cd_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzctMTktMS0xLTgzMDc4_e7545fe0-4ce7-475b-a460-72a9f6920c19">66,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88c33ce611c94db9b64610be315aa469_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzgtMTUtMS0xLTgzMDc4_30642ab2-c2c3-4f4a-9e9f-ce84f94e55ed">12,574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzgtMTctMS0xLTgzMDc4_7c9f11d1-9a8c-4d83-b8f8-2bcc07ae09e9">12,574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzktMy0xLTEtODMwNzg_f65dc1f1-1531-440b-9771-0ee28c93c8ec">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzktNS0xLTEtODMwNzg_c8b448b3-c086-4aa3-a97f-872721daa21a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzktNy0xLTEtODMwNzg_6c34eb7f-5882-4705-be10-fc6d22099951">16,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzktMTctMS0xLTgzMDc4_484eb01d-1eda-4e26-ada7-026e0dc3dfff">16,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock award plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzEwLTMtMS0xLTgzMDc4_e596bb97-4432-434b-95ed-98f3b73b188d">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzEwLTUtMS0xLTgzMDc4_3ffd8270-a64d-4dab-9b49-6d2e5a27e5cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzEwLTctMS0xLTgzMDc4_e3d1f5f0-e990-4127-9106-cf615aa48ace">3,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzEwLTE3LTEtMS04MzA3OA_9106451c-b617-4718-a76c-2aef8d3d23d6">3,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/>&#160;compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzExLTctMS0xLTgzMDc4_0581fe61-aac3-4a05-8692-696de201f93c">67,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzExLTE3LTEtMS04MzA3OA_c088c10c-9ec1-4753-b051-4beb9202f99d">67,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in noncontrolling<br/>&#160;interest from:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231" decimals="-3" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzEzLTEtMS0xLTgzMDc4_c00a993a-07df-4e57-854f-d73d05d1735f">155,011</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15f02743c68844acade340aa85cc54cd_D20190101-20191231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzEzLTE5LTEtMS04MzA3OA_59dbb161-843d-4e37-9230-9a0454010206">78,112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231" decimals="-3" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE0LTEtMS0xLTgzMDc4_43775957-f991-4d03-9ac4-a29cd49eb895">35,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f02743c68844acade340aa85cc54cd_D20190101-20191231" decimals="-3" name="dva:NoncontrollingInterestIncreaseFromContributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE0LTE5LTEtMS04MzA3OA_914fe1bb-1fbc-4667-ae1c-482114d62d65">21,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231" decimals="-3" name="dva:TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE1LTEtMS0xLTgzMDc4_339fc9e6-62a7-4bad-acae-47caed547abb">6,332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15f02743c68844acade340aa85cc54cd_D20190101-20191231" decimals="-3" name="dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE1LTE5LTEtMS04MzA3OA_19eb445d-430e-4d38-bfa3-a922c2acb8f9">10,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Partial purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231" decimals="-3" name="dva:TemporaryEquityDecreasePurchaseOfInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE2LTEtMS0xLTgzMDc4_9cff62f5-8a14-472f-acb0-d59885a546c2">11,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE2LTctMS0xLTgzMDc4_55371a1f-2ae3-4f50-99af-99e187962c54">37,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE2LTE3LTEtMS04MzA3OA_334daf4c-3c79-4da4-8393-dfe965db23d4">37,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15f02743c68844acade340aa85cc54cd_D20190101-20191231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE2LTE5LTEtMS04MzA3OA_f5211d49-7b25-4fad-ac01-6761263b8c80">19,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE3LTEtMS0xLTgzMDc4_affee3cd-bdcd-42de-a966-11213e8b570f">49,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE3LTctMS0xLTgzMDc4_e61a31ff-60bb-4714-afb4-b32bfca6dbdf">49,525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE3LTE3LTEtMS04MzA3OA_5346e8b8-1ec7-4976-afd2-3c26a3db6451">49,525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib5a1a9dd763f490c88b2409ea91246ed_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE4LTExLTEtMS04MzA3OA_18602897-ed9d-4eaf-8e3d-d929c57d35c6">41,020</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5a1a9dd763f490c88b2409ea91246ed_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE4LTEzLTEtMS04MzA3OA_3ed9a3db-f472-4125-a933-bfe7b81f11f9">2,402,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE4LTE3LTEtMS04MzA3OA_d8dc011c-c9ac-4e85-955f-e28ae2da4c42">2,402,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retirement of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTMtMS0xLTgzMDc4_83ab2375-7fe1-4deb-99da-1f92c4a98ca0">41,020</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTUtMS0xLTgzMDc4_86f4154c-ee76-4ae4-848b-480ed1df0add">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTctMS0xLTgzMDc4_733de2d9-bef2-4440-adfb-c678c0598b28">240,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i583e6028240a4d259061cd7bbc80a527_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTktMS0xLTgzMDc4_6cae992b-ba72-4907-9cc4-d47fb9944514">2,162,313</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5a1a9dd763f490c88b2409ea91246ed_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTExLTEtMS04MzA3OA_65485668-f566-4852-89ef-da91fefd028e">41,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a1a9dd763f490c88b2409ea91246ed_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTEzLTEtMS04MzA3OA_a24e5750-190a-4027-b90e-c1b9cedb83a4">2,402,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTE3LTEtMS04MzA3OA_4a3fbd9e-09f9-490d-be57-fa653c3b3df7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06d01a2b80634e908567ea9c88abdc8f_I20191231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTEtMS0xLTgzMDc4_e8028564-212f-4d1f-8753-80d82cce38dc">1,180,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie1b9156dde5743f4b33b9826bbf418bb_I20191231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTMtMS0xLTgzMDc4_e2ab336b-5d0c-470c-8e97-da16abf40a92">125,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b9156dde5743f4b33b9826bbf418bb_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTUtMS0xLTgzMDc4_2f361265-02d9-4b03-85bd-99e2f26d79c4">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f1cb2b785248a3b90677c8293c94df_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTctMS0xLTgzMDc4_ff1231f9-8d99-4225-be8a-882d244d9722">749,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b6aab96951d446ab5be207620dd6ff7_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTktMS0xLTgzMDc4_af425f90-267e-4174-a8d0-d0d762aa54aa">1,431,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i996169fbe8c44228b5349d69256e805e_I20191231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTExLTEtMS04MzA3OA_4eef9c5a-05c6-4fff-acdb-5c6c5339e960">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996169fbe8c44228b5349d69256e805e_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTEzLTEtMS04MzA3OA_06a74bbf-539c-4bbc-8b99-160076abced7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i838fbf8cfb7d4a6cb6315c5d14ce207e_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTE1LTEtMS04MzA3OA_fbe5a0d4-1d8c-4b67-bc78-eb74c706c2b9">47,498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b4abd021662426781fb847359853689_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTE3LTEtMS04MzA3OA_b10545fe-86c0-46b0-8280-eebd33214519">2,133,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifae2538458cc41c69083e653352c94de_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTE5LTEtMS04MzA3OA_04aafac7-3d48-4963-9513-969931b1fc79">185,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIzLTEtMS0xLTgzMDc4_24db60f3-5c78-42c2-b56a-9592153eeed5">141,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5cea8acd3342e28c6385ed6cb5ccd2_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIzLTktMS0xLTgzMDc4_370236b8-279c-425b-8081-d1211e8ba642">773,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIzLTE3LTEtMS04MzA3OA_b69aa4c7-428a-4d46-8bd4-ea5aa8e0291f">773,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide8b363308b74e509b2de9b4dec149b4_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIzLTE5LTEtMS04MzA3OA_954eae27-271d-40e9-bba0-676c3602c0c3">79,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i757f5d8cb16b4caeb7c0303e2e952d94_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI0LTE1LTEtMS04MzA3OA_001c1714-5703-4b07-bde7-b0ec657ba40c">18,656</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI0LTE3LTEtMS04MzA3OA_190b2eea-97b5-4cfc-b94a-4685aa079118">18,656</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI1LTMtMS0xLTgzMDc4_bc32c3ae-7bf6-4a7b-a66f-b74382b0b992">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI1LTUtMS0xLTgzMDc4_da626663-e7a0-4307-8a45-d7f37fab8059">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI1LTctMS0xLTgzMDc4_7e612ae4-3c69-4641-b20a-76f6e39e58b2">17,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI1LTE3LTEtMS04MzA3OA_b1715563-bde5-4f92-b724-576fe8714b59">17,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock award plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI2LTMtMS0xLTgzMDc4_f1c5e47e-a74c-43df-88ed-4e34b58ae803">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI2LTUtMS0xLTgzMDc4_f25520df-1fa6-40ce-9dbd-75f916be4879">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI2LTctMS0xLTgzMDc4_76063889-5313-48cd-9652-829fe7671575">17,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI2LTE3LTEtMS04MzA3OA_01f290fa-031d-4eea-89f3-97e5ffc75efc">17,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/>&#160;compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI3LTctMS0xLTgzMDc4_e48c87b2-74e2-46fd-9aeb-7e5291d6f1cf">90,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI3LTE3LTEtMS04MzA3OA_b4838c2b-975b-489b-a3cb-97e9b639b4f2">90,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in noncontrolling<br/>&#160;interest from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231" decimals="-3" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI5LTEtMS0xLTgzMDc4_d3616fdf-1bb2-4e8d-b25d-4a628b7a18f7">163,175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide8b363308b74e509b2de9b4dec149b4_D20200101-20201231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI5LTE5LTEtMS04MzA3OA_91b06792-8e30-4647-955e-1392cb4bcfea">89,943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231" decimals="-3" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMwLTEtMS0xLTgzMDc4_d2205ec9-b948-4d48-9b7b-98ca45d55906">30,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide8b363308b74e509b2de9b4dec149b4_D20200101-20201231" decimals="-3" name="dva:NoncontrollingInterestIncreaseFromContributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMwLTE5LTEtMS04MzA3OA_b180f3de-5b5c-494c-8dd2-0bc1a6641f5b">12,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231" decimals="-3" name="dva:TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMxLTEtMS0xLTgzMDc4_9822e7db-e313-4c2f-9f18-7ed7de33700e">3,215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide8b363308b74e509b2de9b4dec149b4_D20200101-20201231" decimals="-3" name="dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMxLTE5LTEtMS04MzA3OA_614fa3ea-5cd6-4787-81b8-42f09c303268">248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Partial purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231" decimals="-3" name="dva:TemporaryEquityDecreasePurchaseOfInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMyLTEtMS0xLTgzMDc4_8ee6b8dc-2f1e-471d-a6c3-237cae688f55">7,771</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMyLTctMS0xLTgzMDc4_453af3c5-95da-4dbf-a385-1d776861d6c9">4,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMyLTE3LTEtMS04MzA3OA_2b58ded9-5814-44b3-aa55-361068b1d416">4,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide8b363308b74e509b2de9b4dec149b4_D20200101-20201231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMyLTE5LTEtMS04MzA3OA_d01749f5-6d7c-4294-8b3e-d3c135741e5e">4,424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMzLTEtMS0xLTgzMDc4_ef6d674a-1376-4352-adde-2a81dbd0d00d">151,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMzLTctMS0xLTgzMDc4_3c35f6ed-4269-4c68-80a3-3384ffd5154c">151,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMzLTE3LTEtMS04MzA3OA_ccbef9a3-acc6-4b3a-989d-e5ab568b85bc">151,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8d5b598835d84508b6ec3b7ee400fa41_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM0LTExLTEtMS04MzA3OA_b869c830-56b5-4aee-ad91-91daaea040a6">16,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d5b598835d84508b6ec3b7ee400fa41_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM0LTEzLTEtMS04MzA3OA_acb46ee3-6360-452d-aee0-efdcf78169bb">1,446,767</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM0LTE3LTEtMS04MzA3OA_dfc997bb-1807-4a3c-9f42-0af37b85d316">1,446,767</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retirement of treasury stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTMtMS0xLTgzMDc4_39c0b87a-87eb-4f15-859e-45056972eb7d">16,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTUtMS0xLTgzMDc4_e59da28c-1d9e-4372-9e32-cbcc9189fe34">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTctMS0xLTgzMDc4_664a2a60-9670-426a-90d4-f8de7228e6f4">93,908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e5cea8acd3342e28c6385ed6cb5ccd2_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTktMS0xLTgzMDc4_a3b30139-16b2-4b38-a4a0-087ea769c40a">1,352,843</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d5b598835d84508b6ec3b7ee400fa41_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTExLTEtMS04MzA3OA_274957d0-2744-4146-94fd-6d8fabb14215">16,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d5b598835d84508b6ec3b7ee400fa41_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTEzLTEtMS04MzA3OA_5faaa0d2-ba27-47d8-85be-af5e65b771ce">1,446,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTE3LTEtMS04MzA3OA_7a52372a-1006-4402-93d9-08d31165850c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e3841c62b4348bd05c6b2d0b4d596_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTEtMS0xLTgzMDc4_2b47981a-71c6-47bc-896d-f6ce759fd90c">1,330,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i60ae2bbc50a5435997c99adc86408164_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTMtMS0xLTgzMDc4_b1bc20ff-528b-45bb-93f3-9e1fc8183f4b">109,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60ae2bbc50a5435997c99adc86408164_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTUtMS0xLTgzMDc4_d2a804ea-41db-4473-bb63-63a3680dd74a">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4654e2a535af44d68cb85bf0e223c161_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTctMS0xLTgzMDc4_561e3d6a-263c-4cd7-abbe-28efd00801b0">597,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36a1b963ab624f408820e5a7b1cda4ef_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTktMS0xLTgzMDc4_e3b55890-e442-4e69-ba28-43d5749888db">852,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0dd9625df77a4aa09aad592fdc4607db_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTExLTEtMS04MzA3OA_e260400b-f738-4176-aeb2-ed20ae10b38f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dd9625df77a4aa09aad592fdc4607db_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTEzLTEtMS04MzA3OA_2da34906-cb1b-4e34-b521-4d62dca357f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31cbff30dba64d4c9bbe2eb87db6524c_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTE1LTEtMS04MzA3OA_66c21a6e-2033-45c5-8da0-8a2bfab5827e">66,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebd4f5dd6634fdda4f23120f166d49b_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTE3LTEtMS04MzA3OA_2b5007b5-d831-413b-9449-6b2bc548389f">1,383,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7743b6788a41e5b36480f00efcdabe_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTE5LTEtMS04MzA3OA_ed18f3cd-3c56-4753-92ce-3649c89e4f5f">183,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EQUITY - continued</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.182%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.922%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.863%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.049%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Non-controlling<br/>interests<br/>subject to put<br/>provisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">DaVita Inc. Shareholders' Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Non-controlling interests not<br/>subject to<br/>put provisions</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Retained<br/>earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>income (loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e3841c62b4348bd05c6b2d0b4d596_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMS0xLTEtODMwNzg_2b47981a-71c6-47bc-896d-f6ce759fd90c">1,330,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i60ae2bbc50a5435997c99adc86408164_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMy0xLTEtODMwNzg_b1bc20ff-528b-45bb-93f3-9e1fc8183f4b">109,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60ae2bbc50a5435997c99adc86408164_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtNS0xLTEtODMwNzg_d2a804ea-41db-4473-bb63-63a3680dd74a">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4654e2a535af44d68cb85bf0e223c161_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtNy0xLTEtODMwNzg_561e3d6a-263c-4cd7-abbe-28efd00801b0">597,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36a1b963ab624f408820e5a7b1cda4ef_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtOS0xLTEtODMwNzg_e3b55890-e442-4e69-ba28-43d5749888db">852,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0dd9625df77a4aa09aad592fdc4607db_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMTEtMS0xLTgzMDc4_e260400b-f738-4176-aeb2-ed20ae10b38f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dd9625df77a4aa09aad592fdc4607db_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMTMtMS0xLTgzMDc4_2da34906-cb1b-4e34-b521-4d62dca357f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31cbff30dba64d4c9bbe2eb87db6524c_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMTUtMS0xLTgzMDc4_66c21a6e-2033-45c5-8da0-8a2bfab5827e">66,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebd4f5dd6634fdda4f23120f166d49b_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMTctMS0xLTgzMDc4_2b5007b5-d831-413b-9449-6b2bc548389f">1,383,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7743b6788a41e5b36480f00efcdabe_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMTktMS0xLTgzMDc4_ed18f3cd-3c56-4753-92ce-3649c89e4f5f">183,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzYtMS0xLTEtODMwNzg_5bff08e4-5a7b-42b6-8739-59f829b2190a">160,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i350dba809a5e474b83a7ae6fd0ebf067_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzYtOS0xLTEtODMwNzg_b4f2efb1-d36b-4bf4-95e2-afba61be10de">978,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzYtMTctMS0xLTgzMDc4_f053c878-c492-4f38-a7c9-da5dc735c32a">978,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27ce758ca09a46018cfdba537eef12e3_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzYtMTktMS0xLTgzMDc4_b5ac5965-832a-4fd1-ae34-f82f45e6ae8c">72,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7cd4ee4e9ce4fc7b8372541703a718f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzctMTUtMS0xLTgzMDc4_3a24a058-80e6-4b0c-970f-d8a3d8f8d4e0">73,093</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzctMTctMS0xLTgzMDc4_b37bd921-8fdd-40f3-aba6-c65cf353cd58">73,093</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzgtMy0xLTEtODMwNzg_51cb9d05-2caa-4ff8-9b86-d60f62e75d21">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzgtNS0xLTEtODMwNzg_a32e6061-519e-48d4-a674-72122ebab9f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzgtNy0xLTEtODMwNzg_268c18cd-f5af-4102-b905-e68a2f5a7769">19,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzgtMTctMS0xLTgzMDc4_d633c998-6d1c-4668-aa94-09a15ca84f1e">19,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock award plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzktMy0xLTEtODMwNzg_e9457960-3373-4f7d-8ea3-57c0a8dfda23">1,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzktNS0xLTEtODMwNzg_555a44f8-e6fe-4a1f-bd67-6d277c26a458">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzktNy0xLTEtODMwNzg_b3795ac8-1d88-400f-b032-3d2108ea0f00">80,642</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzktMTctMS0xLTgzMDc4_a85abd28-e381-47bf-bc70-885a7492ae25">80,641</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/>&#160;compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzEwLTctMS0xLTgzMDc4_6567b63c-ddd2-43a0-b508-61bdbfc89764">100,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzEwLTE3LTEtMS04MzA3OA_5765a139-031a-43b4-937a-63c38329762c">100,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in noncontrolling<br/>&#160;interest from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231" decimals="-3" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzEyLTEtMS0xLTgzMDc4_3a3c945d-ddea-45b5-83a7-637be7e5952a">159,259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27ce758ca09a46018cfdba537eef12e3_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzEyLTE5LTEtMS04MzA3OA_577a2e88-5c28-475b-b00c-375d489f149c">84,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231" decimals="-3" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzEzLTEtMS0xLTgzMDc4_828d7d95-5417-4c49-975a-dd88244710a2">22,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27ce758ca09a46018cfdba537eef12e3_D20210101-20211231" decimals="-3" name="dva:NoncontrollingInterestIncreaseFromContributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzEzLTE5LTEtMS04MzA3OA_8469a572-9c86-4dbb-b684-77bda0bd2578">9,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231" decimals="-3" name="dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE0LTEtMS0xLTgzMDc4_42380fee-3aff-466f-92e1-053e5cceff67">5,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231" decimals="-3" name="dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE0LTctMS0xLTgzMDc4_5052b9f6-a9a1-4ebb-a1a9-3fcecd87ea73">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231" decimals="-3" name="dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE0LTE3LTEtMS0xNDE5MTc_a9652b4f-c84a-4a54-bc81-67b30b30cbf8">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27ce758ca09a46018cfdba537eef12e3_D20210101-20211231" decimals="-3" name="dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE0LTE5LTEtMS04MzA3OA_896cbd31-6637-47b1-91ac-7ca2897cb2c6">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Partial purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231" decimals="-3" name="dva:TemporaryEquityDecreasePurchaseOfInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE1LTEtMS0xLTgzMDc4_49aece07-493a-4116-8f54-4a6c66aa8719">588</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE1LTctMS0xLTgzMDc4_4a3d8c53-cc73-48f7-bc62-2c8f0c1fd932">13,853</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE1LTE3LTEtMS04MzA3OA_2b633992-7e89-44e8-bda5-d595ce7af3ba">13,853</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27ce758ca09a46018cfdba537eef12e3_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE1LTE5LTEtMS04MzA3OA_dfd02e79-8a4a-400e-9ee9-ee3c41dbf935">1,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE2LTEtMS0xLTgzMDc4_fe90afd1-9dd5-4148-b62e-905ca07a81d3">75,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE2LTctMS0xLTgzMDc4_d7ba7e36-4eb4-4ff6-9e39-4bdc97d2e02c">75,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE2LTE3LTEtMS04MzA3OA_daed10c0-06ea-4180-87d6-bbe1fea1f245">75,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i518c74e1af094a8bbc78df6c4a5e0e05_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE3LTExLTEtMS04MzA3OA_52847ba4-5df9-4194-a166-5112152dfc2d">13,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i518c74e1af094a8bbc78df6c4a5e0e05_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE3LTEzLTEtMS04MzA3OA_2888e038-1cd6-4a8f-a197-15bf0649d8b1">1,546,016</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE3LTE3LTEtMS04MzA3OA_f258c79b-902f-453d-ad7d-c7254b4f91e1">1,546,016</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retirement of treasury stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTMtMS0xLTgzMDc4_f2bc6009-0d07-4231-9f9e-b47ffbe496c9">13,877</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTUtMS0xLTgzMDc4_058c3d6d-7ef2-4bbc-9092-2a4d1a3dcbfc">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTctMS0xLTgzMDc4_3dea752f-a4f7-4270-b965-08ab23b5c64f">69,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i350dba809a5e474b83a7ae6fd0ebf067_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTktMS0xLTgzMDc4_2c582e91-d7ad-436f-874c-9da337614c3b">1,476,650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i518c74e1af094a8bbc78df6c4a5e0e05_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTExLTEtMS04MzA3OA_80c03ba1-8524-46e7-8606-e2ec27483f10">13,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i518c74e1af094a8bbc78df6c4a5e0e05_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTEzLTEtMS04MzA3OA_3f06615a-4539-441c-b233-5fc2c08282fb">1,546,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTE3LTEtMS04MzA3OA_259c95ec-7add-4c48-bf6e-d9ad2b26e154">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred taxes from partnership<br/>&#160;buyouts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTctMS0xLTE1NjA0Ng_1c40d3f5-28ea-4686-97a8-2a8bca69b02c">62,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTE3LTEtMS0xNTYwNDY_3a1e05b7-1263-4955-943a-652b4bc61961">62,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e84e755ba249e59a9b6aa205496944_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTEtMS0xLTgzMDc4_643b0b8c-71c1-4fca-880f-a32185025a9b">1,434,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3715810153a34e87aa3d4a8555b92c56_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTMtMS0xLTgzMDc4_e01791d2-8bd0-4dd4-9123-52605e0f89f6">97,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3715810153a34e87aa3d4a8555b92c56_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTUtMS0xLTgzMDc4_76100728-500f-4729-b0ef-0a572b860491">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia58cacd8bb944663919470f872cd9f54_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTctMS0xLTgzMDc4_3147728a-a025-41de-9a1e-014ad95455b5">540,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e3c3810c47a4c88b525c4a096aec7af_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTktMS0xLTgzMDc4_5033aad2-2912-4732-bd2b-000c69f36961">354,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7e9c24fd093462cb7636796ea413cc3_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTExLTEtMS04MzA3OA_eeb9ac53-2da9-44c8-8e37-d68989769cc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e9c24fd093462cb7636796ea413cc3_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTEzLTEtMS04MzA3OA_7c40fba6-ff65-4895-9206-201981b98b2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3013c0642fb54553a6a63393504e9d22_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTE1LTEtMS04MzA3OA_ae8e29b5-3dee-4f88-aa72-145d71f1d779">139,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32f5b12383e04ff68c813ea6c09f8e5d_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTE3LTEtMS04MzA3OA_5dcd5f8d-5797-4355-ae35-c25c583af203">755,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9418d8475e0410d982f26661945c8cf_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTE5LTEtMS04MzA3OA_e06ee2a4-742f-423c-a8da-41cbe38c23c7">180,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_205"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div id="i916f7af890114e55a87e260476560c60_208"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODI5_867cfc3b-177c-4d8d-9d0a-a83c3922ffd4" continuedAt="i22dfbf4f4d79497d9a342691909de93f" escape="true">Organization and summary of significant accounting policies</ix:nonNumeric></span></div><ix:continuation id="i22dfbf4f4d79497d9a342691909de93f" continuedAt="i160d0e6a54774d83b4cd6a9f71baf606"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations are comprised of its dialysis and related lab services to patients in the United States (its U.S. dialysis business), its U.S. ancillary services and strategic initiatives and its international operations (collectively, its ancillary services), as well as its corporate administrative support.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s largest line of business is its U.S. dialysis business, which operates kidney dialysis centers in the U.S. for patients suffering from chronic kidney failure, also known as end stage renal disease</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or end stage kidney disease</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ESRD or ESKD). As of December&#160;31, 2021, the Company operated or provided administrative services through a network of <ix:nonFraction unitRef="clinic" contextRef="i32582f828b954718823b2edb03b73ce7_I20211231" decimals="INF" name="dva:NumberOfSites" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzcwMg_1d9d647c-9789-4d9c-b611-ca57b90bce04">2,815</ix:nonFraction> U.S. outpatient dialysis centers in <ix:nonFraction unitRef="state" contextRef="i32582f828b954718823b2edb03b73ce7_I20211231" decimals="INF" name="us-gaap:NumberOfStatesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzc0MQ_ec96c4bf-ceac-4f8c-81fa-fdca6f4e7d95">46</ix:nonFraction> states and the District of Columbia, serving a total of approximately <ix:nonFraction unitRef="patient" contextRef="ie9c338e435f04dd6bb9e00a239820984_D20210101-20211231" decimals="0" name="dva:NumberOfCustomers" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzgxNA_d3603921-23c4-4d70-aa57-8ed4325483c5">203,100</ix:nonFraction> patients. In addition, as of December&#160;31, 2021, the Company operated or provided administrative services to a total of <ix:nonFraction unitRef="clinic" contextRef="idcc6cfbc476149a0b92d93b432177548_I20211231" decimals="INF" name="dva:NumberOfSites" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzkyMQ_7c10e98d-b6d2-4b57-85a2-15b3c974dc82">339</ix:nonFraction> outpatient dialysis centers serving approximately <ix:nonFraction unitRef="patient" contextRef="i34062f45d55f4583ba09a038767a205e_D20210101-20211231" decimals="0" name="dva:NumberOfCustomers" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzk3NA_f821f777-73f7-4d57-bd45-a569855ea881">39,900</ix:nonFraction> patients located in <ix:nonFraction unitRef="country" contextRef="idcc6cfbc476149a0b92d93b432177548_I20211231" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzk5Nw_61b70d91-60f2-4820-9512-85bab3b624e1">ten</ix:nonFraction> countries outside of the U.S.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2019, the Company completed the sale of its prior DaVita Medical Group (DMG) business to Collaborative Care Holdings, LLC (Optum), a subsidiary of UnitedHealth Group Inc. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented in these consolidated financial statements. For financial information about the DMG business, see Note 22.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.S. dialysis business qualifies as a separately reportable segment and the Company&#8217;s ancillary services, including its international operations, have been combined and disclosed in the other segments category.</span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2NzYz_cb1d79f7-c2cb-45f2-b82f-785ddfd1d35d" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of presentation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (U.S. GAAP). The financial statements include DaVita Inc. and its subsidiaries, partnerships and other entities in which it maintains a majority voting or other controlling financial interest (collectively, the Company). All significant intercompany transactions and balances have been eliminated. Equity investments in investees over which the Company has significant influence are recorded on the equity method, while investments in other equity securities are recorded at fair value or on the adjusted cost method, as applicable. For the Company&#8217;s international subsidiaries, local currencies are considered their functional currencies. Translation adjustments result from translating the financial statements of the Company&#8217;s international subsidiaries from their functional currencies into the Company&#8217;s reporting currency (the U.S. dollar, or USD). Prior year classifications have been conformed to the current year presentation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through the date these consolidated financial statements were issued and has included all necessary adjustments and disclosures.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2Nzc4_232af7a3-4688-4a4a-a716-dda03d5c08cd" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. Although actual results in subsequent periods will differ from these estimates, such estimates are developed based on the best information available to management and management&#8217;s best judgments at the time. All significant assumptions and estimates underlying the amounts reported in the financial statements and accompanying notes are regularly reviewed and updated when necessary. Changes in estimates are reflected in the financial statements based upon on-going actual experience trends or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant assumptions and estimates underlying these consolidated financial statements and accompanying notes involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, fair value estimates and loss contingencies. Specific estimating risks and contingencies are further addressed within these notes to the consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i160d0e6a54774d83b4cd6a9f71baf606" continuedAt="i36a0fb5e72b847c6b0bd70aff35bbf6f"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:RevenueRecognitionAndAccountsReceivablePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODA2_3cc1d538-d24d-46b3-9727-f18179cf4044" continuedAt="i4b82f38b229e4095b9b385fedf41483a" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. A usual and customary fee schedule is maintained for the Company&#8217;s dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with Medicare and Medicaid programs are estimated based on: (a) the payment rates that are established by statute or regulation for the portion of payment rates paid by the government payor (e.g., <ix:nonFraction unitRef="number" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="INF" name="dva:MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzY2OTY_73d80c63-4c44-4a03-b687-b8b537dbc3c5">80</ix:nonFraction>% for Medicare patients) and (b) for the portion not paid by the primary government payor, estimates of the amounts ultimately collectible from other government programs providing secondary coverage (e.g., Medicaid secondary coverage), the patient&#8217;s commercial health plan secondary coverage, or the patient.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Medicare&#8217;s bundled payment rate system, services covered by Medicare are subject to estimating risk, whereby reimbursements from Medicare can vary significantly depending upon certain patient characteristics and other variable factors. Even with the bundled payment rate system, Medicare payments for bad debt claims as established by cost reports require evidence of collection efforts. As a result, billing and collection of Medicare bad debt claims can be delayed significantly and final payment is subject to audit. The Company&#8217;s revenue recognition is estimated based on its judgment regarding its ability to collect, which depends upon its ability to effectively capture, document and bill for Medicare&#8217;s base payment rate as well as these other variable factors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Advantage revenues are reimbursed at negotiated contract rates that are generally higher than Medicare fee-for-service rates, but which generally have a slower payment frequency than Medicare fee-for-service payments. Medicare Advantage revenues are subject to meaningful estimating risk based on factors similar to those described for commercial health plans below.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid payments, when Medicaid coverage is secondary, can also be difficult to estimate. For many states, Medicaid payment terms and methods differ from Medicare, and may prevent accurate estimation of individual payment amounts prior to billing.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with commercial health plans are estimated based on contractual terms for the patients under healthcare plans with which the Company has formal agreements, non-contracted health plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in the Company&#8217;s billing and collection processes that can result in denied claims for payments, delays in collections due to payor payment inefficiencies, and regulatory compliance matters.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial revenue recognition also involves significant estimating risks. With many larger commercial insurers, the Company has several different contracts and payment arrangements, and these contracts often include only a subset of the Company&#8217;s centers. In certain circumstances, it may not be possible to determine which contract, if any, should be applied prior to billing. In addition, for services provided by non-contracted centers, final collection may require specific negotiation of a payment amount, typically at a significant discount from the Company&#8217;s usual and customary rates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenues</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's U.S. ancillary service revenues include revenues earned under risk-based arrangements in the Company's integrated care and disease management business, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (our counterparty), with adjustments where applicable, or on trended and adjusted medical cost targets.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For some of the Company's risk-based arrangements (such as its special needs plans), the Company acts as a principal with respect to all medical services provided to the patient by effectively hosting or sponsoring the entire arrangement, and as a </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i36a0fb5e72b847c6b0bd70aff35bbf6f" continuedAt="i5607a25e6ec345d1ba284e7e5071432b"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4b82f38b229e4095b9b385fedf41483a">result recognizes revenue and expense for all medical services provided to covered patients. However, for most of its VBC arrangements, the Company provides health monitoring and care coordination services to patients but does not control or direct the medical services that patients receive from third party providers. As a result, for most of its VBC arrangements the Company does not include third party medical costs in its reported revenues and expenses, but rather recognizes revenue only for the estimated amount of shared savings or shared losses or other revenues that are directly earned or incurred by the Company, and ultimately paid to or by the Company, under the arrangement.</ix:continuation></span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:OtherNonoperatingIncomeExpensePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODM1_50db35d3-1fdb-4de3-9756-487368dbea9f" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income includes interest income on cash and cash equivalents and short- and long-term investments, realized and unrealized gains and losses recognized on investments, and foreign currency transaction gains and losses.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2Nzc0_d606342c-12ef-4b33-ae4f-94439550610f" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are short-term highly liquid investments readily convertible to known amounts of cash that typically mature within three months or less at date of purchase.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODE0_fe93c21e-bfeb-4acf-aba7-fd0ddd53cdae" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted cash and equivalents</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and cash equivalents include funds held in trust to satisfy insurer and state regulatory requirements related to wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company as well as funds held in escrow. See Note 4 for further details.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODMw_f3133f41-501d-4745-855d-c58666ac077f" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in debt and equity securities</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies certain debt securities as held-to-maturity and records them at amortized cost based on the Company&#8217;s intentions and strategies concerning those investments. Equity securities that have readily determinable fair values or redemption values are recorded at estimated fair value with changes in fair value recognized in current earnings within other income. These debt and equity investments are classified as short-term investments or long-term investments on the Company's consolidated balance sheet. See Note 5 for further details.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODM5_3e50995c-50d2-4e37-b688-7b2af718a9a7" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value and consist principally of pharmaceuticals and dialysis-related supplies. Rebates related to inventory purchases are recorded when earned and are based on certain qualification requirements which are dependent on a variety of factors including future pricing levels and purchase volume levels from the manufacturer and related data submission.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODM2_60d75ff9-328a-4e1b-96d6-369ce8e16b1f" continuedAt="i035c6a674eb947e88f994d0df65bb737" escape="true">Property and equipment</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i035c6a674eb947e88f994d0df65bb737">Property and equipment is stated at cost less accumulated depreciation and amortization and is further reduced by any impairments. Maintenance and repairs are charged to expense as incurred. Disposition gains and losses are included in current operating expenses. Property and equipment assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.</ix:continuation> </span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODAz_1b7bb570-fb22-42eb-a6b3-33e855d7ed9d" continuedAt="i809dfc71182c479887899713701249b1" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#8217;s facilities are leased under non-cancellable operating leases which contain renewal options. These renewal options are included in the Company's determination of the right-of-use assets and related lease liabilities when renewal is considered reasonably certain at the commencement date. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company categorizes leases with contractual terms longer than twelve months as either operating or finance leases. Finance leases are generally those leases that allow the Company to substantially utilize or pay for the entire asset over its estimated life. All other leases are categorized as operating leases. The Company has elected the practical expedient to not separate lease components from non-lease components for its financing and operating leases. The Company has also elected the short-term lease recognition exemption and does not recognize right-of-use assets or lease liabilities for leases with a term of less than 12 months.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i5607a25e6ec345d1ba284e7e5071432b" continuedAt="i6de6c8f28fcd4b6ca3f6cbb4ddfa9c14"><ix:continuation id="i809dfc71182c479887899713701249b1"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing and operating right-of-use assets are recognized based on the net present value of lease payments over the lease term plus expected renewals as of the commencement date. Since most of the Company's leases do not provide an implicit rate of return, the Company uses its incremental borrowing rate based on information available at the commencement date or remeasurement date in determining the present value of lease payments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired under finance leases are recorded on the balance sheet within property and equipment, net and liabilities for finance lease obligations are recorded within long-term debt. Finance lease assets are amortized to depreciation expense on a straight-line basis over the shorter of their estimated useful lives or the expected lease term.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rights to use assets under operating leases are recorded on the balance sheet as operating lease right-of-use assets and liabilities for operating lease obligations are recorded as operating lease liabilities. Reductions in the carrying amount of operating lease right-of-use assets are recorded to rent expense over the lease term.</span></div></ix:continuation><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODMx_49a25ad1-a8ad-4583-8f53-5c1189e9a585" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortizable intangibles</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortizable intangible assets include noncompetition agreements, hospital service contracts, and customer relationships arising from other service contracts, each of which have finite useful lives. Amortization expense is computed using the straight-line method over the useful lives of the assets estimated as follows: noncompetition agreements and hospital acute service contracts over the contract term, and customer relationships from other service contracts over the remaining contract term plus expected renewal periods. Amortizable intangible assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODI1_dbfb9710-17a8-41a8-b446-907c94a5814d" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indefinite-lived intangibles</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets include international licenses and accreditations that allow the Company to be reimbursed for providing dialysis services to patients, each of which has an indefinite useful life. Indefinite-lived intangibles are not amortized, but are assessed for impairment at least annually and whenever significant events or changes in circumstances indicate that an impairment may have occurred. Costs to renew indefinite-lived intangible assets are expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODE1_0a23959f-c8d2-4b7c-85df-37a9e136f3b2" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity method and other investments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments that do not have readily determinable fair values are carried on the equity method if the Company maintains significant influence over the investee. Equity investments without readily determinable fair values for which the Company does not maintain significant influence over the investee are carried either at estimated fair value or on the adjusted cost method, as determined on an investment-specific basis. The adjusted cost method represents the Company's cost for an investment, net of any other-than-temporary impairments, as adjusted for any subsequent observation of the investment's fair value.&#160;These equity method and adjusted cost method investments are classified as equity method and other investments on the Company's consolidated balance sheet.&#160;See Note 9 for further details.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method and other investments are assessed for other-than-temporary impairment when significant events or changes in circumstances indicate that an other-than-temporary impairment may have occurred. An other-than-temporary impairment charge is recorded when the fair value of an investment has fallen below its carrying amount and the shortfall is expected to be indefinitely or permanently unrecoverable.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODE3_12411607-2ee8-4965-a528-2c0b6ad0e3d2" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the difference between the fair value of businesses acquired and the fair value of the identifiable tangible and intangible net assets acquired. Goodwill is not amortized, but is assessed by individual reporting unit for impairment as circumstances warrant and at least annually. An impairment charge is recognized when and to the extent a reporting unit's carrying amount is determined to exceed its fair value. The Company operates multiple reporting units. See Note 10 for further details.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:InsuranceAndSelfInsurancePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2NzYw_56f64ad8-46cb-4c9c-bbd3-3a8f52fb2e9f" continuedAt="i4c10bfbd2d89460892bacb95097fd72a" escape="true">Self-insurance</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4c10bfbd2d89460892bacb95097fd72a">The Company predominantly self-insures its professional and general liability and workers' compensation risks through its wholly-owned captive insurance companies, with excess or reinsurance coverage for additional protection.&#160;The Company is also predominantly self-insured with respect to employee medical and other health benefits.&#160;The Company records insurance liabilities for the professional and general liability, workers&#8217; compensation, and employee health benefit risks that it retains and estimates its liability for those risks using third party actuarial calculations that are based upon historical claims experience and expectations for future claims.</ix:continuation> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i6de6c8f28fcd4b6ca3f6cbb4ddfa9c14" continuedAt="id4076d57c9d549a5a808216353fffafb"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2NzYx_b1bb2a4a-5423-4dc6-bc1f-273f758979b5" continuedAt="i009c2eafad4e495d9b8fe67ac868d51d" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted both for items that do not currently have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the financial statements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2Nzcy_9b444699-cff0-49e3-812e-9a5fe62c3b08" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market-based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all stock-based awards is recognized net of expected forfeitures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation to be settled in shares is recorded to the Company&#8217;s shareholders&#8217; contributed capital, while stock-based compensation to be settled in cash is recorded as a liability. Shares issued upon exercise or, when applicable, vesting of stock awards, are issued from authorized but unissued shares.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2NzYy_79742d40-ea3f-4460-b714-af4618aa8cbf" continuedAt="ic8598762d0b94eca996276922d763aba" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate cap agreements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company often carries a combination of current or forward interest rate caps on portions of its variable rate debt as a means of hedging its exposure to changes in LIBOR interest rates as part of its overall interest rate risk management strategy. These interest rate caps are not held for trading or speculative purposes and are designated as qualifying cash flow hedges. See Note 13 for further details.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2Nzc3_fb073501-2722-4c9e-b53e-86ae7876b5e7" continuedAt="i7ec4ffbb75f141858314e869cd7d23cb" escape="true">Noncontrolling interests</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7ec4ffbb75f141858314e869cd7d23cb" continuedAt="i6164d7b272e1436b9c849c098c2505d8">Noncontrolling interests represent third-party equity ownership interests in entities which are consolidated by the Company for financial statement reporting purposes.</ix:continuation> As of December&#160;31, 2021, third parties held noncontrolling equity interests in <ix:nonFraction unitRef="entity" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="INF" name="dva:NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzIwOTk2_39ec2f97-ae86-4ea4-a422-36f6acbdab59">717</ix:nonFraction> consolidated legal entities.</span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODA5_f58c66ca-f6ea-4298-a96c-d48f7760beba" continuedAt="ifdad9b0cfdba4d45968e48e5029f38f8" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair value estimates</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Fair value measurements are determined based on the principal or most advantageous market for the item being measured, assume that buyers and sellers are independent, willing and able to transact, and knowledgeable, with access to all information customarily available in such a transaction, and are based on assumptions that market participants would use in pricing the item, not assumptions specific to the reporting entity. The criticality of a particular fair value estimate to the Company's consolidated financial statements depends upon the nature and size of the item being measured, the extent of uncertainties involved and the nature and magnitude or potential effect of assumptions and judgments required. Certain fair value estimates can involve significant uncertainties and require significant judgment on various matters, some of which could be subject to reasonable disagreement. See Note 24 for further details.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on fair value measurements and estimates for purposes that require the recording, reassessment, or adjustment of the carrying amounts of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity). These purposes can include the accounting for business combination transactions; impairment assessments for goodwill, other intangible assets, or other long-lived assets; recurrent revaluation of investments in debt and equity securities, contingent earn-out obligations, interest rate cap agreements, and noncontrolling interests subject to put provisions; and the accounting for equity method and other investments and stock-based </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="id4076d57c9d549a5a808216353fffafb"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifdad9b0cfdba4d45968e48e5029f38f8">compensation, as applicable. The Company has classified its assets, liabilities and temporary equity into the fair value hierarchy levels defined by the FASB reflecting their differing degrees of uncertainty. See Note 24 for further details.</ix:continuation></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODA1_1f052e97-8176-42bb-b31e-91d8787fa9e1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New accounting standards</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards recently adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued Accounting Standards Update (ASU) No. 2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. The amendments in this ASU became effective for the Company beginning on January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. Effective January 1, 2022 certain LIBOR tenors that do not affect the Company, including the one-week and two-month U.S. dollar LIBOR rate, ceased or became non-representative. The remaining U.S. dollar LIBOR tenors will cease or become non-representative effective July 1, 2023. This change will have no impact on the Company's ability to borrow. The Company is currently assessing the other effects this guidance may have on its consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities (ASU 2021-08)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-08 requires application of ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to recognize and measure assets and liabilities from contracts with customers acquired in a business combination. This ASU creates an exception to the general recognition and measurement principle in ASC 805 and will result in recognition of contract assets and contract liabilities consistent with those recorded by the acquiree immediately before the acquisition date. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Early adoption is permitted for all entities. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div id="i916f7af890114e55a87e260476560c60_211"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzI0MjI_4e7904e5-28bb-421d-bd21-1311f4078c67" continuedAt="i33e6fee70b46432091f257a90e3a902d" escape="true">Revenue recognition and accounts receivable</ix:nonNumeric></span></div><ix:continuation id="i33e6fee70b46432091f257a90e3a902d" continuedAt="ie8feb2f5b3bb4fe1baa8cbbea83ab2f9"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzI0MjA_c04ff31c-9198-483a-8aad-07741df8488c" continuedAt="i2f22165e55334e53a849f8a4db9d3a8f" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues by segment and primary payor source were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:37.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ec096dcca304113bc6030ce985e8e87_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzMtMS0xLTEtODMwNzg_c2c8465c-be52-4608-9187-eeef5da60f18">6,133,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f47d0696ecb4ceea5e3dae2b3f56bbf_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzMtNS0xLTEtODMwNzg_bc738c0b-f337-477b-9d78-b6685f6aa624">6,133,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i844334ff13de4b30b4c03942a019ecc3_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzQtMS0xLTEtODMwNzg_9d481dd1-0641-4bcd-9495-e84407044237">782,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib840efffa3b94830990c3a92b56374e2_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzQtNS0xLTEtODMwNzg_ef7053e5-1654-40e7-82c4-7d3719fc60d2">782,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb5b1eefc8d41fd800f8c1f52603ba0_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzUtMS0xLTEtODMwNzg_dddec6ee-6328-412d-aab2-33cc342d1d9a">328,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90c6f2e663a84d45ba6b27262a653a05_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzUtMy0xLTEtODMwNzg_af01f38a-7cd3-4757-8890-4c743862166b">463,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic04011b05a72411caa75091e3801f7de_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzUtNS0xLTEtODMwNzg_79674086-5a5b-4dfd-88fa-24451b032b14">791,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5041e4e8c2184140828efaa001bdd25e_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzYtMS0xLTEtODMwNzg_8d1ffe1b-24ec-45ef-9891-023368a6e746">3,397,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e0c5744d944b2b9bd9e8a2915c8453_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzYtMy0xLTEtODMwNzg_6f40d461-84fa-4e80-8406-bfc845f0d57e">199,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c40460b5c5b441db56d0568eb1241d1_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzYtNS0xLTEtODMwNzg_a6284b12-ca93-4f97-82b3-28608d275440">3,596,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43f279672ea545869037ea2802282d14_D20210101-20211231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzgtMy0xLTEtODMwNzg_de3bcb50-92eb-4f1f-b2be-b5ba23a25b2e">326,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f47d0696ecb4ceea5e3dae2b3f56bbf_D20210101-20211231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzgtNS0xLTEtODMwNzg_b22e6c4c-958f-4b46-833e-7f1ccef09b73">326,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33d553b0e327490488f4d8edbe627ee0_D20210101-20211231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzktMy0xLTEtODMwNzg_b496de52-e670-469b-aa37-5cec53c9d426">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib840efffa3b94830990c3a92b56374e2_D20210101-20211231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzktNS0xLTEtODMwNzg_a16ff959-7e09-4501-9086-fd9ecd441995">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e0c5744d944b2b9bd9e8a2915c8453_D20210101-20211231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEwLTMtMS0xLTgzMDc4_6d5f41b8-fdb8-401e-b900-cb7d8e21255e">15,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c40460b5c5b441db56d0568eb1241d1_D20210101-20211231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEwLTUtMS0xLTgzMDc4_195a7b0e-60a1-4cca-ac6b-91a026694c6d">15,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3fd96e606364586af971c83948be72a_D20210101-20211231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzExLTEtMS0xLTgzMDc4_3abc2d8e-ec36-4f84-9c0e-e62a53c03881">25,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdf7cce3e8f4dd797d01eb3c13004e6_D20210101-20211231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzExLTMtMS0xLTgzMDc4_2068fed1-b495-47ae-b78e-5b0d27137eac">40,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05351ca6b9d14e4db0eabbbe9c54574c_D20210101-20211231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzExLTUtMS0xLTgzMDc4_9706f9a3-28cd-4459-913d-dce35aa2b04f">66,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0a25508bcb746169dec8366c15ed07a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEyLTEtMS0xLTgzMDc4_b6a880be-c52e-4886-9ecc-ce7f50044d06">90,796</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05cf3e1772d6444ea76bd84771ac5085_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEyLTMtMS0xLTgzMDc4_d289e3b9-5ae5-4f67-8cd9-718986f97f64">4,294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8c57a5b75b1450db44db406dbe6cbb1_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEyLTUtMS0xLTgzMDc4_173b6222-56a8-4f50-8832-465c43705770">95,090</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEzLTEtMS0xLTgzMDc4_aaf4a5d7-d3de-4545-8437-67f8ddefaf8c">10,576,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEzLTMtMS0xLTgzMDc4_ff2cdac4-c42b-403b-a840-3eee7da0df39">1,042,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEzLTUtMS0xLTgzMDc4_a17da9e6-a4c7-43f3-b488-2f597ca60853">11,618,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ie8feb2f5b3bb4fe1baa8cbbea83ab2f9" continuedAt="i3e9196a383dd4960be694b600e5c3d72"><ix:continuation id="i2f22165e55334e53a849f8a4db9d3a8f"><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:37.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d275721d92143bf8c330f70d27cb62f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzMtMS0xLTEtODMwNzg_d1322c79-1219-4b38-9b1d-4667c1a65fbe">6,169,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf3ecd2542b42dbafe63b11f52a5f01_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzMtNS0xLTEtODMwNzg_f8f52c32-9287-4dea-9509-9e2f7b8d026f">6,169,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde88c91df984f719e7c6e7ac45ff483_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzQtMS0xLTEtODMwNzg_b83c73c0-910b-41f0-bad2-a0748856149c">744,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i308c251f3409431ba2ce96afe16e5595_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzQtNS0xLTEtODMwNzg_14cab8e1-8c70-48ed-b303-fcb4833bda75">744,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other government</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5aed74fb770d4a2699f1ddada95c657a_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzUtMS0xLTEtODMwNzg_42a2fbaf-f428-4e46-b3ac-8ce2b5955eab">334,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i304d4d375e0f48c0ab470af39fbd5154_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzUtMy0xLTEtODMwNzg_45250fc0-1110-4725-a4f2-abdcc7f85f2d">380,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f79711127304e7698b87e1bd094348f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzUtNS0xLTEtODMwNzg_e249e84d-4c68-4ae2-b68f-ae652c7102ae">715,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c74d19584d454fa34768055ba7f8dc_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzYtMS0xLTEtODMwNzg_49d4284d-5629-4301-9403-d76f1ed50b9d">3,370,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a725d0f7e941a989ed5bb796119840_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzYtMy0xLTEtODMwNzg_5db7b9e5-4132-42da-9705-455494888f13">170,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec92bd4bff18494083abb72a297d1750_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzYtNS0xLTEtODMwNzg_b558d3b1-d1a8-42be-8e06-6919dbff2e6a">3,540,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08ccea9be2442a6ab45a04b8ae8f5f2_D20200101-20201231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzgtMy0xLTEtODMwNzg_ffbef465-5d11-4239-b7cd-7391c0b1e1cd">419,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf3ecd2542b42dbafe63b11f52a5f01_D20200101-20201231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzgtNS0xLTEtODMwNzg_9853e8b4-3b9e-4def-9e1c-794861ebfd15">419,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1db402b2e17c4fdeabe30ffd0d4e606e_D20200101-20201231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzktMy0xLTEtODMwNzg_6b3767e2-daf2-4a74-be9d-ad45973d57f3">1,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i308c251f3409431ba2ce96afe16e5595_D20200101-20201231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzktNS0xLTEtODMwNzg_e3522b2e-1fc0-42cf-8032-49d32bf5921c">1,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a725d0f7e941a989ed5bb796119840_D20200101-20201231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEwLTMtMS0xLTgzMDc4_dbecab4d-ee9b-477d-8506-78f3dc5ab97e">33,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec92bd4bff18494083abb72a297d1750_D20200101-20201231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEwLTUtMS0xLTgzMDc4_18602fde-28ce-4d7e-8e4f-292b244e0274">33,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9c4a257e0bd4952bb2f643a893d32b0_D20200101-20201231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzExLTEtMS0xLTgzMDc4_c46f8a4e-2a2f-492f-a55e-d5426cba1288">40,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c733ee69934ecb9b5772eec12a55aa_D20200101-20201231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzExLTMtMS0xLTgzMDc4_27812c87-50ab-4f93-906e-1a4e86021dc3">47,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf215d79e0d04757b9564cfbcda02f3a_D20200101-20201231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzExLTUtMS0xLTgzMDc4_38f95d41-9eec-4af6-8364-2a7418e5bc5a">88,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06141d893bb4422fa657c1f835bd0f2b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEyLTEtMS0xLTgzMDc4_5d286f57-7de5-435d-8f48-f01b40c94f42">145,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i295d3ce315bf4c489968d63c7ba4628f_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEyLTMtMS0xLTgzMDc4_c9ac13c6-bb3d-4cf3-97ba-b9fe995133ee">16,743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i867fc66d86b045b5b0590e89915a412c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEyLTUtMS0xLTgzMDc4_0321181d-3c6b-4516-80c4-e1d0211d5ab9">162,029</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEzLTEtMS0xLTgzMDc4_9ea859f6-b6f1-49d9-9d65-577c12756655">10,514,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEzLTMtMS0xLTgzMDc4_b0fbe78b-3530-468b-bf22-54a19d90a9cc">1,035,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEzLTUtMS0xLTgzMDc4_629ee48a-3c45-49f4-a786-317e66047040">11,550,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the "Other government" category to the "Medicare and Medicare Advantage" category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the year ended December&#160;31, 2020 has also been recast to conform to the current period presentation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:37.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i527765f1b1c747358b403c1ee2d8bd10_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzMtMS0xLTEtODMwNzg_1edcd2ca-8967-4385-b003-7d161909c9fc">6,246,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i046bac9a5f584086bb2c35f87b6a1468_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzMtNS0xLTEtODMwNzg_6353785b-f41b-4254-a38d-321473d60bac">6,246,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3875776099b146e2b6fff08d3a03da84_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzQtMS0xLTEtODMwNzg_8ae191ce-5680-41fc-9363-7a580001be98">669,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i409fa2d900b448c8827e86526a38779c_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzQtNS0xLTEtODMwNzg_bce29bf1-c5df-4f72-bedd-1fd483fd8644">669,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other government</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i520c14418180468ba0ed3e50cc99d1cf_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzUtMS0xLTEtODMwNzg_b556ae15-4c94-41a5-a5c4-041b06d7b771">329,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0b031a2280648889e03675a2160e4f9_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzUtMy0xLTEtODMwNzg_40bb8fc0-7750-40e0-9e2e-946ee9fb1672">352,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e7eff1c5284135b2912c47d643c653_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzUtNS0xLTEtODMwNzg_3f8cef83-3fa9-4b43-b4b2-942fcfae25a8">681,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6465f4788ca4b3baa87609dbf71f52f_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzYtMS0xLTEtODMwNzg_34b2d712-7589-470c-9325-c11cc839e61a">3,286,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1db70badf9c4be0b0e0fc9f772301e6_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzYtMy0xLTEtODMwNzg_f1e52ff6-6764-41e3-9e81-687b3b8413ad">144,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7778dcdd0e944f4a8815e82230ee02f2_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzYtNS0xLTEtODMwNzg_25174403-0089-4bba-b446-c3a5f6e3353d">3,430,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5da5750bb2a24b08979a8ec810b8c815_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzgtMy0xLTEtODMwNzg_7a9a0b40-ac6e-43ac-aa22-21157558a023">264,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i046bac9a5f584086bb2c35f87b6a1468_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzgtNS0xLTEtODMwNzg_d18060fb-5384-4595-86f3-4fd74f44c0c3">264,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d3fb78c0dc54d1587b96b694d859948_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzktMy0xLTEtODMwNzg_89b7853f-c96f-4888-bfe0-2d7266c5ba32">606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i409fa2d900b448c8827e86526a38779c_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzktNS0xLTEtODMwNzg_0e0b734d-9564-4a54-8a67-1743e227710c">606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1db70badf9c4be0b0e0fc9f772301e6_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEwLTMtMS0xLTgzMDc4_6e34d59a-8d6a-424d-87d1-96f113edf3fc">130,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7778dcdd0e944f4a8815e82230ee02f2_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEwLTUtMS0xLTgzMDc4_5b9f198e-7d69-4d89-87e1-777bfdb62f4a">130,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icab03bd4111342188781a60000b67316_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzExLTEtMS0xLTgzMDc4_d34725db-f057-4225-aafe-321003ddd076">32,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3959cde560fe4d70a411b92be2612071_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzExLTMtMS0xLTgzMDc4_c7823769-b07b-4b6d-8696-116c7e004ca9">78,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58155ca3f13343d5a0780d211b521c24_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzExLTUtMS0xLTgzMDc4_2472e0e4-3d62-42fc-8da5-2350dd912896">110,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0063865a3f1a46df9d125b3ec015e2eb_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEyLTEtMS0xLTgzMDc4_3fb18278-0934-44ff-b7dd-669ad8d401aa">132,325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i095a32d1f5934a57968454e6e538c10b_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEyLTMtMS0xLTgzMDc4_d6031237-2e78-4899-913d-a93e4da27e3e">14,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba5967b32fb4416ab78a1b0e0114069a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEyLTUtMS0xLTgzMDc4_ee59b45a-1e06-4fe4-9c36-92fe33a8d0c8">146,355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f8e1940aa343e29817e02300203cc7_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEzLTEtMS0xLTgzMDc4_9a8a0b31-12de-4e87-9baa-608ababadac0">10,430,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1b74b97d41414b9d610ad1be460b97_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEzLTMtMS0xLTgzMDc4_a0b195f8-4913-4777-989f-9adcc541c4de">957,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEzLTUtMS0xLTgzMDc4_6430ae91-f3eb-48b3-8613-47298e943ef3">11,388,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the "Other government" category to the "Medicare and Medicare Advantage" category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the year ended December&#160;31, 2019 has also been recast to conform to the current period presentation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other non-patient revenue from the Company's U.S. ancillary services and international operations.</span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's non-patient service revenues from Medicare and Medicare Advantage, Medicaid and Managed Medicaid, and commercial sources represent risk-based revenues earned by the Company's U.S. integrated care and disease management business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 1, there are significant risks associated with estimating revenue, many of which take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues including determining applicable primary and secondary coverage, changes in patient coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period. </span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i3e9196a383dd4960be694b600e5c3d72"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i6b7c2045c16f477c9b93026d6c4bfcca_D20210101-20211231" decimals="INF" name="dva:NumberOfConcentrationRiskCustomers" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzE3MTQ_e1c411d2-3ab8-4c53-b884-3909d70dc9f1">No</ix:nonFraction> single commercial payor accounted for more than <ix:nonFraction unitRef="number" contextRef="i6b7c2045c16f477c9b93026d6c4bfcca_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzE3NzA_8e070bb6-8865-40d6-83ae-2f32d2d27ee8">10</ix:nonFraction>% of total consolidated accounts receivable or consolidated revenues at or for the years ended December&#160;31, 2021 or 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dialysis services accounts receivable and other receivables from Medicare, including Medicare Advantage plans, and Medicaid, including managed Medicaid plans, were approximately $<ix:nonFraction unitRef="usd" contextRef="i70683478a02f41b494c6217a76fe90ea_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIwNTk_a37ab95a-69c3-4abf-b6ec-2fae076e4509">1,174,123</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i1c61506ae168449c8f430ff4e7720a1b_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIwNjY_d976f6a6-9cfd-47f1-b6e9-7071d4d6d4b7">1,101,837</ix:nonFraction> as of December&#160;31, 2021 and 2020, respectively. Approximately <ix:nonFraction unitRef="number" contextRef="i28b42af03e324f849e1bb33d2bda90ab_I20211231" decimals="INF" name="dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIxMTQ_47e54537-e947-4385-a796-0c2e6a5f59c5">16</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i208729e6625e496e9dca88ea4de1c200_I20201231" decimals="INF" name="dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIxMjE_165e9986-5df5-480c-8b35-0192c9082fec">17</ix:nonFraction>% of the Company&#8217;s patient services accounts receivable balances as of December&#160;31, 2021 and 2020, respectively, were more than <ix:nonNumeric contextRef="i264dc38d90f840d89c8f00122dc94dda_D20210101-20211231" name="dva:AccountsReceivablePeriodOutstanding" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIyMzc_0ebd44df-a8f0-40ce-8577-22be43c3b6aa">six months</ix:nonNumeric> old. There were <ix:nonFraction unitRef="usd" contextRef="i28b42af03e324f849e1bb33d2bda90ab_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIyNTY_b01c8307-99fd-42ca-8df5-4208669e72ca">no</ix:nonFraction> significant balances over <ix:nonNumeric contextRef="i28b42af03e324f849e1bb33d2bda90ab_I20211231" name="us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDue" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIyODU_124a0a3e-b174-4628-a4b6-b93a56845c88">one year</ix:nonNumeric> old at December&#160;31, 2021. The Company's accounts receivable are principally due from Medicare and Medicaid programs and commercial insurance plans.</span></div></ix:continuation><div id="i916f7af890114e55a87e260476560c60_217"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90ZXh0cmVnaW9uOjkxMTkyNzFkMGQ3MjQ2ZjNhYmZiOTQyN2FiYmZmODdhXzEyMDA_68a2d825-d1b2-4de1-9614-52e99c9c9bd7" continuedAt="ie8059db0e281491f8b6c40fec53b533e" escape="true">Earnings&#160;per share</ix:nonNumeric></span></div><ix:continuation id="ie8059db0e281491f8b6c40fec53b533e"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90ZXh0cmVnaW9uOjkxMTkyNzFkMGQ3MjQ2ZjNhYmZiOTQyN2FiYmZmODdhXzEyMDI_5de5da57-a668-4249-a8b9-af92c678f058" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either their explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90ZXh0cmVnaW9uOjkxMTkyNzFkMGQ3MjQ2ZjNhYmZiOTQyN2FiYmZmODdhXzEyMTA_fc999459-bdf7-4d3f-84d0-2e44cad4c180" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzMtMS0xLTEtODMwNzg_6c5b67f2-43ae-4f19-8091-c5fcf88b10df">978,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzMtMy0xLTEtODMwNzg_776b7d19-f2d0-4068-8a5d-f994d4c2453f">783,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzMtNS0xLTEtODMwNzg_cc77980e-b331-4892-981b-eb5b5669f38f">706,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzQtMS0xLTEtODMwNzg_37365ad7-c463-437a-8506-9ad9b3165a74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzQtMy0xLTEtODMwNzg_ce335e8d-3555-4734-ac83-df9d973e7bd9">9,653</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzQtNS0xLTEtODMwNzg_0ceb222f-4961-4fca-9efb-b5281f6c5500">104,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzUtMS0xLTEtODMwNzg_f8547aec-4d56-4864-a562-cd9313e7f4d0">978,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzUtMy0xLTEtODMwNzg_9be0b152-8b6d-4e36-98fc-c0bd9b51fb86">773,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzUtNS0xLTEtODMwNzg_f49f9da5-4442-49be-9b85-64628606b70c">810,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzgtMS0xLTEtODMwNzg_da46e7b9-67c9-45ba-909f-8dc542604d4e">105,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzgtMy0xLTEtODMwNzg_9f54559f-ce76-4087-aa1b-e4fa298fa6ca">119,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzgtNS0xLTEtODMwNzg_11637462-9f9e-49b6-89f4-a7f22fb600b6">153,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzEyLTEtMS0xLTgzMDc4_b5f0a24d-ab62-4670-acc0-226778591eb9">4,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzEyLTMtMS0xLTgzMDc4_4538c37e-4e9c-4e33-8e8a-698f9ab691fc">2,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzEyLTUtMS0xLTgzMDc4_378c07ac-2884-4760-a8fd-3b3abaf48eb6">631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzEzLTEtMS0xLTgzMDc4_45bd7aad-35b7-4885-9f80-9f58b4a04a45">109,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzEzLTMtMS0xLTgzMDc4_a54b6d65-eb52-423e-b740-b62bd4ab1bb1">122,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzEzLTUtMS0xLTgzMDc4_da8235c0-19c4-434a-a386-4537792a10aa">153,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE2LTEtMS0xLTgzMDc4_8686b3a8-f052-4d93-aa5c-016a630197af">9.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE2LTMtMS0xLTgzMDc4_2546d20a-62fb-499f-91af-b3a61b094a55">6.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE2LTUtMS0xLTgzMDc4_9aedb01d-5093-462c-aa63-74bfb988fdde">4.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE3LTEtMS0xLTgzMDc4_e06ee9e5-630c-4f38-99eb-89e1e5cfb6b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE3LTMtMS0xLTgzMDc4_6b79ceba-f6ee-4133-b364-26a3847dc8e7">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE3LTUtMS0xLTgzMDc4_20cfb5e9-36d9-4345-abaf-821aa58bb968">0.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE4LTEtMS0xLTgzMDc4_afb1ef5f-e727-4437-b2ed-a15eb7e1349b">9.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE4LTMtMS0xLTgzMDc4_fe6c9913-0810-437d-aa99-f8101bb93d65">6.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE4LTUtMS0xLTgzMDc4_f3a082a4-4806-4739-a19f-d4fee201d649">5.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIxLTEtMS0xLTgzMDc4_8a5bc7ff-59ee-485c-b5e6-6f05ae22de78">8.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIxLTMtMS0xLTgzMDc4_d3f9e8f3-f24f-4d5e-a3fa-8ee5192d9a3a">6.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIxLTUtMS0xLTgzMDc4_96fa8cf1-7ffa-4e53-a02f-7a6d2fa54864">4.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIyLTEtMS0xLTgzMDc4_9732f2f2-d878-4e7f-96a1-22d34b6d5039">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIyLTMtMS0xLTgzMDc4_e397fd28-ee86-4c33-b12d-18974ceea56b">0.08</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIyLTUtMS0xLTgzMDc4_cb166b46-68ce-46d8-be92-d12ee72f11f4">0.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIzLTEtMS0xLTgzMDc4_1161471c-a5a4-43e8-acd6-50eb7ad271f3">8.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIzLTMtMS0xLTgzMDc4_bda76ea7-d68c-4425-b2c9-9111289cf4c6">6.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIzLTUtMS0xLTgzMDc4_3ac5453d-f042-4556-b344-6f4b7e97e3ff">5.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzI1LTEtMS0xLTgzMDc4_e4b6d9b4-ff3a-4285-a108-27fd15dd993c">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzI1LTMtMS0xLTgzMDc4_25f01be2-5c0a-4279-b6f4-781b3af83bca">2,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzI1LTUtMS0xLTgzMDc4_8387e811-1b5e-4922-b300-b8d455fd6d12">5,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div></ix:nonNumeric></ix:continuation><div id="i916f7af890114e55a87e260476560c60_220"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjAvZnJhZzo5N2U5MTBlYjYxNjc0OGI1OGVkYWZmZGZiODk1NDM4Yi90ZXh0cmVnaW9uOjk3ZTkxMGViNjE2NzQ4YjU4ZWRhZmZkZmI4OTU0MzhiXzcwOA_b49d4ced-5704-4bfb-8203-8a4f74b2b077" continuedAt="ia57e51a25da04510b9a4318a87190bd4" escape="true">Restricted cash and equivalents</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia57e51a25da04510b9a4318a87190bd4">The Company had restricted cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjAvZnJhZzo5N2U5MTBlYjYxNjc0OGI1OGVkYWZmZGZiODk1NDM4Yi90ZXh0cmVnaW9uOjk3ZTkxMGViNjE2NzQ4YjU4ZWRhZmZkZmI4OTU0MzhiXzk3_ad3877c4-8747-4473-b5a1-9e102061a67c">93,060</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjAvZnJhZzo5N2U5MTBlYjYxNjc0OGI1OGVkYWZmZGZiODk1NDM4Yi90ZXh0cmVnaW9uOjk3ZTkxMGViNjE2NzQ4YjU4ZWRhZmZkZmI4OTU0MzhiXzEwNA_27b198df-b030-455f-b36c-bccd0f7f55c2">176,832</ix:nonFraction> at December&#160;31, 2021 and 2020, respectively. The decrease in restricted cash and equivalents was primarily driven by the release of escrow funds in the third quarter of 2021 related to a resolved legal settlement. See Note 16 for further details. Substantially all of the restricted cash and equivalents balance at December&#160;31, 2021 is held in trust to satisfy insurer and state regulatory requirements related to the wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company and the remaining restricted cash and cash equivalents held at December&#160;31, 2021 represents cash pledged to third parties in connection with <ix:nonFraction unitRef="number" contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231" decimals="INF" name="dva:NumberOfPartnerships" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjAvZnJhZzo5N2U5MTBlYjYxNjc0OGI1OGVkYWZmZGZiODk1NDM4Yi90ZXh0cmVnaW9uOjk3ZTkxMGViNjE2NzQ4YjU4ZWRhZmZkZmI4OTU0MzhiXzQ5NDc4MDIzMjYzODY_53800914-af08-4ffa-8aea-1d35022c79b8">one</ix:nonFraction> of the Company's ancillary businesses.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_223"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzEyODA_be21d0ff-613c-40a8-94cf-527d52d6e45d" continuedAt="i323e6bedf23c4a8daf35d936aa6804e6" escape="true">Short-term and long-term investments</ix:nonNumeric></span></div><ix:continuation id="i323e6bedf23c4a8daf35d936aa6804e6" continuedAt="i21db2c8035ac4a9fbee22917ac310eb9"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzEyNzY_0f18ac1b-616c-470b-b0fb-785f98f0690f" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:42.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic186c5f3dfeb4441b6f677670d000585_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzItMS0xLTEtODMwNzg_5ecc8552-107b-4301-8f69-6c2d6f3c947d">23,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic186c5f3dfeb4441b6f677670d000585_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzItMy0xLTEtODMwNzg_a07bf996-5202-41a3-8ecb-4f34e7e7f0c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic186c5f3dfeb4441b6f677670d000585_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzItNS0xLTEtODMwNzg_16721476-3430-491f-bce3-4e1eb365b497">23,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19bdab5e4fc54c39bb5f779d936b5427_I20201231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzItNy0xLTEtODMwNzg_acf340b9-edb3-45b0-a93d-be802574b309">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19bdab5e4fc54c39bb5f779d936b5427_I20201231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzItOS0xLTEtODMwNzg_a3187040-2707-466e-a1d6-7bef47d2da8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19bdab5e4fc54c39bb5f779d936b5427_I20201231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzItMTEtMS0xLTgzMDc4_7b3bfaf1-1be3-4fe6-88d9-e7bc26ade686">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in mutual funds and common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ccecfd286b84522bff1dcdb23b998d1_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzMtMS0xLTEtODMwNzg_fbf83565-a391-473a-9014-ef3420a7962d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ccecfd286b84522bff1dcdb23b998d1_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzMtMy0xLTEtODMwNzg_f4b0f744-8f42-4d26-993b-aba5c2357479">48,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ccecfd286b84522bff1dcdb23b998d1_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzMtNS0xLTEtODMwNzg_044570ec-2281-4371-bf3e-fe14a4cab69f">48,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47b17801eff8471da78a0721b8cde413_I20201231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzMtNy0xLTEtODMwNzg_aa78cce4-a3a0-4a9f-97aa-40318b5ed54b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47b17801eff8471da78a0721b8cde413_I20201231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzMtOS0xLTEtODMwNzg_f7065ae7-e18e-4aea-961a-d06ca446d2e3">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47b17801eff8471da78a0721b8cde413_I20201231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzMtMTEtMS0xLTgzMDc4_0359740f-7b94-464b-8061-44eeaa792758">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzQtMS0xLTEtODMwNzg_f977baf6-0cbc-4f15-b4cd-58b4653f7eaa">23,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzQtMy0xLTEtODMwNzg_3f6bcc09-63c9-4efd-8d8d-9e4bbe6eeb20">48,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzQtNS0xLTEtODMwNzg_8bef12a9-b5f3-4fa3-90fd-96c8d1959d04">71,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzQtNy0xLTEtODMwNzg_b324755a-c2f6-42b3-9ae8-11702e22d72e">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzQtOS0xLTEtODMwNzg_0a5f6f6b-d6b4-423d-9464-fbd189dd6f01">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzQtMTEtMS0xLTgzMDc4_8c5a4d34-52b0-484a-8f9b-57a879190dd6">52,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzUtMS0xLTEtODMwNzg_b1c9842b-2ad3-4f60-b80b-e5b7ed5b3ad7">8,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0e8651392b14a558028cc674241e13e_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzUtMy0xLTEtODMwNzg_676ec225-4ab9-4008-b9b4-16e45ebc99bf">14,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzUtNS0xLTEtODMwNzg_1e3cfc7e-c142-4b5f-8fc6-7b5ec54e8fc3">22,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzUtNy0xLTEtODMwNzg_d8fbc891-969f-4e73-bb4c-ace9aa163e16">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b12e4ffb329474094355b4068bcdcd8_I20201231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzUtOS0xLTEtODMwNzg_75510fdc-1e40-4ea6-a45b-591a98e21b3c">11,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzUtMTEtMS0xLTgzMDc4_e51de6a0-5b85-4e9c-b0fe-05c1fd7a60d7">20,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzYtMS0xLTEtODMwNzg_521cb1af-d94e-4437-9cb1-301e8f3b8987">14,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f69079b45d4915928d89956cfa6568_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzYtMy0xLTEtODMwNzg_a668d6f1-8136-4d14-b0fe-3f1988258a15">34,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzYtNS0xLTEtODMwNzg_ece01095-320f-4549-a11e-a7168450a9fb">49,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzYtNy0xLTEtODMwNzg_c9a630f5-c6c5-4284-8b2a-fd37503061b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c28d59a6d30456dbaefa29fc86e6c27_I20201231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzYtOS0xLTEtODMwNzg_b7493f38-913e-4785-a09d-cc2de5ca264a">32,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzYtMTEtMS0xLTgzMDc4_3fb9db6a-7b4f-4e95-ba42-3689c6678c72">32,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzctMS0xLTEtODMwNzg_bdd25f25-c7bd-486a-b64a-8aaec09ecc64">23,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzctMy0xLTEtODMwNzg_17fee8f9-f94c-4db2-97d9-ea3e9a7b7455">48,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzctNS0xLTEtODMwNzg_d017d6d1-b9ba-432a-b6e0-1c38d1501e0e">71,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzctNy0xLTEtODMwNzg_74e525f8-85f1-4d55-af4e-3a3084f8f397">8,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzctOS0xLTEtODMwNzg_cb0973cb-7e54-4d66-8594-24c253dc0ad0">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzctMTEtMS0xLTgzMDc4_ff7fa1fb-808a-4a38-9622-7e8f06023d78">52,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzEyNzk_cbb09c9d-95d6-4dc5-bac9-87c25958710e" continuedAt="i61610e9c143343d5a68617b5f5b0e1ed" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. The Company's long-term debt investments are bank time deposits with contractual maturities longer than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at December&#160;31, 2021 and 2020.</span></ix:nonNumeric></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i21db2c8035ac4a9fbee22917ac310eb9" continuedAt="i80978f7d5cd4466ea3de9610414c9ccf"><ix:continuation id="i61610e9c143343d5a68617b5f5b0e1ed" continuedAt="i9d3d4edcf2e14c21a21f77ca2ac73064">Equity securities:</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i80978f7d5cd4466ea3de9610414c9ccf"><ix:continuation id="i9d3d4edcf2e14c21a21f77ca2ac73064"> During the year ended December&#160;31, 2021 certain of the Company&#8217;s equity investments previously accounted for under the adjusted cost method now have readily determinable fair values from public markets. As a result, these investments were reclassified from equity method and other investments to short-term investments during that period. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#8217;s non-qualified deferred compensation plans.</ix:continuation> During 2021, the Company recognized pre-tax net losses of $<ix:nonFraction unitRef="usd" contextRef="i08588920534148a6a55bbac6aa980054_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzI1Mjg4NzY3NDQ0MTY5_61197a3f-90d0-43e6-abf1-2570eb730ecf">3,768</ix:nonFraction> in other income associated with changes in the fair value of these equity securities, comprised of pre-tax realized gains of $<ix:nonFraction unitRef="usd" contextRef="i08588920534148a6a55bbac6aa980054_D20210101-20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNiRealizedGain" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzI1Mjg4NzY3NDQ0MTg2_e2da99de-9a2e-4b85-8472-be073d16655c">1,762</ix:nonFraction> and a net increase in unrealized losses of $<ix:nonFraction unitRef="usd" contextRef="i08588920534148a6a55bbac6aa980054_D20210101-20211231" decimals="-3" name="dva:NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzI1Mjg4NzY3NDQ0MTkx_a7355755-9505-498d-8e68-7d06b8ecb188">5,530</ix:nonFraction>. During 2020, the Company recognized pre-tax net gains of $<ix:nonFraction unitRef="usd" contextRef="ie5f7e68c3398415a8874d0a8dd8fc0c4_D20200101-20201231" decimals="-3" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzEwOTg_d330f741-9ee9-4c4f-86ac-c89dec04ab8d">3,818</ix:nonFraction> in other income associated with changes in the fair value of these equity securities, comprised of pre-tax realized gains of $<ix:nonFraction unitRef="usd" contextRef="ie5f7e68c3398415a8874d0a8dd8fc0c4_D20200101-20201231" decimals="-3" name="us-gaap:EquitySecuritiesFvNiRealizedGain" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzEyMjY_a055fd73-9480-4a5f-a119-2abf3e0933cf">1,941</ix:nonFraction> and a net increase in unrealized gains of $<ix:nonFraction unitRef="usd" contextRef="ie5f7e68c3398415a8874d0a8dd8fc0c4_D20200101-20201231" decimals="-3" name="dva:NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzEyNzE_c49e37b2-1d12-4e3b-a6ad-cd93063001a3">1,877</ix:nonFraction>.</ix:continuation> </span></div><div id="i916f7af890114e55a87e260476560c60_226"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90ZXh0cmVnaW9uOjBmMzJjMjJiN2E2NDQ3YjY4Mzg3MThkNjdiMzllZDA3Xzg1_fe4b316a-c286-4303-85a6-42a5b9aac7ab" continuedAt="i8be61d61726143a18201299cefa43afb" escape="true">Other receivables</ix:nonNumeric></span></div><ix:continuation id="i8be61d61726143a18201299cefa43afb"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:ScheduleOfOtherReceivablesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90ZXh0cmVnaW9uOjBmMzJjMjJiN2E2NDQ3YjY4Mzg3MThkNjdiMzllZDA3Xzgy_06fed023-b56e-43ae-b5ae-f00faba97aca" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables were comprised of the following:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.935%"><tr><td style="width:1.0%"></td><td style="width:56.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier rebates and non-trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56bb88494d0e4f3eaa70062661dfec9c_I20211231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90YWJsZToxNDlhOWUwYzJlNjI0ODBjOWZjMGNkNGU0ZTlhM2JlMy90YWJsZXJhbmdlOjE0OWE5ZTBjMmU2MjQ4MGM5ZmMwY2Q0ZTRlOWEzYmUzXzItMS0xLTEtODMwNzg_5df9c625-38af-4ad5-ab12-d73ab453abb6">294,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca143f3c4b747dfa1c18ed1ce48c40f_I20201231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90YWJsZToxNDlhOWUwYzJlNjI0ODBjOWZjMGNkNGU0ZTlhM2JlMy90YWJsZXJhbmdlOjE0OWE5ZTBjMmU2MjQ4MGM5ZmMwY2Q0ZTRlOWEzYmUzXzItMy0xLTEtODMwNzg_b4f8f75a-bfb0-47c6-a112-d12cbba96e86">390,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare bad debt claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0991372c81b2467aa534d7228b96ce3c_I20211231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90YWJsZToxNDlhOWUwYzJlNjI0ODBjOWZjMGNkNGU0ZTlhM2JlMy90YWJsZXJhbmdlOjE0OWE5ZTBjMmU2MjQ4MGM5ZmMwY2Q0ZTRlOWEzYmUzXzMtMS0xLTEtODMwNzg_1f9794b2-35e8-4f3c-ab20-a3879ffa41bc">132,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib12ac6055b314dc9aafc2ab60037e0dd_I20201231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90YWJsZToxNDlhOWUwYzJlNjI0ODBjOWZjMGNkNGU0ZTlhM2JlMy90YWJsZXJhbmdlOjE0OWE5ZTBjMmU2MjQ4MGM5ZmMwY2Q0ZTRlOWEzYmUzXzMtMy0xLTEtODMwNzg_66c020e9-c880-469f-aecd-d1f5b02eaf33">153,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90YWJsZToxNDlhOWUwYzJlNjI0ODBjOWZjMGNkNGU0ZTlhM2JlMy90YWJsZXJhbmdlOjE0OWE5ZTBjMmU2MjQ4MGM5ZmMwY2Q0ZTRlOWEzYmUzXzQtMS0xLTEtODMwNzg_33384a16-7e2d-476c-847b-fbff0aee24ff">427,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90YWJsZToxNDlhOWUwYzJlNjI0ODBjOWZjMGNkNGU0ZTlhM2JlMy90YWJsZXJhbmdlOjE0OWE5ZTBjMmU2MjQ4MGM5ZmMwY2Q0ZTRlOWEzYmUzXzQtMy0xLTEtODMwNzg_e150bc64-d81d-4613-8e0d-d51d183f59a4">544,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i916f7af890114e55a87e260476560c60_229"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4Xzg3Nw_f51ed389-0189-4c81-9f17-8b88791d7727" continuedAt="if668983c66284491a59f8c1692f50049" escape="true">Property and equipment</ix:nonNumeric></span></div><ix:continuation id="if668983c66284491a59f8c1692f50049" continuedAt="i29114f3224864e879e1498597e73fea2"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4Xzg4NQ_591b9abc-c330-4cd9-9e03-d134537c9eb4" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment were comprised of the following:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:66.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.467%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzItMS0xLTEtODMwNzg_9a16b0aa-e02b-4bbb-96af-47454683219e">34,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzItMy0xLTEtODMwNzg_08af5f7f-4c3e-49fc-9829-78ef3e7016c4">37,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzMtMS0xLTEtODMwNzg_65d1d617-be6b-45e8-96d1-3b3f44164278">496,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzMtMy0xLTEtODMwNzg_d351993a-8c2b-4c48-8a72-edd31378ec93">400,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzQtMS0xLTEtODMwNzg_80dcf2c0-eb4b-4907-bb82-926fd8a41944">3,828,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzQtMy0xLTEtODMwNzg_56b0b544-dd45-44e7-97e6-ee3553497fde">3,865,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equipment and information systems, including internally developed software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzUtMS0xLTEtODMwNzg_e28732c1-1045-4e24-ac3d-081b47a44498">3,292,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzUtMy0xLTEtODMwNzg_fe2236a9-0101-41b8-920e-0365ae346a98">3,081,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New center and capital asset projects in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzYtMS0xLTEtODMwNzg_b36adfe1-f63d-41df-a807-9f0089b05e9e">592,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzYtMy0xLTEtODMwNzg_977bb729-4e44-4108-acb2-2c96321f8673">616,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzctMS0xLTEtODMwNzg_147a4baa-c7a2-4892-8bad-825370cf7f53">8,243,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzctMy0xLTEtODMwNzg_5f9b9f4e-d1f1-480b-a145-1d92c20a48a4">8,002,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzgtMS0xLTEtODMwNzg_8949a24a-63e5-452f-902d-870506ccca8d">4,763,135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzgtMy0xLTEtODMwNzg_010e294b-6743-4d94-a468-f5608549a7b2">4,480,429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzktMS0xLTEtODMwNzg_517caaf9-68c7-47e8-a15c-52319596317a">3,479,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzktMy0xLTEtODMwNzg_2048ffd5-7ad5-4ad7-b34d-363afa210493">3,521,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses are computed using the straight-line method over the useful lives of the assets estimated as follows: buildings, <ix:nonNumeric contextRef="i05ba62c8cdc74b429954ac9b69ac970f_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzI0Mg_11ab6f33-9d3c-4d06-8ff6-5658b311011a">25</ix:nonNumeric> years to <ix:nonNumeric contextRef="i837096e088984a8bb905c6961208d97e_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzI0OA_f4aa42a4-8273-4a72-bacd-46153cca3e3a">40</ix:nonNumeric> years; leasehold improvements, the shorter of <ix:nonNumeric contextRef="ib3346ac383fd4263ba845f553e8518d0_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzI5MQ_d998908e-a787-41d8-b49e-aceabc3e938d">ten years</ix:nonNumeric> or the expected lease term; and equipment and information systems, including internally developed software, principally <ix:nonNumeric contextRef="i6ef4a9f5101d466cb9f802a38be35ea5_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzM3Mw_3c769d2c-6e50-489e-984d-d2e9992eed27">three years</ix:nonNumeric> to <ix:nonNumeric contextRef="ib2aaedfe7b774b2182eb25476a91fc19_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzM3OQ_804a7173-5367-4629-8206-2392c750dd7d">15</ix:nonNumeric> years. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i29114f3224864e879e1498597e73fea2"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense on property and equipment was $<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzQzNA_a854c019-0946-4760-b8ff-dafe85f84f65">667,755</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzQzOA_b41dddc1-4bd6-4bb6-87c2-e6887f6c2701">616,626</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzQ0Ng_8d78e423-37de-4460-b280-95f80841d007">600,905</ix:nonFraction> for 2021, 2020 and 2019, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on debt incurred during the development of new centers and other capital asset projects is capitalized as a component of the asset cost based on the respective in-process capital asset balances. Interest capitalized was $<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzcxMQ_ea9dd7bb-2f95-406f-954c-4216aa107b49">15,275</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzcxNQ_25b1daf0-e704-487f-90f0-e1b37d413820">17,944</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzcyMg_7d4fff3f-a84e-4036-a815-fd1828de91d0">27,322</ix:nonFraction> for 2021, 2020 and 2019, respectively.</span></div></ix:continuation><div id="i916f7af890114e55a87e260476560c60_232"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzYxNA_fa765025-8132-4c41-bd0d-98a38193a572" continuedAt="i1fef4ff4baf34b47930c2b90e55dad7b" escape="true">Intangible assets</ix:nonNumeric></span></div><ix:continuation id="i1fef4ff4baf34b47930c2b90e55dad7b" continuedAt="i5806ed1f8b4b4fc9a7711a2921e8aa19"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzYwOQ_08a97698-b4ea-4ff6-8fba-4bdbdfde42b7" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets other than goodwill were comprised of the following:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.959%"><tr><td style="width:1.0%"></td><td style="width:54.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived licenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzItMS0xLTEtODMwNzg_fbbcfe3d-c48c-4e6c-ad07-1ed7dc1c808f">104,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzItMy0xLTEtODMwNzg_f6f3da36-6cd6-4c1a-ab85-09474672d4a3">100,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompetition agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:FiniteLivedNoncompeteAgreementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzMtMS0xLTEtODMwNzg_6cacfcd4-5a1b-4a63-b207-96cb223b00b3">70,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:FiniteLivedNoncompeteAgreementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzMtMy0xLTEtODMwNzg_c9353310-2067-4d40-9a92-4fffcd6afa91">84,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:OtherIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzQtMS0xLTEtODMwNzg_786fad2b-bd56-4d97-9a86-035a672f4262">63,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:OtherIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzQtMy0xLTEtODMwNzg_7db9e95a-adcf-4902-a555-ad3001cc1e2d">52,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzUtMS0xLTEtODMwNzg_201dc530-2393-49cf-86fb-95a7c296665d">238,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzUtMy0xLTEtODMwNzg_42f68b31-dfa7-455d-b3bd-cc5d72e472ec">236,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzYtMS0xLTEtODMwNzg_f4fcbba6-b7f8-4d02-b92a-8eb7a93ca2c5">60,730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzYtMy0xLTEtODMwNzg_5eb78fd8-72da-4f08-a66c-c984e04b49cb">70,141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzctMS0xLTEtODMwNzg_75348b1a-3550-43ed-a9b1-767592cd9ce7">177,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzctMy0xLTEtODMwNzg_e7c8ac22-eb33-4dcd-b905-1872feee0fe2">166,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncompetition agreements are generally amortized over <ix:nonNumeric contextRef="i7602e286b8e94ab9a142a5146dae00c4_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzE1NQ_e5044173-f71c-42ca-b870-75191f63f148">three years</ix:nonNumeric> to <ix:nonNumeric contextRef="i2f73dfca446c431ca0404970955b23db_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzE2MQ_5bb4940e-a559-4408-9356-044bb1124abf">10</ix:nonNumeric> years and customer relationships are principally amortized over <ix:nonNumeric contextRef="idd2fb3df258c442a8587eff3039100b2_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzIyMg_1c985d95-0aba-417d-a27e-58d371cc6fbd">10</ix:nonNumeric> years to <ix:nonNumeric contextRef="i4a4806c6b06944568dbe93e7f5881e70_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzIyOA_effaa91e-bd3c-4133-935d-3995f6d00b20">20</ix:nonNumeric> years. The weighted average renewal or extension period of customer relationships was <ix:nonNumeric contextRef="i5ff02df8087d45659dea2988089fd145_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzE2NDkyNjc0NDE3NTQ1_a7bba85a-fa0c-49bb-9d4c-43d054ad284a">three years</ix:nonNumeric> and <ix:nonNumeric contextRef="id31eb9b4ab454ab0bd1eb2e6df77f27c_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzE2NDkyNjc0NDE3NTUz_d1832e64-9eda-4688-a2f9-35574de907d2">five years</ix:nonNumeric> as of December&#160;31, 2021 and 2020, respectively. Amortization expense from amortizable intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzQ5NDc4MDIzMjU5NzE_a8e1b07a-4346-4648-8d07-03c8d3280c3e">12,860</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzI5Ng_2b923892-60e6-49e8-9ce4-0933c19c10a9">13,809</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzMwNA_f6c84cfe-870b-48c6-a31e-4a57522ae514">14,247</ix:nonFraction> for 2021, 2020 and 2019, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized <ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzM5OA_7edb6c6d-c7f7-4009-b007-6b2eed066081">no</ix:nonFraction> impairment charges on any intangible assets other than the goodwill impairment charges discussed in Note 10.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzYxMw_1136d2b1-3214-4b28-8eb8-7514813396b0" continuedAt="id77f48f76f2c4858a063cd569e0e3593" escape="true">Scheduled amortization expenses from amortizable intangible assets as of December&#160;31, 2021 were as follows:&#160;</ix:nonNumeric></span></div></ix:continuation><div style="margin-top:6pt;padding-left:27pt"><ix:continuation id="i5806ed1f8b4b4fc9a7711a2921e8aa19"><ix:continuation id="id77f48f76f2c4858a063cd569e0e3593"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.286%"><tr><td style="width:1.0%"></td><td style="width:37.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.029%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.032%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncompetition<br/>agreements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Customer relationships and other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzEtMS0xLTEtODMwNzg_ed87e7b3-195b-4de9-825c-8992f2d630fe">7,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzEtMy0xLTEtODMwNzg_a27f0c0f-b281-4e8c-9361-42d20f801670">4,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzItMS0xLTEtODMwNzg_98af1ac3-d7a7-465b-b66a-217617ded507">4,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzItMy0xLTEtODMwNzg_80bd125b-b9b6-423c-91c4-3ca73344c968">4,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzMtMS0xLTEtODMwNzg_310ac245-4548-45e7-a3d9-1f6c3e450d1d">2,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzMtMy0xLTEtODMwNzg_4600047b-c6cd-40ce-9c90-75c309dff38a">4,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzQtMS0xLTEtODMwNzg_18d7722d-f12e-4f0f-8d70-a59aa369a1c7">1,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzQtMy0xLTEtODMwNzg_04f0ac07-0d37-45ee-971c-3ddc9097feb9">4,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzUtMS0xLTEtODMwNzg_d44e99f3-86cd-42f2-8346-b5ba6c7ba0cd">888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzUtMy0xLTEtODMwNzg_cef0991a-0700-484d-8379-ec8d896f7a38">4,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzYtMS0xLTEtODMwNzg_7ff23a7f-ebd0-4c45-8b27-76b69c5663b5">1,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzYtMy0xLTEtODMwNzg_26c13b5f-592c-4e1c-b386-57208f243607">33,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzctMS0xLTEtODMwNzg_ed7f5c5c-066e-4f18-a086-64278c1425d4">17,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzctMy0xLTEtODMwNzg_d4171432-51c1-4fee-b163-8dc218e41e56">55,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:27pt"><span><br/></span></div><div id="i916f7af890114e55a87e260476560c60_238"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzIxNDg_46f2fee5-a62d-4de0-a382-9b15da2c33ab" continuedAt="id01723160ca446688b1280258295ef9b" escape="true">Equity method and other investments</ix:nonNumeric></span></div><ix:continuation id="id01723160ca446688b1280258295ef9b" continuedAt="ibfda80c94ff14b8997f119b13148e792"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzIxNDM_cb629059-1ac5-4c2f-8aa1-47792fd6d22c" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains equity method and other minor investments in the private securities of certain other healthcare and healthcare-related businesses, comprised as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.883%"><tr><td style="width:1.0%"></td><td style="width:56.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.611%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">APAC joint venture</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9573fac1bfc4444783c0b158169c7afc_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzItMS0xLTEtODMwNzg_9e1ba7bd-413f-4316-b4af-98d89a87b457">109,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc608d996b8446e4980e0cc9b39bf059_I20201231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzItMy0xLTEtODMwNzg_97e04b62-b5bb-4717-bf8b-9a155acf1d6e">120,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other equity method partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d64f38aa44e457487bb0f100b1f8548_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzMtMS0xLTEtODMwNzg_e27db864-f422-4b05-830e-dceec521f422">115,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie883ccd9687a49048607db5fe42301ac_I20201231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzMtMy0xLTEtODMwNzg_2a28faf4-aa2e-442d-b70d-fd2077cf6c45">107,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted cost method and other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46dab217b75644dabc035f91f7fe782d_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzQtMS0xLTEtODMwNzg_bfa1d662-aa74-474b-a04d-365a6da61015">14,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9be08d57aed4fe3b4db3144e1d9ad04_I20201231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzQtMy0xLTEtODMwNzg_75f2a736-73a4-4943-abe8-7d357949661b">29,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzUtMS0xLTEtODMwNzg_f3032501-0e73-4d2c-b93d-44f5c6bcc59f">238,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzUtMy0xLTEtODMwNzg_e4e11168-e05b-4928-85c1-40c44a96e72d">257,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, 2020 and 2019, the Company recognized equity investment income of $<ix:nonFraction unitRef="usd" contextRef="ib628323096c74e788c6d7a961b4d57af_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzMwMg_8601c228-bdc0-432a-add5-decf5ef1147e">26,937</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i4d9240c1eab54582a445c05ab20d0f19_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzMwNg_57140add-a726-4e6b-94e1-cb05b28a8497">26,916</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="id2265c5d8f9c40e9b91c40988cbafd40_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzMxMw_fecd59c9-1ba9-48a3-8bb9-767b8aac9f2a">12,679</ix:nonFraction>, respectively, from its equity method investments in nonconsolidated businesses.&#160;</span></div><div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's largest equity method investment is its ownership interest in DaVita Care Pte. Ltd. (the APAC joint venture, or APAC JV). The Company holds a <ix:nonFraction unitRef="number" contextRef="i586e32d477c142e5b161872b638df89f_I20211231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzU1NA_ce48f927-651d-4af2-837b-9b4de31c41c7">75</ix:nonFraction>%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">voting and economic interest in the APAC JV and an unrelated noncontrolling investor holds the other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i9573fac1bfc4444783c0b158169c7afc_I20211231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzY1OA_a1a1dd3d-594a-441a-8e3a-81a96513d319">25</ix:nonFraction>% voting and economic interest in the joint venture, however the Company does not control or consolidate the APAC JV as a result of substantive participating rights retained by the unrelated investor over </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ibfda80c94ff14b8997f119b13148e792"><div style="margin-top:9pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain key operating decisions for the joint venture.</span></div><div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's other equity method investments include <ix:nonFraction unitRef="number" contextRef="i4e74dde23e17402298e90d199d2fe1a4_I20211231" decimals="INF" name="dva:NumberOfPartnerships" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzE2Njc_6c0b6086-96d1-4d72-a65d-b52c03dbbd9f">23</ix:nonFraction> legal entities over which the Company has significant influence but in which it does not maintain a controlling financial interest. Almost all of these are U.S. dialysis partnerships in the form of limited liability companies. The Company's ownership interests in these partnerships vary, and are often subject to blocking rights on certain key operating decisions held by outside investors, but mostly range from <ix:nonFraction unitRef="number" contextRef="i84431a6770414fe28573bbddc636eae2_I20211231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzE5ODQ_8d915f15-a02d-4cf5-9233-a4aa0bc31f73">30</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i2538a02f3c984fcab3ed760d226d516f_I20211231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzE5OTA_bcfe8e2d-e053-409e-9f7f-f8e54efdb8a3">65</ix:nonFraction>%.</span></div><div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzIwMDU_933b900e-bb35-4303-b95b-d59636cb2e2f">no</ix:nonFraction> significant impairments or other valuation adjustments on the Company's adjusted cost method and other investments during 2021, 2020 or 2019.</span></div></ix:continuation><div id="i916f7af890114e55a87e260476560c60_244"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:GoodwillDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzUyMjg_95cb7664-dfb2-4068-ae67-522841c53853" continuedAt="ifa4158e095e8425ab3e7bb97d510a6ce" escape="true">Goodwill</ix:nonNumeric></span></div><ix:continuation id="ifa4158e095e8425ab3e7bb97d510a6ce" continuedAt="i53989fc2bd0a4f10b0678e49a527bd36"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzUyMzM_e955b353-580b-48b5-b5f4-80946907fd65" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying value of goodwill by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:40.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.985%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.985%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary<br/>services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4090bf4484176976adbed8bae6da2_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEtMS0xLTEtODMwNzg_7d6e94d2-de04-43b5-95c1-fd293a534df5">6,287,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee6f5fabba1c4c0b9cb21463c121a0ef_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEtMy0xLTEtODMwNzg_ed990b51-1c2e-4d07-b895-19372fe13275">500,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEtNS0xLTEtODMwNzg_ffeb4784-3bdd-4e3b-b8a7-e8741fe9b087">6,787,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzItMS0xLTEtODMwNzg_63b58654-ca1d-4b29-a283-f76fe58f1cd6">24,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzItMy0xLTEtODMwNzg_7c2d8b95-e57a-477b-9375-464984624e7a">105,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzItNS0xLTEtODMwNzg_529b9437-b738-4eeb-abab-27228e41b54b">130,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzMtMS0xLTEtMTA2ODk1_2703392e-7ba5-4c08-887c-7565b4f0a5ea">1,549</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzMtMy0xLTEtMTA2ODk1_62f91d3c-12cf-45a2-8b5b-ba7384dffff6">6,744</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzMtNS0xLTEtMTA2ODk1_a2fa6f8c-9587-430f-a8f9-e5fe44f2d134">8,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzQtMS0xLTEtODMwNzg_77d02ab7-affe-4e89-b9f0-614d4947c9cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzQtMy0xLTEtODMwNzg_bd0e7aff-cfd3-46ed-9936-87599ec8f894">9,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzQtNS0xLTEtODMwNzg_6e4eefbd-b08a-46d5-b0ea-cd93d4df233a">9,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce7de8cdc8f44f5a250fb8c150e4e1f_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzUtMS0xLTEtODMwNzg_2ad60862-bd75-440e-a9f5-953ba707e9f6">6,309,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8a66dcc0dd948fbb741fd4e292faf13_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzUtMy0xLTEtODMwNzg_734c293f-cd6e-4d04-8f92-fa4a771dedea">609,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzUtNS0xLTEtODMwNzg_791d89ed-4165-46b4-8a63-0af84e4cecca">6,919,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzYtMS0xLTEtODMwNzg_c41e1d83-70ff-45e0-b8c2-ca8bf2758307">91,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzYtMy0xLTEtODMwNzg_fe9ea5a2-5a3e-47a9-aa4c-6f75b728adba">81,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzYtNS0xLTEtODMwNzg_4ebdc9f7-91b2-4caa-bd91-5e8d27f44732">173,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzctMS0xLTEtODMwNzg_b72d4581-0491-4b21-b238-f0ad6bff463e">1,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzctMy0xLTEtODMwNzg_b2363897-f680-44cc-bd06-0217aa4c3b6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzctNS0xLTEtODMwNzg_464913f6-d62a-4d8c-a7e7-a94022fc53db">1,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzgtMS0xLTEtODMwNzg_86d073d5-d3f5-4301-b5f3-a477ae97e241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzgtMy0xLTEtODMwNzg_933a37dd-6ac9-4343-a7c0-aab24389cfda">44,367</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzgtNS0xLTEtODMwNzg_d0f1a089-70fb-455c-b003-cd585669ec67">44,367</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzktMS0xLTEtODMwNzg_8d9a7711-ec35-4f1a-9cd1-3a2dcab938d6">6,400,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzktMy0xLTEtODMwNzg_ae11aba8-5691-4ae4-8cd5-90f608476c04">646,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzktNS0xLTEtODMwNzg_4be77cde-e055-4a89-9f8f-fe74fd69f494">7,046,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEyLTEtMS0xLTgzMDc4_76dd50e1-5a5b-4b76-a4e9-6bae9f5a9098">6,400,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEyLTMtMS0xLTgzMDc4_e75c41a7-c882-47cc-808d-eed96c25d02a">772,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEyLTUtMS0xLTgzMDc4_a67a47e9-0354-4aaf-b57f-dc0149c4f3ea">7,172,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEzLTEtMS0xLTgzMDc4_0c2637d1-0219-4eda-a5cf-fa72d4c92dab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEzLTMtMS0xLTgzMDc4_cfcdabfa-641c-475e-b87b-a859cd54f925">126,207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEzLTUtMS0xLTgzMDc4_e275fecf-421d-4d23-a0a0-7e5eec6b50a6">126,207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzE0LTEtMS0xLTgzMDc4_7a54ab85-89db-4c32-9d06-9e2b940a2855">6,400,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzE0LTMtMS0xLTgzMDc4_0f4a2a72-c6f5-46f2-9f3b-0ebca567da23">646,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzE0LTUtMS0xLTgzMDc4_a46263c0-9d8b-4d45-85f6-49495616922e">7,046,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As dialysis treatments are an essential, life-sustaining service for patients who depend on them, the Company's operations have continued and are currently expected to continue throughout the novel coronavirus (COVID-19) pandemic. However, the ultimate impact of the dynamic and evolving COVID-19 pandemic on the Company will depend on future developments that are highly uncertain and difficult to predict, including among other things the severity and duration of the pandemic; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus such as the Delta and Omicron variants; COVID-19's impact for the chronic kidney disease (CKD) patient population and the Company's patient population including on the mortality of these patients; the availability, acceptance, impact and efficacy of COVID-19 vaccines, treatments, and therapies; the pandemic's continuing impact on the Company's revenue and non-acquired growth due to lower treatment volumes, the U.S. and global economies, unemployment, labor market conditions, inflation and monetary policies; the potential negative impact on the Company's commercial mix or the number of patients covered by commercial insurance plans; continued increased COVID-related costs; supply chain challenges and disruptions, including with respect to the Company's clinical supplies; the responses of the Company's competitors to the pandemic and related changes in the marketplace; the timing, scope and effectiveness of federal, state and local government responses; and any potential changes to the extensive set of federal, state and local laws, regulations and requirements that govern the Company's business. While the Company does not currently expect a material adverse impact to its business as a result of this public health crisis, there can be no assurance that the COVID-19 pandemic will not have a material adverse impact on one or more of the Company's businesses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company&#8217;s operating segments described in Note 25 to these consolidated financial statements represents an individual reporting unit for goodwill impairment assessment purposes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the U.S. dialysis operating segment, the Company considers each of its dialysis centers to constitute an individual business for which discrete financial information is available. However, since these dialysis centers have similar operating and economic characteristics, and the allocation of resources and significant investment decisions concerning these businesses are highly centralized and the benefits broadly distributed, the Company has aggregated these centers and deemed them to constitute a single reporting unit.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has applied a similar aggregation to the physician practices in its physician services reporting units, to the dialysis centers and other health operations within each international reporting unit, and to the vascular access service centers in </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i53989fc2bd0a4f10b0678e49a527bd36" continuedAt="i9746d7df69df4327ad3e304363d13793"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">its former vascular access services reporting unit. For the Company&#8217;s other operating segments, discrete business components below the operating segment level constitute individual reporting units.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing quantitative goodwill impairment assessments, the Company estimates fair value using either appraisals developed with an independent third party valuation firm which consider both discounted cash flow estimates for the subject business and observed market multiples for similar businesses, or offer prices received for the subject business that would be acceptable to the Company.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2019, the Company recognized goodwill impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i3967c55184a84f96ba8812e7748f5793_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzM1MTg0MzcyMDk3Mzg3_5b948f67-e29b-40e5-b48c-4f541e774dfe">119,476</ix:nonFraction> in its Germany kidney care business. These charges resulted primarily from a decline in then current and expected future patient census and an increase in then current and expected future costs, including due to wage increases expected to result from legislation announced at that time. The changes in the Company's expectations were informed by developments in the business in response to evolving market conditions, including changes in the Company's expected timing and ability to mitigate them, and based on in-depth operating and strategic reviews completed by the Company's new Germany management team. During the year ended December&#160;31, 2019 the Company also recognized a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i32b056464d244f37914b806833c01276_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzM1MTg0MzcyMDk3Mzkx_90017827-a74d-4df6-827c-9eaa86be9775">5,416</ix:nonFraction> in its German other health operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its most recent assessments, the Company determined that further changes in expected patient census, increases in operating costs, failure to achieve expected increases in reimbursement rates, changes in actual or expected growth rates, or other significant adverse changes in expected future cash flows or valuation assumptions could result in goodwill impairment charges in the future for the following reporting unit, which remains at risk of goodwill impairment as of December&#160;31, 2021:</span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:ScheduleOfReportingUnitsGoodwillBalancesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzUyMzI_1f0c8d61-320a-43b4-b3a7-c4750886b9f3" escape="true"><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.923%"><tr><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.474%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.660%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reporting unit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Goodwill<br/>balance</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Carrying amount<br/>coverage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sensitivities</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating<br/>income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Discount<br/>rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany kidney care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c41f79e5ca947d0a2bcc3fd59da587b_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZTowZjZhYTAxZTcwMDI0Zjk4OTZiNTA1YjMzM2RiYzIzYS90YWJsZXJhbmdlOjBmNmFhMDFlNzAwMjRmOTg5NmI1MDViMzMzZGJjMjNhXzItMi0xLTEtODMwNzg_4a8d8aff-426d-4389-b51d-818228325b6c">298,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c41f79e5ca947d0a2bcc3fd59da587b_I20211231" decimals="3" name="dva:ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZTowZjZhYTAxZTcwMDI0Zjk4OTZiNTA1YjMzM2RiYzIzYS90YWJsZXJhbmdlOjBmNmFhMDFlNzAwMjRmOTg5NmI1MDViMzMzZGJjMjNhXzItNC0xLTEtODMwNzg_fa590760-8c03-4111-ad36-b24b9207a430">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3c41f79e5ca947d0a2bcc3fd59da587b_I20211231" decimals="3" name="dva:PotentialImpactOnFairValueForReductionInOperatingIncome" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZTowZjZhYTAxZTcwMDI0Zjk4OTZiNTA1YjMzM2RiYzIzYS90YWJsZXJhbmdlOjBmNmFhMDFlNzAwMjRmOTg5NmI1MDViMzMzZGJjMjNhXzItNi0xLTEtODMwNzg_8208dba1-cf64-46d2-8e32-4f1f322a60aa">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5d14633c017d4293acaf92b67376ea7e_D20210101-20211231" decimals="3" name="dva:PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZTowZjZhYTAxZTcwMDI0Zjk4OTZiNTA1YjMzM2RiYzIzYS90YWJsZXJhbmdlOjBmNmFhMDFlNzAwMjRmOTg5NmI1MDViMzMzZGJjMjNhXzItOC0xLTEtODMwNzg_abe547a3-f794-4380-915f-147820064b40">9.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excess of estimated fair value of the reporting unit over its carrying amount as of the latest assessment date.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Potential impact on estimated fair value of a sustained, long-term reduction of <ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="dva:PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzQ0NjI_30eed767-45ad-4b16-bbea-66e5530c7bb1">3</ix:nonFraction>% in operating income as of the latest assessment date.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Potential impact on estimated fair value of an increase in discount rates of 100 basis points as of the latest assessment date.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9746d7df69df4327ad3e304363d13793">Except as described above, <ix:nonFraction unitRef="segment" contextRef="i7b36f25a93464b258c27c7f22e113088_D20210101-20211231" decimals="0" name="us-gaap:NumberOfOperatingSegments" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzQ2NzQ_d0a799fe-e43a-41a6-92c3-fbb17cda5482">no</ix:nonFraction>ne of the Company&#8217;s other reporting units were considered at risk of significant goodwill impairment as of December&#160;31, 2021.&#160;Since the dates of the Company&#8217;s last annual goodwill impairment assessments, there have been certain developments, events, changes in operating performance and other changes in key circumstances that have affected the Company&#8217;s businesses. However, these have not caused management to believe it is more likely than not that the fair values of any of the Company&#8217;s reporting units would be less than their respective carrying amounts as of December&#160;31, 2021.</ix:continuation> </span></div><div id="i916f7af890114e55a87e260476560c60_250"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90ZXh0cmVnaW9uOjY0MGZmM2Y4NDdlYTRjOGY4ZmNiMmZiYzUxNDU5ZDI0Xzgw_3db12b93-b428-4264-81f7-07ff4b66ee5e" continuedAt="i5fe3fd019e6f4028ad9c858fbb10d242" escape="true">Other liabilities</ix:nonNumeric></span></div><ix:continuation id="i5fe3fd019e6f4028ad9c858fbb10d242"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:OtherLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90ZXh0cmVnaW9uOjY0MGZmM2Y4NDdlYTRjOGY4ZmNiMmZiYzUxNDU5ZDI0Xzgz_84b52b59-e1e1-40bd-afc4-2431e50a46cf" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities were comprised of the following:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.520%"><tr><td style="width:1.0%"></td><td style="width:51.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.759%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payor refunds and retractions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="dva:PayorRefundsAndRetractions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzItMS0xLTEtODMwNzg_f331d2a8-1f29-426a-ade7-528d71e32e9f">410,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="dva:PayorRefundsAndRetractions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzItMy0xLTEtODMwNzg_f006fcbc-9a13-453e-9cdc-2098d6e5c0d6">371,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance and self-insurance accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:AccruedInsuranceCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzMtMS0xLTEtODMwNzg_3f8a9fa4-e660-4e37-8594-a26e0f15a9ad">55,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:AccruedInsuranceCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzMtMy0xLTEtODMwNzg_2a2af002-30e5-48d5-9641-8bcd2fa29e23">54,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:InterestPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzQtMS0xLTEtODMwNzg_99262dcd-c2a9-4bc2-90b3-0dd5305895e2">32,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:InterestPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzQtMy0xLTEtODMwNzg_b6f23bb1-e8cb-4c08-a224-16fac6d074b0">30,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued non-income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzUtMS0xLTEtODMwNzg_67f1fa78-b9c4-4ee8-919f-441e358dfc0c">41,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzUtMy0xLTEtODMwNzg_b6a6f0e2-51b5-410b-9c64-031fb5ea8857">39,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzYtMS0xLTEtODMwNzg_48821acc-f191-4174-a3ab-06f922b5377c">169,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzYtMy0xLTEtODMwNzg_9c8e08d5-e8cf-47b1-9a50-1e727528f7ec">315,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzctMS0xLTEtODMwNzg_7fe80e36-c9d0-4b1f-b6b9-9fab16c7ba01">709,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzctMy0xLTEtODMwNzg_79e1ade8-ece5-4121-89df-ebc2b07beb63">810,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i916f7af890114e55a87e260476560c60_253"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0NTI_a0beee6a-1755-49f5-a550-b7ab8de494da" continuedAt="i5971017c439f4e1db20ef214ec6564d7" escape="true">Income taxes</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i009c2eafad4e495d9b8fe67ac868d51d"><ix:continuation id="i5971017c439f4e1db20ef214ec6564d7" continuedAt="i21d0988e584d45de95e0636ce7f7ae54">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.</ix:continuation></ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i21d0988e584d45de95e0636ce7f7ae54" continuedAt="i4201cf5c13c4417d8e80e1604260076e"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0NDI_064b0bf7-1fc3-45ee-8af5-618a344a39ed" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes from continuing operations consisted of the following:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"></td><td style="width:37.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzItMS0xLTEtODMwNzg_15ab07ed-e7e2-4d47-89f1-fbd34070ae98">1,463,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzItMy0xLTEtODMwNzg_7d2c695d-0948-4134-95d5-ee156c8a435b">1,287,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzItNS0xLTEtODMwNzg_5875ad03-df69-456b-a7a2-3ebc8fb0b4c4">1,307,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzMtMS0xLTEtODMwNzg_eeb20512-8789-4e49-a8eb-7db7e75680ec">55,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzMtMy0xLTEtODMwNzg_c44838ee-4138-460f-9de3-7cf3a269d1ad">30,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzMtNS0xLTEtODMwNzg_d2a6eaee-a138-4f39-8a0f-4df4a4385272">111,860</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzQtMS0xLTEtODMwNzg_0a1be34b-034a-4967-9344-375727183670">1,518,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzQtMy0xLTEtODMwNzg_835537fd-d6b2-44d2-8d9b-1515f2625e7d">1,318,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzQtNS0xLTEtODMwNzg_7c3ca3ab-8fdc-4e04-92c2-1798973a6075">1,195,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0NDM_3eee3613-d14b-41cf-b6b0-394d22986aef" continuedAt="id3f944c5e38840878ec345f571bc3b68" escape="true">Income tax expense for continuing operations consisted of the following:</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:27pt"><ix:continuation id="id3f944c5e38840878ec345f571bc3b68"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"></td><td style="width:37.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzMtMS0xLTEtODMwNzg_ae67e680-6bc4-414d-9e56-25a1ffda78d9">216,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzMtMy0xLTEtODMwNzg_de2e3beb-84b7-4a48-bcf9-b5cc1aa59a25">47,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzMtNS0xLTEtODMwNzg_ecbee32f-d3bc-48be-96ad-d6588af615cb">208,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzQtMS0xLTEtODMwNzg_e9fcb0ca-2fce-4cf2-b7d5-c9ba640a7567">15,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzQtMy0xLTEtODMwNzg_3625354b-7e11-47cc-bd66-8f9541a45847">21,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzQtNS0xLTEtODMwNzg_ed2b7a00-c4d7-49c8-96b3-9ee259e09ea1">58,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzUtMS0xLTEtODMwNzg_1a3116bd-d473-4508-95de-43b1662e2465">14,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzUtMy0xLTEtODMwNzg_9c299f1d-c365-481d-a99f-029da444e4c3">17,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzUtNS0xLTEtODMwNzg_0279951a-7c42-4f7a-8e56-47f4ffde4ceb">15,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current income tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzYtMS0xLTEtODMwNzg_f2b048fe-33b8-46af-8749-9a6f2a491c39">246,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzYtMy0xLTEtODMwNzg_3218bbe3-cc60-4920-a689-794af25eb836">86,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzYtNS0xLTEtODMwNzg_aafd3f41-1c4c-49a6-9bf6-d6542ce286ea">281,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzgtMS0xLTEtODMwNzg_f37c5925-f5e6-458b-88a7-b9263ba9e098">59,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzgtMy0xLTEtODMwNzg_774dd206-2e23-4544-971a-3d2839077060">198,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzgtNS0xLTEtODMwNzg_92cd14db-cb02-4c32-8571-3aa867c38f74">44,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzktMS0xLTEtODMwNzg_df485cba-f0cf-4e17-a63b-65eb8f96a494">5,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzktMy0xLTEtODMwNzg_3be759b5-8ed7-4a31-86dd-ad64b1219cd4">27,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzktNS0xLTEtODMwNzg_d4bf3d8e-aacb-4c75-be14-06394d3454a3">25,836</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzEwLTEtMS0xLTgzMDc4_5e700173-5257-4b80-8456-69ef2f2056b3">4,525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzEwLTMtMS0xLTgzMDc4_3286ae5a-90ef-4931-87e4-a452ae2c7dd4">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzEwLTUtMS0xLTgzMDc4_9aea5afb-b06e-48f2-b8ff-1765a273b966">20,709</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred income tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzExLTEtMS0xLTgzMDc4_1d4527de-a4c8-4eeb-888a-55cbcc60f4d3">60,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzExLTMtMS0xLTgzMDc4_2b3b70da-4273-455b-95a8-fbadd454fa0b">227,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzExLTUtMS0xLTgzMDc4_adb51fb6-24b4-46b1-bca5-b7f1f57590ab">2,282</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzEyLTEtMS0xLTgzMDc4_680c0897-1dce-4afa-9967-ab27b1795144">306,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzEyLTMtMS0xLTgzMDc4_5fec00dc-5993-4a81-9954-8bdb3472bec9">313,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzEyLTUtMS0xLTgzMDc4_d4dd3b63-28d8-4fd4-9938-90379da4e0d9">279,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0NjQ_ebaa5a81-8dcb-4538-a930-6d84f482f18f" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are allocated between continuing and discontinued operations as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"></td><td style="width:37.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzItMS0xLTEtODMwNzg_c4ef89ab-fb7d-4ef8-bc14-d7d3c4177174">306,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzItMy0xLTEtODMwNzg_12147c66-102c-4fcd-b1bf-b80adbb5ffcb">313,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzItNS0xLTEtODMwNzg_5497504f-d714-4907-98a9-96b2a5672bc8">279,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzMtMS0xLTEtODMwNzg_56a46e27-8458-47ba-b302-7de5d9700463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzMtMy0xLTEtODMwNzg_393d9b78-b010-4918-9add-3a79c5b82948">1,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzMtNS0xLTEtODMwNzg_8799f5a0-6ee3-40f0-957f-84291aef4441">40,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzQtMS0xLTEtODMwNzg_2827222c-5012-4e6e-bfe8-ef92c3a02ee3">306,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzQtMy0xLTEtODMwNzg_1118899c-0d48-438b-af20-b78e7b56a415">315,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzQtNS0xLTEtODMwNzg_fd21af73-981c-48ae-85b0-c34d86b9895b">320,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0Mzk_6526433e-4b77-40ef-86f9-28f9e6800d00" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between the Company&#8217;s effective tax rate from continuing operations and the U.S. federal income tax rate is as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.532%"><tr><td style="width:1.0%"></td><td style="width:49.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzItMS0xLTEtODMwNzg_21a0684c-2353-4ab9-aa47-125a197ce636">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzItMy0xLTEtODMwNzg_a931f3bf-474f-4001-a018-c97f7633d610">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzItNS0xLTEtODMwNzg_44723ad2-f831-442f-9131-c3b38edad6c3">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzMtMS0xLTEtODMwNzg_45a8c371-3b6e-4d96-a1c8-814c236723f8">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzMtMy0xLTEtODMwNzg_843a9d27-8cd1-4912-aecd-4ab6fc3f3dc3">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzMtNS0xLTEtODMwNzg_09ebfaf1-e4e3-4422-a403-01ad7a829b15">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtMS0xLTEtMTYzNjQ3_33144a99-e678-4a5d-b106-5e52f444427b">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtMy0xLTEtMTYzNjQ3_c93c540e-4d8c-408d-a3fd-ad2a30c9118d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtNS0xLTEtMTYzNjQ3_22fc3fb4-3ce5-4ea4-b4f0-3da4ee42dd2f">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal and international tax rate adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtMS0xLTEtMTYxNzg4_4482a734-5d86-46e5-9723-6f490a0360a1">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtMy0xLTEtMTYxNzg4_d56d73d6-ba22-4943-a78c-20fb6eabd958">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtNS0xLTEtMTYxNzg4_563a9a88-33fd-4d89-98e5-d4a612939cd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="3" name="dva:EffectiveIncomeTaxReconciliationInvestmentImpairment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzUtMS0xLTEtMTYxODAw_d715c2ee-34a9-4cd3-b85c-bc9ea290cd7f">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="3" name="dva:EffectiveIncomeTaxReconciliationInvestmentImpairment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzUtMy0xLTEtMTYxODAw_24144686-2a0a-4fed-8710-5c6baa7f8a4a">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="3" name="dva:EffectiveIncomeTaxReconciliationInvestmentImpairment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzUtNS0xLTEtMTYxODAw_e1f2d529-87fb-4592-97ed-aec8f226bcd3">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Political advocacy costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzYtMS0xLTEtMTYxODA3_eaea73f4-94c9-43e5-9d8b-4db986cc07e0">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzYtMy0xLTEtMTYxODA3_6b2eb64e-0545-4b9d-a068-fc41781d93a8">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzYtNS0xLTEtMTYxODA3_927279c3-2825-4b51-b75c-aa5c6e5d295b">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtMS0xLTEtODMwNzg_594dd676-f7b2-4b0c-b5b3-b5b7383748f9">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtMy0xLTEtODMwNzg_fe312e5d-7eb3-407a-ac91-7d1b395a470c">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtNS0xLTEtODMwNzg_011d08a7-fad5-40f7-a889-4923be502bf0">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in international valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzctMS0xLTEtODMwNzg_8401e624-3820-436d-9aff-edb9f2646202">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzctMy0xLTEtODMwNzg_c48a0fdb-ea32-4f2c-8deb-67c2ce00931e">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzctNS0xLTEtODMwNzg_019aaa3f-29d3-4cca-a687-dab4f1614b93">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzExLTEtMS0xLTE2MjIwMw_e79fcaae-a11b-402d-bff2-41ccecc0bb96">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzExLTMtMS0xLTE2MjIwMw_b7c99892-8bff-4152-b100-b2b8966e43f6">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzExLTUtMS0xLTE2MjIwMw_4d721aa0-c792-4fe6-94ce-9f69e84254c6">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of noncontrolling interests primarily<br/>&#160;attributable to non-tax paying entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzEwLTEtMS0xLTgzMDc4_a21a976a-c2ab-40e3-8568-91d56a635cab">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzEwLTMtMS0xLTgzMDc4_54a5c4a7-f075-4a85-9e72-5d8d44dcc5be">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzEwLTUtMS0xLTgzMDc4_382e5ad8-3630-4648-b67d-0200a2a776a8">4.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzExLTEtMS0xLTgzMDc4_c0672cf7-4072-4d98-8c0b-e6608f881489">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzExLTMtMS0xLTgzMDc4_23cfa83d-41bb-4cd6-96dd-5f2e2a8965cf">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzExLTUtMS0xLTgzMDc4_f3f54716-4593-4d97-92be-0fbc55420789">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i4201cf5c13c4417d8e80e1604260076e" continuedAt="ia921a6e69e9344e188a592d9d485005f"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0Njc_1053e4d5-6f3e-4767-b061-1665adf64457" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities arising from temporary differences for continuing operations were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.830%"><tr><td style="width:1.0%"></td><td style="width:56.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.495%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="dva:DeferredTaxAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzItMS0xLTEtODMwNzg_0582ff52-2800-4943-8a5b-62e90fb3cd61">8,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="dva:DeferredTaxAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzItMy0xLTEtODMwNzg_68949269-756d-4a1f-ac3f-404bec43fb41">9,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzMtMS0xLTEtODMwNzg_425c1795-a4fa-4030-abb1-50aa07e41ec0">67,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzMtMy0xLTEtODMwNzg_189fade9-fc77-4e23-b779-ac070808e189">64,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="dva:DeferredTaxAssetsOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzQtMS0xLTEtODMwNzg_ee29e215-e1b3-4143-aece-1b4348bfad14">581,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="dva:DeferredTaxAssetsOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzQtMy0xLTEtODMwNzg_f144f03d-c007-4cf5-8380-a353f53460db">584,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzUtMS0xLTEtODMwNzg_3abdf742-4e8c-42d1-913c-84338ca9af90">162,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzUtMy0xLTEtODMwNzg_ecfc70c2-8ebf-4f22-96e0-e9dd76f14702">167,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzYtMS0xLTEtODMwNzg_27e64a6f-c073-40bc-a317-153c0e340614">52,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzYtMy0xLTEtODMwNzg_ff638296-b6b1-4679-8a6e-483e5854c300">62,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzctMS0xLTEtODMwNzg_c6d28418-19c1-4213-89b3-9ee446a5ccc6">873,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzctMy0xLTEtODMwNzg_b0ef7340-7b2b-487d-9d0d-387724426439">888,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzgtMS0xLTEtODMwNzg_43cd46bb-db71-4de8-9b24-364460bd3a05">100,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzgtMy0xLTEtODMwNzg_a8af7dfa-9419-4417-b31e-651f4cb99cc3">114,824</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzktMS0xLTEtODMwNzg_5cd41dae-a47c-4b3d-99c3-f72081a7cea7">772,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzktMy0xLTEtODMwNzg_55c4aee8-97e2-4ee3-b300-3d953dba583f">773,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzEwLTEtMS0xLTgzMDc4_c3865dc2-d012-4633-94d0-0c1f16504e2e">644,039</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzEwLTMtMS0xLTgzMDc4_39a93411-865b-4abd-8197-642e84c98adc">634,736</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzExLTEtMS0xLTgzMDc4_09144597-fed6-4c1c-8b1a-a6dc35073e8a">283,913</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzExLTMtMS0xLTgzMDc4_0432aeed-91e7-488f-b1e4-2d613854a5d1">274,742</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="dva:DeferredTaxLiabilitiesOperatingLeaseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzEyLTEtMS0xLTgzMDc4_25a9ca62-c6cf-4b5b-a0e8-7fa0738e5cc4">530,839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="dva:DeferredTaxLiabilitiesOperatingLeaseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzEyLTMtMS0xLTgzMDc4_a324d117-5fc8-4664-b3f3-f5d33f44fc7f">532,082</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzEzLTEtMS0xLTgzMDc4_dbbf3fa5-c713-4078-8f77-4eb48880732d">84,407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzEzLTMtMS0xLTgzMDc4_713109e9-7cc9-4d70-8cd0-98f0f91d9e1e">101,996</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE0LTEtMS0xLTgzMDc4_a806395e-43b8-4e23-a9d8-3bcb3d715ce4">37,274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE0LTMtMS0xLTgzMDc4_4676352a-7868-404e-b1ca-83a7141785a6">39,690</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE1LTEtMS0xLTgzMDc4_61d12a7a-ade3-4d98-b0f2-9cdc48864268">1,580,472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE1LTMtMS0xLTgzMDc4_bb9b8628-4ba4-40a3-ab3d-997077fe4160">1,583,246</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE2LTEtMS0xLTgzMDc4_1d84eb33-eb35-4c5e-ad40-7a8b8aaedeb3">808,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE2LTMtMS0xLTgzMDc4_f3a4327d-84b3-4a0a-b3cc-ebd17fa12a00">809,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70ab78105894454bb3a4d66a58c9ce87_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE4LTEtMS0xLTE1Njk0Mw_9b2ecbfc-3fad-446f-b585-ac6680449b1e">830,954</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4bdcb9f103f4aaeb04d4e05c9d4ad58_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE4LTMtMS0xLTE1Njk0Mw_c2eaba27-1364-4e28-9361-3144ad7868eb">809,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets (included in Other long-term assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id251067d050c44fe8c0736b4e398bced_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE5LTEtMS0xLTE1Njk0Mw_e0039fb1-6389-4692-966d-76d43c86ada2">22,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2c1892554643868b5366813ed68ed8_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE5LTMtMS0xLTE1Njk0Mw_03edfb73-2f59-42c3-8bc7-e5cd4e8d617c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 25.75pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzIwLTEtMS0xLTE1Njk0Mw_a0060309-ed1b-4891-a995-bb6bd0c1f0c7">808,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzIwLTMtMS0xLTE1Njk0Mw_1069fcec-c937-425b-a310-95308bd9d798">809,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the Company had federal net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i83a7731ed6494f868aa4389a7de35e85_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzExNDQ_7438fabd-0e98-4ca0-a3f9-689d727bedbc">85,391</ix:nonFraction> that expire through 2036, although a substantial amount expire by 2029. The Company also had state net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="if9d939dcfcda400d965c56313d937123_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzEyNzg_efa811ce-edb4-400c-b96f-113a431feb8a">554,806</ix:nonFraction>, some of which have an indefinite life, although a substantial amount expire by 2041 and international net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i9046f56523ce431bbd0d602da2e2fead_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzE0MTg_38795815-8459-4374-b99c-a5270ed4c175">291,927</ix:nonFraction>, some of which will begin to expire in 2022 though the majority have an indefinite life. The Company has a state capital loss carryover of $<ix:nonFraction unitRef="usd" contextRef="i3eda909ed98c425386284bc3c9809bd2_I20211231" decimals="-3" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzE1NTg_803ebcaa-ad42-44dc-82ac-10cf2500d0ac">313,722</ix:nonFraction>, the majority of which expires in 2024. The utilization of a portion of these losses may be limited in future years based on the profitability of certain entities. A valuation allowance is recorded to account for the unrealizable balances in the table above. The net decrease of $<ix:nonFraction unitRef="usd" contextRef="i600487b6cfcc42429d3cde02ae5b6e4c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzE4MzI_931bfe59-4624-4e40-bd41-d477c0b91b4e">14,208</ix:nonFraction> in the valuation allowance is primarily due to the release of the valuation allowance on indefinite life net operating losses in jurisdictions where the Company has generated sufficient income to support their future utilization, partially offset by newly created net operating loss carryforwards in state and foreign jurisdictions that the Company does not anticipate being able to utilize. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2021, the Company recorded a true-up to recognize net deferred tax assets related to historical purchases of noncontrolling interests in consolidated partnerships. The effect of this adjustment was an increase of $<ix:nonFraction unitRef="usd" contextRef="i5c646949f7af4e90ac555e2e74c3848f_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzc2OTY1ODE0MDIyOTQ_03d309cf-217f-4788-ba74-8cba799fa3a2">46,692</ix:nonFraction> to net deferred tax assets, a charge of $<ix:nonFraction unitRef="usd" contextRef="i5c646949f7af4e90ac555e2e74c3848f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzc2OTY1ODE0MDIzMzg_709a9f58-adb4-4989-a3a4-09fb2000b3d0">16,044</ix:nonFraction> to income tax expense, and an increase of $<ix:nonFraction unitRef="usd" contextRef="i5c646949f7af4e90ac555e2e74c3848f_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzc2OTY1ODE0MDIzODQ_9e2ec84e-df8a-45dc-9366-af484877423a">62,736</ix:nonFraction> to additional paid-in capital. The Company&#8217;s prior purchases of this type have not generated significant pre-tax adjustments to additional paid-in capital in any single prior year. The majority of the $<ix:nonFraction unitRef="usd" contextRef="i5c646949f7af4e90ac555e2e74c3848f_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzc2OTY1ODE0MDI1ODk_d2db89f7-b70f-406e-aa62-d5d7ea7e1cea">16,044</ix:nonFraction> recorded to income tax expense was due to the decrease in the corporate tax rate in 2017.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's foreign earnings continue to be indefinitely reinvested as of December&#160;31, 2021. As a result of the passage of the Tax Cuts and Jobs Act (2017 Tax Act), the Company does not expect such earnings to be taxable if remitted.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ia921a6e69e9344e188a592d9d485005f"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unrecognized tax benefits</span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0NDg_4b34c3c7-1ab7-4808-90cb-3d953ffc69e9" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending liability for unrecognized tax benefits that do not meet the more-likely-than-not threshold is as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"><tr><td style="width:1.0%"></td><td style="width:61.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.717%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.250%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzItMS0xLTEtODMwNzg_50caaf52-f4d7-4933-a38a-07f56983a06e">70,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzItMy0xLTEtODMwNzg_82f1a7ef-b2ab-4f2a-8f91-bc4fd6af497e">68,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions for tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzMtMS0xLTEtODMwNzg_23eb2259-808a-4a9c-9ca4-dfe5be29664e">3,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzMtMy0xLTEtODMwNzg_ade8039e-f40b-46f7-80eb-35d7b681246a">2,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzQtMS0xLTEtODMwNzg_8af575d4-c1d6-4a30-8e9e-d991ef2688db">22,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzQtMy0xLTEtODMwNzg_b467d6b9-a6d2-4d21-be9c-3b7a1dff2db1">258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions related to lapse of applicable statute</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzUtMS0xLTEtODMwNzg_6c1b4f25-6cf4-4646-aa26-4e14a8fab492">751</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzUtMy0xLTEtODMwNzg_78a5fbc8-a630-454e-b8c3-4541f68d5199">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions related to settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzYtMS0xLTEtODMwNzg_c7dd36ff-7682-4c0b-ac9c-aa986f6665fc">22,378</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzYtMy0xLTEtODMwNzg_e659574d-cda2-48cc-b7ac-2a8cf24143b4">430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzctMS0xLTEtODMwNzg_8272dc49-8bbf-4b5d-889a-c328ba36e198">73,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzctMy0xLTEtODMwNzg_50caaf52-f4d7-4933-a38a-07f56983a06e">70,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company&#8217;s total liability for unrecognized tax benefits relating to tax positions that do not meet the more-likely-than-not threshold is $<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzI1NzY_e4524fdb-0d16-44fc-809c-55311c1b7e48">73,024</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzI1ODk_a0d6b9cb-3898-4149-976e-114775d7b085">68,708</ix:nonFraction> would impact the Company&#8217;s effective tax rate if recognized and $<ix:nonFraction unitRef="usd" contextRef="i0110ff4724f848ca85d3284f225e5fb5_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzcxNDY4MjU1ODkyMDU_c8112383-8074-489b-aafd-2febdf965324">42,860</ix:nonFraction> is classified as a current tax liability related to settlements expected to be paid in 2022. This balance represents an increase of $<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzI2ODM_cc8457ef-bb9f-47d8-9ea1-f2805fd1c4cc">2,822</ix:nonFraction> from the December&#160;31, 2020 balance of $<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzI3MDk_acccce0f-acad-4a63-b5f4-5c8985d57c0d">70,202</ix:nonFraction>. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. At December&#160;31, 2021 and 2020, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzI4NzE_331ba000-2847-4320-bbbb-2b57f7539bbe">15,275</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzI4Nzg_2f7c945e-7135-4d23-bd15-574b28b9f2be">17,864</ix:nonFraction>, respectively, accrued for interest and penalties related to unrecognized tax benefits, net of federal tax benefit.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries file U.S. federal and state income tax returns and various foreign income tax returns. The Company is no longer subject to U.S. federal and state examinations by tax authorities for years before 2014 and 2009, respectively. In addition to being under audit in various state and local tax jurisdictions, the Company&#8217;s federal tax returns are under audit by the Internal Revenue Service for the years 2014-2017.</span></div></ix:continuation><div id="i916f7af890114e55a87e260476560c60_259"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMzIx_29cf26f9-68f2-40fc-8286-02c6094bfab3" continuedAt="i4541891d0b944e0b916513c15d474824" escape="true"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMzIz_f372c8de-27bf-4e2c-9471-38b4ce92b9bf" continuedAt="i764080a6f9b649a29e8c4d752856f120" escape="true">Long-term debt</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i4541891d0b944e0b916513c15d474824" continuedAt="ic598a0328b8a4101bada94b17edcf699"><ix:continuation id="i764080a6f9b649a29e8c4d752856f120" continuedAt="i2044b61a51d84b1184f3e33b8e7e774d"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:34.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1db4cfcf189544c5ae3f2c2607ab9bf3_I20211231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzMtMS0xLTEtODMwNzg_3aad132e-6ff1-4259-8339-735bc30cf710">1,596,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e9bc16804444b71ac99a4f60e9d5c12_I20201231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzMtMy0xLTEtODMwNzg_7810b441-fe4a-4f74-b151-c01cad91ec4a">1,684,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i04f7923e726c44b5a317209e10a39819_D20210101-20211231" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzMtNS0xLTEtODMwNzg_3383b993-68e1-4e4e-b1de-8faada27d06f">8/12/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i04f7923e726c44b5a317209e10a39819_D20210101-20211231" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzMtNy0xLTEtODMwNzg_5ffefb84-dc22-4585-8006-ddbab58766db">LIBOR + 1.50%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1db4cfcf189544c5ae3f2c2607ab9bf3_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzMtOS0xLTEtODMwNzg_1510dd12-90c0-47dc-88a1-e06b068903a6">1,600,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib46d077db6cc4fc5ba1ee2fbd6eac6fc_I20211231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzQtMS0xLTEtODMwNzg_5c4ab61c-d65e-4e3c-9ecd-cf7458cf26f4">2,688,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4715240e08ce4789b224f11378f56cf4_I20201231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzQtMy0xLTEtODMwNzg_1dba9ace-e2d3-4ffc-919b-0b1fd19d5ad8">2,715,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5327139cdd234a31b8cc0934bc70b68b_D20210101-20211231" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzQtNS0xLTEtODMwNzg_b1217a32-0940-4965-b99e-93a5c3af1eb8">8/12/2026</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5327139cdd234a31b8cc0934bc70b68b_D20210101-20211231" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzQtNy0xLTEtODMwNzg_9f40e9cf-52a2-46f2-a825-80542f39163a">LIBOR + 1.75%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib46d077db6cc4fc5ba1ee2fbd6eac6fc_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzQtOS0xLTEtODMwNzg_d65be1bc-aaeb-4493-94f1-7f0929102794">2,681,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600b97f9f2a649adb54ed6ff94464b99_I20211231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzYtMS0xLTEtODMwNzg_e3de124c-2735-4d81-a72b-d7c14e50572a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie199cda3ed26463fafa480e81f60a090_I20201231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzYtMy0xLTEtODMwNzg_61d70dd8-3a65-4d04-917f-294537475daa">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c69871249f9445c9b595c58151ff7cb_D20210101-20211231" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzYtNS0xLTEtODMwNzg_6375fbb6-9643-4438-b4a8-0703636fdfb3">8/12/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c69871249f9445c9b595c58151ff7cb_D20210101-20211231" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzYtNy0xLTEtODMwNzg_62b3aaa0-b512-45e3-b825-eb26639becb5">LIBOR + 1.50%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600b97f9f2a649adb54ed6ff94464b99_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzYtOS0xLTEtODMwNzg_bbcea486-239e-44a1-bb19-81fddd48f64d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec717b426f84c228c0d4292f6059e35_I20211231" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzgtMS0xLTEtODMwNzg_947b479e-19db-4c51-8bbb-91af6b0d71a7">2,750,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e611f57b324bf78f55d029bc529436_I20201231" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzgtMy0xLTEtODMwNzg_aeacd8a3-75f6-4dbf-bb6d-de9780af1aa5">1,750,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i12da2441415248babcb9af6aa29feb11_D20210226-20210226" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzgtNS0xLTEtODMwNzg_7287e4dc-6cf2-4c6f-a97f-9bec966fb127">6/1/2030</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i890855c7c3d64bd8ab0ed0292f35e955_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzgtNy0xLTEtODMwNzg_dc1fc32e-15a9-4e59-86bd-5d8b0efe350d">4.625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec717b426f84c228c0d4292f6059e35_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzgtOS0xLTEtODMwNzg_6642fb10-b915-4f70-953c-f26007da1bd4">2,822,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a9bcb8cc67b428099ac387fd810b3ad_I20211231" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzktMS0xLTEtODMwNzg_2ef5eafd-e7e3-4952-9c34-d8c9cb938aae">1,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ee95b0a63934b3fab601bf43c7befac_I20201231" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzktMy0xLTEtODMwNzg_59c39a39-6765-4256-a9a9-b4e5afbfe665">1,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2f95c3f7ea894940b533361538fc95dd_D20210101-20211231" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzktNS0xLTEtODMwNzg_e89c4fe1-ea0a-4db7-ae53-3e82f155ce6e">2/15/2031</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f95c3f7ea894940b533361538fc95dd_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzktNy0xLTEtODMwNzg_1c6a4b70-9db2-4d5e-ae09-7b28f110dfaf">3.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a9bcb8cc67b428099ac387fd810b3ad_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzktOS0xLTEtODMwNzg_87eac518-cb32-4123-9249-fe30b8486d6d">1,464,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition obligations and other notes<br/> payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe46e390006b4b0db6ef499531f4433a_I20211231" decimals="-3" name="dva:AcquisitionObligationsAndOtherNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEyLTEtMS0xLTgzMDc4_79c90ac4-b43e-443c-af17-cd0eeef68e3d">130,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44e756811d3a4db48b9f947147694905_I20201231" decimals="-3" name="dva:AcquisitionObligationsAndOtherNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEyLTMtMS0xLTgzMDc4_940f6aab-a9c9-4010-8989-43efd2b99370">164,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i773db74022044af6886373bcbb94b346_D20210101-20211231" name="us-gaap:DebtInstrumentMaturityDateDescription" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEyLTUtMS0xLTgzMDc4_6a49a697-373f-4b5d-87cd-da610a8cfd11">2022-2036</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibe46e390006b4b0db6ef499531f4433a_I20211231" decimals="INF" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEyLTctMS0xLTgzMDc4_1a5e5c3d-4e2a-4190-8a35-9b1bc4cb6936">4.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe46e390006b4b0db6ef499531f4433a_I20211231" decimals="-3" name="dva:AcquisitionObligationsAndOtherNotesPayableFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEyLTktMS0xLTgzMDc4_63f38a0d-e28c-40bb-9e90-dfd68f48ca57">130,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida3ce71f441045c4b651feea14f7ae6b_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEzLTEtMS0xLTgzMDc4_d1f7c296-0139-48ff-a1aa-62934c0543d4">299,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib96d977216a04df8a88cb6db54969996_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEzLTMtMS0xLTgzMDc4_58cbb312-e538-472a-8b96-53cfea4e67de">274,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i46b324066b524a409692e8df3f51de03_D20210101-20211231" name="us-gaap:DebtInstrumentMaturityDateDescription" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEzLTUtMS0xLTgzMDc4_f8e79317-5e04-4fb9-97ce-e4d1dd3f4ded">2022-2038</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida3ce71f441045c4b651feea14f7ae6b_I20211231" decimals="INF" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEzLTctMS0xLTgzMDc4_e3909ac4-9128-4ef8-a0ca-e8321317f108">4.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE0LTEtMS0xLTgzMDc4_d167e511-bb0a-4c6b-ac79-45b4758e2b00">8,964,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE0LTMtMS0xLTgzMDc4_a3579386-aa23-4580-85ff-1a76dff2831f">8,163,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="dva:DiscountAndDeferredFinanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE1LTEtMS0xLTgzMDc4_bccb1425-1900-49a2-ae18-36fb32072375">56,685</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="dva:DiscountAndDeferredFinanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE1LTMtMS0xLTgzMDc4_0ec9a461-b5f5-4893-ae83-f757b43792d6">77,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE2LTEtMS0xLTgzMDc4_1315124b-a6ef-4343-8984-954cf6f7201f">8,908,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE2LTMtMS0xLTgzMDc4_2324bd54-cf3f-46de-ae18-6542450c91b1">8,085,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE3LTEtMS0xLTgzMDc4_94462ad0-9955-4dd8-8d78-e7fbaccdfd1b">179,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE3LTMtMS0xLTgzMDc4_a1022ed2-d0fb-4096-82d0-e349017798db">168,541</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE4LTEtMS0xLTgzMDc4_6ebbf623-8a91-467d-9613-f847e07051b8">8,729,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE4LTMtMS0xLTgzMDc4_a1e34868-f6dc-4b4d-85f6-dca309a4bb5a">7,917,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented here approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of December&#160;31, 2021.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to <ix:nonNumeric contextRef="i11aa03bc52b94636a23c6f74a4cfed25_D20210101-20211231" name="us-gaap:DebtInstrumentMaturityDateDescription" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzI0MTg5MjU1ODM0Mjkx_56b3fba3-a877-4a7f-89c1-2fe45192c66f">2070</ix:nonNumeric>, in addition to the other lease maturity dates presented in the table above.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i2044b61a51d84b1184f3e33b8e7e774d" continuedAt="i65dbe3b66b3e45368567fb9475f91673"><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><ix:continuation id="ic598a0328b8a4101bada94b17edcf699"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of December&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $<ix:nonFraction unitRef="usd" contextRef="icabbc5daf3b5479cbbc15782e1d08326_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEyODk_82ec6b43-a416-46d0-a5f6-420e88de6deb">4,473</ix:nonFraction> and deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="icabbc5daf3b5479cbbc15782e1d08326_I20211231" decimals="-3" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEzMjQ_15851b4e-602b-40bf-b41b-3d489c213c2e">27,207</ix:nonFraction> and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="ie5c90a9b4f6e4bc8ac5981725f5f1a56_I20211231" decimals="-3" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzE0MTg_b68d300e-3275-4bc7-9ba0-df8f67d73310">40,914</ix:nonFraction> and increased by a debt premium of $<ix:nonFraction unitRef="usd" contextRef="ie5c90a9b4f6e4bc8ac5981725f5f1a56_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzMzU2NzI_2dd6bd07-8b64-4920-bfe2-90727fd426b0">15,909</ix:nonFraction>. As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $<ix:nonFraction unitRef="usd" contextRef="i1edafa8b823d47d6aee45f343d6d4dab_I20201231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzE1MjU_420106bc-a8f3-49e4-bc54-6c63c0b9491f">5,461</ix:nonFraction> and deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="i1edafa8b823d47d6aee45f343d6d4dab_I20201231" decimals="-3" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzE1NjA_fe4575e4-9ebe-4167-9603-c2e6d8b05a01">35,825</ix:nonFraction>, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="ic4a422541b9c4b1d89d6f0b455e51179_I20201231" decimals="-3" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzE2NTU_e994ce8a-7aa4-42e2-b4f0-df7a2a0fb4fc">36,431</ix:nonFraction>.</span></ix:continuation></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMzE4_9ac38e26-eb2e-4b8e-84d6-8b8391dda7e0" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled maturities of long-term debt at December&#160;31, 2021 were as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.274%"><tr><td style="width:1.0%"></td><td style="width:58.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZToxZDEzY2UzYWUzNDk0YjAyOWZkZTg1MGUyMjc5YTJiYS90YWJsZXJhbmdlOjFkMTNjZTNhZTM0OTRiMDI5ZmRlODUwZTIyNzlhMmJhXzAtMS0xLTEtODMwNzg_9e95114a-c68d-4ec5-b721-d1df290e36b3">179,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZToxZDEzY2UzYWUzNDk0YjAyOWZkZTg1MGUyMjc5YTJiYS90YWJsZXJhbmdlOjFkMTNjZTNhZTM0OTRiMDI5ZmRlODUwZTIyNzlhMmJhXzEtMS0xLTEtODMwNzg_5cc280ae-276a-44cd-b06f-96b55df9025f">218,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZToxZDEzY2UzYWUzNDk0YjAyOWZkZTg1MGUyMjc5YTJiYS90YWJsZXJhbmdlOjFkMTNjZTNhZTM0OTRiMDI5ZmRlODUwZTIyNzlhMmJhXzItMS0xLTEtODMwNzg_1b16529a-13d7-41c1-9b5e-cafaf492d577">1,424,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZToxZDEzY2UzYWUzNDk0YjAyOWZkZTg1MGUyMjc5YTJiYS90YWJsZXJhbmdlOjFkMTNjZTNhZTM0OTRiMDI5ZmRlODUwZTIyNzlhMmJhXzMtMS0xLTEtODMwNzg_7e30d19d-215b-41aa-9b76-53ce493afdbe">67,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZToxZDEzY2UzYWUzNDk0YjAyOWZkZTg1MGUyMjc5YTJiYS90YWJsZXJhbmdlOjFkMTNjZTNhZTM0OTRiMDI5ZmRlODUwZTIyNzlhMmJhXzQtMS0xLTEtODMwNzg_8365c207-c63b-4662-abe7-8d7d9f9f0f06">2,625,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZToxZDEzY2UzYWUzNDk0YjAyOWZkZTg1MGUyMjc5YTJiYS90YWJsZXJhbmdlOjFkMTNjZTNhZTM0OTRiMDI5ZmRlODUwZTIyNzlhMmJhXzUtMS0xLTEtODMwNzg_8180a88e-adba-4a51-b729-a90bf8b8b005">4,449,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company made regularly scheduled mandatory principal payments under its senior secured credit facilities totaling $<ix:nonFraction unitRef="usd" contextRef="i04f7923e726c44b5a317209e10a39819_D20210101-20211231" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzMwOTc_1f53c1ea-8768-412c-a0b8-785624ec13bd">87,500</ix:nonFraction> on Term Loan A and $<ix:nonFraction unitRef="usd" contextRef="i5327139cdd234a31b8cc0934bc70b68b_D20210101-20211231" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzMxMTk_08ee388c-e4ec-4161-b853-7eb343099be1">27,431</ix:nonFraction> on Term Loan B-1.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 26, 2021, the Company completed an unregistered add-on offering of $<ix:nonFraction unitRef="usd" contextRef="i2ba1dad9a06d4586808260f76a47066d_I20210226" decimals="-3" name="dva:AdditionalDebtPrincipalAmountDueToNewAgreement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzNDI1ODQ_c5735782-c566-4df7-89db-4fa38331e0e3">1,000,000</ix:nonFraction> aggregate principal amount to the existing <ix:nonFraction unitRef="number" contextRef="i483ab4301786474fb072fbdef5442d37_D20200609-20200609" decimals="INF" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzNDI1ODg_6b890bd1-1b83-4bc6-bd93-4f6147acf9a4">4.625</ix:nonFraction>% senior notes due <ix:nonNumeric contextRef="i12da2441415248babcb9af6aa29feb11_D20210226-20210226" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzNDM3MDg_7287e4dc-6cf2-4c6f-a97f-9bec966fb127">June&#160;1, 2030</ix:nonNumeric> (the Additional 2030 Notes) pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The Additional 2030 Notes were issued at an offering price of <ix:nonFraction unitRef="number" contextRef="i12da2441415248babcb9af6aa29feb11_D20210226-20210226" decimals="INF" name="dva:DebtInstrumentOfferingPricePercentageOfFaceAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzNDM5MDU_58ffaa9c-9c21-461e-b363-19b4332291d8">101.750</ix:nonFraction>% of face amount, plus an interest payment advance to the Company for interest that would have accrued from December 1, 2020 (the last interest payment date) through the closing date, and began bearing full six months' semi-annual coupon interest payments as of June 1, 2021. The terms of the Additional 2030 Notes, other than their issue date, offering price and first interest payment date, are identical to the terms of the $<ix:nonFraction unitRef="usd" contextRef="iee77e0f66a124be69818c3fe1f9d91bb_I20200609" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0Xzc2OTY1ODE0MTc1NTE_991e954d-004f-4dc9-b326-db4f26ff36e4">1,750,000</ix:nonFraction> principal amount of the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="i483ab4301786474fb072fbdef5442d37_D20200609-20200609" decimals="INF" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzNDQzMzk_6b890bd1-1b83-4bc6-bd93-4f6147acf9a4">4.625</ix:nonFraction>% senior notes due June 1, 2030 previously issued by the Company on June 9, 2020. The Additional 2030 Notes are unsecured senior obligations and rank equally in right of payment with the Company's existing and future unsecured senior indebtedness. During the year ended December&#160;31, 2021 the Company incurred $<ix:nonFraction unitRef="usd" contextRef="i8ec717b426f84c228c0d4292f6059e35_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFeeAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzNDI0MjA_6d7a6824-b633-44ca-bd8b-699ec4f18733">9,091</ix:nonFraction> in fees and other professional expenses associated with this transaction, which were capitalized and will amortize over the term of the Additional 2030 Notes. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company's 2019 interest rate cap agreements have the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on specific portions of the Company's floating rate debt, including all of Term Loan B-1 and a portion of Term Loan A. The remaining $<ix:nonFraction unitRef="usd" contextRef="i1db4cfcf189544c5ae3f2c2607ab9bf3_I20211231" decimals="-3" name="dva:SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzgwMjQ_5b3d62c3-c8ea-4535-b7e2-7cc9d6d60dda">785,138</ix:nonFraction> outstanding principal balance of Term Loan A is subject to LIBOR-based interest rate volatility. <ix:continuation id="ic8598762d0b94eca996276922d763aba">The cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date.</ix:continuation> These cap agreements do not contain credit-risk contingent features.</span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMzI2_803d68e0-1871-4d2b-bfcb-23bb73e3daac" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of December&#160;31, 2021 and December&#160;31, 2020, which are classified in other long-term assets on its consolidated balance sheet:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:23.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded OCI gain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8442b0b05e984872893ac93049fee22e_I20211231" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtMS0xLTEtODMwNzg_9ce340c6-c762-4e85-8b25-1d72185fbd90">3,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95df5bcea102459b914d1085942b9258_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtMy0xLTEtODMwNzg_58082ca3-fa75-40c3-a8a6-ed1a0796106c">2.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie83cf4a097b643ee9745264ab855ca7b_D20210101-20211231" name="us-gaap:DerivativeInceptionDates" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtNS0xLTEtODMwNzg_3dfde8da-d0ff-45b3-a4f4-fac5c0043e81">6/30/2020</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie83cf4a097b643ee9745264ab855ca7b_D20210101-20211231" name="us-gaap:DerivativeMaturityDates" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtNy0xLTEtODMwNzg_b87b996b-e788-42a6-bad8-f5f93a95d8e7">6/30/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i214ffb0410c04addafdd70da53f31176_D20210101-20211231" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtOS0xLTEtODMwNzg_acd39586-810b-4365-9f0d-d2fa81e6bff1">5,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b6dd5b3eea468885f8236cc977ca08_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtMTEtMS0xLTgzMDc4_88c839f6-2c73-41cf-aa9c-2cd27221d4c3">9,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeebf4414172413da3e7139927c5aba9_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtMTMtMS0xLTgzMDc4_f63c5640-86a9-4129-b780-e5097c42557b">12,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i387548dbf53e458f864bbbc27c03ff99_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtMTUtMS0xLTgzMDc4_403234c2-7768-4d23-aa6c-01efd0abe209">2,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMzEz_baa1db6c-f8c6-4c56-bb04-a9087e96b9f8" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of the Company&#8217;s interest rate cap agreements for the years ended December&#160;31, 2021, 2020 and 2019:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:28.328%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.102%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount of unrealized gains (losses) in OCI on interest rate cap agreements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Location of losses </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reclassification from accumulated other comprehensive income into net income</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i214ffb0410c04addafdd70da53f31176_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzMtMi0xLTEtODMwNzg_54ef0974-5df5-4fde-9c6b-dd6bc87644f9">9,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic78e16c835d34203a6c659d6e08d50e5_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzMtNC0xLTEtODMwNzg_ffa956b0-3e88-42d9-963e-9cae8c9e03a6">21,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd53a26306b4722840092750230a681_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzMtNi0xLTEtODMwNzg_5638609a-22d0-4893-ab60-4360b7e2d9b7">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i214ffb0410c04addafdd70da53f31176_D20210101-20211231" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzMtMTAtMS0xLTgzMDc4_acd39586-810b-4365-9f0d-d2fa81e6bff1">5,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic78e16c835d34203a6c659d6e08d50e5_D20200101-20201231" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzMtMTItMS0xLTgzMDc4_b2b58860-7a27-4b7c-af48-820bf0d8470e">7,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd53a26306b4722840092750230a681_D20190101-20191231" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzMtMTQtMS0xLTgzMDc4_afc59848-ce43-4929-a49c-3c872ec90238">8,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0e0782bc40d453b86948be43d51725e_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzQtMi0xLTEtODMwNzg_7797cf22-7904-4a7f-a4ce-08a5198527af">2,377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e9c0b63c2e405182c0cf2802b5eca3_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzQtNC0xLTEtODMwNzg_dd76b145-004d-41cb-872f-1295f3be7f92">5,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84fde8e60f5a4538937fd23d973e3361_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzQtNi0xLTEtODMwNzg_8901c7d3-e23c-4fec-9f0c-3b86c6b74121">415</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0e0782bc40d453b86948be43d51725e_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzQtMTAtMS0xLTgzMDc4_306b714a-c945-4ac9-ad1c-1d614dc6afb8">1,376</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23e9c0b63c2e405182c0cf2802b5eca3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzQtMTItMS0xLTgzMDc4_525a7a3c-9ad2-4fc1-9883-22f662bad2b6">1,768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84fde8e60f5a4538937fd23d973e3361_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzQtMTQtMS0xLTgzMDc4_cb8a8c7e-722a-44e9-9993-e7dd6d41f7bb">2,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7258618967043f9bcfd1acc842da238_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzUtMi0xLTEtODMwNzg_dae29272-aeff-4110-81fd-1ca24eeabd2c">7,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cda5450900646759ef0009b9d20a3d1_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzUtNC0xLTEtODMwNzg_3e1412dd-b583-4d98-a908-771043d39081">16,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4fd45d48224399bcab66769793c52a_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzUtNi0xLTEtODMwNzg_00a79bb8-ca16-4e9a-8f73-57b91cce0196">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7258618967043f9bcfd1acc842da238_D20210101-20211231" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzUtMTAtMS0xLTgzMDc4_547647ff-2ba3-440f-a591-f0c766e1cd62">4,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda5450900646759ef0009b9d20a3d1_D20200101-20201231" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzUtMTItMS0xLTgzMDc4_a235a836-8e3e-4b0d-9ddf-9795839b015b">5,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4fd45d48224399bcab66769793c52a_D20190101-20191231" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzUtMTQtMS0xLTgzMDc4_36e0434c-24ce-4ed6-9165-c3ea021fe7d6">6,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 20 for further details on amounts recorded and reclassified from accumulated other comprehensive (loss) income.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i65dbe3b66b3e45368567fb9475f91673"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s weighted average effective interest rate on its senior secured credit facilities at the end of 2021 was <ix:nonFraction unitRef="number" contextRef="i263db25331b246e78a22100f6d1d1509_I20211231" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzkxMTA_7b076bec-3203-4c07-a7b2-67247f8ed97f">2.18</ix:nonFraction>%, based upon the current margins in effect for its senior secured credit facilities as of December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s weighted average effective interest rate on all debt, including the effect of interest rate caps and amortization of debt discount, was <ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzkzNzk_ef1f2dc2-3c00-4f8c-a9e8-48f8445283b2">3.28</ix:nonFraction>% for the year ended December&#160;31, 2021 and <ix:nonFraction unitRef="number" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0Xzk0MDg_85ec4328-aabc-4750-823b-e9bb1b745fdb">3.35</ix:nonFraction>% as of December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company&#8217;s interest rates were fixed on approximately <ix:nonFraction unitRef="number" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="4" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0Xzk0ODg_197df13e-68eb-4b3f-a532-a4c6619efa10">51.6</ix:nonFraction>% of its total debt.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had an undrawn $<ix:nonFraction unitRef="usd" contextRef="i600b97f9f2a649adb54ed6ff94464b99_I20211231" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzgyNDYzMzcyMjg5OTI_550b5dd8-6f99-454f-8864-0724dfa4401f">1,000,000</ix:nonFraction> revolving line of credit under its senior secured credit facilities. Credit available under this revolving line of credit is reduced by the amount of any letters of credit outstanding thereunder, of which there were <ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzE5NzkxMjA5MzIzMDc4_d19fc839-f871-4961-b30f-7ed609eac2c4">none</ix:nonFraction> as of December&#160;31, 2021. The Company also had approximately $<ix:nonFraction unitRef="usd" contextRef="i7f9ca0e521b646668df9e2106ef3225f_I20211231" decimals="-3" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0Xzk4NTk_90fdcbb0-d5f5-40d1-af2f-80d5c1c31c42">69,277</ix:nonFraction> of outstanding letters of credit under a separate bilateral secured letter of credit facility as of December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt expense</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt expense consisted of interest expense of $<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMDI1_f7bf5842-0a43-4c47-bef6-7ecd721eae1a">267,049</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMDI5_d7b6dcff-214a-4d3f-92f7-95080b1d6d82">282,932</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMDM2_6a9b143e-10b4-4ca0-b650-021571e8fef1">419,639</ix:nonFraction> and the amortization and accretion of debt discounts and premiums, amortization of deferred financing costs and the amortization of interest rate cap agreements of $<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMjAz_81887cfc-7533-4b9c-9485-9aa48c120add">18,205</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMjA3_ef7e782c-91db-4102-ad42-32889d122f24">21,179</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMjE0_da6f77d0-205b-4d3d-b52e-cac48f9385a4">24,185</ix:nonFraction> for 2021, 2020 and 2019, respectively. These interest expense amounts are net of capitalized interest.</span></div></ix:continuation><div id="i916f7af890114e55a87e260476560c60_265"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:LeasesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzIzNTY_0a0112e8-4ae0-438b-811b-93cc3b4b3e9f" continuedAt="i8b01682844494acdaa307525d629cbe6" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="i8b01682844494acdaa307525d629cbe6" continuedAt="ic3b41dd17d0d41efaa5ac3844714f15b"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#8217;s facilities are leased under non-cancellable operating leases which range in terms from <ix:nonNumeric contextRef="if350164cad7147d78b7f10200a640f14_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzIwMw_ac60d041-dca0-44b3-9ff6-ba26aae6bcac">five years</ix:nonNumeric> to <ix:nonNumeric contextRef="iad35108069fd45b89fe53b05bbe9c30d_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzIwOQ_99f64e4e-2c27-4178-9357-1a2e6694813b">15</ix:nonNumeric> years and which contain renewal options of <ix:nonNumeric contextRef="if350164cad7147d78b7f10200a640f14_I20211231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzI0OQ_a2a38757-f0a0-4f68-a516-00ac4e94800f">five years</ix:nonNumeric> to <ix:nonNumeric contextRef="iad35108069fd45b89fe53b05bbe9c30d_I20211231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzI1NQ_a6c4a789-9d47-423c-9329-9d92aec47b5d">ten years</ix:nonNumeric> at the fair rental value at the time of renewal. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses. See Note 1 for further information on how the Company accounts for leases.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and December&#160;31, 2020, assets recorded under finance leases were $<ix:nonFraction unitRef="usd" contextRef="i8bd72b308e7b468186e6b9b780fa5baf_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzU1OQ_008af4a5-26ec-4d29-8d13-3f0154b64dab">322,060</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iecb8fa3387954169853ce5d7b54cb5f5_I20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzU2Ng_81783c3e-4bf7-4baa-a0d8-8fc17ff5bfd3">275,389</ix:nonFraction>, respectively, and accumulated amortization associated with finance leases was $<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="dva:FinanceLeaseAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzY0OA_34f3c175-5f53-41cb-96fd-472fa3720c94">75,252</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="dva:FinanceLeaseAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzY1NQ_fc15372c-e0c4-4bab-9258-8f181cd3e231">49,345</ix:nonFraction>, respectively, included in property and equipment, net, on the Company's consolidated balance sheet. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain markets, the Company acquires and develops dialysis centers. Upon completion, the Company sells the center to a third party and leases the space back with the intent of operating the center on a long term basis. Both the sale and leaseback terms are generally market terms. The lease terms are consistent with the Company's other operating leases with the majority of the leases under non-cancellable operating leases ranging in terms from <ix:nonNumeric contextRef="if350164cad7147d78b7f10200a640f14_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzEyMTE_ac60d041-dca0-44b3-9ff6-ba26aae6bcac">five years</ix:nonNumeric> to <ix:nonNumeric contextRef="iad35108069fd45b89fe53b05bbe9c30d_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzEyMTc_99f64e4e-2c27-4178-9357-1a2e6694813b">15</ix:nonNumeric> years and which contain renewal options of <ix:nonNumeric contextRef="if350164cad7147d78b7f10200a640f14_I20211231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzEyNTc_a2a38757-f0a0-4f68-a516-00ac4e94800f">five years</ix:nonNumeric> to <ix:nonNumeric contextRef="iad35108069fd45b89fe53b05bbe9c30d_I20211231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzEyNjM_a6c4a789-9d47-423c-9329-9d92aec47b5d">ten years</ix:nonNumeric> at the fair rental value at the time of renewal.</span></div><div style="margin-top:9pt;text-indent:27pt"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzIzNTc_68168c4f-6656-4ac3-9625-cc884eabdc90" continuedAt="i806ce71d7dc54401b498fde2a6c78018" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"></td><td style="width:42.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzMtMi0xLTEtODMwNzg_5a4ab7c9-a553-4902-90a2-fb93350181c0">547,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzMtNC0xLTEtODMwNzg_bbe2739d-0447-42cb-a5f1-18bc84151217">541,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzMtNi0xLTEtMTIzODY2_533bb736-1de2-44ad-85a4-846a6aec7fc2">526,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzQtMi0xLTEtODMwNzg_d8af13b7-219f-4653-ac49-5d072c501486">125,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzQtNC0xLTEtODMwNzg_398bc07a-bab0-41fe-8354-6f8b8ac03d7c">122,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzQtNi0xLTEtMTIzODY2_ba27c5c8-f774-4a5a-8107-06a0c3b050db">119,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzYtMi0xLTEtODMwNzg_778b5013-5fa7-413f-9779-e07ead454a1f">26,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzYtNC0xLTEtODMwNzg_a416a49c-da0b-4194-9509-90173bacee28">24,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzYtNi0xLTEtMTIzODY2_77b93e16-5a72-4c56-9cdf-bf51d975107d">23,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzctMi0xLTEtODMwNzg_bc832172-bb0d-4f16-913c-07770c6531e4">13,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzctNC0xLTEtODMwNzg_7898a468-7db1-45e1-9ac4-cf7cd0a6af21">14,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzctNi0xLTEtMTIzODY2_7e96ae95-19c2-45e3-9e9c-f849b6c5ee43">14,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzgtMi0xLTEtODMwNzg_e3ee74bb-9bf3-40fc-8fbb-722b3fbefa22">714,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzgtNC0xLTEtODMwNzg_a4d840ad-4893-4b3b-815b-650457fdacdd">702,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzgtNi0xLTEtMTIzODY2_8f7acec9-22da-4007-90e4-2f5212d812ea">684,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i806ce71d7dc54401b498fde2a6c78018">(1) Includes short-term lease expense and sublease income, which are immaterial.</ix:continuation> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ic3b41dd17d0d41efaa5ac3844714f15b"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:LeaseOtherInformationTableTextBlockTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzIzNTQ_ba3d6378-f0c0-4e94-a838-4f8a28246862" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"></td><td style="width:42.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Lease term and discount rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzMtMi0xLTEtODMwNzg_5b0ef1cc-6583-4cfd-a41a-60a623e2d419">8.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzMtNC0xLTEtODMwNzg_2c8aff6a-5809-40b0-9c39-91b1821717c0">8.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzMtNi0xLTEtMTIzODgz_327f7dfc-7a61-43cb-8e87-2ee5bc105c46">9.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzQtMi0xLTEtODMwNzg_5e00b5d0-2c16-4914-acc5-bb75597d30b1">10.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzQtNC0xLTEtODMwNzg_2bb23346-9999-42e9-a7b2-6a9d115cbb94">10.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzQtNi0xLTEtMTIzODgz_46740ced-2baf-45d6-9c23-3837fd986ce8">10.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzYtMi0xLTEtODMwNzg_ee11f559-3710-4771-940e-7cf01143f32c">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzYtNC0xLTEtODMwNzg_40ffedc8-284b-4090-b80d-06bbab46da0c">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzYtNi0xLTEtMTIzODgz_d4f2196e-7c65-4db3-81a2-875af7c3271b">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida3ce71f441045c4b651feea14f7ae6b_I20211231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzctMi0xLTEtODMwNzg_a2dd0e3c-afaf-4b71-af02-f1df90fbc508">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib96d977216a04df8a88cb6db54969996_I20201231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzctNC0xLTEtODMwNzg_160a7f97-f87d-4665-9c10-bd5ecefea4ff">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88356036cde840bc8b51ec086349bd93_I20191231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzctNi0xLTEtMTIzODgz_7c1a8e3e-1629-4736-b029-f406d110ddbc">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"></td><td style="width:42.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gains on sale leasebacks, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzItMi0xLTEtODMwNzg_d476ac1d-6727-4c05-ada7-23fd9178e089">17,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzItNC0xLTEtODMwNzg_e566a078-a01d-42fe-abe6-3200a35c18b2">34,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzItNi0xLTEtMTIzOTAz_e1e1e523-4986-4c46-bf0e-d325a5e07857">20,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the <br/>&#160;measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzQtMi0xLTEtODMwNzg_916e4627-03ad-4543-a156-81bc3ebdde53">684,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzQtNC0xLTEtODMwNzg_2093adf1-22f0-4789-8ca8-4fc771043048">661,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzQtNi0xLTEtMTIzOTAz_93c17c16-fea4-43e4-9f44-1f6f6e789ca8">637,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzUtMi0xLTEtODMwNzg_6441025e-ae2a-4560-81a9-efef7b0b35a2">21,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzUtNC0xLTEtODMwNzg_5c96b7aa-2abb-4c50-a18d-5b3e9556b5ac">20,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzUtNi0xLTEtMTIzOTAz_a1f08df0-4124-452d-9731-82bdfd6279b2">22,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzYtMi0xLTEtODMwNzg_c69b5ceb-a4fd-44e8-8133-de073f642dce">22,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzYtNC0xLTEtODMwNzg_92e6f71e-bddb-4671-98d3-ab12204a484a">24,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzYtNi0xLTEtMTIzOTAz_a966e1ff-fb4f-4d58-ae2f-48f6447c0704">25,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease assets obtained in exchange<br/>&#160;for new or modified operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzctMi0xLTEtODMwNzg_6c23927c-f5c0-4cd9-8011-51ea74177d14">361,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzctNC0xLTEtODMwNzg_d657a816-4392-4a79-a15a-50b38ed65b10">401,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzctNi0xLTEtMTIzOTAz_0f5cf7cb-d9ce-473b-91be-2f1c4df19940">432,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:ScheduleOfMinimumLeasePaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzIzNTU_36f8092b-4cb7-4079-9897-eba02946d808" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancellable leases as of December&#160;31, 2021 are as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.929%"><tr><td style="width:1.0%"></td><td style="width:52.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.054%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.056%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Finance leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzEtMi0xLTEtODMwNzg_5f9a7a67-ae8e-4939-8a84-df679a907a3d">494,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzEtNC0xLTEtODMwNzg_458769d9-285c-4a41-9f55-86e3c3dba0b2">36,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzItMi0xLTEtODMwNzg_65e7c65f-edb3-470e-94eb-c22688fe83be">511,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzItNC0xLTEtODMwNzg_cea9dc82-dfd1-4834-ba04-e65cabf96977">37,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzMtMi0xLTEtODMwNzg_1ad228c6-f2a4-4c0a-b273-015c09cbbd69">463,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzMtNC0xLTEtODMwNzg_96f6083f-a605-441e-99c3-1e2b15a8cd00">38,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzQtMi0xLTEtODMwNzg_44e67bda-c10e-4a75-aa23-c5f3bdaf5ccf">413,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzQtNC0xLTEtODMwNzg_233bab4f-2196-47ef-a092-806bcca3f60a">38,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzUtMi0xLTEtODMwNzg_ab1641d3-be65-4fd7-bb45-1575ae20894f">361,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzUtNC0xLTEtODMwNzg_a9402cc5-f1c9-42d8-bcfe-4a896d8795da">37,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzYtMi0xLTEtODMwNzg_d289372a-9b6f-47db-a070-ec4258772756">1,293,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzYtNC0xLTEtODMwNzg_0be8be44-fba4-4cfe-b764-857893cb9366">183,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzctMi0xLTEtODMwNzg_c34bd8bd-20a9-4d96-bced-9dadfa8259a6">3,537,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzctNC0xLTEtODMwNzg_f3e7acbd-3503-40e7-b7e9-1e9f05991030">371,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less portion representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzgtMi0xLTEtODMwNzg_fbc051a5-d8e6-4219-a9f3-798320004ffa">470,269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzgtNC0xLTEtODMwNzg_9288370d-c955-48a0-9baf-2f47e5cafab1">72,491</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbc2e076ebb1492187444b939215b5ad_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzktMi0xLTEtODMwNzg_790e7976-a7e6-4a44-a017-be3c28463225">3,067,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c510942daa4f38b0c113fc3987e2b4_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzktNC0xLTEtODMwNzg_d3914f36-1b5f-41bf-907c-8243d330d6ba">299,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under all operating leases for 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i06ff6a03ae0d445a88f8a814027ab039_D20210101-20211231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzE5NDE_f6d4c562-86e6-449c-9b41-61ef2bcb94d8">673,904</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="iad36adbebb114059971bb24c387fa559_D20200101-20201231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzE5NDU_5e23b5cb-4a18-474d-8ee9-b69a0fb6ace9">663,819</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iab5a10e4b11d48bf88b5d0ee68ea283b_D20190101-20191231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzQ5NDc4MDIzMjc3MTg_80832c14-ff46-4576-beaf-3905552d9640">646,092</ix:nonFraction>, respectively. Rent expense is recorded on a straight-line basis over the term of the lease, including leases that contain fixed escalation clauses or include abatement provisions. Leasehold improvement incentives are deferred and amortized to rent expense over the term of the lease. Finance lease obligations are included in long-term debt. See Note 13 for further details on long-term debt.</span></div></ix:continuation><div id="i916f7af890114e55a87e260476560c60_268"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzIzNTg_60444073-551c-47b4-b623-dbd40bfd0928" continuedAt="if0b3c1193a434c50853e976f6e76671a" escape="true">Employee benefit plans</ix:nonNumeric></span></div><ix:continuation id="if0b3c1193a434c50853e976f6e76671a" continuedAt="i4f1dbfed431e472f81959a60c9e7af79"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a 401(k) retirement savings plan for substantially all of its U.S. employees which has been established pursuant to applicable provisions of the Internal Revenue Code (IRC). The plan allows for employees to contribute a percentage of their base annual salaries on a tax-deferred basis not to exceed IRC limitations. The Company maintains a 401(k) matching program under which the Company matches <ix:nonFraction unitRef="number" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzQ0NA_0d80ddd2-192b-4c4d-87b7-34a1e23f7339">50</ix:nonFraction>% of the employee's contribution up to <ix:nonFraction unitRef="number" contextRef="ife16d51280fb452d8a63ec87d4093b0f_D20210101-20211231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzQ4NA_49facec6-2d95-4cbe-bf4a-237e80f7c920">6</ix:nonFraction>% of the employee's salary, subject to certain limitations. The matching contributions are subject to certain eligibility and vesting conditions. For the years ended December&#160;31, 2021, 2020 and 2019, the Company accrued matching contributions totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzczMg_dcab7d9a-b8db-4236-818c-9c90a3028762">68,658</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzczNg_3c9f399b-70c6-466e-98ff-47e13b99db28">70,180</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzc0Mw_49cf7386-9cdc-44ed-be14-826f67d345f5">64,988</ix:nonFraction>, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains a voluntary compensation deferral plan, the Deferred Compensation Plan, as well as other legacy deferral plans. The Deferred Compensation Plan is non-qualified and permits certain employees whose annualized base salary equals or exceeds a minimum annual threshold amount as set by the Company to elect to defer all or a portion of their annual bonus payment and up to <ix:nonFraction unitRef="number" contextRef="i80a65d71492d461c921f03cd2f80cb2f_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzEyNDk_85422491-7b7a-43a4-9fcf-e8e3c01b3f82">50</ix:nonFraction>% of their base salary into a deferral account maintained by the Company. Total contributions to this plan in 2021, 2020 and 2019 were $<ix:nonFraction unitRef="usd" contextRef="i5e2d65ac940341779a7bb92437611d0e_D20210101-20211231" decimals="-3" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzEzNzk_fd8284f6-f4ba-4321-bac3-a8bb0041bf73">2,962</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="iaeb01d7a6b7545c59b03e80288b089bb_D20200101-20201231" decimals="-3" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzEzODM_925edbcd-adb9-4744-8679-1b49897fc810">3,637</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3fa45997abe546d1b852b96a64b33d64_D20190101-20191231" decimals="-3" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzEzOTA_25df1915-935f-45fc-959a-08178dbb8c5e">1,751</ix:nonFraction>, respectively. Deferred amounts are generally paid out in cash at the participant&#8217;s election either in the first or second year following retirement or in a specified future period at least three to four years after the deferral election was effective. During 2021, 2020 and 2019 the Company distributed $<ix:nonFraction unitRef="usd" contextRef="i5e2d65ac940341779a7bb92437611d0e_D20210101-20211231" decimals="-3" name="us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzE2OTE_ccfd73f0-547d-4c44-bb93-eae87b7c5782">11,887</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="iaeb01d7a6b7545c59b03e80288b089bb_D20200101-20201231" decimals="-3" name="us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzE2OTU_21fbade8-4c74-4a63-8f0f-134d9cd7937d">3,139</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3fa45997abe546d1b852b96a64b33d64_D20190101-20191231" decimals="-3" name="us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzE3MDI_a468c571-06da-43c6-98ce-7770b3ddb9aa">2,730</ix:nonFraction>, respectively, to participants from its deferred compensation plans. Participants are credited with </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4f1dbfed431e472f81959a60c9e7af79">their proportional amount of annual earnings from the plans. The assets of these plans are held in rabbi trusts subject to the claims of the Company&#8217;s general creditors in the event of its bankruptcy. As of December&#160;31, 2021 and 2020, the total fair value of assets held in these plans' trusts was $<ix:nonFraction unitRef="usd" contextRef="ib37522dd4fa04db58a48b42468502952_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzIwODY_176cdf44-f0be-4895-b8f2-461352b9e0b1">38,019</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iab1bf5046e4745aa8d595dc07340685c_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzIwOTM_f66b3a1d-64b0-4981-99c4-55cdc3fb9f8d">43,844</ix:nonFraction>, respectively. The assets of these plans are recorded at fair value with changes in fair value recorded in other income. See Note 5 for further details. Any fair value changes to the corresponding liability balance are recorded as compensation expense.</ix:continuation></span></div><div id="i916f7af890114e55a87e260476560c60_274"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:LossContingencyDisclosures" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzQvZnJhZzpkN2JjYTZmNDYxMDY0ZDQ2YjVmY2Q0NzA0YTE2MDQ5Mi90ZXh0cmVnaW9uOmQ3YmNhNmY0NjEwNjRkNDZiNWZjZDQ3MDRhMTYwNDkyXzE1MTA2_374ca4bf-2d56-4df0-aea4-83f2262a3a63" continuedAt="ia3c9f9c46a0e4f4eb5a6a1954f2b6f1c" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="ia3c9f9c46a0e4f4eb5a6a1954f2b6f1c" continuedAt="i818059a8fc62438483af5729a04a32e4"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#8217;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#8217;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits, governmental investigations (which frequently arise from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of December&#160;31, 2021 and December&#160;31, 2020, the Company&#8217;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#8217;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Governmental Inquiries and Related Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 U.S. Attorney Texas Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#8217;s Office, Northern District of Texas. The government is conducting a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#8217;s relationships with pharmaceutical manufacturers. The government's investigation covers the period from January&#160;1, 2006 through December 31, 2018. In December 2017, the Company finalized and executed a settlement agreement that resolved certain of the issues in the government's investigation and that included total monetary consideration of $<ix:nonFraction unitRef="usd" contextRef="if21f5702256f425495741fad20cc492f_D20171201-20171231" decimals="-3" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzQvZnJhZzpkN2JjYTZmNDYxMDY0ZDQ2YjVmY2Q0NzA0YTE2MDQ5Mi90ZXh0cmVnaW9uOmQ3YmNhNmY0NjEwNjRkNDZiNWZjZDQ3MDRhMTYwNDkyXzM3NzQ_d434660f-e260-4918-9700-be2439c6f62a">63,700</ix:nonFraction>, as previously disclosed, of which $<ix:nonFraction unitRef="usd" contextRef="ibd5bad9eacc4435abc4605158f6eb4f0_D20171201-20171231" decimals="-3" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzQvZnJhZzpkN2JjYTZmNDYxMDY0ZDQ2YjVmY2Q0NzA0YTE2MDQ5Mi90ZXh0cmVnaW9uOmQ3YmNhNmY0NjEwNjRkNDZiNWZjZDQ3MDRhMTYwNDkyXzM4MTI_3bd696fa-ad51-4b47-a1fd-0bf770708133">41,500</ix:nonFraction> was an incremental cash payment and $<ix:nonFraction unitRef="usd" contextRef="ie0c63c6719e446e98d499e8b261b5511_D20171201-20171231" decimals="-3" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzQvZnJhZzpkN2JjYTZmNDYxMDY0ZDQ2YjVmY2Q0NzA0YTE2MDQ5Mi90ZXh0cmVnaW9uOmQ3YmNhNmY0NjEwNjRkNDZiNWZjZDQ3MDRhMTYwNDkyXzM4NTE_0146e4a5-0aed-4b90-8a6f-96d67e82dfdd">22,200</ix:nonFraction> was for amounts previously refunded, and all of which was previously accrued. The government&#8217;s investigation is ongoing with respect to issues related to DaVita Rx's historic relationships with certain pharmaceutical manufacturers, and in July 2018 the Office of Inspector General (OIG) served the Company with a subpoena seeking additional documents and information relating to those relationships. On September 15, 2021, the U.S. Attorney&#8217;s Office notified the U.S. District Court, Northern District of Texas, of its decision and the decision of 31 states not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Doe v. DaVita Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The court then unsealed the complaint, which alleges violations of the FCA, by order dated September 17, 2021. The complaint was not served on the Company. In December 2021, the private party relator filed a notice of voluntary dismissal of all claims and the Court entered an order dismissing the claims without prejudice. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2017 U.S. Attorney Colorado Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In November 2017, the U.S. Attorney&#8217;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#8217;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i818059a8fc62438483af5729a04a32e4" continuedAt="if5caa9dc87dd42d8ac92a407c6aca795"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018, May 2019, and July 2021, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 U.S. Attorney New Jersey Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2020, the U.S. Attorney&#8217;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#8217;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#8217;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired October 22, 2019. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 California Department of Insurance Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020, and an additional subpoena in September 2021. Those subpoenas request information on a number of topics, including but not limited to the Company&#8217;s communications with patients about insurance plans and financial assistance from the American Kidney Fund (AKF), analyses of the potential impact of patients&#8217; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is cooperating with CDI in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Department of Justice Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In October 2020, the Company received a CID from the Department of Justice pursuant to a False Claims Act investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covers the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and on-going discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#8217;s reputation, required changes to the Company&#8217;s business practices, an impact on the Company's various relationships and/or contracts related to the Company's business, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Antitrust Indictment and Putative Class Action Suit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On July 14, 2021, an indictment was returned by a grand jury in the U.S. District Court, District of Colorado against the Company and its former chief executive officer in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. v. DaVita Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The two count indictment alleges that purported agreements entered into by DaVita's former chief executive officer not to solicit senior-level employees violate Section 1 of the Sherman Act. On September 14, 2021, DaVita and its former chief executive officer filed a motion to dismiss the indictment. On November 3, 2021, a superseding indictment was returned in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. v. DaVita Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that included an additional count alleging a third violation of the Sherman Act. On November 10, 2021, DaVita and its former chief executive officer filed a renewed motion to dismiss the superseding indictment. On January&#160;28,&#160;2022, the court denied the motion to dismiss. The matter is set to start trial on March 28, 2022. On July 16, 2021, a former DaVita employee filed a putative class action complaint in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pena v. Surgical Care Affiliates, LLC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. District Court, Northern District of Illinois based on the allegations in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. v. DaVita Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On August 6, 2021, the plaintiff in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pena</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case filed a notice of voluntary dismissal and the court dismissed the complaint on August 9, 2021. On August 9, 2021, DaVita was named as defendant in a consolidated class action complaint in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Outpatient Medical Center Employee Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. District Court, Northern District of Illinois. This class action complaint seeks to bring an action on behalf of certain groups of individuals employed by the Company between February 1, 2012 and January 5, 2021. On October 18, 2021, the Company filed a motion to dismiss the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="if5caa9dc87dd42d8ac92a407c6aca795" continuedAt="id508510eed10429e8010714ab5e2d60f"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">class action complaint. The Company disputes the allegations in the superseding indictment and the class action complaint, as well as the asserted violations of the Sherman Act, and intends to defend these actions accordingly.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Marietta Memorial Hospital Employee Health Benefit Plan, et al. v. DaVita Inc. et al. No. 20-1641</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On November 5, 2021 the United States Supreme Court granted certiorari of an appeal by an employer group health plan, the plan sponsor, and the plan&#8217;s advisor of the U.S. Court of Appeals for the Sixth Circuit (Sixth Circuit) decision in the Company's favor. The questions presented involve whether the health plan violates the Medicare Secondary Payor Act by "taking into account" that plan beneficiaries are eligible for Medicare and/or by "differentiating" between the benefits that the plan offers to patients with dialysis versus others. On December 23, 2021, the Solicitor General on behalf of the United States filed an amicus brief supporting the petitioners' request to overturn the Sixth Circuit decision. On January 19, 2022, the Company filed its brief in support of the Sixth Circuit decision, and the Company intends to defend against the appeal accordingly. The case is set for oral argument on March 1, 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in Note 16 to these consolidated financial statements, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#8217;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#8217;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, may impact the Company's various relationships and/or contracts related to the Company's business or otherwise harm the Company&#8217;s business, results of operations, financial condition, cash flows or reputation.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Resolved Matters</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Peace Officers&#8217; Annuity and Benefit Fund of Georgia Securities Class Action Civil Suit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On February 1, 2017, the Peace Officers&#8217; Annuity and Benefit Fund of Georgia filed a putative federal securities class action complaint in the U.S. District Court for the District of Colorado against the Company and certain executives.&#160;The complaint covers the time period of August 2015 to October 2016 and alleges, generally, that the Company and its executives violated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">federal securities laws concerning the Company&#8217;s financial results and revenue derived from patients who received charitable premium assistance from an industry-funded non-profit organization.&#160;The complaint further alleges that the process by which patients obtained commercial insurance and received charitable premium assistance was improper and "created a false impression of DaVita&#8217;s business and operational status and future growth prospects."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company continues to dispute the allegations, it reached an agreement to resolve this matter without admitting to any liability.&#160;Settlement of this matter was covered primarily with insurance proceeds. The Company contributed an amount that did not have a material impact on the Company&#8217;s consolidated financial position, results of operations or cash flows. On April 13, 2021, the court granted final approval of the settlement. On August 9, 2021, the court entered final judgment and dismissed all claims in the action with prejudice.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">In re DaVita Inc. Stockholder Derivative Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On August 15, 2017, the U.S. District Court for the District of Delaware consolidated three previously disclosed shareholder derivative lawsuits: the Blackburn Shareholder action filed on February 10, 2017, the Gabilondo Shareholder action filed on May 30, 2017, and the City of Warren Police and Fire Retirement System Shareholder action filed on June 9, 2017. The complaint covers the time period from 2015 to present and alleges, generally, breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, corporate waste, and misrepresentations and/or failures to disclose certain information in violation of the federal securities laws in connection with an alleged practice to direct patients with government-subsidized health insurance into private health insurance plans to maximize the Company&#8217;s profits.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the defendants continue to dispute the allegations, an agreement was reached to resolve this matter without admitting to any liability and the court approved the settlement and entered final judgment and dismissed the case with prejudice on January 29, 2021. As part of the settlement, the Company agreed to certain corporate governance policies, but did not make any financial contribution towards the settlement.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><ix:continuation id="id508510eed10429e8010714ab5e2d60f" continuedAt="i898e241f0caf429894a6ae986e564b30"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2018 U.S. Attorney Florida Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2018, DaVita Labs received two CIDs from the U.S. Attorney&#8217;s Office, Middle District of Florida that were identical in nature but directed to the two different labs. According to the face of the CIDs, the U.S. Attorney&#8217;s Office is conducting an investigation as to whether the Company&#8217;s subsidiary submitted claims for blood, urine, and fecal testing, where there were insufficient test validation or stability studies to ensure accurate results, in violation of the FCA. In October 2018, DaVita Labs received a subpoena from the OIG in connection with this matter requesting certain patient records linked to clinical laboratory tests. On September 30, 2019, the U.S. Attorney&#8217;s Office notified the U.S. District Court, Middle District of Florida, of its decision not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Lorne Holland, et al. v. DaVita Healthcare Partners, Inc., et al</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i898e241f0caf429894a6ae986e564b30">. The court then unsealed the complaint, which alleges violations of the FCA, by order dated the same day. In January 2020, the private party relators served the Company and DaVita Labs with an amended complaint. The Company and DaVita Labs answered the complaint on July 23, 2020. On August 10, 2021, the court entered summary judgment in favor of the Company and DaVita Labs on all of the relators&#8217; FCA claims leaving only the claims for retaliation. The court dismissed the case on October 13, 2021. On October 15, 2021, the parties signed an agreement to resolve the remaining retaliation claims for an immaterial amount.</ix:continuation> </span></div><div id="i916f7af890114e55a87e260476560c60_277"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:CommitmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzQ1ODQ_31d6d778-c5c8-4042-acc4-a06629a78823" continuedAt="i32ee0f9b28bf42579b06557c07dbca95" escape="true">Noncontrolling interests subject to put provisions and other commitments</ix:nonNumeric></span></div><ix:continuation id="i32ee0f9b28bf42579b06557c07dbca95" continuedAt="ifeb461ab146c4932a8638195c68c4aee"><ix:continuation id="i6164d7b272e1436b9c849c098c2505d8"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling interests subject to put provisions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has potential obligations to purchase the equity interests held by third parties in many of its majority-owned dialysis partnerships and other nonconsolidated entities. These noncontrolling interests subject to put provisions constitute redeemable equity interests and are therefore classified as temporary equity and carried at estimated fair value on the Company's balance sheet.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, these obligations are in the form of put provisions that are exercisable at the third-party owners&#8217; discretion within specified periods outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase the third-party owners&#8217; equity interests, generally at the appraised fair market value of the equity interests or in certain cases at a predetermined multiple of earnings or cash flows attributable to the equity interests put to the Company, intended to approximate fair value. The methodology the Company uses to estimate the fair values of noncontrolling interests subject to put provisions assumes the higher of either a liquidation value of net assets or an average multiple of earnings, based on historical earnings, patient mix and other performance indicators that can affect future results, as well as other factors. The estimated fair values of noncontrolling interests subject to put provisions are a critical accounting estimate that involves significant judgments and assumptions and may not be indicative of the actual values at which the noncontrolling interests may ultimately be settled, which could vary significantly from the Company&#8217;s current estimates. The estimated fair values of noncontrolling interests subject to put provisions can fluctuate and the implicit multiple of earnings at which these noncontrolling interests obligations may be settled will vary significantly depending upon market conditions including potential purchasers&#8217; access to the capital markets, which can impact the level of competition for dialysis and non-dialysis related businesses, the economic performance of these businesses and the restricted marketability of the third-party owners&#8217; equity interests. The amount of noncontrolling interests subject to put provisions that employ a contractually predetermined multiple of earnings rather than fair value is immaterial.</span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain consolidated dialysis partnerships are originally contractually scheduled to dissolve after terms ranging from <ix:nonNumeric contextRef="i2be3f954e5f14213b4903797ad633c44_D20210101-20211231" name="dva:DissolutionTermOfJointVentures" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzI4OTI_c4e31996-933d-402b-a87d-04215f3abd3f">ten years</ix:nonNumeric> to <ix:nonNumeric contextRef="ife16d51280fb452d8a63ec87d4093b0f_D20210101-20211231" name="dva:DissolutionTermOfJointVentures" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzI4OTg_f3c79c1a-a3d7-4b84-bb55-0cacb5203d7d">50</ix:nonNumeric> years. While noncontrolling interests in these limited life entities qualify as mandatorily redeemable financial instruments, they are subject to a classification and measurement scope exception from the accounting guidance generally applicable to other mandatorily redeemable financial instruments. Future distributions upon dissolution of these entities would be valued below the related noncontrolling interest carrying balances in the consolidated balance sheet.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other commitments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the Company entered into a Sourcing and Supply Agreement with Amgen USA Inc. (Amgen) that expires on <ix:nonNumeric contextRef="if5bfd09272294ace935620050b39f2f8_D20210101-20211231" name="dva:LongTermPurchaseCommitmentExpirationDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzM0OTA_8e322ef7-737b-411e-b47a-1c6d6ecefae5">December&#160;31, 2022</ix:nonNumeric>. Under the terms of the agreement, the Company will purchase EPO from Amgen in amounts necessary to meet no less than <ix:nonFraction unitRef="number" contextRef="i64d9f8f9c7f64715b2760f70c13f5222_D20210101-20211231" decimals="INF" name="dva:LongTermPurchaseCommitmentPercentageOfQuantityRequired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzM2MTE_cd3430e6-07f2-47c9-b1d6-8c5ebb3c4704">90</ix:nonFraction>% of its requirements for erythropoiesis-stimulating agents (ESAs) through the expiration of the contract. The actual amount of EPO that the Company will purchase will depend upon the amount of EPO administered during dialysis as prescribed by physicians and the overall number of patients that the Company serves.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with various suppliers to purchase established amounts of dialysis equipment, parts, and supplies. As of December&#160;31, 2021, the remaining minimum purchase commitments under these arrangements were approximately $<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzQxNTA_09c1235d-c16a-42ad-9e2a-27351100458c">549,079</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:PurchaseObligationDueInSecondYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzQxNTQ_028c2e00-4c6a-48e1-8f9d-910695ced2bb">510,991</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:PurchaseObligationDueInThirdYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzQxNTg_9098ba8e-d6fa-4acc-8ffe-8a8abb633a2b">430,196</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:PurchaseObligationDueInFourthYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzQxNjY_d7e916bf-ab7c-49a1-86f9-d16929155686">345,863</ix:nonFraction> for the years 2022, 2023, 2024, and 2025, respectively. If the Company fails to meet the minimum purchase commitments under these contracts during any year, it is required to pay the difference to the supplier.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ifeb461ab146c4932a8638195c68c4aee"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $<ix:nonFraction unitRef="usd" contextRef="iafc102d9c4e84b66827b02448eb62b33_I20211231" decimals="-3" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzc2OTY1ODEzOTk2Mzc_5595cc97-db6c-4bd2-b89c-6e2c931a1292">13,469</ix:nonFraction>.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the letters of credit disclosed in Note 13 to these consolidated financial statements, and the arrangements as described above, the Company has <ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="dva:OffBalanceSheetFinancingArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzQ1Mjc_b87357c9-9cb7-4a1e-bf45-e64293d073e0">no</ix:nonFraction> off balance sheet financing arrangements as of December&#160;31, 2021.</span></div></ix:continuation><div id="i916f7af890114e55a87e260476560c60_280"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMzY1_5a37543e-7ba8-48b8-9c32-f2e4dd0715d4" continuedAt="ie6e0286cb57b413584947d70e1cdb0d8" escape="true">Stock-based compensation</ix:nonNumeric></span></div><ix:continuation id="ie6e0286cb57b413584947d70e1cdb0d8" continuedAt="i385fd4e8c7454902974a21e9e8f8fa8f"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation consists primarily of stock-settled stock appreciation rights, restricted stock units and performance stock units. Stock-based compensation, which is primarily general and administrative in nature, is attributed to the Company&#8217;s U.S. dialysis business, its corporate administrative support, and its ancillary services. See Note 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Organization and summary of significant accounting policies" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information on how the Company measures and recognizes stock-based compensation expense.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term incentive compensation plans</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 11, 2020, the Company&#8217;s stockholders approved the DaVita Inc. 2020 Incentive Award Plan (the 2020 Plan). Prior to June 11, 2020 stock-based awards were granted under the DaVita Healthcare Partners Inc. 2011 Incentive Award Plan (the 2011 Plan). The 2011 Plan was terminated with respect to any new awards upon stockholder approval of the 2020 Plan. At the time the 2020 Plan was approved there were <ix:nonFraction unitRef="shares" contextRef="ic622bc7776774482b0a75f8b50b90c1b_I20200611" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzE5NDU_ff1908ca-782f-46a6-95cc-95116b3ebc1c">8,730</ix:nonFraction> shares of common stock available for issuance under the 2020 Plan, consisting of <ix:nonFraction unitRef="shares" contextRef="ic622bc7776774482b0a75f8b50b90c1b_I20200611" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzIwMjk_f373d13a-b154-478a-8791-f3e5cf38519e">5,000</ix:nonFraction> newly authorized shares and <ix:nonFraction unitRef="shares" contextRef="i7cd5dd9a955e4f3595a1f2ea57f1dd2a_I20200611" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzIwNjA_bb575300-2134-456f-96dc-345410cac17b">3,730</ix:nonFraction> shares that were available for issuance under the 2011 Plan as of the effective date of the 2020 Plan and which became available for grant under the 2020 Plan, pursuant to the terms of the 2020 Plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Plan is the Company&#8217;s current omnibus equity compensation plan and provides for grants of stock-based awards to employees, directors and other individuals providing services to the Company, except that incentive stock options may only be awarded to employees. The 2020 Plan provides for the grant of stock appreciation rights, nonqualified stock options, incentive stock options, restricted stock units, restricted stock, performance stock awards, dividend equivalents, stock payments, deferred stock unit awards, deferred stock awards and performance cash awards. The 2020 Plan mandates a maximum award term of <ix:nonNumeric contextRef="i35c0745d14cd45a6967e0f7b75a5a9d2_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzI4ODQ_454c343f-ef4b-472b-9282-f8804a2b2f46">10</ix:nonNumeric> years for stock appreciation rights and stock options and stipulates that awards of these types be granted with a base or exercise price per share of not less than the fair market value of the Company's common stock on the date of grant. Shares available under the 2020 Plan are also stated on a full value share basis rather than on an option-equivalent basis. The 2020 Plan therefore provides that shares available for issuance under the plan are reduced by <ix:nonFraction unitRef="shares" contextRef="i7e9c2f87088c43fb9b9ca96464a7c38f_D20210101-20211231" decimals="INF" name="dva:StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzMzNDE_3a2a6f8e-162c-4670-b900-0ff5d29846be">one</ix:nonFraction> share available for every <ix:nonFraction unitRef="shares" contextRef="i7e9c2f87088c43fb9b9ca96464a7c38f_D20210101-20211231" decimals="INF" name="dva:StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzMzNzA_048bd346-7544-4bb3-ba1b-d0939fd44f9c">four</ix:nonFraction> shares underlying stock appreciation rights and stock options, and are reduced by <ix:nonFraction unitRef="shares" contextRef="i7e9c2f87088c43fb9b9ca96464a7c38f_D20210101-20211231" decimals="INF" name="dva:StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzM0NTU_15d2c35e-e3d3-4e46-b5a2-b66ee576093f">one</ix:nonFraction> share available for every <ix:nonFraction unitRef="shares" contextRef="i7e9c2f87088c43fb9b9ca96464a7c38f_D20210101-20211231" decimals="INF" name="dva:StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzM0ODQ_2e4d8263-0a0f-4bf6-b264-4731a105cac3">one</ix:nonFraction> share underlying stock-based awards other than stock appreciation rights and stock options. At December&#160;31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="ib351125c6c8e42c092e5fa01eb01c2c7_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzM1OTc_f6923cde-5afa-41a3-adc0-76bbf0540b3a">7,672</ix:nonFraction> shares available for future grants under the 2020 Plan. The Company&#8217;s stock awards granted under the 2020 Plan generally vest over <ix:nonNumeric contextRef="i9b85e310c2ac454bb82196389edfda90_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzM3MzA_1e25f07a-b064-47a8-89d4-13b3667fa599">36</ix:nonNumeric> months to <ix:nonNumeric contextRef="i35c0745d14cd45a6967e0f7b75a5a9d2_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzM3MzY_a88e1617-5e87-4466-bfde-46ae32903b2a">48</ix:nonNumeric> months from the date of grant.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2011 Plan was the Company&#8217;s prior omnibus equity compensation plan and authorized the Company to award stock options, stock appreciation rights, restricted stock units, restricted stock, and other stock-based or performance-based awards. The 2011 Plan mandated a maximum award term of <ix:nonNumeric contextRef="i945bf94544c1438d8e7ef2556b93e671_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQxMzA_ba3d1ef9-45a9-46a2-a00b-f97712cbd5f8">five years</ix:nonNumeric> and stipulated that stock appreciation rights and stock options be granted with prices not less than fair market value on the date of grant. The 2011 Plan also required that full value share awards such as restricted stock units reduce shares available under the 2011 Plan at a ratio of <ix:nonFraction unitRef="number" contextRef="i945bf94544c1438d8e7ef2556b93e671_D20210101-20211231" decimals="INF" name="dva:SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQ0MjA_f4bbc865-0728-400e-aec8-ef4e2c2a664e">3.5</ix:nonFraction>:1. The Company&#8217;s stock appreciation rights and stock units awarded under the 2011 Plan generally vest over <ix:nonNumeric contextRef="i4579481a1deb4e84842b772212d72988_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQ1MzA_fad8ea5a-7e96-48c5-a9c3-0e7e95150a40">36</ix:nonNumeric> months to <ix:nonNumeric contextRef="i8af02ad747e04ed092ad98eca4b0cece_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQ1MzY_3f6b9824-d81c-4b91-9a43-c843cf26d1d6">48</ix:nonNumeric> months from the date of grant.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i385fd4e8c7454902974a21e9e8f8fa8f" continuedAt="i17b97f7112e44afe9aa2c38f9ab35cbc"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMzY3_43e37d12-efab-4556-b224-23c85a25358c" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A combined summary of the status of the Company&#8217;s stock-settled awards under both the 2020 Plan and 2011 Plan, including base shares for stock-settled stock appreciation rights (SSARs) and stock-settled stock unit awards is as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:37.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.509%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.509%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.827%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stock appreciation rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stock units</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual&#160;life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual&#160;life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f4abca32687438c9db55fe5ab0adc1e_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzMtMS0xLTEtODMwNzg_09680574-e7ac-42b7-8059-fe0a29ffb1f9">8,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f4abca32687438c9db55fe5ab0adc1e_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzMtMy0xLTEtODMwNzg_73cc22d0-0f2f-4f4f-8f06-32c29906cf42">63.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84101fbfd0514880a929fe88d9382ec5_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzMtNy0xLTEtODMwNzg_b68e509e-c2b0-4d03-9614-854cd60b2729">3,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzQtMS0xLTEtODMwNzg_e1227ca5-fd46-4539-89fa-e43223cccd3b">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzQtMy0xLTEtODMwNzg_cdccc2ee-78b6-4ee6-aaf4-a601c72ab42b">108.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzQtNy0xLTEtODMwNzg_776b8eeb-80c8-43fa-98b5-6f2798515113">789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Added by performance factor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231" decimals="-3" name="dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzUtNy0xLTEtODMwNzg_30754be2-5c3d-4a0b-8be5-9b1d8e0b35d4">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised/Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzYtMS0xLTEtODMwNzg_b436e126-6f7d-4e8d-9819-b29768edd84a">2,093</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzYtMy0xLTEtODMwNzg_c7d56440-e789-4bd4-bf4b-54f207d3bb1d">64.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzYtNy0xLTEtODMwNzg_4df45f60-8042-4af0-b01b-c03678c87214">696</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzgtMS0xLTEtODMwNzg_fd47e451-24d7-4649-80fe-f7e5ba3d8819">180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzgtMy0xLTEtODMwNzg_bc50cfc2-615d-4582-9266-b26026caa4a7">59.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzgtNy0xLTEtODMwNzg_4417c195-cea8-4903-afc4-1b860519412d">398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4d14e355b8248a1b1ab9ddb2b5f20bc_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzktMS0xLTEtODMwNzg_878d52cf-e4d7-42df-b56c-3b6d3dfb5876">5,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic4d14e355b8248a1b1ab9ddb2b5f20bc_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzktMy0xLTEtODMwNzg_4b0c0972-560f-4a8b-91f3-ccfbbad28bcc">64.66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzktNS0xLTEtODMwNzg_8591291b-2b83-4951-b6af-5cabcb2c0b47">2.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic595c1af14b94764aab706a16639ebc2_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzktNy0xLTEtODMwNzg_4c4e6366-a580-4d60-9d0c-62e8a27c4f6a">3,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzktOS0xLTEtODMwNzg_af8d9ca3-49ec-4e96-9b1d-2f646a0e98c7">1.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4d14e355b8248a1b1ab9ddb2b5f20bc_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEwLTEtMS0xLTgzMDc4_2cbe34c9-c803-4afe-ba5c-dcc3e454932f">1,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic4d14e355b8248a1b1ab9ddb2b5f20bc_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEwLTMtMS0xLTgzMDc4_ec08d8fe-0332-4ac5-906d-686bbce91ba4">61.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEwLTUtMS0xLTgzMDc4_883e28db-66ec-4696-82b9-a83d41862a0e">1.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic595c1af14b94764aab706a16639ebc2_I20211231" decimals="INF" name="dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEwLTctMS0xLTgzMDc4_c0d32dd0-c5b7-47ff-a85e-4dd0c1792a4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average fair value of grants:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEyLTEtMS0xLTgzMDc4_93d46f80-3335-4296-af90-241445f162c5">32.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEyLTctMS0xLTgzMDc4_09eda410-8949-4e22-9bf6-35bde5cdb925">109.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i827e2371cbd94ca1a2c25ee147f4a6bf_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEzLTEtMS0xLTgzMDc4_82a8a4ac-c167-4767-9817-9e878786ccc6">26.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0917584175d94759b1facacb37055db9_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEzLTctMS0xLTgzMDc4_e2742d7e-43b2-4ec6-a1cd-89de060fab39">77.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8276ca374b541099daef28f0d1b9d96_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzE0LTEtMS0xLTgzMDc4_6bbda5db-d03f-43b4-ba6d-4418742e7703">14.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i501bc5f3ffe44653996610d022c113bd_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzE0LTctMS0xLTgzMDc4_ce02e648-3484-4e8a-9a18-af2d819c268e">50.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMzYy_326851e0-eb29-48a4-92aa-366b1fe3216c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.269%"><tr><td style="width:1.0%"></td><td style="width:28.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.438%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Awards Outstanding</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Awards exercisable</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Range of SSARs base prices</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$50.01&#8211;$60.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79b0c0d86d8e45d790c2ff8423f37743_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzItMi0xLTEtODMwNzg_04aed0f3-ba79-487b-bdf9-ad0895a17dbe">1,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i79b0c0d86d8e45d790c2ff8423f37743_I20211231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzItNC0xLTEtODMwNzg_1b7bc715-894e-4f9d-a7c8-d1f59c514769">52.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79b0c0d86d8e45d790c2ff8423f37743_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzItNi0xLTEtODMwNzg_23d05769-21e9-4f39-8172-434d90cf3530">425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i79b0c0d86d8e45d790c2ff8423f37743_I20211231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzItOC0xLTEtODMwNzg_1cc724bd-3cae-4298-b2d0-6e43b136001b">52.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$60.01&#8211;$70.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c8c2a2e98ec40d79e375f2a9fffd77c_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzMtMi0xLTEtODMwNzg_6f380406-0682-4119-bb0d-02f76a78970a">3,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8c8c2a2e98ec40d79e375f2a9fffd77c_I20211231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzMtNC0xLTEtODMwNzg_ba020f3f-69f3-4dcc-8d35-38367b109b5d">67.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c8c2a2e98ec40d79e375f2a9fffd77c_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzMtNi0xLTEtODMwNzg_1f818863-31da-4263-b562-c1b204bc8b6a">732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8c8c2a2e98ec40d79e375f2a9fffd77c_I20211231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzMtOC0xLTEtODMwNzg_4804f15c-488f-4986-9b6d-b8229a33b27b">66.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$70.01&#8211;$80.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97843a20897047b5a1130cbd153c19f6_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzQtMi0xLTEtODMwNzg_4c3cd903-1248-4700-b1e5-c071a1ea536a">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97843a20897047b5a1130cbd153c19f6_I20211231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzQtNC0xLTEtODMwNzg_6e4ecf33-e039-4f58-a375-cf9b1cdf8106">75.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97843a20897047b5a1130cbd153c19f6_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzQtNi0xLTEtODMwNzg_e37000e4-4483-43d7-92ea-e3b61c9359ad">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97843a20897047b5a1130cbd153c19f6_I20211231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzQtOC0xLTEtODMwNzg_f9a760d7-a62a-4028-9254-6d29514d7db9">71.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$100.01&#8211;$110.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia27684d4183a41acb4b535601396cbc2_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtMi0xLTEtMTM0NzE1_6ca18f45-5d0c-45f7-a071-cc40cd862a41">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia27684d4183a41acb4b535601396cbc2_I20211231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtNC0xLTEtMTM0NzE1_92348be6-4557-4a7f-ba7c-47532da25111">108.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia27684d4183a41acb4b535601396cbc2_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtNi0xLTEtMTM0NzE1_aa6dc534-19cb-4a2c-a333-2dcc9edc9312">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia27684d4183a41acb4b535601396cbc2_I20211231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtOC0xLTEtMTM0NzE1_d30481d6-9d9f-4cb2-9347-9bf42242053f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtMi0xLTEtODMwNzg_fbf2d89d-dc5d-40cc-bf8f-f86aca2d6735">5,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtNC0xLTEtODMwNzg_75a9f885-c34d-4e14-9a8d-0dbd19a48641">64.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtNi0xLTEtODMwNzg_69714dba-900b-4901-af10-1b20585c0490">1,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtOC0xLTEtODMwNzg_5819895f-c91c-491f-9415-f18ba6770955">61.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020, and 2019, the aggregate intrinsic value of stock-based awards exercised was $<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQ5MDU_cfa227be-17ff-44b0-87c0-b24232b8d4d2">208,585</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQ5MDk_85212619-8a2f-459e-8c26-682df8f409ef">49,258</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQ5MTY_9b144b32-b786-49e4-b1d1-71227a08108e">11,475</ix:nonFraction>, respectively. At December&#160;31, 2021, the aggregate intrinsic value of stock-based awards outstanding was $<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzUwMDk_5e1123cf-4129-4cf7-ab4d-eb9e4c5005f1">680,251</ix:nonFraction> and the aggregate intrinsic value of stock awards exercisable was $<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzUwNzg_0665a602-0d65-4373-9b9b-618499909f16">61,389</ix:nonFraction>.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimated fair value of stock-based compensation awards</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has estimated the grant-date fair value of stock-settled stock appreciation rights awards using the Black-Scholes-Merton valuation model and stock-settled stock unit awards at intrinsic value on the date of grant, except for portions of the Company&#8217;s performance stock unit awards for which a Monte Carlo simulation was used to estimate the grant-date fair value. The following assumptions were used in estimating these values and determining the related stock-based compensation expense attributable to the current period:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected term of the awards:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The expected term of awards granted represents the period of time that they are expected to remain outstanding from the date of grant. The Company determines the expected term of its stock awards based on its historical experience with similar awards, considering the Company&#8217;s historical exercise and post-vesting termination patterns.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected volatility:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Expected volatility represents the volatility anticipated over the expected term of the award. The Company determines the expected volatility for its awards based on the volatility of the price of its common stock over the most recent retrospective period commensurate with the expected term of the award, considering the volatilities expected by peer companies in near industries.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected dividend yield:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company has not paid dividends on its common stock and does not currently expect to pay dividends during the term of stock awards granted.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-free interest rate:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company bases the expected risk-free interest rate on the implied yield currently available on stripped interest coupons of U.S. Treasury issues with a remaining term equivalent to the expected term of the award.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i17b97f7112e44afe9aa2c38f9ab35cbc"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMzY4_407581a4-61f3-4e4f-9fc4-905053762358" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of SSAR awards granted in the periods indicated is as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"></td><td style="width:40.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6b0097cc1b5e467d90993d8c00830861_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzItMS0xLTEtODMwNzg_8ebb0099-64cc-4d50-8cf8-929fb6bfd7da">4.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id524f2487e4c4b6b8d6dfc8130802d34_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzItMy0xLTEtODMwNzg_2d333d93-d50f-46f3-8792-6613cec9721f">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i42692d9f0c4245ddb37f1c5457eb7288_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzItNS0xLTEtODMwNzg_80fec409-2b26-49c2-a965-b195603a477e">4.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b0097cc1b5e467d90993d8c00830861_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzMtMS0xLTEtODMwNzg_7796ed75-385a-4907-8ae6-e549ab4653f8">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id524f2487e4c4b6b8d6dfc8130802d34_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzMtMy0xLTEtODMwNzg_fd711471-76a0-40d5-bc41-f698660559ca">28.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42692d9f0c4245ddb37f1c5457eb7288_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzMtNS0xLTEtODMwNzg_01baeb7c-6b06-432a-b597-4a74f19d0c8e">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b0097cc1b5e467d90993d8c00830861_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzQtMS0xLTEtODMwNzg_d8b78fe1-22bc-45f1-9995-ed2af807fd57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id524f2487e4c4b6b8d6dfc8130802d34_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzQtMy0xLTEtODMwNzg_2bf4ec49-8d55-409d-a764-60eaf8a0026b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42692d9f0c4245ddb37f1c5457eb7288_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzQtNS0xLTEtODMwNzg_3677604c-3288-4e93-a274-8950361b127e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b0097cc1b5e467d90993d8c00830861_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzUtMS0xLTEtODMwNzg_eecdde0e-f2e3-4959-ad1c-7aba6150d481">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id524f2487e4c4b6b8d6dfc8130802d34_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzUtMy0xLTEtODMwNzg_99b7c44b-9c37-4d6a-b540-fa7926281aab">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42692d9f0c4245ddb37f1c5457eb7288_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzUtNS0xLTEtODMwNzg_78a84506-44ed-4ca0-9f21-f09369d0f1f9">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company estimates expected forfeitures based upon historical experience with separate groups of employees that have exhibited similar forfeiture behavior in the past. Stock-based compensation expense is recorded only for awards that are expected to vest.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 4, 2019, the independent members of the Company&#8217;s Board of Directors (Board) approved an award of <ix:nonFraction unitRef="shares" contextRef="i4a9414d6f3884602bb28983144590fd6_D20191104-20191104" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzc0MDI_69e1af5a-6663-4adc-a7d0-57a88608b29c">2,500</ix:nonFraction> premium-priced stock-settled stock appreciation rights (Premium-Priced Award) to the Company&#8217;s Chief Executive Officer (CEO), which award was subject to stockholder approval of a related amendment to the 2011 Plan. Stockholders approved such amendment to the 2011 Plan on January 23, 2020, authorizing the grant to the Company's CEO. Since stockholder approval occurred in 2020, this award was treated as granted in 2020 for accounting purposes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The base price of the Premium-Priced Award was $<ix:nonFraction unitRef="usdPerShare" contextRef="ie576d2314dda4f0ebf4d0fcfd81bff38_I20191104" decimals="2" name="dva:PremiumPricedAwardBasePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzc4OTg_2f1df131-9bc0-47b2-bfde-a4b9499022da">67.80</ix:nonFraction> per share, which was a <ix:nonFraction unitRef="number" contextRef="ie576d2314dda4f0ebf4d0fcfd81bff38_I20191104" decimals="INF" name="dva:PremiumToTheTenderOfferSharePurchasePrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzc5MjQ_e567a4a8-15e3-4a59-86c6-220a3f15154e">20</ix:nonFraction>% premium to the clearing price of the Company's modified Dutch auction tender offer for its shares in 2019 (2019 Tender Offer). The award vests <ix:nonFraction unitRef="number" contextRef="i3aa0d7d04018489e86afb5c88077307b_D20191104-20191104" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzgwNzA_69675f19-c524-46b4-83d0-c55f70b86e11">50</ix:nonFraction>% on each of <ix:nonNumeric contextRef="i3aa0d7d04018489e86afb5c88077307b_D20191104-20191104" name="dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzgwODQ_2facff8e-bd83-4ffe-bfa9-5e320225f9b7">November&#160;4, 2022</ix:nonNumeric> and <ix:nonNumeric contextRef="i3a011ba985114d35aac38e038221e94d_D20191104-20191104" name="dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzgwOTE_3dbc6485-bd25-465b-9161-dcd4c6ea21ca">November&#160;4, 2023</ix:nonNumeric> and expires on <ix:nonNumeric contextRef="i4a9414d6f3884602bb28983144590fd6_D20191104-20191104" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzgxMDk_1616ab48-2b7b-422f-b5f0-5f2e51a18b1d">November&#160;4, 2024</ix:nonNumeric>. The award includes a requirement that the CEO hold any shares acquired upon exercise of this award, net of shares used to cover related taxes, until <ix:nonNumeric contextRef="i4a9414d6f3884602bb28983144590fd6_D20191104-20191104" name="dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzgyNjI_1689e5f7-6245-4fbb-a8b3-185e7f9c7126">November&#160;4, 2024</ix:nonNumeric> (that is, for the full term of the award), subject to lapse of the holding period upon a change in control of the Company or due to the CEO's death or termination due to disability.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee stock purchase plan</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employee Stock Purchase Plan entitles qualifying employees to purchase up to $<ix:nonFraction unitRef="usd" contextRef="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231" decimals="INF" name="dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzg1NTc_724b6fdb-adb7-4ae7-900a-60b844e3001c">25</ix:nonFraction> of the Company&#8217;s common stock during each calendar year. The amounts used to purchase stock are accumulated through payroll withholdings or through optional lump sum payments made in advance of the first day of the purchase right period. This compensatory plan allows employees to purchase stock for the lesser of <ix:nonFraction unitRef="number" contextRef="i43f1797df61c4bada947140a55076305_D20210101-20210101" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzg4NzQ_7bb404bf-ad21-43e9-94f4-386b30e4a74b">100</ix:nonFraction>% of its fair market value on the first day of the purchase right period or <ix:nonFraction unitRef="number" contextRef="i41c89f4e64064444ab4288488f07ab8a_D20211231-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzg5NTE_eca64166-7ef9-406f-bad3-ed7c8f3c87d9">85</ix:nonFraction>% of its fair market value on the last day of the purchase right period. Purchase right periods begin on January&#160;1 and July&#160;1, and end on December&#160;31. Contributions used to purchase the Company&#8217;s common stock under this plan for the 2021, 2020 and 2019 purchase periods were $<ix:nonFraction unitRef="usd" contextRef="iabef7cbe53f54aab89ff94790caaaed4_I20211231" decimals="-3" name="dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkyMjE_ccc74cd4-011a-4502-8e41-338981ff44ea">19,626</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i380e810ddcd14e7bab4d2d061f0adab0_I20201231" decimals="-3" name="dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkyMjU_f1181695-c38a-4864-8687-552512f8ef40">17,148</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i10d2c3b34a424e5d8a056079072420d1_I20191231" decimals="-3" name="dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkyMzI_83a719cd-89de-4804-9ca9-85460497007c">16,569</ix:nonFraction>, respectively. Shares purchased pursuant to the plan&#8217;s 2021, 2020 and 2019 purchase periods were <ix:nonFraction unitRef="shares" contextRef="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkzMjY_741cfe2e-3a0a-4f1c-81c9-ebc4a27c068f">203</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="ie566e44321f64f1aa0fcc5e21f1a0e7c_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkzMzA_068e5860-3468-489a-9f10-95b4b9bb2f2c">222</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i6dd1cc1bae74476ba5ac3d8c45f6fd36_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkzMzc_acbc3644-2192-4375-8677-564ba875f6ff">315</ix:nonFraction>, respectively. At December&#160;31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="iabef7cbe53f54aab89ff94790caaaed4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkzNzM_1b8161d4-7aa1-4cae-b9bd-017be4658271">5,986</ix:nonFraction> shares remaining available for future grants under this plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of participants&#8217; purchase rights was estimated as of the beginning dates of the purchase right periods using the Black-Scholes-Merton valuation model with the following weighted average assumptions for purchase right periods in 2021, 2020 and 2019, respectively: expected volatility of <ix:nonFraction unitRef="number" contextRef="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3MzM_4aaae956-e300-4b62-abf6-c45edd5ad8b1">39.0</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ie566e44321f64f1aa0fcc5e21f1a0e7c_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3Mzc_a1084d13-c846-476a-89f5-b68fe5f76811">40.4</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i6dd1cc1bae74476ba5ac3d8c45f6fd36_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3NDQ_ff4574cf-f70f-42e6-9d87-80ce555573b4">28.8</ix:nonFraction>%; risk-free interest rates of <ix:nonFraction unitRef="number" contextRef="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3NzY_e2806f1e-2a13-4296-8e87-4aa3b4ace9a4">0.1</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ie566e44321f64f1aa0fcc5e21f1a0e7c_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3ODA_a5fa7a68-4019-49f5-822e-4d86f854a865">1.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i6dd1cc1bae74476ba5ac3d8c45f6fd36_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3ODc_f676c0da-4f5f-410f-a6ad-d136e62e0a19">2.6</ix:nonFraction>%, and <ix:nonFraction unitRef="usd" contextRef="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3OTU_bb5e051f-b223-4c97-9cfd-2b2b4ca41102">no</ix:nonFraction> dividends. Using these assumptions, the weighted average estimated per share fair value of each purchase right was $<ix:nonFraction unitRef="usdPerShare" contextRef="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk5MTM_39cf6593-68f7-4c71-9016-d3d7102a5eab">34.94</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="ie566e44321f64f1aa0fcc5e21f1a0e7c_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk5MTc_c0e5fc25-0386-41ad-b817-356a5cbca58a">22.06</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i6dd1cc1bae74476ba5ac3d8c45f6fd36_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk5MjQ_623b33c4-eb23-4fbf-a7d0-4ad36dcb96f1">13.80</ix:nonFraction> for 2021, 2020 and 2019, respectively.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation expense and proceeds</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="iee68ddd110f44f1ab19b2eecfcc796b2_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwMTMz_b3a2fe98-aded-4a7a-921a-bb00a751ff7b">102,209</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ic32b93908745434ba82e999a75ecc6c1_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwMTM3_dae0e6f5-ce2d-4ca3-8a88-f0a8378216db">91,458</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i069396e3d9b14202820b9db352b5ab69_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwMTQ0_6236ca9f-c0e2-456d-bd51-f51cbf9dcbc8">63,705</ix:nonFraction> in stock-based compensation expense for stock appreciation rights, stock units and discounted employee stock purchase plan purchases, which are primarily included in general and administrative expenses. The estimated tax benefits recorded for stock-based compensation in 2021, 2020 and 2019 were $<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwNDUz_eca7db03-e525-4331-9709-36faf2ba0750">13,853</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwNDU3_f3386bdb-be19-44c5-beca-3d7d25023570">11,775</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwNDY0_a74265d9-fea4-4d63-a7c2-012e8fcf9da9">9,186</ix:nonFraction>, respectively. As of December&#160;31, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwNTAy_da6bf7ec-1ac8-43a2-a820-b83c9d2a2e21">161,147</ix:nonFraction> of total estimated but unrecognized stock-based compensation expense under the Company&#8217;s equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of <ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwNzM5_6ea9ef34-7eb3-4aff-86da-b89feabd814f">1.2</ix:nonNumeric> years.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020 and 2019, the Company received $<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMTE0_627923a5-708f-4ff6-add7-e9b4aef1b150">46,990</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMTE4_b367986b-8d05-41ad-bbe6-cde14c3710da">8,957</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMTI1_498878b9-b256-453d-be9f-92df29d553d5">2,251</ix:nonFraction>, respectively, in actual tax benefits upon the exercise or vesting of stock awards. Since the Company issues stock-settled stock appreciation rights rather than stock options, there were <ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="INF" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMzE1_fdebdbce-2040-43b4-9a53-f2fac2960ec2">no</ix:nonFraction> cash proceeds from stock option exercises.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_286"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:TreasuryStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzM0MjA_eb6a6074-d06b-4c3f-97c3-95def66724b3" continuedAt="if4bf65709e9e48c9b4317cb7dcb7cc00" escape="true">Shareholders&#8217; equity</ix:nonNumeric></span></div><ix:continuation id="if4bf65709e9e48c9b4317cb7dcb7cc00" continuedAt="i4467d168d0e741bdb2dc2e1f9d24cfe9"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock repurchases</span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzM0MjE_fc22c571-5b1c-4f74-a049-69d763fadd55" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's repurchases of its common stock during the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"><tr><td style="width:1.0%"></td><td style="width:38.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.155%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.155%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.158%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Open market repurchases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iccf688ffd7124bc6aff7a41fd8083119_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzItMS0xLTEtODMwNzg_adcfea28-f227-449c-9a85-f6992b05ff03">13,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i684fe46545c247fab8d3ef0b725b99a6_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzItMy0xLTEtODMwNzg_55d9cb15-92cc-440a-9a35-91f25ca4f3cf">8,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iba8fa87bf6254cb286350207ba622d6f_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzItNS0xLTEtODMwNzg_9775bac2-5b19-4270-bac4-87b6fc9e8f1b">19,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccf688ffd7124bc6aff7a41fd8083119_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzMtMS0xLTEtODMwNzg_160ab170-fe3d-4ae6-a01f-3b09c57d0942">1,546,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i684fe46545c247fab8d3ef0b725b99a6_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzMtMy0xLTEtODMwNzg_0544ec23-ab10-43a9-9ca4-0f821e3fbaf8">741,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba8fa87bf6254cb286350207ba622d6f_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzMtNS0xLTEtODMwNzg_5fe300a6-0cca-4849-b576-6c61d3dae617">1,168,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iccf688ffd7124bc6aff7a41fd8083119_D20210101-20211231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzQtMS0xLTEtODMwNzg_413c1c68-4d7b-428b-b0f2-092a9ea61c84">111.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i684fe46545c247fab8d3ef0b725b99a6_D20200101-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzQtMy0xLTEtODMwNzg_c68773cc-95ae-4696-b6a9-2d0eb24b7f78">87.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iba8fa87bf6254cb286350207ba622d6f_D20190101-20191231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzQtNS0xLTEtODMwNzg_cd44fca2-64a1-422d-9ed3-bf0c62f658c8">60.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tender offers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88d2ab8df3834c2f925e018980a4b615_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzctMS0xLTEtODMwNzg_5a715e39-6f9e-48d4-a9be-94aeb3f61d85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c74357cd2654da2ab5263e5e1505e1a_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzctMy0xLTEtODMwNzg_f0e6dde0-165d-4c21-88f7-9866872cb8ee">7,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d53d30fe41e4561a3d660180e6b98d1_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzctNS0xLTEtODMwNzg_0625487a-8a31-4c8e-b300-c0f341382df2">21,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88d2ab8df3834c2f925e018980a4b615_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzgtMS0xLTEtODMwNzg_610e0912-b143-40dc-8385-0826c0f9e436">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c74357cd2654da2ab5263e5e1505e1a_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzgtMy0xLTEtODMwNzg_184e71c9-ec64-438d-9135-068386f34367">704,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d53d30fe41e4561a3d660180e6b98d1_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzgtNS0xLTEtODMwNzg_d3e209ab-84cd-49f4-91b4-975ef971ba97">1,234,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i88d2ab8df3834c2f925e018980a4b615_D20210101-20211231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzktMS0xLTEtODMwNzg_9b84952d-d209-42fe-85d3-4a9301b380f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3c74357cd2654da2ab5263e5e1505e1a_D20200101-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzktMy0xLTEtODMwNzg_45db9030-9e9b-4197-b2f9-3152430e271d">88.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4d53d30fe41e4561a3d660180e6b98d1_D20190101-20191231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzktNS0xLTEtODMwNzg_8944cd79-e5e9-4dc7-9022-923d3197b53c">56.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzEyLTEtMS0xLTgzMDc4_faa4e47f-2acd-4162-85a4-c94f4f21dc87">13,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzEyLTMtMS0xLTgzMDc4_1d66e745-f297-46e2-a36f-f8acce65d171">16,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzEyLTUtMS0xLTgzMDc4_ccdc9453-a7f5-41b3-9224-4124131db856">41,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzEzLTEtMS0xLTgzMDc4_8436ad67-800a-40b7-ad4e-2279684b9a7e">1,546,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzEzLTMtMS0xLTgzMDc4_51879387-bea8-4cd3-be21-4cb26df299bc">1,446,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzEzLTUtMS0xLTgzMDc4_e237dd96-bfb6-4dcc-a3c2-4e4875d7693d">2,402,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzE0LTEtMS0xLTgzMDc4_c47b21d4-ca60-464d-8600-ee860a891be1">111.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzE0LTMtMS0xLTgzMDc4_9f765624-f72f-4ce1-bc4a-d20c72696779">87.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzE0LTUtMS0xLTgzMDc4_b6d989d6-b285-439f-9ca1-e0c9e5046ffb">58.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The aggregate amounts paid for shares repurchased pursuant to the Company's 2020 and 2019 tender offers for its shares during the years ended 2020 and 2019, include their clearing prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="i3c74357cd2654da2ab5263e5e1505e1a_D20200101-20201231" decimals="2" name="dva:TreasuryStockAcquiredAverageCostPerShareClearingPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzYwNDczMTM5NTYyNjc_e183b7a8-9f1a-4cd1-9c96-e43f4aa5ed89">88.00</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i4d53d30fe41e4561a3d660180e6b98d1_D20190101-20191231" decimals="2" name="dva:TreasuryStockAcquiredAverageCostPerShareClearingPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzYwNDczMTM5NTYyNzE_1f1101a6-3f35-4b36-b90d-afa19204d7be">56.50</ix:nonFraction> per share, respectively, plus related fees and expenses of $<ix:nonFraction unitRef="usd" contextRef="i3c74357cd2654da2ab5263e5e1505e1a_D20200101-20201231" decimals="-3" name="dva:ShareRepurchaseFeesAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzYwNDczMTM5NTYyNzY_4a14832c-075c-45a0-a62b-8a5082e9f9f1">2,529</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i4d53d30fe41e4561a3d660180e6b98d1_D20190101-20191231" decimals="-3" name="dva:ShareRepurchaseFeesAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzYwNDczMTM5NTYyODQ_2637f65e-2191-4553-a076-1c8906513ca8">2,343</ix:nonFraction>, respectively.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2021 through February&#160;9, 2022, the Company has repurchased <ix:nonFraction unitRef="shares" contextRef="i2f0cb06103bb48559ef92bd1d85fb047_D20220101-20220209" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzUwNw_05d38749-9e14-4481-a38a-5c807e8723b4">1,437</ix:nonFraction> shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i2f0cb06103bb48559ef92bd1d85fb047_D20220101-20220209" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzU0MQ_1754fbac-8df3-44cd-8309-e391798157f9">159,133</ix:nonFraction> at an average cost of $<ix:nonFraction unitRef="usdPerShare" contextRef="i2f0cb06103bb48559ef92bd1d85fb047_D20220101-20220209" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzU2Ng_3459dc90-1f32-424d-a531-cbab39cc29ae">110.73</ix:nonFraction> per share.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on December 10, 2020, the Board terminated all remaining prior share repurchase authorizations available to the Company and approved a new share repurchase authorization of $<ix:nonFraction unitRef="usd" contextRef="i8128ed8de2d8431a8be4d9736d9eb22a_I20201210" decimals="-3" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzEwMzU_e1e7c270-94f4-428a-8bad-b0bcef25cf25">2,000,000</ix:nonFraction>. Effective on December 17, 2021, the Board increased the Company's existing authorization by $<ix:nonFraction unitRef="usd" contextRef="iea987dbdc7b04a8d9e5cc739bde1bfa9_I20211217" decimals="-3" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzYwNDczMTM5NTY0ODk_8e2f90ad-3576-4296-a3e2-c3a06e9e50b8">2,000,000</ix:nonFraction>. The Company is authorized to make purchases from time to time in the open market or in privately negotiated transactions, including without limitation, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing, depending upon market conditions and other considerations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;9, 2022, the Company has a total of $<ix:nonFraction unitRef="usd" contextRef="iee586c56506f498d9a9bab33ee7558dd_I20220209" decimals="-3" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzE0MzM_78b9876f-3877-4ad1-86d9-85fb3794cebe">2,224,806</ix:nonFraction> available under the current repurchase authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, the Company remains subject to share repurchase limitations, including under the terms of its senior secured credit facilities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company retired all shares held in its treasury effective as of December&#160;31, 2021 and December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charter documents&#160;&amp; Delaware law</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s charter documents include provisions that may deter hostile takeovers, delay or prevent changes of control or changes in management, or limit the ability of stockholders to approve transactions that they may otherwise determine to be in their best interests. These include provisions prohibiting stockholders from acting by written consent, requiring 90 days advance notice for director nominations and stockholder proposals and granting the Company's Board of Directors the authority to issue up to <ix:nonFraction unitRef="shares" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzI0MjA_417e796f-e841-4a55-ac9c-1b576a82bd45">5,000</ix:nonFraction> shares of preferred stock and to determine the rights and preferences of the preferred stock without the need for further stockholder approval.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to Section&#160;203 of the Delaware General Corporation Law which, subject to exceptions, prohibits the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period of <ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzI4MjI_aacdace9-b7ab-4f0f-9cc9-9132c2b6818c">three years</ix:nonNumeric> following the date on which that stockholder became an interested stockholder. The provisions described above may discourage, delay or prevent an acquisition of the Company at a price that stockholders may find attractive.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i4467d168d0e741bdb2dc2e1f9d24cfe9"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in DaVita Inc.&#8217;s ownership interests in consolidated subsidiaries</span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzM0MTg_479c4c8b-8531-4e73-99fe-0f60365de35b" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of changes in DaVita Inc.&#8217;s ownership interests in consolidated subsidiaries on the Company&#8217;s consolidated equity were as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"><tr><td style="width:1.0%"></td><td style="width:52.967%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.649%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzItMS0xLTEtODMwNzg_f8547aec-4d56-4864-a562-cd9313e7f4d0">978,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzItMy0xLTEtODMwNzg_9be0b152-8b6d-4e36-98fc-c0bd9b51fb86">773,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzItNS0xLTEtODMwNzg_f49f9da5-4442-49be-9b85-64628606b70c">810,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in paid-in capital for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzQtMS0xLTEtODMwNzg_26d11897-ae92-40dd-8b03-442a4f926c4e">13,853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231" decimals="-3" name="dva:NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzQtMy0xLTEtODMwNzg_57a47f58-21e1-4848-b4cc-3276a8073d57">4,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzQtNS0xLTEtODMwNzg_ca128958-58ba-4411-8ef9-9fd8c1410b89">37,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales of noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231" decimals="-3" sign="-" name="dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzUtMS0xLTEtODMwNzg_c9a3da48-04c9-40f0-b642-9695b3920b87">264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231" decimals="-3" name="dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzUtMy0xLTEtODMwNzg_3427a5ad-2093-4ede-a8df-9df7878b108b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231" decimals="-3" name="dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzUtNS0xLTEtODMwNzg_c4f50753-bcf2-4272-bb30-74a8b11d0905">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net transfers in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzYtMS0xLTEtODMwNzg_0d5298b4-8b37-424f-aa53-447d07aacd94">14,117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231" decimals="-3" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzYtMy0xLTEtODMwNzg_182d78b8-37a6-42a6-87b1-326a55519a19">4,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzYtNS0xLTEtODMwNzg_8fda162b-f503-4a3a-95c2-a2f2fcc2f632">37,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc. net of transfers in <br/>&#160;noncontrolling interests</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231" decimals="-3" name="dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzctMS0xLTEtODMwNzg_0b7780af-36c3-417a-ad73-8fa8dbb5cbd1">964,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231" decimals="-3" name="dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzctMy0xLTEtODMwNzg_bdc025e6-56ed-4dea-968e-fbf3ff7d29d9">778,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231" decimals="-3" name="dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzctNS0xLTEtODMwNzg_28f28a7d-25c2-4781-90e5-36178a2e338d">773,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acquired additional ownership interests in several existing majority-owned partnerships for $<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzMzNzI_5e089c66-6e3e-4939-8a1c-f4e10886fd0e">20,104</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzMzNzY_a83db139-08f7-48d1-be3d-4bad691fbe8c">7,831</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzMzODQ_331a801b-15f6-480d-851a-9fb7240dea52">68,019</ix:nonFraction> in 2021, 2020, and 2019, respectively.</span></div></ix:continuation><div id="i916f7af890114e55a87e260476560c60_292"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90ZXh0cmVnaW9uOjUxNTBmNDFmZjExMDQ5MTk4ODZjNGU1Yzg3YmVlYjU2XzYzNg_f1945382-9497-490a-baec-4eb5782b332e" continuedAt="ic4dcf838dcd8439798f16b39b3b38f4e" escape="true">Accumulated other comprehensive loss</ix:nonNumeric></span></div><ix:continuation id="ic4dcf838dcd8439798f16b39b3b38f4e"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90ZXh0cmVnaW9uOjUxNTBmNDFmZjExMDQ5MTk4ODZjNGU1Yzg3YmVlYjU2XzYzMg_032bf436-1731-4c39-be2d-65a1388d79ca" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges and credits to other comprehensive (loss) income have been as follows:&#160;</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"><tr><td style="width:1.0%"></td><td style="width:48.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate<br/>cap agreements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated other<br/>comprehensive<br/>(loss) income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d67a2844f2a4c2c9c90e44bd33843a0_I20181231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEtMS0xLTEtODMwNzg_e457d9db-1908-40dd-a469-008e2c72f33c">8,961</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9eaadc9608cb41a185326a3a4f0c59f4_I20181231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEtNS0xLTEtODMwNzg_5c764ce6-43eb-45f8-99aa-7ad19cefcbb9">25,963</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11a5e338ac8c41b4ba17536e1b30f48d_I20181231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEtNy0xLTEtODMwNzg_666d4a84-8cd7-479a-b0c7-25ca81b64e61">34,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231" decimals="-3" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzMtMS0xLTEtODMwNzg_35c28988-92ea-49d0-b1ae-f97b048e5bf0">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i274989deb10a476caf0af271f7ed680c_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzMtNS0xLTEtODMwNzg_44a29a03-a54d-4081-bd51-5628a4aedf48">20,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idadb367715dc4267900964561174325e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzMtNy0xLTEtODMwNzg_d2d45ca9-e944-4609-a5e1-208227053900">18,536</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzQtMS0xLTEtODMwNzg_7552d1d6-e2ef-4b2d-aa81-3596439d1526">415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274989deb10a476caf0af271f7ed680c_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzQtNS0xLTEtODMwNzg_f5213ee7-3594-4c60-ab1e-0819e0fbb12d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idadb367715dc4267900964561174325e_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzQtNy0xLTEtODMwNzg_484f577c-a956-4d00-899e-f24191fa6d88">415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231" decimals="-3" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzUtMS0xLTEtODMwNzg_0508b381-8204-4ada-8581-b7e245db61b4">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i274989deb10a476caf0af271f7ed680c_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzUtNS0xLTEtODMwNzg_043f9246-054b-4b0a-98da-00babb29beb7">20,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idadb367715dc4267900964561174325e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzUtNy0xLTEtODMwNzg_24e57162-09d9-4be3-a2e1-5252734465df">18,951</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzYtMS0xLTEtODMwNzg_6711256e-f504-4579-bb29-352a1e090226">8,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274989deb10a476caf0af271f7ed680c_D20190101-20191231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzYtNS0xLTEtODMwNzg_debb3ef2-47dd-4af1-a485-5de976050860">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idadb367715dc4267900964561174325e_D20190101-20191231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzYtNy0xLTEtODMwNzg_4a9e9ad0-0c78-4d9f-894b-99b22c1e532f">8,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzctMS0xLTEtODMwNzg_ea79341d-5098-4c0c-8648-fc0a88c1193c">2,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274989deb10a476caf0af271f7ed680c_D20190101-20191231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzctNS0xLTEtODMwNzg_fccf9336-b3f3-423d-badc-e0df73c77b7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idadb367715dc4267900964561174325e_D20190101-20191231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzctNy0xLTEtODMwNzg_74074095-78d0-4dcc-a1ef-d5f7ec988c49">2,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzgtMS0xLTEtODMwNzg_af7db207-4644-4e1a-9d9c-09545483ce33">6,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274989deb10a476caf0af271f7ed680c_D20190101-20191231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzgtNS0xLTEtODMwNzg_79567c52-2a7d-4cd4-8bd0-64f49383aab9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idadb367715dc4267900964561174325e_D20190101-20191231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzgtNy0xLTEtODMwNzg_ea00bf95-b58f-4cdf-8ace-f92d6696edae">6,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia84ad34d2722493ca0102f68dc85910c_I20191231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzktMS0xLTEtODMwNzg_ca42bb42-6784-4fd5-b10e-0f545e103aa0">1,433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24b7a5a0b9454a6596459b76ca8a77fd_I20191231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzktNS0xLTEtODMwNzg_9a0eb048-9360-43d0-90bd-fbac93c95103">46,065</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a368aff679b44b39b1d63b92999f915_I20191231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzktNy0xLTEtODMwNzg_5195c8e5-6115-4b26-be31-89ab75f1e4b0">47,498</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized losses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEwLTEtMS0xLTgzMDc4_0a6e4e94-cc60-400f-b902-da9bd5a0dab3">21,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEwLTUtMS0xLTgzMDc4_a2b9b2f2-1d91-4df0-bfb5-d23fcf43f58c">7,080</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEwLTctMS0xLTgzMDc4_cecf69fa-6366-4247-b7c4-2f5009080c51">28,861</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzExLTEtMS0xLTgzMDc4_18315bf2-1f1d-431f-bfd3-fbe77cc65089">5,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzExLTUtMS0xLTgzMDc4_6d9dd822-10e2-4678-bca7-21085182c902">543</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzExLTctMS0xLTgzMDc4_ea40fd8b-e71e-42a0-b280-9031f96c21ca">4,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEyLTEtMS0xLTgzMDc4_e8b28302-17b0-451f-ab8b-084e494bb097">16,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEyLTUtMS0xLTgzMDc4_f4393716-d62d-4cff-a861-903c457aa92a">7,623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEyLTctMS0xLTgzMDc4_30d47bbc-b4bb-4552-b3d7-c1e9e7256e41">23,969</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEzLTEtMS0xLTgzMDc4_fb0a4cb4-e152-4a89-b7a1-d68d9bcc56f9">7,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEzLTUtMS0xLTgzMDc4_ef04b809-89c8-40e0-bf8c-ad7a6b208190">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEzLTctMS0xLTgzMDc4_c13b5f82-b83a-4f1c-a834-a5b74bbcead7">7,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE0LTEtMS0xLTgzMDc4_4516958c-26c1-42ed-96ad-f6f2657731f0">1,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE0LTUtMS0xLTgzMDc4_ec0af13f-6a89-481a-8dd0-23458bf38b7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE0LTctMS0xLTgzMDc4_7fce3353-7e7c-49cb-99db-ee611e6c3eaa">1,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE1LTEtMS0xLTgzMDc4_e8bde288-c801-450f-8ee3-3bd7c97dce61">5,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE1LTUtMS0xLTgzMDc4_13003129-ecf8-406e-95d5-1c060dfded27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE1LTctMS0xLTgzMDc4_007044ce-87dc-4d02-9eff-8f0c203dec4f">5,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99108034d2554d938cf6bbf6690251eb_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE2LTEtMS0xLTgzMDc4_c93dfdd8-983c-4b6e-85f4-fdddf204831f">12,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifea37fe88f5b44c18e322f6488b835ab_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE2LTUtMS0xLTgzMDc4_b7a2bc8d-b559-4fd2-a31c-d6d989ee687b">53,688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40dcb33a068e49c5873ade196d5fa5e8_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE2LTctMS0xLTgzMDc4_7c4961e7-53df-4d72-b81b-03d48083b9ef">66,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id404b91855424fc799a056cf6f4b718b_D20210101-20211231" decimals="-3" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE3LTEtMS0xLTgzMDc4_fe46bb66-f692-4049-9abb-a65761c7a9bb">9,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE3LTUtMS0xLTgzMDc4_54164515-8ace-4a6e-8552-cdf00545344c">83,375</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE3LTctMS0xLTgzMDc4_e31017b4-7651-440a-a06b-7b8253a88356">73,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id404b91855424fc799a056cf6f4b718b_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE4LTEtMS0xLTgzMDc4_63605d3e-2b70-4dd9-a8c2-56611fdfbde8">2,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE4LTUtMS0xLTgzMDc4_4c745eda-4346-429a-8227-357a14e28fda">1,006</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE4LTctMS0xLTgzMDc4_70ad46a4-c2a6-4aec-a4cd-7294b4b3b79d">3,383</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id404b91855424fc799a056cf6f4b718b_D20210101-20211231" decimals="-3" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE5LTEtMS0xLTgzMDc4_9f37881a-7839-4b63-bdee-2349b6725f38">7,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE5LTUtMS0xLTgzMDc4_d466bf15-08ee-466c-bdbe-9a39c8be0a58">84,381</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE5LTctMS0xLTgzMDc4_3df79b8a-6b5d-4be4-ac52-470e03424a6f">77,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id404b91855424fc799a056cf6f4b718b_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIwLTEtMS0xLTgzMDc4_88705380-2763-447f-bc05-e7c1ec626833">5,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIwLTUtMS0xLTgzMDc4_4652e9ee-65b9-4978-9d9b-abcadc5dbc93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIwLTctMS0xLTgzMDc4_c34ff6b4-b83b-483d-82ce-1d3d6a6c85f3">5,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id404b91855424fc799a056cf6f4b718b_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIxLTEtMS0xLTgzMDc4_994bc2cb-597d-4654-905f-c70c3bc2f6c0">1,376</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIxLTUtMS0xLTgzMDc4_c0553e19-40b3-48aa-aebe-4b1612a09527">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIxLTctMS0xLTgzMDc4_0ef786a9-c865-4e7d-a191-380be11b36bf">1,376</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id404b91855424fc799a056cf6f4b718b_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIyLTEtMS0xLTgzMDc4_b51de9c5-8b5f-477e-aa0a-5f6987432adf">4,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIyLTUtMS0xLTgzMDc4_3d129041-c9eb-4901-a47a-4d9635ce3516">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIyLTctMS0xLTgzMDc4_a9c93d22-002e-41e8-9e67-67c8840047ae">4,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85c3913492e84060812eb8467e8fd210_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIzLTEtMS0xLTgzMDc4_2644899b-f1dd-40e8-95a4-6c459d4780b2">1,178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf0294b716341479fe2709f0bed1d2b_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIzLTUtMS0xLTgzMDc4_1ef1fb7f-9df1-413d-aa5d-5e8d83f246fc">138,069</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d3d4f666d7c449b92c0699610606f26_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIzLTctMS0xLTgzMDc4_815c8b1c-51a6-4a30-88de-7d58c431ae16">139,247</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90ZXh0cmVnaW9uOjUxNTBmNDFmZjExMDQ5MTk4ODZjNGU1Yzg3YmVlYjU2XzYyOA_151fbb36-0f63-4772-8227-6f6909b14f31" escape="true">The reclassification of net interest rate cap realized losses into income are recorded as debt expense in the corresponding consolidated statements of income.</ix:nonNumeric> See Note 13 for further details.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_295"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM3NjA_40ecd132-ad8b-49e4-badb-66bd74eaba9f" continuedAt="i8ee6e760a1cf4b8486fa9735e7fc5571" escape="true">Acquisitions and divestitures</ix:nonNumeric></span></div><ix:continuation id="i8ee6e760a1cf4b8486fa9735e7fc5571" continuedAt="i9735def800c04cdc82836939b91add5b"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Routine acquisitions</span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzE5NzkxMjA5MzA2NjQ4_9b60ee7d-7e35-42a3-9a6c-15a60bf1ff89" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, 2020, and 2019 the Company acquired dialysis businesses and other businesses, including a transplant software company, as follows:</span></div><div style="margin-top:9pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.192%"><tr><td style="width:1.0%"></td><td style="width:52.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.864%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzItMS0xLTEtMTM5ODYz_3a8d3db2-2754-4594-9851-5bcd58b0feb6">187,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzItMy0xLTEtMTM5ODYz_dabadd1b-faf3-49b8-96ad-d7736f71b694">182,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4a2d038875f4494931bdd14b3909f34_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzItNS0xLTEtMTM5ODYz_0abf36da-fd43-4fdb-862a-089283070dff">98,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzMtMS0xLTEtMTM5ODYz_2e8f6fb5-c6ab-4d7b-bf7b-4802b06da084">14,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzMtMy0xLTEtMTM5ODYz_75b26aac-7704-45b6-84d8-40ed85f23054">14,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4a2d038875f4494931bdd14b3909f34_D20190101-20191231" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzMtNS0xLTEtMTM5ODYz_fd2594d7-dcf7-4dde-a8d5-b0a75005325c">23,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred purchase price and liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzQtMS0xLTEtMTM5ODYz_5f738cff-1949-4737-aaf4-ea537362759a">10,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzQtMy0xLTEtMTM5ODYz_1013659a-06ae-435b-b4a3-f39949282e98">20,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4a2d038875f4494931bdd14b3909f34_D20190101-20191231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzQtNS0xLTEtMTM5ODYz_d44b63df-0414-4acc-a765-0bbcaf3179f6">4,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzUtMS0xLTEtMTQwNDU3_52ef7239-5224-44a5-b5b1-97a52e564a78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzUtMy0xLTEtMTQwNDE0_9e7976c3-6a84-4114-82aa-b65333c30418">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4a2d038875f4494931bdd14b3909f34_D20190101-20191231" decimals="-3" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzUtNS0xLTEtMTQwNDU3_739d3a7e-cfe3-4161-a851-c7aa8e1bef3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate consideration</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzUtMS0xLTEtMTM5ODYz_a16c9535-df15-428c-8730-b3e0946a90ac">212,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzUtMy0xLTEtMTM5ODYz_bc789d09-007a-4526-99c7-87a191da2de6">218,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzUtNS0xLTEtMTM5ODYz_eaf1ae9f-88af-4d71-9772-1a4a2986529a">126,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of dialysis centers acquired &#8212; U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic2" contextRef="i621a25eea7db4a01974ef60b2432c93e_D20210101-20211231" decimals="0" name="us-gaap:NumberOfBusinessesAcquired" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzYtMS0xLTEtMTM5ODYz_d093a307-3d51-4b51-8176-41bcc4f19281">19</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic2" contextRef="i2245b27c94104effb35180d14351a3fd_D20200101-20201231" decimals="0" name="us-gaap:NumberOfBusinessesAcquired" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzYtMy0xLTEtMTM5ODYz_8dd97bcd-ec59-4da7-a2ee-a6cbefa48216">8</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic2" contextRef="i76921e5033604a8fabf20815d5b64089_D20190101-20191231" decimals="0" name="us-gaap:NumberOfBusinessesAcquired" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzYtNS0xLTEtMTM5ODYz_fdae5e12-7e61-4294-92d0-6503a75a2454">7</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of dialysis centers acquired &#8212; International</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic2" contextRef="ie6a746b4356448749bd18ee02e4a5e7a_D20210101-20211231" decimals="0" name="us-gaap:NumberOfBusinessesAcquired" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzctMS0xLTEtMTM5ODYz_de6379a6-e738-449c-bf85-8cfba9036b56">17</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic2" contextRef="ied9a0e0050574260b26da48baf596e12_D20200101-20201231" decimals="0" name="us-gaap:NumberOfBusinessesAcquired" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzctMy0xLTEtMTM5ODYz_09cab8e8-bb27-44fd-9825-117b49b39350">66</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="clinic2" contextRef="ib46805457f7f4d4eae7bb7b5aaa08d10_D20190101-20191231" decimals="0" name="us-gaap:NumberOfBusinessesAcquired" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzctNS0xLTEtMTM5ODYz_be613ce1-e81c-4d05-b3ab-93bc5f98aadb">16</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The assets and liabilities for all acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company&#8217;s financial statements, as are their operating results, from the designated effective dates of the acquisitions. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial purchase price allocations for these transactions have been recorded at estimated fair values based on information available to management and will be finalized when certain information arranged to be obtained has been received. For several of the 2021 acquisitions, certain income tax amounts are pending final evaluation and quantification of any pre-acquisition tax contingencies. In addition, valuation of contingent earn-outs, intangibles, fixed assets, leases and certain working capital items relating to several of these acquisitions are pending final quantification.</span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM3NTM_699a0e85-8fa8-4f4a-9a0d-ca3895a90c5f" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.795%"><tr><td style="width:1.0%"></td><td style="width:52.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzItMS0xLTEtODMwNzg_62fe595c-399e-4c37-ac4a-e8ccecd676e9">9,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzItMy0xLTEtODMwNzg_51f6d098-bcad-44d7-9c94-f05e0c8f0c4e">23,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzItNS0xLTEtODMwNzg_26287d12-a8fd-47a3-8d6b-dfe77301edc6">6,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzMtMS0xLTEtODMwNzg_6485edcc-64d2-453e-a9ef-e7958f5c9043">9,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzMtMy0xLTEtODMwNzg_6c455661-184c-4133-a050-0447586037b3">37,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzMtNS0xLTEtODMwNzg_6f0595d3-6233-493f-bbb2-b12cea57bcd7">4,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzQtMS0xLTEtODMwNzg_4bfcba9d-3c88-4b7d-b3ea-7fccb80d4c31">17,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzQtMy0xLTEtODMwNzg_284f4598-0c03-4942-9e56-84c5503dcdf3">34,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzQtNS0xLTEtODMwNzg_08c78f3f-ad73-4a8f-aba9-35cff4652574">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompetition agreements and other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzUtMS0xLTEtODMwNzg_b724a0bf-a40e-42ac-b83d-db033bd8a8c9">9,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzUtMy0xLTEtODMwNzg_9d122184-734d-4741-9b29-e9cf5e1d4317">10,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzUtNS0xLTEtODMwNzg_079c30f0-e438-46f0-8f70-4dafc7f3b150">1,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzYtMS0xLTEtODMwNzg_7d181066-e68a-4272-938d-ce547ca7ac21">11,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzYtMy0xLTEtODMwNzg_ff32e86c-74a4-4f55-b810-d8e3bdaf24ee">22,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzYtNS0xLTEtODMwNzg_5f67ee20-9456-461b-a038-4ba5103283e7">31,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzctMS0xLTEtODMwNzg_133675bc-5821-4782-bfbf-956acb1355f4">173,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzctMy0xLTEtODMwNzg_b15fd1ee-402c-48e1-aebf-1ddde9a46f69">130,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzctNS0xLTEtODMwNzg_ed250adc-8983-45c2-87b6-aa2c54d538e4">90,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzgtMS0xLTEtODMwNzg_98cf36a7-3ed8-4801-9a11-549f16e0eae3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzgtMy0xLTEtODMwNzg_14d5381a-09fb-4287-9090-e7da96e949af">3,962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzgtNS0xLTEtODMwNzg_c4a8ccfd-adc2-4df7-8a1e-68c59e5f0aad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzktMS0xLTEtODMwNzg_9766fe75-0db6-4c04-a971-05c40e5052c5">14,200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzktMy0xLTEtODMwNzg_28a54edf-2b0d-4add-95a8-6c8506039112">34,068</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzktNS0xLTEtODMwNzg_302cdea3-82a1-4e2f-b722-20d76f4f91a2">7,159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzEwLTEtMS0xLTgzMDc4_633ccea7-b69e-4a4f-b1a7-d239dcf79969">3,921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzEwLTMtMS0xLTgzMDc4_36aebc21-3f41-4ae8-8a7a-7dc6e4acc865">1,729</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzEwLTUtMS0xLTgzMDc4_847435a4-0c1f-476a-be5e-8023bcc65505">1,762</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzExLTEtMS0xLTgzMDc4_90982e24-9a16-4796-9acb-421e4b1ff5cc">212,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzExLTMtMS0xLTgzMDc4_67c6d019-4c63-4ed7-9e1e-f3faa928cec0">218,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzExLTUtMS0xLTgzMDc4_398d3a1c-55f6-479a-b9a8-54a8865249e8">126,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM3NTc_7b9d5233-056d-48db-9e5a-a8b9afb79e15" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes weighted-average estimated useful lives of amortizable intangible assets acquired during 2021, 2020 and 2019, as well as goodwill deductible for tax purposes associated with these acquisitions:</span></div><div style="margin-top:6pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.900%"><tr><td style="width:1.0%"></td><td style="width:56.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.398%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.398%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average estimated useful lives (in years):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3508cbe980914e3d84c8b1cdebe10249_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzMtMS0xLTEtODMwNzg_7b11ff09-7cb7-4aa6-90d4-e9d8d7d702fe">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8e3b5c936ba4ca59945d40967ade470_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzMtMy0xLTEtODMwNzg_9e21639f-596b-47ef-b3dc-4185ec6c3d24">18</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonNumeric contextRef="i14dc4deb3c484a63bee7e80f59d2a7f8_D20190101-20191231" xsi:nil="true" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzMtNS0xLTEtODMwNzg_7e721c52-9df6-418d-813e-f70f1f1e87cd"></ix:nonNumeric></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompetition agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1950b3dc9ab941c69beba84eed98aa3e_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzQtMS0xLTEtODMwNzg_42c8d27a-a663-4e88-9cc9-92ab2a3a4990">6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3a29a18c5e154226819a3fce4b9d0866_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzQtMy0xLTEtODMwNzg_4332d050-06d4-4791-99a5-18937a93590a">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31ffbb8892c441dea9a0c3e595b43682_D20190101-20191231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzQtNS0xLTEtODMwNzg_51f9b27d-6422-40aa-90d6-fbcb81fb0eba">6</ix:nonNumeric></span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill deductible for tax purposes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzYtMS0xLTEtODMwNzg_7c24ed35-d5ff-4b48-b989-6b3bb135cae7">169,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzYtMy0xLTEtODMwNzg_507288f5-e5eb-4412-a0cb-d9279e3c2b09">94,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231" decimals="-3" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzYtNS0xLTEtODMwNzg_fd6b97ee-9d26-41d4-a7da-bca404322a1d">88,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i9735def800c04cdc82836939b91add5b" continuedAt="i9c9d7bf5ac4d49469b6f5a7f98a7ecf2"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro forma financial information (unaudited)</span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM3NjU_c98d88c1-d12f-43da-87ee-819cd2492d2f" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions within continuing operations in 2021 and 2020 had been consummated as of the beginning of 2020, including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"><tr><td style="width:1.0%"></td><td style="width:62.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.739%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.741%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pro forma total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzMtMS0xLTEtODMwNzg_4c6c49ac-2f86-41df-9dd6-2f8f11218549">11,678,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzMtMy0xLTEtODMwNzg_d27b0e07-47b9-40c1-8bca-c4fd72f33c21">11,722,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pro forma net income from continuing operations attributable to<br/>&#160;DaVita Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzQtMS0xLTEtODMwNzg_4f89a9b5-ceee-4802-9bb6-d3f34189ad22">985,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzQtMy0xLTEtODMwNzg_abd3cf20-b15f-4f45-9320-b0d05ee42e77">797,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pro forma basic net income per share from continuing operations<br/>&#160;attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzUtMS0xLTEtODMwNzg_342cefb7-929b-4326-a2c1-837807a792a5">9.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzUtMy0xLTEtODMwNzg_eb56741f-3227-44f1-9f3b-fb4f2db96001">6.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pro forma diluted net income per share from continuing operations<br/>&#160;attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzYtMS0xLTEtODMwNzg_18f6561e-ba84-4a0a-b2ff-a75977216c14">8.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzYtMy0xLTEtODMwNzg_7dfee455-0e77-4b2c-960d-cb6c51b1efd3">6.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of RMS Lifeline</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company divested its prior vascular access business, RMS Lifeline, Inc., effective May 1, 2020 and recognized a loss on sale of approximately $<ix:nonFraction unitRef="usd" contextRef="iaa2fdc006ca3477fbbe827fe56dcb2a6_D20200501-20200501" decimals="-3" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzQ5NDc4MDIzMjg4NTU_ccadf29c-f2b3-46df-9567-ef07557cafe7">16,252</ix:nonFraction>.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent earn-out obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired businesses a total of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzMwNDQ_68405925-dbb0-4739-983d-266d55bdb93d">67,638</ix:nonFraction> if certain performance targets or quality margins are met over the next <ix:nonNumeric contextRef="i3b812c94400f4e9f93e3edc28560ca7d_D20210101-20211231" name="dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzMxMTk_ffac6d24-c146-4d12-a740-8908020b6b54">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="i97ebc821f8af433693f363565139ae7a_D20210101-20211231" name="dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzMxMjU_b8e7e916-bee2-448f-8b1f-01852ff97ea6">five years</ix:nonNumeric>. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent earn-out obligations are remeasured to fair value at each reporting date until the contingencies are resolved with changes in the liability due to the remeasurement recognized in earnings. See Note 24 for further details. As of December&#160;31, 2021, the Company estimated the fair value of these contingent earn-out obligations to be $<ix:nonFraction unitRef="usd" contextRef="i15c23a9ed8c74ad88b0b718d8dcbce70_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM0NTc_93fb3748-dca4-44b9-9203-79f46769f257">33,600</ix:nonFraction>, of which a total of $<ix:nonFraction unitRef="usd" contextRef="i5c26b75f552e487080d6ca8af0cbfbb2_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM0ODE_100f4bcf-32cb-4cb2-8fc1-f79060b8bf19">9,419</ix:nonFraction> is included in other current liabilities, and the remaining $<ix:nonFraction unitRef="usd" contextRef="i34268660f8994614945e3a3ac73ae27c_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM1NDQ_0ce50458-3315-4839-95f0-25dfdd207345">24,181</ix:nonFraction> is included in other long-term liabilities in the Company&#8217;s consolidated balance sheet. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM3NjY_277f65ff-593c-4584-a959-60c137cc0423" continuedAt="if17ba8d8a9744c4eba2b597a503e4e53" escape="true">The following is a reconciliation of changes in contingent earn-out liabilities for the years ended December&#160;31, 2021 and 2020:&#160;</ix:nonNumeric></span></div></ix:continuation><div style="margin-top:6pt;padding-left:27pt"><ix:continuation id="i9c9d7bf5ac4d49469b6f5a7f98a7ecf2"><ix:continuation id="if17ba8d8a9744c4eba2b597a503e4e53"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"><tr><td style="width:1.0%"></td><td style="width:55.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.086%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzItMS0xLTEtODMwNzg_39b707f7-d736-4a6b-8f1d-876b016e18a3">30,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzItMy0xLTEtODMwNzg_cc4f0ef1-e680-48e0-950d-1ad7e261eb09">24,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzMtMS0xLTEtODMwNzg_763c3123-e8c4-45e0-8890-3cb89e69968c">14,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzMtMy0xLTEtODMwNzg_681d53f5-2b80-4a6f-92b9-506d8b0b9be7">14,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231" decimals="-3" name="dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzQtMS0xLTEtODMwNzg_dd1fdb13-0d39-454f-89c1-8abd805462b1">1,674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231" decimals="-3" name="dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzQtMy0xLTEtODMwNzg_f1726cf1-34e3-47e0-b778-daa729da82d9">3,688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzUtMS0xLTEtODMwNzg_4b25465f-9368-41f9-aa2a-7a8587ea25b2">1,292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzUtMy0xLTEtODMwNzg_bf4c8b0e-8e3d-4462-be44-67f93d16b955">2,630</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments or other settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzYtMS0xLTEtODMwNzg_d7efcefe-c78b-4de6-b558-31b73c5fc8f9">8,536</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzYtMy0xLTEtODMwNzg_8bab620b-8698-4301-9987-73fecd9b927f">2,062</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzctMS0xLTEtODMwNzg_4a477cc8-3ae3-43b2-bb2a-ca9e93125d58">33,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9f2f3219c543598584da510ed53480_I20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzctMy0xLTEtODMwNzg_f66e33f2-6835-4937-a232-98ffb3e0e13a">30,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i916f7af890114e55a87e260476560c60_298"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">22.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzI1NzI_2bb42e1c-e132-4cf6-8b70-9f0d522245f2" continuedAt="i3489779303f34f61b7d0bb6fd3bb85ca" escape="true">Discontinued operations previously held for sale</ix:nonNumeric></span></div><ix:continuation id="i3489779303f34f61b7d0bb6fd3bb85ca" continuedAt="i7bac4117c12742a99c017934e7e9954c"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DaVita Medical Group (DMG)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="i94e70ca9077e4db8b762a4fcc4bfbd6f_D20190619-20190619" name="dva:BusinessSaleEffectiveDateOfSale" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzg4_2950e4ae-eb11-4b5b-b8ea-f6cd5fe3f85f">June&#160;19, 2019</ix:nonNumeric>, the Company completed the sale of its prior DMG business to Optum, a subsidiary of UnitedHealth Group Inc., for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i94e70ca9077e4db8b762a4fcc4bfbd6f_D20190619-20190619" decimals="-3" name="dva:PurchaseAndSaleAgreementAggregatePurchasePrice" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzIyOQ_ee29a620-5531-40b8-bcce-22e0a8a99096">4,340,000</ix:nonFraction>, prior to certain closing and post-closing adjustments specified in the related equity purchase agreement dated as of <ix:nonNumeric contextRef="i2aba66ad0dad46008b9826b26fef8363_D20171205-20171205" name="dva:BusinessSaleDateOfPurchaseAndSaleAgreement" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzM1MA_9d800b7b-c159-4af5-a487-53f672c2014f">December&#160;5, 2017</ix:nonNumeric>, as amended as of September 20, 2018 and as of December 11, 2018 (as amended, the equity purchase agreement).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a preliminary estimated pre-tax net loss of approximately $<ix:nonFraction unitRef="usd" contextRef="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231" decimals="-3" name="dva:LossGainOnDispositionOfBusinessInterestsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzUxMQ_d3b63f61-2545-466c-beb8-02b7bf8bea23">23,022</ix:nonFraction> on the sale of its DMG business in 2019. This preliminary net loss was based on initial estimates of the Company's expected aggregate proceeds from the sale, net of transaction costs and obligations, as well as the estimated values of DMG net assets sold as of the closing date. Those estimated net proceeds included $<ix:nonFraction unitRef="usd" contextRef="i7458081d2436470ea923b7c4156197b2_D20190619-20190619" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzgzMQ_b5967ef2-9fa8-4ad6-b459-43ed2d8a201f">4,465,476</ix:nonFraction> in cash received from Optum at closing, or $<ix:nonFraction unitRef="usd" contextRef="i7458081d2436470ea923b7c4156197b2_D20190619-20190619" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzg3Nw_ad0365e0-5b84-4102-b5da-fa9e26ea58b6">3,824,509</ix:nonFraction> net of cash and restricted cash included in the DMG net assets sold.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i7bac4117c12742a99c017934e7e9954c"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At close of the DMG sale, the Company's ultimate net sale proceeds remained subject to resolution of certain post-closing purchase price adjustments described in the equity purchase agreement. In the fourth quarter of 2020, the Company and Optum reached agreement on the final purchase price for the DMG sale, which resulted in an additional payment by the Company to Optum of $<ix:nonFraction unitRef="usd" contextRef="icfd8f32feed247c2a24b065aa98482f1_D20201001-20201231" decimals="-3" name="dva:AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzgyNDYzMzcyMTEwNTc_df129753-f40a-4c02-95b8-1f4f85bdfe43">47,000</ix:nonFraction> and an additional loss on sale of $<ix:nonFraction unitRef="usd" contextRef="icfd8f32feed247c2a24b065aa98482f1_D20201001-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzgyNDYzMzcyMTEwNzQ_926df030-0fd3-417f-9bac-17c4020ee886">17,976</ix:nonFraction>. In the first quarter of 2020, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="iafda8ba2e67442e6935e3adfbd191cc1_D20200101-20200331" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzE0MjA_23e1971d-eb21-47f3-be82-a26497635e00">9,980</ix:nonFraction> in additional tax benefits under the Coronavirus Aid, Relief and Economic Security Act related to its period of DMG ownership, which were also recognized as an adjustment to the Company's loss on sale of the DMG business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the equity purchase agreement, the Company also has certain continuing indemnification obligations that could require payments to the buyer relating to the Company's previous ownership and operation of the DMG business. Potential payments under these provisions, if any, remain subject to continuing uncertainties and the amounts of such payments could be significant to the Company.</span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzI1Njc_572ef072-a838-49b5-b475-d9a63940e1da" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the financial results of discontinued operations related to DMG:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"><tr><td style="width:1.0%"></td><td style="width:70.457%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d86d8eabc947b9afbe06d0abb8af86_D20200101-20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzItMy0xLTEtODMwNzg_d3a61423-790c-40fa-aa7c-570cb0a1d374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzItNS0xLTEtODMwNzg_6316d50d-046e-4f6b-abdb-b2fc8d5571f9">2,713,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d86d8eabc947b9afbe06d0abb8af86_D20200101-20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzMtMy0xLTEtODMwNzg_4da845a5-9949-4c7a-9a97-bc39548eea6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzMtNS0xLTEtODMwNzg_d219b4f0-c6ca-4d75-a488-345b334fc70d">2,543,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations before taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d86d8eabc947b9afbe06d0abb8af86_D20200101-20201231" decimals="-3" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzYtMy0xLTEtODMwNzg_cf4b10b2-e3f4-462b-aaf2-9a6fb22ae536">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231" decimals="-3" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzYtNS0xLTEtODMwNzg_849caa2c-06a0-4789-a395-cac9714af189">169,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale of discontinued operations before taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54d86d8eabc947b9afbe06d0abb8af86_D20200101-20201231" decimals="-3" name="dva:LossGainOnDispositionOfBusinessInterestsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzctMy0xLTEtODMwNzg_11ac5771-8dd5-43cc-8a21-73a79bf3a24b">7,996</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231" decimals="-3" name="dva:LossGainOnDispositionOfBusinessInterestsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzctNS0xLTEtODMwNzg_0ec21879-71d9-413c-a8fa-b2b63bb6ab83">23,022</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d86d8eabc947b9afbe06d0abb8af86_D20200101-20201231" decimals="-3" name="us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzgtMy0xLTEtODMwNzg_71e5e92c-9679-4e17-9584-808a41f8e47c">1,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231" decimals="-3" name="us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzgtNS0xLTEtODMwNzg_15ff1d8c-8bcc-41c3-b803-4d1dadd2060f">40,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzktMy0xLTEtODMwNzg_a04f6180-0d50-4c56-942c-8105692ad70c">9,653</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzktNS0xLTEtODMwNzg_71af1396-b2de-4035-8676-e6f99e3959ab">105,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:ReconciliationOfCashFlowsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzI1NjU_d2f963c9-b7d4-4caf-834d-ce5ee0f839b5" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cash flows of discontinued operations related to DMG:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:414.00pt"><tr><td style="width:1.0pt"></td><td style="width:294.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:55.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:55.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities from discontinued operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZTo3ZjZjZjRkMmU0OWI0NWJkYjJjMGMyOTI5NWQ0OWQ4OS90YWJsZXJhbmdlOjdmNmNmNGQyZTQ5YjQ1YmRiMmMwYzI5Mjk1ZDQ5ZDg5XzItMy0xLTEtODMwNzg_2e36cdcb-6c05-40d9-9d72-bf0e6e37d62d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZTo3ZjZjZjRkMmU0OWI0NWJkYjJjMGMyOTI5NWQ0OWQ4OS90YWJsZXJhbmdlOjdmNmNmNGQyZTQ5YjQ1YmRiMmMwYzI5Mjk1ZDQ5ZDg5XzItNS0xLTEtODMwNzg_c379a225-a5be-4d82-bdb8-309d889c970c">99,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities from discontinued operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZTo3ZjZjZjRkMmU0OWI0NWJkYjJjMGMyOTI5NWQ0OWQ4OS90YWJsZXJhbmdlOjdmNmNmNGQyZTQ5YjQ1YmRiMmMwYzI5Mjk1ZDQ5ZDg5XzMtMy0xLTEtODMwNzg_4e8f2080-706b-429e-81cb-5edd77e18a18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZTo3ZjZjZjRkMmU0OWI0NWJkYjJjMGMyOTI5NWQ0OWQ4OS90YWJsZXJhbmdlOjdmNmNmNGQyZTQ5YjQ1YmRiMmMwYzI5Mjk1ZDQ5ZDg5XzMtNS0xLTEtODMwNzg_6d353547-a1c2-4752-8c7c-72c4259d09e2">43,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DMG acquisitions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period from January 1, 2019 to June 18, 2019 immediately prior to the sale, the DMG business acquired <ix:nonFraction unitRef="clinic" contextRef="icedbf892c351473882af74862a207224_D20190101-20190618" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzIzNDY_f7872178-c6e0-40fc-846d-b5ed94694b85">two</ix:nonFraction> medical businesses for a total of $<ix:nonFraction unitRef="usd" contextRef="icedbf892c351473882af74862a207224_D20190101-20190618" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzIzODM_c9fad6f3-c195-4076-a2d3-a047d85eed3b">2,025</ix:nonFraction> in net cash and deferred purchase price of $<ix:nonFraction unitRef="usd" contextRef="icedbf892c351473882af74862a207224_D20190101-20190618" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredOther1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzI0Mjk_cd5ff12d-c7f6-4094-9242-48c5d76e0f31">212</ix:nonFraction>.</span></div></ix:continuation><div id="i916f7af890114e55a87e260476560c60_301"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDEvZnJhZzo5YzhiNjEwZGNmNDQ0MjY0ODNhYTVjMTYwMTYzODQ5Zi90ZXh0cmVnaW9uOjljOGI2MTBkY2Y0NDQyNjQ4M2FhNWMxNjAxNjM4NDlmXzMxMzc_9d5b56c5-61e2-4b3a-928c-c1abf73f2723" continuedAt="i27ea6ee2a75642e6af22c4382c88b766" escape="true">Variable interest entities</ix:nonNumeric></span></div><ix:continuation id="i27ea6ee2a75642e6af22c4382c88b766" continuedAt="id320ad81c2914ad6a474e556b2eae52e"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDEvZnJhZzo5YzhiNjEwZGNmNDQ0MjY0ODNhYTVjMTYwMTYzODQ5Zi90ZXh0cmVnaW9uOjljOGI2MTBkY2Y0NDQyNjQ4M2FhNWMxNjAxNjM4NDlmXzMxMzI_c7948fff-fc4d-429b-8ce2-ef96daf44207" continuedAt="ic39b94bf280e4e1585ed4a12f3fcd146" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages or maintains an ownership interest in certain legal entities subject to the consolidation guidance applicable to variable interest entities (VIEs). Almost all of these legal entities are either U.S. dialysis partnerships encumbered by guaranteed debt, U.S. dialysis limited partnerships, or other legal entities subject to nominee ownership arrangements. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under U.S. GAAP, VIEs typically include entities for which (i)&#160;the entity&#8217;s equity is not sufficient to finance its activities without additional subordinated financial support; (ii)&#160;the equity holders as a group lack the power to direct the activities that most significantly influence the entity&#8217;s economic performance, the obligation to absorb the entity&#8217;s expected losses, or the right to receive the entity&#8217;s expected returns; or (iii)&#160;the voting rights of some investors are not proportional to their obligations to absorb the entity&#8217;s losses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The substantial majority of VIEs the Company is associated with are U.S. dialysis partnerships which the Company manages and in which it maintains a controlling majority ownership interest. These U.S. dialysis partnerships are considered VIEs either because they are (i) encumbered by debt guaranteed proportionately by the partners that is considered necessary to finance the partnership's activities, or (ii) in the form of limited partnerships for which the limited partners are not considered to have substantive kick-out or participating rights. The Company consolidates virtually all such U.S. dialysis partnerships.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also relies on the operating activities of certain legal entities in which it does not maintain a controlling ownership interest but over which it has indirect influence and of which it is considered the primary beneficiary.&#160;These entities are typically subject to nominee ownership and transfer restriction agreements that effectively transfer the majority of the economic risks and rewards of their ownership to the Company. The Company&#8217;s management, restriction and other agreements concerning such nominee-owned entities typically include both financial terms and protective and participating rights to the entities&#8217; operating, strategic and non-clinical governance decisions which transfer substantial powers over and economic </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="id320ad81c2914ad6a474e556b2eae52e"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic39b94bf280e4e1585ed4a12f3fcd146">responsibility for these entities to the Company. The Company consolidates all of the nominee-owned entities with which it is most closely associated.</ix:continuation> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the VIEs described above, these consolidated financial statements include total assets of $<ix:nonFraction unitRef="usd" contextRef="ia96df5cbacd84affb90640475c11f0a8_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDEvZnJhZzo5YzhiNjEwZGNmNDQ0MjY0ODNhYTVjMTYwMTYzODQ5Zi90ZXh0cmVnaW9uOjljOGI2MTBkY2Y0NDQyNjQ4M2FhNWMxNjAxNjM4NDlmXzI1NjY_753b8a50-1e74-45d6-9b10-96c741676125">299,953</ix:nonFraction> and total liabilities and noncontrolling interests to third parties of $<ix:nonFraction unitRef="usd" contextRef="ia96df5cbacd84affb90640475c11f0a8_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDEvZnJhZzo5YzhiNjEwZGNmNDQ0MjY0ODNhYTVjMTYwMTYzODQ5Zi90ZXh0cmVnaW9uOjljOGI2MTBkY2Y0NDQyNjQ4M2FhNWMxNjAxNjM4NDlmXzI2NTQ_9a587d90-cd9d-4775-806b-e26fa02344ad">200,110</ix:nonFraction> at December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sponsors certain non-qualified deferred compensation plans whose trusts qualify as VIEs and the Company consolidates these plans as their primary beneficiary.&#160;The assets of these plans are recorded in short-term or long-term investments with related liabilities recorded in accrued compensation and benefits and other long-term liabilities.&#160;See Note 15 for disclosures concerning the assets of these consolidated non-qualified deferred compensation plans.</span></div></ix:continuation><div id="i916f7af890114e55a87e260476560c60_304"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">24.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90ZXh0cmVnaW9uOjZiZDhkZGNlNGQzOTQ5ODI4MjA1MzA0Y2NmZmFiZDg1XzQyMjM_6c60c610-b9b5-4e05-86c8-b93f11e54105" continuedAt="i3dd57e9ca6954bd38ac7d5ce58413dd2" escape="true">Fair values of financial instruments</ix:nonNumeric></span></div><ix:continuation id="i3dd57e9ca6954bd38ac7d5ce58413dd2" continuedAt="i81d67461a0e64af384c24d442bd815a8"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equity that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the FASB.</span></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90ZXh0cmVnaW9uOjZiZDhkZGNlNGQzOTQ5ODI4MjA1MzA0Y2NmZmFiZDg1XzQyMTg_74b44480-b9ad-498d-a540-409ea1e0e765" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s assets, liabilities and temporary equity measured at fair value on a recurring basis as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:42.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.245%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Quoted&#160;prices&#160;in<br/>active&#160;markets&#160;for<br/>identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant&#160;other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd41fb8f57d94a9c8174ee4a26733781_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzItMS0xLTEtODMwNzg_9a1713aa-b762-4a40-8aea-2aaaebdc1080">48,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fef43c972784c6a8dbdf6403215466d_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzItMy0xLTEtODMwNzg_059e2fa0-c1d0-4b5d-9a13-758309a3baf5">48,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica05fdb7be334adbaa11280e81f266cd_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzItNS0xLTEtODMwNzg_f9d5ecad-e5de-4c38-a781-e21cd16acd95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6864393609014579b808f5a4cacfb46d_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzItNy0xLTEtODMwNzg_53c53abc-a25d-4c14-b9ee-cb0d23b3723c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i418c9ec9c3c24e6f814f5127bfb19718_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzMtMS0xLTEtODMwNzg_ae7196e9-550e-4216-9adc-6b840d94ad71">12,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83a052e9006844f196962f56a7a3ab82_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzMtMy0xLTEtODMwNzg_d82d53fe-f8d4-4462-8afc-3b8e6a826628">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98fc6e3377174560b321ac0cda63f05d_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzMtNS0xLTEtODMwNzg_57f73608-5b23-44cd-a3da-fca43c9b2183">12,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d558bed55f41d99d2f76f5a51d8b45_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzMtNy0xLTEtODMwNzg_0943f6d2-3525-4320-9582-bc6f4342d4b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd41fb8f57d94a9c8174ee4a26733781_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzUtMS0xLTEtODMwNzg_6a603fc1-655b-405b-b623-92f022caad35">33,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fef43c972784c6a8dbdf6403215466d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzUtMy0xLTEtODMwNzg_8b5a17d8-4a38-444b-b973-14a9a0eccae5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica05fdb7be334adbaa11280e81f266cd_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzUtNS0xLTEtODMwNzg_35be76d1-91fc-41f4-99f8-f678c38b56d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6864393609014579b808f5a4cacfb46d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzUtNy0xLTEtODMwNzg_7bf512fa-21f8-4158-bb4d-cfff1d0158c8">33,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd41fb8f57d94a9c8174ee4a26733781_I20211231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzctMS0xLTEtODMwNzg_2c0ff50e-d316-4683-bb1c-138226017ce9">1,434,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fef43c972784c6a8dbdf6403215466d_I20211231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzctMy0xLTEtODMwNzg_a91ecccc-8040-47b9-94c9-9fdde5fd960b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica05fdb7be334adbaa11280e81f266cd_I20211231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzctNS0xLTEtODMwNzg_ade57ce7-de99-4563-825f-36d8cb979fdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6864393609014579b808f5a4cacfb46d_I20211231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzctNy0xLTEtODMwNzg_de72bd62-8d1b-4d80-a75d-8b6f60ad354a">1,434,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab0bdb00a98b44d1b298eba644850e38_I20201231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEwLTEtMS0xLTgzMDc4_3ef80edc-0b8a-4d25-b8ad-cd340eff7bc4">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094bcb864f7f45e4b54429ab104ba86e_I20201231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEwLTMtMS0xLTgzMDc4_80629e5e-d42d-4c93-9dd6-bbdff68baa3f">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5f11c3daa745e5a80d9f58e885601d_I20201231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEwLTUtMS0xLTgzMDc4_1ce945a3-75b6-496d-a8b6-e63f590786ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6488a2f4b17b4b85a4d7bf553c12175e_I20201231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEwLTctMS0xLTgzMDc4_c07e487b-90b1-45f3-824e-8a4b355c99f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa251283e0a4f088eb92843005d890b_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzExLTEtMS0xLTgzMDc4_c06ba74a-0c62-428b-adb1-fec41ba7fee3">2,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123069f4eb5a4ab69f8ac7158c7ce2a4_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzExLTMtMS0xLTgzMDc4_4a764177-eb9b-41f2-b2fa-43580f68e9f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05d3a24424f8420b8fe59106d9cca3c4_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzExLTUtMS0xLTgzMDc4_46b264ff-704e-43d5-bfcb-bffc5a5172b3">2,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3aa693ad0da4e16b1fa0ce0a7ea10b7_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzExLTctMS0xLTgzMDc4_c70c37d8-3431-4f20-8e68-d321ac9fd82f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab0bdb00a98b44d1b298eba644850e38_I20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEzLTEtMS0xLTgzMDc4_88c78ef0-4827-4ed9-afb8-8f9cb67c8ac0">30,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094bcb864f7f45e4b54429ab104ba86e_I20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEzLTMtMS0xLTgzMDc4_eac15559-db10-44e7-804d-13a2c7343f21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5f11c3daa745e5a80d9f58e885601d_I20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEzLTUtMS0xLTgzMDc4_7f627adc-3ff0-44e5-8f18-e6e6fc8e6ddc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6488a2f4b17b4b85a4d7bf553c12175e_I20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEzLTctMS0xLTgzMDc4_1d4a49a9-6ddd-4680-90f1-1e87712f46e4">30,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab0bdb00a98b44d1b298eba644850e38_I20201231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzE1LTEtMS0xLTgzMDc4_6bc23f72-464e-45b7-ad66-b7e8d40370c9">1,330,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094bcb864f7f45e4b54429ab104ba86e_I20201231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzE1LTMtMS0xLTgzMDc4_0603dc11-7b16-46e2-9ee7-ec18a5ed674f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5f11c3daa745e5a80d9f58e885601d_I20201231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzE1LTUtMS0xLTgzMDc4_c22a4c08-1e8f-4b6d-9206-198f89a0e875">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6488a2f4b17b4b85a4d7bf553c12175e_I20201231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzE1LTctMS0xLTgzMDc4_bbdfa89d-afea-41c5-b237-20a0708504f3">1,330,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For reconciliations of changes in contingent earn-out obligations and noncontrolling interests subject to put provisions during the year ended at December&#160;31, 2021 and 2020, see Note 21 and the consolidated statements of equity, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stock and are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 5 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 13 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA), revenue and key performance indicators. The estimated fair value of these contingent earn-out obligations is remeasured as of each reporting date and could </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i81d67461a0e64af384c24d442bd815a8"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fluctuate based upon any significant changes in key assumptions, such as changes in the Company credit risk adjusted rate that is used to discount obligations to present value. See Note 21 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of December&#160;31, 2021, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $<ix:nonFraction unitRef="usd" contextRef="i773b082f96934fbdb2cc112ef35d5bcf_D20201231-20201231" decimals="-3" name="dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90ZXh0cmVnaW9uOjZiZDhkZGNlNGQzOTQ5ODI4MjA1MzA0Y2NmZmFiZDg1XzMzOTI_9fe41bab-1078-4a6c-b7fe-c4642e26e662">180,000</ix:nonFraction>. See Note 17 for a discussion of the Company&#8217;s methodology for estimating the fair values of noncontrolling interests subject to put obligations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon quoted bid and ask prices for these instruments, typically a level 2 input. See Note 13 for further discussion of the Company's debt. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in the consolidated financial statements at December&#160;31, 2021 and 2020 at their approximate fair values due to the short-term nature of their settlements.</span></div></ix:continuation><div id="i916f7af890114e55a87e260476560c60_307"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM2MzE_dc8713a9-1d9f-45ac-a944-2afb26e4009d" continuedAt="i09996ee113564e00b368cc717b8da145" escape="true">Segment reporting</ix:nonNumeric></span></div><ix:continuation id="i09996ee113564e00b368cc717b8da145" continuedAt="ibb7bc5931e964af3a889c153d5868855"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its U.S. ancillary services and strategic initiatives and its international operations (collectively, its ancillary services), as well as its corporate administrative support. See Note 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Organization" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a summary description of the Company's businesses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="i94e70ca9077e4db8b762a4fcc4bfbd6f_D20190619-20190619" name="dva:BusinessSaleEffectiveDateOfSale" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzQxNQ_a58856c6-b3b2-482d-adc7-5e152622d797">June 19, 2019</ix:nonNumeric>, the Company completed the sale of its prior DMG business to Optum. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating segments have been defined based on the separate financial information that is regularly produced and reviewed by the Company&#8217;s chief operating decision maker in making decisions about allocating resources to and assessing the financial performance of the Company&#8217;s various operating lines of business. The chief operating decision maker for the Company is its Chief Executive Officer.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s separate operating segments include its U.S. dialysis and related lab services business, its U.S. ancillary services and strategic initiatives, its kidney care operations in each foreign sovereign jurisdiction, its other health operations in each foreign sovereign jurisdiction, and its equity method investment in the APAC joint venture. The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other operating segments, including the international operating segments, have been combined and disclosed in the other segments category.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating segment financial information included in this report is prepared on the internal management reporting basis that the chief operating decision maker uses to allocate resources and assess the financial performance of the Company's operating segments. For internal management reporting, segment operations include direct segment operating expenses but generally exclude corporate administrative support costs, which consist primarily of indirect labor, benefits and long-term incentive compensation expenses of certain departments which provide support to all of the Company&#8217;s various operating lines of business.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ibb7bc5931e964af3a889c153d5868855" continuedAt="i71c053a4010149d5aa7ab0c7550f2a9f"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM2MzQ_fa6b3af5-dd9a-48b5-8d8c-ab23d26ba18f" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a546c754ebc4cf29073750fe342c98d_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzUtMS0xLTEtODMwNzg_9444da5e-046a-4f14-b1c0-5a5aaae05397">10,551,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e14e13c061a41a69e38812da9f0c694_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzUtMy0xLTEtODMwNzg_f74dd561-8291-48bd-85c6-5087d24827b5">10,475,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544de1e9a45e4dbaaf258e405bc34603_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzUtNS0xLTEtODMwNzg_becad117-6408-408c-a553-e8b56c25aa43">10,399,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a20be04098a43a2ad690daf6b43b6a9_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzYtMS0xLTEtODMwNzg_0d9ea272-5061-4786-b68b-5f1ff93f5317">90,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489433a3b5c64d6d8c71dff895bfc7c5_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzYtMy0xLTEtODMwNzg_36f14f3f-7fc3-4b97-9497-f5e9d4153909">144,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib875d6317d544b89a9327b5a6ee456e1_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzYtNS0xLTEtODMwNzg_a46ccd56-ec7d-4840-ae0c-d7f280aeb099">131,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d18a39a07e04a829dc76a948808fea5_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzktMS0xLTEtODMwNzg_2b27812a-c1d4-45a2-83da-67ddd1aea1c9">10,641,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341a3fbdfb3a478c8c3956fb1de4ca5a_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzktMy0xLTEtODMwNzg_2ad7370b-be84-4c29-9de0-e847ab5d5a86">10,619,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0c557cfe8294cbea0ed6640742174a4_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzktNS0xLTEtODMwNzg_56a78298-96bf-4776-9b12-b97bd3e7f060">10,530,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:54pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a546c754ebc4cf29073750fe342c98d_D20210101-20211231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzExLTEtMS0xLTgzMDc4_7b483489-8bfc-4df2-bb53-de7b56b72ee1">25,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e14e13c061a41a69e38812da9f0c694_D20200101-20201231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzExLTMtMS0xLTgzMDc4_b12d8111-cf11-44b7-9605-268ad7754c87">39,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544de1e9a45e4dbaaf258e405bc34603_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzExLTUtMS0xLTgzMDc4_a44700c8-ff54-42bc-94de-6d2f6dd65cde">30,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a20be04098a43a2ad690daf6b43b6a9_D20210101-20211231" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzEyLTEtMS0xLTgzMDc4_0050d8ae-3f41-4f86-a657-1dc8bf2ff9e6">284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489433a3b5c64d6d8c71dff895bfc7c5_D20200101-20201231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzEyLTMtMS0xLTgzMDc4_3e0d5f4c-256c-44ac-af77-68c0ccc3c88d">1,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib875d6317d544b89a9327b5a6ee456e1_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzEyLTUtMS0xLTgzMDc4_45e76756-66bc-430b-92b7-3e599a9a3563">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d18a39a07e04a829dc76a948808fea5_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzEzLTEtMS0xLTgzMDc4_a1511fe1-25e0-4211-a1fa-48d8f3b7a970">10,666,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341a3fbdfb3a478c8c3956fb1de4ca5a_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzEzLTMtMS0xLTgzMDc4_2a595be9-8c83-44b9-9dd8-bd14166bdad9">10,659,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0c557cfe8294cbea0ed6640742174a4_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzEzLTUtMS0xLTgzMDc4_1545053c-a5d5-43f6-9c14-5ebda73ec2b6">10,562,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i740db58e2be94545b0d469bbda135eed_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE1LTEtMS0xLTgzMDc4_312bd4a9-9dcb-44f2-89c5-4d95f98daa35">662,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30278d11df6d4599be4d253d8771c646_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE1LTMtMS0xLTgzMDc4_74040d60-929c-48d4-a11e-474784ec4ecd">550,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02fff1f443d0417a9b5ea14a7887642f_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE1LTUtMS0xLTgzMDc4_85e15055-7a14-4ce1-8e73-550b5253e4d5">497,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i740db58e2be94545b0d469bbda135eed_D20210101-20211231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE2LTEtMS0xLTgzMDc4_cde40f75-f09e-4feb-929e-6790a3f98af5">380,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30278d11df6d4599be4d253d8771c646_D20200101-20201231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE2LTMtMS0xLTgzMDc4_9f5aae6e-2555-455d-bfb6-7ddf56ba514d">484,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02fff1f443d0417a9b5ea14a7887642f_D20190101-20191231" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE2LTUtMS0xLTgzMDc4_75faf73d-5452-4693-826d-f190bedc8089">460,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f996697630f4114b1fe31268ca70cfb_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE3LTEtMS0xLTgzMDc4_f701d9cf-32b3-4f82-955a-e9587eef9ab3">4,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6915b80d9b3f460f8e299e65e92465a5_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE3LTMtMS0xLTgzMDc4_49cf2940-72b0-492d-83dc-2d613438ab2c">16,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if07da703894f46ff923b52cd1974f85e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE3LTUtMS0xLTgzMDc4_84119815-6154-46be-914f-efa208860905">14,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total ancillary services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i740db58e2be94545b0d469bbda135eed_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE4LTEtMS0xLTgzMDc4_ae42c1ed-b845-414a-a75a-45e03050ed20">1,046,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30278d11df6d4599be4d253d8771c646_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE4LTMtMS0xLTgzMDc4_d0e9897f-b2b9-436a-b08f-223af64d6548">1,052,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02fff1f443d0417a9b5ea14a7887642f_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE4LTUtMS0xLTgzMDc4_adddad39-6ceb-4a40-8cd4-ca2fce86edf8">971,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaff1da3cd4af4158afb2f7ced0775c70_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE5LTEtMS0xLTgzMDc4_2f90ada8-945f-4581-a0fc-69bce903b5ab">11,713,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2abab19ce64643c5b1ead781e19bc5d4_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE5LTMtMS0xLTgzMDc4_f29b41f9-1772-4169-91a8-40cd97ade055">11,712,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53d5102250e24aa5bd036affff061811_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE5LTUtMS0xLTgzMDc4_b7047176-eff5-4480-8ab1-4a8d4e829a7c">11,534,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8c57a5b75b1450db44db406dbe6cbb1_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIwLTEtMS0xLTgzMDc4_705c0912-29b0-42c5-ad61-5265d79c1376">95,090</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i867fc66d86b045b5b0590e89915a412c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIwLTMtMS0xLTgzMDc4_7a89b18f-0781-41d8-982c-ef949e4481bb">162,029</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba5967b32fb4416ab78a1b0e0114069a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIwLTUtMS0xLTgzMDc4_3c9461f2-463e-419b-97c5-c334f639154d">146,355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIxLTEtMS0xLTgzMDc4_31e650c9-ba31-4a91-a3ab-a5058746f48c">11,618,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIxLTMtMS0xLTgzMDc4_0a2d308e-6be0-41a3-9efd-77b98e140d59">11,550,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIxLTUtMS0xLTgzMDc4_418a8eea-bfbd-47cd-9a0c-99b562e21765">11,388,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment operating margin (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d18a39a07e04a829dc76a948808fea5_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIzLTEtMS0xLTgzMDc4_08a2500c-a102-4ae6-a666-262e41f57c6f">1,974,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341a3fbdfb3a478c8c3956fb1de4ca5a_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIzLTMtMS0xLTgzMDc4_645fc5b3-e106-4275-848c-908fc15e205e">1,917,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0c557cfe8294cbea0ed6640742174a4_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIzLTUtMS0xLTgzMDc4_ce645406-6e67-4cea-a173-17602c406249">1,924,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i740db58e2be94545b0d469bbda135eed_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI0LTEtMS0xLTgzMDc4_85330ea0-a0aa-4044-b487-dbcf067e6314">66,003</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30278d11df6d4599be4d253d8771c646_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI0LTMtMS0xLTgzMDc4_ea5b5c6d-64df-433c-bf31-1d6c104dca2c">76,261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02fff1f443d0417a9b5ea14a7887642f_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI0LTUtMS0xLTgzMDc4_6cb3656e-63a7-42e3-9a8d-b41f4b5a71b1">189,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaff1da3cd4af4158afb2f7ced0775c70_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI1LTEtMS0xLTgzMDc4_24cd6a84-c5e3-41ea-9197-6abcf089bca6">1,908,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2abab19ce64643c5b1ead781e19bc5d4_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI1LTMtMS0xLTgzMDc4_f2040f20-f37c-4f67-b82f-e6e90903828c">1,841,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53d5102250e24aa5bd036affff061811_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI1LTUtMS0xLTgzMDc4_6ca6f94d-59eb-44cc-8622-794efe3acc5a">1,735,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of segment operating margin to consolidated income from<br/>&#160;continuing operations before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="dva:SegmentReportingInformationCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI3LTEtMS0xLTgzMDc4_1589b3e4-cbe4-4e6e-96ef-bdebce10e505">111,615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="dva:SegmentReportingInformationCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI3LTMtMS0xLTgzMDc4_6bcd78f8-fa90-4089-93b1-9f54e547af32">146,707</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="dva:SegmentReportingInformationCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI3LTUtMS0xLTgzMDc4_55d4ad03-2b85-4418-b22d-629a8856a525">92,335</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI4LTEtMS0xLTgzMDc4_a9ddb30d-d74a-46ad-9004-412ffd10c665">1,797,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI4LTMtMS0xLTgzMDc4_150fdb08-c33b-4953-9775-54eb821f4eb3">1,694,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI4LTUtMS0xLTgzMDc4_8a1b8aac-89cd-4211-835b-06736f2ede73">1,643,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI5LTEtMS0xLTgzMDc4_27d7ab4c-78f0-4dbd-b3d0-4c73ba93652d">285,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI5LTMtMS0xLTgzMDc4_bcd788fd-9781-4542-984e-815756eb296c">304,111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI5LTUtMS0xLTgzMDc4_ece863b4-8e5d-4ea7-a8ea-fa26154f11f3">443,824</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt prepayment, refinancing and redemption charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="dva:DebtPrepaymentRefinancingRedemptionCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMwLTEtMS0xLTgzMDc4_06044dfc-b232-48c9-8e20-1cc318fb956e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="dva:DebtPrepaymentRefinancingRedemptionCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMwLTMtMS0xLTgzMDc4_ce8a1c9a-eefe-4e96-b944-6482389e43b7">89,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="dva:DebtPrepaymentRefinancingRedemptionCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMwLTUtMS0xLTgzMDc4_fea3d737-c4dc-4b5a-8bf0-be1d2f0f437b">33,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMxLTEtMS0xLTgzMDc4_e482f775-1382-40f4-bc1e-9256ae99f1af">6,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMxLTMtMS0xLTgzMDc4_e2308e51-4fb4-40f3-b0e0-27b6f71609b9">16,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMxLTUtMS0xLTgzMDc4_ca01b7fe-32d7-4ed2-9072-d7b4861dd3e2">29,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMyLTEtMS0xLTgzMDc4_5f044135-19d9-4c60-9186-41c799d06012">1,518,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMyLTMtMS0xLTgzMDc4_7365fff2-0c9b-4b7c-b5c2-a376e37b687e">1,318,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMyLTUtMS0xLTgzMDc4_370e613f-8ceb-4e97-90e3-0caa925e841c">1,195,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity investment income of $<ix:nonFraction unitRef="usd" contextRef="i740db58e2be94545b0d469bbda135eed_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzMwNDM_da95db82-e63c-46e2-8c4c-0177dce2b0f8">3,177</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i30278d11df6d4599be4d253d8771c646_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzMwNDc_73a1fe3e-2f80-43a3-9fed-5779580dc75e">5,866</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i02fff1f443d0417a9b5ea14a7887642f_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzMwNTU_e612e7e9-8fb9-4e76-8c48-24abcf75a889">9,366</ix:nonFraction> in 2021, 2020 and 2019, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM2Mjk_9917b1cf-0ba5-472d-a914-5c02d3f2efb3" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"></td><td style="width:48.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.071%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.071%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzItMS0xLTEtODMwNzg_52be36c4-046f-45a6-b9d1-7a9f169a095d">642,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzItMy0xLTEtODMwNzg_a7100bfb-0ac2-4f0a-86a2-1425ee5fa1f0">594,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f8e1940aa343e29817e02300203cc7_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzItNS0xLTEtODMwNzg_c24ceab5-515b-49f8-babd-9b72c6a5962b">583,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzMtMS0xLTEtODMwNzg_cce24fd7-fb17-43a1-8460-a1b3d4729461">37,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzMtMy0xLTEtODMwNzg_64805792-17c1-4d5b-8aa2-581024af42cc">35,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1b74b97d41414b9d610ad1be460b97_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzMtNS0xLTEtODMwNzg_f37a5b06-d5e7-4e88-a1c6-213c9a2eb134">31,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzQtMS0xLTEtODMwNzg_86810351-4fc1-498f-8919-5e84cd1d5cd1">680,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzQtMy0xLTEtODMwNzg_4a8a3bfb-0dc3-453f-9c5a-c9290be90864">630,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzQtNS0xLTEtODMwNzg_9c6deafa-16bb-4ef8-95ac-424fa3c0df7a">615,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzE5NzkxMjA5MzA0MjQ4_f4b6d167-3666-41df-936d-eae43a287f04" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for property and equipment by reportable segment were as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"></td><td style="width:48.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.071%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.071%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzItMS0xLTEtODMwNzg_c31e4e39-7157-4585-8db3-20fdad6ee863">589,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzItMy0xLTEtODMwNzg_8573b8c7-5aff-44c7-b6fa-2786586fd471">646,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f8e1940aa343e29817e02300203cc7_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzItNS0xLTEtODMwNzg_9e2c82d2-a1a8-4d11-9340-46bcbdf1e804">681,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzMtMS0xLTEtODMwNzg_b591ea31-7d1e-47c6-b9c7-c652efd2e912">51,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzMtMy0xLTEtODMwNzg_5f1ae454-b605-4cfd-9738-daa70c0a883f">27,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1b74b97d41414b9d610ad1be460b97_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzMtNS0xLTEtODMwNzg_76ca6d2e-d718-49d5-9686-f78e6db05bcb">46,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DMG - Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74654e344444142a656506ce7f98032_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzQtMS0xLTEtODMwNzg_1cfbbe03-04f9-442e-ab8e-e372d91b9694">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i769c9942acbc457e9f36b28d6dc6bcff_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzQtMy0xLTEtODMwNzg_93aeda6b-0a01-4116-b14d-6bf913db206c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5869a8167684e6e92336d2061353dd0_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzQtNS0xLTEtODMwNzg_249efc0e-6b83-4349-899b-0a187146dc39">38,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzUtMS0xLTEtODMwNzg_8cf5d9a3-7987-4698-aaf7-f68be089cb19">641,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzUtMy0xLTEtODMwNzg_a9ce9199-2fbc-41fc-b46b-071630e6f3ab">674,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzUtNS0xLTEtODMwNzg_d633e218-2a9d-4f30-9ab8-f37690d2bc2c">766,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;padding-left:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i71c053a4010149d5aa7ab0c7550f2a9f"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM2NDc_10180a5c-c5b6-47f1-b09c-75cbe646ba75" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summary of assets by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"></td><td style="width:58.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo0NTdiMWIxMTVmZTM0MTY4YTMwMzdhYjE5ZjgxODJhNC90YWJsZXJhbmdlOjQ1N2IxYjExNWZlMzQxNjhhMzAzN2FiMTlmODE4MmE0XzMtMS0xLTEtODMwNzg_18c213ce-617f-441d-9ca5-0e46ee060d67">15,375,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce7de8cdc8f44f5a250fb8c150e4e1f_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo0NTdiMWIxMTVmZTM0MTY4YTMwMzdhYjE5ZjgxODJhNC90YWJsZXJhbmdlOjQ1N2IxYjExNWZlMzQxNjhhMzAzN2FiMTlmODE4MmE0XzMtMy0xLTEtODMwNzg_afb5b9f1-9e36-4a7e-9fa1-d06f6d187262">15,344,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo0NTdiMWIxMTVmZTM0MTY4YTMwMzdhYjE5ZjgxODJhNC90YWJsZXJhbmdlOjQ1N2IxYjExNWZlMzQxNjhhMzAzN2FiMTlmODE4MmE0XzQtMS0xLTEtODMwNzg_f8a666b8-8f43-42c2-b21c-2f93675bdc43">1,746,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8a66dcc0dd948fbb741fd4e292faf13_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo0NTdiMWIxMTVmZTM0MTY4YTMwMzdhYjE5ZjgxODJhNC90YWJsZXJhbmdlOjQ1N2IxYjExNWZlMzQxNjhhMzAzN2FiMTlmODE4MmE0XzQtMy0xLTEtODMwNzg_0d2b2249-26a8-4035-ae54-b78ed6dd752e">1,643,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo0NTdiMWIxMTVmZTM0MTY4YTMwMzdhYjE5ZjgxODJhNC90YWJsZXJhbmdlOjQ1N2IxYjExNWZlMzQxNjhhMzAzN2FiMTlmODE4MmE0XzUtMS0xLTEtODMwNzg_d75cee49-5610-4437-a026-9d10cc7a3543">17,121,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo0NTdiMWIxMTVmZTM0MTY4YTMwMzdhYjE5ZjgxODJhNC90YWJsZXJhbmdlOjQ1N2IxYjExNWZlMzQxNjhhMzAzN2FiMTlmODE4MmE0XzUtMy0xLTEtODMwNzg_9588bbdc-7e7a-4f9d-b577-d381db2265de">16,988,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity method and other investments of $<ix:nonFraction unitRef="usd" contextRef="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzMzNTk_f1b10a7c-aa3f-4f30-8b61-8014936c2da3">112,500</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="icce7de8cdc8f44f5a250fb8c150e4e1f_I20201231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzMzNjY_d126b7ea-2595-42cc-bfa3-e8436deb9d2d">122,974</ix:nonFraction> in 2021 and 2020, respectively. </span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity method and other investments of $<ix:nonFraction unitRef="usd" contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM0NDY_b13c186d-4020-48a9-9598-d434f9ab370a">126,381</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="if8a66dcc0dd948fbb741fd4e292faf13_I20201231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM0NTM_0d27c34f-0771-407f-81a3-e6b7d7243521">134,517</ix:nonFraction> in 2021 and 2020, respectively and includes approximately $<ix:nonFraction unitRef="usd" contextRef="id95aa5b653c348f3afacdc11aed8c324_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM1MTA_855d5f07-10cb-48b1-8a74-779abe277865">190,029</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i7f1ee4e1cd744091960584e2d8db83ed_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM1MTc_681d08bd-aaf0-45cb-b3d3-37dbb9b4b43d">181,137</ix:nonFraction> in 2021 and 2020, respectively, of net property and equipment related to the Company&#8217;s international operations.</span></div></ix:nonNumeric></ix:continuation><div id="i916f7af890114e55a87e260476560c60_310"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">26.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90ZXh0cmVnaW9uOjdjOTFlOTNkZTkwODRkYmFhZWNmZjQzZmJiMTM4MDlhXzEwNg_7a8afa1d-81c5-46b2-aff8-d7740b1d1153" continuedAt="i4473ddbbddcb41a9a8cc68dd8d5dbad2" escape="true">Supplemental cash flow information</ix:nonNumeric></span></div><ix:continuation id="i4473ddbbddcb41a9a8cc68dd8d5dbad2"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90ZXh0cmVnaW9uOjdjOTFlOTNkZTkwODRkYmFhZWNmZjQzZmJiMTM4MDlhXzEwOA_843ff67a-523f-432c-a3e4-4d63e48d5b5d" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides supplemental cash flow information:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"><tr><td style="width:1.0%"></td><td style="width:49.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzMtMS0xLTEtODMwNzg_28624a30-c176-4676-8b26-1280ccc030c1">209,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzMtMy0xLTEtODMwNzg_4bdb97a3-866f-43b8-a059-e650a720903a">154,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzMtNS0xLTEtODMwNzg_03aafcbf-32d3-4c51-aaff-990bc5cb5c99">157,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzQtMS0xLTEtODMwNzg_af5eb3d6-95f5-4345-8cc5-0bf54bf34fbd">279,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzQtMy0xLTEtODMwNzg_82adc69f-9d8e-42fa-80ca-703ad020c9dc">326,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzQtNS0xLTEtODMwNzg_09905d54-8445-413f-81c6-272dd500fc76">473,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets under financing lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzYtMS0xLTEtODMwNzg_077d4eb1-f0db-4934-a904-d2721f78a82f">31,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzYtMy0xLTEtODMwNzg_056e9e9f-26ea-4643-a234-8e58aeb8c226">22,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzYtNS0xLTEtODMwNzg_eb5f0381-38f1-4d41-b5fd-eda57c178512">18,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="padding-left:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_316"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:8.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.972%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312517362136/d496893dex101.htm">2.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Purchase Agreement, dated as of December 5, 2017, by and among DaVita Inc., Collaborative Care Holdings, LLC, and solely with respect to Section 9.3 and Section 9.18 thereto, UnitedHealth Group Incorporated.(2)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312518280459/d621366dex101.htm">2.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1 dated as of September 20, 2018, to that certain Equity Purchase Agreement, dated as of December 5, 2017, by and among DaVita Inc., a Delaware corporation, Collaborative Care Holdings, LLC, a Delaware limited liability company and a wholly owned subsidiary of Optum, Inc., and solely with respect to Section 9.3 and Section 9.18 thereto, UnitedHealth Group Incorporated, a Delaware corporation.(15)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312518350364/d658923dex101.htm">2.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Amendment to Equity Purchase Agreement by and between DaVita Inc., a Delaware corporation, and Collaborative Care Holdings, LLC, a Delaware limited liability company, dated as of December 11, 2018, amending that certain Equity Purchase Agreement, dated as of December 5, 2017, by and among DaVita Inc., Collaborative Care Holdings, LLC, and, solely with respect to Section&#160;9.3 and Section 9.18 thereto, UnitedHealth Group Incorporated (as previously amended).(9)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000156459016027049/dva-ex31_1170.htm">3.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restated Certificate of Incorporation of DaVita Inc., as filed with the Secretary of State of Delaware on November 1, 2016.(1)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000266/ex31-davitaamendedandr.htm">3.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Bylaws for DaVita Inc. dated as of December 10, 2020.(24)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000125/exhibit41-indenture692.htm">4.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture for the 4.625% Senior Notes due 2030, dated as of June 9, 2020, by and among DaVita Inc., the subsidiary guarantors party thereto and The Bank of New York Mellon Trust Company, N.A., as Trustee.(14)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000125/exhibit41-indenture692.htm">4.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 4.625% Senior Notes due 2030 and related Guarantee (included in Exhibit 4.1).(14)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000177/ex41-indentureaugust20.htm">4.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture for the 3.750% Senior Notes due 2031, dated August 11, 2020, by and among DaVita Inc., the subsidiary guarantors party thereto and The Bank of New York Mellon Trust Company, N.A., as Trustee.(12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000177/ex41-indentureaugust20.htm">4.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 3.750% Senior Notes due 2031 and related Guarantee (included in Exhibit 4.3).(12)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000014/dva-123119ex45.htm">4.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description of Securities.(21)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000162828017004680/dva-33117ex101.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sourcing and Supply Agreement between DaVita Inc. and Amgen USA Inc. effective as of January 6, 2017.(4)**</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706619000137/ex1012019creditagreement.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit Agreement, dated August 12, 2019, by and among DaVita Inc., certain subsidiary guarantors party thereto, the lenders party thereto, Credit Agricole Corporate and Investment Bank, JPMorgan Chase Bank, N.A. and MUFG Bank Ltd., as co-syndication agents, Bank of America, N.A., Barclays Bank PLC, Credit Suisse Loan Funding LLC, Goldman Sachs Bank USA, Morgan Stanley Senior Funding, Inc. and Suntrust Bank, as co-documentation agents, and Wells Fargo Bank, National Association, as administrative agent, collateral agent and swingline lender.(17)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000014/dva-123119ex103.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment, dated as of February 13, 2020, to that certain Credit Agreement, dated as of August 12, 2019, by and among DaVita Inc., certain subsidiary guarantors party thereto, the lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent, collateral agent and swingline lender.(21)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519123788/d726706dex101.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, dated as of April 29, 2019, by and between Javier J. Rodriguez and DaVita Inc.(10)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706619000202/dva-def14a.htm#sE0D95A9952875B7195329C9BDDFC0BDC">10.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Appreciation Rights Agreement, effective November 4, 2019, by and between Javier J. Rodriguez and DaVita Inc.(20)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000156459017002409/dva-ex1013_1293.htm">10.6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, effective February 21, 2017, by and between DaVita Inc. and Joel Ackerman.(6)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 1 of 4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:8.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.972%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000162828017004680/dva-33117ex102.htm">10.7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, effective April 27, 2016, by and between DaVita HealthCare Partners Inc. and Kathleen A. Waters.(4)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000014/dva-123119ex1021.htm">10.8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, effective April 29, 2015, by and between DaVita HealthCare Partners Inc. and Michael Staffieri.(21)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312506257237/dex101.htm">10.9</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Indemnity Agreement.(8)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312505041002/dex1028.htm">10.10</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Indemnity Agreement.(5)*</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000156459017002409/dva-ex1016_1294.htm">10.11</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Deferred Compensation Plan.(6)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000104746916013062/a2228594zdef14a.htm#du73201_stockholder_proposals_for_2017_annual_meeting">10.12</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Employee Stock Purchase Plan.(19)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706621000166/dva-93021ex101x2021davitai.htm">10.13</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Inc. Severance Plan for Directors and Above.(3)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000073/dva-33120ex101.htm">10.14</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Inc. Non-Employee Director Compensation Policy.(11)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312514163315/d701196ddef14a.htm#toc701196_76">10.15</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated DaVita Inc. 2011 Incentive Award Plan.(7)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706619000202/dva-def14a.htm#s443F0CA95E025906867096037A067CF7">10.16</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1 to the Amended and Restated DaVita Inc. 2011 Incentive Award Plan.(20)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706620000064/dva-123119xdef14a.htm">10.17</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Inc. 2020 Incentive Award Plan.(22)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706618000167/exhibit102.htm">10.18</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Inc. Rule of 65 Policy, adopted on August 19, 2018.(16)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt 0 5.5pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706618000165/dva-63018xex101.htm">10.19</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Appreciation Rights Agreement-Board members (DaVita Inc. 2011 Incentive Award Plan).(25)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312513085450/d465470dex1061.htm">10.20</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Appreciation Rights Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(13)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312513085450/d465470dex1062.htm">10.21</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Long-Term Incentive Program Award Agreement (For 162(m) designated teammates) (DaVita Inc. 2011 Incentive Award Plan).(13)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312513085450/d465470dex1063.htm">10.22</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Long-Term Incentive Program Award Agreement (DaVita Inc. 2011 Incentive Award Plan).(13)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d22.htm">10.23</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Units Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(18)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d23.htm">10.24</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Performance Stock Units Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(18)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d24.htm">10.25</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Appreciation Rights Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(18)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d25.htm">10.26</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Units Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(18)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d26.htm">10.27</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Performance Stock Units Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(18)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312519198449/d726897dex99d27.htm">10.28</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Appreciation Rights Agreement-Executives (DaVita Inc. 2011 Incentive Award Plan).(18)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312520221812/d905943dex99d31.htm">10.29</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Appreciation Rights Agreement (DaVita Inc. 2020 Incentive Award Plan).(23)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312520221812/d905943dex99d32.htm">10.30</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Performance-Based Restricted Stock Unit Agreement (DaVita Inc. 2020 Incentive Award Plan).(23)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 2 of 4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:8.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.972%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000119312520221812/d905943dex99d33.htm">10.31</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Unit Agreement (DaVita Inc. 2020 Incentive Award Plan).(23)*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-123121ex211.htm">21.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">List of our subsidiaries.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-123121ex231.htm">23.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of KPMG LLP, independent registered public accounting firm.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i916f7af890114e55a87e260476560c60_319">24.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Powers of Attorney with respect to DaVita. (Included on Page S-1).</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-123121ex31110xk.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer, dated February&#160;11, 2022, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-123121ex31210xk.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Financial Officer, dated February&#160;11, 2022, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-123121ex32110xk.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer, dated February&#160;11, 2022, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-123121ex32210xk.htm">32.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Financial Officer, dated February&#160;11, 2022, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.735%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.413%"><tr><td style="width:1.0%"></td><td style="width:5.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.968%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in this filing.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contract or executive compensation plan or arrangement.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portions of this exhibit are subject to a request for confidential treatment and have been redacted and filed separately with the SEC.</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on November 2, 2016 as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2016.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on December 6, 2017 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on October 28, 2021 as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021. </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on May 2, 2017 as an exhibit to the Company&#8217;s Quarterly Report on 10-Q for the quarter ended March 31, 2017.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on March 3, 2005 as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on February 24, 2017 as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2016.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on April 28, 2014 as an appendix to the Company's Definitive Proxy Statement on Schedule 14A.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on December 20, 2006 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed on December 17, 2018 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on April 29, 2019 as an exhibit to the Company's Current Report on Form 8-K.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 3 of 4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on May 5, 2020 as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2020.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on August 11, 2020 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on March 1, 2013 as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on June 9, 2020 as an exhibit to the Company's Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on September 24, 2018 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on August 23, 2018 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on August 14, 2019 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on July 22, 2019 as an exhibit to the Company&#8217;s Tender Offer Statement on Schedule TO-I. </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on May 10, 2016 as an appendix to the Company's Proxy Statement on DEF 14A.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on December 6, 2019 as an appendix to the Company's Proxy Statement on DEF 14A.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on February 21, 2020 as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on April 27, 2020 as an appendix to the Company's Proxy Statement on DEF 14A.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on August 17, 2020 as an exhibit to the Company&#8217;s Tender Offer Statement on Schedule TO-I.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on December 10, 2020 as an exhibit to the Company&#8217;s Current Report on Form 8-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed on August 1, 2018 as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 4 of 4</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_319"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, we have duly caused this Annual Report on Form 10-K to be signed on our behalf by the undersigned, thereunto duly authorized, in the City of Denver, State of Colorado, on February&#160;11, 2022.</span></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.807%"><tr><td style="width:1.0%"></td><td style="width:15.719%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.552%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DAVITA INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/ J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Javier J. Rodriguez<br/>Chief Executive Officer</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL MEN BY THESE PRESENT, that each person whose signature appears below constitutes and appoints Javier J. Rodriguez, Joel Ackerman, and Kathleen Waters, and each of them his or her true and lawful attorneys-in-fact and agents with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form&#160;10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.009%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Javier J. Rodriguez</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OEL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CKERMAN</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Treasurer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joel Ackerman</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/ J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OHN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> D. W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">INSTEL</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Accounting Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John D. Winstel</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AMELA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> M. A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RWAY</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pamela M. Arway</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HARLES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> G. B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ERG</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles G. Berg</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ARBARA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESOER</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara J. Desoer</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AUL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IAZ</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paul J. Diaz</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; G</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">REGORY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OORE</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory J. Moore</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OHN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> M. N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EHRA</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John M. Nehra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AULA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> A. P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">RICE</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paula A. Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160; P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HYLLIS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> R. Y</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ALE</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phyllis R. Yale</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-2</span></div></div></div><div id="i916f7af890114e55a87e260476560c60_322"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90ZXh0cmVnaW9uOmVhYmUwZDY1ZDczYzQwN2FhYWExMDhlYzQxM2QzMzEwXzY2_98622060-32f1-4f09-b162-7dbf762348dd" escape="true"><ix:nonNumeric contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90ZXh0cmVnaW9uOmVhYmUwZDY1ZDczYzQwN2FhYWExMDhlYzQxM2QzMzEwXzY2_bb364d01-f2ed-47b5-85fe-2d25db68b90f" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II&#8212;VALUATION AND QUALIFYING ACCOUNTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:45.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.772%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at<br/>beginning of year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts<br/>charged to income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts written off</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance<br/>at end of year</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for uncollectible accounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8020fe2d892b43739f987d0c488736a0_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzQtMi0xLTEtODMwNzg_ca387eea-1e05-4344-8ec3-99ba638c6847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ce08c39f814ce99981d4545611fa84_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzQtNC0xLTEtODMwNzg_1570553b-42ca-4539-ada9-09116d962a4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ce08c39f814ce99981d4545611fa84_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzQtNi0xLTEtODMwNzg_e95b160b-8f7f-46c4-a261-039b209f6958">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ce08c39f814ce99981d4545611fa84_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzQtOC0xLTEtODMwNzg_5fedf050-465f-4896-8bc4-9bcf95ea8ed5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149a050b3c4645829b359c2948b066e4_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzQtMTAtMS0xLTgzMDc4_758731a0-cd8e-46d2-a93f-ffaf25a0c4d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c153efa63664c3e9cd75b33af39db2a_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzUtMi0xLTEtODMwNzg_ef691e9b-e75a-4ff3-8006-6da3956ca9da">8,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91556d981c14455d82d1dc87f6ab398c_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzUtNC0xLTEtODMwNzg_1994b8b3-9e1f-44f5-ab9d-e77c542cf47b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91556d981c14455d82d1dc87f6ab398c_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzUtNi0xLTEtODMwNzg_44fbb8b8-cc36-457b-b9ab-5a31e6dcc479">13,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91556d981c14455d82d1dc87f6ab398c_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzUtOC0xLTEtODMwNzg_0a7feb12-8244-4f42-925c-3c96037a05b3">21,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8020fe2d892b43739f987d0c488736a0_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzUtMTAtMS0xLTgzMDc4_dd09be38-3d6a-43ca-96e9-5d3f032149c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69bac113d5d84b4b85c181e2fd5a277c_I20181231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzYtMi0xLTEtODMwNzg_4f0a2e60-b19d-415e-8962-a21d9f53809e">52,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a475d47d0d042098ff362c229c4796b_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzYtNC0xLTEtODMwNzg_9526caa8-de39-49de-98ad-e5108b2c0cdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a475d47d0d042098ff362c229c4796b_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzYtNi0xLTEtODMwNzg_ff9f7f68-2c20-45df-9bd2-4b5c23851ffa">21,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a475d47d0d042098ff362c229c4796b_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzYtOC0xLTEtODMwNzg_83b87589-f0c0-4641-9315-d3146c7b64b0">66,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c153efa63664c3e9cd75b33af39db2a_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzYtMTAtMS0xLTgzMDc4_3a5fa0de-1d0f-4f24-99d2-5b30decc38b5">8,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-3</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>dva-123121ex211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icfef1c9e98a94e7bbf0dfd802ede30b5_1"></div><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">Exhibit 21.1 </font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">SUBSIDIARIES OF THE COMPANY </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">as of December&#160;31, 2021&#160;</font></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aberdeen Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accountable Kidney Care, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ahern Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI Care Insights, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alenes Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Fork Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Medical Insurance, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amity Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Animas Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arcadia Gardens Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Artesia Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attell Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austin Dialysis Centers, L.P.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bainbridge Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bannon Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barnell Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barrons Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barton Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basin Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bastrop Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bayonne Renal Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bayshore Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beacon Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bedell Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bellevue Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bemity Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beverly Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Birch Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bladon Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blanco Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bliss Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bluegrass Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bogachiel Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bohama Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bothwell Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bottle Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bowan Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brache Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Braddock Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Braden Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Branbur Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bretton Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridges Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brook Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brooksprings Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brownsville Kidney Center, Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brownwood Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brule Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bruno Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buckhorn Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buford Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bullards Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bullock Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Burman Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Butano Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cagles Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cahaba Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Campton Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canyon Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canyon Springs Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capes Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital Dialysis Partnership</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capron Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carlsbad Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carlton Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Virgin Islands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carroll County Dialysis Facility Limited Partnership</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carroll County Dialysis Facility, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cascades Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Caverns Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cedar Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centennial LV, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Carolina Dialysis Centers, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Georgia Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Iowa Dialysis Partners, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Kentucky Dialysis Centers, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cerito Dialysis Partners, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chaffee Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Channel Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chantry Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cheraw Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chipeta Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chouteau Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Churchill Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cimarron Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cinco Rios Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clark Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clayton Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinica Central do Bonfim S.A.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinton Township Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clover Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clyfee Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coast Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cobbles Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Columbus-RNA-DaVita, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commerce Township Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conconully Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continental Dialysis Center of Springfield-Fairfax, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continental Dialysis Centers, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coral Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Couer Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Court Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cowell Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creek Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crossings Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crystals Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cuivre Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Culbert Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curecanti Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dale Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dallas-Fort Worth Nephrology, L.P.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Damon Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita - Riverside II, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita - Riverside, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita - West, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita &#193;guas Claras Servi&#231;os de Nefrologia Ltda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita APAC Holding B.V.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Brasil Participa&#231;&#245;es e Servi&#231;os de Nefrologia Ltda. </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Care (Saudi Arabia)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saudi Arabia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Ceil&#226;ndia Servi&#231;os de Nefrologia Ltda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Dakota Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Deutschland AG</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Deutschland Beteiligungs GmbH &#38; Co. KG</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Deutschland Verwaltungs GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita El Paso East, L.P.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Germany GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita HealthCare Brasil Servi&#231;os M&#233;dicos Ltda. </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita International Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Kidney Care Contracting, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Nefromed Servi&#231;os de Nefrologia Ltda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Nephron Care Servi&#231;os de Nefrologia Ltda. </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita of New York, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita S.A.S.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Asa Sul Ltda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Cuiab&#225; Ltda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Lagoa Nova Ltda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Pacini Ltda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Servi&#231;os de Nefrologia Taubat&#233; Ltda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Sp. z o.o.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Sud-Niedersachsen GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Tratamento Renal Participa&#231;&#245;es Ltda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita UK Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita UTR Servi&#231;os de Nefrologia Ltda. </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita VillageHealth, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dawson Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DC Healthcare International, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deowee Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DeSoto Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DiaCare AG</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis Holdings, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis of Des Moines, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis of Northern Illinois, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis Specialists of Dallas, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dighton Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DNP Management Company, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dolores Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dome Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dorchester Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doves Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DPS CKD, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dresher Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Durango Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DV Care Netherlands B.V.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DV Care Netherlands B.V. Arabia Medical</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saudi Arabia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DV Care Netherlands C.V.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare - Southwest Ohio, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare of Maryland, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare of Massachusetts, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare of New London, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare of Norwich, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare of Pennsylvania, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare of Tuscaloosa, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Healthcare Renal Care, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Holdings Pte. Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Laboratory Services, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA of New York, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVA Renal Healthcare, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dworsher Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">East End Dialysis Center, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">East Ft. Lauderdale, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">East Houston Kidney Center, L.P.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">East Oaks Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ebrea Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Edisto Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eldrist Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elgin Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elk Grove Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Empire State DC, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Etowah Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ettleton Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eufaula Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EURODIAL - Centro de Nefrologia e Dialise de Leiria S.A.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Falcon, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fanthorp Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal Way Assurance, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ferne Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fields Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Five Star Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fjords Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Flagler Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Flamingo Park Kidney Center, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forester Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freehold Artificial Kidney Center, L.L.C.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freeman Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fremont Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frierton Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frontier Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fullerton Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ganchis Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ganois Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gansett Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Garner Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Garrett Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Garson Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gate Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gaviota Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GDC International, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gebhard Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genesis KC Development, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geyser Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gilwards Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GiveLife Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glassland Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glosser Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goldendale Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goliad Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grand Home Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Great Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Las Vegas Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Los Angeles Dialysis Centers, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Green Country Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Green Desert Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Griffin Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hanford Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Harmony Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Harpett Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hart Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hawn Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hazelton Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hegan Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helmer Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hennepin Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hewett Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heyburn Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hightower Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holten Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home Kidney Care, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Honey Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Honeyman Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hopkinton Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Houston Kidney Center&#47;Total Renal Care Integrated Service Network Limited Partnership</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hugo Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hummer Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hunter Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Huntington Artificial Kidney Center, Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Huntington Park Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hyattsville Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hyde Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDC -International Dialysis Centers, Lda</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDC Mafra - International Dialysis Centers, LDA</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iroquois Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Buffalo Grove, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Corpus Christi, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD I Holding Company, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD II Holding Company, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Las Vegas, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Renal, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Schaumburg, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Spring Valley, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ISD Summit Renal Care, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jacinto Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jericho Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kadden Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kamiah Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kanika Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kavett Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kearn Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kenai Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kerricher Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kershaw Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kidney Home Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kimball Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kingston Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kinnick Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kinswa Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kinter Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kiowa Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Knickerbocker Dialysis, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Knotts Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kobuk Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lakeshore Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landing Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landor Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lantell Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lassen Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latrobe Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasburg Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leawood Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lees Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legare Development LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liberty RC, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lighthouse Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Limon Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Park Dialysis Services, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincolnton Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Little Rock Dialysis Centers, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Livingston Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Llano Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lockhart Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lofield Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Logoley Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lone Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long Beach Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Baltimore Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loup Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lourdes Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lyndale Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Macab Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madigan Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magney Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Magnolia Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mahoney Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Makonee Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mammoth Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manzano Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maple Grove Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marlton Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marseille Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martin Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marysville Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mashero Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mason-Dixon Dialysis Facilities, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mautino Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mazonia Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Meadows Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSleuth, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mellen Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Melnea Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Memorial Dialysis Center, L.P.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mendocino Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Meridian Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mermet Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Milltown Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Milo Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minam Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minneopa Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monad Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monett Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Morro Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mountain West Dialysis Services, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mulgee Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Alzey GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Aurich GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Bad Aibling GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Bad D&#252;ben GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Dillenburg GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Dinkelsb&#252;hl GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Dormagen GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Duisburg GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Elsterland GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Emden GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Falkensee GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Geilenkirchen GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Gera GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Hannover Linden GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Iserlohn GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita M&#246;nchengladbach GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Neuss GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Niederrhein GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Nierenzentrum Aachen Alsdorf GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Nierenzentrum Berlin-Britz GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Nierenzentrum Hamm-Ahlen GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Prenzlau-Pasewalk GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Rhein-Ahr GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Rhein-Ruhr GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Salzgitter-Seesen GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Schwalm-Eder GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MVZ DaVita Viersen GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Myrtle Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nansen Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natomas Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nauvue Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Navarro Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Navin Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neoporte Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nephrology Care Alliance, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nephrology Medical Associates of Georgia, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nephrology Practice Solutions, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Bay Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Springs Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norbert Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norte Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Austin Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northeast Ohio Home Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oasis Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ogano Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio River Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Okanogan Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Olive Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orange Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordust Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Osage Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owens Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owyhee Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Palmetto Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Palo Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Palomar Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Panther Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Papello Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parker Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parkside Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient Pathways, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patuk Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peaks Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pearl Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pendster Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percha Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pershing Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfeiffer Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Philadelphia-Camden Integrated Kidney Care, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Choice Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Dialysis Acquisitions, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Dialysis of Lancaster, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Dialysis Ventures, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Management, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pible Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pine Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pinewoods Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pittsburgh Dialysis Partners, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Piute Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Placid Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plaine Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Platte Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pluribus Dialise - Benfica, S.A.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pluribus Dialise - Cascais, S.A.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pluribus Dialise - Sacavem, S.A.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pluribus Dialise, S.A.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pobello Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Poinsett Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pokagon Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portola Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primrose Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prineville Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prings Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pyramid Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ramsey Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Randolph Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ravalli Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Red Willow Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redcliff Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reef Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refuge Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Beaumont, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Englewood, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Flower Mound, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Fort Dodge, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Lewisville, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Monroe, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Morristown, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Mountain Home, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Nederland, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Newton, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of North Denton, L.L.L.P.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Port Arthur, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Sewell, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Storm Lake, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of the Hills, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Tyler, L.P.L.L.L.P.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of West Beaumont, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Center of Westwood, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Clinic Of Houston, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Life Link, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Services (UK) Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Services Operations Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Services Trading Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers - California, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers - Illinois, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers - Mid-Atlantic, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers - Northeast, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers - Southeast, LP</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers - West, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Treatment Centers, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Ventures Management, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RenalServ LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rend Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhodes Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rickwood Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riddle Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rio Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">River Valley Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RNA - DaVita Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rochester Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rocky Mountain Dialysis Services, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rollins Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ronan Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roose Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rophets Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roushe Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routt Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royale Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rusk Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russell Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RV Academy, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saddleback Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sahara Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAKDC-DaVita Dialysis Partners, L.P.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Marcos Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sands Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santa Fe Springs Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santiam Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sapelo Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saunders Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seabay Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secour Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shadow Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shawano Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shayano Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shelby Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shelling Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sherman Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shetek Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shining Star Dialysis, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shone Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shoshone Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Siena Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Silverwood Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Simeon Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skagit Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sloss Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soledad Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Somerville Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Central Florida Dialysis Partners, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Florida Integrated Kidney Care, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Fork Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Shore Dialysis Center, L.P.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southcrest Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern Hills Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southlake Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Atlanta Dialysis Centers, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Rocky Mountain Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sprague Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Springpond Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Luke's Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Star Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steam Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stevenson Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stewart Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stines Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Storrie Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sugarloaf Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sula Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun City Dialysis Center, L.L.C.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun City West Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sunapee Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sunset Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Talimena Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Targhee Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tarley Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenack Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee Valley Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terbole Participa&#231;&#245;es Societ&#225;rias Ltda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terre Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Woodlands Dialysis Center, LP</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tortugas Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Renal Care of North Carolina, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Renal Care Texas Limited Partnership</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Renal Care, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Renal Laboratories, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Renal Research, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Townsend Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transmountain Dialysis, L.P.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRC - Indiana, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRC - Petersburg, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRC El Paso Limited Partnership</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRC of New York, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRC West, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRC-Georgetown Regional Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">District Of Columbia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tross Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tugman Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tumalo Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tunnel Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tustin Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Twain Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tyler Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ukiah Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unicoi Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">University Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upper Valley Dialysis, L.P.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USC-DaVita Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valley Springs Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valmack Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vancile Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vancleer Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vanell Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Victory Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vilander Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VillageHealth DM, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Villanueva Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vively Health, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vogel Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volo Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wahconah Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wakonda Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Walker Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wallips Dialysis LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Walton Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washburne Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wayside Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weldon Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:65.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name - Continued</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Elk Grove Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Sacramento Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weston Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whitney Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wilder Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Willowbrook Dialysis Center, L.P.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Winds Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Winster Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wood Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Woodcrest Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Woodford Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wyandotte Central Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yargol Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ybor City Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yucaipa Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zara Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zellier Dialysis, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zephyrhills Dialysis Center, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>dva-123121ex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="idb2f75a7b8c04e46baec48bf314a7848_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:63pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="margin-bottom:20pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-bottom:10pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the registration statements (No. 333-240022, No. 333-239191, No. 333-213119, No. 333-190434, No. 333-169467, No. 333-158220, No. 333-144097, No. 333-86550, and No. 333-30736) on Form S-8 and the registration statement (No. 333-182572) on Form S-4 of our reports dated February 11, 2022, with respect to the consolidated financial statements and financial statement Schedule II &#8212; Valuation and Qualifying Accounts of DaVita Inc. and the effectiveness of internal control over financial reporting.</font></div><div style="margin-top:10pt"><font><br></font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; KPMG LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seattle, Washington</font></div><div style="margin-bottom:10pt;margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;11, 2022</font></div><div style="margin-top:10pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:63pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>dva-123121ex31110xk.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i9a7431f3d4f949609334a6ebee831864_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Javier J. Rodriguez, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 10-K of DaVita Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.00pt"><tr><td style="width:1.0pt"></td><td style="width:277.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Javier J. Rodriguez</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;11, 2022</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>dva-123121ex31210xk.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iceee1587176c4ed5af6647bfdb59c937_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Joel Ackerman, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 10-K of DaVita Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; Joel Ackerman</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joel Ackerman</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr></table></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;11, 2022</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>dva-123121ex32110xk.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i944fe5465c0c44c082501b2dce838a7b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of DaVita Inc. (the &#8220;Company&#8221;) on Form 10-K for the year ended December&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Javier J. Rodriguez, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Javier J. Rodriguez</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</font></div></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>dva-123121ex32210xk.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i59bdf5aeed9a41cd934f9c2e8454ab54_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> EXHIBIT 32.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of DaVita Inc. (the &#8220;Company&#8221;) on Form 10-K for the year ended December&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Joel Ackerman, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; Joel Ackerman</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joel Ackerman</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</font></div></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>dva-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1726f308-1cc7-4a47-a8e3-a7d089a83ae3,g:ca3879f3-8750-4d94-926a-aa4c6036a270-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dva="http://www.davita.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.davita.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.davita.com/role/DocumentandEntityInformation">
        <link:definition>000010001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.davita.com/role/AuditInformation">
        <link:definition>000020002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOME" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME">
        <link:definition>100010003 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOME_1" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1">
        <link:definition>100010003 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>100020004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>100030005 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>100040006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>100050007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEQUITY" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY">
        <link:definition>100060008 - Statement - CONSOLIDATED STATEMENTS OF EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPolicies" roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies">
        <link:definition>210011001 - Disclosure - Organization and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220022001 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>240034001 - Disclosure - Organization and Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.davita.com/role/RevenueRecognition">
        <link:definition>210041002 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables" roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables">
        <link:definition>230053001 - Disclosure - Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails" roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails">
        <link:definition>240064002 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Recognition Segment Revenue by Payor (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableAdditionalInformationDetails" roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails">
        <link:definition>240074003 - Disclosure - Revenue Recognition and Accounts Receivable - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.davita.com/role/EarningsPerShare">
        <link:definition>210081003 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.davita.com/role/EarningsPerShareTables">
        <link:definition>230093002 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails" roleURI="http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails">
        <link:definition>240104004 - Disclosure - Earnings Per Share - Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestrictedCashRestrictedCash" roleURI="http://www.davita.com/role/RestrictedCashRestrictedCash">
        <link:definition>210111004 - Disclosure - Restricted Cash Restricted Cash</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestrictedCashandEquivalentsAdditionalInformationDetails" roleURI="http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails">
        <link:definition>240124005 - Disclosure - Restricted Cash and Equivalents - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Shorttermandlongterminvestments" roleURI="http://www.davita.com/role/Shorttermandlongterminvestments">
        <link:definition>210131005 - Disclosure - Short-term and long-term investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandlongterminvesmtentsTables" roleURI="http://www.davita.com/role/ShorttermandlongterminvesmtentsTables">
        <link:definition>230143003 - Disclosure - Short-term and long-term invesmtents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandlongterminvestmentsDetails" roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails">
        <link:definition>240154006 - Disclosure - Short-term and long-term investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandlongterminvestmentsAdditionalInformationDetails" roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails">
        <link:definition>240164007 - Disclosure - Short-term and long-term investments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherReceivablesOtherReceivables" roleURI="http://www.davita.com/role/OtherReceivablesOtherReceivables">
        <link:definition>210171006 - Disclosure - Other Receivables Other Receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherReceivablesTables" roleURI="http://www.davita.com/role/OtherReceivablesTables">
        <link:definition>230183004 - Disclosure - Other Receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherReceivablesDetails" roleURI="http://www.davita.com/role/OtherReceivablesDetails">
        <link:definition>240194008 - Disclosure - Other Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://www.davita.com/role/PropertyandEquipment">
        <link:definition>210201007 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.davita.com/role/PropertyandEquipmentTables">
        <link:definition>230213005 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentDetails" roleURI="http://www.davita.com/role/PropertyandEquipmentDetails">
        <link:definition>240224009 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentAdditionalInformationDetails" roleURI="http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails">
        <link:definition>240234010 - Disclosure - Property and Equipment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Intangibles" roleURI="http://www.davita.com/role/Intangibles">
        <link:definition>210241008 - Disclosure - Intangibles</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesTables" roleURI="http://www.davita.com/role/IntangiblesTables">
        <link:definition>230253006 - Disclosure - Intangibles (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails" roleURI="http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails">
        <link:definition>240264011 - Disclosure - Intangibles - Amortizable Intangible Assets Other Than Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" roleURI="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails">
        <link:definition>240274012 - Disclosure - Intangibles - Scheduled Amortization Charges from Intangible Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesAdditionalInformationDetails" roleURI="http://www.davita.com/role/IntangiblesAdditionalInformationDetails">
        <link:definition>240284013 - Disclosure - Intangibles - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodandOtherInvestments" roleURI="http://www.davita.com/role/EquityMethodandOtherInvestments">
        <link:definition>210291009 - Disclosure - Equity Method and Other Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables" roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables">
        <link:definition>230303007 - Disclosure - Equity Method and Other Investmetns Equity Method and Other Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails" roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails">
        <link:definition>240314014 - Disclosure - Equity Method and Other Investmetns Equity Method and Other Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodandOtherInvestmentsAdditionalInformationDetails" roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails">
        <link:definition>240324015 - Disclosure - Equity Method and Other Investments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.davita.com/role/Goodwill">
        <link:definition>210331010 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.davita.com/role/GoodwillTables">
        <link:definition>230343008 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails" roleURI="http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails">
        <link:definition>240354016 - Disclosure - Goodwill - Changes in Carrying Value of Goodwill by Reportable Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillScheduleofReportingUnitsGoodwillBalancesDetails" roleURI="http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails">
        <link:definition>240364017 - Disclosure - Goodwill - Schedule of Reporting Units Goodwill Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAdditionalInformationDetails" roleURI="http://www.davita.com/role/GoodwillAdditionalInformationDetails">
        <link:definition>240374018 - Disclosure - Goodwill - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilities" roleURI="http://www.davita.com/role/OtherLiabilities">
        <link:definition>210381011 - Disclosure - Other Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilitiesTables" roleURI="http://www.davita.com/role/OtherLiabilitiesTables">
        <link:definition>230393009 - Disclosure - Other Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilitiesDetails" roleURI="http://www.davita.com/role/OtherLiabilitiesDetails">
        <link:definition>240404019 - Disclosure - Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.davita.com/role/IncomeTaxes">
        <link:definition>210411012 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.davita.com/role/IncomeTaxesTables">
        <link:definition>230423010 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails" roleURI="http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails">
        <link:definition>240434020 - Disclosure - Income Taxes - Schedule of Income Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeTaxExpenseDetails" roleURI="http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails">
        <link:definition>240444021 - Disclosure - Income Taxes - Components of Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails" roleURI="http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails">
        <link:definition>240454022 - Disclosure - Income Taxes Income Taxes - Allocation of Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails" roleURI="http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails">
        <link:definition>240464023 - Disclosure - Income Taxes - Reconciliation Between U.S. Federal Income Tax Rate and Our Effective Tax Rate From Continuing Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" roleURI="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails">
        <link:definition>240474024 - Disclosure - Income Taxes - Deferred Tax and Liabilities Arising from Temporary Differences (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails" roleURI="http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails">
        <link:definition>240484025 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet More-Likely-Than-Not Threshold (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetails" roleURI="http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails">
        <link:definition>240494026 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.davita.com/role/LongTermDebt">
        <link:definition>210501013 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.davita.com/role/LongTermDebtTables">
        <link:definition>230513011 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofLongTermDebtDetails" roleURI="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails">
        <link:definition>240524027 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduledMaturitiesofLongtermDebtDetails" roleURI="http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails">
        <link:definition>240534028 - Disclosure - Long-Term Debt - Scheduled Maturities of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtDerivativeInstrumentsDetails" roleURI="http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails">
        <link:definition>240544029 - Disclosure - Long-Term Debt - Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails" roleURI="http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails">
        <link:definition>240554030 - Disclosure - Long-Term Debt - Effects of Interest Rate Swap and Cap Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtAdditionalinformationDetail" roleURI="http://www.davita.com/role/LongTermDebtAdditionalinformationDetail">
        <link:definition>240564031 - Disclosure - Long-Term Debt - Additional information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.davita.com/role/Leases">
        <link:definition>210571014 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.davita.com/role/LeasesTables">
        <link:definition>230583012 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseExpenseComponentsDetails" roleURI="http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails">
        <link:definition>240594032 - Disclosure - Leases Lease Expense Components (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeasesOtherInformationDetails" roleURI="http://www.davita.com/role/LeasesLeasesOtherInformationDetails">
        <link:definition>240604033 - Disclosure - Leases Leases Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" roleURI="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails">
        <link:definition>240614034 - Disclosure - Leases - Future Minimum Lease Payments Under Non-Cancelable Operating and Capital Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalInformationDetails" roleURI="http://www.davita.com/role/LeasesAdditionalInformationDetails">
        <link:definition>240624035 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlans" roleURI="http://www.davita.com/role/EmployeeBenefitPlans">
        <link:definition>210631015 - Disclosure - Employee Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansAdditionalInformationDetails" roleURI="http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails">
        <link:definition>240644036 - Disclosure - Employee Benefit Plans - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.davita.com/role/Contingencies">
        <link:definition>210651016 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesAdditionalInformationDetails" roleURI="http://www.davita.com/role/ContingenciesAdditionalInformationDetails">
        <link:definition>240664037 - Disclosure - Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments" roleURI="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments">
        <link:definition>210671017 - Disclosure - Noncontrolling Interests Subject to Put Provisions and Other Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails" roleURI="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails">
        <link:definition>240684038 - Disclosure - Noncontrolling Interests Subject to Put Provisions and Other Commitments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Stockbasedcompensation" roleURI="http://www.davita.com/role/Stockbasedcompensation">
        <link:definition>210691018 - Disclosure - Stock-based compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermIncentiveCompensationandShareholdersEquityTables" roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables">
        <link:definition>230703013 - Disclosure - Long-term Incentive Compensation and Shareholders&#8217; Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails" roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails">
        <link:definition>240714039 - Disclosure - Long-term Incentive Compensation and Shareholders&#8217; Equity - Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails" roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails">
        <link:definition>240724040 - Disclosure - Long-term Incentive Compensation and Shareholders&#8217; Equity - Summary of Range of Exercise Prices (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails" roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails">
        <link:definition>240734041 - Disclosure - Long-term Incentive Compensation and Shareholders Equity - Summary of Weighted Average Valuation Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails" roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails">
        <link:definition>240744042 - Disclosure - Long-term Incentive Compensation and Shareholders&#8217; Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Stockholdersequity" roleURI="http://www.davita.com/role/Stockholdersequity">
        <link:definition>210751019 - Disclosure - Stockholder's equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersequityTables" roleURI="http://www.davita.com/role/StockholdersequityTables">
        <link:definition>230763014 - Disclosure - Stockholder's equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockRepurchasesTenderOfferDetails" roleURI="http://www.davita.com/role/StockRepurchasesTenderOfferDetails">
        <link:definition>240774043 - Disclosure - Stock Repurchases Tender Offer (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails" roleURI="http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails">
        <link:definition>240784044 - Disclosure - Shareholder's equity Effects of Changes in DaVita Inc's Ownership Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersequityDetails" roleURI="http://www.davita.com/role/ShareholdersequityDetails">
        <link:definition>240794045 - Disclosure - Shareholder's equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncome" roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome">
        <link:definition>210801020 - Disclosure - Accumulated Other Comprehensive (Loss) Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncomeTables" roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables">
        <link:definition>230813015 - Disclosure - Accumulated Other Comprehensive (Loss) Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncomeDetails" roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails">
        <link:definition>240824046 - Disclosure - Accumulated Other Comprehensive (Loss) Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestitures" roleURI="http://www.davita.com/role/AcquisitionsandDivestitures">
        <link:definition>210831021 - Disclosure - Acquisitions and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresTables" roleURI="http://www.davita.com/role/AcquisitionsandDivestituresTables">
        <link:definition>230843016 - Disclosure - Acquisitions and Divestitures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsComponentsofRoutineAcquisitionsDetails" roleURI="http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails">
        <link:definition>240854047 - Disclosure - Acquisitions - Components of Routine Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAssetsacquiredandliabilitiesassumedDetails" roleURI="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails">
        <link:definition>240864048 - Disclosure - Acquisitions - Assets acquired and liabilities assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails" roleURI="http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails">
        <link:definition>240874049 - Disclosure - Schedule Of Other Information Related To Acquired Intangibles and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails" roleURI="http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails">
        <link:definition>240884050 - Disclosure - Acquisitions and Divestitures - Pro Forma Summary of Results of Operation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails" roleURI="http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails">
        <link:definition>240894051 - Disclosure - Acquisitions and Divestitures - Reconciliation of Changes in Contingent Earn-Out Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresAdditionalInformationDetails" roleURI="http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails">
        <link:definition>240904052 - Disclosure - Acquisitions and Divestitures - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleandDiscontinuedOperations" roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperations">
        <link:definition>210911022 - Disclosure - Held for Sale and Discontinued Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleandDiscontinuedOperationsTables" roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables">
        <link:definition>230923017 - Disclosure - Held for Sale and Discontinued Operations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails" roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails">
        <link:definition>240934053 - Disclosure - Held for Sale and Discontinued Operations Financial results for discontinued operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails" roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails">
        <link:definition>240944054 - Disclosure - Held for Sale and Discontinued Operations Cash Flows of discontinued operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails" roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails">
        <link:definition>240954055 - Disclosure - Held for Sale and Discontinued Operations - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntities" roleURI="http://www.davita.com/role/VariableInterestEntities">
        <link:definition>210961023 - Disclosure - Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesAdditionalInformationDetails" roleURI="http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails">
        <link:definition>240974056 - Disclosure - Variable Interest Entities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValuesofFinancialInstruments" roleURI="http://www.davita.com/role/FairValuesofFinancialInstruments">
        <link:definition>210981024 - Disclosure - Fair Values of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValuesofFinancialInstrumentsTables" roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsTables">
        <link:definition>230993018 - Disclosure - Fair Values of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>241004057 - Disclosure - Fair Values of Financial Instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValuesofFinancialInstrumentsDetails" roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails">
        <link:definition>241014058 - Disclosure - Fair Values of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.davita.com/role/SegmentReporting">
        <link:definition>211021025 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.davita.com/role/SegmentReportingTables">
        <link:definition>231033019 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails" roleURI="http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails">
        <link:definition>241044059 - Disclosure - Segment Reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails" roleURI="http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails">
        <link:definition>241054060 - Disclosure - Segment Reporting - Summary of Depreciation and Amortization Expense by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails" roleURI="http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails">
        <link:definition>241064061 - Disclosure - Segment Reporting - Summary of Expenditures for Property and Equipment by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummaryofAssetsbySegmentDetails" roleURI="http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails">
        <link:definition>241074062 - Disclosure - Segment Reporting - Summary of Assets by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingAdditionalInformationDetails" roleURI="http://www.davita.com/role/SegmentReportingAdditionalInformationDetails">
        <link:definition>241084063 - Disclosure - Segment Reporting - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformation" roleURI="http://www.davita.com/role/SupplementalCashFlowInformation">
        <link:definition>211091026 - Disclosure - Supplemental Cash Flow Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationTables" roleURI="http://www.davita.com/role/SupplementalCashFlowInformationTables">
        <link:definition>231103020 - Disclosure - Supplemental Cash Flow Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationDetails" roleURI="http://www.davita.com/role/SupplementalCashFlowInformationDetails">
        <link:definition>241114064 - Disclosure - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" roleURI="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS">
        <link:definition>211121027 - Disclosure - SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SECScheduleArticle1209ValuationandQualifyingAccountsTables" roleURI="http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables">
        <link:definition>231133021 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" roleURI="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails">
        <link:definition>241144065 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dva_FinanceLeaseMember" abstract="true" name="FinanceLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_DeferredTaxLiabilitiesMember" abstract="true" name="DeferredTaxLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_ShareRepurchaseFeesAndExpenses" abstract="false" name="ShareRepurchaseFeesAndExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures" abstract="false" name="TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ReconciliationOfCashFlowsTableTextBlock" abstract="false" name="ReconciliationOfCashFlowsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_PremiumPricedAwardBasePricePerShare" abstract="false" name="PremiumPricedAwardBasePricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" abstract="false" name="ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" abstract="false" name="IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_RangeTwoMember" abstract="true" name="RangeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_InternationalOperationsMember" abstract="true" name="InternationalOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" abstract="false" name="PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" abstract="false" name="NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TenderOfferMember" abstract="true" name="TenderOfferMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_ForeignDialysisCentersMember" abstract="true" name="ForeignDialysisCentersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_StockUnitMember" abstract="true" name="StockUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_RMSLifelineMember" abstract="true" name="RMSLifelineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_OtherSourcesofRevenueMember" abstract="true" name="OtherSourcesofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities" abstract="false" name="NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_OpenMarketPurchasesMember" abstract="true" name="OpenMarketPurchasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_PremiumPricedStockSettledStockAppreciationRightsMember" abstract="true" name="PremiumPricedStockSettledStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" abstract="false" name="LongTermPurchaseCommitmentPercentageOfQuantityRequired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" abstract="false" name="NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_IncomeTaxesTable" abstract="true" name="IncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" abstract="false" name="SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_NumberOfCustomers" abstract="false" name="NumberOfCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" abstract="true" name="CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_RangeThreeMember" abstract="true" name="RangeThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" abstract="false" name="PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_SeniorSecuredCreditFacilitiesMember" abstract="true" name="SeniorSecuredCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_ScheduleOfOtherReceivablesTableTextBlock" abstract="false" name="ScheduleOfOtherReceivablesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" abstract="false" name="ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" abstract="false" name="PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_BusinessCombinationContingentConsiderationAcquisitions" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" abstract="false" name="RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" abstract="false" name="ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_PayorRefundsAndRetractions" abstract="false" name="PayorRefundsAndRetractions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_DMGAcquisitionsMember" abstract="true" name="DMGAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_BusinessSaleDateOfPurchaseAndSaleAgreement" abstract="false" name="BusinessSaleDateOfPurchaseAndSaleAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" abstract="false" name="TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_OffBalanceSheetFinancingArrangements" abstract="false" name="OffBalanceSheetFinancingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" abstract="false" name="ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" abstract="false" name="TreasuryStockAcquiredAverageCostPerShareClearingPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" abstract="false" name="NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" abstract="false" name="TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_IncomeTaxExpenseBenefitMember" abstract="true" name="IncomeTaxExpenseBenefitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_AdjustmentIncomeLossFromEquityMethodInvestments" abstract="false" name="AdjustmentIncomeLossFromEquityMethodInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_OtherCompaniesMember" abstract="true" name="OtherCompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_RangeFourMember" abstract="true" name="RangeFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dva_EpogenMember" abstract="true" name="EpogenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" abstract="false" name="VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_CharterdocumentsandDelawarelawAbstract" abstract="true" name="CharterdocumentsandDelawarelawAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" abstract="false" name="EffectiveIncomeTaxReconciliationInvestmentImpairment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" abstract="false" name="ScheduleOfReportingUnitsGoodwillBalancesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_PotentialImpactOnFairValueForReductionInOperatingIncome" abstract="false" name="PotentialImpactOnFairValueForReductionInOperatingIncome" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" abstract="false" name="NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" abstract="false" name="RevenueRecognitionAndAccountsReceivablePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" abstract="false" name="ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" abstract="false" name="SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_TermLoanB1Member" abstract="true" name="TermLoanB1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_StockIncentivePlanTwentyElevenMember" abstract="true" name="StockIncentivePlanTwentyElevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_DissolutionTermOfJointVentures" abstract="false" name="DissolutionTermOfJointVentures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_ExpectedAmortizationExpenseLineItems" abstract="true" name="ExpectedAmortizationExpenseLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_OtherReportingUnitsMember" abstract="true" name="OtherReportingUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_OperatingLeaseLiabilitiesMember" abstract="true" name="OperatingLeaseLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_NumberOfPartnerships" abstract="false" name="NumberOfPartnerships" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="dva_KidneyCareMember" abstract="true" name="KidneyCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" abstract="false" name="AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_OperatingLeaseMember" abstract="true" name="OperatingLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_RangeOneMember" abstract="true" name="RangeOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_PatientCareCosts" abstract="false" name="PatientCareCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_DeferredTaxAssetsReceivables" abstract="false" name="DeferredTaxAssetsReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" abstract="false" name="StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dva_DebtExpenseMember" abstract="true" name="DebtExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" abstract="false" name="NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" abstract="false" name="TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_IndefiniteLifeNetOperatingLossesMember" abstract="true" name="IndefiniteLifeNetOperatingLossesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_BusinessSaleEffectiveDateOfSale" abstract="false" name="BusinessSaleEffectiveDateOfSale" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_MedicareMember" abstract="true" name="MedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" abstract="false" name="PercentageOfAccountsReceivableSixMonthsOrMorePastDue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_LeasesDisclosureLineItems" abstract="true" name="LeasesDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" abstract="false" name="EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ParentCompanyAndRestrictedSubsidiariesMember" abstract="true" name="ParentCompanyAndRestrictedSubsidiariesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember" abstract="true" name="PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_DaVitaMedicalGroupMember" abstract="true" name="DaVitaMedicalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_SegmentRevenuebyMajorPayorAbstract" abstract="true" name="SegmentRevenuebyMajorPayorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" abstract="false" name="LossGainOnDispositionOfBusinessInterestsBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_PaymentsRelatedToStockPurchasesAndAwards" abstract="false" name="PaymentsRelatedToStockPurchasesAndAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_NumberOfConcentrationRiskCustomers" abstract="false" name="NumberOfConcentrationRiskCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="dva_GroundLeaseMember" abstract="true" name="GroundLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" abstract="false" name="VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_MedicareandMedicareAdvantageMember" abstract="true" name="MedicareandMedicareAdvantageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_CommitmentsAndContingenciesDisclosureLineItems" abstract="true" name="CommitmentsAndContingenciesDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_ScheduleOfMinimumLeasePaymentsTextBlock" abstract="false" name="ScheduleOfMinimumLeasePaymentsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" abstract="false" name="DebtInstrumentOfferingPricePercentageOfFaceAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_DebtRefinancingCharges" abstract="false" name="DebtRefinancingCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_LeasesDisclosureTextBlock" abstract="false" name="LeasesDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" abstract="false" name="NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" abstract="false" name="NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" abstract="true" name="A2019InterestRateCapAgreementsEffectiveJune302020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" abstract="false" name="StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dva_NoncontrollingInterestIncreaseFromContributions" abstract="false" name="NoncontrollingInterestIncreaseFromContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" abstract="false" name="TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_LeasesOtherInformationAbstract" abstract="true" name="LeasesOtherInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_DebtPrepaymentRefinancingRedemptionCharges" abstract="false" name="DebtPrepaymentRefinancingRedemptionCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TemporaryEquityDecreasePurchaseOfInterests" abstract="false" name="TemporaryEquityDecreasePurchaseOfInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_CashPaidForPortionPreviouslyRefundedMember" abstract="true" name="CashPaidForPortionPreviouslyRefundedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_IncrementalCashPortionMember" abstract="true" name="IncrementalCashPortionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_ExpectedAmortizationExpenseTable" abstract="true" name="ExpectedAmortizationExpenseTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" abstract="false" name="PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_OtherGovernmentPayorsMember" abstract="true" name="OtherGovernmentPayorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_DiscountAndDeferredFinanceCosts" abstract="false" name="DiscountAndDeferredFinanceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" abstract="false" name="IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_AllTrustsMember" abstract="true" name="AllTrustsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" abstract="true" name="CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_NumberOfSites" abstract="false" name="NumberOfSites" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_AcquisitionObligationsAndOtherNotesPayable" abstract="false" name="AcquisitionObligationsAndOtherNotesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_DeferredTaxLiabilitiesOperatingLeaseAssets" abstract="false" name="DeferredTaxLiabilitiesOperatingLeaseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_USAttorneyPrescriptionDrugInvestigationMember" abstract="true" name="USAttorneyPrescriptionDrugInvestigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_StockSettledStockAppreciationRightsMember" abstract="true" name="StockSettledStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_LongTermPurchaseCommitmentExpirationDate" abstract="false" name="LongTermPurchaseCommitmentExpirationDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dva_CommitmentsAndContingenciesDisclosureTable" abstract="true" name="CommitmentsAndContingenciesDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dva_PremiumToTheTenderOfferSharePurchasePrice" abstract="false" name="PremiumToTheTenderOfferSharePurchasePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" abstract="false" name="EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" abstract="false" name="PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_InsuranceAndSelfInsurancePolicyTextBlock" abstract="false" name="InsuranceAndSelfInsurancePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_DeferredTaxAssetsOperatingLeaseLiabilities" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_StockIncentivePlanTwentyTwentyMember" abstract="true" name="StockIncentivePlanTwentyTwentyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_AccountsReceivablePeriodOutstanding" abstract="false" name="AccountsReceivablePeriodOutstanding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_PaymentsToAcquireOtherDebtAndEquityInvestments" abstract="false" name="PaymentsToAcquireOtherDebtAndEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dva_DebtFinancingAndDebtRedemptionCosts" abstract="false" name="DebtFinancingAndDebtRedemptionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" abstract="false" name="ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_AdditionalDebtPrincipalAmountDueToNewAgreement" abstract="false" name="AdditionalDebtPrincipalAmountDueToNewAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" abstract="false" name="NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_DeconsolidatedNoncontrollingEntityMember" abstract="true" name="DeconsolidatedNoncontrollingEntityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_LeaseOtherInformationTableTextBlockTableTextBlock" abstract="false" name="LeaseOtherInformationTableTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" abstract="true" name="ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_TermLoanAMember" abstract="true" name="TermLoanAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" abstract="false" name="MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_FinanceLeaseAccumulatedDepreciation" abstract="false" name="FinanceLeaseAccumulatedDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" abstract="false" name="StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dva_SegmentReportingInformationCorporateExpenses" abstract="false" name="SegmentReportingInformationCorporateExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" abstract="true" name="SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_CashPaidDuringPeriodForAbstract" abstract="true" name="CashPaidDuringPeriodForAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" abstract="false" name="BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_LeasesDisclosureTable" abstract="true" name="LeasesDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dva_CommercialPayorsMember" abstract="true" name="CommercialPayorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_ExternalSourcesMember" abstract="true" name="ExternalSourcesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_USDialysisAndRelatedLabServicesMember" abstract="true" name="USDialysisAndRelatedLabServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" abstract="false" name="StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dva_MutualFundsAndCommonStockMember" abstract="true" name="MutualFundsAndCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_LesseeLeaseDescriptionLineItemsAbstract" abstract="true" name="LesseeLeaseDescriptionLineItemsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" abstract="true" name="TemporaryEquityRedeemableNoncontrollingInterestsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_AcquisitionObligationsAndOtherNotesPayableFairValue" abstract="false" name="AcquisitionObligationsAndOtherNotesPayableFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" abstract="true" name="SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_OtherNonoperatingIncomeExpensePolicyTextBlock" abstract="false" name="OtherNonoperatingIncomeExpensePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_MedicaidandManagedMedicaidMember" abstract="true" name="MedicaidandManagedMedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" abstract="true" name="EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_SupplierRebatesAndOtherNonTradeReceivablesMember" abstract="true" name="SupplierRebatesAndOtherNonTradeReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_TaxYear2029Member" abstract="true" name="TaxYear2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_PurchaseAndSaleAgreementAggregatePurchasePrice" abstract="false" name="PurchaseAndSaleAgreementAggregatePurchasePrice" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_CommitmentsToProvideOperatingCapitalMember" abstract="true" name="CommitmentsToProvideOperatingCapitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>dva-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1726f308-1cc7-4a47-a8e3-a7d089a83ae3,g:ca3879f3-8750-4d94-926a-aa4c6036a270-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bdf6a494-01e4-4d3c-8033-8dbd455ab7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e68a9c3b-40aa-43b8-a253-7d2ee79bdad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bdf6a494-01e4-4d3c-8033-8dbd455ab7ba" xlink:to="loc_us-gaap_OperatingIncomeLoss_e68a9c3b-40aa-43b8-a253-7d2ee79bdad0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_86cc9bc2-bc4e-44bc-a497-bffe73c53aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bdf6a494-01e4-4d3c-8033-8dbd455ab7ba" xlink:to="loc_us-gaap_InterestAndDebtExpense_86cc9bc2-bc4e-44bc-a497-bffe73c53aa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_85720f9a-9552-4d2d-891f-61708a70e6cf" xlink:href="dva-20211231.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bdf6a494-01e4-4d3c-8033-8dbd455ab7ba" xlink:to="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_85720f9a-9552-4d2d-891f-61708a70e6cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d9b636c5-4659-4e0b-b65d-9e6ac9962a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bdf6a494-01e4-4d3c-8033-8dbd455ab7ba" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d9b636c5-4659-4e0b-b65d-9e6ac9962a1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b4b9c1dc-6450-4f85-b16f-507a7ac3286d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b79ebdb8-61ff-4ead-b880-d3a32664f1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b4b9c1dc-6450-4f85-b16f-507a7ac3286d" xlink:to="loc_us-gaap_ProfitLoss_b79ebdb8-61ff-4ead-b880-d3a32664f1e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b3bf94ba-de81-4ca5-a3ef-fd57ee77a65d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b4b9c1dc-6450-4f85-b16f-507a7ac3286d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b3bf94ba-de81-4ca5-a3ef-fd57ee77a65d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d24326b7-a0eb-4a82-a254-0caee960f07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_510851e5-d5ca-4f68-a403-3ffe4704d978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d24326b7-a0eb-4a82-a254-0caee960f07b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_510851e5-d5ca-4f68-a403-3ffe4704d978" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_c67952fd-b4b4-4173-b846-e61daa5406ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d24326b7-a0eb-4a82-a254-0caee960f07b" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_c67952fd-b4b4-4173-b846-e61daa5406ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d093175c-b014-49f3-81a9-f3032d77aef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts_6e37f864-a751-4aa2-81eb-6306ecac68f8" xlink:href="dva-20211231.xsd#dva_PatientCareCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d093175c-b014-49f3-81a9-f3032d77aef8" xlink:to="loc_dva_PatientCareCosts_6e37f864-a751-4aa2-81eb-6306ecac68f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_719dd549-2faa-4ec6-acf3-2391aa499657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d093175c-b014-49f3-81a9-f3032d77aef8" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_719dd549-2faa-4ec6-acf3-2391aa499657" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_5c63fbd8-9a7f-4cd6-95a0-58427cd5c54c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d093175c-b014-49f3-81a9-f3032d77aef8" xlink:to="loc_us-gaap_DepreciationAndAmortization_5c63fbd8-9a7f-4cd6-95a0-58427cd5c54c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5ee524e6-e8f3-488e-9224-1ee312f4cfb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d093175c-b014-49f3-81a9-f3032d77aef8" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5ee524e6-e8f3-488e-9224-1ee312f4cfb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_0ca8f1ae-e8b6-478b-8660-ca532724974a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d093175c-b014-49f3-81a9-f3032d77aef8" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_0ca8f1ae-e8b6-478b-8660-ca532724974a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_3f5dd5b5-60bc-4c13-afab-e455e6528235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d093175c-b014-49f3-81a9-f3032d77aef8" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_3f5dd5b5-60bc-4c13-afab-e455e6528235" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_26b7caad-2ca1-4aff-8cc8-776249c03786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_b77ecef3-457b-4589-81a9-875c06427192" xlink:href="dva-20211231.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_26b7caad-2ca1-4aff-8cc8-776249c03786" xlink:to="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_b77ecef3-457b-4589-81a9-875c06427192" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_54faecfd-48da-4fc0-9b9a-f8f1865c0871" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_26b7caad-2ca1-4aff-8cc8-776249c03786" xlink:to="loc_us-gaap_OtherIncome_54faecfd-48da-4fc0-9b9a-f8f1865c0871" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_6bdef4c9-655a-4882-8437-bada86f45c96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_55224126-347b-4c6d-8f16-4f8e31c7fea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_6bdef4c9-655a-4882-8437-bada86f45c96" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_55224126-347b-4c6d-8f16-4f8e31c7fea9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8fc252ab-8c3a-4b24-ab29-c86990556680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_6bdef4c9-655a-4882-8437-bada86f45c96" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8fc252ab-8c3a-4b24-ab29-c86990556680" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5fe1729a-b8a6-40d9-b637-bcf0314b7188" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8aa3c6d2-cabb-40ac-8eef-bcc0ffb9a5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5fe1729a-b8a6-40d9-b637-bcf0314b7188" xlink:to="loc_us-gaap_Revenues_8aa3c6d2-cabb-40ac-8eef-bcc0ffb9a5b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_83ad9331-b9b0-493a-88af-0448b1d9f310" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5fe1729a-b8a6-40d9-b637-bcf0314b7188" xlink:to="loc_us-gaap_CostsAndExpenses_83ad9331-b9b0-493a-88af-0448b1d9f310" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME_1"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a396ecbb-484b-4f33-a489-2a8ca5d449e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_533d8d96-5bf3-4b22-ad0f-cc4380b686d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a396ecbb-484b-4f33-a489-2a8ca5d449e1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_533d8d96-5bf3-4b22-ad0f-cc4380b686d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_bbb9f5f7-cb38-49f1-80b0-6f359c507a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a396ecbb-484b-4f33-a489-2a8ca5d449e1" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_bbb9f5f7-cb38-49f1-80b0-6f359c507a8f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c9c1af1f-bbc6-4e64-963b-a3fcaae4bfea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_257becb2-b4ec-407c-9ae0-9bcb7433512f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c9c1af1f-bbc6-4e64-963b-a3fcaae4bfea" xlink:to="loc_us-gaap_ProfitLoss_257becb2-b4ec-407c-9ae0-9bcb7433512f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_be273188-dba4-4867-a6ee-ac65b6cd43e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c9c1af1f-bbc6-4e64-963b-a3fcaae4bfea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_be273188-dba4-4867-a6ee-ac65b6cd43e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7699a844-de7f-4799-bdb2-c9000607cf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d3a0c5a5-9271-47ea-99f1-e91af588979a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7699a844-de7f-4799-bdb2-c9000607cf6e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d3a0c5a5-9271-47ea-99f1-e91af588979a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_646c59ba-4beb-4cb0-921b-3beca08a5ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7699a844-de7f-4799-bdb2-c9000607cf6e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_646c59ba-4beb-4cb0-921b-3beca08a5ab1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dc2a3d53-c7d5-4a41-9f12-2b0e634ee900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_f96b97c3-ac64-4e90-9a70-1509410dbfc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dc2a3d53-c7d5-4a41-9f12-2b0e634ee900" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_f96b97c3-ac64-4e90-9a70-1509410dbfc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_93fa30fc-ef8c-41d6-8f21-c75f992f54fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dc2a3d53-c7d5-4a41-9f12-2b0e634ee900" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_93fa30fc-ef8c-41d6-8f21-c75f992f54fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_8666de76-0170-4e7d-a60f-507c844bcbee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dc2a3d53-c7d5-4a41-9f12-2b0e634ee900" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_8666de76-0170-4e7d-a60f-507c844bcbee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c1e0c0e2-9ab5-4747-95ce-9269d68223c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ada873f8-82bf-42ce-95f5-2ec8990cbb62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c1e0c0e2-9ab5-4747-95ce-9269d68223c5" xlink:to="loc_us-gaap_Liabilities_ada873f8-82bf-42ce-95f5-2ec8990cbb62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_006b4bf4-1f60-4e50-aca8-1c1b01027930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c1e0c0e2-9ab5-4747-95ce-9269d68223c5" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_006b4bf4-1f60-4e50-aca8-1c1b01027930" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_de6237d0-507b-4214-a48c-ac3dbe3cf740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c1e0c0e2-9ab5-4747-95ce-9269d68223c5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_de6237d0-507b-4214-a48c-ac3dbe3cf740" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_21ea60fb-eeb2-4ea4-b071-0cecacf966bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3d5e236e-2bc8-4a94-bc94-564e61fb5b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21ea60fb-eeb2-4ea4-b071-0cecacf966bf" xlink:to="loc_us-gaap_LiabilitiesCurrent_3d5e236e-2bc8-4a94-bc94-564e61fb5b89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b2ae59f6-898e-48af-b46a-efaedd34c101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21ea60fb-eeb2-4ea4-b071-0cecacf966bf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b2ae59f6-898e-48af-b46a-efaedd34c101" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8bae9677-9496-4ed9-a4a8-153e8de3a8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21ea60fb-eeb2-4ea4-b071-0cecacf966bf" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8bae9677-9496-4ed9-a4a8-153e8de3a8e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_eb2bc122-7522-46cf-bfe6-4c96ec35dc34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21ea60fb-eeb2-4ea4-b071-0cecacf966bf" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_eb2bc122-7522-46cf-bfe6-4c96ec35dc34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a0171fc0-58f9-4576-9f57-c107bc7172a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21ea60fb-eeb2-4ea4-b071-0cecacf966bf" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a0171fc0-58f9-4576-9f57-c107bc7172a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5c104876-5351-4b27-9a60-4d4c7670547b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fb361bc0-1fb6-4cb6-827b-b914aa12128b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5c104876-5351-4b27-9a60-4d4c7670547b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fb361bc0-1fb6-4cb6-827b-b914aa12128b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_a32609d3-7d8e-4cf4-bd49-2e410756d1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5c104876-5351-4b27-9a60-4d4c7670547b" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_a32609d3-7d8e-4cf4-bd49-2e410756d1c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_92bdfe92-398e-4719-9a8d-abaaab922968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5c104876-5351-4b27-9a60-4d4c7670547b" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_92bdfe92-398e-4719-9a8d-abaaab922968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_039b120b-3790-4d2d-a078-91a4c40256bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5c104876-5351-4b27-9a60-4d4c7670547b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_039b120b-3790-4d2d-a078-91a4c40256bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f115733f-9fce-4579-b7c1-4746b24cadbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5c104876-5351-4b27-9a60-4d4c7670547b" xlink:to="loc_us-gaap_InventoryNet_f115733f-9fce-4579-b7c1-4746b24cadbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_05f348d9-df43-4a32-b0d8-919d63a36a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5c104876-5351-4b27-9a60-4d4c7670547b" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_05f348d9-df43-4a32-b0d8-919d63a36a7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3874c5bd-b649-4e3d-9de1-a99f10e5515c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5c104876-5351-4b27-9a60-4d4c7670547b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3874c5bd-b649-4e3d-9de1-a99f10e5515c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_8df53730-98cc-4bb6-87b0-29eba1bf734a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5c104876-5351-4b27-9a60-4d4c7670547b" xlink:to="loc_us-gaap_IncomeTaxesReceivable_8df53730-98cc-4bb6-87b0-29eba1bf734a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ab674e3c-9678-4173-ac4f-b7111e94e6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_12dba275-a5a9-4e27-b326-5ac56493a176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ab674e3c-9678-4173-ac4f-b7111e94e6f3" xlink:to="loc_us-gaap_AccountsPayableCurrent_12dba275-a5a9-4e27-b326-5ac56493a176" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_967631c9-8f96-4b04-8759-83d8873c6c70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ab674e3c-9678-4173-ac4f-b7111e94e6f3" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_967631c9-8f96-4b04-8759-83d8873c6c70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4d4d32d3-6bc8-4e13-8685-88e38323ea0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ab674e3c-9678-4173-ac4f-b7111e94e6f3" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4d4d32d3-6bc8-4e13-8685-88e38323ea0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ee6d4703-709f-46bf-b12a-38303c4ca979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ab674e3c-9678-4173-ac4f-b7111e94e6f3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ee6d4703-709f-46bf-b12a-38303c4ca979" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d0b2c845-0a8b-4758-b9f1-f212be98270f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ab674e3c-9678-4173-ac4f-b7111e94e6f3" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d0b2c845-0a8b-4758-b9f1-f212be98270f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_5c82dff9-3447-4a77-b1f1-ffd9cd41518d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ab674e3c-9678-4173-ac4f-b7111e94e6f3" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_5c82dff9-3447-4a77-b1f1-ffd9cd41518d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f5481d1a-20eb-4108-9688-ccaaf63f885e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_209e9435-e628-4261-b443-b1895fc8aa10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f5481d1a-20eb-4108-9688-ccaaf63f885e" xlink:to="loc_us-gaap_StockholdersEquity_209e9435-e628-4261-b443-b1895fc8aa10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e2b7396d-ac5d-457b-8e3a-2b4795b88ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f5481d1a-20eb-4108-9688-ccaaf63f885e" xlink:to="loc_us-gaap_MinorityInterest_e2b7396d-ac5d-457b-8e3a-2b4795b88ef4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_261c5c79-648d-4d10-aacc-d2c8f4f3a0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0233df19-1559-4046-9e71-0ad71bbfc624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_261c5c79-648d-4d10-aacc-d2c8f4f3a0b1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0233df19-1559-4046-9e71-0ad71bbfc624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d2f173e8-2589-45b7-81e0-174401d5e10b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_261c5c79-648d-4d10-aacc-d2c8f4f3a0b1" xlink:to="loc_us-gaap_CommonStockValue_d2f173e8-2589-45b7-81e0-174401d5e10b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_80abbbdb-c042-4a2e-9f24-6d35b31cdb46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_261c5c79-648d-4d10-aacc-d2c8f4f3a0b1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_80abbbdb-c042-4a2e-9f24-6d35b31cdb46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_47e73919-b39a-4401-ac25-e8d896c80f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_261c5c79-648d-4d10-aacc-d2c8f4f3a0b1" xlink:to="loc_us-gaap_PreferredStockValue_47e73919-b39a-4401-ac25-e8d896c80f10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e4a517b0-aecf-4958-9b98-a05b0a7fa53b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_261c5c79-648d-4d10-aacc-d2c8f4f3a0b1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e4a517b0-aecf-4958-9b98-a05b0a7fa53b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_73f2b966-5110-4f02-9c27-c45a0e75289f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_af9c9543-58e3-4991-b088-1d65b050e88b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f2b966-5110-4f02-9c27-c45a0e75289f" xlink:to="loc_us-gaap_AssetsCurrent_af9c9543-58e3-4991-b088-1d65b050e88b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8d5aa0ef-eda0-4709-8374-ef6db9f30064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f2b966-5110-4f02-9c27-c45a0e75289f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8d5aa0ef-eda0-4709-8374-ef6db9f30064" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c10907bb-d043-48d5-9d50-d3f7f881bb00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f2b966-5110-4f02-9c27-c45a0e75289f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c10907bb-d043-48d5-9d50-d3f7f881bb00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ea5dac57-89f2-4941-a987-ea4a1752ff9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f2b966-5110-4f02-9c27-c45a0e75289f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ea5dac57-89f2-4941-a987-ea4a1752ff9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_af3fbf2f-90ee-4ff0-93ea-194af4394d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f2b966-5110-4f02-9c27-c45a0e75289f" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_af3fbf2f-90ee-4ff0-93ea-194af4394d4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_ebd592a2-b2a6-4cd7-8207-4a93c8ef9e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f2b966-5110-4f02-9c27-c45a0e75289f" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_ebd592a2-b2a6-4cd7-8207-4a93c8ef9e45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_47752fe8-c13e-4488-9e86-66a7e2b73aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f2b966-5110-4f02-9c27-c45a0e75289f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_47752fe8-c13e-4488-9e86-66a7e2b73aa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ab700fcf-e21f-4ded-8aaf-79efe330b5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_73f2b966-5110-4f02-9c27-c45a0e75289f" xlink:to="loc_us-gaap_Goodwill_ab700fcf-e21f-4ded-8aaf-79efe330b5d6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad7d93b-0c76-46ec-b7f5-f7e45adc536d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_32be7915-f203-4cf3-bf4a-74af96f69735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad7d93b-0c76-46ec-b7f5-f7e45adc536d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_32be7915-f203-4cf3-bf4a-74af96f69735" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_98ff1a75-a3dd-4e32-b16d-87e1009c3514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad7d93b-0c76-46ec-b7f5-f7e45adc536d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_98ff1a75-a3dd-4e32-b16d-87e1009c3514" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_c13f0d4f-8a0b-44a2-ae62-bcd5454a7ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad7d93b-0c76-46ec-b7f5-f7e45adc536d" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_c13f0d4f-8a0b-44a2-ae62-bcd5454a7ed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_cdcf1ea5-96df-425e-b6e6-d4cd3bb2ed62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad7d93b-0c76-46ec-b7f5-f7e45adc536d" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_cdcf1ea5-96df-425e-b6e6-d4cd3bb2ed62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_b585ef6e-9496-48a6-9a23-d190ff5bad17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad7d93b-0c76-46ec-b7f5-f7e45adc536d" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_b585ef6e-9496-48a6-9a23-d190ff5bad17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_97c92c37-9edc-4b13-9e10-e9f434856aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad7d93b-0c76-46ec-b7f5-f7e45adc536d" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_97c92c37-9edc-4b13-9e10-e9f434856aa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_02c9da9f-4a09-4f47-9364-b98a5930b58e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad7d93b-0c76-46ec-b7f5-f7e45adc536d" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_02c9da9f-4a09-4f47-9364-b98a5930b58e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PaymentsToAcquireOtherDebtAndEquityInvestments_27550e2b-d484-47b1-93af-65f640147a6e" xlink:href="dva-20211231.xsd#dva_PaymentsToAcquireOtherDebtAndEquityInvestments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad7d93b-0c76-46ec-b7f5-f7e45adc536d" xlink:to="loc_dva_PaymentsToAcquireOtherDebtAndEquityInvestments_27550e2b-d484-47b1-93af-65f640147a6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_336f0bd0-97fc-4b33-a789-3087808252c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad7d93b-0c76-46ec-b7f5-f7e45adc536d" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_336f0bd0-97fc-4b33-a789-3087808252c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_0cb7bbed-b6b0-421a-a8fd-2b2c8ae58126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad7d93b-0c76-46ec-b7f5-f7e45adc536d" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_0cb7bbed-b6b0-421a-a8fd-2b2c8ae58126" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4ea186b8-badc-4ee7-99b5-3531d1243599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_87cdec5f-569b-4929-be49-0fdca415eb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4ea186b8-badc-4ee7-99b5-3531d1243599" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_87cdec5f-569b-4929-be49-0fdca415eb2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_f1e372fe-ad5f-4256-af5b-cd0a1395ae50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4ea186b8-badc-4ee7-99b5-3531d1243599" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_f1e372fe-ad5f-4256-af5b-cd0a1395ae50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_d8d2fc90-7843-4474-b503-23ce269e323d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4ea186b8-badc-4ee7-99b5-3531d1243599" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_d8d2fc90-7843-4474-b503-23ce269e323d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtFinancingAndDebtRedemptionCosts_1b6396e1-56d2-4505-b433-cffce4af050b" xlink:href="dva-20211231.xsd#dva_DebtFinancingAndDebtRedemptionCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4ea186b8-badc-4ee7-99b5-3531d1243599" xlink:to="loc_dva_DebtFinancingAndDebtRedemptionCosts_1b6396e1-56d2-4505-b433-cffce4af050b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_f9fa0db0-0c63-4327-bad2-5c9045436df0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4ea186b8-badc-4ee7-99b5-3531d1243599" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_f9fa0db0-0c63-4327-bad2-5c9045436df0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PaymentsRelatedToStockPurchasesAndAwards_1e8d40d6-adcd-457b-b016-e586d8ce8379" xlink:href="dva-20211231.xsd#dva_PaymentsRelatedToStockPurchasesAndAwards"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4ea186b8-badc-4ee7-99b5-3531d1243599" xlink:to="loc_dva_PaymentsRelatedToStockPurchasesAndAwards_1e8d40d6-adcd-457b-b016-e586d8ce8379" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_bcf34a4d-2244-4b4e-930b-89e6ca15d01a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4ea186b8-badc-4ee7-99b5-3531d1243599" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_bcf34a4d-2244-4b4e-930b-89e6ca15d01a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d340fca4-e433-4a41-b104-c0a0ebc25024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4ea186b8-badc-4ee7-99b5-3531d1243599" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d340fca4-e433-4a41-b104-c0a0ebc25024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8e45bfc3-e42c-474a-ada0-15e39899271e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4ea186b8-badc-4ee7-99b5-3531d1243599" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8e45bfc3-e42c-474a-ada0-15e39899271e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_4d3ed9e9-bb90-4004-bcd4-0390e089a72c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4ea186b8-badc-4ee7-99b5-3531d1243599" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_4d3ed9e9-bb90-4004-bcd4-0390e089a72c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_d313c3b4-6dc3-475d-8984-f91c14cd31d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_d313c3b4-6dc3-475d-8984-f91c14cd31d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_62cb011c-2970-4299-84e4-a7a50f84df99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_62cb011c-2970-4299-84e4-a7a50f84df99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_026f2fbd-cb59-4092-83c1-6da9876cebcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_ShareBasedCompensation_026f2fbd-cb59-4092-83c1-6da9876cebcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_00cc7de1-54f1-4252-8bb5-37882e6bf6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_00cc7de1-54f1-4252-8bb5-37882e6bf6bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0c5dc677-d74c-4521-bcbc-f785abfc29b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0c5dc677-d74c-4521-bcbc-f785abfc29b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_35146628-713c-49c5-9cfd-d5c60238671f" xlink:href="dva-20211231.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_35146628-713c-49c5-9cfd-d5c60238671f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_ce6aa9d5-f572-4fe1-a030-f3203a600f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_ce6aa9d5-f572-4fe1-a030-f3203a600f9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_5508bfd7-3b42-42d2-9d63-1d1aa2a1bf5d" xlink:href="dva-20211231.xsd#dva_AdjustmentIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_5508bfd7-3b42-42d2-9d63-1d1aa2a1bf5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_72d38b5b-193f-47c0-82f1-d3ca4ded2782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_72d38b5b-193f-47c0-82f1-d3ca4ded2782" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_7fbcac28-4d06-4d27-9167-d320b93a66fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_7fbcac28-4d06-4d27-9167-d320b93a66fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges_a184f735-b6aa-4bed-8e78-df003a92ec33" xlink:href="dva-20211231.xsd#dva_DebtRefinancingCharges"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_dva_DebtRefinancingCharges_a184f735-b6aa-4bed-8e78-df003a92ec33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_249d3707-11c1-49a0-9416-d25f029fc859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_249d3707-11c1-49a0-9416-d25f029fc859" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_fd560e21-adc3-4d53-b7f8-252f7bafaefa" xlink:href="dva-20211231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_fd560e21-adc3-4d53-b7f8-252f7bafaefa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d57d88ba-e5db-4764-bf63-30b34da774fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_ProfitLoss_d57d88ba-e5db-4764-bf63-30b34da774fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_2be767b1-849c-48e3-bb8e-79c861f941fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_2be767b1-849c-48e3-bb8e-79c861f941fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2dba0dd0-8eb6-4eb5-a133-e547ff1c27d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2dba0dd0-8eb6-4eb5-a133-e547ff1c27d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f9ae8fdb-f544-4a23-abeb-c1f065b8a007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f9ae8fdb-f544-4a23-abeb-c1f065b8a007" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a6219d9b-3c53-4c3e-bf6a-5cd7aab0f68d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5537ff2-f0e6-44f1-84ef-ff656ac1a7cf" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a6219d9b-3c53-4c3e-bf6a-5cd7aab0f68d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_51fb23b4-a1a5-43dc-b3e0-882f2f006d68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcc46e6a-7214-47de-88eb-48fa067959dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_51fb23b4-a1a5-43dc-b3e0-882f2f006d68" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcc46e6a-7214-47de-88eb-48fa067959dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_56724d8b-bee9-4fd8-b388-feabb2042942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_51fb23b4-a1a5-43dc-b3e0-882f2f006d68" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_56724d8b-bee9-4fd8-b388-feabb2042942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7a5ff2b5-f1c5-449c-8956-f0f3d492a55d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_51fb23b4-a1a5-43dc-b3e0-882f2f006d68" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7a5ff2b5-f1c5-449c-8956-f0f3d492a55d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_e17fe656-ee7c-4554-bbcf-bc9c55e523d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_51fb23b4-a1a5-43dc-b3e0-882f2f006d68" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_e17fe656-ee7c-4554-bbcf-bc9c55e523d3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_18bdc5f7-d89d-448a-b5a7-12694b4d2473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_f2f228a9-d82d-4acd-b45f-12fa7a4b75b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_18bdc5f7-d89d-448a-b5a7-12694b4d2473" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_f2f228a9-d82d-4acd-b45f-12fa7a4b75b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_c180a3b1-6e27-4d27-9897-085696304052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_18bdc5f7-d89d-448a-b5a7-12694b4d2473" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_c180a3b1-6e27-4d27-9897-085696304052" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c40c21fb-de80-4f95-bf6e-cd52d8551a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_2e76c880-93c8-4ff1-bb2d-01552988f530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_c40c21fb-de80-4f95-bf6e-cd52d8551a7a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_2e76c880-93c8-4ff1-bb2d-01552988f530" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_8b538ccf-bc56-4aef-9b26-d892bee4fb29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_c40c21fb-de80-4f95-bf6e-cd52d8551a7a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_8b538ccf-bc56-4aef-9b26-d892bee4fb29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ad2c004d-51eb-4cc2-9479-4af46b0b19cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_2b1854e6-7a55-46a1-a6f1-e408daff3e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ad2c004d-51eb-4cc2-9479-4af46b0b19cd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_2b1854e6-7a55-46a1-a6f1-e408daff3e3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2195083f-154f-4b34-b7ef-c835bfa5f2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ad2c004d-51eb-4cc2-9479-4af46b0b19cd" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2195083f-154f-4b34-b7ef-c835bfa5f2d5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#ShorttermandlongterminvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_131c52fb-e623-4330-a186-ec227670524c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_c3f85628-25b0-4856-94af-32418c5b1d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketableSecurities_131c52fb-e623-4330-a186-ec227670524c" xlink:to="loc_us-gaap_HeldToMaturitySecurities_c3f85628-25b0-4856-94af-32418c5b1d1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_9fa4a986-8cc4-40b7-8972-42ac969e4909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketableSecurities_131c52fb-e623-4330-a186-ec227670524c" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_9fa4a986-8cc4-40b7-8972-42ac969e4909" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#PropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_044b2c7e-6e0b-4ae5-ae0d-f00f9c10b5be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_663bba28-0be5-49bd-9119-6e776d8b58e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_044b2c7e-6e0b-4ae5-ae0d-f00f9c10b5be" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_663bba28-0be5-49bd-9119-6e776d8b58e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f1ff8164-f83c-40c0-b5a1-c8b1759054fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_044b2c7e-6e0b-4ae5-ae0d-f00f9c10b5be" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f1ff8164-f83c-40c0-b5a1-c8b1759054fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_d46d09e3-a461-4e66-96c5-5f866c60739a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_c33e1624-5938-4b27-8c9d-17def086323a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d46d09e3-a461-4e66-96c5-5f866c60739a" xlink:to="loc_us-gaap_Land_c33e1624-5938-4b27-8c9d-17def086323a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_1ea2bea6-1ff4-4440-8110-9e3faa19c15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d46d09e3-a461-4e66-96c5-5f866c60739a" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_1ea2bea6-1ff4-4440-8110-9e3faa19c15a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_f8549c75-f69c-40cf-b626-a239b763993e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d46d09e3-a461-4e66-96c5-5f866c60739a" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_f8549c75-f69c-40cf-b626-a239b763993e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_feb1774d-6253-44be-931a-8562792b81f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d46d09e3-a461-4e66-96c5-5f866c60739a" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_feb1774d-6253-44be-931a-8562792b81f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_09b7ccd3-5387-4e50-8a2a-38971d8bd326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d46d09e3-a461-4e66-96c5-5f866c60739a" xlink:to="loc_us-gaap_ConstructionInProgressGross_09b7ccd3-5387-4e50-8a2a-38971d8bd326" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d9d7b4a6-9396-4a5f-8125-e71685c834dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5f552e54-4fb8-409b-abdc-658b07a6c3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d9d7b4a6-9396-4a5f-8125-e71685c834dd" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5f552e54-4fb8-409b-abdc-658b07a6c3b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_40dc65f7-1c9a-4b92-81ad-ae290662667c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d9d7b4a6-9396-4a5f-8125-e71685c834dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_40dc65f7-1c9a-4b92-81ad-ae290662667c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8372dacc-99bc-4bdd-92f5-51ef9dc7677b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_461bc1cf-bf77-46d2-ad2d-988750bd1256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8372dacc-99bc-4bdd-92f5-51ef9dc7677b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_461bc1cf-bf77-46d2-ad2d-988750bd1256" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross_f0085746-5984-4f9e-9476-1860ffa17e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedNoncompeteAgreementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8372dacc-99bc-4bdd-92f5-51ef9dc7677b" xlink:to="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross_f0085746-5984-4f9e-9476-1860ffa17e4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_ddd612ad-96c0-48d4-97e1-8a3ef3b83d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8372dacc-99bc-4bdd-92f5-51ef9dc7677b" xlink:to="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_ddd612ad-96c0-48d4-97e1-8a3ef3b83d1c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eba8b1ad-b523-4adb-9767-b2bf09e35f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a35ff06a-1959-4eae-8029-23ac59f4c7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eba8b1ad-b523-4adb-9767-b2bf09e35f4b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a35ff06a-1959-4eae-8029-23ac59f4c7fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7c385b47-10bb-4fa5-a04f-71b42b30c2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eba8b1ad-b523-4adb-9767-b2bf09e35f4b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7c385b47-10bb-4fa5-a04f-71b42b30c2d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6ca2dec7-f8c8-42ae-8fa7-5a0ee9bbb786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eba8b1ad-b523-4adb-9767-b2bf09e35f4b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6ca2dec7-f8c8-42ae-8fa7-5a0ee9bbb786" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e3f8a120-8e2f-4ee5-a4a9-aa37c5bfa4af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eba8b1ad-b523-4adb-9767-b2bf09e35f4b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e3f8a120-8e2f-4ee5-a4a9-aa37c5bfa4af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1d5862b4-1f1b-4b8f-8878-091c19c432c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eba8b1ad-b523-4adb-9767-b2bf09e35f4b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1d5862b4-1f1b-4b8f-8878-091c19c432c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f4f70eb0-39be-4e53-a1e8-8f7e257bc4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eba8b1ad-b523-4adb-9767-b2bf09e35f4b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f4f70eb0-39be-4e53-a1e8-8f7e257bc4ab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherLiabilitiesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#OtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/OtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_ccab93a4-3601-42df-a3fb-81e5d3b9381d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PayorRefundsAndRetractions_7a936758-bae2-45bd-ad92-cb7dc77db470" xlink:href="dva-20211231.xsd#dva_PayorRefundsAndRetractions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ccab93a4-3601-42df-a3fb-81e5d3b9381d" xlink:to="loc_dva_PayorRefundsAndRetractions_7a936758-bae2-45bd-ad92-cb7dc77db470" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_f16f93bc-2871-4dff-922c-bb655aedea7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ccab93a4-3601-42df-a3fb-81e5d3b9381d" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_f16f93bc-2871-4dff-922c-bb655aedea7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_832addd4-e323-49ae-a984-65ab3ea05d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ccab93a4-3601-42df-a3fb-81e5d3b9381d" xlink:to="loc_us-gaap_InterestPayableCurrent_832addd4-e323-49ae-a984-65ab3ea05d9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_f1d32564-1501-4739-96ba-b53f5744987d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ccab93a4-3601-42df-a3fb-81e5d3b9381d" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_f1d32564-1501-4739-96ba-b53f5744987d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_7903bb1f-5480-48d8-a6f4-408f25d7e0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_ccab93a4-3601-42df-a3fb-81e5d3b9381d" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_7903bb1f-5480-48d8-a6f4-408f25d7e0e4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3c1bfb2c-5e79-4a46-9110-78a000442382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_74f4e088-c09c-4080-8e4b-8c053e21d903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3c1bfb2c-5e79-4a46-9110-78a000442382" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_74f4e088-c09c-4080-8e4b-8c053e21d903" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_09db5b88-87be-481c-84fb-8b3156bfb557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3c1bfb2c-5e79-4a46-9110-78a000442382" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_09db5b88-87be-481c-84fb-8b3156bfb557" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c1495b57-2b78-418d-8bfd-adc59c8324d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_a2a5f73e-7dd2-4803-92d2-fe7089e0ac77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c1495b57-2b78-418d-8bfd-adc59c8324d3" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_a2a5f73e-7dd2-4803-92d2-fe7089e0ac77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_290167aa-6530-4591-bbf3-93e87bc1ac0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c1495b57-2b78-418d-8bfd-adc59c8324d3" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_290167aa-6530-4591-bbf3-93e87bc1ac0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_46c8be21-6cd3-4425-bf49-1d307daffd33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c1495b57-2b78-418d-8bfd-adc59c8324d3" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_46c8be21-6cd3-4425-bf49-1d307daffd33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_7a9e0474-19c0-4b44-8d33-1da886cf0078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_62bf1493-4124-4829-bcb1-9c804008a703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_7a9e0474-19c0-4b44-8d33-1da886cf0078" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_62bf1493-4124-4829-bcb1-9c804008a703" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_a68c1a1e-9131-48a6-9192-9585cb6ed411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_7a9e0474-19c0-4b44-8d33-1da886cf0078" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_a68c1a1e-9131-48a6-9192-9585cb6ed411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_85d687e6-fba7-4fd9-99b9-9e5a4d01a63f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_7a9e0474-19c0-4b44-8d33-1da886cf0078" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_85d687e6-fba7-4fd9-99b9-9e5a4d01a63f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_02e3c618-84ba-4f9d-82e8-02e56e1f6089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f062cda7-0e45-4d26-80dd-32bf231e69e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_02e3c618-84ba-4f9d-82e8-02e56e1f6089" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f062cda7-0e45-4d26-80dd-32bf231e69e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_02d99d52-1500-4220-8679-b47629997b73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_02e3c618-84ba-4f9d-82e8-02e56e1f6089" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_02d99d52-1500-4220-8679-b47629997b73" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_ff12973d-50e8-4bdd-ad2c-74fb519eb49c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c28e9c56-fe71-49f9-a108-e5eab1a10a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_ff12973d-50e8-4bdd-ad2c-74fb519eb49c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c28e9c56-fe71-49f9-a108-e5eab1a10a4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_8dd69539-a446-48b5-8263-be9ca9bc33ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_ff12973d-50e8-4bdd-ad2c-74fb519eb49c" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_8dd69539-a446-48b5-8263-be9ca9bc33ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3a9b93c5-fed7-4480-aaae-83942e547c74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_49daab52-8efe-4d96-88b5-d0568dedb03f" xlink:href="dva-20211231.xsd#dva_EffectiveIncomeTaxReconciliationInvestmentImpairment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3a9b93c5-fed7-4480-aaae-83942e547c74" xlink:to="loc_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_49daab52-8efe-4d96-88b5-d0568dedb03f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_48955a06-3c4b-4e4e-b0cc-5d99b3048f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3a9b93c5-fed7-4480-aaae-83942e547c74" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_48955a06-3c4b-4e4e-b0cc-5d99b3048f41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ea4b383c-14de-49ed-943a-d81de75c0a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3a9b93c5-fed7-4480-aaae-83942e547c74" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ea4b383c-14de-49ed-943a-d81de75c0a10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_941481b3-733e-4e04-911f-ca98a44ac5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3a9b93c5-fed7-4480-aaae-83942e547c74" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_941481b3-733e-4e04-911f-ca98a44ac5f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_3ebe9d60-2327-4a06-b230-ca213c0f34c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3a9b93c5-fed7-4480-aaae-83942e547c74" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_3ebe9d60-2327-4a06-b230-ca213c0f34c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_9f0df0c6-7f5e-4b60-bcee-4d85aa161f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3a9b93c5-fed7-4480-aaae-83942e547c74" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_9f0df0c6-7f5e-4b60-bcee-4d85aa161f6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_f01e13f0-17f9-4fa8-85a4-abfdeb19daa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3a9b93c5-fed7-4480-aaae-83942e547c74" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_f01e13f0-17f9-4fa8-85a4-abfdeb19daa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_9661c662-ebec-4eab-b8cf-5c0c4e3c0807" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3a9b93c5-fed7-4480-aaae-83942e547c74" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_9661c662-ebec-4eab-b8cf-5c0c4e3c0807" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_5efe5d7f-6b09-458d-be67-bab3958e7a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3a9b93c5-fed7-4480-aaae-83942e547c74" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_5efe5d7f-6b09-458d-be67-bab3958e7a41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3a58d428-9657-4d78-8da0-0a6d0fe9066f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3a9b93c5-fed7-4480-aaae-83942e547c74" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3a58d428-9657-4d78-8da0-0a6d0fe9066f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_84d619ee-6e7c-46f0-9048-11c2713fefb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1cfc6d1b-52cc-49c5-999e-0b1fb13e89af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_84d619ee-6e7c-46f0-9048-11c2713fefb2" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1cfc6d1b-52cc-49c5-999e-0b1fb13e89af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0d12b3b6-3e48-4d8a-bcfd-dd2e99576b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_84d619ee-6e7c-46f0-9048-11c2713fefb2" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0d12b3b6-3e48-4d8a-bcfd-dd2e99576b2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_0f528a4f-ba26-4035-87e2-d47d88dbe38e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_bffd13d5-4050-4206-b4f1-93aece3909f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_0f528a4f-ba26-4035-87e2-d47d88dbe38e" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_bffd13d5-4050-4206-b4f1-93aece3909f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e622c6b8-a9ab-4d09-9515-33eacc01de60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_0f528a4f-ba26-4035-87e2-d47d88dbe38e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e622c6b8-a9ab-4d09-9515-33eacc01de60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_d733172d-7e4a-499d-a306-da5cb6c32ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_3d02309c-53d4-46cd-943c-599c2b102286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d733172d-7e4a-499d-a306-da5cb6c32ac2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_3d02309c-53d4-46cd-943c-599c2b102286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b5e32a0f-3ba1-43d3-ae65-94a07c78e546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d733172d-7e4a-499d-a306-da5cb6c32ac2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b5e32a0f-3ba1-43d3-ae65-94a07c78e546" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_d9c75566-f1b8-43a3-b6e9-989cc831d92d" xlink:href="dva-20211231.xsd#dva_DeferredTaxLiabilitiesOperatingLeaseAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d733172d-7e4a-499d-a306-da5cb6c32ac2" xlink:to="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_d9c75566-f1b8-43a3-b6e9-989cc831d92d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_ca849ad9-2522-408e-ab5b-f3a5d584bde0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d733172d-7e4a-499d-a306-da5cb6c32ac2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_ca849ad9-2522-408e-ab5b-f3a5d584bde0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_fc02814d-75f2-4cac-a819-8d5c6555a9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d733172d-7e4a-499d-a306-da5cb6c32ac2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_fc02814d-75f2-4cac-a819-8d5c6555a9ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_b7c5c1fe-8ea7-4491-8149-433b3a070c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsReceivables_159ba9fa-d868-4d1a-87da-32d0fbae6ae7" xlink:href="dva-20211231.xsd#dva_DeferredTaxAssetsReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b7c5c1fe-8ea7-4491-8149-433b3a070c72" xlink:to="loc_dva_DeferredTaxAssetsReceivables_159ba9fa-d868-4d1a-87da-32d0fbae6ae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_974fb005-ed76-48a7-b7a7-4766fc2f2aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b7c5c1fe-8ea7-4491-8149-433b3a070c72" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_974fb005-ed76-48a7-b7a7-4766fc2f2aa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities_172ccde3-a11c-4fdc-892e-6f0deeec95dd" xlink:href="dva-20211231.xsd#dva_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b7c5c1fe-8ea7-4491-8149-433b3a070c72" xlink:to="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities_172ccde3-a11c-4fdc-892e-6f0deeec95dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9a2dc45f-18c1-4279-9553-1692fd473516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b7c5c1fe-8ea7-4491-8149-433b3a070c72" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9a2dc45f-18c1-4279-9553-1692fd473516" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_65203a6a-3322-40b1-bd41-c39635f66291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b7c5c1fe-8ea7-4491-8149-433b3a070c72" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_65203a6a-3322-40b1-bd41-c39635f66291" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_2548e636-0098-48ca-90c6-b6c4c8d71651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1f5fc945-3438-4b81-862a-909ecb1da79f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_2548e636-0098-48ca-90c6-b6c4c8d71651" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1f5fc945-3438-4b81-862a-909ecb1da79f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountAndDeferredFinanceCosts_5b9ff7fb-b61b-4bdc-bc1e-5aaaa997bf40" xlink:href="dva-20211231.xsd#dva_DiscountAndDeferredFinanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_2548e636-0098-48ca-90c6-b6c4c8d71651" xlink:to="loc_dva_DiscountAndDeferredFinanceCosts_5b9ff7fb-b61b-4bdc-bc1e-5aaaa997bf40" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a0d8a896-0ca0-442e-916d-2036b3206163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_a08af1f7-2d87-41d8-aa32-ac4a4e9b9bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a0d8a896-0ca0-442e-916d-2036b3206163" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_a08af1f7-2d87-41d8-aa32-ac4a4e9b9bb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_1c629c98-e2f9-4d93-b363-f42714af5372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a0d8a896-0ca0-442e-916d-2036b3206163" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_1c629c98-e2f9-4d93-b363-f42714af5372" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4f16a292-fe3c-40a2-a126-69d49060d54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a0d8a896-0ca0-442e-916d-2036b3206163" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4f16a292-fe3c-40a2-a126-69d49060d54d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_8e31d774-d38f-47bb-87be-3b002f152569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a0d8a896-0ca0-442e-916d-2036b3206163" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_8e31d774-d38f-47bb-87be-3b002f152569" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_c8ee5bf5-6874-4928-a7ca-acae0b97d55c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a0d8a896-0ca0-442e-916d-2036b3206163" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_c8ee5bf5-6874-4928-a7ca-acae0b97d55c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_91760fa8-7066-4c78-bf82-d433764c3d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a0d8a896-0ca0-442e-916d-2036b3206163" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_91760fa8-7066-4c78-bf82-d433764c3d5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9d18184-2819-499a-a373-de8be0ad41a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4c02395a-f53d-42f0-ad96-0d47e03c4b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9d18184-2819-499a-a373-de8be0ad41a0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4c02395a-f53d-42f0-ad96-0d47e03c4b17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_08869877-98b8-4575-bd28-35f5e76c0348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9d18184-2819-499a-a373-de8be0ad41a0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_08869877-98b8-4575-bd28-35f5e76c0348" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e86b4e7b-7251-4119-a43f-0c348e3a4862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9d18184-2819-499a-a373-de8be0ad41a0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e86b4e7b-7251-4119-a43f-0c348e3a4862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2ea3786b-0c4f-4043-ad69-075f283c626a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9d18184-2819-499a-a373-de8be0ad41a0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2ea3786b-0c4f-4043-ad69-075f283c626a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_08272c27-bcf6-4050-8d53-3e470982e3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9d18184-2819-499a-a373-de8be0ad41a0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_08272c27-bcf6-4050-8d53-3e470982e3b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f6bd6462-8735-40a0-9571-808e080fb0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9d18184-2819-499a-a373-de8be0ad41a0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f6bd6462-8735-40a0-9571-808e080fb0ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#AccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_c8991832-8be4-48db-ac04-4b0498daed8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_636c6003-3932-4064-b9ea-29b19a1d7fad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_c8991832-8be4-48db-ac04-4b0498daed8a" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_636c6003-3932-4064-b9ea-29b19a1d7fad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3795fc1c-d6e9-49b3-823c-9949e05dafc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_c8991832-8be4-48db-ac04-4b0498daed8a" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3795fc1c-d6e9-49b3-823c-9949e05dafc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_60d2fd68-31c9-4ee6-a1ef-82474df9b023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_13aaa092-74a3-4acd-bce4-91c57b29019e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_60d2fd68-31c9-4ee6-a1ef-82474df9b023" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_13aaa092-74a3-4acd-bce4-91c57b29019e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_87171eb8-7135-4ef3-9bd8-a90a9fa48b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_60d2fd68-31c9-4ee6-a1ef-82474df9b023" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_87171eb8-7135-4ef3-9bd8-a90a9fa48b26" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#AcquisitionsAssetsacquiredandliabilitiesassumedDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d778d746-c238-4f99-81cb-da41d8961bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_6b54f3e4-89eb-4dd1-b841-2ee567e31f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d778d746-c238-4f99-81cb-da41d8961bd6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_6b54f3e4-89eb-4dd1-b841-2ee567e31f64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_5ce4abce-5dc3-4a47-b274-1f1444140f80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d778d746-c238-4f99-81cb-da41d8961bd6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_5ce4abce-5dc3-4a47-b274-1f1444140f80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_12fe7c42-41bc-4b69-b02e-6a99b304a8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d778d746-c238-4f99-81cb-da41d8961bd6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_12fe7c42-41bc-4b69-b02e-6a99b304a8f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0e9760e7-275a-4ad7-a0b7-72d2e5dc4e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d778d746-c238-4f99-81cb-da41d8961bd6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0e9760e7-275a-4ad7-a0b7-72d2e5dc4e35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_289b2b16-53a5-4ca8-abb3-5693093d2bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d778d746-c238-4f99-81cb-da41d8961bd6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_289b2b16-53a5-4ca8-abb3-5693093d2bd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9f88ae8d-cfba-4346-ab60-1ebc77e25e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d778d746-c238-4f99-81cb-da41d8961bd6" xlink:to="loc_us-gaap_Goodwill_9f88ae8d-cfba-4346-ab60-1ebc77e25e99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3774590e-137e-4494-810b-f110a922e8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d778d746-c238-4f99-81cb-da41d8961bd6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3774590e-137e-4494-810b-f110a922e8a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e6d4874f-97f1-4e5e-ba87-d908f36cbbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d778d746-c238-4f99-81cb-da41d8961bd6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e6d4874f-97f1-4e5e-ba87-d908f36cbbcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_fdfbdc29-d1db-4632-80c3-15d455857596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d778d746-c238-4f99-81cb-da41d8961bd6" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_fdfbdc29-d1db-4632-80c3-15d455857596" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>dva-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1726f308-1cc7-4a47-a8e3-a7d089a83ae3,g:ca3879f3-8750-4d94-926a-aa4c6036a270-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="id6840eef2dcd4e2384de809d6cb9a0f7_CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5c525b2b-624d-44b5-aa1f-bcc557fd5210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5c525b2b-624d-44b5-aa1f-bcc557fd5210" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_86bd5025-2e31-47fd-a532-2e44278db65d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5c525b2b-624d-44b5-aa1f-bcc557fd5210" xlink:to="loc_us-gaap_ProfitLoss_86bd5025-2e31-47fd-a532-2e44278db65d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5c525b2b-624d-44b5-aa1f-bcc557fd5210" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_7d9632ff-fc4d-4a0e-a2ce-05d4dd550c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_7d9632ff-fc4d-4a0e-a2ce-05d4dd550c78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_2c6d6ae1-7580-4e9e-b6f7-4de4b81d65e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_2c6d6ae1-7580-4e9e-b6f7-4de4b81d65e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges_4d5dc227-6ba5-4534-ae71-735479110ea9" xlink:href="dva-20211231.xsd#dva_DebtRefinancingCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_dva_DebtRefinancingCharges_4d5dc227-6ba5-4534-ae71-735479110ea9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_989b406e-da8f-40ff-97cc-08f24604f2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_us-gaap_ShareBasedCompensation_989b406e-da8f-40ff-97cc-08f24604f2c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b2754294-4953-4dcd-9026-cc4e27295038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b2754294-4953-4dcd-9026-cc4e27295038" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_6b89c662-b1ee-4509-8b38-b5397d1d7929" xlink:href="dva-20211231.xsd#dva_AdjustmentIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_6b89c662-b1ee-4509-8b38-b5397d1d7929" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_7f6d0172-d5a2-47be-a776-5f6aec8c7989" xlink:href="dva-20211231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_7f6d0172-d5a2-47be-a776-5f6aec8c7989" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_617a5fdc-6304-4122-b83a-c56493643051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_617a5fdc-6304-4122-b83a-c56493643051" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_806763d0-03d8-4516-aabc-6bb90bc57645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_806763d0-03d8-4516-aabc-6bb90bc57645" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_fb53d015-befa-4172-88e1-08ce277f7804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_fb53d015-befa-4172-88e1-08ce277f7804" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_92401789-5ada-42ed-97cf-04c8adfd2ded" xlink:href="dva-20211231.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_92401789-5ada-42ed-97cf-04c8adfd2ded" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a94935e0-32eb-4e88-9b1e-ff5776b48b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a94935e0-32eb-4e88-9b1e-ff5776b48b25" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_66bfb990-e358-4689-af57-9edbbb4d84bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_66bfb990-e358-4689-af57-9edbbb4d84bf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a1496d8b-8de4-444e-b48f-db4bfd4ecdeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a1496d8b-8de4-444e-b48f-db4bfd4ecdeb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_54291aa6-c4b0-4212-819f-75afd99796e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_54291aa6-c4b0-4212-819f-75afd99796e7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_efc7f4dc-60a1-41ae-ae79-a246aac9103c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_efc7f4dc-60a1-41ae-ae79-a246aac9103c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_d1b741b0-67bb-420b-9d7a-f15ca9dba9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_d1b741b0-67bb-420b-9d7a-f15ca9dba9f7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78014bd0-e4e9-4797-9561-ced9f66c3f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5c525b2b-624d-44b5-aa1f-bcc557fd5210" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78014bd0-e4e9-4797-9561-ced9f66c3f1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_08af43d1-9898-44a0-aae9-98729c597cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_08af43d1-9898-44a0-aae9-98729c597cfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_a083ca78-cf9f-429f-8abc-aa5a9d398f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_a083ca78-cf9f-429f-8abc-aa5a9d398f90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_feb0bfe7-2817-4e23-9673-4867d16613f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_feb0bfe7-2817-4e23-9673-4867d16613f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_fe86d8cd-785e-4446-ac6c-a1be58235323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_fe86d8cd-785e-4446-ac6c-a1be58235323" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PaymentsToAcquireOtherDebtAndEquityInvestments_8e289032-98c7-4e0b-b166-37b9df8ee091" xlink:href="dva-20211231.xsd#dva_PaymentsToAcquireOtherDebtAndEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_dva_PaymentsToAcquireOtherDebtAndEquityInvestments_8e289032-98c7-4e0b-b166-37b9df8ee091" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_6c33acaa-cf96-43e3-b104-ab3a935b4075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_6c33acaa-cf96-43e3-b104-ab3a935b4075" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_f7dd497c-0620-4f53-af4f-b680a7c7331d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_f7dd497c-0620-4f53-af4f-b680a7c7331d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_d6714fe7-40e5-497d-bc68-f5e3f51a8ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_d6714fe7-40e5-497d-bc68-f5e3f51a8ed7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_90b8def8-786c-4642-956c-08f3e29890f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_90b8def8-786c-4642-956c-08f3e29890f4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_90a2dd96-5fa1-482a-8d37-1b3c876331de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_90a2dd96-5fa1-482a-8d37-1b3c876331de" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48e31393-a74e-4cb6-bb3b-69d0ff729ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48e31393-a74e-4cb6-bb3b-69d0ff729ef7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d9c33721-c07e-427c-9cda-f55a1d106e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d9c33721-c07e-427c-9cda-f55a1d106e81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_3ea95106-5480-4732-be46-92b1238bdf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_3ea95106-5480-4732-be46-92b1238bdf4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtFinancingAndDebtRedemptionCosts_d31fae8c-2143-4c32-8acc-362104d89ae5" xlink:href="dva-20211231.xsd#dva_DebtFinancingAndDebtRedemptionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_dva_DebtFinancingAndDebtRedemptionCosts_d31fae8c-2143-4c32-8acc-362104d89ae5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e2a26cdc-f3c0-4159-a3b0-cecae5acd544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e2a26cdc-f3c0-4159-a3b0-cecae5acd544" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_61de1b6d-e5d9-4c1d-8b6e-a9c8d4674be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_61de1b6d-e5d9-4c1d-8b6e-a9c8d4674be4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PaymentsRelatedToStockPurchasesAndAwards_90b7b6e4-e877-4ca8-b233-1d22837bdcdd" xlink:href="dva-20211231.xsd#dva_PaymentsRelatedToStockPurchasesAndAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_dva_PaymentsRelatedToStockPurchasesAndAwards_90b7b6e4-e877-4ca8-b233-1d22837bdcdd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_63eafbed-ec56-47ae-a45b-1d3b533efc85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_63eafbed-ec56-47ae-a45b-1d3b533efc85" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_04e6a56f-4dc1-4b52-9fb7-bf57a16f12b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_04e6a56f-4dc1-4b52-9fb7-bf57a16f12b1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_d35ee0dc-6e61-4db5-894a-7023c57dcf16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_d35ee0dc-6e61-4db5-894a-7023c57dcf16" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_aff25097-ed1c-40f7-bed1-d557eafd0a97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_aff25097-ed1c-40f7-bed1-d557eafd0a97" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ce2b2b3c-28e3-4640-819d-39b5adffef34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ce2b2b3c-28e3-4640-819d-39b5adffef34" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_cfaaf0c0-79d5-419e-b15c-8be35911d801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_cfaaf0c0-79d5-419e-b15c-8be35911d801" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_20f75d18-d6be-457a-a78d-8dbde2007e44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_20f75d18-d6be-457a-a78d-8dbde2007e44" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0db4ac37-0828-4783-ad9b-e30f9d6c18bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0db4ac37-0828-4783-ad9b-e30f9d6c18bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_891b32a5-5614-4496-bdba-3c3dc5e04178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5d31572e-c59b-4583-80de-856c5f8e2112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_StatementTable_5d31572e-c59b-4583-80de-856c5f8e2112" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9fe3d870-bbd3-41f6-a0c1-cffe6643fa7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5d31572e-c59b-4583-80de-856c5f8e2112" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9fe3d870-bbd3-41f6-a0c1-cffe6643fa7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_9fe3d870-bbd3-41f6-a0c1-cffe6643fa7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9fe3d870-bbd3-41f6-a0c1-cffe6643fa7a" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_9fe3d870-bbd3-41f6-a0c1-cffe6643fa7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_cd9c4ab0-9142-41f5-b914-338b28716cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9fe3d870-bbd3-41f6-a0c1-cffe6643fa7a" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_cd9c4ab0-9142-41f5-b914-338b28716cfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_c5afec5c-0021-49fc-a396-113ca117b0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_cd9c4ab0-9142-41f5-b914-338b28716cfe" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_c5afec5c-0021-49fc-a396-113ca117b0f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_2c3f88fe-9927-430d-b38c-cbdeccd0e1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_cd9c4ab0-9142-41f5-b914-338b28716cfe" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_2c3f88fe-9927-430d-b38c-cbdeccd0e1b9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDSTATEMENTSOFEQUITY"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="extended" id="i757de702b9f4438bb8804cd006f35635_CONSOLIDATEDSTATEMENTSOFEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_61b7de68-b3c5-46c9-85aa-b418fcc7b5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_61b7de68-b3c5-46c9-85aa-b418fcc7b5b4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0a0d55f9-9fb6-4a60-9f4e-9fc88a8c3f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0a0d55f9-9fb6-4a60-9f4e-9fc88a8c3f9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f7985cc6-096f-490e-a7aa-823308163ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f7985cc6-096f-490e-a7aa-823308163ba2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_64934055-f004-4721-9fde-9401af4e31f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_64934055-f004-4721-9fde-9401af4e31f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_43857806-da84-4763-b77b-f4791688e6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_43857806-da84-4763-b77b-f4791688e6fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_1b166c58-7674-4f38-95ad-5ea398888bef" xlink:href="dva-20211231.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_1b166c58-7674-4f38-95ad-5ea398888bef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_b4f79b5b-c5df-476e-b754-e6142c9a7571" xlink:href="dva-20211231.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_b4f79b5b-c5df-476e-b754-e6142c9a7571" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures_21c1318c-1b36-44b9-a699-0a78e4df2ae3" xlink:href="dva-20211231.xsd#dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures_21c1318c-1b36-44b9-a699-0a78e4df2ae3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_fa3ddd79-6f99-472e-bfff-e6af16d998dd" xlink:href="dva-20211231.xsd#dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_fa3ddd79-6f99-472e-bfff-e6af16d998dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_a393a9fa-7cb5-4bf8-ab15-197069ba429c" xlink:href="dva-20211231.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_a393a9fa-7cb5-4bf8-ab15-197069ba429c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_3a40c8bf-e958-4821-8f29-aeed57bca2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_3a40c8bf-e958-4821-8f29-aeed57bca2a0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_637bf096-b24f-43ea-9a61-882fe94857f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_affcb587-1ca1-479b-89a5-c08198f29d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_affcb587-1ca1-479b-89a5-c08198f29d8a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_34817895-558c-4cd6-938e-6fa454bfc9be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_affcb587-1ca1-479b-89a5-c08198f29d8a" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_34817895-558c-4cd6-938e-6fa454bfc9be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7ffb9201-e476-4d33-bfa3-89feacbff483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_affcb587-1ca1-479b-89a5-c08198f29d8a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7ffb9201-e476-4d33-bfa3-89feacbff483" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9998afc2-fac4-47e1-9ee5-7e84b8b7faa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9998afc2-fac4-47e1-9ee5-7e84b8b7faa2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c03d1866-e305-4269-8591-830196fd5dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c03d1866-e305-4269-8591-830196fd5dc5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_032e0e6f-4b5e-4f3c-afb1-e4e4143a8728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_032e0e6f-4b5e-4f3c-afb1-e4e4143a8728" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f6635504-da59-4840-a13f-c8404299a9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f6635504-da59-4840-a13f-c8404299a9b7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_48888ffe-2723-45fe-b4eb-a356f251ae23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_48888ffe-2723-45fe-b4eb-a356f251ae23" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_cdb8cbe0-3b25-4427-b15c-9d0fad878b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_cdb8cbe0-3b25-4427-b15c-9d0fad878b08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions_0f7fa9b3-0cde-495f-8625-d81111b060a2" xlink:href="dva-20211231.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_dva_NoncontrollingInterestIncreaseFromContributions_0f7fa9b3-0cde-495f-8625-d81111b060a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_74153984-f77a-40cf-8029-071af99d1dd9" xlink:href="dva-20211231.xsd#dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_74153984-f77a-40cf-8029-071af99d1dd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_077b2063-3c7e-46aa-b16d-b085941ed2fa" xlink:href="dva-20211231.xsd#dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_077b2063-3c7e-46aa-b16d-b085941ed2fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_aac0d8ae-407a-4151-947a-da5c7abe6754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_aac0d8ae-407a-4151-947a-da5c7abe6754" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_aa8660e3-cb9e-4a75-843f-d994e030e030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_aa8660e3-cb9e-4a75-843f-d994e030e030" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_cfb39ab9-e946-4a6f-90e4-73b38b5b0fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_cfb39ab9-e946-4a6f-90e4-73b38b5b0fc6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_2bf87289-443f-48a5-93c0-0369827d3fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_2bf87289-443f-48a5-93c0-0369827d3fff" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0b2980a0-2f68-488a-b6ec-983ae7f17b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0b2980a0-2f68-488a-b6ec-983ae7f17b60" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_2ff825f4-2f42-4310-82cd-b62a89996896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_2ff825f4-2f42-4310-82cd-b62a89996896" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_a7354190-45ba-4fad-a49b-9684d202da23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_a7354190-45ba-4fad-a49b-9684d202da23" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_eb218e10-12a2-482b-bf78-3a5d01f1cee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_eb218e10-12a2-482b-bf78-3a5d01f1cee2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1245c9a8-502b-40e9-bbd1-ac1883d29e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_34b6048e-5f35-4d56-a7a9-d6089881ac7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_61870d3a-1f48-4e8c-b392-526e4b067512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_61b7de68-b3c5-46c9-85aa-b418fcc7b5b4" xlink:to="loc_us-gaap_StatementTable_61870d3a-1f48-4e8c-b392-526e4b067512" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d065de14-0a6b-4f81-9056-342da767af68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_61870d3a-1f48-4e8c-b392-526e4b067512" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d065de14-0a6b-4f81-9056-342da767af68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d065de14-0a6b-4f81-9056-342da767af68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d065de14-0a6b-4f81-9056-342da767af68" xlink:to="loc_us-gaap_EquityComponentDomain_d065de14-0a6b-4f81-9056-342da767af68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b038238e-af74-4b7f-a2e3-7681399c61ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d065de14-0a6b-4f81-9056-342da767af68" xlink:to="loc_us-gaap_EquityComponentDomain_b038238e-af74-4b7f-a2e3-7681399c61ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b038238e-af74-4b7f-a2e3-7681399c61ef" xlink:to="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_3bbc1497-13d9-4658-9509-60e1e1dcf6b4" xlink:href="dva-20211231.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_3bbc1497-13d9-4658-9509-60e1e1dcf6b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5f9dfe1f-460b-4b46-9768-f68191747cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_us-gaap_CommonStockMember_5f9dfe1f-460b-4b46-9768-f68191747cc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d89407a7-4e5a-4132-8593-153b7bc172f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d89407a7-4e5a-4132-8593-153b7bc172f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e972bd66-7d78-4849-847a-50dc3e21422a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_us-gaap_RetainedEarningsMember_e972bd66-7d78-4849-847a-50dc3e21422a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7dd66574-74a4-4562-a3e4-bdd01ecc2014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_us-gaap_TreasuryStockMember_7dd66574-74a4-4562-a3e4-bdd01ecc2014" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b90dfdbb-92dd-4500-b2d5-1e30a4386905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b90dfdbb-92dd-4500-b2d5-1e30a4386905" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ac3e40ea-d1bb-48d6-835b-268b6b2cb267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ac3e40ea-d1bb-48d6-835b-268b6b2cb267" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1887079a-ded7-4d2f-ab2a-f1b26369055d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_61870d3a-1f48-4e8c-b392-526e4b067512" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1887079a-ded7-4d2f-ab2a-f1b26369055d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1887079a-ded7-4d2f-ab2a-f1b26369055d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1887079a-ded7-4d2f-ab2a-f1b26369055d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1887079a-ded7-4d2f-ab2a-f1b26369055d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e7c5331-3722-44ea-bb79-801ff2cede39" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1887079a-ded7-4d2f-ab2a-f1b26369055d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e7c5331-3722-44ea-bb79-801ff2cede39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f677b5ed-a982-4b65-8ef6-fad5de0254e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e7c5331-3722-44ea-bb79-801ff2cede39" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f677b5ed-a982-4b65-8ef6-fad5de0254e9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended" id="i0e0a2c5a36674485901acf7f177e93a9_OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:href="dva-20211231.xsd#dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfSites_1f36275f-b40b-42c6-97c0-2b1b479a1da3" xlink:href="dva-20211231.xsd#dva_NumberOfSites"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:to="loc_dva_NumberOfSites_1f36275f-b40b-42c6-97c0-2b1b479a1da3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_374e7add-f28a-4502-9338-1821812067f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_374e7add-f28a-4502-9338-1821812067f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfCustomers_6bac7fb7-bbd9-497d-9469-27baf25369f4" xlink:href="dva-20211231.xsd#dva_NumberOfCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:to="loc_dva_NumberOfCustomers_6bac7fb7-bbd9-497d-9469-27baf25369f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_fff34bb1-4a58-4492-808e-3c7e4c23ac7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_fff34bb1-4a58-4492-808e-3c7e4c23ac7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_5489f1ef-856b-45e4-ab0f-78b7514c3a13" xlink:href="dva-20211231.xsd#dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:to="loc_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_5489f1ef-856b-45e4-ab0f-78b7514c3a13" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_e03e8454-6afa-4f4e-9e39-61955f4967c8" xlink:href="dva-20211231.xsd#dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:to="loc_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_e03e8454-6afa-4f4e-9e39-61955f4967c8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_516a3fe4-0930-455f-aa5f-19d6f8a14fd4" xlink:href="dva-20211231.xsd#dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:to="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_516a3fe4-0930-455f-aa5f-19d6f8a14fd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_27543005-ca25-4034-905c-6b67262ec78c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_516a3fe4-0930-455f-aa5f-19d6f8a14fd4" xlink:to="loc_srt_StatementGeographicalAxis_27543005-ca25-4034-905c-6b67262ec78c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_27543005-ca25-4034-905c-6b67262ec78c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_27543005-ca25-4034-905c-6b67262ec78c" xlink:to="loc_srt_SegmentGeographicalDomain_27543005-ca25-4034-905c-6b67262ec78c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_318ef321-72bc-41fd-942f-6997bce1eef8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_27543005-ca25-4034-905c-6b67262ec78c" xlink:to="loc_srt_SegmentGeographicalDomain_318ef321-72bc-41fd-942f-6997bce1eef8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_33255ac1-dc53-4247-95be-075df1cb47d2" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_318ef321-72bc-41fd-942f-6997bce1eef8" xlink:to="loc_country_US_33255ac1-dc53-4247-95be-075df1cb47d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_InternationalOperationsMember_2008a01d-7e29-40db-aa44-6090a32343ce" xlink:href="dva-20211231.xsd#dva_InternationalOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_318ef321-72bc-41fd-942f-6997bce1eef8" xlink:to="loc_dva_InternationalOperationsMember_2008a01d-7e29-40db-aa44-6090a32343ce" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="extended" id="ic14253430eb748bfb4c89ffd61e16ba2_RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_48407d91-bf78-4005-b238-b10773e57632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_c323cce8-d1be-4f0e-9463-5c44e05d0981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_48407d91-bf78-4005-b238-b10773e57632" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_c323cce8-d1be-4f0e-9463-5c44e05d0981" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_43359c7b-eb85-41b5-beea-6ffef1afd997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_48407d91-bf78-4005-b238-b10773e57632" xlink:to="loc_us-gaap_OtherIncome_43359c7b-eb85-41b5-beea-6ffef1afd997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dbc5882b-b55e-4060-99a3-bdff63ca74dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_48407d91-bf78-4005-b238-b10773e57632" xlink:to="loc_us-gaap_Revenues_dbc5882b-b55e-4060-99a3-bdff63ca74dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1ef5dd48-a420-4fe4-b316-773d34be38eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_48407d91-bf78-4005-b238-b10773e57632" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1ef5dd48-a420-4fe4-b316-773d34be38eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ea5c29c0-30dd-44c2-9fe0-0b53567bf6af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1ef5dd48-a420-4fe4-b316-773d34be38eb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ea5c29c0-30dd-44c2-9fe0-0b53567bf6af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ea5c29c0-30dd-44c2-9fe0-0b53567bf6af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ea5c29c0-30dd-44c2-9fe0-0b53567bf6af" xlink:to="loc_us-gaap_SegmentDomain_ea5c29c0-30dd-44c2-9fe0-0b53567bf6af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7d89f924-79f9-427e-8da4-86df61a758f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ea5c29c0-30dd-44c2-9fe0-0b53567bf6af" xlink:to="loc_us-gaap_SegmentDomain_7d89f924-79f9-427e-8da4-86df61a758f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_6655f6c5-efed-4c00-bfa6-4c3065c2f03f" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7d89f924-79f9-427e-8da4-86df61a758f6" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_6655f6c5-efed-4c00-bfa6-4c3065c2f03f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_d9ce1bd8-a503-43b2-9072-0ec420b7ee80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7d89f924-79f9-427e-8da4-86df61a758f6" xlink:to="loc_us-gaap_AllOtherSegmentsMember_d9ce1bd8-a503-43b2-9072-0ec420b7ee80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_23ef8d6f-6f2f-4ec5-a4b9-c62c573c4980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1ef5dd48-a420-4fe4-b316-773d34be38eb" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_23ef8d6f-6f2f-4ec5-a4b9-c62c573c4980" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_23ef8d6f-6f2f-4ec5-a4b9-c62c573c4980_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_23ef8d6f-6f2f-4ec5-a4b9-c62c573c4980" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_23ef8d6f-6f2f-4ec5-a4b9-c62c573c4980_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_23ef8d6f-6f2f-4ec5-a4b9-c62c573c4980" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember_ff88a976-923e-4caf-b8c7-f29266768606" xlink:href="dva-20211231.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:to="loc_dva_MedicareandMedicareAdvantageMember_ff88a976-923e-4caf-b8c7-f29266768606" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember_36954fa2-cad1-477c-9054-38987a47a625" xlink:href="dva-20211231.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:to="loc_dva_MedicaidandManagedMedicaidMember_36954fa2-cad1-477c-9054-38987a47a625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember_1ce35ea3-89d2-41b6-9a9e-aa5cbf3f256d" xlink:href="dva-20211231.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:to="loc_dva_OtherGovernmentPayorsMember_1ce35ea3-89d2-41b6-9a9e-aa5cbf3f256d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember_28351bc1-c100-4bb5-a043-5be06bf9f223" xlink:href="dva-20211231.xsd#dva_CommercialPayorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:to="loc_dva_CommercialPayorsMember_28351bc1-c100-4bb5-a043-5be06bf9f223" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember_5d59fb73-239e-4749-958e-bb51ed62ffb5" xlink:href="dva-20211231.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:to="loc_dva_OtherSourcesofRevenueMember_5d59fb73-239e-4749-958e-bb51ed62ffb5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f9b3c190-c2c3-41ce-a823-61838b441eb0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1ef5dd48-a420-4fe4-b316-773d34be38eb" xlink:to="loc_srt_ConsolidationItemsAxis_f9b3c190-c2c3-41ce-a823-61838b441eb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f9b3c190-c2c3-41ce-a823-61838b441eb0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_f9b3c190-c2c3-41ce-a823-61838b441eb0" xlink:to="loc_srt_ConsolidationItemsDomain_f9b3c190-c2c3-41ce-a823-61838b441eb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_dd6a2ba3-14ec-4ae3-8b82-436467ae58e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_f9b3c190-c2c3-41ce-a823-61838b441eb0" xlink:to="loc_srt_ConsolidationItemsDomain_dd6a2ba3-14ec-4ae3-8b82-436467ae58e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_832f3239-d0af-4a76-891b-d2e55812e4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_dd6a2ba3-14ec-4ae3-8b82-436467ae58e5" xlink:to="loc_us-gaap_IntersegmentEliminationMember_832f3239-d0af-4a76-891b-d2e55812e4a1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails" xlink:type="extended" id="if1dc198315a2407bab6b24c167fd8a22_RevenueRecognitionandAccountsReceivableAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfConcentrationRiskCustomers_e905d6b3-f9fa-45c5-a1fb-69c3f72beb1b" xlink:href="dva-20211231.xsd#dva_NumberOfConcentrationRiskCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:to="loc_dva_NumberOfConcentrationRiskCustomers_e905d6b3-f9fa-45c5-a1fb-69c3f72beb1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_8f518dec-07a8-400f-83f4-0378cee6c697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_8f518dec-07a8-400f-83f4-0378cee6c697" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0a921050-72fb-48c2-8111-f4d9cbd3d416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0a921050-72fb-48c2-8111-f4d9cbd3d416" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_66a931c1-f051-4c98-9551-e6567f26d7fa" xlink:href="dva-20211231.xsd#dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:to="loc_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_66a931c1-f051-4c98-9551-e6567f26d7fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AccountsReceivablePeriodOutstanding_0973a6e5-b241-4e37-a80a-64c09e09d519" xlink:href="dva-20211231.xsd#dva_AccountsReceivablePeriodOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:to="loc_dva_AccountsReceivablePeriodOutstanding_0973a6e5-b241-4e37-a80a-64c09e09d519" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_d285cd0d-8256-4ec0-a210-011ffa93f893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:to="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_d285cd0d-8256-4ec0-a210-011ffa93f893" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_7a74afc0-d6e8-4768-8577-c6ba4ec4d001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_7a74afc0-d6e8-4768-8577-c6ba4ec4d001" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_860ac5dc-19bd-42e3-92eb-8d9260bd31d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_7a74afc0-d6e8-4768-8577-c6ba4ec4d001" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_860ac5dc-19bd-42e3-92eb-8d9260bd31d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_860ac5dc-19bd-42e3-92eb-8d9260bd31d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_860ac5dc-19bd-42e3-92eb-8d9260bd31d6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_860ac5dc-19bd-42e3-92eb-8d9260bd31d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5a62c4a0-ad72-415d-bd1c-762c75893658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_860ac5dc-19bd-42e3-92eb-8d9260bd31d6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5a62c4a0-ad72-415d-bd1c-762c75893658" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_3b2caff2-4499-445a-a5f1-f3baeb4e942a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5a62c4a0-ad72-415d-bd1c-762c75893658" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_3b2caff2-4499-445a-a5f1-f3baeb4e942a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5cc3cb4f-fa9f-42eb-82fe-abc4df304124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_7a74afc0-d6e8-4768-8577-c6ba4ec4d001" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5cc3cb4f-fa9f-42eb-82fe-abc4df304124" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5cc3cb4f-fa9f-42eb-82fe-abc4df304124_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5cc3cb4f-fa9f-42eb-82fe-abc4df304124" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5cc3cb4f-fa9f-42eb-82fe-abc4df304124_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_18605d28-7922-4c02-9396-8e280a7ad8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5cc3cb4f-fa9f-42eb-82fe-abc4df304124" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_18605d28-7922-4c02-9396-8e280a7ad8cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_860cda6e-f392-4110-9275-2270b5d828f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_18605d28-7922-4c02-9396-8e280a7ad8cf" xlink:to="loc_us-gaap_AccountsReceivableMember_860cda6e-f392-4110-9275-2270b5d828f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_68da3023-1312-4f29-a99b-559e86bea819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_7a74afc0-d6e8-4768-8577-c6ba4ec4d001" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_68da3023-1312-4f29-a99b-559e86bea819" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_68da3023-1312-4f29-a99b-559e86bea819_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_68da3023-1312-4f29-a99b-559e86bea819" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_68da3023-1312-4f29-a99b-559e86bea819_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_ecbf7cb8-c8ba-46d7-88d7-6fdade8cc764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_68da3023-1312-4f29-a99b-559e86bea819" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_ecbf7cb8-c8ba-46d7-88d7-6fdade8cc764" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareMember_109ee4b3-13b9-4487-b2cd-e94a9a6ca5c6" xlink:href="dva-20211231.xsd#dva_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_ecbf7cb8-c8ba-46d7-88d7-6fdade8cc764" xlink:to="loc_dva_MedicareMember_109ee4b3-13b9-4487-b2cd-e94a9a6ca5c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThirdPartyPayorMember_1271dfba-996a-479b-8910-d63c387565a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ThirdPartyPayorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_ecbf7cb8-c8ba-46d7-88d7-6fdade8cc764" xlink:to="loc_us-gaap_ThirdPartyPayorMember_1271dfba-996a-479b-8910-d63c387565a6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#RestrictedCashandEquivalentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails" xlink:type="extended" id="icaa5f2aea43c429fa402a2bfd93b0711_RestrictedCashandEquivalentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_d8045873-7e15-463f-90dd-99f3a570b7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_3252f73d-beb1-4cc5-86cb-58619dbbdbb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_d8045873-7e15-463f-90dd-99f3a570b7ee" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_3252f73d-beb1-4cc5-86cb-58619dbbdbb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfPartnerships_7e171448-fed3-4ac0-8d2f-bc85dd35b4db" xlink:href="dva-20211231.xsd#dva_NumberOfPartnerships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_d8045873-7e15-463f-90dd-99f3a570b7ee" xlink:to="loc_dva_NumberOfPartnerships_7e171448-fed3-4ac0-8d2f-bc85dd35b4db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_8457a051-6151-4e11-8a90-eaabb60e1b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_d8045873-7e15-463f-90dd-99f3a570b7ee" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_8457a051-6151-4e11-8a90-eaabb60e1b11" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4b094b56-24d4-4659-91dc-bcdcbb061e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_8457a051-6151-4e11-8a90-eaabb60e1b11" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4b094b56-24d4-4659-91dc-bcdcbb061e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4b094b56-24d4-4659-91dc-bcdcbb061e1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4b094b56-24d4-4659-91dc-bcdcbb061e1e" xlink:to="loc_us-gaap_SegmentDomain_4b094b56-24d4-4659-91dc-bcdcbb061e1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5067553e-f2be-42f4-97b8-339d1a1ae66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4b094b56-24d4-4659-91dc-bcdcbb061e1e" xlink:to="loc_us-gaap_SegmentDomain_5067553e-f2be-42f4-97b8-339d1a1ae66f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_6d555acb-3211-494d-a45e-8431ee99aecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5067553e-f2be-42f4-97b8-339d1a1ae66f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_6d555acb-3211-494d-a45e-8431ee99aecf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#ShorttermandlongterminvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails" xlink:type="extended" id="ia46fb2ba524d464199246b8912a0b7cd_ShorttermandlongterminvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_1a977609-3cf7-4839-8d8c-976189a35c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_HeldToMaturitySecurities_1a977609-3cf7-4839-8d8c-976189a35c5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_429b308a-e4a8-4073-bac0-7c6a3d8895f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_429b308a-e4a8-4073-bac0-7c6a3d8895f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_a9a57e29-2558-48fb-80ee-cf526f13c480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_MarketableSecurities_a9a57e29-2558-48fb-80ee-cf526f13c480" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent_41fd5a22-679c-454d-ae56-e58f00e53488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesCurrent_41fd5a22-679c-454d-ae56-e58f00e53488" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_2e7edf8b-df9f-4714-900f-7c55d634b2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_2e7edf8b-df9f-4714-900f-7c55d634b2b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_4a8b36dc-610d-4ba6-a335-30ea7a2f5806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_4a8b36dc-610d-4ba6-a335-30ea7a2f5806" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_bf6aa922-d516-4cfa-9578-ec3a318dd02a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_bf6aa922-d516-4cfa-9578-ec3a318dd02a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_00e8eae5-0ce7-4fa4-82ef-14a19cceec3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_InvestmentHoldingsTable_00e8eae5-0ce7-4fa4-82ef-14a19cceec3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_30ded8a6-b5a2-4ae8-b0c4-e3e21fd27d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InvestmentHoldingsTable_00e8eae5-0ce7-4fa4-82ef-14a19cceec3a" xlink:to="loc_us-gaap_InvestmentTypeAxis_30ded8a6-b5a2-4ae8-b0c4-e3e21fd27d8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_30ded8a6-b5a2-4ae8-b0c4-e3e21fd27d8f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_30ded8a6-b5a2-4ae8-b0c4-e3e21fd27d8f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_30ded8a6-b5a2-4ae8-b0c4-e3e21fd27d8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_93a506c4-8e97-44f0-b968-ef7ad542c47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_30ded8a6-b5a2-4ae8-b0c4-e3e21fd27d8f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_93a506c4-8e97-44f0-b968-ef7ad542c47c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_c4c057e0-0a36-45f4-8817-e3e4198183a8" xlink:href="dva-20211231.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93a506c4-8e97-44f0-b968-ef7ad542c47c" xlink:to="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_c4c057e0-0a36-45f4-8817-e3e4198183a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_1be7974e-c1fc-479d-a958-3b426e2d5f8d" xlink:href="dva-20211231.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93a506c4-8e97-44f0-b968-ef7ad542c47c" xlink:to="loc_dva_MutualFundsAndCommonStockMember_1be7974e-c1fc-479d-a958-3b426e2d5f8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_85c9d311-9f2a-441a-8ef5-686ab0e9d839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93a506c4-8e97-44f0-b968-ef7ad542c47c" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_85c9d311-9f2a-441a-8ef5-686ab0e9d839" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_e702bec5-399c-4ad6-a296-6d648fc83eae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93a506c4-8e97-44f0-b968-ef7ad542c47c" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_e702bec5-399c-4ad6-a296-6d648fc83eae" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#ShorttermandlongterminvestmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails" xlink:type="extended" id="i575fdddf3e9e4fc09e868d2e1a9b4262_ShorttermandlongterminvestmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_14c66b5b-01ce-44e6-948c-8f9239e134fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a0bc3b10-9c11-4f35-af07-21e699d16f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_14c66b5b-01ce-44e6-948c-8f9239e134fa" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a0bc3b10-9c11-4f35-af07-21e699d16f37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_9c0a9ae2-9c0b-41eb-854c-7c66de0b1b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_14c66b5b-01ce-44e6-948c-8f9239e134fa" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_9c0a9ae2-9c0b-41eb-854c-7c66de0b1b83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities_71c1ca7c-ea8c-47ba-8c7a-42fe161b8635" xlink:href="dva-20211231.xsd#dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_14c66b5b-01ce-44e6-948c-8f9239e134fa" xlink:to="loc_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities_71c1ca7c-ea8c-47ba-8c7a-42fe161b8635" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_beb27440-b596-4010-a206-795159a8feb6" xlink:href="dva-20211231.xsd#dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_14c66b5b-01ce-44e6-948c-8f9239e134fa" xlink:to="loc_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_beb27440-b596-4010-a206-795159a8feb6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_de4ff842-4af7-4f22-9aa6-7e0ae3d6e70a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_14c66b5b-01ce-44e6-948c-8f9239e134fa" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_de4ff842-4af7-4f22-9aa6-7e0ae3d6e70a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_888aad40-6844-42b4-8f68-36d0424ae591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_de4ff842-4af7-4f22-9aa6-7e0ae3d6e70a" xlink:to="loc_us-gaap_InvestmentTypeAxis_888aad40-6844-42b4-8f68-36d0424ae591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_888aad40-6844-42b4-8f68-36d0424ae591_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_888aad40-6844-42b4-8f68-36d0424ae591" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_888aad40-6844-42b4-8f68-36d0424ae591_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_db8d5dcb-f9c8-464a-adca-651fb19969c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_888aad40-6844-42b4-8f68-36d0424ae591" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_db8d5dcb-f9c8-464a-adca-651fb19969c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_69bf1867-4ae3-4653-8dfe-55d74a3f8988" xlink:href="dva-20211231.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_db8d5dcb-f9c8-464a-adca-651fb19969c2" xlink:to="loc_dva_MutualFundsAndCommonStockMember_69bf1867-4ae3-4653-8dfe-55d74a3f8988" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherReceivablesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#OtherReceivablesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/OtherReceivablesDetails" xlink:type="extended" id="i9613d763c67b4444be3fe841d70205f1_OtherReceivablesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d567513f-1bdd-4223-92e6-c5e1133f3e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_b2074849-71be-4866-b051-713c5ecaa080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d567513f-1bdd-4223-92e6-c5e1133f3e4e" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_b2074849-71be-4866-b051-713c5ecaa080" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_9cbc8d4d-1f08-469f-bb89-c65419cc003f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d567513f-1bdd-4223-92e6-c5e1133f3e4e" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_9cbc8d4d-1f08-469f-bb89-c65419cc003f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_34bc5615-01f0-44b5-8dec-c308c10249ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_9cbc8d4d-1f08-469f-bb89-c65419cc003f" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_34bc5615-01f0-44b5-8dec-c308c10249ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_34bc5615-01f0-44b5-8dec-c308c10249ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_34bc5615-01f0-44b5-8dec-c308c10249ab" xlink:to="loc_us-gaap_ReceivableTypeDomain_34bc5615-01f0-44b5-8dec-c308c10249ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_4a2088e1-cbb1-451c-990d-4551b60c76d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_34bc5615-01f0-44b5-8dec-c308c10249ab" xlink:to="loc_us-gaap_ReceivableTypeDomain_4a2088e1-cbb1-451c-990d-4551b60c76d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_001d484f-a7ee-4404-9ced-fe45574962d5" xlink:href="dva-20211231.xsd#dva_SupplierRebatesAndOtherNonTradeReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_4a2088e1-cbb1-451c-990d-4551b60c76d3" xlink:to="loc_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_001d484f-a7ee-4404-9ced-fe45574962d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareMember_1c13f8ce-95cd-42df-8c62-586ce8dcffa0" xlink:href="dva-20211231.xsd#dva_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_4a2088e1-cbb1-451c-990d-4551b60c76d3" xlink:to="loc_dva_MedicareMember_1c13f8ce-95cd-42df-8c62-586ce8dcffa0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#PropertyandEquipmentAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails" xlink:type="extended" id="id38485efc33442cdbacf6276e165bb67_PropertyandEquipmentAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_46289b90-a619-4167-bb03-9b02db80977f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f0d558cf-e646-481d-99db-79d0cce1e462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_46289b90-a619-4167-bb03-9b02db80977f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f0d558cf-e646-481d-99db-79d0cce1e462" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f58ec251-f145-428c-999a-019a43e1bf31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_46289b90-a619-4167-bb03-9b02db80977f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f58ec251-f145-428c-999a-019a43e1bf31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_71021695-b1bd-40c3-8a65-8a9e751385e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_46289b90-a619-4167-bb03-9b02db80977f" xlink:to="loc_us-gaap_InterestCostsCapitalized_71021695-b1bd-40c3-8a65-8a9e751385e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9b384d59-6064-48f1-afe0-7d41d867cd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_46289b90-a619-4167-bb03-9b02db80977f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9b384d59-6064-48f1-afe0-7d41d867cd1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f36a71f-b6ea-48c2-afdd-3429129a0399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9b384d59-6064-48f1-afe0-7d41d867cd1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f36a71f-b6ea-48c2-afdd-3429129a0399" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f36a71f-b6ea-48c2-afdd-3429129a0399_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f36a71f-b6ea-48c2-afdd-3429129a0399" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f36a71f-b6ea-48c2-afdd-3429129a0399_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b0a0638c-feb8-4801-b2f5-a3f6c6955782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f36a71f-b6ea-48c2-afdd-3429129a0399" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b0a0638c-feb8-4801-b2f5-a3f6c6955782" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_26b647d5-62b9-4733-96f4-157e12935cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b0a0638c-feb8-4801-b2f5-a3f6c6955782" xlink:to="loc_us-gaap_BuildingMember_26b647d5-62b9-4733-96f4-157e12935cbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_55e06146-f56e-4c38-8cf2-4e6b9f0ff12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b0a0638c-feb8-4801-b2f5-a3f6c6955782" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_55e06146-f56e-4c38-8cf2-4e6b9f0ff12f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_b52647e5-1f82-410f-a8c8-e24113eaef3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b0a0638c-feb8-4801-b2f5-a3f6c6955782" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_b52647e5-1f82-410f-a8c8-e24113eaef3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9613fae5-b4fb-40a9-869b-62d0bd104193" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9b384d59-6064-48f1-afe0-7d41d867cd1b" xlink:to="loc_srt_RangeAxis_9613fae5-b4fb-40a9-869b-62d0bd104193" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9613fae5-b4fb-40a9-869b-62d0bd104193_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9613fae5-b4fb-40a9-869b-62d0bd104193" xlink:to="loc_srt_RangeMember_9613fae5-b4fb-40a9-869b-62d0bd104193_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bf4506ad-2f25-4650-9734-3261d2796f67" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9613fae5-b4fb-40a9-869b-62d0bd104193" xlink:to="loc_srt_RangeMember_bf4506ad-2f25-4650-9734-3261d2796f67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7ad0e20e-bf79-4154-b034-a9b7d490dc12" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bf4506ad-2f25-4650-9734-3261d2796f67" xlink:to="loc_srt_MinimumMember_7ad0e20e-bf79-4154-b034-a9b7d490dc12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5c573b6a-3543-4480-8d36-189cacbd79d2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bf4506ad-2f25-4650-9734-3261d2796f67" xlink:to="loc_srt_MaximumMember_5c573b6a-3543-4480-8d36-189cacbd79d2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" xlink:type="extended" id="id9605aaff0624a0b96c6a5723de9f3de_IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:href="dva-20211231.xsd#dva_ExpectedAmortizationExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_191186ab-e495-464e-bb9f-dfecf2ebce65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_191186ab-e495-464e-bb9f-dfecf2ebce65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0b79da38-ee62-4033-be58-227368ee20ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0b79da38-ee62-4033-be58-227368ee20ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_28eaf053-ee4a-4b75-ad96-845bdb50c07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_28eaf053-ee4a-4b75-ad96-845bdb50c07f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e9319c35-2857-40cc-bbd9-19df6cde9f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e9319c35-2857-40cc-bbd9-19df6cde9f29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3770107b-0c09-43cd-8695-2809bc88ecfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3770107b-0c09-43cd-8695-2809bc88ecfd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5b4f25cb-6a57-4b7a-ab0c-b6bf306c2a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5b4f25cb-6a57-4b7a-ab0c-b6bf306c2a76" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eb68b9e2-4e4c-482e-906a-a6b8a81512ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eb68b9e2-4e4c-482e-906a-a6b8a81512ea" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExpectedAmortizationExpenseTable_2029d46f-68f3-4792-ba2a-873cb9afd8ea" xlink:href="dva-20211231.xsd#dva_ExpectedAmortizationExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_dva_ExpectedAmortizationExpenseTable_2029d46f-68f3-4792-ba2a-873cb9afd8ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_162c6490-9130-4dea-82ee-b642591d1abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_ExpectedAmortizationExpenseTable_2029d46f-68f3-4792-ba2a-873cb9afd8ea" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_162c6490-9130-4dea-82ee-b642591d1abd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_162c6490-9130-4dea-82ee-b642591d1abd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_162c6490-9130-4dea-82ee-b642591d1abd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_162c6490-9130-4dea-82ee-b642591d1abd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cff08d36-acaf-46d1-8bee-983b7afc5afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_162c6490-9130-4dea-82ee-b642591d1abd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cff08d36-acaf-46d1-8bee-983b7afc5afa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_78bb986c-bf4f-4505-8546-79eec7a3c814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cff08d36-acaf-46d1-8bee-983b7afc5afa" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_78bb986c-bf4f-4505-8546-79eec7a3c814" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_0134707a-ca40-4f35-835a-8c7c471d57c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cff08d36-acaf-46d1-8bee-983b7afc5afa" xlink:to="loc_us-gaap_ServiceAgreementsMember_0134707a-ca40-4f35-835a-8c7c471d57c3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IntangiblesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IntangiblesAdditionalInformationDetails" xlink:type="extended" id="ibade94bca5344c1f8a3be09881292576_IntangiblesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d3b67a14-cbfd-4a7c-ba21-65832664e12e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_0e064cda-62b1-4413-b6bf-f4bd24c8a995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d3b67a14-cbfd-4a7c-ba21-65832664e12e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_0e064cda-62b1-4413-b6bf-f4bd24c8a995" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_6ba6d6a6-5f11-4fc6-9d7c-245f8afec050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d3b67a14-cbfd-4a7c-ba21-65832664e12e" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_6ba6d6a6-5f11-4fc6-9d7c-245f8afec050" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9ff5cb52-d423-44f8-acfc-85eb5bcfb935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d3b67a14-cbfd-4a7c-ba21-65832664e12e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9ff5cb52-d423-44f8-acfc-85eb5bcfb935" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_d061016d-1d4f-45e2-aaf1-fcbc063231fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d3b67a14-cbfd-4a7c-ba21-65832664e12e" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_d061016d-1d4f-45e2-aaf1-fcbc063231fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6bf3f05-ce3b-49d7-827a-563e3e2f9ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d3b67a14-cbfd-4a7c-ba21-65832664e12e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6bf3f05-ce3b-49d7-827a-563e3e2f9ee3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_79d6b280-19ad-445b-978b-f281b956dcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6bf3f05-ce3b-49d7-827a-563e3e2f9ee3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_79d6b280-19ad-445b-978b-f281b956dcc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d6b280-19ad-445b-978b-f281b956dcc1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_79d6b280-19ad-445b-978b-f281b956dcc1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d6b280-19ad-445b-978b-f281b956dcc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9833ea78-90e4-43e8-90a7-909021a117d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_79d6b280-19ad-445b-978b-f281b956dcc1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9833ea78-90e4-43e8-90a7-909021a117d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_12a3e97f-7ee8-4285-8b6f-7327f366b1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9833ea78-90e4-43e8-90a7-909021a117d7" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_12a3e97f-7ee8-4285-8b6f-7327f366b1ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1b0ae378-104e-46e6-92b6-9cf3098632e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9833ea78-90e4-43e8-90a7-909021a117d7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1b0ae378-104e-46e6-92b6-9cf3098632e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5b6015dc-2db0-471b-8c6b-73b15fbf567f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6bf3f05-ce3b-49d7-827a-563e3e2f9ee3" xlink:to="loc_srt_RangeAxis_5b6015dc-2db0-471b-8c6b-73b15fbf567f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5b6015dc-2db0-471b-8c6b-73b15fbf567f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5b6015dc-2db0-471b-8c6b-73b15fbf567f" xlink:to="loc_srt_RangeMember_5b6015dc-2db0-471b-8c6b-73b15fbf567f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9c6d1afb-1a4e-4ec8-90d5-802e9f884a89" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5b6015dc-2db0-471b-8c6b-73b15fbf567f" xlink:to="loc_srt_RangeMember_9c6d1afb-1a4e-4ec8-90d5-802e9f884a89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a98d05b3-55cc-4236-9f6c-fcd31b662b4c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9c6d1afb-1a4e-4ec8-90d5-802e9f884a89" xlink:to="loc_srt_MinimumMember_a98d05b3-55cc-4236-9f6c-fcd31b662b4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_85a9e962-c59f-42ad-a6e1-4f9986a37e54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9c6d1afb-1a4e-4ec8-90d5-802e9f884a89" xlink:to="loc_srt_MaximumMember_85a9e962-c59f-42ad-a6e1-4f9986a37e54" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails" xlink:type="extended" id="i2a10d45a5e144817822dea66ef976669_EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3a6c1f01-dff5-4543-aab1-39657bec4909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0f372f4f-f511-43fd-a88e-279bfd62caba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3a6c1f01-dff5-4543-aab1-39657bec4909" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0f372f4f-f511-43fd-a88e-279bfd62caba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ddaf7b56-7264-4f83-87e1-4131ceecfcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3a6c1f01-dff5-4543-aab1-39657bec4909" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ddaf7b56-7264-4f83-87e1-4131ceecfcd6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1ed50249-42a1-45a3-b979-051b75e36021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ddaf7b56-7264-4f83-87e1-4131ceecfcd6" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1ed50249-42a1-45a3-b979-051b75e36021" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1ed50249-42a1-45a3-b979-051b75e36021_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1ed50249-42a1-45a3-b979-051b75e36021" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1ed50249-42a1-45a3-b979-051b75e36021_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_a53b4645-7fbb-4f1d-8cf2-bd7caad1c10f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1ed50249-42a1-45a3-b979-051b75e36021" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_a53b4645-7fbb-4f1d-8cf2-bd7caad1c10f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOwnershipInterestMember_a7c8a1d7-8177-40b0-8525-bfb5938870dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOwnershipInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_a53b4645-7fbb-4f1d-8cf2-bd7caad1c10f" xlink:to="loc_us-gaap_OtherOwnershipInterestMember_a7c8a1d7-8177-40b0-8525-bfb5938870dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ff85928d-4234-4aa4-b5ee-75303c5883e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ddaf7b56-7264-4f83-87e1-4131ceecfcd6" xlink:to="loc_us-gaap_InvestmentTypeAxis_ff85928d-4234-4aa4-b5ee-75303c5883e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ff85928d-4234-4aa4-b5ee-75303c5883e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_ff85928d-4234-4aa4-b5ee-75303c5883e1" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ff85928d-4234-4aa4-b5ee-75303c5883e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8c0563cd-90f4-4025-89f7-69afa9f9d4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_ff85928d-4234-4aa4-b5ee-75303c5883e1" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8c0563cd-90f4-4025-89f7-69afa9f9d4a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_6d329473-fa51-4ccc-a18a-8361f3afeef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8c0563cd-90f4-4025-89f7-69afa9f9d4a9" xlink:to="loc_us-gaap_EquitySecuritiesMember_6d329473-fa51-4ccc-a18a-8361f3afeef1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_8d96f101-c0a5-4b4b-a0d5-4f7dfac9edae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ddaf7b56-7264-4f83-87e1-4131ceecfcd6" xlink:to="loc_srt_OwnershipAxis_8d96f101-c0a5-4b4b-a0d5-4f7dfac9edae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_8d96f101-c0a5-4b4b-a0d5-4f7dfac9edae_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_8d96f101-c0a5-4b4b-a0d5-4f7dfac9edae" xlink:to="loc_srt_OwnershipDomain_8d96f101-c0a5-4b4b-a0d5-4f7dfac9edae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_a9d93811-dac5-4754-83ca-93a295fc14e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_8d96f101-c0a5-4b4b-a0d5-4f7dfac9edae" xlink:to="loc_srt_OwnershipDomain_a9d93811-dac5-4754-83ca-93a295fc14e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeconsolidatedNoncontrollingEntityMember_4947b45d-3d50-4b1e-968e-23635ed22713" xlink:href="dva-20211231.xsd#dva_DeconsolidatedNoncontrollingEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_a9d93811-dac5-4754-83ca-93a295fc14e9" xlink:to="loc_dva_DeconsolidatedNoncontrollingEntityMember_4947b45d-3d50-4b1e-968e-23635ed22713" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#EquityMethodandOtherInvestmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails" xlink:type="extended" id="i108d3b854cea4ff0a2f463d79891a311_EquityMethodandOtherInvestmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1d06327b-0f2f-4338-8e3f-3f5b45dd7640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1d06327b-0f2f-4338-8e3f-3f5b45dd7640" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_46c1e978-92a4-4548-bb55-f5c469d7ce79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_46c1e978-92a4-4548-bb55-f5c469d7ce79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8d8b87ed-4367-4044-aca5-709ebdc661fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8d8b87ed-4367-4044-aca5-709ebdc661fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfPartnerships_1966dfff-fc4d-4457-99ba-84a20345748f" xlink:href="dva-20211231.xsd#dva_NumberOfPartnerships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:to="loc_dva_NumberOfPartnerships_1966dfff-fc4d-4457-99ba-84a20345748f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_8dee773d-104e-461a-ba2b-6d2c8d189074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_8dee773d-104e-461a-ba2b-6d2c8d189074" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_cbb2cb74-d977-47ce-8d89-40a59d0f7397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_cbb2cb74-d977-47ce-8d89-40a59d0f7397" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_62fcc4e8-d7d4-46d5-8a1c-9b45ced07de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_cbb2cb74-d977-47ce-8d89-40a59d0f7397" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_62fcc4e8-d7d4-46d5-8a1c-9b45ced07de0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_62fcc4e8-d7d4-46d5-8a1c-9b45ced07de0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_62fcc4e8-d7d4-46d5-8a1c-9b45ced07de0" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_62fcc4e8-d7d4-46d5-8a1c-9b45ced07de0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_2feda846-fe6d-43a5-8038-5199c34c91b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_62fcc4e8-d7d4-46d5-8a1c-9b45ced07de0" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_2feda846-fe6d-43a5-8038-5199c34c91b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_854e5986-e077-4486-ba46-6c901670187c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_2feda846-fe6d-43a5-8038-5199c34c91b7" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_854e5986-e077-4486-ba46-6c901670187c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0b6cc3f5-b42f-44a1-8ca2-ca88244be20f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_cbb2cb74-d977-47ce-8d89-40a59d0f7397" xlink:to="loc_srt_RangeAxis_0b6cc3f5-b42f-44a1-8ca2-ca88244be20f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0b6cc3f5-b42f-44a1-8ca2-ca88244be20f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0b6cc3f5-b42f-44a1-8ca2-ca88244be20f" xlink:to="loc_srt_RangeMember_0b6cc3f5-b42f-44a1-8ca2-ca88244be20f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_087dcf65-2ac3-4c18-ad6e-ce7574fdccf8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0b6cc3f5-b42f-44a1-8ca2-ca88244be20f" xlink:to="loc_srt_RangeMember_087dcf65-2ac3-4c18-ad6e-ce7574fdccf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_df45bf5d-c50e-4e93-b018-e56caf36290d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_087dcf65-2ac3-4c18-ad6e-ce7574fdccf8" xlink:to="loc_srt_MinimumMember_df45bf5d-c50e-4e93-b018-e56caf36290d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bc7fb2ca-76e6-4b8e-b65f-23f8b6495c1c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_087dcf65-2ac3-4c18-ad6e-ce7574fdccf8" xlink:to="loc_srt_MaximumMember_bc7fb2ca-76e6-4b8e-b65f-23f8b6495c1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_5313b733-2b53-4594-b2a2-b1785cf01624" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_cbb2cb74-d977-47ce-8d89-40a59d0f7397" xlink:to="loc_srt_OwnershipAxis_5313b733-2b53-4594-b2a2-b1785cf01624" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5313b733-2b53-4594-b2a2-b1785cf01624_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_5313b733-2b53-4594-b2a2-b1785cf01624" xlink:to="loc_srt_OwnershipDomain_5313b733-2b53-4594-b2a2-b1785cf01624_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_bd837cc9-7e00-4439-92c2-c41ffd676a15" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_5313b733-2b53-4594-b2a2-b1785cf01624" xlink:to="loc_srt_OwnershipDomain_bd837cc9-7e00-4439-92c2-c41ffd676a15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ParentCompanyAndRestrictedSubsidiariesMember_d83601b1-3ca3-4656-9b83-8e1376a2a655" xlink:href="dva-20211231.xsd#dva_ParentCompanyAndRestrictedSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_bd837cc9-7e00-4439-92c2-c41ffd676a15" xlink:to="loc_dva_ParentCompanyAndRestrictedSubsidiariesMember_d83601b1-3ca3-4656-9b83-8e1376a2a655" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeconsolidatedNoncontrollingEntityMember_b834a350-64d3-4b77-a33e-cb1137358728" xlink:href="dva-20211231.xsd#dva_DeconsolidatedNoncontrollingEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_bd837cc9-7e00-4439-92c2-c41ffd676a15" xlink:to="loc_dva_DeconsolidatedNoncontrollingEntityMember_b834a350-64d3-4b77-a33e-cb1137358728" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails" xlink:type="extended" id="i6556763720174b439b89c94fbacd2eda_GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_77de9372-b212-40f4-a29d-0e408b8a8c89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_69df8142-ac54-420b-8fc4-ae2adbfffaac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_77de9372-b212-40f4-a29d-0e408b8a8c89" xlink:to="loc_us-gaap_GoodwillRollForward_69df8142-ac54-420b-8fc4-ae2adbfffaac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_91138be6-e685-4053-a8ad-172e057b5ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_69df8142-ac54-420b-8fc4-ae2adbfffaac" xlink:to="loc_us-gaap_Goodwill_91138be6-e685-4053-a8ad-172e057b5ad6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_352b4cc2-5879-4f00-8239-58c9921c9e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_69df8142-ac54-420b-8fc4-ae2adbfffaac" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_352b4cc2-5879-4f00-8239-58c9921c9e32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_00283302-9fcc-4ebe-9cf3-9901b9518b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_69df8142-ac54-420b-8fc4-ae2adbfffaac" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_00283302-9fcc-4ebe-9cf3-9901b9518b23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d37bf0e5-996f-4ce8-a4fb-8de842e62b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_69df8142-ac54-420b-8fc4-ae2adbfffaac" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d37bf0e5-996f-4ce8-a4fb-8de842e62b21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_17bccde1-4f01-43fd-b66f-d9dcf00b5cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_cc0cec36-9e9e-4301-8fcc-96c6d5528b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_77de9372-b212-40f4-a29d-0e408b8a8c89" xlink:to="loc_us-gaap_GoodwillGross_cc0cec36-9e9e-4301-8fcc-96c6d5528b91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c80593c4-3af7-41e7-8866-51aa2075fcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_77de9372-b212-40f4-a29d-0e408b8a8c89" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c80593c4-3af7-41e7-8866-51aa2075fcfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_b1e4a7ef-b5fd-4e3c-929a-99be472ec789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_77de9372-b212-40f4-a29d-0e408b8a8c89" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_b1e4a7ef-b5fd-4e3c-929a-99be472ec789" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ad7dbe8c-64a9-40ef-868b-0d6051631690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_b1e4a7ef-b5fd-4e3c-929a-99be472ec789" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ad7dbe8c-64a9-40ef-868b-0d6051631690" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ad7dbe8c-64a9-40ef-868b-0d6051631690_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ad7dbe8c-64a9-40ef-868b-0d6051631690" xlink:to="loc_us-gaap_SegmentDomain_ad7dbe8c-64a9-40ef-868b-0d6051631690_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_799cc35c-ff22-4491-9403-01b72706aea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ad7dbe8c-64a9-40ef-868b-0d6051631690" xlink:to="loc_us-gaap_SegmentDomain_799cc35c-ff22-4491-9403-01b72706aea9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_89cb5fca-84f6-4491-a069-42afcf27957e" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_799cc35c-ff22-4491-9403-01b72706aea9" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_89cb5fca-84f6-4491-a069-42afcf27957e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_82600e5d-8d99-40ec-ab8f-c5cdd08638d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_799cc35c-ff22-4491-9403-01b72706aea9" xlink:to="loc_us-gaap_AllOtherSegmentsMember_82600e5d-8d99-40ec-ab8f-c5cdd08638d7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails" xlink:type="extended" id="i00f8ce252e3b4b7e964d7d64e8431d49_GoodwillScheduleofReportingUnitsGoodwillBalancesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_33b1b4f7-6fb7-4d08-a424-1e93ba1b80cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:to="loc_us-gaap_Goodwill_33b1b4f7-6fb7-4d08-a424-1e93ba1b80cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_c26d7c7d-47cc-43bf-9666-74c92bfb0ace" xlink:href="dva-20211231.xsd#dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:to="loc_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_c26d7c7d-47cc-43bf-9666-74c92bfb0ace" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_902b822c-e6bc-4834-b2de-ff0169bca632" xlink:href="dva-20211231.xsd#dva_PotentialImpactOnFairValueForReductionInOperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:to="loc_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_902b822c-e6bc-4834-b2de-ff0169bca632" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_0208fce2-fc38-4b63-bb08-c53b080fc5f7" xlink:href="dva-20211231.xsd#dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:to="loc_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_0208fce2-fc38-4b63-bb08-c53b080fc5f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_b46d59b4-42c8-42ae-a760-b07854ff06de" xlink:href="dva-20211231.xsd#dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:to="loc_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_b46d59b4-42c8-42ae-a760-b07854ff06de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_9c4e9cb9-62a7-42bb-9d6c-acbd90d63ee4" xlink:href="dva-20211231.xsd#dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:to="loc_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_9c4e9cb9-62a7-42bb-9d6c-acbd90d63ee4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_1510b27f-7e0c-473a-acf6-8aa18030b0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_1510b27f-7e0c-473a-acf6-8aa18030b0cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e568b855-957d-4a97-8744-430f86f521de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1510b27f-7e0c-473a-acf6-8aa18030b0cb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e568b855-957d-4a97-8744-430f86f521de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e568b855-957d-4a97-8744-430f86f521de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e568b855-957d-4a97-8744-430f86f521de" xlink:to="loc_us-gaap_SegmentDomain_e568b855-957d-4a97-8744-430f86f521de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_26f851ad-5e5d-4d71-849e-4a902509a042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e568b855-957d-4a97-8744-430f86f521de" xlink:to="loc_us-gaap_SegmentDomain_26f851ad-5e5d-4d71-849e-4a902509a042" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_KidneyCareMember_4d0d9a06-5c15-4b86-9de3-c58388efbfe9" xlink:href="dva-20211231.xsd#dva_KidneyCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_26f851ad-5e5d-4d71-849e-4a902509a042" xlink:to="loc_dva_KidneyCareMember_4d0d9a06-5c15-4b86-9de3-c58388efbfe9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_42abc180-01e9-480b-af3f-c5b2fe355f1d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1510b27f-7e0c-473a-acf6-8aa18030b0cb" xlink:to="loc_srt_StatementGeographicalAxis_42abc180-01e9-480b-af3f-c5b2fe355f1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_42abc180-01e9-480b-af3f-c5b2fe355f1d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_42abc180-01e9-480b-af3f-c5b2fe355f1d" xlink:to="loc_srt_SegmentGeographicalDomain_42abc180-01e9-480b-af3f-c5b2fe355f1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fa95c7d1-13f6-4efb-8c04-78c36298995a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_42abc180-01e9-480b-af3f-c5b2fe355f1d" xlink:to="loc_srt_SegmentGeographicalDomain_fa95c7d1-13f6-4efb-8c04-78c36298995a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_30eed63a-ab75-45e7-97d3-e1fc0ea7dd24" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_fa95c7d1-13f6-4efb-8c04-78c36298995a" xlink:to="loc_country_DE_30eed63a-ab75-45e7-97d3-e1fc0ea7dd24" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#GoodwillAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillAdditionalInformationDetails" xlink:type="extended" id="i71b0d4e98fe94cc887d025046c40c424_GoodwillAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_d5f3a8e0-39d0-43f6-bc5d-09070826cce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_6c745da3-2b3c-4c1c-bf32-d1d803eaea99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d5f3a8e0-39d0-43f6-bc5d-09070826cce9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_6c745da3-2b3c-4c1c-bf32-d1d803eaea99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_6265197d-b80c-4cf9-a07b-410e7698496d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d5f3a8e0-39d0-43f6-bc5d-09070826cce9" xlink:to="loc_us-gaap_NumberOfOperatingSegments_6265197d-b80c-4cf9-a07b-410e7698496d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5fc443e8-c933-4c35-9968-947adee51975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_d5f3a8e0-39d0-43f6-bc5d-09070826cce9" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5fc443e8-c933-4c35-9968-947adee51975" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8095372a-ecf8-4dac-a1c4-57a99d5a80aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5fc443e8-c933-4c35-9968-947adee51975" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8095372a-ecf8-4dac-a1c4-57a99d5a80aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8095372a-ecf8-4dac-a1c4-57a99d5a80aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8095372a-ecf8-4dac-a1c4-57a99d5a80aa" xlink:to="loc_us-gaap_SegmentDomain_8095372a-ecf8-4dac-a1c4-57a99d5a80aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cd251232-1ed4-4d19-8ad3-d1bb91b75123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8095372a-ecf8-4dac-a1c4-57a99d5a80aa" xlink:to="loc_us-gaap_SegmentDomain_cd251232-1ed4-4d19-8ad3-d1bb91b75123" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember_5accc6fb-20a7-457d-a36b-9dd7ad3dcc1f" xlink:href="dva-20211231.xsd#dva_OtherReportingUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cd251232-1ed4-4d19-8ad3-d1bb91b75123" xlink:to="loc_dva_OtherReportingUnitsMember_5accc6fb-20a7-457d-a36b-9dd7ad3dcc1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_KidneyCareMember_e2089486-1cb6-4905-a91e-b27466f873df" xlink:href="dva-20211231.xsd#dva_KidneyCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cd251232-1ed4-4d19-8ad3-d1bb91b75123" xlink:to="loc_dva_KidneyCareMember_e2089486-1cb6-4905-a91e-b27466f873df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_103fbcc3-938e-4d17-90c3-2bb979edaad1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5fc443e8-c933-4c35-9968-947adee51975" xlink:to="loc_srt_StatementGeographicalAxis_103fbcc3-938e-4d17-90c3-2bb979edaad1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_103fbcc3-938e-4d17-90c3-2bb979edaad1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_103fbcc3-938e-4d17-90c3-2bb979edaad1" xlink:to="loc_srt_SegmentGeographicalDomain_103fbcc3-938e-4d17-90c3-2bb979edaad1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6239402b-e947-46f9-a1ea-696308fcdf75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_103fbcc3-938e-4d17-90c3-2bb979edaad1" xlink:to="loc_srt_SegmentGeographicalDomain_6239402b-e947-46f9-a1ea-696308fcdf75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_bb6ea5bf-3d05-419d-a861-7bd3bb3977d7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6239402b-e947-46f9-a1ea-696308fcdf75" xlink:to="loc_country_DE_bb6ea5bf-3d05-419d-a861-7bd3bb3977d7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" xlink:type="extended" id="i44af2e3efcf8482e91498432807d84a4_IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:href="dva-20211231.xsd#dva_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsReceivables_f05250eb-2e45-457a-8142-74581d0cf89e" xlink:href="dva-20211231.xsd#dva_DeferredTaxAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_dva_DeferredTaxAssetsReceivables_f05250eb-2e45-457a-8142-74581d0cf89e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_9cab7874-8b78-4d37-af02-de2b50ce3642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_9cab7874-8b78-4d37-af02-de2b50ce3642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities_4116885e-8ef3-4c16-8722-adb3f91f37b3" xlink:href="dva-20211231.xsd#dva_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities_4116885e-8ef3-4c16-8722-adb3f91f37b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0ee20614-023a-431a-9550-4ff4744cbfcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0ee20614-023a-431a-9550-4ff4744cbfcb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_af6721f8-5ddd-4ee9-9341-49827399838e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_af6721f8-5ddd-4ee9-9341-49827399838e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_6b4d5d78-4e57-419f-9159-92111f1ca18a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_6b4d5d78-4e57-419f-9159-92111f1ca18a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4b79fd5b-9297-428a-89bb-872e0efccb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4b79fd5b-9297-428a-89bb-872e0efccb7e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_59025c8e-f9d5-4344-9a15-fda98030b7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_59025c8e-f9d5-4344-9a15-fda98030b7f1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_6a44ecc5-b6c7-45f8-82c0-2a9e51de4bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_6a44ecc5-b6c7-45f8-82c0-2a9e51de4bdc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_12ed36b3-bc57-4503-a862-ecbf26aa419d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_12ed36b3-bc57-4503-a862-ecbf26aa419d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_35157825-7227-45ab-bc74-22f3ed6c0c8c" xlink:href="dva-20211231.xsd#dva_DeferredTaxLiabilitiesOperatingLeaseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_35157825-7227-45ab-bc74-22f3ed6c0c8c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_c8627727-4892-4632-bd15-e12624ad6d15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_c8627727-4892-4632-bd15-e12624ad6d15" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_c3134bb1-a230-4e26-b578-d4ba885ead80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_c3134bb1-a230-4e26-b578-d4ba885ead80" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e6ee3307-c99e-4eb2-bb6b-b207ea09484a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e6ee3307-c99e-4eb2-bb6b-b207ea09484a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_e08d8721-1709-4ccf-9485-72828657fa94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxLiabilities_e08d8721-1709-4ccf-9485-72828657fa94" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesTable_e5505646-521d-4501-b17a-7ea8ccde7d16" xlink:href="dva-20211231.xsd#dva_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_dva_IncomeTaxesTable_e5505646-521d-4501-b17a-7ea8ccde7d16" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f58f26e0-a725-4aa4-844b-eb0716fe1a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_IncomeTaxesTable_e5505646-521d-4501-b17a-7ea8ccde7d16" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f58f26e0-a725-4aa4-844b-eb0716fe1a03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f58f26e0-a725-4aa4-844b-eb0716fe1a03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f58f26e0-a725-4aa4-844b-eb0716fe1a03" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f58f26e0-a725-4aa4-844b-eb0716fe1a03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a1b17ec0-b949-4809-8bd9-09bfdb305b85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f58f26e0-a725-4aa4-844b-eb0716fe1a03" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a1b17ec0-b949-4809-8bd9-09bfdb305b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxLiabilitiesMember_0a4879a7-38d9-46dc-b810-503a3285f575" xlink:href="dva-20211231.xsd#dva_DeferredTaxLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a1b17ec0-b949-4809-8bd9-09bfdb305b85" xlink:to="loc_dva_DeferredTaxLiabilitiesMember_0a4879a7-38d9-46dc-b810-503a3285f575" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_f14da7e5-2c96-4730-b502-c26efd82f16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a1b17ec0-b949-4809-8bd9-09bfdb305b85" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_f14da7e5-2c96-4730-b502-c26efd82f16c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended" id="icb61bfcb448345198eb696383d6d2b19_IncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:href="dva-20211231.xsd#dva_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_3296c102-7e80-48d7-afca-e6f5e43bd46e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_OperatingLossCarryforwards_3296c102-7e80-48d7-afca-e6f5e43bd46e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_302ea050-7241-4ee8-ab42-a439e025e62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_302ea050-7241-4ee8-ab42-a439e025e62c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_4654d861-0e61-451a-a774-41e880a23e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_4654d861-0e61-451a-a774-41e880a23e2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate_f5352e5b-a735-48af-a2f8-611622569daa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_TaxCreditCarryforwardExpirationDate_f5352e5b-a735-48af-a2f8-611622569daa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_b0e5f922-ddf0-47af-adf2-79c2a3647aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_b0e5f922-ddf0-47af-adf2-79c2a3647aac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dfc1facc-914b-487d-b5e6-06afe2647c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dfc1facc-914b-487d-b5e6-06afe2647c7f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_d99f2466-7344-44ee-ac78-4a7ea4ef95a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_d99f2466-7344-44ee-ac78-4a7ea4ef95a0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_09b69212-ac03-4e6c-a9d6-821d71c9f3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_09b69212-ac03-4e6c-a9d6-821d71c9f3fa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_214f8b4b-d028-4c4b-8df5-571b81cd5187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_214f8b4b-d028-4c4b-8df5-571b81cd5187" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_ae78c9ad-85e1-4932-9122-7380be061b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_ae78c9ad-85e1-4932-9122-7380be061b34" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_747632c5-b729-439a-8f39-b7c219e9b273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_747632c5-b729-439a-8f39-b7c219e9b273" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:href="dva-20211231.xsd#dva_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_19ef732f-6f75-4862-8c1e-5930750c950e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_19ef732f-6f75-4862-8c1e-5930750c950e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_19ef732f-6f75-4862-8c1e-5930750c950e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_19ef732f-6f75-4862-8c1e-5930750c950e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_19ef732f-6f75-4862-8c1e-5930750c950e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_a55d86f0-50c8-4fe8-8d13-2134a5490b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_19ef732f-6f75-4862-8c1e-5930750c950e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_a55d86f0-50c8-4fe8-8d13-2134a5490b83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_8c46068d-2710-411e-be28-6984af515689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a55d86f0-50c8-4fe8-8d13-2134a5490b83" xlink:to="loc_us-gaap_DomesticCountryMember_8c46068d-2710-411e-be28-6984af515689" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_64e9eff7-8e00-4039-b480-d02e22f5dbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a55d86f0-50c8-4fe8-8d13-2134a5490b83" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_64e9eff7-8e00-4039-b480-d02e22f5dbe9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_e6bd05b2-66c2-4d6d-88d2-a515dee86526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a55d86f0-50c8-4fe8-8d13-2134a5490b83" xlink:to="loc_us-gaap_ForeignCountryMember_e6bd05b2-66c2-4d6d-88d2-a515dee86526" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_384a2e9d-92de-4f5b-9124-9988ea092e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:to="loc_us-gaap_TaxPeriodAxis_384a2e9d-92de-4f5b-9124-9988ea092e02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_384a2e9d-92de-4f5b-9124-9988ea092e02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_384a2e9d-92de-4f5b-9124-9988ea092e02" xlink:to="loc_us-gaap_TaxPeriodDomain_384a2e9d-92de-4f5b-9124-9988ea092e02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_2c438094-633a-46ee-ab1d-89c4cf4e64c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_384a2e9d-92de-4f5b-9124-9988ea092e02" xlink:to="loc_us-gaap_TaxPeriodDomain_2c438094-633a-46ee-ab1d-89c4cf4e64c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TaxYear2029Member_8375d927-2cb0-4d81-b1d9-85b4aadb9060" xlink:href="dva-20211231.xsd#dva_TaxYear2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_2c438094-633a-46ee-ab1d-89c4cf4e64c7" xlink:to="loc_dva_TaxYear2029Member_8375d927-2cb0-4d81-b1d9-85b4aadb9060" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_8a42e4a8-06ec-454f-bb31-58a85e8f0dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_8a42e4a8-06ec-454f-bb31-58a85e8f0dcd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_8a42e4a8-06ec-454f-bb31-58a85e8f0dcd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_8a42e4a8-06ec-454f-bb31-58a85e8f0dcd" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_8a42e4a8-06ec-454f-bb31-58a85e8f0dcd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_594a4f3b-bdda-4612-8fbc-1d8f27e2fca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_8a42e4a8-06ec-454f-bb31-58a85e8f0dcd" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_594a4f3b-bdda-4612-8fbc-1d8f27e2fca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_18f69bad-9cf5-4643-b05a-2ab8410e79e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_594a4f3b-bdda-4612-8fbc-1d8f27e2fca4" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_18f69bad-9cf5-4643-b05a-2ab8410e79e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_9cfe694e-de0e-48c0-a4bc-db9d7560486f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_9cfe694e-de0e-48c0-a4bc-db9d7560486f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_9cfe694e-de0e-48c0-a4bc-db9d7560486f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_9cfe694e-de0e-48c0-a4bc-db9d7560486f" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_9cfe694e-de0e-48c0-a4bc-db9d7560486f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_2a5649ad-c9c6-4436-beba-3242edbb19b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_9cfe694e-de0e-48c0-a4bc-db9d7560486f" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_2a5649ad-c9c6-4436-beba-3242edbb19b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IndefiniteLifeNetOperatingLossesMember_588bfd6b-7e46-423c-addd-dce1019d3ea3" xlink:href="dva-20211231.xsd#dva_IndefiniteLifeNetOperatingLossesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_2a5649ad-c9c6-4436-beba-3242edbb19b3" xlink:to="loc_dva_IndefiniteLifeNetOperatingLossesMember_588bfd6b-7e46-423c-addd-dce1019d3ea3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember_af155517-dbc9-452b-8a22-2b5c2ff42b94" xlink:href="dva-20211231.xsd#dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_2a5649ad-c9c6-4436-beba-3242edbb19b3" xlink:to="loc_dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember_af155517-dbc9-452b-8a22-2b5c2ff42b94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6b4b3b57-cb3f-41c1-83ea-ad22e78576b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6b4b3b57-cb3f-41c1-83ea-ad22e78576b4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6b4b3b57-cb3f-41c1-83ea-ad22e78576b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6b4b3b57-cb3f-41c1-83ea-ad22e78576b4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6b4b3b57-cb3f-41c1-83ea-ad22e78576b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a0b4c39e-2d6c-45e7-a44b-f926edd6c4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6b4b3b57-cb3f-41c1-83ea-ad22e78576b4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a0b4c39e-2d6c-45e7-a44b-f926edd6c4cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_ca4dc695-2dfa-4577-b650-0d10410fd749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a0b4c39e-2d6c-45e7-a44b-f926edd6c4cb" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_ca4dc695-2dfa-4577-b650-0d10410fd749" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended" id="i4385d884cc3644198af921634533aafa_LongTermDebtScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_65b3130d-3b7e-4048-8e29-5d84bf2c8b52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_DebtInstrumentsAbstract_65b3130d-3b7e-4048-8e29-5d84bf2c8b52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_608e86a8-0cde-4394-8c57-e7a1707d894b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_65b3130d-3b7e-4048-8e29-5d84bf2c8b52" xlink:to="loc_us-gaap_SecuredDebt_608e86a8-0cde-4394-8c57-e7a1707d894b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_e67da6d9-4817-405c-b82a-90a3778a5a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_65b3130d-3b7e-4048-8e29-5d84bf2c8b52" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_e67da6d9-4817-405c-b82a-90a3778a5a43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableAbstract_a2ca1d0a-b787-44c2-8a4d-44c147d7adcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_NotesPayableAbstract_a2ca1d0a-b787-44c2-8a4d-44c147d7adcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_c26f45ee-86d4-4e03-b575-80c2f27c2b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NotesPayableAbstract_a2ca1d0a-b787-44c2-8a4d-44c147d7adcf" xlink:to="loc_us-gaap_SeniorNotes_c26f45ee-86d4-4e03-b575-80c2f27c2b7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_5e24f880-4020-42ee-a74b-780400bc32a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_5e24f880-4020-42ee-a74b-780400bc32a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_530f8ab1-8225-4ca9-aaf3-1634b86a1315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_530f8ab1-8225-4ca9-aaf3-1634b86a1315" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_fc863465-9e17-429a-9397-d791d3e07ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_DebtInstrumentFairValue_fc863465-9e17-429a-9397-d791d3e07ba1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable_c98fc2b3-55be-4029-b838-08d3cbd77e43" xlink:href="dva-20211231.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayable_c98fc2b3-55be-4029-b838-08d3cbd77e43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_c43d0e9f-19ca-4b18-bb77-a6d15ec69baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:to="loc_us-gaap_FinanceLeaseLiability_c43d0e9f-19ca-4b18-bb77-a6d15ec69baa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_d5b15c76-bf95-4e62-afc5-a734daf54517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_d5b15c76-bf95-4e62-afc5-a734daf54517" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_8e6fde9b-b7d4-41d1-b5f3-ad33f1663ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_8e6fde9b-b7d4-41d1-b5f3-ad33f1663ccd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_9aed00b5-592b-4425-befc-983953fd3d46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_9aed00b5-592b-4425-befc-983953fd3d46" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_0c39f678-ef19-4dd2-b012-05a37ebe427c" xlink:href="dva-20211231.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_0c39f678-ef19-4dd2-b012-05a37ebe427c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_91c50fb4-8820-48b7-b6fa-7d334d849e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_91c50fb4-8820-48b7-b6fa-7d334d849e1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountAndDeferredFinanceCosts_f319ba69-9e41-4ffc-8e74-a27a787f65c0" xlink:href="dva-20211231.xsd#dva_DiscountAndDeferredFinanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:to="loc_dva_DiscountAndDeferredFinanceCosts_f319ba69-9e41-4ffc-8e74-a27a787f65c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_175711e7-7cd0-4479-8ed5-1713281e8fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_175711e7-7cd0-4479-8ed5-1713281e8fa5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9025a0a7-b645-4f76-8489-c599d294ea07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9025a0a7-b645-4f76-8489-c599d294ea07" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_442351e2-4538-476f-bd52-32bd021154ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_442351e2-4538-476f-bd52-32bd021154ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_d3cd7eb7-420d-41a8-9265-54bfda8aebaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_d3cd7eb7-420d-41a8-9265-54bfda8aebaf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b819dcf5-4c7c-4936-be07-f7be5a9c0e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_d3cd7eb7-420d-41a8-9265-54bfda8aebaf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b819dcf5-4c7c-4936-be07-f7be5a9c0e26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_921330c5-a9d9-461f-ac42-02186b92403d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_d3cd7eb7-420d-41a8-9265-54bfda8aebaf" xlink:to="loc_us-gaap_DeferredOfferingCosts_921330c5-a9d9-461f-ac42-02186b92403d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_92a55931-3ff9-4eee-aa27-48f18d510f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_d3cd7eb7-420d-41a8-9265-54bfda8aebaf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_92a55931-3ff9-4eee-aa27-48f18d510f23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2d3d5efb-2e5a-43ef-9a6a-d2063644a0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_DebtInstrumentTable_2d3d5efb-2e5a-43ef-9a6a-d2063644a0c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_325a695c-3d76-40eb-a6c2-52a308e7833a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2d3d5efb-2e5a-43ef-9a6a-d2063644a0c9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_325a695c-3d76-40eb-a6c2-52a308e7833a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_325a695c-3d76-40eb-a6c2-52a308e7833a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_325a695c-3d76-40eb-a6c2-52a308e7833a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_325a695c-3d76-40eb-a6c2-52a308e7833a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ea105134-789c-43d1-b968-899ddae07f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_325a695c-3d76-40eb-a6c2-52a308e7833a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ea105134-789c-43d1-b968-899ddae07f22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_79e89b21-44a1-41ca-a0a6-b85ad48c9940" xlink:href="dva-20211231.xsd#dva_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea105134-789c-43d1-b968-899ddae07f22" xlink:to="loc_dva_TermLoanAMember_79e89b21-44a1-41ca-a0a6-b85ad48c9940" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_bf26e983-ae3b-455f-b8b1-dd55b0c0233b" xlink:href="dva-20211231.xsd#dva_TermLoanB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea105134-789c-43d1-b968-899ddae07f22" xlink:to="loc_dva_TermLoanB1Member_bf26e983-ae3b-455f-b8b1-dd55b0c0233b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_3979330f-b900-4006-a4a4-86868e9b13ba" xlink:href="dva-20211231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea105134-789c-43d1-b968-899ddae07f22" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_3979330f-b900-4006-a4a4-86868e9b13ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ceb652be-54c4-45c6-8cd2-9da6fbc63e46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea105134-789c-43d1-b968-899ddae07f22" xlink:to="loc_us-gaap_SeniorNotesMember_ceb652be-54c4-45c6-8cd2-9da6fbc63e46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_738c5c9c-3168-4fb9-a1ae-e016df806fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2d3d5efb-2e5a-43ef-9a6a-d2063644a0c9" xlink:to="loc_us-gaap_CreditFacilityAxis_738c5c9c-3168-4fb9-a1ae-e016df806fa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_738c5c9c-3168-4fb9-a1ae-e016df806fa2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_738c5c9c-3168-4fb9-a1ae-e016df806fa2" xlink:to="loc_us-gaap_CreditFacilityDomain_738c5c9c-3168-4fb9-a1ae-e016df806fa2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_68df7700-f2ec-4353-a862-fc35f8ea6b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_738c5c9c-3168-4fb9-a1ae-e016df806fa2" xlink:to="loc_us-gaap_CreditFacilityDomain_68df7700-f2ec-4353-a862-fc35f8ea6b69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a835c18b-b8de-4f65-9314-09f9b26ccc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_68df7700-f2ec-4353-a862-fc35f8ea6b69" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a835c18b-b8de-4f65-9314-09f9b26ccc7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_80f051a5-b97b-4245-bd1e-2826bbf8e93e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2d3d5efb-2e5a-43ef-9a6a-d2063644a0c9" xlink:to="loc_us-gaap_DebtInstrumentAxis_80f051a5-b97b-4245-bd1e-2826bbf8e93e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_80f051a5-b97b-4245-bd1e-2826bbf8e93e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_80f051a5-b97b-4245-bd1e-2826bbf8e93e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_80f051a5-b97b-4245-bd1e-2826bbf8e93e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b4d952a1-e5a8-48fd-9a02-53d1110971cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_80f051a5-b97b-4245-bd1e-2826bbf8e93e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b4d952a1-e5a8-48fd-9a02-53d1110971cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_7573b3a1-f77d-447d-a614-bc0283f5242d" xlink:href="dva-20211231.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b4d952a1-e5a8-48fd-9a02-53d1110971cf" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_7573b3a1-f77d-447d-a614-bc0283f5242d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_0fbda97f-e6a8-4699-a521-d2a9d20f1320" xlink:href="dva-20211231.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b4d952a1-e5a8-48fd-9a02-53d1110971cf" xlink:to="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_0fbda97f-e6a8-4699-a521-d2a9d20f1320" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_737b69e7-b68a-402f-bbf2-61ee32c341d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b4d952a1-e5a8-48fd-9a02-53d1110971cf" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_737b69e7-b68a-402f-bbf2-61ee32c341d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_3e75ba4f-c955-4d29-8df3-22a79ad0f949" xlink:href="dva-20211231.xsd#dva_FinanceLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b4d952a1-e5a8-48fd-9a02-53d1110971cf" xlink:to="loc_dva_FinanceLeaseMember_3e75ba4f-c955-4d29-8df3-22a79ad0f949" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_5e799939-b59a-4d49-9678-a7c0aaa8c154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2d3d5efb-2e5a-43ef-9a6a-d2063644a0c9" xlink:to="loc_us-gaap_LeaseContractualTermAxis_5e799939-b59a-4d49-9678-a7c0aaa8c154" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_5e799939-b59a-4d49-9678-a7c0aaa8c154_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_5e799939-b59a-4d49-9678-a7c0aaa8c154" xlink:to="loc_us-gaap_LeaseContractualTermDomain_5e799939-b59a-4d49-9678-a7c0aaa8c154_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_a268bdfd-6f8d-46bb-9f0b-fda001de01b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_5e799939-b59a-4d49-9678-a7c0aaa8c154" xlink:to="loc_us-gaap_LeaseContractualTermDomain_a268bdfd-6f8d-46bb-9f0b-fda001de01b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_GroundLeaseMember_52f0a102-b1a1-49e3-88e0-ae8f906e4233" xlink:href="dva-20211231.xsd#dva_GroundLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_a268bdfd-6f8d-46bb-9f0b-fda001de01b1" xlink:to="loc_dva_GroundLeaseMember_52f0a102-b1a1-49e3-88e0-ae8f906e4233" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongTermDebtDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails" xlink:type="extended" id="ia07b3180808c4b7481f3c4c1db211801_LongTermDebtDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_76f8524a-e802-42ad-af93-463690c9cf9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_76f8524a-e802-42ad-af93-463690c9cf9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_60c7c7a6-6fa5-4c84-be14-9eccd4169c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_60c7c7a6-6fa5-4c84-be14-9eccd4169c3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates_7e05d0e1-9ee8-45dd-b8cd-45b1f411a121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_DerivativeInceptionDates_7e05d0e1-9ee8-45dd-b8cd-45b1f411a121" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_17decac1-321c-45b9-b22d-5c1e216fefdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_DerivativeMaturityDates_17decac1-321c-45b9-b22d-5c1e216fefdc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_7ae9371d-cf86-4d0e-8db8-36ae2d66fd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_7ae9371d-cf86-4d0e-8db8-36ae2d66fd7b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_909e9bbb-b593-4a65-b203-1c40a2f5f6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_909e9bbb-b593-4a65-b203-1c40a2f5f6e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_2223ea10-4409-4568-9ac2-c24332c45a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_2223ea10-4409-4568-9ac2-c24332c45a41" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2d492c2b-86cc-43c6-ac0d-5f8ae785ce84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2d492c2b-86cc-43c6-ac0d-5f8ae785ce84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2d492c2b-86cc-43c6-ac0d-5f8ae785ce84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2d492c2b-86cc-43c6-ac0d-5f8ae785ce84" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2d492c2b-86cc-43c6-ac0d-5f8ae785ce84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7460dbc9-1c56-4d8b-8a7d-748a004a8751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2d492c2b-86cc-43c6-ac0d-5f8ae785ce84" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7460dbc9-1c56-4d8b-8a7d-748a004a8751" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_815b2216-d16b-4da3-970e-2d81d584e55c" xlink:href="dva-20211231.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7460dbc9-1c56-4d8b-8a7d-748a004a8751" xlink:to="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_815b2216-d16b-4da3-970e-2d81d584e55c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_711e9250-25b5-48af-b2e6-c27ff8183011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:to="loc_us-gaap_DebtInstrumentAxis_711e9250-25b5-48af-b2e6-c27ff8183011" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_711e9250-25b5-48af-b2e6-c27ff8183011_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_711e9250-25b5-48af-b2e6-c27ff8183011" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_711e9250-25b5-48af-b2e6-c27ff8183011_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5b49dcf4-5b89-440a-a981-8fb4a8dda69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_711e9250-25b5-48af-b2e6-c27ff8183011" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5b49dcf4-5b89-440a-a981-8fb4a8dda69f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_5b855dc6-1770-49c7-a47b-fde6fb88f30d" xlink:href="dva-20211231.xsd#dva_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b49dcf4-5b89-440a-a981-8fb4a8dda69f" xlink:to="loc_dva_TermLoanFacilityMember_5b855dc6-1770-49c7-a47b-fde6fb88f30d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d420b7a8-e0b1-4036-85dd-7e8b1f6f6510" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:to="loc_srt_RangeAxis_d420b7a8-e0b1-4036-85dd-7e8b1f6f6510" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d420b7a8-e0b1-4036-85dd-7e8b1f6f6510_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d420b7a8-e0b1-4036-85dd-7e8b1f6f6510" xlink:to="loc_srt_RangeMember_d420b7a8-e0b1-4036-85dd-7e8b1f6f6510_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_aff664bd-1173-478d-a408-dbfdb8e273c7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d420b7a8-e0b1-4036-85dd-7e8b1f6f6510" xlink:to="loc_srt_RangeMember_aff664bd-1173-478d-a408-dbfdb8e273c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7eb13553-8747-41c4-bcb0-b90ec110de3b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_aff664bd-1173-478d-a408-dbfdb8e273c7" xlink:to="loc_srt_MaximumMember_7eb13553-8747-41c4-bcb0-b90ec110de3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_174a829f-05fc-4312-a586-22ae4233402c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_174a829f-05fc-4312-a586-22ae4233402c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_174a829f-05fc-4312-a586-22ae4233402c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_174a829f-05fc-4312-a586-22ae4233402c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_174a829f-05fc-4312-a586-22ae4233402c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_70c5cdb1-a534-4bf0-9685-93240e9669a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_174a829f-05fc-4312-a586-22ae4233402c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_70c5cdb1-a534-4bf0-9685-93240e9669a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_a3d73d65-57df-4ac5-9e54-e5959095f4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_70c5cdb1-a534-4bf0-9685-93240e9669a5" xlink:to="loc_us-gaap_CashFlowHedgingMember_a3d73d65-57df-4ac5-9e54-e5959095f4fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_150dc87d-bb89-4d69-9283-efe51a92539f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_150dc87d-bb89-4d69-9283-efe51a92539f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_150dc87d-bb89-4d69-9283-efe51a92539f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_150dc87d-bb89-4d69-9283-efe51a92539f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_150dc87d-bb89-4d69-9283-efe51a92539f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d11780be-1c3d-42ab-bfa0-c9bcc6beaac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_150dc87d-bb89-4d69-9283-efe51a92539f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d11780be-1c3d-42ab-bfa0-c9bcc6beaac0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember_6afa89ea-25ed-4ccb-9703-42dfaa50e32f" xlink:href="dva-20211231.xsd#dva_DebtExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d11780be-1c3d-42ab-bfa0-c9bcc6beaac0" xlink:to="loc_dva_DebtExpenseMember_6afa89ea-25ed-4ccb-9703-42dfaa50e32f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fef0822d-6865-4305-bdd2-f926ab2be255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fef0822d-6865-4305-bdd2-f926ab2be255" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fef0822d-6865-4305-bdd2-f926ab2be255_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fef0822d-6865-4305-bdd2-f926ab2be255" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fef0822d-6865-4305-bdd2-f926ab2be255_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d02727c4-82c5-48d1-aa27-48ed5756d470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fef0822d-6865-4305-bdd2-f926ab2be255" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d02727c4-82c5-48d1-aa27-48ed5756d470" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_6a5ea04c-40db-443e-bca5-04833b59515d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d02727c4-82c5-48d1-aa27-48ed5756d470" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_6a5ea04c-40db-443e-bca5-04833b59515d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails" xlink:type="extended" id="ied19f578d2394feba8e0ef17960b2ba6_LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cbf7e14a-6f40-453d-a395-36178e02f086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_adc2b79d-b4b0-4bf9-aef5-429906dae2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cbf7e14a-6f40-453d-a395-36178e02f086" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_adc2b79d-b4b0-4bf9-aef5-429906dae2c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d48b5be8-db44-42bc-a70a-b036c8e1e030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cbf7e14a-6f40-453d-a395-36178e02f086" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d48b5be8-db44-42bc-a70a-b036c8e1e030" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_51dc8bb0-4a67-437b-832b-5dbe97b662ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cbf7e14a-6f40-453d-a395-36178e02f086" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_51dc8bb0-4a67-437b-832b-5dbe97b662ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dbbee489-0993-4b98-9877-7598b9437061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_51dc8bb0-4a67-437b-832b-5dbe97b662ba" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dbbee489-0993-4b98-9877-7598b9437061" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_dbbee489-0993-4b98-9877-7598b9437061_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dbbee489-0993-4b98-9877-7598b9437061" xlink:to="loc_us-gaap_HedgingRelationshipDomain_dbbee489-0993-4b98-9877-7598b9437061_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0c9d4f35-1c64-4014-99ab-09af34703f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dbbee489-0993-4b98-9877-7598b9437061" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0c9d4f35-1c64-4014-99ab-09af34703f84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_20173112-2a2c-4e56-93bc-fb18f8758a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0c9d4f35-1c64-4014-99ab-09af34703f84" xlink:to="loc_us-gaap_CashFlowHedgingMember_20173112-2a2c-4e56-93bc-fb18f8758a3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d640f6cb-abc8-4f30-b48c-d9344ec27909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_51dc8bb0-4a67-437b-832b-5dbe97b662ba" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d640f6cb-abc8-4f30-b48c-d9344ec27909" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d640f6cb-abc8-4f30-b48c-d9344ec27909_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d640f6cb-abc8-4f30-b48c-d9344ec27909" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d640f6cb-abc8-4f30-b48c-d9344ec27909_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_956fbf6e-2212-4396-88ff-55acb39c65b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d640f6cb-abc8-4f30-b48c-d9344ec27909" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_956fbf6e-2212-4396-88ff-55acb39c65b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_b2925b90-1e73-4873-8661-a71946064991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_956fbf6e-2212-4396-88ff-55acb39c65b2" xlink:to="loc_us-gaap_InterestRateCapMember_b2925b90-1e73-4873-8661-a71946064991" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7e4df425-fc2e-4333-bbcf-2f4df514f317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_51dc8bb0-4a67-437b-832b-5dbe97b662ba" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7e4df425-fc2e-4333-bbcf-2f4df514f317" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7e4df425-fc2e-4333-bbcf-2f4df514f317_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7e4df425-fc2e-4333-bbcf-2f4df514f317" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7e4df425-fc2e-4333-bbcf-2f4df514f317_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6fa39495-6f76-48b5-8136-af655da50462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7e4df425-fc2e-4333-bbcf-2f4df514f317" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6fa39495-6f76-48b5-8136-af655da50462" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember_74884d04-4eee-4868-91e6-49fa309af12a" xlink:href="dva-20211231.xsd#dva_DebtExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6fa39495-6f76-48b5-8136-af655da50462" xlink:to="loc_dva_DebtExpenseMember_74884d04-4eee-4868-91e6-49fa309af12a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxExpenseBenefitMember_9e63924e-3d12-44e3-baf4-e0dcb8ca8a3d" xlink:href="dva-20211231.xsd#dva_IncomeTaxExpenseBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6fa39495-6f76-48b5-8136-af655da50462" xlink:to="loc_dva_IncomeTaxExpenseBenefitMember_9e63924e-3d12-44e3-baf4-e0dcb8ca8a3d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtAdditionalinformationDetail" xlink:type="simple" xlink:href="dva-20211231.xsd#LongTermDebtAdditionalinformationDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongTermDebtAdditionalinformationDetail" xlink:type="extended" id="ib918a84389c84808b43e6eb11169f018_LongTermDebtAdditionalinformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_a25d8add-e300-466d-8651-73efe960fb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_a25d8add-e300-466d-8651-73efe960fb5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_31824a46-88fa-4282-ade6-5e21c3c0f5a4" xlink:href="dva-20211231.xsd#dva_AdditionalDebtPrincipalAmountDueToNewAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_31824a46-88fa-4282-ade6-5e21c3c0f5a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_83812bf9-bcd7-4ebf-946c-5b439bdf371a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_83812bf9-bcd7-4ebf-946c-5b439bdf371a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_1f51ade7-a4a0-4a2d-8ee2-2e97bf986422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_1f51ade7-a4a0-4a2d-8ee2-2e97bf986422" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_51689c75-398b-488b-b257-1d35f742a24e" xlink:href="dva-20211231.xsd#dva_DebtInstrumentOfferingPricePercentageOfFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_51689c75-398b-488b-b257-1d35f742a24e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_48cfd037-ab74-427d-85ad-d29bbd8b253f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_SeniorNotes_48cfd037-ab74-427d-85ad-d29bbd8b253f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_b192be20-abda-4173-8c21-2c6ad16d3517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_b192be20-abda-4173-8c21-2c6ad16d3517" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_b8c18fdb-1073-4522-b92e-4f928d7bcb0b" xlink:href="dva-20211231.xsd#dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_b8c18fdb-1073-4522-b92e-4f928d7bcb0b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_c8da3306-8354-4cd0-af39-3701e77b14f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_c8da3306-8354-4cd0-af39-3701e77b14f5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_62f351b5-a32b-499f-ae6c-b58545d44590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_62f351b5-a32b-499f-ae6c-b58545d44590" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9da3d31e-357b-4d02-b0f6-73bf42df5221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9da3d31e-357b-4d02-b0f6-73bf42df5221" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_3d9d400f-7690-4094-9c3f-5ab92bdb6994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_3d9d400f-7690-4094-9c3f-5ab92bdb6994" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_03b686e3-03e1-4ffd-907d-88636d026358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_InterestExpenseDebt_03b686e3-03e1-4ffd-907d-88636d026358" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_12c839ed-c24b-4da3-b931-cc999cde6c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_12c839ed-c24b-4da3-b931-cc999cde6c8d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_728843af-9cff-4d8f-b40f-53cd2281e1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_DebtInstrumentTable_728843af-9cff-4d8f-b40f-53cd2281e1f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_117119d7-e94f-4e7d-8fa9-cce98ddccaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_728843af-9cff-4d8f-b40f-53cd2281e1f3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_117119d7-e94f-4e7d-8fa9-cce98ddccaa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_117119d7-e94f-4e7d-8fa9-cce98ddccaa4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_117119d7-e94f-4e7d-8fa9-cce98ddccaa4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_117119d7-e94f-4e7d-8fa9-cce98ddccaa4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6865fa36-3990-49ce-951c-10fb59b34976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_117119d7-e94f-4e7d-8fa9-cce98ddccaa4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6865fa36-3990-49ce-951c-10fb59b34976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_4ed4dbef-7157-46f9-8b45-fb98f24e6706" xlink:href="dva-20211231.xsd#dva_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6865fa36-3990-49ce-951c-10fb59b34976" xlink:to="loc_dva_TermLoanAMember_4ed4dbef-7157-46f9-8b45-fb98f24e6706" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_37bc9df3-a5f6-4e0a-a7e8-5df8b485c64c" xlink:href="dva-20211231.xsd#dva_TermLoanB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6865fa36-3990-49ce-951c-10fb59b34976" xlink:to="loc_dva_TermLoanB1Member_37bc9df3-a5f6-4e0a-a7e8-5df8b485c64c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_6adc12be-8374-4a61-b035-70633a8947cb" xlink:href="dva-20211231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6865fa36-3990-49ce-951c-10fb59b34976" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_6adc12be-8374-4a61-b035-70633a8947cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_007e7281-4b0b-4700-8058-a6db52583d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_728843af-9cff-4d8f-b40f-53cd2281e1f3" xlink:to="loc_us-gaap_CreditFacilityAxis_007e7281-4b0b-4700-8058-a6db52583d01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_007e7281-4b0b-4700-8058-a6db52583d01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_007e7281-4b0b-4700-8058-a6db52583d01" xlink:to="loc_us-gaap_CreditFacilityDomain_007e7281-4b0b-4700-8058-a6db52583d01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_010151fe-9376-44c7-a24d-b849f33cbe5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_007e7281-4b0b-4700-8058-a6db52583d01" xlink:to="loc_us-gaap_CreditFacilityDomain_010151fe-9376-44c7-a24d-b849f33cbe5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_17e0b0e9-20c2-4e55-b9b1-b8009132f241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_010151fe-9376-44c7-a24d-b849f33cbe5b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_17e0b0e9-20c2-4e55-b9b1-b8009132f241" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_552a9990-2ff4-4f07-861d-dfefc6b74bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_010151fe-9376-44c7-a24d-b849f33cbe5b" xlink:to="loc_us-gaap_LetterOfCreditMember_552a9990-2ff4-4f07-861d-dfefc6b74bd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9c1dbab7-93f7-4054-82a6-ffcd01b89ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_728843af-9cff-4d8f-b40f-53cd2281e1f3" xlink:to="loc_us-gaap_DebtInstrumentAxis_9c1dbab7-93f7-4054-82a6-ffcd01b89ad9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9c1dbab7-93f7-4054-82a6-ffcd01b89ad9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9c1dbab7-93f7-4054-82a6-ffcd01b89ad9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9c1dbab7-93f7-4054-82a6-ffcd01b89ad9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_734ef9e2-0bd8-4c2b-95eb-4ba9b6df17f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9c1dbab7-93f7-4054-82a6-ffcd01b89ad9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_734ef9e2-0bd8-4c2b-95eb-4ba9b6df17f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_d697f853-6fb0-4a16-a886-62a08b2cb9ad" xlink:href="dva-20211231.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_734ef9e2-0bd8-4c2b-95eb-4ba9b6df17f5" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_d697f853-6fb0-4a16-a886-62a08b2cb9ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_86748e7e-9b71-464a-8309-64118b7e852a" xlink:href="dva-20211231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_734ef9e2-0bd8-4c2b-95eb-4ba9b6df17f5" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_86748e7e-9b71-464a-8309-64118b7e852a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesLeasesOtherInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LeasesLeasesOtherInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LeasesLeasesOtherInformationDetails" xlink:type="extended" id="i3e265ab6a172472393a8ba02eec8d7cc_LeasesLeasesOtherInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_3794d867-89c7-4d0a-a37f-c773db9ec11f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_da4ea528-5f49-4e10-8c78-6a8e93b8d58d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3794d867-89c7-4d0a-a37f-c773db9ec11f" xlink:to="loc_us-gaap_LeasesAbstract_da4ea528-5f49-4e10-8c78-6a8e93b8d58d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_92d022d8-6723-425c-b0b1-bd25c78aad31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_da4ea528-5f49-4e10-8c78-6a8e93b8d58d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_92d022d8-6723-425c-b0b1-bd25c78aad31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_1a86d1e7-fd71-403a-ad41-17282d3be849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_da4ea528-5f49-4e10-8c78-6a8e93b8d58d" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_1a86d1e7-fd71-403a-ad41-17282d3be849" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_38ee53d8-fd14-45ef-b9e6-b87f21aaa648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_da4ea528-5f49-4e10-8c78-6a8e93b8d58d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_38ee53d8-fd14-45ef-b9e6-b87f21aaa648" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_531c3d66-35d4-4cbe-9b97-ec1b925311aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_da4ea528-5f49-4e10-8c78-6a8e93b8d58d" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_531c3d66-35d4-4cbe-9b97-ec1b925311aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesOtherInformationAbstract_886a68cf-4e98-4de9-81d1-2090ad048aad" xlink:href="dva-20211231.xsd#dva_LeasesOtherInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3794d867-89c7-4d0a-a37f-c773db9ec11f" xlink:to="loc_dva_LeasesOtherInformationAbstract_886a68cf-4e98-4de9-81d1-2090ad048aad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_1a6b30a3-abed-4331-87dc-22d4213b3aef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesOtherInformationAbstract_886a68cf-4e98-4de9-81d1-2090ad048aad" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_1a6b30a3-abed-4331-87dc-22d4213b3aef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_e80288bd-f2cb-4249-9270-ee860db25a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesOtherInformationAbstract_886a68cf-4e98-4de9-81d1-2090ad048aad" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_e80288bd-f2cb-4249-9270-ee860db25a3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_10a0d756-4768-45c7-99c1-0f898b2aa7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_e80288bd-f2cb-4249-9270-ee860db25a3c" xlink:to="loc_us-gaap_OperatingLeasePayments_10a0d756-4768-45c7-99c1-0f898b2aa7a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_e0882198-430f-4a56-ae3e-022d12262224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_e80288bd-f2cb-4249-9270-ee860db25a3c" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_e0882198-430f-4a56-ae3e-022d12262224" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_fce5d3eb-f6fb-4dd8-90f1-b00ba168ed3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_e80288bd-f2cb-4249-9270-ee860db25a3c" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_fce5d3eb-f6fb-4dd8-90f1-b00ba168ed3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_7051433b-8bc4-4fee-bec4-53935d430311" xlink:href="dva-20211231.xsd#dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesOtherInformationAbstract_886a68cf-4e98-4de9-81d1-2090ad048aad" xlink:to="loc_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_7051433b-8bc4-4fee-bec4-53935d430311" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_c60f025b-ecd5-4c12-a770-a7fa635b5c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3794d867-89c7-4d0a-a37f-c773db9ec11f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_c60f025b-ecd5-4c12-a770-a7fa635b5c07" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_44318936-2cb6-4ee9-b371-86a06df30fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c60f025b-ecd5-4c12-a770-a7fa635b5c07" xlink:to="loc_us-gaap_DebtInstrumentAxis_44318936-2cb6-4ee9-b371-86a06df30fc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_44318936-2cb6-4ee9-b371-86a06df30fc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_44318936-2cb6-4ee9-b371-86a06df30fc0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_44318936-2cb6-4ee9-b371-86a06df30fc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1397051c-b438-463e-ad5a-e7f84837f5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_44318936-2cb6-4ee9-b371-86a06df30fc0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1397051c-b438-463e-ad5a-e7f84837f5fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_435e5c52-5f78-4329-adfc-f5cf8015e57a" xlink:href="dva-20211231.xsd#dva_FinanceLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1397051c-b438-463e-ad5a-e7f84837f5fa" xlink:to="loc_dva_FinanceLeaseMember_435e5c52-5f78-4329-adfc-f5cf8015e57a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" xlink:type="extended" id="i117411ca5a444f869ed4c3152ab83ab6_LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureLineItems_c4b3481c-8c07-4052-9aa3-8fdd89761622" xlink:href="dva-20211231.xsd#dva_LeasesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d37a42b9-115c-4293-bbdf-04a0e98f4d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesDisclosureLineItems_c4b3481c-8c07-4052-9aa3-8fdd89761622" xlink:to="loc_us-gaap_FinanceLeaseLiability_d37a42b9-115c-4293-bbdf-04a0e98f4d3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a2e42921-b83b-44ec-8746-5bcdbc414b38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesDisclosureLineItems_c4b3481c-8c07-4052-9aa3-8fdd89761622" xlink:to="loc_us-gaap_OperatingLeaseLiability_a2e42921-b83b-44ec-8746-5bcdbc414b38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureTable_2ff8c613-929c-4278-871b-be0af7cf3330" xlink:href="dva-20211231.xsd#dva_LeasesDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dva_LeasesDisclosureLineItems_c4b3481c-8c07-4052-9aa3-8fdd89761622" xlink:to="loc_dva_LeasesDisclosureTable_2ff8c613-929c-4278-871b-be0af7cf3330" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7329aba0-23fd-45d4-8708-bc4be4952691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_LeasesDisclosureTable_2ff8c613-929c-4278-871b-be0af7cf3330" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7329aba0-23fd-45d4-8708-bc4be4952691" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7329aba0-23fd-45d4-8708-bc4be4952691_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7329aba0-23fd-45d4-8708-bc4be4952691" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7329aba0-23fd-45d4-8708-bc4be4952691_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5817aad8-ace7-4c48-ba01-946f9d0f3247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7329aba0-23fd-45d4-8708-bc4be4952691" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5817aad8-ace7-4c48-ba01-946f9d0f3247" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OperatingLeaseLiabilitiesMember_50caa3f1-3da4-41e4-b407-d768837ab9a4" xlink:href="dva-20211231.xsd#dva_OperatingLeaseLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5817aad8-ace7-4c48-ba01-946f9d0f3247" xlink:to="loc_dva_OperatingLeaseLiabilitiesMember_50caa3f1-3da4-41e4-b407-d768837ab9a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_8f1c3d16-eb02-423d-8cc4-5d2f67f4ced4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5817aad8-ace7-4c48-ba01-946f9d0f3247" xlink:to="loc_us-gaap_LongTermDebtMember_8f1c3d16-eb02-423d-8cc4-5d2f67f4ced4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LeasesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LeasesAdditionalInformationDetails" xlink:type="extended" id="i24a1c4b539a4400f89fbd2a72a2feb33_LeasesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:href="dva-20211231.xsd#dva_LeasesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_36671f84-a6a8-4ebf-8f2d-4ab52ed86a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_36671f84-a6a8-4ebf-8f2d-4ab52ed86a9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_e0f4369b-8995-4bc9-b2d5-e07a82d74f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_e0f4369b-8995-4bc9-b2d5-e07a82d74f52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_ab294e44-8971-43d1-ba3a-43bff8f38314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_ab294e44-8971-43d1-ba3a-43bff8f38314" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseAccumulatedDepreciation_7bfe3377-d09d-4ca4-8cf9-bc428723b09b" xlink:href="dva-20211231.xsd#dva_FinanceLeaseAccumulatedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:to="loc_dva_FinanceLeaseAccumulatedDepreciation_7bfe3377-d09d-4ca4-8cf9-bc428723b09b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_873ccfd2-0e95-4392-87a0-8a8fc29c9845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:to="loc_us-gaap_LeaseCost_873ccfd2-0e95-4392-87a0-8a8fc29c9845" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureTable_481e1317-899e-4b45-850a-959159dc4d59" xlink:href="dva-20211231.xsd#dva_LeasesDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:to="loc_dva_LeasesDisclosureTable_481e1317-899e-4b45-850a-959159dc4d59" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e1d46d0a-3f88-470c-a4b0-c33d99245e6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_LeasesDisclosureTable_481e1317-899e-4b45-850a-959159dc4d59" xlink:to="loc_srt_RangeAxis_e1d46d0a-3f88-470c-a4b0-c33d99245e6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e1d46d0a-3f88-470c-a4b0-c33d99245e6b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e1d46d0a-3f88-470c-a4b0-c33d99245e6b" xlink:to="loc_srt_RangeMember_e1d46d0a-3f88-470c-a4b0-c33d99245e6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_27fd543f-3a61-4472-a51a-c4c01fd711b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e1d46d0a-3f88-470c-a4b0-c33d99245e6b" xlink:to="loc_srt_RangeMember_27fd543f-3a61-4472-a51a-c4c01fd711b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f0008066-a1bb-4656-a3e7-1b048dca83fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_27fd543f-3a61-4472-a51a-c4c01fd711b9" xlink:to="loc_srt_MinimumMember_f0008066-a1bb-4656-a3e7-1b048dca83fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e0ae25e4-1363-4ba1-a008-5889a0aa11a8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_27fd543f-3a61-4472-a51a-c4c01fd711b9" xlink:to="loc_srt_MaximumMember_e0ae25e4-1363-4ba1-a008-5889a0aa11a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_5b6fde99-0867-4671-ab86-d21eb45b7cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_LeasesDisclosureTable_481e1317-899e-4b45-850a-959159dc4d59" xlink:to="loc_us-gaap_LeaseContractualTermAxis_5b6fde99-0867-4671-ab86-d21eb45b7cdb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_5b6fde99-0867-4671-ab86-d21eb45b7cdb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_5b6fde99-0867-4671-ab86-d21eb45b7cdb" xlink:to="loc_us-gaap_LeaseContractualTermDomain_5b6fde99-0867-4671-ab86-d21eb45b7cdb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_f6d0438e-3d1e-4967-9b4e-d032a78730db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_5b6fde99-0867-4671-ab86-d21eb45b7cdb" xlink:to="loc_us-gaap_LeaseContractualTermDomain_f6d0438e-3d1e-4967-9b4e-d032a78730db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OperatingLeaseMember_c8c4b306-e61d-492c-a3db-5df1d4d9f74c" xlink:href="dva-20211231.xsd#dva_OperatingLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_f6d0438e-3d1e-4967-9b4e-d032a78730db" xlink:to="loc_dva_OperatingLeaseMember_c8c4b306-e61d-492c-a3db-5df1d4d9f74c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_39480c20-c3b3-45c5-8abc-f2ace27134e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_LeasesDisclosureTable_481e1317-899e-4b45-850a-959159dc4d59" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_39480c20-c3b3-45c5-8abc-f2ace27134e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_39480c20-c3b3-45c5-8abc-f2ace27134e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_39480c20-c3b3-45c5-8abc-f2ace27134e3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_39480c20-c3b3-45c5-8abc-f2ace27134e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d2fa1d04-266e-438e-be6f-b1b08d5af712" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_39480c20-c3b3-45c5-8abc-f2ace27134e3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d2fa1d04-266e-438e-be6f-b1b08d5af712" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_1d714fbc-14e0-4843-8f53-71118c389269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d2fa1d04-266e-438e-be6f-b1b08d5af712" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_1d714fbc-14e0-4843-8f53-71118c389269" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_95ba9c85-62a5-42a5-a11f-e3a9ce12b127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d2fa1d04-266e-438e-be6f-b1b08d5af712" xlink:to="loc_us-gaap_LongTermDebtMember_95ba9c85-62a5-42a5-a11f-e3a9ce12b127" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#EmployeeBenefitPlansAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails" xlink:type="extended" id="i88ccbcf39ced48a78a8ce807f315933a_EmployeeBenefitPlansAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_95f99aae-544a-416f-9aa0-b33b4015bda0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_95f99aae-544a-416f-9aa0-b33b4015bda0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_e9f5ad23-3d93-4b53-9ab7-f4421287106e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_e9f5ad23-3d93-4b53-9ab7-f4421287106e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_fe5682db-8c7e-4c78-a03f-a5407b2424a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_fe5682db-8c7e-4c78-a03f-a5407b2424a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_4b4c4a25-da2c-4884-9405-f64446eca283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_4b4c4a25-da2c-4884-9405-f64446eca283" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_b57805e2-af3a-464b-8f78-f3ab64e68602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_b57805e2-af3a-464b-8f78-f3ab64e68602" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_fed4676a-de57-43a9-9a6e-ea96cdff5b10" xlink:href="dva-20211231.xsd#dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_fed4676a-de57-43a9-9a6e-ea96cdff5b10" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_c23b385e-7a8a-4aec-bd29-3c79dfc17094" xlink:href="dva-20211231.xsd#dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_c23b385e-7a8a-4aec-bd29-3c79dfc17094" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid_516bdbaf-b76a-4609-883b-a2d01f7ca924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid_516bdbaf-b76a-4609-883b-a2d01f7ca924" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_24e9433b-f836-4524-b12a-616d22e65e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_24e9433b-f836-4524-b12a-616d22e65e3c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7142920e-59b1-43e3-b262-1d1b28057a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7142920e-59b1-43e3-b262-1d1b28057a34" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a48df521-d8ff-4332-afd8-09f88a6b11c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7142920e-59b1-43e3-b262-1d1b28057a34" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a48df521-d8ff-4332-afd8-09f88a6b11c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a48df521-d8ff-4332-afd8-09f88a6b11c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a48df521-d8ff-4332-afd8-09f88a6b11c5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a48df521-d8ff-4332-afd8-09f88a6b11c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d63a14c8-7b8b-41c5-9a47-9f18bf793f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a48df521-d8ff-4332-afd8-09f88a6b11c5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d63a14c8-7b8b-41c5-9a47-9f18bf793f45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansDefinedBenefitMember_e58d0611-f59d-4019-b1ae-82563bad8509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d63a14c8-7b8b-41c5-9a47-9f18bf793f45" xlink:to="loc_us-gaap_OtherPensionPlansDefinedBenefitMember_e58d0611-f59d-4019-b1ae-82563bad8509" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67a67702-fdb2-4d37-b348-dbfcb1846e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7142920e-59b1-43e3-b262-1d1b28057a34" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67a67702-fdb2-4d37-b348-dbfcb1846e50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_67a67702-fdb2-4d37-b348-dbfcb1846e50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67a67702-fdb2-4d37-b348-dbfcb1846e50" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_67a67702-fdb2-4d37-b348-dbfcb1846e50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_dfedb0ec-4ad6-40f1-ab4f-332169767263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67a67702-fdb2-4d37-b348-dbfcb1846e50" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_dfedb0ec-4ad6-40f1-ab4f-332169767263" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AllTrustsMember_3f086c05-66b4-41ea-afc1-0bc09fa27761" xlink:href="dva-20211231.xsd#dva_AllTrustsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_dfedb0ec-4ad6-40f1-ab4f-332169767263" xlink:to="loc_dva_AllTrustsMember_3f086c05-66b4-41ea-afc1-0bc09fa27761" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3244a659-7492-47f9-86fb-f989f722fd40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7142920e-59b1-43e3-b262-1d1b28057a34" xlink:to="loc_srt_RangeAxis_3244a659-7492-47f9-86fb-f989f722fd40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3244a659-7492-47f9-86fb-f989f722fd40_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3244a659-7492-47f9-86fb-f989f722fd40" xlink:to="loc_srt_RangeMember_3244a659-7492-47f9-86fb-f989f722fd40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dc3e9f25-818a-4a31-9121-a31d1b884671" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3244a659-7492-47f9-86fb-f989f722fd40" xlink:to="loc_srt_RangeMember_dc3e9f25-818a-4a31-9121-a31d1b884671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e485cd56-3cf0-44d9-ab98-083b76e37753" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dc3e9f25-818a-4a31-9121-a31d1b884671" xlink:to="loc_srt_MinimumMember_e485cd56-3cf0-44d9-ab98-083b76e37753" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1732c644-6cb5-4d17-a2eb-348f216f1c5d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dc3e9f25-818a-4a31-9121-a31d1b884671" xlink:to="loc_srt_MaximumMember_1732c644-6cb5-4d17-a2eb-348f216f1c5d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/ContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#ContingenciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/ContingenciesAdditionalInformationDetails" xlink:type="extended" id="i99a459ae7c8d41288f5abc330fe1e89a_ContingenciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_830225fe-eba4-4fa1-884e-dc70532540ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_dc06254a-25b4-4527-9aea-a730e6b00464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_830225fe-eba4-4fa1-884e-dc70532540ba" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_dc06254a-25b4-4527-9aea-a730e6b00464" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_25898a4b-6582-475a-ad1e-abb207b96aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_830225fe-eba4-4fa1-884e-dc70532540ba" xlink:to="loc_us-gaap_OtherCommitmentsTable_25898a4b-6582-475a-ad1e-abb207b96aed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_5a717d8f-644c-446c-aa24-52c566f3f4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_25898a4b-6582-475a-ad1e-abb207b96aed" xlink:to="loc_us-gaap_TransactionTypeAxis_5a717d8f-644c-446c-aa24-52c566f3f4eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_5a717d8f-644c-446c-aa24-52c566f3f4eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TransactionTypeAxis_5a717d8f-644c-446c-aa24-52c566f3f4eb" xlink:to="loc_us-gaap_TransactionDomain_5a717d8f-644c-446c-aa24-52c566f3f4eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_1cffd40a-4a19-4ced-9426-a10e814fe12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TransactionTypeAxis_5a717d8f-644c-446c-aa24-52c566f3f4eb" xlink:to="loc_us-gaap_TransactionDomain_1cffd40a-4a19-4ced-9426-a10e814fe12f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncrementalCashPortionMember_365d1201-f2c0-45ab-a634-8b3ed50ac8c4" xlink:href="dva-20211231.xsd#dva_IncrementalCashPortionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_1cffd40a-4a19-4ced-9426-a10e814fe12f" xlink:to="loc_dva_IncrementalCashPortionMember_365d1201-f2c0-45ab-a634-8b3ed50ac8c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidForPortionPreviouslyRefundedMember_1ac4891f-ab2a-44e4-894c-413077ea4857" xlink:href="dva-20211231.xsd#dva_CashPaidForPortionPreviouslyRefundedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_1cffd40a-4a19-4ced-9426-a10e814fe12f" xlink:to="loc_dva_CashPaidForPortionPreviouslyRefundedMember_1ac4891f-ab2a-44e4-894c-413077ea4857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b0d6754a-565f-4db7-b044-c460f9abc596" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_25898a4b-6582-475a-ad1e-abb207b96aed" xlink:to="loc_srt_LitigationCaseAxis_b0d6754a-565f-4db7-b044-c460f9abc596" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b0d6754a-565f-4db7-b044-c460f9abc596_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_b0d6754a-565f-4db7-b044-c460f9abc596" xlink:to="loc_srt_LitigationCaseTypeDomain_b0d6754a-565f-4db7-b044-c460f9abc596_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_33d34f7d-e0f8-4a34-85be-69d190d8488d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_b0d6754a-565f-4db7-b044-c460f9abc596" xlink:to="loc_srt_LitigationCaseTypeDomain_33d34f7d-e0f8-4a34-85be-69d190d8488d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_78b9a5ae-7d02-4230-8bdc-947f1676b88e" xlink:href="dva-20211231.xsd#dva_USAttorneyPrescriptionDrugInvestigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_33d34f7d-e0f8-4a34-85be-69d190d8488d" xlink:to="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_78b9a5ae-7d02-4230-8bdc-947f1676b88e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails" xlink:type="extended" id="ib324b562f4c94aacb235768f2e5f1226_NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:href="dva-20211231.xsd#dva_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DissolutionTermOfJointVentures_446b68ab-a2a2-4320-b36c-5c7663b008ea" xlink:href="dva-20211231.xsd#dva_DissolutionTermOfJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_dva_DissolutionTermOfJointVentures_446b68ab-a2a2-4320-b36c-5c7663b008ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermPurchaseCommitmentExpirationDate_cb4004f4-a43d-4bbf-96f7-c922fdcce5b9" xlink:href="dva-20211231.xsd#dva_LongTermPurchaseCommitmentExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_dva_LongTermPurchaseCommitmentExpirationDate_cb4004f4-a43d-4bbf-96f7-c922fdcce5b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_a37d6372-bf00-4417-a0ed-9c6f95ab5868" xlink:href="dva-20211231.xsd#dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_a37d6372-bf00-4417-a0ed-9c6f95ab5868" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_cd8d8978-28d5-4082-bb10-911cda7da509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_cd8d8978-28d5-4082-bb10-911cda7da509" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_77cf7585-bdae-4442-ba71-9e51bc1ed536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_77cf7585-bdae-4442-ba71-9e51bc1ed536" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_d9efa42b-2cc3-48ff-b86f-14b57c9a7fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_d9efa42b-2cc3-48ff-b86f-14b57c9a7fd6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_95b84886-9a86-4d8e-8aea-87aece9ab077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_95b84886-9a86-4d8e-8aea-87aece9ab077" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_c2d12859-60fd-40da-99d5-11ff0c1c308d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_us-gaap_OtherCommitment_c2d12859-60fd-40da-99d5-11ff0c1c308d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OffBalanceSheetFinancingArrangements_08361815-5c32-40e6-9e0f-b0f1903d2824" xlink:href="dva-20211231.xsd#dva_OffBalanceSheetFinancingArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_dva_OffBalanceSheetFinancingArrangements_08361815-5c32-40e6-9e0f-b0f1903d2824" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsAndContingenciesDisclosureTable_a03410b1-c2ee-4e20-8664-23035711cfa8" xlink:href="dva-20211231.xsd#dva_CommitmentsAndContingenciesDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_dva_CommitmentsAndContingenciesDisclosureTable_a03410b1-c2ee-4e20-8664-23035711cfa8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_97480129-c392-44da-8a23-1464c121b09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_a03410b1-c2ee-4e20-8664-23035711cfa8" xlink:to="loc_us-gaap_OtherCommitmentsAxis_97480129-c392-44da-8a23-1464c121b09c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_97480129-c392-44da-8a23-1464c121b09c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_97480129-c392-44da-8a23-1464c121b09c" xlink:to="loc_us-gaap_OtherCommitmentsDomain_97480129-c392-44da-8a23-1464c121b09c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_125d047f-09dc-438f-8b71-6785429ec27e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_97480129-c392-44da-8a23-1464c121b09c" xlink:to="loc_us-gaap_OtherCommitmentsDomain_125d047f-09dc-438f-8b71-6785429ec27e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember_af1bda7b-05dd-46d7-ad0d-edd41b10847e" xlink:href="dva-20211231.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_125d047f-09dc-438f-8b71-6785429ec27e" xlink:to="loc_dva_CommitmentsToProvideOperatingCapitalMember_af1bda7b-05dd-46d7-ad0d-edd41b10847e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd7c8e9a-cc95-4517-9d8f-8d3d98b3bb76" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_a03410b1-c2ee-4e20-8664-23035711cfa8" xlink:to="loc_srt_RangeAxis_dd7c8e9a-cc95-4517-9d8f-8d3d98b3bb76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd7c8e9a-cc95-4517-9d8f-8d3d98b3bb76_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dd7c8e9a-cc95-4517-9d8f-8d3d98b3bb76" xlink:to="loc_srt_RangeMember_dd7c8e9a-cc95-4517-9d8f-8d3d98b3bb76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e09c2679-df47-4c5c-a553-c4a963c427a6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dd7c8e9a-cc95-4517-9d8f-8d3d98b3bb76" xlink:to="loc_srt_RangeMember_e09c2679-df47-4c5c-a553-c4a963c427a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_505089d6-8e74-4776-8ac2-fbffa74dcae3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e09c2679-df47-4c5c-a553-c4a963c427a6" xlink:to="loc_srt_MinimumMember_505089d6-8e74-4776-8ac2-fbffa74dcae3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2193e648-84da-4302-a848-2d2e546649e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e09c2679-df47-4c5c-a553-c4a963c427a6" xlink:to="loc_srt_MaximumMember_2193e648-84da-4302-a848-2d2e546649e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_366681ef-4c91-438a-a8ab-4bf0996e81a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_a03410b1-c2ee-4e20-8664-23035711cfa8" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_366681ef-4c91-438a-a8ab-4bf0996e81a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_366681ef-4c91-438a-a8ab-4bf0996e81a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_366681ef-4c91-438a-a8ab-4bf0996e81a2" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_366681ef-4c91-438a-a8ab-4bf0996e81a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_07e43eb2-7f18-4e53-b0e3-27514969035d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_366681ef-4c91-438a-a8ab-4bf0996e81a2" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_07e43eb2-7f18-4e53-b0e3-27514969035d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EpogenMember_6acbc15e-07ff-4c33-bf8c-1dbe2b1e4960" xlink:href="dva-20211231.xsd#dva_EpogenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_07e43eb2-7f18-4e53-b0e3-27514969035d" xlink:to="loc_dva_EpogenMember_6acbc15e-07ff-4c33-bf8c-1dbe2b1e4960" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails" xlink:type="extended" id="ife265b26b586410abaf1c8bae606ff55_LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a1d49b7f-28ba-45bd-bef7-2483a205b37b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a1d49b7f-28ba-45bd-bef7-2483a205b37b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2257f61e-4c7a-4f0c-82c2-90c46a8b99b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a1d49b7f-28ba-45bd-bef7-2483a205b37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2257f61e-4c7a-4f0c-82c2-90c46a8b99b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2607918a-d898-460e-93f8-fe391d5f2b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a1d49b7f-28ba-45bd-bef7-2483a205b37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2607918a-d898-460e-93f8-fe391d5f2b98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d7c2d085-c549-420e-aa8b-ed8f15ca7154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a1d49b7f-28ba-45bd-bef7-2483a205b37b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d7c2d085-c549-420e-aa8b-ed8f15ca7154" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_bd6be8be-02e0-46d4-8fde-77ca3fadd41d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a1d49b7f-28ba-45bd-bef7-2483a205b37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_bd6be8be-02e0-46d4-8fde-77ca3fadd41d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b72138c7-29ab-4d0e-8748-5347e49f0f08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_fe30be5d-9bec-4654-a704-e6243311dc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_fe30be5d-9bec-4654-a704-e6243311dc74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_71a5fe44-fc09-48bb-bc2c-012a4c397805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_71a5fe44-fc09-48bb-bc2c-012a4c397805" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_578a4110-e38b-41d0-9776-f08a38d7ec8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_578a4110-e38b-41d0-9776-f08a38d7ec8b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6c9361ed-a413-4033-8996-508d1343a6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_578a4110-e38b-41d0-9776-f08a38d7ec8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6c9361ed-a413-4033-8996-508d1343a6ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ce33d86e-a905-4f69-9f16-f48af6027c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_578a4110-e38b-41d0-9776-f08a38d7ec8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ce33d86e-a905-4f69-9f16-f48af6027c45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a83dcebf-6486-4714-a980-2c69693849a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_578a4110-e38b-41d0-9776-f08a38d7ec8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a83dcebf-6486-4714-a980-2c69693849a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_069fe8d0-7c40-4f82-a10f-c485a58c3a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_578a4110-e38b-41d0-9776-f08a38d7ec8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_069fe8d0-7c40-4f82-a10f-c485a58c3a8c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5ef53473-5418-498a-9b50-cf2084ecf930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6d3c6711-b667-43f1-8bb8-8e739e056589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6d3c6711-b667-43f1-8bb8-8e739e056589" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_ca880937-016b-41e2-8f0b-7b9900f3bc13" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_ca880937-016b-41e2-8f0b-7b9900f3bc13" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b36e2577-9c70-41d3-ad90-d8fb0407b6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_ca880937-016b-41e2-8f0b-7b9900f3bc13" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b36e2577-9c70-41d3-ad90-d8fb0407b6bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_377fbf05-a398-4bb4-a7bb-f0c59fe78f92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_ca880937-016b-41e2-8f0b-7b9900f3bc13" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_377fbf05-a398-4bb4-a7bb-f0c59fe78f92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_40c920f9-ef93-4df3-8c21-bf476af10f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_40c920f9-ef93-4df3-8c21-bf476af10f83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_62181ea6-38d2-4fb2-85a3-64f5a3b2a3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_62181ea6-38d2-4fb2-85a3-64f5a3b2a3cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_7c2c4d48-7f25-4e5e-bf03-5febba2b37f3" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_7c2c4d48-7f25-4e5e-bf03-5febba2b37f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_91447b24-aea7-423a-98c0-7b7c89c9bbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_91447b24-aea7-423a-98c0-7b7c89c9bbb4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b4622648-f491-4733-a0f8-44a840df625a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b4622648-f491-4733-a0f8-44a840df625a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20a03a68-61c7-4595-8a42-b396b98c783e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_011c6458-be4b-49c4-9e7a-73f9de3ec7e3" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_011c6458-be4b-49c4-9e7a-73f9de3ec7e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_293bf91e-dcc4-49f7-93f6-5183d530cb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_293bf91e-dcc4-49f7-93f6-5183d530cb8f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_92d0e7d0-a414-466a-9672-b4d8cf52b69d" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_92d0e7d0-a414-466a-9672-b4d8cf52b69d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_d14e7fbc-5411-4ea7-92bb-2cbd38cad1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_92d0e7d0-a414-466a-9672-b4d8cf52b69d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_d14e7fbc-5411-4ea7-92bb-2cbd38cad1f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_641ad394-5159-4a3f-87df-c488a628673a" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_92d0e7d0-a414-466a-9672-b4d8cf52b69d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_641ad394-5159-4a3f-87df-c488a628673a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61a57859-88f1-4941-8d53-7f70cd03cb56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61a57859-88f1-4941-8d53-7f70cd03cb56" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_96745fe9-4e17-4e63-8f6d-01b4e99a3ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61a57859-88f1-4941-8d53-7f70cd03cb56" xlink:to="loc_us-gaap_AwardTypeAxis_96745fe9-4e17-4e63-8f6d-01b4e99a3ea5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96745fe9-4e17-4e63-8f6d-01b4e99a3ea5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_96745fe9-4e17-4e63-8f6d-01b4e99a3ea5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96745fe9-4e17-4e63-8f6d-01b4e99a3ea5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_975f5eda-160d-46bc-af30-c619b1b1fb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_96745fe9-4e17-4e63-8f6d-01b4e99a3ea5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_975f5eda-160d-46bc-af30-c619b1b1fb48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_af1a037d-26a9-4b51-9e3f-ebcd337ca9be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_975f5eda-160d-46bc-af30-c619b1b1fb48" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_af1a037d-26a9-4b51-9e3f-ebcd337ca9be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockUnitMember_fda02ccb-7eda-41cd-bd42-dcadb09491d5" xlink:href="dva-20211231.xsd#dva_StockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_975f5eda-160d-46bc-af30-c619b1b1fb48" xlink:to="loc_dva_StockUnitMember_fda02ccb-7eda-41cd-bd42-dcadb09491d5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails" xlink:type="extended" id="i6196dc938f0c4c61b3840aba6741232f_LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_dc654d3e-1fd8-4460-aa3a-51482b4abcef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_dc654d3e-1fd8-4460-aa3a-51482b4abcef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_bc1a7e74-7dfb-44bc-9f43-598e878ddf96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_bc1a7e74-7dfb-44bc-9f43-598e878ddf96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_dea6d4ac-1dce-4758-9eb1-347ccb51d62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_dea6d4ac-1dce-4758-9eb1-347ccb51d62c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_442fa0a3-fe3d-4798-914b-63ec04577d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_442fa0a3-fe3d-4798-914b-63ec04577d6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_83ec5e1b-bb7c-4134-b0a4-6289797cfca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_83ec5e1b-bb7c-4134-b0a4-6289797cfca4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_b82171a5-4254-42f9-a0d9-45b8ab963484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_b82171a5-4254-42f9-a0d9-45b8ab963484" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_0dd8c057-983e-400c-8cdf-d284e754da6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_0dd8c057-983e-400c-8cdf-d284e754da6d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_02e5d5f2-0e60-44b7-bd5e-8b9d0646b1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_0dd8c057-983e-400c-8cdf-d284e754da6d" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_02e5d5f2-0e60-44b7-bd5e-8b9d0646b1bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_02e5d5f2-0e60-44b7-bd5e-8b9d0646b1bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_02e5d5f2-0e60-44b7-bd5e-8b9d0646b1bd" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_02e5d5f2-0e60-44b7-bd5e-8b9d0646b1bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5d3f7269-66e4-40a4-83bc-f6d9e5186426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_02e5d5f2-0e60-44b7-bd5e-8b9d0646b1bd" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5d3f7269-66e4-40a4-83bc-f6d9e5186426" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeOneMember_a98493b5-4c87-4ba2-a054-1c0cae5e5840" xlink:href="dva-20211231.xsd#dva_RangeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5d3f7269-66e4-40a4-83bc-f6d9e5186426" xlink:to="loc_dva_RangeOneMember_a98493b5-4c87-4ba2-a054-1c0cae5e5840" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeTwoMember_f8a8fee3-5a1c-437e-ba83-b2e068b2387b" xlink:href="dva-20211231.xsd#dva_RangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5d3f7269-66e4-40a4-83bc-f6d9e5186426" xlink:to="loc_dva_RangeTwoMember_f8a8fee3-5a1c-437e-ba83-b2e068b2387b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeThreeMember_bebeb77b-0d95-4b81-acd0-0673371c0109" xlink:href="dva-20211231.xsd#dva_RangeThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5d3f7269-66e4-40a4-83bc-f6d9e5186426" xlink:to="loc_dva_RangeThreeMember_bebeb77b-0d95-4b81-acd0-0673371c0109" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeFourMember_097155c5-25ee-4460-b9f5-22d8299bea96" xlink:href="dva-20211231.xsd#dva_RangeFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5d3f7269-66e4-40a4-83bc-f6d9e5186426" xlink:to="loc_dva_RangeFourMember_097155c5-25ee-4460-b9f5-22d8299bea96" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails" xlink:type="extended" id="iedeb657bfa3d459fa5b3baca9f6b9ca7_LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea11b33e-6311-4640-9c80-9f4c1ad4dcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8292df84-a1fb-4508-bcf2-598a7df8a086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea11b33e-6311-4640-9c80-9f4c1ad4dcfa" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8292df84-a1fb-4508-bcf2-598a7df8a086" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_60628253-55a0-4f53-b79f-7a9112a620a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea11b33e-6311-4640-9c80-9f4c1ad4dcfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_60628253-55a0-4f53-b79f-7a9112a620a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ca4cfc16-3f1b-4b30-854d-2bf334db0dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea11b33e-6311-4640-9c80-9f4c1ad4dcfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ca4cfc16-3f1b-4b30-854d-2bf334db0dc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f06d0e91-b41b-4778-8ebf-7e0af7b5a22f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea11b33e-6311-4640-9c80-9f4c1ad4dcfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f06d0e91-b41b-4778-8ebf-7e0af7b5a22f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c15d036-ccae-4266-b6fb-a1d9e5010be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea11b33e-6311-4640-9c80-9f4c1ad4dcfa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c15d036-ccae-4266-b6fb-a1d9e5010be2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fc9ed172-74dc-419a-8f89-07e0c2c34170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c15d036-ccae-4266-b6fb-a1d9e5010be2" xlink:to="loc_us-gaap_AwardTypeAxis_fc9ed172-74dc-419a-8f89-07e0c2c34170" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fc9ed172-74dc-419a-8f89-07e0c2c34170_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_fc9ed172-74dc-419a-8f89-07e0c2c34170" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fc9ed172-74dc-419a-8f89-07e0c2c34170_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b085cdcb-7f64-48f0-9a6f-3721d91f09e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_fc9ed172-74dc-419a-8f89-07e0c2c34170" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b085cdcb-7f64-48f0-9a6f-3721d91f09e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockSettledStockAppreciationRightsMember_f1b7f18a-c48c-42eb-829e-3ab2a8b83f14" xlink:href="dva-20211231.xsd#dva_StockSettledStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b085cdcb-7f64-48f0-9a6f-3721d91f09e5" xlink:to="loc_dva_StockSettledStockAppreciationRightsMember_f1b7f18a-c48c-42eb-829e-3ab2a8b83f14" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails" xlink:type="extended" id="ic4801456d50649e2b503870c6ec0854f_LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8f5fd551-0b60-44d6-a8f9-591ce757c43b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8f5fd551-0b60-44d6-a8f9-591ce757c43b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_25f16e70-0d9d-4460-87eb-170e9273629a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_25f16e70-0d9d-4460-87eb-170e9273629a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ec66073e-1091-4a99-877e-aad296dcbcac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ec66073e-1091-4a99-877e-aad296dcbcac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_738a382d-c6a7-4023-9250-d57f05c4bf0f" xlink:href="dva-20211231.xsd#dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_738a382d-c6a7-4023-9250-d57f05c4bf0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_84f09561-6f6e-41b4-a573-197edbde47be" xlink:href="dva-20211231.xsd#dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_84f09561-6f6e-41b4-a573-197edbde47be" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_0e0fe807-fba7-4097-b92e-8a2e14a39e6a" xlink:href="dva-20211231.xsd#dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_0e0fe807-fba7-4097-b92e-8a2e14a39e6a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_586d406e-c50e-4612-9c33-61dca7550d7d" xlink:href="dva-20211231.xsd#dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_586d406e-c50e-4612-9c33-61dca7550d7d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_24b9159d-dab1-4eca-b5e2-c8bb0d739fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_24b9159d-dab1-4eca-b5e2-c8bb0d739fb8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_1fce041d-fca1-409a-9581-ebdce468685b" xlink:href="dva-20211231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_1fce041d-fca1-409a-9581-ebdce468685b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_e00f3d16-3fea-4d07-a8b9-248cb783e35e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_e00f3d16-3fea-4d07-a8b9-248cb783e35e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_01aaf03c-ac93-4c5f-ad4d-065e200bc51e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_01aaf03c-ac93-4c5f-ad4d-065e200bc51e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_5e816783-f138-4a11-98e9-7e2357da577f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_5e816783-f138-4a11-98e9-7e2357da577f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_8aad2577-71a6-4d16-9675-1b3070bbfb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_8aad2577-71a6-4d16-9675-1b3070bbfb6f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_69ce4d56-2117-43df-8917-a6958dd975dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_69ce4d56-2117-43df-8917-a6958dd975dc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumPricedAwardBasePricePerShare_b58cd183-9854-4e0b-9321-001f68806bbf" xlink:href="dva-20211231.xsd#dva_PremiumPricedAwardBasePricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_PremiumPricedAwardBasePricePerShare_b58cd183-9854-4e0b-9321-001f68806bbf" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumToTheTenderOfferSharePurchasePrice_85d24125-9dd1-4dbf-a159-333acdacce14" xlink:href="dva-20211231.xsd#dva_PremiumToTheTenderOfferSharePurchasePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_PremiumToTheTenderOfferSharePurchasePrice_85d24125-9dd1-4dbf-a159-333acdacce14" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_67f848f2-8b8a-4080-8ee5-b74b92125b46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_67f848f2-8b8a-4080-8ee5-b74b92125b46" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_758e1a07-ae3a-4b8f-9327-6d1580a60da5" xlink:href="dva-20211231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_758e1a07-ae3a-4b8f-9327-6d1580a60da5" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_5f2152bd-05af-438e-8ad4-220c1f7c0d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_5f2152bd-05af-438e-8ad4-220c1f7c0d96" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_1ba11117-750d-4ca2-847e-1be49adfbc0b" xlink:href="dva-20211231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_1ba11117-750d-4ca2-847e-1be49adfbc0b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_f8418b37-7bd5-4182-9ede-908294d892c1" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_f8418b37-7bd5-4182-9ede-908294d892c1" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1e5d5638-e79f-4b37-9206-ca3bbea122dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1e5d5638-e79f-4b37-9206-ca3bbea122dd" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_4508cb72-d2b4-4887-802e-1f0ad543594c" xlink:href="dva-20211231.xsd#dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_4508cb72-d2b4-4887-802e-1f0ad543594c" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_42f77e72-46b8-440b-b23b-2456e2a720fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_42f77e72-46b8-440b-b23b-2456e2a720fa" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f76d91ff-f5d9-4c6e-b295-5faeb39a4944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f76d91ff-f5d9-4c6e-b295-5faeb39a4944" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a44e87df-b7fa-4124-91b5-19e7de8159d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a44e87df-b7fa-4124-91b5-19e7de8159d6" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_d30171ff-92af-44ee-b67a-3de22e37307f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_d30171ff-92af-44ee-b67a-3de22e37307f" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e6bcf08f-0617-49f2-ae45-a9cb84550e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e6bcf08f-0617-49f2-ae45-a9cb84550e75" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c268df96-6068-4e4f-995e-184a3996dc87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensation_c268df96-6068-4e4f-995e-184a3996dc87" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_444d1a7c-9b0f-49c9-b515-5246e6faafe3" xlink:href="dva-20211231.xsd#dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_444d1a7c-9b0f-49c9-b515-5246e6faafe3" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_06d8a382-a82e-4e2c-98fd-1dcc688c94ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_06d8a382-a82e-4e2c-98fd-1dcc688c94ff" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9bddf630-e082-453f-b07d-7a3230ce6402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9bddf630-e082-453f-b07d-7a3230ce6402" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_757f0c38-940e-4f7a-a08f-6f14a6204e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_757f0c38-940e-4f7a-a08f-6f14a6204e33" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_d1bf0f6d-7275-4bbe-8c28-ae424a77f136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_d1bf0f6d-7275-4bbe-8c28-ae424a77f136" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c660f6c6-898a-4445-ab34-01bf78867fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:to="loc_us-gaap_PlanNameAxis_c660f6c6-898a-4445-ab34-01bf78867fe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c660f6c6-898a-4445-ab34-01bf78867fe0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_c660f6c6-898a-4445-ab34-01bf78867fe0" xlink:to="loc_us-gaap_PlanNameDomain_c660f6c6-898a-4445-ab34-01bf78867fe0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_551a4cae-e995-4e27-97a2-0d965a2b6a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_c660f6c6-898a-4445-ab34-01bf78867fe0" xlink:to="loc_us-gaap_PlanNameDomain_551a4cae-e995-4e27-97a2-0d965a2b6a9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockIncentivePlanTwentyTwentyMember_32b90196-ac11-4cff-91a7-fb4c14e3886b" xlink:href="dva-20211231.xsd#dva_StockIncentivePlanTwentyTwentyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_551a4cae-e995-4e27-97a2-0d965a2b6a9c" xlink:to="loc_dva_StockIncentivePlanTwentyTwentyMember_32b90196-ac11-4cff-91a7-fb4c14e3886b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockIncentivePlanTwentyElevenMember_70cb9c92-2516-405a-9825-a2e3598f51ab" xlink:href="dva-20211231.xsd#dva_StockIncentivePlanTwentyElevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_551a4cae-e995-4e27-97a2-0d965a2b6a9c" xlink:to="loc_dva_StockIncentivePlanTwentyElevenMember_70cb9c92-2516-405a-9825-a2e3598f51ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_f602cc34-1ecc-4cd7-80dd-99a4bc349ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:to="loc_us-gaap_VestingAxis_f602cc34-1ecc-4cd7-80dd-99a4bc349ed2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_f602cc34-1ecc-4cd7-80dd-99a4bc349ed2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_f602cc34-1ecc-4cd7-80dd-99a4bc349ed2" xlink:to="loc_us-gaap_VestingDomain_f602cc34-1ecc-4cd7-80dd-99a4bc349ed2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_c4016264-86f1-43d5-ba80-848baae9c868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_f602cc34-1ecc-4cd7-80dd-99a4bc349ed2" xlink:to="loc_us-gaap_VestingDomain_c4016264-86f1-43d5-ba80-848baae9c868" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1b7110c1-fc65-4e52-8b4a-19b412e16303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_c4016264-86f1-43d5-ba80-848baae9c868" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1b7110c1-fc65-4e52-8b4a-19b412e16303" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_314224f1-2a48-447a-8c2d-e68b3d642aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_c4016264-86f1-43d5-ba80-848baae9c868" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_314224f1-2a48-447a-8c2d-e68b3d642aea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c7e078b8-098f-4752-9105-422b8e1d57d2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:to="loc_srt_RangeAxis_c7e078b8-098f-4752-9105-422b8e1d57d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c7e078b8-098f-4752-9105-422b8e1d57d2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c7e078b8-098f-4752-9105-422b8e1d57d2" xlink:to="loc_srt_RangeMember_c7e078b8-098f-4752-9105-422b8e1d57d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8faefe06-6429-40fb-858d-1c23149d6a2c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c7e078b8-098f-4752-9105-422b8e1d57d2" xlink:to="loc_srt_RangeMember_8faefe06-6429-40fb-858d-1c23149d6a2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_93e60f8f-47f4-40cb-bb59-a0d31ce9cb2d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8faefe06-6429-40fb-858d-1c23149d6a2c" xlink:to="loc_srt_MinimumMember_93e60f8f-47f4-40cb-bb59-a0d31ce9cb2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d3f8e92c-2a7e-4017-8ec6-c477240603b3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8faefe06-6429-40fb-858d-1c23149d6a2c" xlink:to="loc_srt_MaximumMember_d3f8e92c-2a7e-4017-8ec6-c477240603b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0d40bd94-b64a-4601-a0f7-50eb3a2dd0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:to="loc_us-gaap_AwardTypeAxis_0d40bd94-b64a-4601-a0f7-50eb3a2dd0bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0d40bd94-b64a-4601-a0f7-50eb3a2dd0bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0d40bd94-b64a-4601-a0f7-50eb3a2dd0bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0d40bd94-b64a-4601-a0f7-50eb3a2dd0bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32062b2c-7eea-4166-b7ba-5a379069f36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0d40bd94-b64a-4601-a0f7-50eb3a2dd0bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32062b2c-7eea-4166-b7ba-5a379069f36f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumPricedStockSettledStockAppreciationRightsMember_1afddf80-e885-448b-938f-8215d40c79e7" xlink:href="dva-20211231.xsd#dva_PremiumPricedStockSettledStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32062b2c-7eea-4166-b7ba-5a379069f36f" xlink:to="loc_dva_PremiumPricedStockSettledStockAppreciationRightsMember_1afddf80-e885-448b-938f-8215d40c79e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeeStockPurchasePlanMember_c4b70832-428a-4fd8-a646-f474a73220c8" xlink:href="dva-20211231.xsd#dva_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32062b2c-7eea-4166-b7ba-5a379069f36f" xlink:to="loc_dva_EmployeeStockPurchasePlanMember_c4b70832-428a-4fd8-a646-f474a73220c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_14d033cb-5950-44dc-9719-75923a09a2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_14d033cb-5950-44dc-9719-75923a09a2f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_14d033cb-5950-44dc-9719-75923a09a2f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_14d033cb-5950-44dc-9719-75923a09a2f2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_14d033cb-5950-44dc-9719-75923a09a2f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_737a4b59-fc0d-4fcc-aee7-27034f5c624d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_14d033cb-5950-44dc-9719-75923a09a2f2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_737a4b59-fc0d-4fcc-aee7-27034f5c624d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_244a20c8-a8a3-48ca-8108-1135a1476329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_737a4b59-fc0d-4fcc-aee7-27034f5c624d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_244a20c8-a8a3-48ca-8108-1135a1476329" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/StockRepurchasesTenderOfferDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#StockRepurchasesTenderOfferDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/StockRepurchasesTenderOfferDetails" xlink:type="extended" id="i7cd69559a5364d038d19eb584dd026e7_StockRepurchasesTenderOfferDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e9401232-f0a5-40a6-af6b-125ec264e180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_d7263442-a33b-488e-9030-249c8bb4c09b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e9401232-f0a5-40a6-af6b-125ec264e180" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_d7263442-a33b-488e-9030-249c8bb4c09b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_67bfe197-3668-42fb-ac25-80fae33b6284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e9401232-f0a5-40a6-af6b-125ec264e180" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_67bfe197-3668-42fb-ac25-80fae33b6284" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_077e4caa-a6c9-4a0b-a853-1948b630d99e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e9401232-f0a5-40a6-af6b-125ec264e180" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_077e4caa-a6c9-4a0b-a853-1948b630d99e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAbstract_bf355a7a-9e84-4a4e-8b33-3dbc1aeca7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e9401232-f0a5-40a6-af6b-125ec264e180" xlink:to="loc_us-gaap_TreasuryStockSharesAbstract_bf355a7a-9e84-4a4e-8b33-3dbc1aeca7d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_8351d671-e758-4440-81d3-ae2a3a1e1bb2" xlink:href="dva-20211231.xsd#dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_bf355a7a-9e84-4a4e-8b33-3dbc1aeca7d3" xlink:to="loc_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_8351d671-e758-4440-81d3-ae2a3a1e1bb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareRepurchaseFeesAndExpenses_be95348a-babd-47f1-808f-409a9dac06a7" xlink:href="dva-20211231.xsd#dva_ShareRepurchaseFeesAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_bf355a7a-9e84-4a4e-8b33-3dbc1aeca7d3" xlink:to="loc_dva_ShareRepurchaseFeesAndExpenses_be95348a-babd-47f1-808f-409a9dac06a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_2db647a4-b8d5-4aec-862b-d9760cde446c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e9401232-f0a5-40a6-af6b-125ec264e180" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_2db647a4-b8d5-4aec-862b-d9760cde446c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_308a36ed-479a-406b-accb-442e60ede78d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_2db647a4-b8d5-4aec-862b-d9760cde446c" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_308a36ed-479a-406b-accb-442e60ede78d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_308a36ed-479a-406b-accb-442e60ede78d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_308a36ed-479a-406b-accb-442e60ede78d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_308a36ed-479a-406b-accb-442e60ede78d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_699713f4-07f8-4e4a-89e9-fd1c019e90a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_308a36ed-479a-406b-accb-442e60ede78d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_699713f4-07f8-4e4a-89e9-fd1c019e90a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OpenMarketPurchasesMember_f499e6a1-61a7-4191-a682-70f5ae4aebf4" xlink:href="dva-20211231.xsd#dva_OpenMarketPurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_699713f4-07f8-4e4a-89e9-fd1c019e90a2" xlink:to="loc_dva_OpenMarketPurchasesMember_f499e6a1-61a7-4191-a682-70f5ae4aebf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TenderOfferMember_9438416c-9e6d-406b-bc6f-73c777b971b1" xlink:href="dva-20211231.xsd#dva_TenderOfferMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_699713f4-07f8-4e4a-89e9-fd1c019e90a2" xlink:to="loc_dva_TenderOfferMember_9438416c-9e6d-406b-bc6f-73c777b971b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails" xlink:type="extended" id="i862eaf11d6f744b0b711a0f7b897d0cf_ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_4da42bd3-b033-48d1-8496-ca805aeff203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_92857f66-c658-4106-995f-a3f8174042f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_4da42bd3-b033-48d1-8496-ca805aeff203" xlink:to="loc_us-gaap_NetIncomeLoss_92857f66-c658-4106-995f-a3f8174042f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_4da42bd3-b033-48d1-8496-ca805aeff203" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_2fb93980-b310-4c62-9af2-4dfa166c6b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_2fb93980-b310-4c62-9af2-4dfa166c6b6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_0aafe3ac-91b2-4580-bc81-8499b65ec3ef" xlink:href="dva-20211231.xsd#dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:to="loc_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_0aafe3ac-91b2-4580-bc81-8499b65ec3ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_518c6880-a3c1-48ed-8843-6e3048ee00b7" xlink:href="dva-20211231.xsd#dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:to="loc_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_518c6880-a3c1-48ed-8843-6e3048ee00b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_40ba3d82-a8c6-4666-a376-b82fac1c4486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_40ba3d82-a8c6-4666-a376-b82fac1c4486" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_936bb82f-17e1-46b7-b0e6-38720a03a219" xlink:href="dva-20211231.xsd#dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:to="loc_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_936bb82f-17e1-46b7-b0e6-38720a03a219" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_6ef4095c-d2c0-4b64-9830-6c5d38cd0eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_4da42bd3-b033-48d1-8496-ca805aeff203" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_6ef4095c-d2c0-4b64-9830-6c5d38cd0eda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_90a738f6-2d6e-4f34-be42-9b1de7308581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_6ef4095c-d2c0-4b64-9830-6c5d38cd0eda" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_90a738f6-2d6e-4f34-be42-9b1de7308581" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_90a738f6-2d6e-4f34-be42-9b1de7308581_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_90a738f6-2d6e-4f34-be42-9b1de7308581" xlink:to="loc_us-gaap_EquityComponentDomain_90a738f6-2d6e-4f34-be42-9b1de7308581_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_eba9398d-9595-428c-a4a8-ca678b7b93d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_90a738f6-2d6e-4f34-be42-9b1de7308581" xlink:to="loc_us-gaap_EquityComponentDomain_eba9398d-9595-428c-a4a8-ca678b7b93d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_49045594-6690-4e71-b85d-f182abb5b766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_eba9398d-9595-428c-a4a8-ca678b7b93d0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_49045594-6690-4e71-b85d-f182abb5b766" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShareholdersequityDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#ShareholdersequityDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/ShareholdersequityDetails" xlink:type="extended" id="if22211fd601a46d4b1747f41085d2b2b_ShareholdersequityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c45fccbf-0c86-4f57-90a0-5038a1a9d0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c45fccbf-0c86-4f57-90a0-5038a1a9d0d0" xlink:to="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_26476391-d6c4-434b-a766-ca7eaf15aa41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_26476391-d6c4-434b-a766-ca7eaf15aa41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_67e2b044-7810-4742-b4d3-b9f5833e71e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_67e2b044-7810-4742-b4d3-b9f5833e71e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_999a0848-679f-444f-a7f3-5ca92f1aa61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_999a0848-679f-444f-a7f3-5ca92f1aa61c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_8f1102f8-6cb1-4ee8-8c6a-849cbafb1944" xlink:href="dva-20211231.xsd#dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_8f1102f8-6cb1-4ee8-8c6a-849cbafb1944" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4aa687b1-eb2b-440d-8059-dd572d5daf26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4aa687b1-eb2b-440d-8059-dd572d5daf26" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c92eb571-c110-4d04-9a82-6ebbef60cbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c92eb571-c110-4d04-9a82-6ebbef60cbe9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_6852d9f4-1893-4264-97a6-1d63efb0c80f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_6852d9f4-1893-4264-97a6-1d63efb0c80f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CharterdocumentsandDelawarelawAbstract_85fe226c-cad9-4380-ac6b-70dd2a2b3db6" xlink:href="dva-20211231.xsd#dva_CharterdocumentsandDelawarelawAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c45fccbf-0c86-4f57-90a0-5038a1a9d0d0" xlink:to="loc_dva_CharterdocumentsandDelawarelawAbstract_85fe226c-cad9-4380-ac6b-70dd2a2b3db6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b312ef20-b623-4779-9d4e-7798c4ce69c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract_85fe226c-cad9-4380-ac6b-70dd2a2b3db6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b312ef20-b623-4779-9d4e-7798c4ce69c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_5c3f4645-6abd-41d7-9000-71b4c82478a1" xlink:href="dva-20211231.xsd#dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract_85fe226c-cad9-4380-ac6b-70dd2a2b3db6" xlink:to="loc_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_5c3f4645-6abd-41d7-9000-71b4c82478a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_c58220fb-b57d-4c70-a8dd-9bbd33af5e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract_85fe226c-cad9-4380-ac6b-70dd2a2b3db6" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_c58220fb-b57d-4c70-a8dd-9bbd33af5e1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_52769925-305e-4566-add3-139dc54562be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c45fccbf-0c86-4f57-90a0-5038a1a9d0d0" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_52769925-305e-4566-add3-139dc54562be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_89031451-2375-421c-bf65-bece390b5944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_52769925-305e-4566-add3-139dc54562be" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_89031451-2375-421c-bf65-bece390b5944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_89031451-2375-421c-bf65-bece390b5944_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_89031451-2375-421c-bf65-bece390b5944" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_89031451-2375-421c-bf65-bece390b5944_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_03ccb939-3922-4d39-9402-fa832a6c442a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_89031451-2375-421c-bf65-bece390b5944" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_03ccb939-3922-4d39-9402-fa832a6c442a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_00f3570b-a4e0-4550-bdb3-1c71339525f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_03ccb939-3922-4d39-9402-fa832a6c442a" xlink:to="loc_us-gaap_SubsequentEventMember_00f3570b-a4e0-4550-bdb3-1c71339525f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_182beaec-7dc6-4c3f-8fb3-ff04d552d7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_52769925-305e-4566-add3-139dc54562be" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_182beaec-7dc6-4c3f-8fb3-ff04d552d7fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_182beaec-7dc6-4c3f-8fb3-ff04d552d7fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_182beaec-7dc6-4c3f-8fb3-ff04d552d7fd" xlink:to="loc_us-gaap_EquityComponentDomain_182beaec-7dc6-4c3f-8fb3-ff04d552d7fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1933790f-ad08-4740-875d-282da9a47544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_182beaec-7dc6-4c3f-8fb3-ff04d552d7fd" xlink:to="loc_us-gaap_EquityComponentDomain_1933790f-ad08-4740-875d-282da9a47544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_19c0c168-c863-492a-a234-22487d7f24a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1933790f-ad08-4740-875d-282da9a47544" xlink:to="loc_us-gaap_TreasuryStockMember_19c0c168-c863-492a-a234-22487d7f24a7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#AccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended" id="i67cf61e8475a4f4c88e053c66e502c5c_AccumulatedOtherComprehensiveLossIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e635c7a7-8790-43ef-b293-8d5ff1334f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e635c7a7-8790-43ef-b293-8d5ff1334f8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_84ea8113-b92d-49cd-ad7c-32b97fb93131" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_84ea8113-b92d-49cd-ad7c-32b97fb93131" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_7584f32a-9181-4739-b81f-f381439471d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_7584f32a-9181-4739-b81f-f381439471d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_6ade09d6-3123-4e98-a3d6-257c92b3bc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_6ade09d6-3123-4e98-a3d6-257c92b3bc6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_8893e718-2392-4f26-b6e4-6f6f63c4cf58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_8893e718-2392-4f26-b6e4-6f6f63c4cf58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7ddeb584-88b0-4c21-8949-896b2941d69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7ddeb584-88b0-4c21-8949-896b2941d69f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_035dc033-5836-45d2-b856-76edbd657058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_035dc033-5836-45d2-b856-76edbd657058" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f4e2696a-6922-4054-a196-cef7ca8bd8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d9beb75b-1aea-4acd-83cb-c1be5f9d82df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d9beb75b-1aea-4acd-83cb-c1be5f9d82df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_24fadc90-597b-4eb5-ad4a-cce2ce8faea8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d9beb75b-1aea-4acd-83cb-c1be5f9d82df" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_24fadc90-597b-4eb5-ad4a-cce2ce8faea8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_24fadc90-597b-4eb5-ad4a-cce2ce8faea8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_24fadc90-597b-4eb5-ad4a-cce2ce8faea8" xlink:to="loc_us-gaap_EquityComponentDomain_24fadc90-597b-4eb5-ad4a-cce2ce8faea8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0f97554e-914e-4e7c-9878-d4c2b55deef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_24fadc90-597b-4eb5-ad4a-cce2ce8faea8" xlink:to="loc_us-gaap_EquityComponentDomain_0f97554e-914e-4e7c-9878-d4c2b55deef2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_54de4232-4ab5-4fe8-9565-411dcdbce6db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0f97554e-914e-4e7c-9878-d4c2b55deef2" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_54de4232-4ab5-4fe8-9565-411dcdbce6db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_0875059e-e16c-4e7d-8af2-5bd68f768edb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0f97554e-914e-4e7c-9878-d4c2b55deef2" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_0875059e-e16c-4e7d-8af2-5bd68f768edb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_adf07f39-b203-49da-bf5a-93bf53bee7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0f97554e-914e-4e7c-9878-d4c2b55deef2" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_adf07f39-b203-49da-bf5a-93bf53bee7e4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#AcquisitionsComponentsofRoutineAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails" xlink:type="extended" id="i32c7fd463d9140aaa10ba88b9ca36afa_AcquisitionsComponentsofRoutineAcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1deb9dab-8b9b-4905-ae85-63c3e0fcebf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1deb9dab-8b9b-4905-ae85-63c3e0fcebf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_a62872ef-9c00-4658-8006-5976a6a2693f" xlink:href="dva-20211231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_a62872ef-9c00-4658-8006-5976a6a2693f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_8096312e-3678-4fb7-ab9a-a8d18c74025b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_8096312e-3678-4fb7-ab9a-a8d18c74025b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_43af7c2f-0ac2-4c7e-8256-f0de14079258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_43af7c2f-0ac2-4c7e-8256-f0de14079258" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_fc2e7744-0c14-4bb1-90da-52599d65e2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_fc2e7744-0c14-4bb1-90da-52599d65e2d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_7880ff0f-fda6-462b-baba-77936f4579c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_7880ff0f-fda6-462b-baba-77936f4579c1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dd470d23-0624-41fb-8118-fe693fd4adc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dd470d23-0624-41fb-8118-fe693fd4adc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3801424e-7c4e-42ce-817d-973e1f7341ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dd470d23-0624-41fb-8118-fe693fd4adc6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3801424e-7c4e-42ce-817d-973e1f7341ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3801424e-7c4e-42ce-817d-973e1f7341ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3801424e-7c4e-42ce-817d-973e1f7341ea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3801424e-7c4e-42ce-817d-973e1f7341ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9900b322-fdc6-4333-8638-73432f783418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3801424e-7c4e-42ce-817d-973e1f7341ea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9900b322-fdc6-4333-8638-73432f783418" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_f296bf01-09a1-4e02-839d-c7d75f88f2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9900b322-fdc6-4333-8638-73432f783418" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_f296bf01-09a1-4e02-839d-c7d75f88f2ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0e15d3d5-a959-41a8-b730-1667f9bc7b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dd470d23-0624-41fb-8118-fe693fd4adc6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0e15d3d5-a959-41a8-b730-1667f9bc7b09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0e15d3d5-a959-41a8-b730-1667f9bc7b09_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0e15d3d5-a959-41a8-b730-1667f9bc7b09" xlink:to="loc_us-gaap_SegmentDomain_0e15d3d5-a959-41a8-b730-1667f9bc7b09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_45e5e683-51f5-4cfc-842b-157f0a1f26e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0e15d3d5-a959-41a8-b730-1667f9bc7b09" xlink:to="loc_us-gaap_SegmentDomain_45e5e683-51f5-4cfc-842b-157f0a1f26e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_615b977b-7d67-416d-8312-a871fdbdb623" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_45e5e683-51f5-4cfc-842b-157f0a1f26e3" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_615b977b-7d67-416d-8312-a871fdbdb623" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignDialysisCentersMember_ca3840f8-174f-4c27-a7aa-f19f4e41db1f" xlink:href="dva-20211231.xsd#dva_ForeignDialysisCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_45e5e683-51f5-4cfc-842b-157f0a1f26e3" xlink:to="loc_dva_ForeignDialysisCentersMember_ca3840f8-174f-4c27-a7aa-f19f4e41db1f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#AcquisitionsAssetsacquiredandliabilitiesassumedDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails" xlink:type="extended" id="i1781654df96645568d0c84ab45f2894d_AcquisitionsAssetsacquiredandliabilitiesassumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_73e2b5c3-ef6f-4677-94c5-a1ccef1f06ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_73e2b5c3-ef6f-4677-94c5-a1ccef1f06ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8a0f3504-4d7d-4c23-a0b8-df5b06072f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8a0f3504-4d7d-4c23-a0b8-df5b06072f0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2a61e560-ea70-4216-82d9-92de6d4730a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2a61e560-ea70-4216-82d9-92de6d4730a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9d2089f4-5574-4b23-ac4b-19b71b341cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9d2089f4-5574-4b23-ac4b-19b71b341cc5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_1caaf964-b318-4664-9fc2-bd4fb9555428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_1caaf964-b318-4664-9fc2-bd4fb9555428" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e5969a35-932b-4c0a-911c-bb517d5df139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_Goodwill_e5969a35-932b-4c0a-911c-bb517d5df139" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_74b4b824-60c7-43b0-a597-7a1ef30d084a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_74b4b824-60c7-43b0-a597-7a1ef30d084a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_d7f1053e-2fd8-474a-9294-89403708d3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_d7f1053e-2fd8-474a-9294-89403708d3a8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_81e1aa6b-9b0f-46ba-a33a-2fc3a7801840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_81e1aa6b-9b0f-46ba-a33a-2fc3a7801840" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5dce728c-d64f-4ec4-a045-14f250c8284e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5dce728c-d64f-4ec4-a045-14f250c8284e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dc507b80-23b9-449c-a1fe-558ed9c8a682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dc507b80-23b9-449c-a1fe-558ed9c8a682" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_207ed600-c586-4079-a6ae-e8a38126090f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dc507b80-23b9-449c-a1fe-558ed9c8a682" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_207ed600-c586-4079-a6ae-e8a38126090f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_207ed600-c586-4079-a6ae-e8a38126090f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_207ed600-c586-4079-a6ae-e8a38126090f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_207ed600-c586-4079-a6ae-e8a38126090f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc3b70ae-9cc8-4640-afbb-94dd6d5f7b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_207ed600-c586-4079-a6ae-e8a38126090f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc3b70ae-9cc8-4640-afbb-94dd6d5f7b9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_b365d00b-c46e-4c05-a45f-9c6146de5082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc3b70ae-9cc8-4640-afbb-94dd6d5f7b9e" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_b365d00b-c46e-4c05-a45f-9c6146de5082" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails" xlink:type="extended" id="i310064d2c5f5436393295ec8fe3bf3cd_ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_239cdeab-112d-40be-a970-912fa23c44ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_95727be0-2189-4013-b7f0-23d80eddef6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_239cdeab-112d-40be-a970-912fa23c44ac" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_95727be0-2189-4013-b7f0-23d80eddef6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_d00a8504-479d-4b19-8352-283c0d2a4b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_239cdeab-112d-40be-a970-912fa23c44ac" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_d00a8504-479d-4b19-8352-283c0d2a4b3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66c3a278-f99f-4fa0-91ed-46fc87dcbdbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_239cdeab-112d-40be-a970-912fa23c44ac" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66c3a278-f99f-4fa0-91ed-46fc87dcbdbf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d23aef9-e3f4-435b-ab83-c72b5515a200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66c3a278-f99f-4fa0-91ed-46fc87dcbdbf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d23aef9-e3f4-435b-ab83-c72b5515a200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9d23aef9-e3f4-435b-ab83-c72b5515a200_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d23aef9-e3f4-435b-ab83-c72b5515a200" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9d23aef9-e3f4-435b-ab83-c72b5515a200_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68666888-608c-4961-8dd7-38dffd3205ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d23aef9-e3f4-435b-ab83-c72b5515a200" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68666888-608c-4961-8dd7-38dffd3205ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_76974447-f635-49db-8532-12fb7b33a187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68666888-608c-4961-8dd7-38dffd3205ad" xlink:to="loc_us-gaap_CustomerRelationshipsMember_76974447-f635-49db-8532-12fb7b33a187" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_d2f1a178-7c4c-44cb-8293-be47112771cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68666888-608c-4961-8dd7-38dffd3205ad" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_d2f1a178-7c4c-44cb-8293-be47112771cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_af115f03-62a3-4622-b8b2-a1c0df85ae5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66c3a278-f99f-4fa0-91ed-46fc87dcbdbf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_af115f03-62a3-4622-b8b2-a1c0df85ae5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af115f03-62a3-4622-b8b2-a1c0df85ae5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_af115f03-62a3-4622-b8b2-a1c0df85ae5b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af115f03-62a3-4622-b8b2-a1c0df85ae5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a7aaeeb3-d82d-41be-bef0-096770e3c35d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_af115f03-62a3-4622-b8b2-a1c0df85ae5b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a7aaeeb3-d82d-41be-bef0-096770e3c35d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_01685bc2-c516-450f-9f20-2c2f13b9984d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a7aaeeb3-d82d-41be-bef0-096770e3c35d" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_01685bc2-c516-450f-9f20-2c2f13b9984d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails" xlink:type="extended" id="i1d699da572784e8c8564c97e3d4a8bca_AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e4dcb466-47cc-41ab-8911-0e5597f90aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e4dcb466-47cc-41ab-8911-0e5597f90aae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_735219da-6612-4667-81fe-3113f96f294a" xlink:href="dva-20211231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_735219da-6612-4667-81fe-3113f96f294a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_45cae2be-35a1-42da-bfc4-e4b8b0880e61" xlink:href="dva-20211231.xsd#dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:to="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_45cae2be-35a1-42da-bfc4-e4b8b0880e61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_584c7b2b-841a-44f7-b0b0-abdc5f0efba7" xlink:href="dva-20211231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_584c7b2b-841a-44f7-b0b0-abdc5f0efba7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments_45d0cb81-a8d3-4fdd-855e-bd9287a77e3d" xlink:href="dva-20211231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments_45d0cb81-a8d3-4fdd-855e-bd9287a77e3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e6a0bebc-f39b-4455-9075-6f6bf98aa2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c18543df-21b2-4ca1-8053-b96bdc4012a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c18543df-21b2-4ca1-8053-b96bdc4012a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9f58d2c9-5f0a-493b-bfe3-11d55514780d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c18543df-21b2-4ca1-8053-b96bdc4012a9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9f58d2c9-5f0a-493b-bfe3-11d55514780d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f58d2c9-5f0a-493b-bfe3-11d55514780d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9f58d2c9-5f0a-493b-bfe3-11d55514780d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f58d2c9-5f0a-493b-bfe3-11d55514780d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b89822-bd9d-4632-9118-45fa0452286d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9f58d2c9-5f0a-493b-bfe3-11d55514780d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b89822-bd9d-4632-9118-45fa0452286d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_9ceacb92-75f3-4163-b738-8f7930b7e8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b89822-bd9d-4632-9118-45fa0452286d" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_9ceacb92-75f3-4163-b738-8f7930b7e8f4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#AcquisitionsandDivestituresAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails" xlink:type="extended" id="i36aed8910c224df5a7ad54e5ed4c1ad5_AcquisitionsandDivestituresAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_52b32c32-fb71-4801-ae9d-501ce85150c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_d69e63fc-4465-4e83-a539-22f65215c04c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52b32c32-fb71-4801-ae9d-501ce85150c1" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_d69e63fc-4465-4e83-a539-22f65215c04c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eb58c720-f815-4197-8221-3b7ee946a513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52b32c32-fb71-4801-ae9d-501ce85150c1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eb58c720-f815-4197-8221-3b7ee946a513" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_c4d5da8a-55d3-434f-9bea-517616e08e8c" xlink:href="dva-20211231.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52b32c32-fb71-4801-ae9d-501ce85150c1" xlink:to="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_c4d5da8a-55d3-434f-9bea-517616e08e8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_2943e311-606c-40d0-822d-65f9af9f9647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52b32c32-fb71-4801-ae9d-501ce85150c1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_2943e311-606c-40d0-822d-65f9af9f9647" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52b32c32-fb71-4801-ae9d-501ce85150c1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cfa96240-7a92-4aab-8a3a-24de5c26a0cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:to="loc_srt_RangeAxis_cfa96240-7a92-4aab-8a3a-24de5c26a0cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cfa96240-7a92-4aab-8a3a-24de5c26a0cf_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cfa96240-7a92-4aab-8a3a-24de5c26a0cf" xlink:to="loc_srt_RangeMember_cfa96240-7a92-4aab-8a3a-24de5c26a0cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f0ea140-6bff-4210-9397-5be451630191" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cfa96240-7a92-4aab-8a3a-24de5c26a0cf" xlink:to="loc_srt_RangeMember_6f0ea140-6bff-4210-9397-5be451630191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b293cd48-de06-4097-8466-5a1d4bdff633" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6f0ea140-6bff-4210-9397-5be451630191" xlink:to="loc_srt_MinimumMember_b293cd48-de06-4097-8466-5a1d4bdff633" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5c8c0381-4c3b-42fe-adc8-dc19396298d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6f0ea140-6bff-4210-9397-5be451630191" xlink:to="loc_srt_MaximumMember_5c8c0381-4c3b-42fe-adc8-dc19396298d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ae7e3f50-d472-4299-8c00-94392ee24aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ae7e3f50-d472-4299-8c00-94392ee24aeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ae7e3f50-d472-4299-8c00-94392ee24aeb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ae7e3f50-d472-4299-8c00-94392ee24aeb" xlink:to="loc_us-gaap_RelatedPartyDomain_ae7e3f50-d472-4299-8c00-94392ee24aeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_501abe12-f07e-4763-9941-2d861469d58d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ae7e3f50-d472-4299-8c00-94392ee24aeb" xlink:to="loc_us-gaap_RelatedPartyDomain_501abe12-f07e-4763-9941-2d861469d58d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember_c372dfa7-de40-4aec-b906-d537f29c614b" xlink:href="dva-20211231.xsd#dva_OtherCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_501abe12-f07e-4763-9941-2d861469d58d" xlink:to="loc_dva_OtherCompaniesMember_c372dfa7-de40-4aec-b906-d537f29c614b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_facff708-5e56-4b7a-90b9-e409e4ce1dee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_facff708-5e56-4b7a-90b9-e409e4ce1dee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_facff708-5e56-4b7a-90b9-e409e4ce1dee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_facff708-5e56-4b7a-90b9-e409e4ce1dee" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_facff708-5e56-4b7a-90b9-e409e4ce1dee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_24debe17-fb72-4b1a-b983-8e01715f2fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_facff708-5e56-4b7a-90b9-e409e4ce1dee" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_24debe17-fb72-4b1a-b983-8e01715f2fd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_5a78aeda-16f6-4722-9cb8-c6392b012100" xlink:href="dva-20211231.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_24debe17-fb72-4b1a-b983-8e01715f2fd4" xlink:to="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_5a78aeda-16f6-4722-9cb8-c6392b012100" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_79279885-72f5-4656-b318-d99a96fe75dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_79279885-72f5-4656-b318-d99a96fe75dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_79279885-72f5-4656-b318-d99a96fe75dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_79279885-72f5-4656-b318-d99a96fe75dd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_79279885-72f5-4656-b318-d99a96fe75dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6dc8c10c-7107-4210-848b-1a50fd905477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_79279885-72f5-4656-b318-d99a96fe75dd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6dc8c10c-7107-4210-848b-1a50fd905477" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_dbed9a67-aacc-4bf2-9db4-8de433b27413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6dc8c10c-7107-4210-848b-1a50fd905477" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_dbed9a67-aacc-4bf2-9db4-8de433b27413" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_89d89aae-9a9c-493d-a089-cb964630186c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6dc8c10c-7107-4210-848b-1a50fd905477" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_89d89aae-9a9c-493d-a089-cb964630186c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_db88e0b1-474c-4afc-a0b7-d9904c9a6894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_db88e0b1-474c-4afc-a0b7-d9904c9a6894" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_db88e0b1-474c-4afc-a0b7-d9904c9a6894_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_db88e0b1-474c-4afc-a0b7-d9904c9a6894" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_db88e0b1-474c-4afc-a0b7-d9904c9a6894_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fab5128d-eb1c-4d9b-b24f-0b3db38d6ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_db88e0b1-474c-4afc-a0b7-d9904c9a6894" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fab5128d-eb1c-4d9b-b24f-0b3db38d6ff1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RMSLifelineMember_a5bf20da-d809-4fed-87c4-9453d256fa72" xlink:href="dva-20211231.xsd#dva_RMSLifelineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fab5128d-eb1c-4d9b-b24f-0b3db38d6ff1" xlink:to="loc_dva_RMSLifelineMember_a5bf20da-d809-4fed-87c4-9453d256fa72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e68957b2-e930-4620-bd4f-e046dbf9d437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e68957b2-e930-4620-bd4f-e046dbf9d437" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e68957b2-e930-4620-bd4f-e046dbf9d437_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e68957b2-e930-4620-bd4f-e046dbf9d437" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e68957b2-e930-4620-bd4f-e046dbf9d437_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a84f7c5-dd56-4d4b-9cd5-a1fc175c58ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e68957b2-e930-4620-bd4f-e046dbf9d437" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a84f7c5-dd56-4d4b-9cd5-a1fc175c58ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_2bacde3c-ad36-460e-9b51-6afc6ff37e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a84f7c5-dd56-4d4b-9cd5-a1fc175c58ab" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_2bacde3c-ad36-460e-9b51-6afc6ff37e2c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails" xlink:type="extended" id="i489c18119b0f49538a7acebcf5231ef3_HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_1f7b07db-475b-46e0-a8d9-ce1377ad50e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_1f7b07db-475b-46e0-a8d9-ce1377ad50e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_2e8827fb-a8a6-404c-ae99-3b34baf4e68c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_2e8827fb-a8a6-404c-ae99-3b34baf4e68c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_d1e25c40-fa48-4711-924d-e8cbb7d171e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_d1e25c40-fa48-4711-924d-e8cbb7d171e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_919616fc-874c-435e-a747-fc6c1d63e531" xlink:href="dva-20211231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_919616fc-874c-435e-a747-fc6c1d63e531" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_554dd85d-a1c1-4649-9611-2f97d8fcc97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:to="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_554dd85d-a1c1-4649-9611-2f97d8fcc97f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_8e6b2856-b9b1-4102-89b1-6819018f9d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_8e6b2856-b9b1-4102-89b1-6819018f9d0b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a08d3762-555e-4854-b607-4de594556ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a08d3762-555e-4854-b607-4de594556ffb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_31b1627c-1141-48a1-96ae-a6895e147332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a08d3762-555e-4854-b607-4de594556ffb" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_31b1627c-1141-48a1-96ae-a6895e147332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_31b1627c-1141-48a1-96ae-a6895e147332_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_31b1627c-1141-48a1-96ae-a6895e147332" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_31b1627c-1141-48a1-96ae-a6895e147332_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1af36af1-6dcd-4231-88ba-b7b0a6a83fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_31b1627c-1141-48a1-96ae-a6895e147332" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1af36af1-6dcd-4231-88ba-b7b0a6a83fbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_3c2130d6-ac11-4905-bf85-3324be9a56ca" xlink:href="dva-20211231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1af36af1-6dcd-4231-88ba-b7b0a6a83fbf" xlink:to="loc_dva_DaVitaMedicalGroupMember_3c2130d6-ac11-4905-bf85-3324be9a56ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_91d81960-aa55-4359-9b65-c74c99a06057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a08d3762-555e-4854-b607-4de594556ffb" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_91d81960-aa55-4359-9b65-c74c99a06057" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_91d81960-aa55-4359-9b65-c74c99a06057_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_91d81960-aa55-4359-9b65-c74c99a06057" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_91d81960-aa55-4359-9b65-c74c99a06057_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ee69cfbc-b0f4-4767-ab38-cfb9497c3378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_91d81960-aa55-4359-9b65-c74c99a06057" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ee69cfbc-b0f4-4767-ab38-cfb9497c3378" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_dfc2e76a-9d49-4d61-9b69-756d642a7b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ee69cfbc-b0f4-4767-ab38-cfb9497c3378" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_dfc2e76a-9d49-4d61-9b69-756d642a7b66" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails" xlink:type="extended" id="ia34f14ed3ce2450fb782081f34eb1abc_HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessSaleEffectiveDateOfSale_57473ff0-4bc6-49c6-9672-f4940dcb8d3f" xlink:href="dva-20211231.xsd#dva_BusinessSaleEffectiveDateOfSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_dva_BusinessSaleEffectiveDateOfSale_57473ff0-4bc6-49c6-9672-f4940dcb8d3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_f64a336f-f75b-4e00-8a03-fc1ddbb479ee" xlink:href="dva-20211231.xsd#dva_PurchaseAndSaleAgreementAggregatePurchasePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_f64a336f-f75b-4e00-8a03-fc1ddbb479ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessSaleDateOfPurchaseAndSaleAgreement_c4a561e8-b886-459f-8ee4-390a83c295a0" xlink:href="dva-20211231.xsd#dva_BusinessSaleDateOfPurchaseAndSaleAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_dva_BusinessSaleDateOfPurchaseAndSaleAgreement_c4a561e8-b886-459f-8ee4-390a83c295a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_f017e376-e5cd-4def-ab30-4c17a22fe9e5" xlink:href="dva-20211231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_f017e376-e5cd-4def-ab30-4c17a22fe9e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_d5f6a12c-db6d-4860-8952-ea1c1ab2133a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_d5f6a12c-db6d-4860-8952-ea1c1ab2133a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_0a5237b8-ba99-4ce7-9adf-6342d9dcfd35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_0a5237b8-ba99-4ce7-9adf-6342d9dcfd35" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_d5967b0c-e54c-4067-802e-aa8a60541caf" xlink:href="dva-20211231.xsd#dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_d5967b0c-e54c-4067-802e-aa8a60541caf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_081e4386-997c-43ce-9af8-23db653a6bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_081e4386-997c-43ce-9af8-23db653a6bfa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_32402e28-e6e6-4623-8e28-db0c83084679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_32402e28-e6e6-4623-8e28-db0c83084679" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_47a4500d-17c1-43de-8c0d-b99ee1153d61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_47a4500d-17c1-43de-8c0d-b99ee1153d61" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_143f3595-8992-451e-94e0-aff9920f991d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_143f3595-8992-451e-94e0-aff9920f991d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5ba43f4a-12db-40b0-b8cf-4c19b4cf4472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5ba43f4a-12db-40b0-b8cf-4c19b4cf4472" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_387165d9-44aa-4f02-b02d-9d6dacac69b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5ba43f4a-12db-40b0-b8cf-4c19b4cf4472" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_387165d9-44aa-4f02-b02d-9d6dacac69b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_387165d9-44aa-4f02-b02d-9d6dacac69b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_387165d9-44aa-4f02-b02d-9d6dacac69b6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_387165d9-44aa-4f02-b02d-9d6dacac69b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4c675792-ef7e-4f09-bb69-c7d9db305414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_387165d9-44aa-4f02-b02d-9d6dacac69b6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4c675792-ef7e-4f09-bb69-c7d9db305414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_8f07fafa-ff14-4026-97df-e3fc318eabe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_4c675792-ef7e-4f09-bb69-c7d9db305414" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_8f07fafa-ff14-4026-97df-e3fc318eabe6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cf4e8ceb-1a0c-497d-a976-38f8bb335656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5ba43f4a-12db-40b0-b8cf-4c19b4cf4472" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cf4e8ceb-1a0c-497d-a976-38f8bb335656" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cf4e8ceb-1a0c-497d-a976-38f8bb335656_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cf4e8ceb-1a0c-497d-a976-38f8bb335656" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cf4e8ceb-1a0c-497d-a976-38f8bb335656_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f277b359-5c68-43df-945e-5be8ed8cc3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cf4e8ceb-1a0c-497d-a976-38f8bb335656" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f277b359-5c68-43df-945e-5be8ed8cc3d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DMGAcquisitionsMember_17b49736-3897-4ba6-979d-9480d725e90f" xlink:href="dva-20211231.xsd#dva_DMGAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f277b359-5c68-43df-945e-5be8ed8cc3d2" xlink:to="loc_dva_DMGAcquisitionsMember_17b49736-3897-4ba6-979d-9480d725e90f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_93ab76fb-9a27-48a2-8fee-79d3d4231906" xlink:href="dva-20211231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f277b359-5c68-43df-945e-5be8ed8cc3d2" xlink:to="loc_dva_DaVitaMedicalGroupMember_93ab76fb-9a27-48a2-8fee-79d3d4231906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_466bfdaa-c9e4-4120-8950-7c390a0e843f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5ba43f4a-12db-40b0-b8cf-4c19b4cf4472" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_466bfdaa-c9e4-4120-8950-7c390a0e843f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_466bfdaa-c9e4-4120-8950-7c390a0e843f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_466bfdaa-c9e4-4120-8950-7c390a0e843f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_466bfdaa-c9e4-4120-8950-7c390a0e843f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6993557c-4419-46e0-acec-bd5f9e665d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_466bfdaa-c9e4-4120-8950-7c390a0e843f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6993557c-4419-46e0-acec-bd5f9e665d3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_5920d92a-1e45-4694-9b61-459290c0aa53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6993557c-4419-46e0-acec-bd5f9e665d3d" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_5920d92a-1e45-4694-9b61-459290c0aa53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_b179a04b-5404-4850-ac61-dcbd07f6c63e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5ba43f4a-12db-40b0-b8cf-4c19b4cf4472" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_b179a04b-5404-4850-ac61-dcbd07f6c63e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_b179a04b-5404-4850-ac61-dcbd07f6c63e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_b179a04b-5404-4850-ac61-dcbd07f6c63e" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_b179a04b-5404-4850-ac61-dcbd07f6c63e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_fec643bc-7548-4dc4-9907-29779fdc3e38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_b179a04b-5404-4850-ac61-dcbd07f6c63e" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_fec643bc-7548-4dc4-9907-29779fdc3e38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_db446016-8a1e-4f6a-93ed-0b48cce5603f" xlink:href="dva-20211231.xsd#dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_fec643bc-7548-4dc4-9907-29779fdc3e38" xlink:to="loc_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_db446016-8a1e-4f6a-93ed-0b48cce5603f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#VariableInterestEntitiesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails" xlink:type="extended" id="i5c15e5bac4624526aa911b00244f9890_VariableInterestEntitiesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_3d995348-6929-42db-a10a-b74f3e047f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a9295a2c-e0de-4398-bec1-3d5ae9f40c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_3d995348-6929-42db-a10a-b74f3e047f3b" xlink:to="loc_us-gaap_Assets_a9295a2c-e0de-4398-bec1-3d5ae9f40c0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_797f1e1d-04c1-46e4-a4b3-0349b332a0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_3d995348-6929-42db-a10a-b74f3e047f3b" xlink:to="loc_us-gaap_Liabilities_797f1e1d-04c1-46e4-a4b3-0349b332a0ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c0db84de-1af2-4c4c-afb5-053fce7dabda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_3d995348-6929-42db-a10a-b74f3e047f3b" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c0db84de-1af2-4c4c-afb5-053fce7dabda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_57bae6cd-2969-4fab-89e1-249558fb62af" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c0db84de-1af2-4c4c-afb5-053fce7dabda" xlink:to="loc_srt_ConsolidatedEntitiesAxis_57bae6cd-2969-4fab-89e1-249558fb62af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_57bae6cd-2969-4fab-89e1-249558fb62af_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_57bae6cd-2969-4fab-89e1-249558fb62af" xlink:to="loc_srt_ConsolidatedEntitiesDomain_57bae6cd-2969-4fab-89e1-249558fb62af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c0fca861-9ab1-4762-97f2-7c32c8b54738" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_57bae6cd-2969-4fab-89e1-249558fb62af" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c0fca861-9ab1-4762-97f2-7c32c8b54738" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_c6585868-107a-4040-925f-9c1a33d05354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c0fca861-9ab1-4762-97f2-7c32c8b54738" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_c6585868-107a-4040-925f-9c1a33d05354" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="ie7a17cdf60e94cbc9f8dd1406c10b09a_FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9d25b515-fbdc-40dd-8ce0-67ce3301273c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_087e315d-3083-44a8-9539-40a0826869c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9d25b515-fbdc-40dd-8ce0-67ce3301273c" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_087e315d-3083-44a8-9539-40a0826869c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_baa7d334-831a-4ddc-a98f-4a12a95050f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_087e315d-3083-44a8-9539-40a0826869c2" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_baa7d334-831a-4ddc-a98f-4a12a95050f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_240de3a0-195c-4b2e-9c4c-c2ebdfeb56e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_087e315d-3083-44a8-9539-40a0826869c2" xlink:to="loc_us-gaap_DerivativeAssets_240de3a0-195c-4b2e-9c4c-c2ebdfeb56e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_0d7fe61a-6661-4034-a598-09cac2c0d927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9d25b515-fbdc-40dd-8ce0-67ce3301273c" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_0d7fe61a-6661-4034-a598-09cac2c0d927" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_dfd5c889-7105-4c83-a090-f97c3e7515d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_0d7fe61a-6661-4034-a598-09cac2c0d927" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_dfd5c889-7105-4c83-a090-f97c3e7515d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_f26985df-c409-4f5e-beb8-2311ecb6c084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9d25b515-fbdc-40dd-8ce0-67ce3301273c" xlink:to="loc_us-gaap_TemporaryEquityAbstract_f26985df-c409-4f5e-beb8-2311ecb6c084" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_b6dc68b2-a721-45a7-8b32-9aa1951f27af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_f26985df-c409-4f5e-beb8-2311ecb6c084" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_b6dc68b2-a721-45a7-8b32-9aa1951f27af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bebcf891-af84-40d0-bc81-67d73305f8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9d25b515-fbdc-40dd-8ce0-67ce3301273c" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bebcf891-af84-40d0-bc81-67d73305f8d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f48c2b72-c72a-458f-aec6-f26865ecf4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bebcf891-af84-40d0-bc81-67d73305f8d8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f48c2b72-c72a-458f-aec6-f26865ecf4f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f48c2b72-c72a-458f-aec6-f26865ecf4f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f48c2b72-c72a-458f-aec6-f26865ecf4f9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f48c2b72-c72a-458f-aec6-f26865ecf4f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_01478195-6272-4f7e-8ee7-051a10d841c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f48c2b72-c72a-458f-aec6-f26865ecf4f9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_01478195-6272-4f7e-8ee7-051a10d841c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f2e56399-8bea-41db-bc89-52b6eb2c9017" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_01478195-6272-4f7e-8ee7-051a10d841c7" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f2e56399-8bea-41db-bc89-52b6eb2c9017" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_566a3023-2a18-4cb4-b3b9-693a7f60ab8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bebcf891-af84-40d0-bc81-67d73305f8d8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_566a3023-2a18-4cb4-b3b9-693a7f60ab8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_566a3023-2a18-4cb4-b3b9-693a7f60ab8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_566a3023-2a18-4cb4-b3b9-693a7f60ab8b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_566a3023-2a18-4cb4-b3b9-693a7f60ab8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feadcae4-772e-462c-896b-7ea199aeb79f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_566a3023-2a18-4cb4-b3b9-693a7f60ab8b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feadcae4-772e-462c-896b-7ea199aeb79f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_62d0643e-e7d7-4b80-bd9d-8aa0b3a878eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feadcae4-772e-462c-896b-7ea199aeb79f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_62d0643e-e7d7-4b80-bd9d-8aa0b3a878eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_536b4338-388d-447e-beb6-c602db13ccc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feadcae4-772e-462c-896b-7ea199aeb79f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_536b4338-388d-447e-beb6-c602db13ccc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_313f12a8-dd56-418e-8484-7b9758efa11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feadcae4-772e-462c-896b-7ea199aeb79f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_313f12a8-dd56-418e-8484-7b9758efa11c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4f557d67-b25e-4fff-9ec6-7f5b77037ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bebcf891-af84-40d0-bc81-67d73305f8d8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4f557d67-b25e-4fff-9ec6-7f5b77037ea7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4f557d67-b25e-4fff-9ec6-7f5b77037ea7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4f557d67-b25e-4fff-9ec6-7f5b77037ea7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4f557d67-b25e-4fff-9ec6-7f5b77037ea7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_baf464df-15b9-4d9f-a4aa-5502982cbefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4f557d67-b25e-4fff-9ec6-7f5b77037ea7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_baf464df-15b9-4d9f-a4aa-5502982cbefd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_5d3b38b0-106a-4db3-aec1-874dbfc25032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_baf464df-15b9-4d9f-a4aa-5502982cbefd" xlink:to="loc_us-gaap_InterestRateCapMember_5d3b38b0-106a-4db3-aec1-874dbfc25032" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="extended" id="if4d784d2fba94b10b0747d62be3394b8_SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d351dc02-de04-4f3f-a3ef-002548b525ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d351dc02-de04-4f3f-a3ef-002548b525ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_d44bb1b1-133c-46e6-a69d-0cd940a8228b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_OtherIncome_d44bb1b1-133c-46e6-a69d-0cd940a8228b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_67e2d2a4-eb1c-4b55-9a1a-8dac34c1b4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_Revenues_67e2d2a4-eb1c-4b55-9a1a-8dac34c1b4b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d162e61c-884e-4b7a-b1dd-2a18228eac52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_OperatingIncomeLoss_d162e61c-884e-4b7a-b1dd-2a18228eac52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses_1dcaca99-3507-4b80-80bf-af0fb3e31eab" xlink:href="dva-20211231.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_dva_SegmentReportingInformationCorporateExpenses_1dcaca99-3507-4b80-80bf-af0fb3e31eab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_6af272d1-04c0-469a-9adc-3e2161e2c271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_InterestAndDebtExpense_6af272d1-04c0-469a-9adc-3e2161e2c271" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_f9a84d41-ae26-42d3-9de8-6301a1e4591c" xlink:href="dva-20211231.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_f9a84d41-ae26-42d3-9de8-6301a1e4591c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d24c4978-24af-4a62-8021-295a43bc5f33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d24c4978-24af-4a62-8021-295a43bc5f33" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ed05a6b9-40d7-48c1-bf22-78869e2a9e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ed05a6b9-40d7-48c1-bf22-78869e2a9e86" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_6a260455-fb16-4529-9388-f6b42e07a1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_6a260455-fb16-4529-9388-f6b42e07a1f9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7c963b68-2922-45b9-98dd-e9855e3b66f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_6a260455-fb16-4529-9388-f6b42e07a1f9" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7c963b68-2922-45b9-98dd-e9855e3b66f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1c6ec25e-575e-4dd0-9b5e-03fc1c00ef66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1c6ec25e-575e-4dd0-9b5e-03fc1c00ef66" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0343c474-e3b7-4763-ac86-b7d6884047ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1c6ec25e-575e-4dd0-9b5e-03fc1c00ef66" xlink:to="loc_srt_ConsolidationItemsAxis_0343c474-e3b7-4763-ac86-b7d6884047ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0343c474-e3b7-4763-ac86-b7d6884047ea_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_0343c474-e3b7-4763-ac86-b7d6884047ea" xlink:to="loc_srt_ConsolidationItemsDomain_0343c474-e3b7-4763-ac86-b7d6884047ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d705550a-a972-450d-a7e1-678b93b51d38" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_0343c474-e3b7-4763-ac86-b7d6884047ea" xlink:to="loc_srt_ConsolidationItemsDomain_d705550a-a972-450d-a7e1-678b93b51d38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9e3744bb-c40d-4f78-875b-e845ea367560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d705550a-a972-450d-a7e1-678b93b51d38" xlink:to="loc_us-gaap_OperatingSegmentsMember_9e3744bb-c40d-4f78-875b-e845ea367560" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_08732aaa-23a2-4d3b-a5d0-7868a8f38986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d705550a-a972-450d-a7e1-678b93b51d38" xlink:to="loc_us-gaap_IntersegmentEliminationMember_08732aaa-23a2-4d3b-a5d0-7868a8f38986" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4656d28e-1882-495a-9ef2-9b9e0605d5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1c6ec25e-575e-4dd0-9b5e-03fc1c00ef66" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4656d28e-1882-495a-9ef2-9b9e0605d5e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4656d28e-1882-495a-9ef2-9b9e0605d5e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4656d28e-1882-495a-9ef2-9b9e0605d5e3" xlink:to="loc_us-gaap_SegmentDomain_4656d28e-1882-495a-9ef2-9b9e0605d5e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3adeb87f-caf6-4f4e-8d97-20f07140f443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4656d28e-1882-495a-9ef2-9b9e0605d5e3" xlink:to="loc_us-gaap_SegmentDomain_3adeb87f-caf6-4f4e-8d97-20f07140f443" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_9f142de8-803d-4d7e-bfe5-435c4b020f31" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3adeb87f-caf6-4f4e-8d97-20f07140f443" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_9f142de8-803d-4d7e-bfe5-435c4b020f31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_306457dd-a500-4487-915f-6ca54001e59e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3adeb87f-caf6-4f4e-8d97-20f07140f443" xlink:to="loc_us-gaap_AllOtherSegmentsMember_306457dd-a500-4487-915f-6ca54001e59e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_210ba3b5-88b2-4cfd-afca-c454ee1cc1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1c6ec25e-575e-4dd0-9b5e-03fc1c00ef66" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_210ba3b5-88b2-4cfd-afca-c454ee1cc1a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_210ba3b5-88b2-4cfd-afca-c454ee1cc1a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_210ba3b5-88b2-4cfd-afca-c454ee1cc1a0" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_210ba3b5-88b2-4cfd-afca-c454ee1cc1a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_28cb4011-17dc-4008-807c-eb05bc331a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_210ba3b5-88b2-4cfd-afca-c454ee1cc1a0" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_28cb4011-17dc-4008-807c-eb05bc331a9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember_0b0a458c-f40c-42ba-813b-bd032cc0bf13" xlink:href="dva-20211231.xsd#dva_ExternalSourcesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_28cb4011-17dc-4008-807c-eb05bc331a9c" xlink:to="loc_dva_ExternalSourcesMember_0b0a458c-f40c-42ba-813b-bd032cc0bf13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember_c66d0537-d942-4e2a-bc00-63cf71d9b5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_28cb4011-17dc-4008-807c-eb05bc331a9c" xlink:to="loc_us-gaap_IntersubsegmentEliminationsMember_c66d0537-d942-4e2a-bc00-63cf71d9b5b7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails" xlink:type="extended" id="i5312cd4b2edd47bab7e2050d2815077c_SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cf76a08c-3b9c-43d0-bd6d-424c37d08bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_da7cd22b-60b3-4fc9-8a1a-b7c809b5279e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cf76a08c-3b9c-43d0-bd6d-424c37d08bdc" xlink:to="loc_us-gaap_DepreciationAndAmortization_da7cd22b-60b3-4fc9-8a1a-b7c809b5279e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3e17128f-a6a1-4852-815c-6c58b7355bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cf76a08c-3b9c-43d0-bd6d-424c37d08bdc" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3e17128f-a6a1-4852-815c-6c58b7355bf1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6b1cd420-c5bc-4b09-a2e0-5f16913ca146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3e17128f-a6a1-4852-815c-6c58b7355bf1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6b1cd420-c5bc-4b09-a2e0-5f16913ca146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6b1cd420-c5bc-4b09-a2e0-5f16913ca146_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6b1cd420-c5bc-4b09-a2e0-5f16913ca146" xlink:to="loc_us-gaap_SegmentDomain_6b1cd420-c5bc-4b09-a2e0-5f16913ca146_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c01fbe8d-d622-44cd-8394-2a4a9a8b093c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6b1cd420-c5bc-4b09-a2e0-5f16913ca146" xlink:to="loc_us-gaap_SegmentDomain_c01fbe8d-d622-44cd-8394-2a4a9a8b093c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_d848ec85-1707-4169-a688-11533f18be14" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c01fbe8d-d622-44cd-8394-2a4a9a8b093c" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_d848ec85-1707-4169-a688-11533f18be14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_248bb875-3fc7-41c9-8036-fda667aed783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c01fbe8d-d622-44cd-8394-2a4a9a8b093c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_248bb875-3fc7-41c9-8036-fda667aed783" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails" xlink:type="extended" id="i6e673655d26e4567b5894eec2443a700_SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7d2f95c0-fc42-4b7d-b423-47e3775b14c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_73c47192-9105-4722-b526-49b0dd968c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7d2f95c0-fc42-4b7d-b423-47e3775b14c9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_73c47192-9105-4722-b526-49b0dd968c21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bcef3a4-ecb8-4dba-b1e1-3200c1ce5a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7d2f95c0-fc42-4b7d-b423-47e3775b14c9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bcef3a4-ecb8-4dba-b1e1-3200c1ce5a9b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d5169104-7e88-42ba-8167-51cbc9dab475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bcef3a4-ecb8-4dba-b1e1-3200c1ce5a9b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d5169104-7e88-42ba-8167-51cbc9dab475" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d5169104-7e88-42ba-8167-51cbc9dab475_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d5169104-7e88-42ba-8167-51cbc9dab475" xlink:to="loc_us-gaap_SegmentDomain_d5169104-7e88-42ba-8167-51cbc9dab475_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5d9a5558-b30f-4d1c-bd36-a778ef6e2176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d5169104-7e88-42ba-8167-51cbc9dab475" xlink:to="loc_us-gaap_SegmentDomain_5d9a5558-b30f-4d1c-bd36-a778ef6e2176" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_f48a51af-8c74-4ea6-9308-8a0725b0eea0" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5d9a5558-b30f-4d1c-bd36-a778ef6e2176" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_f48a51af-8c74-4ea6-9308-8a0725b0eea0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_6c75d655-ce99-47f2-a1ee-50fc1ef5ded2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5d9a5558-b30f-4d1c-bd36-a778ef6e2176" xlink:to="loc_us-gaap_AllOtherSegmentsMember_6c75d655-ce99-47f2-a1ee-50fc1ef5ded2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_26d927ab-b2ab-421b-b467-4fa22151b958" xlink:href="dva-20211231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5d9a5558-b30f-4d1c-bd36-a778ef6e2176" xlink:to="loc_dva_DaVitaMedicalGroupMember_26d927ab-b2ab-421b-b467-4fa22151b958" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#SegmentReportingSummaryofAssetsbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails" xlink:type="extended" id="i382f8cf34d83489f98cc2d2dfc7a7e6e_SegmentReportingSummaryofAssetsbySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5f132784-157d-438e-94f8-32d54794bbbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_94f5c8d3-8405-4cb8-97e2-b433d3f945bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f132784-157d-438e-94f8-32d54794bbbe" xlink:to="loc_us-gaap_AssetsAbstract_94f5c8d3-8405-4cb8-97e2-b433d3f945bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9bc7d4da-f285-48d8-94fc-37fea35845fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_94f5c8d3-8405-4cb8-97e2-b433d3f945bd" xlink:to="loc_us-gaap_Assets_9bc7d4da-f285-48d8-94fc-37fea35845fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_10286c19-0b92-440c-91f6-47906c0da9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_94f5c8d3-8405-4cb8-97e2-b433d3f945bd" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_10286c19-0b92-440c-91f6-47906c0da9d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cb46ece6-56d6-4808-afdf-35675ce80ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_94f5c8d3-8405-4cb8-97e2-b433d3f945bd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_cb46ece6-56d6-4808-afdf-35675ce80ee5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f004b63c-aa9e-482b-9298-a53b00c9273a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f132784-157d-438e-94f8-32d54794bbbe" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f004b63c-aa9e-482b-9298-a53b00c9273a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_83d0c132-527f-4ca6-8fe5-7e32256cdec3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f004b63c-aa9e-482b-9298-a53b00c9273a" xlink:to="loc_srt_StatementGeographicalAxis_83d0c132-527f-4ca6-8fe5-7e32256cdec3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_83d0c132-527f-4ca6-8fe5-7e32256cdec3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_83d0c132-527f-4ca6-8fe5-7e32256cdec3" xlink:to="loc_srt_SegmentGeographicalDomain_83d0c132-527f-4ca6-8fe5-7e32256cdec3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d05213bd-5c9c-4417-b1ef-42df1af2f79d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_83d0c132-527f-4ca6-8fe5-7e32256cdec3" xlink:to="loc_srt_SegmentGeographicalDomain_d05213bd-5c9c-4417-b1ef-42df1af2f79d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_a8979380-b9b0-4f2a-af48-1dfe074ec5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d05213bd-5c9c-4417-b1ef-42df1af2f79d" xlink:to="loc_us-gaap_NonUsMember_a8979380-b9b0-4f2a-af48-1dfe074ec5cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2e852dba-fc5c-44f5-b00b-e3b8f2e04800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f004b63c-aa9e-482b-9298-a53b00c9273a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2e852dba-fc5c-44f5-b00b-e3b8f2e04800" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2e852dba-fc5c-44f5-b00b-e3b8f2e04800_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2e852dba-fc5c-44f5-b00b-e3b8f2e04800" xlink:to="loc_us-gaap_SegmentDomain_2e852dba-fc5c-44f5-b00b-e3b8f2e04800_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f429f625-bf8e-4c09-88c3-a23e49ba9dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2e852dba-fc5c-44f5-b00b-e3b8f2e04800" xlink:to="loc_us-gaap_SegmentDomain_f429f625-bf8e-4c09-88c3-a23e49ba9dd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_b433a824-ded0-4c96-a259-ebe85669bb97" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f429f625-bf8e-4c09-88c3-a23e49ba9dd6" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_b433a824-ded0-4c96-a259-ebe85669bb97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_b9e155c3-1be5-46f8-9237-9cde6cf55a39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f429f625-bf8e-4c09-88c3-a23e49ba9dd6" xlink:to="loc_us-gaap_AllOtherSegmentsMember_b9e155c3-1be5-46f8-9237-9cde6cf55a39" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#SegmentReportingAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentReportingAdditionalInformationDetails" xlink:type="extended" id="i3349ea07424d41569ca1e5941c54abc4_SegmentReportingAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9f1a34b7-1199-453e-82c8-0a29b210f104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessSaleEffectiveDateOfSale_2049c0bb-cdf7-4cdd-995e-c8f2e61dc58d" xlink:href="dva-20211231.xsd#dva_BusinessSaleEffectiveDateOfSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9f1a34b7-1199-453e-82c8-0a29b210f104" xlink:to="loc_dva_BusinessSaleEffectiveDateOfSale_2049c0bb-cdf7-4cdd-995e-c8f2e61dc58d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e771864e-27d4-4976-98c9-019c0a4de8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9f1a34b7-1199-453e-82c8-0a29b210f104" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e771864e-27d4-4976-98c9-019c0a4de8d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3589fcdd-fe6a-4c59-9b0b-b761c74f0c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e771864e-27d4-4976-98c9-019c0a4de8d9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3589fcdd-fe6a-4c59-9b0b-b761c74f0c0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3589fcdd-fe6a-4c59-9b0b-b761c74f0c0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3589fcdd-fe6a-4c59-9b0b-b761c74f0c0e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3589fcdd-fe6a-4c59-9b0b-b761c74f0c0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e5f08ff4-4e23-41ae-87e7-ba8574432c94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3589fcdd-fe6a-4c59-9b0b-b761c74f0c0e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e5f08ff4-4e23-41ae-87e7-ba8574432c94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_c0f880de-aa97-4d8b-bb64-9f79cfa1ae81" xlink:href="dva-20211231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e5f08ff4-4e23-41ae-87e7-ba8574432c94" xlink:to="loc_dva_DaVitaMedicalGroupMember_c0f880de-aa97-4d8b-bb64-9f79cfa1ae81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2a166c9c-edfc-4412-887d-05b75f595bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e771864e-27d4-4976-98c9-019c0a4de8d9" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2a166c9c-edfc-4412-887d-05b75f595bf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2a166c9c-edfc-4412-887d-05b75f595bf9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2a166c9c-edfc-4412-887d-05b75f595bf9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2a166c9c-edfc-4412-887d-05b75f595bf9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_402e637a-c763-4e67-ab67-06cd303b9459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2a166c9c-edfc-4412-887d-05b75f595bf9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_402e637a-c763-4e67-ab67-06cd303b9459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_ad58438c-0021-4101-9b07-b90515cdd872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_402e637a-c763-4e67-ab67-06cd303b9459" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_ad58438c-0021-4101-9b07-b90515cdd872" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended" id="i296c918b6a1140d98d8d860743e2a941_SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_472fa4e0-9de7-40bf-9afb-65cffeb1d99a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_1fe46792-797d-4d16-b462-1a80f67a8fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_472fa4e0-9de7-40bf-9afb-65cffeb1d99a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_1fe46792-797d-4d16-b462-1a80f67a8fd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_dd8127be-9c78-4672-a235-22b6baa41d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_472fa4e0-9de7-40bf-9afb-65cffeb1d99a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_dd8127be-9c78-4672-a235-22b6baa41d51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a1374e4b-0ab7-4dc7-8f26-35620ce2468d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_472fa4e0-9de7-40bf-9afb-65cffeb1d99a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a1374e4b-0ab7-4dc7-8f26-35620ce2468d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_8cecb657-7eda-4db0-9322-e9a9292b8b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_472fa4e0-9de7-40bf-9afb-65cffeb1d99a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_8cecb657-7eda-4db0-9322-e9a9292b8b91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_4dea8de4-e67b-4b36-b460-0775129c5b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_08208af1-a8b2-4b23-802c-1df057d406dd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_472fa4e0-9de7-40bf-9afb-65cffeb1d99a" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_08208af1-a8b2-4b23-802c-1df057d406dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e1c2248e-a59f-47ed-8e90-c395da490de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_08208af1-a8b2-4b23-802c-1df057d406dd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e1c2248e-a59f-47ed-8e90-c395da490de4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_e1c2248e-a59f-47ed-8e90-c395da490de4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e1c2248e-a59f-47ed-8e90-c395da490de4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_e1c2248e-a59f-47ed-8e90-c395da490de4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_1239fb1c-d81f-482c-bd12-f79f499f5a48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e1c2248e-a59f-47ed-8e90-c395da490de4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_1239fb1c-d81f-482c-bd12-f79f499f5a48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_04c87445-6cda-4604-bbf4-9316f9af970a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_1239fb1c-d81f-482c-bd12-f79f499f5a48" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_04c87445-6cda-4604-bbf4-9316f9af970a" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>dva-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1726f308-1cc7-4a47-a8e3-a7d089a83ae3,g:ca3879f3-8750-4d94-926a-aa4c6036a270-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DerivativeInceptionDates_611c4cc3-5621-4dc4-af81-78372270891a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInceptionDates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, effective date</link:label>
    <link:label id="lab_us-gaap_DerivativeInceptionDates_label_en-US" xlink:label="lab_us-gaap_DerivativeInceptionDates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Inception Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInceptionDates" xlink:to="lab_us-gaap_DerivativeInceptionDates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_96661a72-8276-4a22-b9f4-ea165e1288c3_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e729ad8d-07db-40a3-8727-6796b62b41d7_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised/ Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_806b0086-45ca-431f-8182-bdf549a7fc1c_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_74702ead-8109-4580-b2d1-cd985a1c83e4_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_46bbd0bc-a0fa-48fa-9dbf-1fa6b1ff3031_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RangeThreeMember_d8034bdc-3475-4327-b597-a9ac4c4a51ae_terseLabel_en-US" xlink:label="lab_dva_RangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$70.01&#8211;$80.00</link:label>
    <link:label id="lab_dva_RangeThreeMember_label_en-US" xlink:label="lab_dva_RangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Three [Member]</link:label>
    <link:label id="lab_dva_RangeThreeMember_documentation_en-US" xlink:label="lab_dva_RangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeThreeMember" xlink:href="dva-20211231.xsd#dva_RangeThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RangeThreeMember" xlink:to="lab_dva_RangeThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_50015bd5-be5b-449b-8818-161d916b1f7c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma basic net income per share from continuing operations attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_b5961037-52be-4d0c-a3a0-fde79520bc7a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOfferingCosts" xlink:to="lab_us-gaap_DeferredOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_0377a341-62bf-42b8-bf89-f3b1b022efdc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_feb19c11-91e0-4874-8a5b-766ece384e80_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AccountsReceivablePeriodOutstanding_937ab06d-d207-4835-9e75-ab0f54f265c9_terseLabel_en-US" xlink:label="lab_dva_AccountsReceivablePeriodOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Period Outstanding</link:label>
    <link:label id="lab_dva_AccountsReceivablePeriodOutstanding_label_en-US" xlink:label="lab_dva_AccountsReceivablePeriodOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Period Outstanding</link:label>
    <link:label id="lab_dva_AccountsReceivablePeriodOutstanding_documentation_en-US" xlink:label="lab_dva_AccountsReceivablePeriodOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient accounts receivable months outstanding to be reserved per company policy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AccountsReceivablePeriodOutstanding" xlink:href="dva-20211231.xsd#dva_AccountsReceivablePeriodOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AccountsReceivablePeriodOutstanding" xlink:to="lab_dva_AccountsReceivablePeriodOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_5000f31c-ec37-4863-a2e0-ee87eaf0527c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EpogenMember_8895407f-94f2-43eb-8490-a7691e6d1252_terseLabel_en-US" xlink:label="lab_dva_EpogenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPO</link:label>
    <link:label id="lab_dva_EpogenMember_label_en-US" xlink:label="lab_dva_EpogenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Epogen [Member]</link:label>
    <link:label id="lab_dva_EpogenMember_documentation_en-US" xlink:label="lab_dva_EpogenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Epogen.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EpogenMember" xlink:href="dva-20211231.xsd#dva_EpogenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EpogenMember" xlink:to="lab_dva_EpogenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_9944ca67-c466-4c27-af7f-017164552764_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_bc0675f6-0959-4d68-8eec-74588d5a6789_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtPrepaymentRefinancingRedemptionCharges_1ea1ed91-c6f4-441e-a6c5-e4d6a6f2f9f4_negatedTerseLabel_en-US" xlink:label="lab_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt prepayment, refinancing and redemption charges</link:label>
    <link:label id="lab_dva_DebtPrepaymentRefinancingRedemptionCharges_label_en-US" xlink:label="lab_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Prepayment Refinancing Redemption Charges</link:label>
    <link:label id="lab_dva_DebtPrepaymentRefinancingRedemptionCharges_documentation_en-US" xlink:label="lab_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt prepayment, refinancing and redemption charges related to long-term debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:href="dva-20211231.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:to="lab_dva_DebtPrepaymentRefinancingRedemptionCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_242e2633-9352-417f-bf69-2fa1c6d16bf2_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_4cacaacc-03d1-4303-8178-a06798cf45b5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to DaVita Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_3e171c14-d898-4d37-b701-65365885639b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock_16f87e2d-f36a-48c9-91ca-90b4b6a3a622_terseLabel_en-US" xlink:label="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient service net revenues and accounts receivable</link:label>
    <link:label id="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock_label_en-US" xlink:label="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition And Accounts Receivable Policy [Text Block]</link:label>
    <link:label id="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock_documentation_en-US" xlink:label="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition and accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" xlink:href="dva-20211231.xsd#dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" xlink:to="lab_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1c737b4e-16c6-4290-8228-79d33bfd4fa7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_977e79dc-8681-4a5a-9350-bc0d7b79e7ab_terseLabel_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_label_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase Due To Acquisitions And Divestitures</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_documentation_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase Due To Acquisitions And Divestitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:href="dva-20211231.xsd#dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:to="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_39531482-49ea-4c07-a761-523879848731_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap and cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_99d5e0e7-9775-4299-afc3-552b48aa78b7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of additional noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b2093e2f-a710-4524-a9a2-86dcbfcfdc03_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future grants</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_499e5f86-fed3-431d-a865-cce68cc9f9bd_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_fdc91c7b-cd43-4621-9a2f-c070e5e7e1e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b1e608c5-d70b-4c74-9cb9-ff336e152923_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_KidneyCareMember_e367fc33-37ca-410b-92b6-3fcbf64c60ce_terseLabel_en-US" xlink:label="lab_dva_KidneyCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kidney Care</link:label>
    <link:label id="lab_dva_KidneyCareMember_label_en-US" xlink:label="lab_dva_KidneyCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kidney Care [Member]</link:label>
    <link:label id="lab_dva_KidneyCareMember_documentation_en-US" xlink:label="lab_dva_KidneyCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kidney Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_KidneyCareMember" xlink:href="dva-20211231.xsd#dva_KidneyCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_KidneyCareMember" xlink:to="lab_dva_KidneyCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_57a42fe6-6cb2-4879-aea4-2736003af1ad_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_85423bb0-9735-4244-81b3-c34ee9120183_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_029a1fd3-92aa-414d-a07b-337c3ba17a79_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8da10e90-8d2c-41b1-b53d-a108985350bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of stock awards exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_648a62e6-a5fc-43e7-a76f-c05761713dfc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices, lower range (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_c4c77e27-9ba0-482b-9cc9-3f5296582c2a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts charged to income</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock_c6bb751f-2277-468b-82f7-af1a0ac07e14_terseLabel_en-US" xlink:label="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other information related to acquired intangibles and goodwill</link:label>
    <link:label id="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock_label_en-US" xlink:label="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other information related to acquisitions [Table Text Block]</link:label>
    <link:label id="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock_documentation_en-US" xlink:label="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other information related to acquisitions, including weighted-average estimated useful lives of intangible assets acquired, and goodwill deductible for tax purposes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" xlink:href="dva-20211231.xsd#dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" xlink:to="lab_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_581af2fa-5752-4fd3-9887-e67856138b6c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_83c5b0dd-4040-4c58-a186-c362564de9b8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_aa87277c-67e3-4b27-aa7e-952437aa062b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e9a951c7-c2b5-4ec5-9ef8-478cb5224fdb_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicareMember_f6d1843c-5a35-41ac-a7bd-d3b98e96a648_terseLabel_en-US" xlink:label="lab_dva_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare bad debt claims</link:label>
    <link:label id="lab_dva_MedicareMember_label_en-US" xlink:label="lab_dva_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:label id="lab_dva_MedicareMember_documentation_en-US" xlink:label="lab_dva_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare governmental agency.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareMember" xlink:href="dva-20211231.xsd#dva_MedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicareMember" xlink:to="lab_dva_MedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f6aec4c1-8509-4e54-8dbc-b803e1231617_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense from amortizable intangible assets, other than lease agreements</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_39989bb0-bda5-4757-81a1-2fa2e609efb7_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income:</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_0e374c5e-3600-4695-861a-3140397082d8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f1cbd77d-5523-4513-a079-f23ff1f50bda_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable intangible assets acquired, weighted-average estimated useful lives</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_91b09d26-48d1-4441-8f2c-e8ca64d182a4_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_8397455a-6825-4ef8-9de0-fbeef9ee1905_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_b7bf1a8f-8a8b-49c2-b5e4-1b159d20c1c3_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) expense from continuing and discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a185cedd-e213-4e52-bc8f-da8a0c237ba8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6a1bd7c0-96bd-499c-86bd-d707efc80584_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive stock-settled awards excluded from calculation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_1eadfcb8-546b-4891-9422-e5eb85ec4c3f_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_5dd6604e-4109-4a19-93d2-2c2b2c00aefe_verboseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states where dialysis centers are located</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_53767ef4-2a8e-4fb6-9cba-1241414182e8_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_f41de07b-f9d7-4778-bd63-9ad6e25414c4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_27e50e9d-662b-4a74-b865-a53e0b9b4aa1_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e6e25d3-f611-4df3-8ce9-72bdd15e3e1d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a1e892a1-8a64-4d3b-99a0-4bfd901094fe_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_199136a1-fcf0-4d42-8b88-aa86b0ee968e_verboseLabel_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination contingent consideration acquisitions, earn-outs</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_b6e9fe7a-fa7d-4cbc-a3bc-d2f0af948eea_terseLabel_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_label_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_documentation_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:href="dva-20211231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:to="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_40edb29b-d7af-4fd3-8f75-84f6a9b2b352_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_91bebf81-9aa1-4a2f-85d6-088db1a7c2ab_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_78c92f63-31e0-455b-a9e2-c9ea7832f084_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e64eed0a-d00a-4c73-8aae-6fe83a54ddad_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAbstract_bf08d419-5e6b-449e-9554-6540bf44348d_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares Repurchases, Table Footnotes:</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAbstract_30d8485e-ae35-455f-a05b-06e5ccb31a32_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAbstract_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract" xlink:to="lab_us-gaap_TreasuryStockSharesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_ed42ef9e-5712-415c-b4a7-373587c08ee7_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_5a2292cf-32b1-4718-b8fb-b4927a989adf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses on foreign currency translation.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_fd4e669e-078b-4d68-a85e-d0530b4a109f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_dc4c090e-9733-49d4-9aa5-77695dd3551d_terseLabel_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage</link:label>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_label_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage [Member]</link:label>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_documentation_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember" xlink:href="dva-20211231.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicareandMedicareAdvantageMember" xlink:to="lab_dva_MedicareandMedicareAdvantageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_e37fed12-7f65-4f2d-a37e-6e4865100462_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_de2c9d05-da51-4445-97af-b29bf97c79cd_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage by Parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_790dddae-6b23-41d3-96c7-5c1037dbd998_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_e81c1f0f-9f5e-43d9-93e9-1713367272d1_terseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_label_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Increase From Contributions</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest increase from contributions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions" xlink:href="dva-20211231.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestIncreaseFromContributions" xlink:to="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_4f7f174d-8ffa-4b3d-8c4c-82722bc1d95d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_country_DE_04588577-ae77-4c8b-9fbc-059f2e0624b5_terseLabel_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:label id="lab_country_DE_label_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE" xlink:to="lab_country_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_161bafb4-96c1-4306-95de-ca571d7edd3e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_4dea2c93-2756-4c47-99eb-7894377d5c5b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_37810d88-8323-4557-a181-e7f585b6be07_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6cb0636b-499b-4719-b7f6-b68570d0d3c9_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_5c92e128-f2f7-4e17-9497-bdef63de123c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term Investments</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:to="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_774ff706-c174-47f3-86ea-4ddde0ee2168_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_7eac08ce-8685-432d-8494-fa11d6830c0c_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_19c744d1-f19a-4bae-8882-e4f6fcbaeea7_terseLabel_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Full share awards to shares available, conversion ratio</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_label_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Full Value Shares To Available Shares, Conversion Ratio</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_documentation_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Full Value Shares To Available Shares, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" xlink:href="dva-20211231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" xlink:to="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4ff532a3-8dad-42eb-8478-cbd0a87d6068_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_bc2c7b0e-af19-4e25-9c38-84df699d912b_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share attributable to DaVita Inc. (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_2cbab86d-09ad-46a0-be3b-d9dfaf1e8073_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_7f1f73f3-3d8f-483a-a92d-3af8c009d72e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from asset and business sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sales of Business, Affiliate and Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_97a3784e-312f-4de5-af4d-7514557e20bb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities_e6e49ca2-a77a-4d6f-92bd-ebb141c9bffb_terseLabel_en-US" xlink:label="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities_label_en-US" xlink:label="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Lease Liabilities</link:label>
    <link:label id="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from operating lease liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:href="dva-20211231.xsd#dva_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="lab_dva_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_7bcb2fd3-1300-4832-bf47-d1fbf52b9101_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:to="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_afda4d12-a15d-42b2-92bf-ccad47fc2976_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dcd2cb59-cf18-477b-b546-78446addec4c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RangeOneMember_5bccf3d0-b859-4e2b-8f92-87a2cf144880_terseLabel_en-US" xlink:label="lab_dva_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$50.01&#8211;$60.00</link:label>
    <link:label id="lab_dva_RangeOneMember_label_en-US" xlink:label="lab_dva_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range One [Member]</link:label>
    <link:label id="lab_dva_RangeOneMember_documentation_en-US" xlink:label="lab_dva_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeOneMember" xlink:href="dva-20211231.xsd#dva_RangeOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RangeOneMember" xlink:to="lab_dva_RangeOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2ba37fb8-64be-4534-933a-f8f06ad83692_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherCompaniesMember_ce15527d-3168-4990-8145-703fee0b372d_terseLabel_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other companies</link:label>
    <link:label id="lab_dva_OtherCompaniesMember_label_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Companies [Member]</link:label>
    <link:label id="lab_dva_OtherCompaniesMember_documentation_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember" xlink:href="dva-20211231.xsd#dva_OtherCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherCompaniesMember" xlink:to="lab_dva_OtherCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_9f37e17a-dbdd-4bfe-b3be-b3ed06824944_terseLabel_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award</link:label>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_label_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award</link:label>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_documentation_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" xlink:href="dva-20211231.xsd#dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" xlink:to="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_5f16b3d6-27d6-4e12-9fe9-c436888cdc1f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_15e39dbb-3b64-4a5c-9c3c-dc679f5a21fe_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) attributable to DaVita Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1f25df43-5561-4392-a7c1-c494f3fb09a4_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_50b71be4-020d-426c-b3d9-60eef463e89c_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities from discontinued operations</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Investing Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_68e6d711-5a6b-4384-a207-669df105f879_terseLabel_en-US" xlink:label="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_label_en-US" xlink:label="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_documentation_en-US" xlink:label="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" xlink:href="dva-20211231.xsd#dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" xlink:to="lab_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a5e10ff6-a050-4a93-8fb9-875861f067b4_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_da154186-976c-402b-9232-10a2b2d5f412_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment and Information Systems</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_1854ef7f-e76f-487f-9164-f6522177cea8_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_321b4551-fb49-46f6-b928-69bbe8b1b998_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash charges, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_4336b40b-7790-4515-8f3d-921d59a0085e_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value, gross asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebt_c9837c16-3c18-49ab-b8de-a8d6f17ee869_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebt_label_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebt" xlink:to="lab_us-gaap_SecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DeconsolidatedNoncontrollingEntityMember_688d2c03-7cb7-436a-a52f-c8f821f6e702_terseLabel_en-US" xlink:label="lab_dva_DeconsolidatedNoncontrollingEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC JV - Deconsolidated Noncontrolling Entity</link:label>
    <link:label id="lab_dva_DeconsolidatedNoncontrollingEntityMember_label_en-US" xlink:label="lab_dva_DeconsolidatedNoncontrollingEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidated Noncontrolling Entity [Member]</link:label>
    <link:label id="lab_dva_DeconsolidatedNoncontrollingEntityMember_documentation_en-US" xlink:label="lab_dva_DeconsolidatedNoncontrollingEntityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidated Noncontrolling Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeconsolidatedNoncontrollingEntityMember" xlink:href="dva-20211231.xsd#dva_DeconsolidatedNoncontrollingEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DeconsolidatedNoncontrollingEntityMember" xlink:to="lab_dva_DeconsolidatedNoncontrollingEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock_e22953a0-f083-4628-9665-b23bdac7edb8_terseLabel_en-US" xlink:label="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reporting Units Goodwill Balances</link:label>
    <link:label id="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock_label_en-US" xlink:label="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reporting Units Goodwill Balances [Text Block]</link:label>
    <link:label id="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock_documentation_en-US" xlink:label="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reporting units goodwill balances.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" xlink:href="dva-20211231.xsd#dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" xlink:to="lab_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_27eae8f1-e155-46ff-93f9-f7b6e1ec6a25_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and equivalents</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_bc7ab03c-d554-4d30-9bef-73755d30b6a3_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_USAttorneyPrescriptionDrugInvestigationMember_46be8f60-7d8f-4399-93a7-7e69e9cc3be8_terseLabel_en-US" xlink:label="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorney Prescription Drug Investigation</link:label>
    <link:label id="lab_dva_USAttorneyPrescriptionDrugInvestigationMember_label_en-US" xlink:label="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorney Prescription Drug Investigation [Member]</link:label>
    <link:label id="lab_dva_USAttorneyPrescriptionDrugInvestigationMember_documentation_en-US" xlink:label="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorney Prescription Drug Investigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:href="dva-20211231.xsd#dva_USAttorneyPrescriptionDrugInvestigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:to="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember_4939adda-61b8-4453-86fd-a43e04695c47_terseLabel_en-US" xlink:label="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company and Restricted Subsidiaries(1)</link:label>
    <link:label id="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember_label_en-US" xlink:label="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company And Restricted Subsidiaries [Member]</link:label>
    <link:label id="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember_documentation_en-US" xlink:label="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent company and restricted subsidiaries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ParentCompanyAndRestrictedSubsidiariesMember" xlink:href="dva-20211231.xsd#dva_ParentCompanyAndRestrictedSubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ParentCompanyAndRestrictedSubsidiariesMember" xlink:to="lab_dva_ParentCompanyAndRestrictedSubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_722f6305-d667-4069-a6ca-7b497b3788d2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_d8811e36-8180-41c4-831b-d2c44d102c4f_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filer</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_69a8544d-b247-439b-b0d6-3a412b8bcb56_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Asset Categories</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_eb81d792-7d5a-4889-8cdc-5082a686819b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_966931ef-9c19-4db8-9f9b-5403ad724d7e_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_a9da8d6a-31cb-4bf0-8107-f63c5a7caca9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_d8efbbf8-d78c-49d7-95b6-c90f333507ca_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_204b0b1f-8314-40dc-b26e-191e572fb08e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions from equity method investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution, Return of Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:to="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_eee3d23a-2926-432f-a955-3e3207cfc6fa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;prices&#160;in active&#160;markets&#160;for identical assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis_e9ff1e98-354b-482b-ab66-61bca69119f4_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis_label_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_c6526e81-0284-4558-969e-e355048789d0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesCurrent_578f50c5-fcf4-4e2c-88ec-000a2929c330_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, short-term investments</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_InternationalOperationsMember_c6ed4ec4-689c-4cc9-9850-debbff3c9bc6_terseLabel_en-US" xlink:label="lab_dva_InternationalOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Operations</link:label>
    <link:label id="lab_dva_InternationalOperationsMember_label_en-US" xlink:label="lab_dva_InternationalOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Operations [Member]</link:label>
    <link:label id="lab_dva_InternationalOperationsMember_documentation_en-US" xlink:label="lab_dva_InternationalOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_InternationalOperationsMember" xlink:href="dva-20211231.xsd#dva_InternationalOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_InternationalOperationsMember" xlink:to="lab_dva_InternationalOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_19fe0e96-ddeb-492b-9bb8-81c05876cf55_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_021a39cc-4b98-4c3e-a432-23e99454f1ce_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableAbstract_37cf4283-a85a-48ca-921f-28adb64662a6_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes:</link:label>
    <link:label id="lab_us-gaap_NotesPayableAbstract_label_en-US" xlink:label="lab_us-gaap_NotesPayableAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableAbstract" xlink:to="lab_us-gaap_NotesPayableAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_019a72a0-99cc-4929-9bf3-297ff4f5ecb4_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions related to current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_b40f52c9-0abd-4264-9977-2499500a65e7_terseLabel_en-US" xlink:label="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible executive compensation</link:label>
    <link:label id="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_label_en-US" xlink:label="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Investment Impairment</link:label>
    <link:label id="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_documentation_en-US" xlink:label="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Investment Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" xlink:href="dva-20211231.xsd#dva_EffectiveIncomeTaxReconciliationInvestmentImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" xlink:to="lab_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_e70cc96f-5474-46c4-83a6-723c74ab8ae9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_fafdff90-9fb2-470d-aa42-9b24eabc0a71_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionTypeAxis_661d3577-496a-4660-b80c-5ac5ab844ede_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:label id="lab_us-gaap_TransactionTypeAxis_label_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionTypeAxis" xlink:to="lab_us-gaap_TransactionTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_53aca4be-0008-41bc-baa7-edb05c7d4a60_terseLabel_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual&#160;life</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_label_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_documentation_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_cce26580-135a-448f-a548-55c555ec8423_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests Subject to Put Provisions and Other Commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_28aa09fc-740c-4385-8a64-5f8000b9071e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards, fair value assumptions, expected dividend</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_379787b0-74cc-4e36-a475-90b9a99e9c88_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompetition agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aafc0fb6-df1a-4073-9299-3bcb5cdcccca_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_1eed1c6a-c92a-4f41-988f-3a238068ad6b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_9a4d519f-cdee-465b-a536-f19b05eadb98_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_969161e7-2949-4119-b019-2ba7a1442be8_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_18c0d0ae-1a43-4162-8f0b-f23f1b26527a_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_92763bc5-9cf3-46fa-9f42-5112a6dae2be_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_c1c4a613-1698-4d60-b70c-c3fac340f6db_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_71869b4e-ec3f-42b5-8666-3c0e0970e3d1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2ee02844-f75a-4713-9a65-30a8167c918f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_81d56b14-01f0-4b98-96a6-d07d336f84b0_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions related to settlements with taxing authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_ab58919a-0a07-4be9-812f-22674b87496c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_ec696e1c-bd4d-4656-aa90-4e1ad8993c83_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assets by Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_2a6763a4-5d86-4e32-849b-29df83dbb8da_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_022cef54-0ecf-4569-8046-4f25dbc24560_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Short-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock_0c0f7a14-e8b8-429d-9a37-a57f7faa1f61_terseLabel_en-US" xlink:label="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Minimum Lease Payments</link:label>
    <link:label id="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock_label_en-US" xlink:label="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Minimum Lease Payments [Text Block]</link:label>
    <link:label id="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock_documentation_en-US" xlink:label="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of minimum lease payments under non-cancelable operating leases and capital leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfMinimumLeasePaymentsTextBlock" xlink:href="dva-20211231.xsd#dva_ScheduleOfMinimumLeasePaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ScheduleOfMinimumLeasePaymentsTextBlock" xlink:to="lab_dva_ScheduleOfMinimumLeasePaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_3ad25ee6-3a16-4015-b721-5fde3a7121c7_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a3c7a18b-3fe2-4ec3-b180-9f06ec36cb04_negatedLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_30057607-b562-4cc9-b58a-90da7b9e8476_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_486bcbe1-ae42-449e-9b88-34a6f3cbe1d9_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_6f1266cd-7380-4f93-b066-a41ef26d5150_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_faa84965-a8df-4639-b849-532d34c4a816_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_85f3b9ab-f529-46d2-ba76-63af1db756ba_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_e7202516-2331-4481-9787-2ea967030512_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ForeignDialysisCentersMember_b2700918-b2c6-48c6-a10d-3d0d570fbdd4_terseLabel_en-US" xlink:label="lab_dva_ForeignDialysisCentersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Dialysis Centers</link:label>
    <link:label id="lab_dva_ForeignDialysisCentersMember_label_en-US" xlink:label="lab_dva_ForeignDialysisCentersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Dialysis Centers [Member]</link:label>
    <link:label id="lab_dva_ForeignDialysisCentersMember_documentation_en-US" xlink:label="lab_dva_ForeignDialysisCentersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign dialysis and other medical businesses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignDialysisCentersMember" xlink:href="dva-20211231.xsd#dva_ForeignDialysisCentersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ForeignDialysisCentersMember" xlink:to="lab_dva_ForeignDialysisCentersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_4bbf529d-84ce-4604-8c77-3a51c2abd3a3_terseLabel_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020</link:label>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_label_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020 [Member]</link:label>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_documentation_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:href="dva-20211231.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:to="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_b5a9e21d-3ff1-4705-8079-c1669214dc9a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_553626b3-d0f1-432a-ae60-eb83fa6cfd8f_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partial purchases</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_6bf58d42-edd0-421d-9c8b-d64511db517d_totalLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from accumulated other comprehensive income into net income net of tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_6c10e0ba-7b76-4e04-b1c8-e2388c3c16d9_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_cf85bc09-4614-4e68-9e6c-f277ae80d31b_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_fe3ffc29-80f5-4c3d-9833-3327c1566144_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_e2b7cc9e-598c-40fe-87b7-a68c129bfb48_terseLabel_en-US" xlink:label="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election</link:label>
    <link:label id="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_label_en-US" xlink:label="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election</link:label>
    <link:label id="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_documentation_en-US" xlink:label="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election Effective date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" xlink:href="dva-20211231.xsd#dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" xlink:to="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_bd18f376-eea4-4232-8632-101e5e1cf73c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties related to unrecognized tax benefits, net of federal tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_5211ac33-cb61-4124-a249-55430da233c4_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted cost method investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_2ca294bc-5450-4844-bd2a-7691fb2e180e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2b4836ad-824f-40eb-bf76-1dda432e776d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_10bf1745-de20-4004-a637-880569f2ed37_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_bd2f8a09-bb72-41f5-9a8e-85abd479ccd0_terseLabel_en-US" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner Type of Partners' Capital Account, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_label_en-US" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner Type of Partners' Capital Account, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:to="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_2b57e185-2707-41d8-9150-98f77c941eaf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities, operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4237aeec-b24e-40a2-9528-eccdf7457020_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_96c48515-d64e-4ed1-9f03-1506b6db1d30_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests subject to put provisions</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_3903776b-8be3-4ed0-a5bf-2972fa3f4ad6_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_d6515b4a-ccaa-4596-ad1a-8363ab7d9ad0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_e98eb903-ae4d-42f0-9b8f-97a73a9612ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_b6d34c40-9d43-4b67-936c-e0be370f3915_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, weighted average discount rate, percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_eb84457a-c4cd-4dd9-b9ef-628879d06b6f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_6689ff7a-0b22-4542-8579-5c9841211acc_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_e3665b67-ebe4-4e69-af37-e697dfae9c0b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_307c09de-da4e-4645-b8ac-5d5f55cff975_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of leased assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareRepurchaseFeesAndExpenses_e10c52de-682f-4b39-8c8a-d134a5475ea4_terseLabel_en-US" xlink:label="lab_dva_ShareRepurchaseFeesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Fees And Expenses</link:label>
    <link:label id="lab_dva_ShareRepurchaseFeesAndExpenses_label_en-US" xlink:label="lab_dva_ShareRepurchaseFeesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Fees And Expenses</link:label>
    <link:label id="lab_dva_ShareRepurchaseFeesAndExpenses_documentation_en-US" xlink:label="lab_dva_ShareRepurchaseFeesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Fees And Expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareRepurchaseFeesAndExpenses" xlink:href="dva-20211231.xsd#dva_ShareRepurchaseFeesAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareRepurchaseFeesAndExpenses" xlink:to="lab_dva_ShareRepurchaseFeesAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_3c6c1a05-012e-4f11-a592-e41796620d49_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Noncurrent, Threshold Period Past Due</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Noncurrent, Threshold Period Past Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:to="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_e0e7989a-b9f5-49f7-949b-dde9ae815d5e_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_dccc2c8b-5ab0-40d2-8280-c90a23280449_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2f919ca7-5599-4fe9-ac5a-76a7f46f282f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Weighted Average Valuation Inputs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_5a35bf53-3c7b-4d14-97db-40a87d07b3a2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_3153dc78-908c-4b92-b198-d1241badde17_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_91f62caf-96c9-4bdb-a66f-f0f36fadff88_terseLabel_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Expenditures for Property and Equipment by Segment</link:label>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_label_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Capital Expenditures For Property And Equipment From Segment To Consolidated Table [Text Block]</link:label>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_documentation_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of capital expenditures for property and equipment from segment to consolidated.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:href="dva-20211231.xsd#dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:to="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_5a84ceb5-b66e-4f76-b185-7b9bb2c51c84_terseLabel_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Added by performance factor (in shares)</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_label_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Units, Additions in Period</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_documentation_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Units, Additions in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" xlink:to="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_0c914399-36e9-4fa7-a559-e51495cb817d_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_c7646190-7a34-4da0-9f7f-e95a09c9afce_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_6bfe6348-6806-4e4e-9121-4161aa7fe6df_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Equity Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f616fb42-00a4-4f66-a7ea-a5b7902e63be_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed incremental shares from stock plans (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_0a7dc94f-4462-4817-a830-2a62c12b8fb9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_f2442540-dd75-4c2c-88e7-4851921a163b_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term and long-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_79c93fb2-a47d-4580-8a7e-a26922a8adc6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma net income from continuing operations attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_965e87fc-87d3-4ff1-a4af-97755cc2f525_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_7eb9e660-dce8-49b2-8da6-10f7292450e6_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet the More-Likely-Than-Not Threshold</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_e41a1ea1-e147-4506-9f56-91b0b0dd8b2b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock_f6212dd6-2997-4c11-9c20-34db14fc5efb_terseLabel_en-US" xlink:label="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure</link:label>
    <link:label id="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock_label_en-US" xlink:label="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Table Text Block]</link:label>
    <link:label id="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock_documentation_en-US" xlink:label="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure Table Text Block.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" xlink:href="dva-20211231.xsd#dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" xlink:to="lab_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RMSLifelineMember_c04feb9e-83a4-4aed-a8c3-e0c462e1df0c_terseLabel_en-US" xlink:label="lab_dva_RMSLifelineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RMS Lifeline</link:label>
    <link:label id="lab_dva_RMSLifelineMember_label_en-US" xlink:label="lab_dva_RMSLifelineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RMS Lifeline [Member]</link:label>
    <link:label id="lab_dva_RMSLifelineMember_documentation_en-US" xlink:label="lab_dva_RMSLifelineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RMS Lifeline.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RMSLifelineMember" xlink:href="dva-20211231.xsd#dva_RMSLifelineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RMSLifelineMember" xlink:to="lab_dva_RMSLifelineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_12ffc9de-c244-408b-8d39-13b194374d63_terseLabel_en-US" xlink:label="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</link:label>
    <link:label id="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_label_en-US" xlink:label="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</link:label>
    <link:label id="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_documentation_en-US" xlink:label="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization consolidation and presentation of financial statements disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:href="dva-20211231.xsd#dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_2ae02336-c86d-4261-8e22-4d979e4934b4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash gain on acquiring additional ownership in business acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_9cf1c97c-9a9e-4bc3-bf06-a36ab81831a5_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_ae6be7a6-24bf-4f91-a0e1-20e031af69ee_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3470e8b5-d976-4211-8da7-1f9c1436e5bb_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_23b154f8-7eb1-4a75-ae10-c962f21761b9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_a07f9689-1b23-458f-a6b4-f50539e84dae_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_82dd7fe8-0d0e-4b1b-8e26-33ad1faa566c_terseLabel_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out consideration payment period</link:label>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_label_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration Revenue Earnout Period</link:label>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_documentation_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition contingent consideration revenue earn-out period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:href="dva-20211231.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:to="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_3a13ebe4-4f4a-4d95-970e-9bb08689327e_terseLabel_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_label_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sources of Revenue [Member]</link:label>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_documentation_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other sources of revenue (management fees and revenue from the Company's ancillary services and strategic initiatives).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember" xlink:href="dva-20211231.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherSourcesofRevenueMember" xlink:to="lab_dva_OtherSourcesofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_c445099c-1863-451a-8c11-4f0a3ac94334_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_2ddd8f7a-0a7e-4635-84dd-ddd544e8e5b7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_86bbfd7a-87fe-475c-acd2-cc66929f141e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_52bd6140-c29f-43d7-8a10-310b16cb08be_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_8f0b7b6a-a644-4bdc-8ae7-2807035c6076_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock_db8b3070-355f-4e66-9ae8-63ae9cf56992_terseLabel_en-US" xlink:label="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of allocation of income tax expense (benefit) between continuing and discontinued operations.</link:label>
    <link:label id="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Allocation Of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label id="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock_documentation_en-US" xlink:label="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Allocation Of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="dva-20211231.xsd#dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_681c3501-535a-41c3-80fa-af28af1dcf15_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_5f94db3b-c788-4b4f-b8de-cf2f34f5e200_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_4d6aaac8-749d-4b41-8d09-b5177a389fb1_totalLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses) gains net</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_69c2b016-bf4a-4334-a647-a7f7fdeb8271_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_919840c0-2704-4e92-a6aa-aa845f4bd6c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partial purchases</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_afd3c2f3-ea0c-4fe9-8c93-f525a85b16fd_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f57ccc51-1ab4-4510-98f9-5d65d50d13a2_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_54d09b57-279d-4055-98f4-17b8bbcf9b1b_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of long-term debt, net of unamortized discounts</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ec5022c0-1ce2-4e8b-8dd8-0ed009b6e047_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_4088182a-21b8-4565-8af0-ea9216ddf259_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_19240e52-4366-49e7-a3db-683701a6ea47_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_453682fe-ffab-43d0-96d8-75fb44d1faa1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_ebd866ac-ef05-4760-bd61-56707508665a_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_16b0ed70-d8dd-456f-b893-277b88635434_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_147a4dd8-d4ea-4589-810e-5b6a864cfe9e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_e7c81526-e3e7-45e9-9d30-3b7221509d69_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_56ff665f-6a15-4921-8bab-b398c6e56dc8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments and other investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments_b129c0fa-20e1-4177-b501-6e73f2d7ff0d_negatedLabel_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments or other settlements</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments_label_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions Earnouts Payments</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments_documentation_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions Earnouts Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" xlink:href="dva-20211231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" xlink:to="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockSettledStockAppreciationRightsMember_16f45594-8f00-47e0-ae1e-4d699d89cc98_terseLabel_en-US" xlink:label="lab_dva_StockSettledStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-settled Stock Appreciation Rights</link:label>
    <link:label id="lab_dva_StockSettledStockAppreciationRightsMember_label_en-US" xlink:label="lab_dva_StockSettledStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Settled Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_dva_StockSettledStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_dva_StockSettledStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Settled Stock Appreciation Rights.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockSettledStockAppreciationRightsMember" xlink:href="dva-20211231.xsd#dva_StockSettledStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockSettledStockAppreciationRightsMember" xlink:to="lab_dva_StockSettledStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_1248b841-5113-493c-b811-33461170ff04_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e048a824-dd01-42f9-8f22-771e51481681_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPensionPlansDefinedBenefitMember_f94d36ac-9ee3-4dd3-ae40-931fa9edcec2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan</link:label>
    <link:label id="lab_us-gaap_OtherPensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_022d8bde-43bf-4df6-82f1-e88dbe7030d3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_650962d1-d84a-44bd-8cbd-f179d4f9a4c1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_9de67bd1-b24a-4d4b-a225-a834d4544bd0_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0bf77d89-2ae7-49c8-95c2-d3f951c01ce1_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_ffe80732-17e9-4fee-ad84-63bf7ad6622e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_d057b3fd-6d7c-4e2e-b84f-397cb23dfb94_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total DaVita Inc. shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a76591bb-9b6f-463b-b1c7-f049a46551a1_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_639e0970-cdfa-4c94-8e9d-a37c051424c8_terseLabel_en-US" xlink:label="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Offering Price Percentage Of Face Amount</link:label>
    <link:label id="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_label_en-US" xlink:label="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Offering Price Percentage Of Face Amount</link:label>
    <link:label id="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_documentation_en-US" xlink:label="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Offering Price Percentage Of Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" xlink:href="dva-20211231.xsd#dva_DebtInstrumentOfferingPricePercentageOfFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" xlink:to="lab_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_77d7800f-90b3-4f32-9287-32b0f4595c94_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of stock awards exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_61266133-7571-40ed-84eb-7967cbd2dc84_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_bb49d094-6ccc-4137-af2f-e33ac81f294a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures_6e9caad4-e13c-45ee-8fb9-b2a21d64364b_negatedTerseLabel_en-US" xlink:label="lab_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures_label_en-US" xlink:label="lab_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease Due To Acquisitions and Divestitures</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures_documentation_en-US" xlink:label="lab_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease Due To Acquisitions and Divestitures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures" xlink:href="dva-20211231.xsd#dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures" xlink:to="lab_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_70e39779-dd0e-4928-a76c-46250f7a2c84_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9d4693a1-d4df-462c-a603-321746db2771_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_19fa89f3-cdac-4350-9dba-cad687eb0320_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_6911a92d-c803-4cc8-b7c4-f3a9aeed1e46_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_e4d7d49e-ac8e-4afc-ad26-65012af7e61f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, and equipment useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid_8ca3ef17-61df-4079-9bb5-1131ab7a3299_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan, distributions</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Distribution Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommitmentsAndContingenciesDisclosureLineItems_65f54c88-7ba7-4585-885a-7a9bae96cc46_terseLabel_en-US" xlink:label="lab_dva_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies Disclosure [Line Items]</link:label>
    <link:label id="lab_dva_CommitmentsAndContingenciesDisclosureLineItems_label_en-US" xlink:label="lab_dva_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies Disclosure [Line Items]</link:label>
    <link:label id="lab_dva_CommitmentsAndContingenciesDisclosureLineItems_documentation_en-US" xlink:label="lab_dva_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsAndContingenciesDisclosureLineItems" xlink:href="dva-20211231.xsd#dva_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="lab_dva_CommitmentsAndContingenciesDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_ca863709-ba68-40f2-a177-f072dfb04fc2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_b7fa7cd1-e6b6-42ae-9b48-b28f4b6a39d8_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_6e7730f4-7ffe-4e1e-8163-18fefa45019b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_214f2e7c-e383-4eaf-9a8d-e0da2c3f44c5_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum payments due under finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ThirdPartyPayorMember_b6b5e86b-36b5-4188-9b2b-4a161f2a59a6_terseLabel_en-US" xlink:label="lab_us-gaap_ThirdPartyPayorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-Party Payor</link:label>
    <link:label id="lab_us-gaap_ThirdPartyPayorMember_label_en-US" xlink:label="lab_us-gaap_ThirdPartyPayorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-Party Payor [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThirdPartyPayorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ThirdPartyPayorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ThirdPartyPayorMember" xlink:to="lab_us-gaap_ThirdPartyPayorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_0b3461df-912a-4a28-989f-12d6a5992082_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current income tax</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncomeTaxesLineItems_609961c9-e2dc-4c88-b448-b28e996264fc_terseLabel_en-US" xlink:label="lab_dva_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_dva_IncomeTaxesLineItems_label_en-US" xlink:label="lab_dva_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_dva_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_dva_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesLineItems" xlink:href="dva-20211231.xsd#dva_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncomeTaxesLineItems" xlink:to="lab_dva_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d975e558-90b5-483a-89f8-57384b44d4c7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtRefinancingCharges_abedfdcb-1787-4279-8136-7dd502788637_terseLabel_en-US" xlink:label="lab_dva_DebtRefinancingCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt prepayment, refinancing and redemption charges</link:label>
    <link:label id="lab_dva_DebtRefinancingCharges_label_en-US" xlink:label="lab_dva_DebtRefinancingCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Refinancing Charges</link:label>
    <link:label id="lab_dva_DebtRefinancingCharges_documentation_en-US" xlink:label="lab_dva_DebtRefinancingCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt prepayment refinancing redemption charges related to debt modification of long-term debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges" xlink:href="dva-20211231.xsd#dva_DebtRefinancingCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtRefinancingCharges" xlink:to="lab_dva_DebtRefinancingCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_9add90cc-adb0-4bfb-9123-c5cae2d8fd64_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_927ccc12-1e0b-44ec-9056-ea28f1a5c121_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_e24f7703-2e8e-4580-a522-eeab4cbbe09d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_7fa1c8f2-c1e6-4631-95a8-fd0e77204242_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Purchase Cost Allocations for Acquisitions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_52b56224-f23b-4475-8146-0b9d81930d5a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_b0306485-2ff6-4e4e-8ac0-d831cecb354f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_984a05ae-e856-421a-8cbc-5f59af3dd869_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contribution, percent of match</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_546a4521-cd43-449e-a9ad-ffbf341c35e8_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommercialPayorsMember_5362ed64-b7ce-4334-8afa-e5828f4dcf3b_terseLabel_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors</link:label>
    <link:label id="lab_dva_CommercialPayorsMember_label_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors [Member]</link:label>
    <link:label id="lab_dva_CommercialPayorsMember_documentation_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors in healthcare industry.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember" xlink:href="dva-20211231.xsd#dva_CommercialPayorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommercialPayorsMember" xlink:to="lab_dva_CommercialPayorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_7fc10c85-0a86-433e-a64c-d8cf08afbce5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_2a5728e7-2d67-4299-b28c-e45ee0147e75_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_c0aa6da1-8d05-46f9-a895-15a5d3ffa679_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IndefiniteLifeNetOperatingLossesMember_f7d78480-d6cf-455a-816f-2f3d0ca2c63c_terseLabel_en-US" xlink:label="lab_dva_IndefiniteLifeNetOperatingLossesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite Life Net Operating Losses</link:label>
    <link:label id="lab_dva_IndefiniteLifeNetOperatingLossesMember_label_en-US" xlink:label="lab_dva_IndefiniteLifeNetOperatingLossesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite Life Net Operating Losses [Member]</link:label>
    <link:label id="lab_dva_IndefiniteLifeNetOperatingLossesMember_documentation_en-US" xlink:label="lab_dva_IndefiniteLifeNetOperatingLossesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite Life Net Operating Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IndefiniteLifeNetOperatingLossesMember" xlink:href="dva-20211231.xsd#dva_IndefiniteLifeNetOperatingLossesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IndefiniteLifeNetOperatingLossesMember" xlink:to="lab_dva_IndefiniteLifeNetOperatingLossesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c4a9807b-0773-4a04-a977-2951c87fd826_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_31fa1104-29f4-484f-8378-cc3c2cc89c91_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma diluted net income per share from continuing operations attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_1ba55dc7-2626-4186-bedb-c21385c3e71c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which dialysis centers located</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_54c48ac4-c449-4bd8-bcd2-3ebb2a582905_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_180dfb97-f870-49c6-8e9e-4111e7d1a52f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NumberOfPartnerships_f641296c-9a8c-4111-81b9-90ef5ee6e38d_verboseLabel_en-US" xlink:label="lab_dva_NumberOfPartnerships" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses</link:label>
    <link:label id="lab_dva_NumberOfPartnerships_cc92fe1c-94e7-48ca-bf4e-e7bc8d067e78_terseLabel_en-US" xlink:label="lab_dva_NumberOfPartnerships" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of partnerships</link:label>
    <link:label id="lab_dva_NumberOfPartnerships_label_en-US" xlink:label="lab_dva_NumberOfPartnerships" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Partnerships</link:label>
    <link:label id="lab_dva_NumberOfPartnerships_documentation_en-US" xlink:label="lab_dva_NumberOfPartnerships" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Partnerships that are included in the Equity Investments category.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfPartnerships" xlink:href="dva-20211231.xsd#dva_NumberOfPartnerships"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NumberOfPartnerships" xlink:to="lab_dva_NumberOfPartnerships" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_a9ab6e9b-c815-412d-b705-fb664d17a601_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts written off</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_a154916f-2661-4191-9983-9c48259cf744_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_31d9eb3b-559c-4310-ae2a-66fdc23904eb_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8c355807-2c95-434e-b87d-92e045bed6f2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_cd00a7a6-8bbd-4fcc-a194-fffa8bd4135c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_cdf82b17-d43a-4490-a2c9-22ce5bb54351_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_150e9eaf-0ed5-4847-88d9-519eff8dca06_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_f7635d6b-b711-4c75-a2c2-7568386b945c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_045fcf6a-88cf-4138-bb3f-0d50c7bbef12_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_387ef495-51a2-4431-a326-8989df46d901_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_eae96f35-12e8-4908-a50d-dfd01af1eefd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_96764548-955d-4cff-9865-b258aeb5e726_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_2d5085b1-a1da-4a05-a4a1-52e11dc150a7_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_97c58f1d-cbcf-4a75-bcaa-9ac06af6c9d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Range of Exercise Prices</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a57a1303-bd42-4e76-9837-1939805375d2_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments due under operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_4fb6eacb-033c-443c-993b-6b76f757d0dd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8730d3b6-bfcf-4621-870b-2edc5c4bf176_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b38c24c2-af5e-49af-ab3b-68534c4f144f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification into net income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_8731d03c-20d8-4ffd-8718-c8912cebb959_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Divestiture</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:to="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_74cff105-579c-40dc-b568-11e380f06719_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_fb7930df-c17f-4efe-b1d4-437c9619d090_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_03688119-a7c2-46c7-b30d-bb0e33f80a90_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Four</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:to="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_0f40f6dc-f0e5-47a4-81b9-5e6a498081e5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_e352207a-51d8-461a-8b38-a6746f8d7999_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_bd263ff2-9a39-490d-b222-017720caf90c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_4d8a1dc5-e1d0-49fe-90d8-9e316fe169ec_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_5ce2658f-900c-41e9-af4c-5934f06523ab_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_fa744765-c56f-4ce3-83dd-283f6d9d9c19_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets_f80928e7-8ba3-4d41-a486-2a83b2a4f611_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships and other</link:label>
    <link:label id="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Indefinite-lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e8d298b3-fe81-46bf-b6c1-a97bc1308b6d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value of grants</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a4000f09-4adf-4507-b906-7803fb1ecbe5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_0aea4716-fe13-4f67-9080-453e5d5a41f6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_c31d3365-2625-4739-8c9f-0c2ce6b450c1_terseLabel_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and Leaseback Transaction, Gain (Loss), Net</link:label>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_label_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and Leaseback Transaction, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:to="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7ee3ef32-842f-4396-8bda-8f9362d2e17c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersubsegmentEliminationsMember_31cbc3ab-9828-4642-ac22-f8959a36814e_terseLabel_en-US" xlink:label="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersubsegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersubsegmentEliminationsMember_label_en-US" xlink:label="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersubsegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersubsegmentEliminationsMember" xlink:to="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_FinanceLeaseAccumulatedDepreciation_845fad9e-4609-404b-ae39-400f1260cad1_terseLabel_en-US" xlink:label="lab_dva_FinanceLeaseAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Accumulated Depreciation</link:label>
    <link:label id="lab_dva_FinanceLeaseAccumulatedDepreciation_label_en-US" xlink:label="lab_dva_FinanceLeaseAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Accumulated Depreciation</link:label>
    <link:label id="lab_dva_FinanceLeaseAccumulatedDepreciation_documentation_en-US" xlink:label="lab_dva_FinanceLeaseAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Accumulated Depreciation, contra asset.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseAccumulatedDepreciation" xlink:href="dva-20211231.xsd#dva_FinanceLeaseAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_FinanceLeaseAccumulatedDepreciation" xlink:to="lab_dva_FinanceLeaseAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e4ad3eb3-c226-4581-81d9-0df18a9f0175_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OperatingLeaseMember_743a7299-a203-4731-9c56-90f09bf72ad7_terseLabel_en-US" xlink:label="lab_dva_OperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease</link:label>
    <link:label id="lab_dva_OperatingLeaseMember_label_en-US" xlink:label="lab_dva_OperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease [Member]</link:label>
    <link:label id="lab_dva_OperatingLeaseMember_documentation_en-US" xlink:label="lab_dva_OperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OperatingLeaseMember" xlink:href="dva-20211231.xsd#dva_OperatingLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OperatingLeaseMember" xlink:to="lab_dva_OperatingLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b146d3c8-e339-4cb0-991a-86850e7d26a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_395f430a-373f-426c-8401-15e6e98a8ea7_terseLabel_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. dialysis</link:label>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_label_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S Dialysis And Related Lab Services [Member]</link:label>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_documentation_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US dialysis &#8203;and &#8203;related &#8203;lab&#8203; services&#8203;.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_USDialysisAndRelatedLabServicesMember" xlink:to="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_d7b24cd3-d2c5-4c37-92e9-527e25eff6ab_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ff18bfd9-ea4d-49e0-b3d5-95aa9c38f86a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_efc08bc4-8a11-49e6-8552-888dcc129e25_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Asset Categories</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_d3039eda-529a-4fd6-adf4-10247162ac0b_terseLabel_en-US" xlink:label="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount coverage</link:label>
    <link:label id="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_label_en-US" xlink:label="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit Percentage Of Fair Value In Excess Of Short Of Carrying Amount</link:label>
    <link:label id="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_documentation_en-US" xlink:label="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting unit percentage of fair value in excess of short of carrying amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" xlink:href="dva-20211231.xsd#dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" xlink:to="lab_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_70f4e7a0-1ec3-4701-93fe-2f2462fbdfa1_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_cfb6bb2d-5b2f-4bf1-87ec-1ecb5f8c580f_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_5aaa1d5a-024c-4ac8-8bd7-58499f14987b_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Long-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_9134b09c-4fa9-4cef-8ecf-a727fab76258_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_4fb52d09-c798-402a-b48c-3c69a66c08d0_terseLabel_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dialysis patient service revenues</link:label>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_label_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</link:label>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_documentation_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:href="dva-20211231.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:to="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_7111c660-1933-48ff-8944-acd695dca22f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_09ed6ad7-e8d6-4aff-99db-9a6000fd66d7_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of unrealized gains (losses) in OCI on interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncome_c7a725d9-71dd-4d82-82ba-09edca99f2d6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_us-gaap_OtherIncome_label_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_864fe5b5-aa45-45bf-b6e6-cc2b17e6dd2c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other potential commitments to provide operating capital to several dialysis centers</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c87fdabb-3c60-4a16-bced-35ed3f6250ce_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in international valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_4c9794ef-fe98-43ed-b603-eb56292673f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PaymentsRelatedToStockPurchasesAndAwards_5296b4f1-151a-4088-9ea5-419d821a63b3_negatedTerseLabel_en-US" xlink:label="lab_dva_PaymentsRelatedToStockPurchasesAndAwards" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (payments) receipts related to stock purchases and awards</link:label>
    <link:label id="lab_dva_PaymentsRelatedToStockPurchasesAndAwards_label_en-US" xlink:label="lab_dva_PaymentsRelatedToStockPurchasesAndAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to stock purchases and awards</link:label>
    <link:label id="lab_dva_PaymentsRelatedToStockPurchasesAndAwards_documentation_en-US" xlink:label="lab_dva_PaymentsRelatedToStockPurchasesAndAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to stock purchases and awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PaymentsRelatedToStockPurchasesAndAwards" xlink:href="dva-20211231.xsd#dva_PaymentsRelatedToStockPurchasesAndAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PaymentsRelatedToStockPurchasesAndAwards" xlink:to="lab_dva_PaymentsRelatedToStockPurchasesAndAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_08a65c70-f99e-4999-9a28-bfb6f1d69905_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3672993c-9bbc-46bf-b8c7-3ac7e9d95e43_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7d8513ee-01ae-4ff7-8474-04148d728937_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross (excluding goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cb16cc4c-563c-40d4-ae01-9d001f4746b9_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_28ff6f1d-8e23-460b-9920-051eb2b5fa5c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant&#160;other observable&#160;inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_54887db2-3895-4e17-844c-0381262a638c_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_100c267f-b098-4bfa-ba26-c3359ca09f8c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_43b9d586-2cf5-4985-ad6f-06c61fb5121d_terseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_label_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase Due To Acquisitions and Divestitures</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase Due To Acquisitions and Divestitures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:href="dva-20211231.xsd#dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:to="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_ca47d4cc-3af4-4b61-ac0f-445ab074d566_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_f32287d1-03c5-4858-b709-040b4e66830e_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_18a62a16-4495-440b-b667-e8d05ed75c53_negatedTerseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_label_en-US" xlink:label="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease Due To Acquisitions and Divestitures</link:label>
    <link:label id="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease Due To Acquisitions and Divestitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" xlink:href="dva-20211231.xsd#dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" xlink:to="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_47b04f53-cbf9-4623-8b0c-0613ff20c8b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ReconciliationOfCashFlowsTableTextBlock_d3b1635c-a9af-43ed-b4d8-71b8486488f0_terseLabel_en-US" xlink:label="lab_dva_ReconciliationOfCashFlowsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Cash Flows</link:label>
    <link:label id="lab_dva_ReconciliationOfCashFlowsTableTextBlock_label_en-US" xlink:label="lab_dva_ReconciliationOfCashFlowsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Cash Flows [Table Text Block]</link:label>
    <link:label id="lab_dva_ReconciliationOfCashFlowsTableTextBlock_documentation_en-US" xlink:label="lab_dva_ReconciliationOfCashFlowsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Cash Flows [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCashFlowsTableTextBlock" xlink:href="dva-20211231.xsd#dva_ReconciliationOfCashFlowsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ReconciliationOfCashFlowsTableTextBlock" xlink:to="lab_dva_ReconciliationOfCashFlowsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_cdb89bdd-35aa-42a6-92d2-e27abccb0db4_negatedLabel_en-US" xlink:label="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivities, Discount rate</link:label>
    <link:label id="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_label_en-US" xlink:label="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Impact On Fair Value For Basis Point Increase In Discount Rate</link:label>
    <link:label id="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_documentation_en-US" xlink:label="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Impact On Fair Value For Basis Point Increase In Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" xlink:href="dva-20211231.xsd#dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" xlink:to="lab_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_52554a7b-effa-4760-89c4-022b843cf5ac_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_1c719c96-5f22-4c06-83dd-073681973288_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_bf626d79-2d0e-402e-b590-a65529573691_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_465af676-a405-41cd-9033-03d88095893e_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_8e2fdf27-e723-4d94-953c-3f4ef26e6d61_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_403994ed-84df-4224-834b-7a46fe71756b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding during the period (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Issued, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_48195ba8-5b86-4037-9445-becb92bea79d_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ce1aba68-a37a-4ec5-8ccf-568d44c48521_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_03282cd9-1c11-4058-9225-e13b0526a553_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_e16e1d93-10bd-481f-8608-1ec0ab028e39_terseLabel_en-US" xlink:label="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law Limitation</link:label>
    <link:label id="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_label_en-US" xlink:label="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law Limitation</link:label>
    <link:label id="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_documentation_en-US" xlink:label="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law limitation. The Company is subject to Section&#160;203 of the Delaware General Corporation Law which, subject to exceptions, would prohibit the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period three years following the date on which that stockholder became an interested stockholder.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" xlink:href="dva-20211231.xsd#dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" xlink:to="lab_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_80c02544-34b6-4474-91a0-4e47ed88bb68_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d19c065d-ab35-4909-8e27-c12659124331_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_07d31aa6-47b7-44da-b784-db2a04c2c6db_terseLabel_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_label_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_documentation_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" xlink:href="dva-20211231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" xlink:to="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_79b90139-a30a-47ce-aaf4-663066e93262_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e67cf8d-0f90-4d1a-aab8-922225b83eb1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_660cd4a7-a2a1-450b-a7cd-402069e541ad_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in liability for unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_f18422ed-fb39-4b7d-a2da-0c43d3b0b30e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:to="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_609d9c58-3fed-4277-bc01-66ffe198f51b_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving line of credit</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_f67da016-2ce0-4687-b65a-328945afe54d_verboseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_c8c70e44-a570-4ceb-9415-e125323a3291_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_ce14753d-56e2-44a4-b00d-ab01a33f0c0a_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other - Ancillary services</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_d9b7263b-139b-4145-8c91-7a018d38cf83_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_0282943c-81e5-4e5d-9613-f5cd511012f6_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Expense Components</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_6eb38447-ae78-4f52-955c-013013358380_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of noncontrolling interests primarily attributable to non-tax paying entities</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_GroundLeaseMember_e83e8d18-4e16-413b-ba66-5c321348e371_terseLabel_en-US" xlink:label="lab_dva_GroundLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ground Lease</link:label>
    <link:label id="lab_dva_GroundLeaseMember_label_en-US" xlink:label="lab_dva_GroundLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ground Lease [Member]</link:label>
    <link:label id="lab_dva_GroundLeaseMember_documentation_en-US" xlink:label="lab_dva_GroundLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ground Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_GroundLeaseMember" xlink:href="dva-20211231.xsd#dva_GroundLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_GroundLeaseMember" xlink:to="lab_dva_GroundLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_55515038-9340-4238-a35a-1286fa9ba9e3_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_94df3afb-b097-4c31-86d1-af24ff833693_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_fffe9f82-b107-45e4-a9fa-dc6c3a89ccb8_terseLabel_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable, fair value</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_label_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable, Fair Value</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_documentation_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable, Fair Value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:href="dva-20211231.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:to="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_38073e8c-cea8-4142-9d69-a01ad3a80c76_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_88c59ab2-6468-4f5f-92a3-3b971bbde486_negatedLabel_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables and prepaid and other current assets</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_label_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Other Current Receivables And Other Current Assets</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_documentation_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the reporting period in other current receivables and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:href="dva-20211231.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:to="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_91424428-f291-4b9c-9dbe-768548c4a5ad_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a98851fa-6e0c-4663-bcef-b261385dfa3a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_ec50a036-c205-43e6-b4eb-ca1ff43553d4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, weighted average interest rate, at point in time</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGain_9ff32100-ad64-4b88-bb35-98726adba5a9_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGain_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_e0dce73c-3a84-4a35-b501-a247a2a65869_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_429e0a25-f1e7-4425-9a23-75698f43033e_negatedTerseLabel_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partial purchases</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_label_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease Purchase Of Interests</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_documentation_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease Purchase Of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:href="dva-20211231.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:to="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DMGAcquisitionsMember_3e54ca9e-0a83-4387-8e35-0ba96c423c25_terseLabel_en-US" xlink:label="lab_dva_DMGAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG Acquisitions</link:label>
    <link:label id="lab_dva_DMGAcquisitionsMember_label_en-US" xlink:label="lab_dva_DMGAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG Acquisitions [Member]</link:label>
    <link:label id="lab_dva_DMGAcquisitionsMember_documentation_en-US" xlink:label="lab_dva_DMGAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DMGAcquisitionsMember" xlink:href="dva-20211231.xsd#dva_DMGAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DMGAcquisitionsMember" xlink:to="lab_dva_DMGAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessSaleDateOfPurchaseAndSaleAgreement_8397c6d4-4c66-4783-95ff-0f8fb0362bf1_terseLabel_en-US" xlink:label="lab_dva_BusinessSaleDateOfPurchaseAndSaleAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Sale, Date Of Purchase And Sale Agreement</link:label>
    <link:label id="lab_dva_BusinessSaleDateOfPurchaseAndSaleAgreement_label_en-US" xlink:label="lab_dva_BusinessSaleDateOfPurchaseAndSaleAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Sale, Date Of Purchase And Sale Agreement</link:label>
    <link:label id="lab_dva_BusinessSaleDateOfPurchaseAndSaleAgreement_documentation_en-US" xlink:label="lab_dva_BusinessSaleDateOfPurchaseAndSaleAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Sale, Date Of Purchase And Sale Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessSaleDateOfPurchaseAndSaleAgreement" xlink:href="dva-20211231.xsd#dva_BusinessSaleDateOfPurchaseAndSaleAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessSaleDateOfPurchaseAndSaleAgreement" xlink:to="lab_dva_BusinessSaleDateOfPurchaseAndSaleAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_1dc1f2cf-2333-473f-80f7-62ad08e68e56_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in debt and equity securities</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3a6679e8-5312-4dc5-91fe-1f99ec6e0479_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes associated with acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_b48263e9-cf03-41e0-927d-243cd8861e0e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fb36e522-be8a-44b0-81f8-d175485c087d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for earnings per share:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_26556d6b-7234-459d-8801-266e4cd0ba0e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_3afc12df-358a-449e-aa23-07f627ac02d2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_b6d88082-f780-44a4-b012-46d6c313f2af_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment income, net</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_0c93575c-c40d-4a9b-972d-5d22b9e312ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment income (loss)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_dabc06af-94d6-45e4-9b06-d0deb6e4b999_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_e9965a02-1b92-4346-90ec-1607568ac3cd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeMaturityDates_232fdc24-3122-4f2f-bde0-ba7bba5e8d35_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeMaturityDates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, expiration date</link:label>
    <link:label id="lab_us-gaap_DerivativeMaturityDates_label_en-US" xlink:label="lab_us-gaap_DerivativeMaturityDates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeMaturityDates" xlink:to="lab_us-gaap_DerivativeMaturityDates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_513dbb3b-8a2e-4fe3-b9da-fd8fbb293a56_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_d45a1529-fcc5-4feb-9496-822f8145661c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_66b776ca-1e8a-4153-b5ef-4f19a1e3a7d5_terseLabel_en-US" xlink:label="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions used to purchase shares, employee-related current liabilities</link:label>
    <link:label id="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_label_en-US" xlink:label="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Current Liabilities, Employee Stock Purchase Plan, Contributions Used To Purchase Shares</link:label>
    <link:label id="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_documentation_en-US" xlink:label="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Current Liabilities, Employee Stock Purchase Plan, Contributions Used To Purchase Shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" xlink:href="dva-20211231.xsd#dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" xlink:to="lab_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_2937d282-adab-4e5a-b2be-be4ec5d54220_terseLabel_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests subject to put provisions</link:label>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_label_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Redeemable Noncontrolling Interests [Member]</link:label>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_documentation_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests Temporary Equity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:href="dva-20211231.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:to="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_95dbe389-34b1-46cc-8935-ab2e46585222_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_073b6bfe-233d-4829-922f-32560d3bc468_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_b7f08db3-6405-44d0-a72f-5ea6a26973f2_terseLabel_en-US" xlink:label="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Debt Principal Amount Due To New Agreement</link:label>
    <link:label id="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_label_en-US" xlink:label="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Debt Principal Amount Due To New Agreement</link:label>
    <link:label id="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_documentation_en-US" xlink:label="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Debt Principal Amount Due To New Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalDebtPrincipalAmountDueToNewAgreement" xlink:href="dva-20211231.xsd#dva_AdditionalDebtPrincipalAmountDueToNewAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AdditionalDebtPrincipalAmountDueToNewAgreement" xlink:to="lab_dva_AdditionalDebtPrincipalAmountDueToNewAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_6767d073-ef37-4477-b5fb-a764e93a923d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_91df401e-99d1-4da1-8e41-cb5f2ac17b68_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_944ada00-3696-4df0-8102-de7721183348_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermAxis" xlink:to="lab_us-gaap_LeaseContractualTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_99e27f84-d1ef-4982-a7ee-c67ced0f452c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardExpirationDate_47e0748f-4c53-4485-a019-430dd19da3dd_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State capital loss carryforward, expiration date</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardExpirationDate_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:to="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_fc65978d-a7c4-49ce-82aa-e4b01b6fae36_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e440cfdc-b444-4fc0-952d-537828ad0e63_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0477eccb-9b7d-477a-a648-24f58fff6cdf_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_47a53c46-3387-4750-92c1-23cbf8e50b7b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_8074f1fb-2b25-4869-9656-5257671ac25f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_7ca33d7c-7728-4d98-8a6d-5a8cfc3d0742_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt expense</link:label>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_label_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Debt Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDebtExpense" xlink:to="lab_us-gaap_InterestAndDebtExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LeaseOtherInformationTableTextBlockTableTextBlock_c889d949-13b2-49eb-a262-636bef8ac4d9_terseLabel_en-US" xlink:label="lab_dva_LeaseOtherInformationTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Other Information</link:label>
    <link:label id="lab_dva_LeaseOtherInformationTableTextBlockTableTextBlock_label_en-US" xlink:label="lab_dva_LeaseOtherInformationTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Other Information Table Text Block [Table Text Block]</link:label>
    <link:label id="lab_dva_LeaseOtherInformationTableTextBlockTableTextBlock_documentation_en-US" xlink:label="lab_dva_LeaseOtherInformationTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Other Information in tabular disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeaseOtherInformationTableTextBlockTableTextBlock" xlink:href="dva-20211231.xsd#dva_LeaseOtherInformationTableTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LeaseOtherInformationTableTextBlockTableTextBlock" xlink:to="lab_dva_LeaseOtherInformationTableTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsExpirationDate_0aedd1b2-9b87-4ed8-b350-24b09498932c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, expiration date</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsExpirationDate_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:to="lab_us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_8b615761-66fc-43ad-b142-65589a0767f9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_85500459-91ea-403b-8858-5e96020944df_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5a514322-6cd1-4414-9b21-288d0aa18251_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_01e3789d-0711-4cf5-bade-8eaa51e81b94_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_914c06d2-5297-4fe6-9692-4f27d4668b10_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information footnote:</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanFacilityMember_f5eb8e30-768b-4014-90ad-49a5e485d419_terseLabel_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_dva_TermLoanFacilityMember_label_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_dva_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember" xlink:href="dva-20211231.xsd#dva_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanFacilityMember" xlink:to="lab_dva_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7d422761-a8f1-46c8-87c8-73a680e41c15_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net of accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_aac0ee4c-87ad-4787-a285-4efb6fb5055d_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_a34794ba-2244-4ddb-8320-62df49ef6333_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_99279f94-865b-45e3-a62e-37a78e9e7753_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled Amortization Charges from Intangible Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_0afb6b3d-641b-45e9-a7bb-5a3647f16aee_totalLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_3539d746-4621-43e3-95ff-d9ec26678f88_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to DaVita Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_e7fc7ef1-6734-47f2-baaa-195ba47acd6f_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_5392aa43-a774-47ea-a499-860e0c4b1216_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross, total</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_fa6068f4-0b63-4a80-8492-f5740c9de70a_terseLabel_en-US" xlink:label="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in discount rate used to evaluate fair value of reporting unit for goodwill assessment</link:label>
    <link:label id="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_label_en-US" xlink:label="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change In Discount Rate Used To Evaluate Fair Value Of Reporting Unit For Goodwill Assessment</link:label>
    <link:label id="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_documentation_en-US" xlink:label="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in discount rate used to evaluate fair value of reporting unit for goodwill assessment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:href="dva-20211231.xsd#dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:to="lab_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_57f61e51-88c1-43e8-ab68-49aa34980ecb_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_61530a32-38dc-4c4b-b7d4-260dd5bf8427_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_49684e45-4539-4174-81ad-202e7198ca0f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_6777ad4f-5262-4c0e-bb85-3d7f4d03d039_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Routine Acquisitions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Noncash or Part Noncash Acquisitions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock" xlink:to="lab_us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_277468f1-21c8-4090-b598-dd0e795295cb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of year (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_beffc445-e682-4b7c-ab64-5e13a94862d4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_b4ae4506-8fa9-48ed-8129-d30e0bb76b32_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities_2f795038-3496-452f-b335-de20fa08e3fc_terseLabel_en-US" xlink:label="lab_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Increase (Decrease) In Unrealized Losses On Equity Securities</link:label>
    <link:label id="lab_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities_label_en-US" xlink:label="lab_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Increase Decrease In Unrealized Losses On Equity Securities</link:label>
    <link:label id="lab_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities_documentation_en-US" xlink:label="lab_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Increase Decrease In Unrealized Losses On Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities" xlink:href="dva-20211231.xsd#dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities" xlink:to="lab_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_1e21e4ac-259a-4ab7-b13e-3f1bf7bc4614_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent_db0673d5-dc39-4469-bd38-c5b2ad253634_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, long-term investments</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_52a737c8-5a3d-452a-9011-8f6f49e6c064_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7eba47f0-932f-4e37-9098-b620db14903c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8aee21d7-abba-4e89-8b7f-dfa215825693_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_9a63ba34-1826-49af-815a-a8a86f1ff9c7_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4eb77e49-5dcf-4e85-a1be-aaed048ef029_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of assets held in trust</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_fdf3ff2b-ef75-4325-9fcc-ae9e56823616_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PatientCareCosts_e9624a8a-0796-4b34-9ca6-9169d7c3aaf6_terseLabel_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient care costs</link:label>
    <link:label id="lab_dva_PatientCareCosts_label_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Care Costs</link:label>
    <link:label id="lab_dva_PatientCareCosts_documentation_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts" xlink:href="dva-20211231.xsd#dva_PatientCareCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PatientCareCosts" xlink:to="lab_dva_PatientCareCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_087bdda4-474e-420c-9887-c07495efcd8d_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discounts, Premiums and Deferred Financing Costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_1f99f1ab-c8c7-4e48-ad76-4c13a2993cb5_negatedLabel_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate administrative support</link:label>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_label_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information Corporate Expenses</link:label>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_documentation_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses" xlink:href="dva-20211231.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SegmentReportingInformationCorporateExpenses" xlink:to="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_fb1c8b93-1581-4b2b-93a4-b6eaa76b45dd_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_37783f78-2c22-47b1-a901-ffc03482b9b0_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_dfd45747-0034-4a46-8958-c4dbcc07d321_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DeferredTaxLiabilitiesMember_a4cf848c-8693-4caa-8e37-200fa583f65c_terseLabel_en-US" xlink:label="lab_dva_DeferredTaxLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_dva_DeferredTaxLiabilitiesMember_label_en-US" xlink:label="lab_dva_DeferredTaxLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities [Member]</link:label>
    <link:label id="lab_dva_DeferredTaxLiabilitiesMember_documentation_en-US" xlink:label="lab_dva_DeferredTaxLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxLiabilitiesMember" xlink:href="dva-20211231.xsd#dva_DeferredTaxLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DeferredTaxLiabilitiesMember" xlink:to="lab_dva_DeferredTaxLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ScheduleOfOtherReceivablesTableTextBlock_dde629b6-2e34-48a9-bd64-68a0e10e31a0_terseLabel_en-US" xlink:label="lab_dva_ScheduleOfOtherReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Receivables</link:label>
    <link:label id="lab_dva_ScheduleOfOtherReceivablesTableTextBlock_label_en-US" xlink:label="lab_dva_ScheduleOfOtherReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Receivables [Table Text Block]</link:label>
    <link:label id="lab_dva_ScheduleOfOtherReceivablesTableTextBlock_documentation_en-US" xlink:label="lab_dva_ScheduleOfOtherReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of claims held for amounts due to an entity. Examples include non-trade receivables and Medicare bad debt claims.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfOtherReceivablesTableTextBlock" xlink:href="dva-20211231.xsd#dva_ScheduleOfOtherReceivablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ScheduleOfOtherReceivablesTableTextBlock" xlink:to="lab_dva_ScheduleOfOtherReceivablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_2523341b-04df-4c80-b483-ee4c12ca8a37_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_80e1871b-56a4-4d17-bd2e-1b9e1c88bf63_verboseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases term and discount rate</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_65e6f0c7-c8ef-42cd-af5f-460a1542d859_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance by Deferred Tax Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance by Deferred Tax Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:to="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_6d762240-4e5b-4b3a-a08b-b60b8b51f4b9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on interest rate cap agreements:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_aa5018c6-78c0-419f-abc6-2a0da7f31cd8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_b14f6d5a-3c53-4d30-b6a0-3bcf32018e8f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8015bc0b-a622-4443-ab50-7d1a916d819d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_072025f6-45c8-43f1-b64a-d4ebfde03275_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt investments held-to-maturity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Held-to-maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_3867d6a6-a2c5-4085-ac4d-f8a497aba771_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_ed4a5e2b-629d-4e55-b307-2cbc67c4e9db_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from accumulated other comprehensive losses (income) into net income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_20757c5d-f3b2-49bb-afd4-2855bd43852f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_3fe888ca-f8ef-47a7-9fb9-366c413da2d6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate</link:label>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:to="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1789350e-55dc-48f3-98be-bb45f640e366_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_739b30b2-f197-4a5c-b100-2c04645f6974_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, Due in Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments_6393af59-bd69-4e1e-849b-83f617195cbf_negatedLabel_en-US" xlink:label="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment loss, net</link:label>
    <link:label id="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment Income Loss From Equity Method Investments</link:label>
    <link:label id="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments_documentation_en-US" xlink:label="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents the entity's proportionate share for the period of the undistributed net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:href="dva-20211231.xsd#dva_AdjustmentIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:to="lab_dva_AdjustmentIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ceb5efe2-e154-4800-8645-fde90ec9db90_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7def619b-d301-47c7-8988-4d1ffc53f6d5_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1bd59b69-f068-457a-bb41-ab7c5eed8fd6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_e4016032-2210-4f18-abfd-05722b6805a7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DaVitaMedicalGroupMember_97715a38-bb6c-4016-8050-042881596e1d_verboseLabel_en-US" xlink:label="lab_dva_DaVitaMedicalGroupMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG - discontinued operations</link:label>
    <link:label id="lab_dva_DaVitaMedicalGroupMember_label_en-US" xlink:label="lab_dva_DaVitaMedicalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Da Vita Medical Group [Member]</link:label>
    <link:label id="lab_dva_DaVitaMedicalGroupMember_documentation_en-US" xlink:label="lab_dva_DaVitaMedicalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DaVita medical group.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember" xlink:href="dva-20211231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DaVitaMedicalGroupMember" xlink:to="lab_dva_DaVitaMedicalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_4de1cf64-0c0a-49e6-9a73-790c1884fb08_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_2f8da7de-b9bb-4318-af64-5150cda8f0bc_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_75f5b4cd-8261-4d55-bbf5-8ae638674f57_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR plus interest margin</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TextBlockAbstract_1c24863c-2e04-43c1-b94b-d9c53a3c8b47_terseLabel_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:label id="lab_us-gaap_TextBlockAbstract_label_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TextBlockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TextBlockAbstract" xlink:to="lab_us-gaap_TextBlockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_c0bce3bc-6bef-4190-afe4-6b4ad62c53c8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain_a7846eda-f98d-46c0-8586-400c21b14625_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Domain]</link:label>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain_label_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:to="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_c5e9f91a-4714-492b-91e1-ef51e5be171e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4fd79622-4d12-4e3f-8ae6-26cbcd11a294_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_475a99ef-d537-4364-bcf9-8b532ce6bb5f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1ff1c779-35ed-435b-9d94-ccb208d04092_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_720a1a6f-8c3c-4738-8ee7-797180158cef_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_e5d975cf-5d85-4bd4-ae7c-a1f0e3a40f4f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_3d4c4b7d-810e-448d-bb48-fa0460556878_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_372f60e0-0c50-47a7-a823-7500a59059d1_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6f29d789-85c5-400c-9f7d-afc1b0456504_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_a75456f2-79af-4126-8f11-3bf2efc4863e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_eae86dc6-5651-4f43-b5f4-3ef783ea88b8_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Elimination</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember_315800ac-6d48-41f1-8570-96629668fc51_terseLabel_en-US" xlink:label="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium priced stock-settled stock appreciation rights</link:label>
    <link:label id="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember_label_en-US" xlink:label="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Priced Stock-Settled Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Priced Stock-Settled Stock Appreciation Rights Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumPricedStockSettledStockAppreciationRightsMember" xlink:href="dva-20211231.xsd#dva_PremiumPricedStockSettledStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PremiumPricedStockSettledStockAppreciationRightsMember" xlink:to="lab_dva_PremiumPricedStockSettledStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_0d7394af-965f-485a-859e-ab7c1a562d64_terseLabel_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities</link:label>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_label_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities [Member]</link:label>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_documentation_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured credit facilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember" xlink:href="dva-20211231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorSecuredCreditFacilitiesMember" xlink:to="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_479f6648-4dbf-44f2-9201-567735378bb7_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_5614ff23-9abf-43c3-8883-1fd2e28cf873_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient service revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7e65e161-7a52-464c-8a7a-29bcbf6d3c53_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dialysis patient service revenues before provision</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_cf664d10-9e09-496b-a13b-35562d4b92f4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contribution, percent of employees' gross wages</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_d6b978ef-911c-40a0-8340-5189294fe837_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_92aeeeb1-bb45-41ee-aa2b-58d53250cf53_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_2318ab45-113a-45a9-bbbb-a3958fc85243_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_FinanceLeaseMember_692bf9b3-12c7-44f5-88cf-64e1627fe106_terseLabel_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Lease</link:label>
    <link:label id="lab_dva_FinanceLeaseMember_9fda38c5-4194-4407-93fe-47632acf92a1_verboseLabel_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease</link:label>
    <link:label id="lab_dva_FinanceLeaseMember_label_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:label id="lab_dva_FinanceLeaseMember_documentation_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember" xlink:href="dva-20211231.xsd#dva_FinanceLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_FinanceLeaseMember" xlink:to="lab_dva_FinanceLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_55918925-80a9-4ef6-ace6-fb6536b100ad_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_317e8d5f-c003-4c8f-8433-46df7caaea4f_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New accounting standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_3ca9e7c4-2467-4b4a-a5ef-dc606e2d9a98_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_b4a6ed96-9684-4682-9240-82a3b76354f0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock_709ba3da-0a48-4ab0-bedd-63c1f820c49b_terseLabel_en-US" xlink:label="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock_label_en-US" xlink:label="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income Expense Policy [Text Block]</link:label>
    <link:label id="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock_documentation_en-US" xlink:label="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other nonoperating income (expense), policy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherNonoperatingIncomeExpensePolicyTextBlock" xlink:href="dva-20211231.xsd#dva_OtherNonoperatingIncomeExpensePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherNonoperatingIncomeExpensePolicyTextBlock" xlink:to="lab_dva_OtherNonoperatingIncomeExpensePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1204d049-1ebc-4665-97d1-f7dc9e537b87_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_0373bf92-c707-4aaf-bfd6-6e30cca06efa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_4b44a55b-5733-419f-afbe-d7f5b5cd6399_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_21b8fa8e-f97d-4592-8854-2937dc2e5659_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_81ccd11a-79aa-45ae-99c9-5024c5fc9722_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_c474fae3-5e8a-4f30-8f16-7f8de420929d_terseLabel_en-US" xlink:label="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date</link:label>
    <link:label id="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_label_en-US" xlink:label="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date</link:label>
    <link:label id="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_documentation_en-US" xlink:label="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" xlink:href="dva-20211231.xsd#dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" xlink:to="lab_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_cef2f764-4ca7-48ac-b7e4-496adb996f82_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from discontinued operations before taxes</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_338f93f7-dc5d-4faf-b3dc-dfaf38b8d385_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtFinancingAndDebtRedemptionCosts_338b6313-56fe-4ac1-98aa-0d9d30b0fede_negatedTerseLabel_en-US" xlink:label="lab_dva_DebtFinancingAndDebtRedemptionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing and debt redemption costs</link:label>
    <link:label id="lab_dva_DebtFinancingAndDebtRedemptionCosts_label_en-US" xlink:label="lab_dva_DebtFinancingAndDebtRedemptionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Financing And Debt Redemption Costs</link:label>
    <link:label id="lab_dva_DebtFinancingAndDebtRedemptionCosts_documentation_en-US" xlink:label="lab_dva_DebtFinancingAndDebtRedemptionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Financing And Debt Redemption Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtFinancingAndDebtRedemptionCosts" xlink:href="dva-20211231.xsd#dva_DebtFinancingAndDebtRedemptionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtFinancingAndDebtRedemptionCosts" xlink:to="lab_dva_DebtFinancingAndDebtRedemptionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_8881728f-1756-40eb-b51c-2a2efbfdbe93_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_25e5c727-1d4a-433e-b834-f5408e062a56_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_b3a75304-6691-43de-8509-4f43dc2fa09d_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_cb6d468d-4305-4877-bf72-1f9c841f8fd2_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests not subject to put provisions</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_8a9daeea-a517-4e7f-9526-512fda01c99b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal and international tax rate adjustments</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_6fb9deed-3f2d-44bc-bc83-1cd7f5856269_terseLabel_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 4.625% due 2030</link:label>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_label_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty [Member]</link:label>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_documentation_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:href="dva-20211231.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:to="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_b0145103-243c-410a-995c-99592a1574e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Carrying Value of Goodwill by Reportable Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e7b83993-92d1-4b8b-a27a-0276ad7aba63_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_953ebd00-a393-44e0-92b4-df0cdab00d1f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_58ec5ee9-3bb8-432f-bf88-472867a76a66_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_a61cf95a-3c88-4392-86c7-56c83c314761_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_10773682-0f86-4ea3-9559-bad259b3893e_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_f7e89913-995d-405a-a0fe-6d413b1bccde_verboseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note Principal Amount</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_8e93658e-d66f-4077-9ca6-637a71870e20_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems" xlink:to="lab_us-gaap_InvestmentHoldingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_12248061-f7c5-4933-9590-fd56f528676e_terseLabel_en-US" xlink:label="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price</link:label>
    <link:label id="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_label_en-US" xlink:label="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price</link:label>
    <link:label id="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_documentation_en-US" xlink:label="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" xlink:href="dva-20211231.xsd#dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" xlink:to="lab_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c482ba67-1a76-422b-8300-30614fbbf023_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CashPaidForPortionPreviouslyRefundedMember_00c66b6b-84b4-4b3f-b9d1-99ea69a59bb5_terseLabel_en-US" xlink:label="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Portion Previously Refunded</link:label>
    <link:label id="lab_dva_CashPaidForPortionPreviouslyRefundedMember_label_en-US" xlink:label="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Portion Previously Refunded [Member]</link:label>
    <link:label id="lab_dva_CashPaidForPortionPreviouslyRefundedMember_documentation_en-US" xlink:label="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Amounts Previously Refunded [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:href="dva-20211231.xsd#dva_CashPaidForPortionPreviouslyRefundedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:to="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_bad85b2e-14bc-4a1f-9ae0-daeb04f37cc5_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_70ecf846-6f1b-445f-8944-909d404d7aee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchases summary table</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3debc290-50c8-4167-914c-30ad75e9b6aa_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_81c34d15-2594-46ea-9ed7-206cfdbfb0ce_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_32b6bd1f-fb55-44ca-8879-a558a3dd1709_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_95c42f65-2aec-488d-8fc3-095f66f2cd92_terseLabel_en-US" xlink:label="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor</link:label>
    <link:label id="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_label_en-US" xlink:label="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor</link:label>
    <link:label id="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_documentation_en-US" xlink:label="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" xlink:href="dva-20211231.xsd#dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" xlink:to="lab_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_fa90d768-a369-4fd6-8398-fd04731acfce_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_08fa719a-e02c-4b16-8bac-574c6a7c73e8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_880c17a0-cfc9-421c-b936-424dedcb6e27_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b306cb4f-9ec1-4f24-b7b5-c76458b8548c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_759af72a-0099-4196-a9f5-3e8532cce553_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_0a473278-1dcc-4bab-9f6a-556f45bc4f9f_terseLabel_en-US" xlink:label="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier rebates and non-trade receivables</link:label>
    <link:label id="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_label_en-US" xlink:label="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Rebates And Other Non Trade Receivables [Member]</link:label>
    <link:label id="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_documentation_en-US" xlink:label="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Rebates And Other Non Trade Receivables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SupplierRebatesAndOtherNonTradeReceivablesMember" xlink:href="dva-20211231.xsd#dva_SupplierRebatesAndOtherNonTradeReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SupplierRebatesAndOtherNonTradeReceivablesMember" xlink:to="lab_dva_SupplierRebatesAndOtherNonTradeReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_1a5a7454-86b7-4b15-904e-0a26e11f6162_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1bba800e-7ff5-4487-9e53-71cc01052de2_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_49129895-8526-4497-ab74-2ed29fedb7ee_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_eb69076e-1988-4d6f-880b-0ac1e6c5cb52_terseLabel_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_label_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_documentation_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentRevenuebyMajorPayorAbstract" xlink:href="dva-20211231.xsd#dva_SegmentRevenuebyMajorPayorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SegmentRevenuebyMajorPayorAbstract" xlink:to="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_fd6e09de-2ede-4495-977b-3b42d2594017_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_8bdeb648-b766-4a54-b196-5dae803919f1_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_891cc196-69e4-4377-897c-55ca87ea16c5_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_e650b2f6-877c-4477-b5ca-d2e54a718ea4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_0131d69a-57f6-4018-a087-b7f505ccd44f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_d891e486-411c-4fcd-8881-ff92dd1e8b70_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_7377e21e-0e96-41cc-aa7a-6655c2927a4f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of businesses acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_e53f5d67-0bc5-49a0-abea-6211cc2a6330_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets under financing lease obligations</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_8df86a41-ef27-48a0-b48f-394c6c6c8cf4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_694f3792-24cc-4dd3-879e-c8029f098662_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_a66c4896-0a17-4b07-8b61-c345e155d050_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_452cfd0d-cfbe-4529-a6d5-300b4d4b88a1_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_b3f7d4c9-a678-4ef8-9cdd-6958d6ea4e39_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests subject to put provisions</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_63df83ed-9401-40a9-9b90-e7cafd2976ef_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-settled stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_b81700e3-0a19-4e47-ae1c-c02ad201cf08_terseLabel_en-US" xlink:label="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in operating income used to evaluate fair value of reporting unit for goodwill assessment</link:label>
    <link:label id="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_label_en-US" xlink:label="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change In Operating Income Used To Evaluate Fair Value Of Reporting Unit For Goodwill Assessment</link:label>
    <link:label id="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_documentation_en-US" xlink:label="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in operating income used to evaluate fair value of reporting unit for goodwill assessment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:href="dva-20211231.xsd#dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:to="lab_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_7c152206-50cb-496c-a648-b634a15be2a2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of other debt and equity investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_e003e0c3-b42e-4ec1-9a6a-8da603b59f28_terseLabel_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in mutual funds and common stock</link:label>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_label_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds And Common Stock [Member]</link:label>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_documentation_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds And Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember" xlink:href="dva-20211231.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MutualFundsAndCommonStockMember" xlink:to="lab_dva_MutualFundsAndCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_24582aee-f566-45cd-b486-8cdc104de10d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale and Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c576d753-534f-4265-a3ab-00203ef687e7_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OpenMarketPurchasesMember_2b3c5a14-5e68-457e-bc80-be4855ab2f54_terseLabel_en-US" xlink:label="lab_dva_OpenMarketPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Purchases</link:label>
    <link:label id="lab_dva_OpenMarketPurchasesMember_label_en-US" xlink:label="lab_dva_OpenMarketPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Purchases [Member]</link:label>
    <link:label id="lab_dva_OpenMarketPurchasesMember_documentation_en-US" xlink:label="lab_dva_OpenMarketPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Purchases Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OpenMarketPurchasesMember" xlink:href="dva-20211231.xsd#dva_OpenMarketPurchasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OpenMarketPurchasesMember" xlink:to="lab_dva_OpenMarketPurchasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionDomain_fb9e9ec9-5db3-4335-91e4-ffb18ea2a1fc_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_TransactionDomain_label_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionDomain" xlink:to="lab_us-gaap_TransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncrementalCashPortionMember_b391c9d5-d059-4c07-b07c-8a41d4926898_terseLabel_en-US" xlink:label="lab_dva_IncrementalCashPortionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Cash Portion</link:label>
    <link:label id="lab_dva_IncrementalCashPortionMember_label_en-US" xlink:label="lab_dva_IncrementalCashPortionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Cash Portion [Member]</link:label>
    <link:label id="lab_dva_IncrementalCashPortionMember_documentation_en-US" xlink:label="lab_dva_IncrementalCashPortionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Cash Portion [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncrementalCashPortionMember" xlink:href="dva-20211231.xsd#dva_IncrementalCashPortionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncrementalCashPortionMember" xlink:to="lab_dva_IncrementalCashPortionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_65263a90-71b9-45df-9aa6-ca914d6252d1_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_21d90065-c9b9-43ca-aeb3-6392859d1954_negatedLabel_en-US" xlink:label="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_label_en-US" xlink:label="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment For Contingent Earn Out Obligations</link:label>
    <link:label id="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_documentation_en-US" xlink:label="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment For Contingent Earn Out Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:href="dva-20211231.xsd#dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:to="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_a9b5af19-8919-46c0-96ff-64c957c7626a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease expense</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_807502ba-6472-44f4-9455-7bb78be6697d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_3d8b130f-339b-43e1-92aa-4228afd88991_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_777fde38-a78f-4a99-8040-b84ee1795425_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_da8d0b09-8345-492a-8140-2cc3b337fe8b_terseLabel_en-US" xlink:label="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sales of business interests, net</link:label>
    <link:label id="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_5d38e3ca-4c3c-4de8-bbdf-ff9cde815ed7_negatedTerseLabel_en-US" xlink:label="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of discontinued operations before taxes</link:label>
    <link:label id="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_label_en-US" xlink:label="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (Gain) On Disposition Of Business Interests Before Tax</link:label>
    <link:label id="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_documentation_en-US" xlink:label="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (Gain) On Disposition Of Business Interests Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:href="dva-20211231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:to="lab_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_b868ad4c-eb1c-40f8-9fda-f96494258398_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, significant impairments and other valuation adjustments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f5df54e3-2c54-4fb6-8799-d95037c23003_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value of grants (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_1c1363d5-d7ea-4977-a266-83c535adeb3e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations, other notes payable, and financing lease obligations</link:label>
    <link:label id="lab_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_label_en-US" xlink:label="lab_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Net, Alternative [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract" xlink:to="lab_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_591610f6-263f-4503-bb0a-0dfc40d62330_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities:</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instruments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentsAbstract" xlink:to="lab_us-gaap_DebtInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncomeTaxExpenseBenefitMember_ecc8eb08-a998-4d1e-b4d0-1d00c4306101_terseLabel_en-US" xlink:label="lab_dva_IncomeTaxExpenseBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax benefit (expense)</link:label>
    <link:label id="lab_dva_IncomeTaxExpenseBenefitMember_label_en-US" xlink:label="lab_dva_IncomeTaxExpenseBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense Benefit [Member]</link:label>
    <link:label id="lab_dva_IncomeTaxExpenseBenefitMember_documentation_en-US" xlink:label="lab_dva_IncomeTaxExpenseBenefitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense benefit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxExpenseBenefitMember" xlink:href="dva-20211231.xsd#dva_IncomeTaxExpenseBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncomeTaxExpenseBenefitMember" xlink:to="lab_dva_IncomeTaxExpenseBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fec3e810-4263-4f3b-9d64-c4e49876beef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_eb385f55-adcb-4bae-8ca2-b20814838e94_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents Items [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents Items [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_562dc538-6dec-4572-a701-8be0b7c7b051_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_03ec2910-b97b-4bb9-8d3f-e877f4dcd4a5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_07126bb4-4018-4e69-928c-dba5d481a321_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease cost:</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Description [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:to="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_472ad872-c49f-4b83-ad72-f3a2342209a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Changes in Contingent Earn-Out Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_58e9a2aa-054d-4e83-975d-61cbadc930ef_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_d9fe8305-411a-4252-9145-438609a1bfc9_terseLabel_en-US" xlink:label="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]</link:label>
    <link:label id="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_label_en-US" xlink:label="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]</link:label>
    <link:label id="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_documentation_en-US" xlink:label="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization consolidation and presentation of financial statements disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:href="dva-20211231.xsd#dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="lab_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_a76adf98-bbe4-4e31-9f83-1d984c6e9ede_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_67d789b7-1ada-4cfa-8c38-3a0c0a62c861_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition (Detail)</link:label>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_label_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:to="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_427ae272-4af9-4be4-98ff-5d8a28a08d9f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_90358cc7-9f6b-409d-9c0f-ffa53e70585e_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_label_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:to="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_23287101-9e62-405a-bacc-b514d158e5b2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_5d45a4b2-fc64-47d1-9218-9c01790800d1_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAbstract_726c1d08-65a6-4bf8-9c9d-fe938219ba62_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAbstract_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAbstract" xlink:to="lab_us-gaap_RestrictedCashAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_501cc28f-f791-47d7-a50d-f91bbb2ab5cf_terseLabel_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_documentation_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation arrangement by share based payment award equity instruments other than options exercisable weighted average remaining contractual terms.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:to="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7b4ee5bb-7653-474d-930d-204ca7b4662b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_fb6a5bc6-68ca-428e-abcb-cd7cf08c4ae2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_fa94c322-8ed2-4e50-8b3a-fddc5e0d92a2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_b2df0fed-cc26-4c4e-a43f-cf15d2af6efc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5fb2a1da-1288-4ce4-8406-9e6e026dde32_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a4d5ec6b-27ab-45d9-973e-1c37e35c75cd_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_9ddca16b-9966-4971-8687-5275226a91b0_terseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of noncontrolling interests</link:label>
    <link:label id="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_label_en-US" xlink:label="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Gain Related To Redemptions Or Purchase Of Interests</link:label>
    <link:label id="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Gain Related To Redemptions or Purchase of Interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" xlink:href="dva-20211231.xsd#dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" xlink:to="lab_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_3053975c-4f3e-4448-86a0-f2f867fa5288_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_11e27b25-7e1c-48e7-b398-d3a4715974c6_terseLabel_en-US" xlink:label="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Remaining Prior Share Repurchases Authorized, Amount</link:label>
    <link:label id="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_label_en-US" xlink:label="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Remaining Prior Share Repurchases Authorized, Amount</link:label>
    <link:label id="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_documentation_en-US" xlink:label="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Remaining Prior Share Repurchases Authorized, Amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:href="dva-20211231.xsd#dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:to="lab_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_78e21d58-9bf2-4afb-93b4-6d3d71c038f4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_57523e0b-4c77-461f-a56d-3a9c77441e04_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of individually immaterial business acquisitions</link:label>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_label_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d47e33c5-28af-4a59-a6cd-1b157a02dd4c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_a34957d3-9b39-4287-9750-5868b6bcef25_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangibles</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_0d980c64-72c4-459c-a0c4-21eaa462b70f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Summary of Results of Operations</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_34495db2-8525-416c-80bd-996aa5a91dbc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets and Liabilities Arising from Temporary Differences</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_aafe07da-bdde-44a5-9feb-e70725b162a2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum percentage of employees' base salary to be maintained into deferral account</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_4eaa4ce9-a841-4c26-b0a1-0cd623e646f8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_a7e3c553-48ca-4584-b680-0c4be8ca2b2a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7f23e632-3f9c-4ac7-ab4a-2d4ed236272a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c76a5d05-cff2-409e-9116-ad42dbbf9334_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_0ad2c505-250c-4e83-bc5a-da7db0adeef6_terseLabel_en-US" xlink:label="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated tax benefits recorded for stock-based compensation</link:label>
    <link:label id="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share Based Compensation Estimated Tax Benefit From Compensation Expense</link:label>
    <link:label id="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_documentation_en-US" xlink:label="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee service share-based compensation estimated tax benefit from compensation expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" xlink:href="dva-20211231.xsd#dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" xlink:to="lab_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_d3ea27d1-a152-477c-92ee-fb68c7c7309f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_03dcfb66-7f0c-4ca3-8d8a-90d9bcbc6fba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on changes in ownership interest, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_30210e13-3d8e-483a-a418-0a04c5eeb966_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_43cc3eed-409a-4fba-88e1-91cdabf3238d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (payments) receipts related to stock purchases and awards</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_132ad904-d33d-46ec-9467-47eb5747213a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Category of Item Purchased</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4baaf333-3dbc-45f3-b254-3c587a260467_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_523db39f-d1f2-4893-80da-f6ff9a6b4fc7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanB1Member_2ed7176f-1320-44d6-8e8f-c83133983cc6_terseLabel_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1</link:label>
    <link:label id="lab_dva_TermLoanB1Member_label_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1 [Member]</link:label>
    <link:label id="lab_dva_TermLoanB1Member_documentation_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1 member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member" xlink:href="dva-20211231.xsd#dva_TermLoanB1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanB1Member" xlink:to="lab_dva_TermLoanB1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_30774f8c-d1cf-4f8c-8cf9-71ef001ba10b_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships and other</link:label>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_label_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceAgreementsMember" xlink:to="lab_us-gaap_ServiceAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_796b4f82-0717-436f-a21b-152fd6530e86_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for uncollectible Accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_f5a21052-1a75-4f5b-849d-b3e6962556d2_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowances and Reserves Type</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_0a8dcca1-7fc0-49ad-be08-703dd0f14d8b_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate purchase cost recognized</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_bf30fbc2-20cb-4deb-b187-b131d35637a4_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_53e5bab2-3160-4a9f-8169-930ebf3942b6_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3cc820bf-37db-40a6-9b85-9f7f346a3589_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_84953fe8-7f0f-497f-a139-2b55dde9a8da_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_26ce3ce4-e599-46e7-915f-1454d9c55f2e_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, Due in Third Year</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:to="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d79b93fc-cbcb-4d29-bb3c-49818fe8d188_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompetition agreements and other long-term assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_1eba4bce-2351-4e4c-9ae6-a2e39d0f2e60_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment and information systems, including internally developed software</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_17fd746f-b902-4e23-a534-ce718c0038bc_terseLabel_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee entitlement for purchase of the Company's common stock during each calendar year</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_label_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Maximum Share Value Authorized For Purchase</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_documentation_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation arrangement by share based payment award maximum share value authorized for purchase.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" xlink:to="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_92a141cb-ad57-4af6-b8ae-fb09df8a1853_terseLabel_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance</link:label>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_label_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance</link:label>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_documentation_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" xlink:href="dva-20211231.xsd#dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" xlink:to="lab_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_631395fb-cd85-4dd7-9b19-1c807ddd366f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized under the plan</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_325d7189-57cb-44c7-9a8c-c346c43a122f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_8178ee74-0c4e-43e6-a3ce-58695f3fe1a3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_c3fba055-2185-4646-a4e3-e33237dc9b4e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockIncentivePlanTwentyTwentyMember_6501dd73-61d3-4c34-bb87-9b501699e545_terseLabel_en-US" xlink:label="lab_dva_StockIncentivePlanTwentyTwentyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive 2020 Plan</link:label>
    <link:label id="lab_dva_StockIncentivePlanTwentyTwentyMember_label_en-US" xlink:label="lab_dva_StockIncentivePlanTwentyTwentyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan Twenty Twenty [Member]</link:label>
    <link:label id="lab_dva_StockIncentivePlanTwentyTwentyMember_documentation_en-US" xlink:label="lab_dva_StockIncentivePlanTwentyTwentyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan Twenty Twenty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockIncentivePlanTwentyTwentyMember" xlink:href="dva-20211231.xsd#dva_StockIncentivePlanTwentyTwentyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockIncentivePlanTwentyTwentyMember" xlink:to="lab_dva_StockIncentivePlanTwentyTwentyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OffBalanceSheetFinancingArrangements_0ebc062e-b54e-4322-a776-7505f5fefb41_terseLabel_en-US" xlink:label="lab_dva_OffBalanceSheetFinancingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Off -Balance Sheet Financing Arrangements</link:label>
    <link:label id="lab_dva_OffBalanceSheetFinancingArrangements_label_en-US" xlink:label="lab_dva_OffBalanceSheetFinancingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Off -Balance Sheet Financing Arrangements</link:label>
    <link:label id="lab_dva_OffBalanceSheetFinancingArrangements_documentation_en-US" xlink:label="lab_dva_OffBalanceSheetFinancingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Off -Balance Sheet Financing Arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OffBalanceSheetFinancingArrangements" xlink:href="dva-20211231.xsd#dva_OffBalanceSheetFinancingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OffBalanceSheetFinancingArrangements" xlink:to="lab_dva_OffBalanceSheetFinancingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AllTrustsMember_13bd823b-e86b-4800-895f-c3d351648dd1_terseLabel_en-US" xlink:label="lab_dva_AllTrustsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rabbi trusts</link:label>
    <link:label id="lab_dva_AllTrustsMember_label_en-US" xlink:label="lab_dva_AllTrustsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trusts [Member]</link:label>
    <link:label id="lab_dva_AllTrustsMember_documentation_en-US" xlink:label="lab_dva_AllTrustsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All trusts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AllTrustsMember" xlink:href="dva-20211231.xsd#dva_AllTrustsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AllTrustsMember" xlink:to="lab_dva_AllTrustsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_25c266cc-bb4c-4675-bda9-7f3b78ff5d17_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income from continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4a4eec35-52b1-4d42-81a4-fb5e6d46d8c7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income from continuing operations per share attributable to DaVita Inc. (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_683e3bf0-51ed-40bf-bd77-1ac519839135_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_e1a3b93b-9799-43cd-a29c-aaa328ec4278_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and self-insurance accruals</link:label>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Insurance, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedInsuranceCurrent" xlink:to="lab_us-gaap_AccruedInsuranceCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_ba07df48-cd98-4e39-ba35-063750f56953_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_1f698180-a469-4457-9164-fcbd27e798a9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholder's equity</link:label>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_label_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockTextBlock" xlink:to="lab_us-gaap_TreasuryStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtExpenseMember_5956fcfa-29c8-4543-b985-a8652764d169_terseLabel_en-US" xlink:label="lab_dva_DebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Expense</link:label>
    <link:label id="lab_dva_DebtExpenseMember_label_en-US" xlink:label="lab_dva_DebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Expense [Member]</link:label>
    <link:label id="lab_dva_DebtExpenseMember_documentation_en-US" xlink:label="lab_dva_DebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember" xlink:href="dva-20211231.xsd#dva_DebtExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtExpenseMember" xlink:to="lab_dva_DebtExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f4107ed3-adba-4879-bda9-a760350360c8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_fd60330f-3614-4f89-81f5-49ab7f1c1288_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8e35ab03-e22a-4c93-aeca-edcab8e0b980_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_aa527a8d-729e-4f7a-9180-264a46aee54f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember_8a7edee9-e5a8-44fb-a756-8837f5b6dc75_terseLabel_en-US" xlink:label="lab_dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases Of Noncontrolling Interests In Consolidated Partnerships</link:label>
    <link:label id="lab_dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember_label_en-US" xlink:label="lab_dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases Of Noncontrolling Interests In Consolidated Partnerships [Member]</link:label>
    <link:label id="lab_dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember_documentation_en-US" xlink:label="lab_dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Historical purchases of Noncontrolling Interests in Consolidated Partnerships.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember" xlink:href="dva-20211231.xsd#dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember" xlink:to="lab_dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_edc7cf95-6afe-4177-9c17-6459f0edd865_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2397cd0e-fdc0-4bd7-92d3-a90126066d78_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fedc2f5c-75db-422b-b98b-2c5b643576ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_a47d0b56-e414-4e6e-aa77-585880628f76_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_c48444bf-97b3-46ca-b746-f7b4e88cf46b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_2aaead7d-dc0b-465b-b9dc-16576f52974b_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt totals:</link:label>
    <link:label id="lab_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockUnitMember_adebb2c4-6f4c-4dcf-95da-5272a9e0a37d_terseLabel_en-US" xlink:label="lab_dva_StockUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock units</link:label>
    <link:label id="lab_dva_StockUnitMember_label_en-US" xlink:label="lab_dva_StockUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Unit [Member]</link:label>
    <link:label id="lab_dva_StockUnitMember_documentation_en-US" xlink:label="lab_dva_StockUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Unit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockUnitMember" xlink:href="dva-20211231.xsd#dva_StockUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockUnitMember" xlink:to="lab_dva_StockUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_88629e1d-7735-42a3-b4dd-f25bf434327f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_e7cf1f9d-9884-43d9-9bc5-50145d855745_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_ae12db12-da49-4e28-a703-b8bdbca0dbf0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_d42e6914-d0f2-4296-9d0f-1cff8c4abd56_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d920ab16-f4a1-4021-8cfc-1481704ddd96_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_c36ea3f8-5028-4167-b67b-b3ea40cfe47c_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_9016b3a0-bd0c-4c1d-8d35-efda2bd85823_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of treasury stock acquired</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_5aa045f7-8ffb-47ec-bd1f-5411f05d6195_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock acquired, average cost per share</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_11b432ed-5e04-4d1a-b574-5d1e6ef0937e_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_ad2a7aab-b644-4613-ab00-20d456c87389_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributions from Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TenderOfferMember_b45b81fa-3fbd-4779-8c9d-9a03cbe3a08d_terseLabel_en-US" xlink:label="lab_dva_TenderOfferMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer</link:label>
    <link:label id="lab_dva_TenderOfferMember_label_en-US" xlink:label="lab_dva_TenderOfferMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer [Member]</link:label>
    <link:label id="lab_dva_TenderOfferMember_documentation_en-US" xlink:label="lab_dva_TenderOfferMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TenderOfferMember" xlink:href="dva-20211231.xsd#dva_TenderOfferMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TenderOfferMember" xlink:to="lab_dva_TenderOfferMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7e839cc5-620f-4ecc-a36b-df4dab014fde_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_ac50f510-a4ed-493a-b743-2ffbdc5c979f_terseLabel_en-US" xlink:label="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Increase (Decrease) In Unrealized Gains On Equity Securities</link:label>
    <link:label id="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_label_en-US" xlink:label="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Increase Decrease In Unrealized Gains On Equity Securities</link:label>
    <link:label id="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_documentation_en-US" xlink:label="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Increase Decrease In Unrealized Gains On Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" xlink:href="dva-20211231.xsd#dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" xlink:to="lab_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_21b71955-aadc-42cb-b12b-1051b524a4dd_terseLabel_en-US" xlink:label="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance</link:label>
    <link:label id="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_label_en-US" xlink:label="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance</link:label>
    <link:label id="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_documentation_en-US" xlink:label="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" xlink:href="dva-20211231.xsd#dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" xlink:to="lab_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_cb154ecc-1e2a-4c7b-bc6f-d70aad8d0de0_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_6d204e23-da0a-488f-80f2-99ba3b684619_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_89e9e9e6-e950-451e-a293-5fb869c9e6df_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DeferredTaxAssetsReceivables_9629e36e-ec1d-4e2a-8980-a52a70db26bb_terseLabel_en-US" xlink:label="lab_dva_DeferredTaxAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_dva_DeferredTaxAssetsReceivables_label_en-US" xlink:label="lab_dva_DeferredTaxAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Receivables</link:label>
    <link:label id="lab_dva_DeferredTaxAssetsReceivables_documentation_en-US" xlink:label="lab_dva_DeferredTaxAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsReceivables" xlink:href="dva-20211231.xsd#dva_DeferredTaxAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DeferredTaxAssetsReceivables" xlink:to="lab_dva_DeferredTaxAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_e5a35951-af92-4249-aec3-dcdc3426e52b_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ExternalSourcesMember_b84011bc-cdb0-4db6-88d0-c35140061756_terseLabel_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Sources</link:label>
    <link:label id="lab_dva_ExternalSourcesMember_label_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Sources [Member]</link:label>
    <link:label id="lab_dva_ExternalSourcesMember_documentation_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External sources.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember" xlink:href="dva-20211231.xsd#dva_ExternalSourcesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ExternalSourcesMember" xlink:to="lab_dva_ExternalSourcesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a57b0098-d9bf-4eb3-86ac-028b36f4fb07_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_9a01b807-31a8-4fc4-b105-b37d018cd24e_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_64687b3e-9ad3-4141-a29e-7688b65e631d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_5b379a01-b014-489b-bf93-ba5636d08950_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_7d1a5a10-dd3a-427e-853c-794e0ff796cf_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_2b9cd650-ce4e-49c8-bc19-370b017d9556_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_764534cd-15fc-4c5a-be3d-6c0d2b79f2f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_45e88795-fe2a-424f-b4e3-3e295ef1712e_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of ordinary dividends, common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_567d01a0-43d3-43d1-a822-392629f66556_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NumberOfCustomers_4443e589-0b12-483a-af0c-2b266e6c778a_verboseLabel_en-US" xlink:label="lab_dva_NumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients served</link:label>
    <link:label id="lab_dva_NumberOfCustomers_label_en-US" xlink:label="lab_dva_NumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Customers</link:label>
    <link:label id="lab_dva_NumberOfCustomers_documentation_en-US" xlink:label="lab_dva_NumberOfCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfCustomers" xlink:href="dva-20211231.xsd#dva_NumberOfCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NumberOfCustomers" xlink:to="lab_dva_NumberOfCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_d1ec7fb8-27a3-418c-9c5c-13c28e8b81fe_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in partnerships</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_1523e37f-cc05-4901-9499-5c770e9fc195_verboseLabel_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:href="dva-20211231.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:to="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_ef0bafab-cfb5-4d30-bd20-96a82b779539_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, deferred purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AuditorInformationAbstract_label_en-US" xlink:label="lab_dva_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor information [Abstract]</link:label>
    <link:label id="lab_dva_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_dva_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AuditorInformationAbstract" xlink:href="dva-20211231.xsd#dva_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AuditorInformationAbstract" xlink:to="lab_dva_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_78b9cef8-cb72-4341-bbfa-71e67100ee21_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_d2b37f1b-2307-4490-8de8-fc5d77dd48a4_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_a5b1fb01-b9b3-412f-846d-22cd376a9ec5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1883c017-648c-453c-9556-65c1b0a52065_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_5ea0d573-84f9-4bef-ae22-c25781c48f28_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax (Expense) Benefit from Provision for (Gain) Loss on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:to="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_000de3a3-46fc-4508-81a8-84030790c213_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1c4ce2a7-94a7-4bfa-acbe-88694b203b75_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance of AOCI</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e222050c-b04b-4668-bc3e-04c3ce3832e5_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance of AOCI</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_934c004a-8551-405d-b914-b5539651edc9_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_24d3ad0a-c812-45f7-8370-e2a85f6f2066_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_8bca44d6-0f70-4993-b46f-529f0ab751de_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DissolutionTermOfJointVentures_234975b2-3f7b-4787-9372-ed97c211e341_terseLabel_en-US" xlink:label="lab_dva_DissolutionTermOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled dissolution term of joint ventures</link:label>
    <link:label id="lab_dva_DissolutionTermOfJointVentures_label_en-US" xlink:label="lab_dva_DissolutionTermOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dissolution Term Of Joint Ventures</link:label>
    <link:label id="lab_dva_DissolutionTermOfJointVentures_documentation_en-US" xlink:label="lab_dva_DissolutionTermOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dissolution term of joint ventures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DissolutionTermOfJointVentures" xlink:href="dva-20211231.xsd#dva_DissolutionTermOfJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DissolutionTermOfJointVentures" xlink:to="lab_dva_DissolutionTermOfJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_f0dffc60-d180-4ab8-943b-3c1539185831_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_e94deb5f-d081-4a9c-afd7-9e43262624d9_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_ab7e9e0c-45f9-403b-8011-62426903cda8_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2f7fce21-f34a-4178-b52c-d8b32abfccb2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_9c2b3908-20a6-467e-b19a-92369b2e70b0_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeDisclosureAbstract_02a35ae3-8277-4c76-ad45-01af6aaaebfb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_LesseeDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeDisclosureAbstract" xlink:to="lab_us-gaap_LesseeDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0ba1b298-71ad-45b4-bbb6-1471717553b0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_feaec3ae-a9bc-4b94-80ea-6c49d46b0e64_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less portion representing interest, operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_dff9d83e-ecfb-4324-a7f1-4e1ed64ee58b_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities from discontinued operations</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Operating Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_2a6a0b7e-26a5-4fe1-9b61-0b0e627b7814_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_label_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:to="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_32a1f03c-3fbc-49a3-b2bc-2a46322cdd8b_terseLabel_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual&#160;life</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_label_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_documentation_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based Compensation Arrangement by Share based Payment Award, Other than Options, Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OperatingLeaseLiabilitiesMember_cca6f65d-1a4d-4eb2-937d-e5797e740edb_terseLabel_en-US" xlink:label="lab_dva_OperatingLeaseLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liabilities</link:label>
    <link:label id="lab_dva_OperatingLeaseLiabilitiesMember_label_en-US" xlink:label="lab_dva_OperatingLeaseLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liabilities [Member]</link:label>
    <link:label id="lab_dva_OperatingLeaseLiabilitiesMember_documentation_en-US" xlink:label="lab_dva_OperatingLeaseLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OperatingLeaseLiabilitiesMember" xlink:href="dva-20211231.xsd#dva_OperatingLeaseLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OperatingLeaseLiabilitiesMember" xlink:to="lab_dva_OperatingLeaseLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_e0f40f28-2892-4f66-949e-6127332c4848_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_54e234cd-904e-470a-b6d8-e7361034ae65_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less portion representing interest, financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_2740aaf7-c992-4488-ac80-d2d0f1be7137_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, Due in Second Year</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:to="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d76df28e-d434-4f91-8edd-19c27fd865e1_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_5eb41e97-7b86-48c5-a34c-51d1745b117f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_e8c219c5-50d3-4398-8a8a-e5d2c6a1c9a5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_3f0909ff-f7a8-4808-a810-dd7a83b89ae3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_182879de-4940-4110-99ef-fb5e70da3025_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_a2437b08-be70-49d9-830a-c80294b7f777_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_8ec3f264-0438-40ba-aafa-eb0a467a1160_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments in nonconsolidated businesses</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_37dfb97a-68a6-4b37-812f-8b396f32ab7e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_935305a4-818c-4959-aa77-2f5096be4467_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9b0bae47-2412-4b3b-bb0d-cc228ea0fdf4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_4b8d0524-85d4-4b7b-abcd-6a025286e810_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_9d4fc439-caf4-4696-b9e8-369d8e5c6421_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_997db90b-443c-4795-9d07-b04e4f839de8_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_b6a39cd5-43df-4ae3-854c-1c2717858110_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_139fd7dc-2404-4be6-b584-f73c6d18db2d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_c4e6080d-38f6-40ba-9552-e5b837f270aa_terseLabel_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</link:label>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_label_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</link:label>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_documentation_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:href="dva-20211231.xsd#dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:to="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_e10c2c0f-9553-4313-addd-748bc95eafa3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_bda9caeb-70c8-437b-aa9f-cdd419fcad2c_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Asset, Weighted-Average Period before Renewal or Extension</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Asset, Weighted-Average Period before Renewal or Extension</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c5af6a2f-70d9-4c5d-9a46-7e01a5260b9c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_46030fdd-5d25-4b1e-a0fe-62d6a255f997_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_192ca3b1-2bb1-4324-8ec9-71774718fd8f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenditures for property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_d2b55de9-b4c6-4de5-b27d-47ac8eefe315_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_aa715fa6-6e2e-44ea-a487-58405a747f48_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_0d0335ef-b99a-4db5-9161-3e2c34dc34c2_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_2c7b0885-afc4-4ce0-a23b-b765c93c2c59_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PremiumPricedAwardBasePricePerShare_3595f9db-71bf-4507-b755-80ab774e2475_terseLabel_en-US" xlink:label="lab_dva_PremiumPricedAwardBasePricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Priced Award Base Price Per Share</link:label>
    <link:label id="lab_dva_PremiumPricedAwardBasePricePerShare_label_en-US" xlink:label="lab_dva_PremiumPricedAwardBasePricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Priced Award Base Price Per Share</link:label>
    <link:label id="lab_dva_PremiumPricedAwardBasePricePerShare_documentation_en-US" xlink:label="lab_dva_PremiumPricedAwardBasePricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Priced Award Base Price Per Share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumPricedAwardBasePricePerShare" xlink:href="dva-20211231.xsd#dva_PremiumPricedAwardBasePricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PremiumPricedAwardBasePricePerShare" xlink:to="lab_dva_PremiumPricedAwardBasePricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b25fef3d-790d-4025-94c0-6f26db227aec_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_b4a1eb00-dc78-47b8-9a87-0931bc772004_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_ab75c5fb-df05-43dc-bbb0-6a9022fd58e7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_1371c142-fd28-46f0-b6b2-732cf6d9f7ff_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_deb20fcf-0793-4f72-95ba-35fbea457b01_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_24439b24-4e48-4809-8a0e-19ad7ecfd1e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5f2c59f6-6e69-426e-a297-56c2f92eee53_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of stock awards outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_c1ea9327-51be-4b9b-8bdf-3bf702e7d0e5_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_4ab76cb6-9bd4-49d6-a6e9-d6861e833998_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_1581f002-4a2a-46e5-a530-952d2a8b162c_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_86331726-0db7-429c-ab44-dfb86be7c898_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_1ad9ea32-963d-4cba-a7b1-529683aebfec_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_47eb1f92-a061-4ae9-9542-44c43d100711_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_40e72d1f-8ee8-4a22-979c-1d8ab24ee327_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived licenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PremiumToTheTenderOfferSharePurchasePrice_c088ecbd-610b-4631-8970-958464f42938_terseLabel_en-US" xlink:label="lab_dva_PremiumToTheTenderOfferSharePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium To The Tender Offer Share Purchase Price</link:label>
    <link:label id="lab_dva_PremiumToTheTenderOfferSharePurchasePrice_label_en-US" xlink:label="lab_dva_PremiumToTheTenderOfferSharePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium To The Tender Offer Share Purchase Price</link:label>
    <link:label id="lab_dva_PremiumToTheTenderOfferSharePurchasePrice_documentation_en-US" xlink:label="lab_dva_PremiumToTheTenderOfferSharePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium To The Tender Offer Share Purchase Price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumToTheTenderOfferSharePurchasePrice" xlink:href="dva-20211231.xsd#dva_PremiumToTheTenderOfferSharePurchasePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PremiumToTheTenderOfferSharePurchasePrice" xlink:to="lab_dva_PremiumToTheTenderOfferSharePurchasePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LongTermPurchaseCommitmentExpirationDate_ccb58812-e9e3-4b3e-8bbc-66f0962ec997_terseLabel_en-US" xlink:label="lab_dva_LongTermPurchaseCommitmentExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term purchase commitment, expiration date</link:label>
    <link:label id="lab_dva_LongTermPurchaseCommitmentExpirationDate_label_en-US" xlink:label="lab_dva_LongTermPurchaseCommitmentExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Purchase Commitment Expiration Date</link:label>
    <link:label id="lab_dva_LongTermPurchaseCommitmentExpirationDate_documentation_en-US" xlink:label="lab_dva_LongTermPurchaseCommitmentExpirationDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term purchase commitment expiration date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermPurchaseCommitmentExpirationDate" xlink:href="dva-20211231.xsd#dva_LongTermPurchaseCommitmentExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LongTermPurchaseCommitmentExpirationDate" xlink:to="lab_dva_LongTermPurchaseCommitmentExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_68ea0b68-4775-4355-bc14-477054c0bd89_negatedLabel_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:href="dva-20211231.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:to="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_f6195cd8-72ac-48bb-83fd-20a09c0860e6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsTable" xlink:to="lab_us-gaap_InvestmentHoldingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_e4400ede-1385-43c8-a918-1fb4ff8325d2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_8a76894c-a8fa-455b-9519-b7fd3b1529b3_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Income (Loss) from Discontinued Operation During Phase-out Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_1c27967f-4e53-44ca-8c4a-04d76e109075_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_05037581-cdc5-458d-9fe8-b829791e348d_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_21085f86-d0be-4f83-9b15-73b464038d1d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_537bd165-643f-4d5d-bcb1-86a81521ecd6_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_906b0db2-a031-44e5-99ca-453d1d599d7c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leases, Future Minimum Payments, Net Minimum Payments, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_e3f87bbe-76a3-4db0-9aac-c93fb5dc430d_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_da6ca893-12fe-401e-b461-b8a1e5b7bc4c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_c56bcce4-5332-4ddc-8c6b-361a654ec62b_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestItemsAbstract_a90179f4-2fcf-4c69-ac90-7af2a5b13edd_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in noncontrolling interest from:</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommitmentsAndContingenciesDisclosureTable_9b8b3b51-c6ba-4f54-96aa-76e30b837b98_terseLabel_en-US" xlink:label="lab_dva_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies Disclosure [Table]</link:label>
    <link:label id="lab_dva_CommitmentsAndContingenciesDisclosureTable_label_en-US" xlink:label="lab_dva_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies Disclosure [Table]</link:label>
    <link:label id="lab_dva_CommitmentsAndContingenciesDisclosureTable_documentation_en-US" xlink:label="lab_dva_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsAndContingenciesDisclosureTable" xlink:href="dva-20211231.xsd#dva_CommitmentsAndContingenciesDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable" xlink:to="lab_dva_CommitmentsAndContingenciesDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_18ff73b5-b3c2-4ba0-aca6-161cd7593bf1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_dd01775d-3da4-4da2-acc0-921eb1c22a3f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDateDescription_ab0852a6-7798-47fe-8fd9-605ae3cbf374_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, maturity date, description</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDateDescription_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date, Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_1b55acc5-6591-408b-a652-06aa562cd792_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_20d4060f-4bef-4b9a-bd61-e66102631a4d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_fa2e2253-a75e-4e69-a5d3-9a1032d89cc9_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NumberOfConcentrationRiskCustomers_d69af045-7463-48cf-a3a7-a3e484f60ff8_terseLabel_en-US" xlink:label="lab_dva_NumberOfConcentrationRiskCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of concentration risk customers</link:label>
    <link:label id="lab_dva_NumberOfConcentrationRiskCustomers_label_en-US" xlink:label="lab_dva_NumberOfConcentrationRiskCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Concentration Risk Customers</link:label>
    <link:label id="lab_dva_NumberOfConcentrationRiskCustomers_documentation_en-US" xlink:label="lab_dva_NumberOfConcentrationRiskCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Concentration Risk Customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfConcentrationRiskCustomers" xlink:href="dva-20211231.xsd#dva_NumberOfConcentrationRiskCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NumberOfConcentrationRiskCustomers" xlink:to="lab_dva_NumberOfConcentrationRiskCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_a28691b2-e03e-48de-a82e-9959410d2001_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_975abd82-e365-49ce-a24e-076394499603_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terms of award (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_f001a6ce-33d4-4f12-bb1b-5f91fed2cf40_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_f0093d1b-6f28-4743-94cb-121799425e1a_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued non-income tax liabilities</link:label>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Taxes Other than Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b5f5f68e-c01f-4083-a56d-4744bb0c3f0c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_b401b8de-6229-463e-8118-8ec04bcc2d5b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6675e63b-a529-4d4e-9152-242640df59ae_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock purchase shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a7a2505d-40ad-48dd-94ff-f3fdb4bdab7c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued for employee stock purchase plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_5d3a5d50-d3e8-4fdf-bafb-cd934d8314d3_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6c47dbc0-2386-4e0d-90a7-4f7234306be8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e0eefbe1-44cb-4224-aa16-814bd2524274_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Interest Rate Swap and Cap Agreements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_21703b0a-33ea-46ba-8da7-416245f7abf0_negatedLabel_en-US" xlink:label="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivities, Operating Income</link:label>
    <link:label id="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_label_en-US" xlink:label="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Impact On Fair Value For Reduction In Operating Income</link:label>
    <link:label id="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_documentation_en-US" xlink:label="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Impact On Fair Value For Reduction In Operating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialImpactOnFairValueForReductionInOperatingIncome" xlink:href="dva-20211231.xsd#dva_PotentialImpactOnFairValueForReductionInOperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PotentialImpactOnFairValueForReductionInOperatingIncome" xlink:to="lab_dva_PotentialImpactOnFairValueForReductionInOperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RangeFourMember_deaf3ca5-244a-4fe8-8c43-35b40af24850_terseLabel_en-US" xlink:label="lab_dva_RangeFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$100.01-$110.00</link:label>
    <link:label id="lab_dva_RangeFourMember_label_en-US" xlink:label="lab_dva_RangeFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Four [Member]</link:label>
    <link:label id="lab_dva_RangeFourMember_documentation_en-US" xlink:label="lab_dva_RangeFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Four.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeFourMember" xlink:href="dva-20211231.xsd#dva_RangeFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RangeFourMember" xlink:to="lab_dva_RangeFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_0296d912-d112-4416-a8bc-6c5db02d931a_terseLabel_en-US" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_label_en-US" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partner Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_ed26ede7-a2b3-4422-8ef1-4ffc87e69771_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_8d5ef998-30de-4627-999e-43948b8e0900_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award exercises and other share issuances, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_34f74b65-cdf2-4a9e-8bba-8f9571f333b1_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived licenses</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a76a813b-3c87-4f39-8fac-d186c05078b4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3b02bf3a-7adb-4ca7-8440-f4e9f89864fe_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_486a5252-c667-4246-b455-24eb7f96cb1e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c7bfaefa-8492-47db-9345-fc51754cdb72_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_859b3cd6-b935-4d88-8321-b2ade600b686_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_1f0f7be9-456a-4e3c-b962-91822bd5ff30_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b2be8c50-d612-47ba-af3c-77d496337e06_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_c34eea29-f278-4685-8176-79ea9e53bc1a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_e8e95d5c-0ccd-47c3-867c-6062e2e0a9dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_eb6b976f-2ad8-47fe-861a-d7314be03fb9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_048c8d6b-ff77-46b9-859a-2074bedc05c5_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ExpectedAmortizationExpenseLineItems_f0230fb3-cd32-42d7-8d38-69cfa47bbb35_terseLabel_en-US" xlink:label="lab_dva_ExpectedAmortizationExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense [Line Items]</link:label>
    <link:label id="lab_dva_ExpectedAmortizationExpenseLineItems_label_en-US" xlink:label="lab_dva_ExpectedAmortizationExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense [Line Items]</link:label>
    <link:label id="lab_dva_ExpectedAmortizationExpenseLineItems_documentation_en-US" xlink:label="lab_dva_ExpectedAmortizationExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExpectedAmortizationExpenseLineItems" xlink:href="dva-20211231.xsd#dva_ExpectedAmortizationExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems" xlink:to="lab_dva_ExpectedAmortizationExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_36f1b89e-405b-4453-b9b3-6c7349051ca5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_9d527418-6093-48c3-a845-46100129b303_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_9d3858e7-b839-44e0-bb96-7c0b17223df6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_2b3ec3cd-a5ca-493a-9439-c40a6f269281_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a6e652de-dc0d-4922-abed-1d19b1235b2d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_6ecbe37e-c7c8-4aa9-acea-4bb3320db399_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_762cf60b-cd8e-440d-8024-53597d4496e7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses on foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_496b5e53-0540-4080-8823-7477e0f0db53_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncomeTaxesTable_6e4e13ad-eab0-4b29-8117-6f3e4ae7e4a6_terseLabel_en-US" xlink:label="lab_dva_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_dva_IncomeTaxesTable_label_en-US" xlink:label="lab_dva_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_dva_IncomeTaxesTable_documentation_en-US" xlink:label="lab_dva_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesTable" xlink:href="dva-20211231.xsd#dva_IncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncomeTaxesTable" xlink:to="lab_dva_IncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_5f1e5e7f-c994-4fe3-ad58-df45c0361d6e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in valuation allowance related to changes in the estimated tax benefit</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PaymentsToAcquireOtherDebtAndEquityInvestments_5489b4b2-1c6e-4189-b851-4e4f2d60bdb7_negatedTerseLabel_en-US" xlink:label="lab_dva_PaymentsToAcquireOtherDebtAndEquityInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of other debt and equity investments</link:label>
    <link:label id="lab_dva_PaymentsToAcquireOtherDebtAndEquityInvestments_label_en-US" xlink:label="lab_dva_PaymentsToAcquireOtherDebtAndEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Other Debt And Equity Investments</link:label>
    <link:label id="lab_dva_PaymentsToAcquireOtherDebtAndEquityInvestments_documentation_en-US" xlink:label="lab_dva_PaymentsToAcquireOtherDebtAndEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Other Debt And Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PaymentsToAcquireOtherDebtAndEquityInvestments" xlink:href="dva-20211231.xsd#dva_PaymentsToAcquireOtherDebtAndEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PaymentsToAcquireOtherDebtAndEquityInvestments" xlink:to="lab_dva_PaymentsToAcquireOtherDebtAndEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_0fa1a3b1-38d6-4f1c-8a34-99f4de873dff_terseLabel_en-US" xlink:label="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Accounts Receivable Six Months Or More Past Due</link:label>
    <link:label id="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_label_en-US" xlink:label="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Accounts Receivable Six Months Or More Past Due</link:label>
    <link:label id="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_documentation_en-US" xlink:label="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Accounts Receivable , 6 months or More Past Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" xlink:href="dva-20211231.xsd#dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" xlink:to="lab_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_53ab7145-bd2f-4680-9321-55d727b9cb31_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Depreciation and Amortization Expense by Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_08bee5a4-c390-4e2f-842d-96f4792e5f3a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_bc62ffbd-cc9b-4144-be27-6e70c8c10a84_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_34cfd189-9d97-4204-a6c5-3297bd1d9fbf_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award payment plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_64e62c5b-292a-4cac-98af-c4a96da7957b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_d8b1f3a5-2c41-4acc-91d2-932b1edf60ac_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowances and Reserves</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_6d48b3d5-c127-4cea-96c5-dab028d8967b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_f1f0c211-3ccc-424c-acd6-52fc985d6f91_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category of Item Purchased</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category of Item Purchased [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_b5fc3487-90e3-4960-8047-2aa63b0434f1_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_59412c50-04b3-47a0-8625-57661118828e_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement amount awarded to other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_10c0ef0a-1a52-4207-8978-cb07e562438a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_da95392c-113f-421b-abd4-b43d22ec13f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_2a1245ff-759b-44ac-a43d-43ad513c3540_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_92a5fea0-9d14-4c62-a8ed-4e280bf5bc66_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_54a2fb9c-1d81-4876-b335-315e21d424c1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e7b14479-3c01-4afe-8f01-50393123ceb4_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_3780f227-7ba5-448f-957a-f3b6c15be3ae_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_57f222ab-94b4-4539-bf06-1fc6520b002a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent earn-out consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_f5b0f2c8-d77d-489a-bbac-1a3284b47163_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_b06da182-59b0-4607-9fdc-a866ae1b8dbe_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_66ade8ef-f6b5-423a-8064-d699d730b9a0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock purchase price as percentage of fair market value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0a123084-21c9-44f7-a36c-cf325ac47702_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_bd877cdd-7f04-4c4c-95bd-af078614070f_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_011d0668-5a19-40ed-9341-6b24f23dab29_terseLabel_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid</link:label>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_label_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid [Member]</link:label>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_documentation_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember" xlink:href="dva-20211231.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicaidandManagedMedicaidMember" xlink:to="lab_dva_MedicaidandManagedMedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_b07f1924-4dd8-46f4-a3ea-56d1d4479ea5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_b011ca03-0450-45a5-ac8f-b8fefcf99674_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAbstract" xlink:to="lab_us-gaap_TemporaryEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_168a7511-b008-497e-9365-bf5a5db16956_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6508f66a-b182-48b4-a1bf-947043641ede_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60199e47-b8bb-425e-8582-f49af7aa26a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_82cd1c69-227d-4a1f-8e4b-212349f86e20_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-qualified deferred compensation plan, contributions</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_359762fc-ccb3-496a-813a-0b932fa73544_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_0162fb5d-7855-44aa-893c-11fa5d6a18c7_terseLabel_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Government Payors</link:label>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_label_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Government Payors [Member]</link:label>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_documentation_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other government payors in healthcare industry.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember" xlink:href="dva-20211231.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherGovernmentPayorsMember" xlink:to="lab_dva_OtherGovernmentPayorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_f0d87f89-036d-4baf-afce-3f7834030a66_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_da478859-a100-43bb-b2cb-c641cd96424d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock_cff64a40-fe43-4c89-aed6-7590d998751f_terseLabel_en-US" xlink:label="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net effect of transfers from to noncontrolling interests on stock holders equity disclosure</link:label>
    <link:label id="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock_label_en-US" xlink:label="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Effect Of Transfers From To Noncontrolling Interests On Stock Holders Equity Disclosure [Text Block]</link:label>
    <link:label id="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock_documentation_en-US" xlink:label="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Effect Of Transfers From (To) Noncontrolling Interests on Stock Holders Equity Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" xlink:href="dva-20211231.xsd#dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" xlink:to="lab_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock_00249ea2-0946-46f9-8d76-ff11ffac38fe_terseLabel_en-US" xlink:label="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self insurance</link:label>
    <link:label id="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock_label_en-US" xlink:label="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And Self Insurance Policy [Text Block]</link:label>
    <link:label id="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock_documentation_en-US" xlink:label="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and self insurance policy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_InsuranceAndSelfInsurancePolicyTextBlock" xlink:href="dva-20211231.xsd#dva_InsuranceAndSelfInsurancePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_InsuranceAndSelfInsurancePolicyTextBlock" xlink:to="lab_dva_InsuranceAndSelfInsurancePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_bba192f1-a1fa-4608-bbbb-f8d605ca3ca5_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Total</link:label>
    <link:label id="lab_us-gaap_Assets_fe45ceb4-7d7f-4566-9c1b-e4f24b55c757_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_1553bfdd-97a4-4a11-bb94-397ae0aac1a0_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_57d27bfe-e7d4-4f5b-bf8e-13c372ee47f1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_d02acf2c-c25d-4daa-90d2-cbef183cdabe_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_caa30e08-0f4f-4486-b315-f170c01f19ba_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts attributable to DaVita Inc.:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NumberOfSites_05ef7bf5-daa3-46d8-ac77-a05c4a2c5c82_terseLabel_en-US" xlink:label="lab_dva_NumberOfSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of dialysis centers that the company operated or provided administrative services</link:label>
    <link:label id="lab_dva_NumberOfSites_label_en-US" xlink:label="lab_dva_NumberOfSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Sites</link:label>
    <link:label id="lab_dva_NumberOfSites_documentation_en-US" xlink:label="lab_dva_NumberOfSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfSites" xlink:href="dva-20211231.xsd#dva_NumberOfSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NumberOfSites" xlink:to="lab_dva_NumberOfSites" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_9dff6697-4a34-4687-a2a8-14c474bdf27d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests not subject to put provisions</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_a708d44c-15a5-4ebd-8f62-3a7a4fca1d5e_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_a562ef47-d669-42e8-ae28-a849f43f28d3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAbstract_2247823e-e379-4a64-92bf-5af6ca268e86_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAbstract_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAbstract" xlink:to="lab_us-gaap_TreasuryStockValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_05d7bebd-0a4e-48b9-9904-17d7c0b1ae52_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EmployeeStockPurchasePlanMember_b3f99dd9-f9e2-48bb-b502-593850535f74_terseLabel_en-US" xlink:label="lab_dva_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_dva_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_dva_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_dva_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_dva_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeeStockPurchasePlanMember" xlink:href="dva-20211231.xsd#dva_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EmployeeStockPurchasePlanMember" xlink:to="lab_dva_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_8cc4a747-a83f-4c7c-9520-1d989a7f123f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Total</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_477da818-eb88-48a6-ac31-98e058077c85_terseLabel_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EBITDA or Operating Income Performance Targets or Quality Margins</link:label>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_label_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E B I T D A Operating Income Performance Targets Or Quality Margins [Member]</link:label>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_documentation_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EBITDA operating income performance targets or quality margins.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:href="dva-20211231.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:to="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_a9d03b09-747a-4363-b991-36e67779be9f_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State capital loss carryforward, amount</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_1b3c9dc3-997a-4624-a0b4-00a98bba8b51_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_17dd037d-52a3-409f-8580-b3d2d65484f9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_3ae485f0-3588-409d-b169-fcd4d7b3a904_negatedLabel_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_label_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_documentation_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:href="dva-20211231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:to="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_45e03679-d17e-4951-8cf7-bea640ebdbe2_terseLabel_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit and other time deposits</link:label>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_label_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates Of Deposit Commercial Paper And Money Market Funds [Member]</link:label>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_documentation_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit, commercial paper, and money market funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:href="dva-20211231.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:to="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOwnershipInterestMember_0c6d1870-dbb6-4f0a-9849-69c368281efb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOwnershipInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other equity method partnerships</link:label>
    <link:label id="lab_us-gaap_OtherOwnershipInterestMember_label_en-US" xlink:label="lab_us-gaap_OtherOwnershipInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Ownership Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOwnershipInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOwnershipInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOwnershipInterestMember" xlink:to="lab_us-gaap_OtherOwnershipInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_0cbb6b63-c1e4-4d2e-b511-8a95818c0e71_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) attributable to DaVita Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_76100ba4-86f2-4736-a4c1-79f106f43bb9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_4c24114d-15bc-4fbd-9dd9-7eb1bc6cf488_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermDomain" xlink:to="lab_us-gaap_LeaseContractualTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_2cfa7bc8-a48f-49af-8ddc-74d4bd8ac0c0_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_11ffabbb-78f2-41e2-a4da-4511d0812103_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c666c152-8058-433c-8be6-3fde945d166a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_85fc79c7-ddf7-4a16-8cb9-a1456cf48877_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share attributable to DaVita Inc. (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_e1eb6697-2cdd-4c2b-8a80-b6adece3fd97_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_06ff7878-dcac-4823-b802-9abd2cebd02e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d141a4d6-a7bb-4207-81fb-7efca2a6adce_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of debt expense reclassified from accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_cc285171-1a62-490e-8b71-5c6ee61a943f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from accumulated other comprehensive income into net income</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_370bb004-747d-427b-b6a9-f978e3173422_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method and other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_cd68f4c8-da46-46b9-996f-e4b5c0463609_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable intangibles</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_47479c92-8b69-457b-9003-e07ec373f89b_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_e49a477d-4f94-40ff-a2f8-f1de6d3d178e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_3b8adba7-7267-4bc2-8b91-cea1e699c380_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net of accumulated amortization</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_d68f0748-9579-45bd-8104-ba92673a7ac9_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_29d45641-6a39-4f00-962e-574c9d5d08ce_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6776460d-f4bd-423d-aea9-6a8abc7b63d9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_3adf6332-9da0-41b8-8616-6826da34b20d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_bb75e3ae-4116-4dbd-931d-f1fcab6ffc36_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_3e0b2031-3d43-42f0-a09b-589f18d883ec_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4b1f3626-7581-4842-b638-14d4d5939b6f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_439b2648-4c38-4ed6-b499-7b10076d8850_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income from continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_29b75be5-d5f6-4433-bbec-5f1ff2c7d852_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LeasesDisclosureTable_b837e046-045c-4f46-be1a-0a7a3a9f0baf_terseLabel_en-US" xlink:label="lab_dva_LeasesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure [Table]</link:label>
    <link:label id="lab_dva_LeasesDisclosureTable_label_en-US" xlink:label="lab_dva_LeasesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure [Table]</link:label>
    <link:label id="lab_dva_LeasesDisclosureTable_documentation_en-US" xlink:label="lab_dva_LeasesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureTable" xlink:href="dva-20211231.xsd#dva_LeasesDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LeasesDisclosureTable" xlink:to="lab_dva_LeasesDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_775115a7-aa26-4135-b3bc-8a403f396c5c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation between U.S. Federal Income Tax Rate and Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_0d03ed66-fd79-47b7-8309-6f4155e8f959_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_13ea6ddd-42c9-41f7-8a42-935c249961b8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_60f01ce3-5a5d-46f6-a69c-804b55b344b7_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense on property and equipment</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_0ea440dd-7e77-475f-81da-4f21623d27d2_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_3afa02ef-eaec-48d9-a5db-27e4286749d2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_049795ff-194b-472e-a616-7cf26ab194ac_terseLabel_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options</link:label>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_label_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options</link:label>
    <link:label id="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_documentation_en-US" xlink:label="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" xlink:href="dva-20211231.xsd#dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" xlink:to="lab_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_68da9685-2eb4-4995-b10c-14fd5fe07368_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_4e8dbbc8-a947-4b42-a214-a6e539fa2be1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_32b960ad-6085-4918-9287-c9c48a646706_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_1e0f9589-bad0-410a-a89a-fadd39d3c2f1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_847f6ddd-bdfd-4aea-9077-116271b4f2a0_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_4ad44304-4223-4a0f-a2e0-3f51e16510db_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract_2f078d2f-c154-4c01-b8d3-a048224adf65_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, footnotes to the table</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:to="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_4ff38880-856f-4ad4-85e6-1e8302e02465_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing Operations</link:label>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentContinuingOperationsMember" xlink:to="lab_us-gaap_SegmentContinuingOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_e3d9170e-8364-4d8c-a339-982b29892335_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of DMG division</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_1a3a689e-0194-402e-8939-2ac54dd0b6b8_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_6972548b-a34c-4b48-b5f3-76d878ed22b7_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses)</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_cf7918ff-4dbf-4df6-a3b4-3da522e2fafe_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedNoncompeteAgreementsGross_32d71b8f-5eda-4154-8bd2-3f1474c852b3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedNoncompeteAgreementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompetition agreements</link:label>
    <link:label id="lab_us-gaap_FiniteLivedNoncompeteAgreementsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedNoncompeteAgreementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Noncompete Agreements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedNoncompeteAgreementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross" xlink:to="lab_us-gaap_FiniteLivedNoncompeteAgreementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_23f87174-dbf3-49b3-b4f7-ed5d5f861026_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_123cd964-7781-4568-972c-91847fcd7156_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_67113071-6b55-4193-bdb4-2d592ce4e10f_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent Expense, Operating Leases</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_5d8b5fb6-7f39-4d1e-b1d5-01c6b84d0afd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices, upper range (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1c52b188-7f96-434b-86e9-9d68c656be5e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_c35dc358-f032-43f8-a418-2bc201c5937f_terseLabel_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_label_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_documentation_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" xlink:href="dva-20211231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" xlink:to="lab_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_d5b99481-11ae-47db-86f5-7114df0014af_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_7f376dbb-523d-407c-a83b-c025c58ac67b_terseLabel_en-US" xlink:label="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase And Sale Agreement Aggregate Purchase Price</link:label>
    <link:label id="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_label_en-US" xlink:label="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase And Sale Agreement Aggregate Purchase Price</link:label>
    <link:label id="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_documentation_en-US" xlink:label="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase And Sale Agreement Aggregate Purchase Price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PurchaseAndSaleAgreementAggregatePurchasePrice" xlink:href="dva-20211231.xsd#dva_PurchaseAndSaleAgreementAggregatePurchasePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PurchaseAndSaleAgreementAggregatePurchasePrice" xlink:to="lab_dva_PurchaseAndSaleAgreementAggregatePurchasePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_a8eb825b-688e-4555-916d-9f1f8431b3e7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Political advocacy costs</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8a6e0e0f-0e3b-4f5a-94c8-3e841de17db3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_28add11b-6309-481d-8ae9-de37f811ee9b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_5f444c7a-1d08-4834-acdb-99463e518c41_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_label_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_bd093741-61cd-43d0-9126-bfd1db07618c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_863f211a-bb10-43e5-a174-6dcbe9b50beb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_cdcb571d-b2a0-46cf-848b-7cf05dd9aaab_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_499b7120-ce36-437e-8cfd-a1ed987c7cb6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_259f58fd-f5f3-4aa5-a6aa-0b7c92024554_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_7ee1159f-5096-4976-8c1a-ddace6cbc144_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_a9394b83-2b96-42c0-897d-bf0f467e5dca_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_6d6f68cc-ac9a-43ea-94c0-5b9e61009f12_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma total revenues</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TaxYear2029Member_0af5c859-90fa-441f-83df-171ee7389378_terseLabel_en-US" xlink:label="lab_dva_TaxYear2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2029</link:label>
    <link:label id="lab_dva_TaxYear2029Member_label_en-US" xlink:label="lab_dva_TaxYear2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2029 [Member]</link:label>
    <link:label id="lab_dva_TaxYear2029Member_documentation_en-US" xlink:label="lab_dva_TaxYear2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TaxYear2029Member" xlink:href="dva-20211231.xsd#dva_TaxYear2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TaxYear2029Member" xlink:to="lab_dva_TaxYear2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessSaleEffectiveDateOfSale_56bcbcb9-765b-4d5a-b22a-41a5400185c3_terseLabel_en-US" xlink:label="lab_dva_BusinessSaleEffectiveDateOfSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Sale, Effective Date Of Sale</link:label>
    <link:label id="lab_dva_BusinessSaleEffectiveDateOfSale_label_en-US" xlink:label="lab_dva_BusinessSaleEffectiveDateOfSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Sale, Effective Date Of Sale</link:label>
    <link:label id="lab_dva_BusinessSaleEffectiveDateOfSale_documentation_en-US" xlink:label="lab_dva_BusinessSaleEffectiveDateOfSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Sale, Effective Date Of Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessSaleEffectiveDateOfSale" xlink:href="dva-20211231.xsd#dva_BusinessSaleEffectiveDateOfSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessSaleEffectiveDateOfSale" xlink:to="lab_dva_BusinessSaleEffectiveDateOfSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_fd62b970-0c2a-4483-b072-486d6acadee9_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_8448cbdd-d330-448c-ae80-7c42ad235425_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_44892702-74b0-4411-8635-55b5f7fb00c5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_0a3662d9-2dc9-4c49-a69e-4d99c29200bc_terseLabel_en-US" xlink:label="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.</link:label>
    <link:label id="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_label_en-US" xlink:label="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.</link:label>
    <link:label id="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_documentation_en-US" xlink:label="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" xlink:href="dva-20211231.xsd#dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" xlink:to="lab_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_10ae4a2a-c28b-4172-a350-d3baa735045b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_637c4e82-3758-4d6d-9d57-1357decd59c1_terseLabel_en-US" xlink:label="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term purchase commitment, percentage of quantity required to be purchased</link:label>
    <link:label id="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_label_en-US" xlink:label="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Purchase Commitment Percentage Of Quantity Required</link:label>
    <link:label id="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_documentation_en-US" xlink:label="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term purchase commitment percentage of quantity required.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" xlink:href="dva-20211231.xsd#dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" xlink:to="lab_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_a606aa16-cf29-472f-9da5-c642a9903eb2_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Loss Carryforward</link:label>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_label_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Loss Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLossCarryforwardMember" xlink:to="lab_us-gaap_CapitalLossCarryforwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_f0733309-8e38-424a-99b3-2420c4dbbcc5_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_9582d576-5b19-4532-9d77-a36a5bffd41f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_6da82fb8-5d1e-4025-ba41-829f4ec8ce6a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_6aaeb5f9-0c99-45eb-bed1-69a063c2d58b_terseLabel_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 3.75% due 2031</link:label>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_label_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One [Member]</link:label>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_documentation_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:href="dva-20211231.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:to="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_f3b9cfd1-f415-490a-b5cb-511b5e17c588_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Purchase price and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_f6698fc3-3a98-49b1-94b5-07aa0e3f3291_terseLabel_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period (in shares)</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_label_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number</link:label>
    <link:label id="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_documentation_en-US" xlink:label="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instruments exercisable number.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="lab_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DiscountAndDeferredFinanceCosts_550eeafe-046a-4b49-a6da-52cd351ca32e_negatedLabel_en-US" xlink:label="lab_dva_DiscountAndDeferredFinanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount and deferred financing costs</link:label>
    <link:label id="lab_dva_DiscountAndDeferredFinanceCosts_label_en-US" xlink:label="lab_dva_DiscountAndDeferredFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount And Deferred Finance Costs</link:label>
    <link:label id="lab_dva_DiscountAndDeferredFinanceCosts_documentation_en-US" xlink:label="lab_dva_DiscountAndDeferredFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount and deferred finance costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountAndDeferredFinanceCosts" xlink:href="dva-20211231.xsd#dva_DiscountAndDeferredFinanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DiscountAndDeferredFinanceCosts" xlink:to="lab_dva_DiscountAndDeferredFinanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_874b3332-19ba-4c87-8a6e-1b283b055e38_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_bc363f31-7848-45e0-b5ce-a59ac4e12e25_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current economic interest in the APAC JV, Owned by Noncontrolling Investors</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_a4be76d9-adc9-4021-b191-d466f58a8081_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_af04e77d-14d0-498e-a7ac-6055462c6dab_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_e4027315-03c9-401b-b302-ed1945eb9a78_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4153b0dc-f126-4b74-badf-aa093621f207_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_043eeab7-6415-42ef-9cf5-d546fc9af1ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2826617b-f490-4360-abca-e8143617364d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash of continuing operations at beginning of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_673e5c72-4c9b-4fb0-b014-1505c10ecc15_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash of continuing operations at end of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_312083ba-e5df-4f92-a5ca-6860adcba617_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_1f590047-2a2a-4488-b2d9-2cb54049e383_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanAMember_fdda219e-b0a1-4c62-88c8-636311a9c71d_terseLabel_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A</link:label>
    <link:label id="lab_dva_TermLoanAMember_label_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A [Member]</link:label>
    <link:label id="lab_dva_TermLoanAMember_documentation_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember" xlink:href="dva-20211231.xsd#dva_TermLoanAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanAMember" xlink:to="lab_dva_TermLoanAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_da0dae21-e92b-4858-9915-83ae9d9c201a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of debt investments held-to-maturity</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Held-to-maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3c3f194c-06e6-4b51-894c-3bda6cd52c54_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherReportingUnitsMember_7a3b2837-4fa6-46b2-9dbf-14085ddb1e38_terseLabel_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other reporting units</link:label>
    <link:label id="lab_dva_OtherReportingUnitsMember_label_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reporting Units [Member]</link:label>
    <link:label id="lab_dva_OtherReportingUnitsMember_documentation_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reporting Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember" xlink:href="dva-20211231.xsd#dva_OtherReportingUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherReportingUnitsMember" xlink:to="lab_dva_OtherReportingUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock_3df084f8-e195-4d51-bd01-0a7313489be9_terseLabel_en-US" xlink:label="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets other than Goodwill</link:label>
    <link:label id="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Intangible Assets Table [Text Block]</link:label>
    <link:label id="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Intangible Assets Table</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" xlink:href="dva-20211231.xsd#dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" xlink:to="lab_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_65c0dd41-27d9-41b1-b2fa-64a5751b1ea2_terseLabel_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_label_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_documentation_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:href="dva-20211231.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:to="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a989d2a4-8fdb-426d-a14b-b0ae7dfe95ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_80be430e-526e-449f-9d30-e1ee9dd8d0fc_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised/ Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract_c2d40df2-b7a6-4962-9b3a-c571d996aa95_terseLabel_en-US" xlink:label="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] [Abstract]</link:label>
    <link:label id="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract_label_en-US" xlink:label="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] [Abstract]</link:label>
    <link:label id="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract_documentation_en-US" xlink:label="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" xlink:href="dva-20211231.xsd#dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" xlink:to="lab_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PayorRefundsAndRetractions_daf9d6d4-022a-4310-8841-193c4977b2a6_terseLabel_en-US" xlink:label="lab_dva_PayorRefundsAndRetractions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor refunds and retractions</link:label>
    <link:label id="lab_dva_PayorRefundsAndRetractions_label_en-US" xlink:label="lab_dva_PayorRefundsAndRetractions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor Refunds And Retractions</link:label>
    <link:label id="lab_dva_PayorRefundsAndRetractions_documentation_en-US" xlink:label="lab_dva_PayorRefundsAndRetractions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor Refunds And Retractions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PayorRefundsAndRetractions" xlink:href="dva-20211231.xsd#dva_PayorRefundsAndRetractions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PayorRefundsAndRetractions" xlink:to="lab_dva_PayorRefundsAndRetractions" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LeasesOtherInformationAbstract_d1dd1491-1276-4cd4-a07b-233a2a108800_terseLabel_en-US" xlink:label="lab_dva_LeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Other Information [Abstract]</link:label>
    <link:label id="lab_dva_LeasesOtherInformationAbstract_label_en-US" xlink:label="lab_dva_LeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Other Information [Abstract]</link:label>
    <link:label id="lab_dva_LeasesOtherInformationAbstract_documentation_en-US" xlink:label="lab_dva_LeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Other Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesOtherInformationAbstract" xlink:href="dva-20211231.xsd#dva_LeasesOtherInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LeasesOtherInformationAbstract" xlink:to="lab_dva_LeasesOtherInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1bee306e-94b6-4c11-ad01-8804b0830b89_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_eaf3f453-9bd5-4baf-ba14-faca28b0f380_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fce583b5-02ee-41bf-8720-b63ff9445e9c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_631f99f3-7ebb-46b0-b81d-74ab7a2abfcd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_bd8b13b2-668e-47cc-8a65-0f6a8a77d585_terseLabel_en-US" xlink:label="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member [Member]</link:label>
    <link:label id="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_label_en-US" xlink:label="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member [Member]</link:label>
    <link:label id="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_documentation_en-US" xlink:label="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" xlink:href="dva-20211231.xsd#dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" xlink:to="lab_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_ef8b197a-9671-4389-aaf6-a747b2433e90_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_66680703-4d42-41b8-aa5c-e589a0bfaf17_terseLabel_en-US" xlink:label="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of legal entities that third parties held noncontrolling equity interests</link:label>
    <link:label id="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_label_en-US" xlink:label="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Entities That Third Parties Held Non Controlling Equity Interests</link:label>
    <link:label id="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_documentation_en-US" xlink:label="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of entities that third parties held non controlling equity interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" xlink:href="dva-20211231.xsd#dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" xlink:to="lab_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_9f93f8e7-9aa0-40f0-bc01-0931b23a8a9a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Incentive Compensation and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LeasesDisclosureLineItems_2d940030-8390-4523-812c-a21a63b00759_terseLabel_en-US" xlink:label="lab_dva_LeasesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure [Line Items]</link:label>
    <link:label id="lab_dva_LeasesDisclosureLineItems_label_en-US" xlink:label="lab_dva_LeasesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure [Line Items]</link:label>
    <link:label id="lab_dva_LeasesDisclosureLineItems_documentation_en-US" xlink:label="lab_dva_LeasesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureLineItems" xlink:href="dva-20211231.xsd#dva_LeasesDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LeasesDisclosureLineItems" xlink:to="lab_dva_LeasesDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_f46e527f-a953-4125-b685-4b5e85a71155_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Information Related to Assets Held For Sale and Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c6f5b364-964d-4e17-af91-0b715c516f6a_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions related to lapse of applicable statute</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e142c34f-6b45-4733-af51-9c2d291190bf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_bcdce280-07d1-4162-8596-c41b3fceba2d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value estimates</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_1bac35f9-8990-428b-b2ae-9f248d1cc6e5_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_19513c02-0e27-41d1-93ef-dc2f530d2292_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_858da858-b827-482f-afa4-da08c0db1395_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Total</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_b157965c-fa28-47c7-8b47-b54f772bd942_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:to="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65603322-f426-4c55-ac5c-ae2402f4e283_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_63e78706-8725-42dd-a34b-dd24d9deacd9_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_f01dee5e-031c-498e-bdef-9899401cd07b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts of interest rate agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_fdd05546-8e7a-4582-bd1b-5d196d3c3f3c_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecurities" xlink:to="lab_us-gaap_HeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_e3b71a45-c3d6-497a-b305-460e15003e82_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate during period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ExpectedAmortizationExpenseTable_e2367e4e-845d-492d-8ac1-a421d25f784e_terseLabel_en-US" xlink:label="lab_dva_ExpectedAmortizationExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense [Table]</link:label>
    <link:label id="lab_dva_ExpectedAmortizationExpenseTable_label_en-US" xlink:label="lab_dva_ExpectedAmortizationExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense [Table]</link:label>
    <link:label id="lab_dva_ExpectedAmortizationExpenseTable_documentation_en-US" xlink:label="lab_dva_ExpectedAmortizationExpenseTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Amortization Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExpectedAmortizationExpenseTable" xlink:href="dva-20211231.xsd#dva_ExpectedAmortizationExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ExpectedAmortizationExpenseTable" xlink:to="lab_dva_ExpectedAmortizationExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_dcaa7dd1-f117-40af-b314-cae9ccbf661a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_96385572-8d20-4bc2-9344-00cd16ff515c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_d44b92c8-5bd2-411e-84fa-8bdac6c1c116_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_acf364c6-6040-4c57-8cc9-6480ad0a89c7_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_3193fdb5-477f-4cd9-a025-a16cf72aabfc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_539705e3-b1bb-45f7-ad2e-62602975753c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity on revolving credit facilities</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_483465bd-11a9-4ae7-8d5d-c40be023e9a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_3e7d8caa-6e94-44cb-9514-70569341f344_terseLabel_en-US" xlink:label="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt Outstanding Principal Balance Subject To LIBOR</link:label>
    <link:label id="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_label_en-US" xlink:label="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt Outstanding Principal Balance Subject To LIBOR</link:label>
    <link:label id="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_documentation_en-US" xlink:label="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt Outstanding Principal Balance Subject To LIBOR.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:href="dva-20211231.xsd#dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:to="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0721c8c2-917c-4c5b-b959-f3922c4740b8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_58994c9c-1648-49e7-848e-65dcc1f9e61e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_fa830716-ecc8-42ab-b117-d8fbee4d9bc5_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_01093124-0ad7-4617-8e33-6c6546062584_negatedTerseLabel_en-US" xlink:label="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_label_en-US" xlink:label="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Operating Lease Assets</link:label>
    <link:label id="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_documentation_en-US" xlink:label="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of deferred tax liability attributable to taxable temporary differences from operating lease assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:href="dva-20211231.xsd#dva_DeferredTaxLiabilitiesOperatingLeaseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:to="lab_dva_DeferredTaxLiabilitiesOperatingLeaseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CharterdocumentsandDelawarelawAbstract_857f218d-cf83-4663-bd2f-fcde9b73a9a7_terseLabel_en-US" xlink:label="lab_dva_CharterdocumentsandDelawarelawAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charter documents and Delaware law:</link:label>
    <link:label id="lab_dva_CharterdocumentsandDelawarelawAbstract_label_en-US" xlink:label="lab_dva_CharterdocumentsandDelawarelawAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charter documents and Delaware law [Abstract]</link:label>
    <link:label id="lab_dva_CharterdocumentsandDelawarelawAbstract_documentation_en-US" xlink:label="lab_dva_CharterdocumentsandDelawarelawAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charter documents and Delaware law [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CharterdocumentsandDelawarelawAbstract" xlink:href="dva-20211231.xsd#dva_CharterdocumentsandDelawarelawAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract" xlink:to="lab_dva_CharterdocumentsandDelawarelawAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_b9a84d44-0645-4f40-bcaf-0eacdd9e51b8_terseLabel_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments to Provide Operating Capital</link:label>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_label_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments To Provide Operating Capital [Member]</link:label>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_documentation_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments to provide operating capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember" xlink:href="dva-20211231.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommitmentsToProvideOperatingCapitalMember" xlink:to="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_bb4c8bf4-cc11-4967-b723-45339f474b60_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_58d57cc2-a485-456b-9d1c-1ce66b5b85a8_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_45f93118-d4d9-4b23-8f88-301115e3a68b_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_4cf120a9-8c15-4eb4-a803-44ce645df8bc_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_c9fde9ae-f9dd-443c-b378-0e5945816f37_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes from partnership buyouts</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RangeTwoMember_1f451b14-a13b-4314-bf8d-c444db17156c_terseLabel_en-US" xlink:label="lab_dva_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$60.01&#8211;$70.00</link:label>
    <link:label id="lab_dva_RangeTwoMember_label_en-US" xlink:label="lab_dva_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Two [Member]</link:label>
    <link:label id="lab_dva_RangeTwoMember_documentation_en-US" xlink:label="lab_dva_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeTwoMember" xlink:href="dva-20211231.xsd#dva_RangeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RangeTwoMember" xlink:to="lab_dva_RangeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LeasesDisclosureTextBlock_2b5158ea-3639-49e4-8a54-8691b0a2f160_terseLabel_en-US" xlink:label="lab_dva_LeasesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure</link:label>
    <link:label id="lab_dva_LeasesDisclosureTextBlock_label_en-US" xlink:label="lab_dva_LeasesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Disclosure [Text Block]</link:label>
    <link:label id="lab_dva_LeasesDisclosureTextBlock_documentation_en-US" xlink:label="lab_dva_LeasesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases complete footnote disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureTextBlock" xlink:href="dva-20211231.xsd#dva_LeasesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LeasesDisclosureTextBlock" xlink:to="lab_dva_LeasesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDistributionsToAffiliates_1a6e8578-ee67-4a43-8764-80539769c4dd_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDistributionsToAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Distributions to Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:to="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_7935d90d-4dd9-4878-867a-fea7df7fa595_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_fe980ef6-08f7-4aaa-96c9-dfd7ce92665a_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_5871ee95-ff2f-4dba-8e66-403b832a3964_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_89e0bb62-bac9-411e-b5b8-7e0f219940c5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_cada4f53-2aca-48eb-8afb-6c42da3c5cbf_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New center and capital asset projects in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_1a5886cc-8b77-490b-b9df-5f4ee170364f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b531e938-0d42-44de-9326-5fb2f287d511_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_4a8ef0cc-09b1-4f2d-913f-a5a1a8f56956_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_c92e63b2-ca34-4603-8b1b-3973d1865bf3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_2c6c1af6-2177-46a3-acad-94b71a8c4b74_terseLabel_en-US" xlink:label="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share, Clearing Price</link:label>
    <link:label id="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_label_en-US" xlink:label="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share, Clearing Price</link:label>
    <link:label id="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_documentation_en-US" xlink:label="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share, Clearing Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" xlink:href="dva-20211231.xsd#dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" xlink:to="lab_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_ad1dbf70-fcaf-4e3e-848f-a6be5209106b_terseLabel_en-US" xlink:label="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Lease Assets Obtained In Exchange For Lease Liabilities</link:label>
    <link:label id="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_label_en-US" xlink:label="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Lease Assets Obtained In Exchange For Lease Liabilities</link:label>
    <link:label id="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_documentation_en-US" xlink:label="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Lease Assets Obtained In Exchange For New or Modified Lease Liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" xlink:href="dva-20211231.xsd#dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" xlink:to="lab_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_17df8296-e05c-47d4-b21b-9d69b7448716_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_5764391a-428c-482c-b644-50f83a07f27c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CashPaidDuringPeriodForAbstract_b3f64132-54d7-4617-8e06-8a198b86c170_terseLabel_en-US" xlink:label="lab_dva_CashPaidDuringPeriodForAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid:</link:label>
    <link:label id="lab_dva_CashPaidDuringPeriodForAbstract_label_en-US" xlink:label="lab_dva_CashPaidDuringPeriodForAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid During Period For [Abstract]</link:label>
    <link:label id="lab_dva_CashPaidDuringPeriodForAbstract_documentation_en-US" xlink:label="lab_dva_CashPaidDuringPeriodForAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during period for.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidDuringPeriodForAbstract" xlink:href="dva-20211231.xsd#dva_CashPaidDuringPeriodForAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CashPaidDuringPeriodForAbstract" xlink:to="lab_dva_CashPaidDuringPeriodForAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_StockIncentivePlanTwentyElevenMember_83dddd53-52ea-4807-9606-2b4a6f072ca1_terseLabel_en-US" xlink:label="lab_dva_StockIncentivePlanTwentyElevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive 2011 Plan</link:label>
    <link:label id="lab_dva_StockIncentivePlanTwentyElevenMember_label_en-US" xlink:label="lab_dva_StockIncentivePlanTwentyElevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan Twenty Eleven [Member]</link:label>
    <link:label id="lab_dva_StockIncentivePlanTwentyElevenMember_documentation_en-US" xlink:label="lab_dva_StockIncentivePlanTwentyElevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan 2011 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockIncentivePlanTwentyElevenMember" xlink:href="dva-20211231.xsd#dva_StockIncentivePlanTwentyElevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_StockIncentivePlanTwentyElevenMember" xlink:to="lab_dva_StockIncentivePlanTwentyElevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LesseeLeaseDescriptionLineItemsAbstract_694bb7b5-230a-44a3-badb-6c82686eab71_terseLabel_en-US" xlink:label="lab_dva_LesseeLeaseDescriptionLineItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items] [Abstract]</link:label>
    <link:label id="lab_dva_LesseeLeaseDescriptionLineItemsAbstract_label_en-US" xlink:label="lab_dva_LesseeLeaseDescriptionLineItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items] [Abstract]</link:label>
    <link:label id="lab_dva_LesseeLeaseDescriptionLineItemsAbstract_documentation_en-US" xlink:label="lab_dva_LesseeLeaseDescriptionLineItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items] [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LesseeLeaseDescriptionLineItemsAbstract" xlink:href="dva-20211231.xsd#dva_LesseeLeaseDescriptionLineItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LesseeLeaseDescriptionLineItemsAbstract" xlink:to="lab_dva_LesseeLeaseDescriptionLineItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetDomain_def59fb9-1d14-470e-91af-51366f3f4886_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetDomain_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetDomain" xlink:to="lab_us-gaap_DeferredTaxAssetDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aeee8b3a-62cc-4d1b-b7d0-9f4ae86dc0f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_4b179dc7-c77b-4563-a130-cc6855f64e9a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>dva-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1726f308-1cc7-4a47-a8e3-a7d089a83ae3,g:ca3879f3-8750-4d94-926a-aa4c6036a270-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="dva-20211231.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a91716e7-9d93-4cf5-8dbd-52350336b62d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_DocumentType_a91716e7-9d93-4cf5-8dbd-52350336b62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_e657d416-0081-42b7-90dc-006ea5066772" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_DocumentAnnualReport_e657d416-0081-42b7-90dc-006ea5066772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_252d3e76-289c-4bb9-a8b9-a25c537c0b31" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_DocumentPeriodEndDate_252d3e76-289c-4bb9-a8b9-a25c537c0b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f165d8ba-220c-4437-bfdf-08318c6aa43e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_CurrentFiscalYearEndDate_f165d8ba-220c-4437-bfdf-08318c6aa43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_34a40027-902b-4248-bd16-2749a05d1128" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_DocumentTransitionReport_34a40027-902b-4248-bd16-2749a05d1128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9970f7ab-1793-4223-bec8-c45b8184b8ab" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityFileNumber_9970f7ab-1793-4223-bec8-c45b8184b8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a38e6709-45bc-4b67-b76f-487245d7a2df" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityRegistrantName_a38e6709-45bc-4b67-b76f-487245d7a2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1d3ba718-ab29-421c-ba54-1de1301282e7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1d3ba718-ab29-421c-ba54-1de1301282e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_06b71148-7a69-41fd-b61c-95e67ea8d17c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityTaxIdentificationNumber_06b71148-7a69-41fd-b61c-95e67ea8d17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_23ec8d43-a75e-468f-8602-6b3f7065fc6e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityAddressAddressLine1_23ec8d43-a75e-468f-8602-6b3f7065fc6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0c23634a-0ca6-4c83-a2ab-f6103a145ae9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityAddressCityOrTown_0c23634a-0ca6-4c83-a2ab-f6103a145ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_97847687-d043-4e1b-8789-5121d497e58e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityAddressStateOrProvince_97847687-d043-4e1b-8789-5121d497e58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_5ec3cc7a-4118-4725-a233-dc3f19e76af5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityAddressPostalZipCode_5ec3cc7a-4118-4725-a233-dc3f19e76af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c365fbce-2291-4af0-a7e5-96023b5a84a5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_CityAreaCode_c365fbce-2291-4af0-a7e5-96023b5a84a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_72de0b9e-57b5-47cf-ad7b-12188ef99602" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_LocalPhoneNumber_72de0b9e-57b5-47cf-ad7b-12188ef99602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3c6015b7-bf6b-4971-a5fa-329525f75cff" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_Security12bTitle_3c6015b7-bf6b-4971-a5fa-329525f75cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a6e912d9-c70d-45b1-b412-60d30de83291" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_TradingSymbol_a6e912d9-c70d-45b1-b412-60d30de83291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ff1c7590-9ceb-43b2-92c2-e65e665eb45c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_SecurityExchangeName_ff1c7590-9ceb-43b2-92c2-e65e665eb45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_5aab284b-da67-4425-a741-4c6ed749278c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_5aab284b-da67-4425-a741-4c6ed749278c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_04970ce0-4fde-40f3-ad6f-c0797810012c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityVoluntaryFilers_04970ce0-4fde-40f3-ad6f-c0797810012c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_5d7a5d32-70bd-40fd-9f83-2be5db3797fd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityCurrentReportingStatus_5d7a5d32-70bd-40fd-9f83-2be5db3797fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_39d86466-156c-49f9-8430-2d2a32f22b29" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityInteractiveDataCurrent_39d86466-156c-49f9-8430-2d2a32f22b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_8239b594-c658-4218-a875-74495aa67b0f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityFilerCategory_8239b594-c658-4218-a875-74495aa67b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_432f5818-df3c-43df-b913-c9e239884805" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntitySmallBusiness_432f5818-df3c-43df-b913-c9e239884805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8ad0cc1a-5524-4da2-b332-5e5c25838012" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityEmergingGrowthCompany_8ad0cc1a-5524-4da2-b332-5e5c25838012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_0bd84b60-589c-46a1-b86d-ec8819f54983" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_IcfrAuditorAttestationFlag_0bd84b60-589c-46a1-b86d-ec8819f54983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_8a3c73a9-524f-4392-9724-e53c34a65d30" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityShellCompany_8a3c73a9-524f-4392-9724-e53c34a65d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_17978f85-16fb-4057-aca4-7fd22e6d513a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityPublicFloat_17978f85-16fb-4057-aca4-7fd22e6d513a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_90bf3a61-a74a-4828-8b3a-0657caf0fd9e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_90bf3a61-a74a-4828-8b3a-0657caf0fd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_acfee9f5-c65a-4991-9b83-a630b0c74586" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_AmendmentFlag_acfee9f5-c65a-4991-9b83-a630b0c74586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5750110a-5833-4594-bea5-7d71ed437acf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_DocumentFiscalYearFocus_5750110a-5833-4594-bea5-7d71ed437acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8a371f33-d04c-4965-9f0a-98309772685c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8a371f33-d04c-4965-9f0a-98309772685c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4005e1eb-59cf-45b5-b995-f26d987007f8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6d78d752-dec1-4185-b8dd-65e71fb85b3f" xlink:to="loc_dei_EntityCentralIndexKey_4005e1eb-59cf-45b5-b995-f26d987007f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AuditInformation" xlink:type="simple" xlink:href="dva-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dva_AuditorInformationAbstract_14c38f08-cd67-47aa-92a3-e01cbff43315" xlink:href="dva-20211231.xsd#dva_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_3f87a4f2-77f0-49da-a259-b747159fda69" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_AuditorInformationAbstract_14c38f08-cd67-47aa-92a3-e01cbff43315" xlink:to="loc_dei_AuditorName_3f87a4f2-77f0-49da-a259-b747159fda69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_ea613412-38ac-45ac-b9cd-48e4449b3762" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_AuditorInformationAbstract_14c38f08-cd67-47aa-92a3-e01cbff43315" xlink:to="loc_dei_AuditorFirmId_ea613412-38ac-45ac-b9cd-48e4449b3762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_c0bc87a3-1818-465c-82c5-b283915dd138" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_AuditorInformationAbstract_14c38f08-cd67-47aa-92a3-e01cbff43315" xlink:to="loc_dei_AuditorLocation_c0bc87a3-1818-465c-82c5-b283915dd138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_5fbd1f18-79f5-4e50-b693-fb33aae7544a" xlink:href="dva-20211231.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_5fbd1f18-79f5-4e50-b693-fb33aae7544a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_98923960-26d5-446f-891d-3ee2210a9928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_OtherIncome_98923960-26d5-446f-891d-3ee2210a9928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fb6cf460-3ae3-4aeb-b804-feb66fbcc810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_Revenues_fb6cf460-3ae3-4aeb-b804-feb66fbcc810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_9f2bdb2d-af21-4d28-9314-a104329c4cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_9f2bdb2d-af21-4d28-9314-a104329c4cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts_5f0dcd0e-ed07-4852-954a-056a6b1cc8dc" xlink:href="dva-20211231.xsd#dva_PatientCareCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9f2bdb2d-af21-4d28-9314-a104329c4cd8" xlink:to="loc_dva_PatientCareCosts_5f0dcd0e-ed07-4852-954a-056a6b1cc8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_9870d4cb-bf1f-4565-acaf-14811308a529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9f2bdb2d-af21-4d28-9314-a104329c4cd8" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_9870d4cb-bf1f-4565-acaf-14811308a529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_9ce5f61b-bae2-4ed8-b50b-006d0aebb2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9f2bdb2d-af21-4d28-9314-a104329c4cd8" xlink:to="loc_us-gaap_DepreciationAndAmortization_9ce5f61b-bae2-4ed8-b50b-006d0aebb2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ec23794e-3931-4a0d-ace7-97ff3d25c6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9f2bdb2d-af21-4d28-9314-a104329c4cd8" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ec23794e-3931-4a0d-ace7-97ff3d25c6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_4344e9b2-b792-4f7e-a0c2-3bd273269d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9f2bdb2d-af21-4d28-9314-a104329c4cd8" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_4344e9b2-b792-4f7e-a0c2-3bd273269d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_b06f4401-aa8c-457e-ae29-dfbc61cb953e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9f2bdb2d-af21-4d28-9314-a104329c4cd8" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_b06f4401-aa8c-457e-ae29-dfbc61cb953e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_95b30bb6-a5fa-4202-a0bf-410325866c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9f2bdb2d-af21-4d28-9314-a104329c4cd8" xlink:to="loc_us-gaap_CostsAndExpenses_95b30bb6-a5fa-4202-a0bf-410325866c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4f0192e6-61a5-408e-805e-e4fd105f3e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_OperatingIncomeLoss_4f0192e6-61a5-408e-805e-e4fd105f3e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_b9ecb186-b79e-477b-bf90-cedf91f09f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_InterestAndDebtExpense_b9ecb186-b79e-477b-bf90-cedf91f09f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_1aa8b4fa-cd90-45d7-a3aa-4fce6d3b4493" xlink:href="dva-20211231.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_1aa8b4fa-cd90-45d7-a3aa-4fce6d3b4493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6d966a02-4ebe-4b31-be49-3fafaa92e789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6d966a02-4ebe-4b31-be49-3fafaa92e789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5e7bd349-c468-4eea-920c-0a926dc87e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5e7bd349-c468-4eea-920c-0a926dc87e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c2186474-8e9b-4459-84b5-045e89ccd196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c2186474-8e9b-4459-84b5-045e89ccd196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_be8774ab-4eb4-40c2-b121-f6edc99f066e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_be8774ab-4eb4-40c2-b121-f6edc99f066e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_a094a174-f829-4127-ae90-a49cf0d77b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_a094a174-f829-4127-ae90-a49cf0d77b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_25b3bde3-7b46-49df-8304-7a1cec58b4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_ProfitLoss_25b3bde3-7b46-49df-8304-7a1cec58b4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_96e62616-d374-4cb1-b8c6-d8d432fc5fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_96e62616-d374-4cb1-b8c6-d8d432fc5fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_95185481-4612-4f91-aa21-f5714bcf2b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_NetIncomeLoss_95185481-4612-4f91-aa21-f5714bcf2b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_024bc44e-73f9-4434-be84-b6099eec9748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_EarningsPerShareAbstract_024bc44e-73f9-4434-be84-b6099eec9748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_67d9a145-34a9-4a89-aea5-47488afa6800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_024bc44e-73f9-4434-be84-b6099eec9748" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_67d9a145-34a9-4a89-aea5-47488afa6800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_12c03cda-2536-40e5-9f6e-bfbd2ec7f426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_024bc44e-73f9-4434-be84-b6099eec9748" xlink:to="loc_us-gaap_EarningsPerShareBasic_12c03cda-2536-40e5-9f6e-bfbd2ec7f426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_dadfb645-492e-40cc-88a4-eccfe017997a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_024bc44e-73f9-4434-be84-b6099eec9748" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_dadfb645-492e-40cc-88a4-eccfe017997a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0dc4b514-9c11-414e-a46e-034515d958f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_024bc44e-73f9-4434-be84-b6099eec9748" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0dc4b514-9c11-414e-a46e-034515d958f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f9c68e41-2ac9-4b1e-877e-b8e64850a3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f9c68e41-2ac9-4b1e-877e-b8e64850a3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9139393a-5cab-40cb-8402-87321dd0bc8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f9c68e41-2ac9-4b1e-877e-b8e64850a3dd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9139393a-5cab-40cb-8402-87321dd0bc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_84532834-a661-44b0-a326-0f6dddb5d56b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f9c68e41-2ac9-4b1e-877e-b8e64850a3dd" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_84532834-a661-44b0-a326-0f6dddb5d56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_89bf601e-4103-44cd-ba4e-dde49b800625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_727d3a3f-ba69-40e5-82e1-462870234d08" xlink:to="loc_us-gaap_NetIncomeLossAbstract_89bf601e-4103-44cd-ba4e-dde49b800625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_e829dccf-da15-4a39-911b-14183b47b39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_89bf601e-4103-44cd-ba4e-dde49b800625" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_e829dccf-da15-4a39-911b-14183b47b39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_32b938a5-627e-4283-8d0c-09ad8a088ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_89bf601e-4103-44cd-ba4e-dde49b800625" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_32b938a5-627e-4283-8d0c-09ad8a088ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6dd3eb6d-189a-4992-b2c5-7d8a77867bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_89bf601e-4103-44cd-ba4e-dde49b800625" xlink:to="loc_us-gaap_NetIncomeLoss_6dd3eb6d-189a-4992-b2c5-7d8a77867bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME_1"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bbe5b074-38a6-41e1-9fa1-50c3040c2522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6915cece-d34d-4b1d-b550-84ba347ead91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bbe5b074-38a6-41e1-9fa1-50c3040c2522" xlink:to="loc_us-gaap_ProfitLoss_6915cece-d34d-4b1d-b550-84ba347ead91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_eee75f20-770a-4bc4-9a2e-3687ac30d4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bbe5b074-38a6-41e1-9fa1-50c3040c2522" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_eee75f20-770a-4bc4-9a2e-3687ac30d4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_14e7668f-ba4c-4e9d-b7b1-a173c4b02896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_eee75f20-770a-4bc4-9a2e-3687ac30d4f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_14e7668f-ba4c-4e9d-b7b1-a173c4b02896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_719373f7-3f62-489f-ba30-594b1128d5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_14e7668f-ba4c-4e9d-b7b1-a173c4b02896" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_719373f7-3f62-489f-ba30-594b1128d5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fcc5eec5-886c-4025-bef4-8eeb81240f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_14e7668f-ba4c-4e9d-b7b1-a173c4b02896" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fcc5eec5-886c-4025-bef4-8eeb81240f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_e3ca0784-fa9c-4686-a139-d1a62743d94c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_eee75f20-770a-4bc4-9a2e-3687ac30d4f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_e3ca0784-fa9c-4686-a139-d1a62743d94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_bc356817-c7e1-4961-b745-8cb1aa68d806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_e3ca0784-fa9c-4686-a139-d1a62743d94c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_bc356817-c7e1-4961-b745-8cb1aa68d806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3c89839d-a5be-45b4-b32e-7b87919165fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bbe5b074-38a6-41e1-9fa1-50c3040c2522" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3c89839d-a5be-45b4-b32e-7b87919165fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f1d379a5-ab88-4ead-984e-ba80bba372f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bbe5b074-38a6-41e1-9fa1-50c3040c2522" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f1d379a5-ab88-4ead-984e-ba80bba372f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_524400d4-cdde-44f6-87e8-617dc2e5de15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bbe5b074-38a6-41e1-9fa1-50c3040c2522" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_524400d4-cdde-44f6-87e8-617dc2e5de15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ae5867cc-86e0-4c1a-b75a-d4bb3459e5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bbe5b074-38a6-41e1-9fa1-50c3040c2522" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_ae5867cc-86e0-4c1a-b75a-d4bb3459e5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_97b325aa-b48d-49dd-b3ca-c56e1d284a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_97b325aa-b48d-49dd-b3ca-c56e1d284a0f" xlink:to="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ef5485aa-e829-4576-825f-a8c58cc5a787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ef5485aa-e829-4576-825f-a8c58cc5a787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_ae128f46-4322-45f5-8e23-d21c27390fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_ae128f46-4322-45f5-8e23-d21c27390fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_33c670aa-346c-4652-b812-fe527d6a139a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_33c670aa-346c-4652-b812-fe527d6a139a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2846d376-b65d-48f2-8619-b3127b658913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2846d376-b65d-48f2-8619-b3127b658913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c3975ae8-d80f-4cc0-9dc1-d2c97911e9f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_InventoryNet_c3975ae8-d80f-4cc0-9dc1-d2c97911e9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_59753e89-f37f-4f55-b24b-5cf0b6c7a7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_59753e89-f37f-4f55-b24b-5cf0b6c7a7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9828237e-3723-4e45-a25e-d572460add50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9828237e-3723-4e45-a25e-d572460add50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_657d8331-4b60-45c1-a952-8c26983b1490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_IncomeTaxesReceivable_657d8331-4b60-45c1-a952-8c26983b1490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a554f60a-ad02-4767-a0da-9d1c426ddc78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_AssetsCurrent_a554f60a-ad02-4767-a0da-9d1c426ddc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_690ddc67-44ea-455e-b4e5-3409d87278a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_690ddc67-44ea-455e-b4e5-3409d87278a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_abcfb1fc-a1ad-4def-b634-90d2d294d07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_abcfb1fc-a1ad-4def-b634-90d2d294d07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4b9f5d56-09d6-4505-bc21-5548180cc824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4b9f5d56-09d6-4505-bc21-5548180cc824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_1a829400-c09a-450b-8efc-884ca77bf048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_1a829400-c09a-450b-8efc-884ca77bf048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_0ba8b343-ef91-4511-8f64-3c556684bc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_0ba8b343-ef91-4511-8f64-3c556684bc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8daf84c3-3d64-4059-8798-a0f2d035c7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8daf84c3-3d64-4059-8798-a0f2d035c7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e06014c5-73ff-4140-885f-1bfb2d26f488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_Goodwill_e06014c5-73ff-4140-885f-1bfb2d26f488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3f22b2e6-64be-48f5-8c2c-ca60469243db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e54a5049-b682-44ad-a43d-fe487f7b96ef" xlink:to="loc_us-gaap_Assets_3f22b2e6-64be-48f5-8c2c-ca60469243db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_97b325aa-b48d-49dd-b3ca-c56e1d284a0f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_83b9ee60-7c56-4de1-95e2-c1e6270f7698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_AccountsPayableCurrent_83b9ee60-7c56-4de1-95e2-c1e6270f7698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_5e5bc2f2-6e63-4427-bcb0-119fb11f478f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_5e5bc2f2-6e63-4427-bcb0-119fb11f478f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cb5b8257-dd00-4d51-8e9e-1c3f852b392d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cb5b8257-dd00-4d51-8e9e-1c3f852b392d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_35b5091a-3cec-4606-a417-f758dbee62ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_35b5091a-3cec-4606-a417-f758dbee62ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fd5f7c10-dee4-4087-a8de-ea372206ac03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fd5f7c10-dee4-4087-a8de-ea372206ac03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_d85c5a25-bab2-48ee-9421-504f1253caad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_d85c5a25-bab2-48ee-9421-504f1253caad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1ec083fd-5043-455a-9d6a-7712034f5346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_LiabilitiesCurrent_1ec083fd-5043-455a-9d6a-7712034f5346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5c65a199-5bfb-418d-9a97-230841c3eb64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5c65a199-5bfb-418d-9a97-230841c3eb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_94bd54ab-cb2b-43c0-a87b-30f68036eeca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_94bd54ab-cb2b-43c0-a87b-30f68036eeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4a855ab2-a6d0-4b5d-ae3e-937de926a68c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4a855ab2-a6d0-4b5d-ae3e-937de926a68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_97e5f522-b42c-4dc4-99d8-a22bf41f3cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_97e5f522-b42c-4dc4-99d8-a22bf41f3cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b70d3bd6-33e5-4286-ab6c-434faf2a0f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_Liabilities_b70d3bd6-33e5-4286-ab6c-434faf2a0f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1c7ab4f6-a032-4a6b-af30-eff4aae938a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1c7ab4f6-a032-4a6b-af30-eff4aae938a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_ab39a1fb-79d9-4be1-a1e1-926b4855fdf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1c7ab4f6-a032-4a6b-af30-eff4aae938a4" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_ab39a1fb-79d9-4be1-a1e1-926b4855fdf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ae0dd422-10e0-44a1-baed-1b4a89ac381b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ae0dd422-10e0-44a1-baed-1b4a89ac381b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f2a4c149-6acf-4928-850e-d1000b032d45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ae0dd422-10e0-44a1-baed-1b4a89ac381b" xlink:to="loc_us-gaap_PreferredStockValue_f2a4c149-6acf-4928-850e-d1000b032d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ea3295fb-44fb-46f3-ae13-d9ab44b0c63b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ae0dd422-10e0-44a1-baed-1b4a89ac381b" xlink:to="loc_us-gaap_CommonStockValue_ea3295fb-44fb-46f3-ae13-d9ab44b0c63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_10b8d86f-3e33-4f11-8dc6-19551315827d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ae0dd422-10e0-44a1-baed-1b4a89ac381b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_10b8d86f-3e33-4f11-8dc6-19551315827d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_85a41454-fb0c-4111-ac81-1e1fdd48e1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ae0dd422-10e0-44a1-baed-1b4a89ac381b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_85a41454-fb0c-4111-ac81-1e1fdd48e1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_67957042-b295-4350-90b9-68a4ada29691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ae0dd422-10e0-44a1-baed-1b4a89ac381b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_67957042-b295-4350-90b9-68a4ada29691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7f8a9f7b-5645-41b0-bdf4-ad5318bf381b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ae0dd422-10e0-44a1-baed-1b4a89ac381b" xlink:to="loc_us-gaap_StockholdersEquity_7f8a9f7b-5645-41b0-bdf4-ad5318bf381b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d324cffa-6668-4ba9-ac15-1ad02dfe10a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ae0dd422-10e0-44a1-baed-1b4a89ac381b" xlink:to="loc_us-gaap_MinorityInterest_d324cffa-6668-4ba9-ac15-1ad02dfe10a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c3b291d4-62cc-4b5c-8896-bb31cd0afed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ae0dd422-10e0-44a1-baed-1b4a89ac381b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c3b291d4-62cc-4b5c-8896-bb31cd0afed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4f84a604-de2f-4fff-a840-517b8fd97cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_626ce046-20f6-46fe-9c5a-4847c0e8afb9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_4f84a604-de2f-4fff-a840-517b8fd97cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1ea94787-054e-419f-8149-a3f7e11901de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_97b325aa-b48d-49dd-b3ca-c56e1d284a0f" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1ea94787-054e-419f-8149-a3f7e11901de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_a9a42698-d6d2-41ea-975d-b94b8ded6e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_97b325aa-b48d-49dd-b3ca-c56e1d284a0f" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_a9a42698-d6d2-41ea-975d-b94b8ded6e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_d0f2ed3c-8f1e-4573-998c-52ea9db6265b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_97b325aa-b48d-49dd-b3ca-c56e1d284a0f" xlink:to="loc_us-gaap_PreferredStockSharesIssued_d0f2ed3c-8f1e-4573-998c-52ea9db6265b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_170d361e-bffe-4325-8f2e-b37dc511f1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_97b325aa-b48d-49dd-b3ca-c56e1d284a0f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_170d361e-bffe-4325-8f2e-b37dc511f1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_da52667c-9b0b-42ff-870f-6be9e67b8138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_97b325aa-b48d-49dd-b3ca-c56e1d284a0f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_da52667c-9b0b-42ff-870f-6be9e67b8138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4bc8ce47-e126-465d-b00e-ce3e0a0289d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_97b325aa-b48d-49dd-b3ca-c56e1d284a0f" xlink:to="loc_us-gaap_CommonStockSharesIssued_4bc8ce47-e126-465d-b00e-ce3e0a0289d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d0711e38-fb8f-4bbd-824b-96417544a516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f2140864-a80a-4e32-aedb-08ad451e5ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d0711e38-fb8f-4bbd-824b-96417544a516" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f2140864-a80a-4e32-aedb-08ad451e5ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7fba9953-7645-40dd-886e-633041877660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d0711e38-fb8f-4bbd-824b-96417544a516" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7fba9953-7645-40dd-886e-633041877660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_70b5cd01-db0a-475d-88bc-f52e35ebf00a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d0711e38-fb8f-4bbd-824b-96417544a516" xlink:to="loc_us-gaap_PreferredStockSharesIssued_70b5cd01-db0a-475d-88bc-f52e35ebf00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5411533c-ba0d-4c5e-8deb-6ef34f85f1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d0711e38-fb8f-4bbd-824b-96417544a516" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5411533c-ba0d-4c5e-8deb-6ef34f85f1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8bf8f331-8689-4b07-809e-c5cd89feee31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d0711e38-fb8f-4bbd-824b-96417544a516" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8bf8f331-8689-4b07-809e-c5cd89feee31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9bd594fb-c92d-4279-a2ab-4016b17642a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d0711e38-fb8f-4bbd-824b-96417544a516" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9bd594fb-c92d-4279-a2ab-4016b17642a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_b2dfd733-4db2-4918-bd3f-c690d3591933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5d31572e-c59b-4583-80de-856c5f8e2112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b2dfd733-4db2-4918-bd3f-c690d3591933" xlink:to="loc_us-gaap_StatementTable_5d31572e-c59b-4583-80de-856c5f8e2112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9fe3d870-bbd3-41f6-a0c1-cffe6643fa7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5d31572e-c59b-4583-80de-856c5f8e2112" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9fe3d870-bbd3-41f6-a0c1-cffe6643fa7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_cd9c4ab0-9142-41f5-b914-338b28716cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9fe3d870-bbd3-41f6-a0c1-cffe6643fa7a" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_cd9c4ab0-9142-41f5-b914-338b28716cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_c5afec5c-0021-49fc-a396-113ca117b0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_cd9c4ab0-9142-41f5-b914-338b28716cfe" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_c5afec5c-0021-49fc-a396-113ca117b0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_2c3f88fe-9927-430d-b38c-cbdeccd0e1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_cd9c4ab0-9142-41f5-b914-338b28716cfe" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_2c3f88fe-9927-430d-b38c-cbdeccd0e1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5d31572e-c59b-4583-80de-856c5f8e2112" xlink:to="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5c525b2b-624d-44b5-aa1f-bcc557fd5210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5c525b2b-624d-44b5-aa1f-bcc557fd5210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_86bd5025-2e31-47fd-a532-2e44278db65d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5c525b2b-624d-44b5-aa1f-bcc557fd5210" xlink:to="loc_us-gaap_ProfitLoss_86bd5025-2e31-47fd-a532-2e44278db65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5c525b2b-624d-44b5-aa1f-bcc557fd5210" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_7d9632ff-fc4d-4a0e-a2ce-05d4dd550c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_7d9632ff-fc4d-4a0e-a2ce-05d4dd550c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_2c6d6ae1-7580-4e9e-b6f7-4de4b81d65e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_2c6d6ae1-7580-4e9e-b6f7-4de4b81d65e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtRefinancingCharges_4d5dc227-6ba5-4534-ae71-735479110ea9" xlink:href="dva-20211231.xsd#dva_DebtRefinancingCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_dva_DebtRefinancingCharges_4d5dc227-6ba5-4534-ae71-735479110ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_989b406e-da8f-40ff-97cc-08f24604f2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_us-gaap_ShareBasedCompensation_989b406e-da8f-40ff-97cc-08f24604f2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b2754294-4953-4dcd-9026-cc4e27295038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b2754294-4953-4dcd-9026-cc4e27295038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_6b89c662-b1ee-4509-8b38-b5397d1d7929" xlink:href="dva-20211231.xsd#dva_AdjustmentIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_dva_AdjustmentIncomeLossFromEquityMethodInvestments_6b89c662-b1ee-4509-8b38-b5397d1d7929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_7f6d0172-d5a2-47be-a776-5f6aec8c7989" xlink:href="dva-20211231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_7f6d0172-d5a2-47be-a776-5f6aec8c7989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_617a5fdc-6304-4122-b83a-c56493643051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_617a5fdc-6304-4122-b83a-c56493643051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18a10f55-0a54-4949-83ba-79814eae033c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_806763d0-03d8-4516-aabc-6bb90bc57645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_806763d0-03d8-4516-aabc-6bb90bc57645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_fb53d015-befa-4172-88e1-08ce277f7804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_fb53d015-befa-4172-88e1-08ce277f7804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_92401789-5ada-42ed-97cf-04c8adfd2ded" xlink:href="dva-20211231.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_92401789-5ada-42ed-97cf-04c8adfd2ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a94935e0-32eb-4e88-9b1e-ff5776b48b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a94935e0-32eb-4e88-9b1e-ff5776b48b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_66bfb990-e358-4689-af57-9edbbb4d84bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_66bfb990-e358-4689-af57-9edbbb4d84bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a1496d8b-8de4-444e-b48f-db4bfd4ecdeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a1496d8b-8de4-444e-b48f-db4bfd4ecdeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_54291aa6-c4b0-4212-819f-75afd99796e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_54291aa6-c4b0-4212-819f-75afd99796e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_efc7f4dc-60a1-41ae-ae79-a246aac9103c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_efc7f4dc-60a1-41ae-ae79-a246aac9103c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_d1b741b0-67bb-420b-9d7a-f15ca9dba9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_978ecbad-0797-400d-92cd-5f45ff9dba61" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_d1b741b0-67bb-420b-9d7a-f15ca9dba9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78014bd0-e4e9-4797-9561-ced9f66c3f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5c525b2b-624d-44b5-aa1f-bcc557fd5210" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78014bd0-e4e9-4797-9561-ced9f66c3f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_08af43d1-9898-44a0-aae9-98729c597cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_08af43d1-9898-44a0-aae9-98729c597cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_a083ca78-cf9f-429f-8abc-aa5a9d398f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_a083ca78-cf9f-429f-8abc-aa5a9d398f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_feb0bfe7-2817-4e23-9673-4867d16613f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_feb0bfe7-2817-4e23-9673-4867d16613f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_fe86d8cd-785e-4446-ac6c-a1be58235323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_fe86d8cd-785e-4446-ac6c-a1be58235323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PaymentsToAcquireOtherDebtAndEquityInvestments_8e289032-98c7-4e0b-b166-37b9df8ee091" xlink:href="dva-20211231.xsd#dva_PaymentsToAcquireOtherDebtAndEquityInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_dva_PaymentsToAcquireOtherDebtAndEquityInvestments_8e289032-98c7-4e0b-b166-37b9df8ee091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_6c33acaa-cf96-43e3-b104-ab3a935b4075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_6c33acaa-cf96-43e3-b104-ab3a935b4075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_f7dd497c-0620-4f53-af4f-b680a7c7331d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_f7dd497c-0620-4f53-af4f-b680a7c7331d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_d6714fe7-40e5-497d-bc68-f5e3f51a8ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_d6714fe7-40e5-497d-bc68-f5e3f51a8ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_90b8def8-786c-4642-956c-08f3e29890f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_90b8def8-786c-4642-956c-08f3e29890f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_90a2dd96-5fa1-482a-8d37-1b3c876331de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_90a2dd96-5fa1-482a-8d37-1b3c876331de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48e31393-a74e-4cb6-bb3b-69d0ff729ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_4e741e0e-a80a-4125-9390-66157de0bbd3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48e31393-a74e-4cb6-bb3b-69d0ff729ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d9c33721-c07e-427c-9cda-f55a1d106e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d9c33721-c07e-427c-9cda-f55a1d106e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_3ea95106-5480-4732-be46-92b1238bdf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_3ea95106-5480-4732-be46-92b1238bdf4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtFinancingAndDebtRedemptionCosts_d31fae8c-2143-4c32-8acc-362104d89ae5" xlink:href="dva-20211231.xsd#dva_DebtFinancingAndDebtRedemptionCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_dva_DebtFinancingAndDebtRedemptionCosts_d31fae8c-2143-4c32-8acc-362104d89ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e2a26cdc-f3c0-4159-a3b0-cecae5acd544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e2a26cdc-f3c0-4159-a3b0-cecae5acd544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_61de1b6d-e5d9-4c1d-8b6e-a9c8d4674be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_61de1b6d-e5d9-4c1d-8b6e-a9c8d4674be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PaymentsRelatedToStockPurchasesAndAwards_90b7b6e4-e877-4ca8-b233-1d22837bdcdd" xlink:href="dva-20211231.xsd#dva_PaymentsRelatedToStockPurchasesAndAwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_dva_PaymentsRelatedToStockPurchasesAndAwards_90b7b6e4-e877-4ca8-b233-1d22837bdcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_63eafbed-ec56-47ae-a45b-1d3b533efc85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_63eafbed-ec56-47ae-a45b-1d3b533efc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_04e6a56f-4dc1-4b52-9fb7-bf57a16f12b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_04e6a56f-4dc1-4b52-9fb7-bf57a16f12b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_d35ee0dc-6e61-4db5-894a-7023c57dcf16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_d35ee0dc-6e61-4db5-894a-7023c57dcf16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_aff25097-ed1c-40f7-bed1-d557eafd0a97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_aff25097-ed1c-40f7-bed1-d557eafd0a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ce2b2b3c-28e3-4640-819d-39b5adffef34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_9901fce5-fe18-4f72-8f18-32a857eece2c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ce2b2b3c-28e3-4640-819d-39b5adffef34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_cfaaf0c0-79d5-419e-b15c-8be35911d801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_cfaaf0c0-79d5-419e-b15c-8be35911d801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_20f75d18-d6be-457a-a78d-8dbde2007e44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_20f75d18-d6be-457a-a78d-8dbde2007e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0db4ac37-0828-4783-ad9b-e30f9d6c18bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0db4ac37-0828-4783-ad9b-e30f9d6c18bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_891b32a5-5614-4496-bdba-3c3dc5e04178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_22f60804-cc64-40be-9544-aed8f90079ba" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_891b32a5-5614-4496-bdba-3c3dc5e04178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="simple" xlink:href="dva-20211231.xsd#CONSOLIDATEDSTATEMENTSOFEQUITY"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_913a4190-4cf6-43f1-b732-e3966513e1df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_61870d3a-1f48-4e8c-b392-526e4b067512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_913a4190-4cf6-43f1-b732-e3966513e1df" xlink:to="loc_us-gaap_StatementTable_61870d3a-1f48-4e8c-b392-526e4b067512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d065de14-0a6b-4f81-9056-342da767af68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_61870d3a-1f48-4e8c-b392-526e4b067512" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d065de14-0a6b-4f81-9056-342da767af68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b038238e-af74-4b7f-a2e3-7681399c61ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d065de14-0a6b-4f81-9056-342da767af68" xlink:to="loc_us-gaap_EquityComponentDomain_b038238e-af74-4b7f-a2e3-7681399c61ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b038238e-af74-4b7f-a2e3-7681399c61ef" xlink:to="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_3bbc1497-13d9-4658-9509-60e1e1dcf6b4" xlink:href="dva-20211231.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_3bbc1497-13d9-4658-9509-60e1e1dcf6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5f9dfe1f-460b-4b46-9768-f68191747cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_us-gaap_CommonStockMember_5f9dfe1f-460b-4b46-9768-f68191747cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d89407a7-4e5a-4132-8593-153b7bc172f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d89407a7-4e5a-4132-8593-153b7bc172f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e972bd66-7d78-4849-847a-50dc3e21422a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_us-gaap_RetainedEarningsMember_e972bd66-7d78-4849-847a-50dc3e21422a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7dd66574-74a4-4562-a3e4-bdd01ecc2014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_us-gaap_TreasuryStockMember_7dd66574-74a4-4562-a3e4-bdd01ecc2014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b90dfdbb-92dd-4500-b2d5-1e30a4386905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b90dfdbb-92dd-4500-b2d5-1e30a4386905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ac3e40ea-d1bb-48d6-835b-268b6b2cb267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_414b461d-afbe-4d8a-a03d-3f24cd088b51" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ac3e40ea-d1bb-48d6-835b-268b6b2cb267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1887079a-ded7-4d2f-ab2a-f1b26369055d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_61870d3a-1f48-4e8c-b392-526e4b067512" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1887079a-ded7-4d2f-ab2a-f1b26369055d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e7c5331-3722-44ea-bb79-801ff2cede39" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1887079a-ded7-4d2f-ab2a-f1b26369055d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e7c5331-3722-44ea-bb79-801ff2cede39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f677b5ed-a982-4b65-8ef6-fad5de0254e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e7c5331-3722-44ea-bb79-801ff2cede39" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f677b5ed-a982-4b65-8ef6-fad5de0254e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_61b7de68-b3c5-46c9-85aa-b418fcc7b5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_61870d3a-1f48-4e8c-b392-526e4b067512" xlink:to="loc_us-gaap_StatementLineItems_61b7de68-b3c5-46c9-85aa-b418fcc7b5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_61b7de68-b3c5-46c9-85aa-b418fcc7b5b4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0a0d55f9-9fb6-4a60-9f4e-9fc88a8c3f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0a0d55f9-9fb6-4a60-9f4e-9fc88a8c3f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f7985cc6-096f-490e-a7aa-823308163ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f7985cc6-096f-490e-a7aa-823308163ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_64934055-f004-4721-9fde-9401af4e31f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_64934055-f004-4721-9fde-9401af4e31f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_43857806-da84-4763-b77b-f4791688e6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_43857806-da84-4763-b77b-f4791688e6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_1b166c58-7674-4f38-95ad-5ea398888bef" xlink:href="dva-20211231.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_1b166c58-7674-4f38-95ad-5ea398888bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_b4f79b5b-c5df-476e-b754-e6142c9a7571" xlink:href="dva-20211231.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_b4f79b5b-c5df-476e-b754-e6142c9a7571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures_21c1318c-1b36-44b9-a699-0a78e4df2ae3" xlink:href="dva-20211231.xsd#dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures_21c1318c-1b36-44b9-a699-0a78e4df2ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_fa3ddd79-6f99-472e-bfff-e6af16d998dd" xlink:href="dva-20211231.xsd#dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_fa3ddd79-6f99-472e-bfff-e6af16d998dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_a393a9fa-7cb5-4bf8-ab15-197069ba429c" xlink:href="dva-20211231.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_a393a9fa-7cb5-4bf8-ab15-197069ba429c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_3a40c8bf-e958-4821-8f29-aeed57bca2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_3a40c8bf-e958-4821-8f29-aeed57bca2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_637bf096-b24f-43ea-9a61-882fe94857f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b6a83b8a-376e-4813-b221-6bdf7fd6def4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_637bf096-b24f-43ea-9a61-882fe94857f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_affcb587-1ca1-479b-89a5-c08198f29d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_affcb587-1ca1-479b-89a5-c08198f29d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_34817895-558c-4cd6-938e-6fa454bfc9be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_affcb587-1ca1-479b-89a5-c08198f29d8a" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_34817895-558c-4cd6-938e-6fa454bfc9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7ffb9201-e476-4d33-bfa3-89feacbff483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_affcb587-1ca1-479b-89a5-c08198f29d8a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7ffb9201-e476-4d33-bfa3-89feacbff483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9998afc2-fac4-47e1-9ee5-7e84b8b7faa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9998afc2-fac4-47e1-9ee5-7e84b8b7faa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c03d1866-e305-4269-8591-830196fd5dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c03d1866-e305-4269-8591-830196fd5dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_032e0e6f-4b5e-4f3c-afb1-e4e4143a8728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_032e0e6f-4b5e-4f3c-afb1-e4e4143a8728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f6635504-da59-4840-a13f-c8404299a9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f6635504-da59-4840-a13f-c8404299a9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_48888ffe-2723-45fe-b4eb-a356f251ae23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_48888ffe-2723-45fe-b4eb-a356f251ae23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_cdb8cbe0-3b25-4427-b15c-9d0fad878b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_cdb8cbe0-3b25-4427-b15c-9d0fad878b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions_0f7fa9b3-0cde-495f-8625-d81111b060a2" xlink:href="dva-20211231.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_dva_NoncontrollingInterestIncreaseFromContributions_0f7fa9b3-0cde-495f-8625-d81111b060a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_74153984-f77a-40cf-8029-071af99d1dd9" xlink:href="dva-20211231.xsd#dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_74153984-f77a-40cf-8029-071af99d1dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_077b2063-3c7e-46aa-b16d-b085941ed2fa" xlink:href="dva-20211231.xsd#dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_077b2063-3c7e-46aa-b16d-b085941ed2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_aac0d8ae-407a-4151-947a-da5c7abe6754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_aac0d8ae-407a-4151-947a-da5c7abe6754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_aa8660e3-cb9e-4a75-843f-d994e030e030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_aa8660e3-cb9e-4a75-843f-d994e030e030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_cfb39ab9-e946-4a6f-90e4-73b38b5b0fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_749c0bcf-2633-43f8-b257-c53d7b76c5c0" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_cfb39ab9-e946-4a6f-90e4-73b38b5b0fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_2bf87289-443f-48a5-93c0-0369827d3fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_2bf87289-443f-48a5-93c0-0369827d3fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0b2980a0-2f68-488a-b6ec-983ae7f17b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0b2980a0-2f68-488a-b6ec-983ae7f17b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_2ff825f4-2f42-4310-82cd-b62a89996896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_2ff825f4-2f42-4310-82cd-b62a89996896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_a7354190-45ba-4fad-a49b-9684d202da23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_a7354190-45ba-4fad-a49b-9684d202da23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_eb218e10-12a2-482b-bf78-3a5d01f1cee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_eb218e10-12a2-482b-bf78-3a5d01f1cee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1245c9a8-502b-40e9-bbd1-ac1883d29e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1245c9a8-502b-40e9-bbd1-ac1883d29e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_34b6048e-5f35-4d56-a7a9-d6089881ac7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48829696-c8fb-48ee-add3-82050d3a3559" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_34b6048e-5f35-4d56-a7a9-d6089881ac7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="dva-20211231.xsd#OrganizationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_40ee7e97-f098-4c07-9703-6795738a9736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_8e9a1c68-dbdb-4521-a06e-cd132ebac4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40ee7e97-f098-4c07-9703-6795738a9736" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_8e9a1c68-dbdb-4521-a06e-cd132ebac4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="dva-20211231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_17ff09c8-77fc-49b1-9ce6-a3221f827be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_17ff09c8-77fc-49b1-9ce6-a3221f827be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_489ce7f6-456c-45bf-a17d-8d28dcd1d275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_UseOfEstimates_489ce7f6-456c-45bf-a17d-8d28dcd1d275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock_70871126-41c6-471d-b5c5-58911176f9cc" xlink:href="dva-20211231.xsd#dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock_70871126-41c6-471d-b5c5-58911176f9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherNonoperatingIncomeExpensePolicyTextBlock_a01c5044-49fc-4ea8-a0b5-834e03d846bc" xlink:href="dva-20211231.xsd#dva_OtherNonoperatingIncomeExpensePolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_dva_OtherNonoperatingIncomeExpensePolicyTextBlock_a01c5044-49fc-4ea8-a0b5-834e03d846bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d045e123-4ed0-42cf-8d17-5e4f305d7127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d045e123-4ed0-42cf-8d17-5e4f305d7127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_84ee2a90-55b1-491a-a50c-aab255479978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_84ee2a90-55b1-491a-a50c-aab255479978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_644717e5-dabf-4b82-8fca-02fff1e6ad73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_644717e5-dabf-4b82-8fca-02fff1e6ad73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_c4f9ae46-f789-4e70-9ae7-af144d5a1fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_c4f9ae46-f789-4e70-9ae7-af144d5a1fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_49743901-342f-421c-a21e-f37add9d13dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_49743901-342f-421c-a21e-f37add9d13dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_1bddb2e3-e85a-4946-ab54-f5864f3847a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_1bddb2e3-e85a-4946-ab54-f5864f3847a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_b0279fed-1103-4929-a373-4b9f34bcdbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_b0279fed-1103-4929-a373-4b9f34bcdbfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_500c9f72-b79c-44cd-8e37-5e1e8e91b5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_500c9f72-b79c-44cd-8e37-5e1e8e91b5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_9824650c-a399-4afc-aec1-7e7bc7060e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_9824650c-a399-4afc-aec1-7e7bc7060e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_102579d7-4b94-4139-ac0d-9d026ff14c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_102579d7-4b94-4139-ac0d-9d026ff14c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_InsuranceAndSelfInsurancePolicyTextBlock_1f3451ca-647d-4e78-9827-dc54b5e19059" xlink:href="dva-20211231.xsd#dva_InsuranceAndSelfInsurancePolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_dva_InsuranceAndSelfInsurancePolicyTextBlock_1f3451ca-647d-4e78-9827-dc54b5e19059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_9f6099ef-c699-4801-afe1-a1120c8198f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_9f6099ef-c699-4801-afe1-a1120c8198f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0b4c20a0-1ef5-467d-9cc9-d8ba39a8cb70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0b4c20a0-1ef5-467d-9cc9-d8ba39a8cb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_91ca8861-a2ea-41fc-8a80-74f2de98d6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_91ca8861-a2ea-41fc-8a80-74f2de98d6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_3b287b33-a475-4b7c-a88f-3195e34fde91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_3b287b33-a475-4b7c-a88f-3195e34fde91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_1c6670cc-1b71-42fd-b515-355bd7d378b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_1c6670cc-1b71-42fd-b515-355bd7d378b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_99a13dc3-1812-4dfc-8409-f38ec9fec1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_99a13dc3-1812-4dfc-8409-f38ec9fec1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_180dabbc-dd4b-49ef-a175-86b37b54ed43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_180dabbc-dd4b-49ef-a175-86b37b54ed43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_4653e717-598a-42be-8dac-70f874625c82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_4653e717-598a-42be-8dac-70f874625c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_16efa0e1-48c8-4763-b679-0d24619c4c15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_16efa0e1-48c8-4763-b679-0d24619c4c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_10ad6ca2-309a-4a95-90ef-23ebe61b4f31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef1617d8-63b1-4a07-bc39-a1b732730d60" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_10ad6ca2-309a-4a95-90ef-23ebe61b4f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c4ff793a-c589-483a-bc0a-54b4c610c88d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_516a3fe4-0930-455f-aa5f-19d6f8a14fd4" xlink:href="dva-20211231.xsd#dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c4ff793a-c589-483a-bc0a-54b4c610c88d" xlink:to="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_516a3fe4-0930-455f-aa5f-19d6f8a14fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_27543005-ca25-4034-905c-6b67262ec78c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_516a3fe4-0930-455f-aa5f-19d6f8a14fd4" xlink:to="loc_srt_StatementGeographicalAxis_27543005-ca25-4034-905c-6b67262ec78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_318ef321-72bc-41fd-942f-6997bce1eef8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_27543005-ca25-4034-905c-6b67262ec78c" xlink:to="loc_srt_SegmentGeographicalDomain_318ef321-72bc-41fd-942f-6997bce1eef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_33255ac1-dc53-4247-95be-075df1cb47d2" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_318ef321-72bc-41fd-942f-6997bce1eef8" xlink:to="loc_country_US_33255ac1-dc53-4247-95be-075df1cb47d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_InternationalOperationsMember_2008a01d-7e29-40db-aa44-6090a32343ce" xlink:href="dva-20211231.xsd#dva_InternationalOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_318ef321-72bc-41fd-942f-6997bce1eef8" xlink:to="loc_dva_InternationalOperationsMember_2008a01d-7e29-40db-aa44-6090a32343ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:href="dva-20211231.xsd#dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_516a3fe4-0930-455f-aa5f-19d6f8a14fd4" xlink:to="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfSites_1f36275f-b40b-42c6-97c0-2b1b479a1da3" xlink:href="dva-20211231.xsd#dva_NumberOfSites"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:to="loc_dva_NumberOfSites_1f36275f-b40b-42c6-97c0-2b1b479a1da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_374e7add-f28a-4502-9338-1821812067f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_374e7add-f28a-4502-9338-1821812067f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfCustomers_6bac7fb7-bbd9-497d-9469-27baf25369f4" xlink:href="dva-20211231.xsd#dva_NumberOfCustomers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:to="loc_dva_NumberOfCustomers_6bac7fb7-bbd9-497d-9469-27baf25369f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_fff34bb1-4a58-4492-808e-3c7e4c23ac7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_fff34bb1-4a58-4492-808e-3c7e4c23ac7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_5489f1ef-856b-45e4-ab0f-78b7514c3a13" xlink:href="dva-20211231.xsd#dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:to="loc_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor_5489f1ef-856b-45e4-ab0f-78b7514c3a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_e03e8454-6afa-4f4e-9e39-61955f4967c8" xlink:href="dva-20211231.xsd#dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_1b23db8d-a749-486c-bd3c-5dbc09feec46" xlink:to="loc_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests_e03e8454-6afa-4f4e-9e39-61955f4967c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognition" xlink:type="simple" xlink:href="dva-20211231.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_c3db7795-49bc-4996-bda9-77c0029dec38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_c0346444-c7e9-49b8-abb8-20885f685c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_c3db7795-49bc-4996-bda9-77c0029dec38" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_c0346444-c7e9-49b8-abb8-20885f685c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables" xlink:type="simple" xlink:href="dva-20211231.xsd#RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_7d676833-66db-429c-a180-92783646faf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8886981a-92d5-4fe3-9963-a63e791c06a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_7d676833-66db-429c-a180-92783646faf5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8886981a-92d5-4fe3-9963-a63e791c06a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentRevenuebyMajorPayorAbstract_80e1ac66-e3ad-4a17-85c7-2c49a9b1f69b" xlink:href="dva-20211231.xsd#dva_SegmentRevenuebyMajorPayorAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1ef5dd48-a420-4fe4-b316-773d34be38eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_SegmentRevenuebyMajorPayorAbstract_80e1ac66-e3ad-4a17-85c7-2c49a9b1f69b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1ef5dd48-a420-4fe4-b316-773d34be38eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ea5c29c0-30dd-44c2-9fe0-0b53567bf6af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1ef5dd48-a420-4fe4-b316-773d34be38eb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ea5c29c0-30dd-44c2-9fe0-0b53567bf6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7d89f924-79f9-427e-8da4-86df61a758f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ea5c29c0-30dd-44c2-9fe0-0b53567bf6af" xlink:to="loc_us-gaap_SegmentDomain_7d89f924-79f9-427e-8da4-86df61a758f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_6655f6c5-efed-4c00-bfa6-4c3065c2f03f" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7d89f924-79f9-427e-8da4-86df61a758f6" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_6655f6c5-efed-4c00-bfa6-4c3065c2f03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_d9ce1bd8-a503-43b2-9072-0ec420b7ee80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7d89f924-79f9-427e-8da4-86df61a758f6" xlink:to="loc_us-gaap_AllOtherSegmentsMember_d9ce1bd8-a503-43b2-9072-0ec420b7ee80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_23ef8d6f-6f2f-4ec5-a4b9-c62c573c4980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1ef5dd48-a420-4fe4-b316-773d34be38eb" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_23ef8d6f-6f2f-4ec5-a4b9-c62c573c4980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_23ef8d6f-6f2f-4ec5-a4b9-c62c573c4980" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember_ff88a976-923e-4caf-b8c7-f29266768606" xlink:href="dva-20211231.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:to="loc_dva_MedicareandMedicareAdvantageMember_ff88a976-923e-4caf-b8c7-f29266768606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember_36954fa2-cad1-477c-9054-38987a47a625" xlink:href="dva-20211231.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:to="loc_dva_MedicaidandManagedMedicaidMember_36954fa2-cad1-477c-9054-38987a47a625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember_1ce35ea3-89d2-41b6-9a9e-aa5cbf3f256d" xlink:href="dva-20211231.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:to="loc_dva_OtherGovernmentPayorsMember_1ce35ea3-89d2-41b6-9a9e-aa5cbf3f256d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember_28351bc1-c100-4bb5-a043-5be06bf9f223" xlink:href="dva-20211231.xsd#dva_CommercialPayorsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:to="loc_dva_CommercialPayorsMember_28351bc1-c100-4bb5-a043-5be06bf9f223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember_5d59fb73-239e-4749-958e-bb51ed62ffb5" xlink:href="dva-20211231.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_3cd846d3-5d3f-43e7-95c4-02db4aed28ae" xlink:to="loc_dva_OtherSourcesofRevenueMember_5d59fb73-239e-4749-958e-bb51ed62ffb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f9b3c190-c2c3-41ce-a823-61838b441eb0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1ef5dd48-a420-4fe4-b316-773d34be38eb" xlink:to="loc_srt_ConsolidationItemsAxis_f9b3c190-c2c3-41ce-a823-61838b441eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_dd6a2ba3-14ec-4ae3-8b82-436467ae58e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_f9b3c190-c2c3-41ce-a823-61838b441eb0" xlink:to="loc_srt_ConsolidationItemsDomain_dd6a2ba3-14ec-4ae3-8b82-436467ae58e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_832f3239-d0af-4a76-891b-d2e55812e4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_dd6a2ba3-14ec-4ae3-8b82-436467ae58e5" xlink:to="loc_us-gaap_IntersegmentEliminationMember_832f3239-d0af-4a76-891b-d2e55812e4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_48407d91-bf78-4005-b238-b10773e57632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1ef5dd48-a420-4fe4-b316-773d34be38eb" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_48407d91-bf78-4005-b238-b10773e57632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_c323cce8-d1be-4f0e-9463-5c44e05d0981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_48407d91-bf78-4005-b238-b10773e57632" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_c323cce8-d1be-4f0e-9463-5c44e05d0981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_43359c7b-eb85-41b5-beea-6ffef1afd997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_48407d91-bf78-4005-b238-b10773e57632" xlink:to="loc_us-gaap_OtherIncome_43359c7b-eb85-41b5-beea-6ffef1afd997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dbc5882b-b55e-4060-99a3-bdff63ca74dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_48407d91-bf78-4005-b238-b10773e57632" xlink:to="loc_us-gaap_Revenues_dbc5882b-b55e-4060-99a3-bdff63ca74dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_911f06f5-8b19-4bdc-a2c1-c59aea8d86f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_7a74afc0-d6e8-4768-8577-c6ba4ec4d001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_911f06f5-8b19-4bdc-a2c1-c59aea8d86f4" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_7a74afc0-d6e8-4768-8577-c6ba4ec4d001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_860ac5dc-19bd-42e3-92eb-8d9260bd31d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_7a74afc0-d6e8-4768-8577-c6ba4ec4d001" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_860ac5dc-19bd-42e3-92eb-8d9260bd31d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5a62c4a0-ad72-415d-bd1c-762c75893658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_860ac5dc-19bd-42e3-92eb-8d9260bd31d6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5a62c4a0-ad72-415d-bd1c-762c75893658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_3b2caff2-4499-445a-a5f1-f3baeb4e942a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5a62c4a0-ad72-415d-bd1c-762c75893658" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_3b2caff2-4499-445a-a5f1-f3baeb4e942a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5cc3cb4f-fa9f-42eb-82fe-abc4df304124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_7a74afc0-d6e8-4768-8577-c6ba4ec4d001" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5cc3cb4f-fa9f-42eb-82fe-abc4df304124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_18605d28-7922-4c02-9396-8e280a7ad8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5cc3cb4f-fa9f-42eb-82fe-abc4df304124" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_18605d28-7922-4c02-9396-8e280a7ad8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_860cda6e-f392-4110-9275-2270b5d828f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_18605d28-7922-4c02-9396-8e280a7ad8cf" xlink:to="loc_us-gaap_AccountsReceivableMember_860cda6e-f392-4110-9275-2270b5d828f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_68da3023-1312-4f29-a99b-559e86bea819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_7a74afc0-d6e8-4768-8577-c6ba4ec4d001" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_68da3023-1312-4f29-a99b-559e86bea819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_ecbf7cb8-c8ba-46d7-88d7-6fdade8cc764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_68da3023-1312-4f29-a99b-559e86bea819" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_ecbf7cb8-c8ba-46d7-88d7-6fdade8cc764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareMember_109ee4b3-13b9-4487-b2cd-e94a9a6ca5c6" xlink:href="dva-20211231.xsd#dva_MedicareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_ecbf7cb8-c8ba-46d7-88d7-6fdade8cc764" xlink:to="loc_dva_MedicareMember_109ee4b3-13b9-4487-b2cd-e94a9a6ca5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThirdPartyPayorMember_1271dfba-996a-479b-8910-d63c387565a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ThirdPartyPayorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_ecbf7cb8-c8ba-46d7-88d7-6fdade8cc764" xlink:to="loc_us-gaap_ThirdPartyPayorMember_1271dfba-996a-479b-8910-d63c387565a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_7a74afc0-d6e8-4768-8577-c6ba4ec4d001" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfConcentrationRiskCustomers_e905d6b3-f9fa-45c5-a1fb-69c3f72beb1b" xlink:href="dva-20211231.xsd#dva_NumberOfConcentrationRiskCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:to="loc_dva_NumberOfConcentrationRiskCustomers_e905d6b3-f9fa-45c5-a1fb-69c3f72beb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_8f518dec-07a8-400f-83f4-0378cee6c697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_8f518dec-07a8-400f-83f4-0378cee6c697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0a921050-72fb-48c2-8111-f4d9cbd3d416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0a921050-72fb-48c2-8111-f4d9cbd3d416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_66a931c1-f051-4c98-9551-e6567f26d7fa" xlink:href="dva-20211231.xsd#dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:to="loc_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue_66a931c1-f051-4c98-9551-e6567f26d7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AccountsReceivablePeriodOutstanding_0973a6e5-b241-4e37-a80a-64c09e09d519" xlink:href="dva-20211231.xsd#dva_AccountsReceivablePeriodOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:to="loc_dva_AccountsReceivablePeriodOutstanding_0973a6e5-b241-4e37-a80a-64c09e09d519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_d285cd0d-8256-4ec0-a210-011ffa93f893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_2de4e45e-8f0c-4a38-9823-e03b745fcc5f" xlink:to="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_d285cd0d-8256-4ec0-a210-011ffa93f893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningsPerShare" xlink:type="simple" xlink:href="dva-20211231.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_efb4ae04-ab19-4abe-8e8c-08e5d2ad336d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_035dca49-10c9-4a03-9a91-944c76cfea9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_efb4ae04-ab19-4abe-8e8c-08e5d2ad336d" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_035dca49-10c9-4a03-9a91-944c76cfea9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="dva-20211231.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_568bd6af-01c4-4ee9-8fce-3c3ac50cae53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2c7536ae-4b1e-4165-be09-5b22382bbbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_568bd6af-01c4-4ee9-8fce-3c3ac50cae53" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2c7536ae-4b1e-4165-be09-5b22382bbbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7a31e5af-ce40-4afc-b5b4-5f083998112d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_d691c94d-73a3-412b-8213-a02bbcdc2ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a31e5af-ce40-4afc-b5b4-5f083998112d" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_d691c94d-73a3-412b-8213-a02bbcdc2ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_ebb7e18c-9579-4caa-ac09-68b00baf11de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_d691c94d-73a3-412b-8213-a02bbcdc2ce4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_ebb7e18c-9579-4caa-ac09-68b00baf11de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_b0784cd2-3b84-47c6-ac2a-c90cbbd031e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_d691c94d-73a3-412b-8213-a02bbcdc2ce4" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_b0784cd2-3b84-47c6-ac2a-c90cbbd031e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_25862235-92d4-4d2b-ae21-9c50c21110f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_d691c94d-73a3-412b-8213-a02bbcdc2ce4" xlink:to="loc_us-gaap_NetIncomeLoss_25862235-92d4-4d2b-ae21-9c50c21110f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6f468748-aaf7-456b-a71e-87c6ae281919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a31e5af-ce40-4afc-b5b4-5f083998112d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6f468748-aaf7-456b-a71e-87c6ae281919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_5a51445a-9b79-4c8a-bc9b-b4e59a85c86f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6f468748-aaf7-456b-a71e-87c6ae281919" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_5a51445a-9b79-4c8a-bc9b-b4e59a85c86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f39f0f5b-76e7-4a9b-8e1f-6061e66c610b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6f468748-aaf7-456b-a71e-87c6ae281919" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f39f0f5b-76e7-4a9b-8e1f-6061e66c610b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0f8be84c-a58e-4475-b2b3-8e4622cd1de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6f468748-aaf7-456b-a71e-87c6ae281919" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0f8be84c-a58e-4475-b2b3-8e4622cd1de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_b523f8b4-e700-46dd-95e8-3f2fb7c3710e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a31e5af-ce40-4afc-b5b4-5f083998112d" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_b523f8b4-e700-46dd-95e8-3f2fb7c3710e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_eb8db4ea-15c3-4239-b3ba-e41089b46029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b523f8b4-e700-46dd-95e8-3f2fb7c3710e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_eb8db4ea-15c3-4239-b3ba-e41089b46029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_638df9c5-0eeb-4e08-934e-97e69f1d64af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b523f8b4-e700-46dd-95e8-3f2fb7c3710e" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_638df9c5-0eeb-4e08-934e-97e69f1d64af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3405f871-ba91-4c7d-ac1a-8b96f1b600f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b523f8b4-e700-46dd-95e8-3f2fb7c3710e" xlink:to="loc_us-gaap_EarningsPerShareBasic_3405f871-ba91-4c7d-ac1a-8b96f1b600f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_fa306f14-d506-4539-af71-ecf67cb2105a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a31e5af-ce40-4afc-b5b4-5f083998112d" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_fa306f14-d506-4539-af71-ecf67cb2105a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1cb8d81b-4edd-44ff-82e5-5507e697fc28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_fa306f14-d506-4539-af71-ecf67cb2105a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1cb8d81b-4edd-44ff-82e5-5507e697fc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_9e1c0e60-4190-4703-98c6-2aa8e40b36dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_fa306f14-d506-4539-af71-ecf67cb2105a" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_9e1c0e60-4190-4703-98c6-2aa8e40b36dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_597172cf-ad31-4c08-bd64-11defc793284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_fa306f14-d506-4539-af71-ecf67cb2105a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_597172cf-ad31-4c08-bd64-11defc793284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_849da5be-3b19-4b49-b3dd-fbfc1b4c5795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a31e5af-ce40-4afc-b5b4-5f083998112d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_849da5be-3b19-4b49-b3dd-fbfc1b4c5795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RestrictedCashRestrictedCash" xlink:type="simple" xlink:href="dva-20211231.xsd#RestrictedCashRestrictedCash"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RestrictedCashRestrictedCash" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAbstract_a09773e8-62d0-4171-80d2-d5f369c291e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_220afab7-1914-46f9-b079-9ff85b845add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAbstract_a09773e8-62d0-4171-80d2-d5f369c291e1" xlink:to="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_220afab7-1914-46f9-b079-9ff85b845add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#RestrictedCashandEquivalentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAbstract_a064ef2f-fd98-4440-bc0a-9a9c0f86c2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_8457a051-6151-4e11-8a90-eaabb60e1b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAbstract_a064ef2f-fd98-4440-bc0a-9a9c0f86c2ea" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_8457a051-6151-4e11-8a90-eaabb60e1b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4b094b56-24d4-4659-91dc-bcdcbb061e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_8457a051-6151-4e11-8a90-eaabb60e1b11" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4b094b56-24d4-4659-91dc-bcdcbb061e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5067553e-f2be-42f4-97b8-339d1a1ae66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4b094b56-24d4-4659-91dc-bcdcbb061e1e" xlink:to="loc_us-gaap_SegmentDomain_5067553e-f2be-42f4-97b8-339d1a1ae66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_6d555acb-3211-494d-a45e-8431ee99aecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5067553e-f2be-42f4-97b8-339d1a1ae66f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_6d555acb-3211-494d-a45e-8431ee99aecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_d8045873-7e15-463f-90dd-99f3a570b7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_8457a051-6151-4e11-8a90-eaabb60e1b11" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_d8045873-7e15-463f-90dd-99f3a570b7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_3252f73d-beb1-4cc5-86cb-58619dbbdbb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_d8045873-7e15-463f-90dd-99f3a570b7ee" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_3252f73d-beb1-4cc5-86cb-58619dbbdbb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfPartnerships_7e171448-fed3-4ac0-8d2f-bc85dd35b4db" xlink:href="dva-20211231.xsd#dva_NumberOfPartnerships"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_d8045873-7e15-463f-90dd-99f3a570b7ee" xlink:to="loc_dva_NumberOfPartnerships_7e171448-fed3-4ac0-8d2f-bc85dd35b4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Shorttermandlongterminvestments" xlink:type="simple" xlink:href="dva-20211231.xsd#Shorttermandlongterminvestments"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Shorttermandlongterminvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_88eecad7-baa0-4555-aabd-453d2af9618d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_29653161-0874-4372-8300-619a525b1123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_88eecad7-baa0-4555-aabd-453d2af9618d" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_29653161-0874-4372-8300-619a525b1123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvesmtentsTables" xlink:type="simple" xlink:href="dva-20211231.xsd#ShorttermandlongterminvesmtentsTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvesmtentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0829d9e9-6d74-4913-8c55-a7eaa14f8c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_570cd1af-71eb-41ff-8cf1-c92e97013a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0829d9e9-6d74-4913-8c55-a7eaa14f8c4e" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_570cd1af-71eb-41ff-8cf1-c92e97013a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#ShorttermandlongterminvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_2c28bce1-ce0f-4621-ac15-b2fb875f2d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_00e8eae5-0ce7-4fa4-82ef-14a19cceec3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_2c28bce1-ce0f-4621-ac15-b2fb875f2d2c" xlink:to="loc_us-gaap_InvestmentHoldingsTable_00e8eae5-0ce7-4fa4-82ef-14a19cceec3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_30ded8a6-b5a2-4ae8-b0c4-e3e21fd27d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_00e8eae5-0ce7-4fa4-82ef-14a19cceec3a" xlink:to="loc_us-gaap_InvestmentTypeAxis_30ded8a6-b5a2-4ae8-b0c4-e3e21fd27d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_93a506c4-8e97-44f0-b968-ef7ad542c47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_30ded8a6-b5a2-4ae8-b0c4-e3e21fd27d8f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_93a506c4-8e97-44f0-b968-ef7ad542c47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_c4c057e0-0a36-45f4-8817-e3e4198183a8" xlink:href="dva-20211231.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93a506c4-8e97-44f0-b968-ef7ad542c47c" xlink:to="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_c4c057e0-0a36-45f4-8817-e3e4198183a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_1be7974e-c1fc-479d-a958-3b426e2d5f8d" xlink:href="dva-20211231.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93a506c4-8e97-44f0-b968-ef7ad542c47c" xlink:to="loc_dva_MutualFundsAndCommonStockMember_1be7974e-c1fc-479d-a958-3b426e2d5f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_85c9d311-9f2a-441a-8ef5-686ab0e9d839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93a506c4-8e97-44f0-b968-ef7ad542c47c" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_85c9d311-9f2a-441a-8ef5-686ab0e9d839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_e702bec5-399c-4ad6-a296-6d648fc83eae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_93a506c4-8e97-44f0-b968-ef7ad542c47c" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_e702bec5-399c-4ad6-a296-6d648fc83eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_00e8eae5-0ce7-4fa4-82ef-14a19cceec3a" xlink:to="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_1a977609-3cf7-4839-8d8c-976189a35c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_HeldToMaturitySecurities_1a977609-3cf7-4839-8d8c-976189a35c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_429b308a-e4a8-4073-bac0-7c6a3d8895f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_429b308a-e4a8-4073-bac0-7c6a3d8895f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_a9a57e29-2558-48fb-80ee-cf526f13c480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_MarketableSecurities_a9a57e29-2558-48fb-80ee-cf526f13c480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent_41fd5a22-679c-454d-ae56-e58f00e53488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesCurrent_41fd5a22-679c-454d-ae56-e58f00e53488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_2e7edf8b-df9f-4714-900f-7c55d634b2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_2e7edf8b-df9f-4714-900f-7c55d634b2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_4a8b36dc-610d-4ba6-a335-30ea7a2f5806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_4a8b36dc-610d-4ba6-a335-30ea7a2f5806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_bf6aa922-d516-4cfa-9578-ec3a318dd02a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_ce258f22-cb40-435c-8685-c94dc007745e" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_bf6aa922-d516-4cfa-9578-ec3a318dd02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#ShorttermandlongterminvestmentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_b1ef7c48-06a7-41af-b6e2-cc9beab99431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_de4ff842-4af7-4f22-9aa6-7e0ae3d6e70a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_b1ef7c48-06a7-41af-b6e2-cc9beab99431" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_de4ff842-4af7-4f22-9aa6-7e0ae3d6e70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_888aad40-6844-42b4-8f68-36d0424ae591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_de4ff842-4af7-4f22-9aa6-7e0ae3d6e70a" xlink:to="loc_us-gaap_InvestmentTypeAxis_888aad40-6844-42b4-8f68-36d0424ae591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_db8d5dcb-f9c8-464a-adca-651fb19969c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_888aad40-6844-42b4-8f68-36d0424ae591" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_db8d5dcb-f9c8-464a-adca-651fb19969c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_69bf1867-4ae3-4653-8dfe-55d74a3f8988" xlink:href="dva-20211231.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_db8d5dcb-f9c8-464a-adca-651fb19969c2" xlink:to="loc_dva_MutualFundsAndCommonStockMember_69bf1867-4ae3-4653-8dfe-55d74a3f8988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_14c66b5b-01ce-44e6-948c-8f9239e134fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_de4ff842-4af7-4f22-9aa6-7e0ae3d6e70a" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_14c66b5b-01ce-44e6-948c-8f9239e134fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a0bc3b10-9c11-4f35-af07-21e699d16f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_14c66b5b-01ce-44e6-948c-8f9239e134fa" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a0bc3b10-9c11-4f35-af07-21e699d16f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_9c0a9ae2-9c0b-41eb-854c-7c66de0b1b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_14c66b5b-01ce-44e6-948c-8f9239e134fa" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_9c0a9ae2-9c0b-41eb-854c-7c66de0b1b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities_71c1ca7c-ea8c-47ba-8c7a-42fe161b8635" xlink:href="dva-20211231.xsd#dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_14c66b5b-01ce-44e6-948c-8f9239e134fa" xlink:to="loc_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities_71c1ca7c-ea8c-47ba-8c7a-42fe161b8635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_beb27440-b596-4010-a206-795159a8feb6" xlink:href="dva-20211231.xsd#dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_14c66b5b-01ce-44e6-948c-8f9239e134fa" xlink:to="loc_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities_beb27440-b596-4010-a206-795159a8feb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherReceivablesOtherReceivables" xlink:type="simple" xlink:href="dva-20211231.xsd#OtherReceivablesOtherReceivables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OtherReceivablesOtherReceivables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_a95e24a9-45c1-4b5b-9e18-b1201b027b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_b5568786-5715-41cd-9edf-dac37eb7dc17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_a95e24a9-45c1-4b5b-9e18-b1201b027b1c" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_b5568786-5715-41cd-9edf-dac37eb7dc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherReceivablesTables" xlink:type="simple" xlink:href="dva-20211231.xsd#OtherReceivablesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OtherReceivablesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_883951b8-3072-43e4-8efa-75d506623a18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfOtherReceivablesTableTextBlock_be7b95fa-1b82-4d3c-82ff-9b418dc73512" xlink:href="dva-20211231.xsd#dva_ScheduleOfOtherReceivablesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_883951b8-3072-43e4-8efa-75d506623a18" xlink:to="loc_dva_ScheduleOfOtherReceivablesTableTextBlock_be7b95fa-1b82-4d3c-82ff-9b418dc73512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherReceivablesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#OtherReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OtherReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_52b430af-db23-4f58-a193-cc46e72ae1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_9cbc8d4d-1f08-469f-bb89-c65419cc003f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_52b430af-db23-4f58-a193-cc46e72ae1be" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_9cbc8d4d-1f08-469f-bb89-c65419cc003f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_34bc5615-01f0-44b5-8dec-c308c10249ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_9cbc8d4d-1f08-469f-bb89-c65419cc003f" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_34bc5615-01f0-44b5-8dec-c308c10249ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_4a2088e1-cbb1-451c-990d-4551b60c76d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_34bc5615-01f0-44b5-8dec-c308c10249ab" xlink:to="loc_us-gaap_ReceivableTypeDomain_4a2088e1-cbb1-451c-990d-4551b60c76d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_001d484f-a7ee-4404-9ced-fe45574962d5" xlink:href="dva-20211231.xsd#dva_SupplierRebatesAndOtherNonTradeReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_4a2088e1-cbb1-451c-990d-4551b60c76d3" xlink:to="loc_dva_SupplierRebatesAndOtherNonTradeReceivablesMember_001d484f-a7ee-4404-9ced-fe45574962d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareMember_1c13f8ce-95cd-42df-8c62-586ce8dcffa0" xlink:href="dva-20211231.xsd#dva_MedicareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_4a2088e1-cbb1-451c-990d-4551b60c76d3" xlink:to="loc_dva_MedicareMember_1c13f8ce-95cd-42df-8c62-586ce8dcffa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d567513f-1bdd-4223-92e6-c5e1133f3e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_9cbc8d4d-1f08-469f-bb89-c65419cc003f" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d567513f-1bdd-4223-92e6-c5e1133f3e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_b2074849-71be-4866-b051-713c5ecaa080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d567513f-1bdd-4223-92e6-c5e1133f3e4e" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_b2074849-71be-4866-b051-713c5ecaa080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="dva-20211231.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_88a54afe-1d00-4c72-a2f9-35b8c36d2ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_13ffdc54-7c62-4e5a-b56e-20f796f550aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_88a54afe-1d00-4c72-a2f9-35b8c36d2ef3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_13ffdc54-7c62-4e5a-b56e-20f796f550aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="dva-20211231.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f080479d-13d4-491d-87bd-a0d29586a615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_671efb7c-a91d-468d-9c9d-515671946b43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f080479d-13d4-491d-87bd-a0d29586a615" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_671efb7c-a91d-468d-9c9d-515671946b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#PropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40fba755-2059-46d3-8f03-926c7c5365e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_309482d1-e36a-4a91-9bc5-be0e4e890117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40fba755-2059-46d3-8f03-926c7c5365e4" xlink:to="loc_us-gaap_Land_309482d1-e36a-4a91-9bc5-be0e4e890117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_bd1e307b-a67f-455d-b4e7-c7c6bc6952fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40fba755-2059-46d3-8f03-926c7c5365e4" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_bd1e307b-a67f-455d-b4e7-c7c6bc6952fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_b990a70c-24cf-4038-9a80-a7cec2f42076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40fba755-2059-46d3-8f03-926c7c5365e4" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_b990a70c-24cf-4038-9a80-a7cec2f42076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_21d79c65-53f3-4b2b-8c10-a190b6e63407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40fba755-2059-46d3-8f03-926c7c5365e4" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_21d79c65-53f3-4b2b-8c10-a190b6e63407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_60e69a80-e409-448e-b97b-0f03d66cafa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40fba755-2059-46d3-8f03-926c7c5365e4" xlink:to="loc_us-gaap_ConstructionInProgressGross_60e69a80-e409-448e-b97b-0f03d66cafa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6e6fd6ad-4922-4e5a-a1cf-613228c179ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40fba755-2059-46d3-8f03-926c7c5365e4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6e6fd6ad-4922-4e5a-a1cf-613228c179ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e082ddd2-c7f5-47a7-a31e-f06a5a4ea378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40fba755-2059-46d3-8f03-926c7c5365e4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e082ddd2-c7f5-47a7-a31e-f06a5a4ea378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a526a17a-0f13-467d-8cb5-264d85bb84f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_40fba755-2059-46d3-8f03-926c7c5365e4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a526a17a-0f13-467d-8cb5-264d85bb84f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#PropertyandEquipmentAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ed0eb7f0-b51e-4e65-985b-31b46481185a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9b384d59-6064-48f1-afe0-7d41d867cd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ed0eb7f0-b51e-4e65-985b-31b46481185a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9b384d59-6064-48f1-afe0-7d41d867cd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f36a71f-b6ea-48c2-afdd-3429129a0399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9b384d59-6064-48f1-afe0-7d41d867cd1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f36a71f-b6ea-48c2-afdd-3429129a0399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b0a0638c-feb8-4801-b2f5-a3f6c6955782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f36a71f-b6ea-48c2-afdd-3429129a0399" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b0a0638c-feb8-4801-b2f5-a3f6c6955782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_26b647d5-62b9-4733-96f4-157e12935cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b0a0638c-feb8-4801-b2f5-a3f6c6955782" xlink:to="loc_us-gaap_BuildingMember_26b647d5-62b9-4733-96f4-157e12935cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_55e06146-f56e-4c38-8cf2-4e6b9f0ff12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b0a0638c-feb8-4801-b2f5-a3f6c6955782" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_55e06146-f56e-4c38-8cf2-4e6b9f0ff12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_b52647e5-1f82-410f-a8c8-e24113eaef3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b0a0638c-feb8-4801-b2f5-a3f6c6955782" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_b52647e5-1f82-410f-a8c8-e24113eaef3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9613fae5-b4fb-40a9-869b-62d0bd104193" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9b384d59-6064-48f1-afe0-7d41d867cd1b" xlink:to="loc_srt_RangeAxis_9613fae5-b4fb-40a9-869b-62d0bd104193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bf4506ad-2f25-4650-9734-3261d2796f67" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9613fae5-b4fb-40a9-869b-62d0bd104193" xlink:to="loc_srt_RangeMember_bf4506ad-2f25-4650-9734-3261d2796f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7ad0e20e-bf79-4154-b034-a9b7d490dc12" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bf4506ad-2f25-4650-9734-3261d2796f67" xlink:to="loc_srt_MinimumMember_7ad0e20e-bf79-4154-b034-a9b7d490dc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5c573b6a-3543-4480-8d36-189cacbd79d2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bf4506ad-2f25-4650-9734-3261d2796f67" xlink:to="loc_srt_MaximumMember_5c573b6a-3543-4480-8d36-189cacbd79d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_46289b90-a619-4167-bb03-9b02db80977f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9b384d59-6064-48f1-afe0-7d41d867cd1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_46289b90-a619-4167-bb03-9b02db80977f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f0d558cf-e646-481d-99db-79d0cce1e462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_46289b90-a619-4167-bb03-9b02db80977f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f0d558cf-e646-481d-99db-79d0cce1e462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f58ec251-f145-428c-999a-019a43e1bf31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_46289b90-a619-4167-bb03-9b02db80977f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f58ec251-f145-428c-999a-019a43e1bf31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_71021695-b1bd-40c3-8a65-8a9e751385e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_46289b90-a619-4167-bb03-9b02db80977f" xlink:to="loc_us-gaap_InterestCostsCapitalized_71021695-b1bd-40c3-8a65-8a9e751385e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Intangibles" xlink:type="simple" xlink:href="dva-20211231.xsd#Intangibles"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Intangibles" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_172202d6-fe50-446b-9aac-8077456ba90e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_7f2c1e35-99f4-4f64-be6e-1a7841594c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_172202d6-fe50-446b-9aac-8077456ba90e" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_7f2c1e35-99f4-4f64-be6e-1a7841594c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesTables" xlink:type="simple" xlink:href="dva-20211231.xsd#IntangiblesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IntangiblesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_47c2009a-4804-4f7c-aa01-26abb377209e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock_5d393d91-5f08-42b2-9b10-09d9f511f8d2" xlink:href="dva-20211231.xsd#dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_47c2009a-4804-4f7c-aa01-26abb377209e" xlink:to="loc_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock_5d393d91-5f08-42b2-9b10-09d9f511f8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_17a92cf5-4215-4420-95d9-a16af981bcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_47c2009a-4804-4f7c-aa01-26abb377209e" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_17a92cf5-4215-4420-95d9-a16af981bcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88f0e1da-82ba-4dc2-a7bf-ac024a550ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c73656a0-d6f9-49f3-977e-05d793d3dbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88f0e1da-82ba-4dc2-a7bf-ac024a550ab2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c73656a0-d6f9-49f3-977e-05d793d3dbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross_ff9d45f5-abf9-47ad-9eba-51cc2bd47408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedNoncompeteAgreementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88f0e1da-82ba-4dc2-a7bf-ac024a550ab2" xlink:to="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross_ff9d45f5-abf9-47ad-9eba-51cc2bd47408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_d375bd99-df56-4784-8fc7-80915810d8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88f0e1da-82ba-4dc2-a7bf-ac024a550ab2" xlink:to="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_d375bd99-df56-4784-8fc7-80915810d8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_98671391-cbca-42d2-9d61-141b937eaac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88f0e1da-82ba-4dc2-a7bf-ac024a550ab2" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_98671391-cbca-42d2-9d61-141b937eaac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1d79083c-de3e-4d72-9a74-0879622781e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88f0e1da-82ba-4dc2-a7bf-ac024a550ab2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1d79083c-de3e-4d72-9a74-0879622781e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4a349df1-de49-4bb1-a4d6-45525fe63db4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88f0e1da-82ba-4dc2-a7bf-ac024a550ab2" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4a349df1-de49-4bb1-a4d6-45525fe63db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_04f06c8f-1da6-4f35-907c-1dda8f969aba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExpectedAmortizationExpenseTable_2029d46f-68f3-4792-ba2a-873cb9afd8ea" xlink:href="dva-20211231.xsd#dva_ExpectedAmortizationExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_04f06c8f-1da6-4f35-907c-1dda8f969aba" xlink:to="loc_dva_ExpectedAmortizationExpenseTable_2029d46f-68f3-4792-ba2a-873cb9afd8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_162c6490-9130-4dea-82ee-b642591d1abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseTable_2029d46f-68f3-4792-ba2a-873cb9afd8ea" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_162c6490-9130-4dea-82ee-b642591d1abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cff08d36-acaf-46d1-8bee-983b7afc5afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_162c6490-9130-4dea-82ee-b642591d1abd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cff08d36-acaf-46d1-8bee-983b7afc5afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_78bb986c-bf4f-4505-8546-79eec7a3c814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cff08d36-acaf-46d1-8bee-983b7afc5afa" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_78bb986c-bf4f-4505-8546-79eec7a3c814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_0134707a-ca40-4f35-835a-8c7c471d57c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cff08d36-acaf-46d1-8bee-983b7afc5afa" xlink:to="loc_us-gaap_ServiceAgreementsMember_0134707a-ca40-4f35-835a-8c7c471d57c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:href="dva-20211231.xsd#dva_ExpectedAmortizationExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseTable_2029d46f-68f3-4792-ba2a-873cb9afd8ea" xlink:to="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_191186ab-e495-464e-bb9f-dfecf2ebce65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_191186ab-e495-464e-bb9f-dfecf2ebce65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0b79da38-ee62-4033-be58-227368ee20ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0b79da38-ee62-4033-be58-227368ee20ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_28eaf053-ee4a-4b75-ad96-845bdb50c07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_28eaf053-ee4a-4b75-ad96-845bdb50c07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e9319c35-2857-40cc-bbd9-19df6cde9f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e9319c35-2857-40cc-bbd9-19df6cde9f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3770107b-0c09-43cd-8695-2809bc88ecfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3770107b-0c09-43cd-8695-2809bc88ecfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5b4f25cb-6a57-4b7a-ab0c-b6bf306c2a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5b4f25cb-6a57-4b7a-ab0c-b6bf306c2a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eb68b9e2-4e4c-482e-906a-a6b8a81512ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ExpectedAmortizationExpenseLineItems_f1a0dee3-d161-4c54-a336-c2ea8e516aeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eb68b9e2-4e4c-482e-906a-a6b8a81512ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IntangiblesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IntangiblesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IntangiblesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a589cb08-fec4-48e1-b2d4-14d9930ebe6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6bf3f05-ce3b-49d7-827a-563e3e2f9ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a589cb08-fec4-48e1-b2d4-14d9930ebe6c" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6bf3f05-ce3b-49d7-827a-563e3e2f9ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_79d6b280-19ad-445b-978b-f281b956dcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6bf3f05-ce3b-49d7-827a-563e3e2f9ee3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_79d6b280-19ad-445b-978b-f281b956dcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9833ea78-90e4-43e8-90a7-909021a117d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_79d6b280-19ad-445b-978b-f281b956dcc1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9833ea78-90e4-43e8-90a7-909021a117d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_12a3e97f-7ee8-4285-8b6f-7327f366b1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9833ea78-90e4-43e8-90a7-909021a117d7" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_12a3e97f-7ee8-4285-8b6f-7327f366b1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1b0ae378-104e-46e6-92b6-9cf3098632e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9833ea78-90e4-43e8-90a7-909021a117d7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1b0ae378-104e-46e6-92b6-9cf3098632e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5b6015dc-2db0-471b-8c6b-73b15fbf567f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6bf3f05-ce3b-49d7-827a-563e3e2f9ee3" xlink:to="loc_srt_RangeAxis_5b6015dc-2db0-471b-8c6b-73b15fbf567f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9c6d1afb-1a4e-4ec8-90d5-802e9f884a89" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5b6015dc-2db0-471b-8c6b-73b15fbf567f" xlink:to="loc_srt_RangeMember_9c6d1afb-1a4e-4ec8-90d5-802e9f884a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a98d05b3-55cc-4236-9f6c-fcd31b662b4c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9c6d1afb-1a4e-4ec8-90d5-802e9f884a89" xlink:to="loc_srt_MinimumMember_a98d05b3-55cc-4236-9f6c-fcd31b662b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_85a9e962-c59f-42ad-a6e1-4f9986a37e54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9c6d1afb-1a4e-4ec8-90d5-802e9f884a89" xlink:to="loc_srt_MaximumMember_85a9e962-c59f-42ad-a6e1-4f9986a37e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d3b67a14-cbfd-4a7c-ba21-65832664e12e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e6bf3f05-ce3b-49d7-827a-563e3e2f9ee3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d3b67a14-cbfd-4a7c-ba21-65832664e12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_0e064cda-62b1-4413-b6bf-f4bd24c8a995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d3b67a14-cbfd-4a7c-ba21-65832664e12e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_0e064cda-62b1-4413-b6bf-f4bd24c8a995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_6ba6d6a6-5f11-4fc6-9d7c-245f8afec050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d3b67a14-cbfd-4a7c-ba21-65832664e12e" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension_6ba6d6a6-5f11-4fc6-9d7c-245f8afec050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9ff5cb52-d423-44f8-acfc-85eb5bcfb935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d3b67a14-cbfd-4a7c-ba21-65832664e12e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9ff5cb52-d423-44f8-acfc-85eb5bcfb935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_d061016d-1d4f-45e2-aaf1-fcbc063231fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d3b67a14-cbfd-4a7c-ba21-65832664e12e" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_d061016d-1d4f-45e2-aaf1-fcbc063231fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestments" xlink:type="simple" xlink:href="dva-20211231.xsd#EquityMethodandOtherInvestments"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f7573c35-a925-4164-89ab-3dc918dcd76c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_43a7fab8-f21d-4c33-9d31-81ed37040b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f7573c35-a925-4164-89ab-3dc918dcd76c" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_43a7fab8-f21d-4c33-9d31-81ed37040b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables" xlink:type="simple" xlink:href="dva-20211231.xsd#EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a21f24a5-bd96-4d7f-898c-e29401a7097b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_b4e199e8-90f1-4180-8792-31000a6933f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a21f24a5-bd96-4d7f-898c-e29401a7097b" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_b4e199e8-90f1-4180-8792-31000a6933f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_d8f0b9b2-e00b-4252-b12c-f7499119121f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ddaf7b56-7264-4f83-87e1-4131ceecfcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_d8f0b9b2-e00b-4252-b12c-f7499119121f" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ddaf7b56-7264-4f83-87e1-4131ceecfcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1ed50249-42a1-45a3-b979-051b75e36021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ddaf7b56-7264-4f83-87e1-4131ceecfcd6" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1ed50249-42a1-45a3-b979-051b75e36021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_a53b4645-7fbb-4f1d-8cf2-bd7caad1c10f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1ed50249-42a1-45a3-b979-051b75e36021" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_a53b4645-7fbb-4f1d-8cf2-bd7caad1c10f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOwnershipInterestMember_a7c8a1d7-8177-40b0-8525-bfb5938870dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOwnershipInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_a53b4645-7fbb-4f1d-8cf2-bd7caad1c10f" xlink:to="loc_us-gaap_OtherOwnershipInterestMember_a7c8a1d7-8177-40b0-8525-bfb5938870dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ff85928d-4234-4aa4-b5ee-75303c5883e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ddaf7b56-7264-4f83-87e1-4131ceecfcd6" xlink:to="loc_us-gaap_InvestmentTypeAxis_ff85928d-4234-4aa4-b5ee-75303c5883e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8c0563cd-90f4-4025-89f7-69afa9f9d4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_ff85928d-4234-4aa4-b5ee-75303c5883e1" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8c0563cd-90f4-4025-89f7-69afa9f9d4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_6d329473-fa51-4ccc-a18a-8361f3afeef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8c0563cd-90f4-4025-89f7-69afa9f9d4a9" xlink:to="loc_us-gaap_EquitySecuritiesMember_6d329473-fa51-4ccc-a18a-8361f3afeef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_8d96f101-c0a5-4b4b-a0d5-4f7dfac9edae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ddaf7b56-7264-4f83-87e1-4131ceecfcd6" xlink:to="loc_srt_OwnershipAxis_8d96f101-c0a5-4b4b-a0d5-4f7dfac9edae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_a9d93811-dac5-4754-83ca-93a295fc14e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_8d96f101-c0a5-4b4b-a0d5-4f7dfac9edae" xlink:to="loc_srt_OwnershipDomain_a9d93811-dac5-4754-83ca-93a295fc14e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeconsolidatedNoncontrollingEntityMember_4947b45d-3d50-4b1e-968e-23635ed22713" xlink:href="dva-20211231.xsd#dva_DeconsolidatedNoncontrollingEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_a9d93811-dac5-4754-83ca-93a295fc14e9" xlink:to="loc_dva_DeconsolidatedNoncontrollingEntityMember_4947b45d-3d50-4b1e-968e-23635ed22713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3a6c1f01-dff5-4543-aab1-39657bec4909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ddaf7b56-7264-4f83-87e1-4131ceecfcd6" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3a6c1f01-dff5-4543-aab1-39657bec4909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0f372f4f-f511-43fd-a88e-279bfd62caba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3a6c1f01-dff5-4543-aab1-39657bec4909" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0f372f4f-f511-43fd-a88e-279bfd62caba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#EquityMethodandOtherInvestmentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_0a89396a-ee58-46af-8a71-726b97119c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_cbb2cb74-d977-47ce-8d89-40a59d0f7397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_0a89396a-ee58-46af-8a71-726b97119c7d" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_cbb2cb74-d977-47ce-8d89-40a59d0f7397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_62fcc4e8-d7d4-46d5-8a1c-9b45ced07de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_cbb2cb74-d977-47ce-8d89-40a59d0f7397" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_62fcc4e8-d7d4-46d5-8a1c-9b45ced07de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_2feda846-fe6d-43a5-8038-5199c34c91b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_62fcc4e8-d7d4-46d5-8a1c-9b45ced07de0" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_2feda846-fe6d-43a5-8038-5199c34c91b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_854e5986-e077-4486-ba46-6c901670187c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_2feda846-fe6d-43a5-8038-5199c34c91b7" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember_854e5986-e077-4486-ba46-6c901670187c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0b6cc3f5-b42f-44a1-8ca2-ca88244be20f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_cbb2cb74-d977-47ce-8d89-40a59d0f7397" xlink:to="loc_srt_RangeAxis_0b6cc3f5-b42f-44a1-8ca2-ca88244be20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_087dcf65-2ac3-4c18-ad6e-ce7574fdccf8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0b6cc3f5-b42f-44a1-8ca2-ca88244be20f" xlink:to="loc_srt_RangeMember_087dcf65-2ac3-4c18-ad6e-ce7574fdccf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_df45bf5d-c50e-4e93-b018-e56caf36290d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_087dcf65-2ac3-4c18-ad6e-ce7574fdccf8" xlink:to="loc_srt_MinimumMember_df45bf5d-c50e-4e93-b018-e56caf36290d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bc7fb2ca-76e6-4b8e-b65f-23f8b6495c1c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_087dcf65-2ac3-4c18-ad6e-ce7574fdccf8" xlink:to="loc_srt_MaximumMember_bc7fb2ca-76e6-4b8e-b65f-23f8b6495c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_5313b733-2b53-4594-b2a2-b1785cf01624" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_cbb2cb74-d977-47ce-8d89-40a59d0f7397" xlink:to="loc_srt_OwnershipAxis_5313b733-2b53-4594-b2a2-b1785cf01624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_bd837cc9-7e00-4439-92c2-c41ffd676a15" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_5313b733-2b53-4594-b2a2-b1785cf01624" xlink:to="loc_srt_OwnershipDomain_bd837cc9-7e00-4439-92c2-c41ffd676a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ParentCompanyAndRestrictedSubsidiariesMember_d83601b1-3ca3-4656-9b83-8e1376a2a655" xlink:href="dva-20211231.xsd#dva_ParentCompanyAndRestrictedSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_bd837cc9-7e00-4439-92c2-c41ffd676a15" xlink:to="loc_dva_ParentCompanyAndRestrictedSubsidiariesMember_d83601b1-3ca3-4656-9b83-8e1376a2a655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeconsolidatedNoncontrollingEntityMember_b834a350-64d3-4b77-a33e-cb1137358728" xlink:href="dva-20211231.xsd#dva_DeconsolidatedNoncontrollingEntityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_bd837cc9-7e00-4439-92c2-c41ffd676a15" xlink:to="loc_dva_DeconsolidatedNoncontrollingEntityMember_b834a350-64d3-4b77-a33e-cb1137358728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_cbb2cb74-d977-47ce-8d89-40a59d0f7397" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1d06327b-0f2f-4338-8e3f-3f5b45dd7640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1d06327b-0f2f-4338-8e3f-3f5b45dd7640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_46c1e978-92a4-4548-bb55-f5c469d7ce79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_46c1e978-92a4-4548-bb55-f5c469d7ce79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8d8b87ed-4367-4044-aca5-709ebdc661fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8d8b87ed-4367-4044-aca5-709ebdc661fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NumberOfPartnerships_1966dfff-fc4d-4457-99ba-84a20345748f" xlink:href="dva-20211231.xsd#dva_NumberOfPartnerships"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:to="loc_dva_NumberOfPartnerships_1966dfff-fc4d-4457-99ba-84a20345748f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_8dee773d-104e-461a-ba2b-6d2c8d189074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_286d77b5-d5c8-47f9-abe4-ccd6a0cb78d0" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_8dee773d-104e-461a-ba2b-6d2c8d189074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Goodwill" xlink:type="simple" xlink:href="dva-20211231.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6a9807d2-d57d-43c1-a173-812154e488a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_55a64582-5a28-48b7-807b-22382578425d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6a9807d2-d57d-43c1-a173-812154e488a8" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_55a64582-5a28-48b7-807b-22382578425d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillTables" xlink:type="simple" xlink:href="dva-20211231.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8085a7bf-8b9b-47eb-a635-af601efc9890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_c7d42df4-ed45-47f6-95ee-fb80987033c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8085a7bf-8b9b-47eb-a635-af601efc9890" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_c7d42df4-ed45-47f6-95ee-fb80987033c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock_4cf2e348-afb3-43e8-bad4-8e1af0d7a2a8" xlink:href="dva-20211231.xsd#dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8085a7bf-8b9b-47eb-a635-af601efc9890" xlink:to="loc_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock_4cf2e348-afb3-43e8-bad4-8e1af0d7a2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_999ffeca-e2aa-4a48-82aa-75c8329f6370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_b1e4a7ef-b5fd-4e3c-929a-99be472ec789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_999ffeca-e2aa-4a48-82aa-75c8329f6370" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_b1e4a7ef-b5fd-4e3c-929a-99be472ec789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ad7dbe8c-64a9-40ef-868b-0d6051631690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_b1e4a7ef-b5fd-4e3c-929a-99be472ec789" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ad7dbe8c-64a9-40ef-868b-0d6051631690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_799cc35c-ff22-4491-9403-01b72706aea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ad7dbe8c-64a9-40ef-868b-0d6051631690" xlink:to="loc_us-gaap_SegmentDomain_799cc35c-ff22-4491-9403-01b72706aea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_89cb5fca-84f6-4491-a069-42afcf27957e" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_799cc35c-ff22-4491-9403-01b72706aea9" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_89cb5fca-84f6-4491-a069-42afcf27957e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_82600e5d-8d99-40ec-ab8f-c5cdd08638d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_799cc35c-ff22-4491-9403-01b72706aea9" xlink:to="loc_us-gaap_AllOtherSegmentsMember_82600e5d-8d99-40ec-ab8f-c5cdd08638d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_77de9372-b212-40f4-a29d-0e408b8a8c89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_b1e4a7ef-b5fd-4e3c-929a-99be472ec789" xlink:to="loc_us-gaap_GoodwillLineItems_77de9372-b212-40f4-a29d-0e408b8a8c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_69df8142-ac54-420b-8fc4-ae2adbfffaac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_77de9372-b212-40f4-a29d-0e408b8a8c89" xlink:to="loc_us-gaap_GoodwillRollForward_69df8142-ac54-420b-8fc4-ae2adbfffaac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_91138be6-e685-4053-a8ad-172e057b5ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_69df8142-ac54-420b-8fc4-ae2adbfffaac" xlink:to="loc_us-gaap_Goodwill_91138be6-e685-4053-a8ad-172e057b5ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_352b4cc2-5879-4f00-8239-58c9921c9e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_69df8142-ac54-420b-8fc4-ae2adbfffaac" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_352b4cc2-5879-4f00-8239-58c9921c9e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_00283302-9fcc-4ebe-9cf3-9901b9518b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_69df8142-ac54-420b-8fc4-ae2adbfffaac" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_00283302-9fcc-4ebe-9cf3-9901b9518b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d37bf0e5-996f-4ce8-a4fb-8de842e62b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_69df8142-ac54-420b-8fc4-ae2adbfffaac" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d37bf0e5-996f-4ce8-a4fb-8de842e62b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_17bccde1-4f01-43fd-b66f-d9dcf00b5cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_69df8142-ac54-420b-8fc4-ae2adbfffaac" xlink:to="loc_us-gaap_Goodwill_17bccde1-4f01-43fd-b66f-d9dcf00b5cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_cc0cec36-9e9e-4301-8fcc-96c6d5528b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_77de9372-b212-40f4-a29d-0e408b8a8c89" xlink:to="loc_us-gaap_GoodwillGross_cc0cec36-9e9e-4301-8fcc-96c6d5528b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c80593c4-3af7-41e7-8866-51aa2075fcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_77de9372-b212-40f4-a29d-0e408b8a8c89" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c80593c4-3af7-41e7-8866-51aa2075fcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_abc938bf-6add-495b-b395-caffc139a18b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_1510b27f-7e0c-473a-acf6-8aa18030b0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_abc938bf-6add-495b-b395-caffc139a18b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_1510b27f-7e0c-473a-acf6-8aa18030b0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e568b855-957d-4a97-8744-430f86f521de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1510b27f-7e0c-473a-acf6-8aa18030b0cb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e568b855-957d-4a97-8744-430f86f521de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_26f851ad-5e5d-4d71-849e-4a902509a042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e568b855-957d-4a97-8744-430f86f521de" xlink:to="loc_us-gaap_SegmentDomain_26f851ad-5e5d-4d71-849e-4a902509a042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_KidneyCareMember_4d0d9a06-5c15-4b86-9de3-c58388efbfe9" xlink:href="dva-20211231.xsd#dva_KidneyCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_26f851ad-5e5d-4d71-849e-4a902509a042" xlink:to="loc_dva_KidneyCareMember_4d0d9a06-5c15-4b86-9de3-c58388efbfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_42abc180-01e9-480b-af3f-c5b2fe355f1d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1510b27f-7e0c-473a-acf6-8aa18030b0cb" xlink:to="loc_srt_StatementGeographicalAxis_42abc180-01e9-480b-af3f-c5b2fe355f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fa95c7d1-13f6-4efb-8c04-78c36298995a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_42abc180-01e9-480b-af3f-c5b2fe355f1d" xlink:to="loc_srt_SegmentGeographicalDomain_fa95c7d1-13f6-4efb-8c04-78c36298995a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_30eed63a-ab75-45e7-97d3-e1fc0ea7dd24" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_fa95c7d1-13f6-4efb-8c04-78c36298995a" xlink:to="loc_country_DE_30eed63a-ab75-45e7-97d3-e1fc0ea7dd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1510b27f-7e0c-473a-acf6-8aa18030b0cb" xlink:to="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_33b1b4f7-6fb7-4d08-a424-1e93ba1b80cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:to="loc_us-gaap_Goodwill_33b1b4f7-6fb7-4d08-a424-1e93ba1b80cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_c26d7c7d-47cc-43bf-9666-74c92bfb0ace" xlink:href="dva-20211231.xsd#dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:to="loc_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount_c26d7c7d-47cc-43bf-9666-74c92bfb0ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_902b822c-e6bc-4834-b2de-ff0169bca632" xlink:href="dva-20211231.xsd#dva_PotentialImpactOnFairValueForReductionInOperatingIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:to="loc_dva_PotentialImpactOnFairValueForReductionInOperatingIncome_902b822c-e6bc-4834-b2de-ff0169bca632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_0208fce2-fc38-4b63-bb08-c53b080fc5f7" xlink:href="dva-20211231.xsd#dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:to="loc_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate_0208fce2-fc38-4b63-bb08-c53b080fc5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_b46d59b4-42c8-42ae-a760-b07854ff06de" xlink:href="dva-20211231.xsd#dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:to="loc_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_b46d59b4-42c8-42ae-a760-b07854ff06de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_9c4e9cb9-62a7-42bb-9d6c-acbd90d63ee4" xlink:href="dva-20211231.xsd#dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_469e746b-0867-49fb-b5b6-cf1d70712201" xlink:to="loc_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment_9c4e9cb9-62a7-42bb-9d6c-acbd90d63ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#GoodwillAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_23426aa2-d234-4c3d-870b-9533ae76d31f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5fc443e8-c933-4c35-9968-947adee51975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_23426aa2-d234-4c3d-870b-9533ae76d31f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5fc443e8-c933-4c35-9968-947adee51975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8095372a-ecf8-4dac-a1c4-57a99d5a80aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5fc443e8-c933-4c35-9968-947adee51975" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8095372a-ecf8-4dac-a1c4-57a99d5a80aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cd251232-1ed4-4d19-8ad3-d1bb91b75123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8095372a-ecf8-4dac-a1c4-57a99d5a80aa" xlink:to="loc_us-gaap_SegmentDomain_cd251232-1ed4-4d19-8ad3-d1bb91b75123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember_5accc6fb-20a7-457d-a36b-9dd7ad3dcc1f" xlink:href="dva-20211231.xsd#dva_OtherReportingUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cd251232-1ed4-4d19-8ad3-d1bb91b75123" xlink:to="loc_dva_OtherReportingUnitsMember_5accc6fb-20a7-457d-a36b-9dd7ad3dcc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_KidneyCareMember_e2089486-1cb6-4905-a91e-b27466f873df" xlink:href="dva-20211231.xsd#dva_KidneyCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cd251232-1ed4-4d19-8ad3-d1bb91b75123" xlink:to="loc_dva_KidneyCareMember_e2089486-1cb6-4905-a91e-b27466f873df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_103fbcc3-938e-4d17-90c3-2bb979edaad1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5fc443e8-c933-4c35-9968-947adee51975" xlink:to="loc_srt_StatementGeographicalAxis_103fbcc3-938e-4d17-90c3-2bb979edaad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6239402b-e947-46f9-a1ea-696308fcdf75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_103fbcc3-938e-4d17-90c3-2bb979edaad1" xlink:to="loc_srt_SegmentGeographicalDomain_6239402b-e947-46f9-a1ea-696308fcdf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_bb6ea5bf-3d05-419d-a861-7bd3bb3977d7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6239402b-e947-46f9-a1ea-696308fcdf75" xlink:to="loc_country_DE_bb6ea5bf-3d05-419d-a861-7bd3bb3977d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_d5f3a8e0-39d0-43f6-bc5d-09070826cce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5fc443e8-c933-4c35-9968-947adee51975" xlink:to="loc_us-gaap_GoodwillLineItems_d5f3a8e0-39d0-43f6-bc5d-09070826cce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_6c745da3-2b3c-4c1c-bf32-d1d803eaea99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d5f3a8e0-39d0-43f6-bc5d-09070826cce9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_6c745da3-2b3c-4c1c-bf32-d1d803eaea99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_6265197d-b80c-4cf9-a07b-410e7698496d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d5f3a8e0-39d0-43f6-bc5d-09070826cce9" xlink:to="loc_us-gaap_NumberOfOperatingSegments_6265197d-b80c-4cf9-a07b-410e7698496d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherLiabilities" xlink:type="simple" xlink:href="dva-20211231.xsd#OtherLiabilities"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OtherLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_2b76eee0-35d9-4a50-aace-c67c0f224202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_12d8928e-ff9c-4c8d-81b0-e75e3b85fc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_2b76eee0-35d9-4a50-aace-c67c0f224202" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_12d8928e-ff9c-4c8d-81b0-e75e3b85fc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherLiabilitiesTables" xlink:type="simple" xlink:href="dva-20211231.xsd#OtherLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OtherLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_3c569dea-f5e8-4b13-a329-9b913b38a1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock_5eb58e06-ecab-48ee-b505-2787c9b89db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_3c569dea-f5e8-4b13-a329-9b913b38a1ff" xlink:to="loc_us-gaap_OtherLiabilitiesTableTextBlock_5eb58e06-ecab-48ee-b505-2787c9b89db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/OtherLiabilitiesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#OtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/OtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_83b46e8b-6257-4c66-9b17-62ffc15cfb61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PayorRefundsAndRetractions_4e50050d-215d-4a2e-8121-7ccb29510eda" xlink:href="dva-20211231.xsd#dva_PayorRefundsAndRetractions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_83b46e8b-6257-4c66-9b17-62ffc15cfb61" xlink:to="loc_dva_PayorRefundsAndRetractions_4e50050d-215d-4a2e-8121-7ccb29510eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_bb5a7458-ed6f-44bb-a239-ea2e33263617" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_83b46e8b-6257-4c66-9b17-62ffc15cfb61" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_bb5a7458-ed6f-44bb-a239-ea2e33263617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_047acc43-2182-4bdf-a2a4-ce26ee7a950e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_83b46e8b-6257-4c66-9b17-62ffc15cfb61" xlink:to="loc_us-gaap_InterestPayableCurrent_047acc43-2182-4bdf-a2a4-ce26ee7a950e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_6b1c6c73-5742-448f-b168-bad9c09b5569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_83b46e8b-6257-4c66-9b17-62ffc15cfb61" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_6b1c6c73-5742-448f-b168-bad9c09b5569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_f2d7ade4-ffa6-40f4-98af-cd4d24599bee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_83b46e8b-6257-4c66-9b17-62ffc15cfb61" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_f2d7ade4-ffa6-40f4-98af-cd4d24599bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e97bfd31-e6fe-4b84-8496-ea9d4f3095a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_83b46e8b-6257-4c66-9b17-62ffc15cfb61" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e97bfd31-e6fe-4b84-8496-ea9d4f3095a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxes" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6c05d0ae-80dc-45f3-806c-2580b65c172c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f24080c8-ffdc-41e1-a1d7-4ca6f32eefc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c05d0ae-80dc-45f3-806c-2580b65c172c" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f24080c8-ffdc-41e1-a1d7-4ca6f32eefc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b434e2f3-fa31-499e-882b-cb5fb584c482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_86aa87e2-ea09-4113-bcfe-c472c783ce86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b434e2f3-fa31-499e-882b-cb5fb584c482" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_86aa87e2-ea09-4113-bcfe-c472c783ce86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_a0235359-bf6b-4ae9-9eaa-874ffbe41a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b434e2f3-fa31-499e-882b-cb5fb584c482" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_a0235359-bf6b-4ae9-9eaa-874ffbe41a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock_e0d3b031-127a-4d9a-8d53-cbc4ae3a07fe" xlink:href="dva-20211231.xsd#dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b434e2f3-fa31-499e-882b-cb5fb584c482" xlink:to="loc_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock_e0d3b031-127a-4d9a-8d53-cbc4ae3a07fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9907cbc2-9841-4f21-bb5c-547a31eacc79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b434e2f3-fa31-499e-882b-cb5fb584c482" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9907cbc2-9841-4f21-bb5c-547a31eacc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_b4bcb02a-80de-4762-8f5d-62fe6eb248ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b434e2f3-fa31-499e-882b-cb5fb584c482" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_b4bcb02a-80de-4762-8f5d-62fe6eb248ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_46bc4c6c-1a0f-4301-b503-38050c927fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b434e2f3-fa31-499e-882b-cb5fb584c482" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_46bc4c6c-1a0f-4301-b503-38050c927fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_abe658a8-c4d4-42c8-aad5-e4cc73c49755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_09d2a94b-ef9b-4a13-9388-eefeba098dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_abe658a8-c4d4-42c8-aad5-e4cc73c49755" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_09d2a94b-ef9b-4a13-9388-eefeba098dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_57b715dd-9b74-450e-a430-f7bc4997a42b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_abe658a8-c4d4-42c8-aad5-e4cc73c49755" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_57b715dd-9b74-450e-a430-f7bc4997a42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_30e32ad2-178d-4fc8-8fd1-61218bbe5b35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_abe658a8-c4d4-42c8-aad5-e4cc73c49755" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_30e32ad2-178d-4fc8-8fd1-61218bbe5b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_45b40374-cec4-403f-b54d-ea9832c307ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8b72425e-2521-4186-abba-dcecad198901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_45b40374-cec4-403f-b54d-ea9832c307ed" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8b72425e-2521-4186-abba-dcecad198901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0b30cae5-35c4-4b1e-9497-9e6be9af4c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8b72425e-2521-4186-abba-dcecad198901" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0b30cae5-35c4-4b1e-9497-9e6be9af4c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9be2e248-c181-4dac-b317-2f495fcfcad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8b72425e-2521-4186-abba-dcecad198901" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9be2e248-c181-4dac-b317-2f495fcfcad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_128b6ce8-59d8-44c2-a3cc-3ab756370474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8b72425e-2521-4186-abba-dcecad198901" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_128b6ce8-59d8-44c2-a3cc-3ab756370474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1758c0a2-148d-482a-b171-74472f9deacf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_8b72425e-2521-4186-abba-dcecad198901" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1758c0a2-148d-482a-b171-74472f9deacf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_6d5c3648-4c0e-4f61-afc0-9d83b5221165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_45b40374-cec4-403f-b54d-ea9832c307ed" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_6d5c3648-4c0e-4f61-afc0-9d83b5221165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_faea0fe1-8461-42fb-a2cb-253cf1e2c3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_6d5c3648-4c0e-4f61-afc0-9d83b5221165" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_faea0fe1-8461-42fb-a2cb-253cf1e2c3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_f9fdd84a-78e1-431d-ac11-6eea234fad77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_6d5c3648-4c0e-4f61-afc0-9d83b5221165" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_f9fdd84a-78e1-431d-ac11-6eea234fad77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_a5bce544-defc-4e96-bbee-013517680520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_6d5c3648-4c0e-4f61-afc0-9d83b5221165" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_a5bce544-defc-4e96-bbee-013517680520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_e5a8aec9-4987-45b9-bbae-aef8ebe0e233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_6d5c3648-4c0e-4f61-afc0-9d83b5221165" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_e5a8aec9-4987-45b9-bbae-aef8ebe0e233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5f64f046-3b87-4036-b066-e0fdbcde982a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_45b40374-cec4-403f-b54d-ea9832c307ed" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5f64f046-3b87-4036-b066-e0fdbcde982a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_30ef9b6d-c77f-400b-a0e8-903743ed66f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b87b13f7-6665-4f31-aaca-04e87563e4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30ef9b6d-c77f-400b-a0e8-903743ed66f0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b87b13f7-6665-4f31-aaca-04e87563e4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_5cfd18fb-7a85-4aca-bd79-a730d1b30767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30ef9b6d-c77f-400b-a0e8-903743ed66f0" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod_5cfd18fb-7a85-4aca-bd79-a730d1b30767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_d40151fc-c9ce-49b0-a029-47b2d712cca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30ef9b6d-c77f-400b-a0e8-903743ed66f0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_d40151fc-c9ce-49b0-a029-47b2d712cca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8357f509-f1c4-4db3-bcbb-362bea0bd381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_876cc80f-efcc-4ce4-9265-da5608ff978c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8357f509-f1c4-4db3-bcbb-362bea0bd381" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_876cc80f-efcc-4ce4-9265-da5608ff978c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_87185b0a-3c00-4b92-bab2-cd37fbf69977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8357f509-f1c4-4db3-bcbb-362bea0bd381" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_87185b0a-3c00-4b92-bab2-cd37fbf69977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_03653493-cdf0-4a22-bc2e-09c260d23b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8357f509-f1c4-4db3-bcbb-362bea0bd381" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_03653493-cdf0-4a22-bc2e-09c260d23b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_686d6590-fa0e-4851-a330-c04198f872b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8357f509-f1c4-4db3-bcbb-362bea0bd381" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_686d6590-fa0e-4851-a330-c04198f872b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_e9a89706-a4ef-45d6-931f-30851a8c2c3d" xlink:href="dva-20211231.xsd#dva_EffectiveIncomeTaxReconciliationInvestmentImpairment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8357f509-f1c4-4db3-bcbb-362bea0bd381" xlink:to="loc_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment_e9a89706-a4ef-45d6-931f-30851a8c2c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_325a59f3-faab-4db1-ac01-e9f06032c220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8357f509-f1c4-4db3-bcbb-362bea0bd381" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_325a59f3-faab-4db1-ac01-e9f06032c220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_6be046a7-0da9-4f4b-9a3b-847336525384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8357f509-f1c4-4db3-bcbb-362bea0bd381" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_6be046a7-0da9-4f4b-9a3b-847336525384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_831a7a59-b662-423a-b413-3693c2808e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8357f509-f1c4-4db3-bcbb-362bea0bd381" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_831a7a59-b662-423a-b413-3693c2808e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_23f33f6e-65c3-49bd-a8ab-221467418120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8357f509-f1c4-4db3-bcbb-362bea0bd381" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_23f33f6e-65c3-49bd-a8ab-221467418120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_5e34e94e-f4de-4ad7-a592-7ffe1abac379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8357f509-f1c4-4db3-bcbb-362bea0bd381" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_5e34e94e-f4de-4ad7-a592-7ffe1abac379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ce38e195-8eea-4cf9-9415-c8bb5c291e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8357f509-f1c4-4db3-bcbb-362bea0bd381" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ce38e195-8eea-4cf9-9415-c8bb5c291e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_dd042398-4549-480e-94c2-adf0c619e013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesTable_e5505646-521d-4501-b17a-7ea8ccde7d16" xlink:href="dva-20211231.xsd#dva_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd042398-4549-480e-94c2-adf0c619e013" xlink:to="loc_dva_IncomeTaxesTable_e5505646-521d-4501-b17a-7ea8ccde7d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f58f26e0-a725-4aa4-844b-eb0716fe1a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesTable_e5505646-521d-4501-b17a-7ea8ccde7d16" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f58f26e0-a725-4aa4-844b-eb0716fe1a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a1b17ec0-b949-4809-8bd9-09bfdb305b85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f58f26e0-a725-4aa4-844b-eb0716fe1a03" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a1b17ec0-b949-4809-8bd9-09bfdb305b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxLiabilitiesMember_0a4879a7-38d9-46dc-b810-503a3285f575" xlink:href="dva-20211231.xsd#dva_DeferredTaxLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a1b17ec0-b949-4809-8bd9-09bfdb305b85" xlink:to="loc_dva_DeferredTaxLiabilitiesMember_0a4879a7-38d9-46dc-b810-503a3285f575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_f14da7e5-2c96-4730-b502-c26efd82f16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a1b17ec0-b949-4809-8bd9-09bfdb305b85" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_f14da7e5-2c96-4730-b502-c26efd82f16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:href="dva-20211231.xsd#dva_IncomeTaxesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesTable_e5505646-521d-4501-b17a-7ea8ccde7d16" xlink:to="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsReceivables_f05250eb-2e45-457a-8142-74581d0cf89e" xlink:href="dva-20211231.xsd#dva_DeferredTaxAssetsReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_dva_DeferredTaxAssetsReceivables_f05250eb-2e45-457a-8142-74581d0cf89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_9cab7874-8b78-4d37-af02-de2b50ce3642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_9cab7874-8b78-4d37-af02-de2b50ce3642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities_4116885e-8ef3-4c16-8722-adb3f91f37b3" xlink:href="dva-20211231.xsd#dva_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_dva_DeferredTaxAssetsOperatingLeaseLiabilities_4116885e-8ef3-4c16-8722-adb3f91f37b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0ee20614-023a-431a-9550-4ff4744cbfcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0ee20614-023a-431a-9550-4ff4744cbfcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_af6721f8-5ddd-4ee9-9341-49827399838e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_af6721f8-5ddd-4ee9-9341-49827399838e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_6b4d5d78-4e57-419f-9159-92111f1ca18a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_6b4d5d78-4e57-419f-9159-92111f1ca18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4b79fd5b-9297-428a-89bb-872e0efccb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4b79fd5b-9297-428a-89bb-872e0efccb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_59025c8e-f9d5-4344-9a15-fda98030b7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_59025c8e-f9d5-4344-9a15-fda98030b7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_6a44ecc5-b6c7-45f8-82c0-2a9e51de4bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_6a44ecc5-b6c7-45f8-82c0-2a9e51de4bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_12ed36b3-bc57-4503-a862-ecbf26aa419d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_12ed36b3-bc57-4503-a862-ecbf26aa419d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_35157825-7227-45ab-bc74-22f3ed6c0c8c" xlink:href="dva-20211231.xsd#dva_DeferredTaxLiabilitiesOperatingLeaseAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_dva_DeferredTaxLiabilitiesOperatingLeaseAssets_35157825-7227-45ab-bc74-22f3ed6c0c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_c8627727-4892-4632-bd15-e12624ad6d15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_c8627727-4892-4632-bd15-e12624ad6d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_c3134bb1-a230-4e26-b578-d4ba885ead80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_c3134bb1-a230-4e26-b578-d4ba885ead80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e6ee3307-c99e-4eb2-bb6b-b207ea09484a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e6ee3307-c99e-4eb2-bb6b-b207ea09484a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_e08d8721-1709-4ccf-9485-72828657fa94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_1ef6849a-3718-4cb8-946a-0094bbc48fa5" xlink:to="loc_us-gaap_DeferredTaxLiabilities_e08d8721-1709-4ccf-9485-72828657fa94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_900e1f66-7595-489b-ad41-772bb8db0242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a620da23-9327-4a47-961b-ca677ea5c652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_900e1f66-7595-489b-ad41-772bb8db0242" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a620da23-9327-4a47-961b-ca677ea5c652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_cf128cc9-2f37-46ad-a911-dbbc7ea354be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a620da23-9327-4a47-961b-ca677ea5c652" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_cf128cc9-2f37-46ad-a911-dbbc7ea354be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_e9baab6e-7e95-4e7f-997c-c4c9598811bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a620da23-9327-4a47-961b-ca677ea5c652" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_e9baab6e-7e95-4e7f-997c-c4c9598811bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c22128d0-010a-4326-9c13-df1dbf5ab7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a620da23-9327-4a47-961b-ca677ea5c652" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c22128d0-010a-4326-9c13-df1dbf5ab7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_da632bf8-6f85-41d5-a9ea-3facef305181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a620da23-9327-4a47-961b-ca677ea5c652" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_da632bf8-6f85-41d5-a9ea-3facef305181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_9394ef71-5a64-48fc-960c-8640a826ca46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a620da23-9327-4a47-961b-ca677ea5c652" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_9394ef71-5a64-48fc-960c-8640a826ca46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_76f20a1f-9eb9-4ad6-b1b8-a8ffd3f46335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a620da23-9327-4a47-961b-ca677ea5c652" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_76f20a1f-9eb9-4ad6-b1b8-a8ffd3f46335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ca547820-d25a-4aca-9070-d596702b8d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:href="dva-20211231.xsd#dva_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ca547820-d25a-4aca-9070-d596702b8d5b" xlink:to="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_19ef732f-6f75-4862-8c1e-5930750c950e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_19ef732f-6f75-4862-8c1e-5930750c950e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_a55d86f0-50c8-4fe8-8d13-2134a5490b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_19ef732f-6f75-4862-8c1e-5930750c950e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_a55d86f0-50c8-4fe8-8d13-2134a5490b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_8c46068d-2710-411e-be28-6984af515689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a55d86f0-50c8-4fe8-8d13-2134a5490b83" xlink:to="loc_us-gaap_DomesticCountryMember_8c46068d-2710-411e-be28-6984af515689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_64e9eff7-8e00-4039-b480-d02e22f5dbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a55d86f0-50c8-4fe8-8d13-2134a5490b83" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_64e9eff7-8e00-4039-b480-d02e22f5dbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_e6bd05b2-66c2-4d6d-88d2-a515dee86526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_a55d86f0-50c8-4fe8-8d13-2134a5490b83" xlink:to="loc_us-gaap_ForeignCountryMember_e6bd05b2-66c2-4d6d-88d2-a515dee86526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_384a2e9d-92de-4f5b-9124-9988ea092e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:to="loc_us-gaap_TaxPeriodAxis_384a2e9d-92de-4f5b-9124-9988ea092e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_2c438094-633a-46ee-ab1d-89c4cf4e64c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_384a2e9d-92de-4f5b-9124-9988ea092e02" xlink:to="loc_us-gaap_TaxPeriodDomain_2c438094-633a-46ee-ab1d-89c4cf4e64c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TaxYear2029Member_8375d927-2cb0-4d81-b1d9-85b4aadb9060" xlink:href="dva-20211231.xsd#dva_TaxYear2029Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_2c438094-633a-46ee-ab1d-89c4cf4e64c7" xlink:to="loc_dva_TaxYear2029Member_8375d927-2cb0-4d81-b1d9-85b4aadb9060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_8a42e4a8-06ec-454f-bb31-58a85e8f0dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_8a42e4a8-06ec-454f-bb31-58a85e8f0dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_594a4f3b-bdda-4612-8fbc-1d8f27e2fca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_8a42e4a8-06ec-454f-bb31-58a85e8f0dcd" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_594a4f3b-bdda-4612-8fbc-1d8f27e2fca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_18f69bad-9cf5-4643-b05a-2ab8410e79e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_594a4f3b-bdda-4612-8fbc-1d8f27e2fca4" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_18f69bad-9cf5-4643-b05a-2ab8410e79e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_9cfe694e-de0e-48c0-a4bc-db9d7560486f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_9cfe694e-de0e-48c0-a4bc-db9d7560486f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_2a5649ad-c9c6-4436-beba-3242edbb19b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_9cfe694e-de0e-48c0-a4bc-db9d7560486f" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_2a5649ad-c9c6-4436-beba-3242edbb19b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IndefiniteLifeNetOperatingLossesMember_588bfd6b-7e46-423c-addd-dce1019d3ea3" xlink:href="dva-20211231.xsd#dva_IndefiniteLifeNetOperatingLossesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_2a5649ad-c9c6-4436-beba-3242edbb19b3" xlink:to="loc_dva_IndefiniteLifeNetOperatingLossesMember_588bfd6b-7e46-423c-addd-dce1019d3ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember_af155517-dbc9-452b-8a22-2b5c2ff42b94" xlink:href="dva-20211231.xsd#dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_2a5649ad-c9c6-4436-beba-3242edbb19b3" xlink:to="loc_dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember_af155517-dbc9-452b-8a22-2b5c2ff42b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6b4b3b57-cb3f-41c1-83ea-ad22e78576b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6b4b3b57-cb3f-41c1-83ea-ad22e78576b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a0b4c39e-2d6c-45e7-a44b-f926edd6c4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6b4b3b57-cb3f-41c1-83ea-ad22e78576b4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a0b4c39e-2d6c-45e7-a44b-f926edd6c4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_ca4dc695-2dfa-4577-b650-0d10410fd749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a0b4c39e-2d6c-45e7-a44b-f926edd6c4cb" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_ca4dc695-2dfa-4577-b650-0d10410fd749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:href="dva-20211231.xsd#dva_IncomeTaxesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesTable_aa71c9b2-5a04-4439-af4b-d0d6f2229be6" xlink:to="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_3296c102-7e80-48d7-afca-e6f5e43bd46e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_OperatingLossCarryforwards_3296c102-7e80-48d7-afca-e6f5e43bd46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_302ea050-7241-4ee8-ab42-a439e025e62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_302ea050-7241-4ee8-ab42-a439e025e62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_4654d861-0e61-451a-a774-41e880a23e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_4654d861-0e61-451a-a774-41e880a23e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate_f5352e5b-a735-48af-a2f8-611622569daa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardExpirationDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_TaxCreditCarryforwardExpirationDate_f5352e5b-a735-48af-a2f8-611622569daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_b0e5f922-ddf0-47af-adf2-79c2a3647aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_b0e5f922-ddf0-47af-adf2-79c2a3647aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dfc1facc-914b-487d-b5e6-06afe2647c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dfc1facc-914b-487d-b5e6-06afe2647c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_d99f2466-7344-44ee-ac78-4a7ea4ef95a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_d99f2466-7344-44ee-ac78-4a7ea4ef95a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_09b69212-ac03-4e6c-a9d6-821d71c9f3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_09b69212-ac03-4e6c-a9d6-821d71c9f3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_214f8b4b-d028-4c4b-8df5-571b81cd5187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_214f8b4b-d028-4c4b-8df5-571b81cd5187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_ae78c9ad-85e1-4932-9122-7380be061b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_ae78c9ad-85e1-4932-9122-7380be061b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_747632c5-b729-439a-8f39-b7c219e9b273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_IncomeTaxesLineItems_d8253f2c-780c-48b5-92c7-b7c88dc03c36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_747632c5-b729-439a-8f39-b7c219e9b273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebt" xlink:type="simple" xlink:href="dva-20211231.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8eba4fff-5456-4c0e-8cc9-5e17617f0aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_17113999-ade9-46c9-946b-0fe72078fe3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8eba4fff-5456-4c0e-8cc9-5e17617f0aaf" xlink:to="loc_us-gaap_LongTermDebtTextBlock_17113999-ade9-46c9-946b-0fe72078fe3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="dva-20211231.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e9eabe69-c899-47f9-a44a-d9033089d154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_174baa40-a18a-4fe5-b417-bc03389b6836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e9eabe69-c899-47f9-a44a-d9033089d154" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_174baa40-a18a-4fe5-b417-bc03389b6836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_9481aa95-1a5e-4e43-98fa-d8abb07117a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e9eabe69-c899-47f9-a44a-d9033089d154" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_9481aa95-1a5e-4e43-98fa-d8abb07117a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_1799884e-a41f-4495-83bf-0f179f378877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e9eabe69-c899-47f9-a44a-d9033089d154" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_1799884e-a41f-4495-83bf-0f179f378877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_022d9a50-7726-464a-8fe3-259a5e60c8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e9eabe69-c899-47f9-a44a-d9033089d154" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_022d9a50-7726-464a-8fe3-259a5e60c8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cb67c099-429a-4aa4-b067-6462090db097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2d3d5efb-2e5a-43ef-9a6a-d2063644a0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cb67c099-429a-4aa4-b067-6462090db097" xlink:to="loc_us-gaap_DebtInstrumentTable_2d3d5efb-2e5a-43ef-9a6a-d2063644a0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_325a695c-3d76-40eb-a6c2-52a308e7833a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2d3d5efb-2e5a-43ef-9a6a-d2063644a0c9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_325a695c-3d76-40eb-a6c2-52a308e7833a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ea105134-789c-43d1-b968-899ddae07f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_325a695c-3d76-40eb-a6c2-52a308e7833a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ea105134-789c-43d1-b968-899ddae07f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_79e89b21-44a1-41ca-a0a6-b85ad48c9940" xlink:href="dva-20211231.xsd#dva_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea105134-789c-43d1-b968-899ddae07f22" xlink:to="loc_dva_TermLoanAMember_79e89b21-44a1-41ca-a0a6-b85ad48c9940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_bf26e983-ae3b-455f-b8b1-dd55b0c0233b" xlink:href="dva-20211231.xsd#dva_TermLoanB1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea105134-789c-43d1-b968-899ddae07f22" xlink:to="loc_dva_TermLoanB1Member_bf26e983-ae3b-455f-b8b1-dd55b0c0233b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_3979330f-b900-4006-a4a4-86868e9b13ba" xlink:href="dva-20211231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea105134-789c-43d1-b968-899ddae07f22" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_3979330f-b900-4006-a4a4-86868e9b13ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ceb652be-54c4-45c6-8cd2-9da6fbc63e46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea105134-789c-43d1-b968-899ddae07f22" xlink:to="loc_us-gaap_SeniorNotesMember_ceb652be-54c4-45c6-8cd2-9da6fbc63e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_738c5c9c-3168-4fb9-a1ae-e016df806fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2d3d5efb-2e5a-43ef-9a6a-d2063644a0c9" xlink:to="loc_us-gaap_CreditFacilityAxis_738c5c9c-3168-4fb9-a1ae-e016df806fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_68df7700-f2ec-4353-a862-fc35f8ea6b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_738c5c9c-3168-4fb9-a1ae-e016df806fa2" xlink:to="loc_us-gaap_CreditFacilityDomain_68df7700-f2ec-4353-a862-fc35f8ea6b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a835c18b-b8de-4f65-9314-09f9b26ccc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_68df7700-f2ec-4353-a862-fc35f8ea6b69" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a835c18b-b8de-4f65-9314-09f9b26ccc7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_80f051a5-b97b-4245-bd1e-2826bbf8e93e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2d3d5efb-2e5a-43ef-9a6a-d2063644a0c9" xlink:to="loc_us-gaap_DebtInstrumentAxis_80f051a5-b97b-4245-bd1e-2826bbf8e93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b4d952a1-e5a8-48fd-9a02-53d1110971cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_80f051a5-b97b-4245-bd1e-2826bbf8e93e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b4d952a1-e5a8-48fd-9a02-53d1110971cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_7573b3a1-f77d-447d-a614-bc0283f5242d" xlink:href="dva-20211231.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b4d952a1-e5a8-48fd-9a02-53d1110971cf" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_7573b3a1-f77d-447d-a614-bc0283f5242d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_0fbda97f-e6a8-4699-a521-d2a9d20f1320" xlink:href="dva-20211231.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b4d952a1-e5a8-48fd-9a02-53d1110971cf" xlink:to="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_0fbda97f-e6a8-4699-a521-d2a9d20f1320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_737b69e7-b68a-402f-bbf2-61ee32c341d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b4d952a1-e5a8-48fd-9a02-53d1110971cf" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_737b69e7-b68a-402f-bbf2-61ee32c341d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_3e75ba4f-c955-4d29-8df3-22a79ad0f949" xlink:href="dva-20211231.xsd#dva_FinanceLeaseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b4d952a1-e5a8-48fd-9a02-53d1110971cf" xlink:to="loc_dva_FinanceLeaseMember_3e75ba4f-c955-4d29-8df3-22a79ad0f949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_5e799939-b59a-4d49-9678-a7c0aaa8c154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2d3d5efb-2e5a-43ef-9a6a-d2063644a0c9" xlink:to="loc_us-gaap_LeaseContractualTermAxis_5e799939-b59a-4d49-9678-a7c0aaa8c154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_a268bdfd-6f8d-46bb-9f0b-fda001de01b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_5e799939-b59a-4d49-9678-a7c0aaa8c154" xlink:to="loc_us-gaap_LeaseContractualTermDomain_a268bdfd-6f8d-46bb-9f0b-fda001de01b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_GroundLeaseMember_52f0a102-b1a1-49e3-88e0-ae8f906e4233" xlink:href="dva-20211231.xsd#dva_GroundLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_a268bdfd-6f8d-46bb-9f0b-fda001de01b1" xlink:to="loc_dva_GroundLeaseMember_52f0a102-b1a1-49e3-88e0-ae8f906e4233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2d3d5efb-2e5a-43ef-9a6a-d2063644a0c9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_65b3130d-3b7e-4048-8e29-5d84bf2c8b52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_DebtInstrumentsAbstract_65b3130d-3b7e-4048-8e29-5d84bf2c8b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_608e86a8-0cde-4394-8c57-e7a1707d894b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_65b3130d-3b7e-4048-8e29-5d84bf2c8b52" xlink:to="loc_us-gaap_SecuredDebt_608e86a8-0cde-4394-8c57-e7a1707d894b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_e67da6d9-4817-405c-b82a-90a3778a5a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_65b3130d-3b7e-4048-8e29-5d84bf2c8b52" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_e67da6d9-4817-405c-b82a-90a3778a5a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableAbstract_a2ca1d0a-b787-44c2-8a4d-44c147d7adcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_NotesPayableAbstract_a2ca1d0a-b787-44c2-8a4d-44c147d7adcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_c26f45ee-86d4-4e03-b575-80c2f27c2b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NotesPayableAbstract_a2ca1d0a-b787-44c2-8a4d-44c147d7adcf" xlink:to="loc_us-gaap_SeniorNotes_c26f45ee-86d4-4e03-b575-80c2f27c2b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_5e24f880-4020-42ee-a74b-780400bc32a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_5e24f880-4020-42ee-a74b-780400bc32a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_530f8ab1-8225-4ca9-aaf3-1634b86a1315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_530f8ab1-8225-4ca9-aaf3-1634b86a1315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_fc863465-9e17-429a-9397-d791d3e07ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_DebtInstrumentFairValue_fc863465-9e17-429a-9397-d791d3e07ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable_c98fc2b3-55be-4029-b838-08d3cbd77e43" xlink:href="dva-20211231.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayable_c98fc2b3-55be-4029-b838-08d3cbd77e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_c43d0e9f-19ca-4b18-bb77-a6d15ec69baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:to="loc_us-gaap_FinanceLeaseLiability_c43d0e9f-19ca-4b18-bb77-a6d15ec69baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_d5b15c76-bf95-4e62-afc5-a734daf54517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_d5b15c76-bf95-4e62-afc5-a734daf54517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_8e6fde9b-b7d4-41d1-b5f3-ad33f1663ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_8e6fde9b-b7d4-41d1-b5f3-ad33f1663ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_9aed00b5-592b-4425-befc-983953fd3d46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_9aed00b5-592b-4425-befc-983953fd3d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_0c39f678-ef19-4dd2-b012-05a37ebe427c" xlink:href="dva-20211231.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract_da7be8e4-dad3-4466-9617-e608fa9ebcd3" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_0c39f678-ef19-4dd2-b012-05a37ebe427c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_91c50fb4-8820-48b7-b6fa-7d334d849e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_91c50fb4-8820-48b7-b6fa-7d334d849e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountAndDeferredFinanceCosts_f319ba69-9e41-4ffc-8e74-a27a787f65c0" xlink:href="dva-20211231.xsd#dva_DiscountAndDeferredFinanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:to="loc_dva_DiscountAndDeferredFinanceCosts_f319ba69-9e41-4ffc-8e74-a27a787f65c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_175711e7-7cd0-4479-8ed5-1713281e8fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_175711e7-7cd0-4479-8ed5-1713281e8fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9025a0a7-b645-4f76-8489-c599d294ea07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9025a0a7-b645-4f76-8489-c599d294ea07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_442351e2-4538-476f-bd52-32bd021154ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract_4f2d9baf-943f-4be3-b301-889c1b9f589a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_442351e2-4538-476f-bd52-32bd021154ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_d3cd7eb7-420d-41a8-9265-54bfda8aebaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9366de3a-06d6-4fc9-b409-d5cd811f5c33" xlink:to="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_d3cd7eb7-420d-41a8-9265-54bfda8aebaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b819dcf5-4c7c-4936-be07-f7be5a9c0e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_d3cd7eb7-420d-41a8-9265-54bfda8aebaf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b819dcf5-4c7c-4936-be07-f7be5a9c0e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_921330c5-a9d9-461f-ac42-02186b92403d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_d3cd7eb7-420d-41a8-9265-54bfda8aebaf" xlink:to="loc_us-gaap_DeferredOfferingCosts_921330c5-a9d9-461f-ac42-02186b92403d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_92a55931-3ff9-4eee-aa27-48f18d510f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_d3cd7eb7-420d-41a8-9265-54bfda8aebaf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_92a55931-3ff9-4eee-aa27-48f18d510f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongTermDebtScheduledMaturitiesofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_894afd13-8969-4f9b-b2f0-e3a43335da32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f8ff1d0b-332a-4d39-baec-cc6b912ff7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_894afd13-8969-4f9b-b2f0-e3a43335da32" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f8ff1d0b-332a-4d39-baec-cc6b912ff7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_41539b4e-02d6-468a-b896-8ec06e1d8a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_894afd13-8969-4f9b-b2f0-e3a43335da32" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_41539b4e-02d6-468a-b896-8ec06e1d8a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_53326945-7a28-4284-9e04-90b8cbd05851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_894afd13-8969-4f9b-b2f0-e3a43335da32" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_53326945-7a28-4284-9e04-90b8cbd05851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_25dd0ffb-bd35-4e80-bf1c-ecac14d428e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_894afd13-8969-4f9b-b2f0-e3a43335da32" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_25dd0ffb-bd35-4e80-bf1c-ecac14d428e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_cf9e4130-a2f7-4ce4-9d5a-90b9216f1e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_894afd13-8969-4f9b-b2f0-e3a43335da32" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_cf9e4130-a2f7-4ce4-9d5a-90b9216f1e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_5227687c-c7e3-4aa6-bf4d-40cecfe843c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_894afd13-8969-4f9b-b2f0-e3a43335da32" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_5227687c-c7e3-4aa6-bf4d-40cecfe843c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongTermDebtDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9ca5639b-eb87-4a15-a8ea-d6bf5e7491ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9ca5639b-eb87-4a15-a8ea-d6bf5e7491ef" xlink:to="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2d492c2b-86cc-43c6-ac0d-5f8ae785ce84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2d492c2b-86cc-43c6-ac0d-5f8ae785ce84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7460dbc9-1c56-4d8b-8a7d-748a004a8751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2d492c2b-86cc-43c6-ac0d-5f8ae785ce84" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7460dbc9-1c56-4d8b-8a7d-748a004a8751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_815b2216-d16b-4da3-970e-2d81d584e55c" xlink:href="dva-20211231.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7460dbc9-1c56-4d8b-8a7d-748a004a8751" xlink:to="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_815b2216-d16b-4da3-970e-2d81d584e55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_711e9250-25b5-48af-b2e6-c27ff8183011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:to="loc_us-gaap_DebtInstrumentAxis_711e9250-25b5-48af-b2e6-c27ff8183011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5b49dcf4-5b89-440a-a981-8fb4a8dda69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_711e9250-25b5-48af-b2e6-c27ff8183011" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5b49dcf4-5b89-440a-a981-8fb4a8dda69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_5b855dc6-1770-49c7-a47b-fde6fb88f30d" xlink:href="dva-20211231.xsd#dva_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b49dcf4-5b89-440a-a981-8fb4a8dda69f" xlink:to="loc_dva_TermLoanFacilityMember_5b855dc6-1770-49c7-a47b-fde6fb88f30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d420b7a8-e0b1-4036-85dd-7e8b1f6f6510" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:to="loc_srt_RangeAxis_d420b7a8-e0b1-4036-85dd-7e8b1f6f6510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_aff664bd-1173-478d-a408-dbfdb8e273c7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d420b7a8-e0b1-4036-85dd-7e8b1f6f6510" xlink:to="loc_srt_RangeMember_aff664bd-1173-478d-a408-dbfdb8e273c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7eb13553-8747-41c4-bcb0-b90ec110de3b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_aff664bd-1173-478d-a408-dbfdb8e273c7" xlink:to="loc_srt_MaximumMember_7eb13553-8747-41c4-bcb0-b90ec110de3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_174a829f-05fc-4312-a586-22ae4233402c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_174a829f-05fc-4312-a586-22ae4233402c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_70c5cdb1-a534-4bf0-9685-93240e9669a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_174a829f-05fc-4312-a586-22ae4233402c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_70c5cdb1-a534-4bf0-9685-93240e9669a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_a3d73d65-57df-4ac5-9e54-e5959095f4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_70c5cdb1-a534-4bf0-9685-93240e9669a5" xlink:to="loc_us-gaap_CashFlowHedgingMember_a3d73d65-57df-4ac5-9e54-e5959095f4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_150dc87d-bb89-4d69-9283-efe51a92539f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_150dc87d-bb89-4d69-9283-efe51a92539f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d11780be-1c3d-42ab-bfa0-c9bcc6beaac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_150dc87d-bb89-4d69-9283-efe51a92539f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d11780be-1c3d-42ab-bfa0-c9bcc6beaac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember_6afa89ea-25ed-4ccb-9703-42dfaa50e32f" xlink:href="dva-20211231.xsd#dva_DebtExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d11780be-1c3d-42ab-bfa0-c9bcc6beaac0" xlink:to="loc_dva_DebtExpenseMember_6afa89ea-25ed-4ccb-9703-42dfaa50e32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fef0822d-6865-4305-bdd2-f926ab2be255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fef0822d-6865-4305-bdd2-f926ab2be255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d02727c4-82c5-48d1-aa27-48ed5756d470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fef0822d-6865-4305-bdd2-f926ab2be255" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d02727c4-82c5-48d1-aa27-48ed5756d470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_6a5ea04c-40db-443e-bca5-04833b59515d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d02727c4-82c5-48d1-aa27-48ed5756d470" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_6a5ea04c-40db-443e-bca5-04833b59515d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6ab3b133-d52d-4d4d-8017-a58fb5999038" xlink:to="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_76f8524a-e802-42ad-af93-463690c9cf9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_76f8524a-e802-42ad-af93-463690c9cf9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_60c7c7a6-6fa5-4c84-be14-9eccd4169c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_60c7c7a6-6fa5-4c84-be14-9eccd4169c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates_7e05d0e1-9ee8-45dd-b8cd-45b1f411a121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_DerivativeInceptionDates_7e05d0e1-9ee8-45dd-b8cd-45b1f411a121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_17decac1-321c-45b9-b22d-5c1e216fefdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_DerivativeMaturityDates_17decac1-321c-45b9-b22d-5c1e216fefdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_7ae9371d-cf86-4d0e-8db8-36ae2d66fd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_7ae9371d-cf86-4d0e-8db8-36ae2d66fd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_909e9bbb-b593-4a65-b203-1c40a2f5f6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_909e9bbb-b593-4a65-b203-1c40a2f5f6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_2223ea10-4409-4568-9ac2-c24332c45a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_92e10516-d1e3-4a00-966c-60e429e38a89" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_2223ea10-4409-4568-9ac2-c24332c45a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_86b43887-28d7-4622-942e-fefaf06bde48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_51dc8bb0-4a67-437b-832b-5dbe97b662ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_86b43887-28d7-4622-942e-fefaf06bde48" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_51dc8bb0-4a67-437b-832b-5dbe97b662ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dbbee489-0993-4b98-9877-7598b9437061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_51dc8bb0-4a67-437b-832b-5dbe97b662ba" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dbbee489-0993-4b98-9877-7598b9437061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0c9d4f35-1c64-4014-99ab-09af34703f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dbbee489-0993-4b98-9877-7598b9437061" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0c9d4f35-1c64-4014-99ab-09af34703f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_20173112-2a2c-4e56-93bc-fb18f8758a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0c9d4f35-1c64-4014-99ab-09af34703f84" xlink:to="loc_us-gaap_CashFlowHedgingMember_20173112-2a2c-4e56-93bc-fb18f8758a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d640f6cb-abc8-4f30-b48c-d9344ec27909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_51dc8bb0-4a67-437b-832b-5dbe97b662ba" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d640f6cb-abc8-4f30-b48c-d9344ec27909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_956fbf6e-2212-4396-88ff-55acb39c65b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d640f6cb-abc8-4f30-b48c-d9344ec27909" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_956fbf6e-2212-4396-88ff-55acb39c65b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_b2925b90-1e73-4873-8661-a71946064991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_956fbf6e-2212-4396-88ff-55acb39c65b2" xlink:to="loc_us-gaap_InterestRateCapMember_b2925b90-1e73-4873-8661-a71946064991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7e4df425-fc2e-4333-bbcf-2f4df514f317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_51dc8bb0-4a67-437b-832b-5dbe97b662ba" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7e4df425-fc2e-4333-bbcf-2f4df514f317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6fa39495-6f76-48b5-8136-af655da50462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7e4df425-fc2e-4333-bbcf-2f4df514f317" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6fa39495-6f76-48b5-8136-af655da50462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember_74884d04-4eee-4868-91e6-49fa309af12a" xlink:href="dva-20211231.xsd#dva_DebtExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6fa39495-6f76-48b5-8136-af655da50462" xlink:to="loc_dva_DebtExpenseMember_74884d04-4eee-4868-91e6-49fa309af12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncomeTaxExpenseBenefitMember_9e63924e-3d12-44e3-baf4-e0dcb8ca8a3d" xlink:href="dva-20211231.xsd#dva_IncomeTaxExpenseBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6fa39495-6f76-48b5-8136-af655da50462" xlink:to="loc_dva_IncomeTaxExpenseBenefitMember_9e63924e-3d12-44e3-baf4-e0dcb8ca8a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cbf7e14a-6f40-453d-a395-36178e02f086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_51dc8bb0-4a67-437b-832b-5dbe97b662ba" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cbf7e14a-6f40-453d-a395-36178e02f086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_adc2b79d-b4b0-4bf9-aef5-429906dae2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cbf7e14a-6f40-453d-a395-36178e02f086" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_adc2b79d-b4b0-4bf9-aef5-429906dae2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d48b5be8-db44-42bc-a70a-b036c8e1e030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_cbf7e14a-6f40-453d-a395-36178e02f086" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d48b5be8-db44-42bc-a70a-b036c8e1e030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongTermDebtAdditionalinformationDetail" xlink:type="simple" xlink:href="dva-20211231.xsd#LongTermDebtAdditionalinformationDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongTermDebtAdditionalinformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_029d2673-0364-42e3-827d-707844422ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_728843af-9cff-4d8f-b40f-53cd2281e1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_029d2673-0364-42e3-827d-707844422ceb" xlink:to="loc_us-gaap_DebtInstrumentTable_728843af-9cff-4d8f-b40f-53cd2281e1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_117119d7-e94f-4e7d-8fa9-cce98ddccaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_728843af-9cff-4d8f-b40f-53cd2281e1f3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_117119d7-e94f-4e7d-8fa9-cce98ddccaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6865fa36-3990-49ce-951c-10fb59b34976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_117119d7-e94f-4e7d-8fa9-cce98ddccaa4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6865fa36-3990-49ce-951c-10fb59b34976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_4ed4dbef-7157-46f9-8b45-fb98f24e6706" xlink:href="dva-20211231.xsd#dva_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6865fa36-3990-49ce-951c-10fb59b34976" xlink:to="loc_dva_TermLoanAMember_4ed4dbef-7157-46f9-8b45-fb98f24e6706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_37bc9df3-a5f6-4e0a-a7e8-5df8b485c64c" xlink:href="dva-20211231.xsd#dva_TermLoanB1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6865fa36-3990-49ce-951c-10fb59b34976" xlink:to="loc_dva_TermLoanB1Member_37bc9df3-a5f6-4e0a-a7e8-5df8b485c64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_6adc12be-8374-4a61-b035-70633a8947cb" xlink:href="dva-20211231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6865fa36-3990-49ce-951c-10fb59b34976" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_6adc12be-8374-4a61-b035-70633a8947cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_007e7281-4b0b-4700-8058-a6db52583d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_728843af-9cff-4d8f-b40f-53cd2281e1f3" xlink:to="loc_us-gaap_CreditFacilityAxis_007e7281-4b0b-4700-8058-a6db52583d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_010151fe-9376-44c7-a24d-b849f33cbe5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_007e7281-4b0b-4700-8058-a6db52583d01" xlink:to="loc_us-gaap_CreditFacilityDomain_010151fe-9376-44c7-a24d-b849f33cbe5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_17e0b0e9-20c2-4e55-b9b1-b8009132f241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_010151fe-9376-44c7-a24d-b849f33cbe5b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_17e0b0e9-20c2-4e55-b9b1-b8009132f241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_552a9990-2ff4-4f07-861d-dfefc6b74bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_010151fe-9376-44c7-a24d-b849f33cbe5b" xlink:to="loc_us-gaap_LetterOfCreditMember_552a9990-2ff4-4f07-861d-dfefc6b74bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9c1dbab7-93f7-4054-82a6-ffcd01b89ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_728843af-9cff-4d8f-b40f-53cd2281e1f3" xlink:to="loc_us-gaap_DebtInstrumentAxis_9c1dbab7-93f7-4054-82a6-ffcd01b89ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_734ef9e2-0bd8-4c2b-95eb-4ba9b6df17f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9c1dbab7-93f7-4054-82a6-ffcd01b89ad9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_734ef9e2-0bd8-4c2b-95eb-4ba9b6df17f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_d697f853-6fb0-4a16-a886-62a08b2cb9ad" xlink:href="dva-20211231.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_734ef9e2-0bd8-4c2b-95eb-4ba9b6df17f5" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_d697f853-6fb0-4a16-a886-62a08b2cb9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_86748e7e-9b71-464a-8309-64118b7e852a" xlink:href="dva-20211231.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_734ef9e2-0bd8-4c2b-95eb-4ba9b6df17f5" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_86748e7e-9b71-464a-8309-64118b7e852a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_728843af-9cff-4d8f-b40f-53cd2281e1f3" xlink:to="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_a25d8add-e300-466d-8651-73efe960fb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_a25d8add-e300-466d-8651-73efe960fb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_31824a46-88fa-4282-ade6-5e21c3c0f5a4" xlink:href="dva-20211231.xsd#dva_AdditionalDebtPrincipalAmountDueToNewAgreement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_dva_AdditionalDebtPrincipalAmountDueToNewAgreement_31824a46-88fa-4282-ade6-5e21c3c0f5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_83812bf9-bcd7-4ebf-946c-5b439bdf371a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_83812bf9-bcd7-4ebf-946c-5b439bdf371a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_1f51ade7-a4a0-4a2d-8ee2-2e97bf986422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_1f51ade7-a4a0-4a2d-8ee2-2e97bf986422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_51689c75-398b-488b-b257-1d35f742a24e" xlink:href="dva-20211231.xsd#dva_DebtInstrumentOfferingPricePercentageOfFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount_51689c75-398b-488b-b257-1d35f742a24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_48cfd037-ab74-427d-85ad-d29bbd8b253f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_SeniorNotes_48cfd037-ab74-427d-85ad-d29bbd8b253f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_b192be20-abda-4173-8c21-2c6ad16d3517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_b192be20-abda-4173-8c21-2c6ad16d3517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_b8c18fdb-1073-4522-b92e-4f928d7bcb0b" xlink:href="dva-20211231.xsd#dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_b8c18fdb-1073-4522-b92e-4f928d7bcb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_c8da3306-8354-4cd0-af39-3701e77b14f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_c8da3306-8354-4cd0-af39-3701e77b14f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_62f351b5-a32b-499f-ae6c-b58545d44590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_62f351b5-a32b-499f-ae6c-b58545d44590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9da3d31e-357b-4d02-b0f6-73bf42df5221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9da3d31e-357b-4d02-b0f6-73bf42df5221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_3d9d400f-7690-4094-9c3f-5ab92bdb6994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_3d9d400f-7690-4094-9c3f-5ab92bdb6994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_03b686e3-03e1-4ffd-907d-88636d026358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_InterestExpenseDebt_03b686e3-03e1-4ffd-907d-88636d026358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_12c839ed-c24b-4da3-b931-cc999cde6c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_265ea141-533f-4892-abd0-6f56d7480967" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_12c839ed-c24b-4da3-b931-cc999cde6c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Leases" xlink:type="simple" xlink:href="dva-20211231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_20d53451-de9d-4f60-8a1b-d33c0e7f15ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureTextBlock_eed4988b-730f-4809-a1c2-117201afbb60" xlink:href="dva-20211231.xsd#dva_LeasesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_20d53451-de9d-4f60-8a1b-d33c0e7f15ca" xlink:to="loc_dva_LeasesDisclosureTextBlock_eed4988b-730f-4809-a1c2-117201afbb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesTables" xlink:type="simple" xlink:href="dva-20211231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e54f9475-7752-431e-bd32-e0b7846dcea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_73f7e5e8-14b8-45d6-af0c-8498b256b184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e54f9475-7752-431e-bd32-e0b7846dcea2" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_73f7e5e8-14b8-45d6-af0c-8498b256b184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeaseOtherInformationTableTextBlockTableTextBlock_299c88b9-d1fe-406c-9ef1-b1cd3307ac06" xlink:href="dva-20211231.xsd#dva_LeaseOtherInformationTableTextBlockTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e54f9475-7752-431e-bd32-e0b7846dcea2" xlink:to="loc_dva_LeaseOtherInformationTableTextBlockTableTextBlock_299c88b9-d1fe-406c-9ef1-b1cd3307ac06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfMinimumLeasePaymentsTextBlock_7e7f8475-815b-45fa-84a4-c2f94e99df86" xlink:href="dva-20211231.xsd#dva_ScheduleOfMinimumLeasePaymentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e54f9475-7752-431e-bd32-e0b7846dcea2" xlink:to="loc_dva_ScheduleOfMinimumLeasePaymentsTextBlock_7e7f8475-815b-45fa-84a4-c2f94e99df86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LeasesLeaseExpenseComponentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeDisclosureAbstract_208fe54d-3fc0-4cab-957a-78a62cd89d62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_d5a6ebf0-15ba-4d7a-bee5-4575e81677d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_208fe54d-3fc0-4cab-957a-78a62cd89d62" xlink:to="loc_us-gaap_LeaseCostAbstract_d5a6ebf0-15ba-4d7a-bee5-4575e81677d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_f59d1787-0e9f-4ee8-a808-7a23f930ffd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_d5a6ebf0-15ba-4d7a-bee5-4575e81677d0" xlink:to="loc_us-gaap_OperatingLeaseExpense_f59d1787-0e9f-4ee8-a808-7a23f930ffd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_62f5f1f6-0620-4cd4-851b-692ebf301161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_d5a6ebf0-15ba-4d7a-bee5-4575e81677d0" xlink:to="loc_us-gaap_VariableLeaseCost_62f5f1f6-0620-4cd4-851b-692ebf301161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_c716ce1e-cbee-4193-ada5-cc4da95e6dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_208fe54d-3fc0-4cab-957a-78a62cd89d62" xlink:to="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_c716ce1e-cbee-4193-ada5-cc4da95e6dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_3e6c4c09-6735-4428-a2f5-a0e43da2ba39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_c716ce1e-cbee-4193-ada5-cc4da95e6dba" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_3e6c4c09-6735-4428-a2f5-a0e43da2ba39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_736bb13b-1f9d-4aed-be27-23a697be767a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_c716ce1e-cbee-4193-ada5-cc4da95e6dba" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_736bb13b-1f9d-4aed-be27-23a697be767a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_6a614fae-3336-465b-9110-67061cfb0578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_208fe54d-3fc0-4cab-957a-78a62cd89d62" xlink:to="loc_us-gaap_LeaseCost_6a614fae-3336-465b-9110-67061cfb0578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesLeasesOtherInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LeasesLeasesOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LeasesLeasesOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dva_LesseeLeaseDescriptionLineItemsAbstract_a3c8b581-034e-4ace-805b-06b64f37ebda" xlink:href="dva-20211231.xsd#dva_LesseeLeaseDescriptionLineItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_c60f025b-ecd5-4c12-a770-a7fa635b5c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LesseeLeaseDescriptionLineItemsAbstract_a3c8b581-034e-4ace-805b-06b64f37ebda" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_c60f025b-ecd5-4c12-a770-a7fa635b5c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_44318936-2cb6-4ee9-b371-86a06df30fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c60f025b-ecd5-4c12-a770-a7fa635b5c07" xlink:to="loc_us-gaap_DebtInstrumentAxis_44318936-2cb6-4ee9-b371-86a06df30fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1397051c-b438-463e-ad5a-e7f84837f5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_44318936-2cb6-4ee9-b371-86a06df30fc0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1397051c-b438-463e-ad5a-e7f84837f5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_435e5c52-5f78-4329-adfc-f5cf8015e57a" xlink:href="dva-20211231.xsd#dva_FinanceLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1397051c-b438-463e-ad5a-e7f84837f5fa" xlink:to="loc_dva_FinanceLeaseMember_435e5c52-5f78-4329-adfc-f5cf8015e57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_3794d867-89c7-4d0a-a37f-c773db9ec11f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c60f025b-ecd5-4c12-a770-a7fa635b5c07" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_3794d867-89c7-4d0a-a37f-c773db9ec11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_da4ea528-5f49-4e10-8c78-6a8e93b8d58d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3794d867-89c7-4d0a-a37f-c773db9ec11f" xlink:to="loc_us-gaap_LeasesAbstract_da4ea528-5f49-4e10-8c78-6a8e93b8d58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_92d022d8-6723-425c-b0b1-bd25c78aad31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_da4ea528-5f49-4e10-8c78-6a8e93b8d58d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_92d022d8-6723-425c-b0b1-bd25c78aad31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_1a86d1e7-fd71-403a-ad41-17282d3be849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_da4ea528-5f49-4e10-8c78-6a8e93b8d58d" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_1a86d1e7-fd71-403a-ad41-17282d3be849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_38ee53d8-fd14-45ef-b9e6-b87f21aaa648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_da4ea528-5f49-4e10-8c78-6a8e93b8d58d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_38ee53d8-fd14-45ef-b9e6-b87f21aaa648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_531c3d66-35d4-4cbe-9b97-ec1b925311aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_da4ea528-5f49-4e10-8c78-6a8e93b8d58d" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_531c3d66-35d4-4cbe-9b97-ec1b925311aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesOtherInformationAbstract_886a68cf-4e98-4de9-81d1-2090ad048aad" xlink:href="dva-20211231.xsd#dva_LeasesOtherInformationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3794d867-89c7-4d0a-a37f-c773db9ec11f" xlink:to="loc_dva_LeasesOtherInformationAbstract_886a68cf-4e98-4de9-81d1-2090ad048aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_1a6b30a3-abed-4331-87dc-22d4213b3aef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesOtherInformationAbstract_886a68cf-4e98-4de9-81d1-2090ad048aad" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_1a6b30a3-abed-4331-87dc-22d4213b3aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_e80288bd-f2cb-4249-9270-ee860db25a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesOtherInformationAbstract_886a68cf-4e98-4de9-81d1-2090ad048aad" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_e80288bd-f2cb-4249-9270-ee860db25a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_10a0d756-4768-45c7-99c1-0f898b2aa7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_e80288bd-f2cb-4249-9270-ee860db25a3c" xlink:to="loc_us-gaap_OperatingLeasePayments_10a0d756-4768-45c7-99c1-0f898b2aa7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_e0882198-430f-4a56-ae3e-022d12262224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_e80288bd-f2cb-4249-9270-ee860db25a3c" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_e0882198-430f-4a56-ae3e-022d12262224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_fce5d3eb-f6fb-4dd8-90f1-b00ba168ed3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_e80288bd-f2cb-4249-9270-ee860db25a3c" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_fce5d3eb-f6fb-4dd8-90f1-b00ba168ed3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_7051433b-8bc4-4fee-bec4-53935d430311" xlink:href="dva-20211231.xsd#dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesOtherInformationAbstract_886a68cf-4e98-4de9-81d1-2090ad048aad" xlink:to="loc_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities_7051433b-8bc4-4fee-bec4-53935d430311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c393813c-3025-42ed-965b-21dc00f74f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_ae3f2c13-c820-4f23-81fd-926a9809e43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c393813c-3025-42ed-965b-21dc00f74f05" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_ae3f2c13-c820-4f23-81fd-926a9809e43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6e5e801b-6bb8-4f58-97da-8b320248a263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_ae3f2c13-c820-4f23-81fd-926a9809e43a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6e5e801b-6bb8-4f58-97da-8b320248a263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_406bdf3e-abad-4c33-93af-acaf70430a71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_ae3f2c13-c820-4f23-81fd-926a9809e43a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_406bdf3e-abad-4c33-93af-acaf70430a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_581b3a56-5ba7-4fd5-96d1-bbcad3a3d19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_ae3f2c13-c820-4f23-81fd-926a9809e43a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_581b3a56-5ba7-4fd5-96d1-bbcad3a3d19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6f925385-e1e2-48f5-bde1-95b22cc82175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_ae3f2c13-c820-4f23-81fd-926a9809e43a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6f925385-e1e2-48f5-bde1-95b22cc82175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9e981caf-45ed-4990-ae96-df24d18e851b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_ae3f2c13-c820-4f23-81fd-926a9809e43a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9e981caf-45ed-4990-ae96-df24d18e851b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9ad495f8-399a-45d8-8e7b-bf660720de63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_ae3f2c13-c820-4f23-81fd-926a9809e43a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9ad495f8-399a-45d8-8e7b-bf660720de63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1854bb38-a755-4257-98c6-4614f8bb703b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_ae3f2c13-c820-4f23-81fd-926a9809e43a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1854bb38-a755-4257-98c6-4614f8bb703b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_302da615-d239-4484-8dff-9993334871d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_ae3f2c13-c820-4f23-81fd-926a9809e43a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_302da615-d239-4484-8dff-9993334871d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_328a4660-532d-4c31-b1c9-ab014b6f952c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_ae3f2c13-c820-4f23-81fd-926a9809e43a" xlink:to="loc_us-gaap_OperatingLeaseLiability_328a4660-532d-4c31-b1c9-ab014b6f952c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_040f4adb-0eba-4744-80be-0d66e4e51487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c393813c-3025-42ed-965b-21dc00f74f05" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_040f4adb-0eba-4744-80be-0d66e4e51487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_69cfbed0-3fc7-4729-8e15-d8d61c42c8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_040f4adb-0eba-4744-80be-0d66e4e51487" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_69cfbed0-3fc7-4729-8e15-d8d61c42c8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_e14563cd-fd43-434d-baf6-a79ff67b9104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_040f4adb-0eba-4744-80be-0d66e4e51487" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_e14563cd-fd43-434d-baf6-a79ff67b9104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_1bb0c145-9609-41ba-bc80-4d1ce3e0ca35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_040f4adb-0eba-4744-80be-0d66e4e51487" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_1bb0c145-9609-41ba-bc80-4d1ce3e0ca35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_dfd89b17-50c0-4025-9c92-521eb08d16a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_040f4adb-0eba-4744-80be-0d66e4e51487" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_dfd89b17-50c0-4025-9c92-521eb08d16a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_df250e22-aadc-4391-b71c-099da982d4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_040f4adb-0eba-4744-80be-0d66e4e51487" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_df250e22-aadc-4391-b71c-099da982d4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bad06057-c8fd-4b89-8bd3-0b8a8404b89d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_040f4adb-0eba-4744-80be-0d66e4e51487" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bad06057-c8fd-4b89-8bd3-0b8a8404b89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1e911cc5-b81c-4e3e-adb8-dc4aa95d7ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_040f4adb-0eba-4744-80be-0d66e4e51487" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1e911cc5-b81c-4e3e-adb8-dc4aa95d7ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_eede5f68-3343-429e-8b4c-2c222c723be3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_040f4adb-0eba-4744-80be-0d66e4e51487" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_eede5f68-3343-429e-8b4c-2c222c723be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_46be17e8-86d8-4978-a63b-e57e8897a744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract_040f4adb-0eba-4744-80be-0d66e4e51487" xlink:to="loc_us-gaap_FinanceLeaseLiability_46be17e8-86d8-4978-a63b-e57e8897a744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureTable_2ff8c613-929c-4278-871b-be0af7cf3330" xlink:href="dva-20211231.xsd#dva_LeasesDisclosureTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c393813c-3025-42ed-965b-21dc00f74f05" xlink:to="loc_dva_LeasesDisclosureTable_2ff8c613-929c-4278-871b-be0af7cf3330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7329aba0-23fd-45d4-8708-bc4be4952691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureTable_2ff8c613-929c-4278-871b-be0af7cf3330" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7329aba0-23fd-45d4-8708-bc4be4952691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5817aad8-ace7-4c48-ba01-946f9d0f3247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7329aba0-23fd-45d4-8708-bc4be4952691" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5817aad8-ace7-4c48-ba01-946f9d0f3247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OperatingLeaseLiabilitiesMember_50caa3f1-3da4-41e4-b407-d768837ab9a4" xlink:href="dva-20211231.xsd#dva_OperatingLeaseLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5817aad8-ace7-4c48-ba01-946f9d0f3247" xlink:to="loc_dva_OperatingLeaseLiabilitiesMember_50caa3f1-3da4-41e4-b407-d768837ab9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_8f1c3d16-eb02-423d-8cc4-5d2f67f4ced4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5817aad8-ace7-4c48-ba01-946f9d0f3247" xlink:to="loc_us-gaap_LongTermDebtMember_8f1c3d16-eb02-423d-8cc4-5d2f67f4ced4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureLineItems_c4b3481c-8c07-4052-9aa3-8fdd89761622" xlink:href="dva-20211231.xsd#dva_LeasesDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureTable_2ff8c613-929c-4278-871b-be0af7cf3330" xlink:to="loc_dva_LeasesDisclosureLineItems_c4b3481c-8c07-4052-9aa3-8fdd89761622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d37a42b9-115c-4293-bbdf-04a0e98f4d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureLineItems_c4b3481c-8c07-4052-9aa3-8fdd89761622" xlink:to="loc_us-gaap_FinanceLeaseLiability_d37a42b9-115c-4293-bbdf-04a0e98f4d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a2e42921-b83b-44ec-8746-5bcdbc414b38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureLineItems_c4b3481c-8c07-4052-9aa3-8fdd89761622" xlink:to="loc_us-gaap_OperatingLeaseLiability_a2e42921-b83b-44ec-8746-5bcdbc414b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LeasesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c2bbd8b4-9065-444e-861c-d8993ebdabb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureTable_481e1317-899e-4b45-850a-959159dc4d59" xlink:href="dva-20211231.xsd#dva_LeasesDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c2bbd8b4-9065-444e-861c-d8993ebdabb7" xlink:to="loc_dva_LeasesDisclosureTable_481e1317-899e-4b45-850a-959159dc4d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e1d46d0a-3f88-470c-a4b0-c33d99245e6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureTable_481e1317-899e-4b45-850a-959159dc4d59" xlink:to="loc_srt_RangeAxis_e1d46d0a-3f88-470c-a4b0-c33d99245e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_27fd543f-3a61-4472-a51a-c4c01fd711b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e1d46d0a-3f88-470c-a4b0-c33d99245e6b" xlink:to="loc_srt_RangeMember_27fd543f-3a61-4472-a51a-c4c01fd711b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f0008066-a1bb-4656-a3e7-1b048dca83fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_27fd543f-3a61-4472-a51a-c4c01fd711b9" xlink:to="loc_srt_MinimumMember_f0008066-a1bb-4656-a3e7-1b048dca83fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e0ae25e4-1363-4ba1-a008-5889a0aa11a8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_27fd543f-3a61-4472-a51a-c4c01fd711b9" xlink:to="loc_srt_MaximumMember_e0ae25e4-1363-4ba1-a008-5889a0aa11a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_5b6fde99-0867-4671-ab86-d21eb45b7cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureTable_481e1317-899e-4b45-850a-959159dc4d59" xlink:to="loc_us-gaap_LeaseContractualTermAxis_5b6fde99-0867-4671-ab86-d21eb45b7cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_f6d0438e-3d1e-4967-9b4e-d032a78730db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_5b6fde99-0867-4671-ab86-d21eb45b7cdb" xlink:to="loc_us-gaap_LeaseContractualTermDomain_f6d0438e-3d1e-4967-9b4e-d032a78730db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OperatingLeaseMember_c8c4b306-e61d-492c-a3db-5df1d4d9f74c" xlink:href="dva-20211231.xsd#dva_OperatingLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_f6d0438e-3d1e-4967-9b4e-d032a78730db" xlink:to="loc_dva_OperatingLeaseMember_c8c4b306-e61d-492c-a3db-5df1d4d9f74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_39480c20-c3b3-45c5-8abc-f2ace27134e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureTable_481e1317-899e-4b45-850a-959159dc4d59" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_39480c20-c3b3-45c5-8abc-f2ace27134e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d2fa1d04-266e-438e-be6f-b1b08d5af712" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_39480c20-c3b3-45c5-8abc-f2ace27134e3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d2fa1d04-266e-438e-be6f-b1b08d5af712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_1d714fbc-14e0-4843-8f53-71118c389269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d2fa1d04-266e-438e-be6f-b1b08d5af712" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_1d714fbc-14e0-4843-8f53-71118c389269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_95ba9c85-62a5-42a5-a11f-e3a9ce12b127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d2fa1d04-266e-438e-be6f-b1b08d5af712" xlink:to="loc_us-gaap_LongTermDebtMember_95ba9c85-62a5-42a5-a11f-e3a9ce12b127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:href="dva-20211231.xsd#dva_LeasesDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureTable_481e1317-899e-4b45-850a-959159dc4d59" xlink:to="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_36671f84-a6a8-4ebf-8f2d-4ab52ed86a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_36671f84-a6a8-4ebf-8f2d-4ab52ed86a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_e0f4369b-8995-4bc9-b2d5-e07a82d74f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_e0f4369b-8995-4bc9-b2d5-e07a82d74f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_ab294e44-8971-43d1-ba3a-43bff8f38314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_ab294e44-8971-43d1-ba3a-43bff8f38314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseAccumulatedDepreciation_7bfe3377-d09d-4ca4-8cf9-bc428723b09b" xlink:href="dva-20211231.xsd#dva_FinanceLeaseAccumulatedDepreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:to="loc_dva_FinanceLeaseAccumulatedDepreciation_7bfe3377-d09d-4ca4-8cf9-bc428723b09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_873ccfd2-0e95-4392-87a0-8a8fc29c9845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_LeasesDisclosureLineItems_44f4d8fb-b4ab-4d74-b286-6d12d4813526" xlink:to="loc_us-gaap_LeaseCost_873ccfd2-0e95-4392-87a0-8a8fc29c9845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EmployeeBenefitPlans" xlink:type="simple" xlink:href="dva-20211231.xsd#EmployeeBenefitPlans"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EmployeeBenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1d10d51c-0204-4c15-a66c-a73a61525210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_9e7aa90b-94cb-4f4f-9a7c-54f2567000ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1d10d51c-0204-4c15-a66c-a73a61525210" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_9e7aa90b-94cb-4f4f-9a7c-54f2567000ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#EmployeeBenefitPlansAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c9a4bd4a-4901-4b78-8838-37925b9789d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7142920e-59b1-43e3-b262-1d1b28057a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c9a4bd4a-4901-4b78-8838-37925b9789d9" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7142920e-59b1-43e3-b262-1d1b28057a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a48df521-d8ff-4332-afd8-09f88a6b11c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7142920e-59b1-43e3-b262-1d1b28057a34" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a48df521-d8ff-4332-afd8-09f88a6b11c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d63a14c8-7b8b-41c5-9a47-9f18bf793f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a48df521-d8ff-4332-afd8-09f88a6b11c5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d63a14c8-7b8b-41c5-9a47-9f18bf793f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansDefinedBenefitMember_e58d0611-f59d-4019-b1ae-82563bad8509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d63a14c8-7b8b-41c5-9a47-9f18bf793f45" xlink:to="loc_us-gaap_OtherPensionPlansDefinedBenefitMember_e58d0611-f59d-4019-b1ae-82563bad8509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67a67702-fdb2-4d37-b348-dbfcb1846e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7142920e-59b1-43e3-b262-1d1b28057a34" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67a67702-fdb2-4d37-b348-dbfcb1846e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_dfedb0ec-4ad6-40f1-ab4f-332169767263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67a67702-fdb2-4d37-b348-dbfcb1846e50" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_dfedb0ec-4ad6-40f1-ab4f-332169767263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AllTrustsMember_3f086c05-66b4-41ea-afc1-0bc09fa27761" xlink:href="dva-20211231.xsd#dva_AllTrustsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_dfedb0ec-4ad6-40f1-ab4f-332169767263" xlink:to="loc_dva_AllTrustsMember_3f086c05-66b4-41ea-afc1-0bc09fa27761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3244a659-7492-47f9-86fb-f989f722fd40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7142920e-59b1-43e3-b262-1d1b28057a34" xlink:to="loc_srt_RangeAxis_3244a659-7492-47f9-86fb-f989f722fd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dc3e9f25-818a-4a31-9121-a31d1b884671" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3244a659-7492-47f9-86fb-f989f722fd40" xlink:to="loc_srt_RangeMember_dc3e9f25-818a-4a31-9121-a31d1b884671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e485cd56-3cf0-44d9-ab98-083b76e37753" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dc3e9f25-818a-4a31-9121-a31d1b884671" xlink:to="loc_srt_MinimumMember_e485cd56-3cf0-44d9-ab98-083b76e37753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1732c644-6cb5-4d17-a2eb-348f216f1c5d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dc3e9f25-818a-4a31-9121-a31d1b884671" xlink:to="loc_srt_MaximumMember_1732c644-6cb5-4d17-a2eb-348f216f1c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7142920e-59b1-43e3-b262-1d1b28057a34" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_95f99aae-544a-416f-9aa0-b33b4015bda0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_95f99aae-544a-416f-9aa0-b33b4015bda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_e9f5ad23-3d93-4b53-9ab7-f4421287106e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_e9f5ad23-3d93-4b53-9ab7-f4421287106e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_fe5682db-8c7e-4c78-a03f-a5407b2424a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_fe5682db-8c7e-4c78-a03f-a5407b2424a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_4b4c4a25-da2c-4884-9405-f64446eca283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_4b4c4a25-da2c-4884-9405-f64446eca283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_b57805e2-af3a-464b-8f78-f3ab64e68602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_b57805e2-af3a-464b-8f78-f3ab64e68602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_fed4676a-de57-43a9-9a6e-ea96cdff5b10" xlink:href="dva-20211231.xsd#dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate_fed4676a-de57-43a9-9a6e-ea96cdff5b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_c23b385e-7a8a-4aec-bd29-3c79dfc17094" xlink:href="dva-20211231.xsd#dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection_c23b385e-7a8a-4aec-bd29-3c79dfc17094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid_516bdbaf-b76a-4609-883b-a2d01f7ca924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid_516bdbaf-b76a-4609-883b-a2d01f7ca924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_24e9433b-f836-4524-b12a-616d22e65e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_296ed97e-0374-4c7c-baa0-1f48d19e78db" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_24e9433b-f836-4524-b12a-616d22e65e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Contingencies" xlink:type="simple" xlink:href="dva-20211231.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_10e65f16-9a74-406c-b33b-95bd10787bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_a659222d-a51c-4cb0-bc34-8e74dd59b62a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_10e65f16-9a74-406c-b33b-95bd10787bcf" xlink:to="loc_us-gaap_LossContingencyDisclosures_a659222d-a51c-4cb0-bc34-8e74dd59b62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#ContingenciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ContingenciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4022fa7d-a836-4be0-ad93-bd1a264f55d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_25898a4b-6582-475a-ad1e-abb207b96aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4022fa7d-a836-4be0-ad93-bd1a264f55d5" xlink:to="loc_us-gaap_OtherCommitmentsTable_25898a4b-6582-475a-ad1e-abb207b96aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_5a717d8f-644c-446c-aa24-52c566f3f4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_25898a4b-6582-475a-ad1e-abb207b96aed" xlink:to="loc_us-gaap_TransactionTypeAxis_5a717d8f-644c-446c-aa24-52c566f3f4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_1cffd40a-4a19-4ced-9426-a10e814fe12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionTypeAxis_5a717d8f-644c-446c-aa24-52c566f3f4eb" xlink:to="loc_us-gaap_TransactionDomain_1cffd40a-4a19-4ced-9426-a10e814fe12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncrementalCashPortionMember_365d1201-f2c0-45ab-a634-8b3ed50ac8c4" xlink:href="dva-20211231.xsd#dva_IncrementalCashPortionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_1cffd40a-4a19-4ced-9426-a10e814fe12f" xlink:to="loc_dva_IncrementalCashPortionMember_365d1201-f2c0-45ab-a634-8b3ed50ac8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidForPortionPreviouslyRefundedMember_1ac4891f-ab2a-44e4-894c-413077ea4857" xlink:href="dva-20211231.xsd#dva_CashPaidForPortionPreviouslyRefundedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_1cffd40a-4a19-4ced-9426-a10e814fe12f" xlink:to="loc_dva_CashPaidForPortionPreviouslyRefundedMember_1ac4891f-ab2a-44e4-894c-413077ea4857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b0d6754a-565f-4db7-b044-c460f9abc596" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_25898a4b-6582-475a-ad1e-abb207b96aed" xlink:to="loc_srt_LitigationCaseAxis_b0d6754a-565f-4db7-b044-c460f9abc596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_33d34f7d-e0f8-4a34-85be-69d190d8488d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_b0d6754a-565f-4db7-b044-c460f9abc596" xlink:to="loc_srt_LitigationCaseTypeDomain_33d34f7d-e0f8-4a34-85be-69d190d8488d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_78b9a5ae-7d02-4230-8bdc-947f1676b88e" xlink:href="dva-20211231.xsd#dva_USAttorneyPrescriptionDrugInvestigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_33d34f7d-e0f8-4a34-85be-69d190d8488d" xlink:to="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_78b9a5ae-7d02-4230-8bdc-947f1676b88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_830225fe-eba4-4fa1-884e-dc70532540ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_25898a4b-6582-475a-ad1e-abb207b96aed" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_830225fe-eba4-4fa1-884e-dc70532540ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_dc06254a-25b4-4527-9aea-a730e6b00464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_830225fe-eba4-4fa1-884e-dc70532540ba" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_dc06254a-25b4-4527-9aea-a730e6b00464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments" xlink:type="simple" xlink:href="dva-20211231.xsd#NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8a9b2b13-68e4-4818-8c05-94133e89f041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_738781d2-e787-4bc0-9e8b-f926a9353e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8a9b2b13-68e4-4818-8c05-94133e89f041" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_738781d2-e787-4bc0-9e8b-f926a9353e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_22b01db2-84eb-41ab-8fe2-2d315417add2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsAndContingenciesDisclosureTable_a03410b1-c2ee-4e20-8664-23035711cfa8" xlink:href="dva-20211231.xsd#dva_CommitmentsAndContingenciesDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_22b01db2-84eb-41ab-8fe2-2d315417add2" xlink:to="loc_dva_CommitmentsAndContingenciesDisclosureTable_a03410b1-c2ee-4e20-8664-23035711cfa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_97480129-c392-44da-8a23-1464c121b09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_a03410b1-c2ee-4e20-8664-23035711cfa8" xlink:to="loc_us-gaap_OtherCommitmentsAxis_97480129-c392-44da-8a23-1464c121b09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_125d047f-09dc-438f-8b71-6785429ec27e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_97480129-c392-44da-8a23-1464c121b09c" xlink:to="loc_us-gaap_OtherCommitmentsDomain_125d047f-09dc-438f-8b71-6785429ec27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember_af1bda7b-05dd-46d7-ad0d-edd41b10847e" xlink:href="dva-20211231.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_125d047f-09dc-438f-8b71-6785429ec27e" xlink:to="loc_dva_CommitmentsToProvideOperatingCapitalMember_af1bda7b-05dd-46d7-ad0d-edd41b10847e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd7c8e9a-cc95-4517-9d8f-8d3d98b3bb76" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_a03410b1-c2ee-4e20-8664-23035711cfa8" xlink:to="loc_srt_RangeAxis_dd7c8e9a-cc95-4517-9d8f-8d3d98b3bb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e09c2679-df47-4c5c-a553-c4a963c427a6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dd7c8e9a-cc95-4517-9d8f-8d3d98b3bb76" xlink:to="loc_srt_RangeMember_e09c2679-df47-4c5c-a553-c4a963c427a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_505089d6-8e74-4776-8ac2-fbffa74dcae3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e09c2679-df47-4c5c-a553-c4a963c427a6" xlink:to="loc_srt_MinimumMember_505089d6-8e74-4776-8ac2-fbffa74dcae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2193e648-84da-4302-a848-2d2e546649e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e09c2679-df47-4c5c-a553-c4a963c427a6" xlink:to="loc_srt_MaximumMember_2193e648-84da-4302-a848-2d2e546649e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_366681ef-4c91-438a-a8ab-4bf0996e81a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_a03410b1-c2ee-4e20-8664-23035711cfa8" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_366681ef-4c91-438a-a8ab-4bf0996e81a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_07e43eb2-7f18-4e53-b0e3-27514969035d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_366681ef-4c91-438a-a8ab-4bf0996e81a2" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_07e43eb2-7f18-4e53-b0e3-27514969035d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EpogenMember_6acbc15e-07ff-4c33-bf8c-1dbe2b1e4960" xlink:href="dva-20211231.xsd#dva_EpogenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_07e43eb2-7f18-4e53-b0e3-27514969035d" xlink:to="loc_dva_EpogenMember_6acbc15e-07ff-4c33-bf8c-1dbe2b1e4960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:href="dva-20211231.xsd#dva_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureTable_a03410b1-c2ee-4e20-8664-23035711cfa8" xlink:to="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DissolutionTermOfJointVentures_446b68ab-a2a2-4320-b36c-5c7663b008ea" xlink:href="dva-20211231.xsd#dva_DissolutionTermOfJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_dva_DissolutionTermOfJointVentures_446b68ab-a2a2-4320-b36c-5c7663b008ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermPurchaseCommitmentExpirationDate_cb4004f4-a43d-4bbf-96f7-c922fdcce5b9" xlink:href="dva-20211231.xsd#dva_LongTermPurchaseCommitmentExpirationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_dva_LongTermPurchaseCommitmentExpirationDate_cb4004f4-a43d-4bbf-96f7-c922fdcce5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_a37d6372-bf00-4417-a0ed-9c6f95ab5868" xlink:href="dva-20211231.xsd#dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired_a37d6372-bf00-4417-a0ed-9c6f95ab5868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_cd8d8978-28d5-4082-bb10-911cda7da509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_cd8d8978-28d5-4082-bb10-911cda7da509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_77cf7585-bdae-4442-ba71-9e51bc1ed536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_77cf7585-bdae-4442-ba71-9e51bc1ed536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_d9efa42b-2cc3-48ff-b86f-14b57c9a7fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_d9efa42b-2cc3-48ff-b86f-14b57c9a7fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_95b84886-9a86-4d8e-8aea-87aece9ab077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_95b84886-9a86-4d8e-8aea-87aece9ab077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_c2d12859-60fd-40da-99d5-11ff0c1c308d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_us-gaap_OtherCommitment_c2d12859-60fd-40da-99d5-11ff0c1c308d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OffBalanceSheetFinancingArrangements_08361815-5c32-40e6-9e0f-b0f1903d2824" xlink:href="dva-20211231.xsd#dva_OffBalanceSheetFinancingArrangements"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CommitmentsAndContingenciesDisclosureLineItems_215874c3-615b-45fd-829b-94de0fbe5bb1" xlink:to="loc_dva_OffBalanceSheetFinancingArrangements_08361815-5c32-40e6-9e0f-b0f1903d2824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Stockbasedcompensation" xlink:type="simple" xlink:href="dva-20211231.xsd#Stockbasedcompensation"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Stockbasedcompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d6965a93-529d-4913-8b44-d4f98a616677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f3809486-fd00-40e6-a09f-4df78ec2b712" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d6965a93-529d-4913-8b44-d4f98a616677" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f3809486-fd00-40e6-a09f-4df78ec2b712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables" xlink:type="simple" xlink:href="dva-20211231.xsd#LongtermIncentiveCompensationandShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_392f2c01-f86b-4b0d-abee-6a5453377150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_d24c5160-a606-44b8-8e2b-69811c80ed9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_392f2c01-f86b-4b0d-abee-6a5453377150" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_d24c5160-a606-44b8-8e2b-69811c80ed9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_31131f5b-858f-460c-ac5b-c7a8da90622d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_392f2c01-f86b-4b0d-abee-6a5453377150" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_31131f5b-858f-460c-ac5b-c7a8da90622d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_5e16ecc5-2639-45c8-ac30-08190b3ceee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_392f2c01-f86b-4b0d-abee-6a5453377150" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_5e16ecc5-2639-45c8-ac30-08190b3ceee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c6c286eb-d5d3-4b4e-a8f4-69cca9f50c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61a57859-88f1-4941-8d53-7f70cd03cb56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c6c286eb-d5d3-4b4e-a8f4-69cca9f50c0b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61a57859-88f1-4941-8d53-7f70cd03cb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_96745fe9-4e17-4e63-8f6d-01b4e99a3ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61a57859-88f1-4941-8d53-7f70cd03cb56" xlink:to="loc_us-gaap_AwardTypeAxis_96745fe9-4e17-4e63-8f6d-01b4e99a3ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_975f5eda-160d-46bc-af30-c619b1b1fb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_96745fe9-4e17-4e63-8f6d-01b4e99a3ea5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_975f5eda-160d-46bc-af30-c619b1b1fb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_af1a037d-26a9-4b51-9e3f-ebcd337ca9be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_975f5eda-160d-46bc-af30-c619b1b1fb48" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_af1a037d-26a9-4b51-9e3f-ebcd337ca9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockUnitMember_fda02ccb-7eda-41cd-bd42-dcadb09491d5" xlink:href="dva-20211231.xsd#dva_StockUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_975f5eda-160d-46bc-af30-c619b1b1fb48" xlink:to="loc_dva_StockUnitMember_fda02ccb-7eda-41cd-bd42-dcadb09491d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61a57859-88f1-4941-8d53-7f70cd03cb56" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a1d49b7f-28ba-45bd-bef7-2483a205b37b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a1d49b7f-28ba-45bd-bef7-2483a205b37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2257f61e-4c7a-4f0c-82c2-90c46a8b99b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a1d49b7f-28ba-45bd-bef7-2483a205b37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2257f61e-4c7a-4f0c-82c2-90c46a8b99b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2607918a-d898-460e-93f8-fe391d5f2b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a1d49b7f-28ba-45bd-bef7-2483a205b37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2607918a-d898-460e-93f8-fe391d5f2b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d7c2d085-c549-420e-aa8b-ed8f15ca7154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a1d49b7f-28ba-45bd-bef7-2483a205b37b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d7c2d085-c549-420e-aa8b-ed8f15ca7154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_bd6be8be-02e0-46d4-8fde-77ca3fadd41d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a1d49b7f-28ba-45bd-bef7-2483a205b37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_bd6be8be-02e0-46d4-8fde-77ca3fadd41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b72138c7-29ab-4d0e-8748-5347e49f0f08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a1d49b7f-28ba-45bd-bef7-2483a205b37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b72138c7-29ab-4d0e-8748-5347e49f0f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_fe30be5d-9bec-4654-a704-e6243311dc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_fe30be5d-9bec-4654-a704-e6243311dc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_71a5fe44-fc09-48bb-bc2c-012a4c397805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_71a5fe44-fc09-48bb-bc2c-012a4c397805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_578a4110-e38b-41d0-9776-f08a38d7ec8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_578a4110-e38b-41d0-9776-f08a38d7ec8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6c9361ed-a413-4033-8996-508d1343a6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_578a4110-e38b-41d0-9776-f08a38d7ec8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6c9361ed-a413-4033-8996-508d1343a6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ce33d86e-a905-4f69-9f16-f48af6027c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_578a4110-e38b-41d0-9776-f08a38d7ec8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ce33d86e-a905-4f69-9f16-f48af6027c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a83dcebf-6486-4714-a980-2c69693849a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_578a4110-e38b-41d0-9776-f08a38d7ec8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a83dcebf-6486-4714-a980-2c69693849a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_069fe8d0-7c40-4f82-a10f-c485a58c3a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_578a4110-e38b-41d0-9776-f08a38d7ec8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_069fe8d0-7c40-4f82-a10f-c485a58c3a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5ef53473-5418-498a-9b50-cf2084ecf930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_578a4110-e38b-41d0-9776-f08a38d7ec8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5ef53473-5418-498a-9b50-cf2084ecf930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6d3c6711-b667-43f1-8bb8-8e739e056589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6d3c6711-b667-43f1-8bb8-8e739e056589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_ca880937-016b-41e2-8f0b-7b9900f3bc13" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_ca880937-016b-41e2-8f0b-7b9900f3bc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b36e2577-9c70-41d3-ad90-d8fb0407b6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_ca880937-016b-41e2-8f0b-7b9900f3bc13" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b36e2577-9c70-41d3-ad90-d8fb0407b6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_377fbf05-a398-4bb4-a7bb-f0c59fe78f92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_ca880937-016b-41e2-8f0b-7b9900f3bc13" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_377fbf05-a398-4bb4-a7bb-f0c59fe78f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_40c920f9-ef93-4df3-8c21-bf476af10f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_40c920f9-ef93-4df3-8c21-bf476af10f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_62181ea6-38d2-4fb2-85a3-64f5a3b2a3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_62181ea6-38d2-4fb2-85a3-64f5a3b2a3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_7c2c4d48-7f25-4e5e-bf03-5febba2b37f3" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod_7c2c4d48-7f25-4e5e-bf03-5febba2b37f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_91447b24-aea7-423a-98c0-7b7c89c9bbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_91447b24-aea7-423a-98c0-7b7c89c9bbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b4622648-f491-4733-a0f8-44a840df625a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b4622648-f491-4733-a0f8-44a840df625a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20a03a68-61c7-4595-8a42-b396b98c783e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5282bd6e-b694-4a64-89ad-558c1a05848d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20a03a68-61c7-4595-8a42-b396b98c783e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_011c6458-be4b-49c4-9e7a-73f9de3ec7e3" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_011c6458-be4b-49c4-9e7a-73f9de3ec7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_293bf91e-dcc4-49f7-93f6-5183d530cb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_293bf91e-dcc4-49f7-93f6-5183d530cb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_92d0e7d0-a414-466a-9672-b4d8cf52b69d" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27722057-1d64-4116-908c-4bde97a2d53d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_92d0e7d0-a414-466a-9672-b4d8cf52b69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_d14e7fbc-5411-4ea7-92bb-2cbd38cad1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_92d0e7d0-a414-466a-9672-b4d8cf52b69d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_d14e7fbc-5411-4ea7-92bb-2cbd38cad1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_641ad394-5159-4a3f-87df-c488a628673a" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract_92d0e7d0-a414-466a-9672-b4d8cf52b69d" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_641ad394-5159-4a3f-87df-c488a628673a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1d1dad3e-8456-4e7e-a989-d33511c5401d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_0dd8c057-983e-400c-8cdf-d284e754da6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1d1dad3e-8456-4e7e-a989-d33511c5401d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_0dd8c057-983e-400c-8cdf-d284e754da6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_02e5d5f2-0e60-44b7-bd5e-8b9d0646b1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_0dd8c057-983e-400c-8cdf-d284e754da6d" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_02e5d5f2-0e60-44b7-bd5e-8b9d0646b1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5d3f7269-66e4-40a4-83bc-f6d9e5186426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_02e5d5f2-0e60-44b7-bd5e-8b9d0646b1bd" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5d3f7269-66e4-40a4-83bc-f6d9e5186426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeOneMember_a98493b5-4c87-4ba2-a054-1c0cae5e5840" xlink:href="dva-20211231.xsd#dva_RangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5d3f7269-66e4-40a4-83bc-f6d9e5186426" xlink:to="loc_dva_RangeOneMember_a98493b5-4c87-4ba2-a054-1c0cae5e5840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeTwoMember_f8a8fee3-5a1c-437e-ba83-b2e068b2387b" xlink:href="dva-20211231.xsd#dva_RangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5d3f7269-66e4-40a4-83bc-f6d9e5186426" xlink:to="loc_dva_RangeTwoMember_f8a8fee3-5a1c-437e-ba83-b2e068b2387b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeThreeMember_bebeb77b-0d95-4b81-acd0-0673371c0109" xlink:href="dva-20211231.xsd#dva_RangeThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5d3f7269-66e4-40a4-83bc-f6d9e5186426" xlink:to="loc_dva_RangeThreeMember_bebeb77b-0d95-4b81-acd0-0673371c0109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RangeFourMember_097155c5-25ee-4460-b9f5-22d8299bea96" xlink:href="dva-20211231.xsd#dva_RangeFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5d3f7269-66e4-40a4-83bc-f6d9e5186426" xlink:to="loc_dva_RangeFourMember_097155c5-25ee-4460-b9f5-22d8299bea96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_0dd8c057-983e-400c-8cdf-d284e754da6d" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_dc654d3e-1fd8-4460-aa3a-51482b4abcef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_dc654d3e-1fd8-4460-aa3a-51482b4abcef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_bc1a7e74-7dfb-44bc-9f43-598e878ddf96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_bc1a7e74-7dfb-44bc-9f43-598e878ddf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_dea6d4ac-1dce-4758-9eb1-347ccb51d62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_dea6d4ac-1dce-4758-9eb1-347ccb51d62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_442fa0a3-fe3d-4798-914b-63ec04577d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_442fa0a3-fe3d-4798-914b-63ec04577d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_83ec5e1b-bb7c-4134-b0a4-6289797cfca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_83ec5e1b-bb7c-4134-b0a4-6289797cfca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_b82171a5-4254-42f9-a0d9-45b8ab963484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e42e1d36-8e3b-46a0-aa9b-d9102307c851" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_b82171a5-4254-42f9-a0d9-45b8ab963484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a5582817-0a59-4c69-b829-d514009a34e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c15d036-ccae-4266-b6fb-a1d9e5010be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a5582817-0a59-4c69-b829-d514009a34e7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c15d036-ccae-4266-b6fb-a1d9e5010be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fc9ed172-74dc-419a-8f89-07e0c2c34170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c15d036-ccae-4266-b6fb-a1d9e5010be2" xlink:to="loc_us-gaap_AwardTypeAxis_fc9ed172-74dc-419a-8f89-07e0c2c34170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b085cdcb-7f64-48f0-9a6f-3721d91f09e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_fc9ed172-74dc-419a-8f89-07e0c2c34170" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b085cdcb-7f64-48f0-9a6f-3721d91f09e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockSettledStockAppreciationRightsMember_f1b7f18a-c48c-42eb-829e-3ab2a8b83f14" xlink:href="dva-20211231.xsd#dva_StockSettledStockAppreciationRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b085cdcb-7f64-48f0-9a6f-3721d91f09e5" xlink:to="loc_dva_StockSettledStockAppreciationRightsMember_f1b7f18a-c48c-42eb-829e-3ab2a8b83f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea11b33e-6311-4640-9c80-9f4c1ad4dcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c15d036-ccae-4266-b6fb-a1d9e5010be2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea11b33e-6311-4640-9c80-9f4c1ad4dcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8292df84-a1fb-4508-bcf2-598a7df8a086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea11b33e-6311-4640-9c80-9f4c1ad4dcfa" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8292df84-a1fb-4508-bcf2-598a7df8a086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_60628253-55a0-4f53-b79f-7a9112a620a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea11b33e-6311-4640-9c80-9f4c1ad4dcfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_60628253-55a0-4f53-b79f-7a9112a620a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ca4cfc16-3f1b-4b30-854d-2bf334db0dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea11b33e-6311-4640-9c80-9f4c1ad4dcfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ca4cfc16-3f1b-4b30-854d-2bf334db0dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f06d0e91-b41b-4778-8ebf-7e0af7b5a22f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ea11b33e-6311-4640-9c80-9f4c1ad4dcfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f06d0e91-b41b-4778-8ebf-7e0af7b5a22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_46e971b4-bcf0-4e89-8648-43e13f3d9f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_46e971b4-bcf0-4e89-8648-43e13f3d9f2c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c660f6c6-898a-4445-ab34-01bf78867fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:to="loc_us-gaap_PlanNameAxis_c660f6c6-898a-4445-ab34-01bf78867fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_551a4cae-e995-4e27-97a2-0d965a2b6a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_c660f6c6-898a-4445-ab34-01bf78867fe0" xlink:to="loc_us-gaap_PlanNameDomain_551a4cae-e995-4e27-97a2-0d965a2b6a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockIncentivePlanTwentyTwentyMember_32b90196-ac11-4cff-91a7-fb4c14e3886b" xlink:href="dva-20211231.xsd#dva_StockIncentivePlanTwentyTwentyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_551a4cae-e995-4e27-97a2-0d965a2b6a9c" xlink:to="loc_dva_StockIncentivePlanTwentyTwentyMember_32b90196-ac11-4cff-91a7-fb4c14e3886b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockIncentivePlanTwentyElevenMember_70cb9c92-2516-405a-9825-a2e3598f51ab" xlink:href="dva-20211231.xsd#dva_StockIncentivePlanTwentyElevenMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_551a4cae-e995-4e27-97a2-0d965a2b6a9c" xlink:to="loc_dva_StockIncentivePlanTwentyElevenMember_70cb9c92-2516-405a-9825-a2e3598f51ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_f602cc34-1ecc-4cd7-80dd-99a4bc349ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:to="loc_us-gaap_VestingAxis_f602cc34-1ecc-4cd7-80dd-99a4bc349ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_c4016264-86f1-43d5-ba80-848baae9c868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_f602cc34-1ecc-4cd7-80dd-99a4bc349ed2" xlink:to="loc_us-gaap_VestingDomain_c4016264-86f1-43d5-ba80-848baae9c868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1b7110c1-fc65-4e52-8b4a-19b412e16303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_c4016264-86f1-43d5-ba80-848baae9c868" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1b7110c1-fc65-4e52-8b4a-19b412e16303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_314224f1-2a48-447a-8c2d-e68b3d642aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_c4016264-86f1-43d5-ba80-848baae9c868" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_314224f1-2a48-447a-8c2d-e68b3d642aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c7e078b8-098f-4752-9105-422b8e1d57d2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:to="loc_srt_RangeAxis_c7e078b8-098f-4752-9105-422b8e1d57d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8faefe06-6429-40fb-858d-1c23149d6a2c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c7e078b8-098f-4752-9105-422b8e1d57d2" xlink:to="loc_srt_RangeMember_8faefe06-6429-40fb-858d-1c23149d6a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_93e60f8f-47f4-40cb-bb59-a0d31ce9cb2d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8faefe06-6429-40fb-858d-1c23149d6a2c" xlink:to="loc_srt_MinimumMember_93e60f8f-47f4-40cb-bb59-a0d31ce9cb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d3f8e92c-2a7e-4017-8ec6-c477240603b3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8faefe06-6429-40fb-858d-1c23149d6a2c" xlink:to="loc_srt_MaximumMember_d3f8e92c-2a7e-4017-8ec6-c477240603b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0d40bd94-b64a-4601-a0f7-50eb3a2dd0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:to="loc_us-gaap_AwardTypeAxis_0d40bd94-b64a-4601-a0f7-50eb3a2dd0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32062b2c-7eea-4166-b7ba-5a379069f36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0d40bd94-b64a-4601-a0f7-50eb3a2dd0bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32062b2c-7eea-4166-b7ba-5a379069f36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumPricedStockSettledStockAppreciationRightsMember_1afddf80-e885-448b-938f-8215d40c79e7" xlink:href="dva-20211231.xsd#dva_PremiumPricedStockSettledStockAppreciationRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32062b2c-7eea-4166-b7ba-5a379069f36f" xlink:to="loc_dva_PremiumPricedStockSettledStockAppreciationRightsMember_1afddf80-e885-448b-938f-8215d40c79e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeeStockPurchasePlanMember_c4b70832-428a-4fd8-a646-f474a73220c8" xlink:href="dva-20211231.xsd#dva_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32062b2c-7eea-4166-b7ba-5a379069f36f" xlink:to="loc_dva_EmployeeStockPurchasePlanMember_c4b70832-428a-4fd8-a646-f474a73220c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_14d033cb-5950-44dc-9719-75923a09a2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_14d033cb-5950-44dc-9719-75923a09a2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_737a4b59-fc0d-4fcc-aee7-27034f5c624d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_14d033cb-5950-44dc-9719-75923a09a2f2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_737a4b59-fc0d-4fcc-aee7-27034f5c624d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_244a20c8-a8a3-48ca-8108-1135a1476329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_737a4b59-fc0d-4fcc-aee7-27034f5c624d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_244a20c8-a8a3-48ca-8108-1135a1476329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03669ab6-bed5-4a87-9da7-6e30863f0843" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8f5fd551-0b60-44d6-a8f9-591ce757c43b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_8f5fd551-0b60-44d6-a8f9-591ce757c43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_25f16e70-0d9d-4460-87eb-170e9273629a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_25f16e70-0d9d-4460-87eb-170e9273629a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ec66073e-1091-4a99-877e-aad296dcbcac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ec66073e-1091-4a99-877e-aad296dcbcac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_738a382d-c6a7-4023-9250-d57f05c4bf0f" xlink:href="dva-20211231.xsd#dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions_738a382d-c6a7-4023-9250-d57f05c4bf0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_84f09561-6f6e-41b4-a573-197edbde47be" xlink:href="dva-20211231.xsd#dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance_84f09561-6f6e-41b4-a573-197edbde47be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_0e0fe807-fba7-4097-b92e-8a2e14a39e6a" xlink:href="dva-20211231.xsd#dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward_0e0fe807-fba7-4097-b92e-8a2e14a39e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_586d406e-c50e-4612-9c33-61dca7550d7d" xlink:href="dva-20211231.xsd#dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance_586d406e-c50e-4612-9c33-61dca7550d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_24b9159d-dab1-4eca-b5e2-c8bb0d739fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_24b9159d-dab1-4eca-b5e2-c8bb0d739fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_1fce041d-fca1-409a-9581-ebdce468685b" xlink:href="dva-20211231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio_1fce041d-fca1-409a-9581-ebdce468685b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_e00f3d16-3fea-4d07-a8b9-248cb783e35e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_e00f3d16-3fea-4d07-a8b9-248cb783e35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_01aaf03c-ac93-4c5f-ad4d-065e200bc51e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_01aaf03c-ac93-4c5f-ad4d-065e200bc51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_5e816783-f138-4a11-98e9-7e2357da577f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_5e816783-f138-4a11-98e9-7e2357da577f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_8aad2577-71a6-4d16-9675-1b3070bbfb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_8aad2577-71a6-4d16-9675-1b3070bbfb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_69ce4d56-2117-43df-8917-a6958dd975dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_69ce4d56-2117-43df-8917-a6958dd975dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumPricedAwardBasePricePerShare_b58cd183-9854-4e0b-9321-001f68806bbf" xlink:href="dva-20211231.xsd#dva_PremiumPricedAwardBasePricePerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_PremiumPricedAwardBasePricePerShare_b58cd183-9854-4e0b-9321-001f68806bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PremiumToTheTenderOfferSharePurchasePrice_85d24125-9dd1-4dbf-a159-333acdacce14" xlink:href="dva-20211231.xsd#dva_PremiumToTheTenderOfferSharePurchasePrice"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_PremiumToTheTenderOfferSharePurchasePrice_85d24125-9dd1-4dbf-a159-333acdacce14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_67f848f2-8b8a-4080-8ee5-b74b92125b46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_67f848f2-8b8a-4080-8ee5-b74b92125b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_758e1a07-ae3a-4b8f-9327-6d1580a60da5" xlink:href="dva-20211231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate_758e1a07-ae3a-4b8f-9327-6d1580a60da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_5f2152bd-05af-438e-8ad4-220c1f7c0d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_5f2152bd-05af-438e-8ad4-220c1f7c0d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_1ba11117-750d-4ca2-847e-1be49adfbc0b" xlink:href="dva-20211231.xsd#dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate_1ba11117-750d-4ca2-847e-1be49adfbc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_f8418b37-7bd5-4182-9ede-908294d892c1" xlink:href="dva-20211231.xsd#dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase_f8418b37-7bd5-4182-9ede-908294d892c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1e5d5638-e79f-4b37-9206-ca3bbea122dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1e5d5638-e79f-4b37-9206-ca3bbea122dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_4508cb72-d2b4-4887-802e-1f0ad543594c" xlink:href="dva-20211231.xsd#dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares_4508cb72-d2b4-4887-802e-1f0ad543594c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_42f77e72-46b8-440b-b23b-2456e2a720fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_42f77e72-46b8-440b-b23b-2456e2a720fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f76d91ff-f5d9-4c6e-b295-5faeb39a4944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f76d91ff-f5d9-4c6e-b295-5faeb39a4944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a44e87df-b7fa-4124-91b5-19e7de8159d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a44e87df-b7fa-4124-91b5-19e7de8159d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_d30171ff-92af-44ee-b67a-3de22e37307f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_d30171ff-92af-44ee-b67a-3de22e37307f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e6bcf08f-0617-49f2-ae45-a9cb84550e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e6bcf08f-0617-49f2-ae45-a9cb84550e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c268df96-6068-4e4f-995e-184a3996dc87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ShareBasedCompensation_c268df96-6068-4e4f-995e-184a3996dc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_444d1a7c-9b0f-49c9-b515-5246e6faafe3" xlink:href="dva-20211231.xsd#dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense_444d1a7c-9b0f-49c9-b515-5246e6faafe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_06d8a382-a82e-4e2c-98fd-1dcc688c94ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_06d8a382-a82e-4e2c-98fd-1dcc688c94ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9bddf630-e082-453f-b07d-7a3230ce6402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9bddf630-e082-453f-b07d-7a3230ce6402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_757f0c38-940e-4f7a-a08f-6f14a6204e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_757f0c38-940e-4f7a-a08f-6f14a6204e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_d1bf0f6d-7275-4bbe-8c28-ae424a77f136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c7fa09f-5aad-493d-becb-db7e3fe16fee" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_d1bf0f6d-7275-4bbe-8c28-ae424a77f136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Stockholdersequity" xlink:type="simple" xlink:href="dva-20211231.xsd#Stockholdersequity"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Stockholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c7308125-cc05-4740-9386-605ad96a2f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock_bac9e32a-e7df-48f7-94cf-6e88627d819f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c7308125-cc05-4740-9386-605ad96a2f68" xlink:to="loc_us-gaap_TreasuryStockTextBlock_bac9e32a-e7df-48f7-94cf-6e88627d819f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/StockholdersequityTables" xlink:type="simple" xlink:href="dva-20211231.xsd#StockholdersequityTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/StockholdersequityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c0deed84-d92f-462b-b532-7aa6a0e7c9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_f37781a5-6067-4489-8778-fa1442f15236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c0deed84-d92f-462b-b532-7aa6a0e7c9d7" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_f37781a5-6067-4489-8778-fa1442f15236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock_3fe01cb6-c367-4f80-8164-1bd7e5ee3b78" xlink:href="dva-20211231.xsd#dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c0deed84-d92f-462b-b532-7aa6a0e7c9d7" xlink:to="loc_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock_3fe01cb6-c367-4f80-8164-1bd7e5ee3b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/StockRepurchasesTenderOfferDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#StockRepurchasesTenderOfferDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/StockRepurchasesTenderOfferDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAbstract_a65ee176-9b36-4e02-b7e6-23bc18e21bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_2db647a4-b8d5-4aec-862b-d9760cde446c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockValueAbstract_a65ee176-9b36-4e02-b7e6-23bc18e21bce" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_2db647a4-b8d5-4aec-862b-d9760cde446c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_308a36ed-479a-406b-accb-442e60ede78d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_2db647a4-b8d5-4aec-862b-d9760cde446c" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_308a36ed-479a-406b-accb-442e60ede78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_699713f4-07f8-4e4a-89e9-fd1c019e90a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_308a36ed-479a-406b-accb-442e60ede78d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_699713f4-07f8-4e4a-89e9-fd1c019e90a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OpenMarketPurchasesMember_f499e6a1-61a7-4191-a682-70f5ae4aebf4" xlink:href="dva-20211231.xsd#dva_OpenMarketPurchasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_699713f4-07f8-4e4a-89e9-fd1c019e90a2" xlink:to="loc_dva_OpenMarketPurchasesMember_f499e6a1-61a7-4191-a682-70f5ae4aebf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TenderOfferMember_9438416c-9e6d-406b-bc6f-73c777b971b1" xlink:href="dva-20211231.xsd#dva_TenderOfferMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_699713f4-07f8-4e4a-89e9-fd1c019e90a2" xlink:to="loc_dva_TenderOfferMember_9438416c-9e6d-406b-bc6f-73c777b971b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e9401232-f0a5-40a6-af6b-125ec264e180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_2db647a4-b8d5-4aec-862b-d9760cde446c" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e9401232-f0a5-40a6-af6b-125ec264e180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_d7263442-a33b-488e-9030-249c8bb4c09b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e9401232-f0a5-40a6-af6b-125ec264e180" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_d7263442-a33b-488e-9030-249c8bb4c09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_67bfe197-3668-42fb-ac25-80fae33b6284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e9401232-f0a5-40a6-af6b-125ec264e180" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_67bfe197-3668-42fb-ac25-80fae33b6284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_077e4caa-a6c9-4a0b-a853-1948b630d99e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e9401232-f0a5-40a6-af6b-125ec264e180" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_077e4caa-a6c9-4a0b-a853-1948b630d99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAbstract_bf355a7a-9e84-4a4e-8b33-3dbc1aeca7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e9401232-f0a5-40a6-af6b-125ec264e180" xlink:to="loc_us-gaap_TreasuryStockSharesAbstract_bf355a7a-9e84-4a4e-8b33-3dbc1aeca7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_8351d671-e758-4440-81d3-ae2a3a1e1bb2" xlink:href="dva-20211231.xsd#dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_bf355a7a-9e84-4a4e-8b33-3dbc1aeca7d3" xlink:to="loc_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice_8351d671-e758-4440-81d3-ae2a3a1e1bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ShareRepurchaseFeesAndExpenses_be95348a-babd-47f1-808f-409a9dac06a7" xlink:href="dva-20211231.xsd#dva_ShareRepurchaseFeesAndExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_bf355a7a-9e84-4a4e-8b33-3dbc1aeca7d3" xlink:to="loc_dva_ShareRepurchaseFeesAndExpenses_be95348a-babd-47f1-808f-409a9dac06a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract_3f3bec0c-92ab-438c-adab-041edd3b48a5" xlink:href="dva-20211231.xsd#dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_6ef4095c-d2c0-4b64-9830-6c5d38cd0eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract_3f3bec0c-92ab-438c-adab-041edd3b48a5" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_6ef4095c-d2c0-4b64-9830-6c5d38cd0eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_90a738f6-2d6e-4f34-be42-9b1de7308581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_6ef4095c-d2c0-4b64-9830-6c5d38cd0eda" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_90a738f6-2d6e-4f34-be42-9b1de7308581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_eba9398d-9595-428c-a4a8-ca678b7b93d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_90a738f6-2d6e-4f34-be42-9b1de7308581" xlink:to="loc_us-gaap_EquityComponentDomain_eba9398d-9595-428c-a4a8-ca678b7b93d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_49045594-6690-4e71-b85d-f182abb5b766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_eba9398d-9595-428c-a4a8-ca678b7b93d0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_49045594-6690-4e71-b85d-f182abb5b766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_4da42bd3-b033-48d1-8496-ca805aeff203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_6ef4095c-d2c0-4b64-9830-6c5d38cd0eda" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_4da42bd3-b033-48d1-8496-ca805aeff203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_92857f66-c658-4106-995f-a3f8174042f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_4da42bd3-b033-48d1-8496-ca805aeff203" xlink:to="loc_us-gaap_NetIncomeLoss_92857f66-c658-4106-995f-a3f8174042f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_4da42bd3-b033-48d1-8496-ca805aeff203" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_2fb93980-b310-4c62-9af2-4dfa166c6b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_2fb93980-b310-4c62-9af2-4dfa166c6b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_0aafe3ac-91b2-4580-bc81-8499b65ec3ef" xlink:href="dva-20211231.xsd#dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:to="loc_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests_0aafe3ac-91b2-4580-bc81-8499b65ec3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_518c6880-a3c1-48ed-8843-6e3048ee00b7" xlink:href="dva-20211231.xsd#dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:to="loc_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests_518c6880-a3c1-48ed-8843-6e3048ee00b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_40ba3d82-a8c6-4666-a376-b82fac1c4486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_40ba3d82-a8c6-4666-a376-b82fac1c4486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_936bb82f-17e1-46b7-b0e6-38720a03a219" xlink:href="dva-20211231.xsd#dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract_aed357c1-b6d0-47c5-bb4e-5129142a2ceb" xlink:to="loc_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests_936bb82f-17e1-46b7-b0e6-38720a03a219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ShareholdersequityDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#ShareholdersequityDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ShareholdersequityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_589ffc42-c9c3-4a10-b792-6abe3be0b69e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_52769925-305e-4566-add3-139dc54562be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_589ffc42-c9c3-4a10-b792-6abe3be0b69e" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_52769925-305e-4566-add3-139dc54562be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_89031451-2375-421c-bf65-bece390b5944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_52769925-305e-4566-add3-139dc54562be" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_89031451-2375-421c-bf65-bece390b5944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_03ccb939-3922-4d39-9402-fa832a6c442a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_89031451-2375-421c-bf65-bece390b5944" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_03ccb939-3922-4d39-9402-fa832a6c442a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_00f3570b-a4e0-4550-bdb3-1c71339525f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_03ccb939-3922-4d39-9402-fa832a6c442a" xlink:to="loc_us-gaap_SubsequentEventMember_00f3570b-a4e0-4550-bdb3-1c71339525f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_182beaec-7dc6-4c3f-8fb3-ff04d552d7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_52769925-305e-4566-add3-139dc54562be" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_182beaec-7dc6-4c3f-8fb3-ff04d552d7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1933790f-ad08-4740-875d-282da9a47544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_182beaec-7dc6-4c3f-8fb3-ff04d552d7fd" xlink:to="loc_us-gaap_EquityComponentDomain_1933790f-ad08-4740-875d-282da9a47544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_19c0c168-c863-492a-a234-22487d7f24a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1933790f-ad08-4740-875d-282da9a47544" xlink:to="loc_us-gaap_TreasuryStockMember_19c0c168-c863-492a-a234-22487d7f24a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c45fccbf-0c86-4f57-90a0-5038a1a9d0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_52769925-305e-4566-add3-139dc54562be" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c45fccbf-0c86-4f57-90a0-5038a1a9d0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c45fccbf-0c86-4f57-90a0-5038a1a9d0d0" xlink:to="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_26476391-d6c4-434b-a766-ca7eaf15aa41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_26476391-d6c4-434b-a766-ca7eaf15aa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_67e2b044-7810-4742-b4d3-b9f5833e71e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_67e2b044-7810-4742-b4d3-b9f5833e71e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_999a0848-679f-444f-a7f3-5ca92f1aa61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_999a0848-679f-444f-a7f3-5ca92f1aa61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_8f1102f8-6cb1-4ee8-8c6a-849cbafb1944" xlink:href="dva-20211231.xsd#dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount_8f1102f8-6cb1-4ee8-8c6a-849cbafb1944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4aa687b1-eb2b-440d-8059-dd572d5daf26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4aa687b1-eb2b-440d-8059-dd572d5daf26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c92eb571-c110-4d04-9a82-6ebbef60cbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c92eb571-c110-4d04-9a82-6ebbef60cbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_6852d9f4-1893-4264-97a6-1d63efb0c80f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockSharesAbstract_ee12530a-9d7d-4bd1-8da6-af6c5b8872d2" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_6852d9f4-1893-4264-97a6-1d63efb0c80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CharterdocumentsandDelawarelawAbstract_85fe226c-cad9-4380-ac6b-70dd2a2b3db6" xlink:href="dva-20211231.xsd#dva_CharterdocumentsandDelawarelawAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c45fccbf-0c86-4f57-90a0-5038a1a9d0d0" xlink:to="loc_dva_CharterdocumentsandDelawarelawAbstract_85fe226c-cad9-4380-ac6b-70dd2a2b3db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b312ef20-b623-4779-9d4e-7798c4ce69c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract_85fe226c-cad9-4380-ac6b-70dd2a2b3db6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b312ef20-b623-4779-9d4e-7798c4ce69c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_5c3f4645-6abd-41d7-9000-71b4c82478a1" xlink:href="dva-20211231.xsd#dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract_85fe226c-cad9-4380-ac6b-70dd2a2b3db6" xlink:to="loc_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation_5c3f4645-6abd-41d7-9000-71b4c82478a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_c58220fb-b57d-4c70-a8dd-9bbd33af5e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CharterdocumentsandDelawarelawAbstract_85fe226c-cad9-4380-ac6b-70dd2a2b3db6" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_c58220fb-b57d-4c70-a8dd-9bbd33af5e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome" xlink:type="simple" xlink:href="dva-20211231.xsd#AccumulatedOtherComprehensiveLossIncome"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b618a4da-f657-4ba1-bdd3-f44ec7aefb47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a0e8d5bc-a77b-4fda-bd73-0862bfb6a5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b618a4da-f657-4ba1-bdd3-f44ec7aefb47" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a0e8d5bc-a77b-4fda-bd73-0862bfb6a5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables" xlink:type="simple" xlink:href="dva-20211231.xsd#AccumulatedOtherComprehensiveLossIncomeTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_32a51299-6478-4b14-8a5b-70c792711230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5970eb74-67dc-44d6-be41-51b3efc633c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_32a51299-6478-4b14-8a5b-70c792711230" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5970eb74-67dc-44d6-be41-51b3efc633c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#AccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_830c01e8-c14a-4c8e-b98d-b763cdddeaf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d9beb75b-1aea-4acd-83cb-c1be5f9d82df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_830c01e8-c14a-4c8e-b98d-b763cdddeaf5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d9beb75b-1aea-4acd-83cb-c1be5f9d82df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_24fadc90-597b-4eb5-ad4a-cce2ce8faea8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d9beb75b-1aea-4acd-83cb-c1be5f9d82df" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_24fadc90-597b-4eb5-ad4a-cce2ce8faea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0f97554e-914e-4e7c-9878-d4c2b55deef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_24fadc90-597b-4eb5-ad4a-cce2ce8faea8" xlink:to="loc_us-gaap_EquityComponentDomain_0f97554e-914e-4e7c-9878-d4c2b55deef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_54de4232-4ab5-4fe8-9565-411dcdbce6db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0f97554e-914e-4e7c-9878-d4c2b55deef2" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_54de4232-4ab5-4fe8-9565-411dcdbce6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_0875059e-e16c-4e7d-8af2-5bd68f768edb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0f97554e-914e-4e7c-9878-d4c2b55deef2" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_0875059e-e16c-4e7d-8af2-5bd68f768edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_adf07f39-b203-49da-bf5a-93bf53bee7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0f97554e-914e-4e7c-9878-d4c2b55deef2" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_adf07f39-b203-49da-bf5a-93bf53bee7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d9beb75b-1aea-4acd-83cb-c1be5f9d82df" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e635c7a7-8790-43ef-b293-8d5ff1334f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e635c7a7-8790-43ef-b293-8d5ff1334f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_84ea8113-b92d-49cd-ad7c-32b97fb93131" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_84ea8113-b92d-49cd-ad7c-32b97fb93131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_7584f32a-9181-4739-b81f-f381439471d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_7584f32a-9181-4739-b81f-f381439471d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_6ade09d6-3123-4e98-a3d6-257c92b3bc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_6ade09d6-3123-4e98-a3d6-257c92b3bc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_8893e718-2392-4f26-b6e4-6f6f63c4cf58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_8893e718-2392-4f26-b6e4-6f6f63c4cf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7ddeb584-88b0-4c21-8949-896b2941d69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7ddeb584-88b0-4c21-8949-896b2941d69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_035dc033-5836-45d2-b856-76edbd657058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_035dc033-5836-45d2-b856-76edbd657058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f4e2696a-6922-4054-a196-cef7ca8bd8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f5efb28c-1262-4ae1-bfa9-c7192abfeb3f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f4e2696a-6922-4054-a196-cef7ca8bd8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestitures" xlink:type="simple" xlink:href="dva-20211231.xsd#AcquisitionsandDivestitures"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_c9a21d56-2e72-46a7-a240-d1d111c42ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_d5698847-5f39-4d82-940d-143727d74bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_c9a21d56-2e72-46a7-a240-d1d111c42ff0" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_d5698847-5f39-4d82-940d-143727d74bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="dva-20211231.xsd#AcquisitionsandDivestituresTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_37a786f9-991b-4046-ac07-9e9dd80028b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_0931dd09-446d-47c7-8daf-60eaa2887b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_37a786f9-991b-4046-ac07-9e9dd80028b3" xlink:to="loc_us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_0931dd09-446d-47c7-8daf-60eaa2887b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_90f651a1-2b2f-470b-bebb-db4146f82c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_37a786f9-991b-4046-ac07-9e9dd80028b3" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_90f651a1-2b2f-470b-bebb-db4146f82c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock_53c60313-a93b-4497-920e-1f3506551b41" xlink:href="dva-20211231.xsd#dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_37a786f9-991b-4046-ac07-9e9dd80028b3" xlink:to="loc_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock_53c60313-a93b-4497-920e-1f3506551b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_1fa7807f-cd90-432f-bbfe-0473adaf7329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_37a786f9-991b-4046-ac07-9e9dd80028b3" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_1fa7807f-cd90-432f-bbfe-0473adaf7329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_f178874f-a3f2-4385-9ad2-e5266701868c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_37a786f9-991b-4046-ac07-9e9dd80028b3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_f178874f-a3f2-4385-9ad2-e5266701868c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#AcquisitionsComponentsofRoutineAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_297fdcb8-3fb7-4cc6-82c7-c619def60190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dd470d23-0624-41fb-8118-fe693fd4adc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_297fdcb8-3fb7-4cc6-82c7-c619def60190" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dd470d23-0624-41fb-8118-fe693fd4adc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3801424e-7c4e-42ce-817d-973e1f7341ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dd470d23-0624-41fb-8118-fe693fd4adc6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3801424e-7c4e-42ce-817d-973e1f7341ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9900b322-fdc6-4333-8638-73432f783418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3801424e-7c4e-42ce-817d-973e1f7341ea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9900b322-fdc6-4333-8638-73432f783418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_f296bf01-09a1-4e02-839d-c7d75f88f2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9900b322-fdc6-4333-8638-73432f783418" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_f296bf01-09a1-4e02-839d-c7d75f88f2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0e15d3d5-a959-41a8-b730-1667f9bc7b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dd470d23-0624-41fb-8118-fe693fd4adc6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0e15d3d5-a959-41a8-b730-1667f9bc7b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_45e5e683-51f5-4cfc-842b-157f0a1f26e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0e15d3d5-a959-41a8-b730-1667f9bc7b09" xlink:to="loc_us-gaap_SegmentDomain_45e5e683-51f5-4cfc-842b-157f0a1f26e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_615b977b-7d67-416d-8312-a871fdbdb623" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_45e5e683-51f5-4cfc-842b-157f0a1f26e3" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_615b977b-7d67-416d-8312-a871fdbdb623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignDialysisCentersMember_ca3840f8-174f-4c27-a7aa-f19f4e41db1f" xlink:href="dva-20211231.xsd#dva_ForeignDialysisCentersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_45e5e683-51f5-4cfc-842b-157f0a1f26e3" xlink:to="loc_dva_ForeignDialysisCentersMember_ca3840f8-174f-4c27-a7aa-f19f4e41db1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dd470d23-0624-41fb-8118-fe693fd4adc6" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1deb9dab-8b9b-4905-ae85-63c3e0fcebf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1deb9dab-8b9b-4905-ae85-63c3e0fcebf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_a62872ef-9c00-4658-8006-5976a6a2693f" xlink:href="dva-20211231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_a62872ef-9c00-4658-8006-5976a6a2693f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_8096312e-3678-4fb7-ab9a-a8d18c74025b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_8096312e-3678-4fb7-ab9a-a8d18c74025b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_43af7c2f-0ac2-4c7e-8256-f0de14079258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_43af7c2f-0ac2-4c7e-8256-f0de14079258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_fc2e7744-0c14-4bb1-90da-52599d65e2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_fc2e7744-0c14-4bb1-90da-52599d65e2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_7880ff0f-fda6-462b-baba-77936f4579c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c53bcc38-9344-46b0-b2fc-eb66620808f3" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_7880ff0f-fda6-462b-baba-77936f4579c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#AcquisitionsAssetsacquiredandliabilitiesassumedDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7415e282-1f3e-400b-9c5a-46dfe6cf2729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dc507b80-23b9-449c-a1fe-558ed9c8a682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7415e282-1f3e-400b-9c5a-46dfe6cf2729" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dc507b80-23b9-449c-a1fe-558ed9c8a682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_207ed600-c586-4079-a6ae-e8a38126090f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dc507b80-23b9-449c-a1fe-558ed9c8a682" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_207ed600-c586-4079-a6ae-e8a38126090f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc3b70ae-9cc8-4640-afbb-94dd6d5f7b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_207ed600-c586-4079-a6ae-e8a38126090f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc3b70ae-9cc8-4640-afbb-94dd6d5f7b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_b365d00b-c46e-4c05-a45f-9c6146de5082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc3b70ae-9cc8-4640-afbb-94dd6d5f7b9e" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_b365d00b-c46e-4c05-a45f-9c6146de5082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_dc507b80-23b9-449c-a1fe-558ed9c8a682" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_73e2b5c3-ef6f-4677-94c5-a1ccef1f06ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_73e2b5c3-ef6f-4677-94c5-a1ccef1f06ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8a0f3504-4d7d-4c23-a0b8-df5b06072f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8a0f3504-4d7d-4c23-a0b8-df5b06072f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2a61e560-ea70-4216-82d9-92de6d4730a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2a61e560-ea70-4216-82d9-92de6d4730a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9d2089f4-5574-4b23-ac4b-19b71b341cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9d2089f4-5574-4b23-ac4b-19b71b341cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_1caaf964-b318-4664-9fc2-bd4fb9555428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_1caaf964-b318-4664-9fc2-bd4fb9555428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e5969a35-932b-4c0a-911c-bb517d5df139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_Goodwill_e5969a35-932b-4c0a-911c-bb517d5df139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_74b4b824-60c7-43b0-a597-7a1ef30d084a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_74b4b824-60c7-43b0-a597-7a1ef30d084a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_d7f1053e-2fd8-474a-9294-89403708d3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_d7f1053e-2fd8-474a-9294-89403708d3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_81e1aa6b-9b0f-46ba-a33a-2fc3a7801840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_81e1aa6b-9b0f-46ba-a33a-2fc3a7801840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5dce728c-d64f-4ec4-a045-14f250c8284e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_441261f2-9ef3-4e8f-bac5-b1f8466f60e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5dce728c-d64f-4ec4-a045-14f250c8284e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_9833cf8a-715f-4e2a-ac20-aa313974778e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66c3a278-f99f-4fa0-91ed-46fc87dcbdbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9833cf8a-715f-4e2a-ac20-aa313974778e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66c3a278-f99f-4fa0-91ed-46fc87dcbdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d23aef9-e3f4-435b-ab83-c72b5515a200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66c3a278-f99f-4fa0-91ed-46fc87dcbdbf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d23aef9-e3f4-435b-ab83-c72b5515a200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68666888-608c-4961-8dd7-38dffd3205ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d23aef9-e3f4-435b-ab83-c72b5515a200" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68666888-608c-4961-8dd7-38dffd3205ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_76974447-f635-49db-8532-12fb7b33a187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68666888-608c-4961-8dd7-38dffd3205ad" xlink:to="loc_us-gaap_CustomerRelationshipsMember_76974447-f635-49db-8532-12fb7b33a187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_d2f1a178-7c4c-44cb-8293-be47112771cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_68666888-608c-4961-8dd7-38dffd3205ad" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_d2f1a178-7c4c-44cb-8293-be47112771cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_af115f03-62a3-4622-b8b2-a1c0df85ae5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66c3a278-f99f-4fa0-91ed-46fc87dcbdbf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_af115f03-62a3-4622-b8b2-a1c0df85ae5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a7aaeeb3-d82d-41be-bef0-096770e3c35d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_af115f03-62a3-4622-b8b2-a1c0df85ae5b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a7aaeeb3-d82d-41be-bef0-096770e3c35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_01685bc2-c516-450f-9f20-2c2f13b9984d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a7aaeeb3-d82d-41be-bef0-096770e3c35d" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_01685bc2-c516-450f-9f20-2c2f13b9984d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_239cdeab-112d-40be-a970-912fa23c44ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66c3a278-f99f-4fa0-91ed-46fc87dcbdbf" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_239cdeab-112d-40be-a970-912fa23c44ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_95727be0-2189-4013-b7f0-23d80eddef6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_239cdeab-112d-40be-a970-912fa23c44ac" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_95727be0-2189-4013-b7f0-23d80eddef6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_d00a8504-479d-4b19-8352-283c0d2a4b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_239cdeab-112d-40be-a970-912fa23c44ac" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_d00a8504-479d-4b19-8352-283c0d2a4b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_3d8833ba-64a3-4e1f-bc27-063c4c7a579e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_69143460-060b-4bed-a6a2-c6077c871796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3d8833ba-64a3-4e1f-bc27-063c4c7a579e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_69143460-060b-4bed-a6a2-c6077c871796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_7aa09a82-4426-4ecf-b745-3002ec5affaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3d8833ba-64a3-4e1f-bc27-063c4c7a579e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_7aa09a82-4426-4ecf-b745-3002ec5affaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_fc13db98-282c-4f25-a491-a72ec9a4cf5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3d8833ba-64a3-4e1f-bc27-063c4c7a579e" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_fc13db98-282c-4f25-a491-a72ec9a4cf5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_cedcf342-9943-43ab-b010-4328dd75f780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3d8833ba-64a3-4e1f-bc27-063c4c7a579e" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_cedcf342-9943-43ab-b010-4328dd75f780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b6765907-a2ce-4cdb-a7eb-5c93a3dc9c69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c18543df-21b2-4ca1-8053-b96bdc4012a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b6765907-a2ce-4cdb-a7eb-5c93a3dc9c69" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c18543df-21b2-4ca1-8053-b96bdc4012a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9f58d2c9-5f0a-493b-bfe3-11d55514780d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c18543df-21b2-4ca1-8053-b96bdc4012a9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9f58d2c9-5f0a-493b-bfe3-11d55514780d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b89822-bd9d-4632-9118-45fa0452286d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9f58d2c9-5f0a-493b-bfe3-11d55514780d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b89822-bd9d-4632-9118-45fa0452286d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_9ceacb92-75f3-4163-b738-8f7930b7e8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58b89822-bd9d-4632-9118-45fa0452286d" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_9ceacb92-75f3-4163-b738-8f7930b7e8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c18543df-21b2-4ca1-8053-b96bdc4012a9" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e4dcb466-47cc-41ab-8911-0e5597f90aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e4dcb466-47cc-41ab-8911-0e5597f90aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_735219da-6612-4667-81fe-3113f96f294a" xlink:href="dva-20211231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_735219da-6612-4667-81fe-3113f96f294a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_45cae2be-35a1-42da-bfc4-e4b8b0880e61" xlink:href="dva-20211231.xsd#dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:to="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_45cae2be-35a1-42da-bfc4-e4b8b0880e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_584c7b2b-841a-44f7-b0b0-abdc5f0efba7" xlink:href="dva-20211231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_584c7b2b-841a-44f7-b0b0-abdc5f0efba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments_45d0cb81-a8d3-4fdd-855e-bd9287a77e3d" xlink:href="dva-20211231.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments_45d0cb81-a8d3-4fdd-855e-bd9287a77e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e6a0bebc-f39b-4455-9075-6f6bf98aa2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58c3fa24-2a32-47c8-9608-29f3283d551d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e6a0bebc-f39b-4455-9075-6f6bf98aa2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#AcquisitionsandDivestituresAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_a285e04f-f9d6-4c8e-a6fc-3c5db65ab795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_a285e04f-f9d6-4c8e-a6fc-3c5db65ab795" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cfa96240-7a92-4aab-8a3a-24de5c26a0cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:to="loc_srt_RangeAxis_cfa96240-7a92-4aab-8a3a-24de5c26a0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f0ea140-6bff-4210-9397-5be451630191" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cfa96240-7a92-4aab-8a3a-24de5c26a0cf" xlink:to="loc_srt_RangeMember_6f0ea140-6bff-4210-9397-5be451630191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b293cd48-de06-4097-8466-5a1d4bdff633" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6f0ea140-6bff-4210-9397-5be451630191" xlink:to="loc_srt_MinimumMember_b293cd48-de06-4097-8466-5a1d4bdff633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5c8c0381-4c3b-42fe-adc8-dc19396298d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6f0ea140-6bff-4210-9397-5be451630191" xlink:to="loc_srt_MaximumMember_5c8c0381-4c3b-42fe-adc8-dc19396298d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ae7e3f50-d472-4299-8c00-94392ee24aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ae7e3f50-d472-4299-8c00-94392ee24aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_501abe12-f07e-4763-9941-2d861469d58d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ae7e3f50-d472-4299-8c00-94392ee24aeb" xlink:to="loc_us-gaap_RelatedPartyDomain_501abe12-f07e-4763-9941-2d861469d58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember_c372dfa7-de40-4aec-b906-d537f29c614b" xlink:href="dva-20211231.xsd#dva_OtherCompaniesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_501abe12-f07e-4763-9941-2d861469d58d" xlink:to="loc_dva_OtherCompaniesMember_c372dfa7-de40-4aec-b906-d537f29c614b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_facff708-5e56-4b7a-90b9-e409e4ce1dee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_facff708-5e56-4b7a-90b9-e409e4ce1dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_24debe17-fb72-4b1a-b983-8e01715f2fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_facff708-5e56-4b7a-90b9-e409e4ce1dee" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_24debe17-fb72-4b1a-b983-8e01715f2fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_5a78aeda-16f6-4722-9cb8-c6392b012100" xlink:href="dva-20211231.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_24debe17-fb72-4b1a-b983-8e01715f2fd4" xlink:to="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_5a78aeda-16f6-4722-9cb8-c6392b012100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_79279885-72f5-4656-b318-d99a96fe75dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_79279885-72f5-4656-b318-d99a96fe75dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6dc8c10c-7107-4210-848b-1a50fd905477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_79279885-72f5-4656-b318-d99a96fe75dd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6dc8c10c-7107-4210-848b-1a50fd905477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_dbed9a67-aacc-4bf2-9db4-8de433b27413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6dc8c10c-7107-4210-848b-1a50fd905477" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_dbed9a67-aacc-4bf2-9db4-8de433b27413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_89d89aae-9a9c-493d-a089-cb964630186c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6dc8c10c-7107-4210-848b-1a50fd905477" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_89d89aae-9a9c-493d-a089-cb964630186c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_db88e0b1-474c-4afc-a0b7-d9904c9a6894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_db88e0b1-474c-4afc-a0b7-d9904c9a6894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fab5128d-eb1c-4d9b-b24f-0b3db38d6ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_db88e0b1-474c-4afc-a0b7-d9904c9a6894" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fab5128d-eb1c-4d9b-b24f-0b3db38d6ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RMSLifelineMember_a5bf20da-d809-4fed-87c4-9453d256fa72" xlink:href="dva-20211231.xsd#dva_RMSLifelineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fab5128d-eb1c-4d9b-b24f-0b3db38d6ff1" xlink:to="loc_dva_RMSLifelineMember_a5bf20da-d809-4fed-87c4-9453d256fa72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e68957b2-e930-4620-bd4f-e046dbf9d437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e68957b2-e930-4620-bd4f-e046dbf9d437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a84f7c5-dd56-4d4b-9cd5-a1fc175c58ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e68957b2-e930-4620-bd4f-e046dbf9d437" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a84f7c5-dd56-4d4b-9cd5-a1fc175c58ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_2bacde3c-ad36-460e-9b51-6afc6ff37e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a84f7c5-dd56-4d4b-9cd5-a1fc175c58ab" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_2bacde3c-ad36-460e-9b51-6afc6ff37e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_52b32c32-fb71-4801-ae9d-501ce85150c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e1e451eb-3365-446e-88e5-d7cebcb6f623" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_52b32c32-fb71-4801-ae9d-501ce85150c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_d69e63fc-4465-4e83-a539-22f65215c04c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52b32c32-fb71-4801-ae9d-501ce85150c1" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_d69e63fc-4465-4e83-a539-22f65215c04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eb58c720-f815-4197-8221-3b7ee946a513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52b32c32-fb71-4801-ae9d-501ce85150c1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eb58c720-f815-4197-8221-3b7ee946a513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_c4d5da8a-55d3-434f-9bea-517616e08e8c" xlink:href="dva-20211231.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52b32c32-fb71-4801-ae9d-501ce85150c1" xlink:to="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_c4d5da8a-55d3-434f-9bea-517616e08e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_2943e311-606c-40d0-822d-65f9af9f9647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_52b32c32-fb71-4801-ae9d-501ce85150c1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_2943e311-606c-40d0-822d-65f9af9f9647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperations" xlink:type="simple" xlink:href="dva-20211231.xsd#HeldforSaleandDiscontinuedOperations"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c463259c-117b-4d7d-b3b3-b55775884334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_eb479523-7d11-4055-a83c-2bf3b4fc97b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c463259c-117b-4d7d-b3b3-b55775884334" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_eb479523-7d11-4055-a83c-2bf3b4fc97b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables" xlink:type="simple" xlink:href="dva-20211231.xsd#HeldforSaleandDiscontinuedOperationsTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_537bb241-5029-4eea-85bd-0f013417e8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_c099a81c-3028-47a7-b94e-47cd1208fc1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_537bb241-5029-4eea-85bd-0f013417e8d6" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_c099a81c-3028-47a7-b94e-47cd1208fc1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCashFlowsTableTextBlock_5489346d-2ba6-45e8-bffb-e56720b09cf1" xlink:href="dva-20211231.xsd#dva_ReconciliationOfCashFlowsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_537bb241-5029-4eea-85bd-0f013417e8d6" xlink:to="loc_dva_ReconciliationOfCashFlowsTableTextBlock_5489346d-2ba6-45e8-bffb-e56720b09cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6156f3b6-2f00-4262-860b-c61c2cef295d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a08d3762-555e-4854-b607-4de594556ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6156f3b6-2f00-4262-860b-c61c2cef295d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a08d3762-555e-4854-b607-4de594556ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_31b1627c-1141-48a1-96ae-a6895e147332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a08d3762-555e-4854-b607-4de594556ffb" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_31b1627c-1141-48a1-96ae-a6895e147332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1af36af1-6dcd-4231-88ba-b7b0a6a83fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_31b1627c-1141-48a1-96ae-a6895e147332" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1af36af1-6dcd-4231-88ba-b7b0a6a83fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_3c2130d6-ac11-4905-bf85-3324be9a56ca" xlink:href="dva-20211231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1af36af1-6dcd-4231-88ba-b7b0a6a83fbf" xlink:to="loc_dva_DaVitaMedicalGroupMember_3c2130d6-ac11-4905-bf85-3324be9a56ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_91d81960-aa55-4359-9b65-c74c99a06057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a08d3762-555e-4854-b607-4de594556ffb" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_91d81960-aa55-4359-9b65-c74c99a06057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ee69cfbc-b0f4-4767-ab38-cfb9497c3378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_91d81960-aa55-4359-9b65-c74c99a06057" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ee69cfbc-b0f4-4767-ab38-cfb9497c3378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_dfc2e76a-9d49-4d61-9b69-756d642a7b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ee69cfbc-b0f4-4767-ab38-cfb9497c3378" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_dfc2e76a-9d49-4d61-9b69-756d642a7b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a08d3762-555e-4854-b607-4de594556ffb" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_1f7b07db-475b-46e0-a8d9-ce1377ad50e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_1f7b07db-475b-46e0-a8d9-ce1377ad50e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_2e8827fb-a8a6-404c-ae99-3b34baf4e68c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_2e8827fb-a8a6-404c-ae99-3b34baf4e68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_d1e25c40-fa48-4711-924d-e8cbb7d171e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_d1e25c40-fa48-4711-924d-e8cbb7d171e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_919616fc-874c-435e-a747-fc6c1d63e531" xlink:href="dva-20211231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_919616fc-874c-435e-a747-fc6c1d63e531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_554dd85d-a1c1-4649-9611-2f97d8fcc97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:to="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_554dd85d-a1c1-4649-9611-2f97d8fcc97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_8e6b2856-b9b1-4102-89b1-6819018f9d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_90baecad-0800-4da3-baeb-68a8076e1c1c" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_8e6b2856-b9b1-4102-89b1-6819018f9d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_365bfa3e-5b96-48c8-84f8-29829c984b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_412bc977-b807-4916-813b-bb9d641447d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_365bfa3e-5b96-48c8-84f8-29829c984b8d" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_412bc977-b807-4916-813b-bb9d641447d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_80c89aa8-184e-42bd-8428-20d6877b4289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_365bfa3e-5b96-48c8-84f8-29829c984b8d" xlink:to="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_80c89aa8-184e-42bd-8428-20d6877b4289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_7156dc81-06fd-498c-8ce9-ed0410e63241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5ba43f4a-12db-40b0-b8cf-4c19b4cf4472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_7156dc81-06fd-498c-8ce9-ed0410e63241" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5ba43f4a-12db-40b0-b8cf-4c19b4cf4472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_387165d9-44aa-4f02-b02d-9d6dacac69b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5ba43f4a-12db-40b0-b8cf-4c19b4cf4472" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_387165d9-44aa-4f02-b02d-9d6dacac69b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4c675792-ef7e-4f09-bb69-c7d9db305414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_387165d9-44aa-4f02-b02d-9d6dacac69b6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4c675792-ef7e-4f09-bb69-c7d9db305414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_8f07fafa-ff14-4026-97df-e3fc318eabe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_4c675792-ef7e-4f09-bb69-c7d9db305414" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_8f07fafa-ff14-4026-97df-e3fc318eabe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cf4e8ceb-1a0c-497d-a976-38f8bb335656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5ba43f4a-12db-40b0-b8cf-4c19b4cf4472" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cf4e8ceb-1a0c-497d-a976-38f8bb335656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f277b359-5c68-43df-945e-5be8ed8cc3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cf4e8ceb-1a0c-497d-a976-38f8bb335656" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f277b359-5c68-43df-945e-5be8ed8cc3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DMGAcquisitionsMember_17b49736-3897-4ba6-979d-9480d725e90f" xlink:href="dva-20211231.xsd#dva_DMGAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f277b359-5c68-43df-945e-5be8ed8cc3d2" xlink:to="loc_dva_DMGAcquisitionsMember_17b49736-3897-4ba6-979d-9480d725e90f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_93ab76fb-9a27-48a2-8fee-79d3d4231906" xlink:href="dva-20211231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f277b359-5c68-43df-945e-5be8ed8cc3d2" xlink:to="loc_dva_DaVitaMedicalGroupMember_93ab76fb-9a27-48a2-8fee-79d3d4231906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_466bfdaa-c9e4-4120-8950-7c390a0e843f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5ba43f4a-12db-40b0-b8cf-4c19b4cf4472" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_466bfdaa-c9e4-4120-8950-7c390a0e843f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6993557c-4419-46e0-acec-bd5f9e665d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_466bfdaa-c9e4-4120-8950-7c390a0e843f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6993557c-4419-46e0-acec-bd5f9e665d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_5920d92a-1e45-4694-9b61-459290c0aa53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6993557c-4419-46e0-acec-bd5f9e665d3d" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_5920d92a-1e45-4694-9b61-459290c0aa53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_b179a04b-5404-4850-ac61-dcbd07f6c63e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5ba43f4a-12db-40b0-b8cf-4c19b4cf4472" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_b179a04b-5404-4850-ac61-dcbd07f6c63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_fec643bc-7548-4dc4-9907-29779fdc3e38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_b179a04b-5404-4850-ac61-dcbd07f6c63e" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_fec643bc-7548-4dc4-9907-29779fdc3e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_db446016-8a1e-4f6a-93ed-0b48cce5603f" xlink:href="dva-20211231.xsd#dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_fec643bc-7548-4dc4-9907-29779fdc3e38" xlink:to="loc_dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember_db446016-8a1e-4f6a-93ed-0b48cce5603f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5ba43f4a-12db-40b0-b8cf-4c19b4cf4472" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessSaleEffectiveDateOfSale_57473ff0-4bc6-49c6-9672-f4940dcb8d3f" xlink:href="dva-20211231.xsd#dva_BusinessSaleEffectiveDateOfSale"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_dva_BusinessSaleEffectiveDateOfSale_57473ff0-4bc6-49c6-9672-f4940dcb8d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_f64a336f-f75b-4e00-8a03-fc1ddbb479ee" xlink:href="dva-20211231.xsd#dva_PurchaseAndSaleAgreementAggregatePurchasePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_dva_PurchaseAndSaleAgreementAggregatePurchasePrice_f64a336f-f75b-4e00-8a03-fc1ddbb479ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessSaleDateOfPurchaseAndSaleAgreement_c4a561e8-b886-459f-8ee4-390a83c295a0" xlink:href="dva-20211231.xsd#dva_BusinessSaleDateOfPurchaseAndSaleAgreement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_dva_BusinessSaleDateOfPurchaseAndSaleAgreement_c4a561e8-b886-459f-8ee4-390a83c295a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_f017e376-e5cd-4def-ab30-4c17a22fe9e5" xlink:href="dva-20211231.xsd#dva_LossGainOnDispositionOfBusinessInterestsBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax_f017e376-e5cd-4def-ab30-4c17a22fe9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_d5f6a12c-db6d-4860-8952-ea1c1ab2133a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_d5f6a12c-db6d-4860-8952-ea1c1ab2133a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_0a5237b8-ba99-4ce7-9adf-6342d9dcfd35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_0a5237b8-ba99-4ce7-9adf-6342d9dcfd35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_d5967b0c-e54c-4067-802e-aa8a60541caf" xlink:href="dva-20211231.xsd#dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice_d5967b0c-e54c-4067-802e-aa8a60541caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_081e4386-997c-43ce-9af8-23db653a6bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_081e4386-997c-43ce-9af8-23db653a6bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_32402e28-e6e6-4623-8e28-db0c83084679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_32402e28-e6e6-4623-8e28-db0c83084679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_47a4500d-17c1-43de-8c0d-b99ee1153d61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_47a4500d-17c1-43de-8c0d-b99ee1153d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_143f3595-8992-451e-94e0-aff9920f991d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_8f69f7a1-7162-4a44-b6ff-f32ab6c16391" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_143f3595-8992-451e-94e0-aff9920f991d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="dva-20211231.xsd#VariableInterestEntities"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/VariableInterestEntities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f251c2b5-6884-47f4-87c0-1230998a36a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_07a13321-b67b-4a12-b31c-5f11e1054fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f251c2b5-6884-47f4-87c0-1230998a36a1" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_07a13321-b67b-4a12-b31c-5f11e1054fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#VariableInterestEntitiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d0e7ba4-46e2-44dc-b4bc-fcbbdded5aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c0db84de-1af2-4c4c-afb5-053fce7dabda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d0e7ba4-46e2-44dc-b4bc-fcbbdded5aa3" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c0db84de-1af2-4c4c-afb5-053fce7dabda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_57bae6cd-2969-4fab-89e1-249558fb62af" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c0db84de-1af2-4c4c-afb5-053fce7dabda" xlink:to="loc_srt_ConsolidatedEntitiesAxis_57bae6cd-2969-4fab-89e1-249558fb62af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c0fca861-9ab1-4762-97f2-7c32c8b54738" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_57bae6cd-2969-4fab-89e1-249558fb62af" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c0fca861-9ab1-4762-97f2-7c32c8b54738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_c6585868-107a-4040-925f-9c1a33d05354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c0fca861-9ab1-4762-97f2-7c32c8b54738" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_c6585868-107a-4040-925f-9c1a33d05354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_3d995348-6929-42db-a10a-b74f3e047f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c0db84de-1af2-4c4c-afb5-053fce7dabda" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_3d995348-6929-42db-a10a-b74f3e047f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a9295a2c-e0de-4398-bec1-3d5ae9f40c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_3d995348-6929-42db-a10a-b74f3e047f3b" xlink:to="loc_us-gaap_Assets_a9295a2c-e0de-4398-bec1-3d5ae9f40c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_797f1e1d-04c1-46e4-a4b3-0349b332a0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_3d995348-6929-42db-a10a-b74f3e047f3b" xlink:to="loc_us-gaap_Liabilities_797f1e1d-04c1-46e4-a4b3-0349b332a0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstruments" xlink:type="simple" xlink:href="dva-20211231.xsd#FairValuesofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8e0da58d-15c9-408f-9cef-06b6cda82bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_b6567843-419f-4a83-8704-9ae320336272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8e0da58d-15c9-408f-9cef-06b6cda82bb6" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_b6567843-419f-4a83-8704-9ae320336272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsTables" xlink:type="simple" xlink:href="dva-20211231.xsd#FairValuesofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6a503892-00bc-4a1b-a32d-cbb1c160c229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_634d0a81-e4b5-4cdd-b5c0-e61c61ab9a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6a503892-00bc-4a1b-a32d-cbb1c160c229" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_634d0a81-e4b5-4cdd-b5c0-e61c61ab9a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_efee6eb7-9e3b-4f36-ad75-557cae82eca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bebcf891-af84-40d0-bc81-67d73305f8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_efee6eb7-9e3b-4f36-ad75-557cae82eca2" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bebcf891-af84-40d0-bc81-67d73305f8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f48c2b72-c72a-458f-aec6-f26865ecf4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bebcf891-af84-40d0-bc81-67d73305f8d8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f48c2b72-c72a-458f-aec6-f26865ecf4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_01478195-6272-4f7e-8ee7-051a10d841c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f48c2b72-c72a-458f-aec6-f26865ecf4f9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_01478195-6272-4f7e-8ee7-051a10d841c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f2e56399-8bea-41db-bc89-52b6eb2c9017" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_01478195-6272-4f7e-8ee7-051a10d841c7" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f2e56399-8bea-41db-bc89-52b6eb2c9017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_566a3023-2a18-4cb4-b3b9-693a7f60ab8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bebcf891-af84-40d0-bc81-67d73305f8d8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_566a3023-2a18-4cb4-b3b9-693a7f60ab8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feadcae4-772e-462c-896b-7ea199aeb79f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_566a3023-2a18-4cb4-b3b9-693a7f60ab8b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feadcae4-772e-462c-896b-7ea199aeb79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_62d0643e-e7d7-4b80-bd9d-8aa0b3a878eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feadcae4-772e-462c-896b-7ea199aeb79f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_62d0643e-e7d7-4b80-bd9d-8aa0b3a878eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_536b4338-388d-447e-beb6-c602db13ccc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feadcae4-772e-462c-896b-7ea199aeb79f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_536b4338-388d-447e-beb6-c602db13ccc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_313f12a8-dd56-418e-8484-7b9758efa11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feadcae4-772e-462c-896b-7ea199aeb79f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_313f12a8-dd56-418e-8484-7b9758efa11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4f557d67-b25e-4fff-9ec6-7f5b77037ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bebcf891-af84-40d0-bc81-67d73305f8d8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4f557d67-b25e-4fff-9ec6-7f5b77037ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_baf464df-15b9-4d9f-a4aa-5502982cbefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4f557d67-b25e-4fff-9ec6-7f5b77037ea7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_baf464df-15b9-4d9f-a4aa-5502982cbefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_5d3b38b0-106a-4db3-aec1-874dbfc25032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_baf464df-15b9-4d9f-a4aa-5502982cbefd" xlink:to="loc_us-gaap_InterestRateCapMember_5d3b38b0-106a-4db3-aec1-874dbfc25032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9d25b515-fbdc-40dd-8ce0-67ce3301273c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bebcf891-af84-40d0-bc81-67d73305f8d8" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9d25b515-fbdc-40dd-8ce0-67ce3301273c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_087e315d-3083-44a8-9539-40a0826869c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9d25b515-fbdc-40dd-8ce0-67ce3301273c" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_087e315d-3083-44a8-9539-40a0826869c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_baa7d334-831a-4ddc-a98f-4a12a95050f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_087e315d-3083-44a8-9539-40a0826869c2" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_baa7d334-831a-4ddc-a98f-4a12a95050f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_240de3a0-195c-4b2e-9c4c-c2ebdfeb56e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_087e315d-3083-44a8-9539-40a0826869c2" xlink:to="loc_us-gaap_DerivativeAssets_240de3a0-195c-4b2e-9c4c-c2ebdfeb56e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_0d7fe61a-6661-4034-a598-09cac2c0d927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9d25b515-fbdc-40dd-8ce0-67ce3301273c" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_0d7fe61a-6661-4034-a598-09cac2c0d927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_dfd5c889-7105-4c83-a090-f97c3e7515d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_0d7fe61a-6661-4034-a598-09cac2c0d927" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_dfd5c889-7105-4c83-a090-f97c3e7515d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_f26985df-c409-4f5e-beb8-2311ecb6c084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9d25b515-fbdc-40dd-8ce0-67ce3301273c" xlink:to="loc_us-gaap_TemporaryEquityAbstract_f26985df-c409-4f5e-beb8-2311ecb6c084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_b6dc68b2-a721-45a7-8b32-9aa1951f27af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_f26985df-c409-4f5e-beb8-2311ecb6c084" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_b6dc68b2-a721-45a7-8b32-9aa1951f27af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#FairValuesofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_598936ca-19c6-493a-a640-35c68bb9d04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_18b05366-93ee-4916-b10f-4223a549e57e" xlink:href="dva-20211231.xsd#dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_598936ca-19c6-493a-a640-35c68bb9d04b" xlink:to="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_18b05366-93ee-4916-b10f-4223a549e57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReporting" xlink:type="simple" xlink:href="dva-20211231.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4f9f81b7-0ce0-49bc-8bfc-660aa47ef08a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_38d1d26c-4c8a-463e-abe5-b5177b214c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4f9f81b7-0ce0-49bc-8bfc-660aa47ef08a" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_38d1d26c-4c8a-463e-abe5-b5177b214c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="dva-20211231.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_880d9e3a-51b8-46fe-b7ac-92dd3bf94a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_67aaf368-64f2-443a-9f99-fdaa3eff9d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_880d9e3a-51b8-46fe-b7ac-92dd3bf94a1e" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_67aaf368-64f2-443a-9f99-fdaa3eff9d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_1d27c485-6e79-4fe7-8388-f955f2a139eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_880d9e3a-51b8-46fe-b7ac-92dd3bf94a1e" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_1d27c485-6e79-4fe7-8388-f955f2a139eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_caa853e5-2465-49c4-ad25-aa96171382d9" xlink:href="dva-20211231.xsd#dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_880d9e3a-51b8-46fe-b7ac-92dd3bf94a1e" xlink:to="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_caa853e5-2465-49c4-ad25-aa96171382d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_25b97a66-8b75-48a3-89b8-85824a10da8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_880d9e3a-51b8-46fe-b7ac-92dd3bf94a1e" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_25b97a66-8b75-48a3-89b8-85824a10da8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a195975f-33b8-4f46-a9be-9af24f17767a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1c6ec25e-575e-4dd0-9b5e-03fc1c00ef66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a195975f-33b8-4f46-a9be-9af24f17767a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1c6ec25e-575e-4dd0-9b5e-03fc1c00ef66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0343c474-e3b7-4763-ac86-b7d6884047ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1c6ec25e-575e-4dd0-9b5e-03fc1c00ef66" xlink:to="loc_srt_ConsolidationItemsAxis_0343c474-e3b7-4763-ac86-b7d6884047ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d705550a-a972-450d-a7e1-678b93b51d38" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_0343c474-e3b7-4763-ac86-b7d6884047ea" xlink:to="loc_srt_ConsolidationItemsDomain_d705550a-a972-450d-a7e1-678b93b51d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9e3744bb-c40d-4f78-875b-e845ea367560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d705550a-a972-450d-a7e1-678b93b51d38" xlink:to="loc_us-gaap_OperatingSegmentsMember_9e3744bb-c40d-4f78-875b-e845ea367560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_08732aaa-23a2-4d3b-a5d0-7868a8f38986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d705550a-a972-450d-a7e1-678b93b51d38" xlink:to="loc_us-gaap_IntersegmentEliminationMember_08732aaa-23a2-4d3b-a5d0-7868a8f38986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4656d28e-1882-495a-9ef2-9b9e0605d5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1c6ec25e-575e-4dd0-9b5e-03fc1c00ef66" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4656d28e-1882-495a-9ef2-9b9e0605d5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3adeb87f-caf6-4f4e-8d97-20f07140f443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4656d28e-1882-495a-9ef2-9b9e0605d5e3" xlink:to="loc_us-gaap_SegmentDomain_3adeb87f-caf6-4f4e-8d97-20f07140f443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_9f142de8-803d-4d7e-bfe5-435c4b020f31" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3adeb87f-caf6-4f4e-8d97-20f07140f443" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_9f142de8-803d-4d7e-bfe5-435c4b020f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_306457dd-a500-4487-915f-6ca54001e59e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3adeb87f-caf6-4f4e-8d97-20f07140f443" xlink:to="loc_us-gaap_AllOtherSegmentsMember_306457dd-a500-4487-915f-6ca54001e59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_210ba3b5-88b2-4cfd-afca-c454ee1cc1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1c6ec25e-575e-4dd0-9b5e-03fc1c00ef66" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_210ba3b5-88b2-4cfd-afca-c454ee1cc1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_28cb4011-17dc-4008-807c-eb05bc331a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_210ba3b5-88b2-4cfd-afca-c454ee1cc1a0" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_28cb4011-17dc-4008-807c-eb05bc331a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember_0b0a458c-f40c-42ba-813b-bd032cc0bf13" xlink:href="dva-20211231.xsd#dva_ExternalSourcesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_28cb4011-17dc-4008-807c-eb05bc331a9c" xlink:to="loc_dva_ExternalSourcesMember_0b0a458c-f40c-42ba-813b-bd032cc0bf13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember_c66d0537-d942-4e2a-bc00-63cf71d9b5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_28cb4011-17dc-4008-807c-eb05bc331a9c" xlink:to="loc_us-gaap_IntersubsegmentEliminationsMember_c66d0537-d942-4e2a-bc00-63cf71d9b5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1c6ec25e-575e-4dd0-9b5e-03fc1c00ef66" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d351dc02-de04-4f3f-a3ef-002548b525ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d351dc02-de04-4f3f-a3ef-002548b525ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_d44bb1b1-133c-46e6-a69d-0cd940a8228b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_OtherIncome_d44bb1b1-133c-46e6-a69d-0cd940a8228b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_67e2d2a4-eb1c-4b55-9a1a-8dac34c1b4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_Revenues_67e2d2a4-eb1c-4b55-9a1a-8dac34c1b4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d162e61c-884e-4b7a-b1dd-2a18228eac52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_OperatingIncomeLoss_d162e61c-884e-4b7a-b1dd-2a18228eac52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses_1dcaca99-3507-4b80-80bf-af0fb3e31eab" xlink:href="dva-20211231.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_dva_SegmentReportingInformationCorporateExpenses_1dcaca99-3507-4b80-80bf-af0fb3e31eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_6af272d1-04c0-469a-9adc-3e2161e2c271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_InterestAndDebtExpense_6af272d1-04c0-469a-9adc-3e2161e2c271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_f9a84d41-ae26-42d3-9de8-6301a1e4591c" xlink:href="dva-20211231.xsd#dva_DebtPrepaymentRefinancingRedemptionCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_dva_DebtPrepaymentRefinancingRedemptionCharges_f9a84d41-ae26-42d3-9de8-6301a1e4591c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d24c4978-24af-4a62-8021-295a43bc5f33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d24c4978-24af-4a62-8021-295a43bc5f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ed05a6b9-40d7-48c1-bf22-78869e2a9e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ed05a6b9-40d7-48c1-bf22-78869e2a9e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_6a260455-fb16-4529-9388-f6b42e07a1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afe21cdc-e977-4ed0-b3b3-27d7e6133da0" xlink:to="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_6a260455-fb16-4529-9388-f6b42e07a1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7c963b68-2922-45b9-98dd-e9855e3b66f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_6a260455-fb16-4529-9388-f6b42e07a1f9" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7c963b68-2922-45b9-98dd-e9855e3b66f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_985bb116-53bc-4529-93d0-fd00f94a17ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3e17128f-a6a1-4852-815c-6c58b7355bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_985bb116-53bc-4529-93d0-fd00f94a17ef" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3e17128f-a6a1-4852-815c-6c58b7355bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6b1cd420-c5bc-4b09-a2e0-5f16913ca146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3e17128f-a6a1-4852-815c-6c58b7355bf1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6b1cd420-c5bc-4b09-a2e0-5f16913ca146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c01fbe8d-d622-44cd-8394-2a4a9a8b093c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6b1cd420-c5bc-4b09-a2e0-5f16913ca146" xlink:to="loc_us-gaap_SegmentDomain_c01fbe8d-d622-44cd-8394-2a4a9a8b093c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_d848ec85-1707-4169-a688-11533f18be14" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c01fbe8d-d622-44cd-8394-2a4a9a8b093c" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_d848ec85-1707-4169-a688-11533f18be14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_248bb875-3fc7-41c9-8036-fda667aed783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c01fbe8d-d622-44cd-8394-2a4a9a8b093c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_248bb875-3fc7-41c9-8036-fda667aed783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cf76a08c-3b9c-43d0-bd6d-424c37d08bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3e17128f-a6a1-4852-815c-6c58b7355bf1" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_cf76a08c-3b9c-43d0-bd6d-424c37d08bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_da7cd22b-60b3-4fc9-8a1a-b7c809b5279e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cf76a08c-3b9c-43d0-bd6d-424c37d08bdc" xlink:to="loc_us-gaap_DepreciationAndAmortization_da7cd22b-60b3-4fc9-8a1a-b7c809b5279e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_546a152d-d332-47ce-a5b2-8f5295adb992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bcef3a4-ecb8-4dba-b1e1-3200c1ce5a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_546a152d-d332-47ce-a5b2-8f5295adb992" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bcef3a4-ecb8-4dba-b1e1-3200c1ce5a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d5169104-7e88-42ba-8167-51cbc9dab475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bcef3a4-ecb8-4dba-b1e1-3200c1ce5a9b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d5169104-7e88-42ba-8167-51cbc9dab475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5d9a5558-b30f-4d1c-bd36-a778ef6e2176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d5169104-7e88-42ba-8167-51cbc9dab475" xlink:to="loc_us-gaap_SegmentDomain_5d9a5558-b30f-4d1c-bd36-a778ef6e2176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_f48a51af-8c74-4ea6-9308-8a0725b0eea0" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5d9a5558-b30f-4d1c-bd36-a778ef6e2176" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_f48a51af-8c74-4ea6-9308-8a0725b0eea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_6c75d655-ce99-47f2-a1ee-50fc1ef5ded2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5d9a5558-b30f-4d1c-bd36-a778ef6e2176" xlink:to="loc_us-gaap_AllOtherSegmentsMember_6c75d655-ce99-47f2-a1ee-50fc1ef5ded2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_26d927ab-b2ab-421b-b467-4fa22151b958" xlink:href="dva-20211231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5d9a5558-b30f-4d1c-bd36-a778ef6e2176" xlink:to="loc_dva_DaVitaMedicalGroupMember_26d927ab-b2ab-421b-b467-4fa22151b958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7d2f95c0-fc42-4b7d-b423-47e3775b14c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bcef3a4-ecb8-4dba-b1e1-3200c1ce5a9b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_7d2f95c0-fc42-4b7d-b423-47e3775b14c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_73c47192-9105-4722-b526-49b0dd968c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7d2f95c0-fc42-4b7d-b423-47e3775b14c9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_73c47192-9105-4722-b526-49b0dd968c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#SegmentReportingSummaryofAssetsbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_172f89af-9819-4303-835f-42a708ea1933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f004b63c-aa9e-482b-9298-a53b00c9273a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_172f89af-9819-4303-835f-42a708ea1933" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f004b63c-aa9e-482b-9298-a53b00c9273a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_83d0c132-527f-4ca6-8fe5-7e32256cdec3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f004b63c-aa9e-482b-9298-a53b00c9273a" xlink:to="loc_srt_StatementGeographicalAxis_83d0c132-527f-4ca6-8fe5-7e32256cdec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d05213bd-5c9c-4417-b1ef-42df1af2f79d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_83d0c132-527f-4ca6-8fe5-7e32256cdec3" xlink:to="loc_srt_SegmentGeographicalDomain_d05213bd-5c9c-4417-b1ef-42df1af2f79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_a8979380-b9b0-4f2a-af48-1dfe074ec5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d05213bd-5c9c-4417-b1ef-42df1af2f79d" xlink:to="loc_us-gaap_NonUsMember_a8979380-b9b0-4f2a-af48-1dfe074ec5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2e852dba-fc5c-44f5-b00b-e3b8f2e04800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f004b63c-aa9e-482b-9298-a53b00c9273a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2e852dba-fc5c-44f5-b00b-e3b8f2e04800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f429f625-bf8e-4c09-88c3-a23e49ba9dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2e852dba-fc5c-44f5-b00b-e3b8f2e04800" xlink:to="loc_us-gaap_SegmentDomain_f429f625-bf8e-4c09-88c3-a23e49ba9dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_b433a824-ded0-4c96-a259-ebe85669bb97" xlink:href="dva-20211231.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f429f625-bf8e-4c09-88c3-a23e49ba9dd6" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_b433a824-ded0-4c96-a259-ebe85669bb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_b9e155c3-1be5-46f8-9237-9cde6cf55a39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f429f625-bf8e-4c09-88c3-a23e49ba9dd6" xlink:to="loc_us-gaap_AllOtherSegmentsMember_b9e155c3-1be5-46f8-9237-9cde6cf55a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5f132784-157d-438e-94f8-32d54794bbbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f004b63c-aa9e-482b-9298-a53b00c9273a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_5f132784-157d-438e-94f8-32d54794bbbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_94f5c8d3-8405-4cb8-97e2-b433d3f945bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5f132784-157d-438e-94f8-32d54794bbbe" xlink:to="loc_us-gaap_AssetsAbstract_94f5c8d3-8405-4cb8-97e2-b433d3f945bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9bc7d4da-f285-48d8-94fc-37fea35845fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_94f5c8d3-8405-4cb8-97e2-b433d3f945bd" xlink:to="loc_us-gaap_Assets_9bc7d4da-f285-48d8-94fc-37fea35845fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_10286c19-0b92-440c-91f6-47906c0da9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_94f5c8d3-8405-4cb8-97e2-b433d3f945bd" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_10286c19-0b92-440c-91f6-47906c0da9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cb46ece6-56d6-4808-afdf-35675ce80ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_94f5c8d3-8405-4cb8-97e2-b433d3f945bd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_cb46ece6-56d6-4808-afdf-35675ce80ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentReportingAdditionalInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#SegmentReportingAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentReportingAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cc48b1f0-5cd6-4b9e-b2a5-9dc679db32f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e771864e-27d4-4976-98c9-019c0a4de8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cc48b1f0-5cd6-4b9e-b2a5-9dc679db32f7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e771864e-27d4-4976-98c9-019c0a4de8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3589fcdd-fe6a-4c59-9b0b-b761c74f0c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e771864e-27d4-4976-98c9-019c0a4de8d9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3589fcdd-fe6a-4c59-9b0b-b761c74f0c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e5f08ff4-4e23-41ae-87e7-ba8574432c94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3589fcdd-fe6a-4c59-9b0b-b761c74f0c0e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e5f08ff4-4e23-41ae-87e7-ba8574432c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DaVitaMedicalGroupMember_c0f880de-aa97-4d8b-bb64-9f79cfa1ae81" xlink:href="dva-20211231.xsd#dva_DaVitaMedicalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e5f08ff4-4e23-41ae-87e7-ba8574432c94" xlink:to="loc_dva_DaVitaMedicalGroupMember_c0f880de-aa97-4d8b-bb64-9f79cfa1ae81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2a166c9c-edfc-4412-887d-05b75f595bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e771864e-27d4-4976-98c9-019c0a4de8d9" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2a166c9c-edfc-4412-887d-05b75f595bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_402e637a-c763-4e67-ab67-06cd303b9459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2a166c9c-edfc-4412-887d-05b75f595bf9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_402e637a-c763-4e67-ab67-06cd303b9459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_ad58438c-0021-4101-9b07-b90515cdd872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_402e637a-c763-4e67-ab67-06cd303b9459" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_ad58438c-0021-4101-9b07-b90515cdd872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9f1a34b7-1199-453e-82c8-0a29b210f104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e771864e-27d4-4976-98c9-019c0a4de8d9" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_9f1a34b7-1199-453e-82c8-0a29b210f104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessSaleEffectiveDateOfSale_2049c0bb-cdf7-4cdd-995e-c8f2e61dc58d" xlink:href="dva-20211231.xsd#dva_BusinessSaleEffectiveDateOfSale"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9f1a34b7-1199-453e-82c8-0a29b210f104" xlink:to="loc_dva_BusinessSaleEffectiveDateOfSale_2049c0bb-cdf7-4cdd-995e-c8f2e61dc58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SupplementalCashFlowInformation" xlink:type="simple" xlink:href="dva-20211231.xsd#SupplementalCashFlowInformation"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SupplementalCashFlowInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_971d4e84-b5c8-4b51-a2dd-3505d3f54614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_edbf9159-cfc7-4be4-ab70-5d9b7e348952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_971d4e84-b5c8-4b51-a2dd-3505d3f54614" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_edbf9159-cfc7-4be4-ab70-5d9b7e348952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SupplementalCashFlowInformationTables" xlink:type="simple" xlink:href="dva-20211231.xsd#SupplementalCashFlowInformationTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SupplementalCashFlowInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_df83a13d-d3a8-4501-86af-eb7c838a75b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_613f328a-a9e5-48ff-8892-2afd188553ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_df83a13d-d3a8-4501-86af-eb7c838a75b2" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_613f328a-a9e5-48ff-8892-2afd188553ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#SupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_9d741c59-67e4-4ab1-ba56-b7d7c63ca2a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidDuringPeriodForAbstract_eae55ea9-2a05-49d8-999a-51abae9b8918" xlink:href="dva-20211231.xsd#dva_CashPaidDuringPeriodForAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9d741c59-67e4-4ab1-ba56-b7d7c63ca2a4" xlink:to="loc_dva_CashPaidDuringPeriodForAbstract_eae55ea9-2a05-49d8-999a-51abae9b8918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_4d1c706e-498a-47a3-a57e-0e57f9bb6a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CashPaidDuringPeriodForAbstract_eae55ea9-2a05-49d8-999a-51abae9b8918" xlink:to="loc_us-gaap_IncomeTaxesPaid_4d1c706e-498a-47a3-a57e-0e57f9bb6a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_f53c7327-19f3-4aec-8d57-8a092a36a1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_CashPaidDuringPeriodForAbstract_eae55ea9-2a05-49d8-999a-51abae9b8918" xlink:to="loc_us-gaap_InterestPaidNet_f53c7327-19f3-4aec-8d57-8a092a36a1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_21bde81d-526d-46bc-8e6d-05a27d7142e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9d741c59-67e4-4ab1-ba56-b7d7c63ca2a4" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_21bde81d-526d-46bc-8e6d-05a27d7142e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_fb231b8f-a14e-41cf-b5d7-a90faba57180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_21bde81d-526d-46bc-8e6d-05a27d7142e6" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_fb231b8f-a14e-41cf-b5d7-a90faba57180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="dva-20211231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_3c2e7a10-7387-4a0d-861b-f9b970b3e318" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_9bd42bb1-4547-4d1e-afa4-cd34d0e8fa46" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_3c2e7a10-7387-4a0d-861b-f9b970b3e318" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_9bd42bb1-4547-4d1e-afa4-cd34d0e8fa46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables" xlink:type="simple" xlink:href="dva-20211231.xsd#SECScheduleArticle1209ValuationandQualifyingAccountsTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_fda11fb7-8275-46c1-9182-b8ee6e42b12b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock_fddafd64-4b5b-4ad2-a7f6-732c25670630" xlink:href="dva-20211231.xsd#dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_fda11fb7-8275-46c1-9182-b8ee6e42b12b" xlink:to="loc_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock_fddafd64-4b5b-4ad2-a7f6-732c25670630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="dva-20211231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_c8b6db6d-58cb-4c6b-a24d-8c3d535f75e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_08208af1-a8b2-4b23-802c-1df057d406dd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_c8b6db6d-58cb-4c6b-a24d-8c3d535f75e5" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_08208af1-a8b2-4b23-802c-1df057d406dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e1c2248e-a59f-47ed-8e90-c395da490de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_08208af1-a8b2-4b23-802c-1df057d406dd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e1c2248e-a59f-47ed-8e90-c395da490de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_1239fb1c-d81f-482c-bd12-f79f499f5a48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_e1c2248e-a59f-47ed-8e90-c395da490de4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_1239fb1c-d81f-482c-bd12-f79f499f5a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_04c87445-6cda-4604-bbf4-9316f9af970a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_1239fb1c-d81f-482c-bd12-f79f499f5a48" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_04c87445-6cda-4604-bbf4-9316f9af970a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_472fa4e0-9de7-40bf-9afb-65cffeb1d99a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_08208af1-a8b2-4b23-802c-1df057d406dd" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_472fa4e0-9de7-40bf-9afb-65cffeb1d99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_1fe46792-797d-4d16-b462-1a80f67a8fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_472fa4e0-9de7-40bf-9afb-65cffeb1d99a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_1fe46792-797d-4d16-b462-1a80f67a8fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_dd8127be-9c78-4672-a235-22b6baa41d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_472fa4e0-9de7-40bf-9afb-65cffeb1d99a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_dd8127be-9c78-4672-a235-22b6baa41d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a1374e4b-0ab7-4dc7-8f26-35620ce2468d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_472fa4e0-9de7-40bf-9afb-65cffeb1d99a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a1374e4b-0ab7-4dc7-8f26-35620ce2468d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_8cecb657-7eda-4db0-9322-e9a9292b8b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_472fa4e0-9de7-40bf-9afb-65cffeb1d99a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_8cecb657-7eda-4db0-9322-e9a9292b8b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_4dea8de4-e67b-4b36-b460-0775129c5b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_472fa4e0-9de7-40bf-9afb-65cffeb1d99a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_4dea8de4-e67b-4b36-b460-0775129c5b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>dva-20211231_g1.gif
<TEXT>
begin 644 dva-20211231_g1.gif
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MS#.J_S/5 #/5,S/59C/5F3/5S#/5_S/_ #/_,S/_9C/_F3/_S#/__V8  &8
M,V8 9F8 F68 S&8 _V8K &8K,V8K9F8KF68KS&8K_V95 &95,V959F95F695
MS&95_V:  &: ,V: 9F: F6: S&: _V:J &:J,V:J9F:JF6:JS&:J_V;5 &;5
M,V;59F;5F6;5S&;5_V;_ &;_,V;_9F;_F6;_S&;__YD  )D ,YD 9ID F9D
MS)D _YDK )DK,YDK9IDKF9DKS)DK_YE5 )E5,YE59IE5F9E5S)E5_YF  )F
M,YF 9IF F9F S)F _YFJ )FJ,YFJ9IFJF9FJS)FJ_YG5 )G5,YG59IG5F9G5
MS)G5_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P ,\P 9LP F<P S,P _\PK ,PK
M,\PK9LPKF<PKS,PK_\Q5 ,Q5,\Q59LQ5F<Q5S,Q5_\R  ,R ,\R 9LR F<R
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MVCG$_QL"?PX6(?:)C28HJQRX@8\'AK]9=96'G Z; V^@"0O,9BF!>-'0;S\
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MD1Y'VIR95NU:MFW=OH4;5^Y<NG7MWL6;5V];L_MPDHRV# [&B1<A_"AH8:%
M@3C@A-K7%^W'O94MPYP\,EJT'Q,K2*08D: %AP]TC$Z<&O7J@:(=BK80NS7B
M-\M0]KV<6W=E:#E7ZILGKV?3IDJI+CV.U>A4K5>A*F?_'BQKU'7DMBJ5NBZ8
M,'TU3^K#O5O\>/+ES9]'GU[]>I+T*$?>%RK-1HP0"JL6C?%'FO#L_:?MCZ7
MX,B!,(D(.LB@A!1*+$&$&&0-P8HB6BBCA"C"" >.S%+F+)PR^R_$$*.Q29]\
MVM%N'6"PRRX[=9[*KCFC9'R.JI^:TTJYY:C3#CFF@D&&K+\^"E!$(X]$,DDE
MEV12+_!*\@@.Q&2SH# =+K3OLP=R^ $.3<Z"4K,FU3,KP  G\RB:4.!P@*($
MJL1(MM!:4TW!_%A[K4+2J#3( L0>V&^SF\ <LU"W>B-IR/?")*D[8=9AAZFO
M=*G.1^B*TS$I&EOT,3E,GUO._Z=UYDEF4$-/135555=E]:X/X=LG#2OIO"@V
MU+:LK54E2_QMT6@V26-+!$D#PKZ!<H"HSEKMK.BS'RB,LZ ^,_IA$_A U#5;
MM7#KCAUAGL(N*1\WM<Y&YSC=L47BTCU.NJU\$F:>[F#U2UM[[\4W7WW%$\FV
M4 J4Z"!C$00"0<1R> ,41O<M#]N6RMKG% (KN%):PT*K*,*")J2XH(;VS#.B
M+1V  U;W/%*48593]JTW]\YJY]M/C6.71TT]+9>XFW<L"BEWM^*9J:'6B7?>
M>E5&.FFEETZZ'H]"P>&'SX8E# *K07/@!TUL.RE-WQ9F&L!>%Z476U#4 %1D
MTC862)7"UU(+>6IF&_(82X(*_,&V\!P.^S^63\+I;\JZFT<8GE)$BL6B<K3T
MQDR-LD['H8$6UZG*U]5.&++ZYKQSSS\?<1]-'"@8-#@-&JB"8G/@J*27CS;I
M+[Y!IRFFS#;3!.#[GIWSP<_BCAONC!-C"#$<.J+]7K1P<T^?=@KO446BT(4J
MYW.OO]0Y[)<BQRJM>BHZ>?'')_^__&WW&6PB:=6W@ /4M_Q!X3--7:E(\P44
M$UNN3UJS/HC^#YFR6@/ "UD@!PJY4H(PD@,U" HG]KO?96:'$L&9!#CS.!RZ
M@E:C[$1N<5>IF;MLM"Y0B>LYPDB&=R*X0A:V4%<H.PNWQ!2-,=#'00#['1 J
MP#J%I01$*2N3"PD%JR#Z$# G>5F:XH"8.]4)0M%:30#=EIHY)<: .\0!O<"F
MJ+V!38@SD5U, O<=X$3*7***7,W4N)RA)<<Y0]D>IN#%CLS89$@0_&(>];C'
MO$S&-M#X2V!^@*PGI@XT&<H$'OF(GF44(0?#BDBQ*G2A9STR-00$'@ QAI$O
M><2.1R3_FYCHMTB73% M:!$5<S9XJ>Q!9U,:C",(M:,/]P026Z8D92YUN4N8
M1,-I&)I3P9;%I31T2)2\3,]FU- F(\SI(05:6WXJD!#49-*:PT.81_;GRR&.
M39'(A(M9]&'&HL#H<1X\IXLT>*-SJ=&-3!D&6D)2DD""TY[WS&61T (*TZ".
M-%@Z5@4<PSQ\ZL9,R_A!FT9#-]0\ZW\"G*+;AM?0+>6@A\:4ITF^65"ZE$@8
M[<Q9IA@W/7,]KJ0V6R>HN*,/1''4I2_EI6TT$:V' B&A_%')ZV#:1R@M VT_
M, Q$WA;1:#T13P6L&^H^PSK(O.>.1MRI7N;QJ9%.9X1!<U%5_]G9HIQ9;Y54
M$54R=/J=J);5K$L#$5H& ]367*1T0-@(\LXJP?P=D4!Q2I"#Y(94C6E,3QO+
MTT0HE ,X>+(E,O0++N?:DGG R%-?_: Z.6C53ZDQI":-2C#D,=:,+M:SG\V7
M1X)ED(]M3".%%2=H];(_%48#%$"U9)XPQM#9#H^V?25>P![@&*Z!1+65H<>C
MBM,I6!97G=3#5'$MY<9RTE$S(JG@;Z4[725Q)@>>44V!<# &4.POL;>A;EI
M,IE7:0:ACXRMLJRF2=1@,EF&T6%#"-O#14U0L>$]"T^(NUR2JK.KK>3>5Y.+
M55 1;:6-0C!^%;S@\93(:?O(00+71HO-+0DT#4U-B3$97#N3M%0ST> 21O:J
MFG\V$;?51"I#!'NK!Z1A&7V)[H998D=]B$HJ.ZL.@1\7E9 N3J0 IDX[@0*I
M%,K8R$>VC'=!3*M#'F:WA24KDO,B)6$5!D+%JFUI3@S1+*]MMW+=AX;##+N-
M+A@XHFH.<7/,5>7R^+A"-JXJRUD<S<:35U+&_W.>3PD8$#L4RX0YF-;T?!F/
M; ('6AI(V^*T94:KER&C49_6^F+,EWGXF$=&F3X>5:/&O7.5K:R9C="9(Z\*
M.!CS,HMW![UJ5J<D#07"<FP:\H.H];:;K<;?K542"L0(LZU9=F]^M.S$!3UD
M@0/E$*Y1TAT;JWF_ZH0C4]")W!D)F+\[6E&+MC,/97=;V=H,\43^#)K6T5.C
MWE:)9,!FD\T,\G>U59"=ZB9-!M$VJ=4$K ZW!.;V>!')-:''!J_MXW<^.[)9
M@3-FH<,BH\0C&/'<Q\MBC&Z*JU9O@Y16:#H#*/EIL>)P61[:'M!,MPJP6=<$
MWJT^<Z$V_4!0'C\WGO^!LPY*298XTQYX<G&>W*OL/,CIVE&Y@A*,=MSWXT>?
M*XCE9BRLX12\,*^XND-9$C%'XZ[ZO@A?!8CR]YIF,00I'9>\AFZR;)IREA/P
MFI<BHU!C%L<Y#]=PRRF62R/=[I_ES+,<))&E?JDDJK[[^4ZR5H6L6'@FGG?B
MB?J@3;+5 3BPC:V576.@.6['(]UJVQWWSFA36U- [XJ/MAWQP)<>F16$6&18
M=Y *P&FI0+"#Z4N9EM>YMDWBGFV=W,MEA#"9?<?:4IK^!L2OU9V7Y45L3I#1
M[.5J%>BL?)$[;=XI&(D04VU<#E2"(2\+*LK2L@>_^8+X2=%N?%I_>D-3RQS_
M_OJE1!.#7&ABL.P9"!UP]RA>;YZJ:82-T'?,_Q<SP)FKI\H)_>*@ 9LSR)$*
M=]$%[;,.I*".<MF%HGC [-N@5'*7%9F<I) .FB&:=D@);HH=HV._$D2:!XJ,
M:$B#'] !!X  #D"T@3+!O+ ]T%"?W^,RKALV_&L]@Z U!]*U=3,^CKJSLZ '
MZVN*YD!"G2&AIL@94?$)<[(Q)NP9I?B*J?"4$L(JHML<&)JX&03#S[&)P5BT
M.$DH* M#O/B7 _$?Q<BK"Y$;WQ$VK3NJMU&?!T  ?@O!L[*EEDB&IFC Z&G"
M_N+ R!(:*$P1[2B'*8Q"HW"L=0$&<C .FL&.%2FP<+CS%NY(,']+PT[4%T59
M'C7)FFF9""[!,!*9.D^4"6-ZFA C"-Y)#4*"P]LBMCD<JM30(0? L*/1)]!*
MO9K0+\FYBJI"PJ+8!>U@AV24!W8(CF9TQGD(#G98QF5D"N$*AJ%()3;J&1U3
MEVV#KN)3Q7#_9!J]P0%Q [L'V(B7HZ?O$\?9(R)8$[$!*BV%T+I9O*0GJI!"
M>I8]R0$'\+N_F">H<RH2_"*^,8O&JBPF!+7JJ<9AD)?N\(Z(K E>@4A:2H9Y
M& 9AD!GA"K*A&)H._!EU(9JQ$L!V-$E[F8R9JA"X&J3Y.<F9T"E!.J3[( B!
MB$,N8R_@P8@C* @@R('C2:VN43!',:,%?*RE\!D;V8[F:8L2Z8Y\*)QO"89=
M"$E)L4#MNXKM\PV"?,FN;!+7@B9  90T,#?8\<J7L(F3&0E0N*YB:2^%*+%@
MFRC $J!?4Q^_&Q3[@JE/ J5]2!'GP[;G"Q5F])6^Q PP 3AZD >I_ZR*RHF[
M AO)Y3G+R<P6CQ@=O'DR@5P_3]1+DC@%!*B ()BWN=1!N?0RJN$24-A,(K2?
MD&"VJZ@Y:?NY;41">$$+A\$C4ZJ)X!@.%VF^I=!*6+D=RB1.0[&ZGV0@_XNY
MXA1*<(0/A#J6!)F:9:E#N90B0VH(". _?PR0D"! LTJ]CPC&-LI*A#N*%J&4
MZ3BPO8A(#)(9JGC  YQ*6HJ=363.^T2290"%[NH/DL1/F5 3>*P2!9*DTC10
MB  [N'JQD6!*XUO-@BS+CW"43ZN\= $71PP?V%$4@'PZ@4P)UZ2'QHJ48)@V
MRY&.8/ 6J/K/%44/&'M0!F71EWB_1[H3Z_\<35LDS=_)F'Y<4!D;IV! "O*<
MS:80H9]!48B;,;RHB6&80M\LCGC0'*Z,T2FEBV\J$E:DTI<PIC= %L'*1WO\
MJR\5GGA[2_6Z+@?H41CEQ*@B"TV3K&(\0.G91J+AFSI2B3M3(<QPGMZLCFPC
M4NU 4E <PBPEU+CX0M<IU+7@)TMB'XVAK>#!+=T+F+5)J 5EK0ZU)_LQD6Q\
M+ 5,2!0-$@Y[4;-,&4=IQ#>+S$155?' C3"JNR*<4@CJ#:O;B LQ'=X[//;:
MNM.!DQQ0Q[(*R)BCI:G:&0@LQ(2<L_4$O'#J)<34-(?S2#E-D7A*(@M:U6M=
MCU'UR@!Y [Z3%ATPM:9:Q,G\B!9Q0P 7\]"=&I*7";@,/+O)0BGM@$8[S37[
M3#>60)3)@$B>^(ITB5)L_P78CBI+_[16%NT/WXJRDW@#!( 3B6JB [VFTL&0
M5VPQR3A4E]('>9A Z<N1F?D182@Z>P6E+FJ_E?B;2R4):(R4;-.^=2@R<Y/2
M@)79F7T+W/ (+F66B?T?^\/16WS48GL;!N$/R3"F (RJ&NN46#K&RML.R8Q9
M]LP'F;%$[1NKH*39J\7:RU@&+L$2WEFH%$L@ZR0@9;F(+AD)HRVK)PG18HR1
MA'01GQ@&@OV/92"<#)J.[<@'M7S:K.7;OBW8$"R0L+68GBRJK@.LAW+4=TN
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M)G 1FLB&EH*6X_^6YG_V;-U9K9?$;)C>'L#I!BCBI(WI36EQR \<0 2:BC+
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M[,"$,%.KP?\VK_,R^L++1IW.*3TQ!5.\DT5T1,OT%4CD'<*6%61JV/=FU;@
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M:[--(]V3[+)9'1,2R(IRR"35P9*D<+:;HH'#("!Z*C'26V5UDTT"320//<>
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M8.F".!'63Z+2JHMPZ@%3C :-S(C!J[S,8$"B7<$BHQ[%^"0CF%J*1)@%2:4
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MTI"([C%2U$"%G[',=B8EQHE@P *'_CW%;U-SWJ6LR<7_$"D'IYTJ="?4))5
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M+@B%#G1<;(OD8@D+H[.V[]QJ1VLBI2!8%3S/)A163'M@;BX!DS6?4BZU%&3
M\O^B8=(: L#4(RM]9"4S+3]=\V"HT*+_0";U.%0CP^.W&I!%SW5VAJRTD(E
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M6PFIC\B$N6,QUK SI9LV?B$VH7&3_H*RZ+L4=+,(H&.,'X@LK$ T!CR>4%-
M5 FG8.L9< ,.9EO!G1B,'I(.(*O_.&13B91J"P^4"<2(E16)'J1#F;QQ .OY
M0)Q@(E6I06([.A$B#AS(-.Y8AJ9S-"89)\]IB.JY/V^!'2OR+:-J%NIAD(K;
M0A[D/"B$PFDSOP>P.;]3+6TCB^4*-ER*OUR:- ![H=12PYD0PT8KJ]ZKFN"+
ML1^PPE_Y*U@KDY^0$#-:!CA0N KX#<8+CDZKP6*S%EVB0T*D-*S 0?>(D?DH
M"!]XNM?KQ$$9)";[-/UQQ3VAJ!P@CVAZEL48.FMILTEK&NB*#9>!M_G215=L
M)T.2L5V"#^CS#O0(G?LJ/?9Y1+>2)Y131->CM7O*D0!4 WK9-:K /HT"OM?2
MQE+412F*_Z2AR\!A')P<H,0&V@?\>)N-^YF-:8AN]$;#"!F+X"$=!+5URQ<!
MHS:12L;N"#_Q ;/'"JYN"YJ3>JQB(C-;3#^N>CEENA=]Q,8Y3#WDH"$C <?$
MN)3G@,>,;#ZF,SGCL(LHX;I**1#].L5(_+2">"C\4:SN<!BUXRPJB[%LK!W]
ML+_ML"O$^TCW>2@%;+Z7 LA+H0E@I(?QV81.="^K<(JFT!F.2:]R4J>#I#1.
MR<@E@;N50*()3#! &D2-4Q A0J23*!)2@TJ9B!ASP1<-S#ZY:KY>W >ZVHG+
M^16?ZXJ;LA=[F3DT@;8*B#3/6[J\[$$U<<QQPB^B(R+JN QE9/^,R7PSC?00
MJ\"V("R7EJLT&Z2W$J&Q+Q&6+ P^PV&2NV&,%%P.YR'!O,P3B& ,.Z!+\PB4
MF@@*HN!$A+, ZBHV9L$9Q$M%R>S'''S ,NN<"HA-D$M)H1Q+0FD^%8-*HMF$
M"[RK;[*TE."7,SL?AR07UI =,/.I78*VTGB-$JG%RGS,H+Q#I<P2=#2.YT(A
M>ZP)I9"P*Z/-!@0-B<!$_MM-WQDFZ/*]J.# Q$J1M+S"@I3/R.R?A'  9<A/
M<52;O+F*VH2SE$G#HR@[W924)K2<9<@I"*.DQY*/0CLN!S0]SFS.]8+/%W,7
M-;R\DQB($W*\Y7.H+@*]$"V0FW$HF-/_0F=\DA^L$)S0+8BTEXID%62*+.42
M1689P3394?A\(;<9MR,%3/R;F#G:S,WCT8( @IB42G 4B^V$T'=TN9XJ M=C
MO]=CL\AK2Y=8G;6ST)D(!0<@3<U+3C5)"!_]T9O@K6A( Y&K,"1D"E9Y+#Y5
MSA<-4QG]C-%:EAPX!>U).9%CRZ2Y1=;1/;;#3(",)OK244\SR$,QD6^<E ;=
M/YD<.-&L0..9)&0!"1E;SJV:.NYZ5.+<JI+$4]>#@RP\EE1+.J)CS+1*F)E
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M5%NO)8\+]K02WE0PJAWAX+2_^\"T'CUFO7FCT#%_[5QK."T$ 5O[;>@D#FJ
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MZ#W,HJT&C+3@_^U=E9C0 !*3\^3?#K965&27;KB.\(T-YWF:5W$=U3AAMSS
MH"EA2TC:4*E;] D.9>C7& Y%=Q7_V0ZZ6AZ!QZI8P'@LP\>91'HL1<\4$(T-
MS.8P7/P%#^;@AN10DQVM1PQ*E1%6WELM'_.!R,R9A$+HQ7/(7;00(:KX60YT
M3Z<=!)P<&"?QG.9@!(=THE*H%T;$WN$=F5M5Q.XD# 9Z7549DP'Q(&1]$QY"
M6EBD1^3)Q7W52-R96$7HC9QTWXK@( $:5 =)(0:>%QM^AH8I7 ZNE==4E<.Q
MXG<D(312R5)$RL6<869]5:9,%7Z(R#-6QS+<26X08Z-LEEKADU24S%I,TW8=
MHZW)Q/;9U/A-5=UAA INA@<.2O=L7G((3= $8MT9GXY%Q$_8Q2&R1\4I70'J
M'V^!BT<$_\8]'@6/E$76N:,PR9^66<@*M8:=:.1*@"#L3=K^\-EN8)04<2/"
M>,4/9-1CZ1,':4=TG,Y>V(DF4$<685NPO>#QF6$S=6$^<2(W1IK0K"+9H9 9
M@D22"(92&H=(96#F6,:WF%U"/41(M9OR) >.L..D(1);41XA147V_, %G03,
M!=M)*"*9<0?K555XK!_.E)A#CA'1G90UEEUV[,T53@H>$24QA9>$\$3'-92G
M2=B9L9<!X<[CF 9$2DHH^-M'8J9A5E<VG<IXG*1H5=Q<YM,[5A6ET>%%T 00
M.( :+&$55<XVA21I0J5%642D=,C@$9[ZU(3N&9FFE*5=A!A5KO\$<9@0''RA
M9E);SUV%:E("W[4$Q97*?602E#U<TJT-6PQ$VL56%DH7I?T=[[U5IN%,/137
MPMQ>"<H@=7&<?"3E/BS#MGW6$WI5U+40;-P,;@[*,AD9*?9FEJD.$+;,50)C
M.+9&<.;;V@67#QG=A.D'FVB(030=77VF43!FY?W=U%C&A#:498E7 7)AM\T(
MXPEG2J3+=#J* Y+?ENSF7@1?=8"?,@QC8S)H_XB+6J@4 @2*";FE_21$2<TH
M] 23[%')M6PA!/'E\UUH('Y5"RU529BH*_I<]*D@5V@+^B2:9.Y9B119=N"
M=JZ(8[C=33GEA(TDLT'CHRE,X,AH]!W_W\!DSTLYY[((2C*R*7(RQ &63S(I
MI?JD1>J(8BN^GL<8Z(@N(5#5*?PM5G8LF6?H W7TC.WAR8W95]>YR5WN0_6)
M3+:@TTTF:;$(Y)A$DF.0D=)%8<.]RL*TEF<RA73,E"%Q&]48Q!3MJ)QF$ XN
M$!'V#5:J81":QYJAB.LEJ:P)IU? EF5>7J>^6D@$E5J$%)7]DX:"Q6=LX:'R
MB:6T)Z&6Q-!!X4WR3[!DFBZ*V-746E)DTDQAQ&D^YA"]7BG6H%$DXJ\\QU7&
M8]GIFG10#$"MQY8BYH^"VZ4)*<B)3&!DQ-M ']B\!5#<Q0,<T3ZXC(VRC;RF
M''TL! [$!KB&PEF1I1.R1FP_06M)^ YGJL[M9"PK]M4?"8K%[E=2;,*(^&:6
MQB=&J,$CQMC8X&!CBN09ILYW>"DW;IZ&>0?P4*M^K,V@8NM)-!DH+1)RB>SP
M ,?"L,5:'FAG#)*_ JJFU&%0=*R'P(0M%JQ9/F:.#0Y"B"?9V,::D<\H.@ZX
M8"P.=$H ;LP75FUV.!=')NB*#)Y^!FT[Z1G %$36,D6)81.6(>L<$BVA0M0Y
M[5[B]J?_X MN] <O@>:51J%]65[\(1>'_Q1MMM+.L3YEG>Z'AN2=X;HG0B34
M JG,K=*=KWD$0;725\B<N_I2(X[5\<4FM!P$Q<Z91'+F0@J1,&W6(_JM2[S(
M6,YN@:4;>-K69"A$=%U:O=0N9XT?$E+6"S9EURHCY"@0I(#*Q^ZMGX*>(.[/
M7I@IP,Z9'HI-N1Z-Y;FD15Y7;J@![_@(RIK'V?#KTM(=LHR3<*J/9H!OPU@<
M3C&642720A$JIBI,3?J'A5P<$RV6@T:E;27--MH<?'IO7TZ400GB0'G.IP*4
MRE$>9JVD;-+BGRRJ'9DG9_'3-48.=9F4 )9/=Z)N6MU2O?0& ,7IM70D N'D
M:%I./Y9&Y 053?^ 765RB\ @%0!+5>8D)DQF+E-(&X?MGU0I;?!@!2CM3/#"
M6*UZL$VYJ@*]!?5(Q@]@*E6^B(E6ZQGRW$0]0+L*)_CMPR;D(P._V10;,6H
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M.?GF&TSTC%5Z=Y*N2F7XH):<8[-]2,.BM"AK+"<M'66*5EC(4L0\"ZG-MF8
M[W-E+?+P2(FA*[<FLAQ2<I>']PI3.9>Q]O1JA[XN;F]5\.Q2D]\.8=NPF=G_
M#=.S# Y/SI-HBU-*F(JFZ^UI7Q:E^,FMASDJAM-LW$$"SPRJAS-:!@?^8JOZ
M#$YE]^NV*NV9-3"%L*WW.;=7-YO/G)@AL5/#@RA):T=NK'=Y%"1\SHC[=-M1
M+CB+SE9<192X;RI<T/=O "<':Y4WAV*4EO0R\O#Z9B+ F3C0O-40HT]_/VM8
M&E \IK9.W;*+E77" &ZN[\W2?N^_%?8(-3FC3WP;87IDWF*XAQ6%Q%KHLO=
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M5X>VJ60>  $HTMMG512/JC0MQ<3\#3G_)P3KF$>E]J%[6+L[F7;J,.KV'B"
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M&&!"N<[N>"%!ED7Q!QB P2Y8-BVHFLS]F%0(@5E4"DDAL<3#83O_L6:PD*5
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*!]G,9Q9R0   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>dva-20211231_g2.jpg
<TEXT>
begin 644 dva-20211231_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH \*UO]M*\\1_M#>+?V8OV</@
M]<^.O$?P]L;&X\?WT^N0:9INBRWL336EB9I \DUW)"OG;(XC&B.ADD0NJG5_
M9P_;9^#O[1GPB\5?%BW>Z\*CX?>(-4T'XD:1XI:&&?POJ>FC=>07+QR/"52,
MI*)HY&C:*1'#8) _.S_@H9XB_:K_ .";_P#P4J^(7[9?_!,_2T^+=UXS\!V6
MM?M'_ L6DL[Z3!9P&TT[78Y(B/+=U1@+8'SI5AN'5'CWR6_(_M0_$[X!6_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^$OBZW\/^*-7\-7UEX=UZZA:2/3;V6!XX;ID4AG$;LK[003MQD9S6?\ LQ?
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M^)__  <A_P#)\7A7_LE%C_Z<]3K]L*_$_P#X.0_^3XO"O_9*+'_TYZG7Z)X7
M_P#)5Q_P3_(_-O%;_DD9?XX?F?GW1117]*'\P'Z"?\&WG_)\7BK_ +)1??\
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MQ$Y_]61_^9*_^]M'_$3G_P!61_\ F2O_ +VU^4M%?9?\0ZX-_P"@7_R>I_\
M)GQ7_$2N-O\ H*_\DI__ "!^K7_$3G_U9'_YDK_[VT?\1.?_ %9'_P"9*_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?B?_ ,'(?_)\7A7_
M +)18_\ ISU.OVPKQ/\ :1_X)U?L;_M=>.;3XD?M#?![_A(=:L=)CTVUO?\
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MBRTN.-L0Q$J+FZ1 Y><!F7[,_;Z_:*^$7PO_ ."SO[%G[6OQ(\1W&A?#O5O
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M0+!!,#<3V[,L!NYA##"C$-(P8J"L;E?-_P#@G;^UC\+/^"97_!0[]KK]DO\
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M$WP?\<648_<V?B)X7/A_7Y5_B%OL=96. L%JR@@RYKW#]O[X1?\ !//X&?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4 %%%% !7UI_P0X_Y2<?#O\ Z]]9_P#31>5\EU]:?\$./^4G'P[_ .O?6?\
MTT7E>'Q/_P DWC?^O53_ -(9[W"W_)38'_K]3_\ 2T?T 4445_(9_904444
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M^T7X3_9(\9_&W2+7XD^.))4\->#HA+/>7/EV[W#LZQ(PMU\J-F#3%%;@ DL
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M:E?:%X>N+76[&QOXY9M/F.H79$<Z*2T3$ D!@"1R.*\D_9W^'_[*O[1/@O\
M:S_9^_X*^7OAFV\=ZY\8=6G\36_CO58;&YMO"\2JOA^]TN:X96CL8;=G:WFB
M.$E>X+?.\@8 H_&W]@;X^_LG_P#!*O\ 9.^$>H:K)XNA^"G[2/A/QO\ &"+P
MU;S7-NNA+K%W>7D=O"%,D]G9/>0E5V_ZFS\PJH7 ])_9,\?:;\-/VZ/VX?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#\]/^#DC_ ),P\'_]E/M?_3=J%?BM7[4_\')'_)F'@_\ [*?:_P#INU"O
MQ6K^EO##_DE(?XY_F?R]XJ_\E?/_  0_(****_0C\X"BBB@ HHHH *_;C_@W
M'_Y,5\0?]E/O_P#T@T^OQ'K]N/\ @W'_ .3%?$'_ &4^_P#_ $@T^OSOQ1_Y
M)67^./ZGZ5X4?\E;'_!/]#[\HHHK^:S^G@KY*^-?_!._X[_%7_@I-\.O^"A&
MB?M1^%M(3X:^'-4T32/!MS\+KBZ%U:WZNLS37:ZQ$3( 4VLL2J"G*G.*^M:*
M /$?VTO@O^V5\6=/\)ZI^QA^U_9?"K6/#VN-=ZQ;:UX'@US3?$=HR;3:7,;R
M1RQ 'Y@\,BMR1UVLECX,_LQ>.--^)UM^T5^T_P#%:P\>?$.QT.;2-$N-%\-G
M2-&\/V<[Q2726%F]Q<RI).T$'FSS7$KLL$:KY:;D;V:B@#RS]J+X$^)_VDM,
MT'X2WVN6=K\/KS5?M'Q+L"S_ &K7;")=\6DIA=JVUQ-M%R6;+P1O %(N&:/G
MO^"B7[$VB_MZ_LKZG^SW)XL/AK4H]3T_6?"GB!+/SUTO5;"YCN;65H=R^;%O
MCV.@928W<!E.&'NE% 'S3^S5^Q;\1?#7[:GQ"_X*!?M#^(=!E\:^,?"&E^$M
M'\/^%'GEL-%T>S9IG'VB=(Y+B6>Y<RG,:"-51!OY<_2U%% !1110 4444 >=
M_M6?M(^%/V2_@/KOQV\6^'-:UU-)CBBTWPWX9L#=ZIKE_/*D%II]G O,UQ//
M)'$B#JSC. ":\7_8,_X*8^/_ -MWXD:MX$U[_@FW^T%\'+/2-&-\_B/XP>"C
MH]G=2>:D:VL!=MTTI#,^%!"K&Q8@E0UO_@IS^P+\;/V[O#?@>V^!_P"VOKOP
M7UGP#XCEU_2=3T7P]%J"W.H_9WMX))D>6,E8TEN %!P3,202JX\K_P""7G[9
M'[<,'[3OCO\ X):_\%.K+1M5^*?@GPI#XJ\*?$?PS:BWL_&OAN2X%J;QH55%
MBFCG=(VV(@)++L!BWR ':^"/^"Q'PA\;:EX#\;P_#/6+;X3?%+XJ7?PZ^'OQ
M2DOX&@U3789;F",M:@^9#9W-Q9W,$$Y+,TD8WQQ*ZL?H3]H[X]Z!^SG\,)_'
MVJ:+=ZSJ%Q>0:;X9\,Z:R_;->U:X<1VMA!N( >20C+MA(T5Y7*QQNP_/;X9_
M\$COVC?"?[-W[/\ _P $YM?LM-MOAY\ ?VB7^(,_Q.;6(F&MZ'::CJ&I6%E'
M:@^=%>O)?+%.75(8DMV=)9BX4>]2?M(_"K7O&^E_\%!_COJMRG@@:\G@_P#9
ME\.6=B]S=^)+^_9K=]8M[= 3+<7V'AM#P([!)9RZ1WDVP ^QK"2]EL89=2MH
MX+AHE-Q#%,9$C<@;E5BJE@#D X&>N!TJ6N _9\_:8^$_[36A:UJ_PQU6Y-UX
M8\17.@>*]$U.S:VOM$U2WV^;:7,+<JX#HX92R2(Z.C.C*Q[^@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCUXQ11_9.5?] \/_  "/^0?VQF__ $$5/_ Y?YGL_P#P\(_:^_Z*[_Y0-/\
M_D>C_AX1^U]_T5W_ ,H&G_\ R/7C%%']DY5_T#P_\ C_ )!_;&;_ /014_\
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M HHHH **** "OK3_ ((<?\I./AW_ ->^L_\ IHO*^2Z^M/\ @AQ_RDX^'?\
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M#I$QC,+L/-/Z$T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$LUQ?3NP4)#;P(\TO)&2J$+D9(KYM^(7_!8SQE8_!OXU?M3?!;]DE/%7PN^
MOC74O#?C/5-3\=-I6M7TNFF(:C<:?IYL)HIH83*=IFNK=I!%)A5( ;S?_@X>
M^(_A/XV_\$<_"GQF\%-++HWBGQYX$UO19+F+9(;:ZO()HF9<G:QCD&1GC)%
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M=_C3PQJWC_PY?ZI\'WT3Q7IVMW/BB6T&Z:QGB@*PZ=.J?.[O<201K\SS*F7
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MFY?_ (NNJ-3+U%7@[_UYG)*GF3D[35OZ\CG/^%__ /4I?^3_ /\ :Z/^%_\
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M *]W_P#037\J5?U92Q1SQ-#*N5=2K#/4&OE3_AR)_P $O_\ HV/_ ,O36O\
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M***X3O"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)*X /UC\/K*UFTD>+;KX9)X7UC5U$NLV,BVS7'G#(_>RVS.DI[AMQX(S@Y
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M@/@QH5_\5/#T-W!^SOK.DW%O+K$*M%?S7\KQ6C M\L[JC%8C\Y&,#D5^FM%
M'YA_\$U_VA?@+=?\%T/^"@E_;_&GPJT&JI\/9M+G'B"WV7D6G:!<I?R1-OQ(
MMNV1*RY$>/FQ7SC^S#\6/AAXV_X(S?\ !3G1?!_Q#T74[RY^,WQ4UJVM+#4X
MI99=-N+2T$%ZJJQ+6\A5@LH&QBI )Q7[E5\__P#!4OX1_%O]H;]@/XI_LZ?
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MSV I8;>WM@RV\"1AG+L$4#+$Y)..Y/)- 'X:^*K?4_B!_P &ZW['?[1/P<\
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M':^)(I;+QQ?Z5=SP0176DRX^T2WZPQ&!HT>-YI]A228.X_6/]F/X$:1^S/\
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M^@N=9MK'[+'KMI!>30VNJ+#M4(MS D<P(55<.)%55=5'U!110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!_Q*:RE;P%XY\!7-W'HEU#IMO827$5Q!?1_:$F2W0R6SQJIV*%D0EV?Z+HH
M\<_8!_8P\!?\$^/V1?!W[(WPVUJZU/3/"=M<;M2O8EC>[N;FZFN[F7RT^6)6
MGGE*Q@D(I5<MMR?8Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
5HH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>dva-20211231_g3.jpg
<TEXT>
begin 644 dva-20211231_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\?K>BOFWP1XZ^)'PQEU[3KJ&^\:*\RC1-1U/4;:WEB0A \=Q& G[P.3A4#$
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ@.@=X;J%MK1M#(A5<EMCJ\42H""#\A3G^%L+T+*5CM0(_D4O&^5B6/?N(5
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M&026$K[2YRR,_P H4^9X]\*M+M_@S^U5XF\,A9)+/QQ$/%6GGRV14NMTIO
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M(P! 20N2"=Q+#'3;$!A67S/>H8&@=?+BV^6R($SGYHW=0K,,CAML2OG@2(Q
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M2C?.TBA1DNNTJ1)A QS\LAY4L&D<Q9XU\F;;]IS'"50*C/C".N!@#H=O4<J
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MO)/K-\TUO9$NSR>?*8W\O \P+&2QP=O+ D_5O['7[%&F_LKV5Q<6^L-?:EJ
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M'9SVR+!)&HCC):)80Q4+\I#>3(=O3(. 2BC2M2LD4,T,92.9 I4,,(GERL0
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M23L2V0J;T#-CGYLGS-ZR% \,D2B1HV&PO@LY58F!/(/SY=$ X^9RG967R?\
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M%3%4:?Q27W_U_7J?9?G_ +_R]KDA0Q.WY1DXZ]SP>!T_$99]KDVL?LLWRNJ
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M>V3@!>ASGZC1=F>>.P_N^U>%424VEM_7]?YGT--WBF.HHHJ#0**** "BBB@
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M@,D9./F8_-N .Y&57SNRRR,S$*[[:.B:U;ZQIT%YI_DM9S0Q31)"'Y8Q2-&
M"W +%H\9)82,QY9:MK/'%N*L[+;H@;RWVMY9A!;;MSD[4!!8L"2"O$;,VG*G
MIY?UOW^>^AS<O*N5]K?FMOZ\M]%1Y(HUVB<,N599&#2(Z .5P<_O"_V==Q_N
M*-N-T2,)6*!E$GF)"H;>@!(V1EA(JEFVEU)*G!.YY'!'E@4L4>'\AI(/E*VR
M[/E5B<MO 8C:C;LC@AEF<A2%\L.A<7/EX9-F]=FYC^[$D+C+Y8\-D[\G&R
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M7]K;Q5#%&S?"'Q<9&1'64W,89F5?O#Y, [FDY49W[222&+U[1/3^G_6]O\[
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MO-4FW-9VELR(T;9<!]D"HIW;=QVR[@2-_P"\(4 *]:LD:B [HQ"V&38P4.C
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MRQW;04&,'*Y.9<;QAXO3P;$V_3[R^NG2>X-OIUK)<W 5(R=SQI&'V O)C,;
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M1110 4444 %%%% &5XMUBU\,Z)?:I>1HT-C!YI,LBJAVG( +'"G<!SW.WJ0
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M6*M,T2@R-$NYG4K#(TOS*%_>0QLPWCYAY@;YE+/)OELY-[2W$MPN]DE5F56
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MR@=E)$",JP@C=AE5$&2IW':8\Y^^L@G9[A6D613<3AA$[EF7>DA9,;@#@ J
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M7,T]/Z_#Y=-_NPY_A_HCPM))X;T&&0Q/*ZG1K;$# L&0*;?("G<Q&<@1L>2
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M;1LWF21K*I W8=0I3S A'\2[!UX7[ZK\K"E9%9?WRQLXB?$S+Y:O&Q ^^-K
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M<PV4]@CV\\Y$N\EBO5]LP![;QRK,2>_&9%**<J+_ *_KY>FAY^%SQ2E:OO\
MU^&^NFWH?==AH%CI4S26ME:6TC*$9HH51BHX ) Z# P/:K=?//P8_;I3Q/XT
MTCPKXJT.;1M3OU:W&IK(AL;F[!^6%!DMED#-GE?EX)!R/H"SNOM46XKY;<;H
MRP+1DJ#AL9 (SV)^O->#4IR@^61[U.I&<4X:HFHHHK,T"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AO0JP>8V_P#<GS %
MDV9([=0/P/%<_P"//BOHOPW\G^U]2TZQ^V31VEH)IB/,N'SA7VJ?+3[I,AX
M))P ,^$_&K]O_P ,/J^H>$/#S+J7B)K_ /LJR(:58)I<2QS_ +Q0%!B( P6.
M[S%(! 8K48N6Q,I)+4D^.OQ)C_:,GD\'^#_MVHZ/:WS-X@O6N#%93QQYWVL9
M^_/Y@/5,QC]V.K@CH[+3X;2WAM8?-CLH59 BN"L41.S/0A<9N5&<@;BP&-TA
MY']G_P .ZMX8^%FB66N6MBUU9A,FU7R_MJ*P3<XS@LV)@5SC:9#QM^;K$C1+
M9(Y-LJK;]UPC!4W%E)Y;_5QR'<I.,)@$!7];"T5%*3WMKZ^?_#?FSQ<57E.3
M\O\ +MOU]&]'YXGQ(^*NA_!OX?:IXK\3:M:Z+X>T:V_M*_O)"0((HQYSN V"
M_P HW;,$LT:-\Q$F/R*^&?[3_P 6?VE/^"UOP%\<:]-J&C_"OQ?-J]KX/T))
M7C^WV4.FW9\^XA+,)29RP4.2P1(QG/S'ZI_X+)>!OC!\<=7\$^"=%^%OB;XC
M_"*6Y:_\?6WAW4;2SU*\$-P2+1Y;B:,A6V2;U7<-LF6;YE+?,O[1'QZ\=:!_
MP4S_ &25@_9=^)GA5_!-EJUCI/A.6]TI+K5H3972D6OESF >5&&9FE&3MDQU
MQ6V4U%/&*K4V:J12[7I5/>?J[-6];]M*T5'"U(0TO!MMO9*W+%/71=7\K]3]
M@9(D6V;RV$<>R1(I$D#;E2-CN#_+N(5-H*DY,C9V A#--)YLT\B!7.V:7Y)"
M?*60O,%X9OE"*[@@'#J#@@[WH^%M<N-9TFPOKJTFLKV2T@N;BR+>?- V%G$;
M8;>P#RA3AB"1CC:)*N1H1"%4>=Y(14#.7!8*RCG&-I5X!N8;3O12%4X72373
MT2?]:=E^#[\?Q>\]M?SZ_*WE;?I?S[X+?$2U_9]^,/Q$O/&27VEV_C:_M'L-
M0C0RPR>7;B-2VTNL6Y3N!.V,[20">6^HO"NO6'C#1+36M-N([RSU.WCEAFC<
M,DB')!&"1_$>E> ?%9HD^%OB3SYO+@_LV[D+2(S*52/S<LC+AB&&[#_,@F5\
MM@N/0/V,-/N-)_9B\%VUQ9)8F'2H!L0 +(2NXR+@+\C;@0"H(YZC#'R<;349
M\_67]:_U9=^A[&#K.<7&70]1HIEO.MU!'(F2DBAE)!'!Y'!Y_.GUQG8%%%%
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MNC33(;E(UMV.QE!W#$6YD0*)"H"0DA<R"GS1LTWZ_AOVVV^Y+8SC!M>7]/\
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M&MMOOH22D;C+,JH 7$@8ID%S(L@S@=@D6=V.488)0*L<+M-&/+CN+CS5<IL
M+N_##..=\GRD'& S*5.TB- H-U'M:'=YD:(SR>827 4YVE6^Y&X^4@O][Y<Q
M9C>_CL[?[4\D=NJ1I(TT^Q5APK,DDC8(.&$+/UR/+XRP19ERI.4EIU^2O^7R
MT?3=QUG?K^&MMOZ_0? S./,BD,WE*'C9QN9P7 1R% ?.^1#DC!5W RQ#2)++
M]E9F1H&P@:%BY;=Y:@*Q^7&5\S?\H8E$"KA3\WX__P#!0[]MSXE?M$?M3^!9
M_AU?:UH'P'^'_P 0] T6[UFTNFLD\47DMU"D\,3 *TD0BNE5CRI,);:6+.W[
M!6HDA:&1HY(=H!=8E(=,M&VP8"C.),A2OWUQLR6+3A:G/2]K:RDVM=-$E)?^
ME)WV5ULK&^)IJA75!---7TVNM_NV_+1!Y7D%H5>01PL]L"\A&$5@RL2'[-$H
M9AU DV;A&"&O SP+$L,D,<HQY*A?WA<%3&.FUE8GG)P&ER.&B!$NQX]WDR<#
M"I'YD6PLV8E&Y-R%X]_/"@LV2V&IR0C[2C1[MW%N'/+L1*,YRJ,3E-JEV!!>
M/_5Y &FGPMW7]._S_1G-MK\O^!OWZJ_X!-<BY$CM,7AF9Y9'$FS>K,26!+?)
MYH<1D9)!:0';A@QYDC-O.QYDD;=M7Y?.S$/N^8"5(D*[3@[B%8* !&6SKYL#
M-M55:%OG+;54"$?-_$4CV[7'4GIT)C;;'>(-_G,,!2KL0P)WHZ%SR&D!$70=
M"PPD8!F.VO\ 3_K2UOE<I_%?^O\ @/\ !K?HAS6OF;8_*:2-5VQD 2'@;$VY
M7/[Q!&_RD9.,;/,5BUI/.1E:3Y_*9]N6D0KL9P.3EU5#YC<#)F8LK$!&(E\H
M).R[BNUC(L&>47<S!<?PY<* /E$1!&W?@M\01)'N4JI08+[TRG$?R@G<'7SA
MMP"^XMP'7;26COV^7_#=[Z^KM=7UM_PR77[M/71GB_[3ACN/CE\(0 K&35[H
M!6VM(I#HQ7@DEOWC!AL<[3C;MVR/[0F)TV1R*WFDRAF<,6^8QDL$8;V 3.0/
MF=5"MN)\SQK]IEV_X71\'X2TC2-JEQ@/D-(-MN^-I&'YWDY# ;E;8&9A7LK3
M-'&NYIT6-2RL>9$*JVUR2P^<,9C@?<*MGY0&3&GHY->7]?/\?.YI._+&V_?]
M/QZV[[*P&Y^T[V$C1K,N 0PWPJY:Y7+!B% Y]3EM_+($62.X1YQNE55602.0
M6_=8 ;<,EC\J*A &3((<Y8 ;FRS-;QL?GC,*DA%8G;LCZ %NB2*<#G>("3DH
M-[;AECM[B/<+B.W6163?G>  ""<G(:)-X8<,VW *Q';M;HOZ\K]OPWV9C96L
MMFE_7IV[OLA(H&BC4>7Y-Q&NTJ %\MEC7S@/E'S*2),-M".<Y 5V9ZV^]L1Q
M'<K*(PL);#H(GC' W;@O[H9(+,PZ%F(&W>=N1UN)EE4!U1,.P\Z2/  (_?<,
M%R07&2I7:K-9(841O+C>WCC+G;%E6B65G )VGY=T85L$G*,P.W)<OU7E^+OZ
M]-G\[%.][_U_7?[D$2*L2E(V\M4X,0 (B=MR[3M&64N'R H+2(/EVHA53Y4Z
M^8RQNC;78!$1-IC&Y>5 #.$V[N%")D!& 1=C6CYD7+0S?O-Z ,6PRSAOE(R6
M6/=G  8#>=V]HU4PVL:+E#'A 0Q+)^[D2-\8&67:0>AR0 ,[5CFRMY?JNBZN
M_I^!,K/1_P!?Y>7;KJT>!_M8Z7:ZG\:OAS9Z@9+6*&*ZN=Z1%3*X-LBQN&W;
M8R))'&Y223NPOF-C05YKM(YFS))GY=K,%7]TCM\^P;EW(W7Y6'F@DL% F_:H
M\)3VGQ!\'>)YM.N+C0/#8EAD2ULS(NGR2[9?M3IP\JA+=HB8][?,GS.,YQ]
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MK9K5G4Q^28E<1[8PKA.F_>0 Q6$[5+9958Y7@^%?LK_MM6_[4GC.^TE_@_\
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M<6T>U=L /.&=5C3>IY=@>C1J&*[7"[.!M=%P->^$/A7Q)XST7Q+JWA/PY?\
MB3PT)&TO5;G1+>34-*:4R)*UO.5)MMRJV6A<+N4*_P H&S?LQYXC*X:1=D!\
MM-K$X*%0#S'M9@0<?(R@X $2FO?7MGIMCY]PT?V181+*VQ%'DIN<G:%^[)EB
M%&1YC 94H 95U'1N_>_EO^+U_P @2NN5=?G_ $_+1:='=%J=V:W*AGG$:.K+
M&K*KLBF/:!@\DE,C<"J,NTH&VH?ZR;;\LC!XS&?EVR&0/&[XR/E=E )^5?FV
MEMOENM'1?$-KXLTRWN]+OH-22X!$5QYH6.>1=T2@B0[CAG<E0-O(9_E?Y-$A
MDD7:K(JD"1I'.V)6G(8N&)7!#$LVXY6:,9(W,S33^'T5MON\]NEUIH$E=M+J
M_P#@=.JMTT_%D)C@OH6BECAN8KJ3=,DJ1OYD>X'E638Q=6 .Y0';RRRH53?X
MQ\2]/E_9UTO3_&&B^+-7:ST768KR'08[UX[.6-HI8A8)&C*!&20_EOO)\M .
M5;R_3=4^)>@Z/HLU]>:Q8+I^FR*MW+O\S[.NT+LDP<D#,0*J&*E6RA544^3>
M.=3C_;(U'3?#-EX6\2W,EGK"7>E7^H2/%I[!(I$:[<K(,C#RR;>6+A#MR3NP
MQ,HI-2:OT_X?]-/F=V'C-SYXWM_7]=4O/6_W''.MQ;1RAI(UDVLN]=C#., A
MAD$],$9Y[&I:POAOX-/P]\ :#H?VJ:^;1]-MM/>YF=B]QY,03S#G.6;&2>IS
MR3@5NUXO0]C2^@4444 %%%% !112.VU2=I; Z#O0!!J,JQ02-))Y,*Q.TDK,
M%2, =2<@C')R#T!Y'%?+7P+V:MX5\4W4BONU+Q)J4[L$#2,9)85&\NI. S$X
M)0# &5+*:^H?$#LFA7S*ZQ,MNY#NYC53M/)8,I4#U!&/4=:^5/V29VUKX#:'
M?JMS;_VI$;T+,FSRWGEB?+;1]_8.H; 'E[6)VY[,!_$YNB_KUZ;JWKWX<?)*
M&O\ 7]>G;K8]'NR(KIU.V'*R2[@"$3]TRMM#$#;^[;*+P414/S*4IHG:WE,B
MB(>6T3*ID\O9)'Y2IN9F^7 <#."8V4 G:7+-2153[0 ENIQ/\D:J!D*S8"C&
M[R\.1P \ P,,N7VQ-M);J617C>(==H)7YU95#8RQWA"!RA;:#OC0>H[J]_GZ
M?Y>77L>3*5VI>7?^O\KNR;T&8CB@5&:9H(5*LTB$-Y(8QL=N<@N%DRAY"ID8
M$:[GPCS+A/,P\C2G>Q8MN)C19CC<=P(9.Y$_S<DE &6Q3R80[*L8$*C<YVQK
M(D>><_= <D[LC(16P JR"3-*FYOWTS!&V2#'F\[2&!;(#RIA]W\2@@A9"0]V
MV^OY=+;W??N3T^[^OEU\]]-0MII)H(]L@\QDBSOESY;%-X+_ #D;22[,2,JC
MR+_>"_ WQA_X*Z_'#X?>$=9\86/[$_Q2G^&&CVTLMWJ^L^([/2]9ALHE)>:3
M2&CGN$58P692XVJB#<OEY/WW;3HL\69V6-9(665Y0VQ%DR9>7QN5I2,X(W94
M94L%_.;_ (*?_M0_M>>'? /C_P .^"?V9;ZU\)K!/I4?CC3/%=EJMU/ISP&-
M[J'1$9+CSM@E94=MQ< ,.HK*KS<RUMWLK[*_Y_\ !>]^BCUTN[]7:W=^MM]_
M(^Q_V5/VQO!O[7?[).B_&W1;E='\(ZU#-J3KJ]Q'')9);RRK+O.[RU:)ED#.
MS!1LD/S;VW?+?PA_X+T^!/VB?^"@/P^^"G@3P?XBUSPCXX74H8/B!J"2:787
M0LK"ZDD%G 8I&NUS$8_-WQ[&D.5D4+7=_P#!&FS^$?B#_@F'\/?#'PQO+KQY
M\/\ 3[*ZTVYFO[=XKF:XEFEFO8KNUD22.,M+/(3$"Z!'4!G4ASXM^U_X;L+#
M_@X:_8QT?1],M=/M;7PSXHAAM([8K'&HTJ^VJ%B)X '&W&,= *F7/[&$J=_>
MM?SZ:7;:];+N;2]FIN+C?1W7:VJOJ]^GS]#](6U!IY9'87"QJX+32B01MF.4
M%FW=B[_,,DN&QACG<JW/V=/];\T: -F0,A5?.Z[\%P[J@W," Q<8V.$9\>@W
M7A^VA5;B>:09WQ0PRX3Z'9M/XYIWVB"6]9K?RQ'(\?EA",L%^1<'=SM*@*[#
M[P0'>)&:MI.5XJ>GXZ+>^B2W3W=]]D[^7&LFVHZK1IZJ_2WK_D[(CE5[1I.9
M&DBW(L@S]U9/,#&0*K$H\6UG&"S%M@R&W/*;KG($P7>@!"#*(HW[L*,*^U!\
MO/[R @;E&U(%.^V3RF$CR1*D1<@[W,*LG(8\F1""#D!HPHX#!93Y=PQ8-$T3
MO(49BNW#LJ$C[Y" 12OG!9@'WY4_/5N_7^E_6JO>QKJG;_@?\-V\O5NQ;([F
M#:JKYA1HMK+M5W<#&>?E *X;!4;(6_B45SOQ0U>[T7X0>)+[26C%_:Z#<W%B
M98E8+*,E%VY 7)E4]21O?"E3&XW=ZK#*TC+N>/=*9%VD[@T<C%-V1C8%8#!9
MI"W.(P;*)(MR^2V=S1O(V"$(;:0PWA2"I=2V0I,93B-79AVMIT?]?=O^FHXW
MO_7]6[?\!,\[_9OE\,I\,K&U\,W4<L^W$Q#F2XCF+8/F_-G<"/*#LBJVYER1
MET]"1A<RQD-YD5PZX<[F7#%R O)W(JB5F4$N3.4.6^8>%^(-#TG1/VQ_ NFZ
M3I5GH<BV-Y>W3643*]W%]DE BN(MP&Q7P>78*TFXX4N$]P>,WHVJ9)/M"+$?
M,?YY#(C2ISC[\AE(RQ)^\>8RZIC2]V-GTM^=OPTTO_P=*B3O+O\ U_PVWGL@
MM8EFBAA\EF1BB")#YC,DF8]NXJ=S_NQAOE7>T9  5*(/]0K.L;JV)W;)C1\2
M89]Q (5@=Q( *[H#@!,ATT@N=TREO+NFD==L8?<)-I! V[<AC,"G(.UT7YF9
MC'=B.,R#:L>V95X8*8V5"J_,0I^4"(H0P+*S$YW,%VC%MZ_\'?7YO37Y::6S
M5N:_G_7WO3\K(DB7?=QQB:3S)E\E6V['!W!/,88'_+5P?F'RE7()<[VCU&QO
M]'U=F;^S8=/;!7?YL3LP8M\FW";0Q)"@,RY(WD8 YGXZ?M%^$/V6_AU?>-O'
MGB;2_"GAG29&-U?ZCA(=[,1%&@.=[-)&X$:AG:-5VJ[(-OGO[ W_  4H^&?_
M  4X^&?BCQE\.K/QC8Z'X5UIM!N)M1B%FMW,L,<IEB6,R;8665=ID6-SSE%K
MEQ$TZD8.ZOV>W:_I^O0V49>SYTNNO?\ )V[>7I<]IDU:S\^-88Y//4+G9;;E
M)5PRMY9()(4R(N=O$F-RJ.%$'DQ;88Q)+&NP()6;>\+ A2R_-G:(\,<$&1D
M7.$^>?VR_P#@II\-OV%_$GAG0=9T7Q)XD\9>*BTVB>%?!FEG6=?U6-"=TJQ
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M $<E(7 )(4B!T/V;;M\R3R]J(0 S$H'=!A,J^TRQ9POW% !VG:::6[:>C?\
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M-7P=:2-I)+C5+AW$<! F8O:L6V+C(8R*<<\;,[=\7E^SB?=;;XY/FV"1"I.
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M.CGC( C<$?P87S-J[?X@0@4N.F$@5-K*VV,1(D5P5 R% 596.YO]8%^8?Q;
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MAXSO?9CR\*I552KS"M"E2ES?+O\ \%=>S\S3!TYUJD5%M_/2R>O]=>G4^U/
M7@K3OAGX-TW0]-C6WL-)MH[2W7:%VHO"CC_//J:V)9E@C9Y&5$499F. !]:;
M'-NM%D9MN4W$LI3''<'D?0]*;/$JR)(L*23+\H8\%59EW<_@#COM%? 7;>OW
M_D?<1BH^ZE\CY1_;ZU5?$?QJ^'NEPWEL(])BO[S4(B^TQ*S6OE,QV_+D17 '
M./NDX# UQMT[I!,VZ2.18G4J^R25"R@\;LXYC<9D;YG!)R?+QSGPUU5O%UY>
M>*-2OKB;5?$5PLMX;J9=VG%MS/!'M;(A2:177!*DMMVKD5TT"M,8=WG1[$"!
M@C*8]N&QSM<'>Q9ADK^Z^;: *^YRFBJ-!>>M_5+^M_RU^)S6LJN(<K>7KTO\
M^VOXL9=##2?9UAS'N$8A;YDQ'(." ,?=CVDL/G8 .>=[IQ]HGEBA</N#/$C'
M=')A"I(4LH9,NH(&8_E]2Y,9N5:VD>3;A5,SQG;NB&V.0=2-H'.<(O'("'+5
M,8699+>3?]Z,,3(<G@HTGWG^4A58Y!'&XER-R]^W]>APOXKOY?/O\[+RL"3K
M))(T;LJLZ-$&9PZEFC;>>69<&09W*/E$0)P5:HV@5E\MHRB<0[IB/W0+L@YD
M3Y@N3&,@[S)E@P8D-GNLV+L65>'F7=(%,8P7CE.58(492@.=B[<KD@"L_P 6
M^,+7P-<VIN([I_M5P\$$=N K/M;=( "%93@K@ DM]G4G!Y"E[D>:0Z,)2GRQ
MW_K\U^'70H_$Z\EO='3P_#"U]K7B:XBMK+3(B[23N9(S*#N&2JJCL&.T,$88
M)52?N3X1^#A\/?AAH.AB/R1I5C%;;/D^7:H&#L4+GU('7N>I^?OV8OAGJ?PE
MU+Q/\4O% M[.QDTB2&TM7$D-Y'$C([B1954*7DC)10Q&)%!R>:LR_P#!0.U^
M(%I:W7A'PO?ZA:PS[KHZF5AADA61,-$8UD+R#ED P#CC=D,OR&.J2Q=>U%72
M?3^ON[[GUF7TX82C>KHW_6Z_%_\ #'TU17 _L_\ QGT?]H3P-%K^DVMU#8VU
MU-9I'>A6N(9XF>*0Y#-@$?=)(8JQR!G%=]7D2BXMQ>Z/8335T%%%%(84444
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MXT6VU.ZMTC79+<A8U>0*I^3<L8!920!D@]6KW:2-A(JGRRQ.W>S=74!54/\
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M^/OBSX6>,_A'\+?@MH&H0>%M*\96HM-=\0:K=P^7=3RVHWM%&L!4G=D%UC<
MH\@CQ3;]S>5_/:^[O_P1\J4N=+3EMY]DOO\ ^"]#]$]K&7$>V&:1UV8;9ME9
MIHX\'Y<&/^$G!'<* #&G[F5%*Q_N[A&6(1)L#Q.'<+D==I+YX.7!"[A%M+A+
M]A+2+,J^7(L@E <AWSE)6"'.W9$78@<G<QS^Z!3:L+R1L'"+(JLIVAF1$8@$
MC 9A'&T9) !.[!XDW=?-JY=W^FOW'%HE9?+TZ6_X/KLKCBS"8MDLT4C2.\4>
M"9"N\,$"]'!5TQQF-NJ .C#)]F1=P55C6,NN\XVK^[:/<S -B2;&"2 L8/S+
MMW#_ +N(LX9E\L3.Z.$5@2DARVT*/WQ1-ZD';L((5<O(@D@D_=M-YBL23AE&
MX!"S;8S@,"8XU4%0K%0,%=Y<>T=MONUOZI^OGL-=WMU[:_I^GD.E22.=FQ(V
MV27+<XQ(A4D_+\Q(@D)R20/E;S3N4_/?[*!9?B1\6E216/\ PE(.Y9) (\V4
M6[."2-G!#  #=R'#FO?H1$)5*+$NUE^4%B0&0,5RBC:=V-I'#,7=5R5KP#]E
M=%E^)7Q45GA<?\)4%'R\,?L<3%23@<<;OF VR \8#'@QW\)=KK\[_B]._<[\
M!K4MY??_ ,#KVTMIN>PI(L2R2M^[8PJK*OWBH5HW(4%.H##;M&$.=V029Y$:
M2Z97WW!9DBVIE_,.X&0+M7;N=F4@H<#*_/R"S8IY+>)9%5DDA2*X4%V#'$>-
M^U<L-F\,KG *IP06^9'MO)C:W)^;RR"57K'$H8G:H*LI*L01][)+,,,:\Q:-
M/^OZ[?IJ>OS)VOM_6OS=]=]-+#1RD@.UO,3$AW,@N,M(&*\8\O>J$K@DLN%*
ML<4';/(S;HY$\X.)%**68!0YV@(3D'<!QY8)YW;C1<,HW[XVB9N1&T:%E9^0
MFTK\P5-@!497<>,':)3,Z7.X22(JMO5TEW%760[CYC?*6V[55TW#_5\C<11M
M_7E_P/EZ!K=+]?ZMIIKHM]K,8ZFZ#;_FW?NW;Y9-N7RKG 9ERS@\!V<;@#M)
M+!C^U1<)$87.^1<GRW;K&IVG;_STVJA+*-PRV M-"K:QP^8WD^3%LA9'=<*Q
M:7*LV73<"-ORX(9OE)+.56)6F^>&&:9<JT>,I*8E!(Q&<C*A!C#J#DY09VM:
M-/T_);?EZ] T:;Z?AKV_J]NP//Y@DD:8*+D>8Q>3=YVY,EI'0A^7"XW;E!<A
MCN5B73[OW\S1[BRLV3B1G88<J6VE6.PYXP@"@[=WRTL4K8$T<DDDS%9C)N=F
M9]SIYSA"3NWOPV0>A7=DK4?DC>H581*H"[9$;=#A6BP=@"D!N>/O$CAV++2B
MOL_)>>O];Z: _/Y_.W3Y^OY*1V*+-\TDBHHBD:&4[F7&QB> $0*I"J^PJ'QM
M8;J;*OE2[)MR[7,*NROM8QA]H!8;C\CA0NT8!3/]THQ\XB2-5E\M\*7/F%QQ
M-&A= I$C'>,@JS8;A67!<R?9N&C_ '9=8GRC1@C]W)M=5&-O#_= )P&95XP1
MU>F_Y?\ #=/.R"-D^;L_7T_K9Z6Z"1KY/E[57H&+1IN"E#O=L#Y609(PC8ZL
M0.@;;E!#"K-&L:G(7*%<NP9L%&)7 3YI$"[54 CY@I=/N:*223?O82^;)+A'
M9E;<S;CG+JQ(R7W-N503G;3G^9S_ *WRV<Q$*&97\R/!:-1M&<<JK;6*D+U7
M-&ZT_KMZ;KROKW)^%:]+?\#_ "79V[6"$?9$3S5FC2%C&QVM"1G!F*]2&"D<
M*N AY )S3$\R&)8&55EP8FB.U5?;& .&.#M+9X +'NQ)8)(@<2*R0M-)&JN@
MV(7_ '8; <Y5@H5&)(#;F/)/+.G(FCG8;O+G1I'=4VQR*70%B0N65F7&&P(W
M"DN&)%#_ %_'?\>KZO30NVNO]+;U\[?EL>4_L>L(?B;\6(6GD9CK=KG]YMDE
M/DOD=!R4+#*HQ&0%/(1_;XR;F.-9#EF0.<N"=Q4RE@020$<%L)SLF. K,0?#
M_P!D_P#Y'KXP*S,D8U>W)VJ?G&R1R#CJ"H<8!!SC+*N_'N\DK23NSL&#3N"!
M+M4LLHD922?E+ Y+95E8 ?(J%C[.'TH0:[/[]-NB\^VE^AXE9<U5I^OIW_KK
M8B)64-&TC*N6C((V^4CX?CG'$);!P%;''W$+N99)Y]IAC:8IO:&2-CN9S'L3
M;MR<-&Q_B/'EC#;#2)));1+(K2!LH\3#<J\VZ-DD !>6CP%&044(<DR!T=N
MWEQPL8XY6952/E@&65"F%RI(E2,'A07RA8M@=+T=^S_2[MUMW^_0Y53]V_\
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MU #%>5VB1@RA=VY %_>.699W7V?3XW9W583%*YC?:(P(48Y!^4+P4VE4&3G
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M,D 8'B7Q0^)?B#]H/6+Q]1FU_P -^#[7?+9:?]H>TO)5&P[YF!*\LS#'F,N
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M79F#!8U+D,RJQ5BBERI!VLVT1,7)P2<[R)"6PA=\<,;85?W 03!@2J'RU^\
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M-^]V*"-7;:<,K!4P54>8G(VG:=Q '=B)6D7>FV201K\ZJHR"$W,08]H)W;2
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M."C*T2^6VY-PSO5?D+9YP5 ,8YILHV/\L,*M(^W!B14WIMD.XX*$!G(VJ=K
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MELLGVK2=;B=XO)C>2Y#Q89#Y9).?D8 9;D $*5+?>=NS.TC;G*EN-PV[<<$
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MV*_&'[7/CFRAA^/WQ3^&_@6SL1%-HW@":VTZ_O;[S69[J740))64QB!!'M4
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M!#?0QO'=V,]YY<T,F]<*9&0L2!NRS=2OW>8R.K4J&QYBQJI9"-_ BR!D'?\
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M6<JRY84;NRA%?]O1@E\]5OY][,Z)UE4JU<5%+WIN23UTG)M:+;>VN_F?2?\
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MI8$%3@#!P <-=1&7E*VZO&%42-&2I=CN*G/ ;*A,8*GG/W<EPS:A8T5E6%A
MD?S)OD8C>A7IC!5"%()#*<4G9)K^O^&5_NWTM<Y_Z^7R_KRT3FED"(#)(WF*
MS QRM^_PCKD$$JT:JIYST+#( S30WFS@;XY&\M45P721B'].0"%QQDC;T^;J
MSS%2*1@T+>3B61"F[@-@,S9!4-N*Y#=5''>I7BDCC:/$K*KI(&5-ZR*/DSUV
MD*^57'!W=1FIK6Y97_I6\^FOX]C;#/\ >Q?GZ==K?Y^2[V_9']GB5A\!/ ,<
M=WN\WPSID:L& D\S^SK7D#<J@[GQA5X.,[?O+UJ,Q53&MVC8C8(IR8SM2.).
MI'R[T;#$ A4#',@5.3_9]??\!_ D4<K;O^$;TB)#YK+E&L[=1ACSA77@@;0Q
M88'"2]2LRMMD7[/&2GF1H25C4,1O)P5Q'EV08)(#\8=7S_/=FU[WE?IO;3OV
M_P ]+']+2^'YV7XV]=.@H<_,T<S*&&$D:<K'M;:!(&+ LN6C!++O Y 79M1Y
MF:4R>6]PH"RK&@D5'&&4?, Q(=(@A)(;:/F^\OS)#)&CJV69;5U9T8+YC%96
MD"LJ$_-Y052HPJE "/DS&L$4JI##(LS.KQQ.&9U:5_D?:N<X=Y(TC#CG",1E
M01&2Z\W]*W];[]"+N]W_ %^5^[WZ[:W7>S2EMLN(F+;6W;CMC&%."=K+O2,;
MU9<W+J0Q!+,:62.+_6-\L4AW><S&7;$LC.!G.[ E#?-L E#)G.XI"5"1L%5X
MFCW;4BS\AVJ'5%V@9EE=2O3=NC4A-QH"?N_+&TLN5($PD\UOG53D E@8CN#8
M 8(R[2#&*&N^^GI_7K^H^:7?2W]7[?*_J22$M(P+9+;%Q*X/RB,LN_).5<J&
M;L1'(RD"0 D,C"ZB/F2"3S4VQS7'F-E3(SYP/O!I$);DC>YV[2T:M,7GRE2J
ML)'=MT8(#;QC=G@$OL)49(#0;B2N]R*9)7#?*=X2)=F8FF?>2RLQVLJ^8B#)
MZ,RLS NX92M;7^OE_GK]UR;M+3[OS_I?CJ10PJ8EC7;&?*6$?N_F@!,09 .^
M)C@KC.TN3EI%-2A_WNY5C5^L:NY*MM D4!F/*QLX4N<Y"H0=F\AKX$,>YOD\
MM079"B1JP**=IQPQ9'*EB"A7"XPB%RRR><LQ$?G#=,LL@8/O4!BY/*X;;ECD
M>9&Q8$[$J[?UYW_S]/E>X7MIY>O7;Y?>WY@T.^/;"JRJP18]Z@K,NTLF?D&[
M<PB+$D;6D&#ER%4QK/N90SEF<^8\*MDE)@&.!]U@<L<8*PDD'*@K.DES--E5
M\Z83*QP=S2,CR'AASDR)&V[^% QQ@LBP;6N=ZKM5?G ^8?)YA5EV]5(98T1R
MA( 4_*X2,2_=3?DOG_7_  6F#OU??JU_7Z6L_/R3]M15F^ %S(5G_P"/JQ9L
M@B4(TWFY!7[V[S5)P6(.P\941^LR195?.A^T>8JI*0N&N@%C=U)(4'/FCR_4
M>4%P57=Y)^V? )OV>'A=&F/VO3E*.A"E3+$& &<L!L?.#@- Q;"L5'K<C!K?
MS_+:1#"DC*5R)52-790NTGE@Q))X)9@3^\J%%*I;T_7Y_?;[S25^37^O3N_S
M\Q6>2V61@W[Z#G:F,;@&*N.P5I<S,' 4A5Z ('5I5T]E3>T<5JP9CY\D?[H2
M(P;D;MI,:CY3O4"(9)0J6O&T,C#?*'C8H7B7]YYG&]P5 #,6A"J6SEGSCS%>
MDBDA5HS(T,=OO5I?(8!1&SN90I#_ .K :2,8)+?+L/[T@Z^O7\?\[=/QVNX<
MFW=?U_7W]/0S]A9A)N#0*PE#P[2[1N5="J$!OE9U*YXCD3^$,X<+;[)^YE1F
M^SDJ8^O^K,L1P3@L'^1?F7);&X!5".V.*24^7,VV:3,<NT$;W:-@XPIR,'?@
MJ#EA.,,"$I))5VLTW[E9BT[(J*S[,!GQSC<#AT(&2#&3D#**[>JTW_/IUT_R
MOU)2TVW_ ,K?\"SVVOT'L1"WFR>9,T(5][Y=FV!GD=6&0S;WW DLI,H&[RU<
MOX!^R]NM_BE\6EF9?W/B>W8Y<96,6T:YW88 ;RASPN"ORR[>/H'8T5QF3R;=
MER^>63<)$+R?=WNH1#U8MPAY;8S?//[+A\SXE?%[ "I_PD,81"V"K+:1 -NR
M"@)W..3\T9W*44$<&8).DEY_U;_A_6VM^_ 652S=N_Y'M$416/R9(Y&\EF25
M4MQB,?,=KAEPC#;*P+ G;VC )#K>.;S%5?-,D;H825=L/)N="C#$BESR!]YA
MAMS*"*:0,*RK'MAX7S5WI;H&R28LLJD89V7)&9BNS#"FLL<,>61EC4(%WJJE
M8S(SX#%3N9H^=Y ^ZRE3D"O-WO9?U^F^BZ6U\O8]?G_E\K_*^K5DPM)Q)';"
M.3:L@V(P*KY8P-X51@;MN5.1^\R?D).:EMY&<PMMX:2%V17=U'#>7'R'&#'\
MBJV\_*1@[B:196L9MLCD2PR"+F8Q,YBR03N;A@AVC>I W;2!CYH_+PL<>XHJ
M* #\WSQ_?4Q[N0S$&3&3RV!@%@#3Y=_ZZ;776]_1+MV_X&OY^EEIHPB7;;0K
M(ORQY8(=VT*R$R$@YP0%"9&,"/@.P.V1H97DY22=MA&"I,DTKJ%1 =O!9<$
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MK735.Z7J^LQV2S_P+N\QE!"\*!"PQN4KC8?FQE#$,_, =T;1!K5B4P/*&_<
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M3YMW#F<K@;R=XX<?+R/P$F6'X#?#\\JUOX<TEBC;6F#-90X5 "/FPHQG!)C
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M8_>R)GC<QVHS9 !#2*=AV 4Y5:Y@"MMG\S:6'EH?-9FW28'. V[ELJNX0L&
MVE1X6BM)?U^>R_K4/KE;=RMOT7>VUM^_G;6^W@C^!OV@F$TA\3?"?=M7!70+
MQ/+;:4&!]JP"JJ6&0=F&YR" MSX'_:"@22/^WOA7Y>U@Q.AWX61$\W/!NQG
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M*W/!R%W*CTV/3(;&ZWB.W\P@I)<;5Q*JA(R2_P!TEB^X9)4 H6&V1LR(R1+
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M0!6=Y!F4*Q !BW%!Y@!#8^8L)/+;:P!S)AL[F83TL_\ A].W?^G?8JSO^?\
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M#:FX-M3*I\S@I).]NS_R]?OZ]-).*?)=*_GMMY_\!=3WF<).DPC\N170K'N
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MH7UQ-*\DB2AB;@AUB8<LH821N .03+E 6 (M:]XKTWPCX?O-4U75+33]'TV
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MXV@S_,JE1L^;!!8GC;/XOHG[/L?CC484OBVA)JS6]I%Y\CS.GG&)4*8^?<B
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M9BY7[OSQD=" V3\@0TZZ.QI9/)^55\W9(@)==Y"QD,@/#QJV6X;)+9=]E2/
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MS,'7?Y;[&>0XQDL=C*0=H9@%) C(+IXUVL9(U6UD8,V3F-8BH &=IRJ8"%E
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M_P []OEZ^;TCE@NOE]_^>_XGN5Q']HD820O"LQ+-"Q)VAF+29! R(_*C3:6
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MW_#%\L=I"$^*7Q$*I&XAS-8J!&L#D$#[/M&Y<'  ;+ $;?+#/]XU:WY?U;]
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MONR1*47@&7Y49%;&T#+J""5B5LF/QQI<D37"ZII\?*,Y-\-JJ0'VYW!@22&
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M%7_#/[%&OZ7X;L="\2?$7QWXBBCNM+\-^'8Q-=3P$,0Y(C<JI*$'Y2=I!7G
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M 1%M95&0I< $!&VCLJQO'<;6&) \4LH*(J*D84%F&U#B-=Q&<\'YH@U:UEH
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MF219Y,F61HVW%B8GD=P?F(/RK*AR!\\O RP5)$$L4W^K)9%7Y&'E_O(G)Z$
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M('H6H:;!X4\"Z%:M9V4D<MW%;27FJ2N-]W<,RN?+X6-@I4M\XK]2_#US=/\
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MDFW>KA)'W,7#?,I (R5X9E^7>%P?%H6?7M#L)UC\JXU)#/#-B.-_EF>172-
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MM)8;$Z55H]-'^K?2UE]US\!XVX3G@:LL9AU>E)KKJG:^NB5NVM^OD<5-(EQ
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MTP7S%DF<KMP4D=FFQ')L9QM^;'+8"A$4XR"S Z7#*V8Y(Y70Q,00H5U8*%.
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M 3("\&53AQDGWL/A8TH\SWW_ ,_R^]?)>+B,5*K+39?=ZN]_Q_56R_B;\/\
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M9'JX\SPE!R7*^1::]WY[ZA*GRXNLD[ZQ_P#25I_7_#S4445F6%%%% !1110
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MXUVN=RQJH<K'*?,6,A97.000V(\J."PDR<,')6UD\KR9>N1&Z,D9*R%0A^4
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MF+X^0_$;4?$GQ(^*7Q&L8WL--\4^/-9FUW4-,#!QLMSB$(6W2*K*C,<N%/+
M_6!.[40T1;S#,$C<_>PQE:/A5#,V\%FVY8.BA0#A4A\I9(MJX"S*T(8H6X2"
M*(#Y0-S8E)ZL,D;2Q.UXE34IN4KW>OE?T'&O)044]+>6WK;O\^J/E[]H#_@E
M!X;_ &BOBOJ/CY/BS\?/A9XLUJ.&/4;WX?\ C*;2EU%8@MO%YJ;949]BQ@;
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MPJ)1(<9/R*@V@[6X )&0,\K2Z#\_ZZ?YG3455TZ\CNRS0W"W$;%FR2,H,X
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MNUBW\3>+O&6U+^2*W$=I#"HP(8U/)7 4$MU"*,<$GJ-2_9:^&]_I,T-M\.?
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M]]M/Q5G>Y[?&GSK^\$LL>$WJ%9FPA8%5 ))D"LP'/[Q58X\P815$$+;MI2+
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M-%-/(NZ,R%W.=[*7:1U.2P7./EQDG[@VHI1F'L9;M^']6_JQY>8)*HWO^O\
M7X==B&8+:NWG[3Y>99',:*R[?+\QCN"K@9;Y<$<* 0<*\DZ_9RWF*L8\XF0#
M+*DB/+A0-@)^; 4C$C\$>CJT;)+,L*^7C)V1JP_B\N,#:0R\?QX)!VD-M!:D
MW&5?/C7<[)NB=(QY<@ P"K)N;YA'$"#G>L> F2ZQ^GNOZ_KS/.7NI1?3I\OU
MOZ=.S39XEM8"TT*FWMP2^/GX&]W8$KCDQ#DMCH059"Q=*DMNLFX%IX3N=1*\
M@61(\MA]I*DD,I[L/G'.[:VYM-J2?*44<;]F["G,2MG.YB%4DXDW@1+CJ2I<
MLMXLB?*VXS;(@-SQ/AE )PV&!5@I  7E2F. :,6^F]^O?I?YZ??N[NZLRPR2
M,K,VV1U=E=8Y,@.N2H*J-TD!(SD@LR@#!VDCQ^6PFDCVQL(G8NV8$$;)(0VY
MO+('F)N;!)(#'(R'QOYLT>&V[I&5=F3M!F+'"[R<'"J 1A54Y7YRBL;YA$DG
MF"/:0@<M^[7;A@KL%;=M4J&#%@K9.Y=N#J'-[K?3\-/Q[ZKR\A7FEM7CD=?+
ME^4R%@R$/O",.6"["6? +?(57:"1@ALUDC\L[9&W2P-(L6YB%7R3NX<'.02&
MP3L16&5;<LBR->+O^T>9<*Q<*WE2%CYC;5("<JW .204''RY*P_Z7<Q-((Y&
MDV,Z^7&%D\HD' )X5&8-@G(&/F5<J#;^OZ_KYE2NGKOI]_X_Y+T"SD::XW*'
MM]PCD/EG#1J^<X0+D@.F06PP)<$@]?&_VF45=5\)36ZR#6FN5?+,_DRQ&&X#
M'YV)60!3MR#\V=Q)+5[#!&[_ &=3N,C*LBK(H $NUF<'=&,-OW9X+_.?E P#
MQGQY^%[?%;X;+8V[BTO-/FM]0L9YHL+$8\S,"=HV[PC1D;A@ !L95:FHFH-Q
MZ-?G^/I_DRJ=E*W=/[^_6W=?/3OPNIZG!I#R7$DD%G!%.0'N&")\NUAE\$A@
M-V?G+J)%;.44'.\5ZJVB:9#'9QZ?<75U=06EJ'EB6W5F<PEY&!VIN7RV 7(P
MB,2S?-74_LI_"U_B?\4O$&G_ !$TNWU"ZTG2XY+:UMHRUF1+&NX;MR[9CYFS
M##<0%)4L^QNU\6_\$Z1:WS0>&_%$FCZ"MPC/:WL'VB*WB69<[)IF>1E/S/L8
M?*'0+@!4:<1G5.2E&"VT3UO?K_2UL^Y-#(9<T)-W;M=;*W2V_3KK;=79/^SM
M^RKXM\'?$G2?%7C;7-'DNO#7F3V5OHY$B&4PN)5>29$D?&&) 8+PK#ED5OH<
MC[/ILD:E85BBDBV^8JQQMAP,^ORS(I+#*L9,B,L9 FDZ=_9VF6MBK768(8H2
MTGS3%=B1X;.$+$"9G;:=V'#;=QQ)O^VQ<G:L@,0Q-D0H[[AEG;=M,;;<D9VK
MDIF(%OG92<I^TJ-W>]_U\O/7UZ'T,80IQY:222O9+^O\[_@2,H^T_9PT?[N>
M,11J-N&$J@8))"*<.HQM"%U7<=TBU'+=;+;S-S,S)-/@H<S(8TW$*V[&Y$0D
M<*J/_%&Q1'2W:_-)(K>67>=E*9)7@$.I;.YGC(*Y+8@.6969RD3)9O\ O'^4
MR+(^'W^?Y1R[!@>=R,C;EPQV^8,%1OE:*_\ 5]OZZ;;Z#<F[K^MO^'U]-Q;P
M^6\JR2;F17A:0D,S.DCR2'G?DJH.[ESBX;!="JM#JDMQ;V%ZUOY<-PKRR9<K
MY-M*-B,)-N=P5E5@<=",;G=2)(F:UMXP_P!Y4$; %1DH7,JCYMA(61SC@!?+
M5L[RI=&_E(G[UI-I5"R'/F?NMBE>3AGV%UXY,:-@!DVTM[>NOYVVTZ>OS)E+
M5R\OZ_X;N?F+^QI^Q;_P4"_8A\*^(-+\.S?L<^)-2\8>(+S7?$.NZ_+XCN-0
MU._G=?,>9XHXHMJX"J(T"!4)YP6K*_X-G?'GQ'^'G_!-*'7?&W_"NX?@1X=L
M]7U#29[*'49/$D<T5_)<7ANP%:$P*D$[*8%:3B,'(+BOU+6 2V\?R0W 6-80
M5X6<$ME!@_+F1AMP-HPQ(!C")A_#'X4^$_@QX0M_#?@OPSX?\+>&]/DE^SZ9
MH^G1:=9Q;V,C.D,2@ R>5('"#^(;MTA?=RRPT6MW;7TZ/^O\S9UM;RCK=>NE
M^G=W?DOE8^"OVN?B=_P3$_:&^!_C7Q+X@OO@#=3ZS;76I7.J:1;Z?#XNO+EE
M+&1!%(E^]P[OGYT)+<L#AMO;?\&\VJ_$[7/^"6?@>Z^*,^N75]=W-TVBRZJ)
M9;Z?2?,E2'?YPSM.^?R3DA@8^&'S+]$M^PI\$=1\;P^))?@U\+[KQ(MRLXU0
M>%+!M0:0F-W83+ )-P,A"LI.X[0I&?WOJ=JJVT:M#Y:M"'(,$>V.,I')( -B
MC"G"R K@<(4 Y6-T</R6]']WJ[OT71>=Q.HG2Y(_UW:^_KOTL*H!";F@V>5&
MYD)!C4"0KN;.T>6 =F >1(W0KY2'[MX)'9F:-?DF#DO)"6W[SC!VMY/EJ1@$
MLF2<1N \1M$5VK(&7>44C!!PI495<#" D#')M@0H8%1Q/Q@^.6C?!7PI+=:D
M9(]0M8@UK8@;YK@N)?E2/?A-[%!L( )<C!^4'>]ESO>]O73_ (;IYI="(ZZ+
M9_EMY:;W6FO9(Z/Q9XKTOP)8"\UK5=/TV%@,%RB[T9C%(8@"K2J5/"QYW?(%
M( *)\D_'R'4_VE?$4WBG1;.Z\.VNAV*S:=?.\D-YK<J*N%N".&A14G?#@%<%
M<!V^?<T/X:'Q[KO_  EWBYIK_6]0_P!-M+2XN#<VVG0LYEB#(S!&= RABF#N
MV9)#\=Y#*$F5EW9A"Q_*SF5%!V[>?G^1</LD!PTRME1RO=1R_GC>3TZ+3\?\
MNECCK8V-.7+!7>[?^6BMMK?2_P"'5^'OVH_!6N?#2;7[_48;"*TB+7VF7-QB
M_AWN0T:0$M+-,/D",B'S&2,+N"?/A)^WCX"_LA9M:NM4L;QVFCEL&TNXFED<
MO$"[+$&?YF=_FB;:Y8*A&7%<K??#C0;_ ,56^M7.BV-QJD:O')<RVVYF9FC3
MNJ#<WFMD @[I& !PK5K/9VUSJGVMK:UDN(44F1H5FD;;(4Y;&[[BH <;1@L=
MR'=5?V;4M9N_]:V_/]-0EF4(KWE_7XO?O>_EUY*R^-/QC^*%NY":5X5TF=FF
M6^A+R7S1-(8U94D5HU5HP2R;<@/MSG8#8\$^"]6CO]2\1^)]2;5_%FL1&&ZN
M;9?]%C2)9HXX(A&R 1H4W#<N?D'0@&NG!C8+-()I,J7=I!&_F)B!9,X4LPQQ
MC!)&,C"Q@$ZNT-U]Z:2&+#,^TN0GS(2/++9+*SCAEW%RI8(#7H4<'&E[W7\O
M)?/IZ'#B,94FK-JRVW_SVW72_P"4EU'NGN-JLOVB3RR KG(_=!G;Y=H/R$@M
MNW"/._:&+P7\7DV-PVU8-JO,1MVM"YCER2^['W=BY#JORC#@;8V?*8XWD,0L
MU;<RD,T<<:*7545L9YD9$7KPL3D<JE*D$;3>7&(\;WE1_ECWQF0J3N&#C9./
MNA=K>8-X.XMT1T2_K^OZZ'+)6OY7_7_@OUL?,GQY_8U^('@W]IWQ)\8/@CK7
MAJQ\4>*;=-,U?1_$XFBT>9/*MXI)B]M"TPDVVML@96&W,AZ#G2_9R_9G\=7G
MQMOOBW\9-8\+ZG\0/[._LK2K3PP[+I5G#(%E*@O']H>4^625^8%3A2PP#]$H
M/,DBVKNW,A$CC!E;[X 609R,$!!\H"/DJRA*6$^;$W[PLLD$*;C*65A)Y8\P
MCY\ #YMS9R5^<G -8T:*I.#CO#X?[J\NV[7>S?5MG14Q$YQ:E:TM_-=WYW2T
M79=KKYT^,7[)?C#]I/\ :DT&?Q9KGAUO@[X;:&ZT[PY:!VFU"^10"UR#&%\I
M2SH!N&?+4[%&%'T?;+M2U6/SUCB2 )G<FU6^4*4VXR5#$_*N H&  F(Q(ZIM
M;<C0@3-$ZM(L9&[)(V9(#AR%&!B$X_B4H;;[+(BE&62.3RV=AUD$JA78 !69
MBZL>3M8-M!(2JHTHT8>SAIJ_G?37OHDC.I4G5DI5'LMNB5_PUNWKOOV7,^,/
MB7HOAQK73[S5/[/O+BS66WG82,B,()0I:0+(L;#(8?.'(. 2!'GQ[6?&FJ^)
M%\/^ +S3X=9\52ZF-+L9XA^[U.W21R)82K;5D 17QPPXY XKW/Q9X2TGQQI7
MV?5+:&\CA*$"=Q^Y^1P%;82JXD0.S ;.#M7(;'S=XO\ A*GP1;6M-MM>;3X)
M)KC5]'GEG7[1IRJVP>2X;+2#.<,0H ;/RX5O-S154KOX7V_7KUVN]/DSULM]
MB_AW6]^G5VVZ>7E8^I?VB_B)XK\*_LR?"WPSXVLTC\1ZC>VLVH6MLI5KDI,$
M,)7)4;]^-JESA=PY"@^Y_LH?L=:=\!+.SUJ^EO-5\5W&GQVMY<R:@US"&'WF
MB5@ F0<$+QA%P.M>4_!7XZ^!_P!I7P_\,M#\77E^GBK2KNQO;*><"."\GA9)
M8T"*3'\Q!7 )?Y(R2P-?8T<:PQJB*JJHPJ@8 'H*^3E)J/LW_P /U7W;I>=_
M3Z>-.,G[1?+NN_\ 6OR'4445B;A1110!BS>!+,.QM6FT\2+Y;K;[ C(0 4VL
MI !"KT Q@D8+-NJQ76J:44BU*RCU!5E0K=Q!GR1L7>8U4E6.)'(50BY0;CEF
M'244=;AUN%%-C4HBJ69B!@L>I]^*=0 4444 %-DC$BX.[J#P2.ASV_R:=3+C
M;Y8W-M&Y>=VWG(P/Q/&.^<<]*+VU"]M3.UW0]/\ $"6L.H6>GWRQR)<Q+<P)
M,(G0C]X QX89 ##E2<U^;'_!+-5A_P""NO[74_[Y8X[O2B0D0=RIM68*,!FQ
M^[((78-R_=^?%?>7[4'ACXB^*O@]?6?PK\0:'X9\:23(UMJ&KVK3VJ*K[F5U
MPQ((R.F,9Z U^?W[.W_!*S]K_P" '[3'B3XD6_Q<^$LVJ>/KRUF\4M'I;M+?
MQ1%2_E[[7$;G! *E<ER<H>1G@^6&*?-LH./;63CK\K>JO>XJUYX5P6[E%V\D
M[VO;J?J);';M7;(JA<*'RQP#C);)Z\'GGU]IJS]&2XA@M8[N59KN. +/(IVA
MY,+N(7 !'O@8X'<XT*T]?/\ ,:=]0HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ,<UP?[2/QFM?V>OA#K'C*ZL7OX]%A\UHT9%8KD;L%B.W89)XX(!QWE
M<7^T3\+6^-?P3\2^%H[DVD^M6$MO%+SA&92!D C(YQSQSGM1'EYDY;75_OU^
M=B9\W*^7>SMZVT^7<_ OQ+J<.I:_J5]$JG^T+IY]JP"($NYD)VG=C!X.&#$G
M=QEE%+=@29'^I?RY-I#*C=<$CCD<CU%=?\:O@CXH_9_\676@^+-*N=-NHR?)
M\_<5N.02Z,#@Y ZG@C\ .3N&:.5I-X5HY&=7A.T12C&X;E&#V( ^4"13D\D_
MU#D^.I_5(2PK4H<J6]]NCVU\_P#)7_E?-(UZ6+J+$*TW)MZ6^Y=NO4BBG692
MR_,HVG/KNS@CUZ'D=./495I45-WF1;<@##@Y)!/'/.,'..G?%32QR1%E8%1#
M+N42,J_8E5P 6;L0Q.<A ,J?0EOG-&[*I;<H^9=@21QM;:> <#:4+<G<#GN"
M/4^O5.ENOG_7;S]-O.]H_+^O^!?^EJR1UB>96DC4P#<^9%X&<9!SSSZ9XYZ4
MJLK1E@RG;NR-PW+@!L$=<D$8'4]!DT+<>4T;"9S&F]HR76)C@@*0HZ$;<GJ6
M&#GJS$KX&V0QR*.8]N?+ /F XYWKR=P5ASN!(XS3^OU.J7^7?^O\F/VDK:?Y
M_D]P;<790&<H@=MO( .,9/3/(XZC/-*MW-'&T86:-MOF*/D5CQGJQ&,CIZ]J
M63=/<2.VZ2:-F'WDDS@9D/ ^?E]P<YQ@@'*@ACQX1E4*D3 Y,4JABH.[:P(3
M>?N@9P"4P 0!C.>,E)6DE;?\O/3J^G;3<F4N:#C)?U^*?IKU[6%'D^;(H*)#
M(JKO9V0+R5 VDGG)#, &/3& ,!S32*RR/\CG,K;D\Q]Y52"<J-RLQ[]/0Y^9
MTUP\4[R,S0&WWL5ED.V-E '!+ IA57NV3&!@YP&I&&D81QH69BB[0KL0RM@%
M2H+L3A=V/EQQNPM<O,XJ_9?\#3Y??M?1W4=]/\^O]+[]['6_!#XQ:]^S_P#$
M*SUWP^6AG@9!?0 &'[?"LW,$I!8J <JK%6V':X3. ?U _9E_:S\(_M/Z-"NB
ML_\ :,;!=1LY(9(Q;-((U?Y@OE=9G 7?A0RD 9R_Y'[-\"^4K2-N$98?NU#8
M &6;J25?(^51C((7BMOX<_$O6/A%XXM_$7A?5FTG6(0'@NH45MZ*@,88KD9.
MXC:<X+9)/./D^).&%C+XG#655>6C2\EULWV;Z+<^TX8XLG@[83%N]-^K:OUW
MV\NC>E[Z_M.?,NXX]TGEM<1JTDY#*R!B)7?YB#E?D/##<4W9_>CS%:Y:))+A
M0;5E(VJI"?9I-XE5 P5ON;43+#Y=T88C(5/%/V0?VOO#O[2WA*&U5X-,\106
M\GV_3-H+Q^607ECRH5D ')R=X,>$9E#CVM(F>?:RE9%D,;1J4^4,PC:,;^=R
M1M$FT[%(&TJ0#O\ RFI3E3J>RG%Q>[3_ "_K6^OD?L-.I3J156G)271IJWEZ
MW_X.FB"1&@5XV4>63Y>V42+&R*5C13D[E4M%(S C("@YWJ&!',BW!>3?)^^_
M>;@/,F#ROOW<@*S?/$3]T&-.,$,J6<RI-;R-(JJJQ.)23N4 L[D=9#CYYL-G
M),089"JW&>,/CWX0^'L\>E:UK,=K>QV\32V<<,]TT*XP0XMTD>/<#(QZ9:1@
M!\L@.,I):-Z?\-?[]OUV+BK[?\'^O7;56V1R/[:<SVWP2M%>4R;=:M$=N5+;
M3<+NPQ5CO>23[VYAL.0 0E>Q3P_9I)?+*]%&X!6^3>=H?"A64Q-*A8%0P0X(
M0@R>&_M6>--)^)WP2TMM#U"+6&U/Q);16\0_<S7DK%R%$##*N<,X382" %V9
M#2>Z7%P/M32QLDB,SW"-']^53(4W#.2S,_E=VP54DNROC--2J-]/Z^_H].R:
MN[7N46H6[?G_ %Z$/DK&WRQ+)'"N%61EX C0JI) /SH[!C@YV9(5%9 Z6#?$
MT4F[RV5H?]6)&?Y"W7YOFW$H-V[)2-0<QEU''EV[-&XVJH82H@?8H(65EV@J
M3^[W84@"-9ER5VDN<1P*JR+&D.]48[BRF/YUVAQDG$<F-V[:=\1! 4%]%LFM
M_P"OT6F]]5I8S_O=?U_X&^U_FQMTPN1<-)&-T@>27;&F6+.;AL[Q\S;5')_A
MX*AOE<E$?G,3)&BL3 \OEJR[&<N9#N8@C,A.TDA@\8Y<%@!_+15G\O\ =AC*
MK*"&*L!*A5\LK!H4D^[DY)93O"%]NVR>+S&=I.?E0[G:,;&D12K_ #893(F.
MN\/DEBROE2T_X?7]+?U<3W5_Z[;_ #U>J^=B*XVQ12/Y8A:-'D$8B\SRG!99
M!P,, O!7."1$WW"54:RM0K1FWMVAC<@Q(!(2O(+H0WS,T0W#. QCW9R5WK&S
M?9XV\[:ZQ(PG1_EW>64!Z[AADC?<,8,;DC*!$6:1623=Y<<6UP\3/NV@',JE
M0P!V>2N%'&9%?*# #\G_ %^5UW_0?-=W?]=]/S[:=;H1[?RK=OW$<FZ%PR0C
M<KYD)V*=I4J-P<#!(,L600I8NN8-\$D+^7(I+^:V,)(79LR' ;:K<.&!'^JY
M&TQX6Y7:\TLL+97?)*NU96?E_-3(0KD/$K*!E1EFVE<J!X!'<M%((6;>1(O1
M1\R1E\, 7C+J@Z[B#N.6!*2E=Z[_ /#+^N]E9O9$=-/Z]/-OUV[,"^7D9MJ^
M9.&ECD<0?/YX#"3'W/O-NX!5E4@A=F?!?BI"K?MY_#:)YIE>?0;L;-GERR%[
MH_O,#=@C(Z8";P#G86/O5M,1+"[2E)-X D)PJ,&CE<'!&=OF,)%PH.$(  8K
MX-\3XS%^W7\._P!RL:CP]<*_FM'A&$N-K?*5;^+.[. N"N/E7.I?EC;_ (/X
M_CZ=]]*%KV6__#:WTWWOW[:GO,,KM&KK)Y#3#S'>V.W!YDE<8R<KP5.<'[.^
M '5"&Q1>8D;+'&\FUX$1<AMI7!BROW2=S)@*,^<@PIQL)H))HIH0'D>:-XDW
M!C*<%U&X,O\ SU5CR $\U3DG;L==.MTLDC;?+*O*"2),QEG<KG!(V[RXX (*
MN0246M=+76W7^OZ[F>B?DOZ^_P M+=+*X;U9UW,LB?<VF,[65@2H 3 "D,$P
MO#;<1\HI))')?L/F8RR% LA'F,'<M(SY"8+*;E3N!  '4,T9!=JP#QLN&=9(
M=CYC8MYCE0?EW;C]T_,6.9%QN9V#@5N;A?E6Z69PZ*X$@E4S.^T%2V5RL2;5
M!PS?+UPZ:2^+;TOU^ZSZ_?J3*[5O1?CO^B\^]M&Q',D,\42^9(RL(B,1LP$<
ML: @[<!R5#;F(26-<KG*I'9[Q'Y,3,JC:KK;KF;]T0K,NP,YDW[D#'.752N&
M1RP1YB7:Q$V5"SS*02S1IY;L.<[Q)AP#M&V/<6/WWLBSS_N[=3,Q601N-IR[
ME<'[VT$C:S,Q^9H5?=ARU>;_ $Z^OX.]^CL5MM_72WIY]+VUT$:,>4R_/%%\
ML4C,%A0(S-+_  E5*EID7(QN7.W(/!<R?;8V8-F60M($DD!4R#/# G<&3S2V
MYFR-SDNS(<M\I9H?W*N8_)_<!(M[N'VHFT8)R58H5RV<*H8E-ZR27J-,KM+M
M7<)"PGRRINRG[P'HLD94N"&W%2H8L0QMKT7W?IIZ:[;,KF::MO\ \'STOW7W
M;!+,9WE:W:16E>14*,%8%I&7)'!#*><.0!N!&'ER%$D<ETNUE"RR2MAY&&Z-
M41",AN0T9P2?F5-[C.]0$)9#AF7?$N 6&U$9 ZME1N^3D,5PP;R&4#:%P1"1
MBL:R2,T:B0;V;<<\)OQNW;%>;)4$>:Q0H1M4Q9*+?KY?U:]NR[V469QZ)=?^
M&^?E_F(@/GQR21_OAY1+%7CVLIRKD+AAAU=,CY@#M7[T81;9FMRL:M(C1L$P
M'*E&(5B<#CC$*H!@/Y)V%7*FD@"DJPCD9;C$:^2&5I(V1E5%QD&3R@R -D,V
M0.5?>ZV#^;!AC+Y8B.^W$JC(DB "*%!7=YD3?*V0-G XBIU%:Z_I=[=V_P"E
M=&BUE_7Z_)->B]/#/CI\7?"_PS^/WP[O-<O)-/TVWTO5()ML4MUM7=82+_JP
MR$-LF+ J,,-S,O(&]_PWC\,MNX^,+IEVERR:??LC;E=GY:!>=T9.&!4E3O9@
MA9/FG_@H;9?;?V@=*2X@74!#9-M154MDK:LX7 *JFY2J@%(]I!XSN/AMKX=T
M^.)-MK8R+%$)<HF(F4OA3N 8A#M09*@;1*V6Y(]S*\AGC*/MX22UM\[+:WX=
MNAX>9\14\'55"<&].G;S[_IVZGZ"3?MN?"2W;=+X@C=EF5G0Z)>?O/F4"-G>
M $9,;@MN4L3(,#:5:8?MT_#.":7=XSOG92<2?V?J6YBH==X80@AF96D/!."B
M!P,X_/FV\'6)DC7^S82<H&WP_O,-F%9'*J#]W>25&=V/F5$5C'!H-E-\WV.U
M5GVC!&=F2K<X&U6PQ?&#A!R K!4]-\(5UI[2/W?UTM^GEYG^N>&CK[*6B\OZ
M_38_0B;]NGX9P6\F[Q;<,(PVQ$L-22-,)SC]P$7B-^0 0<GY40/3KC]NCX7Q
M/NE\674RPN793INH#<5><L<-""NX)EOF#!B6+;HI"?ST7PMIT89ETFWC90$1
M(X<-)_LDXW!O+# <9VA&8@[=K_\ A&K&!E9;"R9I"7!"[49%*CS"64C8/+4G
M+$E9&P22H9?ZHU?^?B'_ *W4;<OLG^'7^M.C6J/T"/[;_P ,89 K>,KA2I +
MC2]11PX)#8(M\ ;HBP78"@A7;EU91Z99ZA:ZGHD=Q"L+6[6[N$C5SD;P&VC[
MP&T\ABA*CY@,^:?RDU[PQI<.B7T?V*.$&T\N,O'MP/*<)N5X_O%3D\ %P%Y*
ML:_2S]E])%^!^@XCO!*T32*RG:6<R@+\S8&,JH(V[<LI;)"1#Q<TRN6!E&,W
M\5[6T_X;?Y=-W?W,KSBGCHN=-6LTM?-7_K]#O;F1HYF\QFW*\J<RB?>ZF10>
M<[RX#=E#ONW##C#0YM(,"2XA@A"DF*4[D10L@*?-\V>J'@CR5#' ;!;D13)M
M=EBS&J,KF#]V'C8,IVAD#R!6( R@F5^N[<Q2L"QLZA6A$<C-) IP2P0Y7 4)
MB,1LN\*&*(2,.:\MV:T\O^'^7_ U/2U3O?NON_KRW]!T]U);)+NF:!L/'N1W
M5481X8_>.(Q_HZJ.<XC9=I!2IDN_)NU9I&CVSY.)LF(0NX8#YF!98U$F>06$
M>,D 21(\D+KM\YF6-0,R,)9/WI."P*%6,B+@]<@DC>X%+&"[JJ3*#DQA@V1M
M,J .H5\%2(@ HP W3#>6"W%6=_G_ %Y];^=GHR>9_P!=_P"N^W8BBLCY=O%*
MKB79]E)VA-K$!3'G*E0_/R[CDQR [0THCFCO9+EUF622996$@/F9=W):3:<X
M W,S)P"HS*WRC>IC@DB;!V+#&R*0H;#0JQ$YY&2BJ8\@*N2'D< '*!T2,[1Q
MRL69I(0Q\KS"OG1C?L!."2$.   1%&%W+)RIWLV]^GY+\7?UM>X[MW_KYK\O
M/?S&^9B./]Y(8S&<F-5D,B[H\-MW9;YS,AY8$Y0D$N]->WBDCC3R[%MCE85V
MHT61*\:1A@A+#Y5.00&PWRD[Y*6WG5-K[HH@6B8[92T: 9P02PRB/"JG((;(
MY)$;E5?:G[YMB*Q$[-+C:,",HQ#$G:HV,0 Q#(0K;R&MQL[+^O\ @_-/;;I/
MW?IOKVO;I^ ZSDB,JJK1QK--%,0ACCWQ%E=N%(7C8BGA0&3JH1V:.U97>WV_
M9_MCJ(1N4(&8OY<BD<-G"J-C,H"R](T)42/-(DLRSM-&V]Q(S8W!AO>5R&.!
M\J,A&TJQ>;:&P5IUM<;)(PSK'AT"KYN(ES'#E<[_ )HHU4<G^$<Y!WI":M=[
M*_WW_KSZ"]/Z^7Z?.VB2^8OVRO%FF>%_CK\/=4U:\:TL_LUYB2>8S;F,=VX9
MP%8_,O)8Q@D2L0!^[!H7?[27@6WGG==<CW RIN^QW ;D%CG_ $?(VA(BP_@P
M^<&-<]O^U5;V</Q+^%%Y>0QW"QWES!<+=",[4GM0BL0<G#R3ASG(;(&2V0OJ
M]]\+O"[2S,OA73,2/,%0V$$+ @S9CP;8X(Y ^;G"XVE0(]Z&*JTFXQ2?>^_W
M_IZ_)UL+3J^_/T_KUWMWU5SYR'[2'@?:R+K4O[R<>6O]FW*[6610.!&=K(SQ
M+@*I#!N@*$,C_:5\"7K1M_;&]9F+@'3+F3?O6)5^7R%YV2*F 0,,@(8']W]'
MS?"KPSNDV^&=)FW!W7R[*W(;(W J?LO.[S8AM &W<-V/X%_X55X5DDCD?P[H
M30G#/(EI;.JCS&!DR(E&U<OQNPS-"&7HIZ/K^(6\5?YWOV_JZOMH8_V?16JO
M_P '3R^?;=GS:W[2'@:>W_>:UN\["NS6-PS%BH4N1]FZLC;68@ H@P V[RY;
MC]IGP7<1S^9KTS;XV 4Z;=A/F4@<&' 4,'X8.3A\G[P3Z)M_A-X5@VJ?"OAI
M6V*DA>R50C%F1MSLQ4 2&,-M&X(V1C!8NM?A-X122%O^$2\/E5*M\]B&?[I8
M;QGG_5R*P5>2A V[E(AYE5O\*_X;?K\M/^&?U'#W]UO^NNVWYK3JK_.K_M*^
M!]RK_;EUMA++C['>KPS,A#?N21M Z@]8W&$";*;!^TEX&@D21M<:+R5"2;=/
MN%;<BG)8)&2FT,#\Q.W;(,!D);Z)A^$OA.2*&.3PKX?7:VTYMHE;A%+9X!W*
M?O;L $DC:I^1#\(?"UZL0C\)^'F=D51'%8KN+2*C*%.<9#R*N6+$#)8#Y4:O
MKU?:R_/]>_YZ/0GZC0:M=Z_\-VM_P-=$?.H_:.\#Q6[!M:6%2N)F:RG4KLP6
M#YM_O#S6^4D'G@K\K5(?VC/ Z2+YNO311[B TEA=QK$V]"0-T0"!7\M@6+;<
MN<*5 KZ(_P"%1^$V9GM_#7AU?O,DC6"[44Y".RMN^7#1LRD97>#DC(JKK'@#
MP/X4TN[OKS0?#]K86J/+/--9I"8D5E.=SCY65?F8Y7C=P!M:D\PQ%KJ/_#_?
M_76Q2P%!OJKOU_3?3_@'D'@_QCI/C725U#2[A;RS8"20K$UNO5V.-RQLH.\%
M2<@C>0H;)7C/C+^U-X?^"&N6NCW4=]=:Q=1F6-((%53O9LNRD$A"T89N0Q;;
M@LK(1>^&VE17OC_Q9KVD:3)HOAW6KB22TT\0.HGFAE.Z<(JG:C8'*K\JN I#
M. .,TWPS??$;]L#5AXCL+&31O#]F\-FM]8^87:0 ,[';M?\ =G:23R%*G[V#
MW+$5'34K6D^^WX>:?^=CA5&E&;=1^ZE^'75K^M=MCL?V8/VA?!^CZCXF\0>)
M-:NM-NO%5Q$\=M-!,]Q&BVPB=6-K%+$QPC#.Y=VU\K\K"O7A^V;\+YU\QO%"
MJTVZ<E]-NE$>4@W'FW( .6+!@&"X8EE+;N#7X9^'+J)))?#^D2_:/+)=K&"1
M%)QMW')))"Q*6RRG"/\ P%E;'\,O"[1;_P#A'=!D\I/,.;.)V4<.CD#<?5#A
M3YF\C )*US_4*M^>4U?_ #Z:'1_:%&UHP=EWM_7Y=NMS1^+7[;NB+I6E67@/
M4(=<UK6KUU,=W%/:1V\1MW=I&:6 J2S;0P.=X0$!4*D67_:/^(UINCE^'FE7
MA:3+2#7B5(=>?NPJ=K +G(R"2W&T-6;IGP]T'P]J<=Y9Z+I<%U;NRK+!:9DC
M9-P*HR@EB0OWBW#Q;MI<C=K$>9+,^YCY;^;(R LJN!MDP50,=JME2#EQ&<G,
M;4X9:FOWK?-W6G7II_3UV)GF4KWI+3S3OW\OG=^N]AJ_M+_$:W99)/ .F6_V
M=Q(RR>(&C^9(0S;F$/0K'&Q8-A6Y4@X+6(/VBOB(QDC_ .$#\(*(2%9'\57"
M,VTHS\+;97!6(A5VX9D "!AGE?B[XSA^$WPD\3>*)+-IU\-:5<ZBT,">2S"V
MMV940JN5.\NRMN)V[B'VA@/C7X3?\%0?VD/CK\-]&\8^%OV.1JOA?Q)#]LTR
M=?BSID3/&SDHXCEA#IAEDQNC7&4P%P"V=;"X:DTIREKZ_HOZNS2CB:]57C&-
MM=7I;[WY:K3Y/?[TN_VB/B';3YC\">&9I-WEEX_$TR,9'0 CYH%PQVJ !@94
M;/2J9_:G\?K<+YGPUT_:BKA8/$47R@B.,-^]56("PDKW#1L 5.QJ\P^//[5>
MC_LD_LD7/Q4^(EG-X?M],TV W^EV<@N[B*ZF,:):1'B.1T<JH881BA8E$^[\
MU>-/^"NOQ(^"/AFS\:?$_P#9=\8>!?A=<-#&^O)XHLM0O-.@FE01M<:=&B30
M@%@N'8'.S(9N&GZOA4_BEY[Z*W56;75;VLWT)IU\3-<RC'\KORUU_'?;37[D
M3]J?QLPACD^%=UN8"(2/KEE(JR>64<#=..?W95AMP<?,"$;9:?\ :K\41HS7
M'PMUR&,.TBN=9LU6(;N0_F7/W0S;P2^5W3%=Q 9:F@:[9:_;V.I:;=1WEO>Q
M1SVDJKY0N8<,8^'(<@ [\.",(" 1M8/MK-8$^5>%AC D6,[R$!4JK_+MX#@,
M%5<RJ5P<(W3_ &923^)KY_AM<SEF4N9\R7W?/O:UK?KY:7_#4VN3^<K?"GQE
M*TBM$Z1:EI)91R0A07: ,H89 !PK;1A58L7/[8$J2(TWPX\8QPR$A UQH\T<
MP.QD #79;!5$"@!LA,; '-47(:55FC19FP7\R,*JD2([;-V\;6*KA%XSD$AV
M.&P736\4;^=<*R@JPDGW NGR-_RTW99G"D$D[B>A9"[_ +-IM:M_>M?PZ_UI
M9$_VC4EJE%?)^7GT_7:R.%^*?[3_ ,5/$]Y'!X-\#:EHMGE7&J:A=Z9-<,Y"
M1,PA,F!@[CP^2=N\F1,#B_ EMXN36%\0>)/ U[XI\5-*HAU&]_LQ4M6\LC]S
M$EXPC)5E!.,E8Y"6  8^Z?;O)E^9FQ",/(TS':T)4F0[F"X5O,+$;BV#DGE*
M)[=@O[R-A&J-#(&C9MP3D95%!8,C,",D!@RXW;VJH9?3C+F5WZV[^G]=.B2E
MCZDXVE%?<T_STM=M^O4X-OB)XKF=K>+X:ZQ(\NY&234+,LRDB%C(3.,L2%Y;
MYF"D<[FW1_\ "S_'+W$(7X;ZE._$B*U_9@-M<L^ UUD'=Y00]%#1XR"K#M9]
M3L[>WNI)[JU\NW42W7[YI85\PRDHX4!,%7=0V,N=O&2N_P \\1?M/>'TL6@\
M-/>>)M>OBJ65JEO-;27+LH59"#&BO&ORY.6 $VT_+M#ZU>6]HR>G33>^^VVU
MO\M2*?/>SA\VGY=;[[^>Y3T;]I2^N/%]QH;^ ]>M[W1X8Y91;7]F-BR*LRE_
M,<,N[822C$JKLY/&%UA\?I[&.'[1X+\0;(0"%;[*HW':1N'VMEW;T?(.['(!
M!#EF_"?X+WG@7Q+K'B+5-:FUG5M6M4CN96MR/LK(LS,H*OGY7900IW;G?^(E
MQZ.+R2UNF5KJ:&1=RY>21&XE'F=)?F)4A?E/_+1\[02E%)5.5\SU_/SZV^7W
M$U*E-/17MOY?C_7W7\U/[1MI;JO_ !*]7M&=B5=UMY)AA2PZW'SL2$W-OQ@(
M?EW2;)_^&C?#LMNK?9;E8BR!8FLFDA5FS&$1R^U5*+M&$PVZ+Y2' ?T!KF69
MF620KO*9V,T9!=64$?,"O(3@+V(3>VS8_P"UJ+R.1E,:[R=[3N&$8=CA2Q4#
ME>BD@*77D?.-O9U%M+^G_7FR(SI\S]W;]/SZ6_I+SBW_ &G-!55*W&K2-YD;
M,_V4AB6Q$#][;DLH(& &>(\Y.8T7]ICP_;^7E=4F$93AK4Y,@,8. SC&UCE?
MO.I8!5. I]*_M&9(X1<*QE9,KNFF_>,VQRN"7S\Z$,H8A4&?NMD(E_+ [+'Y
MBO'^\C5IYI <97)((;E!DG;RSEP9 V"_8U=W)?<OT^_3HQQG1TLGO^?Z?AN>
M<G]ICP_$S+':R2>6H\M5TY_F,9==H =@%#187&X?.HPY"^8Z3]I#P^]JNZVN
M)8HQA9/LLC+Y2.2#O\TE@56('G@[\EE&QO1!</+ HVS2!M\#!99<\R!-IV9Y
M&\[B2"6*\*%4HU+EM0E1F%J\EURSK<?>8I&-R_,0'\MW;CDIMRRH!D]C4O\
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MP R3E@<GSWX8_'"#4?@8OB3Q/?0V\UNDSS*)X?,GC:5&8[4089LAOD RZ=
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M6X7$K^:S!IE$P+-E1*KGELELX9QO*GNO!QDG)(7BN&;9,N,3?*,D!G8CS05
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M90R[=X1L'ED.6[<8YP*()U,S'S(4 D:-_+=ML.0<8.=Q3YB6RI. O()Y(O\
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M]?P_'5E?Q/$T&B:GY(59O*N8H<DJ)&6-A\IV[!G<'8#>N8V(CW!MOZ/?LS0
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M6'S"-4D9>GENKHH5-K;6"X< %46)B@8<RAB0$4JYY=TBM(L.))!+N;_4LYX
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MK\-/A#X#\26+>(/A;K-EXDTV?5$DCT_5=0B^T23+.BR2!(Y9+F9UVK\IV*6
M)-<C^T#XP_:V_:Y^#6L?#"^^!?@OX9P^,K-]*U3Q-J'C>TN]-6&3"RR06<"^
M<"5SMW^85.#U%<<J,ZDG3Y9)V6D8[NU[/7:^S>MM3T\)"'LO:TK.%VT[[+:^
MKW[Z;K9-:_H;\/+K2[_P!H]QH<T%QX>:U@DT^6SN&N+=[4P((F1EW>9&RXQP
MN(U+CD"2M LL$;,R_.8Q+L,;,=RQN0I4)R@R[Y554'&%!<H>'_9P^!Y_9O\
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M?R,KE$5F#,A(V+]T* 1G@[=O'3%.N9O.$VZXN/F&Y@0LN"VP[T)ZDL5SC.T
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M-2.%W[3Y<GEN8PJ.&\P990J#>1M:'#+G.\Q $-N!*0D!5D5?M M_*FVN0Q8
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MJ>+=$N=&@UJRB,LUA//;+"UPJ*Z.SJY)R'7EUYP59?S,_:(_X)A_M)?LD_\
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M&CX4_P"">WQ3^)L>F6.K:!X)\,^&9C;73$;I;BU8&0S(8GC1F8EB"3M!#]"
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M+FW!V8X"BZ]9+ECI=._X;^>WR/-8[562&)(?.C9B@$N[$NW< K 9W,V4 PP
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M#*"B[ K@D*0"25VJI)]_\<_$+0?A;X2O-:\2:QIWA_PYH]N;J[O-0U(6<%I
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MRQCE=V#MD9F<$KYAYW("O-^,;5M6_;+^(%[$WF06>DZ;:IE&BD4M:R;%4@*
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MQR7,-Q,]O;:G:*<LN3MS( 86"A0&5SM10Y:N+\)_$6\\;0VS:#\/_'VL0OO
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M^U1KFB_#)I&1=(^RN9TA8_,%<DA6*!5W#)^]R,XKW[XF?\$=?"/CW]C'PO\
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M7/\ @ECX)_9YA\9Z/9ZIX4%D;C5YM(+6]\UJ>OE(0HW+Q\P8\]\$'K/VSO\
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M;UV2V4QV\2KC<JJJ[26X!/ED$8.-T*J2 "V[   2GQ)]H>/REBF$FS8 0WF
M.@"\+M^8RE2 =J@R#+;54)"Q29?)D6.2%E".C%E1@"T9 #!FPJ''7<8(20%8
M921D@W-Y31PX)>,[BYB\D#9\N ^U2JA_1S)E@QV$8O2*_K;^K]O)AO=]_P N
MNN_ZNU[/1 8VFMB5$LB2QLH<J2S%R(0X!QM!5@Q)(SB,$Y*LZEHW\R>,*L<A
M8F2-0V(0$VD+C Q^\'*@E=R[8U!VN6T<W 6--TR?)E(T9A,KK&%"@!-RM(K
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M[%HWU]?Z[Z;_ '>;)O?7T_KS_IL8D_V2RMY)/)_<HBMSB+<LK. ""8QND60
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MX#;(H]KIM*E2,%D)RIVF)F.-SXD56DE:!MT;!A$R?>\M0S,1M8 MM4.3Y@#
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M:WVH>$=4Q)!.HW1Z'*ZH\K%"4+1;1 %))557)RFTG&CB(N6"[+B2&54W%6
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M[?7PXC:8-&WARX 6288<&8LYW,65<.[!B5().3M "U[Y9J;>6WD6/88U24!
M1Y<?R 1AP!U?RRK _P#+4N23LD;P/XCR;/V]_AW&SPR!?#L[LD\2[4'G#@C=
MC;D."IX&TJ#M0%HJ;)[_ *_=?]?F]1TDD[=/^"OQV6MK>FI[]'(994=VDB.Z
M+<RN0T*N$W=\_NFCEVYR00[-AE!:'S<0>8ZJN(_,9 <*K*=NW@94*&F88!;<
MN "L8+38?SAYGF'?(X#.0Q=VPO\ $1N:5=BN, Y212%&\JV"388F\SRU7RR)
MMV?)*,$5\DC_ %:>5M/4ASQ\[$5:ZT_K_@>7?R=W-NC\OQW_ *VOW8A?R#(F
M2VQY<IO"EC\WF# DP&*@DX&V-9FZL4+(]J+J,QL8V\P-$KDX7YRD0(P6*( (
M6  !*Y4@)(@IULPCAC5HO)A58=R!R5C4$AEV[CP TK$8P2IW899 \>2%4,\?
MFO"[L[N?G9A'&SYW?Q*SE\<E"6P1LDJF_>YEV?\ GW_45]?Z]/\ A^O=H<9E
MF26>55C68>=+N4$[6D9G!4$XQ((Y NW"A9,AMKAAY&.[=Y?GX8L X;?*Z,Q
M^9BWF",(2<^8!E=WF$@Q'*/+W;5,DB;=XCVLT0251\_RX,2C^%5#\EDZRB9Y
M3N+MND?+,&/WU+,X",<[E##Y<YV%LA&D ,[:KM_7GTU_6UB^1K^O^!K;[NKO
MJ,:16_Y;,5BQNE$QWQMDR1R##'!VR.=X)VJI(W@-YC2&*%-HMCL,;;0%6'+.
M[;03G;'*Q'IB,N,D'82%M@C^5'6'"!RVT"218P,D9**H4$XP&21&!W9ITS!C
M*T8;;";AE63(6( JNV0E\\[EB8$D%6&=RJI8=TN7^MOUZ6O\R5%M+3]=_P ^
M[[@7:XF9HSB3>TH(^5TE5XXP =PVD"0G))(X4$!4>DRLL6V$M''^\\O P$#D
MF)@ >TD^<#!4 M@ET42H?+GA9MZQK-"L9?#!46+G=\W9% =<]8V52H9@L,,3
M-#;P8;SO+2**-GWL&((* $Y8_/!E2,,01@*NY:]W\OZ\[?AJ'*[:^?S_ .'[
M].@7$T>0[+Y?G*SLA(+%-I&P$<'& N\L2(Y?,Y#_ "N1&5I(U+)([#E&8;IE
M)+<*Y.[" -SDABV'/EY:S?:8YFCW,)EE;<C[C*7MR 20V68NNW()+-YH.?,"
M5)-,S7S%/+\TL70R85"P9)L#.W$99PPV\ ?-G:K/(*5K)^7YW_I/2VZ[$KQE
M=[_\"_RMKMKMU/@']NF7[9^UW>NK+LN-'A;,?W9&,*LR[><M_>!5S[' >O*X
MY/(:(LQ2/$$Z+O.)0-A) +?.Q=@N3O8LR@[3ACZC^W9-"W[5^J#+-#;Z-;HR
MR*-ZQA80B$ J,KDCY2&WKGYLX'EQS 97VR[B?+9H'V^:R>8&7>H0;F>1FPH9
M@=^ &QM_1N%/]P^;_/\ K6WGI<_-^+&Y8_E\DOZ[#1"6B,.Y6;R-KJLFUMS3
M?/P"<$[R"#ELCGSR.)%7S+IY%QEY9&PH"R8:3:N[HPRRX )'/H1F)79HY65F
M\QHWGDR/NA@N78#< @+ A3N^4@YD#,4+(K=9)H8'7=&CQ1"$J6VAD ?^#Y>A
M/W02,G$:EGKZ6_?U^_R_JQ\SKOZ_CI_77R8T7*BVC*;7\L%EXW$JD(5&QN&-
MKGD;D",_(Y$A=>P^6+A=LAC4>3_<W<H$0Y3 8LP8'!*C B5LFFV\OVBUC9I&
M/VA%&\R*<2.1M;EB,; V"V[(& 9@0"[S%1X9(UCADC8L0!CR\2,1R3NVJHP5
M## 90R1H6%/;7^M!='%=U_P$O/?Y=%U)Y 5F9V$JKO)9 .5\PERHRX YSNQM
M8'9(01E7 ;[LCS-LS23AY48Y+A45F7;R<.6P!N()V;T),1;,#;F1&CVE K")
ML*?E:1$7:%())R<!"IQF,2,-U.G9D9EDD8Y,J,T@!R4(R_S-@YW*A))^4;2Z
ML=A-5_PWE^@]UY:_C_7W>A'"ZB/S%17;;$46-D;&-S#:1\G*XD4[1'E>=I!>
MG31LT)4G<P=Y%D4#C"!RZDL=N2%*_,J_,"[,Y*EQ5KG:J^<?/*J1N9]WF12$
M Y&"R*0,D@D8W@*%:B&97E\S<&4F&0MAC(5.4)QN+9._ ).[C<I<80'I_6P*
M.J?I]_\ 7_!!@;F1X\;O/F4%2K93S,2D8*G;@[,@J"1DN@'STBS!MLV9%628
M$2AR!AQ*I 9@N2H 4%FW YX *ADA/V>'Y@JQQ[4D4N @6%%\Q",; N,G)5$!
M.W;&YW&.YB9(I=_++;^3++\RER'"\[L/]QXS@EB0,?O3BA);;?U_7Z$ZMJS]
M/U)"5MU\P[(US&Q!3&Q8V89)V8.UBI "_*6.55LN'!6M-NYVC:,@DY(VE&Y(
M)(0D)L3).T9*LTW(HO'W37%P5W+NF+$'<P5&CP/E()VOG^/Y<'YEQY8&MF^U
M^2VX-(R0*RL%+?,['Y@ 3M:+ POR@'"JN7I*6G-^7Y?UT*EOI\O3^M1(!NE3
M:JQLSQJFT]"RHT:,<<;/EQUX^8QGAJ2WV2^3M9521$9BSY1D;RP226&Y2^2V
M2QD'1V ,9:TZSKNF;:OE9=DCY423ACD'ID \;L-@<39 $DLFV?=,HW,[/(K,
MNURI029)(!^4A-YW+P4_=YVT[-?\%_\ #?\  ^X)>7I]R[@F&9&9<Q331YW(
M<-N.9!C9@EC]Y=H.Y>54CS B13)Y.6W33)OW#YMSH(V#@\!SL^4%=YX(/F $
M!I1MKLJM(PC!#^2Q+[G8]#M+!T" J^-Q0+O=OF5984:64CRY$E\S>=ZMOC7[
MH<=2K @MO.&&PEQP*7G_ %M_7JP3N[/:WX)-_COZ^0DD:R0J%,<,<BJB2N?E
MB'[J0<L2%VCD#<6R6*[0,B>TMX=5UO2898?M%MJ&L:>\D$HZF2]MV$;A6P,[
ME0<ER2=OR@4R+<IAN'W-M>!WD*G<H)#2$LOW1NF!P2ORALJ5!W3:(S6GB+PR
MW[P21ZGIC*Q>2-\F]C##[V&+,^/E8D81R[,8S7!FEGA*JW]V7S=G_7]6._*;
M_7:,G_-'\U_3W[GZ"I^RS\.9-,3/A#1I7 MIED7SD;>/..5&X$!MJ]",X3;C
M(*!_9/\ AH49F\&Z3-'&"0I@WY0Q@JJ_.IPRNS8Y<%Y"6#(91WUM;8TJ-?E:
MW,2KNC0Y8'S-F-JJ?N9)Z%B6X'[UJF??<3M(T<C2.Z23>6V&=OM$9F ;;@/Y
MI 5LY"J@W  !_P AC>R>NR_K>US]AE4=]7W_  >N_P"2VOY'G,_[)GPO5)E;
MP9HC.RL9#\\8RC'*2%9@N2Y"D #.XM@ JU-/[(/PU6-DA\&V,/F'RG :9=C*
MZ%O,7SS\Q'6/.XLR;?F+!?1;4EHD"LLB,D<*K I_> L[C:C C+['*HR_,)?X
M0VP,&V4)OD6,M&BA_-/E@NSN"7+ E2TJ%F/*1OL)W$!B44W;>WKKM:_II_P]
M@YIQ5KN_E_77_A[:LX"#]DCX:RRP_9_"=CY?FP>1;BXFVQDY>( "4X+?(54,
M"#+)EAM++E>)OV/?ASJ7@>YAL?#MK;2OI[1PW4$DJ36@9&0R(!,ZJP;'&,,)
M6X0JU>L,_P!J+;@B^9N<F1-NQ7PLF[)!4E_.X'("OD[0KQMNMSVTWEHZS+&)
M$!\P"%71$R?E/RQLBKT"*T;\J=BB91C9Q77^NO\ P_==1QJ3YE9_C_P&[?G^
M?S[_ ,$TVTM?V:(=/L[J2\D2ZE2ZM=AF2V=H@BQQDJ-JG=$^%!7<Z8SMS7T*
M-LS^846X1F)8 [E=$=2VW*[6/^LRQ*DB-I.-QW_,7[*6B67P0_:9\=>#M'U3
M3?$&AZE!!K-K<6WS2::XD</'.\>5C&43:S  AW ;"C;],3K&BS1SF-=JMQ<%
ME5%!C@.Y0<J-T18+L^0*JKEF3$TO>BK]&O1V_/77733K8UK^[*ZZ]WZ?<_N[
MK0=#NB15WGS 8R54@&1RL:C@E?F<DN#D' YPRY22VPUQ&8]C,3&8G$85G8LS
M( FW./D&U1& 0L9*CB(M,FYV$C(.7$BM)@<^9YJ$AS@ !I,CA/.?@DIN!N$!
M9C\S;!N"Y#._D\Y#'M$1MRJJS(RL%8%=?B23_I_=KMY72ZV.6.BMY+UT_/MM
M>[]".(F&*%EC3<D:;$8LWS.D/&Y3O"XD9>,G"HH^<AJSO']Y]F\ Z]-YTS+_
M &==A9HV1FV[KEP<*^TL=DO(&WYASM)WZH7[+*C',4:SJ20PC'[M@L?SX0@-
MA5!^4JPE/R!7#<3^TOKTWA/]G[QAJ$<LD+6^FB-I IC(<CRL'.%_U=U@H,[=
MI'* !UM&[_I_\.V_N-H4T]%]_E^7](\%_9GT9=)^#FD!U\N74E^V$)^[\[S$
MC**N60G<\A91RN2N2.&7O9RSP32QY:X8,"RDA3DX^7').T9W[MZ!U& 3A<;X
M>6']D?#O1+6/:IM='MK1BF8Y"_V=7)(#@*7!^4L5*%1R5!S=\:#5+SPU??V*
MUG)KDEI<_P!F?:?^/5[CR5V;E4[_ "O-$8*ABV.!D[6;Z*G3:HV5W9:]_.V_
MRZZ>6OSM:HI5.:Z3;6_:^GGO]_6^R_/3X(_"C]KO_@G#^S%>V^C^%_@[X]\+
M^&;O4=9ET^SUR_MM>FAFGEN7"B6W6'<-QPJY)X #&NE_;9^*7@K_ (* _P#!
M)?0?BD_C:#X>6+7=GXET/4=0@^T^3JUI.\0LWMT4RS-YRS18B#$D!PK@;3OZ
M_P#&3]L+X@>"]8\&:=\"_"?AOQ%J%J=/G\67/CNWFT?3O.0J+J.V7_2FR#N6
M,Q?4MC#8?QC_ ."2WBCP)^PO\!_ OPQU33O$7BS]GWQ/9>+8[;4Q+#IOB>\2
M\>2XAW981YN)Y2-P.Q048C=N'DQITE&<:$)32CLV[IZ=/=;MK?1]-CV*E:3G
M&4VDU+=.Z2=^FJ5WM?S[6/$/'G[4OCC]MCXF? GP/^TMX*O_ (!^$I-8LO$<
M=]=V\UPGC+5H=XM;..61%33U;<S-'.YD((&1D$_JU(/LDBV\R3>3(IC>5RJ1
M*N0S[@6/6-''3H6&5!+#\_/VP?#W[0/_  4U^&UG\(_$7P/L?A'X?OM4L[S7
MM?N/%]KKUU%%!(LCI806H),IX :0*,, 0-Q*_H9+>1W-ZK0/-"I<$K,P5]I
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MHVQDG/W1\,_%?_"<?"_PSK]O#);+X@T6WU.%,LQ5)@"OS*0=H2!2 N2=S$9
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M4W%PH"SW+J% 9R -V<$D<#).!R:W-%\/V/AO28+#3[6"QL[90L4,""-$ Z
M?3\:M1)Y42J69RH W-U;W->=5J.;OT_K^ON/6ITHQ5AU%%%9&@4444 %%%%
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M/QD7]BH^!Y/CP[_&+[&8?^%FCP78+B?S]XF_LG=]FP(L1;-V#RV0>GQ/8_\
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M>@] S2KG<Q4I&P&-S_NY&E4 ]2V,E""2<$QH?WA:F'C9%E7;(B;'/*G,<GS
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MZZI:[_U_7^?1'F1C=W7Z[^?W?U8CL\26=JJRLD9"E'5E9HG;=A@ WWBI;E2
MV2,RY&7+&TJLR1M&TBJB+'D?,)W 4#J=J@X! *A?O18W <&"58Y)#',J!&D=
MS$?,0LI)9CG(0CDECM(/[T?-2.GR,R*J^6-BIY0^3_ELGRG!#%L':2FU0&S%
MT:NNG]?U_78:E;WEWNONW]-='ON%P!>?=43>>&VE'\PR%E#+M);EG12I <XC
MPQ* D4\3,X=XY,':F&0.<_O X;DL>68JNY26)R%"@E@S+:R"2,QR10['5@25
M9%DD506V]R2V""HX$:Y :HY;?%LT 5AS) A8-E/E5L<J,DY_AVLV>4D"DF='
MIT_K^NH:*W]:=?Z?_#JZ+YR$1K"P7RP=@#1[=S-@L>-F C$.0!]QD)P9(+V'
M0=1L;RX$L5O9WUO<3HL3!RD,T;,BL,[76*,G[K90Y0MAW)(XD,LT,>W:7FPG
M1061 VY>,;.AWJ5V,H.T$(Q%CAGDAR!MA2%T+K'E%PFP_<VJ1(C<(=H9]H!D
M0MGB*7MJ4H2;M)-7ZZWZN_KZWMW-L-6=&K"K;6+3^YI_UYZKS_3;X>_$'3/B
M%X$TG7M)NVO+&\BCN(9-FW8J EB 4^4#?$WEOMPR&,C*J!LM:BTE2';&JJ5B
M7/S!BDC@XX <$*R@ XD,C'*[2B?)7_!,[QE:_P!O>*O"\VH7$M[>7<-W96*Y
M"!"Z;YC@$Q,)&,8 .\+,2>?E/UI;2?:@L@W@72*6=FVK(9!(I^4$%B%65%"L
MP"MM!#Y4_CM?#RHU)4G]EV[[;/\ !W/V:A4A6I1J+1-=/.VGR_!,<78,DOEO
M,J/ RJ5$FY%CC5U&4 (.Z!.H#[6"G#C*1));1%8IECD4AC)N+J6W.1*67^%P
MJGS%VD^5O)!"EG0,?M%O,R^6TNR0R'!^4<N3MP& $L9^5L%%<90%E$#P,MAM
M=558H@C;NL;"!E?YN_*,3MY"D#E@-F6_];_Y=.FO6^A4KJ_?O^;]&_G\]"94
M6:18XV,?F,L:%\1E.6$.0#A6W,RL ?W8B8K_  XYOXJ_$'P_\/? FH:EK]]#
M:Z;Y$LHC$JK-(Q2*<>6K8(;+,N$R1DKR6W/TETX>2;<&W$S+,F_YN&QY8*M]
MXG;%D9(CDSA@0$^<;R2Z_:-_;,^Q:C:Z?>>&OA7*]S*$:9_M=W([-'$\;'8%
M+QY. 0#*-I^7]Y$VF[/5?+TUUVZ+S[72-J,6V^R_I+KM]VUM[%K_ ()Z?L[Z
MU\$OAMJ6K>*%OX?$?B F282727;?9XN8-S;7RI#,I4Y.4D#'"L&^A!)Y<FUF
MR(9&,B8;Y I:3<3D.<(9'WD@L!E?G!92&W$5Q'&X^:,+"9@-C.B)&K<D?>2,
MQR#^% JL#E29$ACDG@CCV[VF$0:(1[5=C&?+ 7 !5RT()SE08SQ\JH4X)+3]
M/ZWWVUT25M8J2YG_ %U_/ROMNQ"3Y?ES,O[P%3NDW CR?G;(<;MJQH&*@;PX
M*X(C-.ND\QF\S]VTB.=Y3S&0,"9B"(R2(TD4;5)&U6<8W*Q:LPD$C),VZ0*5
M=GS(OF/)*,8QGE8RJ!06)!&P%E9Q17#MM1(Y'V.!C &"KIN"$+L,@ ?D*G)R
M#&ATUN_ZW_JW56\MHOI_7R^_;OMIIHJ(PG22./RVRLX8$OLRQ11E0"Q9)$8E
M3^\\M3A@P8^5_MH7D=K^S-KD,:Q^9="TA@CB7(E U2V<*2,*0=T@89"_(W;R
M]OJ,@,RR2;5:1C+(6:-5 9OD9V!4;0SE]RG(PG!VH WF/[:NV+]FGQ3)&S>7
M;I9,N[Y6B5=6LP"2VX[@J)G()*F,!2.DS;4$E_7EW733>RL:45K?K^"7I_P]
M];',V5J-.LX[5?+9K-4M^-JR,J,&1BJJ_(#1'=P/G+8 6I'A,LMQ&RLJS P2
M@#<TF4$:\8 SE7&65@54X8C>A2!O.TSF,",(DC-@?Z.RC#,@4N!M8 !57"M$
M1R3BD\M7GDC98_FFR(2 JLLDDNX,H9."@=^F-J$[I<+CZF-H[:?TCYF_-[W]
M>OR6G7KH]4222M-(GFAF63:SJ[F./# 93#* 1\J]#G<W(5!FHT^6&*:YA\R-
ME$CL$"JP$8=L\KLR4P&*K@JPPIRM#R-;L\V1#(&=I'P1(@4*26)5<?\ 'NP#
MM@'R\D.0%1WV:-;K[L4;6^V,XCPT*<HBY51MX)!^;$6[!W#I*C96_K^K_/IV
M*LDU=*WZ?K?>_?>UM7-+)';#<TTC6R!6 +-O= S E<,4^8!D_BPRDA2N20QM
M$A=6<!'9"RKE?E 1B51N3SDY VB0[MIC+5&C?:&1?ECF/EJ P^8LLBLO&S>!
M'G:-P5P%8D#(R0.L\$<J+^\C2)XFV^9Y8 \_9@%^5VH^1P?ER20@%:_U_7]?
M@3RR^UY>>MO\G??[[64>HZU#X;TZ:ZG988+%=\Q#N'<@+M;&,D?N$7.0OSDY
M*J*^<OAIYVM2:MKDUQ'>2ZQ=RQQ2R3!]T,<XCC#CE%C#L,YR)-^2RG)7Z#\0
M^'(/&'AG4-$D*I;WMN]@(U=<1B3=D>ORML50 &&TC.YV-?/OPFUN.+0IM/=_
M,71+B6PB*,N]]K'#JS@JI$<B1]"2<8 .7&^$IQ>(4)=G;KK^*^_3S.?&<ZPL
MIQ[I/7;^N[L]K]#PG_@KU:+<_L3ZLS+YJS:MH[QF?+-*YU2$G#% 9'9'!.P,
M7##Y#P*Z_P#:<M_B5J/[(D-E\+;2.[\5:GIEE;!+F[B@'V>06RW#1M,Z(S<,
M?E ^:,J-RE0$^-__  3N^$G[07B>YU?QOX?U+6+[4%B6\(U^^LX)(X]Q0O##
M<)"6*H&4G:28L8 *D]A\ /V9/"/[+^@7UKX-L]7LDU(EY5EUBZO_ )U38H#3
MO+L(D10NPK]Q6(C(!;:.%E/VRK72J.+T>MXQMNUJO-K[CE^M4(4J4Z;YI0;:
M37N[IZ_=>RVU?9GQO\;?#_BOX!_L%Q^%8?@MK.BQ_P#$NGU'69?%&CW3ZA<M
MJ,$CRLL<ID?S90_S<XW'=L*A:C_; \3ZE8?&+]C'QCXA\.S>#;32/$UWH]VE
M[J$5Y';O=BUB@:22WW1 [8&)V]EZ87)^Y_BM\)O#OQF\&W/A?Q%9QZGHUW()
M);629T$Y6<S1,VTQ,0&6-O\ :4$YPH0XGQW_ &9_!G[2/P?N? OB[28[WP[*
M8E,>UC-;21AMLT<@)DC==G!R"$<+B094XUL#5Y:ZIRNY.#BG;:FK*Z2Z.R26
MB6EKF]/,H\U.I)):SNU?12]6U?KW?1VW\5_X+4:O:>$O^"<OCF&[U3[9J>L-
M9:786+!&:>>6[A.V+<%D!")(^ G(0_6OH+X->$[GX=?!7PCX?U 20WFCZ)9V
M<S3IAE>"WC5N&W(-I"ME<D^8@&/W@/@OPW_X)0> ?!WCO1_$6N>*/B9\1KSP
M\QFT.R\7>(/[4L]*N%"*GDQA I82.0@;=_J5.%W;T^HI+MS/<2*VZXF?[0"H
MV_:'R2I"\LVX[0@8%75F $>XFO0C[6I7E7JVB[*-D]K-[NR5[O2UW:UMSSJU
M2FZ*P].7-K*3=N5-Z):-M]-=M6W;2ZBO(UFL9D;<D:AP_F*'>-B"F"I& P4N
MJC*;S&<A6VYP?''B/_A%?&>GZK;:Q=:'XBA:YMK:[AM_MCMYS@RV^'210&PO
MS?Q)MP<@D]!*T<$,S;CY-N7*.Y6;RV5F49(+#^ @D*-RK&,IO+-T/[)'P=7X
MQ?MH6*:MI;:EH'AW3Q?307+"XM$F61UA#)SC: ^TME3\JJ2 :X\ZQ$:&$<FM
M&TM==UJM[?EJWW.S)</*MBXQ3:ZZ.S\M7MIT]'M<^E_V'OV?WU+PM8_$3QQI
M^HS>.=4C\PG4?F@BP0R3PV[?/"222-^' ].*^F:CBMQ$FW+,-Q?YF+=23WSZ
M\#H. ,#BI*_*^9N3?3?^OZ_ _5HQM%(****"@HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "D*@MNP-P& <=/\XI:* (WMHY$96CC96!!!48(/4?CW]:DHHH
MN&VB.!\9_LN> /'NH->:AX8L4OGR6N[)GL;AB3G<98&1RP/(8G(R<$9->7WG
M[!>L-+)]C^*WB6RB9@T<?V"WFV#:!@M(&9AE5/)[$'(8U]'452G):)BY4?-L
M?[ VNQ3JX^+OBAMI& ^FVC84<#^'E@H7DY!;<2&#;0D7[ 6M1IM_X7!XP \L
M)\ME:#/W0Q/R<\(FW.<,"QW$FOI.BJ=6;=W)_>+V<>R^X^;O^&!]<?[WQ@\7
MG"\8L;3",7W-M!0@+T"KT7G.[-8E_P#\$S;R^\96?B%OBEX@;6=-@^S6EP^G
M0[8HR&+ HI56RQ!Y&"% (8DL?JRBI]I/N_O!0BM$E]Q\VW?[!.O28\KXN>(U
M'EB(A]+M6W*$=,_*%.[#;MP/W@#T 4=S^SU^RA9? 3Q!X@U;^W-2UW5/$D,-
MM=75TJI*T4+2F)=PY^43. 01UR<_+M]9HH]I)JS;&HI.ZW&(N\I(P96VXV[N
M!G&<CH>G7Z^M/HHJ1C5C5&8JJJ7.6('WC@#)_  ?A63XS\$Z1XZ\/2:7K6E6
M.JZ7,,2V]S$)$P <87!YZ#C!_E6Q11Z@]=S\TOV]/V$G_9ZNX_$WA2UN+SP3
M<7$AFL$C>8:*S8/(8LQAPK@, =OF.<<+N^;8(6$T;QG:GG[%=LR%&8XC+D%6
MW<*6);<5?8P8D,/VK\7^%;'QQX>OM)U73[/5-+OH#%-:7(#0W(/\+@J>.!R,
M]3QP*_-O]J?_ ()Q>*O@IX@U&_\ !^DW&N>!XU\Z'RY?.GTZ+!>2%T+"1EWJ
M6+;BI7RU; #8_1.&>*.5?5<;)=+/U>SU^X_..*N%7-_6L''_ !)==MNN^K7?
ML?.]H%22%O\ 5JSPDHS'<@CVKAL#DY4[5P22" J,&(CAA46FUCM\E54L>D6&
MC>1B #RK8!V@-G!+9RZ3*Q$BQJP\JX*HJOAX<LP+#9A.5*,K+L)&Y3E,R8;:
M2^=%'CSI(Y$8VN]RSL1&OW#OVYPCA&5<GE@,!FD_1HU(M<RM;^OZ^\_,JDN5
MZZ:^73_+O\[#;E/-@N(V4(S1RJXD(^0ELL&+ X4JBL5"D'!;$X+&K&QI=196
M\PJ+C?M8>6<2,H#?-E^%X!4<'C=&,JE>UD$)5E(_T=1@1 #RL':,* <#]V$V
ME"S./E1-IQ%-:B'3YHU"JJI.C;2JQY3*MT('$:JNXE<?=#0_<JN6^G]?TK?C
MZ!&Z5EI_P=_PLB2V)@BA4+LF58V"%]JR-&^ N,<?,PR5W8)^X'913)U"V\A1
MI"Q@*K(<1Y9;@#EL_P +<G>2PW'+1DMNFO)(XWO#&H53YH0?, ',(/)P.?+5
MN&PR%=NX*P%+)"9+CR57RW+"!/,4X)"L8PRD#H-S; "(RV[R\8D->;]?^ _\
M_D&KE;[OZ\OS[B70"K=,F4W-<*-@&T;2%9L@GD1J4RW'W5#1$E VXS,;A=LC
M-OF,8 9BCR(I&P'')_>*3L&/W@WJ0=[7F6ZS)\J^8(V&_P#>NHW*$.&)+8+L
M-I.&W;D!8X+KE2\;*Q+*PRZ@^9O/F;=A;.2RNJ LA+;>&4,$-"V7]6_K\^U[
M"M]E?\._\EO^9)YRNPE.[RTE:4/&6?*N^'"A>>Q"L"A;)PK'(9L>8Y54_NVW
MHF%)94:(G^$*H<;L@!2"020FY6P33>;*KL>5>9][,/F.%)93D\###AQM QO0
M86D@C(6':J\_9P%W&-2WEDJN?NC+$DG&1\I$>XJYFWN_UYZ_+[AMW=H]5_DK
M?UOMU&1SPV40:9OL\=N/-#*Z_NVZ93G:W.X;^25W*W/-?''[85]I_P"U)^V3
M\'_A[X/CCU&Z^'NH'Q3XAOE4-'I-K&8I%@W+D R",#:O +0\'G'J?_!0#XK^
M-_@_\%?.^'?AKQ%XM\3:Q.UA%]CTZ6Z.BAXWD\]H4!W,%!8+("5+*7/.&\/_
M &7OC1HO[,O@632M/^#/[2U]JVM-'>^(-<N/!I%YJ5R3N\UF%QG;O8[ 6XSG
MEB2?#S7$4*M18.HW&.DI.SV3NHK35M[OHMKMH][*:=6G2EBJ4;RNXQLUI=-.
M4KM6LMEJV^MEKJ?M]^.;U/V\?@SHJ>&];\<0Z/9W?B&VT:PB1I-1O739#-(2
M50>48E;S S*@0[<#*+W'AW]OOQ/X-^*?A[PO\5OA3J7PZ;Q==K8Z+JO]JQ:E
M"\[,H$<DD6!$6W 8!S\W)5<NLW[:/PV\5>%_CQ\.OC)X-\/W7BZX\%R7EAKN
ME6H0W5Y9SIM=HQ@*S1%G+* 1O8#<3NKC/''_  EG[?WQ<^&UO9_#7QI\/?!O
M@K78?$>J:EXHT_[#<W<L(0K;PV\9RY(9OF_N?,-I#;^&<J]'$5E"34Y3BU%1
M3C)6BOBLW96>TE;=[GJTH8>MAJ7M$N2,9<SYFFFG)Z*Z3N[?9ES7MZ)^V1K-
MY^S%^V5X7^*WA\V/BK6_%>D#PW=^#AYKZK?VXF5_M%HJ;VX*#<7POR$ G>=M
M7]EKXA+^U'^V[KWQ"U>6W\(^)/"^E/X=TWP;>1^1K,5NS%GN;C>8"2=YP(F8
M)N&2#@MN>-+;Q5^S7^WQXD^*5Y\/_$GQ&\(^-M(M-.LY?":+>ZAH+Q11EX4A
M#[RK[#+\K*K"0'LRB/1H?$?[6'[;_@;XHZ7\/_$OPU\*^ ].NX+K4O$445AJ
MNO--!(5@:)#PBH2P9F"[7;YU+(3ASU%B[)/^)?DL[;VY^;M]K^7IN95$JF'W
M7\)KVO-'UY.3_P D;TEUO8^OD5FO%5%\LF:-"B# CSAE&WH"@)8 @'G<T?\
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M_ *DE;WE_37^7EL=%\)OB3<? [XI:-XFCC\YM+E@@GM#))'&T8DCP[#<S>6
MDAP!MVB4EF W-]K?M1?M$:Q^SW\'M/USP_\ #?QI\5-4UF^33].T?P]#"LNR
M2$8EN+EF5+:V"P%'F;[QDC! \Y#7P%=VA AM86F^T75[#;0*(5 D9S$J[U4C
M:=NYR% ;(0_*=@K]&?B9KWB_X6? &XO/ _@F/QSXUT?3K>"P\-KJ,>DQ:K=
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M^"W_  48\!?%3P_+>ZE)J7AIH[83VL>J3B*XU5=@#F)%VAB.!\HVAB2,#!*
M^D**Y_P'X^T'XD>'X]9T'4/[4T^'? LT32,K$;=P*GEF& ,D$@[AU)%;7V^%
MO,VR+(T>[<J'<PVXR,#G(R..O(I@345&+N/RY&8M&L)(=G4H!CJ<G''N.*6&
M=9MVT/\ (Q4[D*\^V1R/<<4 /HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ J%HX[>5IFV;I"J[FP,=@N<>I. >['UJ
M:D90X^8!N0>1Z4G%/<#\V/\ @J?^SU:?"[XU6_BW0M/GL[/QK!,NKW(\V99+
MYF_=E@Q,>W_9^49DZA3@_,XE6<+@M,KA)0,N6*",F+/F9SN)"?-P75F"AR2O
MZQ?MZZ)%K?['_P 0/,ACF-GI$UW&),8#1#?GGV!!P02"1WK\E=)F\^QM?,DM
MO,:.'Y)9L*S.I&W#'YMY*E^,=,;G&X?J7!.82JT98:I?W=GZO_-_\/LOR?CK
M+84\0L3#1ST:Z:*R_+T1(SK/8K'YD<BQQ-MW!62-"6#G&&+)AT5EPH7"?*@/
MRS-$QGDRK*5N ,NK\,/EC#-\W.709/)#;U8!=JL2X61$;,C(JI*,G=(X&$./
MF)+L<*I^^NWYGY"E%B6!HPT<6V.0Y<1B(,L>W*C. J8.P*&P,$.78LA^\M?1
M?A_7Z:O;JSX.6UW_ %KM^'IY7U"!\1PM\ZLOER!RQ'R/O+?,6XS(<?>4L%!W
M2?=*VY6'RY&C\M8PIXX55A?;M(4?* 1G!4A><K$S8IAB,NY6\M9I%VEFBV#?
M(@+'!VE1AV+C!^8[RJ@$,L\\<X,C2*JMN.\J&,:.K1(QP2<@1N-Q?+;OE8[O
M+I\M]5M_7EOJM0ZN^]_+^M>WSM9!L:TL77=,ODPE7 S\F&?<<;2N3A1\WR'Y
MB3)M.7SHT3,OEKA1(A3*X*E\!!O##:& 5 >78G:J*,40Q?;1OC6..-U1RR -
MY:MM (X_A5VVL0!Y9"NF,$MA#7+;K?:)]C.J*KJT95P5P.O"D1G:I(&W>A'R
M*:2??7^K;_KY!*\>:,M'Y]WKZ]/R')*QE7S)MK;3%(^Z169%41(<[_,)+NV%
MW9#9&TOF0-8^7&LC+Y?EQH7=#M( 0_=<# X8E"#Y;9="JMDTJR!7(A+!8I)?
M+02;<;=RKQNS@' )&" "&9 &C";4B+2;@L*@MN6 '@AOF#;5P&>./&W;N*Y
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M7&U'%Z)VT_3H];V_S/V'(Z7L<'3A):\MWZ?A;\TC\K?VF_V>/VHO^"Q0\#^
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MT_0^V;?S/L\?F[/-VC?L^[N[X]J?5?2X/LFG0P^6(1"@C" +@!>!C: ,<<8
MX[#I5BF,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH IZWI]KKNG7&FWD4-Q:ZA!)#-!(W^NC8;67'<$,0?3/O7Y=_M
MG_L>:K^SU\2M6O/#_AW4?^$-OW6:RN;>-IH-*>5</&[QE7CA\P( 7Y81Y/S$
M&OU.?<77:5"Y^;(R2,=OQ[^WOD4/$/A^P\7>&KW3=2MOM6GWL3P7$+*R[UZ'
M&/F'J"O/0@]#7I93FE7 XA5J6VS7];_UU/+S?*J6.P[I5/O[?D?B8^V5 $VF
M*Y5UB212OFQ$QA,$Y4H$+?(-V2RDH6W"IOE-[N_>M(9B2"I5R7R.=HWJ?+B!
M[M\X'RH-M?9GQ>_X)!W%I=W6I_#_ ,0+]DE6:8:1J,)5AO+'RXW0ICY3MQ(<
M9"DXVKCY \6>#/$7PWU,6_B+0[K0;U=\L:72$!U6269@CJ"LBMA,LN"2A+EL
M*&_7,KX@P6-2C&?+/L]]?T_'M<_(,YX9QV!;DX\T-=5^%_\ +HWT1E2W"V%F
M96(C$:K\V2,%&95W#CHL1QD<,2=C$[1]G_LE?\$Q=#^+GP?T7Q5XTU?Q197V
MK 7::;IUY'#;I$0 N\/$TJ2$^9NVR_,&R<$E5^5OA#\&=8^.7Q#L?#/A_3YK
MYC*L<\D!+1VMNI$F^1P08]T@&&^4$;L+A58_LEX?TF+P[H]KIMK#Y=II\:6T
M(.%_=J@ P%&/;&!T/M7R_&F<2A5CAL/.W5V?>^GR1]7P1E,*E*>*Q$$[NRNN
MG]?.W9'S_P")/^"5'P;\0ZA'<QZ-JVFO&S2$6>K3JKR,VXR'<S88G ^7 P!Q
MP,<MXD_X(W_#;5EN&M->\=6:MAH+7^T();:)EP44B2!G9%8 X9CCG&,U];T,
MVT=_PKX6.9XJ"_B/[V?=2RW"2T=./W'XL_%OX:Z_\#?B3J'AOQ-:W%O-:OML
MY[J/RXM3B#;3.I(Q(/E,9; +*<_*N2<*0!2WS2!H\Q^8?OI(1'&6ZABXW!/O
M,[(1LDW$@_KY^T;^S;X5_:=\%W6AZ]IT;7.W;:ZFMLC7.F/@LLD;.,-@]5.Y
M&SAE(R*_,#]H;]G?7/V;/BG=>%]3COKC3QN_LS595(758' 4D8RGF<N2I)YC
M+.O1Z_2^&^)H5XQPN)TFMGW7G_5M3\RXHX6EAY/%X?6#W7\MK[;[]?,X=6:2
M]:=57?)*S-MBW!_+<2$ HI+#J1(.I;:P#[<1VC-%!'_JU:-(65R1)M42'YL@
MMF-1@$  9PP\H?,!R^H)GY9?M"^9@\(Q=PJG?@\$%2IY*_-L:500"X/F6ID;
M$D;*\@:9$CC89<G<P. 1RQ)964ABHP2E?;\K^?7^OOW['PZDE*[_ *_KS[?<
MB9@BCC(DC\MLH'?&PC!ZX*[D.XN^ !RI#D[J?;LV5DVR.TCPDMAP=RHJJ"26
M7<V[<H<MR%W,"5*NSBYW%AF9PC$ML8L%F4%B@7:S)\S;?GC)!(VCB)"9+)9-
MJS?*JJC8!<>4=B$;6"AF4*1M5&)5DPW#&O\ 7KUTU7];$].;^OZZ7WMKT'6C
M.%MF55DW.AB!!VRN%)R"6));:X8\R(W+;DR2EO LD,:K$T\/$# QX\Y0RX4K
MG.\KO4HW"IN+>6,J51LL'#)*RLT;, &DD4F1?G&22S!=@63";T(*@A!38E$J
M1Y6-\_(-I5]X.R/ )!R/W8PSJ%=AR$^0A?U_7]>H[:>?^6W]?@( TUJ)#+YL
MC0KN92"7#S [@ &RC;G49P&\LD(XQB22-F,I;YMK2._.<9C7RBS9)49W$-N.
M,?ZQ/]60(Y<[ANF&Q\,&5P\F$'WB6&0A()*X;"+)U(C5U%HK1E66,K("P^4!
M(MF3@-@$':V "AX8.A +7E_P>GI\A:I+\/7^OO'3C[2VQEPTI"'*X<[XR[=4
M4C'RDCY0=Q#JHR[#2B:4/(!B9 S$;4SF20?\M,JV"=ZABPR/EW*20*ZV[_=.
MZ.4,PR%/[LDA6&[;QA0<95058*H8E21?LOS2?,R\R,0=IC);/3@ARH&&_P!8
MQ8A4SFEZ?U_7]:"<7;7^O^'T?>UAPB>$?O(RHW*'1SLC'[PY0G=\H<X=BQ);
M/64?*(;6P75?$NAPM?36T-U>+;RR2S+% GF;H6>0,TB@@Y)&P?\ +0D @E91
M R2QHJLTT*DCY1YCLI91AAESAIB&(<@=6<;G#2V_P\\1?%"TDTWPKH-YKUTJ
MB!WA60B)&8%O+/*;L;B,JJ_ZAMI11CRLXKQI8.I)RY=-'Y]$OG_3V/8R6C4K
M8N$(QYM=O*]M?Z\V=#^T3\,IOV?_ (FV^BI'K&H:=?VMFEI>>5));:I++"DQ
MCA(5%?\ UB@1<#:LH R":['X/_L(_%/XQZA;M)X9N-+\/7";9+S55;3V?(.X
MHKYF*L#N+)%\^SD#=D_<W[.?[(L>E:3IGB#Q^D?B3Q;!% MM!=1/+9Z'&MO'
M&D4,<G&Y>69^3N>0+@ !??H(5,(C$;P1Q, B@A1A>F-I^[QT].",<5^5_P"M
M6.5'ZNI:=_M*_>_W^I^LSX5P$L0Z_*^FG2_6VUMK7[6LUH?*O[._[ 7B+X6>
M'GT^\\2FP5B@^U:7<I)>B/8L;1%I[9HU7R\@JBC=W).''H]Q^QT;9[BYM/B!
MXY-YAWMUE;3UB5R#@-MLPQ7D@Y).&/?!'M-,6WC6X:41H)74(SA?F91D@$^@
MW' ]SZU\^ZTV[M_TSZ+V<=OZ_K_AMCYE\7:-\6/A_<PPQ:+X?\3:6Y:5WTHD
MW$,1+\B&21=Q_>-A8XV'S'G#.&P/'GCSQ1K?P\O-/\+^'_&%EXRD0QV N/#=
M]!!&<%&9S)#Y3J<[23E0IP3M:/'UYGCH>M1M!&;A9FC0R("BOMRRJV"1GL"0
M,_0>E5]:E;5O^N_ZF7U:&]E^G]?>? /B*&32_P!IGP_IMY=_$31M4,HL[R:X
MO8V;4;B9P=PA(EBVG#;3;P( %0Y8UZA\.OBUJ7AZPL=.^(L$_A[Q!#=>5+=3
MQ&.RN)8-QEFBFW&%G"[,;'Y9 A4EB#].:CX'T/6/$=IK%WH^EW6K6*^7:WTU
MFCW-NN2<)(1N49R>"!FO./VU?@UK'QR^!&H:7X?M]/DUL#S(!=1QF7:!ED@D
M?Y89F(4+)D;3SG%51Q+OO_3_ *N/$45.-DOZ_KTN9$%ML2..3Y9,0Q2CRPH#
M1K$) >_R1LRR D$$$Y(9U!&,R<KLGD)*J4PWSQS)G^'.Z0J&###$JN BC=Y;
M\#?B7XBT3PA8Z?\ %#2+CPCXFA1AOU+:MI<[IV2/$JYA11'@X8XQYH(.]E&E
MK_Q'\91>&M0\1Z;X,U23PG:M,1>/DW5Y;HA=KM8,;PI0L(P3NW;]S,')/I?6
MXVNM.WW;V]/S:79>3+#U.:S6G?R].[_#3JSO+W4K.U-J9[F"WFDF,EJ)6VLS
M+R1E1E&8A=Q#)AHGY4$E?*?AS^SM;_&CXC^//#\%Q'X)\-QK]EN;?2K"UM=4
MFN"J%IR)X)AM&\J&^5U*J58]39\)>"K[]JWXP27TFCZI!X)DTH+::MB:U2VO
M=\[^;'&S 2R#]VC%T( X!!)S6\=_#77OAKXTA_X2:/4+-8XHK:'QWI;E&E"B
M)(8[A,E#(VP@NZ!"WWCC:U<M:HI2<-NWW;/^D=M*C*G'O;Y_UIY7NWN?7WA/
MP]'X0\,Z;I-O)--;:7:16D4DS!I9%C0("V !N( )( R2>!6A7SI^S3\5M5TS
MQ=!X-U3Q5+X\M;BV+V^J1)$T\&,)MF-I$L:J-B[7Q'C>V\NX)7Z(@D\Q">?O
M,.01T)'<#_/KUKCJ0E"5I;_>=T)*2O&_S'T445F4%%%% !1110!\X_\ !0S]
MCR[_ &H?"^F76@W6FV7B7P_'<RVQNYA ER#&0JO((W8*KMN!&,%LY['@?AI_
MP1Y\)RZ5977C#6/$TVHC)N+"RU"$63J=Q$986ZR@+YCKA9,8.,D8 ^S*15"#
MY0%Y)X'K7;3S'%4Z?LJ=22CV3T^XXJV6X6K45:I33EW:..^'/[//@7X10VZ^
M&O"/A_1FM26CFM[&-;@,5*%C+C>S%25W%B2#C.*[(#%%(XW*1DKD8R.U<76Y
MV;*R/S[_ ."E7[&.E_#C3]0^*'A&WO(8[RX+Z[9HP:UMR<J7CV*'B9F=PSEV
M"MM5=@)S\APQ@7"^7)M.\K X>-5\M@8PZG"X!8KM'1G)P"/WE?MCXAT*S\1Z
M5+IU_;PW=C?!HIX9(MZRJ03@XZ<\Y/\ ,@U^8G[7_P"P1XH^$?Q3UN\\'^'-
M2U[P7J,<EQ;00PK'!IP<(K1, 1N/[PJ. Y5!SC?G[KA;B-4%]7Q;T>BZVU>G
M;KVU[W/@N+>&5B?]JPR]ZVNVOF]NAX6A"W2G: T;+)L";9-I5B"L1&_**%=0
M0^"[* , K&BR)">BM&A!9'P%D5$C<[AU*J.6)^5AL\P L RWD_M"QE:%9)$_
M>[UDBVON;"\Q_=;S')#J!Y9(+91U(,URPC7S'\Q04>59.7W*I!9U)7+E5X!4
MJS("02P'E_J:]^TH_:U7I^>O]:'Y3LW&6ZW[W??U^^R:.;U:\CU7X@:7:[V,
M6DK]KD5FY5)$ "E<8"L@ QA?G+J/E-?:'_!''Q[8^ ?B5XN\'RRE+OQ2(M8A
M#*S^;)$LXN%0[CQDHP!^?AP5)RP^09]$N8-?AO+:'=/N6"38I810AO+=E((.
M5 P-HSM;G:P#/T?@KXHWWP2\7Z;XQT]U:Z\.317P#+E9U VLCE,#:Q*<8&X+
MN7< JI\AFV5SQ>$KQM[RE=>:LE^&OY;[_89-FT<)BZ$D_<<%%^3OV3ZZO7IY
M'[4Q/(+?=+Y?F*@WA 6 ;'..Y'IQFIJQ?"VN1ZOH-C=+;/:-=6\8&Z$JJG#8
M7H#M!!QG (9<?>K8BF6>-61E=6 (*G((/-?D+33U_K]/N/V*-GK';^O-CJ**
M*"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O&?VLOV>-6
M^.-EX?U32]0AL]6\'W,MY;64C-]EU'<R865U4LN%3< J,=Q S@9/LU<=X]^.
M/A/X::=#)XD\3:+H<K*28FO8S([?,A6-&^>0B0%0$0L67&.HH#U/G_PWXZAU
MC5-3T?4K5](U[2Y&MM3TZXD64V\C*"C1LK;/+"%-O.#\A../+Z.56968[(XW
M@&UI&!0[ RQ*"SE)%RC=FVXV@_+QYS\;_BOI7QN\2:QKG@74M4\$?$#1]$F2
M$ZW!':6>L1"4".%UD8.LC,4=> Y5=O *D\?^R+^U'JGQ2T.VTKQ-H^M+XOL'
M)U:Z-NDEG!(F_:1*@=03&JM_=8%2%.$(&#7]?U][[GNUTBJ\AFC\[R5(9;B&
M1-QC#*%<!LHVU=FU057:VUDPS*RY39$[,T,GF1!&E9M_FNN,'S"I!7>%/<8.
MUF4[0%M;7]Z(1 T$@)MR.$8_NSNB9 -[,&5@Q.!ED.8ARPMRIDANO,:%EG\Y
M75<'<T2MNSL3!#%%+ H,E2I)RX.M_P"OZ?\ 7<.M_P"O^&>_IVW<L);SHE21
MW,+0L,3$,I5EQ(&\W]WM0[ Q^3:H.<D$0PW2(O\ K/W<6R20([C$(D5]H!9#
M@EMVQ=H+<JPP $WQI$T;QJ(XH!+Y:S*Y(#1%T4$D ';N5@C'D[MZ_O!)>M,A
MF5IKB.6-I5^7<@CFWLRJ!MRK,&(V<L".652P4\U_7]?UU%YK\/ZW]/QU"-/(
M#;OD:"2.*5XMK+$R,S%\HI*1C<IQMPQ#<,R[E\[_ &GEQ\*H]TC%8;VWW-.I
M9BNZ5NI#CYV=V&P[-L?(9F!'H4TT8VRY@A6-RT17]Y';%WXQM+;50X<D;F^9
M$.0<GS[]IP#_ (5RL>U-_P!O7Y'4-(J^<P().=S9V\A7) QN(!0#Z^G]?G]P
M][VZ+^OS^[L?9.E[CIT)9E9F0$E9/,7GG ; + = 2,D<GFK%0:69#IMOYKK)
M)Y2[W#!@YP,G(50<^H4 ^@Z5/0&^P4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 -D#&-MA56Q\I(R ?<<?SKA
M_CK^S[X0_:#\.1:9XNT>'5((9&D@E\Z2&YM',94O#(A#JV.< @9 /)45W5!&
M134G'6.Y,HJ2Y6E\SRW]FG]DKPC^RUIMS;^%[>7=?*%N;B:;S)'9>...YR3S
MU '0 +ZA%N$:[RK-@9*C )^G;Z9-.%%$I.3NPC%1CRQ27IH%%%%(H*^6O^"I
MW[-TGQF^"5OXHMYE35/A^)=1CM0@*WR/L25&8\ +'YC*"K#<%/&,U]2U7O+2
M+4]*FM[ZWAN(;B(QW$+IYD<BLN&4@CYE()&".1VK;#UY4:T:L-T[_P!(QQ%&
M-6E*G/9JQ^(L4JWLD#,Q99#&J>=\V(WXCSN(+ AE# DJS#Y3YHY;%,NZ.;=^
M\D <2$[B58HBDNI4L>, J"9/D4,P!SZ!^U+\)9/@%\?O$WALZ;=Z7I4-Y)=:
M3,P94NK66W+EX\ ;\,KKN5@R-E,@!E/!D[VN!*5C"$B8[@,DM$K'C PS*3G!
M0_,KA2"*_>LOQT,70CB(VU6OD^WW_FK[G\_YIE\\'B)X::=D]/-7Z?IV8VY^
M5GV_*S(T2^8__35V8,VS! 7 =N0,\^:0*=.G[VX9CN\MY^2 S $^6&R>3M!Q
MGH 6S(HRH$W>8';$;3R[G1@ZA2Y=AN( /R* XS\X.W/E#FH_M!B@^TJ/FCBC
MN_F(X*J45V"JJX^4'<3'G:0'\L<=RO\ UYVV.&[TOKO^/G_6R[DA#<+^\<1O
M)%Y98X4B+. "55=R'@'8022/D--:-KH20KMEDN8W5@8R"2Q12Q&W&-R[6RF
M<LR%25"RVBPMY6W=#;^9 I91DQHBC!(P NYF)";5QA6=-OEE'7[8GE,K*;DP
M@!N59I!N+8QEL*'7(&[ .7'+1J/1K_/^O0-OBT_X&G]>:\[B.RNI;Y1#(T\D
M9=<(%=V&2#Q@.P9@=V,@E3\OEOD+23/#E5>1OF:7Y5C*@$M+N);*E<H VXX!
M1PI)C;Y_G0FZ;_5^4;EY"I?RTP%!)&0<#+$A@'1=O[P!G%36+V31K%9(UC\R
M -&T9EWK$/G9L[2@!#! "A!'FH"A*QYBK-4H>TEHE_P_SUZ_D71I.I+V<=_+
M_/IKU[>=QXUZUDG:/==*R/%'(C-L<,=C\\$>9CS,@9^>,[2CMDQ_\)'9VEHM
M]<3-;JK;W\R&1'2(NN^0'@A3\HR>,F3YI,@GT;]F'PAXBO/C;%:Z/\/X_%TN
M6M;VVU#3DO+&V$J"..22>($PJH9&8!P,%L#'RG[9^!G_  3$\.V7B?\ X2[X
MAZ7X9U+7[@!O[&TW38H=$L,,256$*$E!&SETR"IP>3G\_P 3QK*A7E348R72
MS]?Z?F?H.#X'IXBA&4Y./DUJMM;ZK\_P27PU^SM^SEXT_:NBD_X1'1I)]+BE
M%K=ZC?[;2PM7P,O\V'<!7VYA1CA-HW%=R?IW^R5^RAHO[*'@ :;IY-WJVIR"
MYU:_91NO+DK\[9"C"\<+PN<D*"2*]-T30;/PUIL-EIUK;:?8VX*Q6UM"L4,8
M)SPJ@ <D]/4U:BB6")450JH H &  *^.S;/L7F-E7>BV2V7XGVN4Y!A,N3=!
M>]W=F_\ @?UT2'4445XQ[84444 %%%% !2$ME< =>>>E+10!1U_POIOBRR^S
M:IIUCJ5OG/E75NLR9^C BK$%N;*UCCCCA&W&0H\M>3\Q Y]SC]>]344 M"*T
MMUM(O*CBBAAC 2-8Q@!0 !Q@ 8Z8'8#Z#$^)_P -=-^+G@J[T'6%FDT^^VB5
M8Y7C8X(/52#D8R,Y (!QD"N@HH] .<\#?"3PW\-U(T71[*Q;:D8E5-TQ5(UC
M4&1LN0%4#DGOZFN@MT:*WC5V#LJ@,P7:&/KCM]*?10 4444 %%%% !1110 4
M444 %%%% !4;!I)'5HXVA*C!+9+$YW C&,8QW.<GICF2H+N\AMMWG2>4L:&5
MW8E415Y)+=!COD]/:@3['X;_ /!17QD_P-_;J\0?"/X8Z3!XBU9(HO$%P=5(
MCT[2HI8P7$DL6YP3YJKR #A]Q 8*_FGPR^.VM77Q.U+P'XZTW3=*\56]E_:"
M3:5)]KTZ[@6X5)FCD=%E+(9T)1U5?WTH ;:17OO_  4+^.O@.U_:7\<_$&^U
M#3;"TCFM-,AU.\$)>62!/L[",JQ+[G52%C(#$J=H4LQ^./@?IGC'XW_&WQM\
M6-?T+5_#NDKHC6/A6TOX?)NYHRT3O<,#C#,8;<J4D&<$@J&VG]8R7&5Z&%H\
MTG-V;FGM%*+:\[WM;37L?DF>1HSQ&(Y8J,5;E:>KFVEIZ7?,^R]4=I9_M&>.
M/C7XLU>/X9>&?#>HZ+HEP;6:_P#$5P;*&[E#M$L5NT*NS@DA2&P"%."P.TW/
M&'QMU[Q/^S_J=]HOAN/4/%4T*Q'23>BWMX;@L@DWS,?*3R1)O?S06)" [BV$
MP?\ @E]!Y'['&CIY=Q_:2"X6_62+]ZL[!=X=&*Y((8_,"<L0I(WBK/PC\06=
MMXU\?MHTFEW6I)XBN_)%P6DMQ<*^(_/90S;.06P0Q!]A6V88C%4J5*FYM^T@
MV_+2^EE>VMEOV;ZG#2HX;ZQ*'(DJ4TEH]=5OJM79=;VUU/K/XD_\%=/VL_\
M@G9X0\(_$7XW> ?@+XF^!>I:E:Z-J,_P^O\ 5EU;0$ER$FF^U?NY3M5B1'$
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M*@JZ@2G).QFCWM9_8T\50H;[4/C T&&Q<3MH<=O'L) RH695CE/'[P#)...
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MHHKS#U HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ['X;Q!D>(P>(E4J+W'+1]-7?\/0FN";D3%F"S2*Y,A=SY&)P0,C=PI*GG!
M))\H *(M23^U;B.*3SXEO;F*UE()>:)9KCRF0?,<J/,PQPR*Q&"0H,;X FU1
ML6?:8T1,JGF8"&,9SA59=WRA0A*Y C;@]!\'/AWJ'Q4^-7@_P[IC+=ZA<:G:
MW$HD_=R/!#):27$C#8'#B!<GJP$CC(VJ#WYM6A2PE2<]N5_E:WS_ *ZGGY/1
M=7&4H):<RZ/;1M_UZ:+1_L1\.M*DT/P-H]FZLGV:PMXMA55\HK$JE<* !C'Y
MD]  *VJ@L;&'3E\NWAAAC 7B-0N< *. ,<*J@>PQVJ>OP-:K4_H3^OZV"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN90@9MO/&[]F?V=OVF-'_:5T*2\TN&]L;C3Y5%W;/M9<,C%2KX^=#P<K@A@
M>,Y^//VO/^"1'B;XO?M(7NL>&+S3;?PEK31ZA.DTBB6SOE2./S$0C;G;&"<#
M# D,":]Z_P""<7[%&K?LA^$-5A\0:A#?ZI?7#B(PMYBK 2#\[L-[.7#-R2%5
MP,G!VG2_]?U_7J=+_P!??U_KY_2U%%% !1110 4444 %%%% !1110!POQM_9
M_P##_P >8=*CUI[ZWN='EDGL[BSG$4T6]/+D )###*=I.,X. 1DY\(_:4\)Z
M)XHU_1?A9HGP[UG5=2TG399--UUHIDM]*=5\Q S[#&PD<! 7955I"?E'-?6-
M1O,T46YA&IW8Y? QNQG..N.WKQGO34FM4[ [O<^0?^%$_$3XP:)IOAG6_#/A
M^QFM8E.KZE=ZC'=?99Q&A18TC ;?CY@X!09  4A\_5G@3PS_ ,(9X+TG23<3
MW3:=:1V[332F624JH!8L>3DY/8#H !Q4#PO9_$.*18V\F[LW#,.<N&7KR> H
M]  6ZDMQ\_-^T7XZLOBEXDDNM+TO6- T.\&FR:3' /MEE 54FZ\P,[2B106V
M*IP >N"0)<STW_K^O3T)]R"5[)?U]_YGT]17FOPS_:4\!_%BYDM=)U:SAU7<
M//T^0QK>)O9!\\8+$;B57GDXSVS7HUOCS)L;\EQD,NW!VCH<<_7GG(SQ@.47
M'26Y2NR2BBBI **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *"N?7GCK110TGN V6)9XF1L[7!4X)!P?<<T"%5G:3^)E"G@=!G'/7N?\YIU
M% :A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!"$\F1=NV-6W?)P S$YSTZ_>/7N>#V_+
MO_@I/\!]+^!G[0S:YI&G-8:'X\MY[J6:)!)YFI*TL<B*FTIG:T6%.#@8R!N5
MOU'\]=F[#XW;?N'.<XZ8Z>_3'/3FOGC]NG]B#4/VM+WP[?:3XB@\-ZIX?$R1
M7#Q22 I(8R055AD_*V""N-V#N&0?0RO'SP6)CB(]._7^OZL>?FN7K&X:6'J-
MJ_7M_7WGYD+MQYJM&8U9-Q+;E0!FC5CC!,87<-S'+[>R@U]>_P#!(#P!I.J?
M$GQ9XBN<2:MI*I9VD$\122R4HH9T( 3YU.TX_NC&1AC>T'_@BU=Q7%C'J'Q*
M5H(-LUPEKI++*\OE[68.9\C<QD.>H'RG<,;?:/\ @GQ^P1'^QAH.L3:EJL/B
M#Q)K,HCDOX[98<6JA3'$0!G(;>QYQ\WKEC]7Q%Q-0QN&5"A==7_EYKS_  /D
M>&^%ZV"Q/UBLTU:R2W]7K:_W_*UCZ,2-ED=C(S!L84XPGTXS^>:=4<7EF>1E
MVM(,([ #<.X!/MNSCW]ZDKX2]]3[YJP4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M &1XXU/5=,\,:A)H5G;:CK4=K)-96MQ.(8[F1<80M_#NR!G& 2,D5S_P6^*5
M]\8O 8U9],_L&^622RN;&X)F^QW,199,/\OFQ[MN#MCR 3W%=O4<MI#/;20O
M%&\,H8/&R@JX;.X$=#G)SZYH#^OZ_P"'_P"!5N+^3[=);K<V,$K*5A1SYDCL
MRY1BN5X^27Y1G<$R&&"*FD,T+-(\UNL*OO;,9&(]G0MNQG=SNQC'&,_-7"_%
M3]GO1?BS8:I-LN-#U[4DC@&K08:Z@6)F"E.2HW*SCU(8;AE0%SO$G[-&G^(O
M#6FZ& MOI,=I>6U^RR2)<323(B^>A#$;B4R=QR W&#F@-#N_$?B>W\)V9FU+
M5])TV,I*1+=#RXTY&QF+.!M4$!LD;BRX*Y .'X=_: \%^+;^.ST?QIX.UN^N
M+@11066K0R.>3D81G)8!6[ $C''6O-_AE_P3=^&OP[>1[BUU+Q(TD;1[=6NC
M-&H8Y.% ')[DDY//ICU+X?\ P1\)_"RYFF\/Z'9:;-<(D<DD8+,P7=CEB3_$
M<D<GOG H X74/CAXW\<:OJ6G^"?!MQ%]E#Q_;_$0:SACG5U7Y4"YEC&'SAP6
M)8!@4(',_#W]@B.[^)NF^.?B9XHU3QYXJT1!!IJ$K;:791<-A;=%!;]X7.)'
M=0 @P.<_0]Q;QW=O)%+&DD4BE'1UW*ZG@@CN#Z4^CU#?<**** &11>6\C;G;
MS&W88\+P!@>W&?J33Z** "BBB@ HHHH **** "FE,N&^;(!'4XYQV_"G44 %
M%%% !1110 4444 %%%% !1110 4444 <G\:?BC%\'_ -UKDEO+>?92F(8]I9
M\NJ]"P.W+ %E#%=V[:P!%>(^!/#]VIO?$FJ7MO?:[XH==0FN8N$$/E@10*2
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MY R<#VR?J:?117F'J!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M&O&KNK,JML.5R.5.,9'X$C\:^8?$'PK\5? 6ZUZWT'PS<>*--U;4KO5+7489
M-UW!<W=R]QY<B$M)(JR/_K"5 "*> &5_J"BJIU'!W1-2"DK,\E^"7[+FD>#]
M!%[XFT_3=?\ %&H!)KRYN[<3_9VQGR8MY8*J%F&4"[@!D<#'JME90Z;9Q6]O
M%'#;P((XHXU"I&H& J@<  < #L*EHJ6V]QQBEL-BC\J)5Y.T 9)))_$\_G3J
M**!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161264829512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> shares in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-14106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DAVITA INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0354549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2000 16th Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Denver,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">631-2100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DVA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161264699320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AuditorInformationAbstract', window );"><strong>Auditor information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KPMG LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Seattle, WA, USA<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Auditor information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161264251080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts', window );">Dialysis patient service revenues</a></td>
<td class="nump">$ 11,213,515<span></span>
</td>
<td class="nump">$ 11,026,251<span></span>
</td>
<td class="nump">$ 10,896,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">405,282<span></span>
</td>
<td class="nump">524,353<span></span>
</td>
<td class="nump">491,773<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">11,618,797<span></span>
</td>
<td class="nump">11,550,604<span></span>
</td>
<td class="nump">11,388,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PatientCareCosts', window );">Patient care costs</a></td>
<td class="nump">7,972,414<span></span>
</td>
<td class="nump">7,988,613<span></span>
</td>
<td class="nump">7,914,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">1,195,335<span></span>
</td>
<td class="nump">1,247,584<span></span>
</td>
<td class="nump">1,103,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">680,615<span></span>
</td>
<td class="nump">630,435<span></span>
</td>
<td class="nump">615,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity investment income, net</a></td>
<td class="num">(26,937)<span></span>
</td>
<td class="num">(26,916)<span></span>
</td>
<td class="num">(12,679)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">124,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss on changes in ownership interest, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,252<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">9,821,427<span></span>
</td>
<td class="nump">9,855,968<span></span>
</td>
<td class="nump">9,745,162<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">1,797,370<span></span>
</td>
<td class="nump">1,694,636<span></span>
</td>
<td class="nump">1,643,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Debt expense</a></td>
<td class="num">(285,254)<span></span>
</td>
<td class="num">(304,111)<span></span>
</td>
<td class="num">(443,824)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtPrepaymentRefinancingRedemptionCharges', window );">Debt prepayment, refinancing and redemption charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(89,022)<span></span>
</td>
<td class="num">(33,402)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">6,378<span></span>
</td>
<td class="nump">16,759<span></span>
</td>
<td class="nump">29,348<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from continuing operations before income taxes</a></td>
<td class="nump">1,518,494<span></span>
</td>
<td class="nump">1,318,262<span></span>
</td>
<td class="nump">1,195,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">306,732<span></span>
</td>
<td class="nump">313,932<span></span>
</td>
<td class="nump">279,628<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income from continuing operations</a></td>
<td class="nump">1,211,762<span></span>
</td>
<td class="nump">1,004,330<span></span>
</td>
<td class="nump">915,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net (loss) income from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,653)<span></span>
</td>
<td class="nump">105,483<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,211,762<span></span>
</td>
<td class="nump">994,677<span></span>
</td>
<td class="nump">1,021,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="num">(233,312)<span></span>
</td>
<td class="num">(221,035)<span></span>
</td>
<td class="num">(210,313)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="nump">$ 978,450<span></span>
</td>
<td class="nump">$ 773,642<span></span>
</td>
<td class="nump">$ 810,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic net income from continuing operations (in usd per share)</a></td>
<td class="nump">$ 9.30<span></span>
</td>
<td class="nump">$ 6.54<span></span>
</td>
<td class="nump">$ 4.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (in usd per share)</a></td>
<td class="nump">9.30<span></span>
</td>
<td class="nump">6.46<span></span>
</td>
<td class="nump">5.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted net income from continuing operations (in usd per share)</a></td>
<td class="nump">8.90<span></span>
</td>
<td class="nump">6.39<span></span>
</td>
<td class="nump">4.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (in usd per share)</a></td>
<td class="nump">$ 8.90<span></span>
</td>
<td class="nump">$ 6.31<span></span>
</td>
<td class="nump">$ 5.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares for earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic shares (in shares)</a></td>
<td class="nump">105,230,000<span></span>
</td>
<td class="nump">119,797,000<span></span>
</td>
<td class="nump">153,181,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted shares (in shares)</a></td>
<td class="nump">109,948,000<span></span>
</td>
<td class="nump">122,623,000<span></span>
</td>
<td class="nump">153,812,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Amounts attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net income from continuing operations</a></td>
<td class="nump">$ 978,450<span></span>
</td>
<td class="nump">$ 783,295<span></span>
</td>
<td class="nump">$ 706,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net (loss) income from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,653)<span></span>
</td>
<td class="nump">104,149<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="nump">$ 978,450<span></span>
</td>
<td class="nump">$ 773,642<span></span>
</td>
<td class="nump">$ 810,981<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtPrepaymentRefinancingRedemptionCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt prepayment, refinancing and redemption charges related to long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtPrepaymentRefinancingRedemptionCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PatientCareCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PatientCareCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161266133176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,211,762<span></span>
</td>
<td class="nump">$ 994,677<span></span>
</td>
<td class="nump">$ 1,021,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Unrealized gains (losses) on interest rate cap agreements:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gains (losses)</a></td>
<td class="nump">7,155<span></span>
</td>
<td class="num">(16,346)<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification into net income</a></td>
<td class="nump">4,133<span></span>
</td>
<td class="nump">5,313<span></span>
</td>
<td class="nump">6,377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Unrealized losses on foreign currency translation.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Unrealized losses on foreign currency translation</a></td>
<td class="num">(84,381)<span></span>
</td>
<td class="num">(7,623)<span></span>
</td>
<td class="num">(20,102)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(73,093)<span></span>
</td>
<td class="num">(18,656)<span></span>
</td>
<td class="num">(12,574)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
<td class="nump">1,138,669<span></span>
</td>
<td class="nump">976,021<span></span>
</td>
<td class="nump">1,008,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(233,312)<span></span>
</td>
<td class="num">(221,035)<span></span>
</td>
<td class="num">(210,313)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to DaVita Inc.</a></td>
<td class="nump">$ 905,357<span></span>
</td>
<td class="nump">$ 754,986<span></span>
</td>
<td class="nump">$ 798,407<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161264568616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 461,900<span></span>
</td>
<td class="nump">$ 324,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and equivalents</a></td>
<td class="nump">93,060<span></span>
</td>
<td class="nump">176,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">22,310<span></span>
</td>
<td class="nump">20,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">1,957,583<span></span>
</td>
<td class="nump">1,824,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">107,428<span></span>
</td>
<td class="nump">111,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">427,321<span></span>
</td>
<td class="nump">544,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">72,517<span></span>
</td>
<td class="nump">76,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">25,604<span></span>
</td>
<td class="nump">70,163<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,167,723<span></span>
</td>
<td class="nump">3,148,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation</a></td>
<td class="nump">3,479,972<span></span>
</td>
<td class="nump">3,521,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">2,824,787<span></span>
</td>
<td class="nump">2,863,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net of accumulated amortization</a></td>
<td class="nump">177,693<span></span>
</td>
<td class="nump">166,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">238,881<span></span>
</td>
<td class="nump">257,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term investments</a></td>
<td class="nump">49,514<span></span>
</td>
<td class="nump">32,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">136,677<span></span>
</td>
<td class="nump">79,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,046,241<span></span>
</td>
<td class="nump">6,919,109<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets, Total</a></td>
<td class="nump">17,121,488<span></span>
</td>
<td class="nump">16,988,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>LIABILITIES AND EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">402,049<span></span>
</td>
<td class="nump">434,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">709,345<span></span>
</td>
<td class="nump">810,529<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">659,960<span></span>
</td>
<td class="nump">685,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">394,357<span></span>
</td>
<td class="nump">369,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">179,030<span></span>
</td>
<td class="nump">168,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="nump">53,792<span></span>
</td>
<td class="nump">7,768<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,398,533<span></span>
</td>
<td class="nump">2,476,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">2,672,713<span></span>
</td>
<td class="nump">2,738,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">8,729,150<span></span>
</td>
<td class="nump">7,917,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">119,158<span></span>
</td>
<td class="nump">150,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">830,954<span></span>
</td>
<td class="nump">809,600<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">14,750,508<span></span>
</td>
<td class="nump">14,091,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,434,832<span></span>
</td>
<td class="nump">1,330,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, Value, Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">540,321<span></span>
</td>
<td class="nump">597,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">354,337<span></span>
</td>
<td class="nump">852,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(139,247)<span></span>
</td>
<td class="num">(66,154)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total DaVita Inc. shareholders' equity</a></td>
<td class="nump">755,508<span></span>
</td>
<td class="nump">1,383,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests not subject to put provisions</a></td>
<td class="nump">180,640<span></span>
</td>
<td class="nump">183,186<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">936,148<span></span>
</td>
<td class="nump">1,566,752<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 17,121,488<span></span>
</td>
<td class="nump">$ 16,988,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">450,000,000<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">97,289,000<span></span>
</td>
<td class="nump">109,933,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161264756520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">450,000,000<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">97,289,000<span></span>
</td>
<td class="nump">109,933,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260479992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,211,762<span></span>
</td>
<td class="nump">$ 994,677<span></span>
</td>
<td class="nump">$ 1,021,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">680,615<span></span>
</td>
<td class="nump">630,435<span></span>
</td>
<td class="nump">615,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">124,892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtRefinancingCharges', window );">Debt prepayment, refinancing and redemption charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">86,957<span></span>
</td>
<td class="nump">33,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">102,209<span></span>
</td>
<td class="nump">91,458<span></span>
</td>
<td class="nump">67,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">60,483<span></span>
</td>
<td class="nump">240,848<span></span>
</td>
<td class="nump">41,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AdjustmentIncomeLossFromEquityMethodInvestments', window );">Equity investment loss, net</a></td>
<td class="nump">5,215<span></span>
</td>
<td class="nump">13,830<span></span>
</td>
<td class="nump">8,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax', window );">Loss on sales of business interests, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24,248<span></span>
</td>
<td class="nump">23,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash charges, net</a></td>
<td class="nump">11,231<span></span>
</td>
<td class="nump">747<span></span>
</td>
<td class="nump">49,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(138,140)<span></span>
</td>
<td class="num">(21,087)<span></span>
</td>
<td class="num">(79,957)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">5,720<span></span>
</td>
<td class="num">(12,349)<span></span>
</td>
<td class="nump">10,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets', window );">Other receivables and prepaid and other current assets</a></td>
<td class="nump">128,661<span></span>
</td>
<td class="num">(79,277)<span></span>
</td>
<td class="nump">2,790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="num">(26,387)<span></span>
</td>
<td class="num">(6,123)<span></span>
</td>
<td class="nump">6,965<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(30,320)<span></span>
</td>
<td class="nump">37,200<span></span>
</td>
<td class="num">(84,539)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="num">(16,717)<span></span>
</td>
<td class="num">(20,931)<span></span>
</td>
<td class="num">(14,697)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="num">(93,645)<span></span>
</td>
<td class="nump">105,637<span></span>
</td>
<td class="nump">181,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="nump">36,921<span></span>
</td>
<td class="num">(87,391)<span></span>
</td>
<td class="nump">95,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="num">(6,732)<span></span>
</td>
<td class="num">(19,851)<span></span>
</td>
<td class="num">(31,446)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by (Used in) Operating Activities, Total</a></td>
<td class="nump">1,930,876<span></span>
</td>
<td class="nump">1,979,028<span></span>
</td>
<td class="nump">2,072,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions of property and equipment</a></td>
<td class="num">(641,465)<span></span>
</td>
<td class="num">(674,541)<span></span>
</td>
<td class="num">(766,546)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Acquisitions</a></td>
<td class="num">(187,050)<span></span>
</td>
<td class="num">(182,013)<span></span>
</td>
<td class="num">(100,861)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets', window );">Proceeds from asset and business sales</a></td>
<td class="nump">61,464<span></span>
</td>
<td class="nump">50,139<span></span>
</td>
<td class="nump">3,877,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities', window );">Purchase of debt investments held-to-maturity</a></td>
<td class="num">(30,849)<span></span>
</td>
<td class="num">(150,701)<span></span>
</td>
<td class="num">(101,462)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PaymentsToAcquireOtherDebtAndEquityInvestments', window );">Purchase of other debt and equity investments</a></td>
<td class="num">(2,987)<span></span>
</td>
<td class="num">(3,757)<span></span>
</td>
<td class="num">(5,458)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities', window );">Proceeds from debt investments held-to-maturity</a></td>
<td class="nump">15,849<span></span>
</td>
<td class="nump">151,213<span></span>
</td>
<td class="nump">95,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments', window );">Proceeds from sale of other debt and equity investments</a></td>
<td class="nump">12,030<span></span>
</td>
<td class="nump">3,491<span></span>
</td>
<td class="nump">3,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of equity method investments</a></td>
<td class="num">(13,924)<span></span>
</td>
<td class="num">(22,341)<span></span>
</td>
<td class="num">(9,366)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital', window );">Distributions from equity method investments</a></td>
<td class="nump">2,944<span></span>
</td>
<td class="nump">3,139<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Payments to Acquire Other Investments</a></td>
<td class="num">(745)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Provided by (Used in) Investing Activities, Total</a></td>
<td class="num">(784,733)<span></span>
</td>
<td class="num">(825,371)<span></span>
</td>
<td class="nump">2,995,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Borrowings</a></td>
<td class="nump">1,615,370<span></span>
</td>
<td class="nump">4,046,775<span></span>
</td>
<td class="nump">38,525,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Payments on long-term debt</a></td>
<td class="num">(861,115)<span></span>
</td>
<td class="num">(4,110,304)<span></span>
</td>
<td class="num">(40,520,722)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtFinancingAndDebtRedemptionCosts', window );">Deferred financing and debt redemption costs</a></td>
<td class="num">(9,091)<span></span>
</td>
<td class="num">(105,848)<span></span>
</td>
<td class="num">(85,319)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury stock</a></td>
<td class="num">(1,538,626)<span></span>
</td>
<td class="num">(1,458,442)<span></span>
</td>
<td class="num">(2,383,816)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDistributionsToAffiliates', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(244,033)<span></span>
</td>
<td class="num">(253,118)<span></span>
</td>
<td class="num">(233,123)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PaymentsRelatedToStockPurchasesAndAwards', window );">Net (payments) receipts related to stock purchases and awards</a></td>
<td class="num">(60,001)<span></span>
</td>
<td class="num">(975)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Net (payments) receipts related to stock purchases and awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Contributions from noncontrolling interests</a></td>
<td class="nump">31,754<span></span>
</td>
<td class="nump">42,966<span></span>
</td>
<td class="nump">57,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Proceeds from sales of additional noncontrolling interests</a></td>
<td class="nump">2,880<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Purchases of noncontrolling interests</a></td>
<td class="num">(20,104)<span></span>
</td>
<td class="num">(7,831)<span></span>
</td>
<td class="num">(68,019)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,082,966)<span></span>
</td>
<td class="num">(1,846,777)<span></span>
</td>
<td class="num">(4,696,450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(10,007)<span></span>
</td>
<td class="num">(13,808)<span></span>
</td>
<td class="num">(1,760)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Less: Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">53,170<span></span>
</td>
<td class="num">(706,928)<span></span>
</td>
<td class="nump">369,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash of continuing operations at beginning of the year</a></td>
<td class="nump">501,790<span></span>
</td>
<td class="nump">1,208,718<span></span>
</td>
<td class="nump">415,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash of continuing operations at end of the year</a></td>
<td class="nump">554,960<span></span>
</td>
<td class="nump">501,790<span></span>
</td>
<td class="nump">1,208,718<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Less: Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(423,813)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Less: Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 53,170<span></span>
</td>
<td class="num">$ (706,928)<span></span>
</td>
<td class="nump">$ 793,298<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AdjustmentIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the entity's proportionate share for the period of the undistributed net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AdjustmentIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtFinancingAndDebtRedemptionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Financing And Debt Redemption Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtFinancingAndDebtRedemptionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtRefinancingCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt prepayment refinancing redemption charges related to debt modification of long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtRefinancingCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change during the reporting period in other current receivables and other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss (Gain) On Disposition Of Business Interests Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LossGainOnDispositionOfBusinessInterestsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PaymentsRelatedToStockPurchasesAndAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments related to stock purchases and awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PaymentsRelatedToStockPurchasesAndAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PaymentsToAcquireOtherDebtAndEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Other Debt And Equity Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PaymentsToAcquireOtherDebtAndEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDistributionsToAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDistributionsToAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow through purchase of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257588264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total</div></th>
<th class="th">
<div>Total </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Non-controlling interests subject to put provisions</div></th>
<th class="th">
<div>Non-controlling interests subject to put provisions </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th">
<div>Retained earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Treasury stock</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Non-controlling interests not subject to put provisions</div></th>
<th class="th">
<div>Non-controlling interests not subject to put provisions </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,387,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,703,442<span></span>
</td>
<td class="nump">$ 39,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (38)<span></span>
</td>
<td class="nump">$ 166<span></span>
</td>
<td class="nump">$ 995,006<span></span>
</td>
<td class="nump">$ 2,743,194<span></span>
</td>
<td class="nump">$ 39,876<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (34,924)<span></span>
</td>
<td class="nump">$ 204,956<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, beginning balance at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,124,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(155,011)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasePurchaseOfInterests', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,394)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,180,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">810,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">810,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="num">$ (12,574)<span></span>
</td>
<td class="num">(12,574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock purchase shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">16,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award payment plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,290)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(3,290)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78,112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,480)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,525)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,525)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury stock (in shares)</a></td>
<td class="num">(41,020,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,020,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock</a></td>
<td class="num">$ (2,402,475)<span></span>
</td>
<td class="num">(2,402,475)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,402,475)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Retirement of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,020,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (41)<span></span>
</td>
<td class="num">(240,121)<span></span>
</td>
<td class="num">(2,162,313)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,402,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,133,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
<td class="nump">749,043<span></span>
</td>
<td class="nump">1,431,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(47,498)<span></span>
</td>
<td class="nump">185,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,843,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163,175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasePurchaseOfInterests', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,771)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,330,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">773,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">773,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="num">$ (18,656)<span></span>
</td>
<td class="num">(18,656)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,656)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock purchase shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">17,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award payment plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,801)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(17,801)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89,943)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151,780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151,780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury stock (in shares)</a></td>
<td class="num">(16,477,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,477,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock</a></td>
<td class="num">$ (1,446,767)<span></span>
</td>
<td class="num">(1,446,767)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,446,767)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Retirement of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,477,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,477,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
<td class="num">(93,908)<span></span>
</td>
<td class="num">(1,352,843)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,446,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,566,752<span></span>
</td>
<td class="nump">1,383,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">597,073<span></span>
</td>
<td class="nump">852,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(66,154)<span></span>
</td>
<td class="nump">183,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">109,933,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,933,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159,259)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TemporaryEquityDecreasePurchaseOfInterests', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(588)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,434,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">978,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">978,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="num">$ (73,093)<span></span>
</td>
<td class="num">(73,093)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73,093)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock purchase shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">19,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award payment plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,030,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80,641)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(80,642)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(84,774)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(264)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(264)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,057)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75,717)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75,717)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury stock (in shares)</a></td>
<td class="num">(13,877,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,877,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock</a></td>
<td class="num">$ (1,546,016)<span></span>
</td>
<td class="num">(1,546,016)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,546,016)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Retirement of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,877,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,877,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">(69,352)<span></span>
</td>
<td class="num">(1,476,650)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,546,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Deferred taxes from partnership buyouts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 936,148<span></span>
</td>
<td class="nump">$ 755,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="nump">$ 540,321<span></span>
</td>
<td class="nump">$ 354,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (139,247)<span></span>
</td>
<td class="nump">$ 180,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">97,289,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,289,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease Due To Acquisitions and Divestitures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase Due To Acquisitions and Divestitures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestIncreaseFromContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling interest increase from contributions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestIncreaseFromContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Decrease Due To Acquisitions and Divestitures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityDecreasePurchaseOfInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Decrease Purchase Of Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityDecreasePurchaseOfInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Increase Due To Acquisitions And Divestitures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161272063416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Organization and Summary of Significant Accounting Policies</a></td>
<td class="text">Organization and summary of significant accounting policies<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations are comprised of its dialysis and related lab services to patients in the United States (its U.S. dialysis business), its U.S. ancillary services and strategic initiatives and its international operations (collectively, its ancillary services), as well as its corporate administrative support.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s largest line of business is its U.S. dialysis business, which operates kidney dialysis centers in the U.S. for patients suffering from chronic kidney failure, also known as end stage renal disease</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or end stage kidney disease</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ESRD or ESKD). As of December&#160;31, 2021, the Company operated or provided administrative services through a network of 2,815 U.S. outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 203,100 patients. In addition, as of December&#160;31, 2021, the Company operated or provided administrative services to a total of 339 outpatient dialysis centers serving approximately 39,900 patients located in ten countries outside of the U.S.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2019, the Company completed the sale of its prior DaVita Medical Group (DMG) business to Collaborative Care Holdings, LLC (Optum), a subsidiary of UnitedHealth Group Inc. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented in these consolidated financial statements. For financial information about the DMG business, see Note 22.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.S. dialysis business qualifies as a separately reportable segment and the Company&#8217;s ancillary services, including its international operations, have been combined and disclosed in the other segments category.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of presentation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (U.S. GAAP). The financial statements include DaVita Inc. and its subsidiaries, partnerships and other entities in which it maintains a majority voting or other controlling financial interest (collectively, the Company). All significant intercompany transactions and balances have been eliminated. Equity investments in investees over which the Company has significant influence are recorded on the equity method, while investments in other equity securities are recorded at fair value or on the adjusted cost method, as applicable. For the Company&#8217;s international subsidiaries, local currencies are considered their functional currencies. Translation adjustments result from translating the financial statements of the Company&#8217;s international subsidiaries from their functional currencies into the Company&#8217;s reporting currency (the U.S. dollar, or USD). Prior year classifications have been conformed to the current year presentation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through the date these consolidated financial statements were issued and has included all necessary adjustments and disclosures.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. Although actual results in subsequent periods will differ from these estimates, such estimates are developed based on the best information available to management and management&#8217;s best judgments at the time. All significant assumptions and estimates underlying the amounts reported in the financial statements and accompanying notes are regularly reviewed and updated when necessary. Changes in estimates are reflected in the financial statements based upon on-going actual experience trends or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant assumptions and estimates underlying these consolidated financial statements and accompanying notes involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, fair value estimates and loss contingencies. Specific estimating risks and contingencies are further addressed within these notes to the consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. A usual and customary fee schedule is maintained for the Company&#8217;s dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with Medicare and Medicaid programs are estimated based on: (a) the payment rates that are established by statute or regulation for the portion of payment rates paid by the government payor (e.g., 80% for Medicare patients) and (b) for the portion not paid by the primary government payor, estimates of the amounts ultimately collectible from other government programs providing secondary coverage (e.g., Medicaid secondary coverage), the patient&#8217;s commercial health plan secondary coverage, or the patient.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Medicare&#8217;s bundled payment rate system, services covered by Medicare are subject to estimating risk, whereby reimbursements from Medicare can vary significantly depending upon certain patient characteristics and other variable factors. Even with the bundled payment rate system, Medicare payments for bad debt claims as established by cost reports require evidence of collection efforts. As a result, billing and collection of Medicare bad debt claims can be delayed significantly and final payment is subject to audit. The Company&#8217;s revenue recognition is estimated based on its judgment regarding its ability to collect, which depends upon its ability to effectively capture, document and bill for Medicare&#8217;s base payment rate as well as these other variable factors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Advantage revenues are reimbursed at negotiated contract rates that are generally higher than Medicare fee-for-service rates, but which generally have a slower payment frequency than Medicare fee-for-service payments. Medicare Advantage revenues are subject to meaningful estimating risk based on factors similar to those described for commercial health plans below.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid payments, when Medicaid coverage is secondary, can also be difficult to estimate. For many states, Medicaid payment terms and methods differ from Medicare, and may prevent accurate estimation of individual payment amounts prior to billing.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with commercial health plans are estimated based on contractual terms for the patients under healthcare plans with which the Company has formal agreements, non-contracted health plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in the Company&#8217;s billing and collection processes that can result in denied claims for payments, delays in collections due to payor payment inefficiencies, and regulatory compliance matters.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial revenue recognition also involves significant estimating risks. With many larger commercial insurers, the Company has several different contracts and payment arrangements, and these contracts often include only a subset of the Company&#8217;s centers. In certain circumstances, it may not be possible to determine which contract, if any, should be applied prior to billing. In addition, for services provided by non-contracted centers, final collection may require specific negotiation of a payment amount, typically at a significant discount from the Company&#8217;s usual and customary rates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenues</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's U.S. ancillary service revenues include revenues earned under risk-based arrangements in the Company's integrated care and disease management business, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (our counterparty), with adjustments where applicable, or on trended and adjusted medical cost targets.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For some of the Company's risk-based arrangements (such as its special needs plans), the Company acts as a principal with respect to all medical services provided to the patient by effectively hosting or sponsoring the entire arrangement, and as a </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">result recognizes revenue and expense for all medical services provided to covered patients. However, for most of its VBC arrangements, the Company provides health monitoring and care coordination services to patients but does not control or direct the medical services that patients receive from third party providers. As a result, for most of its VBC arrangements the Company does not include third party medical costs in its reported revenues and expenses, but rather recognizes revenue only for the estimated amount of shared savings or shared losses or other revenues that are directly earned or incurred by the Company, and ultimately paid to or by the Company, under the arrangement.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income includes interest income on cash and cash equivalents and short- and long-term investments, realized and unrealized gains and losses recognized on investments, and foreign currency transaction gains and losses.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are short-term highly liquid investments readily convertible to known amounts of cash that typically mature within three months or less at date of purchase.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted cash and equivalents</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and cash equivalents include funds held in trust to satisfy insurer and state regulatory requirements related to wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company as well as funds held in escrow. See Note 4 for further details.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in debt and equity securities</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies certain debt securities as held-to-maturity and records them at amortized cost based on the Company&#8217;s intentions and strategies concerning those investments. Equity securities that have readily determinable fair values or redemption values are recorded at estimated fair value with changes in fair value recognized in current earnings within other income. These debt and equity investments are classified as short-term investments or long-term investments on the Company's consolidated balance sheet. See Note 5 for further details.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value and consist principally of pharmaceuticals and dialysis-related supplies. Rebates related to inventory purchases are recorded when earned and are based on certain qualification requirements which are dependent on a variety of factors including future pricing levels and purchase volume levels from the manufacturer and related data submission.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and equipment</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is stated at cost less accumulated depreciation and amortization and is further reduced by any impairments. Maintenance and repairs are charged to expense as incurred. Disposition gains and losses are included in current operating expenses. Property and equipment assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#8217;s facilities are leased under non-cancellable operating leases which contain renewal options. These renewal options are included in the Company's determination of the right-of-use assets and related lease liabilities when renewal is considered reasonably certain at the commencement date. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company categorizes leases with contractual terms longer than twelve months as either operating or finance leases. Finance leases are generally those leases that allow the Company to substantially utilize or pay for the entire asset over its estimated life. All other leases are categorized as operating leases. The Company has elected the practical expedient to not separate lease components from non-lease components for its financing and operating leases. The Company has also elected the short-term lease recognition exemption and does not recognize right-of-use assets or lease liabilities for leases with a term of less than 12 months.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing and operating right-of-use assets are recognized based on the net present value of lease payments over the lease term plus expected renewals as of the commencement date. Since most of the Company's leases do not provide an implicit rate of return, the Company uses its incremental borrowing rate based on information available at the commencement date or remeasurement date in determining the present value of lease payments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired under finance leases are recorded on the balance sheet within property and equipment, net and liabilities for finance lease obligations are recorded within long-term debt. Finance lease assets are amortized to depreciation expense on a straight-line basis over the shorter of their estimated useful lives or the expected lease term.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rights to use assets under operating leases are recorded on the balance sheet as operating lease right-of-use assets and liabilities for operating lease obligations are recorded as operating lease liabilities. Reductions in the carrying amount of operating lease right-of-use assets are recorded to rent expense over the lease term.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortizable intangibles</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortizable intangible assets include noncompetition agreements, hospital service contracts, and customer relationships arising from other service contracts, each of which have finite useful lives. Amortization expense is computed using the straight-line method over the useful lives of the assets estimated as follows: noncompetition agreements and hospital acute service contracts over the contract term, and customer relationships from other service contracts over the remaining contract term plus expected renewal periods. Amortizable intangible assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indefinite-lived intangibles</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets include international licenses and accreditations that allow the Company to be reimbursed for providing dialysis services to patients, each of which has an indefinite useful life. Indefinite-lived intangibles are not amortized, but are assessed for impairment at least annually and whenever significant events or changes in circumstances indicate that an impairment may have occurred. Costs to renew indefinite-lived intangible assets are expensed as incurred.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity method and other investments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments that do not have readily determinable fair values are carried on the equity method if the Company maintains significant influence over the investee. Equity investments without readily determinable fair values for which the Company does not maintain significant influence over the investee are carried either at estimated fair value or on the adjusted cost method, as determined on an investment-specific basis. The adjusted cost method represents the Company's cost for an investment, net of any other-than-temporary impairments, as adjusted for any subsequent observation of the investment's fair value.&#160;These equity method and adjusted cost method investments are classified as equity method and other investments on the Company's consolidated balance sheet.&#160;See Note 9 for further details.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method and other investments are assessed for other-than-temporary impairment when significant events or changes in circumstances indicate that an other-than-temporary impairment may have occurred. An other-than-temporary impairment charge is recorded when the fair value of an investment has fallen below its carrying amount and the shortfall is expected to be indefinitely or permanently unrecoverable.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the difference between the fair value of businesses acquired and the fair value of the identifiable tangible and intangible net assets acquired. Goodwill is not amortized, but is assessed by individual reporting unit for impairment as circumstances warrant and at least annually. An impairment charge is recognized when and to the extent a reporting unit's carrying amount is determined to exceed its fair value. The Company operates multiple reporting units. See Note 10 for further details.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Self-insurance</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company predominantly self-insures its professional and general liability and workers' compensation risks through its wholly-owned captive insurance companies, with excess or reinsurance coverage for additional protection.&#160;The Company is also predominantly self-insured with respect to employee medical and other health benefits.&#160;The Company records insurance liabilities for the professional and general liability, workers&#8217; compensation, and employee health benefit risks that it retains and estimates its liability for those risks using third party actuarial calculations that are based upon historical claims experience and expectations for future claims. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted both for items that do not currently have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market-based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all stock-based awards is recognized net of expected forfeitures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation to be settled in shares is recorded to the Company&#8217;s shareholders&#8217; contributed capital, while stock-based compensation to be settled in cash is recorded as a liability. Shares issued upon exercise or, when applicable, vesting of stock awards, are issued from authorized but unissued shares.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate cap agreements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company often carries a combination of current or forward interest rate caps on portions of its variable rate debt as a means of hedging its exposure to changes in LIBOR interest rates as part of its overall interest rate risk management strategy. These interest rate caps are not held for trading or speculative purposes and are designated as qualifying cash flow hedges. See Note 13 for further details.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling interests</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity ownership interests in entities which are consolidated by the Company for financial statement reporting purposes. As of December&#160;31, 2021, third parties held noncontrolling equity interests in 717 consolidated legal entities.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair value estimates</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Fair value measurements are determined based on the principal or most advantageous market for the item being measured, assume that buyers and sellers are independent, willing and able to transact, and knowledgeable, with access to all information customarily available in such a transaction, and are based on assumptions that market participants would use in pricing the item, not assumptions specific to the reporting entity. The criticality of a particular fair value estimate to the Company's consolidated financial statements depends upon the nature and size of the item being measured, the extent of uncertainties involved and the nature and magnitude or potential effect of assumptions and judgments required. Certain fair value estimates can involve significant uncertainties and require significant judgment on various matters, some of which could be subject to reasonable disagreement. See Note 24 for further details.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on fair value measurements and estimates for purposes that require the recording, reassessment, or adjustment of the carrying amounts of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity). These purposes can include the accounting for business combination transactions; impairment assessments for goodwill, other intangible assets, or other long-lived assets; recurrent revaluation of investments in debt and equity securities, contingent earn-out obligations, interest rate cap agreements, and noncontrolling interests subject to put provisions; and the accounting for equity method and other investments and stock-based </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compensation, as applicable. The Company has classified its assets, liabilities and temporary equity into the fair value hierarchy levels defined by the FASB reflecting their differing degrees of uncertainty. See Note 24 for further details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New accounting standards</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards recently adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued Accounting Standards Update (ASU) No. 2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. The amendments in this ASU became effective for the Company beginning on January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. Effective January 1, 2022 certain LIBOR tenors that do not affect the Company, including the one-week and two-month U.S. dollar LIBOR rate, ceased or became non-representative. The remaining U.S. dollar LIBOR tenors will cease or become non-representative effective July 1, 2023. This change will have no impact on the Company's ability to borrow. The Company is currently assessing the other effects this guidance may have on its consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities (ASU 2021-08)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-08 requires application of ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to recognize and measure assets and liabilities from contracts with customers acquired in a business combination. This ASU creates an exception to the general recognition and measurement principle in ASC 805 and will result in recognition of contract assets and contract liabilities consistent with those recorded by the acquiree immediately before the acquisition date. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Early adoption is permitted for all entities. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161347755496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer</a></td>
<td class="text">Revenue recognition and accounts receivable<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues by segment and primary payor source were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:37.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,133,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,133,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">782,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">782,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">791,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,397,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,596,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,796)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,090)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,576,167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,042,630&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,618,797&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:37.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,169,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,169,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">744,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">744,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other government</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">715,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,370,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,540,956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(145,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,743)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(162,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,514,649&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,035,955&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,550,604&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the "Other government" category to the "Medicare and Medicare Advantage" category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the year ended December&#160;31, 2020 has also been recast to conform to the current period presentation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:37.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,246,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,246,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">669,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">669,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other government</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">681,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,286,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,430,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132,325)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146,355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,430,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,898&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,388,479&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the "Other government" category to the "Medicare and Medicare Advantage" category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the year ended December&#160;31, 2019 has also been recast to conform to the current period presentation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other non-patient revenue from the Company's U.S. ancillary services and international operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's non-patient service revenues from Medicare and Medicare Advantage, Medicaid and Managed Medicaid, and commercial sources represent risk-based revenues earned by the Company's U.S. integrated care and disease management business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 1, there are significant risks associated with estimating revenue, many of which take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues including determining applicable primary and secondary coverage, changes in patient coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single commercial payor accounted for more than 10% of total consolidated accounts receivable or consolidated revenues at or for the years ended December&#160;31, 2021 or 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dialysis services accounts receivable and other receivables from Medicare, including Medicare Advantage plans, and Medicaid, including managed Medicaid plans, were approximately $1,174,123 and $1,101,837 as of December&#160;31, 2021 and 2020, respectively. Approximately 16% and 17% of the Company&#8217;s patient services accounts receivable balances as of December&#160;31, 2021 and 2020, respectively, were more than six months old. There were no significant balances over one year old at December&#160;31, 2021. The Company's accounts receivable are principally due from Medicare and Medicaid programs and commercial insurance plans.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265778200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings&#160;per share<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either their explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">978,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">783,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">706,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">978,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">773,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,936&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161347682904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restricted Cash Restricted Cash<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAbstract', window );"><strong>Restricted Cash [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock', window );">Restricted Cash and Cash Equivalents Disclosure [Text Block]</a></td>
<td class="text">Restricted cash and equivalentsThe Company had restricted cash and cash equivalents of $93,060 and $176,832 at December&#160;31, 2021 and 2020, respectively. The decrease in restricted cash and equivalents was primarily driven by the release of escrow funds in the third quarter of 2021 related to a resolved legal settlement. See Note 16 for further details. Substantially all of the restricted cash and equivalents balance at December&#160;31, 2021 is held in trust to satisfy insurer and state regulatory requirements related to the wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company and the remaining restricted cash and cash equivalents held at December&#160;31, 2021 represents cash pledged to third parties in connection with one of the Company's ancillary businesses.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for cash and cash equivalent footnotes,  which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161347689864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and long-term investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments in Debt and Equity Securities</a></td>
<td class="text">Short-term and long-term investments<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in mutual funds and common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,227&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,083&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,310&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,884&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,824&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. The Company's long-term debt investments are bank time deposits with contractual maturities longer than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at December&#160;31, 2021 and 2020.</span></div>Equity securities: During the year ended December&#160;31, 2021 certain of the Company&#8217;s equity investments previously accounted for under the adjusted cost method now have readily determinable fair values from public markets. As a result, these investments were reclassified from equity method and other investments to short-term investments during that period. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#8217;s non-qualified deferred compensation plans. During 2021, the Company recognized pre-tax net losses of $3,768 in other income associated with changes in the fair value of these equity securities, comprised of pre-tax realized gains of $1,762 and a net increase in unrealized losses of $5,530. During 2020, the Company recognized pre-tax net gains of $3,818 in other income associated with changes in the fair value of these equity securities, comprised of pre-tax realized gains of $1,941 and a net increase in unrealized gains of $1,877.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161347743704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Receivables Other Receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Other Receivables</a></td>
<td class="text">Other receivables<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables were comprised of the following:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.935%"><tr><td style="width:1.0%"/><td style="width:56.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.908%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier rebates and non-trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">390,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare bad debt claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">427,321&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">544,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161347739064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and equipment<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment were comprised of the following:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:66.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.467%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">496,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">400,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,828,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,865,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equipment and information systems, including internally developed software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,292,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,081,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New center and capital asset projects in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">592,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">616,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,243,107&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,002,253&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,763,135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,480,429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,479,972&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,521,824&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses are computed using the straight-line method over the useful lives of the assets estimated as follows: buildings, 25 years to 40 years; leasehold improvements, the shorter of ten years or the expected lease term; and equipment and information systems, including internally developed software, principally three years to 15 years. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense on property and equipment was $667,755, $616,626, and $600,905 for 2021, 2020 and 2019, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on debt incurred during the development of new centers and other capital asset projects is capitalized as a component of the asset cost based on the respective in-process capital asset balances. Interest capitalized was $15,275, $17,944 and $27,322 for 2021, 2020 and 2019, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257496376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangibles</a></td>
<td class="text">Intangible assets<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets other than goodwill were comprised of the following:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.959%"><tr><td style="width:1.0%"/><td style="width:54.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived licenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompetition agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238,423&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">236,726&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,693&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncompetition agreements are generally amortized over three years to 10 years and customer relationships are principally amortized over 10 years to 20 years. The weighted average renewal or extension period of customer relationships was three years and five years as of December&#160;31, 2021 and 2020, respectively. Amortization expense from amortizable intangible assets was $12,860, $13,809, and $14,247 for 2021, 2020 and 2019, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized no impairment charges on any intangible assets other than the goodwill impairment charges discussed in Note 10.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled amortization expenses from amortizable intangible assets as of December&#160;31, 2021 were as follows:&#160;</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.286%"><tr><td style="width:1.0%"/><td style="width:37.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.032%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncompetition<br/>agreements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Customer relationships and other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,682&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,797&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161266154328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method and Other Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Equity Method Investments and Joint Ventures Disclosure</a></td>
<td class="text">Equity method and other investments<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains equity method and other minor investments in the private securities of certain other healthcare and healthcare-related businesses, comprised as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.883%"><tr><td style="width:1.0%"/><td style="width:56.431%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.611%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.846%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.612%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">APAC joint venture</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other equity method partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted cost method and other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238,881&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,491&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, 2020 and 2019, the Company recognized equity investment income of $26,937, $26,916 and $12,679, respectively, from its equity method investments in nonconsolidated businesses.&#160;</span></div><div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's largest equity method investment is its ownership interest in DaVita Care Pte. Ltd. (the APAC joint venture, or APAC JV). The Company holds a 75%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">voting and economic interest in the APAC JV and an unrelated noncontrolling investor holds the other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25% voting and economic interest in the joint venture, however the Company does not control or consolidate the APAC JV as a result of substantive participating rights retained by the unrelated investor over </span></div><div style="margin-top:9pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain key operating decisions for the joint venture.</span></div><div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's other equity method investments include 23 legal entities over which the Company has significant influence but in which it does not maintain a controlling financial interest. Almost all of these are U.S. dialysis partnerships in the form of limited liability companies. The Company's ownership interests in these partnerships vary, and are often subject to blocking rights on certain key operating decisions held by outside investors, but mostly range from 30% to 65%.</span></div><div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no significant impairments or other valuation adjustments on the Company's adjusted cost method and other investments during 2021, 2020 or 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161347835256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying value of goodwill by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:40.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.985%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.985%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary<br/>services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,287,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,787,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,919,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,979&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,265&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173,244&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,400,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,046,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,400,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">772,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,172,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126,207)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126,207)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,400,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646,079&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,046,241&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As dialysis treatments are an essential, life-sustaining service for patients who depend on them, the Company's operations have continued and are currently expected to continue throughout the novel coronavirus (COVID-19) pandemic. However, the ultimate impact of the dynamic and evolving COVID-19 pandemic on the Company will depend on future developments that are highly uncertain and difficult to predict, including among other things the severity and duration of the pandemic; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus such as the Delta and Omicron variants; COVID-19's impact for the chronic kidney disease (CKD) patient population and the Company's patient population including on the mortality of these patients; the availability, acceptance, impact and efficacy of COVID-19 vaccines, treatments, and therapies; the pandemic's continuing impact on the Company's revenue and non-acquired growth due to lower treatment volumes, the U.S. and global economies, unemployment, labor market conditions, inflation and monetary policies; the potential negative impact on the Company's commercial mix or the number of patients covered by commercial insurance plans; continued increased COVID-related costs; supply chain challenges and disruptions, including with respect to the Company's clinical supplies; the responses of the Company's competitors to the pandemic and related changes in the marketplace; the timing, scope and effectiveness of federal, state and local government responses; and any potential changes to the extensive set of federal, state and local laws, regulations and requirements that govern the Company's business. While the Company does not currently expect a material adverse impact to its business as a result of this public health crisis, there can be no assurance that the COVID-19 pandemic will not have a material adverse impact on one or more of the Company's businesses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company&#8217;s operating segments described in Note 25 to these consolidated financial statements represents an individual reporting unit for goodwill impairment assessment purposes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the U.S. dialysis operating segment, the Company considers each of its dialysis centers to constitute an individual business for which discrete financial information is available. However, since these dialysis centers have similar operating and economic characteristics, and the allocation of resources and significant investment decisions concerning these businesses are highly centralized and the benefits broadly distributed, the Company has aggregated these centers and deemed them to constitute a single reporting unit.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has applied a similar aggregation to the physician practices in its physician services reporting units, to the dialysis centers and other health operations within each international reporting unit, and to the vascular access service centers in </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">its former vascular access services reporting unit. For the Company&#8217;s other operating segments, discrete business components below the operating segment level constitute individual reporting units.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing quantitative goodwill impairment assessments, the Company estimates fair value using either appraisals developed with an independent third party valuation firm which consider both discounted cash flow estimates for the subject business and observed market multiples for similar businesses, or offer prices received for the subject business that would be acceptable to the Company.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2019, the Company recognized goodwill impairment charges of $119,476 in its Germany kidney care business. These charges resulted primarily from a decline in then current and expected future patient census and an increase in then current and expected future costs, including due to wage increases expected to result from legislation announced at that time. The changes in the Company's expectations were informed by developments in the business in response to evolving market conditions, including changes in the Company's expected timing and ability to mitigate them, and based on in-depth operating and strategic reviews completed by the Company's new Germany management team. During the year ended December&#160;31, 2019 the Company also recognized a goodwill impairment charge of $5,416 in its German other health operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its most recent assessments, the Company determined that further changes in expected patient census, increases in operating costs, failure to achieve expected increases in reimbursement rates, changes in actual or expected growth rates, or other significant adverse changes in expected future cash flows or valuation assumptions could result in goodwill impairment charges in the future for the following reporting unit, which remains at risk of goodwill impairment as of December&#160;31, 2021:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.923%"><tr><td style="width:1.0%"/><td style="width:37.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.474%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.660%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reporting unit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Goodwill<br/>balance</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Carrying amount<br/>coverage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sensitivities</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating<br/>income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Discount<br/>rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany kidney care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excess of estimated fair value of the reporting unit over its carrying amount as of the latest assessment date.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Potential impact on estimated fair value of a sustained, long-term reduction of 3% in operating income as of the latest assessment date.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Potential impact on estimated fair value of an increase in discount rates of 100 basis points as of the latest assessment date.</span></div>Except as described above, none of the Company&#8217;s other reporting units were considered at risk of significant goodwill impairment as of December&#160;31, 2021.&#160;Since the dates of the Company&#8217;s last annual goodwill impairment assessments, there have been certain developments, events, changes in operating performance and other changes in key circumstances that have affected the Company&#8217;s businesses. However, these have not caused management to believe it is more likely than not that the fair values of any of the Company&#8217;s reporting units would be less than their respective carrying amounts as of December&#160;31, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161347856856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Liabilities</a></td>
<td class="text">Other liabilities<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities were comprised of the following:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.520%"><tr><td style="width:1.0%"/><td style="width:51.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.898%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.759%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payor refunds and retractions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">410,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance and self-insurance accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued non-income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709,345&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161271955944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income taxesThe Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes from continuing operations consisted of the following:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:37.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,463,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,287,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,307,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,518,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,318,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Income tax expense for continuing operations consisted of the following:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:37.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current income tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,836)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred income tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,345&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227,838&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,282)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,932&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,628&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are allocated between continuing and discontinued operations as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:37.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320,317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between the Company&#8217;s effective tax rate from continuing operations and the U.S. federal income tax rate is as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.532%"><tr><td style="width:1.0%"/><td style="width:49.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.892%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.892%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.895%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal and international tax rate adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Political advocacy costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in international valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of noncontrolling interests primarily<br/>&#160;attributable to non-tax paying entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities arising from temporary differences for continuing operations were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.830%"><tr><td style="width:1.0%"/><td style="width:56.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.495%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">584,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873,043&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">888,470&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100,616)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(114,824)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">772,427&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">773,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(644,039)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(634,736)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(283,913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(274,742)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(530,839)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(532,082)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84,407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,274)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39,690)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,580,472)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,583,246)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(808,045)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(809,600)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(830,954)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(809,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets (included in Other long-term assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 25.75pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(808,045)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(809,600)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the Company had federal net operating loss carryforwards of approximately $85,391 that expire through 2036, although a substantial amount expire by 2029. The Company also had state net operating loss carryforwards of $554,806, some of which have an indefinite life, although a substantial amount expire by 2041 and international net operating loss carryforwards of $291,927, some of which will begin to expire in 2022 though the majority have an indefinite life. The Company has a state capital loss carryover of $313,722, the majority of which expires in 2024. The utilization of a portion of these losses may be limited in future years based on the profitability of certain entities. A valuation allowance is recorded to account for the unrealizable balances in the table above. The net decrease of $14,208 in the valuation allowance is primarily due to the release of the valuation allowance on indefinite life net operating losses in jurisdictions where the Company has generated sufficient income to support their future utilization, partially offset by newly created net operating loss carryforwards in state and foreign jurisdictions that the Company does not anticipate being able to utilize. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2021, the Company recorded a true-up to recognize net deferred tax assets related to historical purchases of noncontrolling interests in consolidated partnerships. The effect of this adjustment was an increase of $46,692 to net deferred tax assets, a charge of $16,044 to income tax expense, and an increase of $62,736 to additional paid-in capital. The Company&#8217;s prior purchases of this type have not generated significant pre-tax adjustments to additional paid-in capital in any single prior year. The majority of the $16,044 recorded to income tax expense was due to the decrease in the corporate tax rate in 2017.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's foreign earnings continue to be indefinitely reinvested as of December&#160;31, 2021. As a result of the passage of the Tax Cuts and Jobs Act (2017 Tax Act), the Company does not expect such earnings to be taxable if remitted.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unrecognized tax benefits</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending liability for unrecognized tax benefits that do not meet the more-likely-than-not threshold is as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"><tr><td style="width:1.0%"/><td style="width:61.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.250%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions for tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions related to lapse of applicable statute</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(751)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions related to settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,378)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,024&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,202&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company&#8217;s total liability for unrecognized tax benefits relating to tax positions that do not meet the more-likely-than-not threshold is $73,024, of which $68,708 would impact the Company&#8217;s effective tax rate if recognized and $42,860 is classified as a current tax liability related to settlements expected to be paid in 2022. This balance represents an increase of $2,822 from the December&#160;31, 2020 balance of $70,202. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. At December&#160;31, 2021 and 2020, the Company had approximately $15,275 and $17,864, respectively, accrued for interest and penalties related to unrecognized tax benefits, net of federal tax benefit.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries file U.S. federal and state income tax returns and various foreign income tax returns. The Company is no longer subject to U.S. federal and state examinations by tax authorities for years before 2014 and 2009, respectively. In addition to being under audit in various state and local tax jurisdictions, the Company&#8217;s federal tax returns are under audit by the Internal Revenue Service for the years 2014-2017.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161271953160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-term debt<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:34.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,596,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR + 1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,600,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,688,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,715,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/12/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR + 1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,681,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR + 1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/1/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,822,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,464,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition obligations and other notes<br/> payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022-2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022-2038</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,964,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,163,521&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56,685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,908,180&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,085,804&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(179,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(168,541)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,729,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,917,263&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented here approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of December&#160;31, 2021.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of December&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $4,473 and deferred financing costs of $27,207 and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $40,914 and increased by a debt premium of $15,909. As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $5,461 and deferred financing costs of $35,825, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $36,431.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled maturities of long-term debt at December&#160;31, 2021 were as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.274%"><tr><td style="width:1.0%"/><td style="width:58.359%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.441%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,424,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,625,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,449,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company made regularly scheduled mandatory principal payments under its senior secured credit facilities totaling $87,500 on Term Loan A and $27,431 on Term Loan B-1.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 26, 2021, the Company completed an unregistered add-on offering of $1,000,000 aggregate principal amount to the existing 4.625% senior notes due June&#160;1, 2030 (the Additional 2030 Notes) pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The Additional 2030 Notes were issued at an offering price of 101.750% of face amount, plus an interest payment advance to the Company for interest that would have accrued from December 1, 2020 (the last interest payment date) through the closing date, and began bearing full six months' semi-annual coupon interest payments as of June 1, 2021. The terms of the Additional 2030 Notes, other than their issue date, offering price and first interest payment date, are identical to the terms of the $1,750,000 principal amount of the Company&#8217;s 4.625% senior notes due June 1, 2030 previously issued by the Company on June 9, 2020. The Additional 2030 Notes are unsecured senior obligations and rank equally in right of payment with the Company's existing and future unsecured senior indebtedness. During the year ended December&#160;31, 2021 the Company incurred $9,091 in fees and other professional expenses associated with this transaction, which were capitalized and will amortize over the term of the Additional 2030 Notes. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company's 2019 interest rate cap agreements have the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on specific portions of the Company's floating rate debt, including all of Term Loan B-1 and a portion of Term Loan A. The remaining $785,138 outstanding principal balance of Term Loan A is subject to LIBOR-based interest rate volatility. The cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date. These cap agreements do not contain credit-risk contingent features.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of December&#160;31, 2021 and December&#160;31, 2020, which are classified in other long-term assets on its consolidated balance sheet:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:23.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded OCI gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/30/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/30/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of the Company&#8217;s interest rate cap agreements for the years ended December&#160;31, 2021, 2020 and 2019:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:28.328%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.102%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount of unrealized gains (losses) in OCI on interest rate cap agreements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Location of losses </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reclassification from accumulated other comprehensive income into net income</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,781)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,346)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,133&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 20 for further details on amounts recorded and reclassified from accumulated other comprehensive (loss) income.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s weighted average effective interest rate on its senior secured credit facilities at the end of 2021 was 2.18%, based upon the current margins in effect for its senior secured credit facilities as of December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s weighted average effective interest rate on all debt, including the effect of interest rate caps and amortization of debt discount, was 3.28% for the year ended December&#160;31, 2021 and 3.35% as of December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company&#8217;s interest rates were fixed on approximately 51.6% of its total debt.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had an undrawn $1,000,000 revolving line of credit under its senior secured credit facilities. Credit available under this revolving line of credit is reduced by the amount of any letters of credit outstanding thereunder, of which there were none as of December&#160;31, 2021. The Company also had approximately $69,277 of outstanding letters of credit under a separate bilateral secured letter of credit facility as of December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt expense</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt expense consisted of interest expense of $267,049, $282,932 and $419,639 and the amortization and accretion of debt discounts and premiums, amortization of deferred financing costs and the amortization of interest rate cap agreements of $18,205, $21,179 and $24,185 for 2021, 2020 and 2019, respectively. These interest expense amounts are net of capitalized interest.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265826616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeasesDisclosureTextBlock', window );">Leases Disclosure</a></td>
<td class="text">Leases<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#8217;s facilities are leased under non-cancellable operating leases which range in terms from five years to 15 years and which contain renewal options of five years to ten years at the fair rental value at the time of renewal. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses. See Note 1 for further information on how the Company accounts for leases.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and December&#160;31, 2020, assets recorded under finance leases were $322,060 and $275,389, respectively, and accumulated amortization associated with finance leases was $75,252 and $49,345, respectively, included in property and equipment, net, on the Company's consolidated balance sheet. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain markets, the Company acquires and develops dialysis centers. Upon completion, the Company sells the center to a third party and leases the space back with the intent of operating the center on a long term basis. Both the sale and leaseback terms are generally market terms. The lease terms are consistent with the Company's other operating leases with the majority of the leases under non-cancellable operating leases ranging in terms from five years to 15 years and which contain renewal options of five years to ten years at the fair rental value at the time of renewal.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"/><td style="width:42.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.629%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">547,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">541,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">526,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">714,738&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">702,960&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">684,748&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Includes short-term lease expense and sublease income, which are immaterial. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"/><td style="width:42.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.629%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Lease term and discount rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"/><td style="width:42.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.629%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gains on sale leasebacks, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,833&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the <br/>&#160;measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">684,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">661,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">637,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease assets obtained in exchange<br/>&#160;for new or modified operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancellable leases as of December&#160;31, 2021 are as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.929%"><tr><td style="width:1.0%"/><td style="width:52.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Finance leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">511,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,293,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,537,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less portion representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(470,269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,491)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,067,070&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under all operating leases for 2021, 2020 and 2019 was $673,904, $663,819 and $646,092, respectively. Rent expense is recorded on a straight-line basis over the term of the lease, including leases that contain fixed escalation clauses or include abatement provisions. Leasehold improvement incentives are deferred and amortized to rent expense over the term of the lease. Finance lease obligations are included in long-term debt. See Note 13 for further details on long-term debt.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LeasesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases complete footnote disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LeasesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265820488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefit Plans</a></td>
<td class="text">Employee benefit plans<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a 401(k) retirement savings plan for substantially all of its U.S. employees which has been established pursuant to applicable provisions of the Internal Revenue Code (IRC). The plan allows for employees to contribute a percentage of their base annual salaries on a tax-deferred basis not to exceed IRC limitations. The Company maintains a 401(k) matching program under which the Company matches 50% of the employee's contribution up to 6% of the employee's salary, subject to certain limitations. The matching contributions are subject to certain eligibility and vesting conditions. For the years ended December&#160;31, 2021, 2020 and 2019, the Company accrued matching contributions totaling approximately $68,658, $70,180 and $64,988, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains a voluntary compensation deferral plan, the Deferred Compensation Plan, as well as other legacy deferral plans. The Deferred Compensation Plan is non-qualified and permits certain employees whose annualized base salary equals or exceeds a minimum annual threshold amount as set by the Company to elect to defer all or a portion of their annual bonus payment and up to 50% of their base salary into a deferral account maintained by the Company. Total contributions to this plan in 2021, 2020 and 2019 were $2,962, $3,637 and $1,751, respectively. Deferred amounts are generally paid out in cash at the participant&#8217;s election either in the first or second year following retirement or in a specified future period at least three to four years after the deferral election was effective. During 2021, 2020 and 2019 the Company distributed $11,887, $3,139 and $2,730, respectively, to participants from its deferred compensation plans. Participants are credited with </span></div>their proportional amount of annual earnings from the plans. The assets of these plans are held in rabbi trusts subject to the claims of the Company&#8217;s general creditors in the event of its bankruptcy. As of December&#160;31, 2021 and 2020, the total fair value of assets held in these plans' trusts was $38,019 and $43,844, respectively. The assets of these plans are recorded at fair value with changes in fair value recorded in other income. See Note 5 for further details. Any fair value changes to the corresponding liability balance are recorded as compensation expense.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265764744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Contingencies</a></td>
<td class="text">Contingencies<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#8217;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#8217;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits, governmental investigations (which frequently arise from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of December&#160;31, 2021 and December&#160;31, 2020, the Company&#8217;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#8217;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Governmental Inquiries and Related Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 U.S. Attorney Texas Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#8217;s Office, Northern District of Texas. The government is conducting a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#8217;s relationships with pharmaceutical manufacturers. The government's investigation covers the period from January&#160;1, 2006 through December 31, 2018. In December 2017, the Company finalized and executed a settlement agreement that resolved certain of the issues in the government's investigation and that included total monetary consideration of $63,700, as previously disclosed, of which $41,500 was an incremental cash payment and $22,200 was for amounts previously refunded, and all of which was previously accrued. The government&#8217;s investigation is ongoing with respect to issues related to DaVita Rx's historic relationships with certain pharmaceutical manufacturers, and in July 2018 the Office of Inspector General (OIG) served the Company with a subpoena seeking additional documents and information relating to those relationships. On September 15, 2021, the U.S. Attorney&#8217;s Office notified the U.S. District Court, Northern District of Texas, of its decision and the decision of 31 states not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Doe v. DaVita Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The court then unsealed the complaint, which alleges violations of the FCA, by order dated September 17, 2021. The complaint was not served on the Company. In December 2021, the private party relator filed a notice of voluntary dismissal of all claims and the Court entered an order dismissing the claims without prejudice. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2017 U.S. Attorney Colorado Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In November 2017, the U.S. Attorney&#8217;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#8217;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018, May 2019, and July 2021, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 U.S. Attorney New Jersey Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2020, the U.S. Attorney&#8217;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#8217;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#8217;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired October 22, 2019. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 California Department of Insurance Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020, and an additional subpoena in September 2021. Those subpoenas request information on a number of topics, including but not limited to the Company&#8217;s communications with patients about insurance plans and financial assistance from the American Kidney Fund (AKF), analyses of the potential impact of patients&#8217; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is cooperating with CDI in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Department of Justice Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In October 2020, the Company received a CID from the Department of Justice pursuant to a False Claims Act investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covers the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and on-going discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#8217;s reputation, required changes to the Company&#8217;s business practices, an impact on the Company's various relationships and/or contracts related to the Company's business, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Antitrust Indictment and Putative Class Action Suit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On July 14, 2021, an indictment was returned by a grand jury in the U.S. District Court, District of Colorado against the Company and its former chief executive officer in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. v. DaVita Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The two count indictment alleges that purported agreements entered into by DaVita's former chief executive officer not to solicit senior-level employees violate Section 1 of the Sherman Act. On September 14, 2021, DaVita and its former chief executive officer filed a motion to dismiss the indictment. On November 3, 2021, a superseding indictment was returned in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. v. DaVita Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that included an additional count alleging a third violation of the Sherman Act. On November 10, 2021, DaVita and its former chief executive officer filed a renewed motion to dismiss the superseding indictment. On January&#160;28,&#160;2022, the court denied the motion to dismiss. The matter is set to start trial on March 28, 2022. On July 16, 2021, a former DaVita employee filed a putative class action complaint in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pena v. Surgical Care Affiliates, LLC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. District Court, Northern District of Illinois based on the allegations in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. v. DaVita Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On August 6, 2021, the plaintiff in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pena</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case filed a notice of voluntary dismissal and the court dismissed the complaint on August 9, 2021. On August 9, 2021, DaVita was named as defendant in a consolidated class action complaint in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Outpatient Medical Center Employee Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. District Court, Northern District of Illinois. This class action complaint seeks to bring an action on behalf of certain groups of individuals employed by the Company between February 1, 2012 and January 5, 2021. On October 18, 2021, the Company filed a motion to dismiss the </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">class action complaint. The Company disputes the allegations in the superseding indictment and the class action complaint, as well as the asserted violations of the Sherman Act, and intends to defend these actions accordingly.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Marietta Memorial Hospital Employee Health Benefit Plan, et al. v. DaVita Inc. et al. No. 20-1641</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On November 5, 2021 the United States Supreme Court granted certiorari of an appeal by an employer group health plan, the plan sponsor, and the plan&#8217;s advisor of the U.S. Court of Appeals for the Sixth Circuit (Sixth Circuit) decision in the Company's favor. The questions presented involve whether the health plan violates the Medicare Secondary Payor Act by "taking into account" that plan beneficiaries are eligible for Medicare and/or by "differentiating" between the benefits that the plan offers to patients with dialysis versus others. On December 23, 2021, the Solicitor General on behalf of the United States filed an amicus brief supporting the petitioners' request to overturn the Sixth Circuit decision. On January 19, 2022, the Company filed its brief in support of the Sixth Circuit decision, and the Company intends to defend against the appeal accordingly. The case is set for oral argument on March 1, 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in Note 16 to these consolidated financial statements, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#8217;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#8217;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, may impact the Company's various relationships and/or contracts related to the Company's business or otherwise harm the Company&#8217;s business, results of operations, financial condition, cash flows or reputation.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Resolved Matters</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Peace Officers&#8217; Annuity and Benefit Fund of Georgia Securities Class Action Civil Suit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On February 1, 2017, the Peace Officers&#8217; Annuity and Benefit Fund of Georgia filed a putative federal securities class action complaint in the U.S. District Court for the District of Colorado against the Company and certain executives.&#160;The complaint covers the time period of August 2015 to October 2016 and alleges, generally, that the Company and its executives violated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">federal securities laws concerning the Company&#8217;s financial results and revenue derived from patients who received charitable premium assistance from an industry-funded non-profit organization.&#160;The complaint further alleges that the process by which patients obtained commercial insurance and received charitable premium assistance was improper and "created a false impression of DaVita&#8217;s business and operational status and future growth prospects."</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company continues to dispute the allegations, it reached an agreement to resolve this matter without admitting to any liability.&#160;Settlement of this matter was covered primarily with insurance proceeds. The Company contributed an amount that did not have a material impact on the Company&#8217;s consolidated financial position, results of operations or cash flows. On April 13, 2021, the court granted final approval of the settlement. On August 9, 2021, the court entered final judgment and dismissed all claims in the action with prejudice.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">In re DaVita Inc. Stockholder Derivative Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On August 15, 2017, the U.S. District Court for the District of Delaware consolidated three previously disclosed shareholder derivative lawsuits: the Blackburn Shareholder action filed on February 10, 2017, the Gabilondo Shareholder action filed on May 30, 2017, and the City of Warren Police and Fire Retirement System Shareholder action filed on June 9, 2017. The complaint covers the time period from 2015 to present and alleges, generally, breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, corporate waste, and misrepresentations and/or failures to disclose certain information in violation of the federal securities laws in connection with an alleged practice to direct patients with government-subsidized health insurance into private health insurance plans to maximize the Company&#8217;s profits.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the defendants continue to dispute the allegations, an agreement was reached to resolve this matter without admitting to any liability and the court approved the settlement and entered final judgment and dismissed the case with prejudice on January 29, 2021. As part of the settlement, the Company agreed to certain corporate governance policies, but did not make any financial contribution towards the settlement.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2018 U.S. Attorney Florida Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2018, DaVita Labs received two CIDs from the U.S. Attorney&#8217;s Office, Middle District of Florida that were identical in nature but directed to the two different labs. According to the face of the CIDs, the U.S. Attorney&#8217;s Office is conducting an investigation as to whether the Company&#8217;s subsidiary submitted claims for blood, urine, and fecal testing, where there were insufficient test validation or stability studies to ensure accurate results, in violation of the FCA. In October 2018, DaVita Labs received a subpoena from the OIG in connection with this matter requesting certain patient records linked to clinical laboratory tests. On September 30, 2019, the U.S. Attorney&#8217;s Office notified the U.S. District Court, Middle District of Florida, of its decision not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Lorne Holland, et al. v. DaVita Healthcare Partners, Inc., et al</span>. The court then unsealed the complaint, which alleges violations of the FCA, by order dated the same day. In January 2020, the private party relators served the Company and DaVita Labs with an amended complaint. The Company and DaVita Labs answered the complaint on July 23, 2020. On August 10, 2021, the court entered summary judgment in favor of the Company and DaVita Labs on all of the relators&#8217; FCA claims leaving only the claims for retaliation. The court dismissed the case on October 13, 2021. On October 15, 2021, the parties signed an agreement to resolve the remaining retaliation claims for an immaterial amount.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127197<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127163<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161266181672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Noncontrolling Interests Subject to Put Provisions and Other Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Noncontrolling Interests Subject to Put Provisions and Other Commitments</a></td>
<td class="text">Noncontrolling interests subject to put provisions and other commitments<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling interests subject to put provisions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has potential obligations to purchase the equity interests held by third parties in many of its majority-owned dialysis partnerships and other nonconsolidated entities. These noncontrolling interests subject to put provisions constitute redeemable equity interests and are therefore classified as temporary equity and carried at estimated fair value on the Company's balance sheet.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, these obligations are in the form of put provisions that are exercisable at the third-party owners&#8217; discretion within specified periods outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase the third-party owners&#8217; equity interests, generally at the appraised fair market value of the equity interests or in certain cases at a predetermined multiple of earnings or cash flows attributable to the equity interests put to the Company, intended to approximate fair value. The methodology the Company uses to estimate the fair values of noncontrolling interests subject to put provisions assumes the higher of either a liquidation value of net assets or an average multiple of earnings, based on historical earnings, patient mix and other performance indicators that can affect future results, as well as other factors. The estimated fair values of noncontrolling interests subject to put provisions are a critical accounting estimate that involves significant judgments and assumptions and may not be indicative of the actual values at which the noncontrolling interests may ultimately be settled, which could vary significantly from the Company&#8217;s current estimates. The estimated fair values of noncontrolling interests subject to put provisions can fluctuate and the implicit multiple of earnings at which these noncontrolling interests obligations may be settled will vary significantly depending upon market conditions including potential purchasers&#8217; access to the capital markets, which can impact the level of competition for dialysis and non-dialysis related businesses, the economic performance of these businesses and the restricted marketability of the third-party owners&#8217; equity interests. The amount of noncontrolling interests subject to put provisions that employ a contractually predetermined multiple of earnings rather than fair value is immaterial.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain consolidated dialysis partnerships are originally contractually scheduled to dissolve after terms ranging from ten years to 50 years. While noncontrolling interests in these limited life entities qualify as mandatorily redeemable financial instruments, they are subject to a classification and measurement scope exception from the accounting guidance generally applicable to other mandatorily redeemable financial instruments. Future distributions upon dissolution of these entities would be valued below the related noncontrolling interest carrying balances in the consolidated balance sheet.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other commitments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the Company entered into a Sourcing and Supply Agreement with Amgen USA Inc. (Amgen) that expires on December&#160;31, 2022. Under the terms of the agreement, the Company will purchase EPO from Amgen in amounts necessary to meet no less than 90% of its requirements for erythropoiesis-stimulating agents (ESAs) through the expiration of the contract. The actual amount of EPO that the Company will purchase will depend upon the amount of EPO administered during dialysis as prescribed by physicians and the overall number of patients that the Company serves.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with various suppliers to purchase established amounts of dialysis equipment, parts, and supplies. As of December&#160;31, 2021, the remaining minimum purchase commitments under these arrangements were approximately $549,079, $510,991, $430,196, and $345,863 for the years 2022, 2023, 2024, and 2025, respectively. If the Company fails to meet the minimum purchase commitments under these contracts during any year, it is required to pay the difference to the supplier.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $13,469.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the letters of credit disclosed in Note 13 to these consolidated financial statements, and the arrangements as described above, the Company has no off balance sheet financing arrangements as of December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265734696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Long-term Incentive Compensation and Shareholders&#8217; Equity</a></td>
<td class="text">Stock-based compensation<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation consists primarily of stock-settled stock appreciation rights, restricted stock units and performance stock units. Stock-based compensation, which is primarily general and administrative in nature, is attributed to the Company&#8217;s U.S. dialysis business, its corporate administrative support, and its ancillary services. See Note 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Organization and summary of significant accounting policies" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information on how the Company measures and recognizes stock-based compensation expense.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term incentive compensation plans</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 11, 2020, the Company&#8217;s stockholders approved the DaVita Inc. 2020 Incentive Award Plan (the 2020 Plan). Prior to June 11, 2020 stock-based awards were granted under the DaVita Healthcare Partners Inc. 2011 Incentive Award Plan (the 2011 Plan). The 2011 Plan was terminated with respect to any new awards upon stockholder approval of the 2020 Plan. At the time the 2020 Plan was approved there were 8,730 shares of common stock available for issuance under the 2020 Plan, consisting of 5,000 newly authorized shares and 3,730 shares that were available for issuance under the 2011 Plan as of the effective date of the 2020 Plan and which became available for grant under the 2020 Plan, pursuant to the terms of the 2020 Plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Plan is the Company&#8217;s current omnibus equity compensation plan and provides for grants of stock-based awards to employees, directors and other individuals providing services to the Company, except that incentive stock options may only be awarded to employees. The 2020 Plan provides for the grant of stock appreciation rights, nonqualified stock options, incentive stock options, restricted stock units, restricted stock, performance stock awards, dividend equivalents, stock payments, deferred stock unit awards, deferred stock awards and performance cash awards. The 2020 Plan mandates a maximum award term of 10 years for stock appreciation rights and stock options and stipulates that awards of these types be granted with a base or exercise price per share of not less than the fair market value of the Company's common stock on the date of grant. Shares available under the 2020 Plan are also stated on a full value share basis rather than on an option-equivalent basis. The 2020 Plan therefore provides that shares available for issuance under the plan are reduced by one share available for every four shares underlying stock appreciation rights and stock options, and are reduced by one share available for every one share underlying stock-based awards other than stock appreciation rights and stock options. At December&#160;31, 2021, there were 7,672 shares available for future grants under the 2020 Plan. The Company&#8217;s stock awards granted under the 2020 Plan generally vest over 36 months to 48 months from the date of grant.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2011 Plan was the Company&#8217;s prior omnibus equity compensation plan and authorized the Company to award stock options, stock appreciation rights, restricted stock units, restricted stock, and other stock-based or performance-based awards. The 2011 Plan mandated a maximum award term of five years and stipulated that stock appreciation rights and stock options be granted with prices not less than fair market value on the date of grant. The 2011 Plan also required that full value share awards such as restricted stock units reduce shares available under the 2011 Plan at a ratio of 3.5:1. The Company&#8217;s stock appreciation rights and stock units awarded under the 2011 Plan generally vest over 36 months to 48 months from the date of grant.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A combined summary of the status of the Company&#8217;s stock-settled awards under both the 2020 Plan and 2011 Plan, including base shares for stock-settled stock appreciation rights (SSARs) and stock-settled stock unit awards is as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"/><td style="width:37.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.890%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.827%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stock appreciation rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stock units</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual&#160;life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual&#160;life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Added by performance factor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised/Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,093)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,943&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.13&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average fair value of grants:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.70&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.83&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.58&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.269%"><tr><td style="width:1.0%"/><td style="width:28.821%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.438%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Awards Outstanding</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Awards exercisable</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Range of SSARs base prices</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$50.01&#8211;$60.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$60.01&#8211;$70.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$70.01&#8211;$80.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$100.01&#8211;$110.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,943&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020, and 2019, the aggregate intrinsic value of stock-based awards exercised was $208,585, $49,258 and $11,475, respectively. At December&#160;31, 2021, the aggregate intrinsic value of stock-based awards outstanding was $680,251 and the aggregate intrinsic value of stock awards exercisable was $61,389.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimated fair value of stock-based compensation awards</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has estimated the grant-date fair value of stock-settled stock appreciation rights awards using the Black-Scholes-Merton valuation model and stock-settled stock unit awards at intrinsic value on the date of grant, except for portions of the Company&#8217;s performance stock unit awards for which a Monte Carlo simulation was used to estimate the grant-date fair value. The following assumptions were used in estimating these values and determining the related stock-based compensation expense attributable to the current period:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected term of the awards:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The expected term of awards granted represents the period of time that they are expected to remain outstanding from the date of grant. The Company determines the expected term of its stock awards based on its historical experience with similar awards, considering the Company&#8217;s historical exercise and post-vesting termination patterns.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected volatility:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Expected volatility represents the volatility anticipated over the expected term of the award. The Company determines the expected volatility for its awards based on the volatility of the price of its common stock over the most recent retrospective period commensurate with the expected term of the award, considering the volatilities expected by peer companies in near industries.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected dividend yield:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company has not paid dividends on its common stock and does not currently expect to pay dividends during the term of stock awards granted.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-free interest rate:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company bases the expected risk-free interest rate on the implied yield currently available on stripped interest coupons of U.S. Treasury issues with a remaining term equivalent to the expected term of the award.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of SSAR awards granted in the periods indicated is as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"/><td style="width:40.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company estimates expected forfeitures based upon historical experience with separate groups of employees that have exhibited similar forfeiture behavior in the past. Stock-based compensation expense is recorded only for awards that are expected to vest.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 4, 2019, the independent members of the Company&#8217;s Board of Directors (Board) approved an award of 2,500 premium-priced stock-settled stock appreciation rights (Premium-Priced Award) to the Company&#8217;s Chief Executive Officer (CEO), which award was subject to stockholder approval of a related amendment to the 2011 Plan. Stockholders approved such amendment to the 2011 Plan on January 23, 2020, authorizing the grant to the Company's CEO. Since stockholder approval occurred in 2020, this award was treated as granted in 2020 for accounting purposes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The base price of the Premium-Priced Award was $67.80 per share, which was a 20% premium to the clearing price of the Company's modified Dutch auction tender offer for its shares in 2019 (2019 Tender Offer). The award vests 50% on each of November&#160;4, 2022 and November&#160;4, 2023 and expires on November&#160;4, 2024. The award includes a requirement that the CEO hold any shares acquired upon exercise of this award, net of shares used to cover related taxes, until November&#160;4, 2024 (that is, for the full term of the award), subject to lapse of the holding period upon a change in control of the Company or due to the CEO's death or termination due to disability.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee stock purchase plan</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employee Stock Purchase Plan entitles qualifying employees to purchase up to $25 of the Company&#8217;s common stock during each calendar year. The amounts used to purchase stock are accumulated through payroll withholdings or through optional lump sum payments made in advance of the first day of the purchase right period. This compensatory plan allows employees to purchase stock for the lesser of 100% of its fair market value on the first day of the purchase right period or 85% of its fair market value on the last day of the purchase right period. Purchase right periods begin on January&#160;1 and July&#160;1, and end on December&#160;31. Contributions used to purchase the Company&#8217;s common stock under this plan for the 2021, 2020 and 2019 purchase periods were $19,626, $17,148 and $16,569, respectively. Shares purchased pursuant to the plan&#8217;s 2021, 2020 and 2019 purchase periods were 203, 222 and 315, respectively. At December&#160;31, 2021, there were 5,986 shares remaining available for future grants under this plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of participants&#8217; purchase rights was estimated as of the beginning dates of the purchase right periods using the Black-Scholes-Merton valuation model with the following weighted average assumptions for purchase right periods in 2021, 2020 and 2019, respectively: expected volatility of 39.0%, 40.4% and 28.8%; risk-free interest rates of 0.1%, 1.0% and 2.6%, and no dividends. Using these assumptions, the weighted average estimated per share fair value of each purchase right was $34.94, $22.06 and $13.80 for 2021, 2020 and 2019, respectively.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation expense and proceeds</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized $102,209, $91,458 and $63,705 in stock-based compensation expense for stock appreciation rights, stock units and discounted employee stock purchase plan purchases, which are primarily included in general and administrative expenses. The estimated tax benefits recorded for stock-based compensation in 2021, 2020 and 2019 were $13,853, $11,775 and $9,186, respectively. As of December&#160;31, 2021, there was $161,147 of total estimated but unrecognized stock-based compensation expense under the Company&#8217;s equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of 1.2 years.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020 and 2019, the Company received $46,990, $8,957 and $2,251, respectively, in actual tax benefits upon the exercise or vesting of stock awards. Since the Company issues stock-settled stock appreciation rights rather than stock options, there were no cash proceeds from stock option exercises.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161266184488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder's equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockTextBlock', window );">Stockholder's equity</a></td>
<td class="text">Shareholders&#8217; equity<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's repurchases of its common stock during the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"><tr><td style="width:1.0%"/><td style="width:38.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.158%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Open market repurchases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,546,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">741,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,168,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tender offers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">704,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,234,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,546,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,446,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,402,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The aggregate amounts paid for shares repurchased pursuant to the Company's 2020 and 2019 tender offers for its shares during the years ended 2020 and 2019, include their clearing prices of $88.00 and $56.50 per share, respectively, plus related fees and expenses of $2,529 and $2,343, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2021 through February&#160;9, 2022, the Company has repurchased 1,437 shares of its common stock for $159,133 at an average cost of $110.73 per share.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on December 10, 2020, the Board terminated all remaining prior share repurchase authorizations available to the Company and approved a new share repurchase authorization of $2,000,000. Effective on December 17, 2021, the Board increased the Company's existing authorization by $2,000,000. The Company is authorized to make purchases from time to time in the open market or in privately negotiated transactions, including without limitation, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing, depending upon market conditions and other considerations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;9, 2022, the Company has a total of $2,224,806 available under the current repurchase authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, the Company remains subject to share repurchase limitations, including under the terms of its senior secured credit facilities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company retired all shares held in its treasury effective as of December&#160;31, 2021 and December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charter documents&#160;&amp; Delaware law</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s charter documents include provisions that may deter hostile takeovers, delay or prevent changes of control or changes in management, or limit the ability of stockholders to approve transactions that they may otherwise determine to be in their best interests. These include provisions prohibiting stockholders from acting by written consent, requiring 90 days advance notice for director nominations and stockholder proposals and granting the Company's Board of Directors the authority to issue up to 5,000 shares of preferred stock and to determine the rights and preferences of the preferred stock without the need for further stockholder approval.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to Section&#160;203 of the Delaware General Corporation Law which, subject to exceptions, prohibits the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period of three years following the date on which that stockholder became an interested stockholder. The provisions described above may discourage, delay or prevent an acquisition of the Company at a price that stockholders may find attractive.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in DaVita Inc.&#8217;s ownership interests in consolidated subsidiaries</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of changes in DaVita Inc.&#8217;s ownership interests in consolidated subsidiaries on the Company&#8217;s consolidated equity were as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"><tr><td style="width:1.0%"/><td style="width:52.967%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">978,450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">773,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in paid-in capital for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,853)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales of noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net transfers in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,117)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,145)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc. net of transfers in <br/>&#160;noncontrolling interests</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">964,333&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">778,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">773,836&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acquired additional ownership interests in several existing majority-owned partnerships for $20,104, $7,831, and $68,019 in 2021, 2020, and 2019, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208821<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265732280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive (Loss) Income</a></td>
<td class="text">Accumulated other comprehensive loss<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges and credits to other comprehensive (loss) income have been as follows:&#160;</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"><tr><td style="width:1.0%"/><td style="width:48.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate<br/>cap agreements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated other<br/>comprehensive<br/>(loss) income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,961)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,963)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,924)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,102)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,536)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,102)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,951)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,433)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,065)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,498)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized losses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,781)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,080)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,861)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(543)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,346)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,623)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,969)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53,688)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66,154)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,532&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83,375)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(73,843)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,383)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84,381)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,226)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,178)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(138,069)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(139,247)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassification of net interest rate cap realized losses into income are recorded as debt expense in the corresponding consolidated statements of income. See Note 13 for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265863480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Acquisitions and Divestitures</a></td>
<td class="text">Acquisitions and divestitures<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Routine acquisitions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, 2020, and 2019 the Company acquired dialysis businesses and other businesses, including a transplant software company, as follows:</span></div><div style="margin-top:9pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.192%"><tr><td style="width:1.0%"/><td style="width:52.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.864%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred purchase price and liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate consideration</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">212,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of dialysis centers acquired &#8212; U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of dialysis centers acquired &#8212; International</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The assets and liabilities for all acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company&#8217;s financial statements, as are their operating results, from the designated effective dates of the acquisitions. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial purchase price allocations for these transactions have been recorded at estimated fair values based on information available to management and will be finalized when certain information arranged to be obtained has been received. For several of the 2021 acquisitions, certain income tax amounts are pending final evaluation and quantification of any pre-acquisition tax contingencies. In addition, valuation of contingent earn-outs, intangibles, fixed assets, leases and certain working capital items relating to several of these acquisitions are pending final quantification.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.795%"><tr><td style="width:1.0%"/><td style="width:52.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompetition agreements and other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,962)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,068)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,921)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,729)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,762)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">212,130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,698&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes weighted-average estimated useful lives of amortizable intangible assets acquired during 2021, 2020 and 2019, as well as goodwill deductible for tax purposes associated with these acquisitions:</span></div><div style="margin-top:6pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.900%"><tr><td style="width:1.0%"/><td style="width:56.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average estimated useful lives (in years):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompetition agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill deductible for tax purposes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro forma financial information (unaudited)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions within continuing operations in 2021 and 2020 had been consummated as of the beginning of 2020, including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"><tr><td style="width:1.0%"/><td style="width:62.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.618%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.741%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pro forma total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,678,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,722,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pro forma net income from continuing operations attributable to<br/>&#160;DaVita Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">985,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">797,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pro forma basic net income per share from continuing operations<br/>&#160;attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pro forma diluted net income per share from continuing operations<br/>&#160;attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of RMS Lifeline</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company divested its prior vascular access business, RMS Lifeline, Inc., effective May 1, 2020 and recognized a loss on sale of approximately $16,252.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent earn-out obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired businesses a total of up to approximately $67,638 if certain performance targets or quality margins are met over the next one year to five years. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent earn-out obligations are remeasured to fair value at each reporting date until the contingencies are resolved with changes in the liability due to the remeasurement recognized in earnings. See Note 24 for further details. As of December&#160;31, 2021, the Company estimated the fair value of these contingent earn-out obligations to be $33,600, of which a total of $9,419 is included in other current liabilities, and the remaining $24,181 is included in other long-term liabilities in the Company&#8217;s consolidated balance sheet. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of changes in contingent earn-out liabilities for the years ended December&#160;31, 2021 and 2020:&#160;</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"><tr><td style="width:1.0%"/><td style="width:55.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.086%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.088%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,688)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments or other settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,536)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,062)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,600&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265876152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale and Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Held for Sale and Discontinued Operations</a></td>
<td class="text">Discontinued operations previously held for sale<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DaVita Medical Group (DMG)</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;19, 2019, the Company completed the sale of its prior DMG business to Optum, a subsidiary of UnitedHealth Group Inc., for an aggregate purchase price of $4,340,000, prior to certain closing and post-closing adjustments specified in the related equity purchase agreement dated as of December&#160;5, 2017, as amended as of September 20, 2018 and as of December 11, 2018 (as amended, the equity purchase agreement).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a preliminary estimated pre-tax net loss of approximately $23,022 on the sale of its DMG business in 2019. This preliminary net loss was based on initial estimates of the Company's expected aggregate proceeds from the sale, net of transaction costs and obligations, as well as the estimated values of DMG net assets sold as of the closing date. Those estimated net proceeds included $4,465,476 in cash received from Optum at closing, or $3,824,509 net of cash and restricted cash included in the DMG net assets sold.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At close of the DMG sale, the Company's ultimate net sale proceeds remained subject to resolution of certain post-closing purchase price adjustments described in the equity purchase agreement. In the fourth quarter of 2020, the Company and Optum reached agreement on the final purchase price for the DMG sale, which resulted in an additional payment by the Company to Optum of $47,000 and an additional loss on sale of $17,976. In the first quarter of 2020, the Company recognized $9,980 in additional tax benefits under the Coronavirus Aid, Relief and Economic Security Act related to its period of DMG ownership, which were also recognized as an adjustment to the Company's loss on sale of the DMG business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the equity purchase agreement, the Company also has certain continuing indemnification obligations that could require payments to the buyer relating to the Company's previous ownership and operation of the DMG business. Potential payments under these provisions, if any, remain subject to continuing uncertainties and the amounts of such payments could be significant to the Company.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the financial results of discontinued operations related to DMG:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"><tr><td style="width:1.0%"/><td style="width:70.457%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,713,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,543,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations before taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale of discontinued operations before taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,657&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations, net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,653)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cash flows of discontinued operations related to DMG:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:414.00pt"><tr><td style="width:1.0pt"/><td style="width:294.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:55.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:55.00pt"/><td style="width:1.0pt"/></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DMG acquisitions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period from January 1, 2019 to June 18, 2019 immediately prior to the sale, the DMG business acquired two medical businesses for a total of $2,025 in net cash and deferred purchase price of $212.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265764744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable Interest Entities</a></td>
<td class="text">Variable interest entities<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages or maintains an ownership interest in certain legal entities subject to the consolidation guidance applicable to variable interest entities (VIEs). Almost all of these legal entities are either U.S. dialysis partnerships encumbered by guaranteed debt, U.S. dialysis limited partnerships, or other legal entities subject to nominee ownership arrangements. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under U.S. GAAP, VIEs typically include entities for which (i)&#160;the entity&#8217;s equity is not sufficient to finance its activities without additional subordinated financial support; (ii)&#160;the equity holders as a group lack the power to direct the activities that most significantly influence the entity&#8217;s economic performance, the obligation to absorb the entity&#8217;s expected losses, or the right to receive the entity&#8217;s expected returns; or (iii)&#160;the voting rights of some investors are not proportional to their obligations to absorb the entity&#8217;s losses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The substantial majority of VIEs the Company is associated with are U.S. dialysis partnerships which the Company manages and in which it maintains a controlling majority ownership interest. These U.S. dialysis partnerships are considered VIEs either because they are (i) encumbered by debt guaranteed proportionately by the partners that is considered necessary to finance the partnership's activities, or (ii) in the form of limited partnerships for which the limited partners are not considered to have substantive kick-out or participating rights. The Company consolidates virtually all such U.S. dialysis partnerships.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also relies on the operating activities of certain legal entities in which it does not maintain a controlling ownership interest but over which it has indirect influence and of which it is considered the primary beneficiary.&#160;These entities are typically subject to nominee ownership and transfer restriction agreements that effectively transfer the majority of the economic risks and rewards of their ownership to the Company. The Company&#8217;s management, restriction and other agreements concerning such nominee-owned entities typically include both financial terms and protective and participating rights to the entities&#8217; operating, strategic and non-clinical governance decisions which transfer substantial powers over and economic </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">responsibility for these entities to the Company. The Company consolidates all of the nominee-owned entities with which it is most closely associated. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the VIEs described above, these consolidated financial statements include total assets of $299,953 and total liabilities and noncontrolling interests to third parties of $200,110 at December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sponsors certain non-qualified deferred compensation plans whose trusts qualify as VIEs and the Company consolidates these plans as their primary beneficiary.&#160;The assets of these plans are recorded in short-term or long-term investments with related liabilities recorded in accrued compensation and benefits and other long-term liabilities.&#160;See Note 15 for disclosures concerning the assets of these consolidated non-qualified deferred compensation plans.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265835784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Values of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Values of Financial Instruments</a></td>
<td class="text">Fair values of financial instruments<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equity that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the FASB.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s assets, liabilities and temporary equity measured at fair value on a recurring basis as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Quoted&#160;prices&#160;in<br/>active&#160;markets&#160;for<br/>identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant&#160;other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,203&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,203&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,434,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,434,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,330,028&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,330,028&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For reconciliations of changes in contingent earn-out obligations and noncontrolling interests subject to put provisions during the year ended at December&#160;31, 2021 and 2020, see Note 21 and the consolidated statements of equity, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stock and are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 5 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 13 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA), revenue and key performance indicators. The estimated fair value of these contingent earn-out obligations is remeasured as of each reporting date and could </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fluctuate based upon any significant changes in key assumptions, such as changes in the Company credit risk adjusted rate that is used to discount obligations to present value. See Note 21 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of December&#160;31, 2021, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $180,000. See Note 17 for a discussion of the Company&#8217;s methodology for estimating the fair values of noncontrolling interests subject to put obligations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon quoted bid and ask prices for these instruments, typically a level 2 input. See Note 13 for further discussion of the Company's debt. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in the consolidated financial statements at December&#160;31, 2021 and 2020 at their approximate fair values due to the short-term nature of their settlements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265712104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment reporting<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its U.S. ancillary services and strategic initiatives and its international operations (collectively, its ancillary services), as well as its corporate administrative support. See Note 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Organization" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a summary description of the Company's businesses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2019, the Company completed the sale of its prior DMG business to Optum. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating segments have been defined based on the separate financial information that is regularly produced and reviewed by the Company&#8217;s chief operating decision maker in making decisions about allocating resources to and assessing the financial performance of the Company&#8217;s various operating lines of business. The chief operating decision maker for the Company is its Chief Executive Officer.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s separate operating segments include its U.S. dialysis and related lab services business, its U.S. ancillary services and strategic initiatives, its kidney care operations in each foreign sovereign jurisdiction, its other health operations in each foreign sovereign jurisdiction, and its equity method investment in the APAC joint venture. The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other operating segments, including the international operating segments, have been combined and disclosed in the other segments category.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating segment financial information included in this report is prepared on the internal management reporting basis that the chief operating decision maker uses to allocate resources and assess the financial performance of the Company's operating segments. For internal management reporting, segment operations include direct segment operating expenses but generally exclude corporate administrative support costs, which consist primarily of indirect labor, benefits and long-term incentive compensation expenses of certain departments which provide support to all of the Company&#8217;s various operating lines of business.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,551,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,475,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,399,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,641,618&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,619,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,530,885&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:54pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,666,963&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,659,935&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,562,906&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">662,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">497,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">484,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total ancillary services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,046,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,052,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">971,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,713,887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,712,633&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,534,834&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,090)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(162,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146,355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,618,797&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,550,604&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,388,479&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment operating margin (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,974,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,917,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,924,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66,003)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76,261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(189,174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,908,985&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,841,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,735,652&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of segment operating margin to consolidated income from<br/>&#160;continuing operations before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111,615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146,707)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(92,335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,797,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,694,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(285,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(304,111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(443,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt prepayment, refinancing and redemption charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89,022)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,518,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,318,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity investment income of $3,177, $5,866, and $9,366 in 2021, 2020 and 2019, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:48.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.072%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">594,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">583,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">680,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">630,435&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615,152&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for property and equipment by reportable segment were as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:48.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.072%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">589,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">681,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DMG - Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">641,465&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">674,541&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">766,546&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summary of assets by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"/><td style="width:58.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,375,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,344,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,746,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,121,488&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,988,516&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity method and other investments of $112,500 and $122,974 in 2021 and 2020, respectively. </span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity method and other investments of $126,381 and 134,517 in 2021 and 2020, respectively and includes approximately $190,029 and $181,137 in 2021 and 2020, respectively, of net property and equipment related to the Company&#8217;s international operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265729080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text">Supplemental cash flow information<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides supplemental cash flow information:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"><tr><td style="width:1.0%"/><td style="width:49.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">473,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets under financing lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265758632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II&#8212;VALUATION AND QUALIFYING ACCOUNTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:45.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.772%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at<br/>beginning of year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts<br/>charged to income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts written off</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance<br/>at end of year</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for uncollectible accounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260411672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of presentation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (U.S. GAAP). The financial statements include DaVita Inc. and its subsidiaries, partnerships and other entities in which it maintains a majority voting or other controlling financial interest (collectively, the Company). All significant intercompany transactions and balances have been eliminated. Equity investments in investees over which the Company has significant influence are recorded on the equity method, while investments in other equity securities are recorded at fair value or on the adjusted cost method, as applicable. For the Company&#8217;s international subsidiaries, local currencies are considered their functional currencies. Translation adjustments result from translating the financial statements of the Company&#8217;s international subsidiaries from their functional currencies into the Company&#8217;s reporting currency (the U.S. dollar, or USD). Prior year classifications have been conformed to the current year presentation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through the date these consolidated financial statements were issued and has included all necessary adjustments and disclosures.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. Although actual results in subsequent periods will differ from these estimates, such estimates are developed based on the best information available to management and management&#8217;s best judgments at the time. All significant assumptions and estimates underlying the amounts reported in the financial statements and accompanying notes are regularly reviewed and updated when necessary. Changes in estimates are reflected in the financial statements based upon on-going actual experience trends or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant assumptions and estimates underlying these consolidated financial statements and accompanying notes involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, fair value estimates and loss contingencies. Specific estimating risks and contingencies are further addressed within these notes to the consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock', window );">Patient service net revenues and accounts receivable</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. A usual and customary fee schedule is maintained for the Company&#8217;s dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with Medicare and Medicaid programs are estimated based on: (a) the payment rates that are established by statute or regulation for the portion of payment rates paid by the government payor (e.g., 80% for Medicare patients) and (b) for the portion not paid by the primary government payor, estimates of the amounts ultimately collectible from other government programs providing secondary coverage (e.g., Medicaid secondary coverage), the patient&#8217;s commercial health plan secondary coverage, or the patient.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Medicare&#8217;s bundled payment rate system, services covered by Medicare are subject to estimating risk, whereby reimbursements from Medicare can vary significantly depending upon certain patient characteristics and other variable factors. Even with the bundled payment rate system, Medicare payments for bad debt claims as established by cost reports require evidence of collection efforts. As a result, billing and collection of Medicare bad debt claims can be delayed significantly and final payment is subject to audit. The Company&#8217;s revenue recognition is estimated based on its judgment regarding its ability to collect, which depends upon its ability to effectively capture, document and bill for Medicare&#8217;s base payment rate as well as these other variable factors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Advantage revenues are reimbursed at negotiated contract rates that are generally higher than Medicare fee-for-service rates, but which generally have a slower payment frequency than Medicare fee-for-service payments. Medicare Advantage revenues are subject to meaningful estimating risk based on factors similar to those described for commercial health plans below.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid payments, when Medicaid coverage is secondary, can also be difficult to estimate. For many states, Medicaid payment terms and methods differ from Medicare, and may prevent accurate estimation of individual payment amounts prior to billing.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues associated with commercial health plans are estimated based on contractual terms for the patients under healthcare plans with which the Company has formal agreements, non-contracted health plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in the Company&#8217;s billing and collection processes that can result in denied claims for payments, delays in collections due to payor payment inefficiencies, and regulatory compliance matters.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial revenue recognition also involves significant estimating risks. With many larger commercial insurers, the Company has several different contracts and payment arrangements, and these contracts often include only a subset of the Company&#8217;s centers. In certain circumstances, it may not be possible to determine which contract, if any, should be applied prior to billing. In addition, for services provided by non-contracted centers, final collection may require specific negotiation of a payment amount, typically at a significant discount from the Company&#8217;s usual and customary rates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenues</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's U.S. ancillary service revenues include revenues earned under risk-based arrangements in the Company's integrated care and disease management business, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (our counterparty), with adjustments where applicable, or on trended and adjusted medical cost targets.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For some of the Company's risk-based arrangements (such as its special needs plans), the Company acts as a principal with respect to all medical services provided to the patient by effectively hosting or sponsoring the entire arrangement, and as a </span></div>result recognizes revenue and expense for all medical services provided to covered patients. However, for most of its VBC arrangements, the Company provides health monitoring and care coordination services to patients but does not control or direct the medical services that patients receive from third party providers. As a result, for most of its VBC arrangements the Company does not include third party medical costs in its reported revenues and expenses, but rather recognizes revenue only for the estimated amount of shared savings or shared losses or other revenues that are directly earned or incurred by the Company, and ultimately paid to or by the Company, under the arrangement.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_OtherNonoperatingIncomeExpensePolicyTextBlock', window );">Other income</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income includes interest income on cash and cash equivalents and short- and long-term investments, realized and unrealized gains and losses recognized on investments, and foreign currency transaction gains and losses.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are short-term highly liquid investments readily convertible to known amounts of cash that typically mature within three months or less at date of purchase.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted cash and equivalents</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted cash and equivalents</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and cash equivalents include funds held in trust to satisfy insurer and state regulatory requirements related to wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company as well as funds held in escrow. See Note 4 for further details.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments in debt and equity securities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in debt and equity securities</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies certain debt securities as held-to-maturity and records them at amortized cost based on the Company&#8217;s intentions and strategies concerning those investments. Equity securities that have readily determinable fair values or redemption values are recorded at estimated fair value with changes in fair value recognized in current earnings within other income. These debt and equity investments are classified as short-term investments or long-term investments on the Company's consolidated balance sheet. See Note 5 for further details.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value and consist principally of pharmaceuticals and dialysis-related supplies. Rebates related to inventory purchases are recorded when earned and are based on certain qualification requirements which are dependent on a variety of factors including future pricing levels and purchase volume levels from the manufacturer and related data submission.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text">Property and equipmentProperty and equipment is stated at cost less accumulated depreciation and amortization and is further reduced by any impairments. Maintenance and repairs are charged to expense as incurred. Disposition gains and losses are included in current operating expenses. Property and equipment assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#8217;s facilities are leased under non-cancellable operating leases which contain renewal options. These renewal options are included in the Company's determination of the right-of-use assets and related lease liabilities when renewal is considered reasonably certain at the commencement date. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company categorizes leases with contractual terms longer than twelve months as either operating or finance leases. Finance leases are generally those leases that allow the Company to substantially utilize or pay for the entire asset over its estimated life. All other leases are categorized as operating leases. The Company has elected the practical expedient to not separate lease components from non-lease components for its financing and operating leases. The Company has also elected the short-term lease recognition exemption and does not recognize right-of-use assets or lease liabilities for leases with a term of less than 12 months.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing and operating right-of-use assets are recognized based on the net present value of lease payments over the lease term plus expected renewals as of the commencement date. Since most of the Company's leases do not provide an implicit rate of return, the Company uses its incremental borrowing rate based on information available at the commencement date or remeasurement date in determining the present value of lease payments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired under finance leases are recorded on the balance sheet within property and equipment, net and liabilities for finance lease obligations are recorded within long-term debt. Finance lease assets are amortized to depreciation expense on a straight-line basis over the shorter of their estimated useful lives or the expected lease term.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rights to use assets under operating leases are recorded on the balance sheet as operating lease right-of-use assets and liabilities for operating lease obligations are recorded as operating lease liabilities. Reductions in the carrying amount of operating lease right-of-use assets are recorded to rent expense over the lease term.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Amortizable intangibles</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortizable intangibles</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortizable intangible assets include noncompetition agreements, hospital service contracts, and customer relationships arising from other service contracts, each of which have finite useful lives. Amortization expense is computed using the straight-line method over the useful lives of the assets estimated as follows: noncompetition agreements and hospital acute service contracts over the contract term, and customer relationships from other service contracts over the remaining contract term plus expected renewal periods. Amortizable intangible assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy', window );">Indefinite-lived intangibles</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indefinite-lived intangibles</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets include international licenses and accreditations that allow the Company to be reimbursed for providing dialysis services to patients, each of which has an indefinite useful life. Indefinite-lived intangibles are not amortized, but are assessed for impairment at least annually and whenever significant events or changes in circumstances indicate that an impairment may have occurred. Costs to renew indefinite-lived intangible assets are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity investments and other investments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity method and other investments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments that do not have readily determinable fair values are carried on the equity method if the Company maintains significant influence over the investee. Equity investments without readily determinable fair values for which the Company does not maintain significant influence over the investee are carried either at estimated fair value or on the adjusted cost method, as determined on an investment-specific basis. The adjusted cost method represents the Company's cost for an investment, net of any other-than-temporary impairments, as adjusted for any subsequent observation of the investment's fair value.&#160;These equity method and adjusted cost method investments are classified as equity method and other investments on the Company's consolidated balance sheet.&#160;See Note 9 for further details.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method and other investments are assessed for other-than-temporary impairment when significant events or changes in circumstances indicate that an other-than-temporary impairment may have occurred. An other-than-temporary impairment charge is recorded when the fair value of an investment has fallen below its carrying amount and the shortfall is expected to be indefinitely or permanently unrecoverable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the difference between the fair value of businesses acquired and the fair value of the identifiable tangible and intangible net assets acquired. Goodwill is not amortized, but is assessed by individual reporting unit for impairment as circumstances warrant and at least annually. An impairment charge is recognized when and to the extent a reporting unit's carrying amount is determined to exceed its fair value. The Company operates multiple reporting units. See Note 10 for further details.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_InsuranceAndSelfInsurancePolicyTextBlock', window );">Self insurance</a></td>
<td class="text">Self-insuranceThe Company predominantly self-insures its professional and general liability and workers' compensation risks through its wholly-owned captive insurance companies, with excess or reinsurance coverage for additional protection.&#160;The Company is also predominantly self-insured with respect to employee medical and other health benefits.&#160;The Company records insurance liabilities for the professional and general liability, workers&#8217; compensation, and employee health benefit risks that it retains and estimates its liability for those risks using third party actuarial calculations that are based upon historical claims experience and expectations for future claims.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income taxes</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted both for items that do not currently have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the financial statements.</span></div>The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based compensation</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market-based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all stock-based awards is recognized net of expected forfeitures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation to be settled in shares is recorded to the Company&#8217;s shareholders&#8217; contributed capital, while stock-based compensation to be settled in cash is recorded as a liability. Shares issued upon exercise or, when applicable, vesting of stock awards, are issued from authorized but unissued shares.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Interest rate swap and cap agreements</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate cap agreements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company often carries a combination of current or forward interest rate caps on portions of its variable rate debt as a means of hedging its exposure to changes in LIBOR interest rates as part of its overall interest rate risk management strategy. These interest rate caps are not held for trading or speculative purposes and are designated as qualifying cash flow hedges. See Note 13 for further details.</span></div>The cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Noncontrolling interests</a></td>
<td class="text">Noncontrolling interestsNoncontrolling interests represent third-party equity ownership interests in entities which are consolidated by the Company for financial statement reporting purposes.<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling interests subject to put provisions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has potential obligations to purchase the equity interests held by third parties in many of its majority-owned dialysis partnerships and other nonconsolidated entities. These noncontrolling interests subject to put provisions constitute redeemable equity interests and are therefore classified as temporary equity and carried at estimated fair value on the Company's balance sheet.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, these obligations are in the form of put provisions that are exercisable at the third-party owners&#8217; discretion within specified periods outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase the third-party owners&#8217; equity interests, generally at the appraised fair market value of the equity interests or in certain cases at a predetermined multiple of earnings or cash flows attributable to the equity interests put to the Company, intended to approximate fair value. The methodology the Company uses to estimate the fair values of noncontrolling interests subject to put provisions assumes the higher of either a liquidation value of net assets or an average multiple of earnings, based on historical earnings, patient mix and other performance indicators that can affect future results, as well as other factors. The estimated fair values of noncontrolling interests subject to put provisions are a critical accounting estimate that involves significant judgments and assumptions and may not be indicative of the actual values at which the noncontrolling interests may ultimately be settled, which could vary significantly from the Company&#8217;s current estimates. The estimated fair values of noncontrolling interests subject to put provisions can fluctuate and the implicit multiple of earnings at which these noncontrolling interests obligations may be settled will vary significantly depending upon market conditions including potential purchasers&#8217; access to the capital markets, which can impact the level of competition for dialysis and non-dialysis related businesses, the economic performance of these businesses and the restricted marketability of the third-party owners&#8217; equity interests. The amount of noncontrolling interests subject to put provisions that employ a contractually predetermined multiple of earnings rather than fair value is immaterial.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value estimates</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair value estimates</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Fair value measurements are determined based on the principal or most advantageous market for the item being measured, assume that buyers and sellers are independent, willing and able to transact, and knowledgeable, with access to all information customarily available in such a transaction, and are based on assumptions that market participants would use in pricing the item, not assumptions specific to the reporting entity. The criticality of a particular fair value estimate to the Company's consolidated financial statements depends upon the nature and size of the item being measured, the extent of uncertainties involved and the nature and magnitude or potential effect of assumptions and judgments required. Certain fair value estimates can involve significant uncertainties and require significant judgment on various matters, some of which could be subject to reasonable disagreement. See Note 24 for further details.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on fair value measurements and estimates for purposes that require the recording, reassessment, or adjustment of the carrying amounts of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity). These purposes can include the accounting for business combination transactions; impairment assessments for goodwill, other intangible assets, or other long-lived assets; recurrent revaluation of investments in debt and equity securities, contingent earn-out obligations, interest rate cap agreements, and noncontrolling interests subject to put provisions; and the accounting for equity method and other investments and stock-based </span></div>compensation, as applicable. The Company has classified its assets, liabilities and temporary equity into the fair value hierarchy levels defined by the FASB reflecting their differing degrees of uncertainty. See Note 24 for further details.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New accounting standards</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New accounting standards</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards recently adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued Accounting Standards Update (ASU) No. 2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. The amendments in this ASU became effective for the Company beginning on January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. Effective January 1, 2022 certain LIBOR tenors that do not affect the Company, including the one-week and two-month U.S. dollar LIBOR rate, ceased or became non-representative. The remaining U.S. dollar LIBOR tenors will cease or become non-representative effective July 1, 2023. This change will have no impact on the Company's ability to borrow. The Company is currently assessing the other effects this guidance may have on its consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities (ASU 2021-08)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-08 requires application of ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to recognize and measure assets and liabilities from contracts with customers acquired in a business combination. This ASU creates an exception to the general recognition and measurement principle in ASC 805 and will result in recognition of contract assets and contract liabilities consistent with those recorded by the acquiree immediately before the acquisition date. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Early adoption is permitted for all entities. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per share</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either their explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Short-term and long-term investments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. The Company's long-term debt investments are bank time deposits with contractual maturities longer than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at December&#160;31, 2021 and 2020.</span>Equity securities: During the year ended December&#160;31, 2021 certain of the Company&#8217;s equity investments previously accounted for under the adjusted cost method now have readily determinable fair values from public markets. As a result, these investments were reclassified from equity method and other investments to short-term investments during that period. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#8217;s non-qualified deferred compensation plans.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Other Comprehensive (Loss) Income</a></td>
<td class="text">The reclassification of net interest rate cap realized losses into income are recorded as debt expense in the corresponding consolidated statements of income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages or maintains an ownership interest in certain legal entities subject to the consolidation guidance applicable to variable interest entities (VIEs). Almost all of these legal entities are either U.S. dialysis partnerships encumbered by guaranteed debt, U.S. dialysis limited partnerships, or other legal entities subject to nominee ownership arrangements. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under U.S. GAAP, VIEs typically include entities for which (i)&#160;the entity&#8217;s equity is not sufficient to finance its activities without additional subordinated financial support; (ii)&#160;the equity holders as a group lack the power to direct the activities that most significantly influence the entity&#8217;s economic performance, the obligation to absorb the entity&#8217;s expected losses, or the right to receive the entity&#8217;s expected returns; or (iii)&#160;the voting rights of some investors are not proportional to their obligations to absorb the entity&#8217;s losses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The substantial majority of VIEs the Company is associated with are U.S. dialysis partnerships which the Company manages and in which it maintains a controlling majority ownership interest. These U.S. dialysis partnerships are considered VIEs either because they are (i) encumbered by debt guaranteed proportionately by the partners that is considered necessary to finance the partnership's activities, or (ii) in the form of limited partnerships for which the limited partners are not considered to have substantive kick-out or participating rights. The Company consolidates virtually all such U.S. dialysis partnerships.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also relies on the operating activities of certain legal entities in which it does not maintain a controlling ownership interest but over which it has indirect influence and of which it is considered the primary beneficiary.&#160;These entities are typically subject to nominee ownership and transfer restriction agreements that effectively transfer the majority of the economic risks and rewards of their ownership to the Company. The Company&#8217;s management, restriction and other agreements concerning such nominee-owned entities typically include both financial terms and protective and participating rights to the entities&#8217; operating, strategic and non-clinical governance decisions which transfer substantial powers over and economic </span></div>responsibility for these entities to the Company. The Company consolidates all of the nominee-owned entities with which it is most closely associated.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_InsuranceAndSelfInsurancePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Insurance and self insurance policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_InsuranceAndSelfInsurancePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_OtherNonoperatingIncomeExpensePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other nonoperating income (expense), policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_OtherNonoperatingIncomeExpensePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue recognition and accounts receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265800808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Disaggregation of Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues by segment and primary payor source were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:37.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,133,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,133,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">782,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">782,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">791,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,397,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,596,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,796)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,090)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,576,167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,042,630&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,618,797&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:37.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,169,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,169,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">744,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">744,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other government</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">715,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,370,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,540,956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(145,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,743)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(162,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,514,649&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,035,955&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,550,604&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the "Other government" category to the "Medicare and Medicare Advantage" category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the year ended December&#160;31, 2020 has also been recast to conform to the current period presentation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:37.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,246,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,246,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">669,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">669,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other government</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">681,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,286,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,430,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132,325)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146,355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,430,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,898&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,388,479&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the "Other government" category to the "Medicare and Medicare Advantage" category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the year ended December&#160;31, 2019 has also been recast to conform to the current period presentation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other consists of management service fees earned in the respective Company line of business as well as other non-patient revenue from the Company's U.S. ancillary services and international operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265831336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">978,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">783,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">706,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">978,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">773,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted net income (loss) attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,936&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265817416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and long-term invesmtents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Investments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in mutual funds and common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,227&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,083&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,310&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,884&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,824&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265840120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ScheduleOfOtherReceivablesTableTextBlock', window );">Schedule of Other Receivables</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables were comprised of the following:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.935%"><tr><td style="width:1.0%"/><td style="width:56.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.908%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier rebates and non-trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">390,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare bad debt claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">427,321&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">544,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ScheduleOfOtherReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of claims held for amounts due to an entity. Examples include non-trade receivables and Medicare bad debt claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ScheduleOfOtherReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265832168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment were comprised of the following:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:66.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.467%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">496,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">400,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,828,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,865,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equipment and information systems, including internally developed software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,292,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,081,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New center and capital asset projects in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">592,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">616,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,243,107&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,002,253&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,763,135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,480,429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,479,972&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,521,824&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265860360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets other than Goodwill</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets other than goodwill were comprised of the following:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.959%"><tr><td style="width:1.0%"/><td style="width:54.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived licenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompetition agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238,423&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">236,726&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,693&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Scheduled Amortization Charges from Intangible Assets and Liabilities</a></td>
<td class="text">Scheduled amortization expenses from amortizable intangible assets as of December&#160;31, 2021 were as follows:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.286%"><tr><td style="width:1.0%"/><td style="width:37.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.032%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncompetition<br/>agreements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Customer relationships and other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,682&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,797&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Finite And Indefinite Intangible Assets Table</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265871784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method and Other Investmetns Equity Method and Other Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains equity method and other minor investments in the private securities of certain other healthcare and healthcare-related businesses, comprised as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.883%"><tr><td style="width:1.0%"/><td style="width:56.431%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.611%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.846%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.612%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">APAC joint venture</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other equity method partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted cost method and other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238,881&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,491&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161347671128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Carrying Value of Goodwill by Reportable Segments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying value of goodwill by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"/><td style="width:40.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.985%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.985%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary<br/>services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,287,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,787,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,919,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,979&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,265&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173,244&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,400,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,046,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,400,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">772,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,172,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126,207)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126,207)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,400,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646,079&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,046,241&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock', window );">Schedule of Reporting Units Goodwill Balances</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.923%"><tr><td style="width:1.0%"/><td style="width:37.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.474%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.660%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reporting unit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Goodwill<br/>balance</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Carrying amount<br/>coverage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sensitivities</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating<br/>income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Discount<br/>rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany kidney care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excess of estimated fair value of the reporting unit over its carrying amount as of the latest assessment date.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Potential impact on estimated fair value of a sustained, long-term reduction of 3% in operating income as of the latest assessment date.</span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Potential impact on estimated fair value of an increase in discount rates of 100 basis points as of the latest assessment date.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of reporting units goodwill balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161266173320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesTableTextBlock', window );">Schedule of Other Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities were comprised of the following:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.520%"><tr><td style="width:1.0%"/><td style="width:51.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.898%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.759%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payor refunds and retractions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">410,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance and self-insurance accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued non-income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709,345&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161263191624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income Before Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes from continuing operations consisted of the following:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:37.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,463,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,287,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,307,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,518,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,318,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Components of Income Tax Expense (Benefit)</a></td>
<td class="text">Income tax expense for continuing operations consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:37.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current income tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,836)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred income tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,345&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227,838&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,282)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,932&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,628&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of allocation of income tax expense (benefit) between continuing and discontinued operations.</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are allocated between continuing and discontinued operations as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"><tr><td style="width:1.0%"/><td style="width:37.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320,317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation between U.S. Federal Income Tax Rate and Effective Tax Rate</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between the Company&#8217;s effective tax rate from continuing operations and the U.S. federal income tax rate is as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.532%"><tr><td style="width:1.0%"/><td style="width:49.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.892%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.892%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.895%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal and international tax rate adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Political advocacy costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in international valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of noncontrolling interests primarily<br/>&#160;attributable to non-tax paying entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Deferred Tax Assets and Liabilities Arising from Temporary Differences</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities arising from temporary differences for continuing operations were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.830%"><tr><td style="width:1.0%"/><td style="width:56.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.495%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">584,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873,043&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">888,470&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100,616)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(114,824)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">772,427&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">773,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(644,039)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(634,736)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(283,913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(274,742)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(530,839)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(532,082)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84,407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,274)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39,690)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,580,472)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,583,246)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(808,045)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(809,600)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(830,954)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(809,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets (included in Other long-term assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 25.75pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(808,045)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(809,600)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Reconciliation of the Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet the More-Likely-Than-Not Threshold</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending liability for unrecognized tax benefits that do not meet the more-likely-than-not threshold is as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"><tr><td style="width:1.0%"/><td style="width:61.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.250%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions for tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions related to lapse of applicable statute</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(751)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reductions related to settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,378)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,024&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,202&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Allocation Of Income Tax Expense (Benefit) [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161271977752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Long-term Debt</a></td>
<td class="text">Long-term debt<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:34.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,596,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,684,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR + 1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,600,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,688,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,715,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/12/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR + 1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,681,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR + 1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/1/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,822,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,464,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition obligations and other notes<br/> payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022-2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022-2038</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,964,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,163,521&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56,685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,908,180&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,085,804&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(179,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(168,541)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,729,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,917,263&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented here approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of December&#160;31, 2021.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of December&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $4,473 and deferred financing costs of $27,207 and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $40,914 and increased by a debt premium of $15,909. As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $5,461 and deferred financing costs of $35,825, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $36,431.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Scheduled Maturities of Long-term Debt</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled maturities of long-term debt at December&#160;31, 2021 were as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.274%"><tr><td style="width:1.0%"/><td style="width:58.359%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.441%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,424,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,625,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,449,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Derivative Instruments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of December&#160;31, 2021 and December&#160;31, 2020, which are classified in other long-term assets on its consolidated balance sheet:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:23.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded OCI gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019 interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/30/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/30/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Effects of Interest Rate Swap and Cap Agreements</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of the Company&#8217;s interest rate cap agreements for the years ended December&#160;31, 2021, 2020 and 2019:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:28.328%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.102%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount of unrealized gains (losses) in OCI on interest rate cap agreements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Location of losses </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reclassification from accumulated other comprehensive income into net income</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,781)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,346)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,133&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161270731272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease Expense Components</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"/><td style="width:42.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.629%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">547,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">541,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">526,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">714,738&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">702,960&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">684,748&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>(1) Includes short-term lease expense and sublease income, which are immaterial.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeaseOtherInformationTableTextBlockTableTextBlock', window );">Lease Other Information</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"/><td style="width:42.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.629%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Lease term and discount rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"/><td style="width:42.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.629%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gains on sale leasebacks, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,833&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the <br/>&#160;measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">684,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">661,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">637,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease assets obtained in exchange<br/>&#160;for new or modified operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ScheduleOfMinimumLeasePaymentsTextBlock', window );">Schedule Of Minimum Lease Payments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancellable leases as of December&#160;31, 2021 are as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.929%"><tr><td style="width:1.0%"/><td style="width:52.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Finance leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">511,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,293,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,537,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less portion representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(470,269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,491)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,067,070&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LeaseOtherInformationTableTextBlockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Other Information in tabular disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LeaseOtherInformationTableTextBlockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ScheduleOfMinimumLeasePaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of minimum lease payments under non-cancelable operating leases and capital leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ScheduleOfMinimumLeasePaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265675928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Incentive Compensation and Shareholders&#8217; Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A combined summary of the status of the Company&#8217;s stock-settled awards under both the 2020 Plan and 2011 Plan, including base shares for stock-settled stock appreciation rights (SSARs) and stock-settled stock unit awards is as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"/><td style="width:37.754%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.890%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.827%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stock appreciation rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stock units</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise<br/>price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual&#160;life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual&#160;life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Added by performance factor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised/Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,093)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,943&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.13&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average fair value of grants:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.70&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.83&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.58&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of Range of Exercise Prices</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.269%"><tr><td style="width:1.0%"/><td style="width:28.821%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.438%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Awards Outstanding</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Awards exercisable</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Range of SSARs base prices</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$50.01&#8211;$60.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$60.01&#8211;$70.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$70.01&#8211;$80.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$100.01&#8211;$110.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,943&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted Average Valuation Inputs</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of SSAR awards granted in the periods indicated is as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"/><td style="width:40.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265779080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder's equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Shares repurchases summary table</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's repurchases of its common stock during the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"><tr><td style="width:1.0%"/><td style="width:38.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.158%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Open market repurchases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,546,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">741,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,168,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tender offers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">704,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,234,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,546,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,446,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,402,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The aggregate amounts paid for shares repurchased pursuant to the Company's 2020 and 2019 tender offers for its shares during the years ended 2020 and 2019, include their clearing prices of $88.00 and $56.50 per share, respectively, plus related fees and expenses of $2,529 and $2,343, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock', window );">Net effect of transfers from to noncontrolling interests on stock holders equity disclosure</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of changes in DaVita Inc.&#8217;s ownership interests in consolidated subsidiaries on the Company&#8217;s consolidated equity were as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"><tr><td style="width:1.0%"/><td style="width:52.967%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.649%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">978,450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">773,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in paid-in capital for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,853)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales of noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net transfers in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,117)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,145)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc. net of transfers in <br/>&#160;noncontrolling interests</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">964,333&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">778,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">773,836&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Effect Of Transfers From (To) Noncontrolling Interests on Stock Holders Equity Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265707064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in Other Comprehensive (Loss) Income</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges and credits to other comprehensive (loss) income have been as follows:&#160;</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"><tr><td style="width:1.0%"/><td style="width:48.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.107%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate<br/>cap agreements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated other<br/>comprehensive<br/>(loss) income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,961)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,963)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,924)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,102)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,536)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,102)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,951)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,433)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,065)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,498)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized losses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,781)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,080)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,861)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(543)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,346)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,623)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,969)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53,688)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66,154)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,532&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83,375)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(73,843)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,383)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84,381)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,226)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of income into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,178)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(138,069)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(139,247)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260848888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock', window );">Schedule of Components of Routine Acquisitions</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, 2020, and 2019 the Company acquired dialysis businesses and other businesses, including a transplant software company, as follows:</span></div><div style="margin-top:9pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.192%"><tr><td style="width:1.0%"/><td style="width:52.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.864%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred purchase price and liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate consideration</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">212,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of dialysis centers acquired &#8212; U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of dialysis centers acquired &#8212; International</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Aggregate Purchase Cost Allocations for Acquisitions</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.795%"><tr><td style="width:1.0%"/><td style="width:52.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompetition agreements and other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,962)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,068)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,921)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,729)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,762)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">212,130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,698&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock', window );">Schedule of other information related to acquired intangibles and goodwill</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes weighted-average estimated useful lives of amortizable intangible assets acquired during 2021, 2020 and 2019, as well as goodwill deductible for tax purposes associated with these acquisitions:</span></div><div style="margin-top:6pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.900%"><tr><td style="width:1.0%"/><td style="width:56.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average estimated useful lives (in years):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncompetition agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill deductible for tax purposes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Pro Forma Summary of Results of Operations</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions within continuing operations in 2021 and 2020 had been consummated as of the beginning of 2020, including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"><tr><td style="width:1.0%"/><td style="width:62.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.618%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.741%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pro forma total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,678,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,722,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pro forma net income from continuing operations attributable to<br/>&#160;DaVita Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">985,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">797,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pro forma basic net income per share from continuing operations<br/>&#160;attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pro forma diluted net income per share from continuing operations<br/>&#160;attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Reconciliation of Changes in Contingent Earn-Out Obligations</a></td>
<td class="text">The following is a reconciliation of changes in contingent earn-out liabilities for the years ended December&#160;31, 2021 and 2020:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"><tr><td style="width:1.0%"/><td style="width:55.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.086%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.088%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,688)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments or other settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,536)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,062)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,600&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of other information related to acquisitions, including weighted-average estimated useful lives of intangible assets acquired, and goodwill deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of acquisition of assets or a business through noncash (or part noncash) transactions. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Disclosure may include the equity interest acquired, value of assets acquired, value of liabilities acquired, net monetary assets acquired, number of shares, warrants or options issued as consideration for a business or asset acquired and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161266154328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale and Discontinued Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Summary of Information Related to Assets Held For Sale and Discontinued Operations</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the financial results of discontinued operations related to DMG:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"><tr><td style="width:1.0%"/><td style="width:70.457%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,713,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,543,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations before taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale of discontinued operations before taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,657&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income from discontinued operations, net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,653)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ReconciliationOfCashFlowsTableTextBlock', window );">Reconciliation of Cash Flows</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cash flows of discontinued operations related to DMG:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:414.00pt"><tr><td style="width:1.0pt"/><td style="width:294.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:55.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:55.00pt"/><td style="width:1.0pt"/></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ReconciliationOfCashFlowsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation Of Cash Flows [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ReconciliationOfCashFlowsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265718296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Values of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s assets, liabilities and temporary equity measured at fair value on a recurring basis as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Quoted&#160;prices&#160;in<br/>active&#160;markets&#160;for<br/>identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant&#160;other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,203&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,203&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,434,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,434,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,330,028&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,330,028&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161270799096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,551,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,475,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,399,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,641,618&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,619,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,530,885&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:54pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,666,963&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,659,935&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,562,906&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">662,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">497,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">484,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total ancillary services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,046,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,052,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">971,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,713,887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,712,633&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,534,834&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,090)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(162,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146,355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,618,797&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,550,604&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,388,479&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment operating margin (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,974,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,917,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,924,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66,003)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76,261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(189,174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total segment margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,908,985&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,841,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,735,652&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of segment operating margin to consolidated income from<br/>&#160;continuing operations before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111,615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146,707)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(92,335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,797,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,694,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(285,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(304,111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(443,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt prepayment, refinancing and redemption charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89,022)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,518,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,318,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity investment income of $3,177, $5,866, and $9,366 in 2021, 2020 and 2019, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock', window );">Summary of Depreciation and Amortization Expense by Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:48.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.072%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">594,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">583,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">680,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">630,435&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615,152&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock', window );">Summary of Expenditures for Property and Equipment by Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for property and equipment by reportable segment were as follows:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:48.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.071%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.072%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">589,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">681,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DMG - Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">641,465&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">674,541&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">766,546&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Summary of Assets by Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summary of assets by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"/><td style="width:58.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.406%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. dialysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,375,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,344,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other - Ancillary services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,746,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,121,488&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,988,516&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity method and other investments of $112,500 and $122,974 in 2021 and 2020, respectively. </span></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes equity method and other investments of $126,381 and 134,517 in 2021 and 2020, respectively and includes approximately $190,029 and $181,137 in 2021 and 2020, respectively, of net property and equipment related to the Company&#8217;s international operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of capital expenditures for property and equipment from segment to consolidated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265729080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides supplemental cash flow information:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"><tr><td style="width:1.0%"/><td style="width:49.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">473,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets under financing lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265777592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock', window );">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II&#8212;VALUATION AND QUALIFYING ACCOUNTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:45.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.772%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at<br/>beginning of year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts<br/>charged to income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts written off</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance<br/>at end of year</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for uncollectible accounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure Table Text Block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257248184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>clinic </div>
<div>entity </div>
<div>patient </div>
<div>state </div>
<div>country</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor', window );">Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor</a></td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests', window );">Number of legal entities that third parties held noncontrolling equity interests | entity</a></td>
<td class="nump">717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfSites', window );">Number of dialysis centers that the company operated or provided administrative services | clinic</a></td>
<td class="nump">2,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states where dialysis centers are located | state</a></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfCustomers', window );">Number of patients served | patient</a></td>
<td class="nump">203,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=dva_InternationalOperationsMember', window );">International Operations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfSites', window );">Number of dialysis centers that the company operated or provided administrative services | clinic</a></td>
<td class="nump">339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfCustomers', window );">Number of patients served | patient</a></td>
<td class="nump">39,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which dialysis centers located | country</a></td>
<td class="nump">10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of entities that third parties held non controlling equity interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NumberOfSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of sites.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NumberOfSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Organization consolidation and presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=dva_InternationalOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=dva_InternationalOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260070936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable Revenue Recognition Segment Revenue by Payor (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">$ 405,282<span></span>
</td>
<td class="nump">$ 524,353<span></span>
</td>
<td class="nump">$ 491,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">11,618,797<span></span>
</td>
<td class="nump">11,550,604<span></span>
</td>
<td class="nump">11,388,479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(95,090)<span></span>
</td>
<td class="num">(162,029)<span></span>
</td>
<td class="num">(146,355)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember', window );">Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">6,133,235<span></span>
</td>
<td class="nump">6,169,226<span></span>
</td>
<td class="nump">6,246,636<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">326,696<span></span>
</td>
<td class="nump">419,662<span></span>
</td>
<td class="nump">264,538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember', window );">Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">782,430<span></span>
</td>
<td class="nump">744,862<span></span>
</td>
<td class="nump">669,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">1,321<span></span>
</td>
<td class="nump">1,227<span></span>
</td>
<td class="nump">606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember', window );">Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">791,641<span></span>
</td>
<td class="nump">715,298<span></span>
</td>
<td class="nump">681,836<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember', window );">Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">3,596,721<span></span>
</td>
<td class="nump">3,540,956<span></span>
</td>
<td class="nump">3,430,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">15,553<span></span>
</td>
<td class="nump">33,246<span></span>
</td>
<td class="nump">130,823<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">66,290<span></span>
</td>
<td class="nump">88,156<span></span>
</td>
<td class="nump">110,961<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">10,576,167<span></span>
</td>
<td class="nump">10,514,649<span></span>
</td>
<td class="nump">10,430,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(90,796)<span></span>
</td>
<td class="num">(145,286)<span></span>
</td>
<td class="num">(132,325)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">6,133,235<span></span>
</td>
<td class="nump">6,169,226<span></span>
</td>
<td class="nump">6,246,636<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">782,430<span></span>
</td>
<td class="nump">744,862<span></span>
</td>
<td class="nump">669,089<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">328,256<span></span>
</td>
<td class="nump">334,714<span></span>
</td>
<td class="nump">329,071<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">3,397,697<span></span>
</td>
<td class="nump">3,370,562<span></span>
</td>
<td class="nump">3,286,089<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">25,345<span></span>
</td>
<td class="nump">40,571<span></span>
</td>
<td class="nump">32,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,042,630<span></span>
</td>
<td class="nump">1,035,955<span></span>
</td>
<td class="nump">957,898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services | Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(4,294)<span></span>
</td>
<td class="num">(16,743)<span></span>
</td>
<td class="num">(14,030)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services | Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">326,696<span></span>
</td>
<td class="nump">419,662<span></span>
</td>
<td class="nump">264,538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services | Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">1,321<span></span>
</td>
<td class="nump">1,227<span></span>
</td>
<td class="nump">606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services | Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">463,385<span></span>
</td>
<td class="nump">380,584<span></span>
</td>
<td class="nump">352,765<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services | Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">199,024<span></span>
</td>
<td class="nump">170,394<span></span>
</td>
<td class="nump">144,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">15,553<span></span>
</td>
<td class="nump">33,246<span></span>
</td>
<td class="nump">130,823<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">$ 40,945<span></span>
</td>
<td class="nump">$ 47,585<span></span>
</td>
<td class="nump">$ 78,940<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161264625000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 1,957,583<span></span>
</td>
<td class="nump">$ 1,824,282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareMember', window );">Medicare bad debt claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">1,174,123<span></span>
</td>
<td class="nump">$ 1,101,837<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue', window );">Percentage Of Accounts Receivable Six Months Or More Past Due</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AccountsReceivablePeriodOutstanding', window );">Accounts Receivable Period Outstanding</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue', window );">Accounts Receivable, Noncurrent, Threshold Period Past Due</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Accounts Receivable | Third-Party Payor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfConcentrationRiskCustomers', window );">Number of concentration risk customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AccountsReceivablePeriodOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Patient accounts receivable months outstanding to be reserved per company policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AccountsReceivablePeriodOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NumberOfConcentrationRiskCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Concentration Risk Customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NumberOfConcentrationRiskCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Accounts Receivable , 6 months or More Past Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period for when accounts receivable, classified as noncurrent, is considered past due, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes threshold period past due to write off as uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=us-gaap_ThirdPartyPayorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=us-gaap_ThirdPartyPayorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161259962264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Net income (loss) attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net income from continuing operations</a></td>
<td class="nump">$ 978,450<span></span>
</td>
<td class="nump">$ 783,295<span></span>
</td>
<td class="nump">$ 706,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net (loss) income from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,653)<span></span>
</td>
<td class="nump">104,149<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="nump">$ 978,450<span></span>
</td>
<td class="nump">$ 773,642<span></span>
</td>
<td class="nump">$ 810,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted average shares outstanding during the period (in shares)</a></td>
<td class="nump">105,230,000<span></span>
</td>
<td class="nump">119,797,000<span></span>
</td>
<td class="nump">153,181,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Assumed incremental shares from stock plans (in shares)</a></td>
<td class="nump">4,718,000<span></span>
</td>
<td class="nump">2,826,000<span></span>
</td>
<td class="nump">631,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares - diluted (in shares)</a></td>
<td class="nump">109,948,000<span></span>
</td>
<td class="nump">122,623,000<span></span>
</td>
<td class="nump">153,812,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic net income (loss) attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic net income from continuing operations (in usd per share)</a></td>
<td class="nump">$ 9.30<span></span>
</td>
<td class="nump">$ 6.54<span></span>
</td>
<td class="nump">$ 4.61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.08)<span></span>
</td>
<td class="nump">0.68<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="nump">9.30<span></span>
</td>
<td class="nump">6.46<span></span>
</td>
<td class="nump">5.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted net income (loss) attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted net income from continuing operations per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="nump">8.90<span></span>
</td>
<td class="nump">6.39<span></span>
</td>
<td class="nump">4.60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Diluted net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.08)<span></span>
</td>
<td class="nump">0.67<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share attributable to DaVita Inc. (in usd per share)</a></td>
<td class="nump">$ 8.90<span></span>
</td>
<td class="nump">$ 6.31<span></span>
</td>
<td class="nump">$ 5.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive stock-settled awards excluded from calculation (in shares)</a></td>
<td class="nump">116,000<span></span>
</td>
<td class="nump">2,301,000<span></span>
</td>
<td class="nump">5,936,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesIssuedBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260392744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Restricted Cash and Equivalents - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and equivalents</a></td>
<td class="nump">$ 93,060<span></span>
</td>
<td class="nump">$ 176,832<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfPartnerships', window );">Number Of Businesses</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NumberOfPartnerships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Partnerships that are included in the Equity Investments category.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NumberOfPartnerships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257476168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-term and long-term investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">$ 23,226<span></span>
</td>
<td class="nump">$ 8,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, FV-NI</a></td>
<td class="nump">48,598<span></span>
</td>
<td class="nump">44,077<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">71,824<span></span>
</td>
<td class="nump">52,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesCurrent', window );">Debt securities, short-term investments</a></td>
<td class="nump">8,227<span></span>
</td>
<td class="nump">8,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Total Short-term investments</a></td>
<td class="nump">22,310<span></span>
</td>
<td class="nump">20,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesNoncurrent', window );">Debt securities, long-term investments</a></td>
<td class="nump">14,999<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Total Long-term investments</a></td>
<td class="nump">49,514<span></span>
</td>
<td class="nump">32,193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember', window );">Certificates of deposit and other time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">23,226<span></span>
</td>
<td class="nump">8,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">23,226<span></span>
</td>
<td class="nump">8,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember', window );">Investments in mutual funds and common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, FV-NI</a></td>
<td class="nump">48,598<span></span>
</td>
<td class="nump">44,077<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">48,598<span></span>
</td>
<td class="nump">44,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, FV-NI</a></td>
<td class="nump">14,083<span></span>
</td>
<td class="nump">11,884<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember', window );">Other long-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities, FV-NI</a></td>
<td class="nump">$ 34,515<span></span>
</td>
<td class="nump">$ 32,193<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161270775880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and long-term investments - Additional Information (Details) - Investments in mutual funds and common stock - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Equity Securities, FV-NI, Gain (Loss)</a></td>
<td class="num">$ (3,768)<span></span>
</td>
<td class="nump">$ 3,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGain', window );">Equity Securities, FV-NI, Realized Gain</a></td>
<td class="nump">1,762<span></span>
</td>
<td class="nump">1,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities', window );">Net Increase (Decrease) In Unrealized Losses On Equity Securities</a></td>
<td class="nump">$ 5,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities', window );">Net Increase (Decrease) In Unrealized Gains On Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,877<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase Decrease In Unrealized Gains On Equity Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase Decrease In Unrealized Losses On Equity Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161263215336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Receivables (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">$ 427,321<span></span>
</td>
<td class="nump">$ 544,376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=dva_SupplierRebatesAndOtherNonTradeReceivablesMember', window );">Supplier rebates and non-trade receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">294,574<span></span>
</td>
<td class="nump">390,508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=dva_MedicareMember', window );">Medicare bad debt claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">$ 132,747<span></span>
</td>
<td class="nump">$ 153,868<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=dva_SupplierRebatesAndOtherNonTradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=dva_SupplierRebatesAndOtherNonTradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=dva_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=dva_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161264326056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 34,009<span></span>
</td>
<td class="nump">$ 37,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings</a></td>
<td class="nump">496,455<span></span>
</td>
<td class="nump">400,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">3,828,404<span></span>
</td>
<td class="nump">3,865,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Equipment and information systems, including internally developed software</a></td>
<td class="nump">3,292,176<span></span>
</td>
<td class="nump">3,081,298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">New center and capital asset projects in progress</a></td>
<td class="nump">592,063<span></span>
</td>
<td class="nump">616,686<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross, total</a></td>
<td class="nump">8,243,107<span></span>
</td>
<td class="nump">8,002,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(4,763,135)<span></span>
</td>
<td class="num">(4,480,429)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 3,479,972<span></span>
</td>
<td class="nump">$ 3,521,824<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257224616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation expense on property and equipment</a></td>
<td class="nump">$ 667,755<span></span>
</td>
<td class="nump">$ 616,626<span></span>
</td>
<td class="nump">$ 600,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest</a></td>
<td class="nump">$ 15,275<span></span>
</td>
<td class="nump">$ 17,944<span></span>
</td>
<td class="nump">$ 27,322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, and equipment useful lives</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, and equipment useful lives</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, and equipment useful lives</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Equipment and Information Systems | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, and equipment useful lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Equipment and Information Systems | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, and equipment useful lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161266027560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangibles - Amortizable Intangible Assets Other Than Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived licenses</a></td>
<td class="nump">$ 104,214<span></span>
</td>
<td class="nump">$ 100,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedNoncompeteAgreementsGross', window );">Noncompetition agreements</a></td>
<td class="nump">70,495<span></span>
</td>
<td class="nump">84,022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIndefiniteLivedIntangibleAssets', window );">Customer relationships and other</a></td>
<td class="nump">63,714<span></span>
</td>
<td class="nump">52,566<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross (excluding goodwill)</a></td>
<td class="nump">238,423<span></span>
</td>
<td class="nump">236,726<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="num">(60,730)<span></span>
</td>
<td class="num">(70,141)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets</a></td>
<td class="nump">$ 177,693<span></span>
</td>
<td class="nump">$ 166,585<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedNoncompeteAgreementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date of payments made to third parties in exchange for their agreement not to engage in specified competitive practices in specified geographic territories for a specified period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedNoncompeteAgreementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after impairment of indefinite-lived intangible assets classified as other. Excludes financial assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257227496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangibles - Scheduled Amortization Charges from Intangible Assets and Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompetition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ExpectedAmortizationExpenseLineItems', window );"><strong>Expected Amortization Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 7,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">4,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">2,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">1,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,260<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">17,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember', window );">Customer relationships and other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ExpectedAmortizationExpenseLineItems', window );"><strong>Expected Amortization Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">4,695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">4,669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">4,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">4,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">4,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">33,775<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 55,797<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ExpectedAmortizationExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected Amortization Expense [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ExpectedAmortizationExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161259968104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense from amortizable intangible assets, other than lease agreements</a></td>
<td class="nump">$ 12,860<span></span>
</td>
<td class="nump">$ 13,809<span></span>
</td>
<td class="nump">$ 14,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompetition agreements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-Lived Intangible Assets, Remaining Amortization Period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompetition agreements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-Lived Intangible Assets, Remaining Amortization Period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension', window );">Acquired Finite-lived Intangible Asset, Weighted-Average Period before Renewal or Extension</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-Lived Intangible Assets, Remaining Amortization Period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-Lived Intangible Assets, Remaining Amortization Period</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period before the next renewal or extension for intangible assets with renewal or extension terms, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161259917224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity Method and Other Investmetns Equity Method and Other Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">$ 238,881<span></span>
</td>
<td class="nump">$ 257,491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dva_DeconsolidatedNoncontrollingEntityMember', window );">APAC JV - Deconsolidated Noncontrolling Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">109,153<span></span>
</td>
<td class="nump">120,787<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Adjusted cost method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">14,543<span></span>
</td>
<td class="nump">29,105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_OtherOwnershipInterestMember', window );">Other equity method partnerships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">$ 115,185<span></span>
</td>
<td class="nump">$ 107,599<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dva_DeconsolidatedNoncontrollingEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dva_DeconsolidatedNoncontrollingEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_OtherOwnershipInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_OtherOwnershipInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260047768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method and Other Investments - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Equity Method Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity investment income (loss)</a></td>
<td class="nump">$ 26,937<span></span>
</td>
<td class="nump">$ 26,916<span></span>
</td>
<td class="nump">$ 12,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Equity method investment, significant impairments and other valuation adjustments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dva_ParentCompanyAndRestrictedSubsidiariesMember', window );">Company and Restricted Subsidiaries(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Equity Method Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage by Parent</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dva_DeconsolidatedNoncontrollingEntityMember', window );">APAC JV - Deconsolidated Noncontrolling Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Equity Method Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Current economic interest in the APAC JV, Owned by Noncontrolling Investors</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Company and Restricted Subsidiaries(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Equity Method Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage by Parent</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Company and Restricted Subsidiaries(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Equity Method Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage by Parent</a></td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember', window );">Equity method investments in nonconsolidated businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Equity Method Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity investment income (loss)</a></td>
<td class="nump">$ 26,937<span></span>
</td>
<td class="nump">$ 26,916<span></span>
</td>
<td class="nump">$ 12,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NumberOfPartnerships', window );">Number of partnerships</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NumberOfPartnerships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Partnerships that are included in the Equity Investments category.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NumberOfPartnerships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=124268079&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dva_ParentCompanyAndRestrictedSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dva_ParentCompanyAndRestrictedSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dva_DeconsolidatedNoncontrollingEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dva_DeconsolidatedNoncontrollingEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257418568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Changes in Carrying Value of Goodwill by Reportable Segments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 6,919,109<span></span>
</td>
<td class="nump">$ 6,787,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">173,244<span></span>
</td>
<td class="nump">130,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="num">(1,745)<span></span>
</td>
<td class="num">(8,293)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="num">(44,367)<span></span>
</td>
<td class="nump">9,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">7,046,241<span></span>
</td>
<td class="nump">6,919,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">7,172,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="num">(126,207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">6,309,928<span></span>
</td>
<td class="nump">6,287,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">91,979<span></span>
</td>
<td class="nump">24,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="num">(1,745)<span></span>
</td>
<td class="num">(1,549)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">6,400,162<span></span>
</td>
<td class="nump">6,309,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">6,400,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">609,181<span></span>
</td>
<td class="nump">500,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">81,265<span></span>
</td>
<td class="nump">105,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,744)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="num">(44,367)<span></span>
</td>
<td class="nump">9,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">646,079<span></span>
</td>
<td class="nump">$ 609,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">772,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="num">$ (126,207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161259967048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Schedule of Reporting Units Goodwill Balances (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 7,046,241<span></span>
</td>
<td class="nump">$ 6,919,109<span></span>
</td>
<td class="nump">$ 6,787,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment', window );">Percentage change in operating income used to evaluate fair value of reporting unit for goodwill assessment</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment', window );">Percentage change in discount rate used to evaluate fair value of reporting unit for goodwill assessment</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember', window );">Kidney Care | GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 298,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount', window );">Carrying amount coverage</a></td>
<td class="nump">6.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PotentialImpactOnFairValueForReductionInOperatingIncome', window );">Sensitivities, Operating Income</a></td>
<td class="num">(1.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate', window );">Sensitivities, Discount rate</a></td>
<td class="num">(9.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage change in discount rate used to evaluate fair value of reporting unit for goodwill assessment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage change in operating income used to evaluate fair value of reporting unit for goodwill assessment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Impact On Fair Value For Basis Point Increase In Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PotentialImpactOnFairValueForReductionInOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Impact On Fair Value For Reduction In Operating Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PotentialImpactOnFairValueForReductionInOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reporting unit percentage of fair value in excess of short of carrying amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161259973544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 124,892<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember', window );">Other reporting units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments | segment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember', window );">Other reporting units | GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember', window );">Kidney Care | GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119,476<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_KidneyCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161272112568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PayorRefundsAndRetractions', window );">Payor refunds and retractions</a></td>
<td class="nump">$ 410,038<span></span>
</td>
<td class="nump">$ 371,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedInsuranceCurrent', window );">Insurance and self-insurance accruals</a></td>
<td class="nump">55,548<span></span>
</td>
<td class="nump">54,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">32,926<span></span>
</td>
<td class="nump">30,066<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Accrued non-income tax liabilities</a></td>
<td class="nump">41,784<span></span>
</td>
<td class="nump">39,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">169,049<span></span>
</td>
<td class="nump">315,767<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">$ 709,345<span></span>
</td>
<td class="nump">$ 810,529<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PayorRefundsAndRetractions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payor Refunds And Retractions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PayorRefundsAndRetractions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedInsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedInsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161270863256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income Before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="nump">$ 1,463,029<span></span>
</td>
<td class="nump">$ 1,287,976<span></span>
</td>
<td class="nump">$ 1,307,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International</a></td>
<td class="nump">55,465<span></span>
</td>
<td class="nump">30,286<span></span>
</td>
<td class="num">(111,860)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total</a></td>
<td class="nump">$ 1,518,494<span></span>
</td>
<td class="nump">$ 1,318,262<span></span>
</td>
<td class="nump">$ 1,195,439<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161259993112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Tax Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 216,539<span></span>
</td>
<td class="nump">$ 47,171<span></span>
</td>
<td class="nump">$ 208,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">15,601<span></span>
</td>
<td class="nump">21,442<span></span>
</td>
<td class="nump">58,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">International</a></td>
<td class="nump">14,247<span></span>
</td>
<td class="nump">17,481<span></span>
</td>
<td class="nump">15,545<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax</a></td>
<td class="nump">246,387<span></span>
</td>
<td class="nump">86,094<span></span>
</td>
<td class="nump">281,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">59,528<span></span>
</td>
<td class="nump">198,623<span></span>
</td>
<td class="nump">44,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">5,342<span></span>
</td>
<td class="nump">27,206<span></span>
</td>
<td class="num">(25,836)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">International</a></td>
<td class="num">(4,525)<span></span>
</td>
<td class="nump">2,009<span></span>
</td>
<td class="num">(20,709)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Total deferred income tax</a></td>
<td class="nump">60,345<span></span>
</td>
<td class="nump">227,838<span></span>
</td>
<td class="num">(2,282)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Continuing operations</a></td>
<td class="nump">$ 306,732<span></span>
</td>
<td class="nump">$ 313,932<span></span>
</td>
<td class="nump">$ 279,628<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161271649016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Income Taxes - Allocation of Income Tax Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Continuing operations</a></td>
<td class="nump">$ 306,732<span></span>
</td>
<td class="nump">$ 313,932<span></span>
</td>
<td class="nump">$ 279,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod', window );">Discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,657<span></span>
</td>
<td class="nump">40,689<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems', window );">Income tax (benefit) expense from continuing and discontinued operations</a></td>
<td class="nump">$ 306,732<span></span>
</td>
<td class="nump">$ 315,589<span></span>
</td>
<td class="nump">$ 320,317<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) attributable to income (loss) from operations classified as a discontinued operation. Excludes tax expense (benefit) for gain (loss) on disposal and for provision for gain (loss) until disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current tax expense (benefit) and deferred tax expense (benefit) pertaining to income (loss) from continuing operations and income (loss) from discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121829364&amp;loc=d3e40084-109325<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161259986936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation Between U.S. Federal Income Tax Rate and Our Effective Tax Rate From Continuing Operations (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Equity compensation</a></td>
<td class="num">(2.40%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Federal and international tax rate adjustments</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment', window );">Nondeductible executive compensation</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Political advocacy costs</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies', window );">Unrecognized tax benefits</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in international valuation allowance</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense', window );">Impact of noncontrolling interests primarily attributable to non-tax paying entities</a></td>
<td class="num">(3.60%)<span></span>
</td>
<td class="num">(4.80%)<span></span>
</td>
<td class="num">(4.90%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">20.20%<span></span>
</td>
<td class="nump">23.80%<span></span>
</td>
<td class="nump">23.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_EffectiveIncomeTaxReconciliationInvestmentImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Investment Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_EffectiveIncomeTaxReconciliationInvestmentImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257400872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax and Liabilities Arising from Temporary Differences (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DeferredTaxAssetsReceivables', window );">Receivables</a></td>
<td class="nump">$ 8,430<span></span>
</td>
<td class="nump">$ 9,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">67,993<span></span>
</td>
<td class="nump">64,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DeferredTaxAssetsOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">581,199<span></span>
</td>
<td class="nump">584,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">162,987<span></span>
</td>
<td class="nump">167,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">52,434<span></span>
</td>
<td class="nump">62,110<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">873,043<span></span>
</td>
<td class="nump">888,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(100,616)<span></span>
</td>
<td class="num">(114,824)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">772,427<span></span>
</td>
<td class="nump">773,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(644,039)<span></span>
</td>
<td class="num">(634,736)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(283,913)<span></span>
</td>
<td class="num">(274,742)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DeferredTaxLiabilitiesOperatingLeaseAssets', window );">Operating lease assets</a></td>
<td class="num">(530,839)<span></span>
</td>
<td class="num">(532,082)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInvestments', window );">Investments in partnerships</a></td>
<td class="num">(84,407)<span></span>
</td>
<td class="num">(101,996)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(37,274)<span></span>
</td>
<td class="num">(39,690)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(1,580,472)<span></span>
</td>
<td class="num">(1,583,246)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">(808,045)<span></span>
</td>
<td class="num">(809,600)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=dva_DeferredTaxLiabilitiesMember', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">(830,954)<span></span>
</td>
<td class="num">(809,600)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 22,909<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DeferredTaxAssetsOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DeferredTaxAssetsOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DeferredTaxAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DeferredTaxAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DeferredTaxLiabilitiesOperatingLeaseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from operating lease assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DeferredTaxLiabilitiesOperatingLeaseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=dva_DeferredTaxLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=dva_DeferredTaxLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257476360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet More-Likely-Than-Not Threshold (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="nump">$ 70,202<span></span>
</td>
<td class="nump">$ 68,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions for tax positions related to current year</a></td>
<td class="nump">3,335<span></span>
</td>
<td class="nump">2,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions related to prior years</a></td>
<td class="nump">22,616<span></span>
</td>
<td class="nump">258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions related to lapse of applicable statute</a></td>
<td class="num">(751)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Reductions related to settlements with taxing authorities</a></td>
<td class="num">(22,378)<span></span>
</td>
<td class="num">(430)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="nump">$ 73,024<span></span>
</td>
<td class="nump">$ 70,202<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260127720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 306,732<span></span>
</td>
<td class="nump">$ 313,932<span></span>
</td>
<td class="nump">$ 279,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Liability for unrecognized tax benefits</a></td>
<td class="nump">73,024<span></span>
</td>
<td class="nump">70,202<span></span>
</td>
<td class="nump">$ 68,214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">68,708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Increase in liability for unrecognized tax benefits</a></td>
<td class="nump">2,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties related to unrecognized tax benefits, net of federal tax benefits</a></td>
<td class="nump">15,275<span></span>
</td>
<td class="nump">$ 17,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">42,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=dva_IndefiniteLifeNetOperatingLossesMember', window );">Indefinite Life Net Operating Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (decrease) in valuation allowance related to changes in the estimated tax benefit</a></td>
<td class="num">(14,208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember', window );">Purchases Of Noncontrolling Interests In Consolidated Partnerships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (decrease) in valuation allowance related to changes in the estimated tax benefit</a></td>
<td class="nump">46,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">16,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Deferred taxes from partnership buyouts</a></td>
<td class="nump">62,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember', window );">Capital Loss Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">State capital loss carryforward, amount</a></td>
<td class="nump">$ 313,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">State capital loss carryforward, expiration date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 85,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Operating loss carryforwards, expiration date</a></td>
<td class="text">Dec. 31,  2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority | Tax Year 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Operating loss carryforwards, expiration date</a></td>
<td class="text">Dec. 31,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 554,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Operating loss carryforwards, expiration date</a></td>
<td class="text">Dec. 31,  2041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 291,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Operating loss carryforwards, expiration date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of each operating loss carryforward included in operating loss carryforward, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the tax credit carryforward, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=dva_IndefiniteLifeNetOperatingLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=dva_IndefiniteLifeNetOperatingLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=dva_TaxYear2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=dva_TaxYear2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161266969784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 26, 2021</div></th>
<th class="th"><div>Jun. 09, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.28%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract', window );"><strong>Acquisition obligations, other notes payable, and financing lease obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract', window );"><strong>Long-term debt totals:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt principal outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,964,865<span></span>
</td>
<td class="nump">$ 8,163,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DiscountAndDeferredFinanceCosts', window );">Discount and deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56,685)<span></span>
</td>
<td class="num">(77,717)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Carrying amount of long-term debt, net of unamortized discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,908,180<span></span>
</td>
<td class="nump">8,085,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(179,030)<span></span>
</td>
<td class="num">(168,541)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,729,150<span></span>
</td>
<td class="nump">7,917,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember', window );">Senior Notes 4.625% due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000<span></span>
</td>
<td class="nump">$ 2,750,000<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Jun.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,822,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember', window );">Senior Notes 3.75% due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 15,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,464,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Acquisition obligations and other notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract', window );"><strong>Acquisition obligations, other notes payable, and financing lease obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AcquisitionObligationsAndOtherNotesPayable', window );">Acquisition obligations and other notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130,599<span></span>
</td>
<td class="nump">164,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument, maturity date, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2022-2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AcquisitionObligationsAndOtherNotesPayableFairValue', window );">Acquisition obligations and other notes payable, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember', window );">Financing Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract', window );"><strong>Acquisition obligations, other notes payable, and financing lease obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Financing lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299,128<span></span>
</td>
<td class="nump">$ 274,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument, maturity date, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2022-2038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance lease, weighted average discount rate, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.54%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember', window );">Financing Lease | Ground Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract', window );"><strong>Acquisition obligations, other notes payable, and financing lease obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument, maturity date, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR + 1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,596,875<span></span>
</td>
<td class="nump">1,684,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR + 1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Senior Secured Credit Facilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,688,263<span></span>
</td>
<td class="nump">2,715,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR + 1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableAbstract', window );"><strong>Senior Notes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,681,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember', window );">Senior Secured Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, footnotes to the table</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,473<span></span>
</td>
<td class="nump">5,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred Offering Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,207<span></span>
</td>
<td class="nump">35,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, footnotes to the table</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred Offering Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,914<span></span>
</td>
<td class="nump">$ 36,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt Instrument, Unamortized Premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AcquisitionObligationsAndOtherNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AcquisitionObligationsAndOtherNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AcquisitionObligationsAndOtherNotesPayableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition Obligations And Other Notes Payable, Fair Value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AcquisitionObligationsAndOtherNotesPayableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DiscountAndDeferredFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount and deferred finance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DiscountAndDeferredFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of reference rate used for variable rate of debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescriptionOfVariableRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=dva_GroundLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=dva_GroundLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161264737656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Scheduled Maturities of Long-term Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 179,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">218,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">1,424,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">67,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">2,625,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 4,449,522<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257319480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Derivative Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of debt expense reclassified from accumulated OCI into income</a></td>
<td class="nump">$ 4,133<span></span>
</td>
<td class="nump">$ 5,313<span></span>
</td>
<td class="nump">$ 6,377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member', window );">2019 Interest Rate Cap Agreements Effective June 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInceptionDates', window );">Derivative, effective date</a></td>
<td class="text">Jun. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeMaturityDates', window );">Derivative, expiration date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member', window );">2019 Interest Rate Cap Agreements Effective June 30, 2020 | Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value, gross asset</a></td>
<td class="nump">$ 12,203<span></span>
</td>
<td class="nump">$ 2,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member', window );">2019 Interest Rate Cap Agreements Effective June 30, 2020 | Cash Flow Hedging | Debt Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Recorded Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="nump">9,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member', window );">2019 Interest Rate Cap Agreements Effective June 30, 2020 | Term Loan Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts of interest rate agreements</a></td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">LIBOR plus interest margin</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInceptionDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the entity entered into the derivative contract, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInceptionDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeMaturityDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the derivative contract matures, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeMaturityDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257438360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Effects of Interest Rate Swap and Cap Agreements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Amount of unrealized gains (losses) in OCI on interest rate cap agreements</a></td>
<td class="nump">$ 7,155<span></span>
</td>
<td class="num">$ (16,346)<span></span>
</td>
<td class="nump">$ 1,151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Amount of unrealized gains (losses) in OCI on interest rate cap agreements</a></td>
<td class="nump">7,155<span></span>
</td>
<td class="num">(16,346)<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Reclassification from accumulated other comprehensive income into net income</a></td>
<td class="nump">4,133<span></span>
</td>
<td class="nump">5,313<span></span>
</td>
<td class="nump">6,377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Related income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Amount of unrealized gains (losses) in OCI on interest rate cap agreements</a></td>
<td class="num">(2,377)<span></span>
</td>
<td class="nump">5,435<span></span>
</td>
<td class="num">(415)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Reclassification from accumulated other comprehensive income into net income</a></td>
<td class="num">(1,376)<span></span>
</td>
<td class="num">(1,768)<span></span>
</td>
<td class="num">(2,214)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Interest rate cap agreements | Debt Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Amount of unrealized gains (losses) in OCI on interest rate cap agreements</a></td>
<td class="nump">9,532<span></span>
</td>
<td class="num">(21,781)<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Reclassification from accumulated other comprehensive income into net income</a></td>
<td class="nump">$ 5,509<span></span>
</td>
<td class="nump">$ 7,081<span></span>
</td>
<td class="nump">$ 8,591<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dva_IncomeTaxExpenseBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dva_IncomeTaxExpenseBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260518648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Additional information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 26, 2021</div></th>
<th class="th"><div>Jun. 09, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.28%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate', window );">Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267,049<span></span>
</td>
<td class="nump">$ 282,932<span></span>
</td>
<td class="nump">$ 419,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of Debt Discounts, Premiums and Deferred Financing Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,205<span></span>
</td>
<td class="nump">21,179<span></span>
</td>
<td class="nump">$ 24,185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember', window );">Senior Notes 4.625% due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AdditionalDebtPrincipalAmountDueToNewAgreement', window );">Additional Debt Principal Amount Due To New Agreement</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Jun.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount', window );">Debt Instrument Offering Price Percentage Of Face Amount</a></td>
<td class="nump">101.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Note Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000<span></span>
</td>
<td class="nump">$ 2,750,000<span></span>
</td>
<td class="nump">$ 1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Debt Instrument, Fee Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorSecuredCreditFacilitiesMember', window );">Senior Secured Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity on revolving credit facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Secured Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR', window );">Secured Debt Outstanding Principal Balance Subject To LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 785,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AdditionalDebtPrincipalAmountDueToNewAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Debt Principal Amount Due To New Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AdditionalDebtPrincipalAmountDueToNewAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtInstrumentOfferingPricePercentageOfFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Offering Price Percentage Of Face Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtInstrumentOfferingPricePercentageOfFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Secured Debt Outstanding Principal Balance Subject To LIBOR.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorSecuredCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorSecuredCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161271666952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Lease Expense Components (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Operating lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Fixed lease expense</a></td>
<td class="nump">$ 547,923<span></span>
</td>
<td class="nump">$ 541,090<span></span>
</td>
<td class="nump">$ 526,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">125,981<span></span>
</td>
<td class="nump">122,729<span></span>
</td>
<td class="nump">119,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract', window );"><strong>Financing lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of leased assets</a></td>
<td class="nump">26,846<span></span>
</td>
<td class="nump">24,720<span></span>
</td>
<td class="nump">23,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">13,988<span></span>
</td>
<td class="nump">14,421<span></span>
</td>
<td class="nump">14,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net lease cost</a></td>
<td class="nump">$ 714,738<span></span>
</td>
<td class="nump">$ 702,960<span></span>
</td>
<td class="nump">$ 684,748<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161264625720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Leases Other Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases term and discount rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">8 years 3 months 18 days<span></span>
</td>
<td class="text">8 years 8 months 12 days<span></span>
</td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">10 years 6 months<span></span>
</td>
<td class="text">10 years 6 months<span></span>
</td>
<td class="text">10 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeasesOtherInformationAbstract', window );"><strong>Leases Other Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Sale and Leaseback Transaction, Gain (Loss), Net</a></td>
<td class="nump">$ 17,137<span></span>
</td>
<td class="nump">$ 34,301<span></span>
</td>
<td class="nump">$ 20,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="nump">684,186<span></span>
</td>
<td class="nump">661,318<span></span>
</td>
<td class="nump">637,655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Finance Lease, Interest Payment on Liability</a></td>
<td class="nump">21,343<span></span>
</td>
<td class="nump">20,981<span></span>
</td>
<td class="nump">22,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance Lease, Principal Payments</a></td>
<td class="nump">22,445<span></span>
</td>
<td class="nump">24,780<span></span>
</td>
<td class="nump">25,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities', window );">Net Operating Lease Assets Obtained In Exchange For Lease Liabilities</a></td>
<td class="nump">$ 361,101<span></span>
</td>
<td class="nump">$ 401,559<span></span>
</td>
<td class="nump">$ 432,074<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember', window );">Finance Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases term and discount rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance lease, weighted average discount rate, percent</a></td>
<td class="nump">4.54%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LeasesOtherInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases Other Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LeasesOtherInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Operating Lease Assets Obtained In Exchange For New or Modified Lease Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleAndLeasebackTransactionGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123417830&amp;loc=SL77919786-209982<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleAndLeasebackTransactionGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260080952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Future Minimum Lease Payments Under Non-Cancelable Operating and Capital Leases (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract', window );"><strong>Operating leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 494,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">511,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">463,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">413,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">361,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,293,544<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments due under operating leases</a></td>
<td class="nump">3,537,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less portion representing interest, operating lease liabilities</a></td>
<td class="num">(470,269)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract', window );"><strong>Finance leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">36,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">37,672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">38,199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">38,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">37,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">183,250<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future minimum payments due under finance leases</a></td>
<td class="nump">371,619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less portion representing interest, financing lease liabilities</a></td>
<td class="num">(72,491)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=dva_OperatingLeaseLiabilitiesMember', window );">Operating Lease Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract', window );"><strong>Operating leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities, operating leases</a></td>
<td class="nump">3,067,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeasesDisclosureLineItems', window );"><strong>Leases Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities, operating leases</a></td>
<td class="nump">3,067,070<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract', window );"><strong>Finance leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Financing lease obligations</a></td>
<td class="nump">299,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeasesDisclosureLineItems', window );"><strong>Leases Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Financing lease obligations</a></td>
<td class="nump">$ 299,128<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LeasesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LeasesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=dva_OperatingLeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=dva_OperatingLeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257440360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeasesDisclosureLineItems', window );"><strong>Leases Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_FinanceLeaseAccumulatedDepreciation', window );">Finance Lease Accumulated Depreciation</a></td>
<td class="nump">$ 75,252<span></span>
</td>
<td class="nump">$ 49,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Rent Expense, Operating Leases</a></td>
<td class="nump">714,738<span></span>
</td>
<td class="nump">702,960<span></span>
</td>
<td class="nump">$ 684,748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeasesDisclosureLineItems', window );"><strong>Leases Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="nump">322,060<span></span>
</td>
<td class="nump">275,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=dva_OperatingLeaseMember', window );">Operating Lease | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeasesDisclosureLineItems', window );"><strong>Leases Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Rent Expense, Operating Leases</a></td>
<td class="nump">$ 673,904<span></span>
</td>
<td class="nump">$ 663,819<span></span>
</td>
<td class="nump">$ 646,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeasesDisclosureLineItems', window );"><strong>Leases Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, Operating Lease, Renewal Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LeasesDisclosureLineItems', window );"><strong>Leases Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, Operating Lease, Renewal Term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_FinanceLeaseAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Accumulated Depreciation, contra asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_FinanceLeaseAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LeasesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LeasesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=dva_OperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=dva_OperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260736120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution, percent of match</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="nump">$ 68,658<span></span>
</td>
<td class="nump">$ 70,180<span></span>
</td>
<td class="nump">$ 64,988<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate', window );">Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection', window );">Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employer matching contribution, percent of employees' gross wages</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate', window );">Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection', window );">Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansDefinedBenefitMember', window );">Deferred Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum percentage of employees' base salary to be maintained into deferral account</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer', window );">Non-qualified deferred compensation plan, contributions</a></td>
<td class="nump">$ 2,962<span></span>
</td>
<td class="nump">3,637<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid', window );">Deferred compensation plan, distributions</a></td>
<td class="nump">11,887<span></span>
</td>
<td class="nump">3,139<span></span>
</td>
<td class="nump">$ 2,730<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansDefinedBenefitMember', window );">Deferred Compensation Plan | Rabbi trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Total fair value of assets held in trust</a></td>
<td class="nump">$ 38,019<span></span>
</td>
<td class="nump">$ 43,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election Effective date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions made by employer into fund established for purposes of making future disbursement to individual in accordance with deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution made to individual in accordance with deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=dva_AllTrustsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=dva_AllTrustsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161271621736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies - Additional Information (Details) - US Attorney Prescription Drug Investigation<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement amount awarded to other party</a></td>
<td class="nump">$ 63,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=dva_IncrementalCashPortionMember', window );">Incremental Cash Portion</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement amount awarded to other party</a></td>
<td class="nump">41,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=dva_CashPaidForPortionPreviouslyRefundedMember', window );">Cash Paid For Portion Previously Refunded</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement amount awarded to other party</a></td>
<td class="nump">$ 22,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=dva_USAttorneyPrescriptionDrugInvestigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=dva_USAttorneyPrescriptionDrugInvestigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=dva_IncrementalCashPortionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=dva_IncrementalCashPortionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=dva_CashPaidForPortionPreviouslyRefundedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=dva_CashPaidForPortionPreviouslyRefundedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260103352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Noncontrolling Interests Subject to Put Provisions and Other Commitments - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">Purchase Obligation, Due in Next Twelve Months</a></td>
<td class="nump">$ 549,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">Purchase Obligation, Due in Second Year</a></td>
<td class="nump">510,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">Purchase Obligation, Due in Third Year</a></td>
<td class="nump">430,196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFourthYear', window );">Purchase Obligation, to be Paid, Year Four</a></td>
<td class="nump">345,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_OffBalanceSheetFinancingArrangements', window );">Off -Balance Sheet Financing Arrangements</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=dva_EpogenMember', window );">EPO</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LongTermPurchaseCommitmentExpirationDate', window );">Long term purchase commitment, expiration date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DissolutionTermOfJointVentures', window );">Scheduled dissolution term of joint ventures</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | EPO</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired', window );">Long-term purchase commitment, percentage of quantity required to be purchased</a></td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DissolutionTermOfJointVentures', window );">Scheduled dissolution term of joint ventures</a></td>
<td class="text">50 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember', window );">Commitments to Provide Operating Capital</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Other potential commitments to provide operating capital to several dialysis centers</a></td>
<td class="nump">$ 13,469<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_CommitmentsAndContingenciesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commitments and contingencies disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_CommitmentsAndContingenciesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DissolutionTermOfJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dissolution term of joint ventures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DissolutionTermOfJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LongTermPurchaseCommitmentExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term purchase commitment expiration date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LongTermPurchaseCommitmentExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term purchase commitment percentage of quantity required.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_OffBalanceSheetFinancingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Off -Balance Sheet Financing Arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_OffBalanceSheetFinancingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=dva_EpogenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=dva_EpogenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161266919304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Incentive Compensation and Shareholders&#8217; Equity - Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of year (in shares)</a></td>
<td class="nump">8,084,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised/ Vested (in shares)</a></td>
<td class="num">(2,093,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled (in shares)</a></td>
<td class="num">(180,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">5,943,000<span></span>
</td>
<td class="nump">8,084,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period (in shares)</a></td>
<td class="nump">1,161,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value of grants</a></td>
<td class="nump">$ 32.15<span></span>
</td>
<td class="nump">$ 26.70<span></span>
</td>
<td class="nump">$ 14.04<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of year (USD per share)</a></td>
<td class="nump">63.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share)</a></td>
<td class="nump">108.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (USD per share)</a></td>
<td class="nump">64.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Canceled (USD per share)</a></td>
<td class="nump">59.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (USD per share)</a></td>
<td class="nump">64.66<span></span>
</td>
<td class="nump">$ 63.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period (USD per share)</a></td>
<td class="nump">$ 61.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted average remaining contractual&#160;life</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding at end of period</a></td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at end of period</a></td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dva_StockUnitMember', window );">Stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of year (in shares)</a></td>
<td class="nump">3,537,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">789,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod', window );">Added by performance factor (in shares)</a></td>
<td class="nump">153,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Exercised/ Vested (in shares)</a></td>
<td class="num">(696,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled (in shares)</a></td>
<td class="num">(398,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">3,385,000<span></span>
</td>
<td class="nump">3,537,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber', window );">Exercisable at end of period (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value of grants (USD per share)</a></td>
<td class="nump">$ 109.50<span></span>
</td>
<td class="nump">$ 77.83<span></span>
</td>
<td class="nump">$ 50.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted average remaining contractual&#160;life</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Outstanding at end of period</a></td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms', window );">Exercisable at end of period</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options exercisable weighted average remaining contractual terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instruments exercisable number.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based Compensation Arrangement by Share based Payment Award, Other than Options, Weighted Average Remaining Contractual Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Units, Additions in Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dva_StockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dva_StockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161266869448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Incentive Compensation and Shareholders&#8217; Equity - Summary of Range of Exercise Prices (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Awards outstanding (in shares) | shares</a></td>
<td class="nump">5,943,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 64.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Awards exercisable (in shares) | shares</a></td>
<td class="nump">1,161,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 61.13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeOneMember', window );">$50.01&#8211;$60.00</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Awards outstanding (in shares) | shares</a></td>
<td class="nump">1,561,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 52.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Awards exercisable (in shares) | shares</a></td>
<td class="nump">425,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 52.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices, lower range (USD per share)</a></td>
<td class="nump">50.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices, upper range (USD per share)</a></td>
<td class="nump">$ 60.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeTwoMember', window );">$60.01&#8211;$70.00</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Awards outstanding (in shares) | shares</a></td>
<td class="nump">3,974,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 67.22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Awards exercisable (in shares) | shares</a></td>
<td class="nump">732,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 66.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices, lower range (USD per share)</a></td>
<td class="nump">60.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices, upper range (USD per share)</a></td>
<td class="nump">$ 70.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeThreeMember', window );">$70.01&#8211;$80.00</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Awards outstanding (in shares) | shares</a></td>
<td class="nump">276,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 75.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Awards exercisable (in shares) | shares</a></td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 71.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices, lower range (USD per share)</a></td>
<td class="nump">70.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices, upper range (USD per share)</a></td>
<td class="nump">$ 80.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeFourMember', window );">$100.01-$110.00</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Awards outstanding (in shares) | shares</a></td>
<td class="nump">132,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 108.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Awards exercisable (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices, lower range (USD per share)</a></td>
<td class="nump">100.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices, upper range (USD per share)</a></td>
<td class="nump">$ 110.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dva_RangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161271872168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Incentive Compensation and Shareholders Equity - Summary of Weighted Average Valuation Inputs (Details) - Stock-settled Stock Appreciation Rights<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">34.30%<span></span>
</td>
<td class="nump">28.20%<span></span>
</td>
<td class="nump">29.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dva_StockSettledStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dva_StockSettledStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161259005096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Incentive Compensation and Shareholders&#8217; Equity - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Jan. 01, 2021</div></th>
<th class="th">
<div>Nov. 04, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 11, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of stock awards exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 208,585,000<span></span>
</td>
<td class="nump">$ 49,258,000<span></span>
</td>
<td class="nump">$ 11,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of stock awards outstanding</a></td>
<td class="nump">$ 680,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">680,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of stock awards exercisable</a></td>
<td class="nump">61,389,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,389,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Payments of ordinary dividends, common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,209,000<span></span>
</td>
<td class="nump">91,458,000<span></span>
</td>
<td class="nump">67,850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense', window );">Estimated tax benefits recorded for stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,853,000<span></span>
</td>
<td class="nump">11,775,000<span></span>
</td>
<td class="nump">9,186,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans</a></td>
<td class="nump">$ 161,147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161,147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Share-based Payment Arrangement, Expense, Tax Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,990,000<span></span>
</td>
<td class="nump">8,957,000<span></span>
</td>
<td class="nump">2,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Stock award exercises and other share issuances, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,209,000<span></span>
</td>
<td class="nump">91,458,000<span></span>
</td>
<td class="nump">63,705,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dva_PremiumPricedStockSettledStockAppreciationRightsMember', window );">Premium priced stock-settled stock appreciation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PremiumPricedAwardBasePricePerShare', window );">Premium Priced Award Base Price Per Share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PremiumToTheTenderOfferSharePurchasePrice', window );">Premium To The Tender Offer Share Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  04,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  04,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dva_EmployeeStockPurchasePlanMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants | shares</a></td>
<td class="nump">5,986,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,986,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase', window );">Employee entitlement for purchase of the Company's common stock during each calendar year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Stock purchase price as percentage of fair market value</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares', window );">Contributions used to purchase shares, employee-related current liabilities</a></td>
<td class="nump">$ 19,626,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,626,000<span></span>
</td>
<td class="nump">$ 17,148,000<span></span>
</td>
<td class="nump">$ 16,569,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock issued for employee stock purchase plans | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203,000<span></span>
</td>
<td class="nump">222,000<span></span>
</td>
<td class="nump">315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">40.40%<span></span>
</td>
<td class="nump">28.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Share-based awards, fair value assumptions, expected dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.94<span></span>
</td>
<td class="nump">$ 22.06<span></span>
</td>
<td class="nump">$ 13.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Share-based Payment Arrangement, Tranche One | Premium priced stock-settled stock appreciation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  04,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Share-based Payment Arrangement, Tranche Two | Premium priced stock-settled stock appreciation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  04,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyTwentyMember', window );">Stock Incentive 2020 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants | shares</a></td>
<td class="nump">7,672,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,672,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,730,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized under the plan | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions', window );">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance', window );">Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward', window );">Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance', window );">Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyTwentyMember', window );">Stock Incentive 2020 Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyTwentyMember', window );">Stock Incentive 2020 Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Terms of award (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyElevenMember', window );">Stock Incentive 2011 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,730,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Terms of award (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio', window );">Full share awards to shares available, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyElevenMember', window );">Stock Incentive 2011 Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyElevenMember', window );">Stock Incentive 2011 Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee service share-based compensation estimated tax benefit from compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee-related Current Liabilities, Employee Stock Purchase Plan, Contributions Used To Purchase Shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PremiumPricedAwardBasePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premium Priced Award Base Price Per Share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PremiumPricedAwardBasePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PremiumToTheTenderOfferSharePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premium To The Tender Offer Share Purchase Price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PremiumToTheTenderOfferSharePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award maximum share value authorized for purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Full Value Shares To Available Shares, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the equity-based award expires, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dva_PremiumPricedStockSettledStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dva_PremiumPricedStockSettledStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dva_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dva_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyElevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dva_StockIncentivePlanTwentyElevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260372536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Repurchases Tender Offer (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="nump">13,877<span></span>
</td>
<td class="nump">16,477<span></span>
</td>
<td class="nump">41,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of treasury stock acquired</a></td>
<td class="nump">$ 1,546,016<span></span>
</td>
<td class="nump">$ 1,446,767<span></span>
</td>
<td class="nump">$ 2,402,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock acquired, average cost per share</a></td>
<td class="nump">$ 111.41<span></span>
</td>
<td class="nump">$ 87.80<span></span>
</td>
<td class="nump">$ 58.57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=dva_OpenMarketPurchasesMember', window );">Open Market Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="nump">13,877<span></span>
</td>
<td class="nump">8,495<span></span>
</td>
<td class="nump">19,218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of treasury stock acquired</a></td>
<td class="nump">$ 1,546,016<span></span>
</td>
<td class="nump">$ 741,850<span></span>
</td>
<td class="nump">$ 1,168,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock acquired, average cost per share</a></td>
<td class="nump">$ 111.41<span></span>
</td>
<td class="nump">$ 87.32<span></span>
</td>
<td class="nump">$ 60.79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=dva_TenderOfferMember', window );">Tender Offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,982<span></span>
</td>
<td class="nump">21,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of treasury stock acquired</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 704,917<span></span>
</td>
<td class="nump">$ 1,234,154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock acquired, average cost per share</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 88.32<span></span>
</td>
<td class="nump">$ 56.61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAbstract', window );"><strong>Treasury Stock, Shares Repurchases, Table Footnotes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice', window );">Treasury Stock Acquired, Average Cost Per Share, Clearing Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88.00<span></span>
</td>
<td class="nump">$ 56.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ShareRepurchaseFeesAndExpenses', window );">Share Repurchase Fees And Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,529<span></span>
</td>
<td class="nump">$ 2,343<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ShareRepurchaseFeesAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Repurchase Fees And Expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ShareRepurchaseFeesAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Acquired, Average Cost Per Share, Clearing Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=dva_OpenMarketPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=dva_OpenMarketPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=dva_TenderOfferMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=dva_TenderOfferMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161264625512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholder's equity Effects of Changes in DaVita Inc's Ownership Interest (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income attributable to DaVita Inc.</a></td>
<td class="nump">$ 978,450<span></span>
</td>
<td class="nump">$ 773,642<span></span>
</td>
<td class="nump">$ 810,981<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of noncontrolling interests</a></td>
<td class="num">(13,853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,145)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests', window );">Purchase of noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests', window );">Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests</a></td>
<td class="num">(264)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Noncontrolling Interest, Period Increase (Decrease)</a></td>
<td class="num">(14,117)<span></span>
</td>
<td class="nump">4,364<span></span>
</td>
<td class="num">(37,145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests', window );">Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.</a></td>
<td class="nump">$ 964,333<span></span>
</td>
<td class="nump">$ 778,006<span></span>
</td>
<td class="nump">$ 773,836<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Gain Related To Redemptions or Purchase of Interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161259676392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholder's equity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 09, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 17, 2021</div></th>
<th class="th"><div>Dec. 10, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAbstract', window );"><strong>Stock repurchases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,877,000<span></span>
</td>
<td class="nump">16,477,000<span></span>
</td>
<td class="nump">41,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of treasury stock acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,546,016<span></span>
</td>
<td class="nump">$ 1,446,767<span></span>
</td>
<td class="nump">$ 2,402,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock acquired, average cost per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111.41<span></span>
</td>
<td class="nump">$ 87.80<span></span>
</td>
<td class="nump">$ 58.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount', window );">Terminated Remaining Prior Share Repurchases Authorized, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 329,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CharterdocumentsandDelawarelawAbstract', window );"><strong>Charter documents and Delaware law:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation', window );">Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law Limitation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,104<span></span>
</td>
<td class="nump">$ 7,831<span></span>
</td>
<td class="nump">$ 68,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAbstract', window );"><strong>Stock repurchases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,877,000<span></span>
</td>
<td class="nump">16,477,000<span></span>
</td>
<td class="nump">41,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of treasury stock acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,546,016<span></span>
</td>
<td class="nump">$ 1,446,767<span></span>
</td>
<td class="nump">$ 2,402,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Retirement of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,877,000<span></span>
</td>
<td class="nump">16,477,000<span></span>
</td>
<td class="nump">41,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAbstract', window );"><strong>Stock repurchases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="nump">1,437,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Value of treasury stock acquired</a></td>
<td class="nump">$ 159,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock acquired, average cost per share</a></td>
<td class="nump">$ 110.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="nump">$ 2,224,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_CharterdocumentsandDelawarelawAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Charter documents and Delaware law [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_CharterdocumentsandDelawarelawAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law limitation. The Company is subject to Section&#160;203 of the Delaware General Corporation Law which, subject to exceptions, would prohibit the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period three years following the date on which that stockholder became an interested stockholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Terminated Remaining Prior Share Repurchases Authorized, Amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260709192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance of AOCI</a></td>
<td class="num">$ (66,154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance of AOCI</a></td>
<td class="num">(139,247)<span></span>
</td>
<td class="num">$ (66,154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance of AOCI</a></td>
<td class="num">(12,466)<span></span>
</td>
<td class="num">(1,433)<span></span>
</td>
<td class="num">$ (8,961)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Unrealized gains (losses)</a></td>
<td class="nump">9,532<span></span>
</td>
<td class="num">(21,781)<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax</a></td>
<td class="num">(2,377)<span></span>
</td>
<td class="nump">5,435<span></span>
</td>
<td class="num">(415)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Unrealized (losses) gains net</a></td>
<td class="nump">7,155<span></span>
</td>
<td class="num">(16,346)<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive losses (income) into net income</a></td>
<td class="nump">5,509<span></span>
</td>
<td class="nump">7,081<span></span>
</td>
<td class="nump">8,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="num">(1,376)<span></span>
</td>
<td class="num">(1,768)<span></span>
</td>
<td class="num">(2,214)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">4,133<span></span>
</td>
<td class="nump">5,313<span></span>
</td>
<td class="nump">6,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance of AOCI</a></td>
<td class="num">(1,178)<span></span>
</td>
<td class="num">(12,466)<span></span>
</td>
<td class="num">(1,433)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance of AOCI</a></td>
<td class="num">(53,688)<span></span>
</td>
<td class="num">(46,065)<span></span>
</td>
<td class="num">(25,963)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Unrealized gains (losses)</a></td>
<td class="num">(83,375)<span></span>
</td>
<td class="num">(7,080)<span></span>
</td>
<td class="num">(20,102)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax</a></td>
<td class="num">(1,006)<span></span>
</td>
<td class="num">(543)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Unrealized (losses) gains net</a></td>
<td class="num">(84,381)<span></span>
</td>
<td class="num">(7,623)<span></span>
</td>
<td class="num">(20,102)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive losses (income) into net income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance of AOCI</a></td>
<td class="num">(138,069)<span></span>
</td>
<td class="num">(53,688)<span></span>
</td>
<td class="num">(46,065)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance of AOCI</a></td>
<td class="num">(66,154)<span></span>
</td>
<td class="num">(47,498)<span></span>
</td>
<td class="num">(34,924)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Unrealized gains (losses)</a></td>
<td class="num">(73,843)<span></span>
</td>
<td class="num">(28,861)<span></span>
</td>
<td class="num">(18,536)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax</a></td>
<td class="num">(3,383)<span></span>
</td>
<td class="nump">4,892<span></span>
</td>
<td class="num">(415)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Unrealized (losses) gains net</a></td>
<td class="num">(77,226)<span></span>
</td>
<td class="num">(23,969)<span></span>
</td>
<td class="num">(18,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive losses (income) into net income</a></td>
<td class="nump">5,509<span></span>
</td>
<td class="nump">7,081<span></span>
</td>
<td class="nump">8,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="num">(1,376)<span></span>
</td>
<td class="num">(1,768)<span></span>
</td>
<td class="num">(2,214)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">4,133<span></span>
</td>
<td class="nump">5,313<span></span>
</td>
<td class="nump">6,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance of AOCI</a></td>
<td class="num">$ (139,247)<span></span>
</td>
<td class="num">$ (66,154)<span></span>
</td>
<td class="num">$ (47,498)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161258968648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Components of Routine Acquisitions (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire business</a></td>
<td class="nump">$ 187,050<span></span>
</td>
<td class="nump">$ 182,013<span></span>
</td>
<td class="nump">$ 100,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire business</a></td>
<td class="nump">187,050<span></span>
</td>
<td class="nump">182,013<span></span>
</td>
<td class="nump">98,836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitions', window );">Business combination contingent consideration acquisitions, earn-outs</a></td>
<td class="nump">14,854<span></span>
</td>
<td class="nump">14,042<span></span>
</td>
<td class="nump">23,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Deferred Purchase price and liabilities assumed</a></td>
<td class="nump">10,226<span></span>
</td>
<td class="nump">20,415<span></span>
</td>
<td class="nump">4,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Non-cash gain on acquiring additional ownership in business acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,821<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Aggregate purchase cost recognized</a></td>
<td class="nump">$ 212,130<span></span>
</td>
<td class="nump">$ 218,291<span></span>
</td>
<td class="nump">$ 126,698<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of individually immaterial business acquisitions | U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | Clinic</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of individually immaterial business acquisitions | Foreign Dialysis Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | Clinic</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessCombinationContingentConsiderationAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessCombinationContingentConsiderationAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_ForeignDialysisCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_ForeignDialysisCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260005512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Assets acquired and liabilities assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 7,046,241<span></span>
</td>
<td class="nump">$ 6,919,109<span></span>
</td>
<td class="nump">$ 6,787,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets</a></td>
<td class="nump">9,134<span></span>
</td>
<td class="nump">23,607<span></span>
</td>
<td class="nump">6,713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">9,277<span></span>
</td>
<td class="nump">37,457<span></span>
</td>
<td class="nump">4,842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Customer relationships</a></td>
<td class="nump">17,200<span></span>
</td>
<td class="nump">34,625<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Noncompetition agreements and other long-term assets</a></td>
<td class="nump">9,964<span></span>
</td>
<td class="nump">10,168<span></span>
</td>
<td class="nump">1,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Indefinite-lived licenses</a></td>
<td class="nump">11,432<span></span>
</td>
<td class="nump">22,136<span></span>
</td>
<td class="nump">31,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">173,244<span></span>
</td>
<td class="nump">130,057<span></span>
</td>
<td class="nump">90,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,962)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities Assumed</a></td>
<td class="num">(14,200)<span></span>
</td>
<td class="num">(34,068)<span></span>
</td>
<td class="num">(7,159)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Noncontrolling interests assumed</a></td>
<td class="num">(3,921)<span></span>
</td>
<td class="num">(1,729)<span></span>
</td>
<td class="num">(1,762)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Aggregate purchase price</a></td>
<td class="nump">$ 212,130<span></span>
</td>
<td class="nump">$ 218,291<span></span>
</td>
<td class="nump">$ 126,698<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161271737432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule Of Other Information Related To Acquired Intangibles and Goodwill (Details) - Series of individually immaterial business acquisitions - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes associated with acquisitions</a></td>
<td class="nump">$ 169,014<span></span>
</td>
<td class="nump">$ 94,318<span></span>
</td>
<td class="nump">$ 88,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortizable intangible assets acquired, weighted-average estimated useful lives</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompetition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortizable intangible assets acquired, weighted-average estimated useful lives</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161272321816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Pro Forma Summary of Results of Operation (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Pro forma total revenues</a></td>
<td class="nump">$ 11,678,798<span></span>
</td>
<td class="nump">$ 11,722,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Pro forma net income from continuing operations attributable to DaVita Inc.</a></td>
<td class="nump">$ 985,800<span></span>
</td>
<td class="nump">$ 797,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Pro forma basic net income per share from continuing operations attributable to DaVita Inc.</a></td>
<td class="nump">$ 9.37<span></span>
</td>
<td class="nump">$ 6.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Pro forma diluted net income per share from continuing operations attributable to DaVita Inc.</a></td>
<td class="nump">$ 8.97<span></span>
</td>
<td class="nump">$ 6.51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161271743480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Reconciliation of Changes in Contingent Earn-Out Obligations (Details) - Series of individually immaterial business acquisitions - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Beginning balance</a></td>
<td class="nump">$ 30,248<span></span>
</td>
<td class="nump">$ 24,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitions', window );">Acquisitions</a></td>
<td class="nump">14,854<span></span>
</td>
<td class="nump">14,042<span></span>
</td>
<td class="nump">$ 23,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations', window );">Foreign currency translation</a></td>
<td class="num">(1,674)<span></span>
</td>
<td class="num">(3,688)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss', window );">Fair value remeasurements</a></td>
<td class="num">(1,292)<span></span>
</td>
<td class="num">(2,630)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments', window );">Payments or other settlements</a></td>
<td class="num">(8,536)<span></span>
</td>
<td class="num">(2,062)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Ending balance</a></td>
<td class="nump">$ 33,600<span></span>
</td>
<td class="nump">$ 30,248<span></span>
</td>
<td class="nump">$ 24,586<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessCombinationContingentConsiderationAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessCombinationContingentConsiderationAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Acquisitions Earnouts Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Translation Adjustment For Contingent Earn Out Obligations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161258939448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Fair value of contingent earn-out consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,600<span></span>
</td>
<td class="nump">$ 30,248<span></span>
</td>
<td class="nump">$ 24,586<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_RMSLifelineMember', window );">RMS Lifeline</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Gain (Loss) on Divestiture</a></td>
<td class="num">$ (16,252)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities | Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Fair value of contingent earn-out consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Long-term Liabilities | Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Fair value of contingent earn-out consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember', window );">Other companies | Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Fair value of contingent earn-out consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Other companies | EBITDA or Operating Income Performance Targets or Quality Margins</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod', window );">Earn-out consideration payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Other companies | EBITDA or Operating Income Performance Targets or Quality Margins</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod', window );">Earn-out consideration payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisition contingent consideration revenue earn-out period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_RMSLifelineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_RMSLifelineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161258899160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale and Discontinued Operations Financial results for discontinued operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax', window );">Loss on sale of discontinued operations before taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (24,248)<span></span>
</td>
<td class="num">$ (23,022)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net (loss) income from discontinued operations, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(9,653)<span></span>
</td>
<td class="nump">105,483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember', window );">DMG - discontinued operations | Discontinued Operations, Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,713,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,543,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income from discontinued operations before taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">169,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax', window );">Loss on sale of discontinued operations before taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,996)<span></span>
</td>
<td class="num">(23,022)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,657<span></span>
</td>
<td class="nump">$ 40,689<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss (Gain) On Disposition Of Business Interests Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LossGainOnDispositionOfBusinessInterestsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit on (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161266012488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale and Discontinued Operations Cash Flows of discontinued operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Net cash provided by operating activities from discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 99,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations', window );">Net cash used in investing activities from discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (43,442)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161267530904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale and Discontinued Operations - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 19, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 05, 2017</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 18, 2019 </div>
<div>USD ($) </div>
<div>clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax', window );">Loss on sale of discontinued operations before taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (24,248)<span></span>
</td>
<td class="num">$ (23,022)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of DMG division</a></td>
<td class="nump">$ 4,465,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from Divestiture of Businesses, Net of Cash Divested</a></td>
<td class="nump">$ 3,824,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (Loss) on Disposition of Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(16,252)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,050<span></span>
</td>
<td class="nump">182,013<span></span>
</td>
<td class="nump">100,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187,050<span></span>
</td>
<td class="nump">182,013<span></span>
</td>
<td class="nump">98,836<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DMGAcquisitionsMember', window );">DMG Acquisitions | Series of individually immaterial business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredOther1', window );">Business combination, deferred purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Held-for-sale | DMG - discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessSaleEffectiveDateOfSale', window );">Business Sale, Effective Date Of Sale</a></td>
<td class="text">Jun. 19,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PurchaseAndSaleAgreementAggregatePurchasePrice', window );">Purchase And Sale Agreement Aggregate Purchase Price</a></td>
<td class="nump">$ 4,340,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessSaleDateOfPurchaseAndSaleAgreement', window );">Business Sale, Date Of Purchase And Sale Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec.  05,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax', window );">Loss on sale of discontinued operations before taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,996)<span></span>
</td>
<td class="num">$ (23,022)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice', window );">Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (Loss) on Disposition of Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17,976)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Held-for-sale | DMG - discontinued operations | Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (Loss) on Disposition of Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessSaleDateOfPurchaseAndSaleAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Sale, Date Of Purchase And Sale Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessSaleDateOfPurchaseAndSaleAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessSaleEffectiveDateOfSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Sale, Effective Date Of Sale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessSaleEffectiveDateOfSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LossGainOnDispositionOfBusinessInterestsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss (Gain) On Disposition Of Business Interests Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LossGainOnDispositionOfBusinessInterestsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PurchaseAndSaleAgreementAggregatePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase And Sale Agreement Aggregate Purchase Price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PurchaseAndSaleAgreementAggregatePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredOther1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredOther1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DMGAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DMGAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161266046184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 17,121,488<span></span>
</td>
<td class="nump">$ 16,988,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">14,750,508<span></span>
</td>
<td class="nump">$ 14,091,736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">299,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">$ 200,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260125688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Values of Financial Instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">$ 48,598<span></span>
</td>
<td class="nump">$ 44,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">48,598<span></span>
</td>
<td class="nump">44,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">33,600<span></span>
</td>
<td class="nump">30,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,434,832<span></span>
</td>
<td class="nump">1,330,028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">12,203<span></span>
</td>
<td class="nump">2,671<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted&#160;prices&#160;in active&#160;markets&#160;for identical assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">48,598<span></span>
</td>
<td class="nump">44,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted&#160;prices&#160;in active&#160;markets&#160;for identical assets (Level 1) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant&#160;other observable&#160;inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant&#160;other observable&#160;inputs (Level 2) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">12,203<span></span>
</td>
<td class="nump">2,671<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">33,600<span></span>
</td>
<td class="nump">30,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,434,832<span></span>
</td>
<td class="nump">1,330,028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265782392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Values of Financial Instruments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple', window );">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</a></td>
<td class="nump">$ 180,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260578264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">$ 405,282<span></span>
</td>
<td class="nump">$ 524,353<span></span>
</td>
<td class="nump">$ 491,773<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">11,618,797<span></span>
</td>
<td class="nump">11,550,604<span></span>
</td>
<td class="nump">11,388,479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">1,797,370<span></span>
</td>
<td class="nump">1,694,636<span></span>
</td>
<td class="nump">1,643,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_SegmentReportingInformationCorporateExpenses', window );">Corporate administrative support</a></td>
<td class="num">(111,615)<span></span>
</td>
<td class="num">(146,707)<span></span>
</td>
<td class="num">(92,335)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Debt expense</a></td>
<td class="num">(285,254)<span></span>
</td>
<td class="num">(304,111)<span></span>
</td>
<td class="num">(443,824)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_DebtPrepaymentRefinancingRedemptionCharges', window );">Debt prepayment, refinancing and redemption charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(89,022)<span></span>
</td>
<td class="num">(33,402)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">6,378<span></span>
</td>
<td class="nump">16,759<span></span>
</td>
<td class="nump">29,348<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total</a></td>
<td class="nump">1,518,494<span></span>
</td>
<td class="nump">1,318,262<span></span>
</td>
<td class="nump">1,195,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Reporting Information footnote:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity investment income (loss)</a></td>
<td class="nump">26,937<span></span>
</td>
<td class="nump">26,916<span></span>
</td>
<td class="nump">12,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">10,576,167<span></span>
</td>
<td class="nump">10,514,649<span></span>
</td>
<td class="nump">10,430,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,042,630<span></span>
</td>
<td class="nump">1,035,955<span></span>
</td>
<td class="nump">957,898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">11,713,887<span></span>
</td>
<td class="nump">11,712,633<span></span>
</td>
<td class="nump">11,534,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">1,908,985<span></span>
</td>
<td class="nump">1,841,343<span></span>
</td>
<td class="nump">1,735,652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues before provision</a></td>
<td class="nump">10,641,618<span></span>
</td>
<td class="nump">10,619,364<span></span>
</td>
<td class="nump">10,530,885<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">10,666,963<span></span>
</td>
<td class="nump">10,659,935<span></span>
</td>
<td class="nump">10,562,906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">1,974,988<span></span>
</td>
<td class="nump">1,917,604<span></span>
</td>
<td class="nump">1,924,826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis | External Sources</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues before provision</a></td>
<td class="nump">10,551,106<span></span>
</td>
<td class="nump">10,475,273<span></span>
</td>
<td class="nump">10,399,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">25,061<span></span>
</td>
<td class="nump">39,376<span></span>
</td>
<td class="nump">30,895<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis | Intersubsegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues before provision</a></td>
<td class="nump">90,512<span></span>
</td>
<td class="nump">144,091<span></span>
</td>
<td class="nump">131,199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues before provision</a></td>
<td class="nump">662,409<span></span>
</td>
<td class="nump">550,978<span></span>
</td>
<td class="nump">497,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">380,221<span></span>
</td>
<td class="nump">484,977<span></span>
</td>
<td class="nump">460,877<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,046,924<span></span>
</td>
<td class="nump">1,052,698<span></span>
</td>
<td class="nump">971,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="num">(66,003)<span></span>
</td>
<td class="num">(76,261)<span></span>
</td>
<td class="num">(189,174)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Reporting Information footnote:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity investment income (loss)</a></td>
<td class="nump">3,177<span></span>
</td>
<td class="nump">5,866<span></span>
</td>
<td class="nump">9,366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other - Ancillary services | Intersubsegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues before provision</a></td>
<td class="nump">4,294<span></span>
</td>
<td class="nump">16,743<span></span>
</td>
<td class="nump">14,030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(95,090)<span></span>
</td>
<td class="num">(162,029)<span></span>
</td>
<td class="num">(146,355)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(90,796)<span></span>
</td>
<td class="num">(145,286)<span></span>
</td>
<td class="num">(132,325)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">$ (4,294)<span></span>
</td>
<td class="num">$ (16,743)<span></span>
</td>
<td class="num">$ (14,030)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtPrepaymentRefinancingRedemptionCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt prepayment, refinancing and redemption charges related to long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtPrepaymentRefinancingRedemptionCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SegmentReportingInformationCorporateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SegmentReportingInformationCorporateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsConsolidationItemsAxis=dva_ExternalSourcesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsConsolidationItemsAxis=dva_ExternalSourcesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsConsolidationItemsAxis=us-gaap_IntersubsegmentEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsConsolidationItemsAxis=us-gaap_IntersubsegmentEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161271826440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Summary of Depreciation and Amortization Expense by Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 680,615<span></span>
</td>
<td class="nump">$ 630,435<span></span>
</td>
<td class="nump">$ 615,152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">642,711<span></span>
</td>
<td class="nump">594,552<span></span>
</td>
<td class="nump">583,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 37,904<span></span>
</td>
<td class="nump">$ 35,883<span></span>
</td>
<td class="nump">$ 31,698<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257516424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Summary of Expenditures for Property and Equipment by Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">$ 641,465<span></span>
</td>
<td class="nump">$ 674,541<span></span>
</td>
<td class="nump">$ 766,546<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">589,662<span></span>
</td>
<td class="nump">646,870<span></span>
</td>
<td class="nump">681,339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">51,803<span></span>
</td>
<td class="nump">27,671<span></span>
</td>
<td class="nump">46,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_DaVitaMedicalGroupMember', window );">DMG - discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 38,466<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_DaVitaMedicalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_DaVitaMedicalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161263237000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Reporting - Summary of Assets by Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 17,121,488<span></span>
</td>
<td class="nump">$ 16,988,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">238,881<span></span>
</td>
<td class="nump">257,491<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation</a></td>
<td class="nump">3,479,972<span></span>
</td>
<td class="nump">3,521,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">15,375,000<span></span>
</td>
<td class="nump">15,344,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">112,500<span></span>
</td>
<td class="nump">122,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">1,746,488<span></span>
</td>
<td class="nump">1,643,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">126,381<span></span>
</td>
<td class="nump">134,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International | Other - Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation</a></td>
<td class="nump">$ 190,029<span></span>
</td>
<td class="nump">$ 181,137<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161265743480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Reporting - Additional Information (Details)<br></strong></div></th>
<th class="th"><div>Jun. 19, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember', window );">DMG - discontinued operations | Discontinued Operations, Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_BusinessSaleEffectiveDateOfSale', window );">Business Sale, Effective Date Of Sale</a></td>
<td class="text">Jun. 19,  2019<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessSaleEffectiveDateOfSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Sale, Effective Date Of Sale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessSaleEffectiveDateOfSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dva_DaVitaMedicalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161257389896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dva_CashPaidDuringPeriodForAbstract', window );"><strong>Cash paid:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes, net</a></td>
<td class="nump">$ 209,754<span></span>
</td>
<td class="nump">$ 154,850<span></span>
</td>
<td class="nump">$ 157,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">279,002<span></span>
</td>
<td class="nump">326,165<span></span>
</td>
<td class="nump">473,176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Fixed assets under financing lease obligations</a></td>
<td class="nump">$ 31,690<span></span>
</td>
<td class="nump">$ 22,042<span></span>
</td>
<td class="nump">$ 18,953<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_CashPaidDuringPeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash paid during period for.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_CashPaidDuringPeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140161260427032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - Allowance for uncollectible Accounts - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 8,328<span></span>
</td>
<td class="nump">$ 52,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Amounts charged to income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,458<span></span>
</td>
<td class="nump">21,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Amounts written off</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,786<span></span>
</td>
<td class="nump">66,311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 8,328<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>dva-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:dva="http://www.davita.com/20211231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dva-20211231.xsd" xlink:type="simple"/>
    <context id="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6946ea686e7c41b3a8aa82ffda6fb966_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i50c3ae2124374b73a5fb91701224c115_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i94e3a04a958345dca335a60cee3d8130_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic66c414a255d4ccba5c079ae43f2af9d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6d3dd21038464c23a62a67a39190a154_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1e07643e57f74006b5bcc05f2f454af3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i63999090b4ba4b888b7f56a9059c5fe0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0acb94239c44493880ec3eb2ccd8e937_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1fe0fe3dc214439e993ff7b2ef6840b7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0b6e5fa072d7489db4ab12e204b38a35_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i07d5f8524b0847c08febc20a18ec3e47_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1bca572e906b49798cc07308d3e4bfc0_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i050ebae691a14d39a71068a4d4ddb981_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i88726c7f90b243d4adcbf6e341fa9adc_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6e3632fb440c4f8b987b9e68d47870e0_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2dd50a980cda4949863e518248043db7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib1c551774ede47b9a8a31720f6c90ba1_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7b898106fe1a419ca926f1ea86e57923_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia217ce5b5094494d94eaad3451dec57d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibb2ad82533ae4593ad0e4a15e9fed8e1_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i750133c9d44946099dfeb64f0ff3dda6_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i944596afcbc042b0b7e8ae7c9ea00e76_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia2f800f0bf6140faaf3bda87332ad8ca_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if648bd429f9e4b07af2e909f55c08369_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i583e6028240a4d259061cd7bbc80a527_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i15f02743c68844acade340aa85cc54cd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i88c33ce611c94db9b64610be315aa469_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib5a1a9dd763f490c88b2409ea91246ed_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i06d01a2b80634e908567ea9c88abdc8f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie1b9156dde5743f4b33b9826bbf418bb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i62f1cb2b785248a3b90677c8293c94df_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7b6aab96951d446ab5be207620dd6ff7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i996169fbe8c44228b5349d69256e805e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i838fbf8cfb7d4a6cb6315c5d14ce207e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4b4abd021662426781fb847359853689_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifae2538458cc41c69083e653352c94de_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5e5cea8acd3342e28c6385ed6cb5ccd2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ide8b363308b74e509b2de9b4dec149b4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i757f5d8cb16b4caeb7c0303e2e952d94_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8d5b598835d84508b6ec3b7ee400fa41_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia00e3841c62b4348bd05c6b2d0b4d596_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60ae2bbc50a5435997c99adc86408164_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4654e2a535af44d68cb85bf0e223c161_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36a1b963ab624f408820e5a7b1cda4ef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0dd9625df77a4aa09aad592fdc4607db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31cbff30dba64d4c9bbe2eb87db6524c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ebd4f5dd6634fdda4f23120f166d49b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife7743b6788a41e5b36480f00efcdabe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i350dba809a5e474b83a7ae6fd0ebf067_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i27ce758ca09a46018cfdba537eef12e3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id7cd4ee4e9ce4fc7b8372541703a718f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i518c74e1af094a8bbc78df6c4a5e0e05_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if9e84e755ba249e59a9b6aa205496944_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3715810153a34e87aa3d4a8555b92c56_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia58cacd8bb944663919470f872cd9f54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e3c3810c47a4c88b525c4a096aec7af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic7e9c24fd093462cb7636796ea413cc3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3013c0642fb54553a6a63393504e9d22_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32f5b12383e04ff68c813ea6c09f8e5d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9418d8475e0410d982f26661945c8cf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32582f828b954718823b2edb03b73ce7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie9c338e435f04dd6bb9e00a239820984_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idcc6cfbc476149a0b92d93b432177548_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dva:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34062f45d55f4583ba09a038767a205e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dva:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7ec096dcca304113bc6030ce985e8e87_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6f47d0696ecb4ceea5e3dae2b3f56bbf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i844334ff13de4b30b4c03942a019ecc3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib840efffa3b94830990c3a92b56374e2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0eb5b1eefc8d41fd800f8c1f52603ba0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i90c6f2e663a84d45ba6b27262a653a05_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic04011b05a72411caa75091e3801f7de_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5041e4e8c2184140828efaa001bdd25e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i94e0c5744d944b2b9bd9e8a2915c8453_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0c40460b5c5b441db56d0568eb1241d1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i43f279672ea545869037ea2802282d14_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i33d553b0e327490488f4d8edbe627ee0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie3fd96e606364586af971c83948be72a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9cdf7cce3e8f4dd797d01eb3c13004e6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i05351ca6b9d14e4db0eabbbe9c54574c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie0a25508bcb746169dec8366c15ed07a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i05cf3e1772d6444ea76bd84771ac5085_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia8c57a5b75b1450db44db406dbe6cbb1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0d275721d92143bf8c330f70d27cb62f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idcf3ecd2542b42dbafe63b11f52a5f01_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibde88c91df984f719e7c6e7ac45ff483_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i308c251f3409431ba2ce96afe16e5595_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5aed74fb770d4a2699f1ddada95c657a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i304d4d375e0f48c0ab470af39fbd5154_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3f79711127304e7698b87e1bd094348f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i73c74d19584d454fa34768055ba7f8dc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib4a725d0f7e941a989ed5bb796119840_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iec92bd4bff18494083abb72a297d1750_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic08ccea9be2442a6ab45a04b8ae8f5f2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1db402b2e17c4fdeabe30ffd0d4e606e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if9c4a257e0bd4952bb2f643a893d32b0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i20c733ee69934ecb9b5772eec12a55aa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icf215d79e0d04757b9564cfbcda02f3a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i06141d893bb4422fa657c1f835bd0f2b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i295d3ce315bf4c489968d63c7ba4628f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i867fc66d86b045b5b0590e89915a412c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i527765f1b1c747358b403c1ee2d8bd10_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i046bac9a5f584086bb2c35f87b6a1468_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3875776099b146e2b6fff08d3a03da84_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i409fa2d900b448c8827e86526a38779c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i520c14418180468ba0ed3e50cc99d1cf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie0b031a2280648889e03675a2160e4f9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie2e7eff1c5284135b2912c47d643c653_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie6465f4788ca4b3baa87609dbf71f52f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib1db70badf9c4be0b0e0fc9f772301e6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7778dcdd0e944f4a8815e82230ee02f2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5da5750bb2a24b08979a8ec810b8c815_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4d3fb78c0dc54d1587b96b694d859948_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icab03bd4111342188781a60000b67316_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3959cde560fe4d70a411b92be2612071_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i58155ca3f13343d5a0780d211b521c24_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0063865a3f1a46df9d125b3ec015e2eb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i095a32d1f5934a57968454e6e538c10b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iba5967b32fb4416ab78a1b0e0114069a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i54f8e1940aa343e29817e02300203cc7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6f1b74b97d41414b9d610ad1be460b97_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6b7c2045c16f477c9b93026d6c4bfcca_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">us-gaap:ThirdPartyPayorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i70683478a02f41b494c6217a76fe90ea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1c61506ae168449c8f430ff4e7720a1b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28b42af03e324f849e1bb33d2bda90ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i208729e6625e496e9dca88ea4de1c200_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i264dc38d90f840d89c8f00122dc94dda_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i70ca4b5a53254c4ea41168999c345602_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">us-gaap:ThirdPartyPayorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i37e77621419b4554a580d5c9a5c257e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic186c5f3dfeb4441b6f677670d000585_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i19bdab5e4fc54c39bb5f779d936b5427_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ccecfd286b84522bff1dcdb23b998d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i47b17801eff8471da78a0721b8cde413_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id0e8651392b14a558028cc674241e13e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8b12e4ffb329474094355b4068bcdcd8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i61f69079b45d4915928d89956cfa6568_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6c28d59a6d30456dbaefa29fc86e6c27_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i08588920534148a6a55bbac6aa980054_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie5f7e68c3398415a8874d0a8dd8fc0c4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i56bb88494d0e4f3eaa70062661dfec9c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:SupplierRebatesAndOtherNonTradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0ca143f3c4b747dfa1c18ed1ce48c40f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:SupplierRebatesAndOtherNonTradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0991372c81b2467aa534d7228b96ce3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib12ac6055b314dc9aafc2ab60037e0dd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">dva:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05ba62c8cdc74b429954ac9b69ac970f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i837096e088984a8bb905c6961208d97e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib3346ac383fd4263ba845f553e8518d0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6ef4a9f5101d466cb9f802a38be35ea5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib2aaedfe7b774b2182eb25476a91fc19_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7602e286b8e94ab9a142a5146dae00c4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2f73dfca446c431ca0404970955b23db_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idd2fb3df258c442a8587eff3039100b2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4a4806c6b06944568dbe93e7f5881e70_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5ff02df8087d45659dea2988089fd145_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id31eb9b4ab454ab0bd1eb2e6df77f27c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5a6af38324324be6933f6bddc285dac3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9573fac1bfc4444783c0b158169c7afc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:DeconsolidatedNoncontrollingEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc608d996b8446e4980e0cc9b39bf059_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:DeconsolidatedNoncontrollingEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d64f38aa44e457487bb0f100b1f8548_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:OtherOwnershipInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie883ccd9687a49048607db5fe42301ac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:OtherOwnershipInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i46dab217b75644dabc035f91f7fe782d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9be08d57aed4fe3b4db3144e1d9ad04_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib628323096c74e788c6d7a961b4d57af_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4d9240c1eab54582a445c05ab20d0f19_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id2265c5d8f9c40e9b91c40988cbafd40_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i586e32d477c142e5b161872b638df89f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e74dde23e17402298e90d199d2fe1a4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i84431a6770414fe28573bbddc636eae2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2538a02f3c984fcab3ed760d226d516f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dva:ParentCompanyAndRestrictedSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34e4090bf4484176976adbed8bae6da2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iee6f5fabba1c4c0b9cb21463c121a0ef_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icce7de8cdc8f44f5a250fb8c150e4e1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if8a66dcc0dd948fbb741fd4e292faf13_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3967c55184a84f96ba8812e7748f5793_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i32b056464d244f37914b806833c01276_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3c41f79e5ca947d0a2bcc3fd59da587b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d14633c017d4293acaf92b67376ea7e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:KidneyCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7b36f25a93464b258c27c7f22e113088_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i70ab78105894454bb3a4d66a58c9ce87_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">dva:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4bdcb9f103f4aaeb04d4e05c9d4ad58_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">dva:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id251067d050c44fe8c0736b4e398bced_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec2c1892554643868b5366813ed68ed8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i83a7731ed6494f868aa4389a7de35e85_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if9d939dcfcda400d965c56313d937123_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9046f56523ce431bbd0d602da2e2fead_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3eda909ed98c425386284bc3c9809bd2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i600487b6cfcc42429d3cde02ae5b6e4c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">dva:IndefiniteLifeNetOperatingLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5c646949f7af4e90ac555e2e74c3848f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">dva:PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0110ff4724f848ca85d3284f225e5fb5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie9bff082b91346b1a64d99905758b26e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iece01fa01730408186a67affd6c9484d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">dva:TaxYear2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i62817899f49f4b0d9b02387e82cb91f9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i72a8de58066e4a4a806a5dfa92b2e593_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icaa1d23ca55b42bc9d292cd4c74005e2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1db4cfcf189544c5ae3f2c2607ab9bf3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0e9bc16804444b71ac99a4f60e9d5c12_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i04f7923e726c44b5a317209e10a39819_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib46d077db6cc4fc5ba1ee2fbd6eac6fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4715240e08ce4789b224f11378f56cf4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5327139cdd234a31b8cc0934bc70b68b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i600b97f9f2a649adb54ed6ff94464b99_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie199cda3ed26463fafa480e81f60a090_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3c69871249f9445c9b595c58151ff7cb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8ec717b426f84c228c0d4292f6059e35_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22e611f57b324bf78f55d029bc529436_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i12da2441415248babcb9af6aa29feb11_D20210226-20210226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-26</startDate>
            <endDate>2021-02-26</endDate>
        </period>
    </context>
    <context id="i890855c7c3d64bd8ab0ed0292f35e955_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3a9bcb8cc67b428099ac387fd810b3ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8ee95b0a63934b3fab601bf43c7befac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f95c3f7ea894940b533361538fc95dd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibe46e390006b4b0db6ef499531f4433a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i44e756811d3a4db48b9f947147694905_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i773db74022044af6886373bcbb94b346_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ida3ce71f441045c4b651feea14f7ae6b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib96d977216a04df8a88cb6db54969996_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i46b324066b524a409692e8df3f51de03_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i11aa03bc52b94636a23c6f74a4cfed25_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">dva:GroundLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icabbc5daf3b5479cbbc15782e1d08326_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie5c90a9b4f6e4bc8ac5981725f5f1a56_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1edafa8b823d47d6aee45f343d6d4dab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic4a422541b9c4b1d89d6f0b455e51179_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2ba1dad9a06d4586808260f76a47066d_I20210226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-26</instant>
        </period>
    </context>
    <context id="i483ab4301786474fb072fbdef5442d37_D20200609-20200609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-09</startDate>
            <endDate>2020-06-09</endDate>
        </period>
    </context>
    <context id="iee77e0f66a124be69818c3fe1f9d91bb_I20200609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-09</instant>
        </period>
    </context>
    <context id="i8442b0b05e984872893ac93049fee22e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i95df5bcea102459b914d1085942b9258_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie83cf4a097b643ee9745264ab855ca7b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i214ffb0410c04addafdd70da53f31176_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i82b6dd5b3eea468885f8236cc977ca08_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaeebf4414172413da3e7139927c5aba9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i387548dbf53e458f864bbbc27c03ff99_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic78e16c835d34203a6c659d6e08d50e5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3cd53a26306b4722840092750230a681_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic0e0782bc40d453b86948be43d51725e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i23e9c0b63c2e405182c0cf2802b5eca3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i84fde8e60f5a4538937fd23d973e3361_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:IncomeTaxExpenseBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib7258618967043f9bcfd1acc842da238_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4cda5450900646759ef0009b9d20a3d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iae4fd45d48224399bcab66769793c52a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i263db25331b246e78a22100f6d1d1509_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7f9ca0e521b646668df9e2106ef3225f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if350164cad7147d78b7f10200a640f14_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iad35108069fd45b89fe53b05bbe9c30d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8bd72b308e7b468186e6b9b780fa5baf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iecb8fa3387954169853ce5d7b54cb5f5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i88356036cde840bc8b51ec086349bd93_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icbc2e076ebb1492187444b939215b5ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">dva:OperatingLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib1c510942daa4f38b0c113fc3987e2b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06ff6a03ae0d445a88f8a814027ab039_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">dva:OperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iad36adbebb114059971bb24c387fa559_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">dva:OperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iab5a10e4b11d48bf88b5d0ee68ea283b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">dva:OperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ife16d51280fb452d8a63ec87d4093b0f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i80a65d71492d461c921f03cd2f80cb2f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5e2d65ac940341779a7bb92437611d0e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaeb01d7a6b7545c59b03e80288b089bb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3fa45997abe546d1b852b96a64b33d64_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib37522dd4fa04db58a48b42468502952_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">dva:AllTrustsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab1bf5046e4745aa8d595dc07340685c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">dva:AllTrustsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2be3f954e5f14213b4903797ad633c44_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if21f5702256f425495741fad20cc492f_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ibd5bad9eacc4435abc4605158f6eb4f0_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:IncrementalCashPortionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ie0c63c6719e446e98d499e8b261b5511_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:CashPaidForPortionPreviouslyRefundedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="if5bfd09272294ace935620050b39f2f8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">dva:EpogenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i64d9f8f9c7f64715b2760f70c13f5222_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">dva:EpogenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iafc102d9c4e84b66827b02448eb62b33_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:CommitmentsToProvideOperatingCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic622bc7776774482b0a75f8b50b90c1b_I20200611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-11</instant>
        </period>
    </context>
    <context id="i7cd5dd9a955e4f3595a1f2ea57f1dd2a_I20200611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-11</instant>
        </period>
    </context>
    <context id="i35c0745d14cd45a6967e0f7b75a5a9d2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7e9c2f87088c43fb9b9ca96464a7c38f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib351125c6c8e42c092e5fa01eb01c2c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b85e310c2ac454bb82196389edfda90_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i945bf94544c1438d8e7ef2556b93e671_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4579481a1deb4e84842b772212d72988_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8af02ad747e04ed092ad98eca4b0cece_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dva:StockIncentivePlanTwentyElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5f4abca32687438c9db55fe5ab0adc1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84101fbfd0514880a929fe88d9382ec5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic4d14e355b8248a1b1ab9ddb2b5f20bc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic595c1af14b94764aab706a16639ebc2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i827e2371cbd94ca1a2c25ee147f4a6bf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0917584175d94759b1facacb37055db9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if8276ca374b541099daef28f0d1b9d96_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i501bc5f3ffe44653996610d022c113bd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i79b0c0d86d8e45d790c2ff8423f37743_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c8c2a2e98ec40d79e375f2a9fffd77c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i97843a20897047b5a1130cbd153c19f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia27684d4183a41acb4b535601396cbc2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b0097cc1b5e467d90993d8c00830861_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockSettledStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id524f2487e4c4b6b8d6dfc8130802d34_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockSettledStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i42692d9f0c4245ddb37f1c5457eb7288_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:StockSettledStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4a9414d6f3884602bb28983144590fd6_D20191104-20191104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-04</startDate>
            <endDate>2019-11-04</endDate>
        </period>
    </context>
    <context id="ie576d2314dda4f0ebf4d0fcfd81bff38_I20191104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-04</instant>
        </period>
    </context>
    <context id="i3aa0d7d04018489e86afb5c88077307b_D20191104-20191104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-04</startDate>
            <endDate>2019-11-04</endDate>
        </period>
    </context>
    <context id="i3a011ba985114d35aac38e038221e94d_D20191104-20191104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:PremiumPricedStockSettledStockAppreciationRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-04</startDate>
            <endDate>2019-11-04</endDate>
        </period>
    </context>
    <context id="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i43f1797df61c4bada947140a55076305_D20210101-20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="i41c89f4e64064444ab4288488f07ab8a_D20211231-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iabef7cbe53f54aab89ff94790caaaed4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i380e810ddcd14e7bab4d2d061f0adab0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10d2c3b34a424e5d8a056079072420d1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie566e44321f64f1aa0fcc5e21f1a0e7c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6dd1cc1bae74476ba5ac3d8c45f6fd36_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iee68ddd110f44f1ab19b2eecfcc796b2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic32b93908745434ba82e999a75ecc6c1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i069396e3d9b14202820b9db352b5ab69_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i803f99ff64c84ab393254741b3910d99_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2767101ebdd54c7faa2d837388057e78_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie84513b046464781864c4f5c126a57c1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic0e79d8201f24669b11431997b178ed7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">dva:RangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icd9f925115cc4474bf68992371fa2ba6_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dva:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="iccf688ffd7124bc6aff7a41fd8083119_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i684fe46545c247fab8d3ef0b725b99a6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iba8fa87bf6254cb286350207ba622d6f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i88d2ab8df3834c2f925e018980a4b615_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:TenderOfferMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3c74357cd2654da2ab5263e5e1505e1a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:TenderOfferMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4d53d30fe41e4561a3d660180e6b98d1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:TenderOfferMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2f0cb06103bb48559ef92bd1d85fb047_D20220101-20220209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-02-09</endDate>
        </period>
    </context>
    <context id="i8128ed8de2d8431a8be4d9736d9eb22a_I20201210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2020-12-10</instant>
        </period>
    </context>
    <context id="iea987dbdc7b04a8d9e5cc739bde1bfa9_I20211217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2021-12-17</instant>
        </period>
    </context>
    <context id="iee586c56506f498d9a9bab33ee7558dd_I20220209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-09</instant>
        </period>
    </context>
    <context id="i6d67a2844f2a4c2c9c90e44bd33843a0_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9eaadc9608cb41a185326a3a4f0c59f4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i11a5e338ac8c41b4ba17536e1b30f48d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i274989deb10a476caf0af271f7ed680c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idadb367715dc4267900964561174325e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia84ad34d2722493ca0102f68dc85910c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i24b7a5a0b9454a6596459b76ca8a77fd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4a368aff679b44b39b1d63b92999f915_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i99108034d2554d938cf6bbf6690251eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifea37fe88f5b44c18e322f6488b835ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40dcb33a068e49c5873ade196d5fa5e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id404b91855424fc799a056cf6f4b718b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i85c3913492e84060812eb8467e8fd210_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9bf0294b716341479fe2709f0bed1d2b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2d3d4f666d7c449b92c0699610606f26_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4a2d038875f4494931bdd14b3909f34_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1f41405ceef34baa8b52e118cd782f5d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f9f2f3219c543598584da510ed53480_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i274782ed156b4160aac90d9ee2a76efb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i621a25eea7db4a01974ef60b2432c93e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2245b27c94104effb35180d14351a3fd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i76921e5033604a8fabf20815d5b64089_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie6a746b4356448749bd18ee02e4a5e7a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ied9a0e0050574260b26da48baf596e12_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib46805457f7f4d4eae7bb7b5aaa08d10_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3508cbe980914e3d84c8b1cdebe10249_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia8e3b5c936ba4ca59945d40967ade470_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i14dc4deb3c484a63bee7e80f59d2a7f8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1950b3dc9ab941c69beba84eed98aa3e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3a29a18c5e154226819a3fce4b9d0866_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i31ffbb8892c441dea9a0c3e595b43682_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaa2fdc006ca3477fbbe827fe56dcb2a6_D20200501-20200501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:RMSLifelineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-01</endDate>
        </period>
    </context>
    <context id="i3b812c94400f4e9f93e3edc28560ca7d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i97ebc821f8af433693f363565139ae7a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i15c23a9ed8c74ad88b0b718d8dcbce70_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c26b75f552e487080d6ca8af0cbfbb2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34268660f8994614945e3a3ac73ae27c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i94e70ca9077e4db8b762a4fcc4bfbd6f_D20190619-20190619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-19</startDate>
            <endDate>2019-06-19</endDate>
        </period>
    </context>
    <context id="i2aba66ad0dad46008b9826b26fef8363_D20171205-20171205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-05</startDate>
            <endDate>2017-12-05</endDate>
        </period>
    </context>
    <context id="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7458081d2436470ea923b7c4156197b2_D20190619-20190619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2019-06-19</startDate>
            <endDate>2019-06-19</endDate>
        </period>
    </context>
    <context id="icfd8f32feed247c2a24b065aa98482f1_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iafda8ba2e67442e6935e3adfbd191cc1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dva:CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i54d86d8eabc947b9afbe06d0abb8af86_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icedbf892c351473882af74862a207224_D20190101-20190618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dva:DMGAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-18</endDate>
        </period>
    </context>
    <context id="ia96df5cbacd84affb90640475c11f0a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd41fb8f57d94a9c8174ee4a26733781_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0fef43c972784c6a8dbdf6403215466d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica05fdb7be334adbaa11280e81f266cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6864393609014579b808f5a4cacfb46d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i418c9ec9c3c24e6f814f5127bfb19718_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i83a052e9006844f196962f56a7a3ab82_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i98fc6e3377174560b321ac0cda63f05d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib3d558bed55f41d99d2f76f5a51d8b45_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab0bdb00a98b44d1b298eba644850e38_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i094bcb864f7f45e4b54429ab104ba86e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idc5f11c3daa745e5a80d9f58e885601d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6488a2f4b17b4b85a4d7bf553c12175e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3fa251283e0a4f088eb92843005d890b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i123069f4eb5a4ab69f8ac7158c7ce2a4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05d3a24424f8420b8fe59106d9cca3c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3aa693ad0da4e16b1fa0ce0a7ea10b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i773b082f96934fbdb2cc112ef35d5bcf_D20201231-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4a546c754ebc4cf29073750fe342c98d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6e14e13c061a41a69e38812da9f0c694_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i544de1e9a45e4dbaaf258e405bc34603_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2a20be04098a43a2ad690daf6b43b6a9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i489433a3b5c64d6d8c71dff895bfc7c5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib875d6317d544b89a9327b5a6ee456e1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4d18a39a07e04a829dc76a948808fea5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i341a3fbdfb3a478c8c3956fb1de4ca5a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if0c557cfe8294cbea0ed6640742174a4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i740db58e2be94545b0d469bbda135eed_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i30278d11df6d4599be4d253d8771c646_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i02fff1f443d0417a9b5ea14a7887642f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1f996697630f4114b1fe31268ca70cfb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6915b80d9b3f460f8e299e65e92465a5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if07da703894f46ff923b52cd1974f85e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaff1da3cd4af4158afb2f7ced0775c70_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2abab19ce64643c5b1ead781e19bc5d4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i53d5102250e24aa5bd036affff061811_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic74654e344444142a656506ce7f98032_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i769c9942acbc457e9f36b28d6dc6bcff_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib5869a8167684e6e92336d2061353dd0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:DaVitaMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id95aa5b653c348f3afacdc11aed8c324_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7f1ee4e1cd744091960584e2d8db83ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8020fe2d892b43739f987d0c488736a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic7ce08c39f814ce99981d4545611fa84_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i149a050b3c4645829b359c2948b066e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c153efa63664c3e9cd75b33af39db2a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i91556d981c14455d82d1dc87f6ab398c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i69bac113d5d84b4b85c181e2fd5a277c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3a475d47d0d042098ff362c229c4796b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="clinic">
        <measure>dva:clinic</measure>
    </unit>
    <unit id="state">
        <measure>dva:state</measure>
    </unit>
    <unit id="patient">
        <measure>dva:patient</measure>
    </unit>
    <unit id="country">
        <measure>dva:country</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="entity">
        <measure>dva:entity</measure>
    </unit>
    <unit id="segment">
        <measure>dva:segment</measure>
    </unit>
    <unit id="clinic2">
        <measure>dva:Clinic</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF80L2ZyYWc6OGIwNWVkNDI3ODNhNGEwOTg4YzU4NjBkMWU3MDUxOTYvdGFibGU6ZTY0NWZiMmM1NzAzNDQ2OWFkZjYyZjdiNzdmZTc5YTYvdGFibGVyYW5nZTplNjQ1ZmIyYzU3MDM0NDY5YWRmNjJmN2I3N2ZlNzlhNl8yLTEtMS0xLTgzMDc4_891e2656-60f3-48ce-b832-549cca2ad37b">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF80L2ZyYWc6OGIwNWVkNDI3ODNhNGEwOTg4YzU4NjBkMWU3MDUxOTYvdGFibGU6ZTY0NWZiMmM1NzAzNDQ2OWFkZjYyZjdiNzdmZTc5YTYvdGFibGVyYW5nZTplNjQ1ZmIyYzU3MDM0NDY5YWRmNjJmN2I3N2ZlNzlhNl8zLTEtMS0xLTgzMDc4_a6d48c05-f0a7-4dc4-8b95-dc8ae99e3442">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF80L2ZyYWc6OGIwNWVkNDI3ODNhNGEwOTg4YzU4NjBkMWU3MDUxOTYvdGFibGU6ZTY0NWZiMmM1NzAzNDQ2OWFkZjYyZjdiNzdmZTc5YTYvdGFibGVyYW5nZTplNjQ1ZmIyYzU3MDM0NDY5YWRmNjJmN2I3N2ZlNzlhNl80LTEtMS0xLTgzMDc4_c9d9fc59-981a-4b43-8f8d-6e9cb2dfbb85">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF80L2ZyYWc6OGIwNWVkNDI3ODNhNGEwOTg4YzU4NjBkMWU3MDUxOTYvdGFibGU6ZTY0NWZiMmM1NzAzNDQ2OWFkZjYyZjdiNzdmZTc5YTYvdGFibGVyYW5nZTplNjQ1ZmIyYzU3MDM0NDY5YWRmNjJmN2I3N2ZlNzlhNl81LTEtMS0xLTgzMDc4_6994346f-3d46-41cd-a415-72c9a380d623">0000927066</dei:EntityCentralIndexKey>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzItMi0xLTEtODMwNzg_b371d3e8-c01f-416c-a06b-8e5e5028ffdb"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzMtMi0xLTEtODMwNzg_f46b216e-38b8-4cec-ae5f-c66103c23bea"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzQtMi0xLTEtODMwNzg_d0b0a4f7-ed24-4fdb-a89d-0b61e0048ef4"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzUtMi0xLTEtODMwNzg_fe89440e-2131-47ef-ab6f-f159a2af3973"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzYtMi0xLTEtODMwNzg_e809e663-68ea-4b15-9424-618835163983"
      unitRef="shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzgtMS0xLTEtODMwNzg_e764459e-49db-4e01-8abe-ff0882fdfb10"
      unitRef="shares">97289000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTYvZnJhZzplNTUzZmRiMjQ2Zjg0MjFjYmU2ZjAyOWY1NDdmZjNhYi90YWJsZTozZDU0MjM5NGNlYzg0YTljOGQ5ZDgxMzk3N2U4OTI3MS90YWJsZXJhbmdlOjNkNTQyMzk0Y2VjODRhOWM4ZDlkODEzOTc3ZTg5MjcxXzgtMi0xLTEtODMwNzg_a3c84f97-d2d7-45f3-9daf-12d8d46b9cee"
      unitRef="shares">109933000</us-gaap:CommonStockSharesOutstanding>
    <dva:NumberOfConcentrationRiskCustomers
      contextRef="i70ca4b5a53254c4ea41168999c345602_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTQvZnJhZzo4ZjgyNDJkYjI0OGM0MDI3YWI4ZWRlNmMzYTJlYTU3OS90ZXh0cmVnaW9uOjhmODI0MmRiMjQ4YzQwMjdhYjhlZGU2YzNhMmVhNTc5XzE0_277a7ff7-f8b9-4648-952b-996078570924"
      unitRef="number">0</dva:NumberOfConcentrationRiskCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i70ca4b5a53254c4ea41168999c345602_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTQvZnJhZzo4ZjgyNDJkYjI0OGM0MDI3YWI4ZWRlNmMzYTJlYTU3OS90ZXh0cmVnaW9uOjhmODI0MmRiMjQ4YzQwMjdhYjhlZGU2YzNhMmVhNTc5Xzcw_0a8e5c63-d016-45c3-a6fd-1ab87ae420c4"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzUvZnJhZzphYTYxZTA1ZDE1OGQ0ZTMwYjlkMjRlYWZlNDBlYTllNy90ZXh0cmVnaW9uOmFhNjFlMDVkMTU4ZDRlMzBiOWQyNGVhZmU0MGVhOWU3XzY2_5b0a9fe8-dbb3-420d-80ca-e2ad93c7f25a"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzUvZnJhZzphYTYxZTA1ZDE1OGQ0ZTMwYjlkMjRlYWZlNDBlYTllNy90ZXh0cmVnaW9uOmFhNjFlMDVkMTU4ZDRlMzBiOWQyNGVhZmU0MGVhOWU3XzE5Ng_0380a00c-b1e7-4ff5-8c00-3ec7c8ede187"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDEvZnJhZzo5N2RiNDA1YmNlZDQ0ZjA5YjQzMjY0NjE5ZWEwNTQ2Ni90ZXh0cmVnaW9uOjk3ZGI0MDViY2VkNDRmMDliNDMyNjQ2MTllYTA1NDY2XzE2_ca773252-3dbf-4e3d-87e1-0147649ab86d"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDEvZnJhZzo5N2RiNDA1YmNlZDQ0ZjA5YjQzMjY0NjE5ZWEwNTQ2Ni90ZXh0cmVnaW9uOjk3ZGI0MDViY2VkNDRmMDliNDMyNjQ2MTllYTA1NDY2XzE0Ng_86eb2266-3d86-4a90-b08b-63cedfba6bda"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <dva:PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDcvZnJhZzpkZjg0N2I1NjIxMzY0YmRiYjFjZGRlMjZkYzMwZWY4Mi90ZXh0cmVnaW9uOmRmODQ3YjU2MjEzNjRiZGJiMWNkZGUyNmRjMzBlZjgyXzgz_72f0a86b-90e9-476b-9192-b02765177436"
      unitRef="number">0.0100</dva:PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment>
    <us-gaap:OperatingLossCarryforwardsExpirationDate
      contextRef="ie9bff082b91346b1a64d99905758b26e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTYvZnJhZzo0Yjg3OWJmNTY4NTU0ZmY1YjJjMDI3OTdkOTZkNGI1Mi90ZXh0cmVnaW9uOjRiODc5YmY1Njg1NTRmZjViMmMwMjc5N2Q5NmQ0YjUyXzY1_d9b1b4f6-c1b0-47d1-b80a-04c108d06b02">2036-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:OperatingLossCarryforwardsExpirationDate
      contextRef="iece01fa01730408186a67affd6c9484d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTYvZnJhZzo0Yjg3OWJmNTY4NTU0ZmY1YjJjMDI3OTdkOTZkNGI1Mi90ZXh0cmVnaW9uOjRiODc5YmY1Njg1NTRmZjViMmMwMjc5N2Q5NmQ0YjUyXzEwOQ_e514b8c5-7a7f-4152-a6e5-f6f06eec5dfb">2029-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:OperatingLossCarryforwardsExpirationDate
      contextRef="i62817899f49f4b0d9b02387e82cb91f9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTYvZnJhZzo0Yjg3OWJmNTY4NTU0ZmY1YjJjMDI3OTdkOTZkNGI1Mi90ZXh0cmVnaW9uOjRiODc5YmY1Njg1NTRmZjViMmMwMjc5N2Q5NmQ0YjUyXzE3OQ_4680b45c-fca4-40cd-8eb5-02c4fb932735">2041-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:OperatingLossCarryforwardsExpirationDate
      contextRef="i72a8de58066e4a4a806a5dfa92b2e593_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTYvZnJhZzo0Yjg3OWJmNTY4NTU0ZmY1YjJjMDI3OTdkOTZkNGI1Mi90ZXh0cmVnaW9uOjRiODc5YmY1Njg1NTRmZjViMmMwMjc5N2Q5NmQ0YjUyXzI1MQ_475cbfec-26e1-4138-8f9a-56369995a43b">2022-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:TaxCreditCarryforwardExpirationDate
      contextRef="icaa1d23ca55b42bc9d292cd4c74005e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTYvZnJhZzo0Yjg3OWJmNTY4NTU0ZmY1YjJjMDI3OTdkOTZkNGI1Mi90ZXh0cmVnaW9uOjRiODc5YmY1Njg1NTRmZjViMmMwMjc5N2Q5NmQ0YjUyXzM2Mg_694922a1-3763-497f-9b05-9e78038bc3da">2024-12-31</us-gaap:TaxCreditCarryforwardExpirationDate>
    <dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate
      contextRef="i2be3f954e5f14213b4903797ad633c44_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzEvZnJhZzowNjViNDQxZGUwYzE0MTUzYjM0OGRmYmU3ODI5NWE4Yy90ZXh0cmVnaW9uOjA2NWI0NDFkZTBjMTQxNTNiMzQ4ZGZiZTc4Mjk1YThjXzky_d161914e-1eac-4576-8b48-3898615e3629">P1Y</dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate>
    <dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate
      contextRef="ife16d51280fb452d8a63ec87d4093b0f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzEvZnJhZzowNjViNDQxZGUwYzE0MTUzYjM0OGRmYmU3ODI5NWE4Yy90ZXh0cmVnaW9uOjA2NWI0NDFkZTBjMTQxNTNiMzQ4ZGZiZTc4Mjk1YThjXzk4_d220be28-9980-494e-bc63-f3bfb734a392">P2Y</dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate>
    <dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection
      contextRef="i2be3f954e5f14213b4903797ad633c44_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzEvZnJhZzowNjViNDQxZGUwYzE0MTUzYjM0OGRmYmU3ODI5NWE4Yy90ZXh0cmVnaW9uOjA2NWI0NDFkZTBjMTQxNTNiMzQ4ZGZiZTc4Mjk1YThjXzE2Mw_d36a0e12-4ef5-4297-b44f-31c8097e23ed">P3Y</dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection>
    <dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection
      contextRef="ife16d51280fb452d8a63ec87d4093b0f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzEvZnJhZzowNjViNDQxZGUwYzE0MTUzYjM0OGRmYmU3ODI5NWE4Yy90ZXh0cmVnaW9uOjA2NWI0NDFkZTBjMTQxNTNiMzQ4ZGZiZTc4Mjk1YThjXzE2OQ_beeb74a2-aaeb-4175-a226-86fcc6beeee6">P4Y</dva:VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection>
    <dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms
      contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzk4_1165aa38-f883-4968-8d88-16163128f92a">P0Y</dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i803f99ff64c84ab393254741b3910d99_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzMtMS0xLTEtODMwNzg_9314496a-a768-41b5-8504-c9612a3546b4"
      unitRef="usdPerShare">50.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i803f99ff64c84ab393254741b3910d99_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzMtMi0xLTEtODMwNzg_d627fc49-bdcd-4e29-9b94-f115f0f52434"
      unitRef="usdPerShare">60.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i2767101ebdd54c7faa2d837388057e78_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzQtMS0xLTEtODMwNzg_be86db7d-5a3e-4fcd-8bbe-196ebb3506b7"
      unitRef="usdPerShare">60.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i2767101ebdd54c7faa2d837388057e78_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzQtMi0xLTEtODMwNzg_ee2e0ae3-ea64-483c-a351-23a22761ce97"
      unitRef="usdPerShare">70.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ie84513b046464781864c4f5c126a57c1_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzUtMS0xLTEtODMwNzg_4a5ac597-8540-4470-bdab-01b90074a9d8"
      unitRef="usdPerShare">70.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ie84513b046464781864c4f5c126a57c1_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzUtMi0xLTEtODMwNzg_00ae1b95-d675-41c3-86ba-8bb49639591e"
      unitRef="usdPerShare">80.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ic0e79d8201f24669b11431997b178ed7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzYtMS0xLTEtMTU2NTE5_b07d2e2c-f2d5-4446-933c-fd387232fac2"
      unitRef="usdPerShare">100.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ic0e79d8201f24669b11431997b178ed7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90YWJsZTozYmE5MTUzNmEzMzk0NWFjOTljMTZjN2E4NzIwMjY1Zi90YWJsZXJhbmdlOjNiYTkxNTM2YTMzOTQ1YWM5OWMxNmM3YTg3MjAyNjVmXzYtMi0xLTEtMTU2NTIx_8f920ace-bf94-4f8d-888c-6cc364e05697"
      unitRef="usdPerShare">110.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i3a011ba985114d35aac38e038221e94d_D20191104-20191104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzEyNQ_56a5ebf9-97b1-4341-aa78-f3d2bca12549"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="icd9f925115cc4474bf68992371fa2ba6_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzIzNA_102e738b-2a20-4629-82e7-49e22d20df5d"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzQxOQ_e90b9fd4-6129-470a-b38b-bda78261151f"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzU3NA_04dff9db-9b59-4739-8521-0fd66af4a80c"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzYyMQ_1aba7357-ef40-46ca-b7db-9928602effcb"
      unitRef="usd">0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzYzNQ_617ecb7e-65a4-408c-b620-d09d44c3d645"
      unitRef="usd">0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODMvZnJhZzozNWZhMmE0MzhlYjM0ZjU5YTJmOGU2M2I4YzBiNTQ2Yy90ZXh0cmVnaW9uOjM1ZmEyYTQzOGViMzRmNTlhMmY4ZTYzYjhjMGI1NDZjXzY1MA_687b57d4-7df9-4385-bd02-c1cf796bd651"
      unitRef="usd">0</us-gaap:PaymentsOfDividendsCommonStock>
    <dva:TerminatedRemainingPriorShareRepurchasesAuthorizedAmount
      contextRef="i8128ed8de2d8431a8be4d9736d9eb22a_I20201210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODkvZnJhZzpiN2ZiMThjMzZkZTc0ZDVlOTk0YjMyN2NlMWRkZWE0ZC90ZXh0cmVnaW9uOmI3ZmIxOGMzNmRlNzRkNWU5OTRiMzI3Y2UxZGRlYTRkXzI3Ng_71329a35-1a7d-4ef6-bee1-18ed705bd14a"
      unitRef="usd">329302000</dva:TerminatedRemainingPriorShareRepurchasesAuthorizedAmount>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i518c74e1af094a8bbc78df6c4a5e0e05_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODkvZnJhZzpiN2ZiMThjMzZkZTc0ZDVlOTk0YjMyN2NlMWRkZWE0ZC90ZXh0cmVnaW9uOmI3ZmIxOGMzNmRlNzRkNWU5OTRiMzI3Y2UxZGRlYTRkXzQzNQ_7383caec-d3c6-45ad-8410-96e8f331f16b"
      unitRef="shares">-13877000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i8d5b598835d84508b6ec3b7ee400fa41_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODkvZnJhZzpiN2ZiMThjMzZkZTc0ZDVlOTk0YjMyN2NlMWRkZWE0ZC90ZXh0cmVnaW9uOmI3ZmIxOGMzNmRlNzRkNWU5OTRiMzI3Y2UxZGRlYTRkXzQ0Mg_18c48c80-d974-47c6-8c9c-5b1acc3b9ab9"
      unitRef="shares">-16477000</us-gaap:TreasuryStockSharesRetired>
    <dei:DocumentType
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTk0_ca1cd68f-e765-4e5c-abb1-58347ce28639">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6NTM1ZDUyMDA5MDRlNDM5ODk2Zjk2ZjIxOTNjNjRlNjYvdGFibGVyYW5nZTo1MzVkNTIwMDkwNGU0Mzk4OTZmOTZmMjE5M2M2NGU2Nl8wLTAtMS0xLTgzMDc4_5d511243-5c59-4e5b-b65a-76ff8f521828">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8xOTc5MTIwOTMwMjk4Ng_f1e2c504-4a3f-45d5-923d-3756352023d3">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8xOTc5MTIwOTMwMjk4Ng_e913ee63-57cc-440d-9062-4a4090f0c1d1">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6ODM5NGI3OTcxYjQ2NDQ3MDg3NzcxYTJiNTViNzRjYjMvdGFibGVyYW5nZTo4Mzk0Yjc5NzFiNDY0NDcwODc3NzFhMmI1NWI3NGNiM18wLTAtMS0xLTgzMDc4_fc1ce468-f677-4e6a-94e3-fab7e8a216e5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTg5_468e0ca7-bc84-4cad-a191-5b9e95bb3e0f">1-14106</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTk1_2cc2b28e-93d1-4c27-8add-5181c4c85d8f">DAVITA INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6Mzc4OTk4NGYyNGRlNDZmY2FiNjY0ZDkyMWNiOTAwODQvdGFibGVyYW5nZTozNzg5OTg0ZjI0ZGU0NmZjYWI2NjRkOTIxY2I5MDA4NF8wLTAtMS0xLTgzMDc4_f8cf1898-397e-4e65-9378-47eae4435525">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6Mzc4OTk4NGYyNGRlNDZmY2FiNjY0ZDkyMWNiOTAwODQvdGFibGVyYW5nZTozNzg5OTg0ZjI0ZGU0NmZjYWI2NjRkOTIxY2I5MDA4NF8wLTItMS0xLTgzMDc4_b167a71a-20e6-43a0-a88e-263bf08e513e">51-0354549</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6YWQ5M2ZiYWE0ZjBkNDRkNmJiMzRhYzU3ZTAwOTZkZjUvdGFibGVyYW5nZTphZDkzZmJhYTRmMGQ0NGQ2YmIzNGFjNTdlMDA5NmRmNV8wLTAtMS0xLTgzMDc4_fe9bdfba-b2b7-4c55-8e05-88863c16aee7">2000 16th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6YWQ5M2ZiYWE0ZjBkNDRkNmJiMzRhYzU3ZTAwOTZkZjUvdGFibGVyYW5nZTphZDkzZmJhYTRmMGQ0NGQ2YmIzNGFjNTdlMDA5NmRmNV8xLTAtMS0xLTgzMDc4_82f00f97-425e-4eeb-9ddd-cfb60264a76b">Denver,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6YWQ5M2ZiYWE0ZjBkNDRkNmJiMzRhYzU3ZTAwOTZkZjUvdGFibGVyYW5nZTphZDkzZmJhYTRmMGQ0NGQ2YmIzNGFjNTdlMDA5NmRmNV8xLTEtMS0xLTgzMDc4_1d0c2638-8a4d-4a35-8c09-27ed86f91a31">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6YWQ5M2ZiYWE0ZjBkNDRkNmJiMzRhYzU3ZTAwOTZkZjUvdGFibGVyYW5nZTphZDkzZmJhYTRmMGQ0NGQ2YmIzNGFjNTdlMDA5NmRmNV8xLTItMS0xLTgzMDc4_ab3c9404-3099-40bd-806d-589ea4d54ca9">80202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTk2_ef4966d3-3a05-4224-9fb9-6c4171380e55">720</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTkw_d2e0cf2b-27d4-49ae-a816-b2c0df48b284">631-2100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6M2RjMTQzMjIwMGQ1NDI4MWEyYTZkZGY2YTA4NzU1YTQvdGFibGVyYW5nZTozZGMxNDMyMjAwZDU0MjgxYTJhNmRkZjZhMDg3NTVhNF8xLTAtMS0xLTgzMDc4_ac35f1fe-6e68-4037-9f18-32d0c48f8c8f">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6M2RjMTQzMjIwMGQ1NDI4MWEyYTZkZGY2YTA4NzU1YTQvdGFibGVyYW5nZTozZGMxNDMyMjAwZDU0MjgxYTJhNmRkZjZhMDg3NTVhNF8xLTItMS0xLTgzMDc4_9ce9b5d6-35be-47d4-8cde-826151c451cb">DVA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6M2RjMTQzMjIwMGQ1NDI4MWEyYTZkZGY2YTA4NzU1YTQvdGFibGVyYW5nZTozZGMxNDMyMjAwZDU0MjgxYTJhNmRkZjZhMDg3NTVhNF8xLTQtMS0xLTgzMDc4_024f4979-4a33-4c30-b10b-e53ec7036c3e">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTkx_e1dfe802-cf8a-4c45-85c5-35918c9be41d">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTky_77c010ea-3b36-488d-832a-d1d0d9e43750">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTk3_2f020416-502f-4c76-8cc0-3a19a807fbb5">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTg3_6283efbf-54c9-4ba5-804c-37fa942d558a">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6ZDNhYTlmNjY1ZjA2NDBjYWE0YzI1YzFiOTQyZGJmOWYvdGFibGVyYW5nZTpkM2FhOWY2NjVmMDY0MGNhYTRjMjVjMWI5NDJkYmY5Zl8wLTAtMS0xLTgzMDc4_7b5d7af0-ccff-4b45-be46-92e680cdc66b">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6ZDNhYTlmNjY1ZjA2NDBjYWE0YzI1YzFiOTQyZGJmOWYvdGFibGVyYW5nZTpkM2FhOWY2NjVmMDY0MGNhYTRjMjVjMWI5NDJkYmY5Zl8xLTUtMS0xLTgzMDc4_f3188848-74db-4e0d-b921-75e62a0456ae">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGFibGU6ZDNhYTlmNjY1ZjA2NDBjYWE0YzI1YzFiOTQyZGJmOWYvdGFibGVyYW5nZTpkM2FhOWY2NjVmMDY0MGNhYTRjMjVjMWI5NDJkYmY5Zl8yLTUtMS0xLTgzMDc4_d58956be-e033-4478-9863-18101effb162">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTkz_1420f6ea-a682-4fdd-84ef-5f47455721f2">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yOTg4_6f797e7e-3769-4d15-bd0f-d7fcd4600670">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i6946ea686e7c41b3a8aa82ffda6fb966_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV82MDQ3MzEzOTU2MTQ1_1c832f59-52df-4ad3-bdf0-eaefcbfad6f8"
      unitRef="usd">12700000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i50c3ae2124374b73a5fb91701224c115_I20220131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yNzk0_5b941a75-e376-43c9-ba68-112acb1b6b38"
      unitRef="shares">96300000</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yNDE4OTI1NTgxNDQzNw_23bf5ca6-2cf1-4dfc-9e3b-69525c6fcb91">KPMG LLP</dei:AuditorName>
    <dei:AuditorFirmId
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yNDE4OTI1NTgxNDQ0MA_5a45ab61-88a1-43d5-8733-51f82f69019c">185</dei:AuditorFirmId>
    <dei:AuditorLocation
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xL2ZyYWc6OTNiMTNlZDBjYWZkNDQzYTk1ZmFkY2Q2NzFhMDY1NWUvdGV4dHJlZ2lvbjo5M2IxM2VkMGNhZmQ0NDNhOTVmYWRjZDY3MWEwNjU1ZV8yNDE4OTI1NTgxNDQ0NA_bf9d3b75-58ea-46f8-b1fd-0786eeedfc8a">Seattle, WA, USA</dei:AuditorLocation>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQtMS0xLTEtODMwNzg_34dc1dff-8dfd-4bb6-9784-574a8eb65a7d"
      unitRef="usd">11213515000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQtMy0xLTEtODMwNzg_61a73ed2-98dd-434c-805c-2036b3e07971"
      unitRef="usd">11026251000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQtNS0xLTEtODMwNzg_6f1519ca-b024-49ec-a3e3-73e63c33cdba"
      unitRef="usd">10896706000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <us-gaap:OtherIncome
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzUtMS0xLTEtODMwNzg_bf4d4461-8524-49ed-847f-93519eb03561"
      unitRef="usd">405282000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzUtMy0xLTEtODMwNzg_b05045f6-dfa7-4648-acbb-8bc07ce9352d"
      unitRef="usd">524353000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzUtNS0xLTEtODMwNzg_334f1a94-5060-4144-8abe-07be58f4128d"
      unitRef="usd">491773000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzYtMS0xLTEtODMwNzg_9d0bd332-77ca-480b-8766-f117dd6c02ca"
      unitRef="usd">11618797000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzYtMy0xLTEtODMwNzg_3a9cbd25-b58a-4ccd-ad3d-6e946a501ba2"
      unitRef="usd">11550604000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzYtNS0xLTEtODMwNzg_da77ac14-ac5f-4879-bd03-d71693cba037"
      unitRef="usd">11388479000</us-gaap:Revenues>
    <dva:PatientCareCosts
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzgtMS0xLTEtODMwNzg_38a3b5cb-6e3b-433e-aeb1-985640b16035"
      unitRef="usd">7972414000</dva:PatientCareCosts>
    <dva:PatientCareCosts
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzgtMy0xLTEtODMwNzg_a438d508-8426-49b3-8d95-810ea98287ef"
      unitRef="usd">7988613000</dva:PatientCareCosts>
    <dva:PatientCareCosts
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzgtNS0xLTEtODMwNzg_a4c1e8cf-5bda-4430-85a3-e58b35dad529"
      unitRef="usd">7914485000</dva:PatientCareCosts>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzktMS0xLTEtODMwNzg_fb4e304a-5281-438a-b887-438fb71cfb45"
      unitRef="usd">1195335000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzktMy0xLTEtODMwNzg_78ba6653-fc6e-455c-bec8-d485335f1ebd"
      unitRef="usd">1247584000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzktNS0xLTEtODMwNzg_ea045008-5465-4a0a-9b01-e870c4cce7e4"
      unitRef="usd">1103312000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzEwLTEtMS0xLTgzMDc4_ff28cb03-ac4d-45bb-875c-24e5285f2f85"
      unitRef="usd">680615000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzEwLTMtMS0xLTgzMDc4_3ba77570-cc57-49f2-9f71-0d2cd8755f70"
      unitRef="usd">630435000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzEwLTUtMS0xLTgzMDc4_41484694-34b5-4af3-a387-be1ec61f5e5c"
      unitRef="usd">615152000</us-gaap:DepreciationAndAmortization>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzEyLTEtMS0xLTgzMDc4_d50fc5a2-8315-4e39-854d-8b87f2e1f836"
      unitRef="usd">26937000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzEyLTMtMS0xLTgzMDc4_a79533f8-ca21-487e-b819-b5f35f462200"
      unitRef="usd">26916000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzEyLTUtMS0xLTgzMDc4_6a167cea-c8fd-4f1b-b6c5-1b6a1ba292b8"
      unitRef="usd">12679000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE0LTEtMS0xLTgzMDc4_4f629c1a-18c7-4c6a-a982-ee072fc24be3"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE0LTMtMS0xLTgzMDc4_b0e6e513-1920-4bab-a5d3-9f18fb63aafb"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE0LTUtMS0xLTgzMDc4_ce71496e-7bf5-42af-bc7d-817a2eced9eb"
      unitRef="usd">124892000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE1LTEtMS0xLTgzMDc4_b16a742a-0aa6-4caa-9a65-437669b9d7bd"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE1LTMtMS0xLTgzMDc4_a47655f8-6e75-4961-ac5f-d58aaa3ef559"
      unitRef="usd">-16252000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE1LTUtMS0xLTgzMDc4_f4025a74-f38b-4704-ac16-c0c24a0709fd"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:CostsAndExpenses
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE3LTEtMS0xLTgzMDc4_0fc0ef8b-e240-4522-a8e4-7470a146bd19"
      unitRef="usd">9821427000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE3LTMtMS0xLTgzMDc4_aef82c38-71b5-4387-94da-bc54208041da"
      unitRef="usd">9855968000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE3LTUtMS0xLTgzMDc4_9210bc80-e82f-4057-a05a-d6c4f50e7849"
      unitRef="usd">9745162000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE4LTEtMS0xLTgzMDc4_ecb82bfe-c9c3-4dac-a892-882b233fb17b"
      unitRef="usd">1797370000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE4LTMtMS0xLTgzMDc4_6c013cb1-e03e-4117-8f5b-9d457215d79a"
      unitRef="usd">1694636000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE4LTUtMS0xLTgzMDc4_cdbe8135-3c4d-4a66-b536-4f01e43de998"
      unitRef="usd">1643317000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndDebtExpense
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE5LTEtMS0xLTgzMDc4_27d7ab4c-78f0-4dbd-b3d0-4c73ba93652d"
      unitRef="usd">285254000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE5LTMtMS0xLTgzMDc4_bcd788fd-9781-4542-984e-815756eb296c"
      unitRef="usd">304111000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzE5LTUtMS0xLTgzMDc4_ece863b4-8e5d-4ea7-a8ea-fa26154f11f3"
      unitRef="usd">443824000</us-gaap:InterestAndDebtExpense>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIwLTEtMS0xLTgzMDc4_06044dfc-b232-48c9-8e20-1cc318fb956e"
      unitRef="usd">0</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIwLTMtMS0xLTgzMDc4_ce8a1c9a-eefe-4e96-b944-6482389e43b7"
      unitRef="usd">89022000</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIwLTUtMS0xLTgzMDc4_fea3d737-c4dc-4b5a-8bf0-be1d2f0f437b"
      unitRef="usd">33402000</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIxLTEtMS0xLTgzMDc4_e482f775-1382-40f4-bc1e-9256ae99f1af"
      unitRef="usd">6378000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIxLTMtMS0xLTgzMDc4_e2308e51-4fb4-40f3-b0e0-27b6f71609b9"
      unitRef="usd">16759000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIxLTUtMS0xLTgzMDc4_ca01b7fe-32d7-4ed2-9072-d7b4861dd3e2"
      unitRef="usd">29348000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIyLTEtMS0xLTgzMDc4_427781df-3998-4e11-be89-67507795746b"
      unitRef="usd">1518494000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIyLTMtMS0xLTgzMDc4_8c748163-9a03-45ef-b468-e6e67921214f"
      unitRef="usd">1318262000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIyLTUtMS0xLTgzMDc4_cab4b61b-4d66-4ace-9894-8c9b038cf71d"
      unitRef="usd">1195439000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIzLTEtMS0xLTgzMDc4_163583e2-3f94-45b0-8e4e-8c24684d7ae6"
      unitRef="usd">306732000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIzLTMtMS0xLTgzMDc4_e6019912-2c97-44a3-9a1f-88daffec974d"
      unitRef="usd">313932000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzIzLTUtMS0xLTgzMDc4_417c64ae-535f-49d9-b6fa-204d1e696a7c"
      unitRef="usd">279628000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI0LTEtMS0xLTgzMDc4_f76fd6c7-cb0e-416c-a642-0c6f701dfcd9"
      unitRef="usd">1211762000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI0LTMtMS0xLTgzMDc4_414f935e-178a-4ac4-b511-6bad8349ddf9"
      unitRef="usd">1004330000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI0LTUtMS0xLTgzMDc4_84296cca-c816-4c1b-80f6-4c1a53e130ae"
      unitRef="usd">915811000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI1LTEtMS0xLTgzMDc4_232d0f00-d14b-4c21-88cd-bb93e09b5566"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI1LTMtMS0xLTgzMDc4_d6784983-719c-4f74-bd26-d300afbdee5e"
      unitRef="usd">-9653000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI1LTUtMS0xLTgzMDc4_05e5c20e-e632-4d45-8870-dd01cdb9e155"
      unitRef="usd">105483000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI2LTEtMS0xLTgzMDc4_70f38360-358d-4522-a128-ec9b3f407fdf"
      unitRef="usd">1211762000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI2LTMtMS0xLTgzMDc4_7464d982-1292-45bc-97df-ecea5c54e6a5"
      unitRef="usd">994677000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI2LTUtMS0xLTgzMDc4_439be468-8f76-454c-8761-50ed2b73127f"
      unitRef="usd">1021294000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI3LTEtMS0xLTgzMDc4_0a6f5d21-bd78-4687-88b2-bb0238aaef7a"
      unitRef="usd">233312000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI3LTMtMS0xLTgzMDc4_06fa904c-ce42-47ba-b57e-9025c548cda7"
      unitRef="usd">221035000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI3LTUtMS0xLTgzMDc4_3a57d806-a4e0-4fde-adcd-09b2f16730bc"
      unitRef="usd">210313000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI4LTEtMS0xLTgzMDc4_3e447174-152f-4c60-8d38-d6b5b2974f40"
      unitRef="usd">978450000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI4LTMtMS0xLTgzMDc4_1cba2dc0-e94b-485f-bae9-b565006b1e85"
      unitRef="usd">773642000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzI4LTUtMS0xLTgzMDc4_a3ab5b17-08d8-4bf1-a14e-a0acde01fc6c"
      unitRef="usd">810981000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMxLTEtMS0xLTgzMDc4_8686b3a8-f052-4d93-aa5c-016a630197af"
      unitRef="usdPerShare">9.30</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMxLTMtMS0xLTgzMDc4_2546d20a-62fb-499f-91af-b3a61b094a55"
      unitRef="usdPerShare">6.54</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMxLTUtMS0xLTgzMDc4_9aedb01d-5093-462c-aa63-74bfb988fdde"
      unitRef="usdPerShare">4.61</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMyLTEtMS0xLTgzMDc4_afb1ef5f-e727-4437-b2ed-a15eb7e1349b"
      unitRef="usdPerShare">9.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMyLTMtMS0xLTgzMDc4_fe6c9913-0810-437d-aa99-f8101bb93d65"
      unitRef="usdPerShare">6.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMyLTUtMS0xLTgzMDc4_f3a082a4-4806-4739-a19f-d4fee201d649"
      unitRef="usdPerShare">5.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMzLTEtMS0xLTgzMDc4_8a5bc7ff-59ee-485c-b5e6-6f05ae22de78"
      unitRef="usdPerShare">8.90</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMzLTMtMS0xLTgzMDc4_d3f9e8f3-f24f-4d5e-a3fa-8ee5192d9a3a"
      unitRef="usdPerShare">6.39</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzMzLTUtMS0xLTgzMDc4_96fa8cf1-7ffa-4e53-a02f-7a6d2fa54864"
      unitRef="usdPerShare">4.60</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM0LTEtMS0xLTgzMDc4_1161471c-a5a4-43e8-acd6-50eb7ad271f3"
      unitRef="usdPerShare">8.90</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM0LTMtMS0xLTgzMDc4_bda76ea7-d68c-4425-b2c9-9111289cf4c6"
      unitRef="usdPerShare">6.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM0LTUtMS0xLTgzMDc4_3ac5453d-f042-4556-b344-6f4b7e97e3ff"
      unitRef="usdPerShare">5.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM3LTEtMS0xLTgzMDc4_af20c6e5-cbbd-4592-9a97-045ae934044a"
      unitRef="shares">105230000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM3LTMtMS0xLTgzMDc4_48a44102-6487-4857-a49d-397ce15efc7a"
      unitRef="shares">119797000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM3LTUtMS0xLTgzMDc4_97664f7b-169f-44a8-bc77-c07a947050a2"
      unitRef="shares">153181000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM4LTEtMS0xLTgzMDc4_5415fd43-f5bd-4d7b-abe6-f1e63d1793ea"
      unitRef="shares">109948000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM4LTMtMS0xLTgzMDc4_a17f231f-323a-4f68-a1f1-3bd0d110b878"
      unitRef="shares">122623000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzM4LTUtMS0xLTgzMDc4_2de14e14-c8cf-4185-b755-7fd1a839ea87"
      unitRef="shares">153812000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQxLTEtMS0xLTgzMDc4_6c5b67f2-43ae-4f19-8091-c5fcf88b10df"
      unitRef="usd">978450000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQxLTMtMS0xLTgzMDc4_776b7d19-f2d0-4068-8a5d-f994d4c2453f"
      unitRef="usd">783295000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQxLTUtMS0xLTgzMDc4_cc77980e-b331-4892-981b-eb5b5669f38f"
      unitRef="usd">706832000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQyLTEtMS0xLTgzMDc4_37365ad7-c463-437a-8506-9ad9b3165a74"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQyLTMtMS0xLTgzMDc4_ce335e8d-3555-4734-ac83-df9d973e7bd9"
      unitRef="usd">-9653000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQyLTUtMS0xLTgzMDc4_0ceb222f-4961-4fca-9efb-b5281f6c5500"
      unitRef="usd">104149000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQzLTEtMS0xLTgzMDc4_f8547aec-4d56-4864-a562-cd9313e7f4d0"
      unitRef="usd">978450000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQzLTMtMS0xLTgzMDc4_9be0b152-8b6d-4e36-98fc-c0bd9b51fb86"
      unitRef="usd">773642000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xODcvZnJhZzpmMzRjMGM2Yjg3ODM0ZjFiYmM1MmEwNDg2YWE5YjdjMS90YWJsZTo3NGI2NzEwMDE0ZWY0ZjlmODRjZmY2MDcxZTY5NzVlMS90YWJsZXJhbmdlOjc0YjY3MTAwMTRlZjRmOWY4NGNmZjYwNzFlNjk3NWUxXzQzLTUtMS0xLTgzMDc4_f49f9da5-4442-49be-9b85-64628606b70c"
      unitRef="usd">810981000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzItMS0xLTEtODMwNzg_70f38360-358d-4522-a128-ec9b3f407fdf"
      unitRef="usd">1211762000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzItMy0xLTEtODMwNzg_7464d982-1292-45bc-97df-ecea5c54e6a5"
      unitRef="usd">994677000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzItNS0xLTEtODMwNzg_439be468-8f76-454c-8761-50ed2b73127f"
      unitRef="usd">1021294000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzUtMS0xLTEtODMwNzg_0392d728-4345-4ecf-8a9d-73f6a7ed728b"
      unitRef="usd">7155000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzUtMy0xLTEtODMwNzg_78062ecd-f061-4868-ade2-6bdf357ab59a"
      unitRef="usd">-16346000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzUtNS0xLTEtODMwNzg_84b28537-3d19-4523-a0b4-4427d62a4e50"
      unitRef="usd">1151000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzYtMS0xLTEtODMwNzg_a11d24e9-7baa-4c40-8d4a-b42f8a6ce993"
      unitRef="usd">-4133000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzYtMy0xLTEtODMwNzg_c5612083-b912-438a-ba25-ac3fec41cd53"
      unitRef="usd">-5313000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzYtNS0xLTEtODMwNzg_186ca5ed-7e75-4369-ba2c-4ca2f54b6a53"
      unitRef="usd">-6377000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzctMS0xLTEtODMwNzg_d7fdb29b-26d8-4853-84f1-c85c14ff5292"
      unitRef="usd">-84381000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzctMy0xLTEtODMwNzg_a50e5c68-196a-4ebf-bc63-c8e21123062d"
      unitRef="usd">-7623000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzctNS0xLTEtODMwNzg_2cfe7553-ce79-4efd-9f3a-6b1ce2beeb11"
      unitRef="usd">-20102000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzgtMS0xLTEtODMwNzg_7b863b42-6583-48bf-9f70-da5096716622"
      unitRef="usd">-73093000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzgtMy0xLTEtODMwNzg_22e4e6c7-23fa-49a9-942f-a4a7ad91b736"
      unitRef="usd">-18656000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzgtNS0xLTEtODMwNzg_50498ebc-4b50-419c-932b-447840293da1"
      unitRef="usd">-12574000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzktMS0xLTEtODMwNzg_540df694-c28f-41a3-b2d9-fd02dcf6d5bf"
      unitRef="usd">1138669000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzktMy0xLTEtODMwNzg_5c3cbbf7-ca4a-4f2e-9b51-d0bb293cbc83"
      unitRef="usd">976021000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzktNS0xLTEtODMwNzg_220deafb-d96f-4724-bd72-26d6a512884e"
      unitRef="usd">1008720000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzEwLTEtMS0xLTgzMDc4_e4d5d808-654f-49e4-8bda-68f944e3d7c5"
      unitRef="usd">233312000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzEwLTMtMS0xLTgzMDc4_f3c862e5-7427-4005-ac9d-24bbf45479b5"
      unitRef="usd">221035000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzEwLTUtMS0xLTgzMDc4_94f7704f-5a42-466d-b0df-9b501e1a8af2"
      unitRef="usd">210313000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzExLTEtMS0xLTgzMDc4_214ef793-c0a0-4b2b-87e0-b272c8441fc9"
      unitRef="usd">905357000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzExLTMtMS0xLTgzMDc4_de687ad8-7ae6-4e58-acaa-e78669ff516c"
      unitRef="usd">754986000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTAvZnJhZzoyOGFhNzQ2NGQyOGM0NjY5ODllODYyMjQ5NDQ0NjI1NS90YWJsZTpmYzg5NGU2NTMyNTI0MTFlYjdlNjNjYTM2NDZjOGYyMS90YWJsZXJhbmdlOmZjODk0ZTY1MzI1MjQxMWViN2U2M2NhMzY0NmM4ZjIxXzExLTUtMS0xLTgzMDc4_fbfbc30b-13ad-4850-a30f-e7d7b63d47ad"
      unitRef="usd">798407000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzItMS0xLTEtODMwNzg_418cefab-f43a-4005-9e9d-6a69dad862fc"
      unitRef="usd">461900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzItMy0xLTEtODMwNzg_fb3a50b1-c194-4caa-961c-f1938de04dbe"
      unitRef="usd">324958000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMtMS0xLTEtODMwNzg_ad3877c4-8747-4473-b5a1-9e102061a67c"
      unitRef="usd">93060000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMtMy0xLTEtODMwNzg_27b198df-b030-455f-b36c-bccd0f7f55c2"
      unitRef="usd">176832000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQtMS0xLTEtODMwNzg_7cf65ef6-13b7-40aa-9464-38e67075eeff"
      unitRef="usd">22310000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQtMy0xLTEtODMwNzg_89a5da46-ed08-4f3e-a7b7-b5861f208e18"
      unitRef="usd">20101000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzUtMS0xLTEtODMwNzg_e1d2c79f-8a73-4c22-ad78-bc9d60dbc42d"
      unitRef="usd">1957583000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzUtMy0xLTEtODMwNzg_aa4ef263-bdf0-41b7-af94-04bc95192d23"
      unitRef="usd">1824282000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzYtMS0xLTEtODMwNzg_5164c3ef-a7aa-4c42-8f8f-488e48a22c5d"
      unitRef="usd">107428000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzYtMy0xLTEtODMwNzg_c6301b1c-0a8b-498b-a4fe-9bfe296d4d22"
      unitRef="usd">111625000</us-gaap:InventoryNet>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzctMS0xLTEtODMwNzg_366972f1-bda0-43ea-a206-76c2e007229f"
      unitRef="usd">427321000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzctMy0xLTEtODMwNzg_22026333-d00e-4933-b1e8-a49d7cc4ae55"
      unitRef="usd">544376000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzgtMS0xLTEtODMwNzg_4bf02661-7346-49a3-b67d-f6260247ff53"
      unitRef="usd">72517000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzgtMy0xLTEtODMwNzg_84e6fef2-2f6c-47b2-a3e0-7131541a3b62"
      unitRef="usd">76387000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzktMS0xLTEtODMwNzg_ba200e94-935c-413f-b005-a443bc039ba8"
      unitRef="usd">25604000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzktMy0xLTEtODMwNzg_bd78cf5c-b352-4b5e-8547-8fb250b023e6"
      unitRef="usd">70163000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:AssetsCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzEwLTEtMS0xLTgzMDc4_7709e174-0216-477d-a763-1347341e671a"
      unitRef="usd">3167723000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzEwLTMtMS0xLTgzMDc4_2f0cb0e0-e70d-46ed-bda1-c7cf07c69de7"
      unitRef="usd">3148724000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzExLTEtMS0xLTgzMDc4_196f439c-12e8-4f25-b758-d86da767b464"
      unitRef="usd">3479972000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzExLTMtMS0xLTgzMDc4_8858fe50-b811-4989-a1ca-79cf8303341d"
      unitRef="usd">3521824000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzEyLTEtMS0xLTgzMDc4_31531771-90e9-4d1b-b4db-451f5133ae79"
      unitRef="usd">2824787000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzEyLTMtMS0xLTgzMDc4_c0267bad-1ea3-40c4-9ccf-5a67c7e8ca3d"
      unitRef="usd">2863089000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzEzLTEtMS0xLTgzMDc4_75348b1a-3550-43ed-a9b1-767592cd9ce7"
      unitRef="usd">177693000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzEzLTMtMS0xLTgzMDc4_e7c8ac22-eb33-4dcd-b905-1872feee0fe2"
      unitRef="usd">166585000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE0LTEtMS0xLTgzMDc4_e00c1910-132e-4092-b4d7-5be4fd885c21"
      unitRef="usd">238881000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE0LTMtMS0xLTgzMDc4_d18b4e18-99d9-4c5e-b248-de912146ecd4"
      unitRef="usd">257491000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE1LTEtMS0xLTgzMDc4_54a6ca26-959c-4d86-87b2-6650fa051165"
      unitRef="usd">49514000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE1LTMtMS0xLTgzMDc4_d921d98e-783c-4190-a983-0daa132d7977"
      unitRef="usd">32193000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE2LTEtMS0xLTgzMDc4_a0defcbb-cabf-4d91-9713-09178bede6fc"
      unitRef="usd">136677000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE2LTMtMS0xLTgzMDc4_713a483b-7ded-42f6-bea8-1f193d0549f0"
      unitRef="usd">79501000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Goodwill
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE3LTEtMS0xLTgzMDc4_a472a893-25d4-498d-9542-daaee97bfca0"
      unitRef="usd">7046241000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE3LTMtMS0xLTgzMDc4_d7da35bc-4409-400c-8dca-e9a10a18658c"
      unitRef="usd">6919109000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE4LTEtMS0xLTgzMDc4_08ed0c5c-30ba-4bc6-b2b7-5cc82d5a21d0"
      unitRef="usd">17121488000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzE4LTMtMS0xLTgzMDc4_7443c507-0252-47db-853e-1db917bae3d4"
      unitRef="usd">16988516000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIwLTEtMS0xLTgzMDc4_f96a9e5c-447b-45a3-864e-d1d6d07cac39"
      unitRef="usd">402049000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIwLTMtMS0xLTgzMDc4_1a1866b0-9ae5-4878-ae2d-2f36e4377249"
      unitRef="usd">434253000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIxLTEtMS0xLTgzMDc4_2da532ea-4933-460a-ab13-b61ffa06b091"
      unitRef="usd">709345000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIxLTMtMS0xLTgzMDc4_f8473eea-a0a6-48f8-8e8c-d588bb8610de"
      unitRef="usd">810529000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIyLTEtMS0xLTgzMDc4_be68afb3-8764-4887-8d4e-ce197925146e"
      unitRef="usd">659960000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIyLTMtMS0xLTgzMDc4_687045b9-7bb1-4e72-891f-c33d9e0d8905"
      unitRef="usd">685555000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIzLTEtMS0xLTgzMDc4_d56681fe-2ef6-4301-9dd5-2e3a7cd36c8f"
      unitRef="usd">394357000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzIzLTMtMS0xLTgzMDc4_cfdf3bcd-03d0-470c-9d1d-202156f44ab8"
      unitRef="usd">369497000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI0LTEtMS0xLTgzMDc4_23272319-c4c2-4a2c-a554-5b8a78c9d1e6"
      unitRef="usd">179030000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI0LTMtMS0xLTgzMDc4_9386b79c-f0ac-4971-baf1-c6daedb259eb"
      unitRef="usd">168541000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI1LTEtMS0xLTgzMDc4_dddf6e0f-bf16-4c00-bd80-411210a861ce"
      unitRef="usd">53792000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI1LTMtMS0xLTgzMDc4_cc73f326-851e-4bd4-8049-ef1b86d5c7c9"
      unitRef="usd">7768000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI2LTEtMS0xLTgzMDc4_38dcdef1-92a9-41ff-b79b-3d1ff87c61af"
      unitRef="usd">2398533000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI2LTMtMS0xLTgzMDc4_ce01b789-9ae2-41d6-8415-3dbd58ce51ee"
      unitRef="usd">2476143000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI3LTEtMS0xLTgzMDc4_b1f4bc8e-a2b7-438b-9b6a-e96f3d6f2d3e"
      unitRef="usd">2672713000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI3LTMtMS0xLTgzMDc4_9b7e17f9-6219-4673-85ac-4e04434a846b"
      unitRef="usd">2738670000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI4LTEtMS0xLTgzMDc4_0b21345e-3466-4ad2-927a-3c283dbfeb49"
      unitRef="usd">8729150000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI4LTMtMS0xLTgzMDc4_4d8be9f7-7a72-4c29-98c8-85305b263e99"
      unitRef="usd">7917263000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI5LTEtMS0xLTgzMDc4_4dd42b0c-4559-411e-911e-843ae6c5b513"
      unitRef="usd">119158000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzI5LTMtMS0xLTgzMDc4_7f66a3c9-2a72-4a13-b89d-805ba5681c44"
      unitRef="usd">150060000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMwLTEtMS0xLTgzMDc4_ab4ed086-a94c-4d30-8e14-5978ec03ff04"
      unitRef="usd">830954000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMwLTMtMS0xLTgzMDc4_e7704de6-6e50-46d8-bd95-d5439f81b8f3"
      unitRef="usd">809600000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMxLTEtMS0xLTgzMDc4_c801a5c0-0120-4537-b74d-fef3d90659bf"
      unitRef="usd">14750508000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMxLTMtMS0xLTgzMDc4_f927353f-b062-4dc5-9a20-17d8152dbca0"
      unitRef="usd">14091736000</us-gaap:Liabilities>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMzLTEtMS0xLTgzMDc4_c8b20a15-8902-46ca-b7e0-18d79c1f89af"
      unitRef="usd">1434832000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzMzLTMtMS0xLTgzMDc4_64654a95-79f7-4e50-bb4b-8851c2936c8f"
      unitRef="usd">1330028000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM1LTAtMS0xLTgzMDc4L3RleHRyZWdpb246ZjdjZTk3NzhlMTgwNDJiMjk4MjhhYjdmNTE3MjcxNGZfNDk0NzgwMjMyNTA3NQ_92b4d727-0d5f-41bc-8354-decb0984a45c"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM1LTAtMS0xLTgzMDc4L3RleHRyZWdpb246ZjdjZTk3NzhlMTgwNDJiMjk4MjhhYjdmNTE3MjcxNGZfNDk0NzgwMjMyNTA4NQ_11c47a24-3455-44a3-accb-7ed5d7361144"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM1LTAtMS0xLTgzMDc4L3RleHRyZWdpb246ZjdjZTk3NzhlMTgwNDJiMjk4MjhhYjdmNTE3MjcxNGZfNDk0NzgwMjMyNTA5Mg_2cf10ed4-6c52-4f30-a984-2a7e236c343c"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM1LTEtMS0xLTgzMDc4_a83eac43-b355-4af9-923d-739b1f0da225"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM1LTMtMS0xLTgzMDc4_574556e8-85e6-49bb-8a21-e1233c994230"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM2LTAtMS0xLTgzMDc4L3RleHRyZWdpb246Mzg4MTE3ZmU5MWMxNDg4OGFjYmYzNzYzNGVmY2FmNGNfNDk0NzgwMjMyNTE5Mw_5445d31a-34c0-47f4-b558-988af13a3562"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM2LTAtMS0xLTgzMDc4L3RleHRyZWdpb246Mzg4MTE3ZmU5MWMxNDg4OGFjYmYzNzYzNGVmY2FmNGNfNDk0NzgwMjMyNTIwNA_d59f38e1-87bf-4382-9215-b5d9a974850c"
      unitRef="shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM2LTAtMS0xLTgzMDc4L3RleHRyZWdpb246Mzg4MTE3ZmU5MWMxNDg4OGFjYmYzNzYzNGVmY2FmNGNfNDk0NzgwMjMyNTIwOA_c1bf6c15-97ff-45b5-aef5-dc4d320d7db7"
      unitRef="shares">97289000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM2LTAtMS0xLTgzMDc4L3RleHRyZWdpb246Mzg4MTE3ZmU5MWMxNDg4OGFjYmYzNzYzNGVmY2FmNGNfNDk0NzgwMjMyNTI3Mg_25b2ad24-66ff-4662-b728-2bcfd45ede73"
      unitRef="shares">109933000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM2LTEtMS0xLTgzMDc4_5d3a5f25-fe4c-4415-a086-9c7af8c4d558"
      unitRef="usd">97000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM2LTMtMS0xLTgzMDc4_9d27e2d9-6d73-4c4e-a790-b5a78854ae73"
      unitRef="usd">110000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM3LTEtMS0xLTgzMDc4_1a576f13-6e8f-4c84-9f8d-ec18704ff4b7"
      unitRef="usd">540321000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM3LTMtMS0xLTgzMDc4_b6047fee-e10e-4da6-8756-7e07b0f10434"
      unitRef="usd">597073000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM4LTEtMS0xLTgzMDc4_e20517e9-67a5-4400-a8ac-e7dac3cdc546"
      unitRef="usd">354337000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM4LTMtMS0xLTgzMDc4_20ed74ef-82e9-4f23-ba2e-d30afa58f8f6"
      unitRef="usd">852537000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM5LTEtMS0xLTgzMDc4_c63c157a-2de6-40fa-a523-03b948f5cff9"
      unitRef="usd">-139247000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzM5LTMtMS0xLTgzMDc4_11c854cd-9188-4541-9c11-8c9403f51569"
      unitRef="usd">-66154000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQwLTEtMS0xLTgzMDc4_203341f5-0afe-4d92-a1d9-e0c63515bc92"
      unitRef="usd">755508000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQwLTMtMS0xLTgzMDc4_a446b2fb-8670-4abc-a902-3d8620f6c1e2"
      unitRef="usd">1383566000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQxLTEtMS0xLTgzMDc4_f78f6392-4356-4214-9672-e3558445f2df"
      unitRef="usd">180640000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQxLTMtMS0xLTgzMDc4_c92be1eb-dab4-49de-893c-34da347ce9b6"
      unitRef="usd">183186000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQyLTEtMS0xLTgzMDc4_d9561d9f-6283-4067-9057-5841ff606bf0"
      unitRef="usd">936148000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQyLTMtMS0xLTgzMDc4_84b5e1fd-80a5-43df-8542-70d263ecba05"
      unitRef="usd">1566752000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQzLTEtMS0xLTgzMDc4_36ecc5b2-7f0f-4e83-bb85-8533095f2ee7"
      unitRef="usd">17121488000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTMvZnJhZzpmYTNiMDBhNzM2MTI0ZjNmYmIxNmY5YjAwNDZjYTg1Yy90YWJsZTo0NjNmZDZjZTVjOTg0ZDQzOGM0ZGI3YmI2ZGEwOTRhMS90YWJsZXJhbmdlOjQ2M2ZkNmNlNWM5ODRkNDM4YzRkYjdiYjZkYTA5NGExXzQzLTMtMS0xLTgzMDc4_b46231c2-a807-4eca-b9dd-75b32c6323cc"
      unitRef="usd">16988516000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMtMS0xLTEtODMwNzg_988081fc-bdf0-4482-a188-5fbb87d905de"
      unitRef="usd">1211762000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMtMy0xLTEtODMwNzg_36dd4cf9-6f0d-42f4-8fa1-8644bc260f6b"
      unitRef="usd">994677000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMtNS0xLTEtODMwNzg_c10fb8a6-952b-46cb-a684-55c806058c1c"
      unitRef="usd">1021294000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUtMS0xLTEtODMwNzg_f81932cd-210b-456d-95ec-2eaec449b406"
      unitRef="usd">680615000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUtMy0xLTEtODMwNzg_2a3cc6bc-9ef7-4d13-aa66-f67b3e4da517"
      unitRef="usd">630435000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUtNS0xLTEtODMwNzg_3672032b-ba26-4ddc-8f93-d36ca2d86263"
      unitRef="usd">615152000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzYtMS0xLTEtODMwNzg_9d44de93-3df0-45a9-9e64-d41f0d86c235"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzYtMy0xLTEtODMwNzg_b92eb72e-9c7f-479e-a7ef-e5718223df27"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzYtNS0xLTEtODMwNzg_57eb8b5d-91ce-4785-92b8-51331da644d6"
      unitRef="usd">124892000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <dva:DebtRefinancingCharges
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzgtMS0xLTEtODMwNzg_5c28ba79-814b-4ef8-a036-e2ccf14a2da4"
      unitRef="usd">0</dva:DebtRefinancingCharges>
    <dva:DebtRefinancingCharges
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzgtMy0xLTEtODMwNzg_ca531cf0-f503-4463-b158-eb558b5a9c8f"
      unitRef="usd">86957000</dva:DebtRefinancingCharges>
    <dva:DebtRefinancingCharges
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzgtNS0xLTEtODMwNzg_62b3d499-5381-4a0e-aed5-26eb2b9b2fdc"
      unitRef="usd">33402000</dva:DebtRefinancingCharges>
    <us-gaap:ShareBasedCompensation
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzktMS0xLTEtODMwNzg_ad02580a-1e87-42a4-a0ac-6635c8ea1335"
      unitRef="usd">102209000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzktMy0xLTEtODMwNzg_b75b359b-2d78-4585-b2ea-e5a180fc00dc"
      unitRef="usd">91458000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzktNS0xLTEtODMwNzg_fa326d2e-874e-4b5a-b2d7-0faf36498698"
      unitRef="usd">67850000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEwLTEtMS0xLTgzMDc4_da9eb3f1-3c05-49d1-b411-373e6313053a"
      unitRef="usd">60483000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEwLTMtMS0xLTgzMDc4_84fa430e-1872-4e6b-adae-26274cefc5b5"
      unitRef="usd">240848000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEwLTUtMS0xLTgzMDc4_e6e381df-61d6-4f34-bce9-37fccbd10ad5"
      unitRef="usd">41723000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <dva:AdjustmentIncomeLossFromEquityMethodInvestments
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzExLTEtMS0xLTgzMDc4_6dc8ad1d-e489-4076-b6a7-4eb79edec6e7"
      unitRef="usd">-5215000</dva:AdjustmentIncomeLossFromEquityMethodInvestments>
    <dva:AdjustmentIncomeLossFromEquityMethodInvestments
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzExLTMtMS0xLTgzMDc4_b7b630a2-4c99-4fdf-b113-c41a26a849ab"
      unitRef="usd">-13830000</dva:AdjustmentIncomeLossFromEquityMethodInvestments>
    <dva:AdjustmentIncomeLossFromEquityMethodInvestments
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzExLTUtMS0xLTgzMDc4_b8075d3b-9c1a-4fc6-95bd-a67059b702d6"
      unitRef="usd">-8582000</dva:AdjustmentIncomeLossFromEquityMethodInvestments>
    <dva:LossGainOnDispositionOfBusinessInterestsBeforeTax
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEyLTEtMS0xLTgzMDc4_13f65314-02d3-4bf3-a4d4-3903a2335b93"
      unitRef="usd">0</dva:LossGainOnDispositionOfBusinessInterestsBeforeTax>
    <dva:LossGainOnDispositionOfBusinessInterestsBeforeTax
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEyLTMtMS0xLTgzMDc4_98c188b3-cafe-4ce7-818b-84e30c2b42c5"
      unitRef="usd">24248000</dva:LossGainOnDispositionOfBusinessInterestsBeforeTax>
    <dva:LossGainOnDispositionOfBusinessInterestsBeforeTax
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEyLTUtMS0xLTgzMDc4_9f8aef7a-7bbc-4ee0-8a26-8d78f4e77f94"
      unitRef="usd">23022000</dva:LossGainOnDispositionOfBusinessInterestsBeforeTax>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEzLTEtMS0xLTgzMDc4_5c7982d6-9a20-4322-9a85-aefa6f6cdbcc"
      unitRef="usd">-11231000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEzLTMtMS0xLTgzMDc4_249be201-7740-4ed1-ae18-2d7f5c0e821b"
      unitRef="usd">-747000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzEzLTUtMS0xLTgzMDc4_fbc65ddc-0eb3-4431-bb58-0d393ddffbe9"
      unitRef="usd">-49579000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE1LTEtMS0xLTgzMDc4_6dd11063-9a03-407b-ab43-c45cfcc7c897"
      unitRef="usd">138140000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE1LTMtMS0xLTgzMDc4_c94150ea-7448-440c-80cb-9c604a5ede3d"
      unitRef="usd">21087000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE1LTUtMS0xLTgzMDc4_c1b8b0bd-66d3-4f73-a6b9-3f250cbddc3f"
      unitRef="usd">79957000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE2LTEtMS0xLTgzMDc4_050385a8-7d05-4855-9048-859f0736b100"
      unitRef="usd">-5720000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE2LTMtMS0xLTgzMDc4_da8d0af8-ea13-4694-9bc3-7bf37ed74cfa"
      unitRef="usd">12349000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE2LTUtMS0xLTgzMDc4_a4ac5f08-511e-4f3a-941b-b795851b310b"
      unitRef="usd">-10158000</us-gaap:IncreaseDecreaseInInventories>
    <dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE3LTEtMS0xLTgzMDc4_f2468f3f-8559-484c-bbb9-fd0d7f5a886a"
      unitRef="usd">-128661000</dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets>
    <dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE3LTMtMS0xLTgzMDc4_9fad129e-77c5-45ff-a21b-416687162160"
      unitRef="usd">79277000</dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets>
    <dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE3LTUtMS0xLTgzMDc4_c97c2b56-4c94-4e62-a595-11fb6fb69490"
      unitRef="usd">-2790000</dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE4LTEtMS0xLTgzMDc4_bf2ec4ef-376e-4a90-8b16-857179bb1dff"
      unitRef="usd">26387000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE4LTMtMS0xLTgzMDc4_c6ef8d25-1784-49c4-996b-5fcd693e6999"
      unitRef="usd">6123000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE4LTUtMS0xLTgzMDc4_3330fefc-eaf8-4b09-a044-8ba0d7df5af9"
      unitRef="usd">-6965000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE5LTEtMS0xLTgzMDc4_8b9b1bc0-9d70-4716-9d57-3968a4351eed"
      unitRef="usd">-30320000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE5LTMtMS0xLTgzMDc4_863031d3-8921-4f8f-aa1a-89d8c17a329a"
      unitRef="usd">37200000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzE5LTUtMS0xLTgzMDc4_70bc6660-c747-461b-b1c9-96fcdadc20ba"
      unitRef="usd">-84539000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIwLTEtMS0xLTgzMDc4_575aa354-5a9d-4519-a648-7251150e5bb6"
      unitRef="usd">-16717000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIwLTMtMS0xLTgzMDc4_8fe204bd-e14d-47f5-820c-1def95bd2ab4"
      unitRef="usd">-20931000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIwLTUtMS0xLTgzMDc4_bff5e8eb-dafc-4be7-a88f-be9fc621e579"
      unitRef="usd">-14697000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIxLTEtMS0xLTgzMDc4_bebbb470-5296-4a9b-8e3a-97547fa1b32a"
      unitRef="usd">-93645000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIxLTMtMS0xLTgzMDc4_4676348c-7322-4533-b068-a33b3df9537a"
      unitRef="usd">105637000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIxLTUtMS0xLTgzMDc4_cd1035a0-6df5-4a69-ab8b-2f3302ec6568"
      unitRef="usd">181940000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIyLTEtMS0xLTgzMDc4_316f439f-2811-4f9e-84bf-16179777d0d8"
      unitRef="usd">36921000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIyLTMtMS0xLTgzMDc4_f3d46083-661b-4e78-8283-a163de07f6d7"
      unitRef="usd">-87391000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIyLTUtMS0xLTgzMDc4_b1886544-1483-44a5-8eae-bd37f6183f47"
      unitRef="usd">95645000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIzLTEtMS0xLTgzMDc4_aa7227d9-14c9-43df-b59b-6c2dbc21124f"
      unitRef="usd">-6732000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIzLTMtMS0xLTgzMDc4_33de82d3-756f-4c89-8826-613468ef95bb"
      unitRef="usd">-19851000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzIzLTUtMS0xLTgzMDc4_2e9488d3-2d0b-4a04-afd3-27fc13cb5647"
      unitRef="usd">-31446000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI0LTEtMS0xLTgzMDc4_98daf5a7-9701-4ee6-950a-0b14091e0dc5"
      unitRef="usd">1930876000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI0LTMtMS0xLTgzMDc4_3e1b4a9d-7837-452d-b84e-2371e2927a2e"
      unitRef="usd">1979028000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI0LTUtMS0xLTgzMDc4_0c7d6c30-dc0b-4c04-8a80-0476e24e7ed9"
      unitRef="usd">2072355000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI2LTEtMS0xLTgzMDc4_a14a3f7b-4e10-4bf1-af73-db40c6747a35"
      unitRef="usd">641465000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI2LTMtMS0xLTgzMDc4_6f6a5cd4-472f-4331-966d-0f90bf79f075"
      unitRef="usd">674541000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI2LTUtMS0xLTgzMDc4_77db6437-20b8-4b57-8077-0571982cc685"
      unitRef="usd">766546000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI3LTEtMS0xLTgzMDc4_736a5327-16a9-4f30-af0c-af06a0833155"
      unitRef="usd">187050000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI3LTMtMS0xLTgzMDc4_f263149b-bf7c-4e50-a796-d7e6857c4db5"
      unitRef="usd">182013000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI3LTUtMS0xLTgzMDc4_07130225-d2f1-4204-b4df-5217526416bc"
      unitRef="usd">100861000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI4LTEtMS0xLTgzMDc4_17ce4442-9452-44a8-8dbc-ab8cc0167e77"
      unitRef="usd">61464000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI4LTMtMS0xLTgzMDc4_09a6a9aa-4192-487b-95ee-ad0f456962ef"
      unitRef="usd">50139000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI4LTUtMS0xLTgzMDc4_9ad40c44-03c4-4a23-810a-d115c1dacb5e"
      unitRef="usd">3877392000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI5LTEtMS0xLTgzMDc4_83047c97-4b3d-44ba-8ea3-a5c40d41a842"
      unitRef="usd">30849000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI5LTMtMS0xLTgzMDc4_2477b532-3a0c-4519-9c64-2d758837929f"
      unitRef="usd">150701000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzI5LTUtMS0xLTgzMDc4_7632c024-1f65-4b0b-81ce-e7e9d7688325"
      unitRef="usd">101462000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <dva:PaymentsToAcquireOtherDebtAndEquityInvestments
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMwLTEtMS0xLTgzMDc4_013ce77e-d21a-47a4-85be-ddf745884024"
      unitRef="usd">2987000</dva:PaymentsToAcquireOtherDebtAndEquityInvestments>
    <dva:PaymentsToAcquireOtherDebtAndEquityInvestments
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMwLTMtMS0xLTgzMDc4_ae02466a-abad-462d-be9f-8cb309db452b"
      unitRef="usd">3757000</dva:PaymentsToAcquireOtherDebtAndEquityInvestments>
    <dva:PaymentsToAcquireOtherDebtAndEquityInvestments
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMwLTUtMS0xLTgzMDc4_f8e974af-5b44-4158-8c6d-540d87fec808"
      unitRef="usd">5458000</dva:PaymentsToAcquireOtherDebtAndEquityInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMxLTEtMS0xLTgzMDc4_ad09a92f-3d80-4287-9010-eecca657b35c"
      unitRef="usd">15849000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMxLTMtMS0xLTgzMDc4_fb4e9cd3-25e8-4420-8657-bb193ede9eb9"
      unitRef="usd">151213000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMxLTUtMS0xLTgzMDc4_5c8db413-0a4a-47cd-92b9-3feacf0bc15b"
      unitRef="usd">95376000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMyLTEtMS0xLTgzMDc4_92524e77-bd39-4eda-aef4-0f4527b71999"
      unitRef="usd">12030000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMyLTMtMS0xLTgzMDc4_92653cf3-e0e9-4072-a107-6b722aa2a0b0"
      unitRef="usd">3491000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMyLTUtMS0xLTgzMDc4_abeeca54-915e-4caa-9ec8-58e67f4359a8"
      unitRef="usd">3676000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMzLTEtMS0xLTgzMDc4_e1c5d787-0e64-4303-aaf3-c23c8a4946a8"
      unitRef="usd">13924000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMzLTMtMS0xLTgzMDc4_6beedd16-663f-4a42-aeef-6f8f12aef5df"
      unitRef="usd">22341000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzMzLTUtMS0xLTgzMDc4_146891fb-a603-4e43-a23f-047dcc129969"
      unitRef="usd">9366000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM0LTEtMS0xLTgzMDc4_4770c1fa-866b-4edc-9a6c-f3256acffe99"
      unitRef="usd">2944000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM0LTMtMS0xLTgzMDc4_ddebb90b-bb8f-4ffc-8af3-14cd10824f18"
      unitRef="usd">3139000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM0LTUtMS0xLTgzMDc4_786f31ea-e264-48f7-9030-6f50eeaa56ea"
      unitRef="usd">2589000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM1LTEtMS0xLTE3MTUwMQ_bd45e669-193e-434d-81b9-1ac90ef5a577"
      unitRef="usd">745000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM1LTMtMS0xLTE3MTUwMQ_4a048bf1-a016-44cb-8463-5251e881896c"
      unitRef="usd">0</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM1LTUtMS0xLTE3MTUwMQ_4d8b8932-b76a-4819-904a-d2082bb31a76"
      unitRef="usd">0</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM1LTEtMS0xLTgzMDc4_11a94e68-b4fd-4066-aa09-0145ffd84954"
      unitRef="usd">-784733000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM1LTMtMS0xLTgzMDc4_ea6ff6c4-2cab-4dfe-96b9-a3cf1d711bf2"
      unitRef="usd">-825371000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM1LTUtMS0xLTgzMDc4_69ec032b-fa87-47e9-8673-2014e7a29949"
      unitRef="usd">2995340000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM3LTEtMS0xLTgzMDc4_4567d159-6186-476a-9aeb-89c519a3de31"
      unitRef="usd">1615370000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM3LTMtMS0xLTgzMDc4_efdd1a11-25f9-4dfc-bc81-bc6740dfb1f9"
      unitRef="usd">4046775000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM3LTUtMS0xLTgzMDc4_e67d0a16-a7f9-46d9-b2b6-2be9fc104e58"
      unitRef="usd">38525850000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM4LTEtMS0xLTgzMDc4_441c2ac9-f9dc-4d4a-99bd-28ea34ad07b6"
      unitRef="usd">861115000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM4LTMtMS0xLTgzMDc4_c106d4e9-73e3-420a-9ad7-8e4541e9e4e7"
      unitRef="usd">4110304000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM4LTUtMS0xLTgzMDc4_796f9a9e-e7b2-4ba8-84bc-ed02ca05cfe9"
      unitRef="usd">40520722000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <dva:DebtFinancingAndDebtRedemptionCosts
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM5LTEtMS0xLTgzMDc4_423d74e5-e58b-41e8-8aa9-f943c95b01b8"
      unitRef="usd">9091000</dva:DebtFinancingAndDebtRedemptionCosts>
    <dva:DebtFinancingAndDebtRedemptionCosts
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM5LTMtMS0xLTgzMDc4_999ba41b-e19f-4d45-820c-a3d124f05e95"
      unitRef="usd">105848000</dva:DebtFinancingAndDebtRedemptionCosts>
    <dva:DebtFinancingAndDebtRedemptionCosts
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzM5LTUtMS0xLTgzMDc4_1d4df886-72ba-4e61-a0ff-3756474fe162"
      unitRef="usd">85319000</dva:DebtFinancingAndDebtRedemptionCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQwLTEtMS0xLTgzMDc4_185098d0-b4cc-4863-8efd-d2bae8fd14d3"
      unitRef="usd">1538626000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQwLTMtMS0xLTgzMDc4_d8e7f078-8af7-4368-9b6e-3f9d14c6b724"
      unitRef="usd">1458442000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQwLTUtMS0xLTgzMDc4_98f1dc38-2ff4-4301-86df-cde9dbb27f81"
      unitRef="usd">2383816000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQxLTEtMS0xLTgzMDc4_976e351d-85ce-4dc0-a33a-ad4bc0758d84"
      unitRef="usd">244033000</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQxLTMtMS0xLTgzMDc4_90bb8795-d893-4821-94b9-11ac4f767e13"
      unitRef="usd">253118000</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQxLTUtMS0xLTgzMDc4_9a04622e-cc98-48f2-ba09-c21072b93b9c"
      unitRef="usd">233123000</us-gaap:PaymentsOfDistributionsToAffiliates>
    <dva:PaymentsRelatedToStockPurchasesAndAwards
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQyLTEtMS0xLTgzMDc4_d39dc41e-ecce-4409-933d-7067ee82d25b"
      unitRef="usd">60001000</dva:PaymentsRelatedToStockPurchasesAndAwards>
    <dva:PaymentsRelatedToStockPurchasesAndAwards
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQyLTMtMS0xLTgzMDc4_823e06ce-29d1-4159-9884-b29fa5b094d5"
      unitRef="usd">975000</dva:PaymentsRelatedToStockPurchasesAndAwards>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQyLTUtMS0xLTgzMDc4_3ad3a7e9-1d61-490b-823c-115cf50aa924"
      unitRef="usd">11382000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQzLTEtMS0xLTgzMDc4_ad107878-1546-40d0-88f3-3e2c772d42c9"
      unitRef="usd">31754000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQzLTMtMS0xLTgzMDc4_e73a3582-ea28-436e-ad51-663009a6a4aa"
      unitRef="usd">42966000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQzLTUtMS0xLTgzMDc4_97f8d4eb-ec51-4db6-a471-5a9f34874f72"
      unitRef="usd">57317000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ0LTEtMS0xLTgzMDc4_b6dedd97-77c5-4d92-a1fc-434346521826"
      unitRef="usd">2880000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ0LTMtMS0xLTgzMDc4_482eb8e2-5189-44a8-bf7d-7c9c4eb29191"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ0LTUtMS0xLTgzMDc4_015cc210-1f22-4bce-979d-e9b3b43aac79"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ1LTEtMS0xLTgzMDc4_9c6127af-23f3-4c88-977c-3f00bb81b42f"
      unitRef="usd">20104000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ1LTMtMS0xLTgzMDc4_d30eb1b5-f9ea-4f35-90d1-c5c481ae22ea"
      unitRef="usd">7831000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ1LTUtMS0xLTgzMDc4_5051b5f8-e6e5-451f-b609-25dca865ea21"
      unitRef="usd">68019000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ2LTEtMS0xLTgzMDc4_def554a3-1052-4c49-bce2-9b84fa32ee92"
      unitRef="usd">-1082966000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ2LTMtMS0xLTgzMDc4_1e5fe817-545d-4abd-84fa-9260e47858a1"
      unitRef="usd">-1846777000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ2LTUtMS0xLTgzMDc4_78ba8b9b-11fa-439a-a45b-e6c8d28886a1"
      unitRef="usd">-4696450000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ3LTEtMS0xLTgzMDc4_0bcd8231-6e53-43fd-aff4-3003f39cdca0"
      unitRef="usd">-10007000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ3LTMtMS0xLTgzMDc4_9a7086ea-a1b3-4498-9e55-ce6a762fa456"
      unitRef="usd">-13808000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ3LTUtMS0xLTgzMDc4_44f49ff8-5b30-41e8-b638-08a181904b25"
      unitRef="usd">-1760000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ4LTEtMS0xLTgzMDc4_0175e290-8a39-49b1-a91d-95790601fca2"
      unitRef="usd">53170000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ4LTMtMS0xLTgzMDc4_15b65ffb-9c20-47cd-bd76-5443a3470774"
      unitRef="usd">-706928000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ4LTUtMS0xLTgzMDc4_9b349f16-b100-478d-a2b5-f7ac78f69864"
      unitRef="usd">369485000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6d3dd21038464c23a62a67a39190a154_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ5LTEtMS0xLTgzMDc4_11350493-d398-479d-ae9a-fe03eaab89f2"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i1e07643e57f74006b5bcc05f2f454af3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ5LTMtMS0xLTgzMDc4_dfb2dbe5-fec7-4879-910d-038ef16c9766"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i63999090b4ba4b888b7f56a9059c5fe0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzQ5LTUtMS0xLTgzMDc4_45aa5101-ab6c-469b-8c9b-1a2bc448842d"
      unitRef="usd">-423813000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0acb94239c44493880ec3eb2ccd8e937_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUwLTEtMS0xLTgzMDc4_bb587eb9-938a-4ac9-be40-c9d94e5fb860"
      unitRef="usd">53170000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i1fe0fe3dc214439e993ff7b2ef6840b7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUwLTMtMS0xLTgzMDc4_1e7625b2-a08c-46b7-ae2b-8040367631e3"
      unitRef="usd">-706928000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0b6e5fa072d7489db4ab12e204b38a35_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUwLTUtMS0xLTgzMDc4_799cec1c-7ab1-4b20-8371-c3be69eccd42"
      unitRef="usd">793298000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUxLTEtMS0xLTgzMDc4_e1b132df-a81f-40e7-9c64-aaee2894a613"
      unitRef="usd">501790000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUxLTMtMS0xLTgzMDc4_179d15e2-5ce4-488c-9244-06aedb5a1421"
      unitRef="usd">1208718000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1bca572e906b49798cc07308d3e4bfc0_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUxLTUtMS0xLTgzMDc4_c52e3b43-8f13-452b-8776-249efce55c8e"
      unitRef="usd">415420000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUyLTEtMS0xLTgzMDc4_065e8932-56fd-45ab-abe8-85672b264026"
      unitRef="usd">554960000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUyLTMtMS0xLTgzMDc4_7525ddf9-7f45-4aaa-998d-7822f1c28326"
      unitRef="usd">501790000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8xOTkvZnJhZzphYmExZGRiMDMxYmY0MGI4OTc0Y2I3MTAzMjc5YjIwMS90YWJsZTo5OWY4YzgyYWVlMTk0ZDEyYWFjOWQwZGQ1ZmZiNGI5Ny90YWJsZXJhbmdlOjk5ZjhjODJhZWUxOTRkMTJhYWM5ZDBkZDVmZmI0Yjk3XzUyLTUtMS0xLTgzMDc4_4bac4945-9313-4463-90d0-b2903cdda445"
      unitRef="usd">1208718000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i050ebae691a14d39a71068a4d4ddb981_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMS0xLTEtODMwNzg_faa9297e-a096-413f-9dc8-6973eef31d4b"
      unitRef="usd">1124641000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i88726c7f90b243d4adcbf6e341fa9adc_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMy0xLTEtODMwNzg_c8a84fc4-56fe-4697-b4c6-1c78f03a19e0"
      unitRef="shares">166387000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i88726c7f90b243d4adcbf6e341fa9adc_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtNS0xLTEtODMwNzg_13b1fa97-c103-412a-83d9-baf674dc5a8e"
      unitRef="usd">166000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e3632fb440c4f8b987b9e68d47870e0_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtNy0xLTEtODMwNzg_2afc4c51-6db1-44b0-ae45-0fa0fdb9a7e0"
      unitRef="usd">995006000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2dd50a980cda4949863e518248043db7_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtOS0xLTEtODMwNzg_290e1039-f353-43a0-84d6-373baf4fec79"
      unitRef="usd">2743194000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib1c551774ede47b9a8a31720f6c90ba1_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMTEtMS0xLTgzMDc4_cf5bfa68-0bcd-4989-b681-306decbcbd00"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1c551774ede47b9a8a31720f6c90ba1_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMTMtMS0xLTgzMDc4_96575f62-32d6-4fa9-a79b-0ee5889ea8bf"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b898106fe1a419ca926f1ea86e57923_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMTUtMS0xLTgzMDc4_fe24d732-e3ea-4b42-b60c-b0ba4919a67c"
      unitRef="usd">-34924000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia217ce5b5094494d94eaad3451dec57d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMTctMS0xLTgzMDc4_60e4eb13-6d33-4e97-b34f-34ad9a24099f"
      unitRef="usd">3703442000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb2ad82533ae4593ad0e4a15e9fed8e1_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzQtMTktMS0xLTgzMDc4_468a8e3e-6c3b-4fcd-a09d-7ea1b787eea8"
      unitRef="usd">204956000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i750133c9d44946099dfeb64f0ff3dda6_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzUtMS0xLTEtMTA2NjQ1_dba9052d-87be-40a5-810a-8b2134c3f8f5"
      unitRef="usd">-38000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i944596afcbc042b0b7e8ae7c9ea00e76_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzUtOS0xLTEtODMwNzg_ad67165e-2a3f-47f5-b6a5-9848558f5abf"
      unitRef="usd">39876000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia2f800f0bf6140faaf3bda87332ad8ca_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzUtMTctMS0xLTgzMDc4_fb3fc21e-3846-4c03-b318-1f2c12abffcf"
      unitRef="usd">39876000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if648bd429f9e4b07af2e909f55c08369_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzUtMTktMS0xLTEwNjY2OQ_66001557-94cd-4c96-ba87-bf4e1b1b9234"
      unitRef="usd">-6000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzctMS0xLTEtODMwNzg_2f35745c-87eb-4956-a6bd-541aca790164"
      unitRef="usd">143413000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i583e6028240a4d259061cd7bbc80a527_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzctOS0xLTEtODMwNzg_f7df7e17-fbcd-4a1c-9a1e-a71f90af191c"
      unitRef="usd">810981000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzctMTctMS0xLTgzMDc4_761a4453-ab07-4719-a3ce-492b9e89a81f"
      unitRef="usd">810981000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i15f02743c68844acade340aa85cc54cd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzctMTktMS0xLTgzMDc4_e7545fe0-4ce7-475b-a460-72a9f6920c19"
      unitRef="usd">66900000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i88c33ce611c94db9b64610be315aa469_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzgtMTUtMS0xLTgzMDc4_30642ab2-c2c3-4f4a-9e9f-ce84f94e55ed"
      unitRef="usd">-12574000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzgtMTctMS0xLTgzMDc4_7c9f11d1-9a8c-4d83-b8f8-2bcc07ae09e9"
      unitRef="usd">-12574000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzktMy0xLTEtODMwNzg_f65dc1f1-1531-440b-9771-0ee28c93c8ec"
      unitRef="shares">315000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzktNS0xLTEtODMwNzg_c8b448b3-c086-4aa3-a97f-872721daa21a"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzktNy0xLTEtODMwNzg_6c34eb7f-5882-4705-be10-fc6d22099951"
      unitRef="usd">16569000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzktMTctMS0xLTgzMDc4_484eb01d-1eda-4e26-ada7-026e0dc3dfff"
      unitRef="usd">16570000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzEwLTMtMS0xLTgzMDc4_e596bb97-4432-434b-95ed-98f3b73b188d"
      unitRef="shares">161000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzEwLTUtMS0xLTgzMDc4_3ffd8270-a64d-4dab-9b49-6d2e5a27e5cb"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzEwLTctMS0xLTgzMDc4_e3d1f5f0-e990-4127-9106-cf615aa48ace"
      unitRef="usd">3290000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzEwLTE3LTEtMS04MzA3OA_9106451c-b617-4718-a76c-2aef8d3d23d6"
      unitRef="usd">3290000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzExLTctMS0xLTgzMDc4_0581fe61-aac3-4a05-8692-696de201f93c"
      unitRef="usd">67549000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzExLTE3LTEtMS04MzA3OA_c088c10c-9ec1-4753-b051-4beb9202f99d"
      unitRef="usd">67549000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzEzLTEtMS0xLTgzMDc4_c00a993a-07df-4e57-854f-d73d05d1735f"
      unitRef="usd">155011000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i15f02743c68844acade340aa85cc54cd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzEzLTE5LTEtMS04MzA3OA_59dbb161-843d-4e37-9230-9a0454010206"
      unitRef="usd">78112000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE0LTEtMS0xLTgzMDc4_43775957-f991-4d03-9ac4-a29cd49eb895"
      unitRef="usd">35572000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="i15f02743c68844acade340aa85cc54cd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE0LTE5LTEtMS04MzA3OA_914fe1bb-1fbc-4667-ae1c-482114d62d65"
      unitRef="usd">21745000</dva:NoncontrollingInterestIncreaseFromContributions>
    <dva:TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures
      contextRef="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE1LTEtMS0xLTgzMDc4_339fc9e6-62a7-4bad-acae-47caed547abb"
      unitRef="usd">6332000</dva:TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures
      contextRef="i15f02743c68844acade340aa85cc54cd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE1LTE5LTEtMS04MzA3OA_19eb445d-430e-4d38-bfa3-a922c2acb8f9"
      unitRef="usd">10170000</dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures>
    <dva:TemporaryEquityDecreasePurchaseOfInterests
      contextRef="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE2LTEtMS0xLTgzMDc4_9cff62f5-8a14-472f-acb0-d59885a546c2"
      unitRef="usd">11394000</dva:TemporaryEquityDecreasePurchaseOfInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE2LTctMS0xLTgzMDc4_55371a1f-2ae3-4f50-99af-99e187962c54"
      unitRef="usd">37145000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE2LTE3LTEtMS04MzA3OA_334daf4c-3c79-4da4-8393-dfe965db23d4"
      unitRef="usd">37145000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i15f02743c68844acade340aa85cc54cd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE2LTE5LTEtMS04MzA3OA_f5211d49-7b25-4fad-ac01-6761263b8c80"
      unitRef="usd">19480000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i3a790239a9d649269a477f8a5bea1917_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE3LTEtMS0xLTgzMDc4_affee3cd-bdcd-42de-a966-11213e8b570f"
      unitRef="usd">49525000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE3LTctMS0xLTgzMDc4_e61a31ff-60bb-4714-afb4-b32bfca6dbdf"
      unitRef="usd">-49525000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE3LTE3LTEtMS04MzA3OA_5346e8b8-1ec7-4976-afd2-3c26a3db6451"
      unitRef="usd">-49525000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib5a1a9dd763f490c88b2409ea91246ed_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE4LTExLTEtMS04MzA3OA_18602897-ed9d-4eaf-8e3d-d929c57d35c6"
      unitRef="shares">41020000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib5a1a9dd763f490c88b2409ea91246ed_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE4LTEzLTEtMS04MzA3OA_3ed9a3db-f472-4125-a933-bfe7b81f11f9"
      unitRef="usd">2402475000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE4LTE3LTEtMS04MzA3OA_d8dc011c-c9ac-4e85-955f-e28ae2da4c42"
      unitRef="usd">2402475000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTMtMS0xLTgzMDc4_83ab2375-7fe1-4deb-99da-1f92c4a98ca0"
      unitRef="shares">41020000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i6a8c42eab7184340b8b5606593f1c2ca_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTUtMS0xLTgzMDc4_86f4154c-ee76-4ae4-848b-480ed1df0add"
      unitRef="usd">41000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTctMS0xLTgzMDc4_733de2d9-bef2-4440-adfb-c678c0598b28"
      unitRef="usd">240121000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i583e6028240a4d259061cd7bbc80a527_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTktMS0xLTgzMDc4_6cae992b-ba72-4907-9cc4-d47fb9944514"
      unitRef="usd">2162313000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="ib5a1a9dd763f490c88b2409ea91246ed_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTExLTEtMS04MzA3OA_65485668-f566-4852-89ef-da91fefd028e"
      unitRef="shares">-41020000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ib5a1a9dd763f490c88b2409ea91246ed_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTEzLTEtMS04MzA3OA_a24e5750-190a-4027-b90e-c1b9cedb83a4"
      unitRef="usd">-2402475000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ib4129313fde049fd8077ad4f1cf536b3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzE5LTE3LTEtMS04MzA3OA_4a3fbd9e-09f9-490d-be57-fa653c3b3df7"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i06d01a2b80634e908567ea9c88abdc8f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTEtMS0xLTgzMDc4_e8028564-212f-4d1f-8753-80d82cce38dc"
      unitRef="usd">1180376000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie1b9156dde5743f4b33b9826bbf418bb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTMtMS0xLTgzMDc4_e2ab336b-5d0c-470c-8e97-da16abf40a92"
      unitRef="shares">125843000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie1b9156dde5743f4b33b9826bbf418bb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTUtMS0xLTgzMDc4_2f361265-02d9-4b03-85bd-99e2f26d79c4"
      unitRef="usd">126000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i62f1cb2b785248a3b90677c8293c94df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTctMS0xLTgzMDc4_ff1231f9-8d99-4225-be8a-882d244d9722"
      unitRef="usd">749043000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b6aab96951d446ab5be207620dd6ff7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTktMS0xLTgzMDc4_af425f90-267e-4174-a8d0-d0d762aa54aa"
      unitRef="usd">1431738000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i996169fbe8c44228b5349d69256e805e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTExLTEtMS04MzA3OA_4eef9c5a-05c6-4fff-acdb-5c6c5339e960"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i996169fbe8c44228b5349d69256e805e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTEzLTEtMS04MzA3OA_06a74bbf-539c-4bbc-8b99-160076abced7"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i838fbf8cfb7d4a6cb6315c5d14ce207e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTE1LTEtMS04MzA3OA_fbe5a0d4-1d8c-4b67-bc78-eb74c706c2b9"
      unitRef="usd">-47498000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b4abd021662426781fb847359853689_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTE3LTEtMS04MzA3OA_b10545fe-86c0-46b0-8280-eebd33214519"
      unitRef="usd">2133409000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifae2538458cc41c69083e653352c94de_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIwLTE5LTEtMS04MzA3OA_04aafac7-3d48-4963-9513-969931b1fc79"
      unitRef="usd">185833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIzLTEtMS0xLTgzMDc4_24db60f3-5c78-42c2-b56a-9592153eeed5"
      unitRef="usd">141879000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i5e5cea8acd3342e28c6385ed6cb5ccd2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIzLTktMS0xLTgzMDc4_370236b8-279c-425b-8081-d1211e8ba642"
      unitRef="usd">773642000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIzLTE3LTEtMS04MzA3OA_b69aa4c7-428a-4d46-8bd4-ea5aa8e0291f"
      unitRef="usd">773642000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ide8b363308b74e509b2de9b4dec149b4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzIzLTE5LTEtMS04MzA3OA_954eae27-271d-40e9-bba0-676c3602c0c3"
      unitRef="usd">79156000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i757f5d8cb16b4caeb7c0303e2e952d94_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI0LTE1LTEtMS04MzA3OA_001c1714-5703-4b07-bde7-b0ec657ba40c"
      unitRef="usd">-18656000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI0LTE3LTEtMS04MzA3OA_190b2eea-97b5-4cfc-b94a-4685aa079118"
      unitRef="usd">-18656000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI1LTMtMS0xLTgzMDc4_bc32c3ae-7bf6-4a7b-a66f-b74382b0b992"
      unitRef="shares">222000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI1LTUtMS0xLTgzMDc4_da626663-e7a0-4307-8a45-d7f37fab8059"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI1LTctMS0xLTgzMDc4_7e612ae4-3c69-4641-b20a-76f6e39e58b2"
      unitRef="usd">17148000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI1LTE3LTEtMS04MzA3OA_b1715563-bde5-4f92-b724-576fe8714b59"
      unitRef="usd">17148000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI2LTMtMS0xLTgzMDc4_f1c5e47e-a74c-43df-88ed-4e34b58ae803"
      unitRef="shares">345000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI2LTUtMS0xLTgzMDc4_f25520df-1fa6-40ce-9dbd-75f916be4879"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI2LTctMS0xLTgzMDc4_76063889-5313-48cd-9652-829fe7671575"
      unitRef="usd">17801000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI2LTE3LTEtMS04MzA3OA_01f290fa-031d-4eea-89f3-97e5ffc75efc"
      unitRef="usd">17801000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI3LTctMS0xLTgzMDc4_e48c87b2-74e2-46fd-9aeb-7e5291d6f1cf"
      unitRef="usd">90007000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI3LTE3LTEtMS04MzA3OA_b4838c2b-975b-489b-a3cb-97e9b639b4f2"
      unitRef="usd">90007000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI5LTEtMS0xLTgzMDc4_d3616fdf-1bb2-4e8d-b25d-4a628b7a18f7"
      unitRef="usd">163175000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ide8b363308b74e509b2de9b4dec149b4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzI5LTE5LTEtMS04MzA3OA_91b06792-8e30-4647-955e-1392cb4bcfea"
      unitRef="usd">89943000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMwLTEtMS0xLTgzMDc4_d2205ec9-b948-4d48-9b7b-98ca45d55906"
      unitRef="usd">30154000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="ide8b363308b74e509b2de9b4dec149b4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMwLTE5LTEtMS04MzA3OA_b180f3de-5b5c-494c-8dd2-0bc1a6641f5b"
      unitRef="usd">12812000</dva:NoncontrollingInterestIncreaseFromContributions>
    <dva:TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures
      contextRef="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMxLTEtMS0xLTgzMDc4_9822e7db-e313-4c2f-9f18-7ed7de33700e"
      unitRef="usd">3215000</dva:TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures
      contextRef="ide8b363308b74e509b2de9b4dec149b4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMxLTE5LTEtMS04MzA3OA_614fa3ea-5cd6-4787-81b8-42f09c303268"
      unitRef="usd">248000</dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures>
    <dva:TemporaryEquityDecreasePurchaseOfInterests
      contextRef="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMyLTEtMS0xLTgzMDc4_8ee6b8dc-2f1e-471d-a6c3-237cae688f55"
      unitRef="usd">7771000</dva:TemporaryEquityDecreasePurchaseOfInterests>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMyLTctMS0xLTgzMDc4_453af3c5-95da-4dbf-a385-1d776861d6c9"
      unitRef="usd">4364000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMyLTE3LTEtMS04MzA3OA_2b58ded9-5814-44b3-aa55-361068b1d416"
      unitRef="usd">4364000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ide8b363308b74e509b2de9b4dec149b4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMyLTE5LTEtMS04MzA3OA_d01749f5-6d7c-4294-8b3e-d3c135741e5e"
      unitRef="usd">4424000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i25c2ffd0930d4bc798e8c59b3f8dcaf3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMzLTEtMS0xLTgzMDc4_ef6d674a-1376-4352-adde-2a81dbd0d00d"
      unitRef="usd">151780000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMzLTctMS0xLTgzMDc4_3c35f6ed-4269-4c68-80a3-3384ffd5154c"
      unitRef="usd">-151780000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzMzLTE3LTEtMS04MzA3OA_ccbef9a3-acc6-4b3a-989d-e5ab568b85bc"
      unitRef="usd">-151780000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8d5b598835d84508b6ec3b7ee400fa41_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM0LTExLTEtMS04MzA3OA_b869c830-56b5-4aee-ad91-91daaea040a6"
      unitRef="shares">16477000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8d5b598835d84508b6ec3b7ee400fa41_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM0LTEzLTEtMS04MzA3OA_acb46ee3-6360-452d-aee0-efdcf78169bb"
      unitRef="usd">1446767000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM0LTE3LTEtMS04MzA3OA_dfc997bb-1807-4a3c-9f42-0af37b85d316"
      unitRef="usd">1446767000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTMtMS0xLTgzMDc4_39c0b87a-87eb-4f15-859e-45056972eb7d"
      unitRef="shares">16477000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="if4b9f43dd7394c44b21c320e95ff86ce_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTUtMS0xLTgzMDc4_e59da28c-1d9e-4372-9e32-cbcc9189fe34"
      unitRef="usd">16000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTctMS0xLTgzMDc4_664a2a60-9670-426a-90d4-f8de7228e6f4"
      unitRef="usd">93908000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i5e5cea8acd3342e28c6385ed6cb5ccd2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTktMS0xLTgzMDc4_a3b30139-16b2-4b38-a4a0-087ea769c40a"
      unitRef="usd">1352843000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i8d5b598835d84508b6ec3b7ee400fa41_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTExLTEtMS04MzA3OA_274957d0-2744-4146-94fd-6d8fabb14215"
      unitRef="shares">-16477000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i8d5b598835d84508b6ec3b7ee400fa41_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTEzLTEtMS04MzA3OA_5faaa0d2-ba27-47d8-85be-af5e65b771ce"
      unitRef="usd">-1446767000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i6896c1e5feb64de38a6fcebf85dac8b9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM1LTE3LTEtMS04MzA3OA_7a52372a-1006-4402-93d9-08d31165850c"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ia00e3841c62b4348bd05c6b2d0b4d596_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTEtMS0xLTgzMDc4_2b47981a-71c6-47bc-896d-f6ce759fd90c"
      unitRef="usd">1330028000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i60ae2bbc50a5435997c99adc86408164_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTMtMS0xLTgzMDc4_b1bc20ff-528b-45bb-93f3-9e1fc8183f4b"
      unitRef="shares">109933000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i60ae2bbc50a5435997c99adc86408164_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTUtMS0xLTgzMDc4_d2a804ea-41db-4473-bb63-63a3680dd74a"
      unitRef="usd">110000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4654e2a535af44d68cb85bf0e223c161_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTctMS0xLTgzMDc4_561e3d6a-263c-4cd7-abbe-28efd00801b0"
      unitRef="usd">597073000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36a1b963ab624f408820e5a7b1cda4ef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTktMS0xLTgzMDc4_e3b55890-e442-4e69-ba28-43d5749888db"
      unitRef="usd">852537000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0dd9625df77a4aa09aad592fdc4607db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTExLTEtMS04MzA3OA_e260400b-f738-4176-aeb2-ed20ae10b38f"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0dd9625df77a4aa09aad592fdc4607db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTEzLTEtMS04MzA3OA_2da34906-cb1b-4e34-b521-4d62dca357f7"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31cbff30dba64d4c9bbe2eb87db6524c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTE1LTEtMS04MzA3OA_66c21a6e-2033-45c5-8da0-8a2bfab5827e"
      unitRef="usd">-66154000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ebd4f5dd6634fdda4f23120f166d49b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTE3LTEtMS04MzA3OA_2b5007b5-d831-413b-9449-6b2bc548389f"
      unitRef="usd">1383566000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife7743b6788a41e5b36480f00efcdabe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTpiNGNjMzQ3ZTFkNWQ0YWQ3YTVlMjIzNGMxZjk1NjAyOS90YWJsZXJhbmdlOmI0Y2MzNDdlMWQ1ZDRhZDdhNWUyMjM0YzFmOTU2MDI5XzM2LTE5LTEtMS04MzA3OA_ed18f3cd-3c56-4753-92ce-3649c89e4f5f"
      unitRef="usd">183186000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ia00e3841c62b4348bd05c6b2d0b4d596_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMS0xLTEtODMwNzg_2b47981a-71c6-47bc-896d-f6ce759fd90c"
      unitRef="usd">1330028000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i60ae2bbc50a5435997c99adc86408164_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMy0xLTEtODMwNzg_b1bc20ff-528b-45bb-93f3-9e1fc8183f4b"
      unitRef="shares">109933000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i60ae2bbc50a5435997c99adc86408164_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtNS0xLTEtODMwNzg_d2a804ea-41db-4473-bb63-63a3680dd74a"
      unitRef="usd">110000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4654e2a535af44d68cb85bf0e223c161_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtNy0xLTEtODMwNzg_561e3d6a-263c-4cd7-abbe-28efd00801b0"
      unitRef="usd">597073000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36a1b963ab624f408820e5a7b1cda4ef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtOS0xLTEtODMwNzg_e3b55890-e442-4e69-ba28-43d5749888db"
      unitRef="usd">852537000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0dd9625df77a4aa09aad592fdc4607db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMTEtMS0xLTgzMDc4_e260400b-f738-4176-aeb2-ed20ae10b38f"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0dd9625df77a4aa09aad592fdc4607db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMTMtMS0xLTgzMDc4_2da34906-cb1b-4e34-b521-4d62dca357f7"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31cbff30dba64d4c9bbe2eb87db6524c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMTUtMS0xLTgzMDc4_66c21a6e-2033-45c5-8da0-8a2bfab5827e"
      unitRef="usd">-66154000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ebd4f5dd6634fdda4f23120f166d49b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMTctMS0xLTgzMDc4_2b5007b5-d831-413b-9449-6b2bc548389f"
      unitRef="usd">1383566000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife7743b6788a41e5b36480f00efcdabe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzQtMTktMS0xLTgzMDc4_ed18f3cd-3c56-4753-92ce-3649c89e4f5f"
      unitRef="usd">183186000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzYtMS0xLTEtODMwNzg_5bff08e4-5a7b-42b6-8739-59f829b2190a"
      unitRef="usd">160359000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i350dba809a5e474b83a7ae6fd0ebf067_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzYtOS0xLTEtODMwNzg_b4f2efb1-d36b-4bf4-95e2-afba61be10de"
      unitRef="usd">978450000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzYtMTctMS0xLTgzMDc4_f053c878-c492-4f38-a7c9-da5dc735c32a"
      unitRef="usd">978450000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i27ce758ca09a46018cfdba537eef12e3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzYtMTktMS0xLTgzMDc4_b5ac5965-832a-4fd1-ae34-f82f45e6ae8c"
      unitRef="usd">72953000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id7cd4ee4e9ce4fc7b8372541703a718f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzctMTUtMS0xLTgzMDc4_3a24a058-80e6-4b0c-970f-d8a3d8f8d4e0"
      unitRef="usd">-73093000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzctMTctMS0xLTgzMDc4_b37bd921-8fdd-40f3-aba6-c65cf353cd58"
      unitRef="usd">-73093000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzgtMy0xLTEtODMwNzg_51cb9d05-2caa-4ff8-9b86-d60f62e75d21"
      unitRef="shares">203000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzgtNS0xLTEtODMwNzg_a32e6061-519e-48d4-a674-72122ebab9f7"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzgtNy0xLTEtODMwNzg_268c18cd-f5af-4102-b905-e68a2f5a7769"
      unitRef="usd">19626000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzgtMTctMS0xLTgzMDc4_d633c998-6d1c-4668-aa94-09a15ca84f1e"
      unitRef="usd">19626000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzktMy0xLTEtODMwNzg_e9457960-3373-4f7d-8ea3-57c0a8dfda23"
      unitRef="shares">1030000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzktNS0xLTEtODMwNzg_555a44f8-e6fe-4a1f-bd67-6d277c26a458"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzktNy0xLTEtODMwNzg_b3795ac8-1d88-400f-b032-3d2108ea0f00"
      unitRef="usd">80642000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzktMTctMS0xLTgzMDc4_a85abd28-e381-47bf-bc70-885a7492ae25"
      unitRef="usd">80641000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzEwLTctMS0xLTgzMDc4_6567b63c-ddd2-43a0-b508-61bdbfc89764"
      unitRef="usd">100714000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzEwLTE3LTEtMS04MzA3OA_5765a139-031a-43b4-937a-63c38329762c"
      unitRef="usd">100714000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzEyLTEtMS0xLTgzMDc4_3a3c945d-ddea-45b5-83a7-637be7e5952a"
      unitRef="usd">159259000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i27ce758ca09a46018cfdba537eef12e3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzEyLTE5LTEtMS04MzA3OA_577a2e88-5c28-475b-b00c-375d489f149c"
      unitRef="usd">84774000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzEzLTEtMS0xLTgzMDc4_828d7d95-5417-4c49-975a-dd88244710a2"
      unitRef="usd">22672000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="i27ce758ca09a46018cfdba537eef12e3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzEzLTE5LTEtMS04MzA3OA_8469a572-9c86-4dbb-b684-77bda0bd2578"
      unitRef="usd">9082000</dva:NoncontrollingInterestIncreaseFromContributions>
    <dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE0LTEtMS0xLTgzMDc4_42380fee-3aff-466f-92e1-053e5cceff67"
      unitRef="usd">5903000</dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures
      contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE0LTctMS0xLTgzMDc4_5052b9f6-a9a1-4ebb-a1a9-3fcecd87ea73"
      unitRef="usd">264000</dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures
      contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE0LTE3LTEtMS0xNDE5MTc_a9652b4f-c84a-4a54-bc81-67b30b30cbf8"
      unitRef="usd">264000</dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i27ce758ca09a46018cfdba537eef12e3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE0LTE5LTEtMS04MzA3OA_896cbd31-6637-47b1-91ac-7ca2897cb2c6"
      unitRef="usd">1250000</dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures>
    <dva:TemporaryEquityDecreasePurchaseOfInterests
      contextRef="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE1LTEtMS0xLTgzMDc4_49aece07-493a-4116-8f54-4a6c66aa8719"
      unitRef="usd">588000</dva:TemporaryEquityDecreasePurchaseOfInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE1LTctMS0xLTgzMDc4_4a3d8c53-cc73-48f7-bc62-2c8f0c1fd932"
      unitRef="usd">13853000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE1LTE3LTEtMS04MzA3OA_2b633992-7e89-44e8-bda5-d595ce7af3ba"
      unitRef="usd">13853000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i27ce758ca09a46018cfdba537eef12e3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE1LTE5LTEtMS04MzA3OA_dfd02e79-8a4a-400e-9ee9-ee3c41dbf935"
      unitRef="usd">1057000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i7ce7bfa048934bf78b73e8afaf97800a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE2LTEtMS0xLTgzMDc4_fe90afd1-9dd5-4148-b62e-905ca07a81d3"
      unitRef="usd">75717000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE2LTctMS0xLTgzMDc4_d7ba7e36-4eb4-4ff6-9e39-4bdc97d2e02c"
      unitRef="usd">-75717000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE2LTE3LTEtMS04MzA3OA_daed10c0-06ea-4180-87d6-bbe1fea1f245"
      unitRef="usd">-75717000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i518c74e1af094a8bbc78df6c4a5e0e05_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE3LTExLTEtMS04MzA3OA_52847ba4-5df9-4194-a166-5112152dfc2d"
      unitRef="shares">13877000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i518c74e1af094a8bbc78df6c4a5e0e05_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE3LTEzLTEtMS04MzA3OA_2888e038-1cd6-4a8f-a197-15bf0649d8b1"
      unitRef="usd">1546016000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE3LTE3LTEtMS04MzA3OA_f258c79b-902f-453d-ad7d-c7254b4f91e1"
      unitRef="usd">1546016000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTMtMS0xLTgzMDc4_f2bc6009-0d07-4231-9f9e-b47ffbe496c9"
      unitRef="shares">13877000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ia33df255962e4547b06e97bf9b6c7aa9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTUtMS0xLTgzMDc4_058c3d6d-7ef2-4bbc-9092-2a4d1a3dcbfc"
      unitRef="usd">14000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTctMS0xLTgzMDc4_3dea752f-a4f7-4270-b965-08ab23b5c64f"
      unitRef="usd">69352000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i350dba809a5e474b83a7ae6fd0ebf067_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTktMS0xLTgzMDc4_2c582e91-d7ad-436f-874c-9da337614c3b"
      unitRef="usd">1476650000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i518c74e1af094a8bbc78df6c4a5e0e05_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTExLTEtMS04MzA3OA_80c03ba1-8524-46e7-8606-e2ec27483f10"
      unitRef="shares">-13877000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i518c74e1af094a8bbc78df6c4a5e0e05_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTEzLTEtMS04MzA3OA_3f06615a-4539-441c-b233-5fc2c08282fb"
      unitRef="usd">-1546016000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE4LTE3LTEtMS04MzA3OA_259c95ec-7add-4c48-bf6e-d9ad2b26e154"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTctMS0xLTE1NjA0Ng_1c40d3f5-28ea-4686-97a8-2a8bca69b02c"
      unitRef="usd">62736000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i98082673c6cc4bbebfe3365b01faf162_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTE3LTEtMS0xNTYwNDY_3a1e05b7-1263-4955-943a-652b4bc61961"
      unitRef="usd">62736000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="if9e84e755ba249e59a9b6aa205496944_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTEtMS0xLTgzMDc4_643b0b8c-71c1-4fca-880f-a32185025a9b"
      unitRef="usd">1434832000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3715810153a34e87aa3d4a8555b92c56_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTMtMS0xLTgzMDc4_e01791d2-8bd0-4dd4-9123-52605e0f89f6"
      unitRef="shares">97289000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3715810153a34e87aa3d4a8555b92c56_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTUtMS0xLTgzMDc4_76100728-500f-4729-b0ef-0a572b860491"
      unitRef="usd">97000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia58cacd8bb944663919470f872cd9f54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTctMS0xLTgzMDc4_3147728a-a025-41de-9a1e-014ad95455b5"
      unitRef="usd">540321000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4e3c3810c47a4c88b525c4a096aec7af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTktMS0xLTgzMDc4_5033aad2-2912-4732-bd2b-000c69f36961"
      unitRef="usd">354337000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic7e9c24fd093462cb7636796ea413cc3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTExLTEtMS04MzA3OA_eeb9ac53-2da9-44c8-8e37-d68989769cc4"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7e9c24fd093462cb7636796ea413cc3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTEzLTEtMS04MzA3OA_7c40fba6-ff65-4895-9206-201981b98b2e"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3013c0642fb54553a6a63393504e9d22_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTE1LTEtMS04MzA3OA_ae8e29b5-3dee-4f88-aa72-145d71f1d779"
      unitRef="usd">-139247000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i32f5b12383e04ff68c813ea6c09f8e5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTE3LTEtMS04MzA3OA_5dcd5f8d-5797-4355-ae35-c25c583af203"
      unitRef="usd">755508000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id9418d8475e0410d982f26661945c8cf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDIvZnJhZzo0NDViOWI2YmZjMDA0YTFjODM1NjRmZDc5ZjQwNjYwMi90YWJsZTowNjdjMzYxZjE2MGM0ZmQ3ODJmODI1MzM0YjMyYzZkMC90YWJsZXJhbmdlOjA2N2MzNjFmMTYwYzRmZDc4MmY4MjUzMzRiMzJjNmQwXzE5LTE5LTEtMS04MzA3OA_e06ee2a4-742f-423c-a8da-41cbe38c23c7"
      unitRef="usd">180640000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODI5_867cfc3b-177c-4d8d-9d0a-a83c3922ffd4">Organization and summary of significant accounting policies&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Organization&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's operations are comprised of its dialysis and related lab services to patients in the United States (its U.S. dialysis business), its U.S. ancillary services and strategic initiatives and its international operations (collectively, its ancillary services), as well as its corporate administrative support.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s largest line of business is its U.S. dialysis business, which operates kidney dialysis centers in the U.S. for patients suffering from chronic kidney failure, also known as end stage renal disease&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; or end stage kidney disease&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ESRD or ESKD). As of December&#160;31, 2021, the Company operated or provided administrative services through a network of 2,815 U.S. outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 203,100 patients. In addition, as of December&#160;31, 2021, the Company operated or provided administrative services to a total of 339 outpatient dialysis centers serving approximately 39,900 patients located in ten countries outside of the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 19, 2019, the Company completed the sale of its prior DaVita Medical Group (DMG) business to Collaborative Care Holdings, LLC (Optum), a subsidiary of UnitedHealth Group Inc. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented in these consolidated financial statements. For financial information about the DMG business, see Note 22.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s U.S. dialysis business qualifies as a separately reportable segment and the Company&#x2019;s ancillary services, including its international operations, have been combined and disclosed in the other segments category.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (U.S. GAAP). The financial statements include DaVita Inc. and its subsidiaries, partnerships and other entities in which it maintains a majority voting or other controlling financial interest (collectively, the Company). All significant intercompany transactions and balances have been eliminated. Equity investments in investees over which the Company has significant influence are recorded on the equity method, while investments in other equity securities are recorded at fair value or on the adjusted cost method, as applicable. For the Company&#x2019;s international subsidiaries, local currencies are considered their functional currencies. Translation adjustments result from translating the financial statements of the Company&#x2019;s international subsidiaries from their functional currencies into the Company&#x2019;s reporting currency (the U.S. dollar, or USD). Prior year classifications have been conformed to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has evaluated subsequent events through the date these consolidated financial statements were issued and has included all necessary adjustments and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. Although actual results in subsequent periods will differ from these estimates, such estimates are developed based on the best information available to management and management&#x2019;s best judgments at the time. All significant assumptions and estimates underlying the amounts reported in the financial statements and accompanying notes are regularly reviewed and updated when necessary. Changes in estimates are reflected in the financial statements based upon on-going actual experience trends or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The most significant assumptions and estimates underlying these consolidated financial statements and accompanying notes involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, fair value estimates and loss contingencies. Specific estimating risks and contingencies are further addressed within these notes to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dialysis patient service revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recognized based on the Company&#x2019;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. A usual and customary fee schedule is maintained for the Company&#x2019;s dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues associated with Medicare and Medicaid programs are estimated based on: (a) the payment rates that are established by statute or regulation for the portion of payment rates paid by the government payor (e.g., 80% for Medicare patients) and (b) for the portion not paid by the primary government payor, estimates of the amounts ultimately collectible from other government programs providing secondary coverage (e.g., Medicaid secondary coverage), the patient&#x2019;s commercial health plan secondary coverage, or the patient.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under Medicare&#x2019;s bundled payment rate system, services covered by Medicare are subject to estimating risk, whereby reimbursements from Medicare can vary significantly depending upon certain patient characteristics and other variable factors. Even with the bundled payment rate system, Medicare payments for bad debt claims as established by cost reports require evidence of collection efforts. As a result, billing and collection of Medicare bad debt claims can be delayed significantly and final payment is subject to audit. The Company&#x2019;s revenue recognition is estimated based on its judgment regarding its ability to collect, which depends upon its ability to effectively capture, document and bill for Medicare&#x2019;s base payment rate as well as these other variable factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicare Advantage revenues are reimbursed at negotiated contract rates that are generally higher than Medicare fee-for-service rates, but which generally have a slower payment frequency than Medicare fee-for-service payments. Medicare Advantage revenues are subject to meaningful estimating risk based on factors similar to those described for commercial health plans below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicaid payments, when Medicaid coverage is secondary, can also be difficult to estimate. For many states, Medicaid payment terms and methods differ from Medicare, and may prevent accurate estimation of individual payment amounts prior to billing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues associated with commercial health plans are estimated based on contractual terms for the patients under healthcare plans with which the Company has formal agreements, non-contracted health plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in the Company&#x2019;s billing and collection processes that can result in denied claims for payments, delays in collections due to payor payment inefficiencies, and regulatory compliance matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial revenue recognition also involves significant estimating risks. With many larger commercial insurers, the Company has several different contracts and payment arrangements, and these contracts often include only a subset of the Company&#x2019;s centers. In certain circumstances, it may not be possible to determine which contract, if any, should be applied prior to billing. In addition, for services provided by non-contracted centers, final collection may require specific negotiation of a payment amount, typically at a significant discount from the Company&#x2019;s usual and customary rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's U.S. ancillary service revenues include revenues earned under risk-based arrangements in the Company's integrated care and disease management business, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (our counterparty), with adjustments where applicable, or on trended and adjusted medical cost targets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For some of the Company's risk-based arrangements (such as its special needs plans), the Company acts as a principal with respect to all medical services provided to the patient by effectively hosting or sponsoring the entire arrangement, and as a &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;result recognizes revenue and expense for all medical services provided to covered patients. However, for most of its VBC arrangements, the Company provides health monitoring and care coordination services to patients but does not control or direct the medical services that patients receive from third party providers. As a result, for most of its VBC arrangements the Company does not include third party medical costs in its reported revenues and expenses, but rather recognizes revenue only for the estimated amount of shared savings or shared losses or other revenues that are directly earned or incurred by the Company, and ultimately paid to or by the Company, under the arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income includes interest income on cash and cash equivalents and short- and long-term investments, realized and unrealized gains and losses recognized on investments, and foreign currency transaction gains and losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents are short-term highly liquid investments readily convertible to known amounts of cash that typically mature within three months or less at date of purchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted cash and equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and cash equivalents include funds held in trust to satisfy insurer and state regulatory requirements related to wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company as well as funds held in escrow. See Note 4 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in debt and equity securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies certain debt securities as held-to-maturity and records them at amortized cost based on the Company&#x2019;s intentions and strategies concerning those investments. Equity securities that have readily determinable fair values or redemption values are recorded at estimated fair value with changes in fair value recognized in current earnings within other income. These debt and equity investments are classified as short-term investments or long-term investments on the Company's consolidated balance sheet. See Note 5 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost (first-in, first-out) or net realizable value and consist principally of pharmaceuticals and dialysis-related supplies. Rebates related to inventory purchases are recorded when earned and are based on certain qualification requirements which are dependent on a variety of factors including future pricing levels and purchase volume levels from the manufacturer and related data submission.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is stated at cost less accumulated depreciation and amortization and is further reduced by any impairments. Maintenance and repairs are charged to expense as incurred. Disposition gains and losses are included in current operating expenses. Property and equipment assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#x2019;s facilities are leased under non-cancellable operating leases which contain renewal options. These renewal options are included in the Company's determination of the right-of-use assets and related lease liabilities when renewal is considered reasonably certain at the commencement date. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company categorizes leases with contractual terms longer than twelve months as either operating or finance leases. Finance leases are generally those leases that allow the Company to substantially utilize or pay for the entire asset over its estimated life. All other leases are categorized as operating leases. The Company has elected the practical expedient to not separate lease components from non-lease components for its financing and operating leases. The Company has also elected the short-term lease recognition exemption and does not recognize right-of-use assets or lease liabilities for leases with a term of less than 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing and operating right-of-use assets are recognized based on the net present value of lease payments over the lease term plus expected renewals as of the commencement date. Since most of the Company's leases do not provide an implicit rate of return, the Company uses its incremental borrowing rate based on information available at the commencement date or remeasurement date in determining the present value of lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets acquired under finance leases are recorded on the balance sheet within property and equipment, net and liabilities for finance lease obligations are recorded within long-term debt. Finance lease assets are amortized to depreciation expense on a straight-line basis over the shorter of their estimated useful lives or the expected lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rights to use assets under operating leases are recorded on the balance sheet as operating lease right-of-use assets and liabilities for operating lease obligations are recorded as operating lease liabilities. Reductions in the carrying amount of operating lease right-of-use assets are recorded to rent expense over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Amortizable intangibles&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortizable intangible assets include noncompetition agreements, hospital service contracts, and customer relationships arising from other service contracts, each of which have finite useful lives. Amortization expense is computed using the straight-line method over the useful lives of the assets estimated as follows: noncompetition agreements and hospital acute service contracts over the contract term, and customer relationships from other service contracts over the remaining contract term plus expected renewal periods. Amortizable intangible assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Indefinite-lived intangibles&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite-lived intangible assets include international licenses and accreditations that allow the Company to be reimbursed for providing dialysis services to patients, each of which has an indefinite useful life. Indefinite-lived intangibles are not amortized, but are assessed for impairment at least annually and whenever significant events or changes in circumstances indicate that an impairment may have occurred. Costs to renew indefinite-lived intangible assets are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity method and other investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity investments that do not have readily determinable fair values are carried on the equity method if the Company maintains significant influence over the investee. Equity investments without readily determinable fair values for which the Company does not maintain significant influence over the investee are carried either at estimated fair value or on the adjusted cost method, as determined on an investment-specific basis. The adjusted cost method represents the Company's cost for an investment, net of any other-than-temporary impairments, as adjusted for any subsequent observation of the investment's fair value.&#160;These equity method and adjusted cost method investments are classified as equity method and other investments on the Company's consolidated balance sheet.&#160;See Note 9 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity method and other investments are assessed for other-than-temporary impairment when significant events or changes in circumstances indicate that an other-than-temporary impairment may have occurred. An other-than-temporary impairment charge is recorded when the fair value of an investment has fallen below its carrying amount and the shortfall is expected to be indefinitely or permanently unrecoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the difference between the fair value of businesses acquired and the fair value of the identifiable tangible and intangible net assets acquired. Goodwill is not amortized, but is assessed by individual reporting unit for impairment as circumstances warrant and at least annually. An impairment charge is recognized when and to the extent a reporting unit's carrying amount is determined to exceed its fair value. The Company operates multiple reporting units. See Note 10 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Self-insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company predominantly self-insures its professional and general liability and workers' compensation risks through its wholly-owned captive insurance companies, with excess or reinsurance coverage for additional protection.&#160;The Company is also predominantly self-insured with respect to employee medical and other health benefits.&#160;The Company records insurance liabilities for the professional and general liability, workers&#x2019; compensation, and employee health benefit risks that it retains and estimates its liability for those risks using third party actuarial calculations that are based upon historical claims experience and expectations for future claims. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted both for items that do not currently have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market-based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all stock-based awards is recognized net of expected forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation to be settled in shares is recorded to the Company&#x2019;s shareholders&#x2019; contributed capital, while stock-based compensation to be settled in cash is recorded as a liability. Shares issued upon exercise or, when applicable, vesting of stock awards, are issued from authorized but unissued shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company often carries a combination of current or forward interest rate caps on portions of its variable rate debt as a means of hedging its exposure to changes in LIBOR interest rates as part of its overall interest rate risk management strategy. These interest rate caps are not held for trading or speculative purposes and are designated as qualifying cash flow hedges. See Note 13 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity ownership interests in entities which are consolidated by the Company for financial statement reporting purposes. As of December&#160;31, 2021, third parties held noncontrolling equity interests in 717 consolidated legal entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Fair value measurements are determined based on the principal or most advantageous market for the item being measured, assume that buyers and sellers are independent, willing and able to transact, and knowledgeable, with access to all information customarily available in such a transaction, and are based on assumptions that market participants would use in pricing the item, not assumptions specific to the reporting entity. The criticality of a particular fair value estimate to the Company's consolidated financial statements depends upon the nature and size of the item being measured, the extent of uncertainties involved and the nature and magnitude or potential effect of assumptions and judgments required. Certain fair value estimates can involve significant uncertainties and require significant judgment on various matters, some of which could be subject to reasonable disagreement. See Note 24 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company relies on fair value measurements and estimates for purposes that require the recording, reassessment, or adjustment of the carrying amounts of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity). These purposes can include the accounting for business combination transactions; impairment assessments for goodwill, other intangible assets, or other long-lived assets; recurrent revaluation of investments in debt and equity securities, contingent earn-out obligations, interest rate cap agreements, and noncontrolling interests subject to put provisions; and the accounting for equity method and other investments and stock-based &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;compensation, as applicable. The Company has classified its assets, liabilities and temporary equity into the fair value hierarchy levels defined by the FASB reflecting their differing degrees of uncertainty. See Note 24 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New accounting standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards recently adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued Accounting Standards Update (ASU) No. 2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. The amendments in this ASU became effective for the Company beginning on January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards not yet adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. Effective January 1, 2022 certain LIBOR tenors that do not affect the Company, including the one-week and two-month U.S. dollar LIBOR rate, ceased or became non-representative. The remaining U.S. dollar LIBOR tenors will cease or become non-representative effective July 1, 2023. This change will have no impact on the Company's ability to borrow. The Company is currently assessing the other effects this guidance may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU No. 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities (ASU 2021-08)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2021-08 requires application of ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to recognize and measure assets and liabilities from contracts with customers acquired in a business combination. This ASU creates an exception to the general recognition and measurement principle in ASC 805 and will result in recognition of contract assets and contract liabilities consistent with those recorded by the acquiree immediately before the acquisition date. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Early adoption is permitted for all entities. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <dva:NumberOfSites
      contextRef="i32582f828b954718823b2edb03b73ce7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzcwMg_1d9d647c-9789-4d9c-b611-ca57b90bce04"
      unitRef="clinic">2815</dva:NumberOfSites>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i32582f828b954718823b2edb03b73ce7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzc0MQ_ec96c4bf-ceac-4f8c-81fa-fdca6f4e7d95"
      unitRef="state">46</us-gaap:NumberOfStatesInWhichEntityOperates>
    <dva:NumberOfCustomers
      contextRef="ie9c338e435f04dd6bb9e00a239820984_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzgxNA_d3603921-23c4-4d70-aa57-8ed4325483c5"
      unitRef="patient">203100</dva:NumberOfCustomers>
    <dva:NumberOfSites
      contextRef="idcc6cfbc476149a0b92d93b432177548_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzkyMQ_7c10e98d-b6d2-4b57-85a2-15b3c974dc82"
      unitRef="clinic">339</dva:NumberOfSites>
    <dva:NumberOfCustomers
      contextRef="i34062f45d55f4583ba09a038767a205e_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzk3NA_f821f777-73f7-4d57-bd45-a569855ea881"
      unitRef="patient">39900</dva:NumberOfCustomers>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="idcc6cfbc476149a0b92d93b432177548_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzk5Nw_61b70d91-60f2-4820-9512-85bab3b624e1"
      unitRef="country">10</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2NzYz_cb1d79f7-c2cb-45f2-b82f-785ddfd1d35d">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (U.S. GAAP). The financial statements include DaVita Inc. and its subsidiaries, partnerships and other entities in which it maintains a majority voting or other controlling financial interest (collectively, the Company). All significant intercompany transactions and balances have been eliminated. Equity investments in investees over which the Company has significant influence are recorded on the equity method, while investments in other equity securities are recorded at fair value or on the adjusted cost method, as applicable. For the Company&#x2019;s international subsidiaries, local currencies are considered their functional currencies. Translation adjustments result from translating the financial statements of the Company&#x2019;s international subsidiaries from their functional currencies into the Company&#x2019;s reporting currency (the U.S. dollar, or USD). Prior year classifications have been conformed to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has evaluated subsequent events through the date these consolidated financial statements were issued and has included all necessary adjustments and disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2Nzc4_232af7a3-4688-4a4a-a716-dda03d5c08cd">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. Although actual results in subsequent periods will differ from these estimates, such estimates are developed based on the best information available to management and management&#x2019;s best judgments at the time. All significant assumptions and estimates underlying the amounts reported in the financial statements and accompanying notes are regularly reviewed and updated when necessary. Changes in estimates are reflected in the financial statements based upon on-going actual experience trends or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The most significant assumptions and estimates underlying these consolidated financial statements and accompanying notes involve revenue recognition and accounts receivable, impairments of goodwill, accounting for income taxes, fair value estimates and loss contingencies. Specific estimating risks and contingencies are further addressed within these notes to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <dva:RevenueRecognitionAndAccountsReceivablePolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODA2_3cc1d538-d24d-46b3-9727-f18179cf4044">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dialysis patient service revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recognized based on the Company&#x2019;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. A usual and customary fee schedule is maintained for the Company&#x2019;s dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues associated with Medicare and Medicaid programs are estimated based on: (a) the payment rates that are established by statute or regulation for the portion of payment rates paid by the government payor (e.g., 80% for Medicare patients) and (b) for the portion not paid by the primary government payor, estimates of the amounts ultimately collectible from other government programs providing secondary coverage (e.g., Medicaid secondary coverage), the patient&#x2019;s commercial health plan secondary coverage, or the patient.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under Medicare&#x2019;s bundled payment rate system, services covered by Medicare are subject to estimating risk, whereby reimbursements from Medicare can vary significantly depending upon certain patient characteristics and other variable factors. Even with the bundled payment rate system, Medicare payments for bad debt claims as established by cost reports require evidence of collection efforts. As a result, billing and collection of Medicare bad debt claims can be delayed significantly and final payment is subject to audit. The Company&#x2019;s revenue recognition is estimated based on its judgment regarding its ability to collect, which depends upon its ability to effectively capture, document and bill for Medicare&#x2019;s base payment rate as well as these other variable factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicare Advantage revenues are reimbursed at negotiated contract rates that are generally higher than Medicare fee-for-service rates, but which generally have a slower payment frequency than Medicare fee-for-service payments. Medicare Advantage revenues are subject to meaningful estimating risk based on factors similar to those described for commercial health plans below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicaid payments, when Medicaid coverage is secondary, can also be difficult to estimate. For many states, Medicaid payment terms and methods differ from Medicare, and may prevent accurate estimation of individual payment amounts prior to billing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues associated with commercial health plans are estimated based on contractual terms for the patients under healthcare plans with which the Company has formal agreements, non-contracted health plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in the Company&#x2019;s billing and collection processes that can result in denied claims for payments, delays in collections due to payor payment inefficiencies, and regulatory compliance matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial revenue recognition also involves significant estimating risks. With many larger commercial insurers, the Company has several different contracts and payment arrangements, and these contracts often include only a subset of the Company&#x2019;s centers. In certain circumstances, it may not be possible to determine which contract, if any, should be applied prior to billing. In addition, for services provided by non-contracted centers, final collection may require specific negotiation of a payment amount, typically at a significant discount from the Company&#x2019;s usual and customary rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's U.S. ancillary service revenues include revenues earned under risk-based arrangements in the Company's integrated care and disease management business, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (our counterparty), with adjustments where applicable, or on trended and adjusted medical cost targets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For some of the Company's risk-based arrangements (such as its special needs plans), the Company acts as a principal with respect to all medical services provided to the patient by effectively hosting or sponsoring the entire arrangement, and as a &lt;/span&gt;&lt;/div&gt;result recognizes revenue and expense for all medical services provided to covered patients. However, for most of its VBC arrangements, the Company provides health monitoring and care coordination services to patients but does not control or direct the medical services that patients receive from third party providers. As a result, for most of its VBC arrangements the Company does not include third party medical costs in its reported revenues and expenses, but rather recognizes revenue only for the estimated amount of shared savings or shared losses or other revenues that are directly earned or incurred by the Company, and ultimately paid to or by the Company, under the arrangement.</dva:RevenueRecognitionAndAccountsReceivablePolicyTextBlock>
    <dva:MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzY2OTY_73d80c63-4c44-4a03-b687-b8b537dbc3c5"
      unitRef="number">0.80</dva:MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor>
    <dva:OtherNonoperatingIncomeExpensePolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODM1_50db35d3-1fdb-4de3-9756-487368dbea9f">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income includes interest income on cash and cash equivalents and short- and long-term investments, realized and unrealized gains and losses recognized on investments, and foreign currency transaction gains and losses.&lt;/span&gt;&lt;/div&gt;</dva:OtherNonoperatingIncomeExpensePolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2Nzc0_d606342c-12ef-4b33-ae4f-94439550610f">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents are short-term highly liquid investments readily convertible to known amounts of cash that typically mature within three months or less at date of purchase.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODE0_fe93c21e-bfeb-4acf-aba7-fd0ddd53cdae">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted cash and equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and cash equivalents include funds held in trust to satisfy insurer and state regulatory requirements related to wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company as well as funds held in escrow. See Note 4 for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODMw_f3133f41-501d-4745-855d-c58666ac077f">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in debt and equity securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies certain debt securities as held-to-maturity and records them at amortized cost based on the Company&#x2019;s intentions and strategies concerning those investments. Equity securities that have readily determinable fair values or redemption values are recorded at estimated fair value with changes in fair value recognized in current earnings within other income. These debt and equity investments are classified as short-term investments or long-term investments on the Company's consolidated balance sheet. See Note 5 for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODM5_3e50995c-50d2-4e37-b688-7b2af718a9a7">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost (first-in, first-out) or net realizable value and consist principally of pharmaceuticals and dialysis-related supplies. Rebates related to inventory purchases are recorded when earned and are based on certain qualification requirements which are dependent on a variety of factors including future pricing levels and purchase volume levels from the manufacturer and related data submission.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODM2_60d75ff9-328a-4e1b-96d6-369ce8e16b1f">Property and equipmentProperty and equipment is stated at cost less accumulated depreciation and amortization and is further reduced by any impairments. Maintenance and repairs are charged to expense as incurred. Disposition gains and losses are included in current operating expenses. Property and equipment assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODAz_1b7bb570-fb22-42eb-a6b3-33e855d7ed9d">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#x2019;s facilities are leased under non-cancellable operating leases which contain renewal options. These renewal options are included in the Company's determination of the right-of-use assets and related lease liabilities when renewal is considered reasonably certain at the commencement date. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company categorizes leases with contractual terms longer than twelve months as either operating or finance leases. Finance leases are generally those leases that allow the Company to substantially utilize or pay for the entire asset over its estimated life. All other leases are categorized as operating leases. The Company has elected the practical expedient to not separate lease components from non-lease components for its financing and operating leases. The Company has also elected the short-term lease recognition exemption and does not recognize right-of-use assets or lease liabilities for leases with a term of less than 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing and operating right-of-use assets are recognized based on the net present value of lease payments over the lease term plus expected renewals as of the commencement date. Since most of the Company's leases do not provide an implicit rate of return, the Company uses its incremental borrowing rate based on information available at the commencement date or remeasurement date in determining the present value of lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets acquired under finance leases are recorded on the balance sheet within property and equipment, net and liabilities for finance lease obligations are recorded within long-term debt. Finance lease assets are amortized to depreciation expense on a straight-line basis over the shorter of their estimated useful lives or the expected lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rights to use assets under operating leases are recorded on the balance sheet as operating lease right-of-use assets and liabilities for operating lease obligations are recorded as operating lease liabilities. Reductions in the carrying amount of operating lease right-of-use assets are recorded to rent expense over the lease term.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODMx_49a25ad1-a8ad-4583-8f53-5c1189e9a585">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Amortizable intangibles&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortizable intangible assets include noncompetition agreements, hospital service contracts, and customer relationships arising from other service contracts, each of which have finite useful lives. Amortization expense is computed using the straight-line method over the useful lives of the assets estimated as follows: noncompetition agreements and hospital acute service contracts over the contract term, and customer relationships from other service contracts over the remaining contract term plus expected renewal periods. Amortizable intangible assets are reviewed for possible impairment whenever significant events or changes in circumstances indicate that an impairment may have occurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODI1_dbfb9710-17a8-41a8-b446-907c94a5814d">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Indefinite-lived intangibles&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite-lived intangible assets include international licenses and accreditations that allow the Company to be reimbursed for providing dialysis services to patients, each of which has an indefinite useful life. Indefinite-lived intangibles are not amortized, but are assessed for impairment at least annually and whenever significant events or changes in circumstances indicate that an impairment may have occurred. Costs to renew indefinite-lived intangible assets are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODE1_0a23959f-c8d2-4b7c-85df-37a9e136f3b2">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity method and other investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity investments that do not have readily determinable fair values are carried on the equity method if the Company maintains significant influence over the investee. Equity investments without readily determinable fair values for which the Company does not maintain significant influence over the investee are carried either at estimated fair value or on the adjusted cost method, as determined on an investment-specific basis. The adjusted cost method represents the Company's cost for an investment, net of any other-than-temporary impairments, as adjusted for any subsequent observation of the investment's fair value.&#160;These equity method and adjusted cost method investments are classified as equity method and other investments on the Company's consolidated balance sheet.&#160;See Note 9 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity method and other investments are assessed for other-than-temporary impairment when significant events or changes in circumstances indicate that an other-than-temporary impairment may have occurred. An other-than-temporary impairment charge is recorded when the fair value of an investment has fallen below its carrying amount and the shortfall is expected to be indefinitely or permanently unrecoverable.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODE3_12411607-2ee8-4965-a528-2c0b6ad0e3d2">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the difference between the fair value of businesses acquired and the fair value of the identifiable tangible and intangible net assets acquired. Goodwill is not amortized, but is assessed by individual reporting unit for impairment as circumstances warrant and at least annually. An impairment charge is recognized when and to the extent a reporting unit's carrying amount is determined to exceed its fair value. The Company operates multiple reporting units. See Note 10 for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <dva:InsuranceAndSelfInsurancePolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2NzYw_56f64ad8-46cb-4c9c-bbd3-3a8f52fb2e9f">Self-insuranceThe Company predominantly self-insures its professional and general liability and workers' compensation risks through its wholly-owned captive insurance companies, with excess or reinsurance coverage for additional protection.&#160;The Company is also predominantly self-insured with respect to employee medical and other health benefits.&#160;The Company records insurance liabilities for the professional and general liability, workers&#x2019; compensation, and employee health benefit risks that it retains and estimates its liability for those risks using third party actuarial calculations that are based upon historical claims experience and expectations for future claims.</dva:InsuranceAndSelfInsurancePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2NzYx_b1bb2a4a-5423-4dc6-bc1f-273f758979b5">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted both for items that do not currently have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the financial statements.&lt;/span&gt;&lt;/div&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2Nzcy_9b444699-cff0-49e3-812e-9a5fe62c3b08">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s stock-based compensation expense for stock-settled awards is measured at the estimated fair value of awards on the date of grant and recognized on a cumulative straight-line basis over the vesting terms of the awards, unless the stock awards are based on non-market-based performance metrics, in which case expense is adjusted for the ultimate number of shares expected to be issued as of the end of each reporting period. Stock-based compensation expense for cash-settled awards is based on their estimated fair values as of the end of each reporting period.&#160;The expense for all stock-based awards is recognized net of expected forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation to be settled in shares is recorded to the Company&#x2019;s shareholders&#x2019; contributed capital, while stock-based compensation to be settled in cash is recorded as a liability. Shares issued upon exercise or, when applicable, vesting of stock awards, are issued from authorized but unissued shares.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2NzYy_79742d40-ea3f-4460-b714-af4618aa8cbf">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company often carries a combination of current or forward interest rate caps on portions of its variable rate debt as a means of hedging its exposure to changes in LIBOR interest rates as part of its overall interest rate risk management strategy. These interest rate caps are not held for trading or speculative purposes and are designated as qualifying cash flow hedges. See Note 13 for further details.&lt;/span&gt;&lt;/div&gt;The cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2Nzc3_fb073501-2722-4c9e-b53e-86ae7876b5e7">Noncontrolling interestsNoncontrolling interests represent third-party equity ownership interests in entities which are consolidated by the Company for financial statement reporting purposes.&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has potential obligations to purchase the equity interests held by third parties in many of its majority-owned dialysis partnerships and other nonconsolidated entities. These noncontrolling interests subject to put provisions constitute redeemable equity interests and are therefore classified as temporary equity and carried at estimated fair value on the Company's balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Specifically, these obligations are in the form of put provisions that are exercisable at the third-party owners&#x2019; discretion within specified periods outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase the third-party owners&#x2019; equity interests, generally at the appraised fair market value of the equity interests or in certain cases at a predetermined multiple of earnings or cash flows attributable to the equity interests put to the Company, intended to approximate fair value. The methodology the Company uses to estimate the fair values of noncontrolling interests subject to put provisions assumes the higher of either a liquidation value of net assets or an average multiple of earnings, based on historical earnings, patient mix and other performance indicators that can affect future results, as well as other factors. The estimated fair values of noncontrolling interests subject to put provisions are a critical accounting estimate that involves significant judgments and assumptions and may not be indicative of the actual values at which the noncontrolling interests may ultimately be settled, which could vary significantly from the Company&#x2019;s current estimates. The estimated fair values of noncontrolling interests subject to put provisions can fluctuate and the implicit multiple of earnings at which these noncontrolling interests obligations may be settled will vary significantly depending upon market conditions including potential purchasers&#x2019; access to the capital markets, which can impact the level of competition for dialysis and non-dialysis related businesses, the economic performance of these businesses and the restricted marketability of the third-party owners&#x2019; equity interests. The amount of noncontrolling interests subject to put provisions that employ a contractually predetermined multiple of earnings rather than fair value is immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <dva:NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzIwOTk2_39ec2f97-ae86-4ea4-a422-36f6acbdab59"
      unitRef="entity">717</dva:NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODA5_f58c66ca-f6ea-4298-a96c-d48f7760beba">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&#160;Fair value measurements are determined based on the principal or most advantageous market for the item being measured, assume that buyers and sellers are independent, willing and able to transact, and knowledgeable, with access to all information customarily available in such a transaction, and are based on assumptions that market participants would use in pricing the item, not assumptions specific to the reporting entity. The criticality of a particular fair value estimate to the Company's consolidated financial statements depends upon the nature and size of the item being measured, the extent of uncertainties involved and the nature and magnitude or potential effect of assumptions and judgments required. Certain fair value estimates can involve significant uncertainties and require significant judgment on various matters, some of which could be subject to reasonable disagreement. See Note 24 for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company relies on fair value measurements and estimates for purposes that require the recording, reassessment, or adjustment of the carrying amounts of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity). These purposes can include the accounting for business combination transactions; impairment assessments for goodwill, other intangible assets, or other long-lived assets; recurrent revaluation of investments in debt and equity securities, contingent earn-out obligations, interest rate cap agreements, and noncontrolling interests subject to put provisions; and the accounting for equity method and other investments and stock-based &lt;/span&gt;&lt;/div&gt;compensation, as applicable. The Company has classified its assets, liabilities and temporary equity into the fair value hierarchy levels defined by the FASB reflecting their differing degrees of uncertainty. See Note 24 for further details.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMDgvZnJhZzozYTU1OWJmNmU2ZmU0Y2Y0YTdkNzZlODdjYzJlY2Y3Zi90ZXh0cmVnaW9uOjNhNTU5YmY2ZTZmZTRjZjRhN2Q3NmU4N2NjMmVjZjdmXzI2ODA1_1f052e97-8176-42bb-b31e-91d8787fa9e1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New accounting standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards recently adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued Accounting Standards Update (ASU) No. 2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. The amendments in this ASU became effective for the Company beginning on January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards not yet adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. Effective January 1, 2022 certain LIBOR tenors that do not affect the Company, including the one-week and two-month U.S. dollar LIBOR rate, ceased or became non-representative. The remaining U.S. dollar LIBOR tenors will cease or become non-representative effective July 1, 2023. This change will have no impact on the Company's ability to borrow. The Company is currently assessing the other effects this guidance may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU No. 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities (ASU 2021-08)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2021-08 requires application of ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to recognize and measure assets and liabilities from contracts with customers acquired in a business combination. This ASU creates an exception to the general recognition and measurement principle in ASC 805 and will result in recognition of contract assets and contract liabilities consistent with those recorded by the acquiree immediately before the acquisition date. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Early adoption is permitted for all entities. The Company is currently assessing the effect this guidance may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzI0MjI_4e7904e5-28bb-421d-bd21-1311f4078c67">Revenue recognition and accounts receivable&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues by segment and primary payor source were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,133,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,133,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;782,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;782,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;328,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;463,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;791,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,397,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,596,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95,090)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,576,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,042,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,618,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,169,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,169,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;744,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;744,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;380,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;715,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,370,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,540,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;419,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;419,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(145,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(162,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,514,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,035,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,550,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the "Other government" category to the "Medicare and Medicare Advantage" category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the year ended December&#160;31, 2020 has also been recast to conform to the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,246,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,246,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;669,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;669,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;329,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;352,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;681,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,286,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,430,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(132,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(146,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,430,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,388,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the "Other government" category to the "Medicare and Medicare Advantage" category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the year ended December&#160;31, 2019 has also been recast to conform to the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other consists of management service fees earned in the respective Company line of business as well as other non-patient revenue from the Company's U.S. ancillary services and international operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company's non-patient service revenues from Medicare and Medicare Advantage, Medicaid and Managed Medicaid, and commercial sources represent risk-based revenues earned by the Company's U.S. integrated care and disease management business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in Note 1, there are significant risks associated with estimating revenue, many of which take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues including determining applicable primary and secondary coverage, changes in patient coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No single commercial payor accounted for more than 10% of total consolidated accounts receivable or consolidated revenues at or for the years ended December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dialysis services accounts receivable and other receivables from Medicare, including Medicare Advantage plans, and Medicaid, including managed Medicaid plans, were approximately $1,174,123 and $1,101,837 as of December&#160;31, 2021 and 2020, respectively. Approximately 16% and 17% of the Company&#x2019;s patient services accounts receivable balances as of December&#160;31, 2021 and 2020, respectively, were more than six months old. There were no significant balances over one year old at December&#160;31, 2021. The Company's accounts receivable are principally due from Medicare and Medicaid programs and commercial insurance plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzI0MjA_c04ff31c-9198-483a-8aad-07741df8488c">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues by segment and primary payor source were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,133,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,133,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;782,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;782,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;328,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;463,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;791,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,397,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,596,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95,090)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,576,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,042,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,618,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,169,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,169,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;744,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;744,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;380,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;715,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,370,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,540,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;419,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;419,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(145,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(162,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,514,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,035,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,550,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the "Other government" category to the "Medicare and Medicare Advantage" category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the year ended December&#160;31, 2020 has also been recast to conform to the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,246,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,246,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;669,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;669,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;329,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;352,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;681,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,286,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,430,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(132,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(146,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,430,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,388,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the "Other government" category to the "Medicare and Medicare Advantage" category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the year ended December&#160;31, 2019 has also been recast to conform to the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other consists of management service fees earned in the respective Company line of business as well as other non-patient revenue from the Company's U.S. ancillary services and international operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7ec096dcca304113bc6030ce985e8e87_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzMtMS0xLTEtODMwNzg_c2c8465c-be52-4608-9187-eeef5da60f18"
      unitRef="usd">6133235000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6f47d0696ecb4ceea5e3dae2b3f56bbf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzMtNS0xLTEtODMwNzg_bc738c0b-f337-477b-9d78-b6685f6aa624"
      unitRef="usd">6133235000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i844334ff13de4b30b4c03942a019ecc3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzQtMS0xLTEtODMwNzg_9d481dd1-0641-4bcd-9495-e84407044237"
      unitRef="usd">782430000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib840efffa3b94830990c3a92b56374e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzQtNS0xLTEtODMwNzg_ef7053e5-1654-40e7-82c4-7d3719fc60d2"
      unitRef="usd">782430000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0eb5b1eefc8d41fd800f8c1f52603ba0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzUtMS0xLTEtODMwNzg_dddec6ee-6328-412d-aab2-33cc342d1d9a"
      unitRef="usd">328256000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i90c6f2e663a84d45ba6b27262a653a05_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzUtMy0xLTEtODMwNzg_af01f38a-7cd3-4757-8890-4c743862166b"
      unitRef="usd">463385000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic04011b05a72411caa75091e3801f7de_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzUtNS0xLTEtODMwNzg_79674086-5a5b-4dfd-88fa-24451b032b14"
      unitRef="usd">791641000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5041e4e8c2184140828efaa001bdd25e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzYtMS0xLTEtODMwNzg_8d1ffe1b-24ec-45ef-9891-023368a6e746"
      unitRef="usd">3397697000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i94e0c5744d944b2b9bd9e8a2915c8453_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzYtMy0xLTEtODMwNzg_6f40d461-84fa-4e80-8406-bfc845f0d57e"
      unitRef="usd">199024000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0c40460b5c5b441db56d0568eb1241d1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzYtNS0xLTEtODMwNzg_a6284b12-ca93-4f97-82b3-28608d275440"
      unitRef="usd">3596721000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="i43f279672ea545869037ea2802282d14_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzgtMy0xLTEtODMwNzg_de3bcb50-92eb-4f1f-b2be-b5ba23a25b2e"
      unitRef="usd">326696000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i6f47d0696ecb4ceea5e3dae2b3f56bbf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzgtNS0xLTEtODMwNzg_b22e6c4c-958f-4b46-833e-7f1ccef09b73"
      unitRef="usd">326696000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i33d553b0e327490488f4d8edbe627ee0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzktMy0xLTEtODMwNzg_b496de52-e670-469b-aa37-5cec53c9d426"
      unitRef="usd">1321000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ib840efffa3b94830990c3a92b56374e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzktNS0xLTEtODMwNzg_a16ff959-7e09-4501-9086-fd9ecd441995"
      unitRef="usd">1321000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i94e0c5744d944b2b9bd9e8a2915c8453_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEwLTMtMS0xLTgzMDc4_6d5f41b8-fdb8-401e-b900-cb7d8e21255e"
      unitRef="usd">15553000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i0c40460b5c5b441db56d0568eb1241d1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEwLTUtMS0xLTgzMDc4_195a7b0e-60a1-4cca-ac6b-91a026694c6d"
      unitRef="usd">15553000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ie3fd96e606364586af971c83948be72a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzExLTEtMS0xLTgzMDc4_3abc2d8e-ec36-4f84-9c0e-e62a53c03881"
      unitRef="usd">25345000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i9cdf7cce3e8f4dd797d01eb3c13004e6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzExLTMtMS0xLTgzMDc4_2068fed1-b495-47ae-b78e-5b0d27137eac"
      unitRef="usd">40945000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i05351ca6b9d14e4db0eabbbe9c54574c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzExLTUtMS0xLTgzMDc4_9706f9a3-28cd-4459-913d-dce35aa2b04f"
      unitRef="usd">66290000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="ie0a25508bcb746169dec8366c15ed07a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEyLTEtMS0xLTgzMDc4_b6a880be-c52e-4886-9ecc-ce7f50044d06"
      unitRef="usd">-90796000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i05cf3e1772d6444ea76bd84771ac5085_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEyLTMtMS0xLTgzMDc4_d289e3b9-5ae5-4f67-8cd9-718986f97f64"
      unitRef="usd">-4294000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia8c57a5b75b1450db44db406dbe6cbb1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEyLTUtMS0xLTgzMDc4_173b6222-56a8-4f50-8832-465c43705770"
      unitRef="usd">-95090000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEzLTEtMS0xLTgzMDc4_aaf4a5d7-d3de-4545-8437-67f8ddefaf8c"
      unitRef="usd">10576167000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEzLTMtMS0xLTgzMDc4_ff2cdac4-c42b-403b-a840-3eee7da0df39"
      unitRef="usd">1042630000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo5MmIzZmRmNGQ2MjA0ZmE4YjI1ZDRiNGIxOWFiMTM4Zi90YWJsZXJhbmdlOjkyYjNmZGY0ZDYyMDRmYThiMjVkNGI0YjE5YWIxMzhmXzEzLTUtMS0xLTgzMDc4_a17da9e6-a4c7-43f3-b488-2f597ca60853"
      unitRef="usd">11618797000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0d275721d92143bf8c330f70d27cb62f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzMtMS0xLTEtODMwNzg_d1322c79-1219-4b38-9b1d-4667c1a65fbe"
      unitRef="usd">6169226000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idcf3ecd2542b42dbafe63b11f52a5f01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzMtNS0xLTEtODMwNzg_f8f52c32-9287-4dea-9509-9e2f7b8d026f"
      unitRef="usd">6169226000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibde88c91df984f719e7c6e7ac45ff483_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzQtMS0xLTEtODMwNzg_b83c73c0-910b-41f0-bad2-a0748856149c"
      unitRef="usd">744862000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i308c251f3409431ba2ce96afe16e5595_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzQtNS0xLTEtODMwNzg_14cab8e1-8c70-48ed-b303-fcb4833bda75"
      unitRef="usd">744862000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5aed74fb770d4a2699f1ddada95c657a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzUtMS0xLTEtODMwNzg_42a2fbaf-f428-4e46-b3ac-8ce2b5955eab"
      unitRef="usd">334714000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i304d4d375e0f48c0ab470af39fbd5154_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzUtMy0xLTEtODMwNzg_45250fc0-1110-4725-a4f2-abdcc7f85f2d"
      unitRef="usd">380584000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3f79711127304e7698b87e1bd094348f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzUtNS0xLTEtODMwNzg_e249e84d-4c68-4ae2-b68f-ae652c7102ae"
      unitRef="usd">715298000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i73c74d19584d454fa34768055ba7f8dc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzYtMS0xLTEtODMwNzg_49d4284d-5629-4301-9403-d76f1ed50b9d"
      unitRef="usd">3370562000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib4a725d0f7e941a989ed5bb796119840_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzYtMy0xLTEtODMwNzg_5db7b9e5-4132-42da-9705-455494888f13"
      unitRef="usd">170394000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iec92bd4bff18494083abb72a297d1750_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzYtNS0xLTEtODMwNzg_b558d3b1-d1a8-42be-8e06-6919dbff2e6a"
      unitRef="usd">3540956000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="ic08ccea9be2442a6ab45a04b8ae8f5f2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzgtMy0xLTEtODMwNzg_ffbef465-5d11-4239-b7cd-7391c0b1e1cd"
      unitRef="usd">419662000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="idcf3ecd2542b42dbafe63b11f52a5f01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzgtNS0xLTEtODMwNzg_9853e8b4-3b9e-4def-9e1c-794861ebfd15"
      unitRef="usd">419662000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i1db402b2e17c4fdeabe30ffd0d4e606e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzktMy0xLTEtODMwNzg_6b3767e2-daf2-4a74-be9d-ad45973d57f3"
      unitRef="usd">1227000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i308c251f3409431ba2ce96afe16e5595_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzktNS0xLTEtODMwNzg_e3522b2e-1fc0-42cf-8032-49d32bf5921c"
      unitRef="usd">1227000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ib4a725d0f7e941a989ed5bb796119840_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEwLTMtMS0xLTgzMDc4_dbecab4d-ee9b-477d-8506-78f3dc5ab97e"
      unitRef="usd">33246000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="iec92bd4bff18494083abb72a297d1750_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEwLTUtMS0xLTgzMDc4_18602fde-28ce-4d7e-8e4f-292b244e0274"
      unitRef="usd">33246000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="if9c4a257e0bd4952bb2f643a893d32b0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzExLTEtMS0xLTgzMDc4_c46f8a4e-2a2f-492f-a55e-d5426cba1288"
      unitRef="usd">40571000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i20c733ee69934ecb9b5772eec12a55aa_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzExLTMtMS0xLTgzMDc4_27812c87-50ab-4f93-906e-1a4e86021dc3"
      unitRef="usd">47585000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="icf215d79e0d04757b9564cfbcda02f3a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzExLTUtMS0xLTgzMDc4_38f95d41-9eec-4af6-8364-2a7418e5bc5a"
      unitRef="usd">88156000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i06141d893bb4422fa657c1f835bd0f2b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEyLTEtMS0xLTgzMDc4_5d286f57-7de5-435d-8f48-f01b40c94f42"
      unitRef="usd">-145286000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i295d3ce315bf4c489968d63c7ba4628f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEyLTMtMS0xLTgzMDc4_c9ac13c6-bb3d-4cf3-97ba-b9fe995133ee"
      unitRef="usd">-16743000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i867fc66d86b045b5b0590e89915a412c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEyLTUtMS0xLTgzMDc4_0321181d-3c6b-4516-80c4-e1d0211d5ab9"
      unitRef="usd">-162029000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEzLTEtMS0xLTgzMDc4_9ea859f6-b6f1-49d9-9d65-577c12756655"
      unitRef="usd">10514649000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEzLTMtMS0xLTgzMDc4_b0fbe78b-3530-468b-bf22-54a19d90a9cc"
      unitRef="usd">1035955000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTo4ZTY4Y2M3ZmU3OGI0OTFhOGJjZTY3NTk3Y2EyZGIxYi90YWJsZXJhbmdlOjhlNjhjYzdmZTc4YjQ5MWE4YmNlNjc1OTdjYTJkYjFiXzEzLTUtMS0xLTgzMDc4_629ee48a-3c45-49f4-a786-317e66047040"
      unitRef="usd">11550604000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i527765f1b1c747358b403c1ee2d8bd10_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzMtMS0xLTEtODMwNzg_1edcd2ca-8967-4385-b003-7d161909c9fc"
      unitRef="usd">6246636000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i046bac9a5f584086bb2c35f87b6a1468_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzMtNS0xLTEtODMwNzg_6353785b-f41b-4254-a38d-321473d60bac"
      unitRef="usd">6246636000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3875776099b146e2b6fff08d3a03da84_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzQtMS0xLTEtODMwNzg_8ae191ce-5680-41fc-9363-7a580001be98"
      unitRef="usd">669089000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i409fa2d900b448c8827e86526a38779c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzQtNS0xLTEtODMwNzg_bce29bf1-c5df-4f72-bedd-1fd483fd8644"
      unitRef="usd">669089000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i520c14418180468ba0ed3e50cc99d1cf_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzUtMS0xLTEtODMwNzg_b556ae15-4c94-41a5-a5c4-041b06d7b771"
      unitRef="usd">329071000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie0b031a2280648889e03675a2160e4f9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzUtMy0xLTEtODMwNzg_40bb8fc0-7750-40e0-9e2e-946ee9fb1672"
      unitRef="usd">352765000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie2e7eff1c5284135b2912c47d643c653_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzUtNS0xLTEtODMwNzg_3f8cef83-3fa9-4b43-b4b2-942fcfae25a8"
      unitRef="usd">681836000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie6465f4788ca4b3baa87609dbf71f52f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzYtMS0xLTEtODMwNzg_34b2d712-7589-470c-9325-c11cc839e61a"
      unitRef="usd">3286089000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib1db70badf9c4be0b0e0fc9f772301e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzYtMy0xLTEtODMwNzg_f1e52ff6-6764-41e3-9e81-687b3b8413ad"
      unitRef="usd">144256000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7778dcdd0e944f4a8815e82230ee02f2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzYtNS0xLTEtODMwNzg_25174403-0089-4bba-b446-c3a5f6e3353d"
      unitRef="usd">3430345000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="i5da5750bb2a24b08979a8ec810b8c815_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzgtMy0xLTEtODMwNzg_7a9a0b40-ac6e-43ac-aa22-21157558a023"
      unitRef="usd">264538000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i046bac9a5f584086bb2c35f87b6a1468_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzgtNS0xLTEtODMwNzg_d18060fb-5384-4595-86f3-4fd74f44c0c3"
      unitRef="usd">264538000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i4d3fb78c0dc54d1587b96b694d859948_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzktMy0xLTEtODMwNzg_89b7853f-c96f-4888-bfe0-2d7266c5ba32"
      unitRef="usd">606000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i409fa2d900b448c8827e86526a38779c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzktNS0xLTEtODMwNzg_0e0b734d-9564-4a54-8a67-1743e227710c"
      unitRef="usd">606000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ib1db70badf9c4be0b0e0fc9f772301e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEwLTMtMS0xLTgzMDc4_6e34d59a-8d6a-424d-87d1-96f113edf3fc"
      unitRef="usd">130823000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i7778dcdd0e944f4a8815e82230ee02f2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEwLTUtMS0xLTgzMDc4_5b9f198e-7d69-4d89-87e1-777bfdb62f4a"
      unitRef="usd">130823000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="icab03bd4111342188781a60000b67316_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzExLTEtMS0xLTgzMDc4_d34725db-f057-4225-aafe-321003ddd076"
      unitRef="usd">32021000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i3959cde560fe4d70a411b92be2612071_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzExLTMtMS0xLTgzMDc4_c7823769-b07b-4b6d-8696-116c7e004ca9"
      unitRef="usd">78940000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i58155ca3f13343d5a0780d211b521c24_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzExLTUtMS0xLTgzMDc4_2472e0e4-3d62-42fc-8da5-2350dd912896"
      unitRef="usd">110961000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i0063865a3f1a46df9d125b3ec015e2eb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEyLTEtMS0xLTgzMDc4_3fb18278-0934-44ff-b7dd-669ad8d401aa"
      unitRef="usd">-132325000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i095a32d1f5934a57968454e6e538c10b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEyLTMtMS0xLTgzMDc4_d6031237-2e78-4899-913d-a93e4da27e3e"
      unitRef="usd">-14030000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iba5967b32fb4416ab78a1b0e0114069a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEyLTUtMS0xLTgzMDc4_ee59b45a-1e06-4fe4-9c36-92fe33a8d0c8"
      unitRef="usd">-146355000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54f8e1940aa343e29817e02300203cc7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEzLTEtMS0xLTgzMDc4_9a8a0b31-12de-4e87-9baa-608ababadac0"
      unitRef="usd">10430581000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f1b74b97d41414b9d610ad1be460b97_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEzLTMtMS0xLTgzMDc4_a0b195f8-4913-4777-989f-9adcc541c4de"
      unitRef="usd">957898000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90YWJsZTplYmM1MGRhYjA5ODM0Y2YyODNhNDYxYWEwYWFkYmMwYy90YWJsZXJhbmdlOmViYzUwZGFiMDk4MzRjZjI4M2E0NjFhYTBhYWRiYzBjXzEzLTUtMS0xLTgzMDc4_6430ae91-f3eb-48b3-8613-47298e943ef3"
      unitRef="usd">11388479000</us-gaap:Revenues>
    <dva:NumberOfConcentrationRiskCustomers
      contextRef="i6b7c2045c16f477c9b93026d6c4bfcca_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzE3MTQ_e1c411d2-3ab8-4c53-b884-3909d70dc9f1"
      unitRef="number">0</dva:NumberOfConcentrationRiskCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6b7c2045c16f477c9b93026d6c4bfcca_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzE3NzA_8e070bb6-8865-40d6-83ae-2f32d2d27ee8"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i70683478a02f41b494c6217a76fe90ea_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIwNTk_a37ab95a-69c3-4abf-b6ec-2fae076e4509"
      unitRef="usd">1174123000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i1c61506ae168449c8f430ff4e7720a1b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIwNjY_d976f6a6-9cfd-47f1-b6e9-7071d4d6d4b7"
      unitRef="usd">1101837000</us-gaap:AccountsReceivableNetCurrent>
    <dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue
      contextRef="i28b42af03e324f849e1bb33d2bda90ab_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIxMTQ_47e54537-e947-4385-a796-0c2e6a5f59c5"
      unitRef="number">0.16</dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue>
    <dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue
      contextRef="i208729e6625e496e9dca88ea4de1c200_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIxMjE_165e9986-5df5-480c-8b35-0192c9082fec"
      unitRef="number">0.17</dva:PercentageOfAccountsReceivableSixMonthsOrMorePastDue>
    <dva:AccountsReceivablePeriodOutstanding
      contextRef="i264dc38d90f840d89c8f00122dc94dda_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIyMzc_0ebd44df-a8f0-40ce-8577-22be43c3b6aa">P6M</dva:AccountsReceivablePeriodOutstanding>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i28b42af03e324f849e1bb33d2bda90ab_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIyNTY_b01c8307-99fd-42ca-8df5-4208669e72ca"
      unitRef="usd">0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDue
      contextRef="i28b42af03e324f849e1bb33d2bda90ab_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTEvZnJhZzo4YzE3Njg4NTE5ZTA0MzExYjkxMWI0OTY2NjgwYzEwYy90ZXh0cmVnaW9uOjhjMTc2ODg1MTllMDQzMTFiOTExYjQ5NjY2ODBjMTBjXzIyODU_124a0a3e-b174-4628-a4b6-b93a56845c88">P1Y</us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDue>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90ZXh0cmVnaW9uOjkxMTkyNzFkMGQ3MjQ2ZjNhYmZiOTQyN2FiYmZmODdhXzEyMDA_68a2d825-d1b2-4de1-9614-52e99c9c9bd7">Earnings&#160;per share&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either their explicit vesting terms or retirement eligibility requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net income (loss) attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;978,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;783,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;706,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;978,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;773,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;810,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumed incremental from stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic net income (loss) attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted net income (loss) attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Anti-dilutive stock-settled awards excluded from calculation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90ZXh0cmVnaW9uOjkxMTkyNzFkMGQ3MjQ2ZjNhYmZiOTQyN2FiYmZmODdhXzEyMDI_5de5da57-a668-4249-a8b9-af92c678f058">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either their explicit vesting terms or retirement eligibility requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90ZXh0cmVnaW9uOjkxMTkyNzFkMGQ3MjQ2ZjNhYmZiOTQyN2FiYmZmODdhXzEyMTA_fc999459-bdf7-4d3f-84d0-2e44cad4c180">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net income (loss) attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;978,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;783,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;706,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;978,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;773,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;810,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumed incremental from stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic net income (loss) attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted net income (loss) attributable to DaVita Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Anti-dilutive stock-settled awards excluded from calculation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzMtMS0xLTEtODMwNzg_6c5b67f2-43ae-4f19-8091-c5fcf88b10df"
      unitRef="usd">978450000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzMtMy0xLTEtODMwNzg_776b7d19-f2d0-4068-8a5d-f994d4c2453f"
      unitRef="usd">783295000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzMtNS0xLTEtODMwNzg_cc77980e-b331-4892-981b-eb5b5669f38f"
      unitRef="usd">706832000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzQtMS0xLTEtODMwNzg_37365ad7-c463-437a-8506-9ad9b3165a74"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzQtMy0xLTEtODMwNzg_ce335e8d-3555-4734-ac83-df9d973e7bd9"
      unitRef="usd">-9653000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzQtNS0xLTEtODMwNzg_0ceb222f-4961-4fca-9efb-b5281f6c5500"
      unitRef="usd">104149000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzUtMS0xLTEtODMwNzg_f8547aec-4d56-4864-a562-cd9313e7f4d0"
      unitRef="usd">978450000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzUtMy0xLTEtODMwNzg_9be0b152-8b6d-4e36-98fc-c0bd9b51fb86"
      unitRef="usd">773642000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzUtNS0xLTEtODMwNzg_f49f9da5-4442-49be-9b85-64628606b70c"
      unitRef="usd">810981000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzgtMS0xLTEtODMwNzg_da46e7b9-67c9-45ba-909f-8dc542604d4e"
      unitRef="shares">105230000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzgtMy0xLTEtODMwNzg_9f54559f-ce76-4087-aa1b-e4fa298fa6ca"
      unitRef="shares">119797000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzgtNS0xLTEtODMwNzg_11637462-9f9e-49b6-89f4-a7f22fb600b6"
      unitRef="shares">153181000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzEyLTEtMS0xLTgzMDc4_b5f0a24d-ab62-4670-acc0-226778591eb9"
      unitRef="shares">4718000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzEyLTMtMS0xLTgzMDc4_4538c37e-4e9c-4e33-8e8a-698f9ab691fc"
      unitRef="shares">2826000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzEyLTUtMS0xLTgzMDc4_378c07ac-2884-4760-a8fd-3b3abaf48eb6"
      unitRef="shares">631000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzEzLTEtMS0xLTgzMDc4_45bd7aad-35b7-4885-9f80-9f58b4a04a45"
      unitRef="shares">109948000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzEzLTMtMS0xLTgzMDc4_a54b6d65-eb52-423e-b740-b62bd4ab1bb1"
      unitRef="shares">122623000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzEzLTUtMS0xLTgzMDc4_da8235c0-19c4-434a-a386-4537792a10aa"
      unitRef="shares">153812000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE2LTEtMS0xLTgzMDc4_8686b3a8-f052-4d93-aa5c-016a630197af"
      unitRef="usdPerShare">9.30</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE2LTMtMS0xLTgzMDc4_2546d20a-62fb-499f-91af-b3a61b094a55"
      unitRef="usdPerShare">6.54</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE2LTUtMS0xLTgzMDc4_9aedb01d-5093-462c-aa63-74bfb988fdde"
      unitRef="usdPerShare">4.61</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE3LTEtMS0xLTgzMDc4_e06ee9e5-630c-4f38-99eb-89e1e5cfb6b2"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE3LTMtMS0xLTgzMDc4_6b79ceba-f6ee-4133-b364-26a3847dc8e7"
      unitRef="usdPerShare">-0.08</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE3LTUtMS0xLTgzMDc4_20cfb5e9-36d9-4345-abaf-821aa58bb968"
      unitRef="usdPerShare">0.68</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE4LTEtMS0xLTgzMDc4_afb1ef5f-e727-4437-b2ed-a15eb7e1349b"
      unitRef="usdPerShare">9.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE4LTMtMS0xLTgzMDc4_fe6c9913-0810-437d-aa99-f8101bb93d65"
      unitRef="usdPerShare">6.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzE4LTUtMS0xLTgzMDc4_f3a082a4-4806-4739-a19f-d4fee201d649"
      unitRef="usdPerShare">5.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIxLTEtMS0xLTgzMDc4_8a5bc7ff-59ee-485c-b5e6-6f05ae22de78"
      unitRef="usdPerShare">8.90</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIxLTMtMS0xLTgzMDc4_d3f9e8f3-f24f-4d5e-a3fa-8ee5192d9a3a"
      unitRef="usdPerShare">6.39</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIxLTUtMS0xLTgzMDc4_96fa8cf1-7ffa-4e53-a02f-7a6d2fa54864"
      unitRef="usdPerShare">4.60</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIyLTEtMS0xLTgzMDc4_9732f2f2-d878-4e7f-96a1-22d34b6d5039"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIyLTMtMS0xLTgzMDc4_e397fd28-ee86-4c33-b12d-18974ceea56b"
      unitRef="usdPerShare">-0.08</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIyLTUtMS0xLTgzMDc4_cb166b46-68ce-46d8-be92-d12ee72f11f4"
      unitRef="usdPerShare">0.67</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIzLTEtMS0xLTgzMDc4_1161471c-a5a4-43e8-acd6-50eb7ad271f3"
      unitRef="usdPerShare">8.90</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIzLTMtMS0xLTgzMDc4_bda76ea7-d68c-4425-b2c9-9111289cf4c6"
      unitRef="usdPerShare">6.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzIzLTUtMS0xLTgzMDc4_3ac5453d-f042-4556-b344-6f4b7e97e3ff"
      unitRef="usdPerShare">5.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzI1LTEtMS0xLTgzMDc4_e4b6d9b4-ff3a-4285-a108-27fd15dd993c"
      unitRef="shares">116000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzI1LTMtMS0xLTgzMDc4_25f01be2-5c0a-4279-b6f4-781b3af83bca"
      unitRef="shares">2301000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMTcvZnJhZzo5MTE5MjcxZDBkNzI0NmYzYWJmYjk0MjdhYmJmZjg3YS90YWJsZTplZWFlZDQ4NTIwZTU0OWY1YTNlOWIyOTdjOWYzNjc1Ny90YWJsZXJhbmdlOmVlYWVkNDg1MjBlNTQ5ZjVhM2U5YjI5N2M5ZjM2NzU3XzI1LTUtMS0xLTgzMDc4_8387e811-1b5e-4922-b300-b8d455fd6d12"
      unitRef="shares">5936000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CashAndCashEquivalentsDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjAvZnJhZzo5N2U5MTBlYjYxNjc0OGI1OGVkYWZmZGZiODk1NDM4Yi90ZXh0cmVnaW9uOjk3ZTkxMGViNjE2NzQ4YjU4ZWRhZmZkZmI4OTU0MzhiXzcwOA_b49d4ced-5704-4bfb-8203-8a4f74b2b077">Restricted cash and equivalentsThe Company had restricted cash and cash equivalents of $93,060 and $176,832 at December&#160;31, 2021 and 2020, respectively. The decrease in restricted cash and equivalents was primarily driven by the release of escrow funds in the third quarter of 2021 related to a resolved legal settlement. See Note 16 for further details. Substantially all of the restricted cash and equivalents balance at December&#160;31, 2021 is held in trust to satisfy insurer and state regulatory requirements related to the wholly-owned captive insurance companies that bear professional and general liability and workers' compensation risks for the Company and the remaining restricted cash and cash equivalents held at December&#160;31, 2021 represents cash pledged to third parties in connection with one of the Company's ancillary businesses.</us-gaap:CashAndCashEquivalentsDisclosureTextBlock>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjAvZnJhZzo5N2U5MTBlYjYxNjc0OGI1OGVkYWZmZGZiODk1NDM4Yi90ZXh0cmVnaW9uOjk3ZTkxMGViNjE2NzQ4YjU4ZWRhZmZkZmI4OTU0MzhiXzk3_ad3877c4-8747-4473-b5a1-9e102061a67c"
      unitRef="usd">93060000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjAvZnJhZzo5N2U5MTBlYjYxNjc0OGI1OGVkYWZmZGZiODk1NDM4Yi90ZXh0cmVnaW9uOjk3ZTkxMGViNjE2NzQ4YjU4ZWRhZmZkZmI4OTU0MzhiXzEwNA_27b198df-b030-455f-b36c-bccd0f7f55c2"
      unitRef="usd">176832000</us-gaap:RestrictedCashAndCashEquivalents>
    <dva:NumberOfPartnerships
      contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjAvZnJhZzo5N2U5MTBlYjYxNjc0OGI1OGVkYWZmZGZiODk1NDM4Yi90ZXh0cmVnaW9uOjk3ZTkxMGViNjE2NzQ4YjU4ZWRhZmZkZmI4OTU0MzhiXzQ5NDc4MDIzMjYzODY_53800914-af08-4ffa-8aea-1d35022c79b8"
      unitRef="number">1</dva:NumberOfPartnerships>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzEyODA_be21d0ff-613c-40a8-94cf-527d52d6e45d">Short-term and long-term investments&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short-term and long-term investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificates of deposit and other time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in mutual funds and common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt securities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. The Company's long-term debt investments are bank time deposits with contractual maturities longer than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;Equity securities: During the year ended December&#160;31, 2021 certain of the Company&#x2019;s equity investments previously accounted for under the adjusted cost method now have readily determinable fair values from public markets. As a result, these investments were reclassified from equity method and other investments to short-term investments during that period. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#x2019;s non-qualified deferred compensation plans. During 2021, the Company recognized pre-tax net losses of $3,768 in other income associated with changes in the fair value of these equity securities, comprised of pre-tax realized gains of $1,762 and a net increase in unrealized losses of $5,530. During 2020, the Company recognized pre-tax net gains of $3,818 in other income associated with changes in the fair value of these equity securities, comprised of pre-tax realized gains of $1,941 and a net increase in unrealized gains of $1,877.</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzEyNzY_0f18ac1b-616c-470b-b0fb-785f98f0690f">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short-term and long-term investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificates of deposit and other time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in mutual funds and common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ic186c5f3dfeb4441b6f677670d000585_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzItMS0xLTEtODMwNzg_5ecc8552-107b-4301-8f69-6c2d6f3c947d"
      unitRef="usd">23226000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic186c5f3dfeb4441b6f677670d000585_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzItMy0xLTEtODMwNzg_a07bf996-5202-41a3-8ecb-4f34e7e7f0c1"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="ic186c5f3dfeb4441b6f677670d000585_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzItNS0xLTEtODMwNzg_16721476-3430-491f-bce3-4e1eb365b497"
      unitRef="usd">23226000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i19bdab5e4fc54c39bb5f779d936b5427_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzItNy0xLTEtODMwNzg_acf340b9-edb3-45b0-a93d-be802574b309"
      unitRef="usd">8217000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i19bdab5e4fc54c39bb5f779d936b5427_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzItOS0xLTEtODMwNzg_a3187040-2707-466e-a1d6-7bef47d2da8e"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i19bdab5e4fc54c39bb5f779d936b5427_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzItMTEtMS0xLTgzMDc4_7b3bfaf1-1be3-4fe6-88d9-e7bc26ade686"
      unitRef="usd">8217000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i7ccecfd286b84522bff1dcdb23b998d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzMtMS0xLTEtODMwNzg_fbf83565-a391-473a-9014-ef3420a7962d"
      unitRef="usd">0</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7ccecfd286b84522bff1dcdb23b998d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzMtMy0xLTEtODMwNzg_f4b0f744-8f42-4d26-993b-aba5c2357479"
      unitRef="usd">48598000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i7ccecfd286b84522bff1dcdb23b998d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzMtNS0xLTEtODMwNzg_044570ec-2281-4371-bf3e-fe14a4cab69f"
      unitRef="usd">48598000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i47b17801eff8471da78a0721b8cde413_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzMtNy0xLTEtODMwNzg_aa78cce4-a3a0-4a9f-97aa-40318b5ed54b"
      unitRef="usd">0</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i47b17801eff8471da78a0721b8cde413_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzMtOS0xLTEtODMwNzg_f7065ae7-e18e-4aea-961a-d06ca446d2e3"
      unitRef="usd">44077000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i47b17801eff8471da78a0721b8cde413_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzMtMTEtMS0xLTgzMDc4_0359740f-7b94-464b-8061-44eeaa792758"
      unitRef="usd">44077000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzQtMS0xLTEtODMwNzg_f977baf6-0cbc-4f15-b4cd-58b4653f7eaa"
      unitRef="usd">23226000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzQtMy0xLTEtODMwNzg_3f6bcc09-63c9-4efd-8d8d-9e4bbe6eeb20"
      unitRef="usd">48598000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzQtNS0xLTEtODMwNzg_8bef12a9-b5f3-4fa3-90fd-96c8d1959d04"
      unitRef="usd">71824000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzQtNy0xLTEtODMwNzg_b324755a-c2f6-42b3-9ae8-11702e22d72e"
      unitRef="usd">8217000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzQtOS0xLTEtODMwNzg_0a5f6f6b-d6b4-423d-9464-fbd189dd6f01"
      unitRef="usd">44077000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzQtMTEtMS0xLTgzMDc4_8c5a4d34-52b0-484a-8f9b-57a879190dd6"
      unitRef="usd">52294000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecuritiesCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzUtMS0xLTEtODMwNzg_b1c9842b-2ad3-4f60-b80b-e5b7ed5b3ad7"
      unitRef="usd">8227000</us-gaap:HeldToMaturitySecuritiesCurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id0e8651392b14a558028cc674241e13e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzUtMy0xLTEtODMwNzg_676ec225-4ab9-4008-b9b4-16e45ebc99bf"
      unitRef="usd">14083000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzUtNS0xLTEtODMwNzg_1e3cfc7e-c142-4b5f-8fc6-7b5ec54e8fc3"
      unitRef="usd">22310000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecuritiesCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzUtNy0xLTEtODMwNzg_d8fbc891-969f-4e73-bb4c-ace9aa163e16"
      unitRef="usd">8217000</us-gaap:HeldToMaturitySecuritiesCurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i8b12e4ffb329474094355b4068bcdcd8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzUtOS0xLTEtODMwNzg_75510fdc-1e40-4ea6-a45b-591a98e21b3c"
      unitRef="usd">11884000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzUtMTEtMS0xLTgzMDc4_e51de6a0-5b85-4e9c-b0fe-05c1fd7a60d7"
      unitRef="usd">20101000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecuritiesNoncurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzYtMS0xLTEtODMwNzg_521cb1af-d94e-4437-9cb1-301e8f3b8987"
      unitRef="usd">14999000</us-gaap:HeldToMaturitySecuritiesNoncurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i61f69079b45d4915928d89956cfa6568_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzYtMy0xLTEtODMwNzg_a668d6f1-8136-4d14-b0fe-3f1988258a15"
      unitRef="usd">34515000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzYtNS0xLTEtODMwNzg_ece01095-320f-4549-a11e-a7168450a9fb"
      unitRef="usd">49514000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:HeldToMaturitySecuritiesNoncurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzYtNy0xLTEtODMwNzg_c9a630f5-c6c5-4284-8b2a-fd37503061b3"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesNoncurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6c28d59a6d30456dbaefa29fc86e6c27_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzYtOS0xLTEtODMwNzg_b7493f38-913e-4785-a09d-cc2de5ca264a"
      unitRef="usd">32193000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzYtMTEtMS0xLTgzMDc4_3fb9db6a-7b4f-4e95-ba42-3689c6678c72"
      unitRef="usd">32193000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzctMS0xLTEtODMwNzg_bdd25f25-c7bd-486a-b64a-8aaec09ecc64"
      unitRef="usd">23226000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzctMy0xLTEtODMwNzg_17fee8f9-f94c-4db2-97d9-ea3e9a7b7455"
      unitRef="usd">48598000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzctNS0xLTEtODMwNzg_d017d6d1-b9ba-432a-b6e0-1c38d1501e0e"
      unitRef="usd">71824000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzctNy0xLTEtODMwNzg_74e525f8-85f1-4d55-af4e-3a3084f8f397"
      unitRef="usd">8217000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzctOS0xLTEtODMwNzg_cb0973cb-7e54-4d66-8594-24c253dc0ad0"
      unitRef="usd">44077000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90YWJsZToxOTIxNjZhZGM1ZTI0OWVhYTViNTU4NTcyYmRkMWE0OC90YWJsZXJhbmdlOjE5MjE2NmFkYzVlMjQ5ZWFhNWI1NTg1NzJiZGQxYTQ4XzctMTEtMS0xLTgzMDc4_ff7fa1fb-808a-4a38-9622-7e8f06023d78"
      unitRef="usd">52294000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzEyNzk_cbb09c9d-95d6-4dc5-bac9-87c25958710e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt securities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. The Company's long-term debt investments are bank time deposits with contractual maturities longer than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at December&#160;31, 2021 and 2020.&lt;/span&gt;Equity securities: During the year ended December&#160;31, 2021 certain of the Company&#x2019;s equity investments previously accounted for under the adjusted cost method now have readily determinable fair values from public markets. As a result, these investments were reclassified from equity method and other investments to short-term investments during that period. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#x2019;s non-qualified deferred compensation plans.</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i08588920534148a6a55bbac6aa980054_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzI1Mjg4NzY3NDQ0MTY5_61197a3f-90d0-43e6-abf1-2570eb730ecf"
      unitRef="usd">-3768000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGain
      contextRef="i08588920534148a6a55bbac6aa980054_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzI1Mjg4NzY3NDQ0MTg2_e2da99de-9a2e-4b85-8472-be073d16655c"
      unitRef="usd">1762000</us-gaap:EquitySecuritiesFvNiRealizedGain>
    <dva:NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities
      contextRef="i08588920534148a6a55bbac6aa980054_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzI1Mjg4NzY3NDQ0MTkx_a7355755-9505-498d-8e68-7d06b8ecb188"
      unitRef="usd">5530000</dva:NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ie5f7e68c3398415a8874d0a8dd8fc0c4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzEwOTg_d330f741-9ee9-4c4f-86ac-c89dec04ab8d"
      unitRef="usd">3818000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGain
      contextRef="ie5f7e68c3398415a8874d0a8dd8fc0c4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzEyMjY_a055fd73-9480-4a5f-a119-2abf3e0933cf"
      unitRef="usd">1941000</us-gaap:EquitySecuritiesFvNiRealizedGain>
    <dva:NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities
      contextRef="ie5f7e68c3398415a8874d0a8dd8fc0c4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjMvZnJhZzoxOTQxMTg2YjFkMjY0MjYwYWFhZDMzYmNlNjhiZTJhZS90ZXh0cmVnaW9uOjE5NDExODZiMWQyNjQyNjBhYWFkMzNiY2U2OGJlMmFlXzEyNzE_c49e37b2-1d12-4e3b-a6ad-cd93063001a3"
      unitRef="usd">1877000</dva:NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90ZXh0cmVnaW9uOjBmMzJjMjJiN2E2NDQ3YjY4Mzg3MThkNjdiMzllZDA3Xzg1_fe4b316a-c286-4303-85a6-42a5b9aac7ab">Other receivables&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other receivables were comprised of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier rebates and non-trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;390,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare bad debt claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;427,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;544,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <dva:ScheduleOfOtherReceivablesTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90ZXh0cmVnaW9uOjBmMzJjMjJiN2E2NDQ3YjY4Mzg3MThkNjdiMzllZDA3Xzgy_06fed023-b56e-43ae-b5ae-f00faba97aca">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other receivables were comprised of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier rebates and non-trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;390,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Medicare bad debt claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;427,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;544,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ScheduleOfOtherReceivablesTableTextBlock>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i56bb88494d0e4f3eaa70062661dfec9c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90YWJsZToxNDlhOWUwYzJlNjI0ODBjOWZjMGNkNGU0ZTlhM2JlMy90YWJsZXJhbmdlOjE0OWE5ZTBjMmU2MjQ4MGM5ZmMwY2Q0ZTRlOWEzYmUzXzItMS0xLTEtODMwNzg_5df9c625-38af-4ad5-ab12-d73ab453abb6"
      unitRef="usd">294574000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i0ca143f3c4b747dfa1c18ed1ce48c40f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90YWJsZToxNDlhOWUwYzJlNjI0ODBjOWZjMGNkNGU0ZTlhM2JlMy90YWJsZXJhbmdlOjE0OWE5ZTBjMmU2MjQ4MGM5ZmMwY2Q0ZTRlOWEzYmUzXzItMy0xLTEtODMwNzg_b4f8f75a-bfb0-47c6-a112-d12cbba96e86"
      unitRef="usd">390508000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i0991372c81b2467aa534d7228b96ce3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90YWJsZToxNDlhOWUwYzJlNjI0ODBjOWZjMGNkNGU0ZTlhM2JlMy90YWJsZXJhbmdlOjE0OWE5ZTBjMmU2MjQ4MGM5ZmMwY2Q0ZTRlOWEzYmUzXzMtMS0xLTEtODMwNzg_1f9794b2-35e8-4f3c-ab20-a3879ffa41bc"
      unitRef="usd">132747000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ib12ac6055b314dc9aafc2ab60037e0dd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90YWJsZToxNDlhOWUwYzJlNjI0ODBjOWZjMGNkNGU0ZTlhM2JlMy90YWJsZXJhbmdlOjE0OWE5ZTBjMmU2MjQ4MGM5ZmMwY2Q0ZTRlOWEzYmUzXzMtMy0xLTEtODMwNzg_66c020e9-c880-469f-aecd-d1f5b02eaf33"
      unitRef="usd">153868000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90YWJsZToxNDlhOWUwYzJlNjI0ODBjOWZjMGNkNGU0ZTlhM2JlMy90YWJsZXJhbmdlOjE0OWE5ZTBjMmU2MjQ4MGM5ZmMwY2Q0ZTRlOWEzYmUzXzQtMS0xLTEtODMwNzg_33384a16-7e2d-476c-847b-fbff0aee24ff"
      unitRef="usd">427321000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjYvZnJhZzowZjMyYzIyYjdhNjQ0N2I2ODM4NzE4ZDY3YjM5ZWQwNy90YWJsZToxNDlhOWUwYzJlNjI0ODBjOWZjMGNkNGU0ZTlhM2JlMy90YWJsZXJhbmdlOjE0OWE5ZTBjMmU2MjQ4MGM5ZmMwY2Q0ZTRlOWEzYmUzXzQtMy0xLTEtODMwNzg_e150bc64-d81d-4613-8e0d-d51d183f59a4"
      unitRef="usd">544376000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4Xzg3Nw_f51ed389-0189-4c81-9f17-8b88791d7727">Property and equipment&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;496,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;400,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,828,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,865,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equipment and information systems, including internally developed software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,292,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,081,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New center and capital asset projects in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;592,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;616,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,243,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,002,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,763,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,480,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,479,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,521,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expenses are computed using the straight-line method over the useful lives of the assets estimated as follows: buildings, 25 years to 40 years; leasehold improvements, the shorter of ten years or the expected lease term; and equipment and information systems, including internally developed software, principally three years to 15 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense on property and equipment was $667,755, $616,626, and $600,905 for 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on debt incurred during the development of new centers and other capital asset projects is capitalized as a component of the asset cost based on the respective in-process capital asset balances. Interest capitalized was $15,275, $17,944 and $27,322 for 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4Xzg4NQ_591b9abc-c330-4cd9-9e03-d134537c9eb4">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;496,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;400,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,828,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,865,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equipment and information systems, including internally developed software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,292,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,081,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New center and capital asset projects in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;592,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;616,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,243,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,002,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,763,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,480,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,479,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,521,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzItMS0xLTEtODMwNzg_9a16b0aa-e02b-4bbb-96af-47454683219e"
      unitRef="usd">34009000</us-gaap:Land>
    <us-gaap:Land
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzItMy0xLTEtODMwNzg_08af5f7f-4c3e-49fc-9829-78ef3e7016c4"
      unitRef="usd">37924000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzMtMS0xLTEtODMwNzg_65d1d617-be6b-45e8-96d1-3b3f44164278"
      unitRef="usd">496455000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzMtMy0xLTEtODMwNzg_d351993a-8c2b-4c48-8a72-edd31378ec93"
      unitRef="usd">400616000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzQtMS0xLTEtODMwNzg_80dcf2c0-eb4b-4907-bb82-926fd8a41944"
      unitRef="usd">3828404000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzQtMy0xLTEtODMwNzg_56b0b544-dd45-44e7-97e6-ee3553497fde"
      unitRef="usd">3865729000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzUtMS0xLTEtODMwNzg_e28732c1-1045-4e24-ac3d-081b47a44498"
      unitRef="usd">3292176000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzUtMy0xLTEtODMwNzg_fe2236a9-0101-41b8-920e-0365ae346a98"
      unitRef="usd">3081298000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzYtMS0xLTEtODMwNzg_b36adfe1-f63d-41df-a807-9f0089b05e9e"
      unitRef="usd">592063000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzYtMy0xLTEtODMwNzg_977bb729-4e44-4108-acb2-2c96321f8673"
      unitRef="usd">616686000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzctMS0xLTEtODMwNzg_147a4baa-c7a2-4892-8bad-825370cf7f53"
      unitRef="usd">8243107000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzctMy0xLTEtODMwNzg_5f9b9f4e-d1f1-480b-a145-1d92c20a48a4"
      unitRef="usd">8002253000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzgtMS0xLTEtODMwNzg_8949a24a-63e5-452f-902d-870506ccca8d"
      unitRef="usd">4763135000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzgtMy0xLTEtODMwNzg_010e294b-6743-4d94-a468-f5608549a7b2"
      unitRef="usd">4480429000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzktMS0xLTEtODMwNzg_517caaf9-68c7-47e8-a15c-52319596317a"
      unitRef="usd">3479972000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90YWJsZTo5MTY2ZDIxM2YyZjY0NjEzYjk0Zjg2NGQ5Y2I2OGFhMS90YWJsZXJhbmdlOjkxNjZkMjEzZjJmNjQ2MTNiOTRmODY0ZDljYjY4YWExXzktMy0xLTEtODMwNzg_2048ffd5-7ad5-4ad7-b34d-363afa210493"
      unitRef="usd">3521824000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i05ba62c8cdc74b429954ac9b69ac970f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzI0Mg_11ab6f33-9d3c-4d06-8ff6-5658b311011a">P25Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i837096e088984a8bb905c6961208d97e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzI0OA_f4aa42a4-8273-4a72-bacd-46153cca3e3a">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib3346ac383fd4263ba845f553e8518d0_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzI5MQ_d998908e-a787-41d8-b49e-aceabc3e938d">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i6ef4a9f5101d466cb9f802a38be35ea5_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzM3Mw_3c769d2c-6e50-489e-984d-d2e9992eed27">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib2aaedfe7b774b2182eb25476a91fc19_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzM3OQ_804a7173-5367-4629-8206-2392c750dd7d">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzQzNA_a854c019-0946-4760-b8ff-dafe85f84f65"
      unitRef="usd">667755000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzQzOA_b41dddc1-4bd6-4bb6-87c2-e6887f6c2701"
      unitRef="usd">616626000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzQ0Ng_8d78e423-37de-4460-b280-95f80841d007"
      unitRef="usd">600905000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestCostsCapitalized
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzcxMQ_ea9dd7bb-2f95-406f-954c-4216aa107b49"
      unitRef="usd">15275000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzcxNQ_25b1daf0-e704-487f-90f0-e1b37d413820"
      unitRef="usd">17944000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMjkvZnJhZzpiMzU3NzUwNmExYzg0OTgyYjBmYzlhOGUzZjY3NDU1OC90ZXh0cmVnaW9uOmIzNTc3NTA2YTFjODQ5ODJiMGZjOWE4ZTNmNjc0NTU4XzcyMg_7d4fff3f-a84e-4036-a815-fd1828de91d0"
      unitRef="usd">27322000</us-gaap:InterestCostsCapitalized>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzYxNA_fa765025-8132-4c41-bd0d-98a38193a572">Intangible assets&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets other than goodwill were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.959%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived licenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncompetition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;236,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncompetition agreements are generally amortized over three years to 10 years and customer relationships are principally amortized over 10 years to 20 years. The weighted average renewal or extension period of customer relationships was three years and five years as of December&#160;31, 2021 and 2020, respectively. Amortization expense from amortizable intangible assets was $12,860, $13,809, and $14,247 for 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized no impairment charges on any intangible assets other than the goodwill impairment charges discussed in Note 10.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scheduled amortization expenses from amortizable intangible assets as of December&#160;31, 2021 were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.286%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncompetition&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Customer relationships and other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzYwOQ_08a97698-b4ea-4ff6-8fba-4bdbdfde42b7">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets other than goodwill were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.959%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived licenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncompetition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;236,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzItMS0xLTEtODMwNzg_fbbcfe3d-c48c-4e6c-ad07-1ed7dc1c808f"
      unitRef="usd">104214000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzItMy0xLTEtODMwNzg_f6f3da36-6cd6-4c1a-ab85-09474672d4a3"
      unitRef="usd">100138000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedNoncompeteAgreementsGross
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzMtMS0xLTEtODMwNzg_6cacfcd4-5a1b-4a63-b207-96cb223b00b3"
      unitRef="usd">70495000</us-gaap:FiniteLivedNoncompeteAgreementsGross>
    <us-gaap:FiniteLivedNoncompeteAgreementsGross
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzMtMy0xLTEtODMwNzg_c9353310-2067-4d40-9a92-4fffcd6afa91"
      unitRef="usd">84022000</us-gaap:FiniteLivedNoncompeteAgreementsGross>
    <us-gaap:OtherIndefiniteLivedIntangibleAssets
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzQtMS0xLTEtODMwNzg_786fad2b-bd56-4d97-9a86-035a672f4262"
      unitRef="usd">63714000</us-gaap:OtherIndefiniteLivedIntangibleAssets>
    <us-gaap:OtherIndefiniteLivedIntangibleAssets
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzQtMy0xLTEtODMwNzg_7db9e95a-adcf-4902-a555-ad3001cc1e2d"
      unitRef="usd">52566000</us-gaap:OtherIndefiniteLivedIntangibleAssets>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzUtMS0xLTEtODMwNzg_201dc530-2393-49cf-86fb-95a7c296665d"
      unitRef="usd">238423000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzUtMy0xLTEtODMwNzg_42f68b31-dfa7-455d-b3bd-cc5d72e472ec"
      unitRef="usd">236726000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzYtMS0xLTEtODMwNzg_f4fcbba6-b7f8-4d02-b92a-8eb7a93ca2c5"
      unitRef="usd">60730000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzYtMy0xLTEtODMwNzg_5eb78fd8-72da-4f08-a66c-c984e04b49cb"
      unitRef="usd">70141000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzctMS0xLTEtODMwNzg_75348b1a-3550-43ed-a9b1-767592cd9ce7"
      unitRef="usd">177693000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo0OWUwY2UwODM5ZWE0YmY1ODk3NzdiNjFkYzFhMTliNy90YWJsZXJhbmdlOjQ5ZTBjZTA4MzllYTRiZjU4OTc3N2I2MWRjMWExOWI3XzctMy0xLTEtODMwNzg_e7c8ac22-eb33-4dcd-b905-1872feee0fe2"
      unitRef="usd">166585000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i7602e286b8e94ab9a142a5146dae00c4_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzE1NQ_e5044173-f71c-42ca-b870-75191f63f148">P3Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i2f73dfca446c431ca0404970955b23db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzE2MQ_5bb4940e-a559-4408-9356-044bb1124abf">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="idd2fb3df258c442a8587eff3039100b2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzIyMg_1c985d95-0aba-417d-a27e-58d371cc6fbd">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i4a4806c6b06944568dbe93e7f5881e70_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzIyOA_effaa91e-bd3c-4133-935d-3995f6d00b20">P20Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension
      contextRef="i5ff02df8087d45659dea2988089fd145_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzE2NDkyNjc0NDE3NTQ1_a7bba85a-fa0c-49bb-9d4c-43d054ad284a">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension
      contextRef="id31eb9b4ab454ab0bd1eb2e6df77f27c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzE2NDkyNjc0NDE3NTUz_d1832e64-9eda-4688-a2f9-35574de907d2">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzQ5NDc4MDIzMjU5NzE_a8e1b07a-4346-4648-8d07-03c8d3280c3e"
      unitRef="usd">12860000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzI5Ng_2b923892-60e6-49e8-9ce4-0933c19c10a9"
      unitRef="usd">13809000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzMwNA_f6c84cfe-870b-48c6-a31e-4a57522ae514"
      unitRef="usd">14247000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzM5OA_7edb6c6d-c7f7-4009-b007-6b2eed066081"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90ZXh0cmVnaW9uOjM2OGJiMjIwZWEzMzRiMDE4Y2U0YmU3NWQ2MTM4MjJmXzYxMw_1136d2b1-3214-4b28-8eb8-7514813396b0">Scheduled amortization expenses from amortizable intangible assets as of December&#160;31, 2021 were as follows:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.286%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncompetition&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Customer relationships and other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzEtMS0xLTEtODMwNzg_ed87e7b3-195b-4de9-825c-8992f2d630fe"
      unitRef="usd">7221000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzEtMy0xLTEtODMwNzg_a27f0c0f-b281-4e8c-9361-42d20f801670"
      unitRef="usd">4695000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzItMS0xLTEtODMwNzg_98af1ac3-d7a7-465b-b66a-217617ded507"
      unitRef="usd">4443000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzItMy0xLTEtODMwNzg_80bd125b-b9b6-423c-91c4-3ca73344c968"
      unitRef="usd">4669000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzMtMS0xLTEtODMwNzg_310ac245-4548-45e7-a3d9-1f6c3e450d1d"
      unitRef="usd">2499000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzMtMy0xLTEtODMwNzg_4600047b-c6cd-40ce-9c90-75c309dff38a"
      unitRef="usd">4444000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzQtMS0xLTEtODMwNzg_18d7722d-f12e-4f0f-8d70-a59aa369a1c7"
      unitRef="usd">1371000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzQtMy0xLTEtODMwNzg_04f0ac07-0d37-45ee-971c-3ddc9097feb9"
      unitRef="usd">4107000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzUtMS0xLTEtODMwNzg_d44e99f3-86cd-42f2-8346-b5ba6c7ba0cd"
      unitRef="usd">888000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzUtMy0xLTEtODMwNzg_cef0991a-0700-484d-8379-ec8d896f7a38"
      unitRef="usd">4107000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzYtMS0xLTEtODMwNzg_7ff23a7f-ebd0-4c45-8b27-76b69c5663b5"
      unitRef="usd">1260000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzYtMy0xLTEtODMwNzg_26c13b5f-592c-4e1c-b386-57208f243607"
      unitRef="usd">33775000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5a6af38324324be6933f6bddc285dac3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzctMS0xLTEtODMwNzg_ed7f5c5c-066e-4f18-a086-64278c1425d4"
      unitRef="usd">17682000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5edc52e7b7ac4f76b4d159ce71258a18_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzIvZnJhZzozNjhiYjIyMGVhMzM0YjAxOGNlNGJlNzVkNjEzODIyZi90YWJsZTo2Y2ZhZWQ1YjU1ZTk0MjhkOWIwYTNhNmVmNjYxZGJmYy90YWJsZXJhbmdlOjZjZmFlZDViNTVlOTQyOGQ5YjBhM2E2ZWY2NjFkYmZjXzctMy0xLTEtODMwNzg_d4171432-51c1-4fee-b163-8dc218e41e56"
      unitRef="usd">55797000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzIxNDg_46f2fee5-a62d-4de0-a382-9b15da2c33ab">Equity method and other investments&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains equity method and other minor investments in the private securities of certain other healthcare and healthcare-related businesses, comprised as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.883%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.612%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;APAC joint venture&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other equity method partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted cost method and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, 2020 and 2019, the Company recognized equity investment income of $26,937, $26,916 and $12,679, respectively, from its equity method investments in nonconsolidated businesses.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's largest equity method investment is its ownership interest in DaVita Care Pte. Ltd. (the APAC joint venture, or APAC JV). The Company holds a 75%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;voting and economic interest in the APAC JV and an unrelated noncontrolling investor holds the other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25% voting and economic interest in the joint venture, however the Company does not control or consolidate the APAC JV as a result of substantive participating rights retained by the unrelated investor over &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;certain key operating decisions for the joint venture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's other equity method investments include 23 legal entities over which the Company has significant influence but in which it does not maintain a controlling financial interest. Almost all of these are U.S. dialysis partnerships in the form of limited liability companies. The Company's ownership interests in these partnerships vary, and are often subject to blocking rights on certain key operating decisions held by outside investors, but mostly range from 30% to 65%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-right:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no significant impairments or other valuation adjustments on the Company's adjusted cost method and other investments during 2021, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzIxNDM_cb629059-1ac5-4c2f-8aa1-47792fd6d22c">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains equity method and other minor investments in the private securities of certain other healthcare and healthcare-related businesses, comprised as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.883%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.612%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;APAC joint venture&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other equity method partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted cost method and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i9573fac1bfc4444783c0b158169c7afc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzItMS0xLTEtODMwNzg_9e1ba7bd-413f-4316-b4af-98d89a87b457"
      unitRef="usd">109153000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="icc608d996b8446e4980e0cc9b39bf059_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzItMy0xLTEtODMwNzg_97e04b62-b5bb-4717-bf8b-9a155acf1d6e"
      unitRef="usd">120787000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i3d64f38aa44e457487bb0f100b1f8548_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzMtMS0xLTEtODMwNzg_e27db864-f422-4b05-830e-dceec521f422"
      unitRef="usd">115185000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ie883ccd9687a49048607db5fe42301ac_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzMtMy0xLTEtODMwNzg_2a28faf4-aa2e-442d-b70d-fd2077cf6c45"
      unitRef="usd">107599000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i46dab217b75644dabc035f91f7fe782d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzQtMS0xLTEtODMwNzg_bfa1d662-aa74-474b-a04d-365a6da61015"
      unitRef="usd">14543000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ib9be08d57aed4fe3b4db3144e1d9ad04_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzQtMy0xLTEtODMwNzg_75f2a736-73a4-4943-abe8-7d357949661b"
      unitRef="usd">29105000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzUtMS0xLTEtODMwNzg_f3032501-0e73-4d2c-b93d-44f5c6bcc59f"
      unitRef="usd">238881000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90YWJsZTo1NzUzZjNkYzZiMzU0NmU3OTgyYjA1NWMzODBjNzg1Zi90YWJsZXJhbmdlOjU3NTNmM2RjNmIzNTQ2ZTc5ODJiMDU1YzM4MGM3ODVmXzUtMy0xLTEtODMwNzg_e4e11168-e05b-4928-85c1-40c44a96e72d"
      unitRef="usd">257491000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib628323096c74e788c6d7a961b4d57af_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzMwMg_8601c228-bdc0-432a-add5-decf5ef1147e"
      unitRef="usd">26937000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4d9240c1eab54582a445c05ab20d0f19_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzMwNg_57140add-a726-4e6b-94e1-cb05b28a8497"
      unitRef="usd">26916000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="id2265c5d8f9c40e9b91c40988cbafd40_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzMxMw_fecd59c9-1ba9-48a3-8bb9-767b8aac9f2a"
      unitRef="usd">12679000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i586e32d477c142e5b161872b638df89f_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzU1NA_ce48f927-651d-4af2-837b-9b4de31c41c7"
      unitRef="number">0.75</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i9573fac1bfc4444783c0b158169c7afc_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzY1OA_a1a1dd3d-594a-441a-8e3a-81a96513d319"
      unitRef="number">0.25</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <dva:NumberOfPartnerships
      contextRef="i4e74dde23e17402298e90d199d2fe1a4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzE2Njc_6c0b6086-96d1-4d72-a65d-b52c03dbbd9f"
      unitRef="number">23</dva:NumberOfPartnerships>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i84431a6770414fe28573bbddc636eae2_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzE5ODQ_8d915f15-a02d-4cf5-9233-a4aa0bc31f73"
      unitRef="number">0.30</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i2538a02f3c984fcab3ed760d226d516f_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzE5OTA_bcfe8e2d-e053-409e-9f7f-f8e54efdb8a3"
      unitRef="number">0.65</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yMzgvZnJhZzo5OWU0NTc0OTVmOWI0N2ZlYmIyNzhiNjg1YzBhMzllZi90ZXh0cmVnaW9uOjk5ZTQ1NzQ5NWY5YjQ3ZmViYjI3OGI2ODVjMGEzOWVmXzIwMDU_933b900e-bb35-4303-b95b-d59636cb2e2f"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzUyMjg_95cb7664-dfb2-4068-ae67-522841c53853">Goodwill&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying value of goodwill by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary&lt;br/&gt;services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,287,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,787,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;609,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,919,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,400,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;646,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,046,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,400,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;772,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,172,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,400,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;646,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,046,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As dialysis treatments are an essential, life-sustaining service for patients who depend on them, the Company's operations have continued and are currently expected to continue throughout the novel coronavirus (COVID-19) pandemic. However, the ultimate impact of the dynamic and evolving COVID-19 pandemic on the Company will depend on future developments that are highly uncertain and difficult to predict, including among other things the severity and duration of the pandemic; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus such as the Delta and Omicron variants; COVID-19's impact for the chronic kidney disease (CKD) patient population and the Company's patient population including on the mortality of these patients; the availability, acceptance, impact and efficacy of COVID-19 vaccines, treatments, and therapies; the pandemic's continuing impact on the Company's revenue and non-acquired growth due to lower treatment volumes, the U.S. and global economies, unemployment, labor market conditions, inflation and monetary policies; the potential negative impact on the Company's commercial mix or the number of patients covered by commercial insurance plans; continued increased COVID-related costs; supply chain challenges and disruptions, including with respect to the Company's clinical supplies; the responses of the Company's competitors to the pandemic and related changes in the marketplace; the timing, scope and effectiveness of federal, state and local government responses; and any potential changes to the extensive set of federal, state and local laws, regulations and requirements that govern the Company's business. While the Company does not currently expect a material adverse impact to its business as a result of this public health crisis, there can be no assurance that the COVID-19 pandemic will not have a material adverse impact on one or more of the Company's businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each of the Company&#x2019;s operating segments described in Note 25 to these consolidated financial statements represents an individual reporting unit for goodwill impairment assessment purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Within the U.S. dialysis operating segment, the Company considers each of its dialysis centers to constitute an individual business for which discrete financial information is available. However, since these dialysis centers have similar operating and economic characteristics, and the allocation of resources and significant investment decisions concerning these businesses are highly centralized and the benefits broadly distributed, the Company has aggregated these centers and deemed them to constitute a single reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has applied a similar aggregation to the physician practices in its physician services reporting units, to the dialysis centers and other health operations within each international reporting unit, and to the vascular access service centers in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;its former vascular access services reporting unit. For the Company&#x2019;s other operating segments, discrete business components below the operating segment level constitute individual reporting units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When performing quantitative goodwill impairment assessments, the Company estimates fair value using either appraisals developed with an independent third party valuation firm which consider both discounted cash flow estimates for the subject business and observed market multiples for similar businesses, or offer prices received for the subject business that would be acceptable to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2019, the Company recognized goodwill impairment charges of $119,476 in its Germany kidney care business. These charges resulted primarily from a decline in then current and expected future patient census and an increase in then current and expected future costs, including due to wage increases expected to result from legislation announced at that time. The changes in the Company's expectations were informed by developments in the business in response to evolving market conditions, including changes in the Company's expected timing and ability to mitigate them, and based on in-depth operating and strategic reviews completed by the Company's new Germany management team. During the year ended December&#160;31, 2019 the Company also recognized a goodwill impairment charge of $5,416 in its German other health operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on its most recent assessments, the Company determined that further changes in expected patient census, increases in operating costs, failure to achieve expected increases in reimbursement rates, changes in actual or expected growth rates, or other significant adverse changes in expected future cash flows or valuation assumptions could result in goodwill impairment charges in the future for the following reporting unit, which remains at risk of goodwill impairment as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.923%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reporting unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;br/&gt;balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%"&gt;Carrying amount&lt;br/&gt;coverage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sensitivities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%"&gt;Discount&lt;br/&gt;rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Germany kidney care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;298,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excess of estimated fair value of the reporting unit over its carrying amount as of the latest assessment date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Potential impact on estimated fair value of a sustained, long-term reduction of 3% in operating income as of the latest assessment date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Potential impact on estimated fair value of an increase in discount rates of 100 basis points as of the latest assessment date.&lt;/span&gt;&lt;/div&gt;Except as described above, none of the Company&#x2019;s other reporting units were considered at risk of significant goodwill impairment as of December&#160;31, 2021.&#160;Since the dates of the Company&#x2019;s last annual goodwill impairment assessments, there have been certain developments, events, changes in operating performance and other changes in key circumstances that have affected the Company&#x2019;s businesses. However, these have not caused management to believe it is more likely than not that the fair values of any of the Company&#x2019;s reporting units would be less than their respective carrying amounts as of December&#160;31, 2021.</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzUyMzM_e955b353-580b-48b5-b5f4-80946907fd65">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying value of goodwill by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary&lt;br/&gt;services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,287,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,787,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;609,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,919,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,400,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;646,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,046,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,400,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;772,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,172,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,400,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;646,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,046,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i34e4090bf4484176976adbed8bae6da2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEtMS0xLTEtODMwNzg_7d6e94d2-de04-43b5-95c1-fd293a534df5"
      unitRef="usd">6287100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iee6f5fabba1c4c0b9cb21463c121a0ef_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEtMy0xLTEtODMwNzg_ed990b51-1c2e-4d07-b895-19372fe13275"
      unitRef="usd">500535000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEtNS0xLTEtODMwNzg_ffeb4784-3bdd-4e3b-b8a7-e8741fe9b087"
      unitRef="usd">6787635000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzItMS0xLTEtODMwNzg_63b58654-ca1d-4b29-a283-f76fe58f1cd6"
      unitRef="usd">24377000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzItMy0xLTEtODMwNzg_7c2d8b95-e57a-477b-9375-464984624e7a"
      unitRef="usd">105680000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzItNS0xLTEtODMwNzg_529b9437-b738-4eeb-abab-27228e41b54b"
      unitRef="usd">130057000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzMtMS0xLTEtMTA2ODk1_2703392e-7ba5-4c08-887c-7565b4f0a5ea"
      unitRef="usd">1549000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzMtMy0xLTEtMTA2ODk1_62f91d3c-12cf-45a2-8b5b-ba7384dffff6"
      unitRef="usd">6744000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzMtNS0xLTEtMTA2ODk1_a2fa6f8c-9587-430f-a8f9-e5fe44f2d134"
      unitRef="usd">8293000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzQtMS0xLTEtODMwNzg_77d02ab7-affe-4e89-b9f0-614d4947c9cd"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzQtMy0xLTEtODMwNzg_bd0e7aff-cfd3-46ed-9936-87599ec8f894"
      unitRef="usd">-9710000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzQtNS0xLTEtODMwNzg_6e4eefbd-b08a-46d5-b0ea-cd93d4df233a"
      unitRef="usd">-9710000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="icce7de8cdc8f44f5a250fb8c150e4e1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzUtMS0xLTEtODMwNzg_2ad60862-bd75-440e-a9f5-953ba707e9f6"
      unitRef="usd">6309928000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if8a66dcc0dd948fbb741fd4e292faf13_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzUtMy0xLTEtODMwNzg_734c293f-cd6e-4d04-8f92-fa4a771dedea"
      unitRef="usd">609181000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzUtNS0xLTEtODMwNzg_791d89ed-4165-46b4-8a63-0af84e4cecca"
      unitRef="usd">6919109000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzYtMS0xLTEtODMwNzg_c41e1d83-70ff-45e0-b8c2-ca8bf2758307"
      unitRef="usd">91979000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzYtMy0xLTEtODMwNzg_fe9ea5a2-5a3e-47a9-aa4c-6f75b728adba"
      unitRef="usd">81265000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzYtNS0xLTEtODMwNzg_4ebdc9f7-91b2-4caa-bd91-5e8d27f44732"
      unitRef="usd">173244000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzctMS0xLTEtODMwNzg_b72d4581-0491-4b21-b238-f0ad6bff463e"
      unitRef="usd">1745000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzctMy0xLTEtODMwNzg_b2363897-f680-44cc-bd06-0217aa4c3b6d"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzctNS0xLTEtODMwNzg_464913f6-d62a-4d8c-a7e7-a94022fc53db"
      unitRef="usd">1745000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzgtMS0xLTEtODMwNzg_86d073d5-d3f5-4301-b5f3-a477ae97e241"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzgtMy0xLTEtODMwNzg_933a37dd-6ac9-4343-a7c0-aab24389cfda"
      unitRef="usd">44367000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzgtNS0xLTEtODMwNzg_d0f1a089-70fb-455c-b003-cd585669ec67"
      unitRef="usd">44367000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzktMS0xLTEtODMwNzg_8d9a7711-ec35-4f1a-9cd1-3a2dcab938d6"
      unitRef="usd">6400162000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzktMy0xLTEtODMwNzg_ae11aba8-5691-4ae4-8cd5-90f608476c04"
      unitRef="usd">646079000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzktNS0xLTEtODMwNzg_4be77cde-e055-4a89-9f8f-fe74fd69f494"
      unitRef="usd">7046241000</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEyLTEtMS0xLTgzMDc4_76dd50e1-5a5b-4b76-a4e9-6bae9f5a9098"
      unitRef="usd">6400162000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEyLTMtMS0xLTgzMDc4_e75c41a7-c882-47cc-808d-eed96c25d02a"
      unitRef="usd">772286000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEyLTUtMS0xLTgzMDc4_a67a47e9-0354-4aaf-b57f-dc0149c4f3ea"
      unitRef="usd">7172448000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEzLTEtMS0xLTgzMDc4_0c2637d1-0219-4eda-a5cf-fa72d4c92dab"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEzLTMtMS0xLTgzMDc4_cfcdabfa-641c-475e-b87b-a859cd54f925"
      unitRef="usd">126207000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzEzLTUtMS0xLTgzMDc4_e275fecf-421d-4d23-a0a0-7e5eec6b50a6"
      unitRef="usd">126207000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzE0LTEtMS0xLTgzMDc4_7a54ab85-89db-4c32-9d06-9e2b940a2855"
      unitRef="usd">6400162000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzE0LTMtMS0xLTgzMDc4_0f4a2a72-c6f5-46f2-9f3b-0ebca567da23"
      unitRef="usd">646079000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZToyZmU4NTEwYjE1NmE0YWRiYjUxYjkxMDI0MGJkNzU0OS90YWJsZXJhbmdlOjJmZTg1MTBiMTU2YTRhZGJiNTFiOTEwMjQwYmQ3NTQ5XzE0LTUtMS0xLTgzMDc4_a46263c0-9d8b-4d45-85f6-49495616922e"
      unitRef="usd">7046241000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3967c55184a84f96ba8812e7748f5793_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzM1MTg0MzcyMDk3Mzg3_5b948f67-e29b-40e5-b48c-4f541e774dfe"
      unitRef="usd">119476000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i32b056464d244f37914b806833c01276_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzM1MTg0MzcyMDk3Mzkx_90017827-a74d-4df6-827c-9eaa86be9775"
      unitRef="usd">5416000</us-gaap:GoodwillImpairmentLoss>
    <dva:ScheduleOfReportingUnitsGoodwillBalancesTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzUyMzI_1f0c8d61-320a-43b4-b3a7-c4750886b9f3">&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.923%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reporting unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;br/&gt;balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%"&gt;Carrying amount&lt;br/&gt;coverage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sensitivities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%"&gt;Discount&lt;br/&gt;rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Germany kidney care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;298,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excess of estimated fair value of the reporting unit over its carrying amount as of the latest assessment date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Potential impact on estimated fair value of a sustained, long-term reduction of 3% in operating income as of the latest assessment date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Potential impact on estimated fair value of an increase in discount rates of 100 basis points as of the latest assessment date.&lt;/span&gt;&lt;/div&gt;</dva:ScheduleOfReportingUnitsGoodwillBalancesTextBlock>
    <us-gaap:Goodwill
      contextRef="i3c41f79e5ca947d0a2bcc3fd59da587b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZTowZjZhYTAxZTcwMDI0Zjk4OTZiNTA1YjMzM2RiYzIzYS90YWJsZXJhbmdlOjBmNmFhMDFlNzAwMjRmOTg5NmI1MDViMzMzZGJjMjNhXzItMi0xLTEtODMwNzg_4a8d8aff-426d-4389-b51d-818228325b6c"
      unitRef="usd">298499000</us-gaap:Goodwill>
    <dva:ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount
      contextRef="i3c41f79e5ca947d0a2bcc3fd59da587b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZTowZjZhYTAxZTcwMDI0Zjk4OTZiNTA1YjMzM2RiYzIzYS90YWJsZXJhbmdlOjBmNmFhMDFlNzAwMjRmOTg5NmI1MDViMzMzZGJjMjNhXzItNC0xLTEtODMwNzg_fa590760-8c03-4111-ad36-b24b9207a430"
      unitRef="number">0.066</dva:ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount>
    <dva:PotentialImpactOnFairValueForReductionInOperatingIncome
      contextRef="i3c41f79e5ca947d0a2bcc3fd59da587b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZTowZjZhYTAxZTcwMDI0Zjk4OTZiNTA1YjMzM2RiYzIzYS90YWJsZXJhbmdlOjBmNmFhMDFlNzAwMjRmOTg5NmI1MDViMzMzZGJjMjNhXzItNi0xLTEtODMwNzg_8208dba1-cf64-46d2-8e32-4f1f322a60aa"
      unitRef="number">0.017</dva:PotentialImpactOnFairValueForReductionInOperatingIncome>
    <dva:PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate
      contextRef="i5d14633c017d4293acaf92b67376ea7e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90YWJsZTowZjZhYTAxZTcwMDI0Zjk4OTZiNTA1YjMzM2RiYzIzYS90YWJsZXJhbmdlOjBmNmFhMDFlNzAwMjRmOTg5NmI1MDViMzMzZGJjMjNhXzItOC0xLTEtODMwNzg_abe547a3-f794-4380-915f-147820064b40"
      unitRef="number">0.094</dva:PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate>
    <dva:PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzQ0NjI_30eed767-45ad-4b16-bbea-66e5530c7bb1"
      unitRef="number">0.03</dva:PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i7b36f25a93464b258c27c7f22e113088_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNDQvZnJhZzpiODBlOWIzMGQ3ZjI0YWU4YTBlOTU4NWRmNjU5YWVjMi90ZXh0cmVnaW9uOmI4MGU5YjMwZDdmMjRhZThhMGU5NTg1ZGY2NTlhZWMyXzQ2NzQ_d0a799fe-e43a-41a6-92c3-fbb17cda5482"
      unitRef="segment">0</us-gaap:NumberOfOperatingSegments>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90ZXh0cmVnaW9uOjY0MGZmM2Y4NDdlYTRjOGY4ZmNiMmZiYzUxNDU5ZDI0Xzgw_3db12b93-b428-4264-81f7-07ff4b66ee5e">Other liabilities&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.520%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.898%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payor refunds and retractions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;410,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;371,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Insurance and self-insurance accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued non-income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;709,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;810,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherLiabilitiesTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90ZXh0cmVnaW9uOjY0MGZmM2Y4NDdlYTRjOGY4ZmNiMmZiYzUxNDU5ZDI0Xzgz_84b52b59-e1e1-40bd-afc4-2431e50a46cf">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.520%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.898%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payor refunds and retractions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;410,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;371,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Insurance and self-insurance accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued non-income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;709,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;810,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesTableTextBlock>
    <dva:PayorRefundsAndRetractions
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzItMS0xLTEtODMwNzg_f331d2a8-1f29-426a-ade7-528d71e32e9f"
      unitRef="usd">410038000</dva:PayorRefundsAndRetractions>
    <dva:PayorRefundsAndRetractions
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzItMy0xLTEtODMwNzg_f006fcbc-9a13-453e-9cdc-2098d6e5c0d6"
      unitRef="usd">371183000</dva:PayorRefundsAndRetractions>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzMtMS0xLTEtODMwNzg_3f8a9fa4-e660-4e37-8594-a26e0f15a9ad"
      unitRef="usd">55548000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzMtMy0xLTEtODMwNzg_2a2af002-30e5-48d5-9641-8bcd2fa29e23"
      unitRef="usd">54438000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzQtMS0xLTEtODMwNzg_99262dcd-c2a9-4bc2-90b3-0dd5305895e2"
      unitRef="usd">32926000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzQtMy0xLTEtODMwNzg_b6f23bb1-e8cb-4c08-a224-16fac6d074b0"
      unitRef="usd">30066000</us-gaap:InterestPayableCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzUtMS0xLTEtODMwNzg_67f1fa78-b9c4-4ee8-919f-441e358dfc0c"
      unitRef="usd">41784000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzUtMy0xLTEtODMwNzg_b6a6f0e2-51b5-410b-9c64-031fb5ea8857"
      unitRef="usd">39075000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzYtMS0xLTEtODMwNzg_48821acc-f191-4174-a3ab-06f922b5377c"
      unitRef="usd">169049000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzYtMy0xLTEtODMwNzg_9c8e08d5-e8cf-47b1-9a50-1e727528f7ec"
      unitRef="usd">315767000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzctMS0xLTEtODMwNzg_7fe80e36-c9d0-4b1f-b6b9-9fab16c7ba01"
      unitRef="usd">709345000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTAvZnJhZzo2NDBmZjNmODQ3ZWE0YzhmOGZjYjJmYmM1MTQ1OWQyNC90YWJsZTowZWE2MjIxNjRmNDI0MTQzOTZjOTQ5OWQ1ZWZmMzlkYS90YWJsZXJhbmdlOjBlYTYyMjE2NGY0MjQxNDM5NmM5NDk5ZDVlZmYzOWRhXzctMy0xLTEtODMwNzg_79e1ade8-ece5-4121-89df-ebc2b07beb63"
      unitRef="usd">810529000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0NTI_a0beee6a-1755-49f5-a550-b7ab8de494da">Income taxesThe Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes from continuing operations consisted of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,463,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,287,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,307,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(111,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,518,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,318,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,195,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Income tax expense for continuing operations consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;216,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;246,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;313,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are allocated between continuing and discontinued operations as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;313,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation between the Company&#x2019;s effective tax rate from continuing operations and the U.S. federal income tax rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.532%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal and international tax rate adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Political advocacy costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in international valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of noncontrolling interests primarily&lt;br/&gt;&#160;attributable to non-tax paying entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities arising from temporary differences for continuing operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;581,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;584,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;873,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;888,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(100,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(114,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;772,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;773,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(644,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(634,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(283,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(274,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(530,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(532,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(101,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,580,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,583,246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(808,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(809,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(830,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(809,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (included in Other long-term assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 25.75pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(808,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(809,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021, the Company had federal net operating loss carryforwards of approximately $85,391 that expire through 2036, although a substantial amount expire by 2029. The Company also had state net operating loss carryforwards of $554,806, some of which have an indefinite life, although a substantial amount expire by 2041 and international net operating loss carryforwards of $291,927, some of which will begin to expire in 2022 though the majority have an indefinite life. The Company has a state capital loss carryover of $313,722, the majority of which expires in 2024. The utilization of a portion of these losses may be limited in future years based on the profitability of certain entities. A valuation allowance is recorded to account for the unrealizable balances in the table above. The net decrease of $14,208 in the valuation allowance is primarily due to the release of the valuation allowance on indefinite life net operating losses in jurisdictions where the Company has generated sufficient income to support their future utilization, partially offset by newly created net operating loss carryforwards in state and foreign jurisdictions that the Company does not anticipate being able to utilize. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the year ended December&#160;31, 2021, the Company recorded a true-up to recognize net deferred tax assets related to historical purchases of noncontrolling interests in consolidated partnerships. The effect of this adjustment was an increase of $46,692 to net deferred tax assets, a charge of $16,044 to income tax expense, and an increase of $62,736 to additional paid-in capital. The Company&#x2019;s prior purchases of this type have not generated significant pre-tax adjustments to additional paid-in capital in any single prior year. The majority of the $16,044 recorded to income tax expense was due to the decrease in the corporate tax rate in 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company's foreign earnings continue to be indefinitely reinvested as of December&#160;31, 2021. As a result of the passage of the Tax Cuts and Jobs Act (2017 Tax Act), the Company does not expect such earnings to be taxable if remitted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending liability for unrecognized tax benefits that do not meet the more-likely-than-not threshold is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions for tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions for tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reductions related to lapse of applicable statute&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reductions related to settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company&#x2019;s total liability for unrecognized tax benefits relating to tax positions that do not meet the more-likely-than-not threshold is $73,024, of which $68,708 would impact the Company&#x2019;s effective tax rate if recognized and $42,860 is classified as a current tax liability related to settlements expected to be paid in 2022. This balance represents an increase of $2,822 from the December&#160;31, 2020 balance of $70,202. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. At December&#160;31, 2021 and 2020, the Company had approximately $15,275 and $17,864, respectively, accrued for interest and penalties related to unrecognized tax benefits, net of federal tax benefit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its subsidiaries file U.S. federal and state income tax returns and various foreign income tax returns. The Company is no longer subject to U.S. federal and state examinations by tax authorities for years before 2014 and 2009, respectively. In addition to being under audit in various state and local tax jurisdictions, the Company&#x2019;s federal tax returns are under audit by the Internal Revenue Service for the years 2014-2017.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0NDI_064b0bf7-1fc3-45ee-8af5-618a344a39ed">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes from continuing operations consisted of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,463,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,287,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,307,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(111,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,518,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,318,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,195,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzItMS0xLTEtODMwNzg_15ab07ed-e7e2-4d47-89f1-fbd34070ae98"
      unitRef="usd">1463029000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzItMy0xLTEtODMwNzg_7d2c695d-0948-4134-95d5-ee156c8a435b"
      unitRef="usd">1287976000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzItNS0xLTEtODMwNzg_5875ad03-df69-456b-a7a2-3ebc8fb0b4c4"
      unitRef="usd">1307299000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzMtMS0xLTEtODMwNzg_eeb20512-8789-4e49-a8eb-7db7e75680ec"
      unitRef="usd">55465000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzMtMy0xLTEtODMwNzg_c44838ee-4138-460f-9de3-7cf3a269d1ad"
      unitRef="usd">30286000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzMtNS0xLTEtODMwNzg_d2a6eaee-a138-4f39-8a0f-4df4a4385272"
      unitRef="usd">-111860000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzQtMS0xLTEtODMwNzg_0a1be34b-034a-4967-9344-375727183670"
      unitRef="usd">1518494000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzQtMy0xLTEtODMwNzg_835537fd-d6b2-44d2-8d9b-1515f2625e7d"
      unitRef="usd">1318262000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTo2MDUyNjE0ZTAyM2I0YTE0YTU5ODBiZDU3MTE1ZDVlMS90YWJsZXJhbmdlOjYwNTI2MTRlMDIzYjRhMTRhNTk4MGJkNTcxMTVkNWUxXzQtNS0xLTEtODMwNzg_7c3ca3ab-8fdc-4e04-92c2-1798973a6075"
      unitRef="usd">1195439000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0NDM_3eee3613-d14b-41cf-b6b0-394d22986aef">Income tax expense for continuing operations consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;216,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;246,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;313,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzMtMS0xLTEtODMwNzg_ae67e680-6bc4-414d-9e56-25a1ffda78d9"
      unitRef="usd">216539000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzMtMy0xLTEtODMwNzg_de2e3beb-84b7-4a48-bcf9-b5cc1aa59a25"
      unitRef="usd">47171000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzMtNS0xLTEtODMwNzg_ecbee32f-d3bc-48be-96ad-d6588af615cb"
      unitRef="usd">208339000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzQtMS0xLTEtODMwNzg_e9fcb0ca-2fce-4cf2-b7d5-c9ba640a7567"
      unitRef="usd">15601000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzQtMy0xLTEtODMwNzg_3625354b-7e11-47cc-bd66-8f9541a45847"
      unitRef="usd">21442000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzQtNS0xLTEtODMwNzg_ed2b7a00-c4d7-49c8-96b3-9ee259e09ea1"
      unitRef="usd">58026000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzUtMS0xLTEtODMwNzg_1a3116bd-d473-4508-95de-43b1662e2465"
      unitRef="usd">14247000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzUtMy0xLTEtODMwNzg_9c299f1d-c365-481d-a99f-029da444e4c3"
      unitRef="usd">17481000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzUtNS0xLTEtODMwNzg_0279951a-7c42-4f7a-8e56-47f4ffde4ceb"
      unitRef="usd">15545000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzYtMS0xLTEtODMwNzg_f2b048fe-33b8-46af-8749-9a6f2a491c39"
      unitRef="usd">246387000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzYtMy0xLTEtODMwNzg_3218bbe3-cc60-4920-a689-794af25eb836"
      unitRef="usd">86094000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzYtNS0xLTEtODMwNzg_aafd3f41-1c4c-49a6-9bf6-d6542ce286ea"
      unitRef="usd">281910000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzgtMS0xLTEtODMwNzg_f37c5925-f5e6-458b-88a7-b9263ba9e098"
      unitRef="usd">59528000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzgtMy0xLTEtODMwNzg_774dd206-2e23-4544-971a-3d2839077060"
      unitRef="usd">198623000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzgtNS0xLTEtODMwNzg_92cd14db-cb02-4c32-8571-3aa867c38f74"
      unitRef="usd">44263000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzktMS0xLTEtODMwNzg_df485cba-f0cf-4e17-a63b-65eb8f96a494"
      unitRef="usd">5342000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzktMy0xLTEtODMwNzg_3be759b5-8ed7-4a31-86dd-ad64b1219cd4"
      unitRef="usd">27206000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzktNS0xLTEtODMwNzg_d4bf3d8e-aacb-4c75-be14-06394d3454a3"
      unitRef="usd">-25836000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzEwLTEtMS0xLTgzMDc4_5e700173-5257-4b80-8456-69ef2f2056b3"
      unitRef="usd">-4525000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzEwLTMtMS0xLTgzMDc4_3286ae5a-90ef-4931-87e4-a452ae2c7dd4"
      unitRef="usd">2009000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzEwLTUtMS0xLTgzMDc4_9aea5afb-b06e-48f2-b8ff-1765a273b966"
      unitRef="usd">-20709000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzExLTEtMS0xLTgzMDc4_1d4527de-a4c8-4eeb-888a-55cbcc60f4d3"
      unitRef="usd">60345000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzExLTMtMS0xLTgzMDc4_2b3b70da-4273-455b-95a8-fbadd454fa0b"
      unitRef="usd">227838000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzExLTUtMS0xLTgzMDc4_adb51fb6-24b4-46b1-bca5-b7f1f57590ab"
      unitRef="usd">-2282000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzEyLTEtMS0xLTgzMDc4_680c0897-1dce-4afa-9967-ab27b1795144"
      unitRef="usd">306732000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzEyLTMtMS0xLTgzMDc4_5fec00dc-5993-4a81-9954-8bdb3472bec9"
      unitRef="usd">313932000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToxNDBiOGRhYThhNzk0NDk3YjVhMGExZDQ2ZTk1MmYzNC90YWJsZXJhbmdlOjE0MGI4ZGFhOGE3OTQ0OTdiNWEwYTFkNDZlOTUyZjM0XzEyLTUtMS0xLTgzMDc4_d4dd3b63-28d8-4fd4-9938-90379da4e0d9"
      unitRef="usd">279628000</us-gaap:IncomeTaxExpenseBenefit>
    <dva:ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0NjQ_ebaa5a81-8dcb-4538-a930-6d84f482f18f">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are allocated between continuing and discontinued operations as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;313,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzItMS0xLTEtODMwNzg_c4ef89ab-fb7d-4ef8-bc14-d7d3c4177174"
      unitRef="usd">306732000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzItMy0xLTEtODMwNzg_12147c66-102c-4fcd-b1bf-b80adbb5ffcb"
      unitRef="usd">313932000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzItNS0xLTEtODMwNzg_5497504f-d714-4907-98a9-96b2a5672bc8"
      unitRef="usd">279628000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzMtMS0xLTEtODMwNzg_56a46e27-8458-47ba-b302-7de5d9700463"
      unitRef="usd">0</us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod>
    <us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzMtMy0xLTEtODMwNzg_393d9b78-b010-4918-9add-3a79c5b82948"
      unitRef="usd">1657000</us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod>
    <us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzMtNS0xLTEtODMwNzg_8799f5a0-6ee3-40f0-957f-84291aef4441"
      unitRef="usd">40689000</us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzQtMS0xLTEtODMwNzg_2827222c-5012-4e6e-bfe8-ef92c3a02ee3"
      unitRef="usd">306732000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzQtMy0xLTEtODMwNzg_1118899c-0d48-438b-af20-b78e7b56a415"
      unitRef="usd">315589000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpmZDI2NTRmMDZiNTA0OWU3YTZhNjkwYmM5MzMyZTkxMS90YWJsZXJhbmdlOmZkMjY1NGYwNmI1MDQ5ZTdhNmE2OTBiYzkzMzJlOTExXzQtNS0xLTEtODMwNzg_fd21af73-981c-48ae-85b0-c34d86b9895b"
      unitRef="usd">320317000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0Mzk_6526433e-4b77-40ef-86f9-28f9e6800d00">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation between the Company&#x2019;s effective tax rate from continuing operations and the U.S. federal income tax rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.532%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal and international tax rate adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Political advocacy costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in international valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of noncontrolling interests primarily&lt;br/&gt;&#160;attributable to non-tax paying entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzItMS0xLTEtODMwNzg_21a0684c-2353-4ab9-aa47-125a197ce636"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzItMy0xLTEtODMwNzg_a931f3bf-474f-4001-a018-c97f7633d610"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzItNS0xLTEtODMwNzg_44723ad2-f831-442f-9131-c3b38edad6c3"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzMtMS0xLTEtODMwNzg_45a8c371-3b6e-4d96-a1c8-814c236723f8"
      unitRef="number">0.030</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzMtMy0xLTEtODMwNzg_843a9d27-8cd1-4912-aecd-4ab6fc3f3dc3"
      unitRef="number">0.034</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzMtNS0xLTEtODMwNzg_09ebfaf1-e4e3-4422-a403-01ad7a829b15"
      unitRef="number">0.023</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtMS0xLTEtMTYzNjQ3_33144a99-e678-4a5d-b106-5e52f444427b"
      unitRef="number">-0.024</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtMy0xLTEtMTYzNjQ3_c93c540e-4d8c-408d-a3fd-ad2a30c9118d"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtNS0xLTEtMTYzNjQ3_22fc3fb4-3ce5-4ea4-b4f0-3da4ee42dd2f"
      unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtMS0xLTEtMTYxNzg4_4482a734-5d86-46e5-9723-6f490a0360a1"
      unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtMy0xLTEtMTYxNzg4_d56d73d6-ba22-4943-a78c-20fb6eabd958"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtNS0xLTEtMTYxNzg4_563a9a88-33fd-4d89-98e5-d4a612939cd1"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <dva:EffectiveIncomeTaxReconciliationInvestmentImpairment
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzUtMS0xLTEtMTYxODAw_d715c2ee-34a9-4cd3-b85c-bc9ea290cd7f"
      unitRef="number">0.008</dva:EffectiveIncomeTaxReconciliationInvestmentImpairment>
    <dva:EffectiveIncomeTaxReconciliationInvestmentImpairment
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzUtMy0xLTEtMTYxODAw_24144686-2a0a-4fed-8710-5c6baa7f8a4a"
      unitRef="number">0.012</dva:EffectiveIncomeTaxReconciliationInvestmentImpairment>
    <dva:EffectiveIncomeTaxReconciliationInvestmentImpairment
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzUtNS0xLTEtMTYxODAw_e1f2d529-87fb-4592-97ed-aec8f226bcd3"
      unitRef="number">0.008</dva:EffectiveIncomeTaxReconciliationInvestmentImpairment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzYtMS0xLTEtMTYxODA3_eaea73f4-94c9-43e5-9d8b-4db986cc07e0"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzYtMy0xLTEtMTYxODA3_6b2eb64e-0545-4b9d-a068-fc41781d93a8"
      unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzYtNS0xLTEtMTYxODA3_927279c3-2825-4b51-b75c-aa5c6e5d295b"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtMS0xLTEtODMwNzg_594dd676-f7b2-4b0c-b5b3-b5b7383748f9"
      unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtMy0xLTEtODMwNzg_fe312e5d-7eb3-407a-ac91-7d1b395a470c"
      unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzQtNS0xLTEtODMwNzg_011d08a7-fad5-40f7-a889-4923be502bf0"
      unitRef="number">0.024</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzctMS0xLTEtODMwNzg_8401e624-3820-436d-9aff-edb9f2646202"
      unitRef="number">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzctMy0xLTEtODMwNzg_c48a0fdb-ea32-4f2c-8deb-67c2ce00931e"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzctNS0xLTEtODMwNzg_019aaa3f-29d3-4cca-a687-dab4f1614b93"
      unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzExLTEtMS0xLTE2MjIwMw_e79fcaae-a11b-402d-bff2-41ccecc0bb96"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzExLTMtMS0xLTE2MjIwMw_b7c99892-8bff-4152-b100-b2b8966e43f6"
      unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzExLTUtMS0xLTE2MjIwMw_4d721aa0-c792-4fe6-94ce-9f69e84254c6"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzEwLTEtMS0xLTgzMDc4_a21a976a-c2ab-40e3-8568-91d56a635cab"
      unitRef="number">-0.036</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzEwLTMtMS0xLTgzMDc4_54a5c4a7-f075-4a85-9e72-5d8d44dcc5be"
      unitRef="number">-0.048</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzEwLTUtMS0xLTgzMDc4_382e5ad8-3630-4648-b67d-0200a2a776a8"
      unitRef="number">-0.049</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzExLTEtMS0xLTgzMDc4_c0672cf7-4072-4d98-8c0b-e6608f881489"
      unitRef="number">0.202</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzExLTMtMS0xLTgzMDc4_23cfa83d-41bb-4cd6-96dd-5f2e2a8965cf"
      unitRef="number">0.238</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZToyOTA1ZmJhMTY4NGM0MzZiYTRmZDI3MmRhMjg1OTI3MS90YWJsZXJhbmdlOjI5MDVmYmExNjg0YzQzNmJhNGZkMjcyZGEyODU5MjcxXzExLTUtMS0xLTgzMDc4_f3f54716-4593-4d97-92be-0fbc55420789"
      unitRef="number">0.234</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0Njc_1053e4d5-6f3e-4767-b061-1665adf64457">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities arising from temporary differences for continuing operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;581,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;584,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;873,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;888,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(100,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(114,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;772,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;773,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(644,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(634,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(283,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(274,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(530,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(532,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(101,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,580,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,583,246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(808,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(809,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(830,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(809,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (included in Other long-term assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 25.75pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(808,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(809,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <dva:DeferredTaxAssetsReceivables
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzItMS0xLTEtODMwNzg_0582ff52-2800-4943-8a5b-62e90fb3cd61"
      unitRef="usd">8430000</dva:DeferredTaxAssetsReceivables>
    <dva:DeferredTaxAssetsReceivables
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzItMy0xLTEtODMwNzg_68949269-756d-4a1f-ac3f-404bec43fb41"
      unitRef="usd">9324000</dva:DeferredTaxAssetsReceivables>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzMtMS0xLTEtODMwNzg_425c1795-a4fa-4030-abb1-50aa07e41ec0"
      unitRef="usd">67993000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzMtMy0xLTEtODMwNzg_189fade9-fc77-4e23-b779-ac070808e189"
      unitRef="usd">64982000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <dva:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzQtMS0xLTEtODMwNzg_ee29e215-e1b3-4143-aece-1b4348bfad14"
      unitRef="usd">581199000</dva:DeferredTaxAssetsOperatingLeaseLiabilities>
    <dva:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzQtMy0xLTEtODMwNzg_f144f03d-c007-4cf5-8380-a353f53460db"
      unitRef="usd">584656000</dva:DeferredTaxAssetsOperatingLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzUtMS0xLTEtODMwNzg_3abdf742-4e8c-42d1-913c-84338ca9af90"
      unitRef="usd">162987000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzUtMy0xLTEtODMwNzg_ecfc70c2-8ebf-4f22-96e0-e9dd76f14702"
      unitRef="usd">167398000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzYtMS0xLTEtODMwNzg_27e64a6f-c073-40bc-a317-153c0e340614"
      unitRef="usd">52434000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzYtMy0xLTEtODMwNzg_ff638296-b6b1-4679-8a6e-483e5854c300"
      unitRef="usd">62110000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzctMS0xLTEtODMwNzg_c6d28418-19c1-4213-89b3-9ee446a5ccc6"
      unitRef="usd">873043000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzctMy0xLTEtODMwNzg_b0ef7340-7b2b-487d-9d0d-387724426439"
      unitRef="usd">888470000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzgtMS0xLTEtODMwNzg_43cd46bb-db71-4de8-9b24-364460bd3a05"
      unitRef="usd">100616000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzgtMy0xLTEtODMwNzg_a8af7dfa-9419-4417-b31e-651f4cb99cc3"
      unitRef="usd">114824000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzktMS0xLTEtODMwNzg_5cd41dae-a47c-4b3d-99c3-f72081a7cea7"
      unitRef="usd">772427000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzktMy0xLTEtODMwNzg_55c4aee8-97e2-4ee3-b300-3d953dba583f"
      unitRef="usd">773646000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzEwLTEtMS0xLTgzMDc4_c3865dc2-d012-4633-94d0-0c1f16504e2e"
      unitRef="usd">644039000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzEwLTMtMS0xLTgzMDc4_39a93411-865b-4abd-8197-642e84c98adc"
      unitRef="usd">634736000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzExLTEtMS0xLTgzMDc4_09144597-fed6-4c1c-8b1a-a6dc35073e8a"
      unitRef="usd">283913000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzExLTMtMS0xLTgzMDc4_0432aeed-91e7-488f-b1e4-2d613854a5d1"
      unitRef="usd">274742000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <dva:DeferredTaxLiabilitiesOperatingLeaseAssets
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzEyLTEtMS0xLTgzMDc4_25a9ca62-c6cf-4b5b-a0e8-7fa0738e5cc4"
      unitRef="usd">530839000</dva:DeferredTaxLiabilitiesOperatingLeaseAssets>
    <dva:DeferredTaxLiabilitiesOperatingLeaseAssets
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzEyLTMtMS0xLTgzMDc4_a324d117-5fc8-4664-b3f3-f5d33f44fc7f"
      unitRef="usd">532082000</dva:DeferredTaxLiabilitiesOperatingLeaseAssets>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzEzLTEtMS0xLTgzMDc4_dbbf3fa5-c713-4078-8f77-4eb48880732d"
      unitRef="usd">84407000</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzEzLTMtMS0xLTgzMDc4_713109e9-7cc9-4d70-8cd0-98f0f91d9e1e"
      unitRef="usd">101996000</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE0LTEtMS0xLTgzMDc4_a806395e-43b8-4e23-a9d8-3bcb3d715ce4"
      unitRef="usd">37274000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE0LTMtMS0xLTgzMDc4_4676352a-7868-404e-b1ca-83a7141785a6"
      unitRef="usd">39690000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE1LTEtMS0xLTgzMDc4_61d12a7a-ade3-4d98-b0f2-9cdc48864268"
      unitRef="usd">1580472000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE1LTMtMS0xLTgzMDc4_bb9b8628-4ba4-40a3-ab3d-997077fe4160"
      unitRef="usd">1583246000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE2LTEtMS0xLTgzMDc4_1d84eb33-eb35-4c5e-ad40-7a8b8aaedeb3"
      unitRef="usd">808045000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE2LTMtMS0xLTgzMDc4_f3a4327d-84b3-4a0a-b3cc-ebd17fa12a00"
      unitRef="usd">809600000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i70ab78105894454bb3a4d66a58c9ce87_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE4LTEtMS0xLTE1Njk0Mw_9b2ecbfc-3fad-446f-b585-ac6680449b1e"
      unitRef="usd">830954000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ib4bdcb9f103f4aaeb04d4e05c9d4ad58_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE4LTMtMS0xLTE1Njk0Mw_c2eaba27-1364-4e28-9361-3144ad7868eb"
      unitRef="usd">809600000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="id251067d050c44fe8c0736b4e398bced_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE5LTEtMS0xLTE1Njk0Mw_e0039fb1-6389-4692-966d-76d43c86ada2"
      unitRef="usd">22909000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="iec2c1892554643868b5366813ed68ed8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzE5LTMtMS0xLTE1Njk0Mw_03edfb73-2f59-42c3-8bc7-e5cd4e8d617c"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzIwLTEtMS0xLTE1Njk0Mw_a0060309-ed1b-4891-a995-bb6bd0c1f0c7"
      unitRef="usd">808045000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTowMmUwZjUzZjc1MzI0ZWRkYjgwOTA5Y2UzYmFmMGQ4Zi90YWJsZXJhbmdlOjAyZTBmNTNmNzUzMjRlZGRiODA5MDljZTNiYWYwZDhmXzIwLTMtMS0xLTE1Njk0Mw_1069fcec-c937-425b-a310-95308bd9d798"
      unitRef="usd">809600000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i83a7731ed6494f868aa4389a7de35e85_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzExNDQ_7438fabd-0e98-4ca0-a3f9-689d727bedbc"
      unitRef="usd">85391000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="if9d939dcfcda400d965c56313d937123_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzEyNzg_efa811ce-edb4-400c-b96f-113a431feb8a"
      unitRef="usd">554806000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i9046f56523ce431bbd0d602da2e2fead_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzE0MTg_38795815-8459-4374-b99c-a5270ed4c175"
      unitRef="usd">291927000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i3eda909ed98c425386284bc3c9809bd2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzE1NTg_803ebcaa-ad42-44dc-82ac-10cf2500d0ac"
      unitRef="usd">313722000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i600487b6cfcc42429d3cde02ae5b6e4c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzE4MzI_931bfe59-4624-4e40-bd41-d477c0b91b4e"
      unitRef="usd">-14208000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i5c646949f7af4e90ac555e2e74c3848f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzc2OTY1ODE0MDIyOTQ_03d309cf-217f-4788-ba74-8cba799fa3a2"
      unitRef="usd">46692000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5c646949f7af4e90ac555e2e74c3848f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzc2OTY1ODE0MDIzMzg_709a9f58-adb4-4989-a3a4-09fb2000b3d0"
      unitRef="usd">16044000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i5c646949f7af4e90ac555e2e74c3848f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzc2OTY1ODE0MDIzODQ_9e2ec84e-df8a-45dc-9366-af484877423a"
      unitRef="usd">62736000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5c646949f7af4e90ac555e2e74c3848f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzc2OTY1ODE0MDI1ODk_d2db89f7-b70f-406e-aa62-d5d7ea7e1cea"
      unitRef="usd">16044000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzM0NDg_4b34c3c7-1ab7-4808-90cb-3d953ffc69e9">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending liability for unrecognized tax benefits that do not meet the more-likely-than-not threshold is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions for tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions for tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reductions related to lapse of applicable statute&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reductions related to settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzItMS0xLTEtODMwNzg_50caaf52-f4d7-4933-a38a-07f56983a06e"
      unitRef="usd">70202000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzItMy0xLTEtODMwNzg_82f1a7ef-b2ab-4f2a-8f91-bc4fd6af497e"
      unitRef="usd">68214000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzMtMS0xLTEtODMwNzg_23eb2259-808a-4a9c-9ca4-dfe5be29664e"
      unitRef="usd">3335000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzMtMy0xLTEtODMwNzg_ade8039e-f40b-46f7-80eb-35d7b681246a"
      unitRef="usd">2293000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzQtMS0xLTEtODMwNzg_8af575d4-c1d6-4a30-8e9e-d991ef2688db"
      unitRef="usd">22616000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzQtMy0xLTEtODMwNzg_b467d6b9-a6d2-4d21-be9c-3b7a1dff2db1"
      unitRef="usd">258000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzUtMS0xLTEtODMwNzg_6c1b4f25-6cf4-4646-aa26-4e14a8fab492"
      unitRef="usd">751000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzUtMy0xLTEtODMwNzg_78a5fbc8-a630-454e-b8c3-4541f68d5199"
      unitRef="usd">133000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzYtMS0xLTEtODMwNzg_c7dd36ff-7682-4c0b-ac9c-aa986f6665fc"
      unitRef="usd">22378000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzYtMy0xLTEtODMwNzg_e659574d-cda2-48cc-b7ac-2a8cf24143b4"
      unitRef="usd">430000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzctMS0xLTEtODMwNzg_8272dc49-8bbf-4b5d-889a-c328ba36e198"
      unitRef="usd">73024000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90YWJsZTpiMmNlNDRhMzRjNDE0OWEyYmMwYjQ0ZWVhNGVlODZlMy90YWJsZXJhbmdlOmIyY2U0NGEzNGM0MTQ5YTJiYzBiNDRlZWE0ZWU4NmUzXzctMy0xLTEtODMwNzg_50caaf52-f4d7-4933-a38a-07f56983a06e"
      unitRef="usd">70202000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzI1NzY_e4524fdb-0d16-44fc-809c-55311c1b7e48"
      unitRef="usd">73024000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzI1ODk_a0d6b9cb-3898-4149-976e-114775d7b085"
      unitRef="usd">68708000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i0110ff4724f848ca85d3284f225e5fb5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzcxNDY4MjU1ODkyMDU_c8112383-8074-489b-aafd-2febdf965324"
      unitRef="usd">42860000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzI2ODM_cc8457ef-bb9f-47d8-9ea1-f2805fd1c4cc"
      unitRef="usd">2822000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzI3MDk_acccce0f-acad-4a63-b5f4-5c8985d57c0d"
      unitRef="usd">70202000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzI4NzE_331ba000-2847-4320-bbbb-2b57f7539bbe"
      unitRef="usd">15275000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTMvZnJhZzoyOTdmNjJjYzk5NmU0Nzk1YTdiZjJhYzg1ZmE5NDI3ZC90ZXh0cmVnaW9uOjI5N2Y2MmNjOTk2ZTQ3OTVhN2JmMmFjODVmYTk0MjdkXzI4Nzg_2f7c945e-7135-4d23-bd15-574b28b9f2be"
      unitRef="usd">17864000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMzIx_29cf26f9-68f2-40fc-8286-02c6094bfab3">Long-term debt&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt was comprised of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term Loan A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,596,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,684,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,600,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term Loan B-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,688,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,715,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8/12/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,681,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.625% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/1/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,822,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.75% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2/15/2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,464,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition obligations and other notes&lt;br/&gt; payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;164,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022-2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022-2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,964,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,163,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount and deferred financing costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(56,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,908,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,085,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(179,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(168,541)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,729,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,917,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented here approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of December&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $4,473 and deferred financing costs of $27,207 and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $40,914 and increased by a debt premium of $15,909. As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $5,461 and deferred financing costs of $35,825, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $36,431.&lt;/span&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMzIz_f372c8de-27bf-4e2c-9471-38b4ce92b9bf">Long-term debt&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt was comprised of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term Loan A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,596,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,684,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,600,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term Loan B-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,688,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,715,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8/12/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,681,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LIBOR + 1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.625% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/1/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,822,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.75% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2/15/2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,464,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition obligations and other notes&lt;br/&gt; payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;164,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022-2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022-2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,964,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,163,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount and deferred financing costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(56,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,908,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,085,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(179,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(168,541)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,729,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,917,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented here approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and LIBOR interest rate components in effect as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding. The term of one ground lease runs to 2070, in addition to the other lease maturity dates presented in the table above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of December&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $4,473 and deferred financing costs of $27,207 and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $40,914 and increased by a debt premium of $15,909. As of December&#160;31, 2020, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $5,461 and deferred financing costs of $35,825, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $36,431.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scheduled maturities of long-term debt at December&#160;31, 2021 were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.274%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,424,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,625,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,449,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, the Company made regularly scheduled mandatory principal payments under its senior secured credit facilities totaling $87,500 on Term Loan A and $27,431 on Term Loan B-1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 26, 2021, the Company completed an unregistered add-on offering of $1,000,000 aggregate principal amount to the existing 4.625% senior notes due June&#160;1, 2030 (the Additional 2030 Notes) pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The Additional 2030 Notes were issued at an offering price of 101.750% of face amount, plus an interest payment advance to the Company for interest that would have accrued from December 1, 2020 (the last interest payment date) through the closing date, and began bearing full six months' semi-annual coupon interest payments as of June 1, 2021. The terms of the Additional 2030 Notes, other than their issue date, offering price and first interest payment date, are identical to the terms of the $1,750,000 principal amount of the Company&#x2019;s 4.625% senior notes due June 1, 2030 previously issued by the Company on June 9, 2020. The Additional 2030 Notes are unsecured senior obligations and rank equally in right of payment with the Company's existing and future unsecured senior indebtedness. During the year ended December&#160;31, 2021 the Company incurred $9,091 in fees and other professional expenses associated with this transaction, which were capitalized and will amortize over the term of the Additional 2030 Notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company's 2019 interest rate cap agreements have the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on specific portions of the Company's floating rate debt, including all of Term Loan B-1 and a portion of Term Loan A. The remaining $785,138 outstanding principal balance of Term Loan A is subject to LIBOR-based interest rate volatility. The cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date. These cap agreements do not contain credit-risk contingent features.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s interest rate cap agreements outstanding as of December&#160;31, 2021 and December&#160;31, 2020, which are classified in other long-term assets on its consolidated balance sheet:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;LIBOR maximum rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiration date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recorded OCI gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019 interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of the Company&#x2019;s interest rate cap agreements for the years ended December&#160;31, 2021, 2020 and 2019:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount of unrealized gains (losses) in OCI on interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Location of losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reclassification from accumulated other comprehensive income into net income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 20 for further details on amounts recorded and reclassified from accumulated other comprehensive (loss) income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s weighted average effective interest rate on its senior secured credit facilities at the end of 2021 was 2.18%, based upon the current margins in effect for its senior secured credit facilities as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s weighted average effective interest rate on all debt, including the effect of interest rate caps and amortization of debt discount, was 3.28% for the year ended December&#160;31, 2021 and 3.35% as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company&#x2019;s interest rates were fixed on approximately 51.6% of its total debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had an undrawn $1,000,000 revolving line of credit under its senior secured credit facilities. Credit available under this revolving line of credit is reduced by the amount of any letters of credit outstanding thereunder, of which there were none as of December&#160;31, 2021. The Company also had approximately $69,277 of outstanding letters of credit under a separate bilateral secured letter of credit facility as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt expense consisted of interest expense of $267,049, $282,932 and $419,639 and the amortization and accretion of debt discounts and premiums, amortization of deferred financing costs and the amortization of interest rate cap agreements of $18,205, $21,179 and $24,185 for 2021, 2020 and 2019, respectively. These interest expense amounts are net of capitalized interest.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:SecuredDebt
      contextRef="i1db4cfcf189544c5ae3f2c2607ab9bf3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzMtMS0xLTEtODMwNzg_3aad132e-6ff1-4259-8339-735bc30cf710"
      unitRef="usd">1596875000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i0e9bc16804444b71ac99a4f60e9d5c12_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzMtMy0xLTEtODMwNzg_7810b441-fe4a-4f74-b151-c01cad91ec4a"
      unitRef="usd">1684375000</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i04f7923e726c44b5a317209e10a39819_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzMtNS0xLTEtODMwNzg_3383b993-68e1-4e4e-b1de-8faada27d06f">2024-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i04f7923e726c44b5a317209e10a39819_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzMtNy0xLTEtODMwNzg_5ffefb84-dc22-4585-8006-ddbab58766db">LIBOR + 1.50%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i1db4cfcf189544c5ae3f2c2607ab9bf3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzMtOS0xLTEtODMwNzg_1510dd12-90c0-47dc-88a1-e06b068903a6"
      unitRef="usd">1600867000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SecuredDebt
      contextRef="ib46d077db6cc4fc5ba1ee2fbd6eac6fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzQtMS0xLTEtODMwNzg_5c4ab61c-d65e-4e3c-9ecd-cf7458cf26f4"
      unitRef="usd">2688263000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i4715240e08ce4789b224f11378f56cf4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzQtMy0xLTEtODMwNzg_1dba9ace-e2d3-4ffc-919b-0b1fd19d5ad8"
      unitRef="usd">2715694000</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i5327139cdd234a31b8cc0934bc70b68b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzQtNS0xLTEtODMwNzg_b1217a32-0940-4965-b99e-93a5c3af1eb8">2026-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i5327139cdd234a31b8cc0934bc70b68b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzQtNy0xLTEtODMwNzg_9f40e9cf-52a2-46f2-a825-80542f39163a">LIBOR + 1.75%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib46d077db6cc4fc5ba1ee2fbd6eac6fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzQtOS0xLTEtODMwNzg_d65be1bc-aaeb-4493-94f1-7f0929102794"
      unitRef="usd">2681542000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SecuredDebt
      contextRef="i600b97f9f2a649adb54ed6ff94464b99_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzYtMS0xLTEtODMwNzg_e3de124c-2735-4d81-a72b-d7c14e50572a"
      unitRef="usd">0</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="ie199cda3ed26463fafa480e81f60a090_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzYtMy0xLTEtODMwNzg_61d70dd8-3a65-4d04-917f-294537475daa"
      unitRef="usd">75000000</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i3c69871249f9445c9b595c58151ff7cb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzYtNS0xLTEtODMwNzg_6375fbb6-9643-4438-b4a8-0703636fdfb3">2024-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i3c69871249f9445c9b595c58151ff7cb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzYtNy0xLTEtODMwNzg_62b3aaa0-b512-45e3-b825-eb26639becb5">LIBOR + 1.50%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i600b97f9f2a649adb54ed6ff94464b99_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzYtOS0xLTEtODMwNzg_bbcea486-239e-44a1-bb19-81fddd48f64d"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SeniorNotes
      contextRef="i8ec717b426f84c228c0d4292f6059e35_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzgtMS0xLTEtODMwNzg_947b479e-19db-4c51-8bbb-91af6b0d71a7"
      unitRef="usd">2750000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i22e611f57b324bf78f55d029bc529436_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzgtMy0xLTEtODMwNzg_aeacd8a3-75f6-4dbf-bb6d-de9780af1aa5"
      unitRef="usd">1750000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i12da2441415248babcb9af6aa29feb11_D20210226-20210226"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzgtNS0xLTEtODMwNzg_7287e4dc-6cf2-4c6f-a97f-9bec966fb127">2030-06-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i890855c7c3d64bd8ab0ed0292f35e955_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzgtNy0xLTEtODMwNzg_dc1fc32e-15a9-4e59-86bd-5d8b0efe350d"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i8ec717b426f84c228c0d4292f6059e35_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzgtOS0xLTEtODMwNzg_6642fb10-b915-4f70-953c-f26007da1bd4"
      unitRef="usd">2822188000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SeniorNotes
      contextRef="i3a9bcb8cc67b428099ac387fd810b3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzktMS0xLTEtODMwNzg_2ef5eafd-e7e3-4952-9c34-d8c9cb938aae"
      unitRef="usd">1500000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i8ee95b0a63934b3fab601bf43c7befac_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzktMy0xLTEtODMwNzg_59c39a39-6765-4256-a9a9-b4e5afbfe665"
      unitRef="usd">1500000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i2f95c3f7ea894940b533361538fc95dd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzktNS0xLTEtODMwNzg_e89c4fe1-ea0a-4db7-ae53-3e82f155ce6e">2031-02-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i2f95c3f7ea894940b533361538fc95dd_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzktNy0xLTEtODMwNzg_1c6a4b70-9db2-4d5e-ae09-7b28f110dfaf"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3a9bcb8cc67b428099ac387fd810b3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzktOS0xLTEtODMwNzg_87eac518-cb32-4123-9249-fe30b8486d6d"
      unitRef="usd">1464210000</us-gaap:DebtInstrumentFairValue>
    <dva:AcquisitionObligationsAndOtherNotesPayable
      contextRef="ibe46e390006b4b0db6ef499531f4433a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEyLTEtMS0xLTgzMDc4_79c90ac4-b43e-443c-af17-cd0eeef68e3d"
      unitRef="usd">130599000</dva:AcquisitionObligationsAndOtherNotesPayable>
    <dva:AcquisitionObligationsAndOtherNotesPayable
      contextRef="i44e756811d3a4db48b9f947147694905_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEyLTMtMS0xLTgzMDc4_940f6aab-a9c9-4010-8989-43efd2b99370"
      unitRef="usd">164160000</dva:AcquisitionObligationsAndOtherNotesPayable>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="i773db74022044af6886373bcbb94b346_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEyLTUtMS0xLTgzMDc4_6a49a697-373f-4b5d-87cd-da610a8cfd11">2022-2036</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="ibe46e390006b4b0db6ef499531f4433a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEyLTctMS0xLTgzMDc4_1a5e5c3d-4e2a-4190-8a35-9b1bc4cb6936"
      unitRef="number">0.0480</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <dva:AcquisitionObligationsAndOtherNotesPayableFairValue
      contextRef="ibe46e390006b4b0db6ef499531f4433a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEyLTktMS0xLTgzMDc4_63f38a0d-e28c-40bb-9e90-dfd68f48ca57"
      unitRef="usd">130599000</dva:AcquisitionObligationsAndOtherNotesPayableFairValue>
    <us-gaap:FinanceLeaseLiability
      contextRef="ida3ce71f441045c4b651feea14f7ae6b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEzLTEtMS0xLTgzMDc4_d1f7c296-0139-48ff-a1aa-62934c0543d4"
      unitRef="usd">299128000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ib96d977216a04df8a88cb6db54969996_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEzLTMtMS0xLTgzMDc4_58cbb312-e538-472a-8b96-53cfea4e67de"
      unitRef="usd">274292000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="i46b324066b524a409692e8df3f51de03_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEzLTUtMS0xLTgzMDc4_f8e79317-5e04-4fb9-97ce-e4d1dd3f4ded">2022-2038</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ida3ce71f441045c4b651feea14f7ae6b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzEzLTctMS0xLTgzMDc4_e3909ac4-9128-4ef8-a0ca-e8321317f108"
      unitRef="number">0.0454</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE0LTEtMS0xLTgzMDc4_d167e511-bb0a-4c6b-ac79-45b4758e2b00"
      unitRef="usd">8964865000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE0LTMtMS0xLTgzMDc4_a3579386-aa23-4580-85ff-1a76dff2831f"
      unitRef="usd">8163521000</us-gaap:DebtInstrumentCarryingAmount>
    <dva:DiscountAndDeferredFinanceCosts
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE1LTEtMS0xLTgzMDc4_bccb1425-1900-49a2-ae18-36fb32072375"
      unitRef="usd">56685000</dva:DiscountAndDeferredFinanceCosts>
    <dva:DiscountAndDeferredFinanceCosts
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE1LTMtMS0xLTgzMDc4_0ec9a461-b5f5-4893-ae83-f757b43792d6"
      unitRef="usd">77717000</dva:DiscountAndDeferredFinanceCosts>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE2LTEtMS0xLTgzMDc4_1315124b-a6ef-4343-8984-954cf6f7201f"
      unitRef="usd">8908180000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE2LTMtMS0xLTgzMDc4_2324bd54-cf3f-46de-ae18-6542450c91b1"
      unitRef="usd">8085804000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE3LTEtMS0xLTgzMDc4_94462ad0-9955-4dd8-8d78-e7fbaccdfd1b"
      unitRef="usd">179030000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE3LTMtMS0xLTgzMDc4_a1022ed2-d0fb-4096-82d0-e349017798db"
      unitRef="usd">168541000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE4LTEtMS0xLTgzMDc4_6ebbf623-8a91-467d-9613-f847e07051b8"
      unitRef="usd">8729150000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo3ZmIyOTYwMGRlZTM0ZjIzODVkMTliMDBjMDJmYzQ4Mi90YWJsZXJhbmdlOjdmYjI5NjAwZGVlMzRmMjM4NWQxOWIwMGMwMmZjNDgyXzE4LTMtMS0xLTgzMDc4_a1e34868-f6dc-4b4d-85f6-dca309a4bb5a"
      unitRef="usd">7917263000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="i11aa03bc52b94636a23c6f74a4cfed25_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzI0MTg5MjU1ODM0Mjkx_56b3fba3-a877-4a7f-89c1-2fe45192c66f">2070</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="icabbc5daf3b5479cbbc15782e1d08326_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEyODk_82ec6b43-a416-46d0-a5f6-420e88de6deb"
      unitRef="usd">4473000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredOfferingCosts
      contextRef="icabbc5daf3b5479cbbc15782e1d08326_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEzMjQ_15851b4e-602b-40bf-b41b-3d489c213c2e"
      unitRef="usd">27207000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="ie5c90a9b4f6e4bc8ac5981725f5f1a56_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzE0MTg_b68d300e-3275-4bc7-9ba0-df8f67d73310"
      unitRef="usd">40914000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="ie5c90a9b4f6e4bc8ac5981725f5f1a56_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzMzU2NzI_2dd6bd07-8b64-4920-bfe2-90727fd426b0"
      unitRef="usd">15909000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i1edafa8b823d47d6aee45f343d6d4dab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzE1MjU_420106bc-a8f3-49e4-bc54-6c63c0b9491f"
      unitRef="usd">5461000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredOfferingCosts
      contextRef="i1edafa8b823d47d6aee45f343d6d4dab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzE1NjA_fe4575e4-9ebe-4167-9603-c2e6d8b05a01"
      unitRef="usd">35825000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="ic4a422541b9c4b1d89d6f0b455e51179_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzE2NTU_e994ce8a-7aa4-42e2-b4f0-df7a2a0fb4fc"
      unitRef="usd">36431000</us-gaap:DeferredOfferingCosts>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMzE4_9ac38e26-eb2e-4b8e-84d6-8b8391dda7e0">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scheduled maturities of long-term debt at December&#160;31, 2021 were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.274%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,424,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,625,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,449,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZToxZDEzY2UzYWUzNDk0YjAyOWZkZTg1MGUyMjc5YTJiYS90YWJsZXJhbmdlOjFkMTNjZTNhZTM0OTRiMDI5ZmRlODUwZTIyNzlhMmJhXzAtMS0xLTEtODMwNzg_9e95114a-c68d-4ec5-b721-d1df290e36b3"
      unitRef="usd">179030000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZToxZDEzY2UzYWUzNDk0YjAyOWZkZTg1MGUyMjc5YTJiYS90YWJsZXJhbmdlOjFkMTNjZTNhZTM0OTRiMDI5ZmRlODUwZTIyNzlhMmJhXzEtMS0xLTEtODMwNzg_5cc280ae-276a-44cd-b06f-96b55df9025f"
      unitRef="usd">218460000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZToxZDEzY2UzYWUzNDk0YjAyOWZkZTg1MGUyMjc5YTJiYS90YWJsZXJhbmdlOjFkMTNjZTNhZTM0OTRiMDI5ZmRlODUwZTIyNzlhMmJhXzItMS0xLTEtODMwNzg_1b16529a-13d7-41c1-9b5e-cafaf492d577"
      unitRef="usd">1424692000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZToxZDEzY2UzYWUzNDk0YjAyOWZkZTg1MGUyMjc5YTJiYS90YWJsZXJhbmdlOjFkMTNjZTNhZTM0OTRiMDI5ZmRlODUwZTIyNzlhMmJhXzMtMS0xLTEtODMwNzg_7e30d19d-215b-41aa-9b76-53ce493afdbe"
      unitRef="usd">67812000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZToxZDEzY2UzYWUzNDk0YjAyOWZkZTg1MGUyMjc5YTJiYS90YWJsZXJhbmdlOjFkMTNjZTNhZTM0OTRiMDI5ZmRlODUwZTIyNzlhMmJhXzQtMS0xLTEtODMwNzg_8365c207-c63b-4662-abe7-8d7d9f9f0f06"
      unitRef="usd">2625349000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZToxZDEzY2UzYWUzNDk0YjAyOWZkZTg1MGUyMjc5YTJiYS90YWJsZXJhbmdlOjFkMTNjZTNhZTM0OTRiMDI5ZmRlODUwZTIyNzlhMmJhXzUtMS0xLTEtODMwNzg_8180a88e-adba-4a51-b729-a90bf8b8b005"
      unitRef="usd">4449522000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i04f7923e726c44b5a317209e10a39819_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzMwOTc_1f53c1ea-8768-412c-a0b8-785624ec13bd"
      unitRef="usd">87500000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i5327139cdd234a31b8cc0934bc70b68b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzMxMTk_08ee388c-e4ec-4161-b853-7eb343099be1"
      unitRef="usd">27431000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <dva:AdditionalDebtPrincipalAmountDueToNewAgreement
      contextRef="i2ba1dad9a06d4586808260f76a47066d_I20210226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzNDI1ODQ_c5735782-c566-4df7-89db-4fa38331e0e3"
      unitRef="usd">1000000000</dva:AdditionalDebtPrincipalAmountDueToNewAgreement>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i483ab4301786474fb072fbdef5442d37_D20200609-20200609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzNDI1ODg_6b890bd1-1b83-4bc6-bd93-4f6147acf9a4"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i12da2441415248babcb9af6aa29feb11_D20210226-20210226"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzNDM3MDg_7287e4dc-6cf2-4c6f-a97f-9bec966fb127">2030-06-01</us-gaap:DebtInstrumentMaturityDate>
    <dva:DebtInstrumentOfferingPricePercentageOfFaceAmount
      contextRef="i12da2441415248babcb9af6aa29feb11_D20210226-20210226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzNDM5MDU_58ffaa9c-9c21-461e-b363-19b4332291d8"
      unitRef="number">1.01750</dva:DebtInstrumentOfferingPricePercentageOfFaceAmount>
    <us-gaap:SeniorNotes
      contextRef="iee77e0f66a124be69818c3fe1f9d91bb_I20200609"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0Xzc2OTY1ODE0MTc1NTE_991e954d-004f-4dc9-b326-db4f26ff36e4"
      unitRef="usd">1750000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i483ab4301786474fb072fbdef5442d37_D20200609-20200609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzNDQzMzk_6b890bd1-1b83-4bc6-bd93-4f6147acf9a4"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i8ec717b426f84c228c0d4292f6059e35_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzQ5NDc4MDIzNDI0MjA_6d7a6824-b633-44ca-bd8b-699ec4f18733"
      unitRef="usd">9091000</us-gaap:DebtInstrumentFeeAmount>
    <dva:SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR
      contextRef="i1db4cfcf189544c5ae3f2c2607ab9bf3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzgwMjQ_5b3d62c3-c8ea-4535-b7e2-7cc9d6d60dda"
      unitRef="usd">785138000</dva:SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMzI2_803d68e0-1871-4d2b-bfcb-23bb73e3daac">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s interest rate cap agreements outstanding as of December&#160;31, 2021 and December&#160;31, 2020, which are classified in other long-term assets on its consolidated balance sheet:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;LIBOR maximum rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiration date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recorded OCI gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019 interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i8442b0b05e984872893ac93049fee22e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtMS0xLTEtODMwNzg_9ce340c6-c762-4e85-8b25-1d72185fbd90"
      unitRef="usd">3500000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i95df5bcea102459b914d1085942b9258_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtMy0xLTEtODMwNzg_58082ca3-fa75-40c3-a8a6-ed1a0796106c"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DerivativeInceptionDates
      contextRef="ie83cf4a097b643ee9745264ab855ca7b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtNS0xLTEtODMwNzg_3dfde8da-d0ff-45b3-a4f4-fac5c0043e81">2020-06-30</us-gaap:DerivativeInceptionDates>
    <us-gaap:DerivativeMaturityDates
      contextRef="ie83cf4a097b643ee9745264ab855ca7b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtNy0xLTEtODMwNzg_b87b996b-e788-42a6-bad8-f5f93a95d8e7">2024-06-30</us-gaap:DerivativeMaturityDates>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i214ffb0410c04addafdd70da53f31176_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtOS0xLTEtODMwNzg_acd39586-810b-4365-9f0d-d2fa81e6bff1"
      unitRef="usd">5509000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i82b6dd5b3eea468885f8236cc977ca08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtMTEtMS0xLTgzMDc4_88c839f6-2c73-41cf-aa9c-2cd27221d4c3"
      unitRef="usd">9532000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iaeebf4414172413da3e7139927c5aba9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtMTMtMS0xLTgzMDc4_f63c5640-86a9-4129-b780-e5097c42557b"
      unitRef="usd">12203000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i387548dbf53e458f864bbbc27c03ff99_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo5YzNjYjY1YzQ5OTY0NzhmYTJlODQ0YmEwZTRhNzUzYi90YWJsZXJhbmdlOjljM2NiNjVjNDk5NjQ3OGZhMmU4NDRiYTBlNGE3NTNiXzMtMTUtMS0xLTgzMDc4_403234c2-7768-4d23-aa6c-01efd0abe209"
      unitRef="usd">2671000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMzEz_baa1db6c-f8c6-4c56-bb04-a9087e96b9f8">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of the Company&#x2019;s interest rate cap agreements for the years ended December&#160;31, 2021, 2020 and 2019:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount of unrealized gains (losses) in OCI on interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Location of losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reclassification from accumulated other comprehensive income into net income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i214ffb0410c04addafdd70da53f31176_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzMtMi0xLTEtODMwNzg_54ef0974-5df5-4fde-9c6b-dd6bc87644f9"
      unitRef="usd">9532000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ic78e16c835d34203a6c659d6e08d50e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzMtNC0xLTEtODMwNzg_ffa956b0-3e88-42d9-963e-9cae8c9e03a6"
      unitRef="usd">-21781000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i3cd53a26306b4722840092750230a681_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzMtNi0xLTEtODMwNzg_5638609a-22d0-4893-ab60-4360b7e2d9b7"
      unitRef="usd">1566000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i214ffb0410c04addafdd70da53f31176_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzMtMTAtMS0xLTgzMDc4_acd39586-810b-4365-9f0d-d2fa81e6bff1"
      unitRef="usd">5509000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ic78e16c835d34203a6c659d6e08d50e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzMtMTItMS0xLTgzMDc4_b2b58860-7a27-4b7c-af48-820bf0d8470e"
      unitRef="usd">7081000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i3cd53a26306b4722840092750230a681_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzMtMTQtMS0xLTgzMDc4_afc59848-ce43-4929-a49c-3c872ec90238"
      unitRef="usd">8591000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ic0e0782bc40d453b86948be43d51725e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzQtMi0xLTEtODMwNzg_7797cf22-7904-4a7f-a4ce-08a5198527af"
      unitRef="usd">-2377000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i23e9c0b63c2e405182c0cf2802b5eca3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzQtNC0xLTEtODMwNzg_dd76b145-004d-41cb-872f-1295f3be7f92"
      unitRef="usd">5435000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i84fde8e60f5a4538937fd23d973e3361_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzQtNi0xLTEtODMwNzg_8901c7d3-e23c-4fec-9f0c-3b86c6b74121"
      unitRef="usd">-415000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ic0e0782bc40d453b86948be43d51725e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzQtMTAtMS0xLTgzMDc4_306b714a-c945-4ac9-ad1c-1d614dc6afb8"
      unitRef="usd">-1376000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i23e9c0b63c2e405182c0cf2802b5eca3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzQtMTItMS0xLTgzMDc4_525a7a3c-9ad2-4fc1-9883-22f662bad2b6"
      unitRef="usd">-1768000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i84fde8e60f5a4538937fd23d973e3361_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzQtMTQtMS0xLTgzMDc4_cb8a8c7e-722a-44e9-9993-e7dd6d41f7bb"
      unitRef="usd">-2214000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ib7258618967043f9bcfd1acc842da238_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzUtMi0xLTEtODMwNzg_dae29272-aeff-4110-81fd-1ca24eeabd2c"
      unitRef="usd">7155000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i4cda5450900646759ef0009b9d20a3d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzUtNC0xLTEtODMwNzg_3e1412dd-b583-4d98-a908-771043d39081"
      unitRef="usd">-16346000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="iae4fd45d48224399bcab66769793c52a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzUtNi0xLTEtODMwNzg_00a79bb8-ca16-4e9a-8f73-57b91cce0196"
      unitRef="usd">1151000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ib7258618967043f9bcfd1acc842da238_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzUtMTAtMS0xLTgzMDc4_547647ff-2ba3-440f-a591-f0c766e1cd62"
      unitRef="usd">4133000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i4cda5450900646759ef0009b9d20a3d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzUtMTItMS0xLTgzMDc4_a235a836-8e3e-4b0d-9ddf-9795839b015b"
      unitRef="usd">5313000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="iae4fd45d48224399bcab66769793c52a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90YWJsZTo1MTYzMDk2NWY5Mzg0YTZlODhmYWNlYzAzMjliNzBjOC90YWJsZXJhbmdlOjUxNjMwOTY1ZjkzODRhNmU4OGZhY2VjMDMyOWI3MGM4XzUtMTQtMS0xLTgzMDc4_36e0434c-24ce-4ed6-9165-c3ea021fe7d6"
      unitRef="usd">6377000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i263db25331b246e78a22100f6d1d1509_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzkxMTA_7b076bec-3203-4c07-a7b2-67247f8ed97f"
      unitRef="number">0.0218</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzkzNzk_ef1f2dc2-3c00-4f8c-a9e8-48f8445283b2"
      unitRef="number">0.0328</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0Xzk0MDg_85ec4328-aabc-4750-823b-e9bb1b745fdb"
      unitRef="number">0.0335</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0Xzk0ODg_197df13e-68eb-4b3f-a532-a4c6619efa10"
      unitRef="number">0.516</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i600b97f9f2a649adb54ed6ff94464b99_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzgyNDYzMzcyMjg5OTI_550b5dd8-6f99-454f-8864-0724dfa4401f"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzE5NzkxMjA5MzIzMDc4_d19fc839-f871-4961-b30f-7ed609eac2c4"
      unitRef="usd">0</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i7f9ca0e521b646668df9e2106ef3225f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0Xzk4NTk_90fdcbb0-d5f5-40d1-af2f-80d5c1c31c42"
      unitRef="usd">69277000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:InterestExpenseDebt
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMDI1_f7bf5842-0a43-4c47-bef6-7ecd721eae1a"
      unitRef="usd">267049000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMDI5_d7b6dcff-214a-4d3f-92f7-95080b1d6d82"
      unitRef="usd">282932000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMDM2_6a9b143e-10b4-4ca0-b650-021571e8fef1"
      unitRef="usd">419639000</us-gaap:InterestExpenseDebt>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMjAz_81887cfc-7533-4b9c-9485-9aa48c120add"
      unitRef="usd">18205000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMjA3_ef7e782c-91db-4102-ad42-32889d122f24"
      unitRef="usd">21179000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNTkvZnJhZzo2OTkwMzU3MjM0ZmY0ZmQ0OWI4YzVlZjc3OWEzMTJkNC90ZXh0cmVnaW9uOjY5OTAzNTcyMzRmZjRmZDQ5YjhjNWVmNzc5YTMxMmQ0XzEwMjE0_da6f77d0-205b-4d3d-b52e-cac48f9385a4"
      unitRef="usd">24185000</us-gaap:AmortizationOfFinancingCosts>
    <dva:LeasesDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzIzNTY_0a0112e8-4ae0-438b-811b-93cc3b4b3e9f">Leases&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases substantially all of its U.S. dialysis facilities. The majority of the Company&#x2019;s facilities are leased under non-cancellable operating leases which range in terms from five years to 15 years and which contain renewal options of five years to ten years at the fair rental value at the time of renewal. Certain of the Company's leases are subject to periodic consumer price increases or contain fixed escalation clauses. See Note 1 for further information on how the Company accounts for leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and December&#160;31, 2020, assets recorded under finance leases were $322,060 and $275,389, respectively, and accumulated amortization associated with finance leases was $75,252 and $49,345, respectively, included in property and equipment, net, on the Company's consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain markets, the Company acquires and develops dialysis centers. Upon completion, the Company sells the center to a third party and leases the space back with the intent of operating the center on a long term basis. Both the sale and leaseback terms are generally market terms. The lease terms are consistent with the Company's other operating leases with the majority of the leases under non-cancellable operating leases ranging in terms from five years to 15 years and which contain renewal options of five years to ten years at the fair rental value at the time of renewal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;547,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;541,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;526,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;714,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;702,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;684,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Includes short-term lease expense and sublease income, which are immaterial. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gains on sale leasebacks, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the &lt;br/&gt;&#160;measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;684,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;661,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;637,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating lease assets obtained in exchange&lt;br/&gt;&#160;for new or modified operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;361,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancellable leases as of December&#160;31, 2021 are as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;494,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;511,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;463,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;413,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;361,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,293,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,537,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;371,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less portion representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(470,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(72,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,067,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under all operating leases for 2021, 2020 and 2019 was $673,904, $663,819 and $646,092, respectively. Rent expense is recorded on a straight-line basis over the term of the lease, including leases that contain fixed escalation clauses or include abatement provisions. Leasehold improvement incentives are deferred and amortized to rent expense over the term of the lease. Finance lease obligations are included in long-term debt. See Note 13 for further details on long-term debt.&lt;/span&gt;&lt;/div&gt;</dva:LeasesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="if350164cad7147d78b7f10200a640f14_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzIwMw_ac60d041-dca0-44b3-9ff6-ba26aae6bcac">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="iad35108069fd45b89fe53b05bbe9c30d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzIwOQ_99f64e4e-2c27-4178-9357-1a2e6694813b">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="if350164cad7147d78b7f10200a640f14_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzI0OQ_a2a38757-f0a0-4f68-a516-00ac4e94800f">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="iad35108069fd45b89fe53b05bbe9c30d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzI1NQ_a6c4a789-9d47-423c-9329-9d92aec47b5d">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i8bd72b308e7b468186e6b9b780fa5baf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzU1OQ_008af4a5-26ec-4d29-8d13-3f0154b64dab"
      unitRef="usd">322060000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="iecb8fa3387954169853ce5d7b54cb5f5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzU2Ng_81783c3e-4bf7-4baa-a0d8-8fc17ff5bfd3"
      unitRef="usd">275389000</us-gaap:FinanceLeaseRightOfUseAsset>
    <dva:FinanceLeaseAccumulatedDepreciation
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzY0OA_34f3c175-5f53-41cb-96fd-472fa3720c94"
      unitRef="usd">75252000</dva:FinanceLeaseAccumulatedDepreciation>
    <dva:FinanceLeaseAccumulatedDepreciation
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzY1NQ_fc15372c-e0c4-4bab-9258-8f181cd3e231"
      unitRef="usd">49345000</dva:FinanceLeaseAccumulatedDepreciation>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="if350164cad7147d78b7f10200a640f14_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzEyMTE_ac60d041-dca0-44b3-9ff6-ba26aae6bcac">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="iad35108069fd45b89fe53b05bbe9c30d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzEyMTc_99f64e4e-2c27-4178-9357-1a2e6694813b">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="if350164cad7147d78b7f10200a640f14_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzEyNTc_a2a38757-f0a0-4f68-a516-00ac4e94800f">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="iad35108069fd45b89fe53b05bbe9c30d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzEyNjM_a6c4a789-9d47-423c-9329-9d92aec47b5d">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzIzNTc_68168c4f-6656-4ac3-9625-cc884eabdc90">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;547,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;541,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;526,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;714,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;702,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;684,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;(1) Includes short-term lease expense and sublease income, which are immaterial.</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzMtMi0xLTEtODMwNzg_5a4ab7c9-a553-4902-90a2-fb93350181c0"
      unitRef="usd">547923000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzMtNC0xLTEtODMwNzg_bbe2739d-0447-42cb-a5f1-18bc84151217"
      unitRef="usd">541090000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzMtNi0xLTEtMTIzODY2_533bb736-1de2-44ad-85a4-846a6aec7fc2"
      unitRef="usd">526352000</us-gaap:OperatingLeaseExpense>
    <us-gaap:VariableLeaseCost
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzQtMi0xLTEtODMwNzg_d8af13b7-219f-4653-ac49-5d072c501486"
      unitRef="usd">125981000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzQtNC0xLTEtODMwNzg_398bc07a-bab0-41fe-8354-6f8b8ac03d7c"
      unitRef="usd">122729000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzQtNi0xLTEtMTIzODY2_ba27c5c8-f774-4a5a-8107-06a0c3b050db"
      unitRef="usd">119740000</us-gaap:VariableLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzYtMi0xLTEtODMwNzg_778b5013-5fa7-413f-9779-e07ead454a1f"
      unitRef="usd">26846000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzYtNC0xLTEtODMwNzg_a416a49c-da0b-4194-9509-90173bacee28"
      unitRef="usd">24720000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzYtNi0xLTEtMTIzODY2_77b93e16-5a72-4c56-9cdf-bf51d975107d"
      unitRef="usd">23724000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzctMi0xLTEtODMwNzg_bc832172-bb0d-4f16-913c-07770c6531e4"
      unitRef="usd">13988000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzctNC0xLTEtODMwNzg_7898a468-7db1-45e1-9ac4-cf7cd0a6af21"
      unitRef="usd">14421000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzctNi0xLTEtMTIzODY2_7e96ae95-19c2-45e3-9e9c-f849b6c5ee43"
      unitRef="usd">14932000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:LeaseCost
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzgtMi0xLTEtODMwNzg_e3ee74bb-9bf3-40fc-8fbb-722b3fbefa22"
      unitRef="usd">714738000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzgtNC0xLTEtODMwNzg_a4d840ad-4893-4b3b-815b-650457fdacdd"
      unitRef="usd">702960000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTphYTc4MDQ0ZDUxMWM0MDI5YWZiMGU5YmE4YmZiODkwNC90YWJsZXJhbmdlOmFhNzgwNDRkNTExYzQwMjlhZmIwZTliYThiZmI4OTA0XzgtNi0xLTEtMTIzODY2_8f7acec9-22da-4007-90e4-2f5212d812ea"
      unitRef="usd">684748000</us-gaap:LeaseCost>
    <dva:LeaseOtherInformationTableTextBlockTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzIzNTQ_ba3d6378-f0c0-4e94-a838-4f8a28246862">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gains on sale leasebacks, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the &lt;br/&gt;&#160;measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;684,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;661,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;637,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating lease assets obtained in exchange&lt;br/&gt;&#160;for new or modified operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;361,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:LeaseOtherInformationTableTextBlockTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzMtMi0xLTEtODMwNzg_5b0ef1cc-6583-4cfd-a41a-60a623e2d419">P8Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzMtNC0xLTEtODMwNzg_2c8aff6a-5809-40b0-9c39-91b1821717c0">P8Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzMtNi0xLTEtMTIzODgz_327f7dfc-7a61-43cb-8e87-2ee5bc105c46">P9Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzQtMi0xLTEtODMwNzg_5e00b5d0-2c16-4914-acc5-bb75597d30b1">P10Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzQtNC0xLTEtODMwNzg_2bb23346-9999-42e9-a7b2-6a9d115cbb94">P10Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzQtNi0xLTEtMTIzODgz_46740ced-2baf-45d6-9c23-3837fd986ce8">P10Y2M12D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzYtMi0xLTEtODMwNzg_ee11f559-3710-4771-940e-7cf01143f32c"
      unitRef="number">0.035</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzYtNC0xLTEtODMwNzg_40ffedc8-284b-4090-b80d-06bbab46da0c"
      unitRef="number">0.038</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i07d5f8524b0847c08febc20a18ec3e47_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzYtNi0xLTEtMTIzODgz_d4f2196e-7c65-4db3-81a2-875af7c3271b"
      unitRef="number">0.041</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ida3ce71f441045c4b651feea14f7ae6b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzctMi0xLTEtODMwNzg_a2dd0e3c-afaf-4b71-af02-f1df90fbc508"
      unitRef="number">0.045</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ib96d977216a04df8a88cb6db54969996_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzctNC0xLTEtODMwNzg_160a7f97-f87d-4665-9c10-bd5ecefea4ff"
      unitRef="number">0.051</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i88356036cde840bc8b51ec086349bd93_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTpkOTNlYzY0NjdkM2Q0MzM1Yjc2YWE4ZTdmNTJlYmVkMy90YWJsZXJhbmdlOmQ5M2VjNjQ2N2QzZDQzMzViNzZhYThlN2Y1MmViZWQzXzctNi0xLTEtMTIzODgz_7c1a8e3e-1629-4736-b029-f406d110ddbc"
      unitRef="number">0.054</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzItMi0xLTEtODMwNzg_d476ac1d-6727-4c05-ada7-23fd9178e089"
      unitRef="usd">17137000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzItNC0xLTEtODMwNzg_e566a078-a01d-42fe-abe6-3200a35c18b2"
      unitRef="usd">34301000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzItNi0xLTEtMTIzOTAz_e1e1e523-4986-4c46-bf0e-d325a5e07857"
      unitRef="usd">20833000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <us-gaap:OperatingLeasePayments
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzQtMi0xLTEtODMwNzg_916e4627-03ad-4543-a156-81bc3ebdde53"
      unitRef="usd">684186000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzQtNC0xLTEtODMwNzg_2093adf1-22f0-4789-8ca8-4fc771043048"
      unitRef="usd">661318000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzQtNi0xLTEtMTIzOTAz_93c17c16-fea4-43e4-9f44-1f6f6e789ca8"
      unitRef="usd">637655000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzUtMi0xLTEtODMwNzg_6441025e-ae2a-4560-81a9-efef7b0b35a2"
      unitRef="usd">21343000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzUtNC0xLTEtODMwNzg_5c96b7aa-2abb-4c50-a18d-5b3e9556b5ac"
      unitRef="usd">20981000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzUtNi0xLTEtMTIzOTAz_a1f08df0-4124-452d-9731-82bdfd6279b2"
      unitRef="usd">22257000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzYtMi0xLTEtODMwNzg_c69b5ceb-a4fd-44e8-8133-de073f642dce"
      unitRef="usd">22445000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzYtNC0xLTEtODMwNzg_92e6f71e-bddb-4671-98d3-ab12204a484a"
      unitRef="usd">24780000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzYtNi0xLTEtMTIzOTAz_a966e1ff-fb4f-4d58-ae2f-48f6447c0704"
      unitRef="usd">25692000</us-gaap:FinanceLeasePrincipalPayments>
    <dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzctMi0xLTEtODMwNzg_6c23927c-f5c0-4cd9-8011-51ea74177d14"
      unitRef="usd">361101000</dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities>
    <dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzctNC0xLTEtODMwNzg_d657a816-4392-4a79-a15a-50b38ed65b10"
      unitRef="usd">401559000</dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities>
    <dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0OWI5YTk2Y2U3MGE0MmJlYTQyYjU0YWExMjhhYmYxZC90YWJsZXJhbmdlOjQ5YjlhOTZjZTcwYTQyYmVhNDJiNTRhYTEyOGFiZjFkXzctNi0xLTEtMTIzOTAz_0f5cf7cb-d9ce-473b-91be-2f1c4df19940"
      unitRef="usd">432074000</dva:NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities>
    <dva:ScheduleOfMinimumLeasePaymentsTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzIzNTU_36f8092b-4cb7-4079-9897-eba02946d808">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancellable leases as of December&#160;31, 2021 are as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;494,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;511,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;463,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;413,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;361,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,293,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,537,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;371,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less portion representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(470,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(72,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,067,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ScheduleOfMinimumLeasePaymentsTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzEtMi0xLTEtODMwNzg_5f9a7a67-ae8e-4939-8a84-df679a907a3d"
      unitRef="usd">494442000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzEtNC0xLTEtODMwNzg_458769d9-285c-4a41-9f55-86e3c3dba0b2"
      unitRef="usd">36981000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzItMi0xLTEtODMwNzg_65e7c65f-edb3-470e-94eb-c22688fe83be"
      unitRef="usd">511341000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzItNC0xLTEtODMwNzg_cea9dc82-dfd1-4834-ba04-e65cabf96977"
      unitRef="usd">37672000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzMtMi0xLTEtODMwNzg_1ad228c6-f2a4-4c0a-b273-015c09cbbd69"
      unitRef="usd">463124000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzMtNC0xLTEtODMwNzg_96f6083f-a605-441e-99c3-1e2b15a8cd00"
      unitRef="usd">38199000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzQtMi0xLTEtODMwNzg_44e67bda-c10e-4a75-aa23-c5f3bdaf5ccf"
      unitRef="usd">413117000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzQtNC0xLTEtODMwNzg_233bab4f-2196-47ef-a092-806bcca3f60a"
      unitRef="usd">38376000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzUtMi0xLTEtODMwNzg_ab1641d3-be65-4fd7-bb45-1575ae20894f"
      unitRef="usd">361771000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzUtNC0xLTEtODMwNzg_a9402cc5-f1c9-42d8-bcfe-4a896d8795da"
      unitRef="usd">37141000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzYtMi0xLTEtODMwNzg_d289372a-9b6f-47db-a070-ec4258772756"
      unitRef="usd">1293544000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzYtNC0xLTEtODMwNzg_0be8be44-fba4-4cfe-b764-857893cb9366"
      unitRef="usd">183250000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzctMi0xLTEtODMwNzg_c34bd8bd-20a9-4d96-bced-9dadfa8259a6"
      unitRef="usd">3537339000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzctNC0xLTEtODMwNzg_f3e7acbd-3503-40e7-b7e9-1e9f05991030"
      unitRef="usd">371619000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzgtMi0xLTEtODMwNzg_fbc051a5-d8e6-4219-a9f3-798320004ffa"
      unitRef="usd">470269000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzgtNC0xLTEtODMwNzg_9288370d-c955-48a0-9baf-2f47e5cafab1"
      unitRef="usd">72491000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="icbc2e076ebb1492187444b939215b5ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzktMi0xLTEtODMwNzg_790e7976-a7e6-4a44-a017-be3c28463225"
      unitRef="usd">3067070000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ib1c510942daa4f38b0c113fc3987e2b4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90YWJsZTo0ZTg5ZjVmMGJhYTQ0ZDQwYjAwNjNjYWQzNmYyOTA5OC90YWJsZXJhbmdlOjRlODlmNWYwYmFhNDRkNDBiMDA2M2NhZDM2ZjI5MDk4XzktNC0xLTEtODMwNzg_d3914f36-1b5f-41bf-907c-8243d330d6ba"
      unitRef="usd">299128000</us-gaap:FinanceLeaseLiability>
    <us-gaap:LeaseCost
      contextRef="i06ff6a03ae0d445a88f8a814027ab039_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzE5NDE_f6d4c562-86e6-449c-9b41-61ef2bcb94d8"
      unitRef="usd">673904000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="iad36adbebb114059971bb24c387fa559_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzE5NDU_5e23b5cb-4a18-474d-8ee9-b69a0fb6ace9"
      unitRef="usd">663819000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="iab5a10e4b11d48bf88b5d0ee68ea283b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjUvZnJhZzo3ODczZGQ3MzQxY2I0ODBjOWUyMjIyM2FjMDU5MGMwMS90ZXh0cmVnaW9uOjc4NzNkZDczNDFjYjQ4MGM5ZTIyMjIzYWMwNTkwYzAxXzQ5NDc4MDIzMjc3MTg_80832c14-ff46-4576-beaf-3905552d9640"
      unitRef="usd">646092000</us-gaap:LeaseCost>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzIzNTg_60444073-551c-47b4-b623-dbd40bfd0928">Employee benefit plans&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a 401(k) retirement savings plan for substantially all of its U.S. employees which has been established pursuant to applicable provisions of the Internal Revenue Code (IRC). The plan allows for employees to contribute a percentage of their base annual salaries on a tax-deferred basis not to exceed IRC limitations. The Company maintains a 401(k) matching program under which the Company matches 50% of the employee's contribution up to 6% of the employee's salary, subject to certain limitations. The matching contributions are subject to certain eligibility and vesting conditions. For the years ended December&#160;31, 2021, 2020 and 2019, the Company accrued matching contributions totaling approximately $68,658, $70,180 and $64,988, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains a voluntary compensation deferral plan, the Deferred Compensation Plan, as well as other legacy deferral plans. The Deferred Compensation Plan is non-qualified and permits certain employees whose annualized base salary equals or exceeds a minimum annual threshold amount as set by the Company to elect to defer all or a portion of their annual bonus payment and up to 50% of their base salary into a deferral account maintained by the Company. Total contributions to this plan in 2021, 2020 and 2019 were $2,962, $3,637 and $1,751, respectively. Deferred amounts are generally paid out in cash at the participant&#x2019;s election either in the first or second year following retirement or in a specified future period at least three to four years after the deferral election was effective. During 2021, 2020 and 2019 the Company distributed $11,887, $3,139 and $2,730, respectively, to participants from its deferred compensation plans. Participants are credited with &lt;/span&gt;&lt;/div&gt;their proportional amount of annual earnings from the plans. The assets of these plans are held in rabbi trusts subject to the claims of the Company&#x2019;s general creditors in the event of its bankruptcy. As of December&#160;31, 2021 and 2020, the total fair value of assets held in these plans' trusts was $38,019 and $43,844, respectively. The assets of these plans are recorded at fair value with changes in fair value recorded in other income. See Note 5 for further details. Any fair value changes to the corresponding liability balance are recorded as compensation expense.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzQ0NA_0d80ddd2-192b-4c4d-87b7-34a1e23f7339"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="ife16d51280fb452d8a63ec87d4093b0f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzQ4NA_49facec6-2d95-4cbe-bf4a-237e80f7c920"
      unitRef="number">0.06</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzczMg_dcab7d9a-b8db-4236-818c-9c90a3028762"
      unitRef="usd">68658000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzczNg_3c9f399b-70c6-466e-98ff-47e13b99db28"
      unitRef="usd">70180000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzc0Mw_49cf7386-9cdc-44ed-be14-826f67d345f5"
      unitRef="usd">64988000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="i80a65d71492d461c921f03cd2f80cb2f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzEyNDk_85422491-7b7a-43a4-9fcf-e8e3c01b3f82"
      unitRef="number">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer
      contextRef="i5e2d65ac940341779a7bb92437611d0e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzEzNzk_fd8284f6-f4ba-4321-bac3-a8bb0041bf73"
      unitRef="usd">2962000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer
      contextRef="iaeb01d7a6b7545c59b03e80288b089bb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzEzODM_925edbcd-adb9-4744-8679-1b49897fc810"
      unitRef="usd">3637000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer
      contextRef="i3fa45997abe546d1b852b96a64b33d64_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzEzOTA_25df1915-935f-45fc-959a-08178dbb8c5e"
      unitRef="usd">1751000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid
      contextRef="i5e2d65ac940341779a7bb92437611d0e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzE2OTE_ccfd73f0-547d-4c44-bb93-eae87b7c5782"
      unitRef="usd">11887000</us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid>
    <us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid
      contextRef="iaeb01d7a6b7545c59b03e80288b089bb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzE2OTU_21fbade8-4c74-4a63-8f0f-134d9cd7937d"
      unitRef="usd">3139000</us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid>
    <us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid
      contextRef="i3fa45997abe546d1b852b96a64b33d64_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzE3MDI_a468c571-06da-43c6-98ce-7770b3ddb9aa"
      unitRef="usd">2730000</us-gaap:DeferredCompensationArrangementWithIndividualDistributionPaid>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib37522dd4fa04db58a48b42468502952_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzIwODY_176cdf44-f0be-4895-b8f2-461352b9e0b1"
      unitRef="usd">38019000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iab1bf5046e4745aa8d595dc07340685c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNjgvZnJhZzo5MjBmMjVlOTJlY2I0MDQzYmVjYzhhY2I5OTdlZmM4Zi90ZXh0cmVnaW9uOjkyMGYyNWU5MmVjYjQwNDNiZWNjOGFjYjk5N2VmYzhmXzIwOTM_f66b3a1d-64b0-4981-99c4-55cdc3fb9f8d"
      unitRef="usd">43844000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:LossContingencyDisclosures
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzQvZnJhZzpkN2JjYTZmNDYxMDY0ZDQ2YjVmY2Q0NzA0YTE2MDQ5Mi90ZXh0cmVnaW9uOmQ3YmNhNmY0NjEwNjRkNDZiNWZjZDQ3MDRhMTYwNDkyXzE1MTA2_374ca4bf-2d56-4df0-aea4-83f2262a3a63">Contingencies&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company&#x2019;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#x2019;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#x2019;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; suits, governmental investigations (which frequently arise from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of December&#160;31, 2021 and December&#160;31, 2020, the Company&#x2019;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#x2019;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain Governmental Inquiries and Related Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2016 U.S. Attorney Texas Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#x2019;s Office, Northern District of Texas. The government is conducting a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#x2019;s relationships with pharmaceutical manufacturers. The government's investigation covers the period from January&#160;1, 2006 through December 31, 2018. In December 2017, the Company finalized and executed a settlement agreement that resolved certain of the issues in the government's investigation and that included total monetary consideration of $63,700, as previously disclosed, of which $41,500 was an incremental cash payment and $22,200 was for amounts previously refunded, and all of which was previously accrued. The government&#x2019;s investigation is ongoing with respect to issues related to DaVita Rx's historic relationships with certain pharmaceutical manufacturers, and in July 2018 the Office of Inspector General (OIG) served the Company with a subpoena seeking additional documents and information relating to those relationships. On September 15, 2021, the U.S. Attorney&#x2019;s Office notified the U.S. District Court, Northern District of Texas, of its decision and the decision of 31 states not to elect to intervene at this time in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. ex rel. Doe v. DaVita Inc., et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The court then unsealed the complaint, which alleges violations of the FCA, by order dated September 17, 2021. The complaint was not served on the Company. In December 2021, the private party relator filed a notice of voluntary dismissal of all claims and the Court entered an order dismissing the claims without prejudice. The Company is continuing to cooperate with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2017 U.S. Attorney Colorado Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In November 2017, the U.S. Attorney&#x2019;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#x2019;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018, May 2019, and July 2021, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 U.S. Attorney New Jersey Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In March 2020, the U.S. Attorney&#x2019;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#x2019;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#x2019;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired October 22, 2019. The Company is cooperating with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 California Department of Insurance Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020, and an additional subpoena in September 2021. Those subpoenas request information on a number of topics, including but not limited to the Company&#x2019;s communications with patients about insurance plans and financial assistance from the American Kidney Fund (AKF), analyses of the potential impact of patients&#x2019; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is cooperating with CDI in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 Department of Justice Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In October 2020, the Company received a CID from the Department of Justice pursuant to a False Claims Act investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covers the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. The Company is cooperating with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* * *&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and on-going discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#x2019;s reputation, required changes to the Company&#x2019;s business practices, an impact on the Company's various relationships and/or contracts related to the Company's business, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2021 Antitrust Indictment and Putative Class Action Suit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: On July 14, 2021, an indictment was returned by a grand jury in the U.S. District Court, District of Colorado against the Company and its former chief executive officer in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. v. DaVita Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The two count indictment alleges that purported agreements entered into by DaVita's former chief executive officer not to solicit senior-level employees violate Section 1 of the Sherman Act. On September 14, 2021, DaVita and its former chief executive officer filed a motion to dismiss the indictment. On November 3, 2021, a superseding indictment was returned in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. v. DaVita Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; that included an additional count alleging a third violation of the Sherman Act. On November 10, 2021, DaVita and its former chief executive officer filed a renewed motion to dismiss the superseding indictment. On January&#160;28,&#160;2022, the court denied the motion to dismiss. The matter is set to start trial on March 28, 2022. On July 16, 2021, a former DaVita employee filed a putative class action complaint in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pena v. Surgical Care Affiliates, LLC&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. District Court, Northern District of Illinois based on the allegations in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. v. DaVita Inc., et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. On August 6, 2021, the plaintiff in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pena&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case filed a notice of voluntary dismissal and the court dismissed the complaint on August 9, 2021. On August 9, 2021, DaVita was named as defendant in a consolidated class action complaint in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re Outpatient Medical Center Employee Antitrust Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. District Court, Northern District of Illinois. This class action complaint seeks to bring an action on behalf of certain groups of individuals employed by the Company between February 1, 2012 and January 5, 2021. On October 18, 2021, the Company filed a motion to dismiss the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;class action complaint. The Company disputes the allegations in the superseding indictment and the class action complaint, as well as the asserted violations of the Sherman Act, and intends to defend these actions accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Marietta Memorial Hospital Employee Health Benefit Plan, et al. v. DaVita Inc. et al. No. 20-1641&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: On November 5, 2021 the United States Supreme Court granted certiorari of an appeal by an employer group health plan, the plan sponsor, and the plan&#x2019;s advisor of the U.S. Court of Appeals for the Sixth Circuit (Sixth Circuit) decision in the Company's favor. The questions presented involve whether the health plan violates the Medicare Secondary Payor Act by "taking into account" that plan beneficiaries are eligible for Medicare and/or by "differentiating" between the benefits that the plan offers to patients with dialysis versus others. On December 23, 2021, the Solicitor General on behalf of the United States filed an amicus brief supporting the petitioners' request to overturn the Sixth Circuit decision. On January 19, 2022, the Company filed its brief in support of the Sixth Circuit decision, and the Company intends to defend against the appeal accordingly. The case is set for oral argument on March 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* * *&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in Note 16 to these consolidated financial statements, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#x2019;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#x2019;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, may impact the Company's various relationships and/or contracts related to the Company's business or otherwise harm the Company&#x2019;s business, results of operations, financial condition, cash flows or reputation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Resolved Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Peace Officers&#x2019; Annuity and Benefit Fund of Georgia Securities Class Action Civil Suit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: On February 1, 2017, the Peace Officers&#x2019; Annuity and Benefit Fund of Georgia filed a putative federal securities class action complaint in the U.S. District Court for the District of Colorado against the Company and certain executives.&#160;The complaint covers the time period of August 2015 to October 2016 and alleges, generally, that the Company and its executives violated&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;federal securities laws concerning the Company&#x2019;s financial results and revenue derived from patients who received charitable premium assistance from an industry-funded non-profit organization.&#160;The complaint further alleges that the process by which patients obtained commercial insurance and received charitable premium assistance was improper and "created a false impression of DaVita&#x2019;s business and operational status and future growth prospects."&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company continues to dispute the allegations, it reached an agreement to resolve this matter without admitting to any liability.&#160;Settlement of this matter was covered primarily with insurance proceeds. The Company contributed an amount that did not have a material impact on the Company&#x2019;s consolidated financial position, results of operations or cash flows. On April 13, 2021, the court granted final approval of the settlement. On August 9, 2021, the court entered final judgment and dismissed all claims in the action with prejudice.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;In re DaVita Inc. Stockholder Derivative Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: On August 15, 2017, the U.S. District Court for the District of Delaware consolidated three previously disclosed shareholder derivative lawsuits: the Blackburn Shareholder action filed on February 10, 2017, the Gabilondo Shareholder action filed on May 30, 2017, and the City of Warren Police and Fire Retirement System Shareholder action filed on June 9, 2017. The complaint covers the time period from 2015 to present and alleges, generally, breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, corporate waste, and misrepresentations and/or failures to disclose certain information in violation of the federal securities laws in connection with an alleged practice to direct patients with government-subsidized health insurance into private health insurance plans to maximize the Company&#x2019;s profits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the defendants continue to dispute the allegations, an agreement was reached to resolve this matter without admitting to any liability and the court approved the settlement and entered final judgment and dismissed the case with prejudice on January 29, 2021. As part of the settlement, the Company agreed to certain corporate governance policies, but did not make any financial contribution towards the settlement.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2018 U.S. Attorney Florida Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In March 2018, DaVita Labs received two CIDs from the U.S. Attorney&#x2019;s Office, Middle District of Florida that were identical in nature but directed to the two different labs. According to the face of the CIDs, the U.S. Attorney&#x2019;s Office is conducting an investigation as to whether the Company&#x2019;s subsidiary submitted claims for blood, urine, and fecal testing, where there were insufficient test validation or stability studies to ensure accurate results, in violation of the FCA. In October 2018, DaVita Labs received a subpoena from the OIG in connection with this matter requesting certain patient records linked to clinical laboratory tests. On September 30, 2019, the U.S. Attorney&#x2019;s Office notified the U.S. District Court, Middle District of Florida, of its decision not to elect to intervene at this time in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. ex rel. Lorne Holland, et al. v. DaVita Healthcare Partners, Inc., et al&lt;/span&gt;. The court then unsealed the complaint, which alleges violations of the FCA, by order dated the same day. In January 2020, the private party relators served the Company and DaVita Labs with an amended complaint. The Company and DaVita Labs answered the complaint on July 23, 2020. On August 10, 2021, the court entered summary judgment in favor of the Company and DaVita Labs on all of the relators&#x2019; FCA claims leaving only the claims for retaliation. The court dismissed the case on October 13, 2021. On October 15, 2021, the parties signed an agreement to resolve the remaining retaliation claims for an immaterial amount.</us-gaap:LossContingencyDisclosures>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="if21f5702256f425495741fad20cc492f_D20171201-20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzQvZnJhZzpkN2JjYTZmNDYxMDY0ZDQ2YjVmY2Q0NzA0YTE2MDQ5Mi90ZXh0cmVnaW9uOmQ3YmNhNmY0NjEwNjRkNDZiNWZjZDQ3MDRhMTYwNDkyXzM3NzQ_d434660f-e260-4918-9700-be2439c6f62a"
      unitRef="usd">63700000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ibd5bad9eacc4435abc4605158f6eb4f0_D20171201-20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzQvZnJhZzpkN2JjYTZmNDYxMDY0ZDQ2YjVmY2Q0NzA0YTE2MDQ5Mi90ZXh0cmVnaW9uOmQ3YmNhNmY0NjEwNjRkNDZiNWZjZDQ3MDRhMTYwNDkyXzM4MTI_3bd696fa-ad51-4b47-a1fd-0bf770708133"
      unitRef="usd">41500000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ie0c63c6719e446e98d499e8b261b5511_D20171201-20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzQvZnJhZzpkN2JjYTZmNDYxMDY0ZDQ2YjVmY2Q0NzA0YTE2MDQ5Mi90ZXh0cmVnaW9uOmQ3YmNhNmY0NjEwNjRkNDZiNWZjZDQ3MDRhMTYwNDkyXzM4NTE_0146e4a5-0aed-4b90-8a6f-96d67e82dfdd"
      unitRef="usd">22200000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:CommitmentsDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzQ1ODQ_31d6d778-c5c8-4042-acc4-a06629a78823">Noncontrolling interests subject to put provisions and other commitments&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has potential obligations to purchase the equity interests held by third parties in many of its majority-owned dialysis partnerships and other nonconsolidated entities. These noncontrolling interests subject to put provisions constitute redeemable equity interests and are therefore classified as temporary equity and carried at estimated fair value on the Company's balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Specifically, these obligations are in the form of put provisions that are exercisable at the third-party owners&#x2019; discretion within specified periods outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase the third-party owners&#x2019; equity interests, generally at the appraised fair market value of the equity interests or in certain cases at a predetermined multiple of earnings or cash flows attributable to the equity interests put to the Company, intended to approximate fair value. The methodology the Company uses to estimate the fair values of noncontrolling interests subject to put provisions assumes the higher of either a liquidation value of net assets or an average multiple of earnings, based on historical earnings, patient mix and other performance indicators that can affect future results, as well as other factors. The estimated fair values of noncontrolling interests subject to put provisions are a critical accounting estimate that involves significant judgments and assumptions and may not be indicative of the actual values at which the noncontrolling interests may ultimately be settled, which could vary significantly from the Company&#x2019;s current estimates. The estimated fair values of noncontrolling interests subject to put provisions can fluctuate and the implicit multiple of earnings at which these noncontrolling interests obligations may be settled will vary significantly depending upon market conditions including potential purchasers&#x2019; access to the capital markets, which can impact the level of competition for dialysis and non-dialysis related businesses, the economic performance of these businesses and the restricted marketability of the third-party owners&#x2019; equity interests. The amount of noncontrolling interests subject to put provisions that employ a contractually predetermined multiple of earnings rather than fair value is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain consolidated dialysis partnerships are originally contractually scheduled to dissolve after terms ranging from ten years to 50 years. While noncontrolling interests in these limited life entities qualify as mandatorily redeemable financial instruments, they are subject to a classification and measurement scope exception from the accounting guidance generally applicable to other mandatorily redeemable financial instruments. Future distributions upon dissolution of these entities would be valued below the related noncontrolling interest carrying balances in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2017, the Company entered into a Sourcing and Supply Agreement with Amgen USA Inc. (Amgen) that expires on December&#160;31, 2022. Under the terms of the agreement, the Company will purchase EPO from Amgen in amounts necessary to meet no less than 90% of its requirements for erythropoiesis-stimulating agents (ESAs) through the expiration of the contract. The actual amount of EPO that the Company will purchase will depend upon the amount of EPO administered during dialysis as prescribed by physicians and the overall number of patients that the Company serves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreements with various suppliers to purchase established amounts of dialysis equipment, parts, and supplies. As of December&#160;31, 2021, the remaining minimum purchase commitments under these arrangements were approximately $549,079, $510,991, $430,196, and $345,863 for the years 2022, 2023, 2024, and 2025, respectively. If the Company fails to meet the minimum purchase commitments under these contracts during any year, it is required to pay the difference to the supplier.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $13,469.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than the letters of credit disclosed in Note 13 to these consolidated financial statements, and the arrangements as described above, the Company has no off balance sheet financing arrangements as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <dva:DissolutionTermOfJointVentures
      contextRef="i2be3f954e5f14213b4903797ad633c44_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzI4OTI_c4e31996-933d-402b-a87d-04215f3abd3f">P10Y</dva:DissolutionTermOfJointVentures>
    <dva:DissolutionTermOfJointVentures
      contextRef="ife16d51280fb452d8a63ec87d4093b0f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzI4OTg_f3c79c1a-a3d7-4b84-bb55-0cacb5203d7d">P50Y</dva:DissolutionTermOfJointVentures>
    <dva:LongTermPurchaseCommitmentExpirationDate
      contextRef="if5bfd09272294ace935620050b39f2f8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzM0OTA_8e322ef7-737b-411e-b47a-1c6d6ecefae5">2022-12-31</dva:LongTermPurchaseCommitmentExpirationDate>
    <dva:LongTermPurchaseCommitmentPercentageOfQuantityRequired
      contextRef="i64d9f8f9c7f64715b2760f70c13f5222_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzM2MTE_cd3430e6-07f2-47c9-b1d6-8c5ebb3c4704"
      unitRef="number">0.90</dva:LongTermPurchaseCommitmentPercentageOfQuantityRequired>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzQxNTA_09c1235d-c16a-42ad-9e2a-27351100458c"
      unitRef="usd">549079000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:PurchaseObligationDueInSecondYear
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzQxNTQ_028c2e00-4c6a-48e1-8f9d-910695ced2bb"
      unitRef="usd">510991000</us-gaap:PurchaseObligationDueInSecondYear>
    <us-gaap:PurchaseObligationDueInThirdYear
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzQxNTg_9098ba8e-d6fa-4acc-8ffe-8a8abb633a2b"
      unitRef="usd">430196000</us-gaap:PurchaseObligationDueInThirdYear>
    <us-gaap:PurchaseObligationDueInFourthYear
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzQxNjY_d7e916bf-ab7c-49a1-86f9-d16929155686"
      unitRef="usd">345863000</us-gaap:PurchaseObligationDueInFourthYear>
    <us-gaap:OtherCommitment
      contextRef="iafc102d9c4e84b66827b02448eb62b33_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzc2OTY1ODEzOTk2Mzc_5595cc97-db6c-4bd2-b89c-6e2c931a1292"
      unitRef="usd">13469000</us-gaap:OtherCommitment>
    <dva:OffBalanceSheetFinancingArrangements
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yNzcvZnJhZzpiNWM3MDhmZTBlZjY0MTE2Yjc5OTNjMmUwNTc3MmQyMC90ZXh0cmVnaW9uOmI1YzcwOGZlMGVmNjQxMTZiNzk5M2MyZTA1NzcyZDIwXzQ1Mjc_b87357c9-9cb7-4a1e-bf45-e64293d073e0"
      unitRef="usd">0</dva:OffBalanceSheetFinancingArrangements>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMzY1_5a37543e-7ba8-48b8-9c32-f2e4dd0715d4">Stock-based compensation&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation consists primarily of stock-settled stock appreciation rights, restricted stock units and performance stock units. Stock-based compensation, which is primarily general and administrative in nature, is attributed to the Company&#x2019;s U.S. dialysis business, its corporate administrative support, and its ancillary services. See Note 1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;"Organization and summary of significant accounting policies" &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for more information on how the Company measures and recognizes stock-based compensation expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term incentive compensation plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 11, 2020, the Company&#x2019;s stockholders approved the DaVita Inc. 2020 Incentive Award Plan (the 2020 Plan). Prior to June 11, 2020 stock-based awards were granted under the DaVita Healthcare Partners Inc. 2011 Incentive Award Plan (the 2011 Plan). The 2011 Plan was terminated with respect to any new awards upon stockholder approval of the 2020 Plan. At the time the 2020 Plan was approved there were 8,730 shares of common stock available for issuance under the 2020 Plan, consisting of 5,000 newly authorized shares and 3,730 shares that were available for issuance under the 2011 Plan as of the effective date of the 2020 Plan and which became available for grant under the 2020 Plan, pursuant to the terms of the 2020 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2020 Plan is the Company&#x2019;s current omnibus equity compensation plan and provides for grants of stock-based awards to employees, directors and other individuals providing services to the Company, except that incentive stock options may only be awarded to employees. The 2020 Plan provides for the grant of stock appreciation rights, nonqualified stock options, incentive stock options, restricted stock units, restricted stock, performance stock awards, dividend equivalents, stock payments, deferred stock unit awards, deferred stock awards and performance cash awards. The 2020 Plan mandates a maximum award term of 10 years for stock appreciation rights and stock options and stipulates that awards of these types be granted with a base or exercise price per share of not less than the fair market value of the Company's common stock on the date of grant. Shares available under the 2020 Plan are also stated on a full value share basis rather than on an option-equivalent basis. The 2020 Plan therefore provides that shares available for issuance under the plan are reduced by one share available for every four shares underlying stock appreciation rights and stock options, and are reduced by one share available for every one share underlying stock-based awards other than stock appreciation rights and stock options. At December&#160;31, 2021, there were 7,672 shares available for future grants under the 2020 Plan. The Company&#x2019;s stock awards granted under the 2020 Plan generally vest over 36 months to 48 months from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2011 Plan was the Company&#x2019;s prior omnibus equity compensation plan and authorized the Company to award stock options, stock appreciation rights, restricted stock units, restricted stock, and other stock-based or performance-based awards. The 2011 Plan mandated a maximum award term of five years and stipulated that stock appreciation rights and stock options be granted with prices not less than fair market value on the date of grant. The 2011 Plan also required that full value share awards such as restricted stock units reduce shares available under the 2011 Plan at a ratio of 3.5:1. The Company&#x2019;s stock appreciation rights and stock units awarded under the 2011 Plan generally vest over 36 months to 48 months from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A combined summary of the status of the Company&#x2019;s stock-settled awards under both the 2020 Plan and 2011 Plan, including base shares for stock-settled stock appreciation rights (SSARs) and stock-settled stock unit awards is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.890%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Stock appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Stock units&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&#160;life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&#160;life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Added by performance factor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised/Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercisable at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value of grants:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Awards Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Awards exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Range of SSARs base prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$50.01&#x2013;$60.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$60.01&#x2013;$70.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$70.01&#x2013;$80.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$100.01&#x2013;$110.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2021, 2020, and 2019, the aggregate intrinsic value of stock-based awards exercised was $208,585, $49,258 and $11,475, respectively. At December&#160;31, 2021, the aggregate intrinsic value of stock-based awards outstanding was $680,251 and the aggregate intrinsic value of stock awards exercisable was $61,389.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Estimated fair value of stock-based compensation awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has estimated the grant-date fair value of stock-settled stock appreciation rights awards using the Black-Scholes-Merton valuation model and stock-settled stock unit awards at intrinsic value on the date of grant, except for portions of the Company&#x2019;s performance stock unit awards for which a Monte Carlo simulation was used to estimate the grant-date fair value. The following assumptions were used in estimating these values and determining the related stock-based compensation expense attributable to the current period:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected term of the awards:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The expected term of awards granted represents the period of time that they are expected to remain outstanding from the date of grant. The Company determines the expected term of its stock awards based on its historical experience with similar awards, considering the Company&#x2019;s historical exercise and post-vesting termination patterns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected volatility:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Expected volatility represents the volatility anticipated over the expected term of the award. The Company determines the expected volatility for its awards based on the volatility of the price of its common stock over the most recent retrospective period commensurate with the expected term of the award, considering the volatilities expected by peer companies in near industries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected dividend yield:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The Company has not paid dividends on its common stock and does not currently expect to pay dividends during the term of stock awards granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-free interest rate:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The Company bases the expected risk-free interest rate on the implied yield currently available on stripped interest coupons of U.S. Treasury issues with a remaining term equivalent to the expected term of the award.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of SSAR awards granted in the periods indicated is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The Company estimates expected forfeitures based upon historical experience with separate groups of employees that have exhibited similar forfeiture behavior in the past. Stock-based compensation expense is recorded only for awards that are expected to vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 4, 2019, the independent members of the Company&#x2019;s Board of Directors (Board) approved an award of 2,500 premium-priced stock-settled stock appreciation rights (Premium-Priced Award) to the Company&#x2019;s Chief Executive Officer (CEO), which award was subject to stockholder approval of a related amendment to the 2011 Plan. Stockholders approved such amendment to the 2011 Plan on January 23, 2020, authorizing the grant to the Company's CEO. Since stockholder approval occurred in 2020, this award was treated as granted in 2020 for accounting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The base price of the Premium-Priced Award was $67.80 per share, which was a 20% premium to the clearing price of the Company's modified Dutch auction tender offer for its shares in 2019 (2019 Tender Offer). The award vests 50% on each of November&#160;4, 2022 and November&#160;4, 2023 and expires on November&#160;4, 2024. The award includes a requirement that the CEO hold any shares acquired upon exercise of this award, net of shares used to cover related taxes, until November&#160;4, 2024 (that is, for the full term of the award), subject to lapse of the holding period upon a change in control of the Company or due to the CEO's death or termination due to disability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Employee Stock Purchase Plan entitles qualifying employees to purchase up to $25 of the Company&#x2019;s common stock during each calendar year. The amounts used to purchase stock are accumulated through payroll withholdings or through optional lump sum payments made in advance of the first day of the purchase right period. This compensatory plan allows employees to purchase stock for the lesser of 100% of its fair market value on the first day of the purchase right period or 85% of its fair market value on the last day of the purchase right period. Purchase right periods begin on January&#160;1 and July&#160;1, and end on December&#160;31. Contributions used to purchase the Company&#x2019;s common stock under this plan for the 2021, 2020 and 2019 purchase periods were $19,626, $17,148 and $16,569, respectively. Shares purchased pursuant to the plan&#x2019;s 2021, 2020 and 2019 purchase periods were 203, 222 and 315, respectively. At December&#160;31, 2021, there were 5,986 shares remaining available for future grants under this plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of participants&#x2019; purchase rights was estimated as of the beginning dates of the purchase right periods using the Black-Scholes-Merton valuation model with the following weighted average assumptions for purchase right periods in 2021, 2020 and 2019, respectively: expected volatility of 39.0%, 40.4% and 28.8%; risk-free interest rates of 0.1%, 1.0% and 2.6%, and no dividends. Using these assumptions, the weighted average estimated per share fair value of each purchase right was $34.94, $22.06 and $13.80 for 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based compensation expense and proceeds&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized $102,209, $91,458 and $63,705 in stock-based compensation expense for stock appreciation rights, stock units and discounted employee stock purchase plan purchases, which are primarily included in general and administrative expenses. The estimated tax benefits recorded for stock-based compensation in 2021, 2020 and 2019 were $13,853, $11,775 and $9,186, respectively. As of December&#160;31, 2021, there was $161,147 of total estimated but unrecognized stock-based compensation expense under the Company&#x2019;s equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of 1.2 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2021, 2020 and 2019, the Company received $46,990, $8,957 and $2,251, respectively, in actual tax benefits upon the exercise or vesting of stock awards. Since the Company issues stock-settled stock appreciation rights rather than stock options, there were no cash proceeds from stock option exercises.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ic622bc7776774482b0a75f8b50b90c1b_I20200611"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzE5NDU_ff1908ca-782f-46a6-95cc-95116b3ebc1c"
      unitRef="shares">8730000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ic622bc7776774482b0a75f8b50b90c1b_I20200611"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzIwMjk_f373d13a-b154-478a-8791-f3e5cf38519e"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i7cd5dd9a955e4f3595a1f2ea57f1dd2a_I20200611"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzIwNjA_bb575300-2134-456f-96dc-345410cac17b"
      unitRef="shares">3730000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i35c0745d14cd45a6967e0f7b75a5a9d2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzI4ODQ_454c343f-ef4b-472b-9282-f8804a2b2f46">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <dva:StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions
      contextRef="i7e9c2f87088c43fb9b9ca96464a7c38f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzMzNDE_3a2a6f8e-162c-4670-b900-0ff5d29846be"
      unitRef="shares">1</dva:StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions>
    <dva:StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance
      contextRef="i7e9c2f87088c43fb9b9ca96464a7c38f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzMzNzA_048bd346-7544-4bb3-ba1b-d0939fd44f9c"
      unitRef="shares">4</dva:StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance>
    <dva:StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward
      contextRef="i7e9c2f87088c43fb9b9ca96464a7c38f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzM0NTU_15d2c35e-e3d3-4e46-b5a2-b66ee576093f"
      unitRef="shares">1</dva:StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward>
    <dva:StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance
      contextRef="i7e9c2f87088c43fb9b9ca96464a7c38f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzM0ODQ_2e4d8263-0a0f-4bf6-b264-4731a105cac3"
      unitRef="shares">1</dva:StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ib351125c6c8e42c092e5fa01eb01c2c7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzM1OTc_f6923cde-5afa-41a3-adc0-76bbf0540b3a"
      unitRef="shares">7672000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9b85e310c2ac454bb82196389edfda90_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzM3MzA_1e25f07a-b064-47a8-89d4-13b3667fa599">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i35c0745d14cd45a6967e0f7b75a5a9d2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzM3MzY_a88e1617-5e87-4466-bfde-46ae32903b2a">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i945bf94544c1438d8e7ef2556b93e671_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQxMzA_ba3d1ef9-45a9-46a2-a00b-f97712cbd5f8">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <dva:SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio
      contextRef="i945bf94544c1438d8e7ef2556b93e671_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQ0MjA_f4bbc865-0728-400e-aec8-ef4e2c2a664e"
      unitRef="number">3.5</dva:SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i4579481a1deb4e84842b772212d72988_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQ1MzA_fad8ea5a-7e96-48c5-a9c3-0e7e95150a40">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8af02ad747e04ed092ad98eca4b0cece_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQ1MzY_3f6b9824-d81c-4b91-9a43-c843cf26d1d6">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMzY3_43e37d12-efab-4556-b224-23c85a25358c">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A combined summary of the status of the Company&#x2019;s stock-settled awards under both the 2020 Plan and 2011 Plan, including base shares for stock-settled stock appreciation rights (SSARs) and stock-settled stock unit awards is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.754%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.890%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Stock appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Stock units&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&#160;life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&#160;life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Added by performance factor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised/Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercisable at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value of grants:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5f4abca32687438c9db55fe5ab0adc1e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzMtMS0xLTEtODMwNzg_09680574-e7ac-42b7-8059-fe0a29ffb1f9"
      unitRef="shares">8084000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5f4abca32687438c9db55fe5ab0adc1e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzMtMy0xLTEtODMwNzg_73cc22d0-0f2f-4f4f-8f06-32c29906cf42"
      unitRef="usdPerShare">63.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i84101fbfd0514880a929fe88d9382ec5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzMtNy0xLTEtODMwNzg_b68e509e-c2b0-4d03-9614-854cd60b2729"
      unitRef="shares">3537000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzQtMS0xLTEtODMwNzg_e1227ca5-fd46-4539-89fa-e43223cccd3b"
      unitRef="shares">132000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzQtMy0xLTEtODMwNzg_cdccc2ee-78b6-4ee6-aaf4-a601c72ab42b"
      unitRef="usdPerShare">108.93</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzQtNy0xLTEtODMwNzg_776b8eeb-80c8-43fa-98b5-6f2798515113"
      unitRef="shares">789000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod
      contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzUtNy0xLTEtODMwNzg_30754be2-5c3d-4a0b-8be5-9b1d8e0b35d4"
      unitRef="shares">153000</dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzYtMS0xLTEtODMwNzg_b436e126-6f7d-4e8d-9819-b29768edd84a"
      unitRef="shares">2093000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzYtMy0xLTEtODMwNzg_c7d56440-e789-4bd4-bf4b-54f207d3bb1d"
      unitRef="usdPerShare">64.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzYtNy0xLTEtODMwNzg_4df45f60-8042-4af0-b01b-c03678c87214"
      unitRef="shares">696000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzgtMS0xLTEtODMwNzg_fd47e451-24d7-4649-80fe-f7e5ba3d8819"
      unitRef="shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzgtMy0xLTEtODMwNzg_bc50cfc2-615d-4582-9266-b26026caa4a7"
      unitRef="usdPerShare">59.19</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzgtNy0xLTEtODMwNzg_4417c195-cea8-4903-afc4-1b860519412d"
      unitRef="shares">398000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic4d14e355b8248a1b1ab9ddb2b5f20bc_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzktMS0xLTEtODMwNzg_878d52cf-e4d7-42df-b56c-3b6d3dfb5876"
      unitRef="shares">5943000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ic4d14e355b8248a1b1ab9ddb2b5f20bc_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzktMy0xLTEtODMwNzg_4b0c0972-560f-4a8b-91f3-ccfbbad28bcc"
      unitRef="usdPerShare">64.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzktNS0xLTEtODMwNzg_8591291b-2b83-4951-b6af-5cabcb2c0b47">P2Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ic595c1af14b94764aab706a16639ebc2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzktNy0xLTEtODMwNzg_4c4e6366-a580-4d60-9d0c-62e8a27c4f6a"
      unitRef="shares">3385000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzktOS0xLTEtODMwNzg_af8d9ca3-49ec-4e96-9b1d-2f646a0e98c7">P1Y4M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ic4d14e355b8248a1b1ab9ddb2b5f20bc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEwLTEtMS0xLTgzMDc4_2cbe34c9-c803-4afe-ba5c-dcc3e454932f"
      unitRef="shares">1161000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ic4d14e355b8248a1b1ab9ddb2b5f20bc_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEwLTMtMS0xLTgzMDc4_ec08d8fe-0332-4ac5-906d-686bbce91ba4"
      unitRef="usdPerShare">61.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEwLTUtMS0xLTgzMDc4_883e28db-66ec-4696-82b9-a83d41862a0e">P1Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
      contextRef="ic595c1af14b94764aab706a16639ebc2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEwLTctMS0xLTgzMDc4_c0d32dd0-c5b7-47ff-a85e-4dd0c1792a4a"
      unitRef="shares">0</dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i403917ba9a6e46d299ebc69279a91748_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEyLTEtMS0xLTgzMDc4_93d46f80-3335-4296-af90-241445f162c5"
      unitRef="usdPerShare">32.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia740e99e11b44bf3ba2627ca847d9452_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEyLTctMS0xLTgzMDc4_09eda410-8949-4e22-9bf6-35bde5cdb925"
      unitRef="usdPerShare">109.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i827e2371cbd94ca1a2c25ee147f4a6bf_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEzLTEtMS0xLTgzMDc4_82a8a4ac-c167-4767-9817-9e878786ccc6"
      unitRef="usdPerShare">26.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0917584175d94759b1facacb37055db9_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzEzLTctMS0xLTgzMDc4_e2742d7e-43b2-4ec6-a1cd-89de060fab39"
      unitRef="usdPerShare">77.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if8276ca374b541099daef28f0d1b9d96_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzE0LTEtMS0xLTgzMDc4_6bbda5db-d03f-43b4-ba6d-4418742e7703"
      unitRef="usdPerShare">14.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i501bc5f3ffe44653996610d022c113bd_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTo2OGUxNTllNmViYjg0NzMwYjVhNDA2MmVkNmQ5YzkzMi90YWJsZXJhbmdlOjY4ZTE1OWU2ZWJiODQ3MzBiNWE0MDYyZWQ2ZDljOTMyXzE0LTctMS0xLTgzMDc4_ce02e648-3484-4e8a-9a18-af2d819c268e"
      unitRef="usdPerShare">50.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMzYy_326851e0-eb29-48a4-92aa-366b1fe3216c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Awards Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Awards exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Range of SSARs base prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$50.01&#x2013;$60.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$60.01&#x2013;$70.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$70.01&#x2013;$80.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$100.01&#x2013;$110.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i79b0c0d86d8e45d790c2ff8423f37743_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzItMi0xLTEtODMwNzg_04aed0f3-ba79-487b-bdf9-ad0895a17dbe"
      unitRef="shares">1561000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i79b0c0d86d8e45d790c2ff8423f37743_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzItNC0xLTEtODMwNzg_1b7bc715-894e-4f9d-a7c8-d1f59c514769"
      unitRef="usdPerShare">52.45</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i79b0c0d86d8e45d790c2ff8423f37743_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzItNi0xLTEtODMwNzg_23d05769-21e9-4f39-8172-434d90cf3530"
      unitRef="shares">425000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i79b0c0d86d8e45d790c2ff8423f37743_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzItOC0xLTEtODMwNzg_1cc724bd-3cae-4298-b2d0-6e43b136001b"
      unitRef="usdPerShare">52.55</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i8c8c2a2e98ec40d79e375f2a9fffd77c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzMtMi0xLTEtODMwNzg_6f380406-0682-4119-bb0d-02f76a78970a"
      unitRef="shares">3974000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i8c8c2a2e98ec40d79e375f2a9fffd77c_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzMtNC0xLTEtODMwNzg_ba020f3f-69f3-4dcc-8d35-38367b109b5d"
      unitRef="usdPerShare">67.22</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i8c8c2a2e98ec40d79e375f2a9fffd77c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzMtNi0xLTEtODMwNzg_1f818863-31da-4263-b562-c1b204bc8b6a"
      unitRef="shares">732000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i8c8c2a2e98ec40d79e375f2a9fffd77c_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzMtOC0xLTEtODMwNzg_4804f15c-488f-4986-9b6d-b8229a33b27b"
      unitRef="usdPerShare">66.05</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i97843a20897047b5a1130cbd153c19f6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzQtMi0xLTEtODMwNzg_4c3cd903-1248-4700-b1e5-c071a1ea536a"
      unitRef="shares">276000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i97843a20897047b5a1130cbd153c19f6_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzQtNC0xLTEtODMwNzg_6e4ecf33-e039-4f58-a375-cf9b1cdf8106"
      unitRef="usdPerShare">75.77</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i97843a20897047b5a1130cbd153c19f6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzQtNi0xLTEtODMwNzg_e37000e4-4483-43d7-92ea-e3b61c9359ad"
      unitRef="shares">4000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i97843a20897047b5a1130cbd153c19f6_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzQtOC0xLTEtODMwNzg_f9a760d7-a62a-4028-9254-6d29514d7db9"
      unitRef="usdPerShare">71.64</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ia27684d4183a41acb4b535601396cbc2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtMi0xLTEtMTM0NzE1_6ca18f45-5d0c-45f7-a071-cc40cd862a41"
      unitRef="shares">132000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ia27684d4183a41acb4b535601396cbc2_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtNC0xLTEtMTM0NzE1_92348be6-4557-4a7f-ba7c-47532da25111"
      unitRef="usdPerShare">108.93</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ia27684d4183a41acb4b535601396cbc2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtNi0xLTEtMTM0NzE1_aa6dc534-19cb-4a2c-a333-2dcc9edc9312"
      unitRef="shares">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="ia27684d4183a41acb4b535601396cbc2_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtOC0xLTEtMTM0NzE1_d30481d6-9d9f-4cb2-9347-9bf42242053f"
      unitRef="usdPerShare">0</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtMi0xLTEtODMwNzg_fbf2d89d-dc5d-40cc-bf8f-f86aca2d6735"
      unitRef="shares">5943000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtNC0xLTEtODMwNzg_75a9f885-c34d-4e14-9a8d-0dbd19a48641"
      unitRef="usdPerShare">64.66</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtNi0xLTEtODMwNzg_69714dba-900b-4901-af10-1b20585c0490"
      unitRef="shares">1161000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTpmMDgwNjc3ZDdjNjg0YzExOTYwZGY1Yjk3MGUwMThjYi90YWJsZXJhbmdlOmYwODA2NzdkN2M2ODRjMTE5NjBkZjViOTcwZTAxOGNiXzUtOC0xLTEtODMwNzg_5819895f-c91c-491f-9415-f18ba6770955"
      unitRef="usdPerShare">61.13</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQ5MDU_cfa227be-17ff-44b0-87c0-b24232b8d4d2"
      unitRef="usd">208585000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQ5MDk_85212619-8a2f-459e-8c26-682df8f409ef"
      unitRef="usd">49258000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzQ5MTY_9b144b32-b786-49e4-b1d1-71227a08108e"
      unitRef="usd">11475000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzUwMDk_5e1123cf-4129-4cf7-ab4d-eb9e4c5005f1"
      unitRef="usd">680251000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzUwNzg_0665a602-0d65-4373-9b9b-618499909f16"
      unitRef="usd">61389000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMzY4_407581a4-61f3-4e4f-9fc4-905053762358">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of SSAR awards granted in the periods indicated is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i6b0097cc1b5e467d90993d8c00830861_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzItMS0xLTEtODMwNzg_8ebb0099-64cc-4d50-8cf8-929fb6bfd7da">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="id524f2487e4c4b6b8d6dfc8130802d34_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzItMy0xLTEtODMwNzg_2d333d93-d50f-46f3-8792-6613cec9721f">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i42692d9f0c4245ddb37f1c5457eb7288_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzItNS0xLTEtODMwNzg_80fec409-2b26-49c2-a965-b195603a477e">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i6b0097cc1b5e467d90993d8c00830861_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzMtMS0xLTEtODMwNzg_7796ed75-385a-4907-8ae6-e549ab4653f8"
      unitRef="number">0.343</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="id524f2487e4c4b6b8d6dfc8130802d34_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzMtMy0xLTEtODMwNzg_fd711471-76a0-40d5-bc41-f698660559ca"
      unitRef="number">0.282</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i42692d9f0c4245ddb37f1c5457eb7288_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzMtNS0xLTEtODMwNzg_01baeb7c-6b06-432a-b597-4a74f19d0c8e"
      unitRef="number">0.295</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i6b0097cc1b5e467d90993d8c00830861_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzQtMS0xLTEtODMwNzg_d8b78fe1-22bc-45f1-9995-ed2af807fd57"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="id524f2487e4c4b6b8d6dfc8130802d34_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzQtMy0xLTEtODMwNzg_2bf4ec49-8d55-409d-a764-60eaf8a0026b"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i42692d9f0c4245ddb37f1c5457eb7288_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzQtNS0xLTEtODMwNzg_3677604c-3288-4e93-a274-8950361b127e"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i6b0097cc1b5e467d90993d8c00830861_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzUtMS0xLTEtODMwNzg_eecdde0e-f2e3-4959-ad1c-7aba6150d481"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="id524f2487e4c4b6b8d6dfc8130802d34_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzUtMy0xLTEtODMwNzg_99b7c44b-9c37-4d6a-b540-fa7926281aab"
      unitRef="number">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i42692d9f0c4245ddb37f1c5457eb7288_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90YWJsZTplNjc2NGE4Mzg4NGU0YjRlOWU4YjQ5YWFjMGM5OTg2OS90YWJsZXJhbmdlOmU2NzY0YTgzODg0ZTRiNGU5ZThiNDlhYWMwYzk5ODY5XzUtNS0xLTEtODMwNzg_78a84506-44ed-4ca0-9f21-f09369d0f1f9"
      unitRef="number">0.022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i4a9414d6f3884602bb28983144590fd6_D20191104-20191104"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzc0MDI_69e1af5a-6663-4adc-a7d0-57a88608b29c"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <dva:PremiumPricedAwardBasePricePerShare
      contextRef="ie576d2314dda4f0ebf4d0fcfd81bff38_I20191104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzc4OTg_2f1df131-9bc0-47b2-bfde-a4b9499022da"
      unitRef="usdPerShare">67.80</dva:PremiumPricedAwardBasePricePerShare>
    <dva:PremiumToTheTenderOfferSharePurchasePrice
      contextRef="ie576d2314dda4f0ebf4d0fcfd81bff38_I20191104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzc5MjQ_e567a4a8-15e3-4a59-86c6-220a3f15154e"
      unitRef="number">0.20</dva:PremiumToTheTenderOfferSharePurchasePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i3aa0d7d04018489e86afb5c88077307b_D20191104-20191104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzgwNzA_69675f19-c524-46b4-83d0-c55f70b86e11"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate
      contextRef="i3aa0d7d04018489e86afb5c88077307b_D20191104-20191104"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzgwODQ_2facff8e-bd83-4ffe-bfa9-5e320225f9b7">2022-11-04</dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate>
    <dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate
      contextRef="i3a011ba985114d35aac38e038221e94d_D20191104-20191104"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzgwOTE_3dbc6485-bd25-465b-9161-dcd4c6ea21ca">2023-11-04</dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="i4a9414d6f3884602bb28983144590fd6_D20191104-20191104"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzgxMDk_1616ab48-2b7b-422f-b5f0-5f2e51a18b1d">2024-11-04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate
      contextRef="i4a9414d6f3884602bb28983144590fd6_D20191104-20191104"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzgyNjI_1689e5f7-6245-4fbb-a8b3-185e7f9c7126">2024-11-04</dva:SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate>
    <dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase
      contextRef="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzg1NTc_724b6fdb-adb7-4ae7-900a-60b844e3001c"
      unitRef="usd">25000</dva:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i43f1797df61c4bada947140a55076305_D20210101-20210101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzg4NzQ_7bb404bf-ad21-43e9-94f4-386b30e4a74b"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i41c89f4e64064444ab4288488f07ab8a_D20211231-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzg5NTE_eca64166-7ef9-406f-bad3-ed7c8f3c87d9"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares
      contextRef="iabef7cbe53f54aab89ff94790caaaed4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkyMjE_ccc74cd4-011a-4502-8e41-338981ff44ea"
      unitRef="usd">19626000</dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares>
    <dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares
      contextRef="i380e810ddcd14e7bab4d2d061f0adab0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkyMjU_f1181695-c38a-4864-8687-552512f8ef40"
      unitRef="usd">17148000</dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares>
    <dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares
      contextRef="i10d2c3b34a424e5d8a056079072420d1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkyMzI_83a719cd-89de-4804-9ca9-85460497007c"
      unitRef="usd">16569000</dva:EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkzMjY_741cfe2e-3a0a-4f1c-81c9-ebc4a27c068f"
      unitRef="shares">203000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ie566e44321f64f1aa0fcc5e21f1a0e7c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkzMzA_068e5860-3468-489a-9f10-95b4b9bb2f2c"
      unitRef="shares">222000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i6dd1cc1bae74476ba5ac3d8c45f6fd36_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkzMzc_acbc3644-2192-4375-8677-564ba875f6ff"
      unitRef="shares">315000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="iabef7cbe53f54aab89ff94790caaaed4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzkzNzM_1b8161d4-7aa1-4cae-b9bd-017be4658271"
      unitRef="shares">5986000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3MzM_4aaae956-e300-4b62-abf6-c45edd5ad8b1"
      unitRef="number">0.390</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ie566e44321f64f1aa0fcc5e21f1a0e7c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3Mzc_a1084d13-c846-476a-89f5-b68fe5f76811"
      unitRef="number">0.404</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i6dd1cc1bae74476ba5ac3d8c45f6fd36_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3NDQ_ff4574cf-f70f-42e6-9d87-80ce555573b4"
      unitRef="number">0.288</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3NzY_e2806f1e-2a13-4296-8e87-4aa3b4ace9a4"
      unitRef="number">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie566e44321f64f1aa0fcc5e21f1a0e7c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3ODA_a5fa7a68-4019-49f5-822e-4d86f854a865"
      unitRef="number">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i6dd1cc1bae74476ba5ac3d8c45f6fd36_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3ODc_f676c0da-4f5f-410f-a6ad-d136e62e0a19"
      unitRef="number">0.026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk3OTU_bb5e051f-b223-4c97-9cfd-2b2b4ca41102"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib5384bf6b502412281bbd8841d65cc83_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk5MTM_39cf6593-68f7-4c71-9016-d3d7102a5eab"
      unitRef="usdPerShare">34.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie566e44321f64f1aa0fcc5e21f1a0e7c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk5MTc_c0e5fc25-0386-41ad-b817-356a5cbca58a"
      unitRef="usdPerShare">22.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6dd1cc1bae74476ba5ac3d8c45f6fd36_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2Xzk5MjQ_623b33c4-eb23-4fbf-a7d0-4ad36dcb96f1"
      unitRef="usdPerShare">13.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensation
      contextRef="iee68ddd110f44f1ab19b2eecfcc796b2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwMTMz_b3a2fe98-aded-4a7a-921a-bb00a751ff7b"
      unitRef="usd">102209000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic32b93908745434ba82e999a75ecc6c1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwMTM3_dae0e6f5-ce2d-4ca3-8a88-f0a8378216db"
      unitRef="usd">91458000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i069396e3d9b14202820b9db352b5ab69_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwMTQ0_6236ca9f-c0e2-456d-bd51-f51cbf9dcbc8"
      unitRef="usd">63705000</us-gaap:ShareBasedCompensation>
    <dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwNDUz_eca7db03-e525-4331-9709-36faf2ba0750"
      unitRef="usd">13853000</dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense>
    <dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwNDU3_f3386bdb-be19-44c5-beca-3d7d25023570"
      unitRef="usd">11775000</dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense>
    <dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwNDY0_a74265d9-fea4-4d63-a7c2-012e8fcf9da9"
      unitRef="usd">9186000</dva:EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwNTAy_da6bf7ec-1ac8-43a2-a820-b83c9d2a2e21"
      unitRef="usd">161147000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEwNzM5_6ea9ef34-7eb3-4aff-86da-b89feabd814f">P1Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMTE0_627923a5-708f-4ff6-add7-e9b4aef1b150"
      unitRef="usd">46990000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMTE4_b367986b-8d05-41ad-bbe6-cde14c3710da"
      unitRef="usd">8957000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMTI1_498878b9-b256-453d-be9f-92df29d553d5"
      unitRef="usd">2251000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODAvZnJhZzpkY2JiZmM4YzMzMmI0ZjE5OWFkY2IxYmVlYzI3OWNmNi90ZXh0cmVnaW9uOmRjYmJmYzhjMzMyYjRmMTk5YWRjYjFiZWVjMjc5Y2Y2XzEyMzE1_fdebdbce-2040-43b4-9a53-f2fac2960ec2"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:TreasuryStockTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzM0MjA_eb6a6074-d06b-4c3f-97c3-95def66724b3">Shareholders&#x2019; equity&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's repurchases of its common stock during the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Open market repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,546,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;741,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,168,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tender offers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;704,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,234,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,546,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,446,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,402,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The aggregate amounts paid for shares repurchased pursuant to the Company's 2020 and 2019 tender offers for its shares during the years ended 2020 and 2019, include their clearing prices of $88.00 and $56.50 per share, respectively, plus related fees and expenses of $2,529 and $2,343, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to December&#160;31, 2021 through February&#160;9, 2022, the Company has repurchased 1,437 shares of its common stock for $159,133 at an average cost of $110.73 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective on December 10, 2020, the Board terminated all remaining prior share repurchase authorizations available to the Company and approved a new share repurchase authorization of $2,000,000. Effective on December 17, 2021, the Board increased the Company's existing authorization by $2,000,000. The Company is authorized to make purchases from time to time in the open market or in privately negotiated transactions, including without limitation, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing, depending upon market conditions and other considerations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of February&#160;9, 2022, the Company has a total of $2,224,806 available under the current repurchase authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, the Company remains subject to share repurchase limitations, including under the terms of its senior secured credit facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company retired all shares held in its treasury effective as of December&#160;31, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Charter documents&#160;&amp;amp; Delaware law&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s charter documents include provisions that may deter hostile takeovers, delay or prevent changes of control or changes in management, or limit the ability of stockholders to approve transactions that they may otherwise determine to be in their best interests. These include provisions prohibiting stockholders from acting by written consent, requiring 90 days advance notice for director nominations and stockholder proposals and granting the Company's Board of Directors the authority to issue up to 5,000 shares of preferred stock and to determine the rights and preferences of the preferred stock without the need for further stockholder approval.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also subject to Section&#160;203 of the Delaware General Corporation Law which, subject to exceptions, prohibits the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period of three years following the date on which that stockholder became an interested stockholder. The provisions described above may discourage, delay or prevent an acquisition of the Company at a price that stockholders may find attractive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Changes in DaVita Inc.&#x2019;s ownership interests in consolidated subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of changes in DaVita Inc.&#x2019;s ownership interests in consolidated subsidiaries on the Company&#x2019;s consolidated equity were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.967%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;978,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;773,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;810,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in paid-in capital for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases of noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales of noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net transfers in noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc. net of transfers in &lt;br/&gt;&#160;noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;964,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;778,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;773,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company acquired additional ownership interests in several existing majority-owned partnerships for $20,104, $7,831, and $68,019 in 2021, 2020, and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:TreasuryStockTextBlock>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzM0MjE_fc22c571-5b1c-4f74-a049-69d763fadd55">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's repurchases of its common stock during the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Open market repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,546,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;741,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,168,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tender offers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;704,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,234,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,546,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,446,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,402,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The aggregate amounts paid for shares repurchased pursuant to the Company's 2020 and 2019 tender offers for its shares during the years ended 2020 and 2019, include their clearing prices of $88.00 and $56.50 per share, respectively, plus related fees and expenses of $2,529 and $2,343, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="iccf688ffd7124bc6aff7a41fd8083119_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzItMS0xLTEtODMwNzg_adcfea28-f227-449c-9a85-f6992b05ff03"
      unitRef="shares">13877000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i684fe46545c247fab8d3ef0b725b99a6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzItMy0xLTEtODMwNzg_55d9cb15-92cc-440a-9a35-91f25ca4f3cf"
      unitRef="shares">8495000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="iba8fa87bf6254cb286350207ba622d6f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzItNS0xLTEtODMwNzg_9775bac2-5b19-4270-bac4-87b6fc9e8f1b"
      unitRef="shares">19218000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iccf688ffd7124bc6aff7a41fd8083119_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzMtMS0xLTEtODMwNzg_160ab170-fe3d-4ae6-a01f-3b09c57d0942"
      unitRef="usd">1546016000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i684fe46545c247fab8d3ef0b725b99a6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzMtMy0xLTEtODMwNzg_0544ec23-ab10-43a9-9ca4-0f821e3fbaf8"
      unitRef="usd">741850000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iba8fa87bf6254cb286350207ba622d6f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzMtNS0xLTEtODMwNzg_5fe300a6-0cca-4849-b576-6c61d3dae617"
      unitRef="usd">1168321000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="iccf688ffd7124bc6aff7a41fd8083119_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzQtMS0xLTEtODMwNzg_413c1c68-4d7b-428b-b0f2-092a9ea61c84"
      unitRef="usdPerShare">111.41</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i684fe46545c247fab8d3ef0b725b99a6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzQtMy0xLTEtODMwNzg_c68773cc-95ae-4696-b6a9-2d0eb24b7f78"
      unitRef="usdPerShare">87.32</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="iba8fa87bf6254cb286350207ba622d6f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzQtNS0xLTEtODMwNzg_cd44fca2-64a1-422d-9ed3-bf0c62f658c8"
      unitRef="usdPerShare">60.79</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i88d2ab8df3834c2f925e018980a4b615_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzctMS0xLTEtODMwNzg_5a715e39-6f9e-48d4-a9be-94aeb3f61d85"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i3c74357cd2654da2ab5263e5e1505e1a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzctMy0xLTEtODMwNzg_f0e6dde0-165d-4c21-88f7-9866872cb8ee"
      unitRef="shares">7982000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i4d53d30fe41e4561a3d660180e6b98d1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzctNS0xLTEtODMwNzg_0625487a-8a31-4c8e-b300-c0f341382df2"
      unitRef="shares">21802000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i88d2ab8df3834c2f925e018980a4b615_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzgtMS0xLTEtODMwNzg_610e0912-b143-40dc-8385-0826c0f9e436"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i3c74357cd2654da2ab5263e5e1505e1a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzgtMy0xLTEtODMwNzg_184e71c9-ec64-438d-9135-068386f34367"
      unitRef="usd">704917000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i4d53d30fe41e4561a3d660180e6b98d1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzgtNS0xLTEtODMwNzg_d3e209ab-84cd-49f4-91b4-975ef971ba97"
      unitRef="usd">1234154000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i88d2ab8df3834c2f925e018980a4b615_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzktMS0xLTEtODMwNzg_9b84952d-d209-42fe-85d3-4a9301b380f5"
      unitRef="usdPerShare">0</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i3c74357cd2654da2ab5263e5e1505e1a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzktMy0xLTEtODMwNzg_45db9030-9e9b-4197-b2f9-3152430e271d"
      unitRef="usdPerShare">88.32</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i4d53d30fe41e4561a3d660180e6b98d1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzktNS0xLTEtODMwNzg_8944cd79-e5e9-4dc7-9022-923d3197b53c"
      unitRef="usdPerShare">56.61</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzEyLTEtMS0xLTgzMDc4_faa4e47f-2acd-4162-85a4-c94f4f21dc87"
      unitRef="shares">13877000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzEyLTMtMS0xLTgzMDc4_1d66e745-f297-46e2-a36f-f8acce65d171"
      unitRef="shares">16477000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzEyLTUtMS0xLTgzMDc4_ccdc9453-a7f5-41b3-9224-4124131db856"
      unitRef="shares">41020000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzEzLTEtMS0xLTgzMDc4_8436ad67-800a-40b7-ad4e-2279684b9a7e"
      unitRef="usd">1546016000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzEzLTMtMS0xLTgzMDc4_51879387-bea8-4cd3-be21-4cb26df299bc"
      unitRef="usd">1446767000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzEzLTUtMS0xLTgzMDc4_e237dd96-bfb6-4dcc-a3c2-4e4875d7693d"
      unitRef="usd">2402475000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzE0LTEtMS0xLTgzMDc4_c47b21d4-ca60-464d-8600-ee860a891be1"
      unitRef="usdPerShare">111.41</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzE0LTMtMS0xLTgzMDc4_9f765624-f72f-4ce1-bc4a-d20c72696779"
      unitRef="usdPerShare">87.80</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTphZWZlNTI5MzBmZjQ0ZmU1ODE0OTQ1ZjQxNTg1MmQ4NS90YWJsZXJhbmdlOmFlZmU1MjkzMGZmNDRmZTU4MTQ5NDVmNDE1ODUyZDg1XzE0LTUtMS0xLTgzMDc4_b6d989d6-b285-439f-9ca1-e0c9e5046ffb"
      unitRef="usdPerShare">58.57</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <dva:TreasuryStockAcquiredAverageCostPerShareClearingPrice
      contextRef="i3c74357cd2654da2ab5263e5e1505e1a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzYwNDczMTM5NTYyNjc_e183b7a8-9f1a-4cd1-9c96-e43f4aa5ed89"
      unitRef="usdPerShare">88.00</dva:TreasuryStockAcquiredAverageCostPerShareClearingPrice>
    <dva:TreasuryStockAcquiredAverageCostPerShareClearingPrice
      contextRef="i4d53d30fe41e4561a3d660180e6b98d1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzYwNDczMTM5NTYyNzE_1f1101a6-3f35-4b36-b90d-afa19204d7be"
      unitRef="usdPerShare">56.50</dva:TreasuryStockAcquiredAverageCostPerShareClearingPrice>
    <dva:ShareRepurchaseFeesAndExpenses
      contextRef="i3c74357cd2654da2ab5263e5e1505e1a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzYwNDczMTM5NTYyNzY_4a14832c-075c-45a0-a62b-8a5082e9f9f1"
      unitRef="usd">2529000</dva:ShareRepurchaseFeesAndExpenses>
    <dva:ShareRepurchaseFeesAndExpenses
      contextRef="i4d53d30fe41e4561a3d660180e6b98d1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzYwNDczMTM5NTYyODQ_2637f65e-2191-4553-a076-1c8906513ca8"
      unitRef="usd">2343000</dva:ShareRepurchaseFeesAndExpenses>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2f0cb06103bb48559ef92bd1d85fb047_D20220101-20220209"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzUwNw_05d38749-9e14-4481-a38a-5c807e8723b4"
      unitRef="shares">1437000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2f0cb06103bb48559ef92bd1d85fb047_D20220101-20220209"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzU0MQ_1754fbac-8df3-44cd-8309-e391798157f9"
      unitRef="usd">159133000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i2f0cb06103bb48559ef92bd1d85fb047_D20220101-20220209"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzU2Ng_3459dc90-1f32-424d-a531-cbab39cc29ae"
      unitRef="usdPerShare">110.73</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i8128ed8de2d8431a8be4d9736d9eb22a_I20201210"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzEwMzU_e1e7c270-94f4-428a-8bad-b0bcef25cf25"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="iea987dbdc7b04a8d9e5cc739bde1bfa9_I20211217"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzYwNDczMTM5NTY0ODk_8e2f90ad-3576-4296-a3e2-c3a06e9e50b8"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="iee586c56506f498d9a9bab33ee7558dd_I20220209"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzE0MzM_78b9876f-3877-4ad1-86d9-85fb3794cebe"
      unitRef="usd">2224806000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzI0MjA_417e796f-e841-4a55-ac9c-1b576a82bd45"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <dva:PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzI4MjI_aacdace9-b7ab-4f0f-9cc9-9132c2b6818c">P3Y</dva:PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation>
    <dva:NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzM0MTg_479c4c8b-8531-4e73-99fe-0f60365de35b">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of changes in DaVita Inc.&#x2019;s ownership interests in consolidated subsidiaries on the Company&#x2019;s consolidated equity were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.967%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;978,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;773,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;810,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in paid-in capital for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases of noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales of noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net transfers in noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc. net of transfers in &lt;br/&gt;&#160;noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;964,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;778,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;773,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzItMS0xLTEtODMwNzg_f8547aec-4d56-4864-a562-cd9313e7f4d0"
      unitRef="usd">978450000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzItMy0xLTEtODMwNzg_9be0b152-8b6d-4e36-98fc-c0bd9b51fb86"
      unitRef="usd">773642000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzItNS0xLTEtODMwNzg_f49f9da5-4442-49be-9b85-64628606b70c"
      unitRef="usd">810981000</us-gaap:NetIncomeLoss>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzQtMS0xLTEtODMwNzg_26d11897-ae92-40dd-8b03-442a4f926c4e"
      unitRef="usd">13853000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <dva:NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests
      contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzQtMy0xLTEtODMwNzg_57a47f58-21e1-4848-b4cc-3276a8073d57"
      unitRef="usd">4364000</dva:NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzQtNS0xLTEtODMwNzg_ca128958-58ba-4411-8ef9-9fd8c1410b89"
      unitRef="usd">37145000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests
      contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzUtMS0xLTEtODMwNzg_c9a3da48-04c9-40f0-b642-9695b3920b87"
      unitRef="usd">-264000</dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests>
    <dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests
      contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzUtMy0xLTEtODMwNzg_3427a5ad-2093-4ede-a8df-9df7878b108b"
      unitRef="usd">0</dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests>
    <dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests
      contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzUtNS0xLTEtODMwNzg_c4f50753-bcf2-4272-bb30-74a8b11d0905"
      unitRef="usd">0</dva:IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzYtMS0xLTEtODMwNzg_0d5298b4-8b37-424f-aa53-447d07aacd94"
      unitRef="usd">-14117000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzYtMy0xLTEtODMwNzg_182d78b8-37a6-42a6-87b1-326a55519a19"
      unitRef="usd">4364000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzYtNS0xLTEtODMwNzg_8fda162b-f503-4a3a-95c2-a2f2fcc2f632"
      unitRef="usd">-37145000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests
      contextRef="i313b09d2fcbd4013ae5bf38a39e1c768_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzctMS0xLTEtODMwNzg_0b7780af-36c3-417a-ad73-8fa8dbb5cbd1"
      unitRef="usd">964333000</dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests>
    <dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests
      contextRef="i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzctMy0xLTEtODMwNzg_bdc025e6-56ed-4dea-968e-fbf3ff7d29d9"
      unitRef="usd">778006000</dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests>
    <dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests
      contextRef="ib064173bef904a819f0c8fe867e6af30_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90YWJsZTpmYjk5Y2U3NDhlMWM0MTFlYWFhZWEwZGYwMmE4MjFmNy90YWJsZXJhbmdlOmZiOTljZTc0OGUxYzQxMWVhYWFlYTBkZjAyYTgyMWY3XzctNS0xLTEtODMwNzg_28f28a7d-25c2-4781-90e5-36178a2e338d"
      unitRef="usd">773836000</dva:NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzMzNzI_5e089c66-6e3e-4939-8a1c-f4e10886fd0e"
      unitRef="usd">20104000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzMzNzY_a83db139-08f7-48d1-be3d-4bad691fbe8c"
      unitRef="usd">7831000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yODYvZnJhZzowMTkzMDk1MzBiMWQ0MzE4YmMxYTRjN2VmNmZlOWNmZC90ZXh0cmVnaW9uOjAxOTMwOTUzMGIxZDQzMThiYzFhNGM3ZWY2ZmU5Y2ZkXzMzODQ_331a801b-15f6-480d-851a-9fb7240dea52"
      unitRef="usd">68019000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90ZXh0cmVnaW9uOjUxNTBmNDFmZjExMDQ5MTk4ODZjNGU1Yzg3YmVlYjU2XzYzNg_f1945382-9497-490a-baec-4eb5782b332e">Accumulated other comprehensive loss&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Charges and credits to other comprehensive (loss) income have been as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;br/&gt;cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated other&lt;br/&gt;comprehensive&lt;br/&gt;(loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reclassification of income into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,969)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reclassification of income into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(66,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(83,375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(73,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reclassification of income into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(138,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(139,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reclassification of net interest rate cap realized losses into income are recorded as debt expense in the corresponding consolidated statements of income. See Note 13 for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90ZXh0cmVnaW9uOjUxNTBmNDFmZjExMDQ5MTk4ODZjNGU1Yzg3YmVlYjU2XzYzMg_032bf436-1731-4c39-be2d-65a1388d79ca">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Charges and credits to other comprehensive (loss) income have been as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;br/&gt;cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated other&lt;br/&gt;comprehensive&lt;br/&gt;(loss) income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reclassification of income into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,969)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reclassification of income into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(66,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(83,375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(73,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reclassification of income into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(138,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(139,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6d67a2844f2a4c2c9c90e44bd33843a0_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEtMS0xLTEtODMwNzg_e457d9db-1908-40dd-a469-008e2c72f33c"
      unitRef="usd">-8961000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9eaadc9608cb41a185326a3a4f0c59f4_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEtNS0xLTEtODMwNzg_5c764ce6-43eb-45f8-99aa-7ad19cefcbb9"
      unitRef="usd">-25963000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i11a5e338ac8c41b4ba17536e1b30f48d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEtNy0xLTEtODMwNzg_666d4a84-8cd7-479a-b0c7-25ca81b64e61"
      unitRef="usd">-34924000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzMtMS0xLTEtODMwNzg_35c28988-92ea-49d0-b1ae-f97b048e5bf0"
      unitRef="usd">1566000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i274989deb10a476caf0af271f7ed680c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzMtNS0xLTEtODMwNzg_44a29a03-a54d-4081-bd51-5628a4aedf48"
      unitRef="usd">-20102000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="idadb367715dc4267900964561174325e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzMtNy0xLTEtODMwNzg_d2d45ca9-e944-4609-a5e1-208227053900"
      unitRef="usd">-18536000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzQtMS0xLTEtODMwNzg_7552d1d6-e2ef-4b2d-aa81-3596439d1526"
      unitRef="usd">415000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i274989deb10a476caf0af271f7ed680c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzQtNS0xLTEtODMwNzg_f5213ee7-3594-4c60-ab1e-0819e0fbb12d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="idadb367715dc4267900964561174325e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzQtNy0xLTEtODMwNzg_484f577c-a956-4d00-899e-f24191fa6d88"
      unitRef="usd">415000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzUtMS0xLTEtODMwNzg_0508b381-8204-4ada-8581-b7e245db61b4"
      unitRef="usd">1151000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i274989deb10a476caf0af271f7ed680c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzUtNS0xLTEtODMwNzg_043f9246-054b-4b0a-98da-00babb29beb7"
      unitRef="usd">-20102000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="idadb367715dc4267900964561174325e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzUtNy0xLTEtODMwNzg_24e57162-09d9-4be3-a2e1-5252734465df"
      unitRef="usd">-18951000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzYtMS0xLTEtODMwNzg_6711256e-f504-4579-bb29-352a1e090226"
      unitRef="usd">8591000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i274989deb10a476caf0af271f7ed680c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzYtNS0xLTEtODMwNzg_debb3ef2-47dd-4af1-a485-5de976050860"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="idadb367715dc4267900964561174325e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzYtNy0xLTEtODMwNzg_4a9e9ad0-0c78-4d9f-894b-99b22c1e532f"
      unitRef="usd">8591000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzctMS0xLTEtODMwNzg_ea79341d-5098-4c0c-8648-fc0a88c1193c"
      unitRef="usd">2214000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i274989deb10a476caf0af271f7ed680c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzctNS0xLTEtODMwNzg_fccf9336-b3f3-423d-badc-e0df73c77b7c"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="idadb367715dc4267900964561174325e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzctNy0xLTEtODMwNzg_74074095-78d0-4dcc-a1ef-d5f7ec988c49"
      unitRef="usd">2214000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i63b5de1d3efc49f7aa7ac59a1e3744f7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzgtMS0xLTEtODMwNzg_af7db207-4644-4e1a-9d9c-09545483ce33"
      unitRef="usd">6377000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i274989deb10a476caf0af271f7ed680c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzgtNS0xLTEtODMwNzg_79567c52-2a7d-4cd4-8bd0-64f49383aab9"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="idadb367715dc4267900964561174325e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzgtNy0xLTEtODMwNzg_ea00bf95-b58f-4cdf-8ace-f92d6696edae"
      unitRef="usd">6377000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia84ad34d2722493ca0102f68dc85910c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzktMS0xLTEtODMwNzg_ca42bb42-6784-4fd5-b10e-0f545e103aa0"
      unitRef="usd">-1433000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i24b7a5a0b9454a6596459b76ca8a77fd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzktNS0xLTEtODMwNzg_9a0eb048-9360-43d0-90bd-fbac93c95103"
      unitRef="usd">-46065000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4a368aff679b44b39b1d63b92999f915_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzktNy0xLTEtODMwNzg_5195c8e5-6115-4b26-be31-89ab75f1e4b0"
      unitRef="usd">-47498000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEwLTEtMS0xLTgzMDc4_0a6e4e94-cc60-400f-b902-da9bd5a0dab3"
      unitRef="usd">-21781000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEwLTUtMS0xLTgzMDc4_a2b9b2f2-1d91-4df0-bfb5-d23fcf43f58c"
      unitRef="usd">-7080000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEwLTctMS0xLTgzMDc4_cecf69fa-6366-4247-b7c4-2f5009080c51"
      unitRef="usd">-28861000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzExLTEtMS0xLTgzMDc4_18315bf2-1f1d-431f-bfd3-fbe77cc65089"
      unitRef="usd">-5435000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzExLTUtMS0xLTgzMDc4_6d9dd822-10e2-4678-bca7-21085182c902"
      unitRef="usd">543000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzExLTctMS0xLTgzMDc4_ea40fd8b-e71e-42a0-b280-9031f96c21ca"
      unitRef="usd">-4892000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEyLTEtMS0xLTgzMDc4_e8b28302-17b0-451f-ab8b-084e494bb097"
      unitRef="usd">-16346000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEyLTUtMS0xLTgzMDc4_f4393716-d62d-4cff-a861-903c457aa92a"
      unitRef="usd">-7623000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEyLTctMS0xLTgzMDc4_30d47bbc-b4bb-4552-b3d7-c1e9e7256e41"
      unitRef="usd">-23969000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEzLTEtMS0xLTgzMDc4_fb0a4cb4-e152-4a89-b7a1-d68d9bcc56f9"
      unitRef="usd">7081000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEzLTUtMS0xLTgzMDc4_ef04b809-89c8-40e0-bf8c-ad7a6b208190"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzEzLTctMS0xLTgzMDc4_c13b5f82-b83a-4f1c-a834-a5b74bbcead7"
      unitRef="usd">7081000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE0LTEtMS0xLTgzMDc4_4516958c-26c1-42ed-96ad-f6f2657731f0"
      unitRef="usd">1768000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE0LTUtMS0xLTgzMDc4_ec0af13f-6a89-481a-8dd0-23458bf38b7a"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE0LTctMS0xLTgzMDc4_7fce3353-7e7c-49cb-99db-ee611e6c3eaa"
      unitRef="usd">1768000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ia6708dee89194d2d83adb5dbbac83263_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE1LTEtMS0xLTgzMDc4_e8bde288-c801-450f-8ee3-3bd7c97dce61"
      unitRef="usd">5313000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i344f53a5212045c0a5230bf0f0d571a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE1LTUtMS0xLTgzMDc4_13003129-ecf8-406e-95d5-1c060dfded27"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="iaa2f33a6a1164c2eb0da60fbc5448a4c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE1LTctMS0xLTgzMDc4_007044ce-87dc-4d02-9eff-8f0c203dec4f"
      unitRef="usd">5313000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i99108034d2554d938cf6bbf6690251eb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE2LTEtMS0xLTgzMDc4_c93dfdd8-983c-4b6e-85f4-fdddf204831f"
      unitRef="usd">-12466000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifea37fe88f5b44c18e322f6488b835ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE2LTUtMS0xLTgzMDc4_b7a2bc8d-b559-4fd2-a31c-d6d989ee687b"
      unitRef="usd">-53688000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i40dcb33a068e49c5873ade196d5fa5e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE2LTctMS0xLTgzMDc4_7c4961e7-53df-4d72-b81b-03d48083b9ef"
      unitRef="usd">-66154000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="id404b91855424fc799a056cf6f4b718b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE3LTEtMS0xLTgzMDc4_fe46bb66-f692-4049-9abb-a65761c7a9bb"
      unitRef="usd">9532000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE3LTUtMS0xLTgzMDc4_54164515-8ace-4a6e-8552-cdf00545344c"
      unitRef="usd">-83375000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE3LTctMS0xLTgzMDc4_e31017b4-7651-440a-a06b-7b8253a88356"
      unitRef="usd">-73843000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="id404b91855424fc799a056cf6f4b718b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE4LTEtMS0xLTgzMDc4_63605d3e-2b70-4dd9-a8c2-56611fdfbde8"
      unitRef="usd">2377000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE4LTUtMS0xLTgzMDc4_4c745eda-4346-429a-8227-357a14e28fda"
      unitRef="usd">1006000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE4LTctMS0xLTgzMDc4_70ad46a4-c2a6-4aec-a4cd-7294b4b3b79d"
      unitRef="usd">3383000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="id404b91855424fc799a056cf6f4b718b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE5LTEtMS0xLTgzMDc4_9f37881a-7839-4b63-bdee-2349b6725f38"
      unitRef="usd">7155000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE5LTUtMS0xLTgzMDc4_d466bf15-08ee-466c-bdbe-9a39c8be0a58"
      unitRef="usd">-84381000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzE5LTctMS0xLTgzMDc4_3df79b8a-6b5d-4be4-ac52-470e03424a6f"
      unitRef="usd">-77226000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="id404b91855424fc799a056cf6f4b718b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIwLTEtMS0xLTgzMDc4_88705380-2763-447f-bc05-e7c1ec626833"
      unitRef="usd">5509000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIwLTUtMS0xLTgzMDc4_4652e9ee-65b9-4978-9d9b-abcadc5dbc93"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIwLTctMS0xLTgzMDc4_c34ff6b4-b83b-483d-82ce-1d3d6a6c85f3"
      unitRef="usd">5509000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="id404b91855424fc799a056cf6f4b718b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIxLTEtMS0xLTgzMDc4_994bc2cb-597d-4654-905f-c70c3bc2f6c0"
      unitRef="usd">1376000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIxLTUtMS0xLTgzMDc4_c0553e19-40b3-48aa-aebe-4b1612a09527"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIxLTctMS0xLTgzMDc4_0ef786a9-c865-4e7d-a191-380be11b36bf"
      unitRef="usd">1376000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="id404b91855424fc799a056cf6f4b718b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIyLTEtMS0xLTgzMDc4_b51de9c5-8b5f-477e-aa0a-5f6987432adf"
      unitRef="usd">4133000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i979a8091b1f340589c5f1ea00b16b12a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIyLTUtMS0xLTgzMDc4_3d129041-c9eb-4901-a47a-4d9635ce3516"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ic1e0cbe6c55343adb7870b057355c9a0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIyLTctMS0xLTgzMDc4_a9c93d22-002e-41e8-9e67-67c8840047ae"
      unitRef="usd">4133000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i85c3913492e84060812eb8467e8fd210_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIzLTEtMS0xLTgzMDc4_2644899b-f1dd-40e8-95a4-6c459d4780b2"
      unitRef="usd">-1178000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9bf0294b716341479fe2709f0bed1d2b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIzLTUtMS0xLTgzMDc4_1ef1fb7f-9df1-413d-aa5d-5e8d83f246fc"
      unitRef="usd">-138069000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2d3d4f666d7c449b92c0699610606f26_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90YWJsZTo2NWRkMDY0Y2MwODg0YmM3Yjc4NDk0MjMwY2FjMWEyOC90YWJsZXJhbmdlOjY1ZGQwNjRjYzA4ODRiYzdiNzg0OTQyMzBjYWMxYTI4XzIzLTctMS0xLTgzMDc4_815c8b1c-51a6-4a30-88de-7d58c431ae16"
      unitRef="usd">-139247000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTIvZnJhZzo1MTUwZjQxZmYxMTA0OTE5ODg2YzRlNWM4N2JlZWI1Ni90ZXh0cmVnaW9uOjUxNTBmNDFmZjExMDQ5MTk4ODZjNGU1Yzg3YmVlYjU2XzYyOA_151fbb36-0f63-4772-8227-6f6909b14f31">The reclassification of net interest rate cap realized losses into income are recorded as debt expense in the corresponding consolidated statements of income.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM3NjA_40ecd132-ad8b-49e4-badb-66bd74eaba9f">Acquisitions and divestitures&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Routine acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, 2020, and 2019 the Company acquired dialysis businesses and other businesses, including a transplant software company, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.192%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.862%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.862%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred purchase price and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aggregate consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;212,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of dialysis centers acquired &#x2014; U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of dialysis centers acquired &#x2014; International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The assets and liabilities for all acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company&#x2019;s financial statements, as are their operating results, from the designated effective dates of the acquisitions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The initial purchase price allocations for these transactions have been recorded at estimated fair values based on information available to management and will be finalized when certain information arranged to be obtained has been received. For several of the 2021 acquisitions, certain income tax amounts are pending final evaluation and quantification of any pre-acquisition tax contingencies. In addition, valuation of contingent earn-outs, intangibles, fixed assets, leases and certain working capital items relating to several of these acquisitions are pending final quantification.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.795%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncompetition agreements and other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;212,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes weighted-average estimated useful lives of amortizable intangible assets acquired during 2021, 2020 and 2019, as well as goodwill deductible for tax purposes associated with these acquisitions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average estimated useful lives (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncompetition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill deductible for tax purposes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pro forma financial information (unaudited)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions within continuing operations in 2021 and 2020 had been consummated as of the beginning of 2020, including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.618%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pro forma total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,678,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,722,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pro forma net income from continuing operations attributable to&lt;br/&gt;&#160;DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;985,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;797,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pro forma basic net income per share from continuing operations&lt;br/&gt;&#160;attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pro forma diluted net income per share from continuing operations&lt;br/&gt;&#160;attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale of RMS Lifeline&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company divested its prior vascular access business, RMS Lifeline, Inc., effective May 1, 2020 and recognized a loss on sale of approximately $16,252.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired businesses a total of up to approximately $67,638 if certain performance targets or quality margins are met over the next one year to five years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent earn-out obligations are remeasured to fair value at each reporting date until the contingencies are resolved with changes in the liability due to the remeasurement recognized in earnings. See Note 24 for further details. As of December&#160;31, 2021, the Company estimated the fair value of these contingent earn-out obligations to be $33,600, of which a total of $9,419 is included in other current liabilities, and the remaining $24,181 is included in other long-term liabilities in the Company&#x2019;s consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of changes in contingent earn-out liabilities for the years ended December&#160;31, 2021 and 2020:&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments or other settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzE5NzkxMjA5MzA2NjQ4_9b60ee7d-7e35-42a3-9a6c-15a60bf1ff89">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, 2020, and 2019 the Company acquired dialysis businesses and other businesses, including a transplant software company, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.192%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.862%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.862%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred purchase price and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aggregate consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;212,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of dialysis centers acquired &#x2014; U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of dialysis centers acquired &#x2014; International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzItMS0xLTEtMTM5ODYz_3a8d3db2-2754-4594-9851-5bcd58b0feb6"
      unitRef="usd">187050000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzItMy0xLTEtMTM5ODYz_dabadd1b-faf3-49b8-96ad-d7736f71b694"
      unitRef="usd">182013000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia4a2d038875f4494931bdd14b3909f34_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzItNS0xLTEtMTM5ODYz_0abf36da-fd43-4fdb-862a-089283070dff"
      unitRef="usd">98836000</us-gaap:PaymentsToAcquireBusinessesGross>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzMtMS0xLTEtMTM5ODYz_2e8f6fb5-c6ab-4d7b-bf7b-4802b06da084"
      unitRef="usd">14854000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzMtMy0xLTEtMTM5ODYz_75b26aac-7704-45b6-84d8-40ed85f23054"
      unitRef="usd">14042000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="ia4a2d038875f4494931bdd14b3909f34_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzMtNS0xLTEtMTM5ODYz_fd2594d7-dcf7-4dde-a8d5-b0a75005325c"
      unitRef="usd">23536000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzQtMS0xLTEtMTM5ODYz_5f738cff-1949-4737-aaf4-ea537362759a"
      unitRef="usd">10226000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzQtMy0xLTEtMTM5ODYz_1013659a-06ae-435b-b4a3-f39949282e98"
      unitRef="usd">20415000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="ia4a2d038875f4494931bdd14b3909f34_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzQtNS0xLTEtMTM5ODYz_d44b63df-0414-4acc-a765-0bbcaf3179f6"
      unitRef="usd">4326000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzUtMS0xLTEtMTQwNDU3_52ef7239-5224-44a5-b5b1-97a52e564a78"
      unitRef="usd">0</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzUtMy0xLTEtMTQwNDE0_9e7976c3-6a84-4114-82aa-b65333c30418"
      unitRef="usd">1821000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="ia4a2d038875f4494931bdd14b3909f34_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzUtNS0xLTEtMTQwNDU3_739d3a7e-cfe3-4161-a851-c7aa8e1bef3e"
      unitRef="usd">0</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzUtMS0xLTEtMTM5ODYz_a16c9535-df15-428c-8730-b3e0946a90ac"
      unitRef="usd">212130000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzUtMy0xLTEtMTM5ODYz_bc789d09-007a-4526-99c7-87a191da2de6"
      unitRef="usd">218291000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzUtNS0xLTEtMTM5ODYz_eaf1ae9f-88af-4d71-9772-1a4a2986529a"
      unitRef="usd">126698000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i621a25eea7db4a01974ef60b2432c93e_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzYtMS0xLTEtMTM5ODYz_d093a307-3d51-4b51-8176-41bcc4f19281"
      unitRef="clinic2">19</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i2245b27c94104effb35180d14351a3fd_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzYtMy0xLTEtMTM5ODYz_8dd97bcd-ec59-4da7-a2ee-a6cbefa48216"
      unitRef="clinic2">8</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i76921e5033604a8fabf20815d5b64089_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzYtNS0xLTEtMTM5ODYz_fdae5e12-7e61-4294-92d0-6503a75a2454"
      unitRef="clinic2">7</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="ie6a746b4356448749bd18ee02e4a5e7a_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzctMS0xLTEtMTM5ODYz_de6379a6-e738-449c-bf85-8cfba9036b56"
      unitRef="clinic2">17</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="ied9a0e0050574260b26da48baf596e12_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzctMy0xLTEtMTM5ODYz_09cab8e8-bb27-44fd-9825-117b49b39350"
      unitRef="clinic2">66</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="ib46805457f7f4d4eae7bb7b5aaa08d10_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpmMDcxOTE5ZDZmZTk0MzQxOThkOWU1YjgyODQ2MTU0MC90YWJsZXJhbmdlOmYwNzE5MTlkNmZlOTQzNDE5OGQ5ZTViODI4NDYxNTQwXzctNS0xLTEtMTM5ODYz_be613ce1-e81c-4d05-b3ab-93bc5f98aadb"
      unitRef="clinic2">16</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM3NTM_699a0e85-8fa8-4f4a-9a0d-ca3895a90c5f">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.795%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncompetition agreements and other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;212,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzItMS0xLTEtODMwNzg_62fe595c-399e-4c37-ac4a-e8ccecd676e9"
      unitRef="usd">9134000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzItMy0xLTEtODMwNzg_51f6d098-bcad-44d7-9c94-f05e0c8f0c4e"
      unitRef="usd">23607000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzItNS0xLTEtODMwNzg_26287d12-a8fd-47a3-8d6b-dfe77301edc6"
      unitRef="usd">6713000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzMtMS0xLTEtODMwNzg_6485edcc-64d2-453e-a9ef-e7958f5c9043"
      unitRef="usd">9277000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzMtMy0xLTEtODMwNzg_6c455661-184c-4133-a050-0447586037b3"
      unitRef="usd">37457000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzMtNS0xLTEtODMwNzg_6f0595d3-6233-493f-bbb2-b12cea57bcd7"
      unitRef="usd">4842000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzQtMS0xLTEtODMwNzg_4bfcba9d-3c88-4b7d-b3ea-7fccb80d4c31"
      unitRef="usd">17200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzQtMy0xLTEtODMwNzg_284f4598-0c03-4942-9e56-84c5503dcdf3"
      unitRef="usd">34625000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzQtNS0xLTEtODMwNzg_08c78f3f-ad73-4a8f-aba9-35cff4652574"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzUtMS0xLTEtODMwNzg_b724a0bf-a40e-42ac-b83d-db033bd8a8c9"
      unitRef="usd">9964000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzUtMy0xLTEtODMwNzg_9d122184-734d-4741-9b29-e9cf5e1d4317"
      unitRef="usd">10168000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzUtNS0xLTEtODMwNzg_079c30f0-e438-46f0-8f70-4dafc7f3b150"
      unitRef="usd">1980000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzYtMS0xLTEtODMwNzg_7d181066-e68a-4272-938d-ce547ca7ac21"
      unitRef="usd">11432000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzYtMy0xLTEtODMwNzg_ff32e86c-74a4-4f55-b810-d8e3bdaf24ee"
      unitRef="usd">22136000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzYtNS0xLTEtODMwNzg_5f67ee20-9456-461b-a038-4ba5103283e7"
      unitRef="usd">31858000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:Goodwill
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzctMS0xLTEtODMwNzg_133675bc-5821-4782-bfbf-956acb1355f4"
      unitRef="usd">173244000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzctMy0xLTEtODMwNzg_b15fd1ee-402c-48e1-aebf-1ddde9a46f69"
      unitRef="usd">130057000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzctNS0xLTEtODMwNzg_ed250adc-8983-45c2-87b6-aa2c54d538e4"
      unitRef="usd">90226000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzgtMS0xLTEtODMwNzg_98cf36a7-3ed8-4801-9a11-549f16e0eae3"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzgtMy0xLTEtODMwNzg_14d5381a-09fb-4287-9090-e7da96e949af"
      unitRef="usd">3962000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzgtNS0xLTEtODMwNzg_c4a8ccfd-adc2-4df7-8a1e-68c59e5f0aad"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzktMS0xLTEtODMwNzg_9766fe75-0db6-4c04-a971-05c40e5052c5"
      unitRef="usd">14200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzktMy0xLTEtODMwNzg_28a54edf-2b0d-4add-95a8-6c8506039112"
      unitRef="usd">34068000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzktNS0xLTEtODMwNzg_302cdea3-82a1-4e2f-b722-20d76f4f91a2"
      unitRef="usd">7159000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzEwLTEtMS0xLTgzMDc4_633ccea7-b69e-4a4f-b1a7-d239dcf79969"
      unitRef="usd">3921000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzEwLTMtMS0xLTgzMDc4_36aebc21-3f41-4ae8-8a7a-7dc6e4acc865"
      unitRef="usd">1729000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzEwLTUtMS0xLTgzMDc4_847435a4-0c1f-476a-be5e-8023bcc65505"
      unitRef="usd">1762000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzExLTEtMS0xLTgzMDc4_90982e24-9a16-4796-9acb-421e4b1ff5cc"
      unitRef="usd">212130000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzExLTMtMS0xLTgzMDc4_67c6d019-4c63-4ed7-9e1e-f3faa928cec0"
      unitRef="usd">218291000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTpkOTgxMTA0Yjg2ZDc0NTE1ODk5MWNkNjQ2YTQyMDFmYi90YWJsZXJhbmdlOmQ5ODExMDRiODZkNzQ1MTU4OTkxY2Q2NDZhNDIwMWZiXzExLTUtMS0xLTgzMDc4_398d3a1c-55f6-479a-b9a8-54a8865249e8"
      unitRef="usd">126698000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <dva:ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM3NTc_7b9d5233-056d-48db-9e5a-a8b9afb79e15">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes weighted-average estimated useful lives of amortizable intangible assets acquired during 2021, 2020 and 2019, as well as goodwill deductible for tax purposes associated with these acquisitions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.900%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average estimated useful lives (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncompetition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill deductible for tax purposes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3508cbe980914e3d84c8b1cdebe10249_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzMtMS0xLTEtODMwNzg_7b11ff09-7cb7-4aa6-90d4-e9d8d7d702fe">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia8e3b5c936ba4ca59945d40967ade470_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzMtMy0xLTEtODMwNzg_9e21639f-596b-47ef-b3dc-4185ec6c3d24">P18Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i14dc4deb3c484a63bee7e80f59d2a7f8_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzMtNS0xLTEtODMwNzg_7e721c52-9df6-418d-813e-f70f1f1e87cd"
      xsi:nil="true"/>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1950b3dc9ab941c69beba84eed98aa3e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzQtMS0xLTEtODMwNzg_42c8d27a-a663-4e88-9cc9-92ab2a3a4990">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3a29a18c5e154226819a3fce4b9d0866_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzQtMy0xLTEtODMwNzg_4332d050-06d4-4791-99a5-18937a93590a">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i31ffbb8892c441dea9a0c3e595b43682_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzQtNS0xLTEtODMwNzg_51f9b27d-6422-40aa-90d6-fbcb81fb0eba">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzYtMS0xLTEtODMwNzg_7c24ed35-d5ff-4b48-b989-6b3bb135cae7"
      unitRef="usd">169014000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzYtMy0xLTEtODMwNzg_507288f5-e5eb-4412-a0cb-d9279e3c2b09"
      unitRef="usd">94318000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToxYmNiNDc1ZmQ0ZmI0MTIyYjQ1ZmZkZTVkN2VjZDFiMS90YWJsZXJhbmdlOjFiY2I0NzVmZDRmYjQxMjJiNDVmZmRlNWQ3ZWNkMWIxXzYtNS0xLTEtODMwNzg_fd6b97ee-9d26-41d4-a7da-bca404322a1d"
      unitRef="usd">88517000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM3NjU_c98d88c1-d12f-43da-87ee-819cd2492d2f">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions within continuing operations in 2021 and 2020 had been consummated as of the beginning of 2020, including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.739%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.618%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pro forma total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,678,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,722,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pro forma net income from continuing operations attributable to&lt;br/&gt;&#160;DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;985,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;797,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pro forma basic net income per share from continuing operations&lt;br/&gt;&#160;attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pro forma diluted net income per share from continuing operations&lt;br/&gt;&#160;attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzMtMS0xLTEtODMwNzg_4c6c49ac-2f86-41df-9dd6-2f8f11218549"
      unitRef="usd">11678798000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzMtMy0xLTEtODMwNzg_d27b0e07-47b9-40c1-8bca-c4fd72f33c21"
      unitRef="usd">11722511000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzQtMS0xLTEtODMwNzg_4f89a9b5-ceee-4802-9bb6-d3f34189ad22"
      unitRef="usd">985800000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzQtMy0xLTEtODMwNzg_abd3cf20-b15f-4f45-9320-b0d05ee42e77"
      unitRef="usd">797844000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzUtMS0xLTEtODMwNzg_342cefb7-929b-4326-a2c1-837807a792a5"
      unitRef="usdPerShare">9.37</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzUtMy0xLTEtODMwNzg_eb56741f-3227-44f1-9f3b-fb4f2db96001"
      unitRef="usdPerShare">6.66</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzYtMS0xLTEtODMwNzg_18f6561e-ba84-4a0a-b2ff-a75977216c14"
      unitRef="usdPerShare">8.97</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZToyZjc2OWQ2MWRlNWI0NTcwOTdmYmJkYjNjMjZhODBjYi90YWJsZXJhbmdlOjJmNzY5ZDYxZGU1YjQ1NzA5N2ZiYmRiM2MyNmE4MGNiXzYtMy0xLTEtODMwNzg_7dfee455-0e77-4b2c-960d-cb6c51b1efd3"
      unitRef="usdPerShare">6.51</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="iaa2fdc006ca3477fbbe827fe56dcb2a6_D20200501-20200501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzQ5NDc4MDIzMjg4NTU_ccadf29c-f2b3-46df-9567-ef07557cafe7"
      unitRef="usd">16252000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzMwNDQ_68405925-dbb0-4739-983d-266d55bdb93d"
      unitRef="usd">67638000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod
      contextRef="i3b812c94400f4e9f93e3edc28560ca7d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzMxMTk_ffac6d24-c146-4d12-a740-8908020b6b54">P1Y</dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod>
    <dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod
      contextRef="i97ebc821f8af433693f363565139ae7a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzMxMjU_b8e7e916-bee2-448f-8b1f-01852ff97ea6">P5Y</dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i15c23a9ed8c74ad88b0b718d8dcbce70_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM0NTc_93fb3748-dca4-44b9-9203-79f46769f257"
      unitRef="usd">33600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i5c26b75f552e487080d6ca8af0cbfbb2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM0ODE_100f4bcf-32cb-4cb2-8fc1-f79060b8bf19"
      unitRef="usd">9419000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i34268660f8994614945e3a3ac73ae27c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM1NDQ_0ce50458-3315-4839-95f0-25dfdd207345"
      unitRef="usd">24181000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90ZXh0cmVnaW9uOjBhM2E5YzU2NGExMzRkNDhiOWE3NzU2MWNjMDM5MzQ3XzM3NjY_277f65ff-593c-4584-a959-60c137cc0423">The following is a reconciliation of changes in contingent earn-out liabilities for the years ended December&#160;31, 2021 and 2020:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.086%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments or other settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzItMS0xLTEtODMwNzg_39b707f7-d736-4a6b-8f1d-876b016e18a3"
      unitRef="usd">30248000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i274782ed156b4160aac90d9ee2a76efb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzItMy0xLTEtODMwNzg_cc4f0ef1-e680-48e0-950d-1ad7e261eb09"
      unitRef="usd">24586000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzMtMS0xLTEtODMwNzg_763c3123-e8c4-45e0-8890-3cb89e69968c"
      unitRef="usd">14854000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzMtMy0xLTEtODMwNzg_681d53f5-2b80-4a6f-92b9-506d8b0b9be7"
      unitRef="usd">14042000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations
      contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzQtMS0xLTEtODMwNzg_dd1fdb13-0d39-454f-89c1-8abd805462b1"
      unitRef="usd">1674000</dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations>
    <dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations
      contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzQtMy0xLTEtODMwNzg_f1726cf1-34e3-47e0-b778-daa729da82d9"
      unitRef="usd">3688000</dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations>
    <dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss
      contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzUtMS0xLTEtODMwNzg_4b25465f-9368-41f9-aa2a-7a8587ea25b2"
      unitRef="usd">1292000</dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss>
    <dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss
      contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzUtMy0xLTEtODMwNzg_bf4c8b0e-8e3d-4462-be44-67f93d16b955"
      unitRef="usd">2630000</dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss>
    <dva:BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments
      contextRef="i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzYtMS0xLTEtODMwNzg_d7efcefe-c78b-4de6-b558-31b73c5fc8f9"
      unitRef="usd">8536000</dva:BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments>
    <dva:BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments
      contextRef="i1fa05a6dd6014febb63bbcd620873246_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzYtMy0xLTEtODMwNzg_8bab620b-8698-4301-9987-73fecd9b927f"
      unitRef="usd">2062000</dva:BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i1f41405ceef34baa8b52e118cd782f5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzctMS0xLTEtODMwNzg_4a477cc8-3ae3-43b2-bb2a-ca9e93125d58"
      unitRef="usd">33600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i5f9f2f3219c543598584da510ed53480_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTUvZnJhZzowYTNhOWM1NjRhMTM0ZDQ4YjlhNzc1NjFjYzAzOTM0Ny90YWJsZTozMWRhNmQ1NGI3N2E0MGM2OGQzOGY4NDg0MTQ5YTZiMS90YWJsZXJhbmdlOjMxZGE2ZDU0Yjc3YTQwYzY4ZDM4Zjg0ODQxNDlhNmIxXzctMy0xLTEtODMwNzg_f66e33f2-6835-4937-a232-98ffb3e0e13a"
      unitRef="usd">30248000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzI1NzI_2bb42e1c-e132-4cf6-8b70-9f0d522245f2">Discontinued operations previously held for sale&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DaVita Medical Group (DMG)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;19, 2019, the Company completed the sale of its prior DMG business to Optum, a subsidiary of UnitedHealth Group Inc., for an aggregate purchase price of $4,340,000, prior to certain closing and post-closing adjustments specified in the related equity purchase agreement dated as of December&#160;5, 2017, as amended as of September 20, 2018 and as of December 11, 2018 (as amended, the equity purchase agreement).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a preliminary estimated pre-tax net loss of approximately $23,022 on the sale of its DMG business in 2019. This preliminary net loss was based on initial estimates of the Company's expected aggregate proceeds from the sale, net of transaction costs and obligations, as well as the estimated values of DMG net assets sold as of the closing date. Those estimated net proceeds included $4,465,476 in cash received from Optum at closing, or $3,824,509 net of cash and restricted cash included in the DMG net assets sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At close of the DMG sale, the Company's ultimate net sale proceeds remained subject to resolution of certain post-closing purchase price adjustments described in the equity purchase agreement. In the fourth quarter of 2020, the Company and Optum reached agreement on the final purchase price for the DMG sale, which resulted in an additional payment by the Company to Optum of $47,000 and an additional loss on sale of $17,976. In the first quarter of 2020, the Company recognized $9,980 in additional tax benefits under the Coronavirus Aid, Relief and Economic Security Act related to its period of DMG ownership, which were also recognized as an adjustment to the Company's loss on sale of the DMG business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the equity purchase agreement, the Company also has certain continuing indemnification obligations that could require payments to the buyer relating to the Company's previous ownership and operation of the DMG business. Potential payments under these provisions, if any, remain subject to continuing uncertainties and the amounts of such payments could be significant to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the financial results of discontinued operations related to DMG:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,713,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,543,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on sale of discontinued operations before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents cash flows of discontinued operations related to DMG:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:414.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:294.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:55.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:55.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash provided by operating activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash used in investing activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DMG acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the period from January 1, 2019 to June 18, 2019 immediately prior to the sale, the DMG business acquired two medical businesses for a total of $2,025 in net cash and deferred purchase price of $212.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <dva:BusinessSaleEffectiveDateOfSale
      contextRef="i94e70ca9077e4db8b762a4fcc4bfbd6f_D20190619-20190619"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzg4_2950e4ae-eb11-4b5b-b8ea-f6cd5fe3f85f">2019-06-19</dva:BusinessSaleEffectiveDateOfSale>
    <dva:PurchaseAndSaleAgreementAggregatePurchasePrice
      contextRef="i94e70ca9077e4db8b762a4fcc4bfbd6f_D20190619-20190619"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzIyOQ_ee29a620-5531-40b8-bcce-22e0a8a99096"
      unitRef="usd">4340000000</dva:PurchaseAndSaleAgreementAggregatePurchasePrice>
    <dva:BusinessSaleDateOfPurchaseAndSaleAgreement
      contextRef="i2aba66ad0dad46008b9826b26fef8363_D20171205-20171205"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzM1MA_9d800b7b-c159-4af5-a487-53f672c2014f">2017-12-05</dva:BusinessSaleDateOfPurchaseAndSaleAgreement>
    <dva:LossGainOnDispositionOfBusinessInterestsBeforeTax
      contextRef="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzUxMQ_d3b63f61-2545-466c-beb8-02b7bf8bea23"
      unitRef="usd">23022000</dva:LossGainOnDispositionOfBusinessInterestsBeforeTax>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i7458081d2436470ea923b7c4156197b2_D20190619-20190619"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzgzMQ_b5967ef2-9fa8-4ad6-b459-43ed2d8a201f"
      unitRef="usd">4465476000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i7458081d2436470ea923b7c4156197b2_D20190619-20190619"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzg3Nw_ad0365e0-5b84-4102-b5da-fa9e26ea58b6"
      unitRef="usd">3824509000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <dva:AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice
      contextRef="icfd8f32feed247c2a24b065aa98482f1_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzgyNDYzMzcyMTEwNTc_df129753-f40a-4c02-95b8-1f4f85bdfe43"
      unitRef="usd">47000000</dva:AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="icfd8f32feed247c2a24b065aa98482f1_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzgyNDYzMzcyMTEwNzQ_926df030-0fd3-417f-9bac-17c4020ee886"
      unitRef="usd">-17976000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="iafda8ba2e67442e6935e3adfbd191cc1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzE0MjA_23e1971d-eb21-47f3-be82-a26497635e00"
      unitRef="usd">9980000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzI1Njc_572ef072-a838-49b5-b475-d9a63940e1da">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the financial results of discontinued operations related to DMG:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.701%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,713,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,543,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on sale of discontinued operations before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i54d86d8eabc947b9afbe06d0abb8af86_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzItMy0xLTEtODMwNzg_d3a61423-790c-40fa-aa7c-570cb0a1d374"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzItNS0xLTEtODMwNzg_6316d50d-046e-4f6b-abdb-b2fc8d5571f9"
      unitRef="usd">2713059000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i54d86d8eabc947b9afbe06d0abb8af86_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzMtMy0xLTEtODMwNzg_4da845a5-9949-4c7a-9a97-bc39548eea6e"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzMtNS0xLTEtODMwNzg_d219b4f0-c6ca-4d75-a488-345b334fc70d"
      unitRef="usd">2543865000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i54d86d8eabc947b9afbe06d0abb8af86_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzYtMy0xLTEtODMwNzg_cf4b10b2-e3f4-462b-aaf2-9a6fb22ae536"
      unitRef="usd">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzYtNS0xLTEtODMwNzg_849caa2c-06a0-4789-a395-cac9714af189"
      unitRef="usd">169194000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <dva:LossGainOnDispositionOfBusinessInterestsBeforeTax
      contextRef="i54d86d8eabc947b9afbe06d0abb8af86_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzctMy0xLTEtODMwNzg_11ac5771-8dd5-43cc-8a21-73a79bf3a24b"
      unitRef="usd">7996000</dva:LossGainOnDispositionOfBusinessInterestsBeforeTax>
    <dva:LossGainOnDispositionOfBusinessInterestsBeforeTax
      contextRef="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzctNS0xLTEtODMwNzg_0ec21879-71d9-413c-a8fa-b2b63bb6ab83"
      unitRef="usd">23022000</dva:LossGainOnDispositionOfBusinessInterestsBeforeTax>
    <us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal
      contextRef="i54d86d8eabc947b9afbe06d0abb8af86_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzgtMy0xLTEtODMwNzg_71e5e92c-9679-4e17-9584-808a41f8e47c"
      unitRef="usd">1657000</us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal>
    <us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal
      contextRef="i52ebf3d748884c038bc62868f4779b61_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzgtNS0xLTEtODMwNzg_15ff1d8c-8bcc-41c3-b803-4d1dadd2060f"
      unitRef="usd">40689000</us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzktMy0xLTEtODMwNzg_a04f6180-0d50-4c56-942c-8105692ad70c"
      unitRef="usd">-9653000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZToyN2E1MDQ2YzYyOWI0YTAzOGQyMWJkNWZmY2EwYjYwOS90YWJsZXJhbmdlOjI3YTUwNDZjNjI5YjRhMDM4ZDIxYmQ1ZmZjYTBiNjA5XzktNS0xLTEtODMwNzg_71af1396-b2de-4035-8676-e6f99e3959ab"
      unitRef="usd">105483000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <dva:ReconciliationOfCashFlowsTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzI1NjU_d2f963c9-b7d4-4caf-834d-ce5ee0f839b5">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents cash flows of discontinued operations related to DMG:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:414.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:294.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:55.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:55.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash provided by operating activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net cash used in investing activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ReconciliationOfCashFlowsTableTextBlock>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZTo3ZjZjZjRkMmU0OWI0NWJkYjJjMGMyOTI5NWQ0OWQ4OS90YWJsZXJhbmdlOjdmNmNmNGQyZTQ5YjQ1YmRiMmMwYzI5Mjk1ZDQ5ZDg5XzItMy0xLTEtODMwNzg_2e36cdcb-6c05-40d9-9d72-bf0e6e37d62d"
      unitRef="usd">0</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZTo3ZjZjZjRkMmU0OWI0NWJkYjJjMGMyOTI5NWQ0OWQ4OS90YWJsZXJhbmdlOjdmNmNmNGQyZTQ5YjQ1YmRiMmMwYzI5Mjk1ZDQ5ZDg5XzItNS0xLTEtODMwNzg_c379a225-a5be-4d82-bdb8-309d889c970c"
      unitRef="usd">99634000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZTo3ZjZjZjRkMmU0OWI0NWJkYjJjMGMyOTI5NWQ0OWQ4OS90YWJsZXJhbmdlOjdmNmNmNGQyZTQ5YjQ1YmRiMmMwYzI5Mjk1ZDQ5ZDg5XzMtMy0xLTEtODMwNzg_4e8f2080-706b-429e-81cb-5edd77e18a18"
      unitRef="usd">0</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90YWJsZTo3ZjZjZjRkMmU0OWI0NWJkYjJjMGMyOTI5NWQ0OWQ4OS90YWJsZXJhbmdlOjdmNmNmNGQyZTQ5YjQ1YmRiMmMwYzI5Mjk1ZDQ5ZDg5XzMtNS0xLTEtODMwNzg_6d353547-a1c2-4752-8c7c-72c4259d09e2"
      unitRef="usd">-43442000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="icedbf892c351473882af74862a207224_D20190101-20190618"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzIzNDY_f7872178-c6e0-40fc-846d-b5ed94694b85"
      unitRef="clinic">2</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="icedbf892c351473882af74862a207224_D20190101-20190618"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzIzODM_c9fad6f3-c195-4076-a2d3-a047d85eed3b"
      unitRef="usd">2025000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="icedbf892c351473882af74862a207224_D20190101-20190618"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8yOTgvZnJhZzpmMWQ0NTdhYTFmNzA0ZTk0YTE1MjI5MGFmZDYxY2E3Zi90ZXh0cmVnaW9uOmYxZDQ1N2FhMWY3MDRlOTRhMTUyMjkwYWZkNjFjYTdmXzI0Mjk_cd5ff12d-c7f6-4094-9242-48c5d76e0f31"
      unitRef="usd">212000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDEvZnJhZzo5YzhiNjEwZGNmNDQ0MjY0ODNhYTVjMTYwMTYzODQ5Zi90ZXh0cmVnaW9uOjljOGI2MTBkY2Y0NDQyNjQ4M2FhNWMxNjAxNjM4NDlmXzMxMzc_9d5b56c5-61e2-4b3a-928c-c1abf73f2723">Variable interest entities&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages or maintains an ownership interest in certain legal entities subject to the consolidation guidance applicable to variable interest entities (VIEs). Almost all of these legal entities are either U.S. dialysis partnerships encumbered by guaranteed debt, U.S. dialysis limited partnerships, or other legal entities subject to nominee ownership arrangements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under U.S. GAAP, VIEs typically include entities for which (i)&#160;the entity&#x2019;s equity is not sufficient to finance its activities without additional subordinated financial support; (ii)&#160;the equity holders as a group lack the power to direct the activities that most significantly influence the entity&#x2019;s economic performance, the obligation to absorb the entity&#x2019;s expected losses, or the right to receive the entity&#x2019;s expected returns; or (iii)&#160;the voting rights of some investors are not proportional to their obligations to absorb the entity&#x2019;s losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The substantial majority of VIEs the Company is associated with are U.S. dialysis partnerships which the Company manages and in which it maintains a controlling majority ownership interest. These U.S. dialysis partnerships are considered VIEs either because they are (i) encumbered by debt guaranteed proportionately by the partners that is considered necessary to finance the partnership's activities, or (ii) in the form of limited partnerships for which the limited partners are not considered to have substantive kick-out or participating rights. The Company consolidates virtually all such U.S. dialysis partnerships.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also relies on the operating activities of certain legal entities in which it does not maintain a controlling ownership interest but over which it has indirect influence and of which it is considered the primary beneficiary.&#160;These entities are typically subject to nominee ownership and transfer restriction agreements that effectively transfer the majority of the economic risks and rewards of their ownership to the Company. The Company&#x2019;s management, restriction and other agreements concerning such nominee-owned entities typically include both financial terms and protective and participating rights to the entities&#x2019; operating, strategic and non-clinical governance decisions which transfer substantial powers over and economic &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;responsibility for these entities to the Company. The Company consolidates all of the nominee-owned entities with which it is most closely associated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the VIEs described above, these consolidated financial statements include total assets of $299,953 and total liabilities and noncontrolling interests to third parties of $200,110 at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also sponsors certain non-qualified deferred compensation plans whose trusts qualify as VIEs and the Company consolidates these plans as their primary beneficiary.&#160;The assets of these plans are recorded in short-term or long-term investments with related liabilities recorded in accrued compensation and benefits and other long-term liabilities.&#160;See Note 15 for disclosures concerning the assets of these consolidated non-qualified deferred compensation plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDEvZnJhZzo5YzhiNjEwZGNmNDQ0MjY0ODNhYTVjMTYwMTYzODQ5Zi90ZXh0cmVnaW9uOjljOGI2MTBkY2Y0NDQyNjQ4M2FhNWMxNjAxNjM4NDlmXzMxMzI_c7948fff-fc4d-429b-8ce2-ef96daf44207">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages or maintains an ownership interest in certain legal entities subject to the consolidation guidance applicable to variable interest entities (VIEs). Almost all of these legal entities are either U.S. dialysis partnerships encumbered by guaranteed debt, U.S. dialysis limited partnerships, or other legal entities subject to nominee ownership arrangements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under U.S. GAAP, VIEs typically include entities for which (i)&#160;the entity&#x2019;s equity is not sufficient to finance its activities without additional subordinated financial support; (ii)&#160;the equity holders as a group lack the power to direct the activities that most significantly influence the entity&#x2019;s economic performance, the obligation to absorb the entity&#x2019;s expected losses, or the right to receive the entity&#x2019;s expected returns; or (iii)&#160;the voting rights of some investors are not proportional to their obligations to absorb the entity&#x2019;s losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The substantial majority of VIEs the Company is associated with are U.S. dialysis partnerships which the Company manages and in which it maintains a controlling majority ownership interest. These U.S. dialysis partnerships are considered VIEs either because they are (i) encumbered by debt guaranteed proportionately by the partners that is considered necessary to finance the partnership's activities, or (ii) in the form of limited partnerships for which the limited partners are not considered to have substantive kick-out or participating rights. The Company consolidates virtually all such U.S. dialysis partnerships.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also relies on the operating activities of certain legal entities in which it does not maintain a controlling ownership interest but over which it has indirect influence and of which it is considered the primary beneficiary.&#160;These entities are typically subject to nominee ownership and transfer restriction agreements that effectively transfer the majority of the economic risks and rewards of their ownership to the Company. The Company&#x2019;s management, restriction and other agreements concerning such nominee-owned entities typically include both financial terms and protective and participating rights to the entities&#x2019; operating, strategic and non-clinical governance decisions which transfer substantial powers over and economic &lt;/span&gt;&lt;/div&gt;responsibility for these entities to the Company. The Company consolidates all of the nominee-owned entities with which it is most closely associated.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:Assets
      contextRef="ia96df5cbacd84affb90640475c11f0a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDEvZnJhZzo5YzhiNjEwZGNmNDQ0MjY0ODNhYTVjMTYwMTYzODQ5Zi90ZXh0cmVnaW9uOjljOGI2MTBkY2Y0NDQyNjQ4M2FhNWMxNjAxNjM4NDlmXzI1NjY_753b8a50-1e74-45d6-9b10-96c741676125"
      unitRef="usd">299953000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="ia96df5cbacd84affb90640475c11f0a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDEvZnJhZzo5YzhiNjEwZGNmNDQ0MjY0ODNhYTVjMTYwMTYzODQ5Zi90ZXh0cmVnaW9uOjljOGI2MTBkY2Y0NDQyNjQ4M2FhNWMxNjAxNjM4NDlmXzI2NTQ_9a587d90-cd9d-4775-806b-e26fa02344ad"
      unitRef="usd">200110000</us-gaap:Liabilities>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90ZXh0cmVnaW9uOjZiZDhkZGNlNGQzOTQ5ODI4MjA1MzA0Y2NmZmFiZDg1XzQyMjM_6c60c610-b9b5-4e05-86c8-b93f11e54105">Fair values of financial instruments&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures the fair value of certain assets, liabilities, and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equity that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the FASB.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s assets, liabilities and temporary equity measured at fair value on a recurring basis as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&#160;in&lt;br/&gt;active&#160;markets&#160;for&lt;br/&gt;identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant&#160;other&lt;br/&gt;observable&#160;inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,434,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,434,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,330,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,330,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For reconciliations of changes in contingent earn-out obligations and noncontrolling interests subject to put provisions during the year ended at December&#160;31, 2021 and 2020, see Note 21 and the consolidated statements of equity, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stock and are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 5 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 13 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA), revenue and key performance indicators. The estimated fair value of these contingent earn-out obligations is remeasured as of each reporting date and could &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;fluctuate based upon any significant changes in key assumptions, such as changes in the Company credit risk adjusted rate that is used to discount obligations to present value. See Note 21 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of December&#160;31, 2021, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $180,000. See Note 17 for a discussion of the Company&#x2019;s methodology for estimating the fair values of noncontrolling interests subject to put obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon quoted bid and ask prices for these instruments, typically a level 2 input. See Note 13 for further discussion of the Company's debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in the consolidated financial statements at December&#160;31, 2021 and 2020 at their approximate fair values due to the short-term nature of their settlements.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90ZXh0cmVnaW9uOjZiZDhkZGNlNGQzOTQ5ODI4MjA1MzA0Y2NmZmFiZDg1XzQyMTg_74b44480-b9ad-498d-a540-409ea1e0e765">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s assets, liabilities and temporary equity measured at fair value on a recurring basis as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&#160;in&lt;br/&gt;active&#160;markets&#160;for&lt;br/&gt;identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant&#160;other&lt;br/&gt;observable&#160;inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,434,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,434,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,330,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,330,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="icd41fb8f57d94a9c8174ee4a26733781_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzItMS0xLTEtODMwNzg_9a1713aa-b762-4a40-8aea-2aaaebdc1080"
      unitRef="usd">48598000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i0fef43c972784c6a8dbdf6403215466d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzItMy0xLTEtODMwNzg_059e2fa0-c1d0-4b5d-9a13-758309a3baf5"
      unitRef="usd">48598000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ica05fdb7be334adbaa11280e81f266cd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzItNS0xLTEtODMwNzg_f9d5ecad-e5de-4c38-a781-e21cd16acd95"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6864393609014579b808f5a4cacfb46d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzItNy0xLTEtODMwNzg_53c53abc-a25d-4c14-b9ee-cb0d23b3723c"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="i418c9ec9c3c24e6f814f5127bfb19718_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzMtMS0xLTEtODMwNzg_ae7196e9-550e-4216-9adc-6b840d94ad71"
      unitRef="usd">12203000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i83a052e9006844f196962f56a7a3ab82_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzMtMy0xLTEtODMwNzg_d82d53fe-f8d4-4462-8afc-3b8e6a826628"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i98fc6e3377174560b321ac0cda63f05d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzMtNS0xLTEtODMwNzg_57f73608-5b23-44cd-a3da-fca43c9b2183"
      unitRef="usd">12203000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib3d558bed55f41d99d2f76f5a51d8b45_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzMtNy0xLTEtODMwNzg_0943f6d2-3525-4320-9582-bc6f4342d4b1"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icd41fb8f57d94a9c8174ee4a26733781_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzUtMS0xLTEtODMwNzg_6a603fc1-655b-405b-b623-92f022caad35"
      unitRef="usd">33600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0fef43c972784c6a8dbdf6403215466d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzUtMy0xLTEtODMwNzg_8b5a17d8-4a38-444b-b973-14a9a0eccae5"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ica05fdb7be334adbaa11280e81f266cd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzUtNS0xLTEtODMwNzg_35be76d1-91fc-41f4-99f8-f678c38b56d9"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6864393609014579b808f5a4cacfb46d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzUtNy0xLTEtODMwNzg_7bf512fa-21f8-4158-bb4d-cfff1d0158c8"
      unitRef="usd">33600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="icd41fb8f57d94a9c8174ee4a26733781_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzctMS0xLTEtODMwNzg_2c0ff50e-d316-4683-bb1c-138226017ce9"
      unitRef="usd">1434832000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i0fef43c972784c6a8dbdf6403215466d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzctMy0xLTEtODMwNzg_a91ecccc-8040-47b9-94c9-9fdde5fd960b"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ica05fdb7be334adbaa11280e81f266cd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzctNS0xLTEtODMwNzg_ade57ce7-de99-4563-825f-36d8cb979fdc"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i6864393609014579b808f5a4cacfb46d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzctNy0xLTEtODMwNzg_de72bd62-8d1b-4d80-a75d-8b6f60ad354a"
      unitRef="usd">1434832000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iab0bdb00a98b44d1b298eba644850e38_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEwLTEtMS0xLTgzMDc4_3ef80edc-0b8a-4d25-b8ad-cd340eff7bc4"
      unitRef="usd">44077000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i094bcb864f7f45e4b54429ab104ba86e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEwLTMtMS0xLTgzMDc4_80629e5e-d42d-4c93-9dd6-bbdff68baa3f"
      unitRef="usd">44077000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="idc5f11c3daa745e5a80d9f58e885601d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEwLTUtMS0xLTgzMDc4_1ce945a3-75b6-496d-a8b6-e63f590786ea"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6488a2f4b17b4b85a4d7bf553c12175e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEwLTctMS0xLTgzMDc4_c07e487b-90b1-45f3-824e-8a4b355c99f2"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="i3fa251283e0a4f088eb92843005d890b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzExLTEtMS0xLTgzMDc4_c06ba74a-0c62-428b-adb1-fec41ba7fee3"
      unitRef="usd">2671000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i123069f4eb5a4ab69f8ac7158c7ce2a4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzExLTMtMS0xLTgzMDc4_4a764177-eb9b-41f2-b2fa-43580f68e9f3"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i05d3a24424f8420b8fe59106d9cca3c4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzExLTUtMS0xLTgzMDc4_46b264ff-704e-43d5-bfcb-bffc5a5172b3"
      unitRef="usd">2671000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie3aa693ad0da4e16b1fa0ce0a7ea10b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzExLTctMS0xLTgzMDc4_c70c37d8-3431-4f20-8e68-d321ac9fd82f"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iab0bdb00a98b44d1b298eba644850e38_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEzLTEtMS0xLTgzMDc4_88c78ef0-4827-4ed9-afb8-8f9cb67c8ac0"
      unitRef="usd">30248000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i094bcb864f7f45e4b54429ab104ba86e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEzLTMtMS0xLTgzMDc4_eac15559-db10-44e7-804d-13a2c7343f21"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="idc5f11c3daa745e5a80d9f58e885601d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEzLTUtMS0xLTgzMDc4_7f627adc-3ff0-44e5-8f18-e6e6fc8e6ddc"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6488a2f4b17b4b85a4d7bf553c12175e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzEzLTctMS0xLTgzMDc4_1d4a49a9-6ddd-4680-90f1-1e87712f46e4"
      unitRef="usd">30248000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="iab0bdb00a98b44d1b298eba644850e38_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzE1LTEtMS0xLTgzMDc4_6bc23f72-464e-45b7-ad66-b7e8d40370c9"
      unitRef="usd">1330028000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i094bcb864f7f45e4b54429ab104ba86e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzE1LTMtMS0xLTgzMDc4_0603dc11-7b16-46e2-9ee7-ec18a5ed674f"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="idc5f11c3daa745e5a80d9f58e885601d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzE1LTUtMS0xLTgzMDc4_c22a4c08-1e8f-4b6d-9206-198f89a0e875"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i6488a2f4b17b4b85a4d7bf553c12175e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90YWJsZTo2NWNmNDRlOTA4MjM0MGYwOWNhMDI0MmZhMzkxNTAwYS90YWJsZXJhbmdlOjY1Y2Y0NGU5MDgyMzQwZjA5Y2EwMjQyZmEzOTE1MDBhXzE1LTctMS0xLTgzMDc4_bbdfa89d-afea-41c5-b237-20a0708504f3"
      unitRef="usd">1330028000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple
      contextRef="i773b082f96934fbdb2cc112ef35d5bcf_D20201231-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDQvZnJhZzo2YmQ4ZGRjZTRkMzk0OTgyODIwNTMwNGNjZmZhYmQ4NS90ZXh0cmVnaW9uOjZiZDhkZGNlNGQzOTQ5ODI4MjA1MzA0Y2NmZmFiZDg1XzMzOTI_9fe41bab-1078-4a6c-b7fe-c4642e26e662"
      unitRef="usd">180000000</dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM2MzE_dc8713a9-1d9f-45ac-a944-2afb26e4009d">Segment reporting&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's operations are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its U.S. ancillary services and strategic initiatives and its international operations (collectively, its ancillary services), as well as its corporate administrative support. See Note 1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;"Organization" &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for a summary description of the Company's businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 19, 2019, the Company completed the sale of its prior DMG business to Optum. As a result of this transaction, DMG's results of operations have been reported as discontinued operations for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating segments have been defined based on the separate financial information that is regularly produced and reviewed by the Company&#x2019;s chief operating decision maker in making decisions about allocating resources to and assessing the financial performance of the Company&#x2019;s various operating lines of business. The chief operating decision maker for the Company is its Chief Executive Officer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s separate operating segments include its U.S. dialysis and related lab services business, its U.S. ancillary services and strategic initiatives, its kidney care operations in each foreign sovereign jurisdiction, its other health operations in each foreign sovereign jurisdiction, and its equity method investment in the APAC joint venture. The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other operating segments, including the international operating segments, have been combined and disclosed in the other segments category.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating segment financial information included in this report is prepared on the internal management reporting basis that the chief operating decision maker uses to allocate resources and assess the financial performance of the Company's operating segments. For internal management reporting, segment operations include direct segment operating expenses but generally exclude corporate administrative support costs, which consist primarily of indirect labor, benefits and long-term incentive compensation expenses of certain departments which provide support to all of the Company&#x2019;s various operating lines of business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,551,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,475,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,399,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,641,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,619,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,530,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:54pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total U.S. dialysis revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,666,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,659,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,562,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;662,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;550,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;497,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other external sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;380,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;484,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,046,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,052,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;971,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,713,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,712,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,534,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Elimination of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95,090)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(162,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(146,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,618,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,550,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,388,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment operating margin (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,974,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,917,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,924,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(66,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(76,261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(189,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total segment margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,908,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,841,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,735,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reconciliation of segment operating margin to consolidated income from&lt;br/&gt;&#160;continuing operations before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate administrative support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(111,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(146,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(92,335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,797,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,694,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(285,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(304,111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(443,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt prepayment, refinancing and redemption charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,518,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,318,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,195,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes equity investment income of $3,177, $5,866, and $9,366 in 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;642,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;594,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;583,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;680,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;630,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;615,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenditures for property and equipment by reportable segment were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;589,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;646,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;681,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;DMG - Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;641,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;674,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;766,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summary of assets by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,375,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,344,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,746,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,121,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,988,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes equity method and other investments of $112,500 and $122,974 in 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes equity method and other investments of $126,381 and 134,517 in 2021 and 2020, respectively and includes approximately $190,029 and $181,137 in 2021 and 2020, respectively, of net property and equipment related to the Company&#x2019;s international operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <dva:BusinessSaleEffectiveDateOfSale
      contextRef="i94e70ca9077e4db8b762a4fcc4bfbd6f_D20190619-20190619"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzQxNQ_a58856c6-b3b2-482d-adc7-5e152622d797">2019-06-19</dva:BusinessSaleEffectiveDateOfSale>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM2MzQ_fa6b3af5-dd9a-48b5-8d8c-ab23d26ba18f">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,551,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,475,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,399,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,641,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,619,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,530,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:54pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total U.S. dialysis revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,666,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,659,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,562,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;662,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;550,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;497,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other external sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;380,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;484,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,046,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,052,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;971,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,713,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,712,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,534,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Elimination of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95,090)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(162,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(146,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,618,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,550,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,388,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment operating margin (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,974,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,917,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,924,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(66,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(76,261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(189,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total segment margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,908,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,841,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,735,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reconciliation of segment operating margin to consolidated income from&lt;br/&gt;&#160;continuing operations before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate administrative support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(111,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(146,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(92,335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,797,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,694,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(285,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(304,111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(443,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt prepayment, refinancing and redemption charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,518,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,318,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,195,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes equity investment income of $3,177, $5,866, and $9,366 in 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4a546c754ebc4cf29073750fe342c98d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzUtMS0xLTEtODMwNzg_9444da5e-046a-4f14-b1c0-5a5aaae05397"
      unitRef="usd">10551106000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6e14e13c061a41a69e38812da9f0c694_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzUtMy0xLTEtODMwNzg_f74dd561-8291-48bd-85c6-5087d24827b5"
      unitRef="usd">10475273000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i544de1e9a45e4dbaaf258e405bc34603_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzUtNS0xLTEtODMwNzg_becad117-6408-408c-a553-e8b56c25aa43"
      unitRef="usd">10399686000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2a20be04098a43a2ad690daf6b43b6a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzYtMS0xLTEtODMwNzg_0d9ea272-5061-4786-b68b-5f1ff93f5317"
      unitRef="usd">90512000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i489433a3b5c64d6d8c71dff895bfc7c5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzYtMy0xLTEtODMwNzg_36f14f3f-7fc3-4b97-9497-f5e9d4153909"
      unitRef="usd">144091000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib875d6317d544b89a9327b5a6ee456e1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzYtNS0xLTEtODMwNzg_a46ccd56-ec7d-4840-ae0c-d7f280aeb099"
      unitRef="usd">131199000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4d18a39a07e04a829dc76a948808fea5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzktMS0xLTEtODMwNzg_2b27812a-c1d4-45a2-83da-67ddd1aea1c9"
      unitRef="usd">10641618000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i341a3fbdfb3a478c8c3956fb1de4ca5a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzktMy0xLTEtODMwNzg_2ad7370b-be84-4c29-9de0-e847ab5d5a86"
      unitRef="usd">10619364000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if0c557cfe8294cbea0ed6640742174a4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzktNS0xLTEtODMwNzg_56a78298-96bf-4776-9b12-b97bd3e7f060"
      unitRef="usd">10530885000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="i4a546c754ebc4cf29073750fe342c98d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzExLTEtMS0xLTgzMDc4_7b483489-8bfc-4df2-bb53-de7b56b72ee1"
      unitRef="usd">25061000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i6e14e13c061a41a69e38812da9f0c694_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzExLTMtMS0xLTgzMDc4_b12d8111-cf11-44b7-9605-268ad7754c87"
      unitRef="usd">39376000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i544de1e9a45e4dbaaf258e405bc34603_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzExLTUtMS0xLTgzMDc4_a44700c8-ff54-42bc-94de-6d2f6dd65cde"
      unitRef="usd">30895000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i2a20be04098a43a2ad690daf6b43b6a9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzEyLTEtMS0xLTgzMDc4_0050d8ae-3f41-4f86-a657-1dc8bf2ff9e6"
      unitRef="usd">284000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i489433a3b5c64d6d8c71dff895bfc7c5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzEyLTMtMS0xLTgzMDc4_3e0d5f4c-256c-44ac-af77-68c0ccc3c88d"
      unitRef="usd">1195000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ib875d6317d544b89a9327b5a6ee456e1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzEyLTUtMS0xLTgzMDc4_45e76756-66bc-430b-92b7-3e599a9a3563"
      unitRef="usd">1126000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i4d18a39a07e04a829dc76a948808fea5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzEzLTEtMS0xLTgzMDc4_a1511fe1-25e0-4211-a1fa-48d8f3b7a970"
      unitRef="usd">10666963000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i341a3fbdfb3a478c8c3956fb1de4ca5a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzEzLTMtMS0xLTgzMDc4_2a595be9-8c83-44b9-9dd8-bd14166bdad9"
      unitRef="usd">10659935000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if0c557cfe8294cbea0ed6640742174a4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzEzLTUtMS0xLTgzMDc4_1545053c-a5d5-43f6-9c14-5ebda73ec2b6"
      unitRef="usd">10562906000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i740db58e2be94545b0d469bbda135eed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE1LTEtMS0xLTgzMDc4_312bd4a9-9dcb-44f2-89c5-4d95f98daa35"
      unitRef="usd">662409000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i30278d11df6d4599be4d253d8771c646_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE1LTMtMS0xLTgzMDc4_74040d60-929c-48d4-a11e-474784ec4ecd"
      unitRef="usd">550978000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i02fff1f443d0417a9b5ea14a7887642f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE1LTUtMS0xLTgzMDc4_85e15055-7a14-4ce1-8e73-550b5253e4d5"
      unitRef="usd">497021000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="i740db58e2be94545b0d469bbda135eed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE2LTEtMS0xLTgzMDc4_cde40f75-f09e-4feb-929e-6790a3f98af5"
      unitRef="usd">380221000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i30278d11df6d4599be4d253d8771c646_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE2LTMtMS0xLTgzMDc4_9f5aae6e-2555-455d-bfb6-7ddf56ba514d"
      unitRef="usd">484977000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i02fff1f443d0417a9b5ea14a7887642f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE2LTUtMS0xLTgzMDc4_75faf73d-5452-4693-826d-f190bedc8089"
      unitRef="usd">460877000</us-gaap:OtherIncome>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1f996697630f4114b1fe31268ca70cfb_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE3LTEtMS0xLTgzMDc4_f701d9cf-32b3-4f82-955a-e9587eef9ab3"
      unitRef="usd">4294000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6915b80d9b3f460f8e299e65e92465a5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE3LTMtMS0xLTgzMDc4_49cf2940-72b0-492d-83dc-2d613438ab2c"
      unitRef="usd">16743000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if07da703894f46ff923b52cd1974f85e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE3LTUtMS0xLTgzMDc4_84119815-6154-46be-914f-efa208860905"
      unitRef="usd">14030000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i740db58e2be94545b0d469bbda135eed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE4LTEtMS0xLTgzMDc4_ae42c1ed-b845-414a-a75a-45e03050ed20"
      unitRef="usd">1046924000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i30278d11df6d4599be4d253d8771c646_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE4LTMtMS0xLTgzMDc4_d0e9897f-b2b9-436a-b08f-223af64d6548"
      unitRef="usd">1052698000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i02fff1f443d0417a9b5ea14a7887642f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE4LTUtMS0xLTgzMDc4_adddad39-6ceb-4a40-8cd4-ca2fce86edf8"
      unitRef="usd">971928000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaff1da3cd4af4158afb2f7ced0775c70_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE5LTEtMS0xLTgzMDc4_2f90ada8-945f-4581-a0fc-69bce903b5ab"
      unitRef="usd">11713887000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2abab19ce64643c5b1ead781e19bc5d4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE5LTMtMS0xLTgzMDc4_f29b41f9-1772-4169-91a8-40cd97ade055"
      unitRef="usd">11712633000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53d5102250e24aa5bd036affff061811_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzE5LTUtMS0xLTgzMDc4_b7047176-eff5-4480-8ab1-4a8d4e829a7c"
      unitRef="usd">11534834000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia8c57a5b75b1450db44db406dbe6cbb1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIwLTEtMS0xLTgzMDc4_705c0912-29b0-42c5-ad61-5265d79c1376"
      unitRef="usd">-95090000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i867fc66d86b045b5b0590e89915a412c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIwLTMtMS0xLTgzMDc4_7a89b18f-0781-41d8-982c-ef949e4481bb"
      unitRef="usd">-162029000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iba5967b32fb4416ab78a1b0e0114069a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIwLTUtMS0xLTgzMDc4_3c9461f2-463e-419b-97c5-c334f639154d"
      unitRef="usd">-146355000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIxLTEtMS0xLTgzMDc4_31e650c9-ba31-4a91-a3ab-a5058746f48c"
      unitRef="usd">11618797000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIxLTMtMS0xLTgzMDc4_0a2d308e-6be0-41a3-9efd-77b98e140d59"
      unitRef="usd">11550604000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIxLTUtMS0xLTgzMDc4_418a8eea-bfbd-47cd-9a0c-99b562e21765"
      unitRef="usd">11388479000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4d18a39a07e04a829dc76a948808fea5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIzLTEtMS0xLTgzMDc4_08a2500c-a102-4ae6-a666-262e41f57c6f"
      unitRef="usd">1974988000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i341a3fbdfb3a478c8c3956fb1de4ca5a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIzLTMtMS0xLTgzMDc4_645fc5b3-e106-4275-848c-908fc15e205e"
      unitRef="usd">1917604000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if0c557cfe8294cbea0ed6640742174a4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzIzLTUtMS0xLTgzMDc4_ce645406-6e67-4cea-a173-17602c406249"
      unitRef="usd">1924826000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i740db58e2be94545b0d469bbda135eed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI0LTEtMS0xLTgzMDc4_85330ea0-a0aa-4044-b487-dbcf067e6314"
      unitRef="usd">-66003000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i30278d11df6d4599be4d253d8771c646_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI0LTMtMS0xLTgzMDc4_ea5b5c6d-64df-433c-bf31-1d6c104dca2c"
      unitRef="usd">-76261000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i02fff1f443d0417a9b5ea14a7887642f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI0LTUtMS0xLTgzMDc4_6cb3656e-63a7-42e3-9a8d-b41f4b5a71b1"
      unitRef="usd">-189174000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaff1da3cd4af4158afb2f7ced0775c70_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI1LTEtMS0xLTgzMDc4_24cd6a84-c5e3-41ea-9197-6abcf089bca6"
      unitRef="usd">1908985000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2abab19ce64643c5b1ead781e19bc5d4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI1LTMtMS0xLTgzMDc4_f2040f20-f37c-4f67-b82f-e6e90903828c"
      unitRef="usd">1841343000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i53d5102250e24aa5bd036affff061811_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI1LTUtMS0xLTgzMDc4_6ca6f94d-59eb-44cc-8622-794efe3acc5a"
      unitRef="usd">1735652000</us-gaap:OperatingIncomeLoss>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI3LTEtMS0xLTgzMDc4_1589b3e4-cbe4-4e6e-96ef-bdebce10e505"
      unitRef="usd">111615000</dva:SegmentReportingInformationCorporateExpenses>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI3LTMtMS0xLTgzMDc4_6bcd78f8-fa90-4089-93b1-9f54e547af32"
      unitRef="usd">146707000</dva:SegmentReportingInformationCorporateExpenses>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI3LTUtMS0xLTgzMDc4_55d4ad03-2b85-4418-b22d-629a8856a525"
      unitRef="usd">92335000</dva:SegmentReportingInformationCorporateExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI4LTEtMS0xLTgzMDc4_a9ddb30d-d74a-46ad-9004-412ffd10c665"
      unitRef="usd">1797370000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI4LTMtMS0xLTgzMDc4_150fdb08-c33b-4953-9775-54eb821f4eb3"
      unitRef="usd">1694636000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI4LTUtMS0xLTgzMDc4_8a1b8aac-89cd-4211-835b-06736f2ede73"
      unitRef="usd">1643317000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndDebtExpense
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI5LTEtMS0xLTgzMDc4_27d7ab4c-78f0-4dbd-b3d0-4c73ba93652d"
      unitRef="usd">285254000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI5LTMtMS0xLTgzMDc4_bcd788fd-9781-4542-984e-815756eb296c"
      unitRef="usd">304111000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzI5LTUtMS0xLTgzMDc4_ece863b4-8e5d-4ea7-a8ea-fa26154f11f3"
      unitRef="usd">443824000</us-gaap:InterestAndDebtExpense>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMwLTEtMS0xLTgzMDc4_06044dfc-b232-48c9-8e20-1cc318fb956e"
      unitRef="usd">0</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMwLTMtMS0xLTgzMDc4_ce8a1c9a-eefe-4e96-b944-6482389e43b7"
      unitRef="usd">89022000</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <dva:DebtPrepaymentRefinancingRedemptionCharges
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMwLTUtMS0xLTgzMDc4_fea3d737-c4dc-4b5a-8bf0-be1d2f0f437b"
      unitRef="usd">33402000</dva:DebtPrepaymentRefinancingRedemptionCharges>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMxLTEtMS0xLTgzMDc4_e482f775-1382-40f4-bc1e-9256ae99f1af"
      unitRef="usd">6378000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMxLTMtMS0xLTgzMDc4_e2308e51-4fb4-40f3-b0e0-27b6f71609b9"
      unitRef="usd">16759000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMxLTUtMS0xLTgzMDc4_ca01b7fe-32d7-4ed2-9072-d7b4861dd3e2"
      unitRef="usd">29348000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMyLTEtMS0xLTgzMDc4_5f044135-19d9-4c60-9186-41c799d06012"
      unitRef="usd">1518494000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMyLTMtMS0xLTgzMDc4_7365fff2-0c9b-4b7c-b5c2-a376e37b687e"
      unitRef="usd">1318262000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo4NmEzOWE0YTcyYTc0MGEyOTJlNGU4MzUwNDExYzIzMS90YWJsZXJhbmdlOjg2YTM5YTRhNzJhNzQwYTI5MmU0ZTgzNTA0MTFjMjMxXzMyLTUtMS0xLTgzMDc4_370e613f-8ceb-4e97-90e3-0caa925e841c"
      unitRef="usd">1195439000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i740db58e2be94545b0d469bbda135eed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzMwNDM_da95db82-e63c-46e2-8c4c-0177dce2b0f8"
      unitRef="usd">3177000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i30278d11df6d4599be4d253d8771c646_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzMwNDc_73a1fe3e-2f80-43a3-9fed-5779580dc75e"
      unitRef="usd">5866000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i02fff1f443d0417a9b5ea14a7887642f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzMwNTU_e612e7e9-8fb9-4e76-8c48-24abcf75a889"
      unitRef="usd">9366000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM2Mjk_9917b1cf-0ba5-472d-a914-5c02d3f2efb3">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;642,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;594,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;583,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;680,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;630,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;615,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzItMS0xLTEtODMwNzg_52be36c4-046f-45a6-b9d1-7a9f169a095d"
      unitRef="usd">642711000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzItMy0xLTEtODMwNzg_a7100bfb-0ac2-4f0a-86a2-1425ee5fa1f0"
      unitRef="usd">594552000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i54f8e1940aa343e29817e02300203cc7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzItNS0xLTEtODMwNzg_c24ceab5-515b-49f8-babd-9b72c6a5962b"
      unitRef="usd">583454000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzMtMS0xLTEtODMwNzg_cce24fd7-fb17-43a1-8460-a1b3d4729461"
      unitRef="usd">37904000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzMtMy0xLTEtODMwNzg_64805792-17c1-4d5b-8aa2-581024af42cc"
      unitRef="usd">35883000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6f1b74b97d41414b9d610ad1be460b97_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzMtNS0xLTEtODMwNzg_f37a5b06-d5e7-4e88-a1c6-213c9a2eb134"
      unitRef="usd">31698000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzQtMS0xLTEtODMwNzg_86810351-4fc1-498f-8919-5e84cd1d5cd1"
      unitRef="usd">680615000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzQtMy0xLTEtODMwNzg_4a8a3bfb-0dc3-453f-9c5a-c9290be90864"
      unitRef="usd">630435000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo3ZDY4NDgzNjNjZTM0NjM5OTE2NTU3MzMxNzI3ZjAxMC90YWJsZXJhbmdlOjdkNjg0ODM2M2NlMzQ2Mzk5MTY1NTczMzE3MjdmMDEwXzQtNS0xLTEtODMwNzg_9c6deafa-16bb-4ef8-95ac-424fa3c0df7a"
      unitRef="usd">615152000</us-gaap:DepreciationAndAmortization>
    <dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzE5NzkxMjA5MzA0MjQ4_f4b6d167-3666-41df-936d-eae43a287f04">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenditures for property and equipment by reportable segment were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.072%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;589,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;646,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;681,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;DMG - Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;641,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;674,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;766,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzItMS0xLTEtODMwNzg_c31e4e39-7157-4585-8db3-20fdad6ee863"
      unitRef="usd">589662000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7ec60231870c44dd824e88b8c67d610c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzItMy0xLTEtODMwNzg_8573b8c7-5aff-44c7-b6fa-2786586fd471"
      unitRef="usd">646870000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i54f8e1940aa343e29817e02300203cc7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzItNS0xLTEtODMwNzg_9e2c82d2-a1a8-4d11-9340-46bcbdf1e804"
      unitRef="usd">681339000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1c91dd40dc8e4790965b49f483d8a517_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzMtMS0xLTEtODMwNzg_b591ea31-7d1e-47c6-b9c7-c652efd2e912"
      unitRef="usd">51803000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6a8a9b75b8e646e9a6bfee94454cbd43_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzMtMy0xLTEtODMwNzg_5f1ae454-b605-4cfd-9738-daa70c0a883f"
      unitRef="usd">27671000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6f1b74b97d41414b9d610ad1be460b97_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzMtNS0xLTEtODMwNzg_76ca6d2e-d718-49d5-9686-f78e6db05bcb"
      unitRef="usd">46741000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic74654e344444142a656506ce7f98032_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzQtMS0xLTEtODMwNzg_1cfbbe03-04f9-442e-ab8e-e372d91b9694"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i769c9942acbc457e9f36b28d6dc6bcff_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzQtMy0xLTEtODMwNzg_93aeda6b-0a01-4116-b14d-6bf913db206c"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib5869a8167684e6e92336d2061353dd0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzQtNS0xLTEtODMwNzg_249efc0e-6b83-4349-899b-0a187146dc39"
      unitRef="usd">38466000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzUtMS0xLTEtODMwNzg_8cf5d9a3-7987-4698-aaf7-f68be089cb19"
      unitRef="usd">641465000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzUtMy0xLTEtODMwNzg_a9ce9199-2fbc-41fc-b46b-071630e6f3ab"
      unitRef="usd">674541000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTpmOGZkMTNhZjI0OGY0MmM3YmE2N2NiOTllNDkzZGU3OS90YWJsZXJhbmdlOmY4ZmQxM2FmMjQ4ZjQyYzdiYTY3Y2I5OWU0OTNkZTc5XzUtNS0xLTEtODMwNzg_d633e218-2a9d-4f30-9ab8-f37690d2bc2c"
      unitRef="usd">766546000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM2NDc_10180a5c-c5b6-47f1-b09c-75cbe646ba75">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summary of assets by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.921%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,375,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,344,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,746,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Consolidated assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,121,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,988,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.298%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes equity method and other investments of $112,500 and $122,974 in 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes equity method and other investments of $126,381 and 134,517 in 2021 and 2020, respectively and includes approximately $190,029 and $181,137 in 2021 and 2020, respectively, of net property and equipment related to the Company&#x2019;s international operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo0NTdiMWIxMTVmZTM0MTY4YTMwMzdhYjE5ZjgxODJhNC90YWJsZXJhbmdlOjQ1N2IxYjExNWZlMzQxNjhhMzAzN2FiMTlmODE4MmE0XzMtMS0xLTEtODMwNzg_18c213ce-617f-441d-9ca5-0e46ee060d67"
      unitRef="usd">15375000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="icce7de8cdc8f44f5a250fb8c150e4e1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo0NTdiMWIxMTVmZTM0MTY4YTMwMzdhYjE5ZjgxODJhNC90YWJsZXJhbmdlOjQ1N2IxYjExNWZlMzQxNjhhMzAzN2FiMTlmODE4MmE0XzMtMy0xLTEtODMwNzg_afb5b9f1-9e36-4a7e-9fa1-d06f6d187262"
      unitRef="usd">15344647000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo0NTdiMWIxMTVmZTM0MTY4YTMwMzdhYjE5ZjgxODJhNC90YWJsZXJhbmdlOjQ1N2IxYjExNWZlMzQxNjhhMzAzN2FiMTlmODE4MmE0XzQtMS0xLTEtODMwNzg_f8a666b8-8f43-42c2-b21c-2f93675bdc43"
      unitRef="usd">1746488000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if8a66dcc0dd948fbb741fd4e292faf13_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo0NTdiMWIxMTVmZTM0MTY4YTMwMzdhYjE5ZjgxODJhNC90YWJsZXJhbmdlOjQ1N2IxYjExNWZlMzQxNjhhMzAzN2FiMTlmODE4MmE0XzQtMy0xLTEtODMwNzg_0d2b2249-26a8-4035-ae54-b78ed6dd752e"
      unitRef="usd">1643869000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i94e3a04a958345dca335a60cee3d8130_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo0NTdiMWIxMTVmZTM0MTY4YTMwMzdhYjE5ZjgxODJhNC90YWJsZXJhbmdlOjQ1N2IxYjExNWZlMzQxNjhhMzAzN2FiMTlmODE4MmE0XzUtMS0xLTEtODMwNzg_d75cee49-5610-4437-a026-9d10cc7a3543"
      unitRef="usd">17121488000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic66c414a255d4ccba5c079ae43f2af9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90YWJsZTo0NTdiMWIxMTVmZTM0MTY4YTMwMzdhYjE5ZjgxODJhNC90YWJsZXJhbmdlOjQ1N2IxYjExNWZlMzQxNjhhMzAzN2FiMTlmODE4MmE0XzUtMy0xLTEtODMwNzg_9588bbdc-7e7a-4f9d-b577-d381db2265de"
      unitRef="usd">16988516000</us-gaap:Assets>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="iaa4bedb416e84ecc89440f4a9b0c3597_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzMzNTk_f1b10a7c-aa3f-4f30-8b61-8014936c2da3"
      unitRef="usd">112500000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="icce7de8cdc8f44f5a250fb8c150e4e1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzMzNjY_d126b7ea-2595-42cc-bfa3-e8436deb9d2d"
      unitRef="usd">122974000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i37e77621419b4554a580d5c9a5c257e3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM0NDY_b13c186d-4020-48a9-9598-d434f9ab370a"
      unitRef="usd">126381000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="if8a66dcc0dd948fbb741fd4e292faf13_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM0NTM_0d27c34f-0771-407f-81a3-e6b7d7243521"
      unitRef="usd">134517000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id95aa5b653c348f3afacdc11aed8c324_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM1MTA_855d5f07-10cb-48b1-8a74-779abe277865"
      unitRef="usd">190029000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7f1ee4e1cd744091960584e2d8db83ed_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMDcvZnJhZzozMDAwNGExMjUxMjE0YWM2OWNkZGYxMGNhMDg4NjhjYS90ZXh0cmVnaW9uOjMwMDA0YTEyNTEyMTRhYzY5Y2RkZjEwY2EwODg2OGNhXzM1MTc_681d08bd-aaf0-45cb-b3d3-37dbb9b4b43d"
      unitRef="usd">181137000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90ZXh0cmVnaW9uOjdjOTFlOTNkZTkwODRkYmFhZWNmZjQzZmJiMTM4MDlhXzEwNg_7a8afa1d-81c5-46b2-aff8-d7740b1d1153">Supplemental cash flow information&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides supplemental cash flow information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;473,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash investing and financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets under financing lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90ZXh0cmVnaW9uOjdjOTFlOTNkZTkwODRkYmFhZWNmZjQzZmJiMTM4MDlhXzEwOA_843ff67a-523f-432c-a3e4-4d63e48d5b5d">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides supplemental cash flow information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;473,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash investing and financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets under financing lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:IncomeTaxesPaid
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzMtMS0xLTEtODMwNzg_28624a30-c176-4676-8b26-1280ccc030c1"
      unitRef="usd">209754000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzMtMy0xLTEtODMwNzg_4bdb97a3-866f-43b8-a059-e650a720903a"
      unitRef="usd">154850000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzMtNS0xLTEtODMwNzg_03aafcbf-32d3-4c51-aaff-990bc5cb5c99"
      unitRef="usd">157983000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaidNet
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzQtMS0xLTEtODMwNzg_af5eb3d6-95f5-4345-8cc5-0bf54bf34fbd"
      unitRef="usd">279002000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzQtMy0xLTEtODMwNzg_82adc69f-9d8e-42fa-80ca-703ad020c9dc"
      unitRef="usd">326165000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzQtNS0xLTEtODMwNzg_09905d54-8445-413f-81c6-272dd500fc76"
      unitRef="usd">473176000</us-gaap:InterestPaidNet>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzYtMS0xLTEtODMwNzg_077d4eb1-f0db-4934-a904-d2721f78a82f"
      unitRef="usd">31690000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzYtMy0xLTEtODMwNzg_056e9e9f-26ea-4643-a234-8e58aeb8c226"
      unitRef="usd">22042000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="i2d69b4e646704dbcb67bd470c3b08537_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMTAvZnJhZzo3YzkxZTkzZGU5MDg0ZGJhYWVjZmY0M2ZiYjEzODA5YS90YWJsZTo1NWVlODEwN2JhZjA0OWMxOGU1NzViNGU5ZDMzZjFiOC90YWJsZXJhbmdlOjU1ZWU4MTA3YmFmMDQ5YzE4ZTU3NWI0ZTlkMzNmMWI4XzYtNS0xLTEtODMwNzg_eb5f0381-38f1-4d41-b5fd-eda57c178512"
      unitRef="usd">18953000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90ZXh0cmVnaW9uOmVhYmUwZDY1ZDczYzQwN2FhYWExMDhlYzQxM2QzMzEwXzY2_98622060-32f1-4f09-b162-7dbf762348dd">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;DAVITA INC.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE II&#x2014;VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amounts&lt;br/&gt;charged to income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amounts written off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;at end of year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for uncollectible accounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90ZXh0cmVnaW9uOmVhYmUwZDY1ZDczYzQwN2FhYWExMDhlYzQxM2QzMzEwXzY2_bb364d01-f2ed-47b5-85fe-2d25db68b90f">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;DAVITA INC.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE II&#x2014;VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amounts&lt;br/&gt;charged to income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amounts written off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;at end of year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for uncollectible accounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8020fe2d892b43739f987d0c488736a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzQtMi0xLTEtODMwNzg_ca387eea-1e05-4344-8ec3-99ba638c6847"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired
      contextRef="ic7ce08c39f814ce99981d4545611fa84_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzQtNC0xLTEtODMwNzg_1570553b-42ca-4539-ada9-09116d962a4a"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ic7ce08c39f814ce99981d4545611fa84_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzQtNi0xLTEtODMwNzg_e95b160b-8f7f-46c4-a261-039b209f6958"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ic7ce08c39f814ce99981d4545611fa84_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzQtOC0xLTEtODMwNzg_5fedf050-465f-4896-8bc4-9bcf95ea8ed5"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i149a050b3c4645829b359c2948b066e4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzQtMTAtMS0xLTgzMDc4_758731a0-cd8e-46d2-a93f-ffaf25a0c4d9"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i9c153efa63664c3e9cd75b33af39db2a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzUtMi0xLTEtODMwNzg_ef691e9b-e75a-4ff3-8006-6da3956ca9da"
      unitRef="usd">8328000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired
      contextRef="i91556d981c14455d82d1dc87f6ab398c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzUtNC0xLTEtODMwNzg_1994b8b3-9e1f-44f5-ab9d-e77c542cf47b"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i91556d981c14455d82d1dc87f6ab398c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzUtNi0xLTEtODMwNzg_44fbb8b8-cc36-457b-b9ab-5a31e6dcc479"
      unitRef="usd">13458000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i91556d981c14455d82d1dc87f6ab398c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzUtOC0xLTEtODMwNzg_0a7feb12-8244-4f42-925c-3c96037a05b3"
      unitRef="usd">21786000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8020fe2d892b43739f987d0c488736a0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzUtMTAtMS0xLTgzMDc4_dd09be38-3d6a-43ca-96e9-5d3f032149c9"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i69bac113d5d84b4b85c181e2fd5a277c_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzYtMi0xLTEtODMwNzg_4f0a2e60-b19d-415e-8962-a21d9f53809e"
      unitRef="usd">52924000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired
      contextRef="i3a475d47d0d042098ff362c229c4796b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzYtNC0xLTEtODMwNzg_9526caa8-de39-49de-98ad-e5108b2c0cdf"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i3a475d47d0d042098ff362c229c4796b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzYtNi0xLTEtODMwNzg_ff9f7f68-2c20-45df-9bd2-4b5c23851ffa"
      unitRef="usd">21715000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i3a475d47d0d042098ff362c229c4796b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzYtOC0xLTEtODMwNzg_83b87589-f0c0-4641-9315-d3146c7b64b0"
      unitRef="usd">66311000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i9c153efa63664c3e9cd75b33af39db2a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkxNmY3YWY4OTAxMTRlNTVhODdlMjYwNDc2NTYwYzYwL3NlYzo5MTZmN2FmODkwMTE0ZTU1YTg3ZTI2MDQ3NjU2MGM2MF8zMjIvZnJhZzplYWJlMGQ2NWQ3M2M0MDdhYWFhMTA4ZWM0MTNkMzMxMC90YWJsZTplNTg4MzhiY2MxN2Y0NGRiOGVjODI1MDA1YzA0YzA3Ny90YWJsZXJhbmdlOmU1ODgzOGJjYzE3ZjQ0ZGI4ZWM4MjUwMDVjMDRjMDc3XzYtMTAtMS0xLTgzMDc4_3a5fa0de-1d0f-4f24-99d2-5b30decc38b5"
      unitRef="usd">8328000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>139
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M,1]O!C <Y<D8ER(X%B<1FX@A&P0'\PN.K^I-8GCBB#)TA0+LW&@\#L4U!@Q
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M[>5:92M5-P#X_DEK^W;3O&#WOPXN_@=02P,$%     @ [H!+5*@-X$$#!
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MPQW5OJ[A?P>3!@#?ET+H]X$)T/R3&?T/4$L#!!0    ( .Z 2U0X\/.Z,@@
M /HC   8    >&PO=V]R:W-H965T<R]S:&5E=#4N>&ULG9IM;]LX$L>_"F$L
M<+M $_-1E(HD@)OD;@WDVER==G$O%9N)=95$KT0G[7[Z&\F.:8L/=C<O6C\,
MJ?^,AO,;4KYXU<VW=JF40=^KLFXO1TMC5N_'XW:^5%7>GNN5JN&;)]U4N8&W
MS?.X734J7_2#JG),,4[&55[4HZN+_K/[YNI"KTU9U.J^0>VZJO+FQP=5ZM?+
M$1F]??"Y>%Z:[H/QU<4J?U8S9;ZL[AMX-][-LB@J5;>%KE&CGBY'$_+^6N!N
M0&_QM5"O[=YKU+GRJ/6W[LUT<3G"G2)5JKGIILCAOQ=UK<JRFPET_+F==+2[
M9C=P__7;[/_LG0=G'O-67>ORCV)AEI>C=(06ZBE?E^:S?OU=;1T2W7QS7;;]
MO^AU8RN2$9JO6Z.K[6!04!7UYO_\^S80>P,(#PR@VP'TU %L.X#UCFZ4]6[=
MY":_NFCT*VHZ:YBM>]''IA\-WA1U=QMGIH%O"QAGKJX_?9Q]NIO>3!YN;]"'
MR=WDX_4MFOU^>_LP0V?HR^P&_?K+;^@75-3H8:G7;5XOVHNQ@2MWX\?S[54^
M;*Y" U>Y4?-SQ,@[1#$EGN'7IP_'A\/'X._.:;ISFO;SL<!\D]D,_(M,Q'83
ML7XB'HI>WBX1A 3-NQ?JSW7QDI>J-MX0;::2_53=ZGJYX@G),#CTLA\*UXQ1
MGHET9W:@E.^4\JC2SZHU33$W:JNU$WU$[V;"=$](QG RE.M:$9FDC/KEBIU<
M$94[6^K&G!G55)!Y+Z"]"JD4SO4I962HTF.%"29^D<E.9!(5.9G/]1ID03F;
M*XCD8ZE\"A,W0IF0(F4#C1Z[E'*:!D(I=RIE5.44XE<;W13*&S_I7A5+N.I
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MX/LGK<W;F^[G'[N?^US]'U!+ P04    " #N@$M4H%!%W[0"   Z"   &
M 'AL+W=O<FMS:&5E=',O<VAE970V+GAM;)U66V_:,!3^*U:TAU;JR(U+J" 2
M#52MU LJW?8P[<$D!V(UL3/;@6Z_?K:31E!*@?% ?#G?=[[O^! S6#/^(E(
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M14WY1: JR&"J@+LHTW*MH!.*(K*SYX0XHD"AKGA#;QS7<5ZF5=&QSB<S=<#
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M 77+?E03 NTC^_G%*0H]GE$ B,QUM44_:UT[AVKGH?F$]E#]7B1/49ML(K7
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M$0I3%P/L),.,F%<'F-24Q8"A!ISO2@D;RH$2E42U%([=T8S/>XF1W;*88Z>
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MVPEH;I'/U1;!H&WV4+T6Y:&I[8PD)"="EA=]QFPGIPE'^@GG)=*<A+1%Q_X
M;./?GIW_7/1\<1&\$'8C9"H8$GCUSR)08)P!CX@I79U#=H@*SLT:_P*8UK_+
MFB9E!TTF]TF>JRJBC'\H:J[X5Q5N>;E,\F*6KH*[]<]L[< /FT Y%L04*CO-
MVO^'2]-L]!)1$6HFCR-;C8L(MYX_CP [P1@SM=4S:#P3/0$;1D-BO98(V!%&
MB:4H G:FH@B8J-L786J,-08,456L.FY>I$N1Z+4D17B?H-87R\A6%'M;7@"6
M9IK#G;]>4?U]F7&</Z2J.IDG]\HG?%<U*?GF3[9LOBFS5?T'+>ZRLLP6]<=9
M$D^3O#)0O[_/LO+IF^IO9&S_<,[1_P!02P,$%     @ [H!+5'?W\B**(0
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M;GS:HT>@Y'N8CF/0>44VSN;1=IDYDO!XHT^<1(Y*@5E-0'(?3<7SD4H/VH1
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MDK,B3A5;=A"O2-.JY3@.S9H/W?%.9M0>R[>T!]RFE*])OD>=2/2#L\-\2<7
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M_,^=*VLWX 'Z?=.3=ZX?,$'XHUE?_A]02P,$%     @ [H!+5(#*)5/;!P
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M59;]V6TP^(I==I5J&A)MI;E6%50C"E8WJA8.<CX(I\B(870R\#5[+VM5";(
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M(T4M#4W ^$J#](<.*9C^(7#Q*U!+ P04    " #N@$M409 V2YD$  !X"P
M&0   'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6RM5FUOVS80_BL';QA20)7U
M9EG*D@!Y:;%^Z! T6XMAV =:.MM<*%(EJ3CY]SM2LFPO+PVV?I$H\N[A<\>[
M1SS9*'UKUH@6[ALAS>ED;6U[/)V::HT-,Z%J4=+*4NF&6?K4JZEI-;+:.S5B
MFD11/FT8EY.S$S]WK<].5&<%EWBMP71-P_3#!0JU.9W$D^W$)[Y:6S<Q/3MI
MV0IOT/[>7FOZFHXH-6]0&JXD:%R>3L[CXXO,V7N#SQPW9F\,+I*%4K?NXT-]
M.HD<(11868? Z'6'ERB$ R(:7P?,R;BE<]P?;]'?^]@IE@4S>*G$%U[;]>FD
MF$"-2]8)^TEM?L$AGIG#JY0P_@F;WC:-)E!UQJIF<"8&#9?]F]T/>=AS*)YS
M2 :'Q//N-_(LKYAE9R=:;4 [:T)S Q^J]R9R7+I#N;&:5CGYV;-W3$LN5P:N
M4</-FFD\F5K"=:O3:L"XZ#&29S#B!#XJ:=<&WLD:ZT. *1$:625;5A?)BXA7
M6(60Q@$D41*_@)>.4:8>+WUUE/#G^<)8347QUPOXV8B?>?SL?V7QE1@M81C/
M\8(97@$^7N &*B:J3C"+-2P>H.9WO"8CD-3'7%:J06#6:K[H+%L(!*O KA$N
M5=,R^>!<W.?&%RU!L#O4U(,@NV9!NZ@E$$1#7>/W,T#M;"R3;HL0OOS;ZUE;
M1T5T-5+[4K)YY9RHI*M;Z"2WP#9,UX:8,!I36%*!4'+EPNP6?U/?.MHD/$OD
MMJ/U!5:L,^BI:ZQXRU%: VOB 899;I:<-B#C-4'0@VO ^U;PBO:Z(P:.D47=
M$$=- )9K)'VQ@(*O^((+;A]H^FLWS)L0KKCH'.FGSJ /S7@VM;,C>0%<+AUO
M2N!^&GS,;PU:*\8,L+9U,3 O3MIEU "94V8<U8-$T8)Q26X]EXZ:S(<'EF38
M=/IA,&W0KE4=PF]]>I2L*"2/;QPAYT'G2T=FE>[WJE$J$I5^@C);NX2/E>7D
MCNK/&SZ?APW2@_@ME2"%-\?P!QD!.B4 ZF/T!;7M9?>(Z!&7\.NN4H^$,N;-
MHX*]8I^Y9?!!5N$Q5:ZD\^M<-NF/I(>P?H1R7@39+*+1O$B#I)RY490'19K0
MZ9FJ=R,N>UX__5 D<?(S')5!/DO?0!QE09P=4'J!R^&F\S3(LX1&11P%91$_
M[H[';7$\=/:P$D>S($DCB.,RF)=SB&=I$!/2N:%?)0$1I;X@F8"E5LUPW*U@
M%$L6S.,"DJ!(<LC3>*S8$;L,RJR .$F"/$D]=D&"W1.0W^,,=J5 B0E3EY4\
MG&7TRL(\?O80=F[C<41A5+R!*,R+Q_QVYM\XFBV#+*?7+$S*,27?/=HB+/N]
MTK*/-OI/T<Z?8OC:>'<<XC[>.9S3_F]'13K4GD%R\=Z+5]W7T[;CG1(=Q=0/
M<4X5E48QS((RS?W<35]/S!CE1(M<-Z2S6RU["G7413P0FH/=]A3]85"2 _+?
MTKJG_MW3O=L0J=W*W_F<?G;2]A>C<7:\5I[WMZF=>7\G_<CTBM/I"5R2:Q3.
M9Y->JK<?5K7^;K50EFYJ?KBFJS%J9T#K2Z7L]L-M,%ZVS_X!4$L#!!0    (
M .Z 2U02%BYS= ,  -$'   9    >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM
M;(U547/;-@S^*SBMM[ZDEBRG;M;9OHN3[K:'[G))MSWT^D!)L,4+12H$%,7_
M?B EN^Z6^/)BDQ3P?1] $%CTSM]3C<CPU!A+RZ1F;C^F*94U-HHFKD4K7S;.
M-XIEZ[<IM1Y5%9T:D^99-D\;I6VR6L2S&[]:N(Z-MGCC@;JF47ZW1N/Z93)-
M]@>W>EMS.$A7BU9M\0[YK_;&RRX]H%2Z04O:6?"X62:7TX_K\V ?#?[6V-/1
M&D(DA7/W8?-'M4RR( @-EAP0E/P]XA4:$X!$QL.(F1PH@^/Q>H_^6XQ=8BD4
MX94S_^B*ZV5RD4"%&]49OG7][SC&\S[@E<Y0_(5^L)T+8]D1NV9TEGVC[?"O
MGL8\'#E<9"\XY*-#'G4/1%'EM6*U6GC7@P_6@A86,=3H+>*T#9=RQUZ^:O'C
MU2T2>UTR5G"EJ(;_[!<I"TDP3<L1<#T YB\ 3G/X["S7!)]LA=6/ *FH.TC,
M]Q+7^4G$:RPG,)N>09[ETQ-XLT/(LX@W>V7(7R\+.9#R^'8"_/P ?A[!SU\)
MKNRX^/30Z4=ET#+!M:;2..H\PM<O^,2P-JZ\__9<LE_-5N[9\#O1EQKARC6M
MLCNH526/Z/_F<7'D VX#;WZ9G67S+'Y_,_TP/[N8Y: 8Y":P*=#__--TGOVZ
MOY)H)HOL+!"T&-^9V4T@T%=82J\@!&V?I3]F[A5!Z[4T!VUV4'F!L5#L@ 7'
MRSL.,*(.J0R7LNEL10$V?.9:^PH>.N49?3"*PL1)!39VH *[,X^R,[A5!@B9
M#4I[X0G<(<*?CA&F<Y ^)]!>0+V(9Z4-B4$G):(L:V5$F?P$BD'6Z9 *990M
M\43R-$&-IHJ!>'GO02PIUK39R5FH$1]1A9\#W[:3F)S?R5)X?(R CB,-LOK:
MB=!WKK=16!MN9$"+:LI8$QI)C$59@<I+XMT&*?1:24X@W*)%+VNC5:&-YET\
M#3T6/;V-&-*;5>RM7M,]Q=3Q4<D%^R%)83IHNWU= <9TO)PPCS)]*%I&U]9@
MM=V''JJ@E2((L4E&2V?MV/Y[S34XB_N;&T6^)1%1:F-D(D'1D3PP(J3)<ZT@
M/6JS#?IM'":BPG66AXY[.#W,J\NA37\W'X;=9^6W<A]2BQMQS28?WB>2Q#A
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MH?9.6NDM.TZ^U]ISI-% BW^(EX=G6:8::;&$<=2?+6,-F=*YJW,LB0J=XO^
M2U=CL29+GI6$U;56+QRE\ (+!BMY6,XH]W.I.F17H:-3338:3+<*],;/<.PY
MSMIVT/74_C?AIIV.!_;V'^,3TQOL6T1 @:+Q:#H)B&[G=GNPJO:S<JTL3EZ_
M+;%!@78,>%\H9?<'IZ#_>5K]"U!+ P04    " #N@$M41%PRLV8"   Y!0
M&0   'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6R-E-]OFS 0Q_^5$^HC*P3(
MCT9)I*;=M#U4BUIM>YCV8. (5HW-;*=T__W.AK!4;:.]@'V^[^=^P'G5*?UH
M:D0+SXV09AW4UK;+*#)%C0TSEZI%22>5T@VSM-7[R+0:6>E%C8B2.)Y%#>,R
MV*R\;:<W*W6P@DO<:3"'IF'ZSQ:%ZM;!)#@:[OF^MLX0;58MV^,#VF_M3M,N
M&BDE;U :KB1HK-;!]62YS9R_=_C.L3,G:W"5Y$H]NLV7<AW$+B$46%A'8/1Z
MPAL4PH$HC=\#,QA#.N'I^DC_Y&NG6G)F\$:)'[RT]3I8!%!BQ0["WJON,P[U
M3!VO4,+X)W2];SH+H#@8JYI!3!DT7/9O]CSTX42PB-\1)(,@\7GW@7R6M\RR
MS4JK#K3S)II;^%*]FI+CTGV4!ZOIE)/.;K[:&C7<8X'\B>4"#;RRK")+@9Q[
M5 S0;0]-WH%.$KA3TM8&/LH2RY> B#(<TTR.:6Z3L\1;+"XAG820Q,GD#"\=
MRTX]+WV'=UKPS^O<6$V_QZ\SX&P$9QZ<_6\_W^K>680;PZ5I68'K@.;,H'["
M8.#J5]_IU-*A1BA4TVINL 15 ;E I01-'I?[)5 7L<E)=>RD>\3P<&A;P3TL
M9Y9 3)8@E?Q 72GQ18@+2*ZR<#K/:)5>Q>$T7L =EKQ@%#IG)0U$;J$0C#<&
M)FD2SK,Y3*9IN)@M2)(E\S"EL!<PS;(PG<_@K99')[]S@WKOA]9090=I^S][
MM([WPG4_#O_<^TOECND]EP8$5B2-+^?3 '0_J/W&JM8/1ZXLC9I?UG2WH78.
M=%XI98\;%V"\+3=_ 5!+ P04    " #N@$M4)A/T_!8$   N"0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q-2YX;6RE5FUOVS80_BN$D0\MP$82]6:GCH&D
M[; "[1"TV/9AV =:.EM<*=$EJ3CNK^\=)2M.D60;^L4^'N^>>^Z%I)9[8[^X
M!L"SNU9W[G+6>+^[B")7-=!*=VYVT.'.QMA6>ES:;>1V%F0=G%H=B3@NHE:J
M;K9:!MV-72U-[[7JX,8RU[>MM(=KT&9_.4MF1\4GM6T\*:+5<B>W\!G\[[L;
MBZMH0JE5"YU3IF,6-I>SJ^3B.B/[8/"'@KT[D1EELC;F"RW>UY>SF B!ALH3
M@L2_6W@#6A,0TO@Z8LZFD.1X*A_1?PFY8RYKZ>"-T7^JVC>7L_F,U;"1O?:?
MS/Y7&//)":\RVH5?MA]L,XQ8]<Z;=G3&=:NZX5_>C74X<9C'3SB(T4$$WD.@
MP/*M]'*UM&;/+%DC&@DAU>"-Y%1'3?GL+>XJ]/.K&XO]M?[ 9%>S=U][M<.*
M^V7D$9LLHFK$N1YPQ!,XB6 ?3><;Q]YU-=0/ 2(D-3$31V;7XEG$MU"=LS3A
M3,0B>08OG3)- U[Z+YER=J-EYQ\FS/ZZ6CMO<4;^?B94-H7*0JCLIXOZ/W!@
MXOJ$>@\66&7:G54.:F8VS#? -D;CP5/=]H)A1:%=@YVJ2C\Q^T P9RS->!PO
M2"CY0F3LNE>Z1C_'LD7!LSQG61SS(BG8!\!CT!A=,X7!S"U0>,=2/A=SGL49
M247.2[$X*3 %4=UPB]!Q= ?GH74<E97N*1!*'FPGM3[@N;K%^V*':3BS\7N)
MF:5<+ 1/R@*E>)[@:LY^PU-? ;D%_$KNE)>:2>?P.D-J_^#9=XA+\M:"<RQ'
MC+A(&>;!BWG!YEQD*4_B$J4X%ESD*>:'AK*J^K;7TB.'&O#"J]1 _$7&RP)=
MTOPER=D\YIE8O*3"\:Q<\$4I@IR+! N28=5/G(FE;(WUZMN@@#N\7AU@O+%Y
M/07L'=6#VD=#21?+*YH-UH)O#+;V%A.FW=[!IM=,X\7FC@T/R3L&SJLVL)=N
M' )WP=;'IN( Y.P TCKF#79VD%\S_6AO^<"E0>(8F0)!-WJ;@0GE45&T (#[
MMGW]PWS^[ 1P["*:JEW8]XT%N,\@&;,Y?UCOL;S,A!%X]-1@><Z*HN1EGG.4
M:"Y$P8/568$3OXASK)\-!X8/)X;V1)PL.#Y+CO+&^NO#.7M/]+'P%*Z&M:?,
M>FMI@GI[[.B86 B.E>RF$78!UZ"-?7*2W7%'?1LZ*\/0F&Y$FP8 U<B#WJN:
MV)#^GBOR>H68%<WYPTAKB7<CZD]R.0T8BI7D7)14JP0OBBP;*B5*G@KQ'POU
MV!4;G;QA+=AM>*F1GND[/SQGDW;Z&+@:WL![\^%+XJ.T6]4Y',4-NL;G93YC
M=GB=AX4WN_ BKHW']S6(#7[0@"4#W-\8XX\+"C!](JV^ U!+ P04    " #N
M@$M4L#;FUQ4$  !$"0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6R=
M5MMNXS80_96!D(==0+5UEQS8!G+I98%N$6RV[4/1!UH:V\12I$K24=RO[Y"2
MO=XX3HN^2.1HYLR9&ZEYK_07LT6T\-P*:1;!UMKN>CHU]19;9B:J0TE?UDJW
MS-)6;Z:FT\@:;]2*:1)%Q;1E7 ;+N9<]Z.5<[:S@$A\TF%W;,KV_1:'Z11 '
M!\$GOME:)Y@NYQW;X"/:7[L'3;OI$:7A+4K#E02-ZT5P$U_?9D[?*_S&L3<G
M:W"1K)3ZXC8?FD40.4(HL+8.@='K">]0" =$-/X:,8.C2V=XNCZ@_^!CIUA6
MS."=$K_SQFX7015 @VNV$_:3ZG_",9[<X=5*&/^$?M#-TP#JG;&J'8V)0<OE
M\&;/8QY.#*KH@D$R&B2>]^#(L[QGEBWG6O6@G3:AN84/U5L3.2Y=41ZMIJ^<
M[.SR@[1,;OA*H)E/+0$Z\;0>C6\'X^2"<9S 1R7MUL#WLL'F6X I,3G220YT
M;I,W$>^QGD :AY!$2?P&7GH,+_5XZ06\'Y5J>BX$,-G UUCAQABT!NZYJ84R
M.XWPQ\W*6$U-\N<;;K.CV\R[S?Y?5M\T=F-X;3I6XR*@.3.HGS X000V<#^7
M*+M%#7;+)&P.<?=(L=6J[30WV(!:TW>$M1(TC5QNKH$RCNV*[ Y9=X^(T*FU
MN>06OQ,T-@T(7M,HHH$KB*,L3.+,KZ(P3BOX14GG RT?1FVC$6ERB5,9A=DL
MARH+HR2!.]_0Y$RC8$[5;'EG?'$&\D4:EH2<)V%>%)"D59@E*;V+L$P*^!D-
M*=?UKMV1.9%BK=*6_^VAX%T1A64:O8=WY#3.XO>.8%F&Q2QUJZ((\RI_@RJC
M3&U0HF9"[ _0+F=//JND!WMDVH!5%/BX=M3K"U$1'J5=UKQ[#?$(07#)N)[
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M:+\['G4JTIN--^LP1BV,IZ$L+.DER]#R!?J^-,8W&U:PFZNG_P%02P,$%
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M^(S #3O<\7R^)WMTB+ NFNC4UI16V1?0Q_'.V#8(! LYTP X!,VTFOTV.!(
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M [-K"Y5KS\D%Z6@MN#^+NO78.6Y 2%&DJ_YO:KOHW#788L/IX:PL#)?> .S
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MO>+BZ.<@?F5&/WHQLJL0?QGJ[G:_JUW'GY/ZY?%'N5\ =,*J41ML'8^6BS.
MEG_HBE^"K?G')70LP99\"9I"#T,+\'QCX9_TA0[H?FU\_3]02P,$%     @
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M-/- ];N@=XQLW?SMI:%I=F9%ZQ.53:#S4DIS<NP%XT)>_P902P,$%     @
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M&M]UAZ5'\^[(^4FZ-:\+325<I^/%V4BX[AC7703;Q*/3R@8<Q.+?"B=?<FR
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MD,I/)M]U8A'R[G)JK$@4/RI=&C\HJQX^P -/#BD.$R(E8 ?Z=1UE1WDW<F6
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MRZ@'_X9B(E4^/1? RCE#WY)AL)(D-3,YC).;2$4MAXFW/LV8A%Q*?,+?IJ_
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M &@!OA<.'FU_D(+^]OOJOU!+ P04    " #N@$M4#^173BT0  !T,0  &0
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M+C@RG!9@?J>4[1[H@/Y;Y=5_ 5!+ P04    " #N@$M46+2*B <$  "B"0
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M+KDV7H/CBS>[</5<&8^+;'C<D@2]\09\7QO07_/""KK_15S]!5!+ P04
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M;1U>O&GXJGAAO#<5/Q9* N-I [XO#5(SOI" _G\'%_\'4$L#!!0    ( .Z
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MX]^[.:<30^>%,C=#5:)Q[UOE&DXCY+8[!#^R8\38"P(2'**DL'!Y<C9RBUX
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MFY[7]B#!%<F9OA/;"]SET[1\L6#*_<*V\&VU/(ASI46Z QL%*>7%2IYW=3@
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M#,FNV]V^: YPGJL:3A'1!HTJ^><,T*-Q!;$<WNFJJ!&<+ML6MR9;&=-DIK9
MRG@IB^R'?PZX/]O<PKH*%OEH8%1["[OELT6[@,G<: _K>C!X;7BCG<%;A-L!
M3,!1AA?9F7[;5CE.5YOQD@)1?M*9<N@8M,E\19^M"]MEMP6L1M#D!8KJ#^!5
M\$#9 O1T'=ACL=\#[12KVBPR8*/Q&?[R'\^7E]^^= R_AO 6\2.Y^+HMX3O8
M3 >'T^T@6MO*(,K"?+"=]="4,CP\"HB'=U$+;Z,=\FGABH%I9^NNW?%]X3.
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M1ZW;-=P!Q]5Q,;&L?2R3/268$P9*V1<TAVD<ZUL<"QFY?!-U)3DD6KYHU=X
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MNZ;A(UMV+O)5</P@=I"IAK'(WAJ0&1W/)"MZ/6D%F"G.>[-+E?:P$Y+YM"[
MG.MKQ,A4C)10+=(E9S&J5A@I'^$<$MY&C,':$=L.KB:O<I6FH%?1QF-O?NRV
M^Q5^"GT3O&&LR6D>Q<)I]L6!LTJCO4VM-/8VRE36H>PM"VDJ$52>()M=(IQ[
M;%:S83,9<_D)T%070VB@.$WQYC1T$/S(-I&:+)P5B3")8-]2/XH8VMLT=();
MQ6<E@BT^@M$-;3E+0YSUZ"Q@UED,(L0+>1R?]O5MQ0KM)UZ0LSV2U@,^9>$8
MQEAG/+6@3>L(TZX,;'5CC'_RVC#Q5BY_I =J6F@JK2F8422PPF1%4"CK"H\
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M<7\NHA:[B]Y](!UF\.4J8595O4&L1CW"8).X9PS@[\QHO['G(>P(^,/?BF9
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MK #M+Z4TNXDU,#[ YO\!4$L#!!0    ( .Z 2U1XK9Y420,  &8'   9
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MM[^[VA=3;^POIF5M3%W:Z5I)]%*T =]7=6WV+R2@_^=X^C]02P,$%     @
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M!/!^V:(ZZ">TP?#E\^)_4$L#!!0    ( .Z 2U37V!VEZP0  ,L+   9
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M/#[^XG".KVUEPP9<GQKC-S]!P?;]/OH/4$L#!!0    ( .Z 2U2ED>N'#P4
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M7U(<#]UVA?.XT$2 ]PNE;'L@!=V$/_D'4$L#!!0    ( .Z 2U3OC\/DF 0
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M:TZN!:[(-#X[IYKI=E:U&ZL:/Q^6RM*T\<N*QCMJIT#RE5+VL'$.NC\,BW\
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M@-IM('NIZ!(.$Q=@_*A8_0U02P,$%     @ [H!+5'.+;=GL!@  <A(  !D
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MM5"6AM^+-6U;U,Z WI=*V8/B O3[>_$'4$L#!!0    ( .Z 2U1TA$;6ZP(
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M@=H%T/NE4G:_<06J/U'_+U!+ P04    " #N@$M4A_T:_-4#   ##   &0
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M73HH>P#WUU*:_<0::/O^V7=02P,$%     @ [H!+5,*$)EDM!P  CRH  !D
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M18^-UANAV;HHLU736-W!*DZW_T<_FP?1:8!%3P/2-"!F ];3@#8-Z+X-6-.
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MYC*O!.KW^RPKGS]4%VC/H)[_#U!+ P04    " #N@$M4=!S3EKL#  !9#0
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MP7F$^TX5=7S1,7+M2N&Y-!A"UUSAVP>4G8#?%U*:7<<N4+VFAK\!4$L#!!0
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M0N,HMLL$+TN0)@#?SX30ZXU)4%V__;]02P,$%     @ [H!+5,/=, &. @
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M)D _GW*N5AMS^C9?6_U_4$L#!!0    ( .Z 2U1E""\EZ@,  -(.   9
M>&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;*U7;6_B.!#^*Q;:DUJIU\3FK:P
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MM$C-H]S]SBI"?8L7R52[7[2K;,,.B@IM9%8Y0P09%^4_?:X2L>> !T<<2.5
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M#D$!5-E E0,C<]=2K*2!!L4])M!T,F4-X/U:2O,ZL O4;>ST7U!+ P04
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M(,0!&K@;QPVKMF<P:0TF3H.O:]%F+1E;0Y&IQ-C>)((=?.&9)9"619D333/
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MW,Y&AU](Z=12.O]OG=9P<7YW-;S^N2/9;CU#]Z F8F]U?'D'W+]A15LWK]G
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M6-"*FVNY_@Z-GI[ERR37[I>L&]O (UFEC2P;,$90,E%_Z5.3APU F+X#B!I
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MI<$N[)8%#E90U@#O%U*:EXUUT([JR7]02P,$%     @ [H!+5-_^-G*/ P
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MZ7^=!'21@,*$RDMM_/R8H(LOE^@+(@P]%;R2F&5RXBH=I''EIDU BSJ@X$A
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M5T;4<Z#>*+ZQG7'%E>ZS=EGHT0G"&.C[G'.UWQ@'[3">_0=02P,$%     @
M[H!+5*X]FJLN!   O!   !D   !X;"]W;W)K<VAE971S+W-H965T.# N>&UL
MG5A=3^,X%/TK5J65NM),/DN!45L)6M#R, ."8?9AM0]N<MMZQ[$[MD-A?_U>
MNVG:0N+ OM#8R3G7]]B^'XPV4OW4*P!#G@LN]+BW,F;])0QUMH*"ZD"N0>";
MA50%-3A4RU"O%=#<@0H>)E$T# O*1&\R<G-W:C*2I>%,P)TBNBP*JEXN@<O-
MN!?W=A/W;+DR=B*<C-9T"0]@'M=W"D=AS9*S H1F4A %BW'O(OXRBP<6X+[X
MP6"C#YZ)=64NY4\[N,G'O<BN"#ADQE)0_'F"*7!NF7 =ORK27FW3 @^?=^S7
MSGET9DXU3"7_D^5F->Z=]4@."UIR<R\W?T#ET(GERR37[B_95-]&/9*5VLBB
M N,*"B:VO_2Y$N( $ ]; $D%2%X#!BV M *D[P4,*H"3.MRZXG2844,G(R4W
M1-FOD<T^.#$=&MUGPN[[@U'XEB'.3&Y$)@L@W^DS:/*9W$,F1<8XHVY7+L%L
M  1Y#!X"<@TY*,K)'D+NJ0%"14YN2T6N%@MPN[A_=:UD0:92&"9*)I;D=HT,
MEEF3_@P,95S_/@H-^F%7$V;5FB^W:TY:UAPGY"MRKC2Y$CGDQP0A"E"KD.Q4
MN$R\C#/( I+&GT@2)7'#@J;OAT<-\-F[X?&YQYNTWM/4\:6=>TIF3&=<ZE(!
M^>MBKHW">_:WQ\2@-C%P)@8M)G9G@6U-&32%&PM->^DG2N(@BGYKDOQ_XF8?
MQQTI<%(K<.(E>C#V@._]!_V)"(S3<D$6E3AS$+!@IDD4/W?:IDD7;- LB1^6
M!*E7D6&MR-#+<_6K9.:%H""8E+2[YDVN^TGZB76B*2A,_<"H[3QTP4Z\SI_6
MSI^^ZT+88,B$ 26< #BSNQN$YO]@/,><:723+G[^^.TF;57QPUI5^3#L2)6S
M6I4S+\\W:0-TB5EASH' ,V2E2Q!=9\3/&@5GS5KX87&0-&OQ86M'6IS76IQ[
M>>XD9X9E]HSD3S*CF;TJNODL^)FB%D>F?E@<G#;[_V%K1_['T;[4B+Q,CT)A
M>;$4[%_(W;6H F2C!!U<_2B(6^)$!S)JBY(=N.0M[EB'@Y(K]C)-5U0L;>YX
M%2F>*"^W=1?E6(]3D34FU [VOLMPS<KXD?';6%@ITX7S)Y XV2N3>)ENS0I4
MH\]^7&L1T8'#4S1LUFK6C4S>((^]WI=K<>KENBG66);9RD%@\8V5K9*<VW+9
M'0_ &$'6BF%;QO@+H<8H-B\-M1'52 OY;._2FKY8"&87C#+0?*7\R^BG;6),
MNY #&R.;9>Q$GG?(N"])8W]IM^\_?.5H!TG2&ER[@&E+5IIU UL"2WC0UA6@
MEJX]UI@U2F&VO4T]6[?@%Z[Q?#5_:5MSUR[N:;9]_5>JE@R[,0X+I(R"4RP5
MU;95W@Z,7+OF<2X-MJ+N<044:QW[ ;Y?2&EV VN@_H?%Y#]02P,$%     @
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M+(YIU,.8U(S)(.-WENW8T:TRXY?,M$@78])Y^!@;%\9A"]*EPS3N6]S8;SS
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M,JT.M\!6(*W W%\+H5].[.=I_>^(^?]02P,$%     @ [H!+5)R5U,5U P
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MU.]ZTQX_Z+?=]B]<GOT+4$L#!!0    ( .Z 2U3#89*&7@(   T&   9
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MBUA_7*(IT\U \:4I7%.N=!DTW4+?;$#4 /U^SKG:#NH%NKO2^!]02P,$%
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M<WE61WO"]0#U_9$Q^7RC3YO]/PM6_P)02P,$%     @ [H!+5!38_*&P P
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M^]/,B2Y@*953>J+L?INZ_S:^#EJ"P7OX6I,,#WSMQKUCO@Y;;<.3VFHO"<W
M-J"]J>[(;:@]4&P'][BN_G,NKEJNJ[<Q.HY>.DWT'E8W+(?_<)(D_W@='O1$
MCBKWG5]#ZMCJ]MCNMK?+M.ZI+^'UU71'5$Z%!H9K"XTN!_8XJ+K;UPLC2]]A
M'Z7MB]Q/"WM#HG(!]OU:2K-?.(+VSIW\ 5!+ P04    " #N@$M4(YDID#@$
M  "W#@  &0   'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6R]5VUOVS80_MS]
MBH/1 2V01F]^+1P#2=Q@ 9K&J-,-P[ /M'2VV%*B0E)V NS'[RC)DMO("E9@
M^6*+$N^YY^[(A[SI3JIO.D8T\)"(5)_U8F.R]XZCPQ@3ID]EABE]64N5,$-#
MM7%TII!%A5$B'-]UAT[">-J;38MW"S6;RMP(GN)"@<Z3A*G'"Q1R=];S>OL7
MG_DF-O:%,YMF;(-+-%^RA:*14Z-$/,%4<YF"PO59[]Q[?^$'UJ"8\3O'G3YX
M!AO*2LIO=G =G?5<RP@%AL9",/K;XB4*89&(QWT%VJM]6L/#YSWZ51$\!;-B
M&B^E^(-')C[KC7L0X9KEPGR6N]^P"FA@\4(I=/$+NVJNVX,PUT8FE3$Q2'A:
M_K.'*A$'!KYWQ,"O#/R"=^FH8#EGALVF2NY V=F$9A^*4 MK(L=36Y6E4?25
MDYV9?9)I*%.CI* O&[A.#2K41L,R7WVES(&1L,@-+)3<<EL*#2R-X-;$J.!2
M)@DW5".:_P[.HXC;3#-!,.5ZL7E_,T?#N-!OX37P%.YBF6N"T%/'$'_+P@DK
MKA<E5_\(5\^'&^(::_B01AA]#^!0X'7T_C[Z"[\3<8[A*03>"?BN[WU9SN'-
MZ[<=L$&=U*" #8[ 'N;EG+)U2:PINYB&'#7,N0Z%U+E"^.LC6<*UP43_W>&W
M7_OM%W[[1_PN<A7&M$3A=B7XIDC_"<QSM'G_A \&[G8HMEAEL:T )?ZHP+<;
M>CL;]"?N:#)UMBV\!C6OP4_S6B*MOPC^1*;:")7 XT-"GCN9>.V$AC6AX4\3
MNHNY.LYG^(1//W"]R;"=SZCF,_KO?&CGK1 6C$<G!1VXDGDKI]$33D%_,!X&
M[9S&-:=Q)Z?;]1K>73#!TA!A69P05SRED=6)<Z48+>ABB;=1&C]91VX[FTG-
M9M+)YL/BMF.#>&XC=^Z+;DWO0&B]S@@^2LH;J6L"V;[:84WF!/ AXZI4S(@9
M;%7';@=[,?OEU2N2,[^+M-^0]CLQ;WC*DSSIPFI$T7M95?0:6?2Z=7%)=YDH
M%QA!Q+66(B_27-1"KN&KY*F!+?$BY^W'4C>\Y\(C[4_=Q;612J];*ZN,PS_P
MS))OM,X;OFS>&U7SNF7-+OEWQY=\ABJD![K\V3+<YXQXF4>ZZ]WG7%&Q2@'<
MFT:ME>DF,'%/7??7KE@:-?2ZY?"&/3RW$QHM\R8O6A&_D3_?_5]WPC/P@^=W
M@M\(IM^M9X=9LK=0>P.-Z(BD9<-LNN"29=PPT>6L$3K??]F2-++H!]WG;'&5
MSJ0AWYSNSN'W86=5V+(..RS#MA\U;NFMH&(R\:BY!KN?\,?\5Z4+GIS)7M ?
M_GBU<PYZB035INB8"%CFJ2G;BOIMW96=E[U(,[ULZ6Z8VG!J& 2NR=0]'9'R
MJ;)+*@=&9D5GLI*&^ISB,:;.$I6=0-_7DK)2#:R#NE>=_0M02P,$%     @
M[H!+5,G #&$M!0  VA8  !D   !X;"]W;W)K<VAE971S+W-H965T.38N>&UL
MM5AM<YLX$/XK&O>FT\Q< $D80YMXQHG3N\Y<YS+QI/VL@&PS >1*<MS\^Y.
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M7%.24*X7J/=+QN3+C3;0'&=/_P-02P,$%     @ [H!+5)JO,^&U!   O1@
M !D   !X;"]W;W)K<VAE971S+W-H965T.3<N>&ULS9E=;]LV%(;_"N$90PHD
MDDA:DMTZ!O(U+$"+!0FZ7@R[8"S:%BJ)+DG'"; ?/Y)21*4R%2^ST.;"EF3Q
MG)<O>1[+)],MXU_%BE()'O.L$*>#E93K][XOYBN:$^&Q-2W4)PO&<R+5*5_Z
M8LTI2<R@//-1$$1^3M)B,)N::S=\-F4;F:4%O>% ;/*<\*=SFK'MZ0 .GB_<
MILN5U!?\V71-EO2.RL_K&Z[._#I*DN:T$"DK *>+T\$9?'^.)WJ N>//E&Y%
MXQCHJ=PS]E6?7">G@T KHAF=2QV"J+<'>D&S3$=2.KY500=U3CVP>?P<_3<S
M>369>R+H!<N^I(E<G0[& Y#0!=ED\I9M?Z?5A$(=;\XR85[!MKHW&(#Y1DB6
M5X.5@CPMRG?R6!G1&(!= U U !G=92*C\I)(,IMRM@5<WZVBZ0,S53-:B4L+
MO2IWDJM/4S5.SCZR8GDB*<_!=3&GA;8(7+!<+;H@I6U% NY6A-,5RQ+*Q:^_
MC!&,/X"K;YM4/H$3<%>N)V +<$N*)=4'5X^4SU-!P0U/YU2 HTLJ29J)=U-?
M*M$ZM3^O!)Z7 I%#($3@$ROD2H"K(J')RP"^FFT]9?0\Y7/4&?&2SCV X3%
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MHB2A7-^@/E\P)I]/=(+Z/Q:S?P%02P,$%     @ [H!+5-E2Y786 P  ?PD
M !D   !X;"]W;W)K<VAE971S+W-H965T.3@N>&ULG59=3]LP%/TK5Y$F;=+:
M?/0+4%NIT$U# @F!-AZF/9CDMK%P[,QV*?WWNW9"5EB:=7M);,?G^)YSKV-/
MMTH_FAS1PG,AI)D%N;7E61B:-,>"F;XJ4=*7E=(%L]35Z]"4&EGF084(DR@:
MAP7C,IA/_=B-GD_5Q@HN\4:#V10%T[MS%&H["^+@9>"6KW/K!L+YM&1KO$/[
MM;S1U L;EHP7* U7$C2N9L$B/EM.W'P_X1O'K=EK@U/RH-2CZUQFLR!R :'
MU#H&1J\GO$ A'!&%\;/F#)HE'7"__<+^V6LG+0_,X(42]SRS^2PX"2##%=L(
M>ZNV7[#6,W)\J1+&/V%;SXT"2#?&JJ(&4P0%E]6;/=<^[ 'BR0% 4@.2-X!D
M=  PJ &#MRL,#P"&-6#HG:FD>!^6S++Y5*LM:#>;V%S#F^G1))]+E_8[J^DK
M)YR=7RFY[EG4!5S*%*5+ ERH@JK*L"HQ,H.[G&G,E<A0&_CT<\/M#GIP5U4*
MJ!7<>WLQ@\43:JH6^,;$IL)?RG)C#;Q?HF5<F \.:%7ZV#-HK2"([\&BI*I-
M>87QQ6>FH26!+LPPK<6<5V*2 V+B!*Z5M#D%*3/,7A.$Y$QC3_)BSWG2R;C$
MM ^#^",D41*W!'1Q/#QJ@2^/AL>G'6H&3;('GF]P@,_GL>>V2?8ZR0NMF5PC
M;6<+#SO8GW?#=GYXL64Z@^]71 F7%@OSHR.@81/0T <T/!#0I^>2]C^MXBJP
M+=_=\"'LD%%)CJ'P:6]+T'$,IS4#Q">0L5T;T_(HI@Y31HTIH^-,>5*"TB-H
MM[59TTTR&/8'T;LV0[IQR4D_:<4M_X([[8_>XEZI'S?JQ\>IS_@3SY#^/CN.
M(FMSH)LHZD?M!OP?;/G/L%?R)XW\22?/+3>/O95&!"YI4Z"QH)G%-OG=1%%_
MTBZ_&Q;_F<9*?C<L^;-J*OGAWM%4H%[[(]Y JC;25K_A9K2Y12S\X?EF_)QN
M%]5EX#=-=36Y9GK-I0&!*Z(DW52INCKNJXY5I3\ 'Y2EX]0W<[HAH783Z/M*
M*?O2<0LT=Z[Y+U!+ P04    " #N@$M4(*-7VDP*  !G-@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970Y.2YX;6S-6VUSX[81_IS^"HR;II<9GT3P7:G/,_;9
M.KMSR7EL7_*ATP\P!4F<XXL"DK;5Z8_O J (2@1!YN(T_F+K97>YBUWL\RQ(
MG3SE[$NQIK1$SVF2%>^.UF6Y^6$Z+:(U34DQR3<T@V^6.4M)"6_9:EIL&"4+
MH90F4]NR_&E*XNSH]$1\=L-.3_*J3.*,WC!45&E*V/:<)OG3NR-\M/O@-EZM
M2_[!]/1D0U;TCI:?-S<,WDT;*XLXI5D1YQEB=/GNZ S_<.T'7$%(_!S3IZ+U
M&O%0'O+\"W]SO7AW9'&/:$*CDIL@\.^1OJ=)PBV!'[_61H^::W+%]NN=];D(
M'H)Y( 5]GR>_Q(MR_>XH/$(+NB154M[F3U>T#LCC]J(\*<1?]%3+6D<HJHHR
M3VME\""-,_F?/-<+T5*P@QX%NU:P#Q2PVZ/@U K.6 6W5G /%)R^&+Q:P3M4
MZ(O!KQ7\L0I!K1",50AKA?!P6?MBF-4*,U$.,G\B^1>D)*<G+']"C$N#-?Y"
M5)#0AIS'&2_VNY+!MS'HE:<?\VSUMJ0L1==91#->>>A]GL)>*HBLQFR![M:$
MT76>+"@KOOMK:./@'^CRURHNM^@M.ELL8BY)$C A=Q_7>W-!2Q(GQ?<GTQ+\
MY%>;1K5/Y](GN\>G"QI-D(./D6W9^//=!7KS[?<%=Z'0V'IOMO7/*ID@J[:E
M4;\84">94?W2K/Y3_@CJ+E?'LV_1%,DP>H.9__:%&6'UPWBKUGBK5Z.MXMEX
MJ]=#Z81\X-I7G9$IU'^S">QF$]C"JM-C5=3W6]XS%_O%?\88R584FGN)'K:H
M+7=#MN+CLR?"%NA?'\$DNBYI6OS;X)#3..0(A]P>A\Y6*T97I*0HSDH6 [1$
MZ)$D%47Y$D%/B+X@PJ];(/I,612#0[IJDA<)Q$4XZCV>VE;HA9YE62?3QW:%
M="7=F>V%'<&KKB#&;K!G<2]BMXG8?:&( ;&+$KI2G*UTK<7M..B'ENWA3BAS
M*1D:)?=B\9I8O)?-'GE(J"X6K^LA=L)9-Y01@GN1^$TDOC&2NL@+[GC.8,F!
M#Z%%_!@O:+8HCE&4IREL$Q&3K@#]CE^'A3<H<662V LJ:((*C$'=<6_K71RU
M=SM]YJ]UF9@''2>P9=M6-Q4?NI(S[.IV4E?0#\36[ DO;,(+C>%=%F4,& S!
ME>09/=",+F/((*,19! ^!8B6"=,L@2[TL!NZ$WI.-W*-( Z";K.YZ@K.<.CW
M!CYK I\9 _^<\1A76?R?P\1&>5'" B1R57*4Y=DC+?B;OH5 1'7^ E49,!]$
M)>.)#MF1W-&;BD5KL(,V"<ETR'8^Z[9.GS?/[G8>([FW1-A2=,_Z4Q?I4#;/
M.$A"^_AX?WTCK@%MXTF,("!!'BF#D0HNR^<RZ.AH0UF<+]";.$-;2IB6/LX'
M8L1"%=D(>E.Y+A"VT8)L340!M^@R-C</'050RW",+F43.4;WL/O.Y>[3QH"[
MD.O/9E9W7]62[?T2SKQNV5QI!&T3GF'%C[ ]W#(E:#6,HQ#%GY=KGG6^*B@N
MBHK % $9SJ@^:'L0$(9%KHPB^Q$JPH7-C.L#9(K!",-C.EO H!47)2-B'+K4
MP<+^913+P>[K8)I8D15L9BM? X>UR6 $'N(N-^D!1(VD[P16/[?$BL;@ 1X#
M#2:N4K1A<=0TM(*69;)[A\AF YTQEJ$SWI^,#4.1#1R\DHPK@H#-#$'NYA5<
MGO?@_Z+>8>P2=Z':%A2E+R,*J[$9K'<9N9$9D9&><_P4GZ ;Z"IB2< _-39J
M?907FNT1J4FH=]!60&F;063GX'V.[M<4W5,!;Y^6R\:QFQWB"X]UK@U<PK8F
MEO4WT_RJ8,D>#TM?564"N&(FE2Z  VCC,3LA3CO<X[]\\PU,YZXIKM9@/@ \
MOS\N65JWG+T5,<QD5WG"9T=>8< T(&[H^+T!F[T;'[#"(=N,0Y?I)LFWE.I8
MI>D""H'L5X) MD(@>P"!Q-X&,DCBA(_"8D195F4%FTQTJ<+4I,[M+FYXL_UY
M0J+6",']"!2^V&9\:;+&3U !5,1J\2B:_ $#!J8D5IQDV[\7>Z,S6E2,ER0E
MT1I%)(%> _R5DU@=^-:^!(=-N2<(A53VB+FX57&B#Y."4W)^,LQY.D2Q)#%#
M*6%?:"D/-;0I,5\I]+J-3Q[F#B@"E^W1O/@:S?V%4OAIF_'S?<Z/=1XJOFU@
M[BGDO-0LG*S48T3KHGB[&ZJBBC%>&$E,'N(D+N.>>@Z[Y&KFV[J"'BOY02<9
M8%?#PG22ON?WGR79"O-M,^;+ N-30GT,00W-SKCGY_65]HB)I3F3T,D!3^U&
MW95S</^F<A2-<,P8SX>'B"?_,8<BX%G?HEL]VLP'3#FSGMK_,*#H6A-7JW@U
MH&B'D]"X9QQ%4!PS-[B-BR]OEXR*,U$*62T1ZUL&LR5K@GM6P:R'>U;O:D#/
MGOCF-5!DQAE/9N0!\+%LI_)PF,#&2#>BJ1R+X4O4S>ZT5;M2=F>O]A5LZ\Z#
MF8#\<G@VT_)P@(K/:]-M*NZXDYE[>+.A*V;;$\L_O-70%<-.'[%W% %RS'<:
M!D]P[N%U!%C]*>,1O_CHZ"A>Y'BO@ZHYBN@X9J+S8GS\9^@ G/*(IRN@WF\:
MDJ'CX0->>4/8[B@2Y R0H)<.L&^T&/!C;[2P3:$IVN(,C/UC"__^*?]#"E\1
M!6?V.@K?53CNFJ'P3RK\ :\&"]]5 .W^X2<(XPI_P(^]PG=,H2G<=<><7JOG
M6_BS ^C&/%"["C!=YY44:^M>^@B(^_J!VNW>&0_\H,N:YV,%KS6"8>#TGR.Z
M"B-=\]G!3U7Z0)FXL5X'797KG(G;6_*.%!^[^4!A"OG:U1P-6(:#3E<AICN
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MT4 ;E]#&O=!^D'BO4,EC!G-<)(04\^;2RT'E%KUZN&/'-;';@*61<QS7<YO
MVG*68UJ.-]9#<TMH;B^T!SVB(2(OE,/6#H44$NV@V54!=4AS!T$= <8C!S>
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M2_6XI02V\4P WJ]A"1T'F8/R+XCI_U!+ P04    " #N@$M4)_B!U<H#  "
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M+7D*EI\.G$B5TSW,-9%$:72S(!I3IF[1/?JR7J";-[?HC7%\RD6I,,_4V-4
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MS^^A!5O2+%8/?/,'JP@-<W\!CV7Q%VTJ6ZN'@DPJGE1@B"")TO*3_JP2T0*
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M&\#O2\[5^T.^0'VO-_D74$L#!!0    ( .Z 2U2&=S8(HP4  ) =   :
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MLJNN[(&N;O@VSK(XVZ(;EK LXDALT/6GU2U4U3J45X4J9Y>'Y87K8L=>S!^
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MQZ\.<ZQICB?$.09 [5#7[Y4+T-FNY?;0 >B($[A#]=)0QQ-2'0/$]BGU>N@
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M^J @#J==(7U4F(3$+21IA23_$@F;2IF"6B5H?83VO')&).GMCF.HHATE?50
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M#DEA2<M</XKM5]CYZ1B^1.3*?I/M+M9W2%(J+8H=&!44C%>_]&V7AP8@B,X
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M.P&>;Z0TKS?V@%8>^:?_ %!+ P04    " #N@$M4BFV529P#  #S"P  &@
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MDB![1R=$3==>5F^L*KT=+)0E<_'+G.P?M0N@]TNE[';C"K1_*.._4$L#!!0
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MQV?"O'34@V+YO_G<,_X?4$L#!!0    ( .Z 2U0.&-]+, (  $8$   :
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M;2[L/S$C2.,]OTP D=RH)QU)=8@C9Q(FYV_(KPE HS(RH>%GH1 P89BR@5T
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M\4S9'G5KO]1ZTQS^NM%UK=?-QY5*EZJT /.[33R>OM@%^@.'%_\"4$L#!!0
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ME;QLS.5 LK5I50LF5>,SKYFZS #7 >K[DC&Y'^@%ZNO1Y!]02P,$%     @
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M+WW9B<UZHNR9)S8[JP2.PS0.@N"D9(.!491$Z7#-\EY:_C=.;'XN!Y/X3/5
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M"9"&*4DTY,O@;G:[6KAX'_"%06,&9^(J.2CU[(Q-M@RF3A!P2*UCH/CZ"??
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MWEVJBRW:\=!N%*]MPUQPI=NO799ZHH(P!OK[DG.UVQ@'_8R>_ 502P,$%
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ [H!+5$Z5&!O+"   !%    \
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M  :UZR@TD_3> QC4KJ/03-)[$=2!L@0)!X7[$[2D-RC \U"M6P^W+&A)[UG
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M4;T+0.^B>A> WD7U+@"]B^I= 'I7U;L"]*ZJ=P7H757O"M"[JMX5H'=5O2M
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MEF &LP0SF27_=33K^S@>_G'\Z1KW=3N\Y"=+47?S$U!+ 0(4 Q0    ( .Z
M2U0'04UB@0   +$    0              "  0    !D;V-0<F]P<R]A<' N
M>&UL4$L! A0#%     @ [H!+5'QJ;8[N    *P(  !$              ( !
MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ [H!+5)E<G",0!@
MG"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    " #N@$M4XV23U[L%   M&   &               @($-"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ [H!+5)2[HWH8 @
M804  !@              ("!_@T  'AL+W=O<FMS:&5E=',O<VAE970R+GAM
M;%!+ 0(4 Q0    ( .Z 2U1;&Q_T?0<  ($@   8              " @4P0
M  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #N@$M4J W@
M00,$  #5#   &               @('_%P  >&PO=V]R:W-H965T<R]S:&5E
M=#0N>&UL4$L! A0#%     @ [H!+5#CP\[HR"   ^B,  !@
M ("!.!P  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( .Z
M2U2@4$7?M (  #H(   8              " @: D  !X;"]W;W)K<VAE971S
M+W-H965T-BYX;6Q02P$"% ,4    " #N@$M4FZ:WB=,*  #I,0  &
M        @(&*)P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%
M  @ [H!+5+[&71(\#   1$<  !@              ("!DS(  'AL+W=O<FMS
M:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( .Z 2U1W]_(BBB$  $!K   8
M              " @04_  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"
M% ,4    " #N@$M4@,HE4]L'   <&   &0              @('%8   >&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( .Z 2U1!D#9+F00
M '@+   9              " @==H  !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&UL4$L! A0#%     @ [H!+5!(6+G-T P  T0<  !D              ("!
MIVT  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " #N@$M4
M'KT37,D#  !("0  &0              @(%2<0  >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;%!+ 0(4 Q0    ( .Z 2U1$7#*S9@(  #D%   9
M      " @5)U  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%
M  @ [H!+5"83]/P6!   +@D  !D              ("![W<  'AL+W=O<FMS
M:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " #N@$M4L#;FUQ4$  !$"0
M&0              @($\?   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+
M 0(4 Q0    ( .Z 2U1M>D(OT@0  &,+   9              " @8B   !X
M;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ [H!+5 /3#B8S
M"P  >1P  !D              ("!D84  'AL+W=O<FMS:&5E=',O<VAE970Q
M."YX;6Q02P$"% ,4    " #N@$M4FDRR/ID"  "<!0  &0
M@('[D   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( .Z
M2U2ZW,!5XPL  &(?   9              " @<N3  !X;"]W;W)K<VAE971S
M+W-H965T,C N>&UL4$L! A0#%     @ [H!+5/KVK(-1#   'B(  !D
M         ("!Y9\  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M    " #N@$M44..,U'4'   D$@  &0              @(%MK   >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( .Z 2U0.2))Y @4  %<+
M   9              " @1FT  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL
M4$L! A0#%     @ [H!+5'<##$FC&   XTD  !D              ("!4KD
M 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #N@$M4=>2C
MI+,(   )%P  &0              @($LT@  >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;%!+ 0(4 Q0    ( .Z 2U0/Y%=.+1   '0Q   9
M  " @1;;  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @
M[H!+5*H"5TY>"   MQ0  !D              ("!>NL  'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q02P$"% ,4    " #N@$M46+2*B <$  "B"0  &0
M            @($/]   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4
M Q0    ( .Z 2U3=XW]H4 D  '07   9              " @4WX  !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ [H!+5)PJI0ZG!@
MEQ   !D              ("!U $! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6Q02P$"% ,4    " #N@$M4O@7 \X,&  #Z$   &0              @(&R
M" $ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( .Z 2U3(
M0UD2L @  $<8   9              " @6P/ 0!X;"]W;W)K<VAE971S+W-H
M965T,S(N>&UL4$L! A0#%     @ [H!+5%#.36 Q"0  K1@  !D
M     ("!4Q@! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .Z 2U14U;5E[@,  (P)   9              "
M@7)4 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ [H!+
M5'BMGE1) P  9@<  !D              ("!EU@! 'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6Q02P$"% ,4    " #N@$M4(_),OFX"   J!0  &0
M        @($77 $ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0
M   ( .Z 2U2UA0[# 0,  "(&   9              " @;Q> 0!X;"]W;W)K
M<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ [H!+5- [<R9L P  N0<
M !D              ("!]&$! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q0
M2P$"% ,4    " #N@$M4GL.3B,\"   B!@  &0              @(&790$
M>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( .Z 2U15JS'H
M7@0  #4*   9              " @9UH 0!X;"]W;W)K<VAE971S+W-H965T
M-#0N>&UL4$L! A0#%     @ [H!+5 W8\,>J @  GP4  !D
M ("!,FT! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " #N
M@$M407Z:?]@'  !_%   &0              @($3< $ >&PO=V]R:W-H965T
M<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( .Z 2U1.A\9+^ <   45   9
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M970U,2YX;6Q02P$"% ,4    " #N@$M43Q7,UTT'  "S$@  &0
M    @(%QDP$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (
M .Z 2U30>_=74@,  #P(   9              " @?6: 0!X;"]W;W)K<VAE
M971S+W-H965T-3,N>&UL4$L! A0#%     @ [H!+5*;\HI]> P  8 @  !D
M             ("!?IX! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"
M% ,4    " #N@$M4<XMMV>P&  !R$@  &0              @($3H@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( .Z 2U1%E[9IL@(
M ,L%   9              " @3:I 0!X;"]W;W)K<VAE971S+W-H965T-38N
M>&UL4$L! A0#%     @ [H!+5'2$1M;K @  E08  !D              ("!
M'ZP! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " #N@$M4
MA_T:_-4#   ##   &0              @(%!KP$ >&PO=V]R:W-H965T<R]S
M:&5E=#4X+GAM;%!+ 0(4 Q0    ( .Z 2U3"A"99+0<  (\J   9
M      " @4VS 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%
M  @ [H!+5'0<TY:[ P  60T  !D              ("!L;H! 'AL+W=O<FMS
M:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " #N@$M4-$)<LNP$  "T$P
M&0              @(&CO@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+
M 0(4 Q0    ( .Z 2U1W"7_X5@(   4&   9              " @<;# 0!X
M;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ [H!+5!"'<$OD
M P  K!   !D              ("!4\8! 'AL+W=O<FMS:&5E=',O<VAE970V
M,RYX;6Q02P$"% ,4    " #N@$M4=&>.R]\"  "*!P  &0
M@(%NR@$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( .Z
M2U3#W3 !C@(  (P'   9              " @83- 0!X;"]W;W)K<VAE971S
M+W-H965T-C4N>&UL4$L! A0#%     @ [H!+5,9MUS%' P  :0D  !D
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M=#<P+GAM;%!+ 0(4 Q0    ( .Z 2U0QH(]EUP(  'D)   9
M  " @?SA 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @
M[H!+5&4(+R7J P  T@X  !D              ("!"N4! 'AL+W=O<FMS:&5E
M=',O<VAE970W,BYX;6Q02P$"% ,4    " #N@$M4H$0F4I $  "G$@  &0
M            @($KZ0$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4
M Q0    ( .Z 2U1^XK3&2P,  %@*   9              " @?+M 0!X;"]W
M;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ [H!+5&SZC 'L @
M<0D  !D              ("!=/$! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX
M;6Q02P$"% ,4    " #N@$M4^[W,D;P"  "U!P  &0              @(&7
M] $ >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( .Z 2U1M
M4I!I\ (  +8'   9              " @8KW 0!X;"]W;W)K<VAE971S+W-H
M965T-S<N>&UL4$L! A0#%     @ [H!+5-_^-G*/ P  '@P  !D
M     ("!L?H! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .Z 2U11]G1:@@4  ,L7   9              "
M@0(. @!X;"]W;W)K<VAE971S+W-H965T.#,N>&UL4$L! A0#%     @ [H!+
M5(X?!OKP!P  ?"D  !D              ("!NQ," 'AL+W=O<FMS:&5E=',O
M<VAE970X-"YX;6Q02P$"% ,4    " #N@$M4PV&2AEX"   -!@  &0
M        @('B&P( >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0
M   ( .Z 2U2:]#@"'00  .P-   9              " @7<> @!X;"]W;W)K
M<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ [H!+5)C&NSSJ P  T@X
M !D              ("!RR(" 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q0
M2P$"% ,4    " #N@$M4E86;P)P%  #C%P  &0              @('L)@(
M>&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( .Z 2U0(\N>(
M#0,  #<)   9              " @;\L @!X;"]W;W)K<VAE971S+W-H965T
M.#DN>&UL4$L! A0#%     @ [H!+5%PI9-I=!   V \  !D
M ("! S " 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q02P$"% ,4    " #N
M@$M4/"Z]X!T$   X$   &0              @(&7- ( >&PO=V]R:W-H965T
M<R]S:&5E=#DQ+GAM;%!+ 0(4 Q0    ( .Z 2U04V/RAL ,  'T-   9
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M @!X;"]W;W)K<VAE971S+W-H965T.34N>&UL4$L! A0#%     @ [H!+5,G
M#&$M!0  VA8  !D              ("!R4@" 'AL+W=O<FMS:&5E=',O<VAE
M970Y-BYX;6Q02P$"% ,4    " #N@$M4FJ\SX;4$  "]&   &0
M    @($M3@( >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM;%!+ 0(4 Q0    (
M .Z 2U394N5V%@,  '\)   9              " @1E3 @!X;"]W;W)K<VAE
M971S+W-H965T.3@N>&UL4$L! A0#%     @ [H!+5""C5]I,"@  9S8  !D
M             ("!9E8" 'AL+W=O<FMS:&5E=',O<VAE970Y.2YX;6Q02P$"
M% ,4    " #N@$M4M/[N\T($  ".$   &@              @('I8 ( >&PO
M=V]R:W-H965T<R]S:&5E=#$P,"YX;6Q02P$"% ,4    " #N@$M4)_B!U<H#
M  " "P  &@              @(%C90( >&PO=V]R:W-H965T<R]S:&5E=#$P
M,2YX;6Q02P$"% ,4    " #N@$M4JZ\*9! %  #C$P  &@
M@(%E:0( >&PO=V]R:W-H965T<R]S:&5E=#$P,BYX;6Q02P$"% ,4    " #N
M@$M4AG<V"*,%  "0'0  &@              @(&M;@( >&PO=V]R:W-H965T
M<R]S:&5E=#$P,RYX;6Q02P$"% ,4    " #N@$M4;[57L"8$  #N#@  &@
M            @(&(= ( >&PO=V]R:W-H965T<R]S:&5E=#$P-"YX;6Q02P$"
M% ,4    " #N@$M4Z#(Y3QH$   0#@  &@              @('F> ( >&PO
M=V]R:W-H965T<R]S:&5E=#$P-2YX;6Q02P$"% ,4    " #N@$M44"#/OV(#
M  !2"@  &@              @($X?0( >&PO=V]R:W-H965T<R]S:&5E=#$P
M-BYX;6Q02P$"% ,4    " #N@$M41:6NH@$#   K"   &@
M@('2@ ( >&PO=V]R:W-H965T<R]S:&5E=#$P-RYX;6Q02P$"% ,4    " #N
M@$M4<:9I_U$#  """0  &@              @($+A ( >&PO=V]R:W-H965T
M<R]S:&5E=#$P."YX;6Q02P$"% ,4    " #N@$M4 )=_\^,#  #^#P  &@
M            @(&4AP( >&PO=V]R:W-H965T<R]S:&5E=#$P.2YX;6Q02P$"
M% ,4    " #N@$M4BFV529P#  #S"P  &@              @(&OBP( >&PO
M=V]R:W-H965T<R]S:&5E=#$Q,"YX;6Q02P$"% ,4    " #N@$M43,ZL6HP"
M  !<!@  &@              @(&#CP( >&PO=V]R:W-H965T<R]S:&5E=#$Q
M,2YX;6Q02P$"% ,4    " #N@$M4@TFFR)H%  "T%P  &@
M@(%'D@( >&PO=V]R:W-H965T<R]S:&5E=#$Q,BYX;6Q02P$"% ,4    " #N
M@$M4/(D/XVL"  #)!@  &@              @($9F ( >&PO=V]R:W-H965T
M<R]S:&5E=#$Q,RYX;6Q02P$"% ,4    " #N@$M4I$QMPL0$  #Z&0  &@
M            @(&\F@( >&PO=V]R:W-H965T<R]S:&5E=#$Q-"YX;6Q02P$"
M% ,4    " #N@$M4#AC?2S "  !&!   &@              @(&XGP( >&PO
M=V]R:W-H965T<R]S:&5E=#$Q-2YX;6Q02P$"% ,4    " #N@$M4H^%21 0(
M  !\*   &@              @($@H@( >&PO=V]R:W-H965T<R]S:&5E=#$Q
M-BYX;6Q02P$"% ,4    " #N@$M4YQ0%;^X"   J"0  &@
M@(%<J@( >&PO=V]R:W-H965T<R]S:&5E=#$Q-RYX;6Q02P$"% ,4    " #N
M@$M4X/V(G#0#  #T"@  &@              @(&"K0( >&PO=V]R:W-H965T
M<R]S:&5E=#$Q."YX;6Q02P$"% ,4    " #N@$M4-#@=<T\#  !0"P  &@
M            @('NL ( >&PO=V]R:W-H965T<R]S:&5E=#$Q.2YX;6Q02P$"
M% ,4    " #N@$M4J('AOA@"  "0!   &@              @(%UM ( >&PO
M=V]R:W-H965T<R]S:&5E=#$R,"YX;6Q02P$"% ,4    " #N@$M4.I[,4]8"
M  "O!P  &@              @('%M@( >&PO=V]R:W-H965T<R]S:&5E=#$R
M,2YX;6Q02P$"% ,4    " #N@$M4U_8%KC(#   ="0  &@
M@('3N0( >&PO=V]R:W-H965T<R]S:&5E=#$R,BYX;6Q02P$"% ,4    " #N
M@$M4VK$\:2D#   ,$P  #0              @ $]O0( >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( .Z 2U27BKL<P    !,"   +              "  9'
M @!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( .Z 2U1.E1@;RP@   10   /
M          "  7K! @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #N@$M4
M1&=]JUH#  "51P  &@              @ %RR@( >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " #N@$M48Q0[:9X"  "?1   $P
M        @ $$S@( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     @@"" -PC
(  #3T (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>441</ContextCount>
  <ElementCount>715</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>127</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100010003 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100020004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100030005 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100040006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100050007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100060008 - Statement - CONSOLIDATED STATEMENTS OF EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Organization and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210041002 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210081003 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210111004 - Disclosure - Restricted Cash Restricted Cash</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RestrictedCashRestrictedCash</Role>
      <ShortName>Restricted Cash Restricted Cash</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210131005 - Disclosure - Short-term and long-term investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Shorttermandlongterminvestments</Role>
      <ShortName>Short-term and long-term investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210171006 - Disclosure - Other Receivables Other Receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OtherReceivablesOtherReceivables</Role>
      <ShortName>Other Receivables Other Receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210201007 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210241008 - Disclosure - Intangibles</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Intangibles</Role>
      <ShortName>Intangibles</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210291009 - Disclosure - Equity Method and Other Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EquityMethodandOtherInvestments</Role>
      <ShortName>Equity Method and Other Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210331010 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210381011 - Disclosure - Other Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OtherLiabilities</Role>
      <ShortName>Other Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210411012 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210501013 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210571014 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210631015 - Disclosure - Employee Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EmployeeBenefitPlans</Role>
      <ShortName>Employee Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>210651016 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>210671017 - Disclosure - Noncontrolling Interests Subject to Put Provisions and Other Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments</Role>
      <ShortName>Noncontrolling Interests Subject to Put Provisions and Other Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>210691018 - Disclosure - Stock-based compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Stockbasedcompensation</Role>
      <ShortName>Stock-based compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>210751019 - Disclosure - Stockholder's equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Stockholdersequity</Role>
      <ShortName>Stockholder's equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>210801020 - Disclosure - Accumulated Other Comprehensive (Loss) Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>210831021 - Disclosure - Acquisitions and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsandDivestitures</Role>
      <ShortName>Acquisitions and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>210911022 - Disclosure - Held for Sale and Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/HeldforSaleandDiscontinuedOperations</Role>
      <ShortName>Held for Sale and Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>210961023 - Disclosure - Variable Interest Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/VariableInterestEntities</Role>
      <ShortName>Variable Interest Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>210981024 - Disclosure - Fair Values of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairValuesofFinancialInstruments</Role>
      <ShortName>Fair Values of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>211021025 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>211091026 - Disclosure - Supplemental Cash Flow Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>Supplemental Cash Flow Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>211121027 - Disclosure - SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS</Role>
      <ShortName>SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>220022001 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230053001 - Disclosure - Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables</Role>
      <ShortName>Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230093002 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/EarningsPerShare</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230143003 - Disclosure - Short-term and long-term invesmtents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ShorttermandlongterminvesmtentsTables</Role>
      <ShortName>Short-term and long-term invesmtents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Shorttermandlongterminvestments</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230183004 - Disclosure - Other Receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OtherReceivablesTables</Role>
      <ShortName>Other Receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/OtherReceivablesOtherReceivables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230213005 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/PropertyandEquipment</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>230253006 - Disclosure - Intangibles (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IntangiblesTables</Role>
      <ShortName>Intangibles (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Intangibles</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>230303007 - Disclosure - Equity Method and Other Investmetns Equity Method and Other Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables</Role>
      <ShortName>Equity Method and Other Investmetns Equity Method and Other Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>230343008 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Goodwill</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>230393009 - Disclosure - Other Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OtherLiabilitiesTables</Role>
      <ShortName>Other Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/OtherLiabilities</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>230423010 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/IncomeTaxes</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>230513011 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/LongTermDebt</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>230583012 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Leases</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>230703013 - Disclosure - Long-term Incentive Compensation and Shareholders??? Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables</Role>
      <ShortName>Long-term Incentive Compensation and Shareholders??? Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>230763014 - Disclosure - Stockholder's equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/StockholdersequityTables</Role>
      <ShortName>Stockholder's equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Stockholdersequity</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>230813015 - Disclosure - Accumulated Other Comprehensive (Loss) Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>230843016 - Disclosure - Acquisitions and Divestitures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsandDivestituresTables</Role>
      <ShortName>Acquisitions and Divestitures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/AcquisitionsandDivestitures</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>230923017 - Disclosure - Held for Sale and Discontinued Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables</Role>
      <ShortName>Held for Sale and Discontinued Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/HeldforSaleandDiscontinuedOperations</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>230993018 - Disclosure - Fair Values of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairValuesofFinancialInstrumentsTables</Role>
      <ShortName>Fair Values of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/FairValuesofFinancialInstruments</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>231033019 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/SegmentReporting</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>231103020 - Disclosure - Supplemental Cash Flow Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SupplementalCashFlowInformationTables</Role>
      <ShortName>Supplemental Cash Flow Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>231133021 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables</Role>
      <ShortName>SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240034001 - Disclosure - Organization and Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240064002 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Recognition Segment Revenue by Payor (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable Revenue Recognition Segment Revenue by Payor (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240074003 - Disclosure - Revenue Recognition and Accounts Receivable - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240104004 - Disclosure - Earnings Per Share - Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails</Role>
      <ShortName>Earnings Per Share - Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240124005 - Disclosure - Restricted Cash and Equivalents - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails</Role>
      <ShortName>Restricted Cash and Equivalents - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240154006 - Disclosure - Short-term and long-term investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ShorttermandlongterminvestmentsDetails</Role>
      <ShortName>Short-term and long-term investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/ShorttermandlongterminvesmtentsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240164007 - Disclosure - Short-term and long-term investments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails</Role>
      <ShortName>Short-term and long-term investments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240194008 - Disclosure - Other Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OtherReceivablesDetails</Role>
      <ShortName>Other Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/OtherReceivablesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240224009 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/PropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240234010 - Disclosure - Property and Equipment - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails</Role>
      <ShortName>Property and Equipment - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240264011 - Disclosure - Intangibles - Amortizable Intangible Assets Other Than Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails</Role>
      <ShortName>Intangibles - Amortizable Intangible Assets Other Than Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240274012 - Disclosure - Intangibles - Scheduled Amortization Charges from Intangible Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails</Role>
      <ShortName>Intangibles - Scheduled Amortization Charges from Intangible Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240284013 - Disclosure - Intangibles - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IntangiblesAdditionalInformationDetails</Role>
      <ShortName>Intangibles - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240314014 - Disclosure - Equity Method and Other Investmetns Equity Method and Other Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails</Role>
      <ShortName>Equity Method and Other Investmetns Equity Method and Other Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240324015 - Disclosure - Equity Method and Other Investments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails</Role>
      <ShortName>Equity Method and Other Investments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240354016 - Disclosure - Goodwill - Changes in Carrying Value of Goodwill by Reportable Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails</Role>
      <ShortName>Goodwill - Changes in Carrying Value of Goodwill by Reportable Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240364017 - Disclosure - Goodwill - Schedule of Reporting Units Goodwill Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails</Role>
      <ShortName>Goodwill - Schedule of Reporting Units Goodwill Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240374018 - Disclosure - Goodwill - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillAdditionalInformationDetails</Role>
      <ShortName>Goodwill - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240404019 - Disclosure - Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/OtherLiabilitiesDetails</Role>
      <ShortName>Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/OtherLiabilitiesTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240434020 - Disclosure - Income Taxes - Schedule of Income Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Income Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240444021 - Disclosure - Income Taxes - Components of Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes - Components of Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240454022 - Disclosure - Income Taxes Income Taxes - Allocation of Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes Income Taxes - Allocation of Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240464023 - Disclosure - Income Taxes - Reconciliation Between U.S. Federal Income Tax Rate and Our Effective Tax Rate From Continuing Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails</Role>
      <ShortName>Income Taxes - Reconciliation Between U.S. Federal Income Tax Rate and Our Effective Tax Rate From Continuing Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240474024 - Disclosure - Income Taxes - Deferred Tax and Liabilities Arising from Temporary Differences (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax and Liabilities Arising from Temporary Differences (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240484025 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet More-Likely-Than-Not Threshold (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet More-Likely-Than-Not Threshold (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240494026 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240524027 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240534028 - Disclosure - Long-Term Debt - Scheduled Maturities of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails</Role>
      <ShortName>Long-Term Debt - Scheduled Maturities of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240544029 - Disclosure - Long-Term Debt - Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails</Role>
      <ShortName>Long-Term Debt - Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240554030 - Disclosure - Long-Term Debt - Effects of Interest Rate Swap and Cap Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails</Role>
      <ShortName>Long-Term Debt - Effects of Interest Rate Swap and Cap Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240564031 - Disclosure - Long-Term Debt - Additional information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongTermDebtAdditionalinformationDetail</Role>
      <ShortName>Long-Term Debt - Additional information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240594032 - Disclosure - Leases Lease Expense Components (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails</Role>
      <ShortName>Leases Lease Expense Components (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240604033 - Disclosure - Leases Leases Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LeasesLeasesOtherInformationDetails</Role>
      <ShortName>Leases Leases Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240614034 - Disclosure - Leases - Future Minimum Lease Payments Under Non-Cancelable Operating and Capital Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails</Role>
      <ShortName>Leases - Future Minimum Lease Payments Under Non-Cancelable Operating and Capital Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240624035 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240644036 - Disclosure - Employee Benefit Plans - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails</Role>
      <ShortName>Employee Benefit Plans - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240664037 - Disclosure - Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ContingenciesAdditionalInformationDetails</Role>
      <ShortName>Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240684038 - Disclosure - Noncontrolling Interests Subject to Put Provisions and Other Commitments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails</Role>
      <ShortName>Noncontrolling Interests Subject to Put Provisions and Other Commitments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240714039 - Disclosure - Long-term Incentive Compensation and Shareholders??? Equity - Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails</Role>
      <ShortName>Long-term Incentive Compensation and Shareholders??? Equity - Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240724040 - Disclosure - Long-term Incentive Compensation and Shareholders??? Equity - Summary of Range of Exercise Prices (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails</Role>
      <ShortName>Long-term Incentive Compensation and Shareholders??? Equity - Summary of Range of Exercise Prices (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240734041 - Disclosure - Long-term Incentive Compensation and Shareholders Equity - Summary of Weighted Average Valuation Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails</Role>
      <ShortName>Long-term Incentive Compensation and Shareholders Equity - Summary of Weighted Average Valuation Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240744042 - Disclosure - Long-term Incentive Compensation and Shareholders??? Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Long-term Incentive Compensation and Shareholders??? Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240774043 - Disclosure - Stock Repurchases Tender Offer (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/StockRepurchasesTenderOfferDetails</Role>
      <ShortName>Stock Repurchases Tender Offer (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240784044 - Disclosure - Shareholder's equity Effects of Changes in DaVita Inc's Ownership Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails</Role>
      <ShortName>Shareholder's equity Effects of Changes in DaVita Inc's Ownership Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240794045 - Disclosure - Shareholder's equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ShareholdersequityDetails</Role>
      <ShortName>Shareholder's equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240824046 - Disclosure - Accumulated Other Comprehensive (Loss) Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240854047 - Disclosure - Acquisitions - Components of Routine Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails</Role>
      <ShortName>Acquisitions - Components of Routine Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240864048 - Disclosure - Acquisitions - Assets acquired and liabilities assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails</Role>
      <ShortName>Acquisitions - Assets acquired and liabilities assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240874049 - Disclosure - Schedule Of Other Information Related To Acquired Intangibles and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails</Role>
      <ShortName>Schedule Of Other Information Related To Acquired Intangibles and Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240884050 - Disclosure - Acquisitions and Divestitures - Pro Forma Summary of Results of Operation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails</Role>
      <ShortName>Acquisitions and Divestitures - Pro Forma Summary of Results of Operation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240894051 - Disclosure - Acquisitions and Divestitures - Reconciliation of Changes in Contingent Earn-Out Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails</Role>
      <ShortName>Acquisitions and Divestitures - Reconciliation of Changes in Contingent Earn-Out Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>240904052 - Disclosure - Acquisitions and Divestitures - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails</Role>
      <ShortName>Acquisitions and Divestitures - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>240934053 - Disclosure - Held for Sale and Discontinued Operations Financial results for discontinued operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails</Role>
      <ShortName>Held for Sale and Discontinued Operations Financial results for discontinued operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>240944054 - Disclosure - Held for Sale and Discontinued Operations Cash Flows of discontinued operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails</Role>
      <ShortName>Held for Sale and Discontinued Operations Cash Flows of discontinued operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>240954055 - Disclosure - Held for Sale and Discontinued Operations - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails</Role>
      <ShortName>Held for Sale and Discontinued Operations - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>240974056 - Disclosure - Variable Interest Entities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails</Role>
      <ShortName>Variable Interest Entities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>241004057 - Disclosure - Fair Values of Financial Instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Values of Financial Instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>241014058 - Disclosure - Fair Values of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails</Role>
      <ShortName>Fair Values of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/FairValuesofFinancialInstrumentsTables</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>241044059 - Disclosure - Segment Reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails</Role>
      <ShortName>Segment Reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>241054060 - Disclosure - Segment Reporting - Summary of Depreciation and Amortization Expense by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails</Role>
      <ShortName>Segment Reporting - Summary of Depreciation and Amortization Expense by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>241064061 - Disclosure - Segment Reporting - Summary of Expenditures for Property and Equipment by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails</Role>
      <ShortName>Segment Reporting - Summary of Expenditures for Property and Equipment by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>241074062 - Disclosure - Segment Reporting - Summary of Assets by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails</Role>
      <ShortName>Segment Reporting - Summary of Assets by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>241084063 - Disclosure - Segment Reporting - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentReportingAdditionalInformationDetails</Role>
      <ShortName>Segment Reporting - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>120</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>241114064 - Disclosure - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SupplementalCashFlowInformationDetails</Role>
      <ShortName>Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/SupplementalCashFlowInformationTables</ParentRole>
      <Position>121</Position>
    </Report>
    <Report instance="dva-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>241144065 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="dva-20211231.htm">dva-20211231.htm</File>
    <File>dva-123121ex211.htm</File>
    <File>dva-123121ex231.htm</File>
    <File>dva-123121ex31110xk.htm</File>
    <File>dva-123121ex31210xk.htm</File>
    <File>dva-123121ex32110xk.htm</File>
    <File>dva-123121ex32210xk.htm</File>
    <File>dva-20211231.xsd</File>
    <File>dva-20211231_cal.xml</File>
    <File>dva-20211231_def.xml</File>
    <File>dva-20211231_lab.xml</File>
    <File>dva-20211231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dva-20211231_g1.gif</File>
    <File>dva-20211231_g2.jpg</File>
    <File>dva-20211231_g3.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="1660">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="36">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>145
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dva-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 51,
   "contextCount": 441,
   "dts": {
    "calculationLink": {
     "local": [
      "dva-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dva-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dva-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dva-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dva-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "dva-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 1012,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 34,
    "http://www.davita.com/20211231": 8,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 46
   },
   "keyCustom": 100,
   "keyStandard": 615,
   "memberCustom": 59,
   "memberStandard": 65,
   "nsprefix": "dva",
   "nsuri": "http://www.davita.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Document and Entity Information",
     "role": "http://www.davita.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210041002 - Disclosure - Revenue Recognition",
     "role": "http://www.davita.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240774043 - Disclosure - Stock Repurchases Tender Offer (Details)",
     "role": "http://www.davita.com/role/StockRepurchasesTenderOfferDetails",
     "shortName": "Stock Repurchases Tender Offer (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "iccf688ffd7124bc6aff7a41fd8083119_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240784044 - Disclosure - Shareholder's equity Effects of Changes in DaVita Inc's Ownership Interest (Details)",
     "role": "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails",
     "shortName": "Shareholder's equity Effects of Changes in DaVita Inc's Ownership Interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i5b3f42eda369449eb421c9c7b1d39b74_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "dva:NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794045 - Disclosure - Shareholder's equity (Details)",
     "role": "http://www.davita.com/role/ShareholdersequityDetails",
     "shortName": "Shareholder's equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "iea987dbdc7b04a8d9e5cc739bde1bfa9_I20211217",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "ic66c414a255d4ccba5c079ae43f2af9d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240824046 - Disclosure - Accumulated Other Comprehensive (Loss) Income (Details)",
     "role": "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails",
     "shortName": "Accumulated Other Comprehensive (Loss) Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i6d67a2844f2a4c2c9c90e44bd33843a0_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854047 - Disclosure - Acquisitions - Components of Routine Acquisitions (Details)",
     "role": "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails",
     "shortName": "Acquisitions - Components of Routine Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864048 - Disclosure - Acquisitions - Assets acquired and liabilities assumed (Details)",
     "role": "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
     "shortName": "Acquisitions - Assets acquired and liabilities assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i1f41405ceef34baa8b52e118cd782f5d_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i1f41405ceef34baa8b52e118cd782f5d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874049 - Disclosure - Schedule Of Other Information Related To Acquired Intangibles and Goodwill (Details)",
     "role": "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails",
     "shortName": "Schedule Of Other Information Related To Acquired Intangibles and Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i1f41405ceef34baa8b52e118cd782f5d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240884050 - Disclosure - Acquisitions and Divestitures - Pro Forma Summary of Results of Operation (Details)",
     "role": "http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails",
     "shortName": "Acquisitions and Divestitures - Pro Forma Summary of Results of Operation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i5f9f2f3219c543598584da510ed53480_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240894051 - Disclosure - Acquisitions and Divestitures - Reconciliation of Changes in Contingent Earn-Out Obligations (Details)",
     "role": "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails",
     "shortName": "Acquisitions and Divestitures - Reconciliation of Changes in Contingent Earn-Out Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i1e75a2bcc15b4201a30ee6053a94ded7_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i1f41405ceef34baa8b52e118cd782f5d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240904052 - Disclosure - Acquisitions and Divestitures - Additional Information (Details)",
     "role": "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
     "shortName": "Acquisitions and Divestitures - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i1f41405ceef34baa8b52e118cd782f5d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210081003 - Disclosure - Earnings Per Share",
     "role": "http://www.davita.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:LossGainOnDispositionOfBusinessInterestsBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240934053 - Disclosure - Held for Sale and Discontinued Operations Financial results for discontinued operations (Details)",
     "role": "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
     "shortName": "Held for Sale and Discontinued Operations Financial results for discontinued operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i54d86d8eabc947b9afbe06d0abb8af86_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ReconciliationOfCashFlowsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240944054 - Disclosure - Held for Sale and Discontinued Operations Cash Flows of discontinued operations (Details)",
     "role": "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails",
     "shortName": "Held for Sale and Discontinued Operations Cash Flows of discontinued operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ReconciliationOfCashFlowsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i098ec0c09ca14a05bc4adda0e29fbb52_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:LossGainOnDispositionOfBusinessInterestsBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240954055 - Disclosure - Held for Sale and Discontinued Operations - Additional Information (Details)",
     "role": "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
     "shortName": "Held for Sale and Discontinued Operations - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i7458081d2436470ea923b7c4156197b2_D20190619-20190619",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974056 - Disclosure - Variable Interest Entities - Additional Information (Details)",
     "role": "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails",
     "shortName": "Variable Interest Entities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "ia96df5cbacd84affb90640475c11f0a8_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004057 - Disclosure - Fair Values of Financial Instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Values of Financial Instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "icd41fb8f57d94a9c8174ee4a26733781_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i773b082f96934fbdb2cc112ef35d5bcf_D20201231-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014058 - Disclosure - Fair Values of Financial Instruments (Details)",
     "role": "http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails",
     "shortName": "Fair Values of Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i773b082f96934fbdb2cc112ef35d5bcf_D20201231-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241044059 - Disclosure - Segment Reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Details)",
     "role": "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails",
     "shortName": "Segment Reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "dva:SegmentReportingInformationCorporateExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241054060 - Disclosure - Segment Reporting - Summary of Depreciation and Amortization Expense by Segment (Details)",
     "role": "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
     "shortName": "Segment Reporting - Summary of Depreciation and Amortization Expense by Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241064061 - Disclosure - Segment Reporting - Summary of Expenditures for Property and Equipment by Segment (Details)",
     "role": "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
     "shortName": "Segment Reporting - Summary of Expenditures for Property and Equipment by Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i0ba037f130084290a6239ff2ba715a4a_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241074062 - Disclosure - Segment Reporting - Summary of Assets by Segment (Details)",
     "role": "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
     "shortName": "Segment Reporting - Summary of Assets by Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "iaa4bedb416e84ecc89440f4a9b0c3597_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210111004 - Disclosure - Restricted Cash Restricted Cash",
     "role": "http://www.davita.com/role/RestrictedCashRestrictedCash",
     "shortName": "Restricted Cash Restricted Cash",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e70ca9077e4db8b762a4fcc4bfbd6f_D20190619-20190619",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:BusinessSaleEffectiveDateOfSale",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241084063 - Disclosure - Segment Reporting - Additional Information (Details)",
     "role": "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails",
     "shortName": "Segment Reporting - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R121": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241114064 - Disclosure - Supplemental Cash Flow Information (Details)",
     "role": "http://www.davita.com/role/SupplementalCashFlowInformationDetails",
     "shortName": "Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R122": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8020fe2d892b43739f987d0c488736a0_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241144065 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "role": "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i69bac113d5d84b4b85c181e2fd5a277c_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210131005 - Disclosure - Short-term and long-term investments",
     "role": "http://www.davita.com/role/Shorttermandlongterminvestments",
     "shortName": "Short-term and long-term investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210171006 - Disclosure - Other Receivables Other Receivables",
     "role": "http://www.davita.com/role/OtherReceivablesOtherReceivables",
     "shortName": "Other Receivables Other Receivables",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210201007 - Disclosure - Property and Equipment",
     "role": "http://www.davita.com/role/PropertyandEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210241008 - Disclosure - Intangibles",
     "role": "http://www.davita.com/role/Intangibles",
     "shortName": "Intangibles",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210291009 - Disclosure - Equity Method and Other Investments",
     "role": "http://www.davita.com/role/EquityMethodandOtherInvestments",
     "shortName": "Equity Method and Other Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210331010 - Disclosure - Goodwill",
     "role": "http://www.davita.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210381011 - Disclosure - Other Liabilities",
     "role": "http://www.davita.com/role/OtherLiabilities",
     "shortName": "Other Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "000020002 - Document - Audit Information",
     "role": "http://www.davita.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210411012 - Disclosure - Income Taxes",
     "role": "http://www.davita.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210501013 - Disclosure - Long-Term Debt",
     "role": "http://www.davita.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:LeasesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210571014 - Disclosure - Leases",
     "role": "http://www.davita.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:LeasesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210631015 - Disclosure - Employee Benefit Plans",
     "role": "http://www.davita.com/role/EmployeeBenefitPlans",
     "shortName": "Employee Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210651016 - Disclosure - Contingencies",
     "role": "http://www.davita.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210671017 - Disclosure - Noncontrolling Interests Subject to Put Provisions and Other Commitments",
     "role": "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments",
     "shortName": "Noncontrolling Interests Subject to Put Provisions and Other Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210691018 - Disclosure - Stock-based compensation",
     "role": "http://www.davita.com/role/Stockbasedcompensation",
     "shortName": "Stock-based compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210751019 - Disclosure - Stockholder's equity",
     "role": "http://www.davita.com/role/Stockholdersequity",
     "shortName": "Stockholder's equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210801020 - Disclosure - Accumulated Other Comprehensive (Loss) Income",
     "role": "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome",
     "shortName": "Accumulated Other Comprehensive (Loss) Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210831021 - Disclosure - Acquisitions and Divestitures",
     "role": "http://www.davita.com/role/AcquisitionsandDivestitures",
     "shortName": "Acquisitions and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010003 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210911022 - Disclosure - Held for Sale and Discontinued Operations",
     "role": "http://www.davita.com/role/HeldforSaleandDiscontinuedOperations",
     "shortName": "Held for Sale and Discontinued Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210961023 - Disclosure - Variable Interest Entities",
     "role": "http://www.davita.com/role/VariableInterestEntities",
     "shortName": "Variable Interest Entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210981024 - Disclosure - Fair Values of Financial Instruments",
     "role": "http://www.davita.com/role/FairValuesofFinancialInstruments",
     "shortName": "Fair Values of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211021025 - Disclosure - Segment Reporting",
     "role": "http://www.davita.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211091026 - Disclosure - Supplemental Cash Flow Information",
     "role": "http://www.davita.com/role/SupplementalCashFlowInformation",
     "shortName": "Supplemental Cash Flow Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211121027 - Disclosure - SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS",
     "role": "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS",
     "shortName": "SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220022001 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Organization and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230053001 - Disclosure - Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)",
     "role": "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables",
     "shortName": "Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230093002 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.davita.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230143003 - Disclosure - Short-term and long-term invesmtents (Tables)",
     "role": "http://www.davita.com/role/ShorttermandlongterminvesmtentsTables",
     "shortName": "Short-term and long-term invesmtents (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:ScheduleOfOtherReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230183004 - Disclosure - Other Receivables (Tables)",
     "role": "http://www.davita.com/role/OtherReceivablesTables",
     "shortName": "Other Receivables (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:ScheduleOfOtherReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230213005 - Disclosure - Property and Equipment (Tables)",
     "role": "http://www.davita.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230253006 - Disclosure - Intangibles (Tables)",
     "role": "http://www.davita.com/role/IntangiblesTables",
     "shortName": "Intangibles (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230303007 - Disclosure - Equity Method and Other Investmetns Equity Method and Other Investments (Tables)",
     "role": "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables",
     "shortName": "Equity Method and Other Investmetns Equity Method and Other Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230343008 - Disclosure - Goodwill (Tables)",
     "role": "http://www.davita.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230393009 - Disclosure - Other Liabilities (Tables)",
     "role": "http://www.davita.com/role/OtherLiabilitiesTables",
     "shortName": "Other Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230423010 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.davita.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230513011 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://www.davita.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230583012 - Disclosure - Leases (Tables)",
     "role": "http://www.davita.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230703013 - Disclosure - Long-term Incentive Compensation and Shareholders\u2019 Equity (Tables)",
     "role": "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables",
     "shortName": "Long-term Incentive Compensation and Shareholders\u2019 Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030005 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230763014 - Disclosure - Stockholder's equity (Tables)",
     "role": "http://www.davita.com/role/StockholdersequityTables",
     "shortName": "Stockholder's equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230813015 - Disclosure - Accumulated Other Comprehensive (Loss) Income (Tables)",
     "role": "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables",
     "shortName": "Accumulated Other Comprehensive (Loss) Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230843016 - Disclosure - Acquisitions and Divestitures (Tables)",
     "role": "http://www.davita.com/role/AcquisitionsandDivestituresTables",
     "shortName": "Acquisitions and Divestitures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230923017 - Disclosure - Held for Sale and Discontinued Operations (Tables)",
     "role": "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables",
     "shortName": "Held for Sale and Discontinued Operations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230993018 - Disclosure - Fair Values of Financial Instruments (Tables)",
     "role": "http://www.davita.com/role/FairValuesofFinancialInstrumentsTables",
     "shortName": "Fair Values of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231033019 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.davita.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231103020 - Disclosure - Supplemental Cash Flow Information (Tables)",
     "role": "http://www.davita.com/role/SupplementalCashFlowInformationTables",
     "shortName": "Supplemental Cash Flow Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231133021 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Tables)",
     "role": "http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables",
     "shortName": "SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "dva:RevenueRecognitionAndAccountsReceivablePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dva:MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240034001 - Disclosure - Organization and Summary of Significant Accounting Policies - Additional Information (Details)",
     "role": "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "dva:RevenueRecognitionAndAccountsReceivablePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dva:MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064002 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Recognition Segment Revenue by Payor (Details)",
     "role": "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
     "shortName": "Revenue Recognition and Accounts Receivable Revenue Recognition Segment Revenue by Payor (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i6f47d0696ecb4ceea5e3dae2b3f56bbf_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074003 - Disclosure - Revenue Recognition and Accounts Receivable - Additional Information (Details)",
     "role": "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails",
     "shortName": "Revenue Recognition and Accounts Receivable - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i70683478a02f41b494c6217a76fe90ea_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104004 - Disclosure - Earnings Per Share - Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share (Details)",
     "role": "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails",
     "shortName": "Earnings Per Share - Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124005 - Disclosure - Restricted Cash and Equivalents - Additional Information (Details)",
     "role": "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails",
     "shortName": "Restricted Cash and Equivalents - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i37e77621419b4554a580d5c9a5c257e3_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "dva:NumberOfPartnerships",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240154006 - Disclosure - Short-term and long-term investments (Details)",
     "role": "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails",
     "shortName": "Short-term and long-term investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i08588920534148a6a55bbac6aa980054_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240164007 - Disclosure - Short-term and long-term investments - Additional Information (Details)",
     "role": "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails",
     "shortName": "Short-term and long-term investments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i08588920534148a6a55bbac6aa980054_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfOtherReceivablesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240194008 - Disclosure - Other Receivables (Details)",
     "role": "http://www.davita.com/role/OtherReceivablesDetails",
     "shortName": "Other Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfOtherReceivablesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i56bb88494d0e4f3eaa70062661dfec9c_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240224009 - Disclosure - Property and Equipment (Details)",
     "role": "http://www.davita.com/role/PropertyandEquipmentDetails",
     "shortName": "Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234010 - Disclosure - Property and Equipment - Additional Information (Details)",
     "role": "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails",
     "shortName": "Property and Equipment - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240264011 - Disclosure - Intangibles - Amortizable Intangible Assets Other Than Goodwill (Details)",
     "role": "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails",
     "shortName": "Intangibles - Amortizable Intangible Assets Other Than Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i5a6af38324324be6933f6bddc285dac3_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274012 - Disclosure - Intangibles - Scheduled Amortization Charges from Intangible Assets and Liabilities (Details)",
     "role": "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails",
     "shortName": "Intangibles - Scheduled Amortization Charges from Intangible Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i5a6af38324324be6933f6bddc285dac3_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAmortizationAndAccretionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284013 - Disclosure - Intangibles - Additional Information (Details)",
     "role": "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
     "shortName": "Intangibles - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240314014 - Disclosure - Equity Method and Other Investmetns Equity Method and Other Investments (Details)",
     "role": "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails",
     "shortName": "Equity Method and Other Investmetns Equity Method and Other Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i9573fac1bfc4444783c0b158169c7afc_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240324015 - Disclosure - Equity Method and Other Investments - Additional Information (Details)",
     "role": "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
     "shortName": "Equity Method and Other Investments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "ic66c414a255d4ccba5c079ae43f2af9d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354016 - Disclosure - Goodwill - Changes in Carrying Value of Goodwill by Reportable Segments (Details)",
     "role": "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
     "shortName": "Goodwill - Changes in Carrying Value of Goodwill by Reportable Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364017 - Disclosure - Goodwill - Schedule of Reporting Units Goodwill Balances (Details)",
     "role": "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
     "shortName": "Goodwill - Schedule of Reporting Units Goodwill Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "dva:ScheduleOfReportingUnitsGoodwillBalancesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "2",
      "lang": "en-US",
      "name": "dva:PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240374018 - Disclosure - Goodwill - Additional Information (Details)",
     "role": "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
     "shortName": "Goodwill - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i7b36f25a93464b258c27c7f22e113088_D20210101-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PayorRefundsAndRetractions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240404019 - Disclosure - Other Liabilities (Details)",
     "role": "http://www.davita.com/role/OtherLiabilitiesDetails",
     "shortName": "Other Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PayorRefundsAndRetractions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240434020 - Disclosure - Income Taxes - Schedule of Income Before Income Taxes (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes - Schedule of Income Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444021 - Disclosure - Income Taxes - Components of Income Tax Expense (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails",
     "shortName": "Income Taxes - Components of Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240454022 - Disclosure - Income Taxes Income Taxes - Allocation of Income Tax Expense (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails",
     "shortName": "Income Taxes Income Taxes - Allocation of Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i88726c7f90b243d4adcbf6e341fa9adc_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060008 - Statement - CONSOLIDATED STATEMENTS OF EQUITY",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i88726c7f90b243d4adcbf6e341fa9adc_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464023 - Disclosure - Income Taxes - Reconciliation Between U.S. Federal Income Tax Rate and Our Effective Tax Rate From Continuing Operations (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails",
     "shortName": "Income Taxes - Reconciliation Between U.S. Federal Income Tax Rate and Our Effective Tax Rate From Continuing Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:DeferredTaxAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474024 - Disclosure - Income Taxes - Deferred Tax and Liabilities Arising from Temporary Differences (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails",
     "shortName": "Income Taxes - Deferred Tax and Liabilities Arising from Temporary Differences (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:DeferredTaxAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "ic66c414a255d4ccba5c079ae43f2af9d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240484025 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet More-Likely-Than-Not Threshold (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails",
     "shortName": "Income Taxes - Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet More-Likely-Than-Not Threshold (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494026 - Disclosure - Income Taxes - Additional Information (Details)",
     "role": "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240524027 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)",
     "role": "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails",
     "shortName": "Long-Term Debt - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240534028 - Disclosure - Long-Term Debt - Scheduled Maturities of Long-term Debt (Details)",
     "role": "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails",
     "shortName": "Long-Term Debt - Scheduled Maturities of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "ib7258618967043f9bcfd1acc842da238_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544029 - Disclosure - Long-Term Debt - Derivative Instruments (Details)",
     "role": "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
     "shortName": "Long-Term Debt - Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "ie83cf4a097b643ee9745264ab855ca7b_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInceptionDates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240554030 - Disclosure - Long-Term Debt - Effects of Interest Rate Swap and Cap Agreements (Details)",
     "role": "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails",
     "shortName": "Long-Term Debt - Effects of Interest Rate Swap and Cap Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "ib7258618967043f9bcfd1acc842da238_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564031 - Disclosure - Long-Term Debt - Additional information (Detail)",
     "role": "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
     "shortName": "Long-Term Debt - Additional information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtPercentageBearingFixedInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240594032 - Disclosure - Leases Lease Expense Components (Details)",
     "role": "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails",
     "shortName": "Leases Lease Expense Components (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Organization and Summary of Significant Accounting Policies",
     "role": "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies",
     "shortName": "Organization and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:LeaseOtherInformationTableTextBlockTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240604033 - Disclosure - Leases Leases Other Information (Details)",
     "role": "http://www.davita.com/role/LeasesLeasesOtherInformationDetails",
     "shortName": "Leases Leases Other Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:LeaseOtherInformationTableTextBlockTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfMinimumLeasePaymentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614034 - Disclosure - Leases - Future Minimum Lease Payments Under Non-Cancelable Operating and Capital Leases (Details)",
     "role": "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails",
     "shortName": "Leases - Future Minimum Lease Payments Under Non-Cancelable Operating and Capital Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dva:ScheduleOfMinimumLeasePaymentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:FinanceLeaseAccumulatedDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624035 - Disclosure - Leases - Additional Information (Details)",
     "role": "http://www.davita.com/role/LeasesAdditionalInformationDetails",
     "shortName": "Leases - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:FinanceLeaseAccumulatedDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644036 - Disclosure - Employee Benefit Plans - Additional Information (Details)",
     "role": "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails",
     "shortName": "Employee Benefit Plans - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "if21f5702256f425495741fad20cc492f_D20171201-20171231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664037 - Disclosure - Contingencies - Additional Information (Details)",
     "role": "http://www.davita.com/role/ContingenciesAdditionalInformationDetails",
     "shortName": "Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "if21f5702256f425495741fad20cc492f_D20171201-20171231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684038 - Disclosure - Noncontrolling Interests Subject to Put Provisions and Other Commitments - Additional Information (Details)",
     "role": "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails",
     "shortName": "Noncontrolling Interests Subject to Put Provisions and Other Commitments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i5f4abca32687438c9db55fe5ab0adc1e_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714039 - Disclosure - Long-term Incentive Compensation and Shareholders\u2019 Equity - Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements (Details)",
     "role": "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails",
     "shortName": "Long-term Incentive Compensation and Shareholders\u2019 Equity - Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i403917ba9a6e46d299ebc69279a91748_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724040 - Disclosure - Long-term Incentive Compensation and Shareholders\u2019 Equity - Summary of Range of Exercise Prices (Details)",
     "role": "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails",
     "shortName": "Long-term Incentive Compensation and Shareholders\u2019 Equity - Summary of Range of Exercise Prices (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i94e3a04a958345dca335a60cee3d8130_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i6b0097cc1b5e467d90993d8c00830861_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240734041 - Disclosure - Long-term Incentive Compensation and Shareholders Equity - Summary of Weighted Average Valuation Inputs (Details)",
     "role": "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails",
     "shortName": "Long-term Incentive Compensation and Shareholders Equity - Summary of Weighted Average Valuation Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i6b0097cc1b5e467d90993d8c00830861_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240744042 - Disclosure - Long-term Incentive Compensation and Shareholders\u2019 Equity - Additional Information (Details)",
     "role": "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
     "shortName": "Long-term Incentive Compensation and Shareholders\u2019 Equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20211231.htm",
      "contextRef": "i8afd395e770d4907903d6f72b7c71a09_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 127,
   "tag": {
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY",
        "terseLabel": "GERMANY"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r914"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filer"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r940"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r908"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dva_A2019InterestRateCapAgreementsEffectiveJune302020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Interest Rate Cap Agreements Effective June 30, 2020.",
        "label": "2019 Interest Rate Cap Agreements Effective June 30, 2020 [Member]",
        "terseLabel": "2019 Interest Rate Cap Agreements Effective June 30, 2020"
       }
      }
     },
     "localname": "A2019InterestRateCapAgreementsEffectiveJune302020Member",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_AccountsReceivablePeriodOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient accounts receivable months outstanding to be reserved per company policy.",
        "label": "Accounts Receivable Period Outstanding",
        "terseLabel": "Accounts Receivable Period Outstanding"
       }
      }
     },
     "localname": "AccountsReceivablePeriodOutstanding",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_AcquisitionObligationsAndOtherNotesPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.",
        "label": "Acquisition Obligations And Other Notes Payable",
        "terseLabel": "Acquisition obligations and other notes payable"
       }
      }
     },
     "localname": "AcquisitionObligationsAndOtherNotesPayable",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AcquisitionObligationsAndOtherNotesPayableFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition Obligations And Other Notes Payable, Fair Value.",
        "label": "Acquisition Obligations And Other Notes Payable, Fair Value",
        "terseLabel": "Acquisition obligations and other notes payable, fair value"
       }
      }
     },
     "localname": "AcquisitionObligationsAndOtherNotesPayableFairValue",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AdditionalDebtPrincipalAmountDueToNewAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Debt Principal Amount Due To New Agreement.",
        "label": "Additional Debt Principal Amount Due To New Agreement",
        "terseLabel": "Additional Debt Principal Amount Due To New Agreement"
       }
      }
     },
     "localname": "AdditionalDebtPrincipalAmountDueToNewAgreement",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price",
        "label": "Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price",
        "terseLabel": "Additional Payment To The Buyer Related To The Final Agreement On The Purchase Price"
       }
      }
     },
     "localname": "AdditionalPaymentToTheBuyerRelatedToTheFinalAgreementOnThePurchasePrice",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AdjustmentIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the entity's proportionate share for the period of the undistributed net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment.",
        "label": "Adjustment Income Loss From Equity Method Investments",
        "negatedLabel": "Equity investment loss, net"
       }
      }
     },
     "localname": "AdjustmentIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AllTrustsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All trusts.",
        "label": "All Trusts [Member]",
        "terseLabel": "Rabbi trusts"
       }
      }
     },
     "localname": "AllTrustsMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor information",
        "label": "Auditor information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://www.davita.com/20211231",
     "xbrltype": "stringItemType"
    },
    "dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business acquisition contingent consideration revenue earn-out period.",
        "label": "Business Acquisition Contingent Consideration Revenue Earnout Period",
        "terseLabel": "Earn-out consideration payment period"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_BusinessCombinationContingentConsiderationAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.",
        "label": "Business Combination Contingent Consideration Acquisitions",
        "terseLabel": "Acquisitions",
        "verboseLabel": "Business combination contingent consideration acquisitions, earn-outs"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitions",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Acquisitions Earnouts Payments",
        "label": "Business Combination Contingent Consideration Acquisitions Earnouts Payments",
        "negatedLabel": "Payments or other settlements"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitionsEarnoutsPayments",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss",
        "label": "Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss",
        "negatedLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_BusinessSaleDateOfPurchaseAndSaleAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Sale, Date Of Purchase And Sale Agreement",
        "label": "Business Sale, Date Of Purchase And Sale Agreement",
        "terseLabel": "Business Sale, Date Of Purchase And Sale Agreement"
       }
      }
     },
     "localname": "BusinessSaleDateOfPurchaseAndSaleAgreement",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_BusinessSaleEffectiveDateOfSale": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Sale, Effective Date Of Sale",
        "label": "Business Sale, Effective Date Of Sale",
        "terseLabel": "Business Sale, Effective Date Of Sale"
       }
      }
     },
     "localname": "BusinessSaleEffectiveDateOfSale",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_CashPaidDuringPeriodForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid during period for.",
        "label": "Cash Paid During Period For [Abstract]",
        "terseLabel": "Cash paid:"
       }
      }
     },
     "localname": "CashPaidDuringPeriodForAbstract",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_CashPaidForPortionPreviouslyRefundedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Paid For Amounts Previously Refunded [Member]",
        "label": "Cash Paid For Portion Previously Refunded [Member]",
        "terseLabel": "Cash Paid For Portion Previously Refunded"
       }
      }
     },
     "localname": "CashPaidForPortionPreviouslyRefundedMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certificates of deposit, commercial paper, and money market funds.",
        "label": "Certificates Of Deposit Commercial Paper And Money Market Funds [Member]",
        "terseLabel": "Certificates of deposit and other time deposits"
       }
      }
     },
     "localname": "CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CharterdocumentsandDelawarelawAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Charter documents and Delaware law [Abstract]",
        "label": "Charter documents and Delaware law [Abstract]",
        "terseLabel": "Charter documents and Delaware law:"
       }
      }
     },
     "localname": "CharterdocumentsandDelawarelawAbstract",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_CommercialPayorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Payors in healthcare industry.",
        "label": "Commercial Payors [Member]",
        "terseLabel": "Commercial Payors"
       }
      }
     },
     "localname": "CommercialPayorsMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CommitmentsAndContingenciesDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies disclosure.",
        "label": "Commitments And Contingencies Disclosure [Line Items]",
        "terseLabel": "Commitments And Contingencies Disclosure [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureLineItems",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_CommitmentsAndContingenciesDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies disclosure.",
        "label": "Commitments And Contingencies Disclosure [Table]",
        "terseLabel": "Commitments And Contingencies Disclosure [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTable",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_CommitmentsToProvideOperatingCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments to provide operating capital.",
        "label": "Commitments To Provide Operating Capital [Member]",
        "terseLabel": "Commitments to Provide Operating Capital"
       }
      }
     },
     "localname": "CommitmentsToProvideOperatingCapitalMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] [Abstract]",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] [Abstract]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] [Abstract]"
       }
      }
     },
     "localname": "ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsofChangesNetLineItemsAbstract",
     "nsuri": "http://www.davita.com/20211231",
     "xbrltype": "stringItemType"
    },
    "dva_CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member.",
        "label": "Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member [Member]",
        "terseLabel": "Coronavirus Aid Relief And Economic Security Act Additional Tax Benefit Member [Member]"
       }
      }
     },
     "localname": "CoronavirusAidReliefAndEconomicSecurityActAdditionalTaxBenefitMemberMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_DMGAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DMG Acquisitions [Member]",
        "label": "DMG Acquisitions [Member]",
        "terseLabel": "DMG Acquisitions"
       }
      }
     },
     "localname": "DMGAcquisitionsMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_DaVitaMedicalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DaVita medical group.",
        "label": "Da Vita Medical Group [Member]",
        "verboseLabel": "DMG - discontinued operations"
       }
      }
     },
     "localname": "DaVitaMedicalGroupMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_DebtExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt expense.",
        "label": "Debt Expense [Member]",
        "terseLabel": "Debt Expense"
       }
      }
     },
     "localname": "DebtExpenseMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_DebtFinancingAndDebtRedemptionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Financing And Debt Redemption Costs",
        "label": "Debt Financing And Debt Redemption Costs",
        "negatedTerseLabel": "Deferred financing and debt redemption costs"
       }
      }
     },
     "localname": "DebtFinancingAndDebtRedemptionCosts",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DebtInstrumentOfferingPricePercentageOfFaceAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Offering Price Percentage Of Face Amount",
        "label": "Debt Instrument Offering Price Percentage Of Face Amount",
        "terseLabel": "Debt Instrument Offering Price Percentage Of Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentOfferingPricePercentageOfFaceAmount",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_DebtPrepaymentRefinancingRedemptionCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt prepayment, refinancing and redemption charges related to long-term debt.",
        "label": "Debt Prepayment Refinancing Redemption Charges",
        "negatedTerseLabel": "Debt prepayment, refinancing and redemption charges"
       }
      }
     },
     "localname": "DebtPrepaymentRefinancingRedemptionCharges",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DebtRefinancingCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt prepayment refinancing redemption charges related to debt modification of long-term debt.",
        "label": "Debt Refinancing Charges",
        "terseLabel": "Debt prepayment, refinancing and redemption charges"
       }
      }
     },
     "localname": "DebtRefinancingCharges",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DeconsolidatedNoncontrollingEntityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deconsolidated Noncontrolling Entity [Member]",
        "label": "Deconsolidated Noncontrolling Entity [Member]",
        "terseLabel": "APAC JV - Deconsolidated Noncontrolling Entity"
       }
      }
     },
     "localname": "DeconsolidatedNoncontrollingEntityMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_DeferredTaxAssetsOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from operating lease liabilities.",
        "label": "Deferred Tax Assets Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilities",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DeferredTaxAssetsReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets, receivables.",
        "label": "Deferred Tax Assets Receivables",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "DeferredTaxAssetsReceivables",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DeferredTaxLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities",
        "label": "Deferred Tax Liabilities [Member]",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_DeferredTaxLiabilitiesOperatingLeaseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from operating lease assets.",
        "label": "Deferred Tax Liabilities Operating Lease Assets",
        "negatedTerseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingLeaseAssets",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DiscountAndDeferredFinanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount and deferred finance costs.",
        "label": "Discount And Deferred Finance Costs",
        "negatedLabel": "Discount and deferred financing costs"
       }
      }
     },
     "localname": "DiscountAndDeferredFinanceCosts",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_DissolutionTermOfJointVentures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dissolution term of joint ventures.",
        "label": "Dissolution Term Of Joint Ventures",
        "terseLabel": "Scheduled dissolution term of joint ventures"
       }
      }
     },
     "localname": "DissolutionTermOfJointVentures",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EBITDA operating income performance targets or quality margins.",
        "label": "E B I T D A Operating Income Performance Targets Or Quality Margins [Member]",
        "terseLabel": "EBITDA or Operating Income Performance Targets or Quality Margins"
       }
      }
     },
     "localname": "EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_EffectiveIncomeTaxReconciliationInvestmentImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Investment Impairment",
        "label": "Effective Income Tax Reconciliation, Investment Impairment",
        "terseLabel": "Nondeductible executive compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationInvestmentImpairment",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee service share-based compensation estimated tax benefit from compensation expense.",
        "label": "Employee Service Share Based Compensation Estimated Tax Benefit From Compensation Expense",
        "terseLabel": "Estimated tax benefits recorded for stock-based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationEstimatedTaxBenefitFromCompensationExpense",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Member]",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee-related Current Liabilities, Employee Stock Purchase Plan, Contributions Used To Purchase Shares.",
        "label": "Employee-related Current Liabilities, Employee Stock Purchase Plan, Contributions Used To Purchase Shares",
        "terseLabel": "Contributions used to purchase shares, employee-related current liabilities"
       }
      }
     },
     "localname": "EmployeerelatedCurrentLiabilitiesEmployeeStockPurchasePlanContributionsUsedToPurchaseShares",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_EpogenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Epogen.",
        "label": "Epogen [Member]",
        "terseLabel": "EPO"
       }
      }
     },
     "localname": "EpogenMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ExpectedAmortizationExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected Amortization Expense [Line Items]",
        "label": "Expected Amortization Expense [Line Items]",
        "terseLabel": "Expected Amortization Expense [Line Items]"
       }
      }
     },
     "localname": "ExpectedAmortizationExpenseLineItems",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_ExpectedAmortizationExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected Amortization Expense [Table]",
        "label": "Expected Amortization Expense [Table]",
        "terseLabel": "Expected Amortization Expense [Table]"
       }
      }
     },
     "localname": "ExpectedAmortizationExpenseTable",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_ExternalSourcesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External sources.",
        "label": "External Sources [Member]",
        "terseLabel": "External Sources"
       }
      }
     },
     "localname": "ExternalSourcesMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_FinanceLeaseAccumulatedDepreciation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Accumulated Depreciation, contra asset.",
        "label": "Finance Lease Accumulated Depreciation",
        "terseLabel": "Finance Lease Accumulated Depreciation"
       }
      }
     },
     "localname": "FinanceLeaseAccumulatedDepreciation",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_FinanceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease [Member]",
        "label": "Finance Lease [Member]",
        "terseLabel": "Financing Lease",
        "verboseLabel": "Finance Lease"
       }
      }
     },
     "localname": "FinanceLeaseMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Translation Adjustment For Contingent Earn Out Obligations",
        "label": "Foreign Currency Translation Adjustment For Contingent Earn Out Obligations",
        "negatedLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_ForeignDialysisCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign dialysis and other medical businesses.",
        "label": "Foreign Dialysis Centers [Member]",
        "terseLabel": "Foreign Dialysis Centers"
       }
      }
     },
     "localname": "ForeignDialysisCentersMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_GroundLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ground Lease",
        "label": "Ground Lease [Member]",
        "terseLabel": "Ground Lease"
       }
      }
     },
     "localname": "GroundLeaseMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_IncomeTaxExpenseBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax expense benefit.",
        "label": "Income Tax Expense Benefit [Member]",
        "terseLabel": "Related income tax benefit (expense)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_IncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Line Items]",
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesLineItems",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_IncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Table]",
        "label": "Income Taxes [Table]",
        "terseLabel": "Income Taxes [Table]"
       }
      }
     },
     "localname": "IncomeTaxesTable",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the reporting period in other current receivables and other current assets.",
        "label": "Increase Decrease In Other Current Receivables And Other Current Assets",
        "negatedLabel": "Other receivables and prepaid and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests",
        "label": "Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests",
        "terseLabel": "Increase (Decrease) In Paid-In Capital for Sales of Noncontrolling Interests"
       }
      }
     },
     "localname": "IncreaseDecreaseInPaidInCapitalforSalesofNoncontrollingInterests",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_IncrementalCashPortionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental Cash Portion [Member]",
        "label": "Incremental Cash Portion [Member]",
        "terseLabel": "Incremental Cash Portion"
       }
      }
     },
     "localname": "IncrementalCashPortionMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_IndefiniteLifeNetOperatingLossesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite Life Net Operating Losses",
        "label": "Indefinite Life Net Operating Losses [Member]",
        "terseLabel": "Indefinite Life Net Operating Losses"
       }
      }
     },
     "localname": "IndefiniteLifeNetOperatingLossesMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_InsuranceAndSelfInsurancePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance and self insurance policy.",
        "label": "Insurance And Self Insurance Policy [Text Block]",
        "terseLabel": "Self insurance"
       }
      }
     },
     "localname": "InsuranceAndSelfInsurancePolicyTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_InternationalOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International operations.",
        "label": "International Operations [Member]",
        "terseLabel": "International Operations"
       }
      }
     },
     "localname": "InternationalOperationsMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_KidneyCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kidney Care [Member]",
        "label": "Kidney Care [Member]",
        "terseLabel": "Kidney Care"
       }
      }
     },
     "localname": "KidneyCareMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_LeaseOtherInformationTableTextBlockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Other Information in tabular disclosure.",
        "label": "Lease Other Information Table Text Block [Table Text Block]",
        "terseLabel": "Lease Other Information"
       }
      }
     },
     "localname": "LeaseOtherInformationTableTextBlockTableTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_LeasesDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases Disclosure [Line Items]",
        "label": "Leases Disclosure [Line Items]",
        "terseLabel": "Leases Disclosure [Line Items]"
       }
      }
     },
     "localname": "LeasesDisclosureLineItems",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_LeasesDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases Disclosure [Table]",
        "label": "Leases Disclosure [Table]",
        "terseLabel": "Leases Disclosure [Table]"
       }
      }
     },
     "localname": "LeasesDisclosureTable",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_LeasesDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases complete footnote disclosure.",
        "label": "Leases Disclosure [Text Block]",
        "terseLabel": "Leases Disclosure"
       }
      }
     },
     "localname": "LeasesDisclosureTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_LeasesOtherInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases Other Information [Abstract]",
        "label": "Leases Other Information [Abstract]",
        "terseLabel": "Leases Other Information [Abstract]"
       }
      }
     },
     "localname": "LeasesOtherInformationAbstract",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_LesseeLeaseDescriptionLineItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Lease, Description [Line Items] [Abstract]",
        "label": "Lessee, Lease, Description [Line Items] [Abstract]",
        "terseLabel": "Lessee, Lease, Description [Line Items] [Abstract]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItemsAbstract",
     "nsuri": "http://www.davita.com/20211231",
     "xbrltype": "stringItemType"
    },
    "dva_LongTermPurchaseCommitmentExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term purchase commitment expiration date.",
        "label": "Long Term Purchase Commitment Expiration Date",
        "terseLabel": "Long term purchase commitment, expiration date"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentExpirationDate",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_LongTermPurchaseCommitmentPercentageOfQuantityRequired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term purchase commitment percentage of quantity required.",
        "label": "Long Term Purchase Commitment Percentage Of Quantity Required",
        "terseLabel": "Long-term purchase commitment, percentage of quantity required to be purchased"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentPercentageOfQuantityRequired",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_LossGainOnDispositionOfBusinessInterestsBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss (Gain) On Disposition Of Business Interests Before Tax",
        "label": "Loss (Gain) On Disposition Of Business Interests Before Tax",
        "negatedTerseLabel": "Loss on sale of discontinued operations before taxes",
        "terseLabel": "Loss on sales of business interests, net"
       }
      }
     },
     "localname": "LossGainOnDispositionOfBusinessInterestsBeforeTax",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_MedicaidandManagedMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and Managed Medicaid Member.",
        "label": "Medicaid and Managed Medicaid [Member]",
        "terseLabel": "Medicaid and Managed Medicaid"
       }
      }
     },
     "localname": "MedicaidandManagedMedicaidMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_MedicareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare governmental agency.",
        "label": "Medicare [Member]",
        "terseLabel": "Medicare bad debt claims"
       }
      }
     },
     "localname": "MedicareMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor",
        "label": "Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor",
        "terseLabel": "Medicare Payment Rate Established By Statute Or Regulation For The Portion Of Payment Rates Paid By The Government Payor"
       }
      }
     },
     "localname": "MedicarePaymentRateEstablishedByStatuteOrRegulationForThePortionOfPaymentRatesPaidByTheGovernmentPayor",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_MedicareandMedicareAdvantageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare and Medicare Advantage",
        "label": "Medicare and Medicare Advantage [Member]",
        "terseLabel": "Medicare and Medicare Advantage"
       }
      }
     },
     "localname": "MedicareandMedicareAdvantageMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_MutualFundsAndCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mutual Funds And Common Stock [Member]",
        "label": "Mutual Funds And Common Stock [Member]",
        "terseLabel": "Investments in mutual funds and common stock"
       }
      }
     },
     "localname": "MutualFundsAndCommonStockMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Effect Of Transfers From (To) Noncontrolling Interests on Stock Holders Equity Disclosure",
        "label": "Net Effect Of Transfers From To Noncontrolling Interests On Stock Holders Equity Disclosure [Text Block]",
        "terseLabel": "Net effect of transfers from to noncontrolling interests on stock holders equity disclosure"
       }
      }
     },
     "localname": "NetEffectOfTransfersFromToNoncontrollingInterestsOnStockHoldersEquityDisclosureTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/StockholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.",
        "label": "Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests.",
        "terseLabel": "Net Income Attributable To Parent Net Of Transfers To Noncontrolling Interests."
       }
      }
     },
     "localname": "NetIncomeAttributableToParentNetOfTransfersToNoncontrollingInterests",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase Decrease In Unrealized Gains On Equity Securities",
        "label": "Net Increase Decrease In Unrealized Gains On Equity Securities",
        "terseLabel": "Net Increase (Decrease) In Unrealized Gains On Equity Securities"
       }
      }
     },
     "localname": "NetIncreaseDecreaseInUnrealizedGainsOnEquitySecurities",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase Decrease In Unrealized Losses On Equity Securities",
        "label": "Net Increase Decrease In Unrealized Losses On Equity Securities",
        "terseLabel": "Net Increase (Decrease) In Unrealized Losses On Equity Securities"
       }
      }
     },
     "localname": "NetIncreaseDecreaseInUnrealizedLossesOnEquitySecurities",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Operating Lease Assets Obtained In Exchange For New or Modified Lease Liabilities.",
        "label": "Net Operating Lease Assets Obtained In Exchange For Lease Liabilities",
        "terseLabel": "Net Operating Lease Assets Obtained In Exchange For Lease Liabilities"
       }
      }
     },
     "localname": "NetOperatingLeaseAssetsObtainedInExchangeForLeaseLiabilities",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease Due To Acquisitions and Divestitures",
        "label": "Noncontrolling Interest, Decrease Due To Acquisitions and Divestitures",
        "negatedTerseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Gain Related To Redemptions or Purchase of Interests.",
        "label": "Noncontrolling Interest, Gain Related To Redemptions Or Purchase Of Interests",
        "terseLabel": "Purchase of noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestGainRelatedToRedemptionsOrPurchaseOfInterests",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase Due To Acquisitions and Divestitures.",
        "label": "Noncontrolling Interest, Increase Due To Acquisitions and Divestitures",
        "terseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NoncontrollingInterestIncreaseFromContributions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling interest increase from contributions.",
        "label": "Noncontrolling Interest Increase From Contributions",
        "terseLabel": "Contributions"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromContributions",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NumberOfConcentrationRiskCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Concentration Risk Customers.",
        "label": "Number Of Concentration Risk Customers",
        "terseLabel": "Number of concentration risk customers"
       }
      }
     },
     "localname": "NumberOfConcentrationRiskCustomers",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "dva_NumberOfCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of customers.",
        "label": "Number Of Customers",
        "verboseLabel": "Number of patients served"
       }
      }
     },
     "localname": "NumberOfCustomers",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dva_NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of entities that third parties held non controlling equity interests.",
        "label": "Number Of Entities That Third Parties Held Non Controlling Equity Interests",
        "terseLabel": "Number of legal entities that third parties held noncontrolling equity interests"
       }
      }
     },
     "localname": "NumberOfEntitiesThatThirdPartiesHeldNonControllingEquityInterests",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dva_NumberOfPartnerships": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Partnerships that are included in the Equity Investments category.",
        "label": "Number Of Partnerships",
        "terseLabel": "Number of partnerships",
        "verboseLabel": "Number Of Businesses"
       }
      }
     },
     "localname": "NumberOfPartnerships",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "dva_NumberOfSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of sites.",
        "label": "Number Of Sites",
        "terseLabel": "Number of dialysis centers that the company operated or provided administrative services"
       }
      }
     },
     "localname": "NumberOfSites",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dva_OffBalanceSheetFinancingArrangements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Off -Balance Sheet Financing Arrangements.",
        "label": "Off -Balance Sheet Financing Arrangements",
        "terseLabel": "Off -Balance Sheet Financing Arrangements"
       }
      }
     },
     "localname": "OffBalanceSheetFinancingArrangements",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_OpenMarketPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Purchases Member.",
        "label": "Open Market Purchases [Member]",
        "terseLabel": "Open Market Purchases"
       }
      }
     },
     "localname": "OpenMarketPurchasesMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OperatingLeaseLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liabilities",
        "label": "Operating Lease Liabilities [Member]",
        "terseLabel": "Operating Lease Liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OperatingLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease",
        "label": "Operating Lease [Member]",
        "terseLabel": "Operating Lease"
       }
      }
     },
     "localname": "OperatingLeaseMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization consolidation and presentation of financial statements disclosure.",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization consolidation and presentation of financial statements disclosure.",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]",
        "terseLabel": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_OtherCompaniesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other companies.",
        "label": "Other Companies [Member]",
        "terseLabel": "Other companies"
       }
      }
     },
     "localname": "OtherCompaniesMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherGovernmentPayorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other government payors in healthcare industry.",
        "label": "Other Government Payors [Member]",
        "terseLabel": "Other Government Payors"
       }
      }
     },
     "localname": "OtherGovernmentPayorsMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherNonoperatingIncomeExpensePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other nonoperating income (expense), policy.",
        "label": "Other Nonoperating Income Expense Policy [Text Block]",
        "terseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpensePolicyTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_OtherReportingUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Reporting Units [Member]",
        "label": "Other Reporting Units [Member]",
        "terseLabel": "Other reporting units"
       }
      }
     },
     "localname": "OtherReportingUnitsMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherSourcesofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other sources of revenue (management fees and revenue from the Company's ancillary services and strategic initiatives).",
        "label": "Other Sources of Revenue [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSourcesofRevenueMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ParentCompanyAndRestrictedSubsidiariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Parent company and restricted subsidiaries.",
        "label": "Parent Company And Restricted Subsidiaries [Member]",
        "terseLabel": "Company and Restricted Subsidiaries(1)"
       }
      }
     },
     "localname": "ParentCompanyAndRestrictedSubsidiariesMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_PatientCareCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.",
        "label": "Patient Care Costs",
        "terseLabel": "Patient care costs"
       }
      }
     },
     "localname": "PatientCareCosts",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PaymentsRelatedToStockPurchasesAndAwards": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments related to stock purchases and awards",
        "label": "Payments related to stock purchases and awards",
        "negatedTerseLabel": "Net (payments) receipts related to stock purchases and awards"
       }
      }
     },
     "localname": "PaymentsRelatedToStockPurchasesAndAwards",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PaymentsToAcquireOtherDebtAndEquityInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments To Acquire Other Debt And Equity Investments",
        "label": "Payments To Acquire Other Debt And Equity Investments",
        "negatedTerseLabel": "Purchase of other debt and equity investments"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherDebtAndEquityInvestments",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PayorRefundsAndRetractions": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/OtherLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payor Refunds And Retractions",
        "label": "Payor Refunds And Retractions",
        "terseLabel": "Payor refunds and retractions"
       }
      }
     },
     "localname": "PayorRefundsAndRetractions",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage change in discount rate used to evaluate fair value of reporting unit for goodwill assessment.",
        "label": "Percentage Change In Discount Rate Used To Evaluate Fair Value Of Reporting Unit For Goodwill Assessment",
        "terseLabel": "Percentage change in discount rate used to evaluate fair value of reporting unit for goodwill assessment"
       }
      }
     },
     "localname": "PercentageChangeInDiscountRateUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage change in operating income used to evaluate fair value of reporting unit for goodwill assessment.",
        "label": "Percentage Change In Operating Income Used To Evaluate Fair Value Of Reporting Unit For Goodwill Assessment",
        "terseLabel": "Percentage change in operating income used to evaluate fair value of reporting unit for goodwill assessment"
       }
      }
     },
     "localname": "PercentageChangeInOperatingIncomeUsedToEvaluateFairValueOfReportingUnitForGoodwillAssessment",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_PercentageOfAccountsReceivableSixMonthsOrMorePastDue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Accounts Receivable , 6 months or More Past Due",
        "label": "Percentage Of Accounts Receivable Six Months Or More Past Due",
        "terseLabel": "Percentage Of Accounts Receivable Six Months Or More Past Due"
       }
      }
     },
     "localname": "PercentageOfAccountsReceivableSixMonthsOrMorePastDue",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law limitation. The Company is subject to Section\u00a0203 of the Delaware General Corporation Law which, subject to exceptions, would prohibit the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period three years following the date on which that stockholder became an interested stockholder.",
        "label": "Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law Limitation",
        "terseLabel": "Period During Which The Company Is Subject To Section 203 Of The Delaware General Corporation Law Limitation"
       }
      }
     },
     "localname": "PeriodDuringWhichTheCompanyIsSubjectToSection203OfTheDelawareGeneralCorporationLawLimitation",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential Impact On Fair Value For Basis Point Increase In Discount Rate",
        "label": "Potential Impact On Fair Value For Basis Point Increase In Discount Rate",
        "negatedLabel": "Sensitivities, Discount rate"
       }
      }
     },
     "localname": "PotentialImpactOnFairValueForBasisPointIncreaseInDiscountRate",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_PotentialImpactOnFairValueForReductionInOperatingIncome": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential Impact On Fair Value For Reduction In Operating Income",
        "label": "Potential Impact On Fair Value For Reduction In Operating Income",
        "negatedLabel": "Sensitivities, Operating Income"
       }
      }
     },
     "localname": "PotentialImpactOnFairValueForReductionInOperatingIncome",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple",
        "label": "Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple",
        "terseLabel": "Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple"
       }
      }
     },
     "localname": "PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PremiumPricedAwardBasePricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premium Priced Award Base Price Per Share.",
        "label": "Premium Priced Award Base Price Per Share",
        "terseLabel": "Premium Priced Award Base Price Per Share"
       }
      }
     },
     "localname": "PremiumPricedAwardBasePricePerShare",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "dva_PremiumPricedStockSettledStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premium Priced Stock-Settled Stock Appreciation Rights Member.",
        "label": "Premium Priced Stock-Settled Stock Appreciation Rights [Member]",
        "terseLabel": "Premium priced stock-settled stock appreciation rights"
       }
      }
     },
     "localname": "PremiumPricedStockSettledStockAppreciationRightsMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_PremiumToTheTenderOfferSharePurchasePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premium To The Tender Offer Share Purchase Price.",
        "label": "Premium To The Tender Offer Share Purchase Price",
        "terseLabel": "Premium To The Tender Offer Share Purchase Price"
       }
      }
     },
     "localname": "PremiumToTheTenderOfferSharePurchasePrice",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_PurchaseAndSaleAgreementAggregatePurchasePrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase And Sale Agreement Aggregate Purchase Price.",
        "label": "Purchase And Sale Agreement Aggregate Purchase Price",
        "terseLabel": "Purchase And Sale Agreement Aggregate Purchase Price"
       }
      }
     },
     "localname": "PurchaseAndSaleAgreementAggregatePurchasePrice",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Historical purchases of Noncontrolling Interests in Consolidated Partnerships.",
        "label": "Purchases Of Noncontrolling Interests In Consolidated Partnerships [Member]",
        "terseLabel": "Purchases Of Noncontrolling Interests In Consolidated Partnerships"
       }
      }
     },
     "localname": "PurchasesOfNoncontrollingInterestsInConsolidatedPartnershipsMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_RMSLifelineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RMS Lifeline.",
        "label": "RMS Lifeline [Member]",
        "terseLabel": "RMS Lifeline"
       }
      }
     },
     "localname": "RMSLifelineMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_RangeFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range Four.",
        "label": "Range Four [Member]",
        "terseLabel": "$100.01-$110.00"
       }
      }
     },
     "localname": "RangeFourMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_RangeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range One [Member]",
        "label": "Range One [Member]",
        "terseLabel": "$50.01\u2013$60.00"
       }
      }
     },
     "localname": "RangeOneMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_RangeThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range Three [Member]",
        "label": "Range Three [Member]",
        "terseLabel": "$70.01\u2013$80.00"
       }
      }
     },
     "localname": "RangeThreeMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_RangeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range Two [Member]",
        "label": "Range Two [Member]",
        "terseLabel": "$60.01\u2013$70.00"
       }
      }
     },
     "localname": "RangeTwoMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of capital expenditures for property and equipment from segment to consolidated.",
        "label": "Reconciliation Of Capital Expenditures For Property And Equipment From Segment To Consolidated Table [Text Block]",
        "terseLabel": "Summary of Expenditures for Property and Equipment by Segment"
       }
      }
     },
     "localname": "ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ReconciliationOfCashFlowsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation Of Cash Flows [Table Text Block]",
        "label": "Reconciliation Of Cash Flows [Table Text Block]",
        "terseLabel": "Reconciliation of Cash Flows"
       }
      }
     },
     "localname": "ReconciliationOfCashFlowsTableTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reporting unit percentage of fair value in excess of short of carrying amount.",
        "label": "Reporting Unit Percentage Of Fair Value In Excess Of Short Of Carrying Amount",
        "terseLabel": "Carrying amount coverage"
       }
      }
     },
     "localname": "ReportingUnitPercentageOfFairValueInExcessOfShortOfCarryingAmount",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts",
        "label": "Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts",
        "terseLabel": "Dialysis patient service revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_RevenueRecognitionAndAccountsReceivablePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue recognition and accounts receivable",
        "label": "Revenue Recognition And Accounts Receivable Policy [Text Block]",
        "terseLabel": "Patient service net revenues and accounts receivable"
       }
      }
     },
     "localname": "RevenueRecognitionAndAccountsReceivablePolicyTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure Table Text Block.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Table Text Block]",
        "terseLabel": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure"
       }
      }
     },
     "localname": "SECSchedule1209ScheduleOfValuationAndQualifyingAccountsDisclosureTableTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Allocation Of Income Tax Expense (Benefit) [Table Text Block]",
        "label": "Schedule Of Allocation Of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of allocation of income tax expense (benefit) between continuing and discontinued operations."
       }
      }
     },
     "localname": "ScheduleOfAllocationOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Finite And Indefinite Intangible Assets Table",
        "label": "Schedule Of Finite And Indefinite Intangible Assets Table [Text Block]",
        "terseLabel": "Schedule of Intangible Assets other than Goodwill"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ScheduleOfMinimumLeasePaymentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of minimum lease payments under non-cancelable operating leases and capital leases.",
        "label": "Schedule Of Minimum Lease Payments [Text Block]",
        "terseLabel": "Schedule Of Minimum Lease Payments"
       }
      }
     },
     "localname": "ScheduleOfMinimumLeasePaymentsTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of other information related to acquisitions, including weighted-average estimated useful lives of intangible assets acquired, and goodwill deductible for tax purposes.",
        "label": "Schedule of other information related to acquisitions [Table Text Block]",
        "terseLabel": "Schedule of other information related to acquired intangibles and goodwill"
       }
      }
     },
     "localname": "ScheduleOfOtherInformationRelatedToAcquisitionsTableTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ScheduleOfOtherReceivablesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of claims held for amounts due to an entity. Examples include non-trade receivables and Medicare bad debt claims.",
        "label": "Schedule Of Other Receivables [Table Text Block]",
        "terseLabel": "Schedule of Other Receivables"
       }
      }
     },
     "localname": "ScheduleOfOtherReceivablesTableTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_ScheduleOfReportingUnitsGoodwillBalancesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of reporting units goodwill balances.",
        "label": "Schedule Of Reporting Units Goodwill Balances [Text Block]",
        "terseLabel": "Schedule of Reporting Units Goodwill Balances"
       }
      }
     },
     "localname": "ScheduleOfReportingUnitsGoodwillBalancesTextBlock",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Debt Outstanding Principal Balance Subject To LIBOR.",
        "label": "Secured Debt Outstanding Principal Balance Subject To LIBOR",
        "terseLabel": "Secured Debt Outstanding Principal Balance Subject To LIBOR"
       }
      }
     },
     "localname": "SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_SegmentReportingInformationCorporateExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.",
        "label": "Segment Reporting Information Corporate Expenses",
        "negatedLabel": "Corporate administrative support"
       }
      }
     },
     "localname": "SegmentReportingInformationCorporateExpenses",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_SegmentRevenuebyMajorPayorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Revenue by Major Payor [Abstract]",
        "label": "Segment Revenue by Major Payor [Abstract]",
        "terseLabel": "Segment Revenue by Major Payor [Abstract]"
       }
      }
     },
     "localname": "SegmentRevenuebyMajorPayorAbstract",
     "nsuri": "http://www.davita.com/20211231",
     "xbrltype": "stringItemType"
    },
    "dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Four Point Six Two Five Percent Due Twenty Thirty.",
        "label": "Senior Notes Four Point Six Two Five Percent Due Twenty Thirty [Member]",
        "terseLabel": "Senior Notes 4.625% due 2030"
       }
      }
     },
     "localname": "SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Three Point Seven Five Percent Due Twenty Thirty One",
        "label": "Senior Notes Three Point Seven Five Percent Due Twenty Thirty One [Member]",
        "terseLabel": "Senior Notes 3.75% due 2031"
       }
      }
     },
     "localname": "SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SeniorSecuredCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior secured credit facilities.",
        "label": "Senior Secured Credit Facilities [Member]",
        "terseLabel": "Senior Secured Credit Facilities"
       }
      }
     },
     "localname": "SeniorSecuredCreditFacilitiesMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options exercisable weighted average remaining contractual terms.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms",
        "terseLabel": "Exercisable at end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award maximum share value authorized for purchase.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Share Value Authorized For Purchase",
        "terseLabel": "Employee entitlement for purchase of the Company's common stock during each calendar year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumShareValueAuthorizedForPurchase",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments exercisable number.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number",
        "terseLabel": "Exercisable at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]",
        "terseLabel": "Weighted average remaining contractual\u00a0life"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based Compensation Arrangement by Share based Payment Award, Other than Options, Weighted Average Remaining Contractual Term [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Weighted Average Remaining Contractual Term [Abstract]",
        "terseLabel": "Weighted average remaining contractual\u00a0life"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsWeightedAverageRemainingContractualTermAbstract",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dva_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Units, Additions in Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Stock Units, Additions in Period",
        "terseLabel": "Added by performance factor (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceStockUnitsAdditionsInPeriod",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dva_ShareRepurchaseFeesAndExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Fees And Expenses.",
        "label": "Share Repurchase Fees And Expenses",
        "terseLabel": "Share Repurchase Fees And Expenses"
       }
      }
     },
     "localname": "ShareRepurchaseFeesAndExpenses",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period, End Date"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteHoldingPeriodEndDate",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardAwardVestingDate",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Full Value Shares To Available Shares, Conversion Ratio",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Full Value Shares To Available Shares, Conversion Ratio",
        "terseLabel": "Full share awards to shares available, conversion ratio"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardFullValueSharesToAvailableSharesConversionRatio",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "dva_StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance",
        "label": "Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance",
        "terseLabel": "Stock-based Compensation Number Of Shares Underlying Full Share Types Of Stock-based Awards, For One Full Share Available For Issuance"
       }
      }
     },
     "localname": "StockBasedCompensationNumberOfSharesUnderlyingFullShareTypesOfStockBasedAwardsForOneFullShareAvailableForIssuance",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dva_StockIncentivePlanTwentyElevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Incentive Plan 2011 [Member]",
        "label": "Stock Incentive Plan Twenty Eleven [Member]",
        "terseLabel": "Stock Incentive 2011 Plan"
       }
      }
     },
     "localname": "StockIncentivePlanTwentyElevenMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_StockIncentivePlanTwentyTwentyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Incentive Plan Twenty Twenty",
        "label": "Stock Incentive Plan Twenty Twenty [Member]",
        "terseLabel": "Stock Incentive 2020 Plan"
       }
      }
     },
     "localname": "StockIncentivePlanTwentyTwentyMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_StockSettledStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock-Settled Stock Appreciation Rights.",
        "label": "Stock-Settled Stock Appreciation Rights [Member]",
        "terseLabel": "Stock-settled Stock Appreciation Rights"
       }
      }
     },
     "localname": "StockSettledStockAppreciationRightsMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_StockUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Unit.",
        "label": "Stock Unit [Member]",
        "terseLabel": "Stock units"
       }
      }
     },
     "localname": "StockUnitMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options",
        "label": "Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options",
        "terseLabel": "Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every Four Shares Underlying SARS And Stock Options"
       }
      }
     },
     "localname": "StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryFourSharesUnderlyingSARSAndStockOptions",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dva_StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award",
        "label": "Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award",
        "terseLabel": "Stockbased Compensation Number Of Shares Available For Issuance Reduced By One Share Available For Every One Share Underlying Other Full Share Type Of Award"
       }
      }
     },
     "localname": "StockbasedCompensationNumberOfSharesAvailableForIssuanceReducedByOneShareAvailableForEveryOneShareUnderlyingOtherFullShareTypeOfAward",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dva_StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance",
        "label": "Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance",
        "terseLabel": "Stockbased Compensation Number Of Shares Underlying SARS And Stock Options, For One Full Share Available For Issuance"
       }
      }
     },
     "localname": "StockbasedCompensationNumberOfSharesUnderlyingSARSAndStockOptionsForOneFullShareAvailableForIssuance",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dva_SupplierRebatesAndOtherNonTradeReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Rebates And Other Non Trade Receivables [Member]",
        "label": "Supplier Rebates And Other Non Trade Receivables [Member]",
        "terseLabel": "Supplier rebates and non-trade receivables"
       }
      }
     },
     "localname": "SupplierRebatesAndOtherNonTradeReceivablesMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TaxYear2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Year 2029",
        "label": "Tax Year 2029 [Member]",
        "terseLabel": "Tax Year 2029"
       }
      }
     },
     "localname": "TaxYear2029Member",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Decrease Due To Acquisitions and Divestitures.",
        "label": "Temporary Equity, Decrease Due To Acquisitions and Divestitures",
        "negatedTerseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "TemporaryEquityDecreaseDueToAcquisitionsAndDivestitures",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityDecreasePurchaseOfInterests": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Decrease Purchase Of Interests",
        "label": "Temporary Equity, Decrease Purchase Of Interests",
        "negatedTerseLabel": "Partial purchases"
       }
      }
     },
     "localname": "TemporaryEquityDecreasePurchaseOfInterests",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions"
       }
      }
     },
     "localname": "TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Increase Due To Acquisitions And Divestitures",
        "label": "Temporary Equity, Increase Due To Acquisitions And Divestitures",
        "terseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders",
        "label": "Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders",
        "verboseLabel": "Contributions"
       }
      }
     },
     "localname": "TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityRedeemableNoncontrollingInterestsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interests Temporary Equity [Member]",
        "label": "Temporary Equity Redeemable Noncontrolling Interests [Member]",
        "terseLabel": "Non-controlling interests subject to put provisions"
       }
      }
     },
     "localname": "TemporaryEquityRedeemableNoncontrollingInterestsMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TenderOfferMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tender Offer Member.",
        "label": "Tender Offer [Member]",
        "terseLabel": "Tender Offer"
       }
      }
     },
     "localname": "TenderOfferMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan A.",
        "label": "Term Loan A [Member]",
        "terseLabel": "Term Loan A"
       }
      }
     },
     "localname": "TermLoanAMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanB1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B-1 member",
        "label": "Term Loan B-1 [Member]",
        "terseLabel": "Term Loan B-1"
       }
      }
     },
     "localname": "TermLoanB1Member",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility [Member]",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TerminatedRemainingPriorShareRepurchasesAuthorizedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Terminated Remaining Prior Share Repurchases Authorized, Amount.",
        "label": "Terminated Remaining Prior Share Repurchases Authorized, Amount",
        "terseLabel": "Terminated Remaining Prior Share Repurchases Authorized, Amount"
       }
      }
     },
     "localname": "TerminatedRemainingPriorShareRepurchasesAuthorizedAmount",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TreasuryStockAcquiredAverageCostPerShareClearingPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock Acquired, Average Cost Per Share, Clearing Price",
        "label": "Treasury Stock Acquired, Average Cost Per Share, Clearing Price",
        "terseLabel": "Treasury Stock Acquired, Average Cost Per Share, Clearing Price"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShareClearingPrice",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "dva_USAttorneyPrescriptionDrugInvestigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Attorney Prescription Drug Investigation [Member]",
        "label": "US Attorney Prescription Drug Investigation [Member]",
        "terseLabel": "US Attorney Prescription Drug Investigation"
       }
      }
     },
     "localname": "USAttorneyPrescriptionDrugInvestigationMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_USDialysisAndRelatedLabServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US dialysis \u200band \u200brelated \u200blab\u200b services\u200b.",
        "label": "U S Dialysis And Related Lab Services [Member]",
        "terseLabel": "U.S. dialysis"
       }
      }
     },
     "localname": "USDialysisAndRelatedLabServicesMember",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails",
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election Effective date.",
        "label": "Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election",
        "terseLabel": "Voluntary Deferral Plan Contribution Cash Payout Period After Deferral Election"
       }
      }
     },
     "localname": "VoluntaryDeferralPlanContributionCashPayoutPeriodAfterDeferralElection",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date.",
        "label": "Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date",
        "terseLabel": "Voluntary Deferral Plan Contribution Cash Payout Period After Individuals Retirement Date"
       }
      }
     },
     "localname": "VoluntaryDeferralPlanContributionCashPayoutPeriodAfterIndividualsRetirementDate",
     "nsuri": "http://www.davita.com/20211231",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r180",
      "r342",
      "r347",
      "r355",
      "r652",
      "r653",
      "r663",
      "r664",
      "r765",
      "r905",
      "r918",
      "r929",
      "r938",
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r180",
      "r342",
      "r347",
      "r355",
      "r652",
      "r653",
      "r663",
      "r664",
      "r765",
      "r905",
      "r918",
      "r929",
      "r938",
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r180",
      "r241",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r265",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r350",
      "r352",
      "r354",
      "r355",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r180",
      "r241",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r265",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r350",
      "r352",
      "r354",
      "r355",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r0",
      "r193",
      "r198",
      "r204",
      "r290",
      "r562",
      "r563",
      "r564",
      "r603",
      "r604",
      "r703",
      "r704",
      "r705",
      "r706",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r0",
      "r193",
      "r198",
      "r204",
      "r290",
      "r562",
      "r563",
      "r564",
      "r603",
      "r604",
      "r703",
      "r704",
      "r705",
      "r706",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r0",
      "r193",
      "r198",
      "r204",
      "r290",
      "r562",
      "r563",
      "r564",
      "r603",
      "r604",
      "r703",
      "r704",
      "r705",
      "r706",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r360",
      "r390",
      "r518",
      "r523",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r780",
      "r859",
      "r861",
      "r906",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails",
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r360",
      "r390",
      "r518",
      "r523",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r780",
      "r859",
      "r861",
      "r906",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails",
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r360",
      "r390",
      "r461",
      "r518",
      "r523",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r780",
      "r859",
      "r861",
      "r906",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails",
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r360",
      "r390",
      "r461",
      "r518",
      "r523",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r780",
      "r859",
      "r861",
      "r906",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails",
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r188",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r268",
      "r269",
      "r426",
      "r429",
      "r860",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r917",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r268",
      "r269",
      "r426",
      "r429",
      "r860",
      "r891",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r917",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r186",
      "r187",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r71",
      "r768"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r33",
      "r56",
      "r273",
      "r274"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period for when accounts receivable, classified as noncurrent, is considered past due, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes threshold period past due to write off as uncollectible.",
        "label": "Accounts Receivable, Noncurrent, Threshold Period Past Due",
        "terseLabel": "Accounts Receivable, Noncurrent, Threshold Period Past Due"
       }
      }
     },
     "localname": "AccountsReceivableNoncurrentThresholdPeriodPastDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": {
     "auth_ref": [
      "r41",
      "r75",
      "r569"
     ],
     "calculation": {
      "http://www.davita.com/role/OtherLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrual for Taxes Other than Income Taxes, Current",
        "terseLabel": "Accrued non-income tax liabilities"
       }
      }
     },
     "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r50",
      "r806",
      "r834"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedInsuranceCurrent": {
     "auth_ref": [
      "r40",
      "r41",
      "r75"
     ],
     "calculation": {
      "http://www.davita.com/role/OtherLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Insurance, Current",
        "terseLabel": "Insurance and self-insurance accruals"
       }
      }
     },
     "localname": "AccruedInsuranceCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r69",
      "r326"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r98",
      "r105",
      "r115",
      "r116",
      "r117",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r100",
      "r105",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r59",
      "r102",
      "r104",
      "r105",
      "r837",
      "r866",
      "r867"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending Balance of AOCI",
        "periodStartLabel": "Beginning Balance of AOCI",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails",
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r115",
      "r116",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r101",
      "r105",
      "r115",
      "r116",
      "r117",
      "r190",
      "r191",
      "r192",
      "r659",
      "r862",
      "r863",
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average period before the next renewal or extension for intangible assets with renewal or extension terms, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Asset, Weighted-Average Period before Renewal or Extension",
        "terseLabel": "Acquired Finite-lived Intangible Asset, Weighted-Average Period before Renewal or Extension"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetWeightedAveragePeriodBeforeRenewalOrExtension",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Amortizable intangible assets acquired, weighted-average estimated useful lives"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r190",
      "r191",
      "r192",
      "r562",
      "r563",
      "r564",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Deferred taxes from partnership buyouts"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r525",
      "r527",
      "r567",
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-settled stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r236",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "Other - Ancillary services"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r186",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "Allowance for uncollectible Accounts"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r131",
      "r160",
      "r373",
      "r739"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of Debt Discounts, Premiums and Deferred Financing Costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r160",
      "r311",
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense from amortizable intangible assets, other than lease agreements"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive stock-settled awards excluded from calculation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r101",
      "r105",
      "r115",
      "r116",
      "r117",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r174",
      "r249",
      "r256",
      "r263",
      "r287",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r353",
      "r355",
      "r356",
      "r652",
      "r663",
      "r722",
      "r766",
      "r768",
      "r804",
      "r833"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Assets, Total"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r35",
      "r36",
      "r92",
      "r174",
      "r287",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r353",
      "r355",
      "r356",
      "r652",
      "r663",
      "r722",
      "r766",
      "r768"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r529",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails",
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r685",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails",
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r38",
      "r325"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r514",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r514",
      "r519",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Pro forma basic net income per share from continuing operations attributable to DaVita Inc."
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Pro forma diluted net income per share from continuing operations attributable to DaVita Inc."
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Pro Forma Summary of Results of Operations"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r642"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill deductible for tax purposes associated with acquisitions"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r621",
      "r622"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Pro forma net income from continuing operations attributable to DaVita Inc."
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r621",
      "r622"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Pro forma total revenues"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresProFormaSummaryofResultsofOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r627"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "negatedTerseLabel": "Noncontrolling interests assumed"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r632",
      "r634",
      "r635",
      "r639"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Deferred Purchase price and liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredOther1": {
     "auth_ref": [
      "r638"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.",
        "label": "Business Combination, Consideration Transferred, Other",
        "terseLabel": "Business combination, deferred purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredOther1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r641"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Fair value of contingent earn-out consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r633",
      "r636",
      "r640"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Contingent earn-out obligations"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r626"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "verboseLabel": "Current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r626"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r626"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Indefinite-lived licenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r626"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r625",
      "r626"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Noncompetition agreements and other long-term assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r626"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedTerseLabel": "Liabilities Assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r625",
      "r626"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Aggregate purchase price",
        "verboseLabel": "Aggregate purchase cost recognized"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r625",
      "r626"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r620"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Non-cash gain on acquiring additional ownership in business acquisition"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Leases, Future Minimum Payments, Net Minimum Payments, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "CapitalLeasesFutureMinimumPaymentsNetMinimumPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalLossCarryforwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deductions derived from capital losses that cannot be utilized on the tax return during a period that have been carried forward to reduce taxable income or taxes payable in a future year.",
        "label": "Capital Loss Carryforward [Member]",
        "terseLabel": "Capital Loss Carryforward"
       }
      }
     },
     "localname": "CapitalLossCarryforwardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r31",
      "r65",
      "r162"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for cash and cash equivalent footnotes,  which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.",
        "label": "Cash and Cash Equivalents Disclosure [Text Block]",
        "terseLabel": "Restricted Cash and Cash Equivalents Disclosure [Text Block]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RestrictedCashRestrictedCash"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r44",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r44",
      "r163",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted cash and equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r155",
      "r162",
      "r168"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash of continuing operations at end of the year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash of continuing operations at beginning of the year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r155",
      "r725"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Less: Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Operating Activities, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r22",
      "r155"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Cash Provided by (Used in) Investing Activities, Discontinued Operations",
        "terseLabel": "Net cash used in investing activities from discontinued operations"
       }
      }
     },
     "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r22",
      "r155"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations",
        "terseLabel": "Net cash provided by operating activities from discontinued operations"
       }
      }
     },
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsCashFlowsofdiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments Disclosure [Text Block]",
        "terseLabel": "Noncontrolling Interests Subject to Put Provisions and Other Commitments"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r190",
      "r191",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r55",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending Balance (in shares)",
        "periodStartLabel": "Beginning Balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r55",
      "r768"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common Stock, Value, Issued"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r110",
      "r112",
      "r113",
      "r128",
      "r823",
      "r851"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to DaVita Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r110",
      "r112",
      "r127",
      "r648",
      "r649",
      "r674",
      "r822",
      "r850"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r110",
      "r112",
      "r126",
      "r647",
      "r674",
      "r821",
      "r849"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Comprehensive income:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r125",
      "r139",
      "r820",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r230",
      "r231",
      "r271",
      "r720",
      "r721",
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r230",
      "r231",
      "r271",
      "r720",
      "r721",
      "r869",
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r230",
      "r231",
      "r271",
      "r720",
      "r721",
      "r869",
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r230",
      "r231",
      "r271",
      "r720",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r230",
      "r231",
      "r271",
      "r720",
      "r721",
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "auth_ref": [
      "r660",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r662",
      "r666",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r325"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "New center and capital asset projects in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r600",
      "r607"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r600"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r600",
      "r607",
      "r609"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current income tax"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r600",
      "r607"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r229",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r48",
      "r50",
      "r51",
      "r173",
      "r180",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r377",
      "r378",
      "r379",
      "r380",
      "r740",
      "r805",
      "r808",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails",
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "LIBOR plus interest margin"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r51",
      "r375",
      "r808",
      "r831"
     ],
     "calculation": {
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Total debt principal outstanding"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of reference rate used for variable rate of debt instrument.",
        "label": "Debt Instrument, Description of Variable Rate Basis",
        "terseLabel": "Debt Instrument, Description of Variable Rate Basis"
       }
      }
     },
     "localname": "DebtInstrumentDescriptionOfVariableRateBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r366",
      "r377",
      "r378",
      "r719"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Fair Value Disclosure [Abstract]",
        "terseLabel": "Debt Instrument, footnotes to the table"
       }
      }
     },
     "localname": "DebtInstrumentFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "terseLabel": "Debt Instrument, Fee Amount"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r78",
      "r370",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "verboseLabel": "Debt interest rate during period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r79",
      "r360",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Debt Instrument, Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentMaturityDateDescription": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.",
        "label": "Debt Instrument, Maturity Date, Description",
        "terseLabel": "Debt instrument, maturity date, description"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDateDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r81",
      "r173",
      "r180",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r377",
      "r378",
      "r379",
      "r380",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails",
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Debt Instrument, Periodic Payment, Principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r81",
      "r173",
      "r180",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r377",
      "r378",
      "r379",
      "r380",
      "r403",
      "r404",
      "r405",
      "r406",
      "r737",
      "r738",
      "r740",
      "r741",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r364",
      "r737",
      "r741"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt Instrument, Unamortized Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r364",
      "r737",
      "r741"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt Instrument, Unamortized Premium"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instruments [Abstract]",
        "terseLabel": "Senior Secured Credit Facilities:"
       }
      }
     },
     "localname": "DebtInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions made by employer into fund established for purposes of making future disbursement to individual in accordance with deferred compensation arrangement.",
        "label": "Deferred Compensation Arrangement with Individual, Contributions by Employer",
        "terseLabel": "Non-qualified deferred compensation plan, contributions"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualDistributionPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution made to individual in accordance with deferred compensation arrangement.",
        "label": "Deferred Compensation Arrangement with Individual, Distribution Paid",
        "terseLabel": "Deferred compensation plan, distributions"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualDistributionPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r601",
      "r607"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r601",
      "r607"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r160",
      "r175",
      "r601",
      "r607",
      "r608",
      "r609"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r52",
      "r53",
      "r590",
      "r807",
      "r830"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r573",
      "r574"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "totalLabel": "Total deferred income tax"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r91",
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred Offering Costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r601",
      "r607"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetDomain": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the deferred tax asset for which a valuation reserve exists.",
        "label": "Deferred Tax Asset [Domain]",
        "terseLabel": "Deferred Tax Asset [Domain]"
       }
      }
     },
     "localname": "DeferredTaxAssetDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r591"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r598",
      "r599"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r598",
      "r599"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r598",
      "r599"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r592"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r574",
      "r593"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r598",
      "r599"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Liabilities, Investments",
        "negatedLabel": "Investments in partnerships"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r598",
      "r599"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r598",
      "r599"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r447",
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r461",
      "r462",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r487",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Asset Categories"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r451",
      "r462",
      "r464",
      "r465",
      "r507"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "terseLabel": "Total fair value of assets held in trust"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Employer matching contribution, percent of employees' gross wages"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employer matching contribution, percent of match"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r160",
      "r324"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r160",
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation expense on property and equipment"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r678",
      "r679",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amounts of interest rate agreements"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r94",
      "r95",
      "r96",
      "r719"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r93",
      "r96",
      "r97",
      "r687",
      "r779"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "verboseLabel": "Derivative asset, fair value, gross asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInceptionDates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the entity entered into the derivative contract, in YYYY-MM-DD format.",
        "label": "Derivative, Inception Date",
        "terseLabel": "Derivative, effective date"
       }
      }
     },
     "localname": "DerivativeInceptionDates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r96",
      "r686",
      "r688",
      "r692",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r683",
      "r686",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r683",
      "r686",
      "r692",
      "r695",
      "r696",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r691",
      "r694"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Reclassification from accumulated other comprehensive income into net income",
        "verboseLabel": "Amount of debt expense reclassified from accumulated OCI into income"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeMaturityDates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the derivative contract matures, in YYYY-MM-DD format.",
        "label": "Derivative, Maturity Date",
        "verboseLabel": "Derivative, expiration date"
       }
      }
     },
     "localname": "DerivativeMaturityDates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r677",
      "r680",
      "r681",
      "r683",
      "r684",
      "r690",
      "r692",
      "r697",
      "r699",
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r179",
      "r677",
      "r680",
      "r683",
      "r684",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Interest rate swap and cap agreements"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Abstract]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableSegmentrevenuebymajorpayorTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r20",
      "r123",
      "r846"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "terseLabel": "Income from discontinued operations before taxes"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share",
        "terseLabel": "Diluted net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod": {
     "auth_ref": [
      "r9",
      "r25",
      "r614"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) attributable to income (loss) from operations classified as a discontinued operation. Excludes tax expense (benefit) for gain (loss) on disposal and for provision for gain (loss) until disposal.",
        "label": "Discontinued Operation, Tax Effect of Income (Loss) from Discontinued Operation During Phase-out Period",
        "terseLabel": "Discontinued operations"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal": {
     "auth_ref": [
      "r10",
      "r12",
      "r25",
      "r614"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit on (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.",
        "label": "Discontinued Operation, Tax (Expense) Benefit from Provision for (Gain) Loss on Disposal",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsHeldforsaleMember": {
     "auth_ref": [
      "r4",
      "r7",
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations, Held-for-sale [Member]",
        "terseLabel": "Discontinued Operations, Held-for-sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsHeldforsaleMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "terseLabel": "Expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r21",
      "r28"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "terseLabel": "Net revenues"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r29",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Held for Sale and Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r514",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share attributable to DaVita Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r129",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r205",
      "r208",
      "r214",
      "r215",
      "r216",
      "r220",
      "r221",
      "r706",
      "r707",
      "r824",
      "r852"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income (in usd per share)",
        "totalLabel": "Basic net income per share attributable to DaVita Inc. (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic net income (loss) attributable to DaVita Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r129",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r208",
      "r214",
      "r215",
      "r216",
      "r220",
      "r221",
      "r706",
      "r707",
      "r824",
      "r852"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income (in usd per share)",
        "totalLabel": "Diluted net income per share attributable to DaVita Inc. (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted net income (loss) attributable to DaVita Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r217",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Net income (loss) attributable to DaVita Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r217",
      "r218",
      "r219",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r725"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r177",
      "r576",
      "r611"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r576",
      "r611"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in international valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r576",
      "r611"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Federal and international tax rate adjustments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense": {
     "auth_ref": [
      "r576",
      "r611"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent",
        "terseLabel": "Impact of noncontrolling interests primarily attributable to non-tax paying entities"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r576",
      "r611"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent",
        "terseLabel": "Political advocacy costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r576",
      "r611"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r576",
      "r611"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r576",
      "r611"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": {
     "auth_ref": [
      "r576",
      "r611"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationBetweenUSFederalIncomeTaxRateandOurEffectiveTaxRateFromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r559"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Share-based Payment Arrangement, Expense, Tax Benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r115",
      "r116",
      "r117",
      "r190",
      "r191",
      "r192",
      "r195",
      "r201",
      "r203",
      "r224",
      "r290",
      "r402",
      "r407",
      "r562",
      "r563",
      "r564",
      "r603",
      "r604",
      "r705",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r733",
      "r862",
      "r863",
      "r864",
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r28",
      "r174",
      "r287",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r28",
      "r174",
      "r287",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOtherMember": {
     "auth_ref": [
      "r28",
      "r174",
      "r287",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee classified as other. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee, Other [Member]",
        "terseLabel": "Equity method investments in nonconsolidated businesses"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Equity method investment, significant impairments and other valuation adjustments"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Equity Method Investments and Joint Ventures Disclosure"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r66",
      "r154",
      "r285",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity investments and other investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r717"
     ],
     "calculation": {
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_MarketableSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities, FV-NI",
        "verboseLabel": "Investments in equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Equity Securities, FV-NI, Gain (Loss)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGain": {
     "auth_ref": [
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain",
        "terseLabel": "Equity Securities, FV-NI, Realized Gain"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r45",
      "r49",
      "r281",
      "r832",
      "r887",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Adjusted cost method investments"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r366",
      "r377",
      "r378",
      "r462",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r507",
      "r709",
      "r770",
      "r771",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value, Hierarchy"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r708",
      "r709",
      "r710",
      "r711",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Values of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r366",
      "r462",
      "r464",
      "r469",
      "r507",
      "r709",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted\u00a0prices\u00a0in active\u00a0markets\u00a0for identical assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r366",
      "r377",
      "r378",
      "r462",
      "r464",
      "r469",
      "r507",
      "r709",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant\u00a0other observable\u00a0inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r366",
      "r377",
      "r378",
      "r462",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r507",
      "r709",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant unobservable inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r366",
      "r377",
      "r378",
      "r462",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r507",
      "r770",
      "r771",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r713",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r712",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r716",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair value estimates"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r744",
      "r752",
      "r760"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r747",
      "r755"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Finance Lease, Interest Payment on Liability"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r743",
      "r759"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total future minimum payments due under finance leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r759"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less portion representing interest, financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r746",
      "r755"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Finance Lease, Principal Payments"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r742"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r744",
      "r752",
      "r760"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of leased assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r757",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance lease, weighted average discount rate, percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r756",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r317"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r312",
      "r314",
      "r317",
      "r321",
      "r786",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r312",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r317",
      "r786"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Finite-Lived Intangible Assets, Remaining Amortization Period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedNoncompeteAgreementsGross": {
     "auth_ref": [
      "r317"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of payments made to third parties in exchange for their agreement not to engage in specified competitive practices in specified geographic territories for a specified period of time.",
        "label": "Finite-Lived Noncompete Agreements, Gross",
        "terseLabel": "Noncompetition agreements"
       }
      }
     },
     "localname": "FiniteLivedNoncompeteAgreementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r160",
      "r661"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Loss on changes in ownership interest, net",
        "terseLabel": "Gain (Loss) on Disposition of Business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee": {
     "auth_ref": [
      "r132",
      "r133",
      "r160",
      "r816",
      "r853"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee",
        "negatedTerseLabel": "Gain (Loss) on Divestiture"
       }
      }
     },
     "localname": "GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r297",
      "r299",
      "r768",
      "r803"
     ],
     "calculation": {
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Indefinite-lived intangibles"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Foreign currency and other adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r300",
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r300",
      "r305"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedLabel": "Accumulated impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r160",
      "r298",
      "r303",
      "r307"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Divestitures"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Axis]",
        "terseLabel": "Health Care Organization, Revenue Sources [Axis]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Domain]",
        "terseLabel": "Health Care Organization, Revenue Sources [Domain]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecurities": {
     "auth_ref": [
      "r275",
      "r280",
      "r291",
      "r292"
     ],
     "calculation": {
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_MarketableSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "HeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesCurrent": {
     "auth_ref": [
      "r279",
      "r280",
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as current.",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Current",
        "terseLabel": "Debt securities, short-term investments"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesNoncurrent": {
     "auth_ref": [
      "r279",
      "r280",
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Debt securities, long-term investments"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r160",
      "r322"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r135",
      "r161",
      "r196",
      "r197",
      "r198",
      "r199",
      "r213",
      "r216",
      "r646"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Net income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r176",
      "r610"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r121",
      "r249",
      "r255",
      "r259",
      "r262",
      "r265",
      "r800",
      "r817",
      "r825",
      "r855"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r176",
      "r610"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "International"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r249",
      "r255",
      "r259",
      "r262",
      "r265"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesScheduleofIncomeBeforeIncomeTaxesDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r174",
      "r194",
      "r249",
      "r255",
      "r259",
      "r262",
      "r265",
      "r287",
      "r342",
      "r343",
      "r344",
      "r347",
      "r348",
      "r349",
      "r351",
      "r353",
      "r355",
      "r356",
      "r647",
      "r707",
      "r722"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r119",
      "r129",
      "r194",
      "r196",
      "r197",
      "r198",
      "r199",
      "r208",
      "r214",
      "r215",
      "r707",
      "r814",
      "r818",
      "r824",
      "r845"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "verboseLabel": "Basic net income from continuing operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r119",
      "r129",
      "r194",
      "r196",
      "r197",
      "r198",
      "r199",
      "r208",
      "r214",
      "r215",
      "r216",
      "r707",
      "r824",
      "r845",
      "r848",
      "r852"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Diluted net income from continuing operations per share attributable to DaVita Inc. (in usd per share)",
        "verboseLabel": "Diluted net income from continuing operations (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r25",
      "r28",
      "r616",
      "r846"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net (loss) income from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r20",
      "r25",
      "r647"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Net (loss) income from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r123",
      "r129",
      "r212",
      "r214",
      "r215",
      "r824",
      "r846",
      "r848",
      "r852"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Basic net loss from discontinued operations per share attributable to DaVita Inc. (in usd per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r122",
      "r160",
      "r246",
      "r284",
      "r815",
      "r844"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity investment income, net",
        "terseLabel": "Equity investment income (loss)"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r514",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails",
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r2",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r23",
      "r26",
      "r27",
      "r28",
      "r330",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsFinancialresultsfordiscontinuedoperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r328",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r177",
      "r577",
      "r588",
      "r595",
      "r605",
      "r612",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r178",
      "r202",
      "r203",
      "r247",
      "r575",
      "r606",
      "r613",
      "r856"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "totalLabel": "Continuing operations"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails",
      "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems": {
     "auth_ref": [
      "r615"
     ],
     "calculation": {
      "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current tax expense (benefit) and deferred tax expense (benefit) pertaining to income (loss) from continuing operations and income (loss) from discontinued operations.",
        "label": "Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations",
        "totalLabel": "Income tax (benefit) expense from continuing and discontinued operations"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesIncomeTaxesAllocationofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r114",
      "r571",
      "r572",
      "r588",
      "r589",
      "r594",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r157",
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes, net"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r86",
      "r811",
      "r843"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r216"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Assumed incremental shares from stock plans (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r320"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived licenses"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangibles"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/Intangibles"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r170",
      "r316",
      "r782",
      "r783",
      "r784",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Amortizable intangibles"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, gross (excluding goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r310",
      "r315"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net of accumulated amortization",
        "totalLabel": "Total intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDebtExpense": {
     "auth_ref": [
      "r736"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.",
        "label": "Interest and Debt Expense",
        "negatedLabel": "Debt expense"
       }
      }
     },
     "localname": "InterestAndDebtExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r735"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "terseLabel": "Capitalized interest"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r137",
      "r371",
      "r376",
      "r379",
      "r380"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest Expense, Debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r152",
      "r156",
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r41",
      "r42",
      "r75"
     ],
     "calculation": {
      "http://www.davita.com/role/OtherLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r241",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Elimination"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersubsegmentEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in subsegment consolidation.",
        "label": "Intersubsegment Eliminations [Member]",
        "terseLabel": "Intersubsegment Eliminations"
       }
      }
     },
     "localname": "IntersubsegmentEliminationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r32",
      "r89",
      "r768"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r43",
      "r90",
      "r171",
      "r223",
      "r293",
      "r294",
      "r295",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Investment Holdings [Line Items]",
        "terseLabel": "Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "InvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentHoldingsTable": {
     "auth_ref": [
      "r871",
      "r881",
      "r884",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The investment holdings table is used for any listing of investments. The \"Investment [Axis]\" identifies the investment for which the line items apply. The other axes are used for categorizing the investments and creating useful subtotals. These axes cover different categorizations. The appropriate axes are expected to be used. Additional axes can be added for alternative categorizations.",
        "label": "Investment Holdings [Table]",
        "terseLabel": "Investment Holdings [Table]"
       }
      }
     },
     "localname": "InvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r285",
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments in debt and equity securities"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r882",
      "r883",
      "r886",
      "r887",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r882",
      "r883",
      "r886",
      "r887",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Equity method and other investments"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r281",
      "r801",
      "r827",
      "r890",
      "r915"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments in Debt and Equity Securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/Shorttermandlongterminvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r37",
      "r68"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term [Axis]"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term [Domain]"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r758",
      "r760"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Net lease cost",
        "verboseLabel": "Rent Expense, Operating Leases"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Operating lease cost:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease Expense Components"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r38",
      "r325"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]",
        "verboseLabel": "Leases term and discount rate"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee Disclosure [Abstract]",
        "terseLabel": "Lessee Disclosure [Abstract]"
       }
      }
     },
     "localname": "LesseeDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Finance Lease, Description [Abstract]",
        "terseLabel": "Financing lease cost:"
       }
      }
     },
     "localname": "LesseeFinanceLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future minimum lease payments due under operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r759"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less portion representing interest, operating lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lessee, Operating Lease, Renewal Term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Secured Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of Credit Outstanding, Amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r73",
      "r174",
      "r257",
      "r287",
      "r342",
      "r343",
      "r344",
      "r347",
      "r348",
      "r349",
      "r351",
      "r353",
      "r355",
      "r356",
      "r653",
      "r663",
      "r664",
      "r722",
      "r766",
      "r767"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r62",
      "r174",
      "r287",
      "r722",
      "r768",
      "r810",
      "r840"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r77",
      "r174",
      "r287",
      "r342",
      "r343",
      "r344",
      "r347",
      "r348",
      "r349",
      "r351",
      "r353",
      "r355",
      "r356",
      "r653",
      "r663",
      "r664",
      "r722",
      "r766",
      "r767",
      "r768"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r72"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity on revolving credit facilities"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Litigation settlement amount awarded to other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Other Receivables"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesOtherReceivables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "negatedLabel": "Less current portion",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Carrying amount of long-term debt, net of unamortized discounts"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r180",
      "r340",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r180",
      "r340",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r180",
      "r340",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r180",
      "r340",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r180",
      "r340",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r180",
      "r340",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduledMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails",
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.",
        "label": "Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate",
        "terseLabel": "Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of items purchased under a long-term purchase commitment.",
        "label": "Category of Item Purchased [Axis]",
        "terseLabel": "Category of Item Purchased"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment.",
        "label": "Long-term Purchase Commitment, Category of Item Purchased [Domain]",
        "terseLabel": "Long-term Purchase Commitment, Category of Item Purchased"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt and Lease Obligation, Net, Alternative [Abstract]",
        "terseLabel": "Acquisition obligations, other notes payable, and financing lease obligations"
       }
      }
     },
     "localname": "LongtermDebtAndCapitalLeaseObligationsNetAlternativeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r81",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Long-term debt, weighted average interest rate, at point in time"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r337",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r38",
      "r325"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Equipment and information systems, including internally developed software"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Equipment and Information Systems"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r813"
     ],
     "calculation": {
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r34",
      "r74"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Short-term investments",
        "verboseLabel": "Total Short-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Long-term investments",
        "verboseLabel": "Total Long-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Short-term and long-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Investments"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvesmtentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r29",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Acquisitions and Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r88",
      "r174",
      "r287",
      "r342",
      "r347",
      "r348",
      "r349",
      "r355",
      "r356",
      "r722",
      "r809",
      "r839"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests not subject to put provisions"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "auth_ref": [
      "r385",
      "r386",
      "r387",
      "r408"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "terseLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "MinorityInterestChangeInRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r407",
      "r650",
      "r651"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedLabel": "Purchase of noncontrolling interests",
        "negatedTerseLabel": "Partial purchases"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Current economic interest in the APAC JV, Owned by Noncontrolling Investors"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "verboseLabel": "Ownership percentage by Parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Noncontrolling Interest, Period Increase (Decrease)"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net Cash Provided by (Used in) Investing Activities, Total"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r155",
      "r158",
      "r161"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net Cash Provided by (Used in) Operating Activities, Total"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r28",
      "r108",
      "r111",
      "r117",
      "r124",
      "r161",
      "r174",
      "r194",
      "r196",
      "r197",
      "r198",
      "r199",
      "r202",
      "r203",
      "r213",
      "r249",
      "r255",
      "r259",
      "r262",
      "r265",
      "r287",
      "r342",
      "r343",
      "r344",
      "r347",
      "r348",
      "r349",
      "r351",
      "r353",
      "r355",
      "r356",
      "r707",
      "r722",
      "r819",
      "r847"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net (loss) income attributable to DaVita Inc.",
        "totalLabel": "Net income attributable to DaVita Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails",
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Amounts attributable to DaVita Inc.:"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r108",
      "r111",
      "r117",
      "r202",
      "r203",
      "r656",
      "r673"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r384",
      "r656",
      "r657"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New accounting standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "auth_ref": [
      "r165",
      "r166",
      "r167"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "terseLabel": "Fixed assets under financing lease obligations"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Noncompetition agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails",
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "auth_ref": [
      "r408",
      "r650",
      "r658"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.",
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "terseLabel": "Partial purchases"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest Items [Abstract]",
        "terseLabel": "Changes in noncontrolling interest from:"
       }
      }
     },
     "localname": "NoncontrollingInterestItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r190",
      "r191",
      "r192",
      "r407",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling interests not subject to put provisions"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable [Abstract]",
        "terseLabel": "Senior Notes:"
       }
      }
     },
     "localname": "NotesPayableAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Acquisition obligations and other notes payable"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of businesses acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which dialysis centers located"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of Operating Segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "verboseLabel": "Number of states where dialysis centers are located"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "OCI, before Reclassifications, before Tax, Attributable to Parent",
        "terseLabel": "Unrealized gains (losses)"
       }
      }
     },
     "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r105",
      "r118"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "totalLabel": "Unrealized (losses) gains net"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r249",
      "r255",
      "r259",
      "r262",
      "r265"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r745"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Fixed lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r743"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities, operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r743"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r743"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r748",
      "r755"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r742"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r757",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r756",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancelableOperatingandCapitalLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r596"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsExpirationDate": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of each operating loss carryforward included in operating loss carryforward, in YYYY-MM-DD format.",
        "label": "Operating Loss Carryforwards, Expiration Date",
        "terseLabel": "Operating loss carryforwards, expiration date"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsExpirationDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r30",
      "r189",
      "r235",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Organization and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Other Commitment",
        "terseLabel": "Other potential commitments to provide operating capital to several dialysis centers"
       }
      }
     },
     "localname": "OtherCommitment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of other commitment.",
        "label": "Other Commitments [Axis]",
        "terseLabel": "Other Commitments"
       }
      }
     },
     "localname": "OtherCommitmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other future obligation.",
        "label": "Other Commitments [Domain]",
        "terseLabel": "Other Commitments"
       }
      }
     },
     "localname": "OtherCommitmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]",
        "terseLabel": "Unrealized gains (losses) on interest rate cap agreements:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax [Abstract]",
        "terseLabel": "Unrealized losses on foreign currency translation."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r99",
      "r102",
      "r723",
      "r724",
      "r726"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Unrealized losses on foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r103",
      "r115"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedLabel": "Related income tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r100",
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Recorded Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r100",
      "r102"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Unrealized gains (losses)",
        "verboseLabel": "Amount of unrealized gains (losses) in OCI on interest rate cap agreements"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.davita.com/role/LongTermDebtEffectsofInterestRateSwapandCapAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r102",
      "r106"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Reclassification into net income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r109",
      "r112",
      "r115",
      "r116",
      "r118",
      "r125",
      "r402",
      "r727",
      "r732",
      "r733",
      "r820",
      "r848"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r857"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r320"
     ],
     "calculation": {
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after impairment of indefinite-lived intangible assets classified as other. Excludes financial assets and goodwill.",
        "label": "Other Indefinite-lived Intangible Assets",
        "terseLabel": "Customer relationships and other"
       }
      }
     },
     "localname": "OtherIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAmortizableIntangibleAssetsOtherThanGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r39",
      "r40",
      "r75",
      "r768"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.davita.com/role/OtherLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other liabilities",
        "totalLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other liabilities.",
        "label": "Other Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLongTermInvestmentsMember": {
     "auth_ref": [
      "r868"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term investments classified as other.",
        "label": "Other Long-term Investments [Member]",
        "terseLabel": "Other long-term Investments"
       }
      }
     },
     "localname": "OtherLongTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash charges, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesDeferredTaxandLiabilitiesArisingfromTemporaryDifferencesDetails",
      "http://www.davita.com/role/LongTermDebtDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Long-term Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net",
        "verboseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOwnershipInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Holder of an ownership interest in a partnership who is not classified as a general partner, preferred partner, or limited partner.",
        "label": "Other Ownership Interest [Member]",
        "terseLabel": "Other equity method partnerships"
       }
      }
     },
     "localname": "OtherOwnershipInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPensionPlansDefinedBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide retirement benefits, classified as other. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Other Pension Plan [Member]",
        "terseLabel": "Deferred Compensation Plan"
       }
      }
     },
     "localname": "OtherPensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/OtherReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r75",
      "r339"
     ],
     "calculation": {
      "http://www.davita.com/role/OtherLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PartnerTypeOfPartnersCapitalAccountAxis": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of partner's capital account. Examples of classes of partners include, but not limited to, general partners, limited partners, preferred partners, and other ownership interests.",
        "label": "Partner Type [Axis]",
        "terseLabel": "Partner Type [Axis]"
       }
      }
     },
     "localname": "PartnerTypeOfPartnersCapitalAccountAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain": {
     "auth_ref": [
      "r410",
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital accounts of each type or class of partner. Examples of classes of partners include, but are not limited to, general partners, limited partners, preferred partners, and other ownership interests.",
        "label": "Partner Type of Partners' Capital Account, Name [Domain]",
        "terseLabel": "Partner Type of Partners' Capital Account, Name [Domain]"
       }
      }
     },
     "localname": "PartnerTypeOfPartnersCapitalAccountNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchase of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDistributionsToAffiliates": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.",
        "label": "Payments of Distributions to Affiliates",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDistributionsToAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "terseLabel": "Payments of ordinary dividends, common stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r144",
      "r637"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedLabel": "Acquisitions",
        "terseLabel": "Cash paid to acquire business",
        "verboseLabel": "Payments to Acquire Businesses, Gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedLabel": "Purchase of equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": {
     "auth_ref": [
      "r143",
      "r278"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities.",
        "label": "Payments to Acquire Held-to-maturity Securities",
        "negatedLabel": "Purchase of debt investments held-to-maturity"
       }
      }
     },
     "localname": "PaymentsToAcquireHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investments classified as other.",
        "label": "Payments to Acquire Other Investments",
        "negatedTerseLabel": "Payments to Acquire Other Investments"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions of property and equipment",
        "terseLabel": "Expenditures for property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Purchases of noncontrolling interests",
        "terseLabel": "Payments to Noncontrolling Interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r461",
      "r463",
      "r469",
      "r486",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r507",
      "r509",
      "r510",
      "r512",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r461",
      "r462",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r487",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Plan Asset Categories"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r529",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r54",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r54",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r54",
      "r768"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred Stock, Value, Issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r35",
      "r63",
      "r64"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.",
        "label": "Proceeds from Contributions from Affiliates",
        "terseLabel": "Contributions from noncontrolling interests"
       }
      }
     },
     "localname": "ProceedsFromContributionsFromAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of DMG division"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds from Divestiture of Businesses, Net of Cash Divested"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": {
     "auth_ref": [
      "r141",
      "r154"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.",
        "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital",
        "terseLabel": "Distributions from equity method investments"
       }
      }
     },
     "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": {
     "auth_ref": [
      "r147",
      "r561"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised",
        "terseLabel": "Net (payments) receipts related to stock purchases and awards"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Proceeds from sales of additional noncontrolling interests"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": {
     "auth_ref": [
      "r140",
      "r278"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.",
        "label": "Proceeds from Sale and Maturity of Held-to-maturity Securities",
        "terseLabel": "Proceeds from debt investments held-to-maturity"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.",
        "label": "Proceeds from Sale and Maturity of Other Investments",
        "terseLabel": "Proceeds from sale of other debt and equity investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Proceeds from Sales of Business, Affiliate and Productive Assets",
        "terseLabel": "Proceeds from asset and business sales"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r147",
      "r561"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Stock award exercises and other share issuances, net"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r28",
      "r108",
      "r111",
      "r117",
      "r153",
      "r174",
      "r194",
      "r202",
      "r203",
      "r249",
      "r255",
      "r259",
      "r262",
      "r265",
      "r287",
      "r342",
      "r343",
      "r344",
      "r347",
      "r348",
      "r349",
      "r351",
      "r353",
      "r355",
      "r356",
      "r647",
      "r655",
      "r657",
      "r673",
      "r674",
      "r707",
      "r722",
      "r825"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r69",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r332",
      "r893",
      "r894",
      "r895"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r68",
      "r325"
     ],
     "calculation": {
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment, gross, total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r46",
      "r47",
      "r327",
      "r768",
      "r828",
      "r841"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.davita.com/role/PropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net of accumulated depreciation",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/PropertyandEquipmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r67",
      "r327",
      "r893",
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r46",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r46",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, and equipment useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PurchaseObligationDueInFourthYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Four",
        "terseLabel": "Purchase Obligation, to be Paid, Year Four"
       }
      }
     },
     "localname": "PurchaseObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year One",
        "terseLabel": "Purchase Obligation, Due in Next Twelve Months"
       }
      }
     },
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInSecondYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Two",
        "terseLabel": "Purchase Obligation, Due in Second Year"
       }
      }
     },
     "localname": "PurchaseObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInThirdYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Three",
        "terseLabel": "Purchase Obligation, Due in Third Year"
       }
      }
     },
     "localname": "PurchaseObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/NoncontrollingInterestsSubjecttoPutProvisionsandOtherCommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]",
        "terseLabel": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "terseLabel": "Reclassification from accumulated other comprehensive losses (income) into net income"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r105",
      "r118"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "totalLabel": "Reclassification from accumulated other comprehensive income into net income net of tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r103",
      "r107",
      "r115"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "negatedTerseLabel": "Related income tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r256",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Assets by Segment"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r255",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r257",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.",
        "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Depreciation and Amortization Expense by Segment"
       }
      }
     },
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r382",
      "r383",
      "r385",
      "r386"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Noncontrolling interests subject to put provisions"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": {
     "auth_ref": [
      "r382",
      "r383",
      "r385",
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Fair Value",
        "terseLabel": "Noncontrolling interests subject to put provisions"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r487",
      "r762",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r487",
      "r762",
      "r764",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation.",
        "label": "Repayments of Debt and Lease Obligation",
        "negatedLabel": "Payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash [Abstract]",
        "terseLabel": "Restricted Cash [Abstract]"
       }
      }
     },
     "localname": "RestrictedCashAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r44",
      "r162",
      "r168",
      "r802",
      "r836"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash and equivalents"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restricted Cash and Cash Equivalents Items [Line Items]",
        "terseLabel": "Restricted Cash and Cash Equivalents Items [Line Items]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsItemsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r58",
      "r407",
      "r565",
      "r768",
      "r838",
      "r865",
      "r867"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r190",
      "r191",
      "r192",
      "r195",
      "r201",
      "r203",
      "r290",
      "r562",
      "r563",
      "r564",
      "r603",
      "r604",
      "r705",
      "r862",
      "r864"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r487",
      "r490",
      "r494",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r519",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r487",
      "r490",
      "r494",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r519",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r240",
      "r241",
      "r254",
      "r260",
      "r261",
      "r267",
      "r268",
      "r271",
      "r425",
      "r426",
      "r785"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Dialysis patient service revenues before provision",
        "verboseLabel": "Patient service revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r427",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]"
       }
      }
     },
     "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.",
        "label": "Revenue, Initial Application Period Cumulative Effect Transition [Table]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition (Detail)"
       }
      }
     },
     "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRecognitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition [Abstract]",
        "terseLabel": "Revenue Recognition [Abstract]"
       }
      }
     },
     "localname": "RevenueRecognitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r120",
      "r174",
      "r240",
      "r241",
      "r254",
      "r260",
      "r261",
      "r267",
      "r268",
      "r271",
      "r287",
      "r342",
      "r343",
      "r344",
      "r347",
      "r348",
      "r349",
      "r351",
      "r353",
      "r355",
      "r356",
      "r722",
      "r825"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving line of credit",
        "verboseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleAndLeasebackTransactionGainLossNet": {
     "auth_ref": [
      "r754",
      "r760",
      "r761"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.",
        "label": "Sale and Leaseback Transaction, Gain (Loss), Net",
        "terseLabel": "Sale and Leaseback Transaction, Gain (Loss), Net"
       }
      }
     },
     "localname": "SaleAndLeasebackTransactionGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeasesOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OtherReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r105",
      "r732",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Changes in Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Reconciliation of Changes in Contingent Earn-Out Obligations"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SupplementalCashFlowInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Components of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r81",
      "r180",
      "r377",
      "r379",
      "r403",
      "r404",
      "r405",
      "r406",
      "r737",
      "r738",
      "r741",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Deferred Tax Assets and Liabilities Arising from Temporary Differences"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r493",
      "r494",
      "r495",
      "r496",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r686",
      "r692",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Effects of Interest Rate Swap and Cap Agreements"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r2",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r23",
      "r26",
      "r27",
      "r28",
      "r330",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Summary of Information Related to Assets Held For Sale and Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation between U.S. Federal Income Tax Rate and Effective Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]",
        "verboseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r28",
      "r174",
      "r286",
      "r287",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EquityMethodandOtherInvestmentsAdditionalInformationDetails",
      "http://www.davita.com/role/EquityMethodandOtherInvestmetnsEquityMethodandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r708",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r312",
      "r316",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r306",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r306",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Carrying Value of Goodwill by Reportable Segments"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Scheduled Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock": {
     "auth_ref": [
      "r165",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of acquisition of assets or a business through noncash (or part noncash) transactions. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Disclosure may include the equity interest acquired, value of assets acquired, value of liabilities acquired, net monetary assets acquired, number of shares, warrants or options issued as consideration for a business or asset acquired and other information necessary to a fair presentation.",
        "label": "Schedule of Noncash or Part Noncash Acquisitions [Table Text Block]",
        "terseLabel": "Schedule of Components of Routine Acquisitions"
       }
      }
     },
     "localname": "ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r69",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "verboseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Aggregate Purchase Cost Allocations for Acquisitions"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable": {
     "auth_ref": [
      "r44",
      "r168",
      "r802",
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table]",
        "terseLabel": "Restrictions on Cash and Cash Equivalents [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r249",
      "r252",
      "r258",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r541",
      "r546",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r529",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Summary of Range of Exercise Prices"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Weighted Average Valuation Inputs"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt and Equity Securities, FV-NI [Line Items]",
        "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]",
        "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Shares repurchases summary table"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/StockholdersequityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r652",
      "r653",
      "r663",
      "r664",
      "r665",
      "r667",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Scheduled Amortization Charges from Intangible Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebt": {
     "auth_ref": [
      "r51",
      "r808",
      "r835"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Secured Debt [Abstract]",
        "terseLabel": "Long-term debt totals:"
       }
      }
     },
     "localname": "SecuredLongtermDebtCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentContinuingOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity expected to operate in the foreseeable future.",
        "label": "Continuing Operations [Member]",
        "terseLabel": "Continuing Operations"
       }
      }
     },
     "localname": "SegmentContinuingOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDiscontinuedOperationsMember": {
     "auth_ref": [
      "r3",
      "r5",
      "r6",
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations [Member]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "SegmentDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r236",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r265",
      "r271",
      "r334",
      "r335",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails",
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations.",
        "label": "Operating Activities [Domain]",
        "terseLabel": "Operating Activities [Domain]"
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r236",
      "r238",
      "r239",
      "r249",
      "r253",
      "r259",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r270",
      "r271",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingAdditionalInformationDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment Reporting Information footnote:"
       }
      }
     },
     "localname": "SegmentReportingInformationOperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r812",
      "r842"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior Notes",
        "verboseLabel": "Senior Note Principal Amount"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtAdditionalinformationDetail",
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "terseLabel": "Series of individually immaterial business acquisitions"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsAssetsacquiredandliabilitiesassumedDetails",
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresAdditionalInformationDetails",
      "http://www.davita.com/role/AcquisitionsandDivestituresReconciliationofChangesinContingentEarnOutObligationsDetails",
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/ScheduleOfOtherInformationRelatedToAcquiredIntangiblesandGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceAgreementsMember": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.",
        "label": "Service Agreements [Member]",
        "terseLabel": "Customer relationships and other"
       }
      }
     },
     "localname": "ServiceAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IntangiblesScheduledAmortizationChargesfromIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted-average fair value of grants (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Outstanding at end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Exercised/ Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the equity-based award expires, in YYYY-MM-DD format.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility",
        "verboseLabel": "Expected volatility Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r555"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend",
        "terseLabel": "Share-based awards, fair value assumptions, expected dividend"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Maximum percentage of employees' base salary to be maintained into deferral account"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized under the plan"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for future grants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable at end of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of stock awards exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Stock granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value",
        "verboseLabel": "Weighted-average fair value of grants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r560"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of stock awards outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r536",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period (USD per share)",
        "periodStartLabel": "Outstanding at beginning of year (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r526",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche Two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r529",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Range of exercise prices, lower range (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Awards exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Awards outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Range of exercise prices, upper range (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Terms of award (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r553",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofWeightedAverageValuationInputsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r560"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of stock awards exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at end of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding at end of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Stock purchase price as percentage of fair market value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofRangeofExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r886",
      "r887",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]",
        "terseLabel": "Short-term Investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShorttermandlongterminvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r13",
      "r236",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r265",
      "r271",
      "r306",
      "r329",
      "r334",
      "r335",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsComponentsofRoutineAcquisitionsDetails",
      "http://www.davita.com/role/GoodwillAdditionalInformationDetails",
      "http://www.davita.com/role/GoodwillChangesinCarryingValueofGoodwillbyReportableSegmentsDetails",
      "http://www.davita.com/role/GoodwillScheduleofReportingUnitsGoodwillBalancesDetails",
      "http://www.davita.com/role/RestrictedCashandEquivalentsAdditionalInformationDetails",
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableRevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofAssetsbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofDepreciationandAmortizationExpensebySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetails",
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r85",
      "r115",
      "r116",
      "r117",
      "r190",
      "r191",
      "r192",
      "r195",
      "r201",
      "r203",
      "r224",
      "r290",
      "r402",
      "r407",
      "r562",
      "r563",
      "r564",
      "r603",
      "r604",
      "r705",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r733",
      "r862",
      "r863",
      "r864",
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/AccumulatedOtherComprehensiveLossIncomeDetails",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/ShareholdersequityEffectsofChangesinDaVitaIncsOwnershipInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]",
        "terseLabel": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r190",
      "r191",
      "r192",
      "r224",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r54",
      "r55",
      "r402",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Stock purchase shares issued (in shares)",
        "verboseLabel": "Stock issued for employee stock purchase plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r54",
      "r55",
      "r402",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock award payment plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r54",
      "r55",
      "r402",
      "r407",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised/ Vested (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquitySummaryofStatusofAwardsUnderStockBasedCompensationPlansandAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r54",
      "r55",
      "r402",
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r54",
      "r55",
      "r407",
      "r528",
      "r547"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "negatedTerseLabel": "Stock award plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r55",
      "r60",
      "r61",
      "r174",
      "r276",
      "r287",
      "r722",
      "r768"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total DaVita Inc. shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r116",
      "r174",
      "r190",
      "r191",
      "r192",
      "r195",
      "r201",
      "r287",
      "r290",
      "r407",
      "r562",
      "r563",
      "r564",
      "r603",
      "r604",
      "r644",
      "r645",
      "r672",
      "r705",
      "r722",
      "r727",
      "r728",
      "r733",
      "r863",
      "r864",
      "r942"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r172",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r407",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Long-term Incentive Compensation and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/Stockbasedcompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Axis]",
        "terseLabel": "Subsegments Consolidation Items"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Domain]",
        "terseLabel": "Subsegments Consolidation Items"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SegmentReportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r734",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r734",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r734",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r579",
      "r587",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Reconciliation of the Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet the More-Likely-Than-Not Threshold"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r596"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "State capital loss carryforward, amount"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardExpirationDate": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of the tax credit carryforward, in YYYY-MM-DD format.",
        "label": "Tax Credit Carryforward, Expiration Date",
        "terseLabel": "State capital loss carryforward, expiration date"
       }
      }
     },
     "localname": "TaxCreditCarryforwardExpirationDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/HeldforSaleandDiscontinuedOperationsAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Abstract]",
        "terseLabel": "Temporary equity"
       }
      }
     },
     "localname": "TemporaryEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/FairValuesofFinancialInstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity to its redemption value during the period.",
        "label": "Temporary Equity, Accretion to Redemption Value",
        "terseLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r83",
      "r174",
      "r287",
      "r722"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Temporary equity, ending balance",
        "periodStartLabel": "Temporary equity, beginning balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Text Block [Abstract]",
        "terseLabel": "Text Block [Abstract]"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ThirdPartyPayorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization other than the patient (first party) or health care provider (second party) involved in the financing of personal health services.",
        "label": "Third-Party Payor [Member]",
        "terseLabel": "Third-Party Payor"
       }
      }
     },
     "localname": "ThirdPartyPayorMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionandAccountsReceivableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction [Domain]",
        "terseLabel": "Transaction [Domain]"
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]",
        "terseLabel": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury stock acquired, average cost per share"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r84",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "auth_ref": [
      "r55",
      "r402",
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "negatedTerseLabel": "Retirement of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockSharesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Shares [Abstract]",
        "terseLabel": "Stock repurchases",
        "verboseLabel": "Treasury Stock, Shares Repurchases, Table Footnotes:"
       }
      }
     },
     "localname": "TreasuryStockSharesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r55",
      "r402",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchase of treasury stock (in shares)",
        "terseLabel": "Repurchase of common stock (in shares)",
        "verboseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r55",
      "r402",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "negatedTerseLabel": "Retirement of treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockTextBlock": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Treasury Stock [Text Block]",
        "terseLabel": "Stockholder's equity"
       }
      }
     },
     "localname": "TreasuryStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/Stockholdersequity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Value [Abstract]",
        "terseLabel": "Treasury Stock, Value [Abstract]"
       }
      }
     },
     "localname": "TreasuryStockValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r402",
      "r407",
      "r411"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchase of treasury stock",
        "terseLabel": "Value of treasury stock acquired"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITY",
      "http://www.davita.com/role/ShareholdersequityDetails",
      "http://www.davita.com/role/StockRepurchasesTenderOfferDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r570",
      "r581"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Liability for unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r584"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedLabel": "Reductions related to settlements with taxing authorities"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r578"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties related to unrecognized tax benefits, net of federal tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions for tax positions related to current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "terseLabel": "Increase in liability for unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r585"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Reductions related to lapse of applicable statute"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesReconciliationofBeginningandEndingLiabilityforUnrecognizedTaxBenefitsthatDoNotMeetMoreLikelyThanNotThresholdDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r586"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r228",
      "r232",
      "r233",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceByDeferredTaxAssetAxis": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of deferred tax consequences attributable to deductible temporary differences.",
        "label": "Valuation Allowance by Deferred Tax Asset [Axis]",
        "terseLabel": "Valuation Allowance by Deferred Tax Asset [Axis]"
       }
      }
     },
     "localname": "ValuationAllowanceByDeferredTaxAssetAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r593"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase (decrease) in valuation allowance related to changes in the estimated tax benefit"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r181",
      "r187"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Amounts charged to income"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "terseLabel": "Amounts written off"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r186",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "Valuation Allowances and Reserves"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired": {
     "auth_ref": [
      "r185"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from business combination.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesReservesOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r186",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "Valuation Allowances and Reserves Type"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableInterestEntities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r652",
      "r653",
      "r663",
      "r664",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/VariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r753",
      "r760"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease expense"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LeasesLeaseExpenseComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/LongtermIncentiveCompensationandShareholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r207",
      "r216"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted shares (in shares)",
        "totalLabel": "Weighted average shares - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
     "auth_ref": [
      "r205",
      "r206"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).",
        "label": "Weighted Average Number of Shares Issued, Basic",
        "terseLabel": "Weighted average shares outstanding during the period (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesIssuedBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares for earnings per share:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r205",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.davita.com/role/EarningsPerShareReconciliationsofNumeratorsandDenominatorsUsedtoCalculateBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868656-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2646-109256"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=124268079&loc=d3e32787-111569"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721491-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/subtopic&trid=2144439"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127163"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127197"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "16(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.F)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.F)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/subtopic&trid=2208821"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721501-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121829364&loc=d3e40084-109325"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613673-111683"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4616395-111683"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759068-111685"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123417830&loc=SL77919786-209982"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(g))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r908": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r909": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r910": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r911": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r912": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r913": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r914": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r915": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r916": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r917": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r918": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r919": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r920": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r921": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r922": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r923": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r924": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r925": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r926": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r927": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r928": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r929": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r930": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r931": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r932": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r933": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r934": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r935": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r936": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r937": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r938": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r939": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r940": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>146
<FILENAME>0000927066-22-000012-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927066-22-000012-xbrl.zip
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M33H2]M,B,9O'Z^K(Y@]Z=N@X],<+7>77)J9M [ 1'F:C?Z'?27_ER,IKKLT
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MA?HJ2+B=&.+&P1W*?(S'LJ"0QT96! X#?'OB;B.K\\>Q.R+O-_)V(M;2QW&
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M=VUFPC5U(. SQP48+-[>&FK= !%O/%T<"O@\ ^<8'0AXV_K$M"] P-U[AD)
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M?27:ATXD:4%,&SUY^>\G=>Y22(P'0*T?IGSA7; ?VZ=+\XB:_0502P,$%
M  @ [X!+5)T#G7'U!P  @20  !<   !D=F$M,3(S,3(Q97@S,3$Q,'AK+FAT
M;>U:6W/;MA)^/[\"E>>DSHQNE&3+EAW/.+;2*FV3CJLVYYR7,Q"YE# &"18
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M5#KF=)#;$<@@!FNY69)(RN\ Y]T8T^([@<K@E,I3*<Y! K$T2)THEF%WU$2
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M_99R]Y)=5;SS9K/\+>Y9]8WO\3]02P,$%     @ [X!+5(>ORK4[!0  Y10
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MIC ZG4VF,)W-A_/1;'B&GU Z61X,[+D$<GZQ7%T,YS[XBV?OJWL,%XU58]2
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MORJ_-]@VYF6E496UG)IBEJ,,<_>^UJSMK8*>EUZ#>S]9&@'[P15QU9Z8@SP
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M'G((Q0>OW,K?X@+07$6>_ -02P,$%     @ [X!+5&HW6(6NH 4 L$([ !
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M6]V#P+6')"2E:I<D9JPV!;MD+N<#L5CYF^N3E=U/9(6C2NR][?G(+3H1\II
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M>FB,&'!?<_;R*;._<Q>^!684)M4V2V@)?8'$+*#Q)F2,$O\F<%]B6 WF657
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M/[$QQ:A279FYH046Z'^V3<0H,Y?)H_'HZ /G\LZQ_'VWB$779-\\WD_?MJK
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M4%*-->50?9O'3B:T+K J:ULE$C4=0/B[R>%*=GY,=K!FK4Q)&3@">1]-(&4
M(I,W9.WR)RMF =Y[-#^(-3]X<V?T9#QZ+9=[M^+V (_[0F\ZDBG(WAC*(00?
M@H!C2&%P-9)8\21Z_JZ3K%Y:F%KLO8E''_9$GX[R*V&:[=RO>1:]GW>+G?V\
MYL!<^9Z>R[Z!7%PI"9-S#-6ZY%!7P^A"U:48O$W /!RT47\= <:ZK *XHB$7
M<.B3;ZV8 P6'#E/I@E.\)M7Y+F=\>Q>\ Z<L-#BH&#/82HE2QN3! X9L8Q<J
M%);'QBX>3K(2,AN7?8X,)LM39E=1Z;:@FDT.RT]H%H_B]72TINC8:I4-9G!
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MCEE#$)+GJ79HH\,R*,KB]S8HH1A.:&!P FAPB73%C)EL4,X5ZM*6XP7ZJH5
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M25=&1)8\D@PXO_X]Y]Q[M=B&0 +!!G?-$+"ENYY]-?1FH!^(6&"![\5A''D
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M$:T;D%L/#AO:KJ]CC^'$2^S8YHQ[8>B%#F-,]V-#WW#81PQR#\-8+0>K*_
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M^H89!;:MZXG-@R2PN,7CR/0=5X^8%Z^!>%:5]8M.XR#\\P!HU'@ZOBL*LTL
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MN.E%&^"Y?^!!K7I=X2>P@4=%+- ]C]MQZ(>>:S([B2(;:$_;C\T%#5C]LJJ
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MU6>19SA^Y$7<9/8&8%8$8#8"US*)W8DM9MK82=JW33WT$^X$AN[&010Q*]I
M[Y.$WG61]KC%F!M8E+AF<VQNG3 ] L[M<6;HH;>!WJ<(O>LB:GJ>%>J^F00
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M"$7.DXBF<#=D>D.F'X!,.YBH+>M?OFZJ'&++J@TU?734U'DJU-3;4-,--7T
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M2MB%D$^$*6P.U/#$A9P!)\<2+@-D+GB6#4-.6))<=?Y]":8Y6.%2X]E$&GQ
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MO]NF#[O!?/!AKPI;<Z7[8X1XWO*>=]U0UG>R]56E[8B.4*:N^S(Q>HRMUC$
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M$&?A$BBU350\ ;A[)LC,$.8:A@5(<RC3BW97 &?5<QP' ^9+3E8#D29(CGN
MA.*++%TKT^4M(<+U(L@;?01NT_Q%%<="$K:)\NY<O;N)\KXVRKM3()>23>(.
M;TT /H',D&$#T-[;UEY+ VBCA #HI#S1,BP (@6D:DJ0+J4"T'P;D)78(1-8
M*&OB@"G2K#?3*NN)UN;GH'P RFB-VOI\&L7.&/8>P=F]9N48=54:^+C!Q%U
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M8*@B9Y^]?GW\?/YA6<6**LU6<C'/C@_?5<][YZBJ%54,I3@T3I--NIO$;QJ
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M%9QV(?F?Q.JV-B)$+XW7\610N+!=;+%IF2A?\Y-:O /V_"@\@*MH1E5.ZY
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M(E?WZ,6+Y]G]']X>'1P\8+UB?ZTCN6WXS#=/7UZ;6V"W\/_XA;]IW:^M>B%
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M7UD@A6;^14.DPR!XNP5C!G_2'M^I&G04,66N?:T4B[T/H_WZ^/TKM2];&&S
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M!C\\-)Q:(*;B2[E[3NY()'O+UO^MG)&*NVL(^L?-#*YEA$O ?UX!5C5_I=+
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MFD6E0[162IB,H@S"4IMPB!;V<+Q2["RQTQWK'LEDQ,XM@[/ 9.AS^#6@3-'
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MH))*0RTLC2)7P7C6:OE4'I6@!HS"VW0A*O=F9W[,7(R"&B[I< ;8'R-- ?B
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MS@DMHE#;ORAYY.'L_ZI-5S)O>'HEJ2T@I;2Y.\<4@4]]O-BUHP3:@9N1Y_]
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M!-$S!A174EC@!5^,%"M#9^) VU*>2'38(Q@&H?N5U<P1[,A$PG^<A)*\3E(
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MJC<T0/-809,\C9@Z<W5O&DD1@R=7VF@X=0'PJ^.&?+H0'?"<L?ICGVVR88'
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MHK'ZWF8Q_U]1?C]$.-<YMWGRLOOXW8-M6\L'E,+D"LO2^;7&J(X(]8QM!D0
M0K)NM 8XB7(BW$I %3AM @$CJLT0*H_KN[??(PD::J!6%Z[OSOR!!. 1X[*4
MM<&OYX]5?4'R28H4=;1#2DZ]KH-_+G5(ZB%!4<QNVYI1& IVQ7_SGT'*&\'S
M&J. IJ), BI53OK3D[HQ\2KYL9#)'5F?UTQ'O;C#Z2@AV8U=&UNR^SYHUWP
M./AG\A:]846!V'8#PDA_"!?26<Z\_-11FD/77LNCU(JO?$TBW6<HB $UJ->
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MB!."MTL6-\KZEI@POWS>_NW:B>$= /'&8&4D\[G!F $S 1!,O08(5ZEI%[Y
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M'$*AH6!W$.\.XCOQ?#?8@-^^^.;>WP> <Z$/8::IT,6;Z+CRP1"5%[?7 F$
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MPR6GSRTAS.4D*YE8TT#X KX!^;.X-CX5?D2L@&S$E87.5(MR37S9_KBHA^[
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M;=JF7 !+CT=X@4&8X8CF'_/@*O:_7%1N44EW"TZC7_ZX,4N9R((+[*;B'4T
M[F%C4W)0>O+' 2' !+1 GC!N/5L9R1%'2X(YC+C0CCQ/UIGB7D)YKG>M:+$-
M,?D1^1Z[5MH.>V L2>Y\F,J$W; ?A!-W0M^6P(MPM3/CMB?,%DXI)]FX[! Z
M) >XQ/.[O(KW>IT]FK!EQ*P6O0(QL:R$+X.C/M^1$:SF=A2X+1/; \=:-Y3$
ME[DPI1I:@7C9IY3&F]$&F6WPN C_2(L,EP>QHA2,]=K+5!TQYRE&T4B2B8%]
M(;_P*%K@C9LB:1$SM/1*+=I3XD!.Q0ZR&Y.7TIN=0$XG,6\T^<AUL4!8"5M7
M&2E9NZ(7CD$,(T+A=Y\]!>ZRX2*F%;1J"/AR I%<7YL+I(AEG!39C67OYR?<
MF4DV7$,9OL\)G.YK8C_9 )HPPQJF=)P%D9I+.R:%W$F]9MA/&>A&Z3;W:H*"
MDIW;CSUXNHS'4R[U?[5SR3&XK""E3[2)KZL1VU0:OVRRL3-,VY,WC=@@$^:Y
ML<'OX)8TO%3^P?G_RPIR]Q4AH:\N*C*=Y+=D*=]X%Z-IYN9[_A3V:NC]<=G9
M*TB[2_H&:&MQ^JY2['SZ-:*\ &%&N5@ >OOAG<X_@IZCDR)EMX[**CB^/E;"
M@7&+^4-%DMC#&1%T41,C6Y9VP4@U?3%4$ZY[A14;N!KZL5/=TZFO!@<U-AWV
M/>U0K22Q_XS7C;TVNP+D'HE$O-15#T"[,4DZNI",'/AH-"?)04B<V]OC"28F
M?&IYDKN=((_L@.MA0ST@5HUS@T".%S4ENY(98R?[<H,O%&;AU,QN$F*Y(90
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M .BO/O8Y^L .E.C8Q^QH)DL'ZS&8RI';2AB-H_I[2P/DH",F%7VVM.$=L8]
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MQ2N33U5.H@ CQJK^-?T-E[LV #3&-SIOVR4=+%I'Y3L@R8?H#4U?TY@@$J_
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MN/U@(U^TE<[:B3.M=137%>3,;_8GL$2XS<@W(7WTG7-3 _YB7=8;@B>PWOL
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M,>L:=9&V4M^#.@OEJ"(LXSL9#$FRF3Y",3DBBB3M=?M&YE ^[R^^OK<9YM>
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M;D.?QF3CK-N'7<MIRL=]F%N3A4>Q8&(A6 *A'S!V-WD*;/RZB6^@^@R<V93
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M.RF8W6BPD*IM95H2#ZZ)1TGX2*&CM\;_9/Q1; C[JT J$W6DO"@5 B668S]
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M>&R>?7[R!8Q%1& ":4?$"TKD&*%NLUQDVCVY#M:=&5)M$9F-X/:B\+<5983
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MMO?H;)&9!:W,DCN^>.P2PB1A#:+.08N/Z\0_:./HAQX'+9O7MRQXTWB(.K>
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MDZ(NO<D)F>IMX\L[B,J'3TL<<4\A:> 3FPCTATG'=@G'BYXYYR[FG*<1U3#
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MF=HP#RBK@;4(9.^#Z8["[IHI*'N#$^+$SR;12A2\'586K@Q6"N^^]?;;+<M
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M5<2.A^J[0HUT!XC?2C M23E;JHXHT5&(4QUG7D%XHI0!DJ<C,IT +2NX[(%
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M88F6QP[P#[CQ#)T5.@-H<4M=6EFOQHAXB<+R+S9U7?$7(IT*XY/3"W&+*RI
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M>AT,]]>LU^EX>-ROUY.L%S:/<4 KHD\^;2R#72J.'>W68G0'3;9T,<CO+J7
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MJS*5@P:73\+I+EL>I$(]7I ':=0M@X[_PCG$ =>BT*O^,R<.?3\IQ:FG'3M
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M<IV]W=_KS$0'^_)7?,/U(W/W^GL-FE9NM6NVP!MW"OAG/4V[;QVCT5M&UV@
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MP3@0EB)'>2K@J+C6S)"U#%&(7$IG$*%SM^3#BLX8/%GD7F9ZE<&.O5R1:6E
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M_CZ!;N%.13)'#>_)["7__126D8(B8>X<2D]Y^BY"<(\-W+$Z_<[X!;=K#5H
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M][BIX"^ANT*&H#%9*\J58IW/L#5]"_[@1)6O/A6&I);??N#?__WAX3>@&R:
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M(R<1\T=>$VR0-JBV0UDO_;O1.*TKJF3!9@L+*4K3U^&I:2QK 0-;R6J@WUE
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M(T5P/A\*TBL7@4/RV+UM9)?U$C,IO+6,3H(TCD&V\JED)9Z]/ 5*!%B33;2
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M*8!U9\!.W\DF47 #VR)&8I S( C &B$R(D5 I%50 M^-1BEJX?^^\'!A_!(
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M-IWF%CK[3+[QQ(- LX$M8V!E[G<K"0_@ S[L?_,!0@-&"6P42&5S))&P+,J
M_)ALGP8-XF@):\#?-MXV9MSG(4%)B3RQR<L=,^5F"CIX",)YX($L6\"#CXHY
MLQ*690$1T_B)G'&E>?&G$-9C\Q:IZ;U+S! 9P("" F>HWR2'D_&MCG8PT <8
M]61H1A@"U#AWP&/$T A1@CUW 5 B%YF$MZ:PW GJ%@K3D3;'D+23G^ ?H(-L
M)"L;3VK0-) "'K>=#@_4!;H.CZ)@TSB<6JJ,&0(%3L%EHE$!( \I1H%%4@K:
M X<,061M1&"<R%@2Z'F&#[B^B]^HV!FBI65,XFACBR34LR@*[BDC F;;W$/0
M8+0 'EP$(9V9P>;IO :(+8#Y/7?AXB/$.!&I.;E&U\<0*"Q(405\0AIQ'8[*
MGTDEJ90M^$;8PH3\2(!X^.C:I-OWP( ,JM7<M><X9;!"*MA1&AW/ .63N,,5
M$*RWOH<W.+$3H"5T9#A.QA5##BB3!)Y;Z)3SQD7(4!K(LTD9*!1S1/.>2& N
M/ Z0R6Z1;,%>0@\@)-_@SIM#0-.]Q&DIUEN4'G;5X]+>V.QV1P<=EU89UFJ;
MPU[GJ&'W_];O'G:VJQ=;F\4.JAS&[SIY?S)+9[SU:$D:CF3M\R2H##?$U[ T
M0>6?YF=SYVVUZ]_^!UR0SZ0;6J7"R[$YZ2^ZQ_(<I/*DR]W9)0?=;:\W6C$<
M>:H-'W(-XIH USZ%.+A2V&BB.@E1G:C499WSJG]-[?K4G%\FCEX$K@*8V#XY
MH%-R4)]3"?-Y%6EJES+;:8VL(_NNU:8XRPE+ EX==H?]JA>/-':;@MUNQ]*X
MO5+<=OI']BM]<=R>M/I,O<T*&<7&0S1I5=Q8H9FJ%*AO=9T70<V_X'G=^+&&
M&D&U1M"@JN=S0@2=M %%O=7H.WE\_TP]VMBB[;VJC9UU5?TSZ]$CW2B-H#,A
MJ*H>U?@Y+W[ZE\-/7:I<#2Y5XNI7'F'*K#^C_%<_\%4>D$STH8R6)!N)E[BR
M)UWQI6IA7;>5VOS*4=>-G__ZRZAC=7[46-)8TEAZ;J&BLY<INL@1>>VLB,^8
M\D[)TUX@&FXE=)YC)336!K^S*K38U0Y2?<6:QLV9<7/V?HH:-R]KM.GPPNDP
M\+;Y]D#W)J,&=_V>KL=:6^1TVAHYM45.!4-:X^;,N*G>S[>)\8':I=!SWSEA
M\KRZ[;K1=V]WZF(#"17SZH\\%CL%D!KDE=P633SOKH6FB6NCB6[W>7G>FB*N
MCB*>>:OC(A11J'JOFP=D^WY&\X GZH[HTOV'E^[_Q%5K#+%=^"6MN",S9C!A
M)JGJLZ>,#Y8>>K)<#]8THKI+E:OVM%0!QJ2TUH-PF?$;L[$XD_%' ",:C[#^
MF&HV'5[KNMYDTVD2V63UIX4Z._T!T*N.3Z<IIK$TT8+]$5#%+/"@5.TG(5_%
MEBXAQXXO_+#"]O5&8+>9"*R(M 1A=%X.LL$74QZJ<NN!++6*+"OKQ1U0^VP/
MZ]YDA6IK(UQ?TPK5=:Y[^1DK>.9*?C:M\0J6>9N">J3"^:K@FX@76(KW/UC@
M<*-6:7ZGFT6TQ?XJVDF?EH.JO0W*(71>>W<P-JU^YZCJ;VUS/#RN8-B^83M#
M,,"/K4.V[[=!K_\RB^WJ&F6SG?5C_G>[M+ !['),N:[GU-UI7-&=9U4K.J)4
M4:EG>;B;7WMX5BIB5($9KP1"=PXJ%EDT5E4PEG6*54EOJLP;Q#"#0R6=;0Z;
M70(OT^^&PR+VN@J$FW7&50ZSCTL.P&+A5QZ5&D<O$=N\Y!@W5*KC,U']C17H
MH#8O^D9#K9$T:O7&50^"ZY>YT 01\$#]7P1UB7Q.KNB5=9(OVV&M.<9J]7M'
M'I/7Z'!34UQS*&YXR1(=-V2D/<!:\(@-)73FBSQ'+5X9YY3ML-:<8UF6V:N:
MKU _$U237'-(;C0TNU7%]>D-ZHT3.JNS+Q6DD<&#&@4@JER?NDA@Z0N7;1.Q
M^?2Y[DB5K>3E*JN<PK^_Y!@WY <_(Q2F+XHV*"6V>5@:ML8C[6G5-A:FC=W:
M<<RU5"W2--<<FANV]7E% Z)A.HY<.\ZY%BM4TUQS:&XTJAX..[U-_;QP6!,"
M"#4*0M2#TW9$PH)HH[5K76*1-8IG-L$ZT0E5C76VKAQ)@U;ODDBZ)0]%9U1=
MA8VH,ZHTQ9V;XGJ]"W9MN2$[3>=475O\5>=4:9([?T[5J'UAD_K0LC<7OX"M
M"PYAB8U>OT:%1VI7< @+&+#9+.0S%L%?.3^*RHRH.YK9'410W7$H8N9'5$4D
M#HTHEU)&[^"7ZKV-$@?[*ARTDTI"W'!A!;8'S^.[R]"UJ53)=Z.1V6[G;H8N
MO1A7YE'ISRGG\E8I_[;D/I97P%<Z9C^Y<WI0U9H:59;X'$\$_S/F$M#E12%:
M6-!ISAYY 4%@TG:'+:L]3+"@ZKP4"E$@HKZS^N,$/%@[%3;)E)%F!U@%"B!H
M66USV,U!/9J#<)W-C?=\$L8L7,L5C6E!'=/XG<K.4"]RYGFY%11FGW//H8N_
M(6<B#M<&V-/<IMI5>\I?E---XQ#+N3&-0RJZ Y+>CH5 ^"LD22!GZ#08@@7+
M^R $6!S-@]#]#XOH%C5 \-< V-8:(XT@E]GP-0I3R1.NSWS;98"&"+Y88&6@
MHZ!5LZ(Q#X_,]4B3>NZ?L>L =!I& P_$$KN8FIB5B;DQ81X@D!LK)HSO>H-.
MQJQ "\CZR$9LN0R#;^X",.RM0>1E3P%Y"""7Z#[BX0(^/7(122(P'B)95BJ"
M7>%(S!,!2!(L%66 Z12RE0^\;[:-B1HKY(^!]X@"&7=## T\[D;X-%<RG_LN
MJ@QNQ]2_4?X^9;;KN5@JSC3>RJ]8BC_Y<C1WQ>X)Z#<GMI/B<XF6PD>8OS8\
M'LDJT.D;01P!P?N.4CTAIVE:^$1:-@OKVLG"9C 9VX,.@-6>7Q%V@B]9**%/
M$"SB8S#.XV/_8B4X6#HB0A_^$R('*ZC* 7+O*_BNFR@&I?#J'BR\2&N!(ED"
MTO"CDIE> %8-T;C#)Y&L=@9SA5D]0P3F<:+OPK6EWG[\UX=W]R#?87Z'+UQ;
MVCA3 $1$Y1V7P#=H(Z#-). #$" 9!,#"0('H'@ 1)OPS\P(0*08'0 <T5EZW
M."&H7R12&Y4R/ W\""-XLC D(2C#B:Q-(4C?TWP+!L"6U>8FL8#_"H'5*6W\
M+U::='VJ,)DS"+>W!NS-?9 +^,0"#1#TY="P1 LPXFR!/$6[7@4AUM):!,AC
M+:D:B1QP8*0?^3>)CB6 *C.4L) AFHBARWT$"3-PT!#WY'#\(PA)N>*6B;82
M#6,D-Q9P)@;CBMB+DBG3O=BA*UP "^(.?B<I8+B+)4 Z>3;=[@K$ DRZI)+U
M/M@$5"73D3WH);V3C$:#8 YT 8B,8<TA@EEBS$70X#(D(3BN'36-R(%^)MQS
M8=-RLZGNFWK!RIB&P4*5]T_+QLARA0(>M*5EF:(H7XN4WDS<F4V%<XBVDG/!
M@\PF(DYD%%NBG9(P0$MB<8)5WQ 9KK+7I[%Z6]AS8#X/9B#9I"JSIHH/Z3I<
MI)),RB_PQI2\R_8; %O,%!10"A([!E@SDM/&)/7D(8!/^(!DPP*+ / P![+\
M&&/-6*#*$(4"[#S$]9;!DJA.(J($!]D/X,R'5/P.09&6C!7QY ^PYQ$2,^ZC
M FNE4J>5B9$6"7-P%]#R;\&*9C&(G"!<YS8.&(%O<JPPX>M  5>5L&TA2SI<
M /--./D5'T!A&-:#:7QRQ5?CO1HB _H<Y"3"Z-6+>.-'&[8H-3SD_]1E4QA"
M<*3R 4C$#F)/"7ITVASPVD0F9Z3D2L1P*Z/DB93F*58BA6+X(B%,? ZEP@1T
M, EQFCI(JH2B1B4?'OP3$(AY-LD&3W0!8==SI0GK1O-D[:!F&%4Z)=DG<,$+
MM.025&]CV'QA/.W%RJN=(O4FJYYV=E<]Q>6ZSE]?N6-K,!VRZ6C<MJP>[_?9
M:,@[@W9O..@/VO:@_6^K8[WZ6PUKI;XX4+>2T0BHGU XHN91,A;8'QR3^[\_
M//QF+"A$<@V5445:KSS<WB]S_H@%&OY*U<!+H,L"<$_OO$"(UQ1NW/$3PY&I
M?#(G4XH9_S0_FXGJ ;L)=?B2.@39-IH$*K (2UCBLNX0T*_!W,1:QTD(DX9(
M*R!+.U*&[_EL04(9RRR#\F<;[Z!NPXIWZ[0.>TN)52!IGW8,!D11/"<#1)B5
M6#*"TJVPZ0F^A4IL02^Z@H)(LC T$[F"SFJ98'Z#G)^!4B6K5/",LF#.5PG8
M7Z5T1DHV ^>$VRP62=%YVK@RV&@5^$O^17AT&GN$3=\F%Z5%)>C1[F:> @"^
M"SN68*&E2'.Z<2[:YR6G2O=(9*T\B&)2C0>0-*I(A!NY=8_,B\EY03.-AP"B
M!2E/=%<"& ;4?/(W/I^HF60<-*1 ?[;P,RS%6_^'D[5#=H^W)CX,2>.ZFR8"
MO %^,OI>8 ZDQAZ1J3/C46H& #&([!-N!W:+2Z#Y?2%]I\0X(/<P,^^!5C>E
M&M(OQ9X4W< Z9)P*[0!RZW ?."4L6<$G:360AQ"!AH)9>P&38UGRH1!&B:W\
M))1H-[38PI84J\B=<W^.ZT$/$784_K<R.M,(C[+K?%RWMTT7Z %_2PSXQ-5S
MP9C-=7]P F*F9 U(/, (0(.TXZ2F>PA#2"N?&(N^3VWXIK'9![1Q'3*4I,S(
MC@L4X"+VC8(\!GGN]!6Y)TGH 4&?<V&B"%R%6(IS/%UA_P(;W?C@VZ:"/Q>;
M+3*P_44H_EN-GC@[TIER*<;B)=$))')<T)(1-2&'R/CG)C>D F+W?N"IC#4R
M =,ZCDU(RB1\3FO[!A(LROF5V?Q4FI4<$"=Q*;:H:@\@&T9B[V%C),1QGU-P
MP#>C$.64%&9]&WP>R7>4D4/AZHS#5:P-(PM[QO/0Y7*PDPN"E;Z2!)4GQ22L
MJ5 /\BR)2M#A)S *J>.[+!:0"RJ5/@N^=P#3^2J.A_Z9HA;7)^(AX19Q>^X#
M/F;KURUY^DJK2E=*^]J[5HH(<D<]BE)7,(^$EN#>]%XMD].#2QY*KOG'AEHE
MUDGT!ZHZ(1!J&TXH16"8_6?L2@]++F#!>91%6E*G-Q=<44<K!3[-*2O^9TP6
MY9/Z"J.$?F('D2)*Z$D40BH'DT86$DD-+AG00'W:-';[0.<Z[H*,:ADRFV""
M -6(IO@]'DX5S=5=MBIJP_0+(*4L2IT7?1FL5/%I"J%(34HG#\"RH8P>N8(B
MWQB3!72T4%LC.D4\$2#)XRBQ7N4A T6JI1E'8K#@M!V$E\$E<H/:;;,M_>6J
MR4'=@=D;'M:9H,JP0W-P9,^'_;_UNX<E,EWK6L=F?]AIR%J;!%<+&,AJRF*!
M"$:'K>?9'3.VGVU$FX(=W42,K889.RX26WLR'@^YYAF"8;!Y%VY7 XA\EF0C
M@$MQ,8K&)@&UY_0@V9DDFA_'ZE\A'!^V H,O#L>]I+DSA_=Z0/XV")<!N>)$
MO_E.FX%_#N@?/<X+":KJC]X.L:"<.S]-W !@/^3/3C2$7P#"A];#N(R(:!0H
MW^;R&$_;C:XB@3<"6F7]P:ZXX5?YO;:/Y2>$NI9!DV^6CX=5ZQ/J6@::XH[?
MVIW5'CU+9&A:T[1VX-8NV8A(D]O-D=O=8* E6XWP<<VD9ED=36LU0L@5TYK5
M&H[K6WTJR37 .[+[B50_V<PG-0'<^).: &[\R7,WOKN DGUXXAI&U4)BQ;.*
M+NA>)X@Q=^\O>T^$KMGP.B5D:FZP50_JGA X-:^4J#GC=CFC6O!9\X3FB>OG
MB<I!<LT6FBVNGRTJ!?,U2VB6N &6J'3HH'E"\\3U\\0QAR,UX(SC*Y4/.Y>J
M2_Y6E9J Z>(%UN,)Z=*'L6!KNB(KX@5]QV'3-M9HXX83\Z0F7J$"1C U""/<
M,?P8;U$=7&T";R7H.["-N?_8I+7J.[#Z#JR^ _N<.[!M?0=6WX&M!1SU'5A]
M!U;?@:TOL>@[L/H.;$,AK._ ZCNP^@ZLO@-;U]!O _/;Q]9(7Q33%'>^@[3Q
M6%_>J1$^KIC4.ETMV32YG4^R#?45V#KAXYI)S>H--:W5""%73&M6:S"^8)D<
M?0'NQI\\T04X(KZA[$968T'R2R"HWYX]9_Z,RQ8WU-AD[BZS7@TM;&9Q2(2Y
M:KK?2<?H5$-2J:"OGS@<')?Q5J.<SMJ-H0E%$XHFE$L0BK:N;OQ)30 W_N2)
MSBT;8EX_V'88,T^VTO/XC!K%1V!5'Y2C5C7,H<>X@3'VV22'AK-J9Y-TFU\8
M62-(A^3TD_6P&<H]EEH;"KHFE;XG>\$DJQK<DSU1\$9SAN:,G>?8HZXNJJ!9
M0K/$,Y+6-%MHMKA^MK@;M+6FT"RA64*7I-(\H7EB3TFJWI''Z;HDU<&@OF1)
M*K6&7D>>-2X#X>(8;T(.4[B//"L=A=5B<B\JQ+:S5]@$T!A'NU_9NI)Z:DA;
M[8- />P6P9'_=Y[63EBR&;^?A)Q]O6=36.P;YJW86KSZH4A,0$D;,-S<OMSD
MWZB41-G$]2D0-NZ9P^X EUVU/MBP9XY'+U)OJ3?LO42]I2-+3CVYV/Y9"BZ-
MKZK>TFGORU_A=?E.NV/I A@O ]C20E\G8,RG#*,K@)ZNXD!5:N@8<QH&"]BB
M'[E^C*>;ZIP3(&),^#0(>7+>&;%OVQ6\GIU043>H7/4%KKZN\: I[JP4U[TD
MQ=W8C3$NQ!OCU\!'81Z"@B-I3G?&_NLOHXXU_#&1Y,O0!1\+%F"P* K=22R=
M-?#(_0!\./;-6+(UO@V*&SSD/74;K_(>QEVGVZL<3ZU17/3:L=.I'NV^B#2Y
M$9-P2XB\8_]R(V; 8%OE)9^"U<$NQG5J]L.W7VL6M5J=4>\XM5_%QZRS%:H)
M^3H(N7ULU_<7)^3R@LF#/?627_3*;FZ_&T=F56-X-5OE[:A]-/SYMR7W!:=K
M<:46@ X -=<=[[:/%&8-4KR:WNJSM:YUI!6H@S_/$.$E,9U\1"BM'71C01U+
MAW0T;FXTH%.P['8'=W0@1_N_&P9CU1Q*'<;19%P_,K:.+ !^H2#.2 =Q=!"G
M*I'_/)UR&Q.?<X<S!K6""_SDJ]/H_H.,T2('E2?3'R1$:R=-.EWSR)R&2L X
M0J1< !C?OVBYK!LEL)'Y/+/K>@FLTOV8%[^U4>O[,9>^D=$W+7FGH.J-C$'?
M[%FG[]AN]<VNO")RXAL9/>NX>QY/+G:H;V3H&QGZ1D9S *MO9.@;&<^Q=7[E
MD6$S,0>E'SRZ*-HFZUS=.8;N76D^KCX4;4XPRFJ-NY8^AM<4=TZ*&XZOXR#>
MNN!!_--W]',%0Q>@807Z<.#6!;[M@N?EETGW[6 <_$47[B7",IF/@TU#SN48
M4R]8[0GGO:E]3Z!CQSAIF?IZBZ1WKI Q60K0GCJ3H[$5K^\ZO0K7<^JG.J\=
M._T*I3QKJF9J+AC>HA!(!0-I 9WD10>]G>MIM765".H=6=2T1NE>31 0/V.N
ME^-&,<@ 2N6'?8&1R(T%0\G@,]_F!O,=D!/PZT(>+D3<GONPOMGZQNR)7J="
M_J&V)\Z,G>YXK.V),XL+AS]R+UBB$WM;!L1=IU.]O+"V'LZ&G6&_R9GB39 %
MOX4!K-U1;H5@'L>L \&]Z;V2"MS!"-82EWQD99#&*J/^D7DYVEHX$X+&1R;Z
MULA@J+-P>%^(/^O65[H>]^%G4%97-S31G*$YHX0S1@UL"J<S<9_.Q'6=O[YR
MQ]9@.F33T;AM63W>[[/1D'<&[=YPT!^T[4'[WU:G]^J0_-V7/<S>2LLBB'V<
M3N\GS*-XH9AS'ADL#)D_X_)\&T.(;#8+^0QA10<0S(YBYAG!!+"]43%D_PXE
MD;@ 4C]ZTQF>8<OE1/+!-Y ]9$A48M[ADRB_(]IW=ESO<2:XX;ELXGKRJ#[D
M4X_;U#442"4.C0(,6\:*&W/VB!!;+%R5*\"$"&R7X4LK-YK#J-2.'"G-#CDL
MJ 6/P)N>A_^U%2FO@O KKL%F2S<"N$^!)BD5(+_:C9%Q0?S/V(W6ANL_\B19
M 4:3IT@D*>AQQV7>6KC">(0G*#H4S5F$RP<PLYF,(0N\691]14^P$+Z:!YZW
MOL<*E)3J$,W=$%Q'1G[CH7GK=:&*WV&OG@@DVI9!A)4QBV2.Q+*,0WN.Q(!4
ML^M(SIAS;QL@E/C(_#7B&Q&T8'\$(:!(P2_%!#Z.)3WG[E+1(<P5;F$NJ=QI
M&E_F(+:*]$ %_&B-&/W'&9=Q)--2A-Q*@D/^C8>V*^CF 'R%K]"J[W$9ZXWJ
MHHXK@%*)<9#.8 JQY+8[=3%B & /'*1%V%V$\,7#!X,S>YX\91=781KO018G
MK BPSI]5"/!#?@4L&-8P8=+"]J<NGG$@A@0(;"FMFD9R7P@_'CA:1#X .U10
ML%:BD8C02K[8#KE+U%&4,/ABDBTO38ZNU3(P)?S-(< 97.(>R=#L=#K'W"/I
MM\UVY[ [%%6&'9GM8><E&GOT3]_80Z]5KQ76.CILU ,O+-3L/D&Y5U7N4#5G
M5SOOF'0J[.D$]W.:!I[N/?S3TS#:!Z,^PFB@8;031F!YA9Q:IVD@[092 /[F
M22^\=8;ZQMN-W7A[AY$5]%,HAG+DM87F;?M@Z^3XXUT-, TP#3 -L',"[-P9
M$+DHE1I"]D*V++/3OT [9-F&*8!E@*VQH&.#!#XG74C?'/4/6$M)3V2TF^Z[
MIE42>IN  L81"N58+P"_C4ADK2X?ZC&N=XQ3YGA:XWK+[M]"U[?=)?.PT1L=
M#NB*$@V^W]_O-SXM5=-;@^BMU1]=L)Z$IKB;H[A.:U Y>U13G*:X9UQ4;G6T
MC-,4=\:MC5J#P06O%YVT2E/-W9\/*A4O]7XP35,F61I39B=9G)3<R'TWP/2Z
MZ-:Z8'?Z1V:EU^C>Q75CJ-^^8#4-C:%#K(A>58FN,71># W&6LK5&T-6:]RN
M&M\Z(8[.G82Q\TQK=*D#K?<RESZYZ"(:>:35>?W$L=)57H?O7+#_JJY7<(@)
MIQ%4;P0-VAI!M4:0-6A^,?7KQE!GW/SBX\U.2?I8O*HL6M@/T(OIHK"[6,81
M7<:4,;';L^X:ZQGUQE6M!^V[GA=#XZ'&4+TQ-!Q>,+:@,710_*>CY5S-<=1M
M];O#VXG1U2/;_@ +6K>OOX;V]4?W"WOQ]O5G2E/19'P-9-QM69TCHVF:D#4A
MUV??W=;8.C)NKPE9$W)]]CUH]7I5.R9I0M:$7#M"MGJM7KNJ WHN2K[ $<1E
M+A5FE2ESQ2Y%//F#VY&LCIDO,OFFD2<-W:=.&@Y ;([B-FHVEY!<G<7-,VHF
M'!HNT^#4X-3@U."\!7">M )!A_(-Z@R!CWZQM/Q)BG^=HOB.'N-&QCCIG;=1
M[1GNUUT%Z7?:Z+=UX\UJ6?VJ 6I]TGQF'/6KGH5I#)TYJ*B3->J-H*&6<?5&
MD-7J=9M_XZTQ;LAFBROMA^@QM!_RLGZ(ZFJ%%386KD^-K@SYU4T[(-8%DRBU
M:C[DON;UX$>/<0/T:G6JYG?4SY!\2I5%P;(V(?S#\PUTK^>7@4R]V;'5&3PO
M3:767=!/DXNE.>,6.:-_9.U#S1>:+ZZ8+RI'TS5;:+:X?K:H?(:AV4*SQ?6S
MA=7J]QOH7U"@X =J$?^WO0WHNQ=H0&^-S5ZO=TP#^O'('+=W_US2>CMY0"%5
M;?=9O62W#QH.!'0R0E9^4F+5]1WN1V_N+U*0LD.=4R_5GZR#%P?R4!F:_0Y"
MX3/GQJ]!Q VKBTE4T9P#RGQ"",/B2E-90I-YL%;X0M8<GP8A/+58!KXL03XU
M@C@TO$+[.#HAH2L*N1)-1@@?A6D4;R+D$*G6V^N80R3Q[;L.BG8E<>9>5-34
MSEYA$]A%'.U^9:O'[JEIPFH?1!3#WL;%C-R_\Y2QEFS&[R<A9U_OJ;_S&^:M
MV%J\^J'(", %&S#<W+[<Y-_^9Q+"JR43-Y&M.O5EJ]ZSV8H*GQW'3HU!8+=N
M"/S$EP!AP@-;@-&AT+.:N_;<6'&#A831*&1V%#//6R/F%FX$Z&D98A[$GD-8
M#^)(N XWEO**F<&_\=!V!3=<&!%/C(,E2BOS$!2.-Q#6&9X>7P?*K <BSW?<
MYHL)#Z7=UK5:1J?=L1 \<_8H]QX!W<KR?0":D-Y2[2I<GP#$9K.0SX".%9SQ
MB>\&XZ2QN 'V'H"-&8(#"/&QB8M,$"+K<#N&L=38N:%5)XQUTZ#ZP0< 6L,6
M0I TDN3U +;_&40!5;)&.? Y7BZ!XAX <B0ZC)4;S8V'Q8S[QC\_/Q@??-LT
M[NCS:P RBX#LEB[0,W8+*45:QS3^28!&E* .)TQ)_*A):%4KP J0;6C/02@9
M/__VT9B&P4)-#1A->,6'281@X1JEWX+SR/ #P),0N!S?&+>_Q_&1!T+^9PQ+
MRR0@#]?1/ R6@<N%"Z",W$7LR1J0H +QJ;N?/S\(W!AX [,YK9+VQY"3DG4G
MS&D:7W 7Q*4Y$L.E$V2V-D6?'+[D .@89+&$0N%%YH">=85$D!.'N#8'A/D:
M%FPPX&L M1VZ$_AULC:6<_@>9+TOA3A)A4<D8,_P8\0$#KN$Q=/FDD4!"3WR
MIA%P9;&00CTE,R&)^9&%;A!C@C^0NHN2@U+\U=,"""HA-9@PA3W2TE(2*PI<
MT9*=<.08H"@_3'$54^9Z*5TB.A";BWB1C2]EN5Q.G/"%R(A*)%AG_MI8<Q:V
M$IV@R-FAY;(U#>^XTRF0"J;I*5L@V95IO >*1_V#I L$ZOK  @M)R"*U(88'
MVQ!-(YC? 6J>""1AV.#0,A B2]BT'^'&\GA @&)V%2C351!^1>C;;.E&\-@T
M)FIJ&>XTDSPM?",9TJ<+)!GL4HJ9Q (6)=#"2C@/-@6"AB@'WDPU?K "\:8&
M2F^B(+:C=6:0I28"TL)J#D^M5<+8!&G!#1TB3"+&&T?]0[IU;RTUWK<E7N5!
MFQ<U4HI=_![P&\6HP  :$TZ:!AVW3/F1A"E[HVE@ 1L@(8I6*C+9$DC_FPO4
MP4'O?S<:I>812#_^#521O!8%_ (RAGTS/)=-DF9@J%1C/^1V,/-A(0X],.$^
MG[I1L:"RHF(0GAS0DG82"X#^\N[]Q@2F\7N*/+#3 "WNU+498&89A#F5+.5V
MY/&4GR=H%[O$9M(&V<:5Z_SUE3NV!M,AFX[&;<OJ\7Z?C8:\,VCWAH/^H&T/
MVO^V.L-73V+XQ1$Z+$7H6W@"H OBW\TU8FL&,:+IE)=+@"@IE@:'>[62OLB2
M10F(%A_2A>'23T$('^AE$) A3_0D/ N4"-:74#H3GX812[CY0 KIMNM+(:%+
M@5RP4FVT:<@P J BP;0,CA8P^OG$BW_$SJS8]KP9E/0Q#@^@%=PA F$!*UPC
M&*A[(2E3L*E!<THRPD="A^X]D/#_I^_BD)\C A.P&EG7:WR.+_&7/&!E WD/
MY=87$DJE/R:&G!&3I%JPKSS#1"M#@URR$/&"_'AE13 P^&QI6TIJQS5D]FK(
M'[D?$W)14U%=>QB#HSC."=86V9NI[*"I_,HW88T[@!K8UG3TL&&OB->F\0!^
M2%YH'[1+Q(@#N_"");(NV,R.H5RE"=I!>:'!'L'>IMEA;0!.)@$#LZ"MY4A+
M2]K.,_#T0@\%P:/+5RK-/EY*BEG-P<=,S3M8N/3I8!^Q1VX#;"3#O32ZI7LJ
ME4]N8](K #,M,\T%K&6-&@D?"8$N3>,MN*HSCF(JSX2TT*D'L);$B/;*#L%'
M^US":(%#T0D:3T&+7,O OY\%Y$?(O2 YA*[T%&!5CD"#$C K &]HZN3UIPP(
M@AGT'R9Q(GU6'$UAPF=H =&#2PR,V)$DK77B(Q=%2X'88/?*=,ZQ1PZ"F=40
MS0/I&8&M[>,7BKH-97%(&O!3)D36LKG[B!310E\L!&?/B_.K08ME%@0.H70?
MU;?RJ\.W,A,H0;,7"+')1S)VAW$YY:D!VNU$",-'C@M2(0<D0/0 4Y>UB.^$
M^B;<9C$JJSE']GH,O$?48G,DK@C(,?835P2V2)$P%0N [3-T!FW)+$KL".F7
M!L!*2**N#9,H)"U /'W;8,T4=/N\BA:Y%5CKROCPP?@ 9&I8_9;QZD4BKYE:
MH!'?H%WNV@<HBI^_S=T)&:;O4R!_3IC*^&S/N1.#?'YE_-=?1AW+^E$9).G'
M5Q_#&?,54RA&7RPP$@5$GY=S)<KVA2&Q=]^O,'!$!A#2)(FM JI&M<-4"7Y$
M%IZDSPCV=RQBEP2L^:I^IE)%2/_3_&QF(8L*\O6B<$?S*I11L1+[@C2%*[YB
MP%0$0$:DXM&:*\9;R_>>Q&I2KY;,0F/FPL_*Y"+&)MUK B=1MVQY7D8K"J81
M/)DSFO)+3(4UN<#)J1L\M,+H$X8FE<I5*MZF>.YL(W*.P2L\[ $&F8.>CN8V
MV;$>!H)E4#&-+4F,\;2KMVD4P@#@>0=2[XDX)+,WG5':%" M9SR8A6P)(V8_
MYJR;EOJ0JD^P""*U"S1-5& S?;>5\_QA5:A:P?SC0BH@U%9<6GNN5,E2-WEH
M%B$]@OF)=IH,OB\X@W5+ 2ZMEHQP,VNXJ/I0EV)L([4)DN,(945+ D#[ #1C
M$AB9<&41<2=5\!07A+=0<]-NT(T$<,#VPP!VC&!GSA^Q2,*,.+ R!3<I4QJH
M41 F%BK:&& %H;9* *%^R(%/*?RF!:(^*2=E"PK_0%.2*<-2?G#1PD3Z6R0&
M<AIL2GV#._9:'@B045Q@2.DSA60"@MARQ5S& ]"8CH'0@/H4Z)%DT,ZC,0K1
MI8TA*:XTD?'W&=*TC!5*4K[CYLQL&:/V]S18NJ'D$.8U;>UNHA:\.2$XI87Q
MP6LD V-SGE;!R':>I-V$?]!5(@- TD]^V 3(,A*.]"8 U+Z#TZ=LK[:7HF;[
MD=<M!3+:+YE.PQ_%ML0B:57R?LM(0")', WT[W-26DK,D+N+21R*Y'0/]Y11
M#^J%3/XFYG%.NDHAF;R0KE+ M@%"$_C9PVO7.;P;8BW06%JAY@'LH*V^L0@0
M\,3:Q/)H:<%.=#I2/AVIWX!TI',$Z\K!DQY22<I'!8R*$P8#/K?S<I\HF7@9
M?@]  1"3E%EOTG,7*B8 #R5^.OJB%$H"6L,4$[9$CQYT>6#'J3I%S5.08RFG
MH.PM\H=R.E&YTAK3I17L#?!$F/)L4^F:GLF%%,2 KW.<2A(-.2NP[3A,HB*)
M/+@_2!ZDYZP','A+<?8V*-U") PL0B!13 YQ.!XPYTR*Q/YLFEI^N]NJS$=E
M$H,.X"?/,YU[I>) ,:'9$DK;#=62/'.+!65(H!T'DC$@C4:Z]$=C'JP U&$K
MA3C)^&T5GZDZGT=)< HY('DOT:28W.!BS$V=Z(*)_FOY&WBHGXZ:3I3+O%(V
M][2HD(1455P%;_;:XF34I*8XG;=1S,3+)26T, 1UGP/J[@$WO0%W:GSU@Y7?
MRFTDKU$3FQGFF(,,"4**0N5LZ2PH6'@B"1"B 8T'X%+T2 ,G89F\87N'%B^3
M4[U&4N$85W)53$RQ['YSGN<X78D'%Z67[R)$/.8J1"1NS*8!!/^E"-JTN&T[
MB[/B&N118N:;;)O]Z7$CV@UR).58I/:Y=%/(5TKL;^,=1XRX%*14,3<DM<1\
MHUC1MC6%&R*97#B#[;2[+5!B&^YI2GUHS_IKD)K@:Y&7""( $Q)FG,1NZN?F
MMIXJ%#6QVJR4J)P!=8(3$\U;F9^D8H'XC<#T,'Z/GAVX/>A))A@SC;=Y6&_3
M2HXLC&B]1-JB;$8,C<44LY=+H&/DI3R-0U&*:2\4G\:#84S10S,@XVQY9J.X
MNV$R]G>>.TA(2 W/<A+5A_10'IC8T"XJN(SX!A1;W^?\W9:2.9*95+8IJMX%
M'DR@"BX07/_[\HF3!)94Z:>6;9#V3I91\4,/-.AP9LY!W,4A1J_+3S=26?SD
M&4;KDH<8V8XW,*2.&8#Y\5^*$TE8)(FF=(8D;"\0ZAPJ/<D#B9X<$J7'X I4
MFZ$G=01!#")S)Q D\"UB+SFB()6#3N6$8TPJ"T0UC6_2D %"UF,3/-E'89P(
MA58N.0I%U4QR6"[ EC<;<Z]MQ!2*)VNE(B<Y9=QIDJ0:)9!A(PK U5%258P5
M)\=V90=KYB7CP<;[;$6YB.#& 98Z.B>9D?H<>)2OOF;D=G#)_MPK'K6^E8D#
M_RW*$^2,+ZL@E1K)JW3&EN,YF,N%46R5DE)Z/HF$5IPO/:W$=]U0&E^H?D5>
MSA6VK?*?CSC05S4?:TBK>PG@[RF,!$D[X$ 0E?_!"Q.3F/*!),144"8'23KY
MSYE*MAN"_XLGLLCV*Q:&3/G"P/5X7P8_^'0MPS0>_/Q0Z*[/4@<F=)*\ G*,
M Y5+'A'Z<L(\!N_ROS%V%(:4EJ*.)US45]*FE.*+?[,YRJ<H[[5D)%301_E-
M9%'G*'1G9$T]05+2+/53:R0Q VBI,LJE$J\*T>^BM8V[]?@,E;;_Z(:!+U.G
MF>.$F&2!8A)(Z2N/6MGX(D+E.%NWDOP/6DV06X'R10O./KX6VS)XD=DE\ =Y
M6N3:3&-2]$#G @TN&D%&?+$ODW+3U#4:J3A_"$*U/L6A0./J'#US"!,V2I9'
MV8IXNE"0)"H.0C$#@O$FF#*!@@Z"BI-L+CD7_"F2Z#0''UY@[?U8-HW_D[C>
M,FJS*5-DAI%4GRII 3<OT2^3$'8?;$FA)-.<\D\EN05H@B5Y^*D3E=UL:U>[
MV897>'P,ACZB\98>RF]*[B+3B7RB!K (V=2 KW*P[;Y\T#19^26#"0E&S)'/
M7RU(=<FQ.@2%58F$DH[F]@'JEV(&56%!9-L#H=-16IYV8(GH:T]C;X/P<LE"
ME-F9)[Y$N:6$)C )'DFU4_$J)<MG?A2)C%PKW*D<4/ <\\B@11*\%2H#*+]\
MQ5E.*V7!/&6GR<XY?L0X129/6!9R2"^_I0\#U$ 'V#4DV(J&Z,/NS*S+IB5\
MC/.K25(P49^IY!O\5J9C2O<MGY&Y\<7^Y/K$KU8AV$7^K(W2)'/Z/'?8[:3N
M),ZFE P!+I<T3WILXPPM#^-$<15S8RF9+E[PD.Y61<F1 .P"8.0#]X* 11];
M,@(YU#D]B'G_;"6*Y[%IXN02+^U14" $>T):T#)<2+=AF0-Z3/#4EB>S);D(
ME[]2L"Y<V9/&.(('92$E;9:M0<Z12]],4T#)6*+35$Q!5H#==HGJPV=[R?=S
MB9[><J'R]] H0)O%/8/-/.QM3L! J>*$ D&!1!3J8!K$+*;MA^M" NV$1RN,
M8%  "=F H1>/F"MEIEP&Y%:2]);5E<GV)(A ZC^+0L.$9+ &>-;CQ.H8?7,\
MXB4Z[<KE>&Z<N"$S/W(9]"V3"2J8A^,5^$6"1BZ.TD )8'2))S%B#*3U+!]:
M'@X_2A[T41'@!XX!##*)L^,<H?(>'0ICA0+T+UU\S"^O(*> &?^0$;U,?M"<
M$J4M>@,M=:(*9=33FTE&*T4J;1)-TF!/14(A$7P2Q-%&RI::<<H=9.Z6Q%VK
M(&B6(=:U^;85HRR>RU.JCI0A3D ^(X7*\$6$*,43;97(7[*JTIWOM7A%FHM.
M&!-1>K^,XDU><H<WX[65=";HB@!=&Z3D)3QS\LA3S*Q^6&7!OZ1M*5I;)SZQ
MYW[E>!V.Z9R$0D["0.<D[ %/9CR"? E6%%&0!Z=)-I5BD?RO3]RVH&(DNT(N
M\AB.5*Y,>V?)Y0;7SUR 3#8D<=="X#[Q6TMD; VU<D7K]Y>M:P=FL;K9A:[G
MXY%&3#$V=9</W"O">X4K?:32I.16>;=SF(0(B0PR&MP!,:X.567>02BU:Q)0
M0",NILQ)>7#<,D L PDL#/5UEO9&UQ@>4>;.E+5'HU+BI7&7*LD626HD.<]=
MN)&Z\[#Q)D;-*$"3''E*=4=>2F(D!L T\GE*#.;>]%[=610Q!7HPV.(&7G9$
M#9MYW<J2:+& 6YR8V^KV+(79Z%26XV(3<GC(!73P@@+:M\D-D7P4!Z,GH<M5
MLN[6'9"\OL-#&*7)Y-DB8&;.V2/04SY)8^M2%WD4,BJ*N>1AC$8&G>1L7Z'!
M.^KYI4;;JFW%L^ H3 5*<<H>P6@D(RV.2!>[E $RD0<RRI?.[ @*3]+<,F</
MI(@(?'AXG;E*^8#4"2ZEXG:G<4@H4ZQ27IWGT%NGW=K>.LU[$CX,F;L/0W>=
M6.@T[9)I1@JGH83\+4:,TX0RM4J=L"GK.!NU#(*2%\ALI=-=RJ)/,X??/WS^
MZ1G$-:@M<>&5)2G@A@]*TFW_^__%&#2,6.H"P1=>\OF=/'NGH@]2O/U#AOH_
M54C:N]3N\_79\L'!AO'3%W+D*0HZX6 ZI@58"M=["3G%6Y&NC^<]N0L5,K'"
M5^YN,1RZ6<WN"SG^(7PARZ4F4ZMR;.J.-MV]3!+-5-JBC.W(+:$YJS*XBA,8
M*L>6BE1FJE[L/S^@5:49O>J.@5P2.>4RSH<\O37]+Q]^^OA)O8*9-S+Z11%J
MJC0%RXCP5L\<A_1B45RO(4DC_^K3"_V"J2:_!$ Q#Z6CY0>+=HP$YA1,9)G]
M]O>F\;#[J:@PWT_WUE,SRF&'_>_E6C>PDSVG\)3?BSRQ0HN(:LJY\OQ357W;
M"(9FN8^YI"+*L-[(-_2X0A0%.0X2+8-+5/-MM\VV=%&KEO.U1F97%@)^LIQO
ME6&'9GLT/&K4_;_UNX>5'M9KU6N]WK5VNMW&K+5)<&W26L?#PZ1V>1%VJ[>G
M"GO%5G4OTQM@^(QN==F>#MJ4C%]?9EM;7D);5KI0L:0%ICAC8!3=U -:.%=H
M*GGB1\-@)?_N5*[FWPB4/$A+D +_B5U*'\+38>:T,-S+J^<\R3D,P)@#+-F9
MTHU>)!C>,_O] Q93<G*&IOU]Q^SUMNUQO.Z (Q1Z.*@SH3T2V+H-";Q)R=O=
M5AHG"K @Y:DV?$CWWR=$P%4!MJL!^S* [6G O@Q@^QJP+P/8@0;L"P"6*F]1
M#LQIW8FK,O:_!!'SSN!N/=%,_GK,P+YUA7;@G8.!_)!."U31=?&Z ((G\/MD
MF\P&-*S\!2^0I:W=WAPBLX_8=>V:4A[N]E1MA:HAIB&F(:8AIB&F(:8AIB&F
M(78DQ"H;WU/Z7VGS;ZMC=OKU-L3?N]\PW:SD-*K*AMM& WR.[YZUPUK3<;=?
ML=/]'J*MVK'^2#[9%#&:W)I#;KVV)C=-;N>3;I8F-TUNYR.WCB8W36[G4Z::
MW#2YG9'<6KW>4%.<IK@S4MR@TWR*2\?H5(L%E5)?_7!D]GH70=$%]OK]41%2
M+9"N2"!U!]W+":03I7<T)<+\K_P=YX/A7;+G*V.;LAW6FFVLRBIB#^&^E!9_
MXB!+TUN#Z&TXTO2FZ>U\]-;JCK6$TQ1WQDCS0).;)K>S;:W3ZH^J^CV:XC3%
M/4/ :6K3U';.N$ZW^2[#08'F0ZFO=CCJF)VJR4.G05%C LU:(%V50+J@B4^!
MYA^H/N#?]E8?[%ZB^N#8[,D2@E6+#XY'YKA]6'&L\B(JW3TU5 Z]D+Q](3<!
M]$GI[,"ZJALTMA_5R1[N41*\L48;Y6'O\9NS\PMM(U<)Y^RS%Z$R-/L=A,(G
MGI:)I78O65\SU2816_'>IQ=9L5^C:K"B:M=B55'.Q.%]@<[.B,A.P\$QC-CI
MFD.K?_(J=0-SV!F]2$6]XT;5:]5KU6L]_UJMGFE9QQ49O@A@NX>5 3UM8;=+
MUK<X]A9B2<'"FNZPO(+'KP%6^</^#-19Y!057SK#9H+B;: ZU+Q$R=%K+P[Z
MB=L<NQ<D70 TV XN^6D4JGU>F5PMW_;!M[MU 3-=??.L@-75-W7US68!5E??
MO&#US<N5/ZP?R)Y0ZKV^+H!XG040.VUKO-'7RF9+@\U"+OL(ZDSYYI[[=5O]
M]F5.N?5)\VU2W'_]9=2Q.C]JFM,TIVE.T]S5TIS6K)KBM)33-*=IK@DT=R+?
M_9PAC /;%U ';C8)'KG1,=LZT??&&1;+,#0@SW>\D>K9&9X^T_/ C-7WV*W>
MF,9A-.>AX;C"CH5PL4.[S*O$;,J6(3@W?@TB;EA=[,"./]B!3[%/AHU.59(E
M\V#Y\ 4%SK !_6\LC(P/'XP/\)UA]5O&JQ?)*\WV2B.^<2- CWW [G_^-G<G
M;B1:QOMT!Y^3'1B?[3EW8H^+5P9I NO'! @OO(N]:S:8,$(^Y6&(@ ^#11'*
MH]H!N02T0!R^8WR.ETN//K-P;;QC$3,O"=@4; UAW=^Y,>&>RT'W17-@-N)*
M)N;&U M6DC*")0\9)DE)@ ?$Y (>M&$9P.&>^V?L.FZT;AFNGV9,XYLRI0I>
M>V2N1WG0(#/A99HD!MH#_K"! MW(F#+;]=S(Y6H2>(*!5!4"105F:]MLB<1B
M !B_<F2VE>MYL'9#Q-.I:[LX%CPZC=7;0O&=(W.Y 3R/KITL  ?$/&^1EU"Y
M>'UNH\$$A+3:_C20K\)_.4@SVM$TCN*0Y[>.3_B 7</J& M P%R8QD>88QFZ
M"Z31D"=[+P.BP4*N,% "_.R'21"&P0KF.S@9O2XD]]'GQH+# +AO)@0@&<'&
MORT# :!$+"(Z[JGQ+N!OXV!ESOP9+,8%@!A.+(%SCPUX'8 0\];"%9*480X<
M3R;[+T'F^A'*#R\0=%KE\PB1%BPX8$3$7I21K3%?+Q'[I*7QH1"S_O&EPEIH
M V S&# [3+H,7"(=.\09&%#G8[Y:4I)5AR1^E\I>V"S#G2Q9"&]PT'US=XH+
MHU6O7>XYR"J/_+5I_%/1+LRU"!SN(0]$<YJ)>[ ^U*81\T'5 D/!0[!.H#@$
M(<%#Q#8\[&?[604QC#YGCP@!)[;AP1Q0)D"*RV48?*,QO+7Q7;=KCI)#OA9\
M[.4_(G5^U^V8O>PK' P@%+%OK91UUAP/"SGLQ#'><9LO)ERU?.Y:+:/3[LA_
MVW) /%AK(7JP%[K["*LXBMBMKME_27*O;#!((I9D(;B/G:8?@?<;QLB_SUV@
M;12?DQA8&(4UL@'04K! =1T!T0!- F5)-B8"^*?YV03"Y9+N'% \7K!$ULM)
M.GR4^TH VZA#0E(, M[S/-- >S.S%D.^#$+BWF4<@@SAH!R2F0QY/(WKPG5F
MCTH1;*]-X_\$*UA$*-\!]6&K?&#UA,M3):%6"&\G^^6TUJUUHA!;+U%X  2B
M.2R)^ "U6/H0O+>:N\"1\/5:#<U-@WISHGYI99). HZ(!8;9220*-[V..<2[
M0ML-S%7BN[QNEWM19;.TLU?8!,SR.-K]RHLWC#^0!(?#C6[KN7_G:?KHDLWX
M_02$WM=[:GOZAGDKMA:O?B@R&7#8!@PWMR\W^;?_F83P:LG$^RZ"70(\/)$T
M$QZM./>W^ *%+'[G!7:1Y%/R1,(GK><SQ1AYDR3D.0YGTRF(:<5HJ%$EYQ0M
MF(QO$VJ3O@@RII02!SF&33-Z?E<"K[ QA/R$>; Y4 -SSJ-4U/A@T^3Q!,LG
MF8IO%00EV ^YY\A?QE%Y7L603$83'$67>J P+>7Y2_30(J,0=NHE2W01G8_<
MC]4C8*B!RN(X$CP< F]M3@=F&5ET#.@'%NL&CBEU_(/CN)**// 6)&D!ZEPG
M1N3&$P$F,$ME*%F$TD:B%;%$-(>N^ HV$'-];[UIO!&M@@$#.%[G7Q,I#^ >
MP#.!%PHSDBWEN$##9)N7:@*4SVA8T<*D85D8 QT0#Y@ASBFRG.@N94?7?PQ<
MNEL:Y+V-/#,F7)HHK8+R<$/%O;OXLH&LPO%&  $-2"3O&*!F!*63(S@@!8!"
M&,0S@H;Q1^S,*/"B.*DHN\B'"L!*4!:Y#]1+3T><+82BTB]J.&F-[A6 RGA&
M4D1!Q=P0*%(LT"1/U&[BP"((DD4]*=Y:TIAWHY@HNVB(C[\O'0==*>6Z%I\?
ME#^?,G7>-G_"-"<F\0,#/38O,6?6Q<4N@I""";[1I8E+%JD _0&844D$">?8
M!R7M :"<%-,IS2=""7D#?3AD66#5C;WVOV\9;;/WO?0?K/*=9X:<\G6J>B>I
M<](TWOH[$*2228H\4WK-T^<N>F_E6<8)8%U^$!%LW22N<P"W!A2V@1_<*=C(
M,FXCC>,<CLBJ7,(+/-$=@CS85LKM.VE4J5I<&O=GL%SI?.1U <PXY\Z,*V6I
MEERZ^\)[0"?217X$YUJ&BG+[3&D5]VGNJN/@.G]]Y8ZMP73(IJ-QV[)ZO-]G
MHR'O#-J]X: _:-N#]K^M[OC5Y<W*K:1?HB*,$<O=C=0N#__WF$!N0YCK,Y?T
M] %6\@WI8N=>]SV1G1BHF")*S:CIIQ]F26#\0$;H=1K "./*C/ V<^^1)-ZY
M(A=_)CW[8)-^9?@%*#WUD>P!>"$#-[QJ>R3!FL8QOP9^V9H/)8Q^$PCC82=E
MT'WKP),BX;<PL(%5PL.+R]0%B?_(3((YHZ@S R\&'$N'-H:V<03_+^A@6-(I
MJOILZ\MTZ^#GHET@?3YP,N-0'4NY/NC8A33^0OYG[*K8.1@2:M0LPBAC">H0
M (^67)2EH+G!55N I,(PH8AS=L=G/)"1@?DT-/M@DP=AC;L]XR[_[6N*UR^D
MC>ABY,+&RSQ.2VX#[%+X4\0+P!79L;C!-+J!;*U6&0$*E',,ALV2VV ,97OX
M_/-;.BT>_@@SD"Z@V G 0+24.YA$]/.@P4,1VXX7L73>I;>S6,0^V%F1A!@:
M.#DC+CNVPA_>SET^!2  0,AU^8A':V#8W;W]^>-K&DX^D<F>[(GW'R5HT!P'
MNPW]*SS<\.@<$>UKV# 8FP[L5) M%?(9"VGJ%*,9A32."QY4X 4/#F6L5R(7
M$/#(<6^3M3RZD<1 9JK-PA"1'L01'LPHKY>\H>R<4L1+/+ND? K$ *D&&I]A
M&HF[E*A7MBL@2N+I_<=6LA!.<3FT_#%$K[Z4G"8/.A/[/OGMK0R?_/=!+(OZ
MRT8>H'A2NKH")RD$*P.(UI!8[T9BN)O&3W2(%R\#7Y)W'AZTK&QON!IE&]&C
ME5=-KF,*&!F"5$1(B-K8@%PS\1NZ)T30".Z-79+@*9X%IQ@WC9R@1*D!_L]_
MN$C7+W8O%IPD_/@(3A88 A3S8@*<$SQ:!(<Z#@GTL$!$:B@)"OW:O*Q(#@/E
MX$F41(:*X"</SSGG,O2E9)"29SAN(L,IJI<";<=RF\:Y=.1BK!@ZL^K0)0%!
M1E+*)_2231O(U:6'4 1M',W%C4FIK@*BQ(PI4:N$"YN\QL(STP!3J6!T@7&]
M/V-@=/2NI\0G\C74M(A.$+1XR"1#[ZAZ@E!J)44@:\-SOZ+<!5F\]7SKV$T^
MPV8;-<%F^VFGS?:1SOH^9#JW:=3^+)-[:/4&HTZ_/^IVNHU Y-N=B,R<)N-3
M:HB\5X&<_PN\*!PW"18AP_U&X5+PPWV9C  _- _U$9IGX->CYMB]^IL\2![M
M/DBN(-[ZUJLZ'C]O)^!?B#5_>_CTQ?CPX</1^J/?:X#8L=J5HT'OP&ZSHR $
MDVW+_9(&UMOTV.KOJ)91)S<NWO,[)QO#)T\T<=P-/*DECUI:I&#!K!AL/TQS
M/]\&#IFW/X,Y;8N<#$L<6O W??2$/(.GP LD\%JY'S-+IN1'EH77U*^X$F4)
M>?(3.$H"-0+\%PT ?%:X "<6IN?%@,! YC"L^ 2DH,RMB&00]W*9R9("' Q6
MD-GRAAQ,?.K5W^91M'SSPP^KU<ITV*,;,1.<ATLF49N@9<'6;7?(2V9.L"3X
ME;+ )G&0LB8*D>?QYR(/Y6I1Q"-QQK,!63%VZX'%X:'+-.5T48*!$[6:!^2,
M.20)P$8/9':$^H1I MYC%B%:@C'.0N4=9]X'A8FPIIXJ=5T(#I3?L( WRMQ8
MRD7;A"ZEN0HZ0RT0>4M3^1%4#N(0,!^D[G6!Q!/(OY5Y'%N$G:,SOEAZP9JC
MOQ_D58:3*169+K(+?4W3(_],KQ&4BH2_Q^![XULR#?NG ,Q[=',7;A3Q]%PM
M\;8?8KR D/[<,GZ5J58).Q5DC7HH3<E!YYG[0K)9;@P);YF'LZ!C; ?+/*$G
M#DA#""XY@3%#$@:9'#ZE3))<H-AS!2T%4[L=V$@:P4-8_F\0?C4^1X']->7A
MECS]7H6X$A\#&A@]$,GUC@CAHH[;U6K32+/*GVT9LP#HLF4L*$(GYNYR(X)'
M,6VQQ'/_B;JV0>)"\&P^W'O(9S$H1XI8/;I\I6+2\3))!C%\CC$F//&=K FA
M$ED8($S@8AH/VTC,S2.S@O&_$B%/$$3(RWE 2[#J$JQA8@,5FDS6/N@\*8G8
MNWCT3M>-0/QBCI2K[CNX)$H2@J,7Z&('1YK#;$098!,J7H Y+6Z$5Y)J=H;_
M6Q@ 2X!98!D_>W*Q!0Y\Z>7N75SM,A[*),R%(83$6#,HJ4/5M?%QY2L=@L8,
M#\G0^8G['&_MX0DB_4Y;R Y(+@I/)0C2[!N5DTZZV27G 3,.UYD1K9+IT)Z0
M#@<6*(8=^936C-IY'GAHL2PX?U[XO#]L0OC#JAS^R&(>>8.JB?JE5+/<C"8I
MQ^-%+V373G_\QM;&)X1++G%+0ZBH87-.5=X0N2B8ZJAER]U/XP.&^,&?^9JD
MF\K\[-_R&2.7A>4+*E=CGQC.M%2O/;SCK^_ZKY'"/I&C2D]_OO]_&R+Z, F=
M%]"UE<\[Z.43A?RNV^CZT9AG-WT)FQF%B#G&B?#" #J F(2;>(.8/%AV@^I
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M8D0+*IO*K&F1:6!=%(.W56&]JAJP.^WVNZ/QL*RSE(,=5^7#K/=@J^^VKNW
M3F6XR4S5'%-]GM,90KQA"*0:,"Q1U!FD!D9*D7X*1B ;7X\Z RJ08@4A"S-5
M#J!J+:X;]T]F7*\2US-JA)!&<\X(")9[0!FSP'@K@8OB1L1Q0-ZDY-X"4U$P
MN; M(..ZM;ANW/>8<;U"7,]J%EY#RB"4@%'.0.1I#92)6^=EW%$:%0'A:7E?
M0U(0U*:4A6?F<MCV9\/4E?FRJKX^3664J_K9V?NP*N5B>AL28TUM0B:JYHAJ
MYVLBJ4JY./X>GTO_"0%+:R !VE(7)9"4DR%2JCSU4==@ 0<9-0LN8<$;JRV2
MS9CM@W3C>D6&],H@O7<=TL1H(9B P%HF %4! Q4$ M!AZR*X61 P0IK @BYN
M*LB0;BVD&U<I,J17!ND_KT.:(BHI5Q00:I(^$>)]3:0 QB-O.0K,,QLAC5B!
MV,+:Q.K\%.TK2]F*4I?K[:S9*;O+=KK]+WXTKGIQUGUG^W[\O/PUOSRF3E4E
MQ?X^&(U2*9YJ5_;\^&3@=B^W)CN8F^3MBSGMRC$8+-,82((B;WNB@&11SY)&
MBH ]"I+PC4W,"T7FT]%>9+ON$\!UXXI5QO4CX'I&Q=)",4*"!%9CE%)./# 2
M*6!8("Q0CN..5KA&\X6R,JZ? JX;UZXRKA\!US-Z%M>("^LUL#(56P[( ,,M
M \C$5XS&"ANYL8EPP6]((WL47&<-Z_DYK=X.!NYKM]?K=$_/='=8ZECV1 ^/
M%ROXL7Y\_:CQ</4F[%[N0:+NZ_P<NM^\ ]_]<)"I^6'4#.=4*1HX5A9I@*05
M@%JN00JT!]Y#@8/%U'B2,OTD1OC7%IG LE6[Y8ZJ#.0E WE&=S+0<\\0 4AA
M"*C1!FCF"% !R6 XT3J8#.2G#^3F(][N >2L,2V*YAF-R7J!J.(>"!,8H%@'
M8*QP0"*AL;?>*6^2QD0+J=;(,_74G#()"9V(QZ@F](^KAL>#KWT_')UTS^(O
M8S_TH_$S]- \J@:AN_VT+P?]#Y&##L)OYZ,XOBQZ-$56:$Z',(AK$3D*0*UY
MU"&T!DJG %TB>+R,E!,IW+XAT2,;;UL+Y09TB%&<;OSIYS"=I9!%@3WKCZ&"
M,Q8DX%Y$."N.JF)@CDFM-?&!,16ED-3LJ4W!]AG7;5<I\A6];"3/Z!.!0LSB
M)0T"D0;$O4ME_1 'D:YQI&H!56CE%9W],,^UUOI@KH9AKKK>"OVJK*"RU7=U
MQF.6P9ID;C*G7,%@H0^1M#VF$%"&,=#24R BB4<QFQN'H@RFBLC<!<6Y^GKF
M@!4X=S('+)<#9O6P2 #8$@D$2GD**45!4:>!L8QB*"%%3I<<P%BAN,P<D#E@
M^4I<YH#E<L",!J>BD&:LA,!+' "%3(#(Y!HX;FE@T M)2SE 4%8@WI1/*%=C
M;[(:>Y6QLX@KZ/GR5_-M9B?;<A4AG"FL00JC<ZJ,MT9B$SRPRA(0!1@;51F%
M@8Q_Q80$@T1R:J<F4@41L"$S5&O$F ;-S<^7!IKO59MI8-DT,*/-< L1L08!
M#XD'%"$!9& &*$>9P(@YH5)#N8(K6G RG^B3:2#30/,-;S,-+)L&9D/<G/$2
M$09(62))<PX,(QS0 )&GQ'FE9$D#-!5S6]BPN2H:>&9),]O>C"<>FN>5)?/(
M50BJV,*MODL[D*M/-L]8;$Y_P<();:@%0@88]1?C@"$N_F0%,5H1SK#;V,22
M%9C-%Y6]?QYCCJYO+Y*74'<@(WGY2)Y-EK%.R)2+K$0J_,XH!DI2#R1B@G%O
ML.)V8Y- 6B"$,I*?))*74&D@(WGY2/YSUJ;H)2>& NE9U"*\%BD\0L?3A3EB
M-" 4R,8FC3J$Q"VYDY]9CDRI(9P-_9F^2,EC16?H0[>O^S9Y1%)MZ*%W_O2L
MA.LBZ?;/(1*WT?Z4:6/>7>[+^ZM=>7^Y(:^K_<AQN8W0U^Y\G6C((:4N6& P
MP8!*JR*180B0M23E[:HHC;0Q+C>'V+=5KU@$V5DZ613>>[-IO%(CJS2(PH./
MTHGBP"A* :<2$ZD\)49L;$I50#P?L9$+FCT%8#?:R#(#^[& /9M/XS5Q@@A@
MJ;. &J:!- &FRM$.!Q@H2:$,A!04M@38S\PO<3 ^\<.%2R2OK2'D40.KTM+O
M#_J#ZR[5; ]IGIB^S<=81<DB",$ (C(J%)&)@+'( X49UUZI@'38V.0%$4V%
MB6?C9OLPW7R45,;T"C$]HT5X3*#T# $:#$V8)L! #P$6)A)UQ*PR51J^8//E
M4S.HGPJHFX]YRJ!>(:AGPY\T1$8$#PAV E#O,(C"%P9.&"HY<HYXO+&)54%H
MFV[J9Y"O4:&@$X:#TQ* W?YY<E74*!GT1QWC(S1\K5UTQOK;8BZ+YQO&N>3N
M+*\O=^_@<O-^*_>N>M]AVKF=;^.ACCO0[>OAQ>[8GXXB):91#@>]7DF*E5LW
M\V&#?#C?TX5B(21R 1"E9.1#A(#Q4@$N&!1",4%YF1S"D"RH:JIG=XX*?TIT
MLN2F,)E.6DPG,SJ3M()*Q E0&A) F0_ 4"Z!YYX+A1%&-"0Z(9%.\.+ILIE.
MGB"=++D73::3%M/)G+9FJ.'( .HX!U1;#Y14%$BK#"32!H%<HA.D6$')PE:8
MG*RR3,TN*FS/,V7E\36SR&FU>>DWW_>AFWFK2=[Z/J=510F(2>(Q("&R%64&
M NE3H+O%41JB3FC/4Z [+P1I4QWY;#M>"\THPWG)<)[U!/$H9T9!$V"K!*!4
M)_T&!2"ETR'X^$<:Q1""2*$RG)\PG)>DF60X+QG.,UH%1<)RJCU@A 5 E5/
M\*#CGE&'/%=<"[NQB84J.,Y.H)6"<=^/)_Z=VQU!V>G3(M7B+K-*?$?O/*WH
MN\$P_6%K/!YVS?E8FYX_'&2+RM*Y;[[Q9! \.&X%L :F*D#< LTI!M#&LP"1
M"]:EH)8B'H!"9 -M9I)V^'LRDSP^D^S-2E$T*,(\0$+J9)NEP#"$ #?:21*E
M*A=*)H&0%H3DLH*925KAZLE,\OA,,J./29H*?U@-K$2ID1TR0,)0_J09\8A
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M;VQ*6I ;*KIDN^]38(?5:T69'=K*#C/ZDF;0,\LE0(IK0+T)P%A.(COX\IJ
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MZ\22Q8G)6E]$YLF4TQSE',U7ST:<6N)#5%ZTCN(#Q4"&5$=;2D^EQMBR)#Y
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M/,X9#!HRA#C;V*2J8*A-+N)L!FFGX)&QO$HLSTH6"B.GI ="DI3=IB#02A(
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M;!)&"T*RK>+I KJY!+@,Z-4">D;4P- [07T $D=4TX ),!I[X C403,99(B
ME@P7K%6 ?F[FC2M<= 9E]6L[.#T;^A/?'W6_^$YO,'IF*?F_K$3\&,5IQI]N
MZ)P\V8ZRC.[KZ<VH"M_]'G=DWX\/PJ'^ECFL00Z;KXQM.;&("0UP*GQ'8=!
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M??IYWZ]-,LXZW/]_SME'@D2*8.M W+IX_S/NHB3@+<!>>TMI%.H@W]CDJ9X
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M>/#>!9LTMMJV)^L]^>@863R>QD^_LYHNU7BN3YZ3&YHD"]0VRUQ$B')%DV
M[[V#'%E-!")K]<I^L6.M6P[?CD'_051)@_S0(-^M(LH4N7 )C D*4.4,)(II
M@UQK:[@6!=,K#ZDP _&0-K /7;(TT \-]-VPB#-!>*5K(Q.L?10%D'(*.,]>
ME_^[8N\='8MQL?D&=,H?6&AD+6=.9M.?89GFIW>1*SOK>1E8NM6'1.;&5??$
M5;BA27P6*6#*((U.@.086,]UD2B&&^<]CSD7KM)C>:?,C.93'2ZRMQ C:<C>
M K*[.5<Z91M%,3N,+5:("PC.:0\JAV*2RJ2=<T?'>LROZ/K:@#U48 \T6-(
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M1AG7@!@\6-02E% \6<NMTZ$.++:"B[\-*%^\H7KH.J*A>FNH_FD#U=%ZZZ0
M;S05<5!;X#$DB()9X;WD9/004=UG_$.:86N#EVDY"K1X,_K+^2+54,=_UD'H
M55K'D;^L^BAO:E1WY>VJ=.HN,1 _F\<TA^7L[*MZAQ:SDTD<U3>Y@[RV98VQ
M*.^WO.HR7-G )V7_OKO8M*_?_53V\?GT^>7&/?ZP;\T5<C^2Y#+,R\F5H\N"
MQQP!F=9 96>!<50Y1XM.81$D%L=&WF4:VJV0M$,.TD.EAAZ43*.&@5%#)TB2
M2.>L X((Y %C3N"T=T R9!X-YSZ+HV,K:CEL#R/7&S4,F!H>4@TU0GAH;729
M[>D*Y4OARQ-F#:!)#JPVLFXC)D/".5PG3=0*>>RKG/1^>:&GH,HPQ)*Y$KL5
M/*-\,OOM(DTL3Z8T#9^KHZ^NE4<WN!=_OD/7TF@?[J=#O,(#2W;\>C:?SWXK
M%]Y2&1\DE?'Y8G%>.".]RM_.IC^_3O/3VD>S';<]'K=R,T=1:1.Y<J"YU>6X
MU02.D@?K@N*.9$QE"X_Y6/-J@;?N#?N+[7O-4VS8W@:VN]HZQ\B)E_U2V55M
M'< 'R\L';9#%['DNIC2.&>JQ,9O9  W;^X+M>TU";-C>!K8[,CF58YL1UT"F
M8EM'!UYX#:)VLP^<85(UN=B.E5!CJX9T<!]8BN%EG'U4('I2  ++@I!5#[F6
M=[@UG?%#.KO8AE?YHCO_11;TMXD6Z94OMX=62=*-MWKD+=S4&\B#H. @NQB*
M38)%;S@?0=3IGL7@9,;KHV.K^9CSEI^XG^CN76DT=#\4NCN*HQ@>.F)R8&22
M@()5;T(T8!,JY,DE3*8J#L[96++6B&4_\=V[VFCX?BA\=VN:G,Z.7)WFZ06@
M)PL6?8 4F0B%R4-.U:/ BNI@8R/:?,\':=J0<IK/4_PT!C>-ZZ[5Y<OI]&P%
MX#!;'%K3A@<;[UE)ZYO+W2CL53__X<-6/*D[T9BK1^92F[I#R&@P*4C*>BBV
M2&$NHBI#4 :G/./>UDXS[(KVM6WNWSX NM>9G@W06P=TMQ^U<YZ0>TC<Y>I(
M4& %"T R<H&9J>16<\;K@*R!C/MKD!ZJT&B0?A!(=[O!18S96@W%RB(H^UJ+
M'G,&:91&@SEQ77.!U5CRS98);8#G=GM/+^=%>I_/WY5+F(5?6RACZRT4OIG-
M?TAG%SOR*C^9G9[.IC_6S6@TU1]-??_;9C635<66C P\A@!HM02;<H186"O9
M'#E&65.FE+1C+0;2N+(Y.8<J)QJN'PK7W7YM-IG,3'4,9 ,HM07G=0*97<%T
MJ(-NL.(:E1TC#L2WV7 ]5$W1</U0N.[("F<SCT%:$#FO1D-PL#IF"#&YZ+TP
MV?):422M'%L^D//ZT&(6GS6:7LY&90,J+.>SDY,:P)@4A,Y3"U@\A-!XE3_;
MG=>SQSE/3B:T;+60O3+7[YMS-8U.4O$(5H4$& ,#DI* (OK C++1%HM$((Y9
M'WT3FH]S@+"^-YW18+TU6'=#%\Q[:YR":)T$M(*#P]J?D5/ ;+1)7!98*SGF
MO(4N]A/6]R8S&JRW!NNNSB"&6H@$(3A;&SX+\+7+42A65S'#G/0N%%C+ FLQ
MD-/ZP.(7M:/;92;A:)Y."BAB%1NK$,;H4ILO5NE2]!O-8QNDN9W\J$OR^F&]
M)Z]G*[_(9;AI\7@:'Z^VHS%8CPSV;D-OE V- 7F"%*K>P$)>3LH(AA6;)%D1
MA?)'QYJ-B[TY##=)<W\.56[<#M8-N;=$;D=26"$3TP6TPD4.6!LZ.&L1?-DV
M4IXYC.KHV%U1Y-U@.U38#J^^^\<W-$^+GZ:Q]HD.!=F3MZF >/7EKPNBXY/9
MZ5F:+E:U&-^=4*O'Z!OV'<DA*4JJ+=)XU 7V==A488( G*N0%2-RJY E'TN[
M&:_<CR[2.R [GM1 QN=3-%MX8TB=IS[;H/J%YC.Y%P)[OZ$X*')FK+' %6I
M%AE8FR7()((Q(J(([NA8\K%1;4;F_J+[7GM/-71O#=W=!E1&DE160")A:T95
M HJ*@]:2,4>:D.CH&,7873'?NZ%[7]!]K^JDH7MKZ.[&.TRV$9.'% JFR\9J
M(#0<%+DLT1HLYMG1L3)CR<V T'U@,8]+K*QUQZ(\\HM:OE'?3-T(.KE.BQQ6
MZ&,H4N3%9#J;3Y;O5CZ5-[.3F.:-Q_KD,;:A0;R.*49GP)B@"H\Y <1SJ(,S
M)6HEN!6ZYH=:>^<N>LV%.EA4WZL$^7-4M_%Z=P!T1W:@%<G;)$!QZP"1+/AL
M(IC@0K%7A"LVYA"'ZS5([Y#N:)"^5TAWM ;C*M0\*N!9U,93(8$S+D)R7GJ4
M1,&X(4+ZP"(='T+[56*T&,=@2CA>SYJNN&?.VIQZZ8+FPE &(;,$#-86SC(!
M9&8U 9Q[%+GH"C;F=^J$V1R?PP7TO15O-$!O ]#= G')DN=>07:) +-4X%CD
M$%1 RRD)D>CHV(RM;#WD]A//]U:UT?"\#3QW1(5BJJ Y6T@Z*4#%,WC-' @5
M UFM$@E^=*SMF.UCOREIAJTE:K%&J%,ESQ<I%O5PY4C)NP0IKIV&R'9R>NZ6
MA<;M!FM_;*S7YNC>![F)S5J.E)5"DL"9$D5]H ,?D@#G+6:2(B4G:C<;9J].
MO[AU7OB-X;1#[M$#IH@>I$NCB(%11$?/\*1RLMR 0A4!R4>HW !.:);06&5I
M-?O3KN8#;N9P-(HX;(KH00TUBA@8170'?EA/UCL/G!=B0.D(")4OBBG8**RU
MNE($CK738[QBRN#P***GB,R0E=.SG%-8UA!,^CV\H>G/:32G91JM7Z\&$59A
M-5[+J_3O\\G;@I):$U\+WVN,9CX)M32^?K]%:[8OHM8;^"H_N]B^'\KNO9I6
M1JS_/?NX83]\V*OZC<?3^/D7/OG)Y]-P<EXWX^ED<39;T,E_EPT[JVW.)XOZ
MKB;3\Q1?G:5YFZ/4.ZUN3EUG/D1;G@?02<E"JSD"U>:$DC&9I0LQ$*O#"\:,
MW<7L:J[DX;+'_>FKQA[[QA[=_F%DF-6IF&+<%_9 9\$EI2 D34:+7"PT7=A#
MCBUK[</VDSWN3WHU]M@W]OBI.X$YH\O9@O*2K2>A>2TM,$O<EF<&O:B#D\9&
MWT7.#2_H-63%5F-=DVFH(U72Z"_E45^]^L\:];IGI;:?7JR'S+F[$U5^5][N
M+#Z_>!2>7CP('PCT4U)>$W4CRQ[)<G-</>-&%8N<@27I )WG0(Y'<*H\*)KQ
M'*C6.,HQ-WT5!S4G^>#I91@ZKQ'-+A---Q:GO%8Y>W!!%*O,A @^&@T*49(L
MEKTQ>'1LF!X[<1=1UTAF5TCF(=,2&[7L,K5T^S1X600?U^#+@U6HQ48@4;.8
M#05CLW96%VJ1VHW1;O:''*@1<P!AO&_38O'5J$K#2T%X.SVX[O@0/_&QC&8?
MG"R'%=:[!9?J*&,L@D]:U!B$)"U(FV+]%P(EKG"G]& K0?U2&E6;8S^Y5 R=
MA"AK>_]:?4K)$>3$9"+RUF716PEJ\[T/EB!X8D:C3,ID4Q;3ODBZP%06&152
MEK>NZ6H$L:,$T2T/RUY$GXIAE8(!M,:!XRQ".4I2,;^",UHW@MA1@KB-RT=+
MYQQSS*,G]-9:;[+2Y)AR097CXLN#<TV7[3)?= -QBDC5AX"\#H!%PH,--=6R
MJ+. :"V*6+MCUJFD^S4O:,BJJY=0W%IZ7>BN\L;_R\__>L'P=Y1@!^_K8A2\
M*Z!P!2+%&K>6I2"3%R%$F]S:U[4S^JQQZETX]:??-GOY>65-\G5ND25 "@Y\
M0@;!18=)96\U:_&Z0Z.7VQAOO!AH.<D8!$>4+CDG<S9>I*PM,F]:O.XPB6:C
M=LYHH;P 8K8:;]X )5$L.(9,:J,E3[+%ZPZ)9&YCPWA=SB)B1D2#UD6/Y+E(
M@J$OQY94+5YW4-32K;ES+J3  YCR5 !ZP<!*PR%(G[1+Q=!%4:C%R;%PF]0R
M4"/F .)U3VXN#V?Y$W'X251N1,N13S]/IM/5U_-H^2:-WB6:MW#=-50:M [(
MD812$4/PI (SCA+*+"B[^*_G6W#"-T+LD1!_WQ!UB7LN1<Q EF= E@RXH!&(
M4A+6(6E>;"W%^-BX.ZNZYE@?+-:9B2I;)= SBR8PFY,/@A&WU06$IF+]WJVE
MAO5^L=[55<9%KFKO]I 0T!9QY00B,$TI>D4<Q:HGB6!V;/B=S9^&]L&BG?M
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M?-,?=1_=P#?Q@]S@3]YYG0_/QRW7W)&'YW&YVNK/H)/UHT&3")/IZG6@LP+
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MR=)D\I8IUW<OC8;T(2)=>9E1I$A2.T27/!:HNV \C](5TG\(I#?9=5>X=\=
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MHZ+@1\>"#<G;TQ#=>X/Q+<'Y[W1RGJY%<ZOT[PGDW>:9)$723'-0W"7 HJJ
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MN%\NGB-?1?%D@NC94>B%P3L@FL%L#K1SWUP^.Z;V/)K'XW'[@(Y&X5'K>#H
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MPR8I6I(H%QT;N)$RA]LM%KML*FAB/'KCU)M-BJG@HE>ZCG3%;[LQ]GJ,>V>
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MP[H<!ON5!:*\7=4[JY%GU??:*+?'HE AB9@O9D&[?!IPF?,JX[MRB(T3(V]
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MA(4LM,V '<,9 BMOG2Q<K-FPM9Y)!.K_6'/W$.$&%@6\/C.00X#-E >!=,+
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MKTK@:C'=YL0!F,\J4*Y"<Z8KCL+F=/NU.^\B.Y#>Q:J"P+R0;G.4%03";@X
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M?S+?TTV;E+M8I_1ZWOU:JFP119YK(_-.&[]P(W;4"&[7@!L.Y>(\DW/>L6Q
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MI1Y]HZU6XN%2NLG!Z).LN\(AQE(,/U<SJ*H3NXUF-#NC(S8?W6>YAKTAE!-
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M*L(4U@L_71*$/NU Z@9!ZF)#47#2:HU=1%[0B+C6$N5B;<A'E03(B#Q@>?#
MX+[:$B+S8V<VO0,TC(5/+!*E:)"<\VB5=$%SI8CU0-I7*571T? WI>$U52%0
M;2)S!@D;055(4B&0. Q21!L-(HA*DH.J '+&9AI81\)W@82M]D)9X91PA L<
M'."VXUCF,"SOW%5<'QT)?U,27G> *.8DI10)X,= P@(CK5FN!"\\9PH+I3"P
M8=''6W2%[T+#-QFD2LRN* G;4[R.Q[/-"([/+;1N;5(WH6/GN='[/+>T:Z9[
MY09#=[.&^PWNST[C^'4D,6<Q4RD;9S6G!EM)F4F).JN(L/SZ#I<.O6\!O3]N
M*%'6)FY%4"BP $J4X )I0&TD5=(AQ&23]@</".X+)?M$?G79C1NGH.]L[>V@
MM(/2&X92X@T)@>/@=>3*8".%XR9QS8*V@GQQRZ0.2F\82M=T6>!V/EC/D>?4
M(8Z90U9SC%B,406+0V(F1S5C3OORZTL^=TC:(6F'I)]NZ_$E'>8[)/WV2+IF
M4K $\-)$B2SW"G&6&')<:T23,,I;B;5@@*2D+XGNJZ^O!;<S4%HL$_\LG> ?
M?++///L.?>:).>2<?TF?>:,/#;[\XRUMRYL':LJOE_NI9L?U2J[3BO6*&_WS
M2L JT0W?&(Q"',U^0ODOWQP*:;&S+N- O_G;5W=%'0J:=Z&J* 0@/!U,9\4K
M?5;2HL_:C8Q3A#E$.QG%T!N,>O"5WB1.SZ//$;"]A^,S6,M%+[\P#^#F4_AI
M.NW9:>]]' [S?\?E-4#QZ'Q[D^1>FHS/RLCU</^8]DIS<[O1E[LD;Q??>>5+
MM\/>^#Q.*K_ZX5J<;84SS^=GL&.^^CUSG,%H7IY?N47U9O%,7)N!OC755&31
M^E9]C_'R*];!A9[/+O_*1@?OF[Z-!%_I.CY!1*[M5^O?TP51G\.%0&X2[=_(
M)ICN3W;XWEY,#_ZY2H1 @?7P0A_F3=R=]6_86LOZ'QW]Y^GQ4>_I\X=KUV8'
MY_K\Q?'C5[WC%[V'+YZ_>O';TT='QX\?]9X\?7[T_.'3H]]ZKX[A#\\>/S]^
MU4.]'^H['L./ERYLE:&P;8WEO]-2?PB9$TXJ0I^>6L":"G;&<Q@V3/N]^,%'
MX!M ]=7GO6!G]O*E7K:P!__E)G"'MU# &DQ48F'4*3H0:1QSCN?*M]9J[URT
MFEGXNZF$V;+M1UG29-$0(RW3+( T*[&+TG G,8["LZ#HP27OH8E2(D44@C$>
M1>[J8)*V/#@3X)=T<!GO,]]!R##LD%#])4(&4X>8JRL)&=<9EH#L8O@7#?OI
MSX3^LE'OUF2O=F"?\=A]ULM.Q,:S6TP %3%_&UU77<E[]QJDI%X$.3/T'D4?
MSQP@%"/]'FBK>$6[^=H-VA"GKZ3C[/;F%7DO#.SP H31JR2Q7V7E]VH'*VD>
M]8XVA.9N.[]@.Q^"0I%G;V<Q7(=ZKQH,L1OFS.UK_WV[GO:%16?K]=_8%;O-
M\A5W=))= O&5*]S>B=3BKTYEVGL'RYUTD>2,/*$H"882SES2GC&<5/ZS=Y)6
M)4)QXR+!707^+_6F\+^.7_/7]!G[Z^P/]N+7_-R3TQ>__NLM_)T]/_Z;O::/
M+_[Z]>F'UQO>E-/A\[>G;U]_#&=_'7O^^NV_Q;,_'_/79\_A[YZ\. YO7Q__
MZ^_7;Y\,_N?CL\VVGH11ZI5!A!*#N&,:&4<"XE(J3ZP4R0'=Y^ >TZ?T+C?V
MW-?B_5?$KV_AA.]0?G>6=@V4#SE-Q@<J.'6<!F=3E,R1W+W9BH1)A_+[AO+K
M)163AK/TC")#M4(\1(N,P :92)-R.F JTVZB_/TJJ_AE):/O9);0=4J]AJAU
M#HM,1O.DB(G*RZBLYR+EP,@.O_8+O_Z](:4ZS;QB'B-#L$.<)(R<#119K+C6
M0A)N_,$#Q7E?2[I#==1VL1YJEY=X \7AL?94D,0X-IP19ZF/1H+<1&04PH@.
M<?8-<=8E)L*]=3H2I'TN(J]C0(YAAI)WP%&8"U:)742<SO#:.*9.QC#G40XM
MNU.6UJZ 5-/SV\:@>'(E?-M2:4PB(=A@C?!2U!5:.@S>&PS^8T/JX]32Y&Q"
MB5.->.02,-AZ@.1('7!9$:T[>, 8[RORU7V =]@R>=\IG6$>>&!*1 SJG,?6
M<85M8B:Y((C@':7O':6OM>SA@@J<0+\CA("TI:A EB?0[USP7B4M$@U Z1KW
MA>XH_0Y3>E)&P1V@"F@^*FFTTRH2%[*:Q77G;]P[2E_7JR+E)FH>$/<2>+J-
M%#FI$[)1"NH5P=2"]*N(Z%.C=XC2[Y<=^@KM?>Z["4@QKW@@!AA2X((GR[B2
M&@OA;"Z.X3NHVB^H>KVI?N1.@1FJA*0&<9;[D'',4% RD1@$=B8+)7VF0"S9
M*2-09^Z]80<3MR"2!IQ4-)Q8HPT<OW/*2$*,YKBC];VC]34%1 2GG,E%)DDN
M3D>#149A^%4(;KC6.I&<4PZ4SK;4FNPH_:Y0>O2&NL!=2D3#P>.<;.<4M=2H
M0)3H*'WO*'VC=[H0.C!'4""Y("5U$>F()9*&F #G3J.TF:N+W(%"W,'NZ;NA
M=WPJI>CKLC]N(=[SSHYQO[3:*R9D=%$7.\J</=:P3&M<I)Q3*ZWCPF+NM(TZ
MB42OS9SO6\N8;\1T3S;$ZY1<3%P*) (AP'2904[Y@!0SQ&-'(O&@2G-B^K)3
MI.\P!=]XI'E'P;=$P>MBL]&"1>TX8J FYPCRA Q0+5*@'4L270I$["(%WV0U
M]WV1<*X;/[XK4NQ]]WZ2W-J".AJ)\CR%:%UD.*6  \^]:F.'CKN!CG]OR#?2
M,255I"C81!&WBB,734 V<&$4"T*E;#[L4WI3U2B[Z(7=H]\;CPKOZ/>6Z'<C
M*H$)FH$7D1R$Q*E/2./L"#"!49>$H<3O'OW>+^O-%6(2.D/-;@#AC?M+.R"\
M%2!\_'ZSY9Z+WCH>4(S&(:Y40%I@B91.+'AAG5$QQUSW*=\EWTA'P3ON!^TH
M^-8H>+WCGI:8@O:8NW-G2XW*#DZ>$(43I9Q'3!7?00KN$M=J]^=>9JO1+EOM
MTX":C.>6"A4QP*H1U#F:)&=6&Y95C Y0=P50/VPTP?-<YH+8 *B6)E )X1\K
M1$1!<"J]LX1J??" YR9X9(>TP\ZZ<[,43+%7C,4HC6$\>F><4(K&Z F%ZV"O
MGV_:4?"M4?":4D.5)M1KA02VH-0DPY#!,B("5)VE)1(\ PI6?:%%1\%WEH)]
MHD0$92(.F"NAG!&2^^1\L" QLXZ"=XB"UY0:II,1@1-D ' 1MTDBS20'EJPX
MT5$X+^S! ZW[Y.M#-G?40DMVWD+[>#@X&U1MDDISI](V:1I/2GNG)JCS?B64
M_7"=8KN2<!) (7".<TJ3E4)YDC03+N!$W17@:0KKA9_N=6/";P52%QN*@@A4
MRR044B%GDC 1D$Y<HX2)X]@;GC@]>$"XZ,-S&RCU8V<WO0-$3(%-,1\9$2YQ
MS[4Q4@?)O'*62WJE#/:.B+\I$:_I"MY83YB7R#F6L]03Z IP>,B9%(T1)*N
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M"_, ;CZ%GZ9PVG!=XW"8_SLNKP%.B<ZW=X'OI<GXK$VC_YCV_CA\=0AWVP^
MGP")U-^8ENM>PDZJ,!2XS6.X+55(RI7NB/D.3,RP0T+UES QI@Y!\K@2$[O.
ML 1XH^%?-.RG/Q/ZRT:]6Y.]VH%]QB/T63<N$1O/;E$Q?<S4\FUT*74E[]#K
M37;1JS@%,2O2\]=NT(:X=B49>K<WK^!B&-CA!8#V5?*DK[+R>[6#%==#O:,-
MYM)MYQ=LYT-@O'GV(,R&ZU#O59WMNV$NV[[VW[?+,U]8U[1>_XU=L=NLD'!'
M)]GEJ%ZYB.I>9:]>UFOQJ[-E]MZ ?R=-\((J)44BCGC%%1/:<<P\B9$&[0(I
MN;C$U"9X8KHB[U]HK3\?OCY[1I[]^O+T]=LC\>+1,_R:OKYX\>CYZ?-'KS^\
M_A.>_?/)W_#,\CN-M?[L/X/7'_]X_]>O3P;/'OW-GWU\^?:OMT_Y,_H8/W_[
MY/3U\2^GK_]\"<_\\O9_/C[;:-U"8O"!>HNTD0IQI@5R&#.D I%PLL:;Y \>
MR%P"H2_9+F4,?<>ZC/N(7]_"R=NA_.XL[3J.5BYAP<:*)#3'6CI'/1-)*R<M
MX5)W*+]O*+]>M4\RP906#B5.'.)4<&29#HA1 FP]2 SGOYLH?[\J]WU95>([
MF89RG6JB6@F04[$Q#N J4B?A]F$=F,4L6,T[_-HO_/KWAI2J;81S\Q$)J3'B
M)'EDF 0IU0H-MY"X:#3@ES1]K+\ZR'F'$\YV98S[CC@<FV1I,!@[SK77FJJH
MI: 2N*I2QG>(LV^(L]'\S$=J7"+(BY 03XHB%T- ) 6N60I:<KZ+B-,97AO'
MU#( Z$Y96KL:10O;)/:$<Z*)QCE<W^(86!38>V,"\:G#X/W"X#\VI#XGA 3!
M3R#N#0>ISPIDA><(@Q*+95!.*7+P@%' X*Z>X!VF](@=9L12JK','89-Q$PJ
M82D<<.3)=)2^=Y2^UA6&8^=T;BBAE #]#D>,3*01&5#GHTF.2$6!T@7M*]G5
M';S#E$ZC DF8>$$U)TPX"M3LN0J2,R\%ZRA]WRA]7:]B2?N8-$,L68.XXPPY
M[BA0.DT^V4B%S98<3?JZLT/O<@>9^VX"RMG=(G&EM;?<,6>MSB;HX)+*33H[
M]6//H.KUAOK! )>"(A0IH0&J%,Y&9RJ0)\1[S4R4Q()0DDL4[I@1J#/WWBRM
M.Q*<PLZ&W)O 974DXN1-4HHR3*+L:'WO:'V][3:)@-E)(JED-C5$!@J()DAJ
M!=B>95$;<D%2WJ=?7S:YH_2=I72EE X^!)PKMB1NM28B:@ID'B.FB7:4OF^4
MOJZ 4$$4YY@AC#-7=[E@*><2>69%DI$QP4+FZISA/N-?;6S88]?.=\@#J3PW
M7Y?]<0OQGG=VC/NEU5XQ(:.+NMA1YBR"%4I@YZBEW %\*V-U])I@I^%?<6WF
M?,^ZDGPKIGNR(5XK:RQV'"/K942<68^LI1110N!$A;:8LH,'5/*^8'J'6&Y'
MP3L>:=Y1\"U1\+K8'(C&$B>'@$!!019&("T30SP%!8K2_\_>FS:UE21MH']%
MP7W?^\Y$J)C:%_<$$;3!OG2TQ+B-[88O1*T@K(61A#'\^IMU)#9)8!8! FIZ
M6HV6<TXMF4]E9F4]R3WV"ZG!\V0+?RD6SEWSQQ?%BGWKNY\\L.24]CAXP0,1
M (M&.FEXT,(8_D!T+ !X!P#\/F7": -3(UA"WLB$<AH*<BEB1(.B4GKA+*-+
M*Q(OTJ9E4= %3_LN"GI_!9VT4'#$3C$>4*Y5B;@5'&DK%2**LTBI4@3[15/0
MMQ5_N45600FU+ ;2S7W'LSAJCP*#Z\=31/8R @@*8Y$.TB). 1&U"@2!V4((
MBR&QS.A &*YK.EV7K<1:7HL*SWTKLZCPHZGP!(.Z<"81HR-201H$[I\!%8X$
MP92Z%)RD,)V+J,+E\-EX"_-%GCBCY<39S8CJK</,!4Y@'>64:*TTL3(WSTG%
M2#&*%@51?TX52@N,*RJ"0PD+!481%<C:%#,!"L8LP"JI9#Y*5L>TG"1[O1K,
MC# ^1"%QBCPH;$&7G:$N4DDH5J1H\.)H\&2U:06VC@)SR&'E$'<2W!II)")$
M>A4QYMZ:I16EZX;CHL&O5H,%>#'"6Y8(8YP%8;'2.%!08T&)IW?G^BD:_&@:
M/.'54%B"(XX<L2 IRN>]D Y6(,H$#@&F2AN9ZT+ANI&+M C/,TA+%CY(N]YN
M=5JCFB!5)9.J1L@@[E6U3,XR,]_6J;!_W"7#!4NFI<@ 9;D,R01"A6/18R(B
MC>X6^#2 _L)?;[EZW9.AU,F4I\"2(YHJC;!A''&>$G(J!"2EL4$'CHFM8B^T
MSNAT=O@_2^3T-2BQ 06F@20!,F"%,E)SP:.,@FE/<%'BA5/B"6<A2,Q@5A2B
M$329:V.0(2P@:QCX?9:JR&(^SE7';-I9*#K\&G3866&D<HPFQSF1UBEM2=[&
M)(1CP/*BPXNFPQ/N0HS"."XL(A%+Q!,X#L8SB0Q-D3&K _8ZZ["LLQGEN)]%
MB>>9;$K,HO@)LX]J;?6&TWD<O^IHJ0+^9..ST$!^EX /3SH2P[&U+"=R&4U4
MQ)1A3#'S7MWW1&Z![WG"]^F4'V6LMM@Q@@@-$?&H%3+.6B2QM@[^"=;G*N"X
M.F@K]+P"/L]?!?R):FT4*"U0>D<HE8DXQ9U1@1/XQYD@";:!N,@EAH\+E"X(
ME$YXLX"CQ(@$CBPXL8@K!5"J34+&!N\%)YX'\&:-4'5M'GSVJN!HP=&"HS?B
M* T2/--, *<P#\X[J5S(_&#,82U8P=%%P=&)B(($4]-&0U!BT2&N'4-:5H@*
M7D4TX%TDEC<@ZTSK.E</9G1;&"BMXA+_&EIXZ%ERWZ74R8[M[[6ZU>-9!9W5
M#\^[-6H<=*EM#P?QW=D?OX76X+!M3]ZUNI4R51?]-K[7N*\S\@VKAH^^_FU<
MZ-TL<U[5CQ]'3L8/_G6)>*.7#;[^ZQDEXL]^,-;\<7=O*BP][LE=RM[><J!_
MNY*R2O39NM'JAM@=OD/YDR>'0EJ%62]J#SSYTZ^.BEH6-(_"VE$?/JL-]V,M
MM?J#8>V_1[8_C/V\04TQ)?7JJ_>]#C3WI-:/E:S%4'WJVW8P:"60P0K7X8KQ
M+G;M$/YH]8X&[9,:"+-O]P9P2:M;7;4T640"U@ [C'N]_DEMV!O]Y!=\,I>N
M %BO>5 $"W>_N"7JQU;''?7S8T&5NH/:\7[+[]?V[8^L?OTC/SP:W_W0GE0;
M\'[?9C""@1V 5@UJ@Q9,@.U73>K;4.7]VO:,QHP>L%S;NG%$<CNA:X/QS\_>
MUTXB/"."8(;:6O2QXV)_A(4,ACZO<=#F00U6MU[-Q=B%^WD+LP2M@H4SKVEG
M8^:/^OW<CT/H02_D&1C VZH=RU>SCU^BWM!%TYN1$,,<#$!>JG2.3D4*T+E<
M;#U%: -,</="^F%:#J//N>/G2I4?F&_@C@;PUP!F&\0UMMOYO[WJ,;!2HL-Q
M(?=S@>KW.I=U\_\&M2_+GY=!IGT+UA%0C7$K!I685\DFH^03D.(>2,DH$65"
M-O*ZG"VR5O>H^OXZ:3$3LD'5_$6#X%O)1M:[CCWH]5O#DSR,5\?D\M"=3<M9
MKLUH#'^!-?7:C=0/]>I3?W[^$M:RHWX>]'X<JV -$.4[RJ<!PL63QT+A3F9-
M89ZK/9@?^,%YPP!&(]SBLI2=R<NMU'N!)FQU ";[P/=;;J06S=XPUD8+3>XL
M_)NW!RL4'8]>5HE!#X8W#\EQ:[A?BP#28,[GI6L\IO4\-)4 C*!^:+_#C>"[
M/DQ*1ME!1DJ8DE[[1ZS0&D9S?)NL(_FQ1^X =#/_KM?=Z^6;M[J#HSZH%.!K
M7EPRW,-"T=V+@WIM+_9@E@[A:1=?AE9*T NX 'XP>C.Z#6@?R,/P(OO+CSDK
M+Z[-TSS2=UB38'EH#09'^3:7X.!,DD=?P6W'')<PH/" 3JN;_[:'A^U\HJ*=
MUV'H'D!!OO4@PB-#?G?VQ/I97_(LG-WZ2G-\#VRU<<Y:!5&Q&U-K"*L=3.)P
MQA#VX>LLV/DF-?@"G@%VWGYM='+FQ^BNW;AG1V_"P=%@F(5Y/#DC:!O=R/=
M"$XOD//J K=<FSMPK?S;]?^U<JTRC6689]-[^B#0V*8>&<V7KAI;N?CB$NM
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MP=FWO6ZLG43;7YYH9OO\L.O,5E8M&\(PG35G<.OV7'GB(([N?S%7U>VM]X"
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MR[6KE-6SRQ:,;=VQ0<HSP?1A;]#*/WC7CVWXY8\XYI4>NY67KAH;_OCB$NO
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M"&%@CA#/$?-6,<:Y-U)7YHB<3GTH+,*/:W'PMT5W\S(LCIR'6B!I?I T7:J
M$6P]Y0)QP36\1(4L"P:1)#V+7.! ,H]?G9L'0U*AO5E<%7\^FZ.H^-Q5?)*<
M3X*8<>60ESX@CGU$QIM\?M S;$(";+<CMV*1Z,'?1IQ#E#C'PED='WI'_8)(
M\T.DZ8H%1 >E* TH$1HS&5="\ E&5AAKF326^$SB4F?JP5M4)="QN!K^;$9'
MT?"Y:_B$S8%!J:W/IWD"RX3 $6R.S%[  , --BI%9[+-0?!TIG^)=#RNS2%+
MI&/Q; [X;0&=.X'.=$V"P'DT)C&D*T>')HIT/EOHA+/2*V>Q#TLK6L^K1FR)
M9"R@"C^?45&I<#$JYJC?DU488\+&$(NPPAAQS0/HMS(H>AVTD4E9IN=D5)1
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M_QZUAB>-.-SO 4#]B(-A1>6QUAKX=F]PU%\@/JB],Q 2F]^^X.:6QYM;7SL
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MCG(U!UA$W"I%0@SYG%X"M9'[5Z*LJ*VBMG6FME65B:RH[2&H;5%W5H8$;6)
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MLH'XBEGXKSC(0A&H;GOIK6T/_LZN)[N]-]^R ]%>^G@$E^ZEF<JW76A\<R9
MM**"6U%!\_55*DA6&*PD1MICAC@A!-G )'*4.T.QLISAC2VY>>^\U8]  T\
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M>^+%P\5F0=%[:<Z;'Z=!Q3\L\X1?'BO2YOG[SP%;94R**')F$2=6(D,]J,O
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M//?VW*[\!C?>[?*#=V^/]MZ]87NM]QC>WV[^\^9TO_7V2W/GH+/7^G1V<-S
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MQ@ABD?*<(IZ413I[=G"5>$H!,!U=8?D3O$R)&5=Y(D'%IBJY#M'JCVRGYB=
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MK,8R%W-%G#D]2>-L3="(.>]84$3XR#>VF*I351+O^\I(L5821 7B!P#Q@NS
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M$%QR!KN4$PPD:,)B@!TK_(S4<0.&4_M;#.@\#OH5?.\,WR5Q \,$):<8HDD
M?*EG"#A7H9@3TT8=)%%^ W"J*:&_E0B_][4R%4#.,)P<B-_]M&72G.NL8M5Q
MS*K&I]3D6)U*/T>2W#V]1L:Q&$O,L$$QD%S(R!!DC1'(.>E"SF*)O5K]N?0*
M$%1R$U-%I1655D??SYE*E^1-4/1-\M$C;Y@">3/GKV$$(R,8UBZ8H(Q>_>'W
M$U)I(:C^.K+P4O@_M+]NS7K5''<!+7[K?^'#64>*9[=[(?9&KZ@JR'3283?X
M=6O>^>(IE^[JVL%ANU=T0LXH</DA*P,UP3]"-<VHWA[5=J*/71<'$SV!D7HM
MRSGUVN@HUE[WN]"HL]J1#;4481)LI]:+HUK_(KU7?SBL>3L8G $H3^T@#&O]
M5+,G)X/^-\#C*';.:O]U!^K(@4N*$=!(N>$)=%1K054U5H7(1-3BME+8198<
M:.#KR^U[WO1Q\.\1]MV_>_8?,]X[WA5-ND\;</=>ZPL]:+UG>]#&)OVCV^B^
M/=[;^;N[WP+('X<O.;=><^?]9P6CG7)>7QR-1MQ;#-A/!DD-L*?*Q>! U]2B
MS@Q9@CZL&3NJQ6\G[4&$WP'LAT>PFIBLUVQG=%3\:6O#L1N.;&_4AL5DNT (
M\UO<65Y[9K/6NK3V8(+[Q0*$FT;Q5LOO+@L.MB/#3/#)!PL8^?_9>_>F-I*E
M??"K*-B=?6=B54S=+YY?$,$8>Y83EAC;V#[X'Z*N("PD7EV,X=-O5K<$0A*V
M  $">D[8!R-U=W55YE.969E/!B.%%Y(1!K]6(&>5P-V;P)WE!ALQ64V(CV"W
MNUP+@#UR1B9$2$[!(BFZS,PJ!*]K/%L)4(?=X#CF-3\];/E#D)/OL08PFI$U
MM6#58ZW=2O$F\L=)097< AGI=8I^< N"WDVDSF NDY"",@]6$7'@H@2):; T
MTA3MPN'T2NIN+'6XL7NPS[0"/Y\(I'D.J3'%46XXAZR@"D<P6HD2:QO4D+J9
MT])I6NHR.7W-1=C?:X/N6)C@'["&M#:2N[R='MNC;J\U.+M.3*\"WZ'M9VDM
M4,_;D]8 Y/!2\KI@T=Q4ZE@,UF 3@]$>S#J6:W"X\\P;,.9<H(M*'=CCK\$L
M;PTF)6ZS4*5*[*X1.]($L=.81>=MKGWD%'$>/-+4>D2P3U3 [H,M[*ZP^=05
MG:U\K%\5H@OQ*P6N/Y(X7DK1< #NTGG9(CA;9+6<$CGZ!]RF'PM9@JN.[1G(
M+LC?<6M0GHVFX6 ( GP6;:]?<[8/OX7K\K/!JDL@AX4G5@S @UEMX1(P8PO?
M;+VV6?L^VYJXUNK7>M%G.SYD%;'>%[@+LE+<=]CI19N'F\U^9]OYFN)]\H>%
M75ZS#B2^?+5.47WD>P6S[ U5 #P6KI63L-^#"G!J O,A8FJC<#)RO[^550##
M_]!UNM '!P)^FE:*V?:AT^<DKP]MYR!N=RI-^:FF<'!W]PULBBEF;)8TIUAP
MC%S@! 6NE,?.$,<S*1*O4ZQG[="1Y%PCB2<]F.(>.%.U,(Q9'/-W>[$]EJ?K
M+NW. /8<NZ"4VZ-AK]4/K6(X?5#36!C$5['](';RA: 1_6%*+=\")8)K<S5J
M'E1_>))5-E_6ZHUU<D*KZP7C(1@Q[:R)">0KVR^=> K_SKJ1;_Q+LZ75&6TP
MV>2!WX)O.#WXPJ:?''OHPCMVNH-:MJ%\ZR1?[F)^0*&H,/1RE*"MBWC#9B6\
M84)SU@B\.+Q&?MD,?H!J&:\6<9 OP,W6!KUA1,.3/ _YMP<=&, (LF9S4D#J
MBH6"+Q^V^@, =E#[VLFPYT%"8F%6@F!G!.MUV^T\N,(NC?V2\Q(^**(AQ3TF
M"3!+H(PI13\H11KDWH:C84GI5CO-MD46Y]NAJ/"22\--4C;Q:&#7$D)$&A7W
M3'.=%D#1"CSO SP]W=G=(SM;8.5N;<,SW^]C%A@V/B%*5$)<:8V<!7-7>_@_
M8Y)E.?>#R[HTLQ9'ELMK1!=<JAH(:>_@\87GHH+_S8^3V.G'OP%8P4RI9&0!
M&3EO@ ^NL+$F"0UF:?;!C38(Q((C;)*C +F.A5R/+^N8S^979QD9[UH@';%<
M@WJQHZP2Q&Q>H%]_M[L9P'LI7/M_;2ML=UZ7_M4+H*Q:EMSL;+W?-[ >7O.(
M0M(6Y4/SG <K$:P8+)%2G#*[MB'IW&Y@A1]PL0RP>[4"REM:N1)77.$BM47]
M55ANX#%<V1Z+G6UP=A)+ISK;)1.&%9@S+3"MP%*!:R,JX.M2#GX^A+S!YKV]
M#]MN.XZ>G>V"<FR3?E@V!2H(?**B#/__;3_0X#2L!W(*PS:)940VMW ((JAH
M520^VNLA<-*WG<7"PMJ:<#4N?->1FP+7@J6?S>A\4?%#X<H3M?[$#.@)G?V?
M_H4_ 2K3 1WJ%SK0ZI03X>*$,]7.%G2K8!PNJC:S3LTWN]=KFSDJ!A;PL#T8
MJ]X)F"3VX,)W S6HO1X.^L46])^NZ]<VP0K^/4]H\1G\ZX_Z?)<FKQA\MS_,
M897QL,O1PMH4_DTKP=./6P,8Z=3R9+$8O6)ARUY9L-$\\9PX?]+M%YCSJC#_
M6]_C7Z>M,#@<9W1.7#4Z%,67EU@'%O]P</TE$T>?/F9GX9&.%M\BRJ?F9^+O
MP]YX/">P<LB!0GR#?0.&^\JV3^U9?^W/J_(.PCZZO=#K>1)7Y_W5W/??VOR\
MO;M9VVZ^OEZ+5V6LS9W=-Q]KNSNUUSO-CSOOMK<V=]]LU=YN-S>;K[<WW]4^
M[L(O&F^:NQ]KJ/;[6(W#'[^"I\LS_;]6Y55_#^!(Y\!F!H<^.##C0&-W"+<-
MX-?$'SZ>@+T0>^7G-7"O[?6O>MV+S<L'*/^>@HER\[6&$BNC--$PSB/1V@I#
M@PE<"XQ%6EL-^"_N^"J;1RV_  A\ZES$0$KGT96&2?_JO%Q)MIA*"+ I9)IB
MI7#@!BL##JU,BCKE%;'8S#65KAI''X?',%]G.^G"2GI=3#_8B;X5^[OPK+_;
M7?_MQ9E!#=S<.MCGCH'9Z14BUN4.>E@C@[U#+!C!4O)9)-=J$8S%DRSNO6%<
M$5G\>69+893! K=;=N+<HSRFZQ31RMP0MQ.*R&AK?*:13R2&UPEM&0L-W<)4
M.(ZQC(L>@YF#VJUO8,4@^$('Y4\'AP LA]UVR %GFVVA'-B:H*/X17[0**T)
MY?S(\326!R$7ED&1%.4SFIWTXZOQ#W^%5O^D;<]>M3K%I!07_745C_/V.940
M5:Q:^?%H9U5F72J=-]=1"O_HP:-]=[W8=Z=RO,K/)%FG6ES[,5XGUW[VL]N"
M.4RYOM5M?_Z9(NI>!BNN_WCRMK\HDUB)G@EJH1S1^:4F%^]D%GFG<@]]G+>:
ML1B*M]J;/0JH@3MRY35?S!I.9)K?("MSM1<XVPW+>N%%B'R>T\3AFZC!<^@+
M\_>%_3#*4ZCX3E\B$^ C5$-,^E+@PXQ"O,\\T:\LASAI@4/3;FY].&R<?SAJ
M;KW!.U_>G.T=-T[WCM[CKU_ P?GG<WMGZVN[<395#G&\?;9'X1G_O#EO_M/
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M\77-V]@ZF=.4>Z)Y&YW7O.WE'F+/X2>)7$9F8#C2<8>#DS%Q8P0CB7/&[*^
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MHTK^FBU+^:>><B$9A;B-#@I3ZT<L!?S=]M\['Z8N\:!=W0Y\KP\?U&)*T0]
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M<)4>!N#7K7-XG)\Y>>B%)W7AV?JD/PB99O$HH/J@[[&&5KG.("Z?._![S$.
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MT6 88X, ZZ?48CLDG, +EX;IFPF>PF__WS>! >GNQ6@F+*D.5X^A7B&$O1Q
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M5_2@7?[4<3.!X_.'6*U (V:SF$/B!T LYDC,!YC'Y)X:Q5<N3"_8,J.ZDLT
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M5O#5>"0>$M46^*YU@%S<>Y+E!E#-^Y1H74BB4\ILQK61V&N6T7Q3+?<<??+
M=@_^MM8@< _'PDUGK.%]'9U)Z@$L&3-2FD(8S5.D"+G,G)+)ZMH1C^1$F(?4
MA@S>$C87W019EIK<>T-R:G,B!?! E9N$I 5HS3QA"6-B8RO+EWL6-IBYIGO_
M(4S]U4$03\74WW8NUD:<+0U=:*SB_5U]U,T]'L7OWZCG*]7S?,/2.VOFM].]
M%$)^_\*(7]AI(0&Y4<AW4\A_+2ED0;-$&L])8H4C4E-0S<8G1!GF<D^-P):0
M6RRYMQ%S!<0_ <?\RGN\,(]VY4!P__X['*N]+-?V3X_NVT84Q"JQWNU,AG69
MC5C19[;>=KU.S8GGPR'GT9)?VTB1>L93L%TR0$Z?.S!EF"*&JRS-O7.YU!M;
MO$U7.(!^?L)V3./4;IS:/]*I7<%9X]?^+JBVZ-?.7))*28G/<D6D<9(8['.3
MR(+3S D#O'!C*Y6;*QK@-2Z:-86!QJW]0SC?4_)K1PK?F-%WA,U%,UJZ0B9%
M2DE.)0<SNJ#$4&:(I2+-<IMGG($9G:KT65'!%X27+\RE_0K];MT[VOA/UD_Z
M8VW\!^S5,>VT5?@.]HEH'*1W0_:3)3._<#+S,H$EE"XC,I4*,+[PI,A\@L6W
M<[#Y-[98ODR';X[LZ^<;O??>7C= NW5N76/D_T@C?P5R-6;^0Z+:8KJ&3:@M
M+"<I2QR12<Z)XFGHID5Y:K66.MO82M0FNW<DQOJ!VSWXVUH#P7JDQ3U[VO>4
MS/P25QM+_\[(N63I2Y99IA)BO<Z)5%0075A)F,E3FC E&7<;6T+ESXH/OB#(
M?*!3_74FPPL5?#PVF"HP>@T XCZG^B\Z(]I*QZ0726)R+G/-#--&.6>X20I.
MC5W=L+.IWO.T%,*G)0=!GN4NX;8@/C@(N"N(25)+A$F=<(5)\BP%*MU6\J$2
M0=8F\_F>D0(OM7K/K5__::+DY>Z'NT%E4[WGJ2#D(F4VU%*5<9*DV+5;YX8H
M5@AB;6&,=CPWUH:8@G3Y>.QY(^1M[O%L:D-<V<'N+H[)!^HV>BTJO*]J@;Z:
ME@$]],,>7]GI#$MA-H!Q(\#87Z14B6)<,4.XR078V DC)M4%2:PVUG!+C<PV
MMOBF7.R4]M@A+B_; $I48IDNF#1*9JG4VF0TU2Q-!>YB_OT-H*8DU*/NXD6U
M;Z5/19H2G>18$BJE1#EJ2<I]KGEF99%J+ DE\N6^JHW:?U%J_TXN]1\%&K<G
M!*.&$-P/2@X6"($N<J>L1B[@+9'8/1<3U @O4IEJ$)W< B%@UQ""%U";O31<
M0]NW!_'L+A>F$X!";C#!)[P89G,G?\7#QW?-K&Y#8!X:=5Y_0<2)WMV3;WL[
M5AYS:[R05A&;4X%1O9X8G5CBK!4>.Z0*7@#LM%G*'KZHY37[;,T#Q.X)&.N&
MJ_<IS7[=^S]-H%Q[[^X,6#;>W0=%R;UYE/26YBX';*1"8.Z#38BBJ2-IGAIC
MO6)&8^X#VV0/543@R:#D;>YQJY=Z"IBQK@[>RX'A,GN.-?;<?3'CKWG,R'/A
M>>X,25,TZ%(PZ')N%-&Y<)+E*0>C#@VZY$$\O-^GZ/]+-(3NZ^*]5TF@_4'I
MDEERV5QC&!6=K]Z1;WXX:+3]K7>NG=^YECK!G:/$)B8C,BL*V+2))Q+^9EFF
MN,:R%__[_\DYX[^^6'W_ I&D7/)U7>$7$-99L1E2-K!L%;HS;'W6W8E'+^!)
M*&7ZRWW.2"]?I@?-$7Z@\Y(K)*D9Y;-?[@>JV?:T\[B1CMTK\_%9.N>>M?OM
MA^=VWJ<I0?AP1X_]&U!5?Z.F:ACZ[1CZQ=*IA0(3.BUR2H00"9$<;&M=*$JX
M9%(F!4NY33:V!-]D]XZ[:!*5GE%N9S-C37&$1H'>.[_WX13H+9M3-*KUX57K
M@O.+*N^T9)3D2BHB/>=$F2(E(C'.)]89Q1/L^J,VDWN71VQTZ]-/ GY"9B*]
M1[#MRXKPN/W[K[7TWT%#YCSS7&3,&E"(5C/-+4^\9S(KI$Y-$30DK33D4A?H
MQL1\6GKPVY*)F7.=:ZDML2S%0R#X1^4,_O%Y!O])K;4IH$JZF3U4E>#U.0)J
M:F)^KP2K9L8>/K&^4<TO2S53Q;(DE_ /J.8L4885VFIK1$:3!.R3'Z::&^/U
MT97V@O'J>2:YRSR1PG P7FU*-+,.;%GG:4H+;83:V,JRS?P[%"IIE/::J* 7
M=P"*%2SO%(P2A[U*<E^L?OT.$[36^^<."K@ XSBU6F32)))1I9SV!<\+ZIA1
M3J6H@)DJ%3!3C6W\M-4L7;*-4V.<!JI%'!4%ZEI)C$X=D9+EH(!]EE&QL<7D
M)I4/&Q[Y$-NQ\3"OFRG8S-@//KUMM'^C_>^L_1/*C$T*411>RC012J4IHXYR
M;AD3QOTP[=^8WX_."Q83)SSE/I4Y$3*7V"]4$Z593G3!7<Z4Y6GN-[82NIDL
MEXYN>,&+T7+!/O_W&%.9X']=Y_/64@H<_+$:9T\/3SK]L()IF+$K4B]S73BA
M$B2@3BJ:*2I<6F3<9#9CFJJ;I%[:4^\F77]0K :FV(QX>S(^'0QA%MQ??9"O
MF=[$;[LP5[]=S"5@OT<H.X11_M:%[SU1=/GXGU-J>W_W]3]J<M![?W;4^Z-W
M].WT#*Z\.#I[W]L[_)0<_0-_/WO3^?C/WV=[9S8YXD<<HTSVOAU=' O8_@GS
ME'C#%9&YED1QK8E(4\,*+SA+[4;+ PB?PWH J -6_)\@)?6&B)L9)+>KST?^
ME^J'7UUG=-[5%[]T^D$ PT6_EH)38@,Z<1:V1=@V\>-?OW3<^/273&[R5*%>
M+-U'Y8/CIVPSJ,P%;(J?\7PSY^S2C^GF73_+<GFG*Z\:+$LVI4B:P3:#E2*_
MT6U+EVKUA0KAHPI;K;W6(JLL>UA+[";*>SCXLI@@><546""N?O@XDY&MG(S
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MXDPQ9)QQ2!+-C3'8)"(S]:HS;>9D;?.2=MV![1"V*1Z3[Q1/?-,"6]CRMV!
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M(U ,U":-50I"+2T'^G(2)CT[K%95E5>-2%:8M-:8-+MCY1*/GAND@Q! ,$U
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M[XP6DG(?$5C68:U*!!XL A>[1R01&&DK$4L,++]CX ,8')!-EAB*<^VM6)S
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M_KBQ\]/JP>_] ?P%5^&7?N%3]>.B;L.O)RW7*ASRJ:84GE5^/UP W_Q[KS4
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M9&V_V?[6./W2/FA^N&CL[(J#WSZ(+\V_6@<[>[RQ<_BCT?SP_>^+O='>X.X
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MT'C+7M\!&T4RB29&B?&",V&TT#Q807 ,@G%=UG.XGW];8^/*8./L@ISS2IN
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MW: :$7X*(LRZ1#)A841@2%*6B]NSA)QS%#E"?;0BG^I5N02!7JDBB2]BN70
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M-V\]5[<MWKAJHW;G/*[/$JM_*JULQ>%.(9U_]@8OHN#DST+L!><?DS;6.($
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MKA VO:@H96CG0Q7AB:ED'0EX#G#]A%1RNQ3C&K#O!-CS60.(3E)($E'.MX?
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MF>0;"$8!8/UX$NU@E,TEB'.R[<ST.Z/8L/DF?P07G.9#_V!L ]A*,(S#=J=
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MX)P7H:SF#4J59V,19$_!4;YT]I(+T9YJ$#3CR'Z;FG3X_6O;?T49?.!I^5X
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MB036*M!<R=V) KJX$DVJ_O_VOK2KC21+^Z_HT#/SNN8HY-@7UXS/H0"[J;;
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MZ30!Z31F@(6)0!UU5IG4 I?7!9O7:4-9J:NGU///=LI*_81*/=G76D-D1/"
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MHSE_%0LB%4+I-]\I YRGNN=&=KW(JI]5OP*J_ZNZ!4K)&[BQKM@6Q$Q!+KF
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MNZ>IMKH_: V& ]\O*J?CN]U6HGXWR+A>^[/KVY'=??.]^!CUX@O_TH.C=BK
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M$!0!11 #CB#*K3"<&KCVFO,Z02BC54:K)4&KG$2[M @U%8,@F@4-(P5$#@9
M Z9 J6A017G&5ZTETK Y9='.N_[A^LDU+Z\=@S']=S[9YD;='YUL0VX_V>:E
MZ;JS^,_1X+C]^O\#4$L#!!0    ( .^ 2U2J)!!]228  (>D 0 0    9'9A
M+3(P,C$Q,C,Q+GAS9.T]_7/J.)*_[U_ARU7=[58-+R$D+\F[>7-%$C+#7A+8
M0-[L_K1EL #M&)OU1Q+FK[]N2;8%-I8,Y$6[YJ[>; "I6U*W6OVEUH__^S9W
MK1<2A-3WOAXU/YT<6<0;^P[UIE^/GH=WC<NC__WI#W_X\3\:C;]>/]U;M_XX
MGA,OLFX"8D?$L5YI-+-^=4CXFS4)_+GUJQ_\1E_L1N,GUNG&7RP#.IU%UNG)
MZ>GZK\&7YL7IYTGKY++1'(\O&F?VV47#OB2MAGWAG%Q>V9<MF[1^F'X9VZW+
MBZM)JW%Y<7[2.'.NSAI7IY_MAFV?C3^?M#[;IQ<G#.A;^"4<S\C<MF!B7OCE
M+?QZ-(NBQ9?CX]?7UT^OK4]^,#T^/3EI'O_UX7[ FAZ)MB[U?EMI_38*W*1]
MZQA_'MDA29H[+_9*:\=^H9']:>S/H?UILWG::B9-$1 M 4V],+*]<08Z"AK1
M<D'"XC[P\S'^C'A.&B?-QND*)B=*N\EHSH_YCT>6'44!'<41N?.#^2V9V+$+
M76+OG['MT@DE#C"!2Y#,*PVDGR,[F)+HT9Z3<&&/B7(=?OJ#92%MZ'SA!Y'E
MY3I.['#$!AH&$>N&T\(%Y-2\]\=VQ%@4VX?)S'*]CHD;A?BID<'X]!8Z1\?Z
M(XC#QM2V%UN,0N[)1R*^J3X:B5F;5U=7QV_(?<7C*.0HUKZ!?S::I]70;F)-
M?=SPJ9'TV\<8LIU7;0Q)OQW'4+C=-G&$JB?['&H.HWC[:BY"T@%G?UX%84C&
MGZ;^R_'8C[TH6#)V5FR!HB[)!\;\V^!W"&6 _GFFB3WK@'\V^)^KF&W/\R,&
M [\1WRT6U)OX_ OX"MGF2\([3V22B-;<^5"P0=G_?+&#<>"[BMU\O C\!0DB
M2D+Y;&$ 9@&9?#V"$Z:1B-"_N_;H$PPD:9&#O\K_^/,Q="'N?3:1I"^RX->C
M$*C@$KXT!L][$9"J\X8N(1Q>C,S_ZM,?VV[5Z4.7<>S^6\S>(9.JLX<NU*-;
M3!Y[#^%WBSI?CQ(]U_:<CA?1:-D%"1',V:(>6=CT^:F[2>UAXRB%D&!.<&>#
M_ND$_J^)_ZQ&IFU+?P(\BP.T)(@_'J_#6<,0A\3I>3^QO]?WA^@LFI1T7.,L
M[7ZK-"GL)KY,B%!"FG;LT*@R.7*]%"0XQ7^K)& @:KKH-[W'0>^^>]L>=FX'
M0_CO0^=Q..C==1]O>@\=/1(H8)00I"GV1 NH,( E)((B,D0K VGU[BP.]$ A
ML;I_;^Z#1G]O'JCT/E2"9>@_=7[I/ ZZWSK[V%1% !6T0Y%WID^[%0SUIN1U
M^[[]>-,9_-+I# ?5Z;;:74&E%OP[+Z.2@&9Q< >*# =].X!9S4A$89P[DF<5
MEH)69_#OLSZMK#^N0/]336FW(L;:@U_N[GN_;K&KBL$H*'8._RXJR$" :S'
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MN\1)5@Y1W,RP?$V(]8K6:0=GR#VU1]2E>$5]6^;8#U8%NUQ@=*:<7=)Q6/)
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MV+28JRORK,HG4MK%@"DI#@C,$R-[/' VPS-4 (+VY#W8P6\D2F2U0GR4=#"
MW"LV+),0 Q)%KOB[O<@2M)[P%0[%7+>%9L!"L -Y5'*@CY99$_E OXM=EQWD
M[.=PZ+=?;,IFP[^X\;T7."]PS@BR7*/X+@-X)TMU$>OX(O !CR$)YLEFR%Y'
M['.5V)Z2WN0OL8UW#I=/A!<@V[AJVX(S1+7G)=Q[DR%0.015*;P+_/G0W_
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M>*#7?'P]6> ,YXM1S,6")GQS@9J0KA+S7!'P<\S:&(@NPO4EKVLSI\598J/
M/"X!LJ;UQRJ,'_%T,;_\9"D>>OH:)_]Z *964MY]O=<DU =>TCA"ZR$D%9GF
M $RKZ!E(HYC+$M&%F"'S+NMT!S'7^;N"XZ-9>D;K@S-2K3\\^XQ5$:ZU[(HR
MF*5; +^^Q]??^'%^<7:V?"8;TT)?_ONJ<H>)S<6TK0Q76*'5V!=,E]P<3?(+
MC(N7OY[C9(XC;U,*,4D6DT:F=4R,6'4LEH).):, 0J=]=Q<]FT!*?H,4^UUB
MJH$H]X85&;Q1??G;&9[#E^H:D:DEKB>)N'R'&<_.ZPH]/X'91YR/O'&2EP L
M&".)79F9#Z(P*QSWX#C:5!ZPJ-N]<1,@J=\KD#H*KYF^.EZ<X(QXGEY7H)=@
MSR%:99-AVIK -/+(HC69!;200K 21.QC![]+UR:PT[]WD]A.LLW0]@LNKACH
MJ&-((B=F=0V[BC<L"EN8X0X<)"6]S5W =8V,?7EZ.YN6\6+%D L8,_D95I1"
M:PJ91>\YRPJ4M%87@:(+0]]H&)*SN+NT;V)YQS7N@]NCQ6(VCA<+B*?X87K?
MSE6Q!!V!9?2"Z02&@<+"2C:.O$\'M-?Z8WL34@?E"[:#3%^1-4/6%61GJ0G!
MT3'@2$$+>%GC%=+]"1"#Y86[/K;V/NW1(W5!WSB]J/F_M]/9$F2;2,8([HU
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M3V%2T]1U6Y[7*<JU^-!G \1$89B!>'.\'IHZS;#8'$-1G-L^$=7WJ!J2D]P
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M)P?4H2W)N"@#%Z%/K[@="1Z2"3D ,F]NU4.(N=W.O>6@?IO%>@\75<MX)YS
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M+[Y/?=!!V!M2[<)O=:NTP=8@M\W-)J1+1_'#"4PN&Y>.A"SHDI9,BYCJV+K
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M4%GG)(0%$X,&I64U<2T!E%I9SSG#X&_Q6K=_^A.F14\BOTX">>AN\Y%@X/-
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MH\E2$2;;$CH<4_L\^\D0YRC*Z?EJ^#K&9</D*^.HF;<R&*R)_HK@H;3D,K,
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M<<SNFEI]U7 ?B5F[Z*E1#?>JUI!Y1!7K@F.]:G 6HD@9T*O@@TE!IUWJM1]
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M<29$ACX[V:;4=#NF1\.,GL7?X%9]GG_P=CSZO!D=6B9B'1LJ?;W2#=E $-Z
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M$)3TR(1&(QH=.1T1/EJ*'*"(!EX(+?D%64S#V56,R[E3RFB5:PD60_J#-N)
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M_\CC+U\7.;WZD6=82UG_,N9'+IN2L@\0;#T X(E#T&3 DUADX<;(V"CQKB/
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MO00X0MPMND#LPF9<*M;2'E1$[7HA-1D@M;-MB5(7E]$$T^8$;C@*/.!'#<&
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M1A,BH&4(@4D37>:9R38D?HI% )JQ^2S4W[C 3;<KP-<_[SCU>?WSKA2AU9F
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MW+25V!O4!%A=)FWNDC9]Z;7 VM $1"EDI!1FP1F>()5<H@E6A=2FBM$N-$^
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MR:?%-/[GK:ZMRR*B]*Q77V9Y=8M[>';-:?$>G7YS1N+>RL\I61@=A*G!PF0
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MP%"!$<Y;;V.).&0Z9#^C>IDRYT2;P=(;#QS;/[]_OS&VX 2OK9% ":WH2_&
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MMU05<@T<SNFWR]F5J;1"=^>X"+<HUF;"K4QPH!0+$(0,()0V6: 5K%75^,,
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MP7HZ&@.6P+WJ$KU_Z/L?/TL&DWZ+,N0W*Q)M<EBV4/*1(NHZ2P@S>1=$;);
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M2*=BLEQ*KX5NU.%B(SD':#(TC+CN!\$.O&Z0WW)_GBEW=/_59HDVU_HR,J;
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MRD,=LJ/)8G/%&H?M\=U@74\,VX>6?(NS>Y:F>U ?<F&VU$B38#5/*0<RM70
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MS[Y/JXOIM]G\NB/CFK\3K57.3N<ZEI63BJ,\T,(XB.)M=B4E;]L,51]J!<^
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M,UFLAD$(6E=?H@<?C89D5?(^,,-TFWS:!PA[5A.WJXE#RK1!<\9[R%L/4.Q
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M<$)KD6OULT%UQ88BC'<Z%TB*51>61H@8:Z]1SC%%DYAKX\'90M#S078W1VL
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M#34DV14J[O*EARS1M:8N<]>F>/.0F-2L% C6B<M3C,ZIO7MI>D5>%O).ZWY
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M6[(8%IV'8V'N V9^_OP^3503!A%G2KHV*>I23"**L(Q_3BK:Q@B"()WS"#"
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M26F(6:C%<E#EBVG> <8/3/L]" V1WIVOO6TBD&LB?FP4DR](C^!C*1Z)VGP
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M[.U2O2)F-,E%W:[YG.]&%ZFG>%<(G%:_Y8A[E0S7Q,9=^V;24\:24['*=@1
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MC-_Y7W2??S><,NFIU1=030E?0M%0[JOJW'/;TTX?,W%1!>="]51R[X!(:Y'
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M&H!$P$<XE/^$7Y>Q66C"S@3AG8^G*F+%7X[RL6-(0G:.O?C=F@L<V>@(G.9
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M1ABE<H:$B #39F[28*!$L_++ O<A%%B%D7(P,12F"K<N/2QC)-!2*Z+!/N#
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M%"VT]R;#+D.QV,0)1BZ"/K,59HX4=_W.#]=V=M6M,^UO@(:.+LTS>-\B!WS
M+TAS:S7P8@7Q5%GT*+AG=."D71FOBI"D1GL(9F*L=,%4:)4B;$ V0C3AE$XW
M"UNJ/!(W>I4V;&DNJV1W2QWR?RNR:G3@4PV%UN[P3*Z1>XLQ,-/-$0GXV&A$
M/!Z.7?A-87T5(QZX,,02:GW6I22PCZJS55,E2_77E2SX#;\4T?;Q /<VD0XK
M6I=D6H,G:O^-+G<M-808N.-44R&'IW2%<)8ZPFW'E?I6@E4(<T5)K2?_MFJ(
MHH2^\;2.-G ZLDW#%G.,A([*9%2BH1=7R6GQ]RU;,QO[\JK,[D0Y+$CN=F"^
M+Z6&;262S G#\"8T)#T^1IY(='UU.+STZC)2;R172"\F>(=Y$A'Q@V*IC1T3
M]D^#:BT,"D%Z$26<D V7A!X%&6?Y-WV/T=W:AJF:V'#74BP5;7\'=I.;EA*#
M5HR1]VW6XB\5$DQ^8&L)0SR,UX+?E.;L*RDR&()5(QJ*@$AW9&K3U96(P@&8
M:1Y9Q;_(DXB\-U-F;C43,I O]911%))"-"@ S+!^X!E]A7S[B5O_! Q!"#-Y
M!]ES6@4"D(;A-' MSJ-$]CB3?_9'"QC<EL<-A^J.K_9LD[;POC.2=V<MSP1C
M1<X<E\J29<Z4*VR(0&),X;-B-\[E,".ENIAIE?4!N15!:1=LU:.=1T>X*&("
M?S148?D^#*T8N]44==@C//DXF2<C6R,.;G?=:F^6L08N0@L"F%$D%:SZ&@\O
M9O.#>EIZLS4H+]A_31IYF593!$^2R$]!A <WIC*>^9E)N458,E=P<9B*E]9%
M7GEWWMB?%)%U$R\V^L>B</*ZUC.'04*;96L=(5#^%$D/D>,QAT(91>(VO3HW
ME620R!,_@_F9V29'BWK_UCFF?@"&YP,P_[ L_;0.A5E9D4T-W=!S!Z&9@&#3
M>Q%"HR_;B5&HDPBT0UJE!8W()\^CL*.:0&\$8Z!%<]&ZP'RM*";'C2^NGPV#
M5 E/8/71J"5U^T8/@G!NE+MW/2O9KX/B7"JE(/99;ZR4Z7IIC_PF<E\S:AD0
M*-/L85JB56.2,,"C@)';5_(G6 @"2(Z:H"-CCY>C,FH,)O$Z+!=PHJDYD(,5
M.OZ":5 E2PNUM$HZ=F5:F0VF<_%O&^O2L.>CLT2)13WXL3V,HTGD]%J8[ AP
MU$ GJV];/^OS1SKE%)946T1LB'=)%/,X81D[76,FGT+Z)OIIC;+IL@K6G:GV
M-_PF2:[;.NV.<X1ZVYE+6/;>8TU%F;V;6+#==(6KY%CN-V.09C0"\C(#L%KA
M.I$!L19M5Z'3FW>01,54),D1-AO%A\4&XCNOM];NHL-)>L7#=&-4=W<:=3[<
M[U>9EYR7>,T#1&,K&H<G(Z5IT"5TY(HIVH!V\'C]JH(;7*"M>BG2%,%-CXR_
MO)6"JS=J2\/_J6H?'.Z21#DZCW!AQ#>D :FZ_=7?=B^KV[P?B=8K7CP\ADH/
M/?+.OY:@@*E>F4PG+;GTAF6O%PA*D@8P&D?N@&FL"+(?5WCWAM!=VGA?O@DF
MH O"=J0BIQ"<%3EG':BF<$/.LR+K4FH_CY?-ASE:7YQ7RM7YT-:9F?5Q5SM3
M<_0REE#1J4T-9,9-59+_-L>+;<>N*MF%TOA"M=&E%D)[8!2J1_PK#FUO*[%V
M@_':ED*S[_TK(A0^^FL%2[8#6;,BX/G)N4,L)7)A^%W"82FR)X\Y+]7R6EB_
M]=8'4?1N%2,D/A9(WQ4S$X-84M@2'3"PW22G[)WAT88LFN.GWYR+_VZJ:]PV
MDLV(5U588S_<RPI"=:O46K+/<QGX9R.\,[OW2J"OX,J-E1^[JU(%+&3YSY4<
ML(_+H+ UMR$@C>-OYZ/WDCE7[WXX68S"12!$A"WS$9L9T3J7"!$MET-:H^;8
MD9!>ZE#TA"L-!P9THQY4-4#!EY#+A!L25]1U:BRIZ?L[10RF1SLF)=TBV.+=
MWWD+"%6I. 98FY_</MYX);!L*UU,8??W[])SWF_>I,2=L;XBB@\PR]!6 :G)
M+1(+/\*:*^@9A-*3K-KD0TQ"MN>QC2RM;B,QVFGF,4,<N'U\^)\=3AHT0BK$
MQ!4_Q(7Z%/>N8_#NU0?HC-DS1'_<K*^_^/^O4/#BJQ?;U1O[WC(OQ(@5I-WA
MO>DOF]GQ=.Q^6I,#NNQ"RX%$ NVYX\SUC"%OIA0! D(%@00A/" X,"'!!Q8>
M,'R8D&&.!PHK.&P8$:'&BAL[<HP8\<$/@PPAC+3X8U^T>OOVZ6OI$J;,F2KA
M.#SXT:/!ACP?]OSI$V+'D@\TT9SY\JC2I4JCR4Q*KV724Q,M-KP(0: .H0J#
M JWH%:?(4/M8RG1*TRQ:F' L4M0Y,"Q0N (? '&8 Y1,94S[^I49ZFW.KD +
M<]T8U.3#A8-W^G1L.#+%Q7$M5LCQ \[?S4O-_LC14ZYHR18@E&YH.FC&BJ 7
MHAXX4B+AR2 ?@A;_/9@RW<$YM#[(D8/LT:2<BQL_[A=X7-*'E^MNK/#V54UK
MD5N_CIPX3*=I'/#$.#H\<\,'+5Q^@WTI6@=WS:<&&CXW>(,?=0Q<J//G[;H-
M8T>\>Y=)NPW(D6"I676173Y-)!Q4+55'$W&AY "$!0W=)5Z&/3DGF4(_B.24
M=NF-^&!-WD%$U&N3#:B::R5A!!R$(OZEB70X>=0A?^$!@5(.RVS7TH\D-B42
M8XB-%Y]'S>EX%4;TT?=64 ]1)A9=#>&@V9!,.653>4>&%9%AJ1'T%6*NT274
M;PWM9UE8!+X)'4(H.I"&EG;>*953#MQ8@7U+Q@GHDZC!:!2>AF+G%(2;_WSX
MVGNZ:1B>5^TYY$"6)4HU8C3L/3>9?7"^9]!6D_:4E7..=M3HHP*!=IN;*I+:
M6(8(.EE!3^WE4">$F,KTHY#;_?#A3F#1:J:I@3:VYB8SZ7KH7YM<A)%Y#.F
M)'.-_0!$2E*9!21+,VZG"4@NNKCAFR595%=>OC:[W80&.G?LI[,N"=1)"L)6
M%Z-%6G2717[2VMQDA3;[$I<YU!IEHP4J3.ZY2OZDT6*&P:OCO/'&^RC#7=D%
M8 X#1Z@2NR+3% UFY_(I9[5N<E2N19DP.W+,?96<(+$?M1BFK'4A9$$.."2Z
M3U1( 6E<&EZ1^2Z!4YI7&KZ5V64!$-2^9:.<H_^"-A*/!UTT]4T:RVLEBD[>
M>% .#@@'T[=,/:O@J)"*&2MI$."*%K>[RIRV2C2/9&1! -\\<<I4(L LS$MI
MDJ;*.:Z<VL]X[[/,B4U2*5G$"S\7L;45ZV@D@F RZ5AJF1D^(K?1+/.APQ?3
MY^?6@WJJD'NUVOI0OQ?UYF\%%<:F==0.S6W!5H(E?;GBB=ULT%WH[</7X\[#
M]#O%QT,6'IH,>_S\\]]&\UF3G[Z=\<8YD'X=ET4V+3C<#V_MF@6IEW93[@=/
M9+(.'_HY$8:WFU>A0[I;R)7/S:9E*,M9RWYB$5R%;%E]20K-, <^XT5&(!;
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MJ5P^4^C7%<R?_\Q!-9<QSQ5I3V$[K>X!09<ACC"L*]41%8*U/7J+MR1E.ON
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M/612EQ1UCC="LPFPIA%UUY-_S7ST_6\2Q4&ZC=CYF2UG\]!#8DA0PT>L'<!
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M4T@;A^V?5"EM\& %*.U,\,)8K7JP3;FJ KT%]4C&#V J5;Z(B5;K&?+<1#U
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M(3+1Y@_PM?TM=.^LSM/;-0-S\!OEZ-8*<V^XN!6(1NLJV(]NQU?NE+^-BJP
MB*U+(A-LU4 .>EZ'Q/:-6B')17HJET.?.>;ACEN7=L.B+ FDQ@7M;Y]E*!)H
MXF43/7=X)8L23+:CH_T+E."\:O/@V3^FO/.8'WI-1.Q+SWPZAL(GF+[EHAS1
M2QQTMA"CR3N77/8OC_M!#?Y2W3Z4QZ#UZ81ND/_26OAB!+[:M:LE<W& 9PZH
M*<?\@"(M^HV,/O0 !8V&?:+1!ZS2%*E6>0Y^XRO.0TP6P@%.91E6$Y!U*H*?
MR+F-@4-AEE>H]3KH^*2"@^J>\436EB*RBW,B IVK?!#$J4''9;Z)69^(B+<=
MA>R!K@E2H\KB&+HM0RA#H0SP*#:0XQC1C'F#619!!J>PO<D"F_&-_5SHD;]P
M28KT IX:W87$)UV.02/<!T:(5SW;C8UX_)-;>!XV-;2 IF-32J/^]@BVL"@*
M(S?"G+!P\ZPCM2N1JRJC#G$(D36ZJE]U% \.#'>>[TFOB$MBR$#&E"E5>N1A
M.($5*'+@@(981&)75./_(75X*K@E1$I$L0!&A#06_^A#107TR%A&-2]*W@YA
M#CS.2; "'@(*\);[*%2)R"28(Q)LBMKTF&"<%4+0% H(A!S(3+@%)NN1")_!
M.X\5"7(<7BUNDYGC$HVP=4;E'*Z5]--@1$3V'2?RS$@L,6<*;248)1*'.T8;
MTJQ&PC+1Y(^;TR.F\""$F6(598NW# ]YDN.U)UG,.+[Y8#A#HY&2 .=YZ())
MT]PTL0K,R85CH9M0EZ$&WQ#$=LU!JOQX6A^Z'#5[GY%J=/*R#',1B&F><VF+
M(-#5"N @4ZD,J* >==59ZO-M+ZV.::(JK -NXD$3.9 ][V9)RZ2U*RO1CRK5
M_Q91;;*Q:=2#34:&9-2MYG!-6ZO>66,3'TV-=2I"34-(TZG$_OT521!))FP>
M*JB';>D@I HL3"<9)<C2E"<E3,Z'G#28ND"%IGG)R[.*5$+6Y?&R^+DF10]#
M(JQ<#CIU&HLTX:/4F;TQJR[9T6H[8T=5\M)[>JN92/7H&X9U))7_X11N4AD-
M('RR@9:M[.RP2+@(I?5I;2F)1E%;KC?AE4E,C0B\<'05F!PN?L8T4$N054/K
M1N.T_\D$>SH+SH\4ZB6MPVP]KTBMLCT@7/MH)/O& BD:O12?,*)=MP[W@(RU
M-W Z"EIU\XO98^:'P#M#7:?ZTN) O=# ($2@ZJ@CE+&Y1NIF8]SOT@HYS'N:
MS3=&L"66"BR2%UI5F-Z2+FNZH\&2_.!^@+M-:'C'LF==#0BBO$R/A/:#MB[/
MP'GIY#Z X  (I,2824ZACU(#I8>(KX'#*]EP50D=0HU766B])DNB%Z< F^57
MH"U<%9O4XX3TTHDN3IV1/U.U%0]P&6^(03L7_4.IR%"WTX.EC\EHPZ?$^-%3
ME1J,8]S9: )88&K"9YJ32)RG.7@@X2&N5%JLKT7_6^@I\HT=DQ%9,*56@+V*
M%C5HH@E"3^'2HRI6'1SL1EF%))F\VE+G\=+3D" 5F2J-/,W$#'UB_>'W(0YH
M)WTSI.QO>E2HI.X+?>$5C8=!U[4\-:0;'6*E4;-O&62Z:J+2RF VCQ>I*+%N
MLFE*'</L^FW?(R9"'.!-"UF5GD!CEA7S>A]SY0 \8Z&O/I;A&-R0F]39]:BC
M(W,0<<-J([E<L:P_H@E"[K=)$S]BN]*3 YW!:U9!/&#:_.(?W?PEUQ=%G_RX
M++OCT/?81"KWO6>CL2KSQ$&@2Q5UQ4OUI<#6/;2Q\[X:.68!1KJ7S\OSFK\=
M7Z^9Y'JP^0&V!]61'Z03_\^ZCMM%3?;G!?5+(Z-Z&5=$%.TUQA=)#'MZHZ(!
MC7+.4EX7RU:;ZVIU^[SI.#F8*8C%>496\WK!9)R; 57';5!23Z=D]Y%@R@P$
M4-]$*@]3$;GINXRW)[@D49EU2'@)',4+S;(&BV!P<N"19>R+4;@9_$]^'UQ8
M>?DU%3"O4M(I>J_4>_+_P9!L>3+\:>YC+08Y*>BW=7E@HJM*[(%DLNU,?H+O
MY%/C"<5D7^:;I\9=;\V7/TDG0A$<1/\]CBE4=L ]O7/NNCM*9NV A7?2[?16
M[-A"1<;V >3V(13>0%YXC$0N2]/TAU?"(@=,K[W\JD0X[)0L:M6*SJ[\QTTB
M8O_.4H[R#.YP.*B0$$66&G!!WH[[IJNRN,WS;(4HLDSMT 9SGF7I[JW\HL'+
M'(!:%F-1.*+=[@2!1&QP*' $Y6LY"()72L9H^D)M0(/ZINHVLO  628-C HS
M0HG$/D>A#,+N&N3Z#M GJHP-_46UL(F4U"QL8JDH0J<K,.)D%B3I0,('54<9
MC$0H@""##L1F)&D.K>F!=HQX\N=W8"/" LDC0$$H^LY\*)&-%$_NF./:DH<J
MA(TJ;&)+3.(D,@WN6FV/"J8N7N('HH:FHB% ^HG31'!9;F=D<"B-D,M:8N^6
ML.2._F]$;D?A\LESJD>ORL1"GD5*%$ZAY@T$B2E"S,7_+7Q#-F*E(V"P"\<%
M&2$E..8)-M[@H=2&I8X)]#ZO,-RE,$ZQ()IB@CX"<Z!)-*0%^TS"N%REZ@HD
M9@S*!8^#[:Y12\X-</9Q(W!@8(K)[]A$3U:B2FR)Z:IO 6U#17SP632AY!P@
M W=D(B;C F6N,FX/L#:M.9X*-3#% (^Q>6 'KZ*MBN1'8MCK(\KO,^+C@)!&
MN%QNACJP'&GP%@_+\:01(+,$(S*RUZ@($>^1C1COO&!.CNIB@C1BP@K.K+A&
M(^U*] [.YK)$#0C)O$(')4M+EBK#-.9I3!P@7 !,>W9F_/S%:BB2*#Y2(DQF
MI7Y"_WPKA9@1%^>01 1#!WX _R< 1I"B@QH_(]"$4-_DJBL\DK<2"@KOAV>4
MT, **(B&#U9$*Q;[Q%#2<6QB(P\[$2ZM#"UA91G@( URC4PN4 <[<)UD9H-T
M*AT38BZ>@F%F#RWL3%Z09"<'S2)FLS(@[,-49BJT#B1 T5_2($T>["&2:>ZV
MDCDTPS1>K,Y"<\OV:;S@*[=2LSD$HF08+838ACGJ<?&8SW62"I"&Y"KFQ[SF
MT?N$!O:NJ"$HXKMB(X9*!PL'J ^501-<QLPRB]HDI9?\HH"$"YX2)BIYZS+0
M+. 6 UJ:$L;>\MS J8)<,>R"3#CB*'*(":;>;&:JTE&4SKG,8C@Y$O,,LJL
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MPJ<X*X8S!TO\2G_^RB@5Z:1?5%*-#I@&#L0TIE962)!ULF".:TK(Q'#/5G5
MRE1P%Q/+\: Y!^'PK')LLG703ET09EEH\[9T $HWI26/)*)M&JQ395H-:38[
MD%?40!,4E6[$+$-2]3-55TIRE1S_KG%KTRC#JR2NJS8^:X T(32]S''7^"=[
M"5,8Y>GZ(M<:D</2U*[2*SC.\:B"VHW_ZK6D'X #%-;VIL@H-@SRCC:;))8[
M%0E7EW4_1,Y7R K[^HF-E?K@K [N)O0D=)!Y(0QGA9?GTO!^Z1,"(>PBD4J-
M?:.4R%.%0+1T5TLQ6UI8FCB2)(Z@Y[KL4GGLDL0N,-FAE?IN:;B3&<X:%P0,
M*Q:GF5NRTV7+(EFA<P\X;L?B+F8IVC9GWK)Q.LEELI>T"O*((4)>2 ]GH.(N
MGJ6C.%K][!1Y@5M]O>3]N.:J;9$H#0.]G\0HC!-1F3@G LU?KM)QI2B8R"00
M07J_&RW]9LP!],H[G_JROH*6*,((;-+B;)>?K25K"'*KQH<YZCAQX_@)5='#
M;(.ZSW?1$.R&_P.95(<[I+#I=Y@"(W# R])@PR&R9T(A5C%"+?-H7U6[;*K'
MZBJXHJB'3,0V@NU$,.>MXA +.KM60.T[7\:CB5V:.4'KJ[4,3#>,&%^+L*3O
MP!(6%IO4.[?RNJ7RG 8'0!F"$5\#62J#5[S%.@3/FY5PFO7L6A];*YY-*Q5,
M!^/D*7!V&:#!MG,[<C=$?RMR:=B42>&K3;;LNEH68X5*$]KS5W\@#F"%U6$E
M%"(C3?2-TDX;ZIX"=,[IGL:.?R+02SI0<_$5AV6;?VMFXH02\Q(JYBK6@X8J
M2^A,=9Q'?4-PS!O/8)7CY?97A[:I9!X  2C2VV=5%(^J-"W%Q/P-.?\G!.N8
M1Z7VH7M8NSN9=NHPZO8>(( H#R1\!L'M2=Z\ D//Q(N,4ZZ/W8_"5;'N2[6Y
M0N (4L%=HXYU8!W+<NEF:YSV1Z*Q5#M^&4F4W8P.0A1%,]:A]V4H-AFY8W,+
M>9Y8<W%/,YO\QU@.!P<8\QTW@4_Y%%$U.B1<[\E@HQBPS<PLN%ZN@S*>MK5I
M",%%1XJV@G&!L5CG.\2=,(T(*75_(!0X%N+=HP%G2Q2ME 7A[!ECG!!E0HK(
M&8WAQ(:J5%X&\4L1GH&GKH;-I7>W7 ]W8[ LJA%QTL2B$V]EXKO*U]Y7)(D_
M7=Y;GBJ+>B="!8B,H"*.D[C9E)8,"5T^=6G_-4B)]/36VV+H"*;?IZ*3.#"\
M%WMD*2[%@;LHT.R7 =>$B6667!1)O_[_5)A][1KLORRR0FW*0G&PI+Y9(0.J
M]#)6SAP^;+V+7SQF99Q'HGMBU27T*;31C;F+[U4U*-.B#N^\W10'BBVH0B'5
M+F\IBL7=MQZO)Y_>$MS*D_:7O*9K@?JX9OW\4$:0)KYRVCS9U32F/ ?"T&:M
MLS,->WHUD7V2T10@(%00^."!LFC[$BI<R+"APX<)HT7+4>&!!0@/*D*P8+'C
MP(H<.0K$&+*CR($F4PHLR5+EQY064'X<^8!@2XXR278$4I!CCC00]R%\B##:
MCQP\@0C4 ;+F#YU-_W%B1'FSYLRK*:].]6C3ZDBJ/2U*!?M59UF+.B]6+:NU
MX]F27Q\PM5@!Q[*(08DFU+>0[[*".1X4N:NPJ-"B0Q5N"LS3@="\"Z/A ,M4
MIUNMF&F>I-EV<V;,,&N6=,FV],O-)M.&K@HW)U8+.5KRA/"CXX.C0'X0ALR[
M=]#$$7/4+GDZX]F!+4F3_5QZ+?.9QCLK[]K:].J47)]O# O[A^_OX!_28ZC)
M 1#MQ=&7OKP>M>?C$'@^@ -\;_C[W_DRA(.69U/H+6EV75QC=46; [OA!QEP
MR]0&1$QH(9<50::IQEIH E;'G'(AM8?A3#@)5U]]C^U53V'E<>=19:FI!__6
MA3!&^-9UU='(7DN9#>ABAES%%)A$"C8$S3X-9C3?4)IH H>2FFRRY)*A+&/8
M/J?4]D .;T1#CS(+[I-#8,15""![KT5G78WO@4BFC6G.>.&8,1;HDIE1W6A1
M;5^2N,^)0?:YCW[[@/* ?VR%5F><.E9H')D>LB2FHA=I)"%L(SEG5HX:"OA1
M#@N-Y^>G#AFETE-C>M@HFS9J=QMLH(#J*F3Z:2+I5!9.>*A7MV9:$8*O\J;)
M;=NQ>))ML$F5J'0Q/OKBA]2ANAE'#^! (J"\420?1_(MN]RI%_*(H[?3/4=F
M@"B16BNDUZ'7T0^:[./I??50NP]_=0%AV*\$W7;_904.X/!3@J'H^\ FODD&
MIZ$$AN7:C.!NB!JF:Y)[*;B%#DNAI%Z9E -4EN7T%%H$R??#&Y$E-&2O^)TH
MD;71*;S5:&GB>FZIRW8+\:RD*9>Q2!->EEW.QKY4<4'2H@PJ<-&H :R*V4W<
M%+$M=Y73HNDQK!5'/R16'Y]&?PH*3S'6#/6R"8]-VP,)=LV0J"&]>7%<S6XK
M=\)H6M6T=,W6[5D.#N@9E#XJ"_4KV& ;1]&CC-(L\YCL)6IFXFXN3M!P*HYE
M]L&:#@WM#W#@IV<TF@066*L1:?)@;(!5$!B>[#X6S1NUU384UQ"!:;?%V]H(
M;IB)WSUCSWK;"G3CB+[G_];'%4$\&[0YM.L0[6KW-I2@%2T:],7,VDHKG;Z3
M[?W; Y7->W$X5C:KV.XYN_B@O"84>/0*AA)8!=BVN>/WNN=N.4VUJ5%B0_*"
M7W@:Q"/P"2AR,P(-07) NNC59Q,.J!7,Z*0:'JG'>ADKCJDP)C&QH60V'<D!
ME[H4JGW$CF>P>=Q%N@<UNA$/59K[V?4P&" 4UF1XZ!+:K99"01]YQSY^*H*^
M2+:0@!4D2:!X$AQX\@,$I&&$1!K4$7DC$1PPK7B0*U.!\ 8:+,8,B^13GZ7*
M1)V-4&H@L<O:_P28%[^-1R)J<(!'+O.:R.G*CEP17I@ !!8U(<I4=-D@XI+U
M$H8&*B2 ;.3-D$1U+1591UF0O)^B?A"*M0$QD;S1QXB, Z%(BDE[,T$=<7*0
M-C9.A'(C^>0GTR?)SQS,B\/K4$5R()$ 0D\AGDI,**RTD9=$!8_?.I@6NR=!
MR?D1.[)$'.7&",D)66YS:^P-M?@2C66@CI;V =UM.*6U:(2"7CAHUQM#1S_O
M1/\#D0SY4DA$*488(LN=Q=20XV!I*9TYRC7"DIE/KJ2)*;GKDJ5,Y"T/(YS#
MA61J86PENK:H+/OE37TT*1PQA\G,/>: /@L9*"85\CZ%P&%C$O(D^MJ)1>LD
M!IT;=0A*3<C)09)4ABWCB ,.HC:N(216L7%:PD2*KE4RZJ7!O(Y2/F(7E1:F
M9$!$R*\J\J":H&Y20(6HN.A)0?I!;8\\?2<8)X=-(OF)/SQ)PSD7,KBB-<0H
M$/@)7B82DZ*V<1\.P-E4H\I3H+J(60K-*ZU>-!**?*F2EDQI"5?ZT:EA55TE
M5=6%X*G7PWJRJNO!R@^ (EC?) @4%)FH,7<WSZA:P"?_?PIM9<%ST\=0;JY4
M)9=M9*>VDX7J*-GSS&8A]LS59)5;[AS4.AWSG7<QQ)H?B\LK:>C9<-75H7R5
M266225Q8GNDZ9@6/?FSZ ZR1+EZ"<\"7#@FH:!3$ 414B)4<X+PVJK.X6T0O
MJF@KU6;N4;TVC ^V5$=>OXV6A(6Q4E,MH!28;E6O '[L4#$RJ -6+[6,Q0@M
M[3M:X !*O_%L;W'%AYT'].VL]WW(B0((.I!LIX.X==O5"@)%M<F++Z"PDE>J
MZQ27(CB&" 8Q54"Z'=M05K0,YFA?HH'9"BC% G-I*FTB;#QF*C:64:W 7-+W
MV?:B]G8MDT\_/1>9P%P)2&0=_Q0.#K,VGFPW,3T63F_DR)F919BS50DC(=&<
MQ:&Y^*4MU*V<"^+EK@8VP](+#IV/!>,V*W2]QUW4H(RPSB;'9U 4!;2:?:8;
M/!?L5Z2J''P3[#"ZJ/5/&G5T7D)A'JDV37W(U%= >T4[/B4M(_Y9(06E&&,^
M(]:85T65%*_D \#NZ3</Z2Z]"N)C7I\OQ)3N,T./G.8A6P1L-2Z<KB9Z)A=B
M24&T\RYM.'74:,#A!PY P% ,LPQ!'?&F".$TMF_\FR\UA5 +XR*P@]?JUKQT
M3%K%(<V@)9\'&(%O#YAR-#6MXTMF-"&G6%6M_C.Q%Z;/I8^<VT]922!H%42*
MVZF>@?\MTZ87&@B-^8[&B3*-9_U$PSP'QJMJ$GIQ*$,KO:HM"4_"RV%^([4P
MAZ/90H?'E4B/9J8Y5M!)CRK>PSV<OSN+]=ST&MO-IBNRFI$/N>_\'6M31 =T
MN:&1$<Y>Y,Y\Z@JSV[7@HT-!"C-A%5$CM!,2L,"$-S&:P--ABG**CTX;2+FT
MDK0XCI#)0," ?2QSKO*(T)G9#7MOBQK.DO.PB<.3:@_=.[0J,%XU#"5M.<?S
M4$I\ESA8.5)X?ZB(H=;FHP_7OXV;,^-_@.PFQV1H"OSU9^:8D<ZYW+S*#@O?
M U]DH]>S]B(Y"F$T^?J_I1.5!/]>WA4O]2BC3;"YM":=9Q7_>[U3N(7+R>,$
M67AR%7Y(9K:Y3?M$BY>^_.V-1#I*]1[$U*>]-_"N@6G?H:.M[<F<X+8I_U;T
ME2TB!UV#C!O62?+D)]"=+1,+(27[D';ZD@/^<B7SHUU9TA" L64+,C^X935E
M-FEW-%+&$DQL!A:,-2K89P%XHEUJA! GXUN]5S#SHEV-Y$(UDG[-5!RSYWDN
M92.#D@,(, 9&<1ZV<7' A##X=W<#(2*O5UH.\2M_EU>P)EMXQ'YLX0!BMR>(
MQ'$9AB0WY"'I=BIETA8546)=PW'\<6R&]TXNQ5[&I7!6]TY\,PG^U'_[(#](
M<44=.%L]16P&QX/W-Q(2Y8&K$PIQ_T!Z8A%J[D5<7?01Y!4D?()9$.  KK<?
M>U80R(. <%!*$[$K8T9C1G);[:2#%DB!+G%[^2.!=;(4(J-=7 (<4-AQI)4&
M#C)'0S=S?[AF<X)@^N(#4\8?&V%&8K.#AE<5MP%%I1B%WI4\IV*)B!)O7_$E
MY>5]);)2B8007!-M/9&)6/=>^I<1/R)8" %^'_5PYZ%3%V0SD>1N<1)O)Z%R
M%6"#7<-C5J01$$)\:[8CFGA/QQ$8#I &4C(1T->*J;)3JI-QTM408/4 X64?
M<% N?G5LG',*)<(EU.17U(9KME-LF5AI;W9'^2,Y<[@]PU8HMU4GV]0\^Y80
M(Z2,_&933O^87Y5H$2 E8W^XD8_%9-"W+A:&40,X/] BC,SF89P43B7H;Q&1
M!A W7!)#5^+H$CF D&FXDWDA*^R$*,SF3CC00 +%<]%@!$VQ$E"'>57G9(I2
M%HG59Q%%2D.BA;Z'5'J"6:Q6*8=7>W&X;C[#63"!$O-(4T9A4)VH/G*3$C_@
M@-_!)UPC/VF%3;ZE"0(A=O*3$8XW.SS7$=$%$0;C:I=X5RH)AEG)&D=&,8NV
M1:)S421"@LC8B\NH8:*E'PV"%/!7)D(I2#XS0=WX4Z(#E?;($T;P:=[X:N8#
M&Q6P=)K6<M96&T 9,4C&68IBFN0FDDAY(J<P%W'FDA5(A31!2B;_UGT*X5J/
M$0I X%?;,1(?4WTB-X?+:5435#=2HX,9,1<" 007]G(\QY,.L1M%89;9@D&H
MIWE(YEBJQXUXM!($=A1BA1?\87./<YE!AX$<F9<.EA@;!D ,DA$_\$-'U9\/
MX#K9:&<-L0P@V)!Y\26_J3]!1W7!.%(LV8,R9RY*!B(O,2CU9D;%>!19$WE(
M&236UFFB\1Z%DRT@Y4C0R"9;D7^\EB\9@2W'9B2W<9N 14WSHE\X@9PA1Y^/
MLGA&XA-]<XV:9J!G=7EP&%+$.)DH"0%,X1]T-A4,))T8UJ+<MP]*0WH)T&NS
MAF[WR5>39! L"C\-X@#T=G+CET)JJC&=5OAJ6!&>M[*C5"$?3!$8]/B1*)-V
M8%(XY2=%&'<V2AI\^#AQS'%R!'&5U?D36)80RV!%/HJ# H$Z^72+-8.6'7(E
M,GEKT*F>)GEE2.-M%FI"HG.4H)-&_U045Q.)>&UI?@4A@2Z#,8#'06%10772
M157E$E<9(=B'%CSC95?R!G?QIF+:&R?S>!"$@R&1G63TB6B$$;.!'%0'=1\Q
M%ZHC%2)J$BPB'TJ1&PC K&=E33":$\E4$>9#?='Q5"MA51Y9@MU5&&FP*5@D
M+*B#DGA*;QU1KEY!'*.*-:7DF2F%3J8F%#YY&TE!$ASC/44HL1B"%E<R:BF%
M$-:T,16&@T*5J[U9?3=#$(XJ<Y^E7$ G1<+!H)@$7#T!!/)Q*3'5I!]2K/V*
M&?2J5?M3G0X E871A< XM)!:0*!Z=Z.QG[X!?@N163]0#']"I)"FEX(C'/EV
M%YZB'W5VC/]!X2_$<97SDUEBBQ&DXK0H^8-H>S970HW50SDUNF0Q][8@83N9
ME4+A*A?!RJ>SQ7<PT38QYV6< R0C\JPHTV&9)63UZ9T/R1ZBFIIA43C"92%L
ML63]81M65%\),1[=]08],7)\&C<F>WW (A.W(;B.EF,!@SP" C7>.G\AQWK:
MF3Q9)ZP7L3H!^*P:1:35I"\GUT@CJG6,"+"V":0< 74]<3@4\90N)Q$^*;,]
MFB\2"U78&6N94Y7!YYN^]%!/,2PH*4<71:BODJ_1X),JME^!I&:9<7#8FA:U
MR)6+N#<4(AK;$5:&P8PFF7L%@I7(%52.PK($8S)&=58>5Q[=41__LJ(Z:_0&
M&"$M2&./%L# "Y*.J\LSF;,H-!%_V),I/Q._*,%Y[L<Q&3FB(;.K+O01 1*S
M#Q<8.  'K@E$Q$FXF109D0AUM8IY03F-<V2RF:<2U:<6>"H<2DL4?S$<'2(;
M1I*]"44GYJ,3K/5Z\K)M]E@!J[<\TH<K.=AW7[&M/D@@2,L^M@;#Z"G#^'(1
MU\DST/&K4=,X<YL24.>LI@0'<F2^,;&-QV2T7<&W+ B,AC-+*.%)#@?$E828
M("E $@%I/6(A((4ZE>*^0;FG53B>2+Q7)O$Q^O*_)%(/$@''F-<CQKIPQ5=;
MD[(=6"+(X?%Q/%$T^J ?_/' #2PZWN%Q__L0!_KBL@"T$/JR%.'Z%2\FAZ8Q
MCF_YH46K@<5C5;>AG_KFQF!L@MBEB+RICQ9$(=E9I3O8&;H<2/-U&RN<8PAQ
M;=K#N$KFAV3H$2&! XXGIM126!623&4H)E]7-76&S$A)+=:F.CZ&$=5<S0=E
M?S11BUD(SRB3()M@1;WDHP5[&3A[?22[I,#3,KG3N-A6S@O;$"FVH^G5=5I1
MBR"S+2YY=8[4B L*!!H;@%:2LO?XM1I!.<C3NKC:9+,4R+C$F/M6IK1!)+$R
M$.<)*-SLD6\4#?#*CV\EP:L88$*YSNYX(4&61?$'&(#!+E@V+:B:S/V85 B!
M650*22&QQ,-A._^Q9K"0I4 B@950IUVEBF.FBJDL);*>&W9VW!9@LT+8TE>-
MMI,C0DZ5$BGY#%53=]'>J817DT(!F<SU@4C?=)96"BESM1(>X9R.IA^YM$LQ
M]W/$HLCO*B8BEC>(+14SM$+Y H)3PC70H+#XX5OAAAM,Q<\1)RR+K"94@9:B
MJAI40[E7D4_'EH<, <MKLPE[%G$O\Y\9C$%+PYO/R&L^_7*9YG$(H*"6/"_;
M9!^YU+QN=6IA5S!6ZRB@#':?>[THQ] Z/+0U6S6@X5>RFWJ27!5X(AQ D :@
M<)10C4FYM,VK UDW41JM3;NV%Z#G2[;ZR9[_Q!!<TMX+FEE'/&18X9W_4E5]
M"Y0E_NPJ7(-2<QG)=0+;<P0AU4VT)(<<(4(,Z\UTW%<4_-&&RR4C,*5^4,<3
M6.VFN9FYVY:-D=8B))%/2EJSK&$JQA)[40?$Z;U&"9X7"_X;IV"UBEH:9?MA
M7$QL[GL:3T?/%<,WK=-]^B&6I<.'5N4?HC-BO;3%52XAR7.X+7YEAP331-&%
MN6%KA@K!KK.&2KYEWM21^L8;<E3$SW6%?4;?F-W5\3G@DQ.<S3*>D,RV!5C,
MCZ@U1(')1@6F&0X1(^1/@%,8I[0OR HTC5N&'@&@I1(I!2A6ZGV4@%*83\<H
MBBQ)GZ43$G44+A= :;.OD)SD);&]HUL96<VO_ZR6'4RATDM\);3\)R'=HH3!
MF2GR%(_.@W5>*(N)9X*^-F^ ;TQD/?;<S>F!@2_U8;>CK&FPYB58R'5;3+H*
M?/:I1S5[G>6M76O.%YRI$(>>$-FX$TR:D0MM.;]$9P[@T@V;:V,J%&U8ND6A
M"9D @&4!A@AY]_T82Y(DNVLE?UW+^>6Q<XX3NVJSZBXUW/,? 8YX(:?P=V.S
M[ =E0W5L(4''1H(G^Y@#:@ *-%7H3LP0H5#LM\$4:J&MJ=C#/&+?H.$RQ[.R
M/Y#Q?Q[ O5$$N5$0)"^R/K'2@10=/<QJ%EX0-Z8/MRY8@"(EBIH4PKUXDHP5
M4)8>?%LVQHJ;,/S"PSZ:^@(2_SJ@:@1/NEL_@?FRCTY.]"64$%_#Z'3F@7:X
M$T"Z>@3O<+IH>ME'.$>:0CCP ^F=XR@S32AB;EM*8+'>P4S/W2R1K:1[QE]=
M?"F:EP(($2(9JWUX$?+!3O*E3X^OW6;RZ?VR&R_<$#V^3;H1V+^Q2W*!B*3\
M/(\A1][I[%BYQ9!)-US94#"10*9]%78=Z<)=/0]'S\(!@BQ<CRSJ-WCO\=NF
M%Z#3A:=%8 ]78%;R3JMGPC5)^,D_\L(A[2Z:-'+T\B3!7P3&R)>QR:='>/)1
M]V&_L0^8J_<-$JN?=Z<WLB)7+-@\]!X?6M2R2RB8_'0\O^F+DK4_2O _6@"A
M;U^T??\%0QG)\0,(D </(%C0T1 "PP<6*CJL4#&'18X7(53X&#*C2 @/0)Z$
M8*3DCX8/*#[  8=@09HU;=[$F5/G3IP"!^X[I8EE0Y 615HH>='BR(P6+UX\
M6;%H0PM +#BML/1C50LY8*8)]5-L39\\Z1442I7C4J4F*W8,2;4BR:QSG3Z
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M !_M\P-'FW#P!X>\\,/5J/RQNE_$/O_5&8LFE$U [-SV*M<^R:&M<'X3G.'
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M^C/9;F(V;0<RE)Z_XG>[A7V(\D-#NX06'&FL)7ZV)*0.6MRC\H!MG6 )6W-
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M.L>W0/:T7R "*G&F?UO-3PS_]=35]L_HR$4<M>'2:86.T ^L(P*+7=9AYWE
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M^+ZVP>M+$4$73U_S'XJXKWYD[EA$B%=[-^AC .G8M$XD8RKG%OE8/C@R\\9
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M[RD&U-JE2)OUW'K4PQLZZQ /2!R#0>\4ZL<<:KGG*[@NF@E%3[!E^+D983Q
MMQF>WMO/?Z)HD@PDFP,3A!@T#\@EPBLDD9@ SGW"L@61[%?<F!^DN2DN,@*&
MB,,\H.0^S"X,K'C M#;J7]E9PMUA(,$#>BD82)H'K+N '9Y4XOJ*&P_@@\F
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M##03AL[9UCVU>A,O>6['N4M.DMKE[QY&V]B<O//?]!U7H;DRMG(6S'H\)WD
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M@[65=:%_]N98Q2TO%;4(M^YV5JZ^%>-OOK!EO\>VUX+(7YO^7T_9]E\MN#O
MWYW;9.7_';OKG=@!=.Q#,KN7T)DUL.^75@=,QDZMYR:ZA[O^KR<+_W:7!$SY
MNRV5%V N[. 5$MM0_5RUQI15-7=("(HE/V;R$!P)<=9KD,XPH6W+I 3&0 ;0
MUP^?&/WV0<;<IWY&,UE4BDA ELKEQ9P'_,D&-_WFA4%^2+B"AU#ESP&&GPFL
MGURDC&F<2%;2.UL@N<<KUY+P"5]S(T"Q3DXU*%<?]M.>V2R8PRB/%.02B+_@
MA?J#'P;5J3MH"@55L<*5)'->^L"]2'$[:(I[QDU_#'PW1#,$>8C457M6:R /
M82R)9AP!GL+&%X8A$OL?,*0#O^N_8#@&^!>\Q:]#.$WBW+\1\!"XY@F36U'8
ME/!GPA#^G^H":N2(/9<?MFV(E%6!_\[GXXOQ_!SS0K!ILNU>C2-5K;O<5Q9_
MOS" 4&Q88:/GL\L\F/1R_X_XPPB^8?MS+C!-Y"%4Z)-HMGAY-W=/<K4OQUE2
M<J?MR<=I@4OHH(;.\XT7_,<_$MKWYB34_S("UO>.?(@D]B2J54O(!R4 8S,>
M]@I:%A!^4N) HS45M1EL.UTQH.-<3^M\X# K-MIF>.WY:O8=1-"+:C,0XL=N
M!B-I6J1J)VZ=T5%0#"4$WE^JMX-$&$#TT+G[BW,6/1E,0K%R7?:&[Q4#+0V)
M!T\LFHHYM54ZRIHK_3JUE[\)[:<EQ#'AOL):YD =3@J)[X9#59NE" #3N>5&
M;HO$YT.';>:/AIEIW\"N)I_//^BTIVV?\N \MAH2CF8?Y)@S"0F 9S=,##?7
MB-\HG"%NJ#LT/%>WFX&+W;"ZZ%WDO^=U&>GX 96, 5=EA^V!5\4$FXSZ TOV
MOD0F Y-/, A( W1F17/S83\=B)M ]M<<?(WU!?$^=R>)6^?./M&R/]TW+]85
M.%V%UBUS^> E:B%E>_+$[.O)NTG_%X=&-A? IJT:O[8"<#<.+>9A!@+^4E$5
M>I1! WZCH F<).T,B&+#>/FQ,6$O@932]*\'KNO*UT^B IUGC.1YB*&Z,ECK
M$SM7-?^VF@'B(<N:0.Z==SS$:^T)2N#JO@_H/VMX*"/EUX8:/T@8GE256"H/
ML7(-6*Z;J,WXYSKBHT7\JNS9];,FRZ\!EVG4XKYF( I8LT(?6C_U4<_9_F]W
MF=C:D) T1*0*L+,P2]6$<C58#JB,68-Q'_7;!_CVN^X[H?UP/F1>0:23N2JJ
M])TP_U#FHMCA/(35^I&8I;9>T0E'DJ]4VC"&U&8HWMK3M:5=1MELQ_YZAO'&
M**03N$01X(B;T&SFOS"T6\@E*?,][#,^60(-"]LG9FTHB=96C8?<_+*%ROK=
M++74KVGB!A]^C;+T# ]3C<G:_&A!>O<)?,FOE]N0,%>N)PI"7X"RC$0V&M=5
M)U%2TLN1HSSN,U3*FY4^\S!=XJ3I=.?[A25BE_(KQXZ0:P</ZQ ]B!%:;#1'
M/_TT4S7N/I&&$O4][P=L-[2[M#CJ-.AE*WY:(LT]1E(I2K 4^RP\5''CO8[E
M+-C?'FU&,4Q3I&>S$8. NQ\J058"P\<Q81]'QJ\]L D\,K0[8MP<4(W-/1VF
MLKGFP:$)Z6VI!Q\TSAOVK8G_/P@9L7^$O0V#WN=1J %> +G*!'O"7G".AU"Z
M7<6-AB'$S-)U)(3=W?%<)I-=\,=<TE3"O@;+)'&$UQM-0PT$N)'2/QI)KC?J
MYD;#?,#,W(W@MNTRM,@573X2R'[_9WV+4&A"<HJ'0!$#",,++-L!NHX6R8:5
MS,!'%E?P)QFA)7S?>6HF\S7[JVR\M^&01-HA;;<23"; N%67_](;Q4_T1(N"
MV;,3HS8?N,4U&KK<\1Z^W57._L:O/55S8ESPEX^C7KGI<?,@?HX>>(8H;[0+
M>Z;O%D;@R=<DZC'K+#D'&E]\2##"+$))OBNRS<W4E,'/>L=]#OO;!*0U=6&$
M2%.)IOFK"(RH%%"^] 3Y?Q03CK^PMWF[,2+MX#>U:9O1HY#P>IP1BQDX'\[$
M-'[6HH=,'IT;MZ$45_OX>$A5R>DVE_HLY9A)?[IRG+_.[RMZ,A:%PHE#G;!5
MS&PDDU1I]G'N/36J%*2 GT%VU=T?&6JR<_K3OKM^3(7LEA30_/W^B [?FK8I
MUH?9!@F_8J)9-J M!4/*9Q5RDWX;:C#\FD,JM\].J/09^NIJ^#4PR8?RBEI+
MWH@<IMT_MFB6)N=7_2;IN>;0X>ZWV-/<"JU+W#?+P @_*Y3A%6OH2O.WHHR&
M_@1 BQI?DA%>*BZ@Y?6A%AVID#072^51QKMM+19?=!(_ZUY'AN?4*7+?HB<_
M0/NYJ>MX/D2L$FC!#T>WJ-UX#7XYQYBHI3AK20SKW#%MJ2S1S-S9-W[$/-0K
M59(6'JJRZG'^..8)%7L5!IKQT#*6!PS,HA0B*1T2XM+P"(XTF$IU*$=MYEP;
MU&7K.VK^:(\DW/K8\,PZX;A^Y/6Y P^T=?:[IV[GG]/:@1O$EW5'$'U0@KAV
MG :8O@G?'*@PHT_*O%=S:-!^VPJKTMN-:KR_]4J*;X%\\>Q7T<K[I!N_!A;)
MS2FC-#-&($=2E8*?1Q9!7[)2!PQ]*/Y>%WN,5'P-8N*BU/R<@]29I#;1C. Q
MIKE</*Y[).(A'UZ2^QRX1AS%4P&.%)&&GV=3B=%U* 4I\"X%(^+H.&,W<>2V
MJV8CR[$8<_$:2?1VB/K-?=[V7RYN-]^1FCRS@W_9H(; >L.MY"$\T,/XICLA
M"41?=%*6^3W_VXG+I;U*-6)=-^X>_7#VX6A]BDY-:MK;$U-7$U:KJ-(<*>U6
M._1F2!?73]Y$O/J(:=^X$%&GVU^C3SMVX0*SS\=I8/FS3YROOBPN^YI*@O?E
M0R_>^!4$/S15D;3@JR%#VQ3 % HZB<@P1PMC/1D7K#23J'B%4''GGJN?$J_>
M)\TN"N5XNKPH=']XU>M!ZG%4WL"TTS3=AVT(^K'PWWD(=XT@ZFDI'D+<T)(2
MQC'- 1T+BT7&9CZT]W0<?F1VV>708<%O\I4'A4^D'9.J<QY$!R;)P3PFJ@@,
MA(16"N !?IQ=48#5[\>:ON&<ZO\C@M)T%LP7_#YJ+I1Q)44=./#XY27W"S\^
M[/?FGSVE1ED0!!K<Z@Y@G;AY1D>@=O(F>)$]S]89J EG^)2?A#H'..YYPPUW
MN:\VM=1GS-*=_/QVW+M1[RZDT;PDE[W;]KZG>:@ )&(/LW@YH$&' Z/7ILV8
M$?-6_K.@<^'LFE8S_O[@G=KH\5^RR<^B@U."=!Z^_IY3'N"F['. <[)9]#@J
ML ?SC"Q%G"3BM]<)PTL28+N#"Y#08^9FY C,7>YX)J'C</O;J'YZ=Z6<P9PK
M[GUZ=]]0!Y0S.YP_;?I\IG/+J2_J*C:OC31AY\>8U@?X:"%P[>0RFR8_E +8
M1Y6.^%WCE^\V.Z&<;O&=KK/#433@=6U"[V\SGZNI4H=ID6N_@X]?_"#0JYO*
M%&BK$P7M)^'A!YJW^A[3-V9,I :]][OSX.W7RLI@ID[9J1,;FM6]OQ[?R*Q7
MJ;,&80#:9 (F,I=8%B"=J46QG__A\X9C!XI270.;%/8QM.)J;*NM4R[TY2PI
MA"Y0(W2[WIG4VJ2+U_4^2=D]UPU,/D=5V=.U>(AM/GW$:P22- M7RZRO9"B\
MHH9_*1)HL4O'A-Z36= ,5$Z;F'=N\XU["=$]'B=0SFW;\!!9A=O "0%MV&<X
M\HR5-AXB$J>5@F&D))3_J/M^.X[N&>%ZO#EBPJ4]S>RFX/[90L%=$7[%A$RC
M+4"#6=T./Q3CS$(,4+D+-+_QRIRI.6K9QQ%A])WX=-\O,>G4&D;QBU75S0\G
MA5H=A\UWGFM3*A&2T4T-@E_W,)/8T#WJ5\]#E$C34]FZ(Z%:MF!1'L:%H\[4
MOU<3PJU^,V=OYZUPU\#S8VE)6N^4FLI807.7XMYTC>,HUW,8H7_$XC=A;W-?
MU@0R"RC(^1D8Q;N9&;4T3'2=ANNVA1.#-4%Y,P_/8"N#TZC+3_U?7KFH?N/X
MRAEVE7Y&1,5-3#F:(X6BQK80P-TA"<#D:V()T-B^?!>G(7>V?/#6@I3OA N$
M_!P57/8I]<1)TZD>R_OQ0'"AC#R+DK,+E6O[ Q %_+M'K"AH.A\%.>+<1I2[
ME:@5EWWT8RA6BR+87#;A6GJB[Z!'C%R[C89,=.<Y&X28A8 ^:P,SI(6'D,%U
M0)L'< =!X3Z3];0$)I92YYU#G\^FO#U^;9?B3_L#)]U3XX^8U"17)_O!+AFH
M/IW@SM#B2+!9?,PGC.*"(AMW&D&&^^S4]\+FE<SD->O2PH/[]K^LGI=[D:;#
M[C50+(M ]OJJ39%'W"%A9]I"(@:&KP3@$I+DSC+KQXF"*Z<8ZFXZC.;S8&N?
M<^50N50U6\E%R#]52NC\S>U-3XWF'DYI6@,/,(SSY(0LK7JR/&X058:9?^7'
M1%%"FA)?V.J.!P-Q_*>( Z]Z7V=HG)FV*&=+,">:-CYT,?_L0W]0%*CZ2!Y;
M^9!_[KT:A?P S7 )C#$2!,/9A[&>H"/;"&QJK1/FYG+L\[RSD/%%JI7Q.I\(
M>_;MJ<GH*1^ZX'9"Z=D!92/G&E,I;#;J/0PLD!KG(+>T'!B>8R7 $Q\"]C7)
M5J5PC@#OL:B[XBUW@JN"J/'^FV<*O1(V?)CI>X_]O7!#693P=6F_1[W Z+)]
M)ZH4R9'(;0/D>(AK&#E< [&<,(\/9Z13;6*P>_RI7?OK0QM'7<L'EV6\8,CT
M2Z8*TD0_G^Z0.VER*?W^46N-3(Z$,W6H%<\/DFFJ\Y;LO:.<,PSS2-TN$XOT
MB]7,:9;U0OSO:T)6#3G.(FKW:DZFNDF$_:QPO)H4Y1%<C;CKZN;()+-&N8_1
MGH%Q"L*@#;.-YIGZ$L1358A>.:!V4Z^0:FW_@F:QU,0FA\OFM\P>1X5]D]JS
MZ_=UB=0?)%6.Y KK&-.&(TX[#;]]<N@%IX$*E."<S=;D%,J<WQZ#@8DJC?J*
ME)-6_J!^T4UL437+?>49AS!AWXYB.*(2T.73<=!AJ,E(!EQA:WE#8N6UW%)#
MR;<SG\FQ-=C;Y56I*E?#15K"Y3"*D_'1A+0 Q<L;B;5R]J$"OQ82_Q$-4$\N
MS[_'0UQ%2F(MH_JHZ&0=OW'[Q@D9/[7[X7-6QYW"-A;()!Q[Y1#S;Z-"=N'(
MLOIPJ\EW^&W )== EDM_IBT3N'<[R=D,?/IV5DIQ!]T_YY"U?.$-&:]+"V)*
ML,GN<5"+T(YE\D/"84Q9-JPJ"K>T1J)93N7,VMCY:3'5%$*-.2WS>QZQFBV.
ML?++:_Y\]_NG4,I9D3.L]F^SD@GX0Q''YEBON,5HS^[A*LKM[M9 4@IM<_HD
M>2OI!0%X?U3J\2+"(B?)R9&<NFA6.+9</-WDIMA3<YG2A6ZIDZ]AF^'?.YJ&
M7+[QHS3L0WMD3^6'+9_L!#9NT&Z77!V%@2N$FU>'@D@ P[^J.9"43JF-F9)%
M)N-V^GRNB,G.ERUJJ:2?^O[DWT>$U")9#_XQ;560$(VAQ KO_V,STAR*;^ A
MMHLWN4D^:\4P,HMBB+&WU=JO)*O^(R3$UUYC^A7VVNV]^5^6$$9C.36!K&3N
MFYH0AA45V9@2 VT#C3VHM5[4V/B?/5"GX=EKWQX]=.@*OX%;K4C_6I%P6-ZU
MSGYI3Y6IV2%.'8:Z .Y#-=/]FE"R."7H*ZI,)9,IWD3DU^7:&S--:_#;O[TH
MPLS>\?]L';[UQ<,/V7H7R26GA[;7W-<?D=FLO4N@"L;9(K07?B2W&=K "&Q#
MQA_P-L W+T@U4?#\3E8>-PX.Z#H" Z/16P(4N_FQ,=NESCI((=9TL;EL;]B:
MGE@.',FGH>>7&,065&EQ'M4;.H0]T7?K&+*E;-;NX+"W_I#29M,M5S_YT.*G
M+L>YFYV_>%IHUVWH$+?,T+T UY^]EYL*>))C< I,KP2."$5>OUGA $8"_+%\
MF!)[-CRF/*K?W#UXY5"J+WVWFL2Y^$N;3_3ZGT4".3"TLES @6+H.WG#+:W$
MB;V@1]ADEXVM]+ZWX(5S-<Z)29JAFAY5:4)7386_%8EN+;^T,\)A"_[X?S)Z
M&CB#+L^<?\<09U4S7/%-9!*J'F \_,62S9G5RP!(F7;9KIUMRB>L6;VM;5,9
MQE&G.".MQY5:@'].J!9Z-&41I]"A%-W<]W8J3S7T;47!4AH0"0[)@F$O;BB$
MJP?(YND*["BP[#@F_4B68S--38 B>8B_"LK]N_QM:P0PT>4(#V&T?A7. 1[B
M1VS'/Z5KPR>HK<'.?ZPBT #3B%_#/,3B\B!Q52\%O*G*$>,AH*04'D++VH^'
M2(<G-*ZB";\T2X#XD9 #BBGP\1D$G(-]ZGP>HK/[O](S]+]/(R? ,?ZMPD/@
M^P'&>NK(LE7P[SXMV_Q--VNK63>XF;A-4(?1QH^@#]LH5 X2Y8K-74P_E_V%
M?69VX?:7MIW^*NRG5V\\3C@8$<SYU&K9W7DC$W658YI6HR#[PE1U;W6'J<8Q
M9?+DW9"-8/B+ZQ.A)1^S'OU0<%0S[:BN#HG"Q).'ZE$,6\+J87EQJ'D8O5S\
MNXZ'(*!! EN#(P22J8*&%Y@F]412"&O0SV<+#T$*.>L?XSJF.>QAB]8NZ9"9
M)FP@&K:7R1YQNU0P8%V@FT<@%)C/[#3.&.HJG8[-Z7W<-\CJZ]%>3$[@ZOXU
MZ@'%6 !&!*!X:<C^#Q*R(%3Q$*ZEA"G\. JR +7^B.M#=P L<55\:?]_W#B7
M&]Q)3 -N :N[>(ASVL!T_LH7V.M''WI+Z,. (<3Y:![B9"*\*M9B>0CE<^NY
M3+D/@5^IP _@+#QK">BA:P6KJBOPVDE#_K<\^2AJI "R'JT'6*H^^#4K^> !
MJR:WG3TU*,HH4@@,[IY?PSWUDBQ*(C[I_F$B>\]TK+GL\G$9Y?2Q 1*GM];4
MKN9GI3^Q%O_N\DQGLL+V\->98\E(%W"$FU0X[H-F/%C%>[[(73(:31H^_$UO
MIRT&Q/ 0?_8!4^N?7_V*<]B4S"A=M8[;(N/BV#X+-WOVZ=P@\;3K<AMR>(@8
M*P8;BN$A.,\R>8C$XK?]7_IM)Q>X8<_3\I\>.6KMO+9XI/O?B<N%I'D([BG,
M*AJ>_[G<OTK(A22UFA;6X-\L!F @S0*2![D=7D-/:C.\.'-KJSNG.?"R7GM$
M7 1XB(H>'D($UKP\K?58$_IM^,_&// N#W$"KK2&QZT%KA'.I*QPX5^MZL,-
MI<W+OQ!AWQYS@.6(7R+,307A&;#"S9[G(6"-AX;,_ZWT(?-_:LW9CXDE+\/_
MG1HC<EP5^C0A<RZV:<03^$8DI,;F<6Y"O?WT\@70E'4WYU8*,!I4%<3W_-IT
M4<B?2#\&L;[2_MR$LW?XU83CS"J2Q^%+-Y$:<\Y_NMP<PG3GTS%#!08?F,TM
M:']E+IJROMWW[=;_?0":HY5$4//WSD_VYPNU^V57+_P=@'#%(SY6:U \XAS6
MLZ*FC;U#QV:MU.2..P<M!6[_>%2;VG9_[34%Y=6-"]G#O$D:?$!\3'9?!7.(
M+X&_!;9_ A:BR;]'.UP@;++#XXG3?U <88!3".'V_F>S9N9"BD/;@.[W1' +
M>O42\+\1@/]V/YA[X6^D?R9'$AE6P+ -RQ]\D8^]"FHPM-G2S5FGOGY>SPPI
MI/<NZ(?0Y="KW+$5+3G/(_)A%QY,78KPZ_J&M6G7WI(K&I-_ZOUCBU/[F3&$
MO>4$GUK=^6Z;/8R"N)OS-&1B@5UZDL'#]/+\<#/+:C<AC+6N^7=)&H9Q%KVJ
M@X95H!H>K#S6G_F*)*8 9>6>T3[PQ%(]SK#7B/R:' <-^;#B%9?T+$JUNN34
MMAS:-YG\9 :3<*F@:6M2GI.SV;F T1&=[C'FLFI"_4#NUA\R>^X6]SGA4Q[]
MIX+(<$E0M0>F _T9S4E=S5R+?\9#'$/783CQJX]-<5D\1%,M3'51:\J854P_
M>E4QY9]1\5_;/_RW(6A/+_ZG'H^:J[3EI+-A>.@0^&][>+8&O ;AWV"8_-PN
MK=7Q(9)D"T>1FXU#<@3]C>LD0!/VWMFHW;#NBXO$<\A:N.X_O49C82E],MU'
MZHM[ZY &;>>_!NVC[E/)50NLB]=,8J%/M#,D2[\69\L6G#E7-^JGLI9'+FGE
MN#'=B)30:Z@3Q,4M7;LR5RQ&2ZI0H3MOZS8#C200[JF) '0*?OEF^T(_2.*[
MX=D2E>K+TW&6!W%_A@)NX#^;W1'N^BLP%OZZ<N#1S-YOTKBX/M'[K1??_Q :
MN5/V#:#XKY\>>P4+W:/(0U#AD8RI8 I ]Y&<1^L?E EF_P'"5JY-"$!W(<&V
MV;!8#H?C.(UF5*Z'TWZ'>5Q:*L"4^&N7<X'_$&0'&>BE!8;Q'\,F"(=37\*#
MSICMP*]+\&1:$,$$]%^ZK-9#I)SG&,$U\,BKP!-%_?5/?9X+1:VN@+O6LB_S
M$&BT5%@W1X,0AUX^ $R]QG!,[P0V);F?'ZI1\G_O.V1T;5$GDGS)A=*^<R__
MR[?HO\B>\S/O61[?W*!3JS+:&77HE,KB<$?'C_ACUD%4/\K["Q6'1\BEYF>D
MD0EYY_^HW@Z@0QY9>W,^GF'\5T\2_O5C@AO!T6 ADJ-%]6LA#BX3C2X^,"-,
M?Z88J^ZPXW^GVQ=3)"L9]CKHRJ_.6@6+WZ'6DG0TXQT.!7R',3/])@_!O/77
M81_*Y^:9E''07Q>)I4SY(1ID+LU0@\SF\.S-1.A!<JU;Z7K\!*9)/PG(\<&=
M),@DX;N#.].V'?AJ?E;-J:;&UGNHJ$M\H/'<8V'#M+&].0G3!B>(JC !GL$D
MHP2P^R;)(YD-D!+XZN7(+,F>;D-Y$7*A=WK@BG.B]2%!3<Y<A[O&I]TV>H;M
M]7LGCOPD.L N (S3@=TI /\R&E0-:4''9Q%:D5M,*'1[2C9Q<WI1974@RWGU
MV9E/%Q.$0NA99A[[W]XKVWY\X]"/P 9RC.P"G<Y#;,8YXKI0I=T)ZEA+V@+R
M5]+==Z%'S?J5LE:[\/&>M>%'=ID=4B9L\;1(?22SPTSZ: -A?/]>_B4DZP_W
M(\0'-%BB)Q,,NIL"(W![>VNLF"94'N+^\CC_2=#F<IC<7.7$KO "P*C73WVU
M$H:0U#UICLJVR8<G#V6,5"2A2=VL(]QHW%YP@:(_K\1<8*7UUR&A[RB!.CX0
MMT ):4,A0ZO9JN<^)VT=CVD6+8^1HKAG-'AY/VW.TQQK[8G41O45H$5 KS.#
M 5CS?#"X=>L)YHD)3)-WHLZL@<!U_0,*/Y-"FHSDF-;I/MDJ#&YR[K4?5J-D
MDG)[L]?&@JAMAV[\T>$#P]@W.('<PKJ#0$,)1GJ!"!LT:2>PS8Z1V>J,V0JZ
M4\U>7-T=VW9'/C:N'"RJ>!L54:K\3>7D8S-E!]O%ED3]?B+#!2F&74_GG(5K
M=1/B/B!Z '$D5%*-.]./JA*I'WN9\?N5?#_)Z,6F]FRV_2>+CG '#7ISO%*[
M1$%GB7MXC-'ZC8MD;CH/X0V,QD)",P1<.[D4AMUJUPMN3)6"O#.96<DE@>[N
ME[<^YM;V"<F,AGENG[<]>;E#N1B!=N 8E58\LU30^ Q>S98>U+TM-J=W2*/,
M):Q)::5T5/MU_D?_MBCMZ(<(M '@CTHB"^B@P"-RK+,]NL2$;(6RZCXC6;"Q
M[WS4M$.,;"]U=J"N:TOUD[! S;X2YTT@:9N9_61W*SX67[; V1G-M@@UIWXK
M,GK\'GL!O#MI"X9<NK4ZE8XYX/PL#/HFNHTIES$QME_]?+6DPWCF<N^301;=
M8%Q'T,-V?ZFD7-3SJ_Q# OR++Y%-F"0>HLHKDAC0/2S.(I9RWQOZ4;5 5P49
MS X?-WDN?KG:&:1SE/(=FQM%9@J+'FF,(F1]*N3&9R2BK^',.PD5\(#MX^8;
M;0HM@+86@'PJ3YEBG<>Z&-36$:TFIXHI$M;.;'FTL,&Z\;CMH*72EH2>SQF=
M#]&^?:=Z:9\^UJ185SD6-R:^LY/<>N!<Q$Z:1F1]M_$%XXUZW_,JRM5VWGCK
M0#/ELSU>C]@6%;$OU+U%0899'.E#)6X&$YKL>Q>H8L.S3AXD%^<QLSN&-W?O
MG_LM)+E:QIRFA31TZ4/;(L"#KS"<BXQE_>NX;VO?TF\$:I8(E]LO83J93@<T
M%K_-/K!36DI]L TVK3W'44\ AC5 DI[4&.)(FT#"0D @,[^Q:/-[/-*S=UIA
M5]5(F-2+ERYYG%0]CD4E/55-\V3H:@GF,/05+66T(W04$H0MUZ8C/5@4$VG:
MOZ")T\9>'"PJ4M<]G)?AJD?M_6Y\YWVAE7.[;53GYM;]QU4EV8\QL"?0<!X2
MY3AS7Q$OH1. LOSZ!7X>(B#T61NTM>Z[3O.S\U7E517A3YS01F$JUT_Z"ATV
M#5;E#Q"ZQ,=$MJ)(<I/V;410;[014Q;;&+AC1D$;C*21(^MD&#8Q1B@?Z1Z;
M M?0>R,C#2R@]/>2:-&469;Y):G#DSXR44D#X50,_1ARWH?M@.O&,TYUDZ9I
M\&)H0M^[(SW?DZ\-#IE]_ECRK,U-J>S # \Q//?N^$;6A\+K.FR-B7T_4G/,
M[I8J6JZ@..)+%&0\;CO4@=I2(\!TIMCFQ]8$4I"Q3EHQ?V9H&8,_BK,;6T6"
M0W_O\CQTO$MF+\J/;T":6#;N\_GV\G<7MV$3G8S>L(Q>J^WNXI-)G1:K9X1D
MY.-?(MMM0.64A#J4KQC08 )XXF.@'8/S?XKLJ5[Q%5K;P//332&#*P=FJF2]
M'GOW*3/O1_ZXMK_MH..3Z1][,')HAG4W:8D5!)N0Z&NZ6GPI"5)Z:RD1$']H
MM 4S@1Q;F6C9GR6WG-SJZ"&,]\$5".[I?'ST^DSUGS0U9X<]&:$:N>9/HT__
MBI 1Y#-V'YODZ[ZT[W)55>662H;RY>?5&\\>:IY*3YY:M$;@9,'WY M@) S?
M<[@VH-RFH1OA0Y;6(8XLM-;),\V;87HW>*[I+;?,JCR!18)(SMC#A\RJ=I4:
MO(CK5MKZUF]N8;B:-0@CUD%H""5FJ(QGG %&"/59TXFY:1H77/L+C9 J#R<V
ME9AJ:0S0:8XYQGKV[?&*J21+UU/I8AW[H=@!#>FF; 7&6) I97QS9X.FJD^Q
M5.> HEC[G>I-_$$*4XO>_$M'(<$AMAG4W8L;)U>UOC;2!RW]WX #@6^;;D**
ME0X_RI)[J&D_'.ID)5-E3D?O%YP:^HHJQ<=CCS!CH:VWN.\,D0R"6RES<YD'
M%;6#[.IC<*QSS*7E&BEM7+E+3*Q!=I./9%R#K;+79F*(]TLD'_PV'K@>L@#:
M!S-<19E.P F%?O0CN3V=+$+95/?3Z7LL-DT%'X@O&IBR%3,\K6<AO1NUU\+#
M Z6\?DL/I(>59V XDD.LS7TUKLP+39^OKNDG&]K>*&P!"AM$?!AC/AE,8V7*
MDS UY=@KVI-'VETFAV:2:FMK7XOX^VTPE=VB?..M[;E?B!F;E\BO>$GL#?
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MA_Q[_-]3#Q<0'P\?^+\M]YT ,GQ,:6QF+ Q6 "89!A89QGTO@.G!4AR,_Q#
M?PD&)A8V#NZ#281$#QL:2!_,Q\+"?# 6!_L!(D; P_\ ;#(<<A:!E[@4VA9X
MK&Z/!8,3O^"#9&NZ*'4F#\%"ENXA!(14U#2T=&SL')Q<$.%G(J)BXL_EY!6@
MBDK**KIZ^@:&1L:OK*QM;.WL'=Z^_^#AZ>7MX_OQ4VA8>$1D5%)R"CPU+3TC
M\VM^0>&WHN*2TMJZ^H;&IN:6UNZ>WK[^@<&AX:GIG[]F?L_.S:^NK6^@-K?^
M_-T^.CXY/3N_N$1?_<.% <#"^#_E?XJ+[ $7YD,,L/'^X<+ ]/JW@0P;AT4
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MJ:+[NBDS-\J7^8SBEX]5A:-:N-L</Y? 4KQZ%;P>IS-ZE/"]A!C5#E(X.*[
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M_6=*FGZ\F3)[= \H1)R5G8@]ODV38AQJ&SV,2Q^C><1:V-=;/K?<["9V(F7
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MW@-\K-S7W^YZDJ(4<;K(<4YHB&O*.+>X:\K(X28^]*-JY>2EI".L^$>A.O>
M@>I:<__Q4J2SUM>O5>_\JQ9, JL0%QXD3A('MQ]N/B "J#W^Q=2,Q%2FI_NY
MCK,1,O!N!6V-MM"*KR?)J"[XL/H^N#Y]BF0N>G5%2?.&]96D7_Z)H+.S .,T
M#9:T V C%",,%RH.\4?(G&RT:@JYBI)S962*>R=!?1A6PCDR*$&\76A2NZW5
M'<'R$59XDD@BG8AFPO#CB/6! UR&_<04NXMWS=9[M\C6MPN!_%7HT]W4DNV>
M!<VRO7L WO3I#8G4QX>^[FL="5LEF[+B*'X7';R1 )(@N5+:L'#W)HCSW&,A
MGSZWO/1=PV4DFTIV[U^_N, ;X1@A_!3PV7\L%%1$E/VH8&"9(_6'(D,MMVPG
M.-VB9DU?WO)+-H#(RF&%6BW;_--[C9,G_0HFD:(2>6+]=+K7FUN>AMC]<7,X
M!E*^-:\^K.7< PS_-EYYGGIY5?N]S;F^8SI\[K&LD1M LCMPN&<5BEBEF%S'
ME19BWUPG<Q(($CI/(%'X+Z]4!X["2%AD!KJ?Z_F),T^X77^5+/]R#U!FB'^8
M6_'>'O9"?!_7^9 +01" IV9GCBKYX'=!OHF;Q6\\JXG"%.A#Q>"RH\Y@ ])X
MKLZ3!(E\RIY3'\DFH 9V<!8S_!$DVZ4QT^/F]DV'Y]]2N\:<@P#I"9=+6%N^
MY$1O7BUUL$< X?$X$]!D84CP68H[6^_N9,X:&T:F>M!JP8C@WE:HUO"[Y-O,
M.R)_B<NT0\/N"QWOP.$3+57Z%Q*Z2=O;;AP+_M^,7]YNAP(0S"4#8UT898MY
M[V39#6)*<)(\>):9PUZ/8I@CMG\^BH$>DQDEU>X?2<]"^??XP]^P_2Q($A"-
MN#$,*'X]0$3"-^R0*)\Z3+R<S/'V!NU2EZNX;(K6R:NZ>=)V=3M^SCVOF3CT
M'?9 C].6/"*OG_J_: U;?/#IU'N/3UK3R&.-8U&2>HI4%P$-$HPLC%FX(=-#
MUUT<F*>^(WOQ7$'WES.'+:O"B2!L2J!!#E&IE]Q\,_Z"D)9NTWZVCBIOA.6F
MNVUNU <G$EAJ+)<J&?],F3FGBB3W:S\7#09A?RVY\5<M2M5\IR5\B85'(30\
M&6J1I.RYX\_1QH'2_#_RG/AWFFZD<L:)7>9<5F][=6!]]%8G25F?FC@UUI_^
ML744V4C#Z00X\U0U.RT?BG;#B+RI#9K3Y":=ZN>J*(8R=B^B(Z%H*J7P=./?
M87@.Q$_[AN180(%K)*+C3<DC3*!.(XLH_^WP_1"AK:$V2TS9I)<NB\^43I[U
MK7,K,UY'&@AU/%W2MIRBG(7VZX)H*5U?]CP:-1 IW8B]!S!=PA!%VQ057-P<
MZ'N &2Q/74-N531R5Q+O6G^'FN[;%ZNO<Y<?94/74GW6%V">M=1PJX !"1 4
M68!)#21@>GHET</(5G=DD-(D(IK:-%E)]JTQ>30RR]ZJ(1SXM#-$@N[P@-S;
M3/.H(_))7%G1PI)1=>P\ 3N$E*\;]=K]"&XT!*3?5 :!;2("(=)S^7)3?//K
M\AV_VI]/L0C![/!?>DADIU$3"89@.RKI#[JOX +P5BL^NE]\?1@UMA?VIFN6
M%9]04M+RY<U\]_-R.;I:BD(W=3$^OTP\['_MI]$:=MT?=<(Y^>R)IG9C4RJ8
M!6O C8;@NG-C54L 8)54R4T!/6R*ES2-+?;.6\-M*=@F5SLI]Z5?0/N^/9C_
M@[ /CJH9TLX& &VB*I511J\JYOCSY*IV],X[BG[5&PZWAO<C&.[&QQ[U%P9X
MK,>3#(:P^>73+<V]OLVN$QYC[!/ '"XO%[.E(80J_K@'D 3RV$L_E@2Y5/ZY
M.$0Z>/%8*4>'+K#6*$8&BQL:8),&U&2.5W"]G+L'=%Z/%+YZ!AIM/$'#,B8G
MU:-L<I]]L/F0@%E>Q!*\P3!=)H'\R?FYD00V',67CO-86^;_4_4^V)L4+-H=
M6@M-^N7<\<-I+TE\DZS32Y-@Q")X'O\4S'#4]&Q7O__&X]*-H^_@T_.+\+E/
MY&90($]XX"M18]"X9YPQ@#D;>";\H[#FY.!3(.4[,VQ>T1N)(\R_0<,''E8P
MI\>-:<YKO"=V8;$%A&T;2&U/D'MEZ2+AW;*@MX5!S^M#O&A>%UXWAB+U.*=7
M@OKZ'<:IO+58R!!-L[7.4C.@_VLW-XN +]LU0U9K5<!.IP9N!P*'E%#W-!H\
M1K48PQ%FJPNU;3U<WEF-W<!)!L5]=$WIU_VY!CBI8Q<39[(S$D ]"I+H<C&<
MA1;HY?^^\N4V&SF6#(W*H>7\#ELQYH9I-I5Z*YZ?'O)'9ZZ]@#JI=L<"[?R?
M[]5,9\IZ.LX?"X:.KPFZ"MW(,>S]131L!7DX8>G\4HP2?BVB*B4U4FQ6T3X-
M_02WB8*^ :-#GF^(CF3#.9MYL;VX&[Z<Y",GL(1H]5*WG(V&B?QK[0C&,=#1
M7&\DUAZ(2![>Y<-=5/HPV6'>,=.I77?4Q;E0)O,=]I(-$MM>U@M,=@($5<';
MZ)K!\.D;!'W3K>CW6%"Z\N*S2[13XSV@,BLOE_S&L./0L*_9PX74I! 15UGY
MYAY@\ M.:]X:61,)I2F/6W@)VNS'!P31W&5ZP_1>>\DUM,9[=#77G> .W@.\
M%Z;8YY>Y)'I4<X7" [:<.XM62*@NTU2/LF>\Z/3AF_D<G^KG5FJ.C =FS_Q,
MY,G+ ^T61?%KN4LDL;B?%&S$/W!-6QC1]AN<V[S3)]*OFIN;.\+FE3F430%/
M:]4> W-)<@N#]<UIPWP2HKN&Q_H7?.X!)GQ-?B:>!D+P/CW-_;^-2]%.PGZY
M(33[\]8ZJYU.L9M<YK7DLN@,"]8,P!O)&3T.1@L<.A2AD$_$\*KUO!V]<<Z/
M1^-,V)!>*[Z7/4Z.L9WAR#QV94L[VV3B.%%'Q_)2:[!S)^PI2#!$I#C0\Y/[
M92585!M:J[RI-H6MI7$@-&:NJ-%F%>0$2#QF<"*N6&3,RROZN]S8MNWC(/%F
M>?H>P)N\4)0^I4:!,S\M2+K#. 4L))A+'S<Z6-)E0%6"%R_<M,K=NJC'YT(M
MYZ>JV+X03E(/8GE)3)K@P;7CE\@G%R>>E$*&4+,%UI!N)I862R(G=!K>R"#0
M5PFJFF#R_D/M&U.3+]>2HQFQH$1Z6@.+(->70%8= "@,XEH3G/WNI<(PW\[(
MU8E9X-@WL[HL!&_]=.VQZDC'@O$YKX!]T;+;=5-HC8 F/%7!]3AV#BF"D81K
M1!J;>L( C]UH-/*V\^B!X]DG[T.U15I,!>*>(0OVELK%F+_@3'9D?8 YA$E+
M1J"HQHB[T5J&FS:OR_5#2MY8:0DJ<3]VQXP:+F.(;4B4TL)(Z!_\9$W%2S\8
MZEZJK<5 :9XY+-FQ,^W2OWVQ-WD&6ER4OO0+6&Q/O7(DAY;8<7"SA#U^">*G
MF=VF64V/Z2/#4>3P1/%A^V2@GBZJ>$FA$I0HT]N&K9AQ(54C(G_)?K<-SG)L
MXL\61-&2VRX*<\YYT5L[:.O[+\6($H" Z?TF0XZ[N IDO:_P*?5_CRO]Q#6&
MSH$5( BAI\@O8,6A[HC9$FQ.P-GT ]%ZY?_19/EJ&H:H.P.39E@>3U8:1QA!
MNZW=,3.,V(72V'6P@';8MP-.7Y+'>07KY+:4\+V]Y,E,AYZRQ#T5A983N"3$
MI\=6-;M^%(,V![M'R>+")Y?]S:F10C.R^!NCU( ]R.S>C+R>K:'Q8YEN7 -C
M:J]43U)->ATH\/U=D=O*%U.4L\'2/:#T[UU@H"'^]FY[P_$]X./216!F%>DE
M&T_TM=F-1D9[WS%+(P8E$=CL^PF *'$R,5&O=FM#1]EPX8'%VMG/BV50;TK;
MZ2F8DH^!.:S\B^>0)IM=C[Y7E_5XVW6Q.R#>544E"\,$HCB04=#WD%14W#Z-
MD$T<]+?$1Z4[L]8AAD1:R818H<W'R#8##>IAPT'\3I<!B)C]SV)@=\3NWN)#
M^Y<JU'LH%C-5(X=G" -OOI+-U[ NJ),1?\:F-YV(;OLN3F&;@NG'G(K-H+8(
MBZVD!=?Q@*-&R9A2HX*D.AL9 XD4\@'4H L2*T$*[8\+D?.>Z$<0/=2MVLNN
M;S>F85S/'HFJ5-/9W/T8XRV,0^>*IR1U?3(5<D2Z.0Y]3-*L_NOE]M97O6+#
MHJ VZ7%S3'^YE1%-&V:@SK5D14%.*= QW $27+2:?#)]$E@XO,?FA)!:AC<U
M-O[6-KR503,CHRF<"*F -?!:&=V(3@?M8.:G6PE=DVRWW8VS-_U-L8?QU*.R
M\9Q\A&' ,3(>\>Y5;VU>%O:E1].*U[/!B;_RH9:S"X*B /+N%Y<XT#XLM@+V
M0E(G@?X.ZZ-^.C8]=@46_<0(IR*6_ \2:57I;?CSY WP.[:VN[R\T_/&YK]^
MB,L C^M[0-GWU$UI=DW^#TF\;=6QHS;1CWUT0:YLZ7='/=98X"S/FW:.I"FD
M?QL\H\E%@0/;A:")DS;1TONP9=R8,HPP5&G=<NLM.(D_E7Y#IY8RVA4H@M%P
M4<M%B_M,'*T=W?!YRS+<SOZ7?DZ@K> PM=^33Q^(Z!LU1^.*V+KR4Z_X+_T>
MBN8+&%&\.OT=8NB.*4A&_RM4W]YRU*1;N==-X"2%(COVB^&F)3$IJ4AO5W9D
M,V2TK7>R;%?O=0PFMYA"?Z?F(#4*Q$4'+(%\'2'U]M:/QU3"2BJ=Y *2)F<G
MTD'[@EGT./=J%FC>N4Z@(MF,9MQSS:ZZ*2F<D?X+A<=3:G'&]'BIA"W.\[#?
M155O;@<>:,\] "<P>JL,J/K49DE]U+'82$2U61_?==914+(28Y;@&DVHRM8[
M N8'!UKR+!1@Y^H!5"@7X_1SLOBZJH&?K"NI:'[IT'LO9CZS#A(4T1S]07.H
MBM&\QT-#N4A'BAE\C&F0P!,)*1K95&1-U3>T#T(6 ?8,@JQJ<22QAL6NQ^\!
M\2.("4U>ROV/5_> \&.3CFNS+R!FT1"!8^&DQEYI2+%@1 8<]BGP3RC OTT/
MDU:_P)%E^1V.72:U#F4:4'.XR\N*1<W"2HRP+.)]O1 OQ@QR>#L6Z(S["X+@
ML2\VA&$_*;8R0+;O,^,ZAL5J\R:)78#?D6K-CNQZ:"?GN@Z.#S^=.\[G (1:
MIBZ9W"#TR]#5OXM&;CI@(;L0I:]L#RZ-,KIS)!&((B5L'#WN-P:+V8I;U+%X
M)9W<M3[;V<34BJ1L2M[DTMIP0DZ%S0_3;\K.0DJQ/GN%;5/-3]8+LN@/.<55
M/58)"B$9U,U;=>27'3:0T *A'[>[P".MEIM#96BE_C T[9OQ9$C) <3(?IQ-
MPR9AAK\KVW#CS79^W[1Z_ JVY6*)4\90PV %2OII^]<6''_1X0 G8:8'V0Z#
M0_M +AF@>X!BEJ5234AS;)#U7G/"YV^J=N0<(RT9KT0\XQ:- S63?3^Y#I?+
M2EAE _$[7Y<#8E@ (J)J5F8-^[;FT:SP##DNK''\F"SHVF MB^SGD*=X&!^S
MVI9O[NX6%C83)?AWKAP\]D^/Z9M&;<-6FW,N:I"EY2J;EB1$=5M6*4QNK@5A
MGL21*+\T6W+>;B4P\Z-:4)F2U^GR+TJE>=RSB)50/7LKFR@N41[7>P"%?(S(
M5Z<,,X"KGL Z5Y!A;%^'3>8S)3HJLMJRQTZC5)SCL_H?L_=T3'$PC+ )YI0\
M>!I]83WG-P<SJ&<5B+)[0);)^2MLE]HE]O!1??T(2 PNS[!_=8^TGVN<#&VU
M[,J&/ "61A"C.+4DQZ+S"<>HFG(XAI(V1L60.4$U)DVM+1?J5S&\W.Z@RC4"
M'1UIA()H(*H\<LDIR)459E8!5KX9)$AM@,N^$RIF(/%+U>(UJWM/-A?-'YW<
MV#=FAY('EXM7(6V^,+/#1?YOX_M7XAG(DF:S;(X#R:YZZ_)1@L41OE\091NB
MGS>[O<\%GNH;+3DG?K+&H1+L8HL-[NPQKUYU%975%P5\%5XD+XD?"=/3_^"M
M1QH3]Y7U^^L.NUCHFMD(<D$SG1-NV13ME53&X)<-$.>F<U8PZ*$BM+:_",-C
M-,$$O-786_9"+'9<[9^J%JW!,UOO$!7W@&>SRG+L+(GYK^,&,<.3V/"_L>GS
MR.:4-!,7N<?4J&]+YFJG] _'=E@&@[E1:.M:*$TM?'Z"@A'W!S%F;;.=X)@+
MU?*23V+8^'3Z"1VV[HF-9[%ZYY,B@5186HI+U@;4OT7*2-[&$R%3PB(7LH61
M]#(F!&_BNU&9D$&6XM7?>\"C*]. BIV+#\?3^;]?,WXL@$/W:D5^,9/P-N;$
MA,DJ3H0.DJ4\ZL;W=3'+5%H]J6(Q.!Y&JM2$ 1+D:J)'97MO.G2A" $0B[(E
M_C)M"KA2RE-!\%%9!KVY/W;7^S1!-1FS+ 9G05 =+6\^OQ]=G6)+-F]O\%P3
M>7$\AY:Q$5="M4NZ$ -FVY1/>0NBZ-;3U_</6>ROU'E8)]KGXE>NZK6TVMC1
MQ%IACQ"@Z;E$?60VIXER^B&QC/:F.!F\?W:PY\FO[1 VA6,;39:H<LTD+!Y+
ML757H:#7F'L@ +4G1T03"=<E#M]#J6*B+'#A'S^IS\ ]5"DQ<2"\*6M>-0%#
M2IAI/=?YAK:SJ#A!"RU6(KN%%Q [,BBUH!4M<#@H3)S8A(@>1PC[U_7>Y<YM
M(.?4MW/8;_3V^0X:L0?LK1NBM27B#CRL=S805XW91W\<8&T1$U^L#[,*TV\6
M4&>84KIN-N_6HK<GW, ]$6?1SQ91TI*S;@O#F;8HC%.O?5(T*NN/>-9^/,4%
M[,SW/SJ[+BV,VH]'&=-NY2K$.4VK')<.3SGY,,K1@UR7.2WE@^QR0GW0T3JU
MAF:_\K9/SZYCKG90EP\AQ)I6?V;EM''<7K,)'$#%)V\"8D-=VX[E?-3TO?ED
M)<PIYX.;3$JS);U=%;-I1/>']Y:;C](+<,9Q94E%. E+_*MJ;6!I%[J<)[*D
M10(K@2>HKN,(\-J+3ZZ#G=_T("5.=Z;N\OF>2U8<H#2)E[%?=0H8*)$[$;-U
M#8MIIZ=W]<OOV"Q>4"]?5!W_7:CSC5-TL";:(A&8>RRR+TJ6GH6#!B8_7ZVY
MJWKOX0XZ66]K0A<>6V1*U@@Z'Z_!6R0[8%[@L217$_M!P%#XX)BXS>+W0L%>
MS&$]\01G'0)WZ!$W)#D5[<-3.)/].]!"*(-.:39#%-J+.SSLA8'X8LA,7"K_
M:6^^:P;Q>^ON=>J2OI/3EDOWFK+[M)!PAC&=G!!G&C )\YO^(P0$YM?.V*6R
MOIF4::QL8_>ZB$E2S7 $&=H3<) HKQ*%9ZT=U"MI)]T?*#$=2.<-O>ZEFREY
M]^UO*P._G\>#H$R@B;7BMI;#A.1/XC:!Y-!D/(FL"9B-YH+$ZL1>W8JZ8J_T
M(W]UZ2CA)^S;ZI"UE7EE^[J1>O:?Y!#A9<@J6$9.V'BN_@!"'IT<]4[=/[7Q
MC;)C19M5C,T07=*D\ISO JKJC^\7VQP35^ T9AO98;D-AZMI2W>9BNP^MK.U
M/SP%-22A+MC,*[6U?!&%GG7_%#O^OD,\N,>Z!9S\\:01NBSD$]=78*OS2D%?
M0HN1>-=19J&'SWW*^78E)I5R=KBT9\LRJ&#74P!$1(8^?FDA[G9"D52 _F2Q
M#4]+&WGHWVSY/R8\;OT1E?&& =-.QL8@A439FE#LJ!M2@P\:7C81.H8,E/I<
M"2LV5>^SI(5&C7[VFL)A9Q ]D @6J;[-)THL&FRRH==1OZ74.)<^)*9$J#"(
M;()QH %?JI6,>E9(:9Y3'%=NI]0I2.PMT,MOT/Q$!QMC]K(.;J#]$K6.C:C!
M@LT&HJ\\[@%A-\]?J$S=+/\NREFNN)D)AO D22N=#UM9AG^H>>H9"D59*FN!
M)*)QD,-BQ+M+9->X$5F=C$+-)GZ><3M]%Q?:/8SD2E_=7%J)=9G]QX.*F5-E
MBS".]D.;H+4^)<?]P7:+FZR/REHB:;%3R3NFMGAB[@&<NIO>%]T5?,LK$WOZ
M:R[ T"15:09Y2?VB/-Y$G9T/WPX!+<#2NOD0?<^A!-E<RG"J9<&_13=XMP$C
MND;]1^\.;@WS[!8:4U^$*,PG.>>*6C(HN[&PF&: 8C?'#]8CTR1#%B(Y/KUU
M5V-M.1%%\U0RO?>O(-V0[W6A>=JXP<'@%"G3DZ@6?>$Y<T W0*1,3A-29RX>
M38@G%].H--\O1\0%U,]88E,@MRBPUW<? 3G?+A^ ,8*L1L*-:5;#KWZT!=F/
MO+OIV+D']%SM[)"WFOTNRKV]!L2$Q8H,$>(<]RHIT5A.ML8 1&VLX\'9Z+;6
M2-H(&[OC@6R0 1:]!I+]R2P_<^P7*P^PA:'M;FT_K>YHG&>&_-1@)8,8SP0X
M6(Z;_+$SWY1\J:M<BJ%CZ<VH48))Q,_NR149*AF17<+RMFHE?3M#> MWRG 2
MTY878NOXQFOY:N9UUN^K/_< >E^/AMD_U!.QG@,CU31_)JE2GWE(YA1(IRX$
MJG<X1B?H/;5P.54@;-P:589;$E]K[/6!:$$A>MD8%\C2H-4:$///#/T3D(:*
MDHUXIQ6]4KG@\E,F4=.0<>./W.2I=16]-77*' ?&X/00+Q*!3_O$2$KUH,.R
M[*][_7\?:Y2*OKX'J-^]NO+HV,_G\#N[JWH@S,<=8^"DOG>;S]MY:OI[1OE6
MV*FM"W)V,<"8+TUK')^LAHPV*22R&SBB(98Z('F/XS48[Q6@EYN!@215L-0X
MY!F5(2^]B=+HY&"P*M\O#8J1$WVH#!#!!4["2XL3'$R,D':OEF!*%0DQK4K-
MMP[4C3.$O#Q6Q<6C,>PGQFI,]5VXNDO;JBW^^9HJ[U":[?)B-M>A^D26_7AM
MWNF;SDX*"X@0WZG7AC)L2D,@C*!ZZ WOVL3<;X,CL[BSZ->J6@TNX9FHD>W?
M=*HL#E(SQ&A&<5'S0RO"R5 .!W144,]<@6>2IZ$>A=!@/X&<N4],\,O7<UI@
MP3 \,*96S>"(@7XJ"!PS)3M(!^5/YJ3/E.DSJN&9<^K,YA[%72N4U8[)V:P\
M_7WU,#D';T+K9\K4$4_\ L8'\KQA:U51TM8D>-M4L?D]E9?LPZA<B:H]HXK-
MP]-'3=[V2@F#-2T<$C\!4!]S[C_1TK$=U#_;GSBM<=XHY)O\$6+)?J/I'LU0
M\PFGL7$%0V>87IPYI !K\*0O^:*M$N$_@LH($TM(WTQ2VS-@?C*U ;= 6BA9
MK_I+7 M?TLO]VOCYY7 _R0,W0>.81/C);G629WE,@?\^FBR7A<T58VZ AS!U
M?!EV%ICSW2N@WJWVS4[\V:W)QK[]Y<+Y\<\]?D.C'_X@+[^5,:G])?J1D0R%
M]N0^]B/AHYBG C*?E7HQO;7O ;RX+Z N\^NKL>D.WR[AA^<2KQ=NACRN[?4M
M9Z5L;-W!](/T88^M8U!*DM:-;O-_W;M_*-64)(8H*>O6,9,L)HA2D.+AY7Q)
MQZ"UJZKT-E&<XMEW<7;:8XX32;/92!3L#G+AYC,0+(-[2*3L]7S&+AN*07V,
M/86%/3"2&\K?JL1B:)'YV#O8H;3TFU;?>\!'J:>7AFM"2%BW])HZGFG<#%NJ
M\8=;%:("!?$=5 N(!@^,<0*D&'^N<IG6-[\??23=6^9UN*#;_LM?W5DR@Z*[
M//&V1*./U?B3#:A[BV7(5#EVG5;JY)K-G^@HO)N)P)0_QM^F^#)<JS5EZ#%]
M\NXY&94!&:04D@K X<'C\+/C4UK/D=++N0=4[6SX/MY^7Z&?I_N[J#EN#DN9
M%5H(Q[ *,HX !"@S8R 3WR@?59U/'\9WY9$9_9%??'<'_KD_-;R@.O5[SY#=
MUK+MC=B%4CJ@4<6*88L6U'D/>(N@O;&\;#DRN.B6PIWT5[<JZ)&D2FZ.,UIK
M-M;/A&8J$T]PO<[",*9-!-#HM)QKSFF>LTS![/P$2LP&.YB/K(<'+]XW_BG_
M<7"+I$_SEFL_1J4[F^/C.:0D&R+.7'9.F\7K3Q7;M!4HV8,5'FMA_+^M+VD?
MZ_)A-;2'O,BUT&WR'MYJ#"A>EI'RO?T";CH,WQ-?I=]0FI&F=*!NI$B';K4W
M,\HNE.>)DNWYZ)'%$(#%AYZ5CYP/N'#1V=OZ4(($L@7W2!A_S@(<E#XR &">
MF'ML^HBF^)#]9R3A5]+1>]_,A%;'"UK132?^J2WRB@8RMQ@2*2&N&+1(@2B>
MC7@]K?/K5P39Z83=HIP\=$^^^ 5-%1,2FS+E\10&\ "3#?X@JA":?[=]Q+9=
M,AXF(%B:^O.(O?/N_;JJ#$%FU23-0=,R 0[G75QC,/+E/%F7Y1;W*JPA/H*_
M@\>[5?I3*]#IG5LI]&*^X4=LQH<%EI/T0DS)/KB4V<@2^TI$)^-^;8F"#:&^
MGE276X,26;Y\09");5_,Q]R:G%79$ 39W:S9HS.7($;PD6&<[5'_YY*UD=YP
MU;KI"E38E0-VKJG;-_;%#3Q:@0CT<J@>R.U/A;27_JU4CB3BV8^MGC[Q.<0E
M4UY._?69^#U@WJY3=+DNMVE5&O_O<\VY&^G\/],O"[>G2YJ<H&@+*RY.#+R-
M1PDRMF0L+BZE#R4KFI'YLN0PE;Z*U.%Y6'*%0Q*]\;K]!H& 4F*@SG8!(S-]
M.' 7X5U,=#31^] ;'FI&SY%AJ/!"@_T^IG+QO$+AP+-=$2HOGA&R5/7K+VG<
M]8>E@E LIJQ3CFY?T7/J4.%;D>VU)73Y"IG:#^I,4<(:.3X"WN; ;4$2X.<T
M0*BL;4S EE2\XK^C[YZ_((Y1U6!H0WP_*(+? Z0N?DY&6@D.D.QOQ(]&+2D8
MD-7_L0&V:0D&,8J"WR?X3R8(-(7>?KE[[B!=-]%51>:]T'M5=.X<OKHHI:ZK
MV]X<F2K^13X1*5]T(%&W^ER 3P]6/B_Q+<G:($EI@YR<SM2&.O!AKCR:E)Z1
M'Y#$0E4;B-TN=R$.30X^YM%UB"/].0Y_]R#"A&Y>71H7[/"O\3->.K5K%UUZ
M;X_93MZ&_2IL]<^"I@SNDHL26\IXBDQK4HX-.>U?-_P>F=#(R8BC>NJ2:<:]
M9W?KN^W_>D4ZW(ST6=4EI&K7Z_JE/]3DFO])X(]7B,@S;B> RMSA>;#3-Y-8
MR,CPP/"=WO%H+T;SQ FG^=R%V24_1T@'S>7U^?9MG/^+H[CKEYJAF0^^B;X'
M-!G< PR>LV4I/H$'AR@[DZT+4'!A> DF:$RYCN5QW#8BWFK.OQN0/M31G*/:
MZ5VN;?DAJ;UJ<@^@&%B%/9+N>\1Z<4?>Y"=AW:K9I$@3]5,F(K;5-%)T[TT8
M0EL2=MBV:K8G7NXM"KTL67$)8V0_0G4D,Y91A][H-&;NSG.;0LO<60TB9Q1.
M+*T=$CT'CZBVGXJ!7HFZANBD5 3P31T$"+MHYNE^+2AMX?P5-_1=M*VU,2UU
MYK="8.O?5<2AQO(L_;GXY>LC$>D(1%U'_$K9V*O^J77-+-U)23^/-6B4N"$P
MEF0>%9_TF2F%%,M=O*J!MWV0BHQ5G3!?D1YP3$'7*P/NT,.4#+>Q^5M?NC\O
M#TNZ!S1X=56%P^I(;JA!YQ9UM[G"ZB1=4L]_;?ZD6&,*]^=Z;)#J]F<P4;EU
M<UZ0-3(JH*!JWY"7G-$8Q''V)95;W/^;P./@42#X)620]0.Q1,E0G*"&*+;=
M<&WH1,687Q$EO4-^Z\FQ2=GW\M:W;GI;DT/??5_\JC=IJC*L1' #R6'Y959C
M\\2RL5V_1V*>$K71\$R2?@D2<RIZ!YE><J,7$IY6ICL@X82)"6+>O?O8!C3-
M<-7PPA;', K%E)(='9NTLO-$+G,INBLS[ JH8/3/<&ZECJ]R^/N$.Y_I)R9!
M+3\?4N*/V'BU]_W<XO!EJ.-^]O;TP&6B:N*.(,EP^JHI[>\<^FF"4M5)J7#B
M/CKJIK:QEWS==PM#GL-+FELB.V3P">,T:^V^O8U[6Y009NC3T)J+%(AXC_/[
MYM*<[=&:6FP'LBR4 61"A-H=B]79*L9J+(5;9(JF+H9!0)!5^3SVFCUNU>S]
MX)%@1)=K'PVQ457*7E.,1&)SZ\WT: 7L(2,K<_,JXS.6=@Y/[IKVOF<JAMQ@
M)P_=5DAQJDU!:GOL56V,00 99:(D J0J\,,"*8V!F=#2E^#/#_1Q 57+K+:U
M&;LH6P>,HW=40:\HQ<A(R%YJ[EYPI%T;^FO9WPSV.@'T:/@I C<XL9.^!)-1
MY'I!/H;Z$%['D/;.[' D/ND5Z)7^57D/$'@:3H.5J_WS8WQ.='"*.7MJ3=.9
MR_;M09'E-K_/P/$=_#K@O,FH:&K/(YJVO(I<(IJ[F)'VHX "_-4S<DR909T2
M>"=:*_]1;.R=YC7]=H7?%^]XC7B]]E^\'UYX[#HN><?G6+=%/H((WAT0=U&:
MB.GK8^,.7QU3B8QT*&1,ZA/HM'CB%- X)F&WT<20]AVN!)[D41PQA9ZYS WT
MM1Y$W8@6CJQ]!_72Y)X/0G%^FG7:Q9M;0:HE/$F?$%4C50 %^55G.[?^L_F'
MKSVNVQ$5DJUL>XV#Q=5W!T,QY1*-*O1O8T![VEUB\+CI-N]$+YN/+OJQ&QXG
MDLLB J@Z;-X;0NMY)0[N[_@\F@<B@DE/(OHN/=:SI"-S*9MFA&O]VQ#-3[34
M*>Y."%@_T]B'C3KK P8SNFFB'(7)D)W1A&C7.M(8C)>D[OY%UP7?YD1$<&EX
M/@4WG!<7CC6-C&CNJ#LW51?22WC=(8H*3Y^\(U*9N3.*-8YAI27#7=R40^WI
M?*("&G<.C';8#R?6@"*MU 6LC2Q-/&)MF-FM(.5M71+*+-E8;<5&1J)CFY8R
M(^ 2D&*=FR'DZ%')]^[6T*X[FD%\XE]FB_'9_G^Q;=XLDY6ITI=!O^BG?3"A
M)"7/N?E>Y(Q,,JXN)BAYL=%TARA$4P0B9A!;MT;&CPOB:M7!"ADIH[6Q6RS&
M*(O8\6UR$7.A86?3-.)\ZI-?!B(AAZW/T=G*6,"O-> G2Z:)H4/B..E./"BR
MQDE;,84VMXA\8WP),U\$'($R'RYKR0)_1+6:%\O@_]ZC&I:R7\UZFTHN0,^
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M;M X( 3;' X2D8P4G]'>V:'2E3=(\DUC29JN?O)=GZPE]*(6<ZO6#?(72>+
M53[2U*P)/64IV53S[7M^2=0I>YYS6]GTC])6]X!^P6+/!>C+\HJ7#YN0-*Y)
MFXD:<E]P2F .%4(*6W,9_C>&Q<_2]2._9T^7V#[F_85\-=^I=QPX<$?2"F=Q
M&WS",OLSGIS1JYGQHQ,09[[K7K&=CI!>D=G8_1D=RO9;7B[9S,_RE=I"]2=$
M$=SRV9UL:71RQ/D1-:$])"JY,PUW^O[H[?5631?K!_>%T^$"_F_DG>G[4E-/
MN]*$9K@+>6$WG=0B @[U?>@)?+WO/?6+?PP^WXV?FSQFN!JP?OLF'/_O&_/2
MZ@PXX6L[,%"V(6MZ0]JBQN1I"S_9EZ;:6B/TSUOHF9.TA59UX(1#^\5=\_/Q
M%?66XWBS)_H?93FPQIX[%'G4[H7E9=^>!<6[LS$<XT2"W3 CF*QS(6F0^@-O
MZ3X"%KZWF&>1"3P?\?^_@[>!2+2EO^('3@,(N$Y6R > =2N]ZS<OQ#()V=$1
MX3[OPH,9"7=.DS\ KYP3JL]@JEL+:/<YLXF=E6#?P7N LU?A88S/1'[X1M+-
M_@@E*NFV5)XOK+_Y2.0]HT<S]4-KW99GCME0]0MQ?C40?A4+'<.#_- ]SQWJ
M+.A,B0L3JJ]P66]3M]E_2]! XGJIF>3&R-^W?%2@Q@R;O_%(\]-++&+VI38H
MKHBMSF=;?2XCW:WL[!9:[0LT3LA)O.NX75] NF'W^/N@8=?O7/YCN5F0?]C<
M>KSVB=D=V/0^HVM^,Z/^@5701.K>1BTR1IIR&#"L,)"2$LI]I'*;%_JL"?5!
MZ_A!G\A>ZEO:SO_ FY9L^9R^6<=)X\S4:X2@K#QMUW%+A=K]XZ]S1NR/*^]Z
M:O??AW"J2/(:!V6J+UDR$QF_2NW]RS9?H4G&4Q3^?T(-E)&$&!U6>_N&AP!Y
M.?.Q-K$;Z):CN_ZTF1Q8?(($K7@,JYJ&+/#IU?7N)%P6GNO>%I_U,/ZZHHX]
MLR0S'[9G?FS2;OM(*'6*BO,1+,DDLB\[X>9+=%I,;8_0C]*JI/HQ?CY:6C'Z
MPN1P.(![)>5+;9S?<^.1S4,L0<A&"MG^&ZK23]W%(9(-SK,.J)YY]*0L]F9N
M#(05A2:!P[H'G?]+^Q[S95LVS'KQ[!MF6$6SH&?A&A=R]60K78,&!I>$%7F)
M#-.E<#AFU.&)GS34\SVN\P$, %/B0V<5ZC/3KU6#[@$#_RV45:RLF/WR&>K0
M31W@A TUN<2+# B/SO.)[4@2(_/J5GZBLS2Z)4^@Z(R0O;R&;'"F4KV_[81<
M\#+ZY')GU"I'$19Y %?W!HB)JS<J P'R*>VJ\0E)\(<;V&7^A0R.=?Z#?TYR
M%=JS4<"?KGL<MG /B+DXL31*-MD<Z:\6WDPN%%MJ'L*@E<LE3M4IX%46<7%>
M;8VIC( ^:.,),_@L6>ZWL61:&:R4KR,9.UAOI^4,,J5C-.C-P$MOE7/UIA>7
M0'][>+"K?YMOUF!:Z7-"Y-&:MB!"/)/C(_X2X@%V]_<W(Y?\'NWT%!%(1)XZ
M4&ZWWFG<YR04;9?QVG@=J65=LUS;4\15DAL8>-?R-VP!]BE-SL?.^A\KH$M1
MO/!@^IFL5YY*-TN4,83OYI^XB2^$U4/GG,>7K]&A]MX=)WW9X7QK#M&B)O89
MAM6=V22!<G9R1 @C_*HH/CUD';M%O?L(D) B#8-8 8Z7NQ>$98"=;S>7&V0X
M/^2 <6@R57/1DNR-FL,,I+X;TOP>8+VP@"VM_>B.+0L31DY4=K>\R:,>$EXR
M[[T' .7%@PA&"GAFG;Y!+8]:M,Z/IDO/K^,6M0H.( D[<44\Z;)X#$R*/QST
M*R+F6N\!R]=WI+-'"N?GW?/.EZBC"Y7CIPLIK.D/EG+>:U4&:3RB$^N#B >;
M,YB<?%\4&$P2]7_R#?+X8;Q(Y4_\D4D;Z" O9$@\==!G[P?_6/SEMI@&ZS(X
M6XMC1)SX'<:+$&BO,_D0.EC5QJYHUR]IC,;D3 V]638_/0V1NFNG9X+O&K[?
M]SS?K^RQ/$?[#O4XA%UR?^BS_O%L.>#RU='ARZ/2A=*'R;M_,SNZ"MCH<XC:
ML]<T'K:,.(AY]%="*\%_SE.:@FV7LG=H(J_3$"ON^"KI[R M9S\4P17.!Y_'
M*0=3A+.J>MQ<*=9Y)R1BC5YU[O!3#FNG]IEMZRM:MBF-'_/$++Y%GC@*F;N0
M7K=<CWB33'\($*GC84/PN"&X;UUOH?< -;&+7!^KGMJU[GVKK;A+%Y.P_">]
MU<#)H<BF8("7L\>?A&< !W_"!R9*A@W#4R=5(IEIG<U"'!1S)U%. 57NFE*L
MX@X.^/;6"I/I&.%FW>-'\#=/G;/*97PT-*CM3+.?$1MDXK3.0];>-!D<R!;Q
MT0-.65H0AFU*7#@DWFM>_1=\&F9E(?"[SMSUKL@KM]O@>P RL!G.C*Y.#OLV
M!F1!D:RQ:3#>L=/R"K7ADO3KI_?<,\?M1+!+0 .RSSYTLHZJ ;23LU6Y(&*^
MU%0QNOF6GIQ6HY7!"NQX#4:]1%^$>**5(Y*44P9"^$J'$733(SY)HD2/,Q57
M,K<UN,AJ,O?^&,W^ 61O_V9][7_%L*Z]YOH>8'SS'W=+V0<H81@J="&, 8(#
MEA2(* T"-01;4XD?>%^ \8ZT'"2_KUOM1J\RKAJ5>/SJE:%UGC*-D NOG,F@
M\FZ5!KMQ%))?XOD";\N[^=6Q=\FHL>% 2&7#\WL -SC56S60AR)?;D1^4\ ]
M#>=3,<%V^IK=ZPR^V2#6H>M@.JM%63IJ(V]W_:[L4"W',FQCO27__.]AM0ZW
M%W+[GRVDATQJ-5]X\2U1QI,.(-@U"#MC1= O7IWRRB8O:CP1]W88WFKD9X>S
M^;S.EMR(P;6,<- 2<YJ!>U<33,)D4@Y+LIT$IN]L5K:,4]6O4>XK]%GV>#XU
M2P3R]JJ>=7T&#HY&H!?IE/S]4A3%HJ\8^<3A 77+@Z(>N1X=8>;F+;<!?^=-
M87.8%/AU4]CB^[<SP..0_)^]U/'S095:9IM'JG6?/9SFAI(&M!&EY"S?#-CM
M!^&JU4W46;2,= ^Z$M8<ODO\S9GJUL!&F8\J8<FP;4#-\E%ROM1'TLLET#\1
M=HM^YJSTOZ4DF:IH+5Q-X"1K%/5FU;U)$_WYO0+OJ5XX ?B=7GQ(Z?WT39XS
M=#R%JM"U2..8?"" '5NE3)OE*;&D_SAY=>*QD[*,=@PA!>P0KON?VM^[[A"_
MMJKBR:[5?RF?!1;KL"KIH@6=,AF7I14SU;^QA;12C -^J*KQ[?=C3_^#8QQ.
MHDU )I-&)CC-PC2E:)H-1-^$A*/&SA_C,$1&&?6U_(V5%RR,:M["@S:$]HI2
M=6NLBML/L?U>(QO_L3(H]T+LLY'B]! H#-J,5LZR%A-E3J@&#7$C\P< JN8D
M>@"&7F)R4(R,&(T!4FS7^N@>L!C&_\>9YXWQ7?[%OQ&Q^"M_=)DS<RE1"E[*
M*A8,B3- L L4>Y%5-%*6>/%%G^%%SY"OKF#A0+DE2#ZG*H&?'A>[ [<K*U@\
M<-,*'+M,)S[V8U2RY<>H>M07@5*]]*2TV/6V?_-;D(28K]4HF3"C2OOC$#@N
MF<##@6*=[Z8CD7&^CC!K4=9,Y%OUK9].V #V]Z="J0[_6[>RO^?[W@D*S1JL
M!_/B&DQ9HSN=]>5 61^Y_@K93-B/O+H WK?04Y! (K#M-;EX#%!8Y">+:;SD
MZ$/\8MHOUYT0T=PLI)]-!T?C3;A8TP2I3"_K?Q G-IJT5EB;1X*YKT1$24P+
M?*Z<GR/<5%O^EXPA041XL:_4^)\(H]SFGLV>S7L >>!RJ=?,P>I-[6EHE%:P
M<:B]VDY%AC\LEH%85'Z(&&$QNLV]PR?7V"I+RXD^UXH1$T@:/<8E5>#YJ=FC
M\GC[X^=E#%J>OFK*U(05_YC4=F.J/5@?U]?T%'L6S6X23D3'VOFG>I1F@P1%
MR2&1 !.K0"95BO&K8$9[/^!Z>?:>':PHP>>(C/@EUV_$L6&"?ZW:HU&!)W?=
M;CHWL9O:YMPN]X @(.=R;]4'5OF#Z]C]P E\$UMN@21*#ZNY!2SL^_>NXE5S
M M%3N191]7HQ6:&3=7&Q!@8;#4Y%POJWW=QP,WJD?^>,&*%11FVF ]EX>$&H
M"@U?.1L_GTA_<>;V'?^/R_7!)S37K -3[_O:GY1V94QM63X[-&PP#TB29) 6
M\M@EI* 6S>,72"[VU*BJ9YZ/:NAHM$*VK'595R]+%C5[=\/<EA=UUP,6;OUQ
M)G>DY"=0I=N*?WQ33[NQ6'20M89@.[I\R/%:?\K*6V!5^OCHPZ_?^KUW=LQ.
MWG=EG4P5FL,XAAQ&DC!Z5">%FTG2LZ>S\H7^<\CU4D,*2R9;K#!_\YGX=2KH
MR](;P^/G,_'^E2YRI%]^6(X\G]Y2J:K^,L'$,29&_XB_#D>E:U2YE\5F/FQT
M H$YB Y60AP#BY7U'Z$")S :CY70XNEM*3,EH21E(70F4Y#"G5N/?><$.")X
MRJR,5X%?HP5Y\^0>X.L:)Z"&B6:\&35]=-W)\?G7:3Y:#RFZK&XCB1)XY5NP
M/>'L)1-9":CZ8Y;WT=AP( @7*9>PGT>4%L\-^0CC1 ]PU%QG&IWTR69E,XB4
M%W9='/EH\#F^&A#U5O%._9-F?J'58B00H#J;36)Q"JOL_&0C)B46KB2YO["Z
M?L,Z,6&>M^_6L]]A_6'"PU/2CX;KN^E+U:J*)*+9>DM-6I.#-#+\P<A>>@#E
MADR2>\ A E$7 5V=U#^T*?LYYLR9+)[9UT?.QH:"V;G8IJ*0CU2 *^OOE*T[
M#U=PI;'OLL(WN$;</;&>11H.L:I&IYS E:I-8U>2&2&*$"I?S.B(O4?_[EY/
M[=.?M>L573E4EAXGMX9_]S_?_K=Z/.F8+3=RFCAQ>G=ZB'Q]JI#"F"$7$\3(
M&?L84BPX!H<XHB4*+,3PP:=R(W@!-XEYL>L01_%3]6FSE*FZ3(MB27"T)HRC
M:"Q#T7(%8!3!S_0.@:L74M7_(F9!>2)6*(-\OV$O8)JTG6KR7K@P@Y4G+0O:
M$?M(PRS@5NKZ+@0Z4G:&[IDY6N(:5CPF@N6H/MP5!Q\8SHYTJP0*D$7B=WR"
M"NWRO)B@* *R??!5KN10#H1=T["PQOS%TTAW[2-PHK)7<WH7T-^]&\:E@C"6
MOIEIYP!['EZY[)1#/(53\GHXT'5\]44'HQ':CJ43Q*](K?0"'@0^B7B-?6 V
MTGQW.!+V_7=M<>>2N6[EX3T@HNSSZL/Z4;ML>[-</['4W!WR4P'%>FC;K[57
MTGL -B^:),D9^^:&$7ZE:1N8 RUA4%2#Q\BD*D;1[(6<IYWI,UI]W5HFG';B
M+A#.85ISQL&EER5Y8 9Y+C8H31#,5VL&#LX YMJI)\STNM@O:]A')>&XF1^6
M"(.@S2L79_> */3<10^N"!6F,']UR_IR/)1HZB?TO\MFOA',F$"[3I_<D?R8
MGQCIJ+\QR;K,Z(EI/0D]\MM!B5N0*?^SN,U4ME.@AF@Y!9$%_;*]ZK3&C[0O
MX)@P_DM>UMQC]-:ISI.%4[_F/.=0DOK\['>GDIN[8(=(M0S=V4;A?7U^#>A'
MK&O.:T/Q#G%2B)*\B6]Z6F%GC_R63Z\&_.V:]>+O6[?/\.::;LN.]:N3.G0<
M]'>VO;6L+^.603R#X9SJ(_+TDZQA_(/EP@YFEN3CIEV7'R/>YI,K]:.FF.SH
M04DIBGL [0.#5#WR'C_'EC]/EA^[C_U4JMK3=?"V-^ 2N76P>_@$<SI1_F/3
M!]_S6O%5W-$8#TQQH@+!=P_@6DAF[[SY,L#\43]@8>$N<_'D[ V_VZZS$Z*G
M5J*C [J*5DZ:\ TX5MT02!=P0ZXV!O*4:FVV(N*X,0&$]<O G*?=:*_SF.4)
M%!;/T*G/2(#,<UKUUS;FSE@@OE=4YN,XN[&Q2Y%1W$W) ]AK=759\B1^N>D.
M]5'>:;K1BM]T2(?5MNR"YZ6).'L\"^HL7TRP =X)TE55%[/EYZ;3?%>(#!U]
M$_:OJU&_>HM?<HSL$CG:XW<0C"D^"L([(8VC6Q;16,,32O@8<T%RWOC '>^Z
MKSFPC7B70I&$0Z ,9#*J.@XWSIKVW/;B4YG\S>S2ETRND-]83$7SDJV70EJ)
M>(I%WLQP=T_G$R1F66=T4)Q>B 7<YYLZB4[^BN/1K*1$[_W3XW_+*GOWS)7U
MSMH](#E:F,YWB*ZF;KP>/L7\E52N*QQID_=P*'OI6UUO+UY/P%OEYMCYR1Q^
MB%MX0T4PT-1'<7J%8'A$&0_%GVW/S9FO7;DK<=29* #7X* =OP=(B8WT4(&8
MVP],UH@D,R'C) GHBS&&>>ILGVZKO_&FZCZ?1)]XOV /)R3B:^2BVJ@4U5#P
MU?KO=NH>8!7CJ[GPC]8?;@+>>'D$F#>?Z@P/K>Z29B3Q[QQ$1&()B0P0#N#8
MM#HM7J'I]W7I8]S9H,?(:4,A*D:DOZ%I_68+Y8$J.0F*"B08WE1@\J^:PE8_
M9X(=KU35T M.<!_CM-QJ=*8-"X._"$^RAN"FH\U#Z/":Y&!]>B8W#YZT7&I:
M6J9%J6OC768[]'K=S5T)??POF=O_A"U5%-.TF,-DLP:MI;(FV)7]2=E C:UB
MSVQ]QKF,"-C87B@L;>!EBF,J*X>IP*E"G/XJ%"\L>M8(6#M]I-@Y9, (N(J#
M?EONI(HJ%4W\+^HL8HJAB$W+ ,"K*1M[%,(^X3F<)^D!GW:Q)YUJO>A$,A6.
M#DY'.\G(CD- WW2%?4;A O985T/#%BM_-;>O;1]W&S:(:].O6C2R3)M]4A5X
M#6>9-E8LV?1^X7YS)W4=Z++XA.TV^VENC$,[TYN:2F\81WTVO9.)M,"C^+RB
M9#'1IDH1L?</!45-OZ/]*HZYMH;J=+]#Q!VBO.=N#Y0:=R3/R#'6* $3IMH_
M'L?/0&"PQ6I0Z#O/. M:? YI:6C-QIYY@3$]I.YZW.0[M"O@&H4N6K?4<;VQ
M3MD\055?_$E1/@KH(NK:9)&\(N W7WTSXFWX&A1+_YK7$DVT+CHVC:=VMC)@
MR"")Y-WUI&3NEQ1 F^+<0/):]GEC0EIXX7] ! +9\@_@"Q?]S[1SPM)9\LY'
MZS28XK8YBTQ?TI.?I*YI?_#2C@K7Y)EKYH?H3U$X@K/Q$10B\9CQ04!BLUFW
M(RY"6@ _K8O!9ETH7T'ADN6QAT177&8M(LPJ;.'V/:'!GUC&>T#L*H4- AP
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M_^_-C1$..;)#CF9:E7SL-!0<F-@C"\2+OKZ)AY,;+7L&*_1:3JK(T+F''?8
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MVGFH(K\L^)DSWMC1\C/;"T$VBQ*;E%SO0#%/?74^3=A2(FWMQ&79Z>^+>\"
M_W^<96[0>X#5^7H(FMG.U6O;[/$%?))#-O7+^L_Q4F\:W05ICV(*H"ZA?48R
MQ"T:UMDC/@V3-TZ1P5<!8-(I6QMH0;'0MOZ6)[3T$@N._B[&*W?'ZA['62V1
M 1OUUED^1)('O^!.*[_L.M+NIJLQ8Y _) :%:WSJ26CU ;Z&0\+: _076G&C
M:@CR#(/C_W70K?POF<+%D%NR'?YEZBZQ=KF2!^B?C@ P@A+))3*X&></QOM!
M2L#:'$:1^T,]F/P\QI:C;2.2OLV*>"W__(- 2=&'><G84QHL%+4VUAP?*3E@
MSW9@^0G0G];\C?G0+H5VN%N#G]DCBTD2E[&9 F04+M0^$"3M?45;+ BZ:[GK
M$J[]@BEJO@>4+85ZN0FUKU;*VSHENRRU>,%6OQ%/OJO0N(@S-"?#C9?C?'S9
MRTG- W'B#5Q*%>_YB$_Z"(]CXQQH)3<;7C.0@4I;$3D:V?;9J$;@!_8E!C5(
MBXC!JN[C6_LZJVMR5V\.N!I,23TB.WFUP1.XIO6P&&3O$_K+<A#3W[%J/O8/
MF>#U*QU^&!:%W$/N79T%O*$\5:F0WXW#N?6(R1BELHNTW -RWU')]:M2O0RV
MYTQW]2;DY<ZJ9D^JXSR:5 ?ZJ.\-Z8_TZ:^9[\1ZFI,:M;Q.]TGA-31:(?A#
M D:0",-&(0(=K?AR]6-0]45J^I%LL!IG?V-Z?$NL(_]/M<Y6.1C<T]/$M\"2
ME-RH\JYGL^?Y69U_>YC"_D$WTMS\'1JXBXO2.GW@"K8641#)EJ0LX]]MS?#
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M-S4MA_/^^Z_4(.]F0+PQ&5,@'AMC<69EO.^Z)N/CD02T1H6R)M 4MM-5[WL
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M7D.F;^_]K0?. ]RF _2J)A\ W?=%K>[G+R5V:R@6&?5Q&#$#:>P\ZB)$^45
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M/4_?:$3CX99G[MN5.RHND3/S^7]AH\>5 ?\"MA;/Z5TQN>Y5[!PZG*'=1JN
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MYER*@OH,_*>J21L,S-:[^YT/ ,O:XNE3NL2PO7LB#YC6QQ-BH;*STL6&=HL
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M26XMZ!FUM?XD%LB/R#?_]0!HZA1T6]4CVHVD(-T)#?F=T!+"T:EB]"O>N6"
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M[ !-5DN@+?@1)WJB]@8L$=T_3@V]:XT5C@\#">1>X+&K\'""X_ #AI+N61X
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MDQY0^R&SF*\''5 6N"8LU&]D-*/&D+7* E#GX_(BX=*(^N\NSW-54O?I!RZ
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M'HYMNLZ?K:_X[ //KM'"WKI?UV6_>B2P,,LZT*S&!<J58(V)!@PLI[F)* 4
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M*;<9\.KIH$.Y%H/UM-%DF')-6\?.K-/?]4_%'UME[SP1# \ \K!G;[R4&QX
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M][V5WE?3#;$XGKJ)*%GVNRNMAUA$=,W!*H9N+"^.YS\/G)K<4Y#?5;6_"7%
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M6HR7IL_47S#S[P3$&WYAK;Q1%!-B;CE3R*]?W6M7^J1(;C<$2K#3AW1F7#V
MK346]BZ-!H8'_OOQ85M![?\^&".@L)BN(/?9!;EES+,1.5F9KG>2ZK#(14-0
MSD.[I<3_T(-A_J]UD6ZAM0.:5,/5:5:2H:4O-<29*8T\[A7 >EH:S08B(S!]
MZ%8T)YU\R#O'7)Y<E!M;'+IH[5@F\)RS:G-FK>[>&*QZZ9._<[_XWR8^Q>N8
M\(.,ZJ]*:9&8K/N0(SI_\)#6)AN%^8#KP:2\UX"5 &>+_M2PV/WKFGU%B0.
MMT X# I_N\6;\T/D>]B.=CA_C70G]Z5> Q ..X$O1SL@:TT8&$T U /SL7L?
M@UC\I$K^S15XX.F82;,A2XODB,SGNC'J1(A<%Z2886L WW1W*YIAV)],<#!(
M]):?K3\E\+,L2/?Y];?*W119D]GM8VRUJ@_!&?DB(37B[1(J#$]Y+M2W;9*4
M75_87UPQ-C\"GMPJ+8):WH%7GLXB39C)4/E478UB(_FP*)5>!6 ;B-6]H8F^
MZ.HN1+(ZO5C+V@C3U8H.EML@_(_BUF+XJ=C,SF4S<.:JW7.[_=.><S?R_->L
MF##$?'2*+-*A+<=)+_F[C&OE1-8H=E7;)8G@+R!CZ)1)"[[](%)OI]E2"9RH
M*..P:<5\P@3RUW!P!8?=(Y"O08V"DE]LOU"H2_(BOV7W"X)>;$'AK=<)#RV*
M7CL>M<OPOD< D3 ::]-*SXKPN$>AK</G5DODNT*I=+)KA:&V1(Z;6!S#]&CO
MCXBTI^]HOA-4AEO,!#X"8EL*5F^[7A:^RZYDYC^LC.R^0QPL_H2&5)T/X89D
M"X\L&S?%GGQUOM(P2^8?_8X*865PTN+)]Z)IK%W!K5L5=Y/N>B.AT3;<J?8%
M^):X-)M#W[4QDR('!<<0'=X'Z=_;A%H,+?2(_+;X!^54/<S'1J[6?#/V=D$L
M(8J(M@] (.\S[+%6CHN$/KL6]3TF L38O6KD,I1"T;6H\6V\$FUM5!=.A5:)
M]K8^RYH[\6?$7P4FIX;T:3=C]3U$&,%4"9V<?8H^HY[4CLF&50Z4&7&\Z'$:
M(_LNNRMPSFH^YV[#NB#,:MF*S4=G3*S-7%J=:W12XN*^\"A!BVRK[<1VO(M,
M^AF6VER-0[].C[&''^\U!T4]>;U^7ENEM_HEGBV ^%=QIB*T\!&P^86MU6D1
MD;%5R^"JQ'L^@N90INJA/[KX#\,U4RU"^EM=,M<BK!J>(Z:UUV[XVS,8MW9J
MXZ6%P*HJ?5Y]<3['&HN#XZ>\,_*UAXTO".Y45$9A&:G4P#:7$<NA5-<CH)9+
M\94<L(P+N8Q>W,+XZ.IQ;8X,6N'?7\]?T*7A#57G_/DLNJPC[&TO(\&S-YAN
M:O =R EAR8Y1,@AQ(?AOZ"FH469\%C3["*A SM+9IN2"GG22/.V,LL<GLA_X
MEPI3I7W-;Z>WYN>K:^ I"%,NJ7I9G^9ZG=':M#V,T3(JF6-$9%SU+@5V6696
MMTA:QKZ'*DR-+2Q[\%MJ(^X5L]:F[.A1EBX[J1?!0!?UOO9TL#E]G#<:J+%^
M!$ PU8U7BC?7L7_R+/]WF' MFK<M0<#P:@+_)U"GV#'G]L+>OE?:0?[BF8ZI
M_ R&&8*/@)@X="AX">=:8"803/)NI JDL:BC1'D._,A%NC)5[=?"L!H;;PL1
M0HY.1B?5=YVJ1= BH,U0KQ?/)X#.LVA>G\U7!)2=5F/TL'A/UF)'1T00M:T(
M<;._<NL!FIJ^_Q'0<C,HBGT+-?X7]3( MRE;8+C%2^@Y73M=5H"[MPX)]P^-
MUJSYC-$*3B<.;>HN,?<J5AEBO2HEGJ ]S+M(40<6G<46P_!(:,PC(!H)[<M5
MKI\HJDM$K/W[N/OSM-TB[PN3X>8=W9#!][]YM:ZJC0[T&G+#\\:XD2I62PJT
MZOY/(C^BM?XX9%Q/W[K/G)D4Z'R>L7)D(9<6$=-ZT]R2J71-2,IPXH"JOW_[
M".AC!MF1(S;NQ0X[](?)5VZ&U]GF:Y]?S7>] 6^/^9R!"*FFX&,>'AN-<74>
MV?GY;8/]/"9['G_UMPD2N&Y?76AL/9E_&"X/^7X;N1R8@; 8*VGOZNJ@**=:
M6Z5E4108*M7/ WU+MWK]]Y6H\YZ'^V<4#_CH^C#@:^D>_Y!',72C]&[E$9";
M=&-!M>&<0IECSOG*\9+1Y(UMEM;J447%Q" DX!*X##M3XMNI7>ZT?NA"LVW3
MSX',>JA_GYR5SDX$7W;H"JI@CXLP\ Z/$6N+A*WU>BXZ[3S[>9O&AV9_3W:<
MYF#TB@KFC&UQF'OO0*5Y$ F\G5JE(*D040T>?V \']E*R#BO[*>3U\O^N6PV
MXL- 9A=/,W[ O+9L$M))"1G$'LF>]-\1E%4.B< \ HJL:FMMN"IQ7FE=*B?^
MG=/K;L9D72Z>_",]7-@Y=*!;B55["#AB?A$GW_2N>7#!1?KW1'X6Y\KQI<"9
M':3"W-(1.\#&2-6%M?:S@XGIIXGT->T6P-B+6T X@$!%X)W@Y*'#;&J8219K
MTQ/O.*E9':TI2WZNZ(??2M T.75\KR'-:5AT*BE93]?!W-W<KV_??GS@!_R_
MZZ<EOC32RVJR:=,;GGV%N"K[#7S%])?\S?X98^C7C:&BYO5R(7^AA77*WV_U
MPZ(>5O'W-4L"VKP)L%^4;-8)T;N-D7<2N?*D1B(9B\7+W1+/N"*03IJX],X1
M2 E'I)KCQY75KCN6(E*HJPW5X=QIVRQ:]^ VXW6[;FJ_8Q[]C$,NEN(\H/(9
MV;AOU_,@2-FR-X,FW($ZS$C389",SC>U--04(([['<">YM\N:+U ]^R-*=(F
M!.7Q", _Q3R5.'V/>6=SAX);3Z0S#*Y;^@VG#A+NF%EJ\3_\9VP0XAB?63M%
M2&I/<)O2N%V D*@42A$8-^PQE@WTR1/P)2--:6;(:DK*&>NE+'&L$CS@HH0X
M&83XJ$2URK)WC% R<JA+:K8)L"B\HR>AFO@5:5LD@4&LABF\97C38,A&TD8Q
MJC%:L=_RWF.N;!)^_M_B=YAP-0JC#[69K\9-</(PN^2LLC9;>^9 54%@T(!'
M*I[[\2+JI>>@K?R):0<_XZ>%9W5H"/.8D]B8P([?%O?#?P:$]SMG+%S5-29[
M"< VFVYF(NZ/XH9<Q8QF><.FP"#GWK5<-E$%JEDW.F;[:F[O3G,3+>?D&0?#
MS@.>5$_#J".]P8-H5J^>6LP3C)5B3O,3&? B^%:Y2-6QORNK2-Q$^^7W?%!4
M92+L?_7Q.IZKNU$ )8,?YK16GV+QTK0S)RJ&S'[D":BN3#:]'!KKXU,8S<SM
MIP?Y#B^9//2JBMF^_HY</ /TH2=7037]ZN,0X^1<1Y[78[\EQ!0L%5_3M##[
M_S+.VY?E5(2H4V@VO??"@!=W(K]7/P*JT8\ I9X46^(6"=&[-G1FK"]><$,,
M#@&&(I41YYD(#O_6A9%%[1F7Z<H%*H:.4;@.$CTW%V/X.KJ)\$^J8'SH( ;(
M6/"$D5,]LVHB*<9@4))UB;(5)VHJ+)!F!X>R.5<:I1ACCZ5EN[Q2FKSRO<]$
M5M8-2_;A=VGM7BV:[39R3<KB$6 #KOU\/%?LUT>M[\.BW5X:NI-,'+'5SAG=
M(JJB&62M227R[[13A<&X*SDEU"#:+!]"3LSZ-EC XERV2?(T/EW?/V:JF)A6
MP3BEH)U99E7?<ISB<N_']8#&1>)%7%C4N!""W/]H8X'UC= \=A,%'$TFZ30U
M3R,)N''9.O.GCZ#.5LW6C=.K,V3W?#?% [CVN/BX.:%8$)$V/[KTR]Y6O<H1
M1@8048-("Y)%7U-M"#J)<#NXSVJN.]2Y69MB&5[&92'UT<UN-(YB"@Y&P<_P
MV+R:UV67EU0[.(U[-FGP5D.\QUZF-9B1$7.19_E6V8@1P@1' N%J5=\ 3DNC
MG^2FPG)&=R6?D9(H+6W(F/RS5?+#&Y$']=*[R*+S.XN@EN*]5*&)U!G)EV8B
M_V5R2=]@^;YP((WC!T31\/[7:U<2 ?&65+#=[/IN%3O6*625M/HV>)^]9MEI
M2K&AM,;T91%,6,CA?<TA_B;Q3Q*9":RL2(=,57%)[Z4I <V]9?^:JE28>&:R
M.-W9AE:RDLLXMF\)'3/P2M8%[^/\G,TB6AHZNV*:BP);A\S_/5O'<)VOAQ9<
M+]ZF24'"8C&4Q\]",L4I[MT4%@]D49&>X@1"-)5,UR.M9J40^A1'!Y NL9,%
MKQ:5RK>?LI?8M;A.C5GW@T\%SQL<V!"5.]=D]0\% ^_\?7*F\.%[Q%-F+ *G
M!,P::Y;?!ZA/#MF6MN]3DYDJLCCSYP&0EU[H]'SDFJ:<9 L6RO2G?&5-[B-
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M-L/JSHJ^#_1X(B@!8KMMYQLUKF(R7%E2*XUF&.Z-KY.L#_9KII"!\@S6C\_
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M]?:^*V2]"_7M ME9PW-9,[7,6/*&G?2B?JE$A-N60IKQ!W>YI[RWG"\#TV2
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M,.U]=;I1MWC"5QPY#"9QF7%<J%4TWQ:E<*<Z7N>^4&Q]<EWM?[?I'9ZPTBO
MPF]@%D6^[FQOT=O%>(\;.<-6]PA(0WN1GQSL@./.T7(7/TM%.@*5V2QL^-!<
M,D8QO/=<\-HI@ERQ!H :I[?*/\HJ Y;2$IF/5:X+FK9_=D,A?&X)-!:>+7S<
M&M^I\KS>W],%Y15YB39P/21M0O1OA3,021W _3EP(UJ6YQ[( 0^YYD_BUGX*
M9-$?!HRPI+Y=#^ 2\^JS"_:19*<#H+ !6,2,/?X57:=![.4';N?@)9)K*K8&
MF7BT8<2V/N4[]*O;K O)0>'*VT9+R.)8NL</,R'QD=@&_E99@Y$SA?/B79O
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MQ[46C#>C#5;(,:40J]&"4>:N8(N0,44J@US$^=EP$%[?B9+BO@K'C0#X-29
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M>-(<#H3Q=.80L*]-=&J74]HSH^T$5:#&(H/QHQ,1A>\1C#=VSAF9&A)C@1\
M:IE*)[J^ON61D'KD&OEH\N=W\'.S*/&&A$_,!3KSM5OSM0WLB=(D);!UO]-Q
M)4(?:"2]R0AV<S/SL'3EW93M]-4I\O?=J6N%?I'D2TC5RN'[X_=""_]3$CDL
MN^6=05WMC#]P(+W$R#E</'(U$-'Y.;W[Y*YL]W@U>9,5ZU[2RYO>:^]BJ2Q*
MH<3"+#V/#0JH#-A*HC&"RRV\_(0C//Z^P5)@*/>C=W$5HY;%AJB3.8ZJM@A[
M,SR'[00'YX#LE.]S"MWT75HNSY[!N+,]76%$?YNW$/SL*_</V%QGST8LDX"E
M9@.'1LWE"B(<@9(#4B0.&U1N\>;"3N#A7?L;*W^:AM(B/M'K=+%_DDAS5Z-5
M7R7$=Z?W$RD:"B<6QMY;^YQY3W#VIS7_OBM-4)P^;=+4/#T'X*P%WB>5%!F3
M@N/:Z_DNLO(QGS*H?G7E,GU.4(-R#3Q;>]H=RT67L*%&&,JG$*3!,0H_DAGY
M 5A9U=S2^G*,CZ,*J7UZ]Z3^$6!8LD#X'O/]0;NW141^^OCB^,^UA_<HPR,
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MB[#L5CM(,R+9F]U"P61%)Y@W[)>M>+P_69S$U3DR3YSA2#.0.6,?&4$&S:X
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MIW-PAY!PN_G+GC_7CMX.A!MS2A>"5^/L.P(T?GY*S U$C7TK$:Y1@+3-4[2
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M*4$12.B<["+AU]^/[\:;T7M/VW9EA^8IU=B2?D'&BF8=>N?T,^9,MW0S12=
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MF[RORZ?<7D[\1H6;EM\RUD=^E)+<A*3%A][,JB.U?HJ_794P@ZO3(M6"ET;
M[%$RK )^B56,D&56N>-4*Y([]1Q78V>XZB%=,M4:WG:)'S9%T:26%[TDTXE7
M_N$U3&_NPF81@?H3Y@%J$-+ZYTN'O1M=,9-3_'6-]<L6EF)L1/0CBPE_I==,
MK&0BK2/;ARP^?'&T>O"()1T2=RZ[JSX0I@6$'9T%X5X4QOJ5S,R$P]3NJ=JV
M<H^$2"3"^'^="-VKW,'27O_\9?U&@%&Y<6RV*R9%$C (2:P%ZE-'$/7\*3]X
M^^:6Y&5\3L9*R]-WV%\:358:XI[('7RFQ)>&[(<R#)M63/^IXAM9M&F8Q<BY
M&ON^6'M5(9CF9=I9\PC0FM$MWW6.[48Z97FH_AX(>BW/YWDSZ,0DR1K$60Y
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M).$FVELY+V+4.EC]02Z2R3W!.%3)$8HRT7%L]XDU;W$';Q! XJH@CJ;_!UQ
MH[]<-Y[R;PN< 8+D!0I"YC9P5 =2L@CG,C1P[K9BTJG@+Y)("@#&"54#KA2T
M+?=\MB[:L^5_UKHOG9Z;VWZB3TO_ %_7=?/0'3;-.VSRV^9MD<2DLN$&U4QC
MY267!R%#%-Q 8JK,T$[^9,T8#-*9%<KYK@PYD& '(7Y)5<!B5;<2=K*4$)G*
MQR;)"V%8A3\S.NXYW9).SRP W!95<D%7 2*1MT;[HUDR9F*':LI&XR,>F<8C
MDP6"E22<* %4==?Z^6^VVOJ/5/T_KYO_ (9:78- TJ21R1[=Q99(DC#B(C$9
MCX7#,C/&^WN  20(VI+B563=<")HWQ*REU\N4AF)4N<$"3/7C++N4*L:T!%5
MHTQ'#Y2Q;0R_ZM^#&Q(&5 ?>APQ_Y: D.<N1R[8F*(4P ZX;R&)10"KD,&&9
M-XP#\H5_X0'C25E[OR_3_/Y6\A/;7^OZZO;;?4\G_;:BV_L_7EO-(K[M0LX9
M/-3<K,)PC,R,WRR LA .3N<%ESD)ZU) MZ%_=;]\:EA+&>$<1DJ57#-A,2 $
M\-*?F:3#/Y/^VRCP_L^74*R>3_Q,+)4<)Y:C_2=N[RVYY<DA< +O4$'@IZQ/
M#]I22%8RC7(3%NXVE2Y5$!&2% 5,9Q@.R%N<;)B_WGW?K_6_EH:RB^1?U;;^
MNOY7$D^U_.S>8LQ+M)YH4DMB1GR>^=V7V@YA7 PCJ4$CE?O,C>6778K[1N2-
M\*-X.T;XP%XPZ1%<9(!+<><[2#R\R'SU\QO]:H5)E4J6S@N1N7^ '()'FDK)
M$ICDA=F:/]Y&_F-RZ<,V[DY=6=3G*CS,$X6/-5TO_6GW;6_5KH\_/Y_UZ]>E
ME;2UTVY/[B;*_*T,KD)DAU\IE !.0Q"%/GYXX(5B0[KB7[+),=RQ@,SR2 _*
MS#!SU&%8!#]X'=Y3$]'8:5I'5Y9(XYM\CRR%1S)NV-(1R2/,&XEB /*.1S&H
M;MD@3:D;6[+@1><2N'&[865FXV21RJ23A=B DID-76Z_K7].P2N]>G]:/\];
MOUO8<UOS)^[5BRK"1G:&8DJP+(H 5-S19 7:?+QE'(/SQ<_ GXJ>%/B-XTU+
MP;XA\ 6NF>+KM]0F.K:;-<R1R^2D0.]9%#*W;)W!HP205./H>X@$DZQ[9U$C
M&*/,9:0"52 #N!;S-@*<L<GA06BH:\4R2,S?*K-*PC<Y0-&"Q7+%<LNUEQG:
MT*[20"]8SI1J.W;IW_3?[NUS2G6E3>G7\?S^2[KJ>%W7@G]HF-VD_P"$N^$Z
ME2UPO_%-WJ[-LKA0O^D# 5HW 5<85L\;694/@#]H3,BKXK^$ZLY<ED\.7D@=
M-@B!!68_-B7<&/+?*<;V!?W/S!:?O)-NV/YCL53YH"J7"@C# ((6 "D$$Y 4
MN$)D\M3#-(?W3-"[$^8G[LN9"?XMK$3.3GY_,**0%>I^K4NGGT^_[N]C?Z[5
M6KE;Y+SL]OG;Y'A:>!OVA'B61?&GPD@41JP:/1;S]UA@ RM]I.Q0S9P#]Z/@
M<'/&Z]XN^/&B?&_2OA_<:]\+/M&N6$VJ1WB^'+D00JI6$K(6N=V%\S@D$(ZG
M[O2OJU!++>0JRR-(T^6+ GDNJ  \YPSY^7:-LH.TJQ6OGCQ]"LO[?W@.-1(J
M3>#;DLL:!B 6MHR2N[D[VW#Y<G(*E<@UG+#4UHE^7ITMU^_7H:1QE5K67Y?C
MTOZW[[[V)O G[0CQEW\3_#)FN9',QET+4 )FSN9)&:Y W#<6RQ!&P-DC&YP\
M _'^[;Y?$'PM<2.A8#P_?N&/";2/M)(V-*@*KR"R\8Q7N]T_VBZE9EC6:X+K
MD*,8:3!489<[Y#*JKP0H)(. R+>2><#*V9MS&6,K*WS[9&*_.%)W/AL/NR9&
M(P/W@&OU6AT^?]?+Y?<9_7:_?MT7^71=;?D>#Q^!_P!H*3:K^(OA6(F=<"31
M=0DW%V7!&+H_*<AB<8(*')W+NA;P9^T!):J\WBKX4W >$RH6T&^V^6 ,A5%R
M 6&]@0!\IW'Y5''OOR_:/+$L</F$PDKL0#YFD8AL!1&-T;'!*J3O3*QX#UFW
MW[>9NC\YQ(BL#']Z,QA7!*ECN9ALP<K&RDF/YE'AJ"=E_6GZ_P# 8OKE5Z\V
MG]>6G^?8\%E\$_M"(TV?$GPK5M^70Z)?!0T:LAZ70!.U9"').3N^8MQ0W@/]
MH(,(Y/%OPO>-47?G1=04':LBAG/VD?=2-P% RH8@+DD#W:!_-6/.V9=FUSYC
M,V/WLB9XW,=J,V0 0TBG8=@%.56N8 K;9_,VEAY:'S69MTF!S@-NY;*KN$+!
M@-I4>%HK27]?GLOZU#ZY6W<K;]%WMM;?OYVUOMX(_@;]H)A-(?$WPGW;5P5T
M"\3RVVE!@?:L JJEAD'9AN<@@+<^!_V@H$DC_M[X5^7M8,3H=^%D1/-SP;L9
MP(Y0,\C P.@/O!N69/-\Y&:-3< R'@[A&RMSC[S,87/RY7:=H$9 <56TPJQR
M&.-BD*%L$93:H')W;E66,J 1OB4$E<)0L)1T27]+_@V]+OYMXRMJN;\OSW]+
M['@T_@?]H,_-_P )-\*H9%3RTD&C7TBR(H;C<+HJT>%*]<8!&0%)6>+P-^T'
MY:B+Q5\*8MTACR="U)_WIR"I*W)_><,,$[BH( PRY]R9&DW+DW7F+AFX9;@+
M,5) R%8,\2.1N)VQR#(55PMPK3R[G4S2!F3E=QD\PS$(S8W#*A]S!@00P;8=
MSK*PM)K^NWY7TU_ /K=9MZ^7;OY)^OS6I\T> ?V>_CA\/=1U_4--\9?"V=O$
MEROVPS:'?3QY/R;56.XZ!CN(Y8$!AU1CU%QX4_:*F$W_ !5GPCC?.6QX6U"1
MMSKV(N2"'1]I9?O95L_<Q[;<R><K22/GRXR)))G.XCE2S=P&DW2X)W!UQ@,0
MSJ=LD_\ JU;K(HCB$C?-Y2MGC+F1F4;5.<+G>0YE-^S45[OGI_5M^O?L]S-U
M[V\^FWJK?UYGB#^'?VAMMQ=#QA\(+A8P9,Q^&;[<J, P'%SGD'>"?XG+#E6P
MO_"-_M$6K[E\7_"%A;[2?+T"_P!K[%V*>;O#Y125/(*N6!($I'MR$R^6VU;H
M;?,V$^8TP;Y9"#C!/[ORR<X=D]'VN;II(UQ<22NJD^:/F:60#<)"=I_Y:D $
M_?6Y  #,Q+]FM4]_GJO^'W7?5KO"K.^_Y?-_=_75^"Z5XW^*'@'XY^%/#'C3
M4O"&M:;XL%Y;%M,L+F&6W*>2-P,DI21%D<R8)+;V0X9MU>]>=Y\WG'8)G&]M
MSAFRY=WWMD\$1;QSQYC2(%)4#Q3X]1*W[4GP?18[?RY'OEC)1EB57-@$<;B>
M2KJ.A(3;GS3\I]J=V,;-AED99&4ME0Y9DW,2X)W-\L1W#!'+ >9O"HV6_P#7
MIWOUU?3?JY7DTD_Z\_QWW^6KT4[E5EF$;.H8&,G:AWRN2F"%<@N.GWHG4*59
ME6.U+O'\AQ--G?L8[7E*0KGA22?G9@RCF1EY;"$MO(8HX9$^2.-P\.X@X1=[
M LV<8"1R;,'!!"@$@N@FEF=YV92T;F;A<JYB<2NW0L5R)-@P3C$F?E\QJTUY
M;OR_KN]>V]K/9&',F^;I_7]-Z[W35](8C%:!;J.&)8T'G *BIYL816P JCDL
MDBMSP<A=RH]-CTR&QNMXCM_,(*27&U<2JH2,DO\ =)8ON&25 *%AMD;,B,D2
MP,O[N/<KQD@21JN%9MY)^90JR1ME@&$?W?E.'1/Y;HV&8IM<<^8QR?DYQ\S;
MEF+-_P M!)M4@N *VTB[+[O^&OMIU^\)4XMWDE?^OZ?3757O>%M+M[V*.VN(
M8ID7:&BF1E_=AE0E4.XJ79>H!898XRZ(',RS1_O%C<O$21,53[0K..2W\/[R
M0@DD*C 8.4+J96VMN<-Y,><,Z^3(JE5"L01\KMY.3D,5&<(A!J61/*R&$MPJ
MAG8?,LD@CD.T_+C+,\4BDCYOF9\ ^;0Y-O77^G^FCM_P1Q5W=+K_ %\^BZ:7
MUT"4^4N&:3RU)VMMVYC5PVX<9!"A^!WC("@PC+$CWQ#,8FDA!0QXX#1@+L)!
M<@%'6+;T)\D')\Q57;Y9W?-/)N5BZ-M,K*4=65@N1O*2)$1T4J, ')4#SI88
M\><\+*H1Q_&&4[=HP=KH[# 8(0,?=C$E$?BU_KO^E[^5A:)?U\OD]K;]M6QP
MW)(K,LLV)1<!E'G,Q5PS?-@[F9Y 1M8X7^(K*7:+;Y%O&QVMY$6\.%;;DQJA
MR57YD<K(-N>8XW.2H7:D2K+;Q^1Y<C*B"-BPD69MDPB#$@[E$:G(^Z#\K@*
M$D 5G>09E"L0 8MQ0>8 0V/F+"3RVVL <R8;.YF$]+/_ (?3MW_IWV*L[_G_
M %W\]NBZL'C9]T?_ "T9_*PQ#89MRL?F!5L*D*#.-PE!.TN2/+?VT=&&K_LJ
M^.)89([8V.C7-S;R39>)0(?.C#YV[E!#H6(R5B   1P/40"9&C8KYB.D&';=
MN8L3@Y.2KA QX!?#<+Y@+<U\8_A5'\;OA=K7AF::\M4URT$*SQI^^02M&P'!
M7+-NC/\ =_>,P(927))M6\_TT?I_6VJJ$G=-Z:_=U?\ P7MV\I/A-JJ^)_AC
MHDT5O+;QS6(BDA=<-Y:H\*L!@'!V1X*Y!)0X<[(TZ*>9I%D96PSRNZ>;]P$H
M60$,, 8$I;.T8D#,SKD5\M_"W]O'Q#JNF7F@P_#/5]2N?#,[Z=++#K%G9PJD
M0@6(@3$R(%@2-]Y[E3S@*W4K^VOXM5E)^$?B:WD $Z!=7M$ &%=1A-S!5/(
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MO$G@3Q OB#3+'4)=.N+R&.2)#=Q)&63,P7S'^88?YT:.<# W8.]\1?B3X?\
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M;VW[?,^<(\F.%"T3*IA6.157SI%B$<@^56 \U%.#@ M)*KLNTJ-V>IS\D?\
M!03_ (*=_P##*\S:'X)T<^+/%%BT!U>>02&PTZ&Y=E229T7*2R;DR"S9,@XV
MG ]C$XRG0A"576^B7?;U\U?563W1\SA<)4Q-3V5/9ZO56Z)]M7?9V;6K32/K
M=1MP(6D>.596C,;[-W0DE8SC!^:0[?,.U$')0DD*+-,G[M75IB=JO&,H6)<!
MU.-H,_S*I4;/FP06)XVS^+Z)^S['XXU&%+XMH2:LUO:1>?(\SIYQB5"F/GW(
M@!!)#H$) =3X7X;^/_Q\\;_!R?XC66D?#_1_#$EE_:,7AS4[:[.M-8+(Y9!.
M91%YGEON577:2A;+8!.N(Q4:$I0GKRW;[)7M?77==-?(6'P<ZT4X:.3LE^EK
M_P##[NVY]2(\DD"MYDC22J9FE7Y7PT0RXR-@WJIDR2C$>;N)7+./(MK9S-F-
M(U4,$5"L8W@\,O(/^H&5V_,%!"E<%.0^ GQ@L?V@O@_H/BRPA6.#Q%I\=^T#
MNJ+ K*\CK\V%**\@!(PH5F8(VU7'FGPM_:SU[X]_M+Z]I/@V'3YOA[X2@6/5
M-=N?,=]4U"1IT,4+JRQ2;/)FW!E9L%4 %:RQ"C.-%:OHM-M.NV[MY[:M:Q1P
MM5QG.]E&U_F_O_#3KT/>V54D.X12"%F1I)'C8G_5A [.I!7]V$P"/W?S[<9+
MHP^Q_*S2+)%MP[QM&\; Q@,"0/WF8P_&"2HRS\Q"2+_C^C5@.I:-=X+8=)!\
MKAOF#%=WW"K'>X7#JK0EOLQW$*LB,)"VY822J)(,Y5#SM;!#@_O V26+-HM]
M7VVV[[]>C[=%W)C>5[>O?>Z]/)/O^.#\7BUM\+/$2^5,8AITZ!$+Q_>%RHVG
M:BCB)0,L1UQDXV;FDHT,=GM7=(KQ,A2+:K88,=IVH1EHF(*MDF,XSN KB?VC
M?%$G@SX?:IY</_']#)9/,J^7'&"')W@*@'R["5()#+@E=JA.TTZV\S3HD7[/
M&TR"+GYOF>-CL( &X+(59E^8A5C !,;J>6E43Q$XP_EC?[Y?Y]/T-Y1<</"5
MNLK;:Z1OU\O1ON3+'Y"(VV1HTPJ$EU#1J95 W+&#SYB,W*DO*I/+CRV^>)T:
M-KB+]X,>;-.&1LNS;B-Y/(#N64'YC]T@X5R2).RM$OEMGY%=U9H?,\ME!)^Z
MHW N2R#>X"XP4I'NC&=J,RL@(7?,RL77[.H!WR*5(*QK@9QMW<M& .I<O7;U
M_K_@=[*YC+W=MU_FOQOT7R[GPA_P6?\ @CX2^&W["GQ0\0:5X:M;/Q%XLU/3
M;G4M4^S;;RY(O85VRNV7XVXV*Q13D#YMP'W=X(%UJ7A;24CAF2%K"W+&=2V/
MW:]05++[=*_/[_@L'\;M6^,WP1\:_!_PO\&_C5JFL)?6BPZS:^#&ET>Y2*XC
MF)CN8W=V!1<?*@7<".>7;ZE_9O\ VL;[X\_"#7VM?A/\6?#>J^#-,@^SVGC7
M1(M#M]7G:.39';2L2N-T05W;;L\V,D-G%>+'$8>&-ERZ:15W=ZIROI:S_JVY
M[&)^L+!0DY;2=[6V?*EOJET6GJD>-?\ !17_ (*57?@WX)_$GX?Q_!WXN6,6
MH1WGA:;Q-KOAF2#PC;Q2A[>2^^TQ"22> *S2*%B!< <'.*]7_9-^'GAWX2?L
MB_!?P_X5\86?C32=-TIE;6],?_0[^1G>24QAD#%5D=UP,LH7# ,"*\]\:_\
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M2Y]/+]?O_K<OE_=6Z6_K[_PVWU$MQY+J$5A'&!(0ZNK;5)CC# L.$C$Q);'
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M K3#Y0=V1R(@R@E3Y:A 0& CB+1&,QLEOY4<<)('[J-E$QVG:PRH*(-H9CD
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M)TIY5#F:=J<-^DE37XZOTUZGJR5:.93C33UF^FK3EY=&OOUW39Y-_P $8O\
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M#%PR*"Q'=_\ 61<Z/B5I"ZG(MQK.DVRJC!Q)/&NT[7^<[FVM@%QM;(8,5XW
MANL_$JTL-'6XCM=0GTJZ=+%M2B22YLTF8IY<0)1M\F[?CRF)#RL PRN[.MC:
M-)6E*VJWZOMZ7ZZKND;0P=6I[M-7[6_'T;?H][.QM26UYXU2QT?[:+.U\M(Y
MVEO%ZA5.!B-PWH> 0<@Y(-? _P +] ^#_P"R7^U_\<M/_:^\(^'[C5_%VKW&
MK>$O$WBS1/[3TO4=#4'RH+%WB=4FB7:"B(C_ '4!) 6OT.^%W@@>/Y[;5I]#
MU:RMVDW_ &:ZB2"15SE=I(&WC!PH (((X(KX3_9-^('P+^/FB_'6\_:H\1>!
M;7]H:'Q9>Z/#IWQ'NX;>U\.Z-'Y8@M=-@N2((E),H+0YE; 8DY#-\7F&(G4J
MIQU>MKI6M;MW[?YW/N,OPM&G0::Y=%=JZ???>WX'9?\ !)S]EK4A\./C%XH\
M+V^N^ ?A_P#$#Q%/J'PVT2_N'5HK(QL%NW@492.0F,JI^8+'W&UFYO\ X)V>
M+OV,/V:/V(O&/@']K3X5Z')^T1I-Y?S^($\2^&FU7Q%XT:XNW%FVBW)1G?S$
M*PAX94VO&TI^5C(//_V!OB9\2M G_:<\,_LZ3S^)_AGX:C,_@:V9VU&TBU'[
M.[RVNGRW&W?%YO\  "<CRR-QDW/[O_P2KG_8)^,'_!-ZXO/VCO%/PAUKXK>*
MI+B3QU>^/-<2'Q5#.LDBJMJTQ%S$(XP BVN%X Y)KP\5RVBXKO\ /7IM\NGK
ML>UA.:#;G]II+1WV5KM_CY]3]$/^#?3]G;XD?LL?\$O/ O@_XH6NH:3KUO+>
M7EIHU_*TUWH-C/=2R6]I*Y &]4()0 ;-^T@?=7[7K\W_ /@V'^(/CCXA_L(^
M)I/$&K>*O$7@#1_&VI:7\,]8\1%SJ&I>'8O+%NS,ZJSHK;T5B/EV-& JQA:_
M2"N$](*CN2$C9F95C5&W$G;@>N[L/\]JDJ.9UB9696+<@%4+$<9/3Z?GCOBB
MUQ/S/CO_ (+LJL?_  3I\<<?ZRUN6+/M90197  PS#D]L=#DC+$ _$?C;_@F
M+^S_ /#C_@CGIGQDL]&NO!_Q)@\,P:S;:[:>*K^"2;4E5R %EG\K<Q!'EQH&
M!)"X'-?;?_!="21?^">/CAHUO(I!#/&K+-L5P;*?YN&X4=#G' ;L<G\N_BI_
MP3JU3]GO]CSX-?'"&_\ %WQ.\ KI<&H>+/"6L:A)+86Q;;A8U7:1!M+Q_*-P
M 4CN!Q:-54I<J<H+FML[2?376WWZ=->SF?/0LN9I3?+_ #)-?Y6UTWM<]4_X
M*#?%3Q-\0O\ @B!\)=>\=%FU!-9T]C<W!$SWD4<-NS3[AM.\MY@+;'R=RK@,
M!7TC\)?^"\^B6GQ)\&^"M6^$OQ"\+^'_ !!)::/IGB6]@:UL+F8&--J)+$ 5
M8MDL&^X1SG!/!_\ !;/XN^$_C7_P3 ^&VN>"6TV?PS>:Q8>7#;2;H+:+;&0G
MWU(V#9PR/MXR O-=9_P73T.-OV%O@_#Y,;7-CK6BM 857=!()[5691CLI;.$
M() ) Q@^G[;FKRERVC/$1A;?XHTU?S2U_P"!=GCKW,-3CS:QHSES?X93=K=N
MY] _M]?\%7_#/[%&OZ7X;L="\2?$7QWXBBCNM+\-^'8Q-=3P$,0Y(C<JI*$'
MY2=I!7G K*_83_X*_P#AO]LOQ[<>"=7\-^*OAK\0H0C_ -@:S:O#<.@0NSH)
M84^7Y&R"6((<9&!N^<_BA\0?#?[.W_!?O1_%'Q(NK?0]!UKP79+HNJZG,1:6
MLBVUPD@WR A7#*0,[&_>YP=V1B_M%_$+P_\ M=_\%T?A'??"'4K+Q-%X;TJ>
M'7M4T:47%NKF#4D^>:-FC "!4W'YE)], XTK6CS*_/SWUUCR\UO_ $E.RT:?
M4Z:EVIM/EY8P>V[DH?YNUCV[]HK_ (+L>'/AK\==0\"^"_AQX\^+LGAV:/\
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MI[*E.$8N*O>,K=[JWYW[>9QTZKFU..TNG;\/ZN_)'L5%%%<YU!1110 4444
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M?FZ*00%<OC*K3ORWO:.]NNGJNN_E^/H8?$4^5M6U].O?S_X>[1XG_P $]/\
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M; <C+J,%C(VYB2R[HLE3O1#Y/^VW.X^ EW+'(R[[^T=<RATP)867:OR\?O\
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MR6\;VRQJ0\&#$DN%;;'L*.^[D?,A)!8#E&08*(0XW3MB1IO+:-U4;Y-RPO\
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M$_%5K:,[V0U?38-4CM2Y"LT9F0C>=J\[LR>0%)*&,-ZU\8?AKI'Q \+R:K<
MPW6F0K);W,$BR2LQC&Q&V_+OPS8+97:$) ' \W\ ^()/$O@G3]2N(1;W,EJM
MR^'4L@!<<OR?E/*-A<&1 VS$==V$FZK]E7CJEIV\OR7R]3R<9AU1Y:U%V6O5
MW3V:3T_72VFMGP^A_L8_"#P;XOM=:T;X8?#W0]7L;H7-G=6OA^RM+BSD$DNU
MT;R$V-&P3)5EV@,!AE.S>^(?[-WP^^+^O6]QXM^'O@WQ1=6N;>"35]"M[Z:"
M/>J>6GG1%E5L-C[P5ID!PZ@GKXR;!UCD9XHT?RBB.4<;=P) .S)5H"5& < #
M<'&*8\.Q")5C6-@%?[K1DLL+X4Y4'@D%E# [TR7$A)[_ &-)+D<4EVM]^G?2
MW?;4XXUJG,I<SOWOT[;W7ELK:G!_#O\ 96^&'PO\06>K>%/AQX$\/ZU$@CAO
M-,\/VEK=*3&^Y-Z(IR2L09-Y^=F!5@=E=-J/P[\/ZWXIL_$4NCZ5>:]9V[65
MGJ\UG'+=64+_ ",@F?E$9_E8$QDAD)&3MK8GD/E^6[]2&=B1(RDNKA=KR?WB
MQ!WE7X)RX9T?) TL^WRVP6,9$8;:N-P*98*=GEJZ@[P1&2>6C9::IQ4;))+?
M^OO_ !=R?:3E[S;?3??ROZ^J=GY61I%U)&<-',CR&5"Y#9,F2O#!]S?NADM\
MS*"I+ABR\=\=2L7PKUA)/,C;;;XW%BQ"O\N5;[R[9%P[;3R<*2IQV#3K)+#)
M+)YGR#>TDFW>KA)'W,7#?,I (R5X9E^7>%P?%H6?7M#L)UC\JXU)#/#-B.-_
MEF>172- 0V=N3C&V,9^4IG''2<</*2U_K\?/MZ:FV"UK1?GZ/[N_IIWU/I'5
M%_XF=XJG9Y;2*CA5.QI&CW;B"S<L#T &$ /));A_BI^SS\/?CO\ 89?&?@'P
M;XP%AB2T;6-#@O\ R5:0@A/.C?9C<,,#@@YP#D5VTRSB[W-'OG,V\(ZO(CMY
MD6P@;L+M;()*@[C)A0-YJO\ :$CA\]9%\I 9XY-GWR-H4_<_B#NBE?F8;",F
M3->-&.B6^WGT7]?\'4]Z=W/F6C=]5I^/6_7RO=6V;X<TNW\%Z1:Z;I-G9Z/9
M648@BL[#3EMH;=?DWA%0,HVE@=H)'+88*"X\_P#'?[(7PU^+'B^U\4^(/AYX
M'UOQ$$CEBUB\\/VMY>!R(]G[PJ[-M9E7@@88,& 'S>@2Q+96YQ^Y6U=U.SR]
MR[(V.3M5=IVNI W+]T9VAMH=.BB9MPC:;# ;50L[H5 V$MG>)&C3)R"8F V[
MD!FI1A-IR2?]?UO<J,G%6C_5[:?/].HMO';W<*E55K28HCQPL9-J;(SC$8/)
M+XV*V"N.6W#/BG[8?F277@<76[S)-6B\[ CVR83><'Y=^6(^Z.A3"'&YO;+@
M^=(TBL)ER5C<1^9YAP)8^D9!0#Y05!W*<#+,%7PW]KF.2[\3^!--TVU>ZOOM
M]Q<K C1HRQ0V[3,<R'#-Y9=\,Y;(#@ MOK&O'V=%./1K3_@_UHO*QIA8WG:/
M5-6WZ7;[Z?Y=[%J63%U&S2+\WE[BDORD;A&"O"E@H3 !;JR@@;) 86E^T:8W
MS1J&CV,P8&,_()41F#$X5W!W%E "="V%3G_#OQ?T?Q!XE;3[.Z9KAG-R WF1
MJ\@W.57<"S %57@J"(E/RLH(Z(EX7;S+A?E WR %O+4@+N ^7Y3OB9=B\AR#
MN*B,_3TZU.K=T6G%=>VRVUW[/YGRM2E4HM0JIQ]=W;ITUVV]>KM)=7#6T\TW
M^E)Y>^4@[H\;74J1@G!#94L0X66-,E@":(80TWEB-9%CFCA9 #)^[#;=F1O8
M@*NT!LKC9\K>8"\<2+++#^ZC16D**BL)8\A2CJNU_F5@BKM4<BXR!\T8HC_T
MJ,>8S&*4F,,9//)R Q(RW[Q\NC$!%!#2M\F014M%[WE_P/7^NF^491Z?U;II
MWUNTK=PBD\ZWA9Y,*VT#$O+'RMP56W$#Y2J[@2"8UWJ%7!%FWV+2?NS#P6$(
M^10(/,8#;NPN=S*IP5*!E("%5)&;RFD$>T^4IVC>[0C:Q12P ;&?-3+-DIM(
M)**S2/()KF-BOFD7 4%E%P=@60^2"F<MNW*-I0L&)^8Y9"4E%?U_5_ZU*BKV
M?_!Z_P##WVOMTL076HVFCVTS7TT:6MN4,ORQ@ +*^2$!* !%.1A05EQD A9$
MT&TU+QWK-IX=\-PV.HZU>1Q'?=-FSL$!/[RXP" /FY(4%F9PH?<[G<_9;^$T
MWQ^\:3^(-6O+R#P_X7U!8X;%(89;/4YT5HW$RJ=ZJJA&VHOW47 ;YMOU%\,/
M@YX=^$EO+:^%]+M=.;4;D2/&B*,SQE>-P9=P4MC:<#*QO\J-E?F<=GB4G1IZ
M)WU\UIY;6Z^>A])@LCNE5KZ];>6^NGH]%UUZ&+\&?@#I_P */A-=>%I#<:S;
M:R]P^J"\B1OMSW*[60]$5LQKC +*<JV2H1LK_ABGX4R3QJOA+1PLC;HS^]6.
M92YV'#/ECM(Y5A@<$;@0_J:;<QD"1H55]I'S$1@#;A\EF(0RQ?)U$"_W=RD\
M$D,;1%O+9^&D1@ L@62 NH. %4Q2?=/W&SQL^7YZ[<K2LWOJO.WJ_P 7T[,^
MG;Y4DU9+\/+[FOEUZGE=I^Q)\)QY;+X)TQ8?W),,CS<Q8:0%]KAA\B9.XJO
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M:HZC/JJ&'A2IJFKZ?KO?S(=.LX-+MHK.UMX[6UMHECACC54CC1> JJ.@4 <
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M_P#"W_@HCX3^)W[:OBWX'V>F^((_%O@[38=0N[J98FL+I)$AD B*RLV[$_H
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M2V\22;E$;@*A> *2N#\Q&<@G:HR <9(8C)S]URV5T]/Z_K75VTMJ?G_6S?\
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M7.S;=^U\GN?W?7OM$BD:+&3..RX$%!=78BP"<^+O=* =XRA<49*J41Q4P%R
MD-ON1<@H2+I#RMI>=&.N4=KJ=@B1+ZWUJ#VXC1!1@JWNAD<'X_+YO3 BD0FH
M)=17<R\(S<-.<3%*COOMWW<'5*1G]\(OC 7&ZX$5_,=J3KTT<-06V,HER:[
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MNSN_5!J8.57?_)L#N?>JWQR'+-3,!\=TKHT8@H^&RH)+TROTPYR)_*-4\VE
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M6;;V1<U=WR:1N8O1@W^+8W"G2HO["I]C\WV\G;YB8X.W>0<'+P:*YUU*Q#,
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MUFAB1M_O)D[^\]$PNSE0K]-1FD\&Q0\:9=%0545[A7-XY#ZJ*@=!_EX^*IK
M?6#*I;#<L)]N=ZGG[3'LQH]2R HS'%1;NZP1?=[>&%Y>.YB,M&.?6FZ%> &*
ME"A%VI#R&RIX5BDM^S;?7-.-ZI(J@;ZZ&$5-WESOD"QGAGB77NO4%#%Q(^I[
MKL</XBJ8;K1[UNC2NV0S./&+)OMQXRG.U\Q0(S%#_+_5PMI]]KY(.>G%9-(\
MY&T5+M[FVM4C:K?W::2\NE4\\FH<WJ?<6 [CCR48CE(\T"Z1'XO^>*Q.7VEK
MX:/$G)1N*.RS>FHTJ(Y(@4+[7#QA<DL%M_=GMP_=Z/0&%=Z:+\!1=])ZHM#P
MYG=,E!R_T!4JDV?E=N3TR,Q4Y<3RS+JS.O=4GSC6KD5M *_+UXE1KFMR87)C
M253"Y13N5[RLXX,8;""[J^[<X#V5HW$J'B;=N'T 0<]^(]HY\T-*6D4K=-G=
M8TV5FASMX]MB3PR T+UBNM=5SO+E_BF^7N/2I-7)C!U\>LD=LF3P#*A=K8E1
M6S=[-3'2*'3U=&'G:)0"X&+9XZ6;]XKC;3<T+N.I/CE4S78F<E!JFA:NW(I0
MH0DG%E7]DM%,3!&*_YV5AYVJNXW_N[?]V/T5X2';6I;>E]%8R_BA+([<E"]S
M87?TKA?[@-"8W/Q]R?>R.SYI+,288WH;?YX!5HL%'M=8%GSAM76AB&"0:Z'2
MH\NG $11&<]M@$XKE#O+/F-J$+<*!.@PKP07GV'!<=AW_Y)\RR^E=YC+3)E*
M3?QK*)4C[NE?Q*[8GW#&>X2Y;JGY"*+B#W<\B6;.O+ZAX>#N3XBRCVPE5I#C
MLB[^\L7<KJC;=?$@^Z<S76*^%^TTR2$OMB0C2L'4FYDH]2/U#>D1\][5[/3P
MKZ49GDW_YA9 B" B*?6],:1T*N0Q8X:.*^UY8U9W:)P0(06 4RD1P*HN?=K4
MI,J1:J3_>S\G2$%3&8<A)]-@N31=Y+&^&@FG5]*&&S=01_S-:CV/2NUW7+4.
M5F(4>W7)?L/':COFE^R@=BJ:-C;3'MGP/3'SDR<K&2YXB@L78TH8N1+%NW'N
M-VAIYM^<7Z/(W#X"^,2P^(@7M3H#K1^9/!",Y]3YPM!!7;2>3D.L4<8:\5WV
M<K6GOFV21N",7(^VJPW<A3X QWV/_H\%5[ RCJEDKU"\P\C90(LU_B?'@R0.
M$]L=H-?2TU)MW*J[*RW;B<6V.X,WB9K7XV"<- 1X%[/>:WA<+/*ZLA"3.'LS
M]1WV>ITC0J!H>VG&B!ZR=+, M/CU(5%T.M&K>0+[+"W-2-V$D-#;,!77^J\1
MALLY])4K%U8J>>I;E.TPQVQANY149(UO /&D,[)8_WH<2LT^">+?8QLVG237
ML3YMKF[3ZD;<ABJ+:4M4$R+O'=1*\O?:0/EM0[UF0RO.:^780DW^R.Y40K)K
MLH*:73>/S4OG/5W!V&:;_]V/#X7BM[4137I0W[LW8I;@CGKDMWS0D(@=! ^8
M"T[_J@ZS)IRSSI'6])S:["+2/J6?DUC?L(-V5W&?KXXC6>A,-N0 .#:N5I02
M-2K'J12_":02#62JIH+6"SKT%?!:GH":HEZ-]S4'';@3NNYKNE=]M W9!^:X
ML1\^LW!:Y;]T /)#PJX.)&?8V@,^#0WI2DQCC>5JBO]N4BBQC%,\E-0&H"73
M;[0C5$N9TG^%ULVRXV7Z$BR_/J'%M)X] SYH/!(V;[@._;BRGE*Q"K3,C^I@
M"K317K@SMDN7F25/9MGOL!FF,LPB(^B(8"R;,+C02%5'@@1M]\JIMK^$SD]P
MN:1=H[1N29_.5[$_8\Y:"7@O*&L7H51 IP%ZHJR&ZIX%A._JPXK3S2]H3,93
M9[A%.-Y,H--*01/5VA3AE9H1[S(5U"?._V,.XB!P.0ZW/R]=G<J9S $T& *@
M;+(N=^/_)7&FQX@!R"WQ[Y='?2O]R)9Z;Z=%\O=J]UYE/U/M73/#V0?4"KGC
M\2D[WCGNTNE'195&*F$*3V5E/U90"@R'6'P7F<+^*G;-=4/''A$F=7N<6>/N
MY]NK'GJV&:<S;T=TJOS12%Q6O]HIPL:05],V"CG=+L4KA>JSKR)RY\KDAS2Z
M7'N<ZZQ7DKHJ:OCBWY@<I#.=Y!D_X_XT'R'93\O?9R-K;:*K!+H"2+>I"=O[
M^!,,OG!YZS;VYQ92I7TH=*OVKB[^83<0?;7_RJ*O=B[J>PDVL&KUX7$Q^T_M
M$I<[]&4%I,+R_-O3VI:_K7\D%HLIR)CTR/1OW"N&EH!C]0U(1BB8<,1DE<FG
MCJ?>&WC&M$;O?X@)HK*L:OA$!Q%:]IH0QC>CV@N2'@-.\9]]X(W?>)_9Z8;K
M3>BNB_[>$[MNB@;WTV.K,=!_="+@3'<:N$]O*?&>L!R02&D[RFO G_T$V3JI
M.EE:L%SO/(&YWH<N;BK*_U)@1C.!^%..E'B^G>XPQ]U#84[JF9<$8.#;29D.
MN&>[_*RW"2MG)6ZEX;LS4,2M5)TH3IJDVEC.+%%;,?S=:ZS5P4-/AMWJN<+T
MUBOV'$)#F;6Q_DV0PBUA;,,$T[^QDI4M:K^+7,H[2)BXVHHFN:87LICRA(=
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MIF2HXR)C$N@#NT*V 5\!J+JFP7*"*E0_]#CRJC/P\HT4C<C8A=*Q&WFV"(=
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MZ)X6G5OXT=L_VE)R)R7FW=.O)_&Y;IH?5J9_[M)_BL&S ])5]RJ'NJQ24=3
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M<M-QO5#E,U-D]Q!&'^IWLE0BZP7K>7P?&/5XVV05:84-%B@^+I1N^DUC-2\
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MX<2$(/XQ2-98J5UD9(3:=>M;0B/ZJU&WK8HYO@EB\H/1LWI2$+L>NPKR>42
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M]H/57<O^ 1%_RNG=/Q*+MTEP(?% 'B(5;9TSIMT:8&"X6.I6?60NRE>=&(N
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M=4+/ 8:9.Y]IV$N['@I_4//:IV$ZI?W3^,$]?<R5I<PO,# 0K_I3J(-5H$L
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M!F7JL6N5?8E>:Z%E?B%@J=>_&5\(.72,-:AFZ#*XKPUG#O2\6P:ECEW;/U2
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M\R\IDN\!/6)# RP)M<Q8Q89S[/.RXYK+HX'M50%5ZDRFH8D4W4E=20'VR.-
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M[LH#9&Z"EE_U1?" I0[PB6EVL!?U@TZ.3T1Y^3O5'8+C577]A0Y.4"B 7?*
M/+A4<MS$B6W&2U$]A5YXZ8"AR;:N(RTDA5MV)RYAO3Z*:<35,^PQ2T2=H?](
M\Y3=X=^[IHN1KH31M8"5;S@X36R"L' BMQ:?&HN>+S-*7E5GF*/]PE*7"T2D
M17R36Y-;4.[LX@]IU(,FS3"PE#K_[WVLQ=G?V_#P/A>KQ.-0A+=(KV#%"A/?
M<'JP6TV:;A+@99,NGL%RVT\67RYW\>?W ,$@Z'BAA0M1G#MW:JC] NNWWGY'
MT=KTCM?^9G?PC7:/VH_ :-1$Q1U\JGW?0_'-H'8"DRQN'H9G\8P8%YZJ8WK@
M/\'X)/VBL;3!9_UK+T_"B$NB.;=81C*?RDJ&/RM13_)X!BV5/&<MMI'+V22Q
MQ&$G0S0_',D=WO[6D?63>XD@GG%=/64*<T+J3BZTT/78V!PX^&P]A<0N>U>5
M3H'_I-B@2A\AM/AOIJP5N8(75&6%TY>O7/]#$XKK@Y&'NL+-Q]^1>2;O,'+8
M@0"^4%#@U7:#E$Y_M*L 3_1&"<P2[%>'# =R=(Q"P>^$\1YD*D#3?&1K*$@7
M(X]3TW82J MU_=,(O$@\FN? G93?2;=(R-7K)%\"DU%&.G7?A;4F1NX!PLA<
MGI,FU0>9G-ND!6\;Q/1D5VI5#F]0RX^S_]8635ZOU'SG)</796Y><'B09A$4
M2_LLD6[GZO@EE\L>%-MBFPQ*C51FQ/A6I;7:J\PYE%V0LNBN,'G^8 2*C>,Y
MF7[P*CR72<SC3W-H9+MU7.'^$A(.(]*$ALDOAI$2"BF1X/@>=EG_;$GPZS<R
MC4^!QEUP&B^(I*G:QB8!EAKGD UKWLKW@!CMO>8\FCG+?ZF'<*V8X];YLL9=
M^03:D>]$SG+MQ)BGWF(#MABW)P(P*+QBX)584ED2<?1M,BGU4\9[PB*U#5;I
M:PSZ3&Q;S IF'9U,36'B?7]18C/RA.9,T/MBB)"6P2X%$&1;FP( 3XU9CS/;
M23JZF>@QB6M4XHY]'CZ8W89R211MXO;?H=[CP+.@???5/U;\8H>(X\7C8*%_
M!$9B@=R:S('^_'Y+6:,UF%"0JO D3(^]1;!R2/ Q=X<WBE;U4+HLDZFD(-:Q
M62W+U9[,WJ^'[GVW0(7JTMZ"BO?^,X[&!]#7[U-1ES.E]$*[C!NQT(?ZK!E;
M@43JZX*9QDK>HTC1?L]<&L,&P:X-_G%J0TL-Q<@+68V']=["U3<<9(-HPHZU
M/_ 1CL]G(?/_C8V$_@?!2UVJ7316N!)V(]>YC>81*I)H&,8S+:5<-&1$.7(Y
M&H=\U1H'-SFYFZEUX 93']:.(H,NY&_KTMNC:6F9+# SI7 IN;RZ2+@7F7U\
M\,27:,; I(M=1WF6I#[&E3"Z$9K1B@I7OQ9S@C<1$GR_B+L-YIB"S^Q>N/QU
M'=.W>__AGWIK<#AM5Z<<B]-12T>[C&%HCM&U&@O"-YC>F9RX!SIK=RVN,UI]
MX?1#-4AB<-A_F(J 7GXT;<,H^ER]HF.XDM\D2<97B+Y'4[6?A[(87&&"<:YG
MBEMJ(1\>"L,(,ID+$8CBMPN0L_AML41 (TQ45ON=NP$*H__[,!]Q^9=-7\'N
MYB]6A<W2KO],FIFO?#O*LJ,RIWA$$.B<&#/J?\2TS!:VVIH8F^P#AI>L-4@#
ML'33&IJ[ BN-TH+?--W)%%BA)-"4(T:PEG!+;]$$+@3FSIS.F5BH[PY0=DO\
MML8:$VTL)\?T6@YO9^-QQ-R-VJVH0/IZ5R0S-GW91898VLR=0?7QK*]RT!\*
M+TUG9Z-,["V4]NJR%B[TKRC6,=:7HA1W1'9GHBOY]X!H=]$_QTH364?!O2V6
M/.YX_<C'XR[!K!SBXA>RLJ3+N?)+PYC17=7@ELTU;GA:Q6A^Q_IPN1N+O_*E
MO0]A3 2>P'"A LH!$X^LUR)U5K22HAK<9J4,<GWK.TXY,6Q2KG-N>_SV8G+(
MP7:/V_Z@1ZH%O"@D3GAN-,R:P;\#^_ 7%Q"  _W8]P:A.>1F3Y;!!S+]<GA%
M(^[AHCUR>+'=&?13G'*YL[R?@@B#W*KWUIH?HSZ>[EVQHJU69='5FY4@XC^/
M5CKSAN=G5W1%!A"YS3(1;#/9--D8(U+5>BDG+YE]2I<'76NH*"]F,TLCNS19
MP=3KB)V7_A+=SI/^)=0CU$MMQ]YHP>C\6_U@Y]:V?$.TQ.U_6*4S[QAE=NVG
MN5\1?QM*ET6+*T_QZY^IO*4XER2H8;(P%W'7SY2_J>:XO)R[P1PB0=3_K2;4
MK'1]1*%/'"^O-U0&13BV8OI Y.CTOJ>1'E;\T*K'QC/')8FHNT5OH)M]BM8!
MZX.83P)5+0:AIB;;,BK(PPV&Y%OC?0Z"DP['K_> WB7$P!@2';K"VYI!6IRV
MZ5RPA5NI#!(2(BK8\BL]8G(HHOJ'PWY_9@.W[LC&;A4"0S?!6I-K5FAO=\>K
M?#*HG'\";WQY/@7&+R-5;;DZO"F,IRQX;K-VH60#=D3R+S$.<8G!*J=[:C&]
M_K \DOB:ORP8YZ=15S]\WK5CI]Y*1Y5F3NI@?C[V)?_B:S%$+SOK;W5Y<7X)
MQ\I O?7 ,Q\KEY9N5I&82JF_>?KN(O> @';W-"4A3(LA7#S YF&.,:>\/,')
M:R7:1.O$FIIV6IW%4IV59M1KF@5[%<JDJ?0P'9?;'VFI2*FV3?]S+Q:F5/5/
MQDQ.JPG+ A(2@W1A>[Z]OU..?2K9%U3F"J+5Z2F>;4IJR-'4G&,XCS4N0A:E
M_@C4V,J\*BHJ#Z@^F5N>&-!>,=CGO0C5#[D)Z)K<<GSB3K6JE*-^AXHD?!=;
M+YG"<@R?[ ?S[V;O@"OTSZ2TNG6!LR---$O/,6E*WB-<\>?G#_L36YZT!^18
MY;*>U68=4+XI54@L"! <-'H6#%]5U2A8>R?TJ&#RNS1O@)#H(AV]*+^@:<9>
MH(MG9,1HE9\OPPP@Z?GWT;&\>P "<PT;?]5E"_]/&>25)S4(\1K3X47S>U3R
M#,,7;OY&S37VEPB2B:Z+['I=L5@GEL' !(Y2'WFKMP/VZ>:1YE-"VYYX.4)5
M]8.5Y]M;?D=&C5+@D>%>'W@31Y3=8!$!5N.-RCO/XNR7!#O0H2N7--L>VSKF
M2/R*'\9TX;\><CBN5U_FP7J*R WJAROY$EV81NMIVE9L8!,1^'5:;&_9&=?[
M=48+6E?@Y>5K-VL:EK9]-[9WH=65):6)9EK1\F:T]?1N)L/DK0$4T4OA_I4G
MA,D9NZKX<0\_V5VV\*1:64;R+S%H*99Z<11LKP]3Z/*!*&YG]!F[J:6D*<^%
MG0V"YYG.>QP*ZB*452OKIA1,M9R!]2*2@1TY5Z1.+><VZN$,ALYY/*QZI?9M
M>RXZME64Q19A)@6M^?[P"7AAI\PQ;'Z^*_=\3=O[T/EB_T G>(376U!I6&DH
MB3<NS.61GN$G?JX %)0@B](WC856IC1ID0TFEL[>RU3J+!RK(2!,\2[)MF*+
M1S#?1SW+#,!@)ZG@-T;;&&K-8'S.TP+(Q)2N16C)MO]P?L!NS2WM?RY9+%RG
M6_=XUXQ8_#&>CLM+!CI6+X74)-D\GJH.N-WA6/FJ9:?5WW\V@PM]$+$([I71
M9?H0Y%433R_;/$\1 Z#7C(LG9AUE3*'1:]U9X6Y,H *FZ+?"?S<4 ESPU(S9
MF!8HP3E/EM0C]L-:"K"#619,5XJXW:'A;L5UA_QQP3T%JFT)-:ZQUP5YD$(0
MMRZ3AI[6O+KUNW)'UK2OO/(.$3%I[:DFT%+<-NK.+F!T14Y-H-WZ9LX##3%C
MQN\@!+LSQI%D'!6/>0I@UBL4$J=!+'D@@8TX>X6IA#N")G3=Z?7+7\>U9<U-
M76;NKLWY8_Z)S%*PDP?#=S9US9NZM,-27/9.?SJNHDFW<<M@9NGIZ(Q&(X>(
MKUFB% Z6/-O02J>: 3/7[U"=7\>+S'6PG3G6_M0OSCRA<D3="HP/I#(YGTAO
MSGHTK 1WOK-:TT9+O#>^@\UBVYIVFR *Z+$KVU^A]($N^M4O-P,2/#W!,V)B
M*+GZ(<JC0BNO%<H9'WK&:'+_3()4>M][0+U7^G>W>\ #T5H9@>JKU3?I-E:V
M].,P7^FOC'EF;R]>*SSTP3N(Y*QG#/T/^R+]JAV]Z+'!QK J\06MK".CB#/>
M$GKGZF]<2R'QVEQB(P,V'D7,F)YL<'Z%.@^S))9MW[',B(Q*#[O]9/1]T#*,
MR?/H]4HNF$1L37=_.I39KJRQ#0[2H.RC<=.+,6_O6ILK<MY5,!]?&.,N6*?A
M]&ZD[S;3=H3M\L2,/4*$,BJ03C5J<8Z/=MG89QN;^W%:[-A;#O?NC$HLE6+B
M50ED>"H.R':RD&Q3.=5<4!U\G3Y&QU9=)YOHR>4CWM"#KYI^"-X <))Z?WUC
MF:F3L[D$:]>ZCM=A01TT/++(6Z=3I?;P9OD, Z?"-6.:LVV;YBQ7&GH'5]V<
M1*2J_(B7Z&%94(:X4+-N7A@@:#NQIOP!U_O6SSRZ=$5=Z93 VT]ZXTY,+ICF
M?O_/K$&@Y;9*1IE1>=)Q2V?C<3E6^I#OR)04';RX]\,8+28MULRKTK)2=AN'
MDNQ0='.QL36_[V+4^546A]!0>-B?YY<_:]T.T;A_:39ERX:A7B+IG@W615-L
M45.KSB^%[,5**ZYP,6]0IX.!\\FL00NMI 02HW6 .H#NJ%@/.SX$J7%'-G++
M\\=_[10:3'*&B.AB^K-8.*75-O<%L=T0RP3T?KK#L%A@TLHM[8E2-/E,<$-P
M5GM'>V@7=;-<2%3_ZSC8V?L-BU[S7);.T:O %%@V%U1*,.7H2Z4X42LP>.*L
MMO\>D+C67(YZ<'IH@PXHQY*<0OJ>=*AYR*9^W!R;8K8^D/6O&_WV!!B]Q#B^
MJ5JU )2=D=1FK.60*D/QLIL*E95E(OX>!#@X"PRL96?=M%J#!F]JEE;^RL#?
M0!+O 03W@/6OD%.=%QJ#[/*(6B6*];5'%IHA#_9!3:_<VZ O,W12";P*-5L2
M-P4JE :H&\,"J-.ZY$-G5=A#>>\FN\A.(2B-#=S';@@ J_81/S![B-DL"3C_
MUUI^QZSY<5:"HFS1GN3@S,_$?%[U;Q0\.(5;$*2'K_82A.:K[0-]4B8XXTT(
MC-SP:G#>?"$;8@1,!LV])^V:!HX]%4XC3+(4=7F_!'^R4!8&1/#<JJ+[KIIQ
M-:$//#@HQ;J(T&(;GY4E&T*$3,YDB[<^ZG?*.*13"*=8=G?Y\+Z%07),UO_2
M#PE*_> '9>DNNC,>HS[^Y]\U<0@&@<A(/XIYZ$T^!BL>-7?5AMYX-;_PN&$Y
M/3_4AY\2)_L63Q -Q>3-DTEC/(^9-U=0STFYG9Q7=K7&H#XMB?I)JFF-%,(T
M#9+870G1/A:)Y;I6<A-^ <F33%-#WRBB47:.*Q\T.\3E'K XV[.*G^5V4G)J
MENA=0E';@/'3W[:LC\L?7ZYL^:Y$9XJ)E "X=A2:ZCJ!I_N:C<\)1-=$TIF
M^*5\IHQ9BAEZ?>2,Q#<Z P,M(Y97MB+3RO"YW NDG77U^_ECI)W^U0?/JV,*
M_$=**N<CH!.E7-D3HU:F+I/M3R2<3A$/H:@'+PK_3!!, !. \>VE^%IV(LVZ
M:>2PX=(!?N&Q"-W)K;8"'S-Y8-H&[\,??"_.DL4)!8_*<C(8N:ZRR$LX\:F6
M?>]$SB;KOJ-_=(AMF-:US1]M)6W>'.P$#Q\1;,C5V)RXBX=J3 X!?KHX"[XT
M:BR\!VS+O]S[7'MX#\"[7)N3\RA(W(YF28B^8++@T:,L%:POM;]4]*%XFB9I
MI%X\?/C*_>S1EDQTNPPB1NG!]\6#0M%"[P9AGR'XT:=13(!QN[K@.K8ZS?"'
MLSS587*,,M]9A_\I.G_ ISF!->[#])_3$.@!.9M^5=3G2!H_Z&3W-KZX_MD?
M9HX8E)+$58CL/(NB]4=3G9(X[O-->]F:T\]LXX,RPV)0P0BVL._7WQJG@TZ<
M#VO'2O9_M93I(@-FUA"U:Y5*QT-7GDE;+V^UZFK?6'5F#CO-B6R+3J\MHZBS
M19&F)NF"WVV4C2+8<MBC<.EO^&$%GBBEPW?B2S:.$S0TK,Z63+&C$738W/7@
MTL]X2@)G[N[2'MP8-R8RK_*'F^(45);-4'OJG!\$'Z7TZM67$@3'6 2?!Z ^
M8T9+%(0MP_$LNUZFE8RS$1"_+@ 6S+2?X((N3T+[?E@9^\,-LK$?[QQ?<0GK
M;U?6?_M3[&J_:G1!P&4&@ J8<EU,[@@'B!/DHH?.2OK@#7M]*Z !]B=S7-/O
M*(C=75O:Q@4>COM4D0)('C [F_L]I.;5^I# &U0&>]WEU/U5*=00<U71)=G*
MZ11M&$1Y6R_5<J$LBS;=*(J;9WX!CY=6H4;'26.V\B@4#P-W37QT,8;.:AI[
MX,%-NCV1"Y>=]Z=-;1\..NZ>3;^;-:CM*;N[Q0AYX#R\\?\-$F\A/5K'<.]D
M>NRSI+7>\T (Z#1Q+=O^7'IZ>2T&TS'"0SY:96L:9B<12U$8X%J*1MU:!R9H
MH'=(>N\!4>STL\$.6]&-CQ'NWU?&7,O=_9$%W!=+P #59Y+<8>6\<H2VY=ZI
MD!X9>I6-#I4WAM^8.+UIB-A-/!U3GK@\8)RD%:^C!T@!*.RWUX]#^Z/!YG?D
MCV[UUVPA90<<[C/@K21GX6<4Y3W<J>F?R=CJTA0H [3#0/0*DQ5]TWX>>45*
M1>9.M7].@+?*"6\KWOWFMUOI_/:UC7^"KPGF85??WJY=$CI9U)35NF47SWS=
MEQS'SC*#93MCT8T2ZQIP?.=5_=XCZ)7S(PT>8<_A<^$M6JUR/X$^B:WT5ER3
M,E>P_]E07-4=<2!'7Y?P*>+3\;>?<^]5'KYYN_]Z]X\ 'XO%9K13QO?<F!/U
M:)$(4@ B_A[08_C7NO/1';GKJ4B',H)CZ<6&&*VGIGVU8%DF&KJ>LLX )&:D
M=+*!.1Y!3K4?*"^M70%.!\9%FN\^YN][[:14H')L)]@#M_QW;?![GRN3*?W>
MJ# 94- <R\[:Q]S.@UYD-J'@N1:?O@N,(O9TJ[W'CIOG<58A_DTWA;6W_*&S
M5_> QNMPT:8GC5-'+US[8'OZ\XUC16NZ#OZ)V5&2<KJ=A+R@,V]5>DFUOSIV
M1S/:%UZI_EI^PX.:F"T"Q7JDJD@VD#YXG<%^C?%N[,5[UW] %HK[(OP.S9NL
M?2LMZJCIHG,<7?1U4(UGQY//A&^=>EBBG1.7"SSZV9C W29NSO(\7XM, N6G
MY2?W@;8%TW6. #,7SD0)-J,WF%3,WR$V($4:2?5->AGSRS.P$KW5$!4VA/DS
M9H&2]U)*/LC![MC%YMKQB3!Z"M>QVY(T9TRF"7WY $50/8\V,+4ABF)RD4 )
MVIT$'0A(L02 #^24M[F%8AU;'@,$1R1)PD[3E,"M*5*?6_DE'A.U$$M:,S+Q
MTXP$26Q*"(Y^&0]NB,Y@=?CEH*]@[%\'C ;*<UHC-'$0N]/^@[GFNP+<TU!"
M/\DQK]4/0=,8B8Y85OZB5J:GSJ0/FAQ9VM+P3 6_=D">X]+S]=N20# WJ\S,
MJ.6VI()RV_TZ&RN;'RLQ$G6IMG1/-TP$J'3W(A2]XS@>G72Q'NC? ^CNRBO<
MWZJ+.G^4'TY[6#-P#_ ?S^6LL_U".RB]:N 3O-6KTOP>GAS*I^LDLC'[CB4V
M3ZNU8#C//W6+5.DK718G:LRA^3NO96L-J^N<LXJK78CB/N[-/:"2+<<"X?.V
M_/0>D-7UX1[P_/C=/6#IX]!:0TS_!$=O6VCQQFT"Y"$/DBY&.T8?-AN?6"E.
MP$]:-16MRI@X8"$N<^:-N@<X?[<-)+DU0&C IK$J]P REZ+RU26K_D-G$:R<
M"MPVWS)2K(#*I&8Y_+SN2?O12"C-_C]]/1[4#PR6.T?W&4:A5!K!QTM<)6I8
M<T[Z[ER2')/BI7X B:*VU#_E9. 2.]36518)>NY83K72(5LA$..S4KF9*K,S
MS:O;_;Q%]2AA/:&0SY3B*0^Z6<-DL86>WXT^\W!@,"_:K>;W$CZ"P3<!AXZ'
MDGF9AZNEEP92:Y4^[MZ5[4B$XR7BB&9MW]A*UQLL4SU*UZI;(AET&[[*RJY@
M%)FF9: 20W+&<B5QMMMT"@+A6B]52%;?Y)E%;100O)Q[%U3M]4JVKEU KM')
MT9$@B2#)5)6*[N=-9+\*#(+J/%-1;_TE;;?X%()_8)5'$=@T=@^@^>^W++#!
M!20HHY'"PA49$4AI(!Z@S +I$6J:6C2_(POY%^<S+SB@RH+!JM,R"C4[S<G^
M^\XQ9!Z/&H@%F,R)\ID4N"+"7QEP?6PZY/L;&=^,:M72FX>XGK8?3Z^$)\Z1
M2]IY4=U8/1%2WC]N5'H\"&E6&013WY'NG(K9U)U%M\%/\]_(986*GU5=O/ -
M*K>Z![@WJGO+-__%Z&.7[;7PGB0V708<O3Q]/% HA+;;5.B0N[5"PS<Y(K&Z
M98WB;[)3)7XWAJB5&D]")U)^1*:W0Y]^QLO;[<(/#+B"XE)5UG-4R"XA9%B.
MF6#+6K>)H'\Z4(E^_^^^^3 ;:3<AJ=KU<F9K=/6/14OM:Z;37KA">B15G(H2
MF.$HW&9R,KLPVKH$2WAZ7%[*)ARH\<+M:MF@;K#P;07PS=NQ:(K&% Q>\G^,
MWP=^#ZB]*9L\^5K?4&^^B@+F=18M.S.5Z2586:+FN@)JBE;^SH;0K,-/U4\6
M*0;L&)2YT+?]\Q#F.^X_>9 (K+NP56$V717/F49L;R-,9)=!I.DG8Y:"H1I3
MS=B5R3\3#$XA\Z\0N"_!LJ'*@5O==R2G'(GEA8A;Y:N@<JIL6L&E(1[]G/6'
MWEJV6+#--UGF?97U_'L .=RM:.'1U9=_+*"R 2JB#=0>*N1Y6K4J</NACZJ(
MXMA0%C7&2E6*&N:4<@WZ>X(&7A]-;9U$0)I=42J;U R!K^\!FM/!CILC)XW6
MAPD^\*5?+/G9%Z;UDVJK++M"1>*OQ4U29PV,WAK?TI27HS-KV_Z<>%S"QX+-
MVP6Q;3!Y,#;IUGH4@;'95B8(G2X4/I7#TD]MJ42]+V(.S+<Z50G'TM/W^V=_
M^)0MH>E#E5?-#:QMU#N1>@(H>6W6LTVTJ>)(':722(VE5^EY6C38"G=+9L)*
M65>_VA1YI/%K%53'$K@;$B=(1N\?,IU"=98&6AFJ">;!92DY5_\K*L<NN<!:
MT^D3SV"*S1,RE@>*ENK%7KP/'.]J=_EW2*G9= BA]N:)=^/-D*8U["/JOB58
MSQ0QEO@G.G>CI8DBKA%$.U"9KP-.V]3@V^=9.%@G ;P]SUEX%,W7PB/FQWH/
M>%R?+ +/SWL3<+&S _OQ>;_E5K/\C.6#T/GYQV:XP:%UYRTK!/LX?3V[GYH2
M3;+^XCI662@PW?BW#)LQ0AO^LS%V:4GS[96Y:==Y9'W5EPC0*'UL3[=(T:S*
M OS*<Q[N0AW-<9IX"'FD9'XF>6,);$TV13B)^%)ZCP[F)SRH_$/*$2 TTZ7U
M;[J!A8Y V%3>B"U4;O 5NVZL\-BB4]=#7K%Y6TQ?6A==NAL,$@M(FOM!*R*G
M7JQ(V=F$#D 80H'8-VA-7.V9XL8H5NZ,,DU)MT0W&*'YVJ[-MJ-,<X0_BF2'
M(FUN3E=^MI+(HR+-V^,?@LS=>,/T+UOEDS^4/4U%!]&^JC!&9[\0F5FC=MRV
M0^IO7@^H( GNR$6*0Z?@5'><MEC%T\Z:Z)ORV/>)G.VKS\=\NY/=";P6AC=^
MWUU&$Q+Q)Z,US_BW'A_]+TR9IN\!KA FK/$927\R8>#%\Z J&9R6YMU<0TL^
MBMQ"]I514\:C"]PIV3$HY#8H=%R%,90P=/E&#$5_ZMKS,_AY= C39>+;/N-7
M%!YQ*[ON#,]$JTB7CJJO?2HJ(WRT'A^MW$H$^^,:(>O%'\10>&?I/0P0BG?>
MQ$B1PMP-.*QS8#OM:SM/8Q3@_'J8; &PDI[>2# 4N7MEDE$]<?+1^F;, ^.W
MM%*4VBSK<Y5I(]L84M TYW>R]_'";J0ZN0CB!%K('_P Q]*7;)Y$@>^4@@WJ
MND[C]\T1;=O&'"H#>,5)OA[O-K<\^#A8 IP_07V3M%&@F,L1:5ORR4GK7&^7
MIG#NM%U#PFQ*P ,>Q\1Q/U"KS&G14<RM+!K9?0\XM:!.9E>8"Q;[[GY'<T9<
M\,UZ/Z\QM;+'7P35K.3[\-B<",WB.)JU5%F4?^+F:)%.7M&1ILHXP@^\XR\:
M;!,8P9E!.<X/MX]/]F?!1+'Q-SOND(\OFLSL:E:M_0V^Q@L\--*D _R_EHG+
MXHM*C3;5JG:ICF."_W^;7%H\<UL#V]("UON?!G/N^J=#1PME8DQ@"&\9#VIZ
M6Z5O_/@*Z1\[DB@H*1E8ZO$4DW0./'9:39U2,[]%I0RK-[HW:?F?+]AD*FUH
MD1Y]<9+;O\8^+M%I@D06DG=0,*_)-AH5.;BZ&9-9?%<,,Z7L3E,C"8>BAG8E
MQP>/)9EU9NS)X\C,G>X!YCMQY.O!Y82X6>A[1HX.'U');_PBG>8!#'.K;99!
MX&N[9XM8S":5G3Y%[H5QLF >Z(684/L](']_6]9M.Q,QGF0\QAEUK=N4>F??
M*BQ>07)ZK+#@1TP7+3J68^6"N]3;B8V7L0V#*ONW;%@D?L'F;D&9/?4X37#C
MOK"T+[O_M?^F[Q58>LK6_9/3B6:87_+[Q0XHU\7-0E@D6:+00#U%-LM9L%B5
MAT#IU-?.8>D>,)]P>M?T,9C5>RRTX!ZPWH4$(RO\'?#25'^P0GB$,C1=*(=U
M%N#O! A=(V'>;!(&K?F3C[Q:6C#1NX3"+2(_3]0_I V\A:( >XH6+PF_<QKM
M2H%5VYWL2?%:"005A"D>=! )!VW/;J>N^^L"TU3$MI.)3)V7<X8UHC$9]C#;
M5J"LIH*M[/]W>N#&FD%"V4V!-R[T@Q=<?_G=G7V;R_EHHV=%8L$T3$5,TO$-
M>-N+GROH,)P5(&#RJ4AJPB3VLU>[0(#]T 5ERE 2,0'>Y OYQ9-<!QH-EDRW
M$HNY+E.'%B(B.;;NL-*"OC>7&Q$4T07Y8YC2-.[G8CS2X73AC>OV&8S>QY1^
M@?@9[Y"V;?ZSEY?8O@D4SAOV]?:33B9GHID"@V(:G2 \;;(L3GB(-XA?P=C'
MJ*&0+&"IZ_>JX_/JBVBSL2)NU37IJ/I02*J!ZG\@SC!\XF=9NBI!MXT6XRVD
MMVP_R5/$)67%)MIYX;&%K,G<\B?<H?MFQH[^#I_<UG9'OS !PJCP4+VU8H?Z
MH5GW )'^JGM ]?_V Z-@^G' YV<_TZ0M2MUZ=+F5;33GXC#UUHR>WX<FH)\O
MBUU2&J*2W!G!FHE%. >,_V 0Y>,=H(/!TT>)+4GR)29+B12>T*]XS%QJUSFT
M9%PPO#!Q'9ZDB ).^T2.B2CS;B@#5%1=N(\7-#ZJ]H?8 $^>PJ;K;]9-<*TW
MPOS/WS:=?X\E' &?"E%&F2:*400F&Y\&Q%6]!Q-O'3&7?9[&!,@>WSG($Q9S
M!/[H,5M220Q3BK_]>/4&5R>J\L9[Z7%WO8W[K_VEO1B>]HBKG9=.<O[;.B,_
MZ<^WR,_5^QG(R:-8TI00O:_99N23Q])D4RVT2F/U$L=&^ 7QY%E^^JPT7 3<
M QI4AMJG%A&;7?F;E1X67@X4V_IMO&9QS+)L&O8/_U 9!%!)Q(C"N09R625R
MW#=_\**X9E^89?^=O5FXG:2>VHD:T'Y@9=>>'=#0G-?9M(^8',>%Z/O^]Q6Y
M\>U3./LLUF&87%=P@860'\+HSF7<8L#&6L6L&*6S6)HRBF?6UR+0;4])PJ&L
M2[F@;3O0YHJVZW_J#>V0<ZUP/V_?OYFK7T%&/JV/S2W:F=QD\2Y*4WM-S^IM
M;,$7IF@W#BXPS=-2MBJFK.CS!0!<#!<(Z2VEHD7.[T B0-3*">+F+O?F'B#Z
MXQ\.X;K\/1.KYU>716>W!_/-@R'"/WZ* P5L&.)M<X;'FM]F"S<0C]=+,:GX
M_W%&9CGS7/NYNLG;SW(G*5!D"LCB,45]M:17#[JS267;;Q".!_:PJ!(IS22F
MB%?0H4!2M$\QLU4>/*+[Y-I[?+OG2UJD2$M5#F748K>WS&\!#,&/-P5M]P!;
MI5OWG581I#GNOW^ZNX%Y>&JEQ5*"^;/4A]E5+0C];#MZ4KX$.3@F\9D.4B^/
M%M0<RKBM$.CSY[+TL*;ART4;U5V,*)@+G:,P'2U^+(%\T>TU<C'!8B$_D(LK
M:[K.;M<22U;XB,?$0OY9\G.6O5G>(CK&JBNLJB?&[%UTZ+%;\[L5#JJNQP=P
M!BZTU*F&P2E)]!'?[UHE^N_H!,.N,]A"&K%[T10,?\))'-IAKV-84D.=A>]L
M34-J.WGPQ+;=$U[9V6DVV/C'H"K#\4S_61NL!!;:"?YXLW;R/O>K3F[ZB.QT
M591EON=S_!2X%+$SC83:A;U7(DMBU4S0J]>,F99;O<A,CLYUHD]/.,27@0)(
ME=AB+P+MY,_2(/23\O#W'&B^'1CJOZ '.\F1=L]"/GQ4D&6)RBW4<6[D\'VE
M]3DDYR&^;I(/P 33;OBO>2+OD%V,:#XXFU@7"98Q?R.Q\',7%X14N>$[+#']
M>4_1Y$7RC5A.:I9?%&7"1<W$HM5\YY^1V<+$_\ S:\D&72[O3N1O=3PNK%:G
M]/^>+]W\N<:Q/;-L;IYSSG_K]5PR2A0/O!/JMRO%?D3;K3+:ETO(DNM?,<1G
M=.?6O3#PDL2=0-GF#:DA,G*\0LX9YO//0N9#:U1WO]< P1QGC_JH>="006:3
MIYD--H T3::8$0D=O3 G[51N<"OY="MGV"N# PM+_:KAHWQ+)U%+ "7TY#P]
MVPA(^>&846&\G/RHRZYH;=;NL,JC?O;R_*[9 R3+D(C*Q3:Y9>HS#M/2:X/D
M\;]@%YXP#?I  BWK;?BC@TTN^'%P939D@TRO=O&R4(E$EJ4=BB@^2Q T;GEQ
MGH:,I/K:N1Z4/LQ4FEI0J,#\/&A58YCYY9,IIO7/N)7OQ^*LC];AM%E:N,X[
M-J)/Y=B7"(MP5:<'>Q=,ADP6QVO0']WKB8L/$E]E0Q"0@3O;!S^.$7_1?V^O
M,>Q_#$2L-ORF6$'*IV%24I(2?OBT<@/LRZS0NF&,DPQ/U%HCQB_(RY$\B66<
MR9D\,HC%BE5R3W%<]2$R_ D9GIFF72,%1!!<H\$ R+)=QI;%+=ML40 [_5_G
MC-?UCLY(5;E+?QP9+Q)V46#T"HY!MH["B)[IIZA6SR_MSUW=I=^VYYY #F]
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M;I>C1O4[24$6VV7XF3:<ZJ& V8;V*+/6RD]ZIE5R6OHBYA%!4H3P##Z/&OL
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MKGB&7))99"0_GDFKX,G2B"!E#T/FN5(NID]H<>WUY<H)#6N( U"TWSXJ)$\
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MS.!XR)T&6ZA:2[9/&3K[56=S;$4;GG3Z"!)QGF[%XG-^[<MK;T>E_D0JN<5
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MCSH06> QI]+B1';]=-@V;;;'#^G4[R))PJUT-XM-&GNOVYJQ<0?)6.15&7*
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MIFE3DM])=RLC8_?S%7RGJJ$EC0_Y].R^S>1V13M=\:6B ^4<WF7V/^+'P*/
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M#2[6AZ@>7Q:GL?YJ4O2M4^U16TU"/_*SD3*RB7BUJ+SU55;6F#LHX^(NV#Q
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MN\RZ['2R(,[CT<$$K2<\D?*O3N"7.J=1W7,-ATY(+>9UNKN?KW^O:4(ME:L
M\>'I7KVB0"I-"4O$FWOJ?Z ^LCD9.("<9JRYQ8!M094:IVI]0M5H)REZ'5<7
MQA_]U)2B\CF>(SI9*2F_[X[D^A1/E-FB(;0*A*-K;$^QP3/R1AZEB]V*4;H'
M?8':R2Q>]#9B8HY&^5*K1T"ZK:]Z2X9&DE]+^8(*K#MC)C0T7>$SXYK"ER_$
MZ#<SA*NU868M>>L7G0F7;JHYKN.EN])AKC:=)TT%'L"<[/4%:5< B@XES8JB
MUCDCDBS/Y;P3D%.:0&9\0\\-+OO-6QARCUCJ6SU6\Q@<8 U*4*^B>Q>^A1/
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MX8\AOF7BY$W3[Y)J-3*&DJVA].\2XHQT0X28 *)V/84#9DAB#1Q#6Z!-N%>
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MRE%RZLN>;9$?>#+_B^JU#$>DLL2)Z9FUBY$._EB<J'N#R;-RR-O$U9:6\=0
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M>/I6FN0!T"QB<!=,M"-O9I\I!^'_W\GR+%:QS-+>B',AX ;<41S7>84>7.S
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MIJ_OI"TB\1QE&+.S4R1_!WN;H-VSMWPI1?NW\>#X4M,N]#>1TQQU0':IK;N
M?PW?"6,GG=\=I/?F<LF%?W#7/[8YZW6MO>!^"U(*RKQMUNLNGP$@OTE>)5YO
MZ>-4-VP:?#T4EA,R- ]WL&+>6?#=8M(XFX;342LOFU0O?1>=H"=5P'[.>L7(
M N[=Y \/$ J=U(M3)VC W4!!)>,S(VW0OQNZL^"X4JY$V[9#W;;\0(<M$TGT
M+39V&SI[B[YGF_(KRP@VENQI12_2G1?U]WU+JHVK7N^+LU0U^KWY15"[?XFN
M*98P3)AZ!?0SJ6WP-*^4=/LYD:]AB*?::(A9M$U/BM/C%YE%R4LV5B\B&:T9
M?;O(B2W:ADCQ$T:TZ7">20A;WX";YZUUGP+/>MSTYR3^#VEG%1;5%[;]H;M#
M.F3H'I 0!$1IZ2[)H8<2AQ 81 %!&BF14$"Z.X>2&D) :N@80A@80+H^_M_Q
M>_2^!^ML'ZQKKWO=S_V[UM[/>A\I'NM)^K3T $B$>\VGZ9:ON5<1$Z>9%%4'
M.89+0ZZN@A26/_[>;S7GC"MOX!NG7FA)&!(O!=!SGM^9$X?W$L@,DO_(1/7'
M 2<^.2!'Q845+AG'AP2]%D<TS"FSV\)KBR^CNU)GHPV6%86=;)+H09^ZU&T)
M]4!5A$:4JNI=0EEZ93EK!4Y^7\$GM+]HB)KD;@X,<\6#DKD,+O&:=WSG!\A4
M13-5;"IS8:?W -RJ"GO90*OL-NLKF(W"AO5F#-&GKR;TA1@</#- @MTVE(O+
M(Y8$3[O7Q99\Z^U0X@C"NQ)1+TO!IJ'BU8Y3;?]1@8%>3KK:KCZ6WU#R&EI[
MZ5N*9V_V?,O!<R55$Z"V)*<[7*@N? ):.JYN? D1US#OOEZP=!]^;B6U2(^P
M,QHLJ-RGJ8N;WJRZA:7> VCDY@_05S!KDZP@WA?K%)0N%LJ[3SU;BAL_</]J
MLW(%+64*6T^D3KQ0;W=VB=-@%TNDU.@?+[QCNP=TOX0X=F Z(]ZNMI6],YAA
MTOXS&DCU,K/'4K#:K)=J2RLEC2Q\E<Y1V$;"8J!E[9+YC:3/ ?-QIUOX@KF9
M%!0?(;6]V+W@QL>-=/I.EE.SABB+KIBD:)K3$E3O=@B7>$=<!\Y"F#7Z]-+I
M,%SFDRJ82JWMB];E/$YVT[!!J(1T6L]NAICH]IG],LAAJOAF&3-[8 UCA4RP
MEU0/SXI5C$"XEM1Q\V'D!Z@MO$RUD8(RG/K2F[S$\A%]LI9FU09]*>BE^OL/
M8B9R=#$'[#Z.R !FRX"_YK-)31=+J_/U?3&Z-#MYY50%G]Z:,6K&_5WXDIOZ
M_'7H(3\#+]>H5-:&Z0>45F%*WU?:WT-O^0-FCJ6%2 1E9.:P// -:T*ML-\T
M(6Z.C1W<I<ONFJ[_[83&[C1W/+)N/SN^OBHZMI;.21X>9>/2^&K>98K\(74\
M(X9O1+<X-"8F7R 36[::2/,ER7&-40?EVY4!K09$@H$@7ZS%I!(9L&U@S5%1
MS\X^; WX&YPU FH4H=E*V7+REH:LEA ^PKW<?ZZ]8 3[K$ ;%NA:Y>(V$5?S
M_AT.$9L,2H5::KW(<W,[8TG+<<.MS#B_%98P?M+0%I0RQ%V0GJX-K[A[Y^+W
M/GCP6X3U%$O<=TWJK2<B 6! ,9\&P^U^<#5D(.$V3UZ7-UR!Z"+?*$KJC;EK
MK3;S< \%</^;:IC$P=C2!T!2"H?]"*BIXDXH 'Q YW"$G]9#SPE\^A$OXWC#
MVUEHA)W -YR$4KEQVC!WW2MZF:(9 RTD6RXI6#37<!ORP>OH&>XC<;(>_-2W
M_2Z'3H/'E%T0;TC8=H,UZ!Z0OE%Z0\;7XS;A-JY]#V#?M8$EH=@QKRC(=H)T
M]]?8"O-71 J+W4>YM[[7:K"AN.4,Y$(_TI,/]SK0X2757-<R-]S^N <XC!/?
MS01M?_AQY/?U9^':"KF;CYM!0)#<:"NTA@/LIV&K5%8]1(VHK[%9BLL++VQ9
MN>"Y39V&[__R\A4ZH-'I_","KHLMD3:T2&+*U_P>Z,%/+-'K":1U&BB\L;Z8
M+;HAQIS^+"QW95.8V?AZB$B2%US3&J>TXGH\GWVB@NL)??.!![#4$&GT[6A#
M^%16LG(?.579<>5WN-4@E3]ZFOMV_O(NM.R.Q/H.> _X\';?;E(1K/A)F]2=
M1:I3OJV9A D/^3C!QY@X1HTTSRZ:4;2_WVU/<35Z$$YY]RA8X^BL ?=I;O2-
M]A&O26/.L<K(N!=$4DR-$#IX::_E+=9-N"@MSD= \N ]O+,-N1\4\(^DW]\8
M8E;65Z+DGZ^+TKYV:R30Q[!5.?Q\5JW\AANAE-2__T,%+Z/Z;0H6^59E[^K;
M[1C%U:\P9@6. $]=[("-/ANB8,M2Q ;9(YO?DHP-T6@O+XXF<V%@8VVD06GM
M"Q^.9.72'VJLE"7_!(ST^WKR_3OX^F^_<3'?7O.B(-+B9;J91J@%Y+#-V9ZO
MNTZC04=3*_@AS*BT_W?1*?QH.?5GV4#11<K:4F3-L]IB\25KM)'Y)UPT11JW
MSN@"QBB[Y?JU2=^Q!M:U;KKW7_+;0Z[H08-Y9G\O@84,O-N-<$+'%\?L^UJ8
MHOX5.I@[Q2<XNWS(ZJU6E[_%6#IDC9UL]VE8JB>-;LP?OD ';S8>D A*.0IZ
MW)7]MVC//?LYKM.6+&THNE*_B33"V4 S[I?.3%?O6X\-D>=6._JH7H-"D237
M2QNC^OVF6P/ZQT52C\N_5Z"]C.GH[Z[K;RWK(.P\P71_%G[E4G4"5Q8E-%C[
MV\[X;GJWA!*[MTH8!H4*7X2UR#R6PD$)/:,"NO>3UBI/B9&;-:XS?.KU98_H
MJZE[W[LJPM 06+2?[\F-<>IX2SQ ^*?=O/0I1>:L2VNJB8*F)Q'CBR8<:-=S
MX:%_ ^E!JBOME#>Q.?9IS.')Y0M?6$0P$LV4$Q KV<>=47AOE0569FUV Z]R
MZ*6MM/2/9YM."QL[6Q.:!'TD/1&/GW1C 9>VU*5QFNFMU^Y<%]&*(LP<=L:O
MJ.JX/QHPS)&5 -\GHD5, P8%\!^-\OHCDHW$!XEL:"]@=R0A:[E,KE6!:ROS
M]X"S'T=.J:Q],^Q("]WW&YTUK>):C]4_2_J;)0IN0KL)!!B^7DFLIZ,=5N\!
M[^\!M87P7PDL(H6K'=00A>7+_)D*S;\8#=\6+>FFA#?EUUM\$[S\F0"!O&J?
M7Y-!347^3:\[K?VGE\@#9+L+9BH6VG:GKBPLD#F90I_)=^G!I"L"PP^$33O0
M/O2-A5TR<6$0NI3*@&_YV?<\2GQPI!8/3R^3^0O_AWHVW+H^AD8 !Z4EJBI5
MGO%!:7Z8M)*-0PJ74($+V%'"FM8%<E?R'D#^MU,4LYGVU*G([X+J%_-E+3JI
ML<0X22^XEVOJ;S1:KV>!*RS3=.1EO,S8>M%%U+(3Z7[7JNV@+S,@;D?1G2W@
MWY3-+*+A'H"37 #6^5'DWN;5"K?4JLI.H+\M$(;7=?)=/#)Q]<'#M%2O;$DM
M7FI).F\+51S7^9Q@OY 6,</J"RNYCK&P2OQA-OTA68V7V:C:N_!3XJ>,O$4S
M]-T?I+WV6@>!^:6%-F^?5')!1/SLDJ]^[5I=4NQ)$VYU%[#<:C%2+OM)@?%E
M< +?TU_UE 8J>M+8.E)4R;V)V-_%!69?6P(O?[2M_#N\<IU;&^5H^2ZXHA6"
M7-'I"+4>JBA,&"$CC2TCU40TKDH-YB-WZTL,Q,R)AK-_\CC$C4?366A8X"\Q
MXU.!0@Z%7TA0-80)-[Q(V0)TJ9%$$KB -+<LHZGMF4>3^6-J0.%,&H']NZ V
M,^G@RK66]&@!Y_VS0DM4DK$#/R?6RQ;E[H0EW$N?IK%\.:=%X\3J,^FVD.G6
M_S[SR-SX-5^TX)D;]6#UX]H%30ECC?%/7O/HD].=1W!#,V(:43+(SUW C/4U
MGQB5E&"ABJ8MXU1[(^'F<$T^P]DWZBCU6$_[]F)@4G!;9*8B].BIO",'@4>
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MTWRBEC74"+B!PM]DG(B6[/'-O\HR6LA:)=\9THM*--I\"VSS]K41:$]+PLG
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MS4;#D;X"VY*%#W4<Q4#'5JR32:'NQM%,.L<,*CY??!;- GS;%@& GGD33@Y
M@)%3T3EJB[AFH %HL,IAIA_<Q\6,O<'+K8\E!^W?]HG?XE$O7$$(PU.$X*!T
MSIZ3-HIS-HEPLT3QZZD8:DO(+<SF^]/&\EM% V63I>#>VB<C'L]?>9C-1VK,
M?VB(2<2^*8PWMA1AH:N0.H#&Y7.D)$M]\50'?@3R] W)J6K6:0_^.#K7]O$V
M]3W(J"%X@Z>:@(/BR*[*W;CT#@4/I.$W>C5<"C=+QB8*"N()G\BQ9P!T9C[C
MD!R'>9>V!&E:O FU23_]7>)5A)BZ^J..OVOH5NXQSO1SZG=MOFJL3_]X.FO
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MW#8J\ 038131PJME]X"P4.H4L]HC%O]9Z(D5;VR#B_]G2QE4$IWD*61DE.7
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M3I!)WV*E:C6]Z.;9:<W(O$7<TS$YX^/Y\FGA"V0M*!]?5:#T)FR"=9'B6R/
M(FD-A/!A%A08(:4.DY;,?,YT%":1ZI-F@F>T]FDY@L-+[M66&!=ALH0M++\V
M5H+#8!5B"S"V$GRI!EQ/09CFJ,\[7/X<_!A6B@ F'Y!^3PE_O_)3ZKM<8<_&
M7P<7=-&_A$RX=,=MT$U:=M#.Z<MDS2GU'!<G<ZFZLI9X>3'&5Z PM>$.<G]I
M3CVG?-TTAI\M42-Q7]3W*06JJ:(\CMM AE@QE<35/=\J*+@LZT:32-]G%P13
M/<8CUK W]KD'L.WC-&(='[](I&,]<YG9._C%;(F.79>7Y!]^C#*"K":&>JBT
M$7CO"DB9W,'+;JZ@ D-/_"JN0IN6;\\;&MYH :&];[2Y+#E, '5>?J1=J;VT
MEV&.=T*@9-I*#5((]2,3;ZIY$@%4J!Y5M)&GKJPLCDOB =)!6#\_Y'M2J-F6
M@D58[Y90K: HL_1[-FA<MQ6>O=+@$$XY1DU ])!+/8=G82O0ED+1"2O4U$U!
MC0 U!.2@JSI]*(#OY6NO7[\.6KC)/K]&@]GR*UZL=3QU+YFW"__E/_*BV9]#
M9*8?I'9 ]281+BLK\*/3]\)UV]W #;DY2[6L56Z-8#$8$@OY/2 3+[;QQ:RW
M>LP7N)(\[&NZHTAYX4O!$."L-P$42#MO/+3E,K52!2XE[1TW_M(#V-7''D"?
MG!SV0#QEZOGKSV'B?EK1'H_Y$!UG-;UE,@(%:H_5?B?[A)%;>7TL>O1)+]W9
ML_5.\'!J9+O_3;E0$=ON,^A=6]NSJM^8W O!Z1^+=WU7=:#+,JF*_':GX#K-
M;:./W\25'*%JN/ND5F*7%-BM]P"D[\JZ2?[UXQ=@3..D')S.+0B<6JV5U9S'
M[IQH*=RK.O642YHT5$_!93ANV CW8N6_;G07&M?/ W*V38_@4:?"]M=Z9FF8
MN-"K,2*N!!]E3*]W8IK ^R_9!1DU8<0I<\& VTQYKFO1G4<SG61UT_LI!MPH
M\[>?'X@KV] ^;*J]C3")5J0'[F/V:1"O,9[>\&RX8;)X_5_0LG@CVJT=>1UO
M4Z$7(6#X\[(0'ZG]KJVH:NF=<$-(YA&\?X7BHFJ5??\1>X3=A7#Y3LT]H*\U
M1,T\_1?3LZF_CX2+N[F&$2P_U4[ %"=OX@:@/=_=%!=P^JY2H_I%YP;Z%3@Q
M^\MD]9/RVO[Y2X4'W^DVH8=08?OW!<DK?DKH]]$+\T%VOJ';%Q68K%XX8SOS
MFS48E?E R<ZL+Q%W0[+S<UGSD0D)B+@X5IK4/<#UN6S/1YE<UGN $PP_=%*1
MX""89!W-([="/FQOR#8C8:G! *E3X^!17X)Z^Q*JD43C&VU8XIBFM18)MLC(
M%$%*R@0+6N6 :=&N[EE3(_FC.@7)%F-H&Q51D^FK\Q#6IB.;"V'5*M<UT0M>
MT7B[MFF%^9(],G#AG%FUJNMVV@%-HW"W(^YC]0NBP1>G57F=9 $ZVVNSW3:$
M%S ]ZA>!^3MIT#>2NY&FX<M//)E]R0H$P;ZZ&6$.YV$7HKVP"VZ"L&#6C0[V
M/HOM& 6>8-5VS ECO9SHHX /UP;CFLUZ,3FO[+#3J&4)F?VO4F6L%Z;^\HLL
MCOL\;MR+SD4#BA?.HH8$E(]'F_\?;V\5%%<;A.L.[AI\< 8)[A((FJ#!W=T=
M@B4# R1H<#) (#@$@OO@[IK@S. 2@CL,?O*?JGVU+[;4J7/15>OR6^M;U?V\
M72U'V%3D?@X I>;,2Y8C%T/HAZ8O=?&I\(GC0^CQ9>-*I?O4JT95C]B^F731
MNE3_'?6_:?&P&?-&=X1::36+<86#XG)RJ=>3353@8G@&IR(:!F^98-:X(Y.I
MAQ?8>U,&^1;L6++?!!^8C]KD,/D#AQ\#(4V209/X3<CWR;)N?!,/*C LQM1?
MJK][\">:;T5W1B6A66/V#MHI>$3KC$F%/A6V+]OKW\O4*?7,(0?NG8Q^5!8W
M%><%!FA2SLCY]&[^9C.FL\;_ON5$U-"D]U!6%.J:^*I?,9)DI!*H9AY@4GET
MZ[+F6\_:-]K$*Z!>U2HIPV,!?W_YT>S.\IK^,7=-Y[0QL5^3UODN;E5BCN4"
M9S;$B;D'/[7/8TT*E**\%H4V$WOG4!B[_";+9UR,\C8#IJ,)OCM]10CHWBRJ
M'KW-2@T6^Z=9NQ]-!!IT<#D*PL-C.?)0__^VI%*>-C0O*BPZF<F73GG8JW )
M$FAA/#0,G9R*\8HA$6*2$LO1[%X@SD#]-)8#.#O.6\B,BN36N3TW.1[)&=R(
MD5BV#TL>0QNV\1'T4E0/"MX]I*P0K@M.W(3%N!4X$-!"K&!95G!,/&7J#'N]
M\X_$/E0+OV?U7XXX9;1H7[A!:D3;R/:W-D]B@<Y41#_@HF1>,E%IN)2I2:;>
M3)_<<2@/,2H5LR ;7H'=1-SL8_9.0C<*+\Y]>]F6=_'QZ/HS[S1B2PS<5T8>
M-Z^]#SNW_IP@K8*]GVX&B2B_\U'5-O0*!$\TD#'RR9;_#IH\G&=]!CR\$#V_
M'S0(8?*,M6!T=U3_=#B?3E2BT,0Q;--= #48(PZB8I)EBN$.J2@H@6NVW??(
M<[U)7P8C N[1#Z9M1Y$MFR+T1M%1TT>F/I_?3XV2'?=Y+!.M BY1E'SO7X>,
M4EBB2,EM$IC>^^HL^&F2*A TSLU-EZG^EI_.2/?:W7DACDZRP"[#NV9<D.C,
M5H&@B=4X\(YN&U7N@39M>1QC>G]/B"JQK*Z4CN54%+'5<^ L*YXT"KM) (P\
M !@B[)!3/:^4$MI?LZ57.AN\JDKG[V^Z$<!Y :"U]@KZ*][SI%_[EC[O:OEA
M^K%#QIK],:=JZTPL@L>#3^J%MS=39@]+4&3LQ*=AFW'KWF9\%,0?B2&\MC^+
M3-;"GM3PG) !__$(Z@067CF#E=XT5AAY<!Q54M]U]< 3>>W94%1U0[:A9OV<
M<-M??%T3L]!?RY\>>'%SQ&GCKJ2\N"X\KTO^H:EW8/EZ2;3(?PV1>V(TNV%;
MEJ\8>"U?!;_BIDRAE.]5--\W:MHL!C>Z 18?7T0&%D*##8&LTU-SAU?WB9/B
MY1%F:_,U_^B!U-P?4777N%9[T9&GET+Q##"H.$V)&_+!OJX"HJ5")0W14[!Q
MXZBB-R+>_IB7!$/UN3^\C8S?M@%(E5O1Y8EZJ3GRIG*1, ]62)6'EY8A WW&
M\0@R-/0*N7A[%7<DWHU$PM5VW])+[;$D4\%/?";[%;N\3A#?63[;F^48X6,Z
MRRC&*S>.5WH>W-U/C9>I00]^=)K+C'5-]GGH3H1OBFK%_1ZM K%LL];U?$&+
MX(P=D$_R,GT1/ECAYNQ'87"!^R7^WBC(D50P=$W4,F*=G)9>3%'PI\6\'(Z!
MCLSO6:LW@/,:_S@.++0;:]&OW)/2>NHE).HN3#-_XN7+RC3B&\J&OH["Y+%(
MRJHV#1G>"\OXE*?]0]IIV-9?DE8#$TC/VFD=J(D-.U^KC4T_/IP27B?L&=H\
MQ""$#UT)#UGWUWZ7+8\8UB[BMN*LHU5*,PV5^*? \'P"4OJ\QQ35/#+/E;<^
M]M%$Z/[YS,"/,LYX[B5Q/M?L)DB.:.9"40.QJ26R&H[Y]*)?D*TG5=CB%Q%^
M\G4#1(]YG)_%$ 1U62*)'I[DRJ&=)P=C%\>LOW!A[[ZI3W@56@$5I\FS&'/>
MN.CR#*UH_2;5$MT2 D8@6$1OXZPP;1*97P)1AMAO8C5Z$E<)]N56%[YYU+./
M=EK%1SX#5EOC1XDW8GC"#T53(U=:4&S##Z!\0"[2T3[>O-NLJ6\P:[?MNM8\
M[L]-J]0*Z,(\Z5>>!Q=''W'7["%]7>>F3W8Y/FTX&B<\K,X*@\;G54BO_*!#
M^1H.4W;<(:8L>ENHWM,1K,!:Q5XQ.G<#-W_P,)0L7 [$MN/V0OW/:-40-"CW
M(_]M EF:;FIW'R&M.QKPE[4S8UQ$E$NUC"-* -4L+$VU*N3O&*G*H-+HFX^Q
M+5D?NQ9RNOB:W5?@KPUON2"F1[-VOGWVQ,Y9AV>(1&'!UJ>C5GL)^/(Q\)8U
M@,MW NQ];VWI_ QH9#]*/85LG'S:2M1N17XL92!#1M[J"7]0KW!X24$PEH0?
MSB]:#6B0HO?>AYQJ$<4^B2%E3@TGD0$;U22!L'YX_Y$UY>+EGD="++U8ZI23
M%MTX&04>(ZO:2]])8-\SP/XDGH;O<&S=6+A29GWJB">XW%6=[B1:9"P1,SGH
MIUEJVX0#)36B(Z';-&XW#91+)-*O5:YMM2]&M?=2\G5J:^R,P>I) ?RH<'74
M>:Y$U:A,N[UJ"RA2/*.ATV90M^2".+"O*CFZV<J:?6P/P?_[<Z/#<XCX[W5
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M<'IZX!(,G'8Q ;)WW2V77#=)GV8A3<<=9WB&:6N]TJ#3SJ]/=#-@8!!#<L6
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MJZ.VC=+O?0=VP!%V+RM:Z5%+<:4*>\1[=+S0710OW[ \#5DPD B)Q4C9E--
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M" F^8#1M2LX:X7P&@ L5FWK8<('A;;@J;3L[4#;]X9V%L6> 6ZF)Y5+Z $J
M HBBQHHY8Z*-K= 5E!7&R0(/9&R>DGD5'F.1Q>D1':-O[4QI%S;+U$A H@ K
MP0TQ.(#MH->3X^PR- FKESY-6(@#31Q<J:#$X%WO%&I*P"Y*^Y(R'"B^WLQ]
M5#1][<*U<P?I/JAK*LT,T+R[NIRYA-G&G=[<:805#U.\+'(U\DT!R),7(1IX
M^\W(V7]H]QQ$.GMXLC0V9!KSIL 9OF4:&%@5PP0<\!HB;U,90RV_LGZK6:+1
MC*D0EHF$2^>7KL 12Q,EIFTJ+(J5("L/=-HC^[Z?4^A<%"LCU@-/<^GT3 P$
MMNV__?"BN9DR5W>U4KK+QY.$W:8C? =7ZAG1T'88[16[U^2HVWRN9CS%+BX1
M"KM!$C"DYZW+,Z!2\NY../,QUGP\WL_1XX#K-G;!)4LI8XW)O*NWHGO'QX@7
M[SMY=&")9N!7T7R7F2 .'U8=/8QDS;,:?#34(= 1*Z8<".S3R36__>D]/?.\
MZ(G 4-8 M,>.H%N 7 EMC.LF1LM_VWTL=<"D(<)W\[65?(A506 FV_+]+VN]
M=0$2ZZ_\-OY;XN1[0UR#)OLOU^J? :'_#D7$?N^(VBEZ4CE7/5=Y:1D!@_D>
M9CRH_RA>2VLM+DG?)>LUXT/[*(A2$_8]XUQ?N=\-)TDP]C.RY%U;U$UF?.*)
M[7EBQE]LHAA@9-Q#GOMZ.)['^O:GL\L0UGF>(ME.YH4 .9BS:ZG>BPY_(8'$
MO,5V5$'R&FI]!1&_1^,4\6< 3&0@@5B( 5[H$,>I..F]<]*[BU\(C &&\?0]
MC0T>KW>=LCY9+@SG'HUW'(R?K" \UF:ZU-9T#Z/.(AI(U)C7C%3X]9(973/T
MQ)=]Z:^')?W+CI>#'%^C\M^NK5^>LD<>QP7@+A"4F7>,U7)JQ\^(#U.#B]S&
MQZ!O 6(3H5R3!?,B]F%%3VOS1?'A@\^ KI@FCMO!FT5,,_>>?SA3'.. Z_'
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M+KS,C<.C0-4'E$<'!6\KGX:> <12P[892WLOS =!@VAOQ'9SK>1ZT,.5/CQ
MIQTN#MW!(SSM@PD,*<8U%9-%[GT,64&<EG'O!W>!4?MF+S)4*ZFMRRQ7ENZZ
M+B"G]WPCR .>""GY_CZEUS1[!74/'20LKZ9L:F^3AVO[$0$8=O$X5KM4-B-1
M;^U[(WK!I41C0F\&@P0KBCT 8^6G?3MQ0N#EG5]VYPJ>!BC^Y:0;=F_<AH?+
M4N*RI\6I%!(S4@Z]RD+NCFYSDXHI6,,*"6A-;9-V^FT8Q^B72R=1?Q!VY]?P
M*Z3;#(><+_P.85C8*T>42Q.:FC\#3(Z0'X(LM<+.:'DNROG2&7WZP8GML''3
MN&'OFZ\U6@$J-ZH(:-18<N'Y/']) KD!):(A@H$#W1%#V<*G5L@FPT;PV.!\
MWIG2V>&+U1HSZA"6LW:4S1;6'\G14G3!*2G?3RS*997-)YQ4@PF5I (][(R*
M6][@IA-HP@EO+L^5*<3"=+^1L.I^;>QN 38Y+U=;R6T>\*[S':L9_D.&X[)W
M0Y4&&7B-Z39&T%T"_/>W$%]:LS8SV>CZ3S ZL(\@/U0/*]W&OXQC@'C@^G>G
M2(+XBO88(\%.N3L@02;"O*D6$&3']8-?S9K !U%Y'7,M5,;9VF!O1MY]T)M,
M#2\*@WT@.7]9E!L,*?>\NT6OIG<:4]I=.3B8.:=-J86"1YJ:9L@26]\ZO-4F
MI3VYP.$]BEA)6@*J_9&=ES9S9>%+WQF,6"&<!BC<F.$34GUEO'5/ER];$BYG
M-&0F[;%)L>1!S_*&^50#ZT.]<*@84:F3,./89J,;LL)[\YIV0NFQ/3-$Y[H=
M$Z3<$<U5LG]W/"$'=[^8MUPK.Y\!R("=D&SBP^!XM%>W7H/%1HKOG,J^= $D
M@"@ <GR]?A7X>%%F@I5M [\DFS=GVT_9HK*2;PTI*&/6A.@J[=(;*>3??[DI
MC\>D)<_:\>XD464%&@"XL*0V_(_9CPOMXY)')WS;)(W"?>*;CWL'37= L-$.
M'R.&))4+=Z)JP?O_Y+GLFM+,G>?IPL4O5OK@NV.#"U"V4 -Q +^_5=:M ;RT
MZ+S[)9.-;F?Y$'N64Y$;]_6^TO$-5_RJB1?.<JZT'GA44/D"R*,),^NO+>,\
M-BK@:@!WEW&K:N "!"=N4.VC]7G2BE-.\2P%EG[$N\_+CN^Z,J)H<A]!;>F?
MS+@XJ->'MQ&:!S,/82;[3^:0RALZKTGJ/H+:A[.40SL,$GV? 01!N)<8<3Z,
M5*SI5[5PN.>M)]EH&;F%?#$DX+YQC/@DW4]+C=?8#F-P,R(EL:YKU-8!%G3S
MBKAJFQ,_1V\WSDN/\V@,?2>&!?MBB![TN-P&KH5]1)?U+[50\V8R3RA":33;
M9=[S1$I;^G_N,+SJND*\>6WX?M1+_*--V"_K825[B]C."/W:$<L446LF&RS9
MB98TIVL'^:,6<UO"HF.,F',8+Q46-3!-5D&;'\%%Z7[ Y)TQ^G01F!QMF>4Y
MSB]/P5E^/P38C \W,!\4 %(,QW]2N@BO>)& HF4DA@.5C%R?4-IY-'U",:G\
M\ Q0@9BO=J#'BD2*8)?5EJN /AI&R-&:*DOTA@I\.E^W):"Z5<T[!S<MSV^D
MK EBWJ:]CBW:9> 5R_E.L+18#)NFKG?^(Q4!0T^1;\L 2"W>8*XD#>T,4HE^
M4&'4-_E(Q&S59B!R<1'IF42UF22^7=;D'^=N?7XZG,_ >EG_U%5RA\7U@4\S
M^Z1+4SN%;VG>6?36TR/OH7QGA!HC!B]4GGP+U]"6R<9$=GP4)@1TC80(\O^2
MY \(+K,07,+X%L; '"DC>M0R_'Y#P;,#].GF2W-'#0C#?"='?_)8SD:W+D51
MK05W#J0QO4H0->*8K/'PU=[XBP\.2X)77FC;U]1OTOK@R@Z1IX:+^D>5COG$
M._60MBM8,FW3$3!(JUPX.6P',UY_Z9,0\U&W1'_1T3# -T/34"SMO#12)'6<
MDV5$@)^(J\X=]- V_J9^US>-H$=?9WA%]6*G[*?.!@ E+*:HVV"*D](GG]<P
M1#0"P4H@Z;RI:,R48.KH]PPP4HTOFU394;GM=*0B8)ON8P10FG8=:.8^$/67
MPG7J]I\!Q8^0;_LR-<<1E#%=+N:B9P4UK8ER,PC=^&)XE^UWI7--*N[]V[4:
M7B-B/2MW0P:MD$5Z">3*Z3.@+].B_%2I-X08&19LZY\+A].W5*C\,#.#W^+:
MBM:#?]U^86:I2585)Y1/^F:9U65U@KIO4GTDY%H>G.U^^<CPKED_S?GL.I'3
M/$-?!_>A3<,G+_=XE_U$WU+(91@XBC9L[XB;EQ+ZTVP]N8$Y0I%]&+]4'ITA
MQ1$*-7-7HBSPG[G\>]71-?X8Q5)\Z/5^@[6:9ZUDPW."Y1QVG?68(^/"A^36
M.I4)#6%_8#]-/WP&G*;++:PO7/W,&IC_)VI$M-$]PH'6=F2*DW7B/(SH38-\
MG^&K_U68JSQ^"^% ;EU'(27N9<',J;(+TBQ@VI:V<!DB5XFFIC.*K "&=&\/
MLSRC;5RSESYD0<7U4*V0WSF#"T;Q;\9H4\376E@Y^O B@[N_%]0PIF"*4MQV
M^QJZ'_5K86^H@)*].]Z\=6!H<^JV'TMC_2,7[K5JK=NH2#D83[$FM=IDZKHP
M8FZ"<"_1G?,K9J>DH[B&03I7'?^LYI^J72?\HX."D-]=V%=$<4\HIPO=79%=
M6."WE'$VIP\6;%'FLXV/&J@_5MZDE=7T 21A[]V$"%4,-*=9?@JM*NUJ>OL%
MN5ZXR;X+&G;/3_B'"M+:#7%5RG":GWV%2R,?SM^R;M:R8S,( (J%VKS@1;P^
MIDX$S"_J\;\XO>MR<)9:N=<2:J.K&&GBK_(*J-JTZV'WPB\#K-2>+,[L_HF\
M$RMNLYC__0!=(L_\6NB>OH$T-_>L7BM>G@]?G1GQUZ49KDE/XIW7(C?Z?C4U
M,A<Y?48\7%8Q=W44,M9'06D2?[EF&[[R[CSHNP!PV/9&7ZV>6&F4T!J4" U8
M6>2IMK42E31[J&*AQI0(B(LP\PKKQI7[&PLP).@':__[#Z-Y/=X#)S#%KS@N
MN:Z:6WX?&[5_J)#D21-?\"48!P5N[^Y(RLFVH_E^_6H_5YU]^>#Q='\7(=[W
M[>T19!H.R:E:$&0[@T1V.4WA[:^2-YL>@584KQ,Q"QVOG7_745#*\1'U< ((
MBS9J[A. IZZ;PG##/G6;L?X?\S-:2 AWFABSH+UADYJ#'<<W4ALC$$P1F^I$
MQ32Q3:_S-?+$ #FWWA/8A8-0Z/QUI%V4LG].[0$72$O QJC(@K_N8_=:5V[#
MO $@T[L'3T\BI"#Y@5&#K4V-6P2^YJUAC<%\RFG4ET=L1,L#6 CC?X&0D]$Z
M97&1M8?4;2.-N2B$]0)6LO;H$3!$A%.4=_+XWN!![/R#Y<K5&AS6=YTLW_HZ
M-Z9=Q<^;,@N_-211HFEEAU.19H/EO8Y4=X^*+DTYGPSOZL?-Q".,(O [I&VE
MTY="9,'DO;9L)+"#<,/Z(M/(J)?^C:Q9V6!;"U%C!I.X[34D0IA.J*_5!_&W
MZ95]9-H^6PRWM5&!S1)KJ"QE<L.VWT/9X;7_77;]D##)!%E\NHKML$U)N!SM
M>BGC/:JD@="@ADEY4 @D=[W"E197\]M_2^O&/)-OC^ZYC6&#B3$Y^*?9U_&;
MP,!+=?$55X/6B,_7&^_\0_0\IIC+QF*:"/L]1FQHRI$^CU*4IP5TE":M42KS
M4@(_1%.#\6_0;*1$G\P^4[*,1[?N@&0%.\CR);O>5/'<4*2(?#;#'BV*:QD"
MT]_[8*$V4\G8KT7]W,*;(E;9^"@YH:N3-"&UD..^D'G8GZ*C:$];R^@.#!H4
M,-?SC4TJYZRTV)]_ZA!^U/BP9,>J07;B80@Y>&+0['_P.>V*D-*N1!H<&$^_
M#];5J6]L9@O254G;\RSR!\J#G,]Q1#W1>/M&$>=I(WLA] ]<R)BMD:VZ^E/+
MV*VNN.B;%:,5^8H#($?Z;EP:2LBU4'/H!\SJI16L/A//".Z)SO02H[VFOES.
M^17K=\^ UCS<+O/9P&J@NOC,!]?"IP:$9_\%EU<":IG%_*NJ5DCZ53!1[]H+
MOF@I#!_;N<O7CFJU#<XL:<=;JJWUC5'H/YV.03K8(VO-/MTW5*@333\)=EJ[
MX#S?C.U2/>$*= .RGE_3 /2:G*)5QI,F;V5@F3>1ER=DBR)5/TN67 PJY/A7
M9.L5E2<)Y]$#9++!A?<6SX >-JF79_,JC=5XRRH;KS\ G=M+W=/].F8K4_(B
M66VUOV-H-X";T<CW[!^<HW]D]E>Y7CVUY838=R-=Y@,=1YX!!(\A);OC.QF<
MX^?@4F(!]%=;._NW[QT@3-T8BQN*XSO?8$![6*I/'^^+"0%R8Q:><_P<(( R
M61 ;19<:10U/FO&4_8LT36"]UNE:G+!$0[;/ (UHW)%]BX5^48)-147\!>D2
M2L(J6?JXX C(N_YH.<MPG "/T1]!;!8.)-3HN^^>?($B9]4=DAHYH-,_K6]=
M80E)']N],7N D4=6?JX^=)'YP%=B#ED/*GRUU6-B=D,84S+$(CC<HZ8,'C"T
M#L^[Q#44'QGI0:FI5@FA_WM.[ED_PJ*H.&?ZS3 $#".45\Y+WR84K2>65A\O
MJ4+:KB-.XIX!+X2[L)$A!^KJNOHY3BGG1ZNNEM+"RSDV0^TGEBLD*>/$@\KL
M3O359^E/.&MGNNMKGRNOWLZX@35+6G+F__ (J*G;?/*?3WD))$Q0H9;MWQ1<
MVK,PX!(;_;MP+6+RYV,;%\^K+I%G /HU?XNTITD4K&1\[F[DQY-A1U6N9_?M
M*$,$#4%CC5&E71@+^@N,V6T,9?^XXW0)-C8=JI<Z41A&6$&53W1&>PNF^;EZ
M$09OL-Q_H_C"J'D+IQ5W<6DY"?4X_IKX?^N\'*U=#GI)=L!%MT%G._E 6P.G
M5MNHPX$;PT0=SNDRK49)BB[P /XD5 %F+=ABQ^#4"'%\,J*,  6>[K'5"/&#
M);Z)$-'E\YUOMHWQJBG3]TU/!A^=F^"6OTJ*>H+SY;ML%T2<+,1KDAO.CNWD
M&.T>MTT550F]L@+PUT,)-;](&5:X&J9]X*V9=B'=>]5@J!(R?Y8HN-(^O,/0
M2FN[PV1L+(AZVL?UV[W'_-Y>VN<V+-U'2"QC7)D3\ZA-;A@?(..M[*+L03,M
MW'_!=YPNJ8'WD@D-)8GZ5+YZ%?U[9%*I29RBIJ+[JY#CGVU^Y_>M)_O^6I.U
M9+,M'0=[U6I'KD$0:)PES?X!&9>C8/'<=5&G:9&T(X8=O0,:9.8-9PD6)[%W
M6-MUX77 V3MI<23E>J7-!"AA1OO7D0-)U^CO5'P(KVC8$ L+6@(*.@FRX(^Y
MY&;$UQQ_QDR*6-(H?-!Y>&B;Y0YP#*5AG5AQ!Y%ZE_7?YB!D&$."C/T!T'RC
M2HJ/[YKEQZ\?(I%4J 1%F'@)6 R]'T^ET>)R7RO/-L5J2*>I/+6"5X?^F@'O
MRWCC3P('3=<"W,WO(-W!QI>59-J6I,'=_U]TC/_/%K0[F)L 9^A.)#3:IUQX
M8?YE1*H<Z&2\_3%]DBH-&(/F1<>/LYN@1S FTV XP/%$"N:=%>'CA9^?%?+#
M]\X9H5<X#"05KM3O5]%>"0&"9/OBPJ6-D5D%#[J//Q\HBV$QU1["XG^RS1]D
MK#K-X^?:7KVJ'.X/=R8DD:>TQV(!9HG\#JS?A,3(N-!YOH6UGOZIW."A[$NO
M<U$TEW>?*CV,-2\"N>8D4M]W<<:(T550774YF':4P\:2MS*(Y:"_:-OPCX?]
M>B:]\B7<*-S^:WH)P/AO@6+8,X#0-E!SX^G3!@_S)D+M]_LQ4\FP/\MR!%U+
M&RWV\($59OU)M.$  5#1HID8DXA,9 A])P677_[>BV> ?>_OQ8:FY.'Y9,70
MNJ%._GQ)JJ^HQAJ;_$)-1_2EX?X)_'%HVV6CS$!O6,"CD)X.RQ@I)D#62"^,
MMKQ>"13O%?2(R#XL,WJYTN5+:XM.'/?9.WM]R?3NJ7-#S.Z_GG:B/8^.J=>_
MI*F041OD4=>>86#GGTXT!'_*V<J]2?NH$MW"%1B;,.&RM<=\H8LRK69'<-F_
MV\BH,]V-C@G8-7TU0UP%=2:E-!-,A==Z++17@C%AS9?@=QJI;36N]+MCQ%0+
M%#V;5JC4GX!: 111U^=DU?O.<X1S43+$QOJ+G7U1O+6^4[]=>#E0])?T 1FC
MF_NHD?VP5T!XO^2_,W95-G!.0"P7=O>*1S\X'J5OQ<NHMIM[]G+[^<733[P_
M8,M<U;=2\_BG"67XNUG\YQ"I[78\ ;DH$!>*LZ/#5UA?6&"GL'BRDW2UED_#
M%PM ?_E!0Q5:E>^? SBQQLN,#/DW"E+4D]OC=RH4Q6B_*AIM&*,Y1EI1E;MW
MZW.2<3J.=;G@X=DC/=W+WHJ.9=.?2U3RN1]=>!."6!_:?;Y=H$AQ@4O+-$%3
MN5>UK_EF+F8NI9=@%])3#%GU$W"QP_NVMBUXKOYEL_1(B0)1&A-Q7APC7BAE
M6'P>OO<@8*MFS^!EW/_N>NG_8265>]>MQ]G>/U;?$@Q4Y:,G3:#'/[6* HV]
MEXG[&=[=+^RL'>7>T[MTU2_T5YI<]#W1S4(V"+K\,D?_K(IF$KS<,9/R.(,&
M;ER@ BS32+8?^FD>-8('%IRU6F[K!)6'/(>Z8)UOB8B1(7T#JS0=,WY<GHW.
M-[52E,1U=2<6452W4:5<4_)$"A9INIGZW9OD+J9N"U==5[/G%^"R-$G"/;W[
M^Q"E3=LC*$#]!Q?4+P:DT^GV9O %^HXJ.L\YP1)W4;Y[[X];]>.3U89(&V5.
M_1%P@G_\/K@Y['A-G(&3H/':<> $":(;*%Z9+_G'X_UXURH&SI')I;WZD>=#
M8_&_?DCKPDAI[5Z*PYMOT09R\,\H^X+?F2*_*+3^\C0$UQ9/$],9J#A8)>15
MQ"Z^JUM/^=SBQN&Y(-C)V&.K$^<X)CT5#-$<:IP:%LJA'K(R34T4%ID+H7P&
M\,9?*NK!\*P=[&U82,H>EE@PJ*$!A*^XE:AI!=AM7S0$Y]ZS0GH$WLM\R<6Z
MM"0/G#$\>PN]KL" .[?Z;7LABMX VOKZIXL^WV8UC5U@CO2P&NYX?I;!]$M,
ML"0^! MM/$J[_A&L\!U!X:&K;$UFNZ4EMEUAI/+\2M*&%V$@4V?!,&US>ISH
M^@/>MP-W/BMN8-R ^)<"NK43W:S>2\^=/SA_5R6WC>R;7#'/_;AWKC1WJJB+
M^[4DME].LHVK*G=A<B7YXAD0([,.9<!\4"A5\J6/+W>N!@I_-MZ?*6N/0\1%
M^8I2?2=*1P-X=P_Q;&HB62!][L8>-#,69W.9331XED?8K$TQZ1AD,8R.=@:
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MAD2':PK@[)[P;Y/\2EXFNCB8;]Z7UX(6=ZT&R*NJGG6-!Y-I&W\ETWX+^,_
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MV>';ND?HUYZG"*+<T$)>;3R]>IKJ)'[,>Y"@^+9Y1$^G@VWGS)@^F0+,4A*
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M9;3D<S_[T8L9)4@%'4Z*L\8*_M:8\UO P-*7ZH/4I)NGH^TA61[B_,<A5/C
M'Y*M$'5*%?.^I%\_N;@\P]9VUVOTAE?+,R6@WCH&)(RJTXU=30V#B9;LM+)V
M-Z3? _IT<89I6^3J5<C;9*O&\9XK.3PB0WZ75)V@@D%GV]5NP'M>"-ZP]6DI
M;2'.IY.J.TU-8<A:/-%1^+ :$/(#_?-]7. 1]Z?N>T"PL<R&/YQ&PL>+$:'$
M0W%K\>5ON23V,CU5E=+SV%&\$9*"Z+4*-,LI=E93-,P?(91N^+L@F[GM3+[;
MEKN_IX/E?%Y.9%S&@:2/T53?BBI*FT.KM*7ID&GA;/):SP@Q[S3?4?R$0\RI
M0IDN@D,38G,QXU0V,^_QHV'Z>F)-#4T^=5GWT 9/;[D>\%-_46]<)&]$!_;>
MA^2JZ)*)D^M[@(ZA_BN(*ZEMQ\Q-R]L9L]<N@.-0KM#NZCFA4*Q*=OES>MFZ
M]2T3@5=L/RWNK#ISJE'LY-6'U%XG(5T@Z=L2*<F3IC7*@W+D#[L1K5-0Z(GQ
MN^;ZK]_CS8+U-Z;S!=0>^X@(J;=R4LOP?"4$^_B3PU0F_070PB<K7X1HJQMM
M_-FFH!=^$INX0Q[V4IQ<:H.#A DOX;B@^>K!K8J%V0NP9:BC3=$#X4O[]4M]
MH2E]0#Y!04>;EOK5G(_X  96L !Q+M(MK4Q5]E]ZF@@G;__RRX83SUB1;R5&
M>KNM'@50X?ZED2 ZI68N_O@A=90X,B:\$&"GVW4/H/@6HX8P4R.&:==.MZM6
M&>-V_K2$O$F7;DA%I&E[4K"S$K)J)A$W!&YZO;Q1Z3(F=P='1+/8M ZDEL"=
MVI53)JEIRY+%UZDT1 GI*#&E8(L3\(#YHHEU[HY$X:I2C]4E<[GDS9K.1HVQ
MI[ T@6^I_NO!*L\&V4J!V:9;WA.1H"<V_J*SSZ=Y*C?"(!B1>*:M^L^EE*F(
MEW&T&=G5"<NZ:H=FXDJE<)%.A-X4B*/9WI,=YW#/[-6LZ26G*Q$\&:M>@1H.
M_-:@ET.2U/G+OP/,U<AEPV[445T_36M<)&U<%N#?XP2^66G':,*/ 4-BZX&<
MH2?6095WY##W4^)PAPM(PXB?\AC/H=/R1C//: N1UP7Q\'<@^NM5F$ZTR%6
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M_8<4[_<J ;LSI@!Z4&N#E!C+?3WD9]33.)GJ-+#]Q/SV6E.L/]/[16\6H]8
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M& \*DH:QS[:SE*BZ6$++NS<)/O?4O4:&Q\A3;UM$5H9$)</?VI_'KN>@GV7
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M 8&>,".)C:P8S:1(K'M*K:3".,95;8=;?/V9TI_N&YQ( )KZ-AML4_D1R?M
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M>A3=9X2^2X>]^#]E^;K(JJ>VOT?+-3*5]6U6U@U!I!%UK"'(?ZU78K1RR:*
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M[@AK._&CU*@EZEG2S(WGQ"/EF5G%YTV&GJ4[&<0CTZ<J@B$5 5*3!6AT>5J
MO\JMJG@_[!F95C"S:CB>)]&DQJ 5\/8-/#LW-3?:E#DH;4J4B_&:Y9<P-PR]
MF(I)BA)9M\V!B1N$,'9\SIB#_=BCNJ;;H0'F1FSU%H^T0NJ;+0?1.VW"G8O)
MR$Q4P[&5;X Y=Q 7?:/N7'PF,NWV'AM+1[E]RO>8=P>_-IF1UR=TU]3KO6Y
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MW,<IPI"'7BHX@7H0HSB"D8^X2W$<1A@M*WD6K,<)AX<Q8H3M8.,][:V4RCQ
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M*)WF@0XPECLU"I. R +K3@ 3$L?01Z%+/(2IC[228\Z086Z<*[78'A.J'@=
M*-)M/+7K@B!U ;ZS %(=?8X9.ENG^7J".1B9R@?#/X#KA\Z#_C(PP7Q,M$(,
MGA=+J\692/8L)$/O/-D:<Z;JW>7GW%L-=15<4"I&++^(IY1=%ZH7N5![B4.4
M,L\5ACSG+@QB)X2)$Z>0N%&4>FY 2:J5;W1JH+FM,<W>MA%6;&NEN )2T IL
MZA@X@J^N2^!\U*9Q!@P ;( ;H!^-,QT 1VX^\=:_7\67F_X3UY_1&/9%X$W;
M$40E0B(9A?T)R02;NH#M-@ N#/W(B[ /J2.IP_<01"QR(,.)SU%$.#4KB7:.
M,'.C%R%C)388X$'<\$ZF"PQH*CMT7O3.+*9">V1:.A)<N #;+D1U@C>JDT!J
M;=KNDO9#$6V@:K_#[5"!IN^!>R9T![ODGGO/P=4R5J@L,Y[5<>ARL(LUR9ID
MQ4\J*.UP.&0MS3+"/$QHX$%&J0,#::2E),&01D'HNA2';DQ-3G+/EFANA[[[
M"M6O.B)B-[:I2ZC5_C-R**@\RV4D.:O:W_,Z@KE"WXQ+;YPYSWI\/>GLC4S:
MAR?NXOKR:IM=#6J%^B/+:\6LEN2P@['MVAQG2C5UD0X[(!ZHUF'IQH,9O2FD
M="-NT,2+1<1UF(,1C'$LZW4X <0N22#S_"0AOMA&T]2PMM&+0>9FW'X>6/3L
M((#:['<6+.,36B/>""%V?;K;)IJ7 TW-'4=5/4 'QZ\=]H;_A>6L0*N+G%Y0
MF2XNFY9+9UQ3:7=)>!)BXLBP.C<0+WN4P)1%!'(OCA%+'.J[1HW$3XPWM_>^
M$5>=3*)G IOQP"F8]2C!(G@CLT,7M^>R@D98>V2AB8I5WC@UYJ04H@G /IOH
M?FT8L:@PG3=BRTEE3IRX8=UGKBC$8Z(<_V^>=I<T90XNOJ*"7C^HFM#OOK&"
M9*4DNU]9=GLG]C87CT+>6];\A7TJ,L*6G/F<$T\6MN(A#(@OMHR)[T/?]V+B
MAI&@+:THG8GEGAO1=<0&J ),1F)P4.>1@>]__O)6_@Q*J;EA+[JI'@0]"IWA
M](Y,Q4H=B*4^H*LSZ"BMJG!VKFL4!TKS!6ATE]T8MMHO0*L_: !H_\J @L >
MP4\\9U87BJEDGW3!F7A"]A>NJ8<WCXSZ9;W:Y!4JGNH@>+3Z)%[)2^F6E1MT
M(<,E*N^$9.M-LX=7[7[:B]^M&*F#/#P<$Y(R&*8)@8'#&4S$IANB*"&NEV*.
M ZUN\?9$FMNRM=4*M)("J1?H*@:D9J!6K?&Q :7<[CNM>OI1/)9F^,19^:O,
MV\CKT1]]RO3CL*:?NHG"LBQ/82>(2Q8=MA2[91?]GE N2P--%MEE%YANH)?E
M.ULM@K)-2?W$<K22-53%QK<]^+P@I-@PNL343;@?1Y Q%,# DZ6H(_$?UW%9
MR%S"8]^HM\<9LLQMI6W$VI:>4JZ=AU;^;@>GH[4K%NV)(V=4>8>L%[;0FF2]
MC>)$4S?R8MO3L*F3+;_514WJ-MZV46?T6AHFF$Y1;T-+GCG4Y# !3K-NA]$M
MAQ'T?E/X)KX]%,LJ(KX/"8Y<&+A> )$G*WN$@>]0Y/D^,7+D'1YF=K1*_[8I
M)7&2M7CC[EEUMZ;#R]0?@5:/\<X';&0R:T+8=A*>SKXPIJA^$*RRSY&A)B66
M?G7W.>/$U</H0)#*6EB-67[[:;W*B&0<+(\B2+7T"/+2 !,8!J$# ]F+&%,/
MP3A*78X]YB8.,Z&$XT/-CA:VDH)65/!;*ZQFLI$&P'K$8 >VD<EA(&+&!'$:
M#*LDT3/<I$1Q6NU]LM#XQADGB_BT^Q<?<?]V2@?LN7\_,QE1(3Y7>U8AZ0:M
M9+]V;^GA(/$C1&'B!1P&#L,0<[%/="E%@>^Q.(ZH\2GCM#K,C>(Z*KPX<1QP
MPCCQ V%PVCC?:?X#G3QVD#AP\KA% W3@ !(/RZ>0KS.7]D\D)]9C^M/)UYFH
M@R>5KR3*T!)[1?:HPH"N<K%:J].$SUGY^\6WK%RZ#N9N'(20,D_8XXXCMNB1
M'\,D<<(HY1ZCOE&+D+[!YK9<[60%.V&%A2E$-;3'>R'66U=L 3?R C (LP%5
M^$Z#8;D67\^ $U?D.ZWZR[I\&M\91AXR!31GA0Q.5@EF\I?RLNXAU6P'/HK'
MI0F#%UMYGB GA1C''@Q<'L(4)0PF(<(TB%-"J%&A;Z/1YT8OC;Q 2M]D;2KY
M_P=H- "-"@L@E3@=<V]A@O2X:#381R8GZX@;$]<@Y*PRF9D$DU+;('#VN6[8
M38:1WW7;0$\U;MN6\U]Z.(R9FX30BYU8T!Q-8.J&#DP3'L<D#5R&C&H&'!EG
M=H0F;B97^T>TVJCWJVY"N&KD56UE]WL.FI'9,<#U:,L"C",3U%;"NDGF FR%
MM$=!)U"P2C;'QIJ45DXHO$\@IRX?V%NM3M]\7X=!W*!O3<I%<PB[##P_1HP1
MB+V B7T6\F :>@EDPB3B8O\5.YZ1971BO+E11R.G86^S$YCJL8)%I$9FAS9I
MO!%5Q7$TPH+O&W&/9VJ8-QS3 \9N0[$38T[;,$P/@!<-P32_-C0_FS)V+P/9
M#Y?]J ]L+U%1/(E/+^ZEP;-,(Q(DH1O*JAJ"71AU95-&'PJC),(1Q2[UC=AE
MB!!SHYR]FCK;_HJ@W."_,5+)N+:'304>9!&J4KKF3// !TR4'F6-#?_(/+83
M_UC7Q$53NV@!6B5 K87-?//A&%K.1Q\@R,3YZL.A>IG/?L:]S*M"OFVBXV\*
ME)>9=+!_9@_KHEKZJ>/'<81A@IDO&=&!*,0<>FGL<>3S %&MIE)]@\R-\5HY
MP4Y04$NJ7P;R**#]S&4+IK&]U^8(&=5]/ 7!X)J/1V\\6;W'4ZIU:SV>O'9P
M_^JV8\0OT@6QI)&P>7" ("$(P2!,(XBHBV#B1S[",4V1F;MY?X"YO>#/>Y@H
M$1?@JBS[(KKUD-3<2IV!S]A[IP'0#&G1?%!_VSV7GP\R=1/E@RH>Z(I\^+IS
MFD/*-MRR'I8\ ,_RC3 0&F>-,,Z7+$T8%JNZ[,M+8>!Q1_;EY3"-4>RC-'(]
M;N1T/3WDW%[_C[LZ?ZK4'-G*W+I=C3<Q&KCK48-=-$<FBV=MWVLL=Q*#G<C3
MUNW3AW"$=I2]P[Y"8TH=& ZWJ-3ZYC"6>I_ELBFV<ASO!>^\S4IU]B1KX7]B
MXCD5FWT<J?ZU@J=H(/8@.(IAZD<$,D?L26*'^ZD;FC"6V?!S8Z]&^OI<: &^
MM@%_J GXHXT*0,R5^/M#K849G1E.D!ZUC0?[R#37(MZ<-;T(L6RE5UTX%N#3
M"<2-"6T8<%;)S5"$28EN&#S[I#?P+@/S_.X?5NLGQKZPXC$C['#5EH]KE>LF
MQ)!AC^6-K*'<_?OENJP^KJN_LNKS-EVQSAU_ORZ:C^1U[I+A) C"6.SO B),
M/DI3B%/&8>0E29Q2Z=LV,OFF%7]N!/PL<9AT@[=5HF(GW3MO(0"E-/";..YG
M7T&[@-<2;'(J*XGM7;O.I:=%6$\?;JX^J3'* [1?;..\V\ID60Z>&"I*PZ)D
M$S^;>FO'?)^XD=>>@PD NV=F ;9*MWD!4DOQ:24F7ZQ(6T47;:41OBY 1UF+
M^:&O,D=V\TZG56':?-97F9X7>;*O(\708!3!Q?>LN)0(YU6]^9$!P4WR>!0E
M*>=B776PY\$@##R8A'$*0Y(F@:N2]HUJHIP8;VX+82LN>"8OD *;!JCTXZP;
MH&(-O=$#5(X"-T+>OB8NEN-3^L><.#Y%"X"7\2EZ7QN8$%"L"6-4N5C>9I+N
MLFI3L&O^9MO75W4OD'6AZK\SNF1^%(72_\$P4R7'4XBX+WZ-TIARQ%+B&)4<
M'R+$W%BHU:'V/W:TD";S3H^M#U(57VN5,<P1&#)G>N0U]DR,S&CC3()YVL 9
M*-K-'A@BR+1)!&= ]2*7X)Q[G>]"_BRWPM?\YY)=B*&JB_MU467_J(M0^DY,
MG)0R2)&,Z(N"$.($$1C2D(<AX3R-!_N.>\:=&TEV9=MF'%" I-R&1UVZR)L[
MA2WA.:TW6 D-UQP*L8&2>P&ZDH_C!M: :C3_;]_8K^;XU0"DS^.K\W7S6M=J
M=_N9M6T_WS-5,JX)<RZ7S'5(Z ENBA*/PP#[*4Q(@B!U_0"%01PRI%76[?10
M<Z,C)2W8B0NDO$ (W,;I:W*2!LC]-&07NBE\@=.@IE_)V1YZ$U5H/HVBI2K+
M>LCT5$\^<8/)JB+K*=*M=JSYC;.JXI6[EE\R1+I.)KD1<)9WZU7C#OR$RNKM
MABU]$A$7.:%8V3QA!7+7A2A,/<@"-TZCR'-H8-27SUR$N3%PJP'8J:#.$AHE
M%F"K1GMN(!4!0I-!%?9,)DO/<!QW"D9F\A'0'UJM;P" 8U3Q,Q'C-:K[#8#I
M2-6_(7<R3^BX(KRXV-!,/ ,7525VW'63U!6Z73*'Q6F2(HA3V18LY3%,@Q1#
M2EF*6.**K;%6Z=#^8>9&>%>7[S^#1E30D15(8?7S.GIP/6%I6D-K9&X:!I11
M>L=I' 8G>/3<>K(4C]/J=9,\-*X>6J\,5[LZ1C^A2I8F?GJ+*K:DA!!/=H\/
M$9;5RJ@'$R]Q($D=Y/GBI\#,'CH^U-QH0$K:J;BU /^7O'?MC1O'_H2_"H$%
M=KL!<_ZZ4!*Y^\I).CU9I)-LXI[!HE\4>+7U3+G*4RHG\?_3+ZE+E>I.JDA9
MNP\PZ'%L2>><'Z4?#\ESZ90%1EO7:F4G ;;S8?S %I@/!B(VH%;9)3 \5RH[
M*6[D.F67S#ZL4G;QCH'5@_F#%,]S^5D=[Q%79ZFTY1=-LDI3L;&JGA^;W]W5
M[9?ES_4;;>"_9HDB,>&T@%E&B%YT20(ISTR)<EHHE*L$)TY1AW[5FQHQ?7M^
M?#1MHY;J,,!X8XW^#I^>73?L/0^K';6]WF"%WH1K#3,#=:8Z;VW?MD;O=@1[
M-H*_:BN!,1/4=GJ,^@@S '[+[?I5<=Q*ND'@/2B2&T;*P"INZP<3#//X6#;]
M5^J'SS*:9DQE*4QYP2 2,8*D$,R49L*%B J6TL2IAMLQ*5,CZUI)T-.R_90=
M:TX>1]2.8*_&*3!/ND/D7J'M' 1^Z[,=E31N=;9SQA[49CM[L3_O<*=TMVE3
MJ1W1/7<AC;-4\ )#$IE&O8PDD,4$0Q$G*&94"!D[%<8>IL;4"*3G[7W3"_[G
MROS41#N#/^LLD)K:X9O##@&F<633C>[V?B7E@%98 T=RN./G=WS&.&4]EW'1
M63"Z^V8/8W WS4*55W?'[.&R<;L<GN8>*&)R%A:\G)?UXTV@7%V'MSXP%74L
M7?5^N?JR,N4)UB_F*/7?S^63>1U-R-TW>5]7B5F^U2[?<EZ:3L%B[^,EL<H3
M3A4D.=>+<:8]-)KG"JI(I;FB0BELW2\]N+839NN^D74J56=FS<@;0^O>+8VA
M]C$9X=^""T<44QO;P$R_:ROXK#;ES7=&^7U_E&]W1MG8W(TSN%N"OMF@F1W^
MLID>7N%5L(_PF=0K,5*0T-ZKH3]\WKX:<I\ GOH$(#>O1AT(7[6OQGIIBLQL
MS/<48#3:P)R)40JOPVAA3J/!V8^4&D_HP/#50^?GH$73P;;4%[G27\:CB:ZM
MES%_+LIU=2M$G919?5@T00ZSC&+$)<L@RW,3E57D>FF(,U@PPEC"LYACM_C7
M<+I.S2/1"NH91CL93UOU@:+<G-F;Q/_*V&J;^3_&6%_V/"8T@B.N, <V_^O9
MW!XUU%;KQ6EG-]!OP1>'CI%CO 2.4<73>!G&#$N>P$OA'N(<?I@NQ4@'U&#<
M(.OP4!Y$:8\@TLWSJ%;KV><?IAO10_E4-_Z+.(E12@A,<VD""6@!:981*+,8
MD8PS'!=6'88/GCRU67VCG%/SQ$/ SD^V5\$0^M3(%@%KFCII[;D]4GU3;W]4
M_VM_;_3PJ:,0Q4ECNL_Z] 5#8PB57*VDJ:LBR_M%4QGRL(,,+W*4QR2"!4T1
M1()&D*A"04DR&A%.J.)6(<5N8J?V^=:U^1<UB;JVZ+'$V>X(QC]Z@;_Z3F'0
M:@S:PK*!&_>XX>0Y^M!*],B1B"YP'$8E.MT]M+RU*1Y0'WE^6)@XR-N%^(.N
M_B7K8L)-3XQODIN R+)..7LK5VM:+NY6U#2*KG-[*U/.<;ZLGE>]W="<*9FG
M",,<1SE$$DE(8CUR*,YC2@O]1^%8%#N,HM.CO(V=9FU1QPIW!R%K<P32F>A:
M3CO0.-L1Z!1&+S#EGAJXK9F'8PA^,5>TMH+6V*;F0?4KV-IK=^8QH*YWV%'Q
M7 T\D+(CUQ /"_EAY?' \@9W55C5"^*Z#*'IUU!OK_8+V=\M#Y?*O=*N,Y7'
MN6(H@5%$M8>L\AS20E+33*D@4:(G'^;D(5^OTM2FDCIL5?N Y=:R=AN[/4NK
M=[2>ZN@GYRUNCR-I.X6,.3[!)XOMD'0-8IJ1V>_E\*Z</Z_+[WKR4,KT!CP5
M)-^STVOC!T^8^VX,<:U:8S>.\ 3CD<82OIX\C,A_7R[%CW(^_U@NY(>U?*QF
M$2T$)TA!A/($(AP7D.(T@@G-$QXG#"OFE EY(&%J--LI"/XR*H):1\>P]4,4
M[3CQ*FP"4YP;+,[4=-)TKTQS*&54XCAIY#X/G+YPV&>]=1&WSN&7Y;SD+S.5
M()1D*()"%!E$/.$08UE T^:7)#&-M>/E\GV?%C6U#_W;PW*UAEK28[VPFR\7
M]\V_RJV3[?;=GX'9C@#\@!>8"7HKX*V6-Z#1$_S5_G^0%>YE?+S2Q1EQH_+&
M9;/W"<3BCF%,TA4LO>5ZK=FTW*R^K);OS6GG)[G>=L::%8235+$$4E0(B#(<
M0:Q7=) F.4D2BJG@5HUQG25/C6>TDJ ^#08+F[YZ@.XO&>@_RC4U6_ZGPR*O
M'"L[=@HR H')JM,9])2^,='*H%:[+K>\TZ7/'UDYP^65N^RECTIESJ#L,YO[
M ZX[V+VC/YM=,_U#][OVR.:KK.3J>[W-=LOYZIG.J_K_I?A84E;.:]:=D3R3
MN%#:K2I$"I%2L69$DV=2%%G&>:*RQ*G LB_%ID:3K89@OE5QV!'QU2/F=H@\
MYCB,=<QLSI4;HV[JGS=_: V[ 9UI39YE:]P-Z ;QH\4@#CZ.]H5XD /KJY5[
ME2-M7Y">.O3V]OR!J=E-?MIGM3EU;YJVWLL%UT_?'G\6DA&9YWHUS"6&B&CW
M%0N:PSA214(2E$72R6FU%3PU,CY,[UD_2/!&WI>+NH5>?82]J(\WNU%ZJ9-]
M=GK_&>IHXQHJ_0"Z!N^6=>>U/Z1VN\P3_UBN)/Q8_DO.7^#= UU \]=-K4?'
MK&W;0;;C]Q!#%YB_>VF8O0"A';7#YF0[0N8W"]M6^+AYUXZ0'&1:N]X_^ "W
M>?KM\_IA:<JEU7&R$L4TEC2&,D:%7L-'.20JT_^)6<0B(3!+G#8'CXN9&OGU
MOIV-GD.ZW1_ :7TR>B5(X4\[#_#Q%HYLAT* QO0'HEZA&?TI<X\WH#]Y]8!,
MQM_>=C4=XB0BV_H.VZ)9"_&_M&]6JA<31])6:NY%DNPF3ZL\B1,A<I@0HHF#
MQS$D/(E@B@2+D>*95%;$$4"WJ;&--@]T-MV .($1N0'](GK;TGC&Z]H:"C9%
MTK>F.J2R>1[Q\]SVRN,8VN_R.80N'EKP475(2'R]T1TK ='K*.\/LJ^>*F&&
MX5R"H6>)XR44AH%J)X$PD(@!!93^^/:Q5%+_5;8]@WF$E-GM@#@U 9=4"D@Q
M3Z&,.,H3&0L56?5F/OKTJ4VR6D'0:>A09.8 M,NSW%50!)ZG^BA<[J-L 8=#
MC9QK8!FKIDT/'E\5:$Z9?:YBS,$]XU5X.:7N3D66DQ>YT]+GU3U=M'T$MR5:
M&E[\HL>V&_3/JFE&6-*Y*0?9Q#IN:?+C)M N3I3BIITI3Y!FM0@SB$5*8)RR
MF*"T0")/;5G-MW)3(\6^?3=@Q\+:@^G;:/R;C95@:^:.X_K1-6 RR"MPF:-?
M<V #4WS?M+TAO=T?TL__UPRI_3SSFD,[TC2U,\3\X*M]VOMJU6:(J^T0BXVE
MGB:Z4+B?F2>]BQQMF@T%5G^6#B;CNKC!M\M'5C8E +ZMY5,OBJ=)7JM+!,AJ
M_6%1_VDEY5>M$C6J&,U^I^5BEE 9)6F:0XYS 5&2QQ#+)(%(D()(1%+$K,JB
M!=!M:E/\I^4"<EH]@'N3D6H8HM:\/L)MR]%H8EANBHKHBU@7,4>W]@^+._0Q
MUG9')J\T@H'G\DWL8L\LTSA%/NU&,[9YR)UQ9A [\TR@3L] 8"ST'^'H$?8@
M,9 ^]'N5*$F/P)Z*H_0IXKJV*=IQ>9"+JOPNMT&<;Z1:FD;)?$ZKJE0E;V*D
M[^C/&>$JYJ3@D% B(6(\A4Q%.:1I3AF.<1K3;+:0]Z;BI]T\,$P1*\(@#6'T
MU0D9O#.OZRNWH>9K^G-8UQ7' ;&CZH @C]RW96O!;@0Y8+49X,"..I;2?W>7
M84@&:?_BJ,JK](<9!M>I!C(#GS:,*1M/77[4]"LW87=M$G#U[EG>*LW5_UO2
MU7NMSXS*G,F"YC!!3$&D2 QI)&,]AC+2Y*AR(ITJ*CA)GYHC?*>'2U*CH1L7
MND%N1X'!@ S,?*W>H%;\9AOX>6.RE)@$7V@I;D -,C#J Z._/[X;!)M7FG/3
M8%1V&P3./JD->\@P+ONRDD_Z?6F#P&\7HF;4)DC\;=/S?9:B(I*895 O['.]
MT(]C$XU=P%@1'J,TEQES"C^TD#DUWFI5KG?VEK7GP1M% :W5=F,S&]#M.,PS
ME(&9JT.QJY5HT&S\N"[+I=79'ULY .25HVSDCLI,#D#L\Y'+K0,30XY6>&ZK
MKC2QE?\I1=UPKM=*M.XP]]M/N>)E);^L2BZ_F@(LV_.*)&5QAA2&A60Q1+3(
M()6Q:1^?)RJ)BSQV*YH21LVI<=W%QG*-63>@LPG41H':JBO*M01Z">R(]/6'
M-C#WCC"J[HDJ04'WF]821M5QDV""PGV0,A-6VA6;G+V$QKTX6QH5BN28P)@E
MJ2F6H2#-&8(JB[*42(P$=5JKGQ<W.>+O!=$V;IE-_O 0G!WV*+V@-\I>9$_3
MH.E]=K#XWU@\+7+\#<2+YA_=*+Q\EWOHW)%"&)O4P+4Y\2]%6U+FJ_PN%\_R
M-[I:+)_7;:LAG A1*(EA)")S?!(S<XB>PS2E(E:49GEN'?Y[G2I38R.C'-3:
MU;$U&\W!4^N[/#GVC+IRG,XSUKCHCW7>W;-DF[V\!CNV@-88T%KCW,OKRG&Q
M#TD;;WQ&"D![<R1"I*UE58_3[G>S:L=)=I]5\P%YBCOS ^Z9*+,K!8P64^8'
MB'X$F:<G#@@*-U/FM_IUK9:J?7B;<9#2.)5,F@KAB)J(KPR20D]@A+$(:P<Z
M30HK1_F"G*G-2;6J#@&X9Q"\/*%XPF44W[=5TZP<N@G!/;'E'%P.H<=^8!LK
MBKB&K]K"U_'T+X]T0=MVBDJV%9ZZ/]9E"TWA%K.TIHN7_V;^S,OYW)0=,75\
M2M[>4:TU-\C[DH-RH;F#FJ+GU:^^HHTO0WTN</C,W>/% %\V82><U^+R83L3
M'Y=T47U:KO729$7%9I?]J^2R_&X6*T?[Q'"$LH@0#F.<FPV+F$)LLOR1BFA*
M.4%IZA2#.TB+2;(TZ.GLMG<Q;"3LMC2"XQN8[6O];T!MP4W=6J=_BM<S(WR;
MG:N@]+H[,DR343=-K@)K?R_ENH<-C+FBY<ID:\LW+YL?_UYJQW?%'UX^:AZ>
MUZ5]$B$$5@6%D:EQC/(T@Q@) ?6O,X0DEADKG(*MK,1.C0"-JG49!'D#-MHZ
M!ES9X6W'>OY1#$QS6P"W^-4\]^GV']Y+++FAXS>2RD[TN"%43G <Q$ZYW3V,
MC)J0_%MFG&N^GN&<,24TZ>!":=(I,@XI%PGD/,])0E2,8J=3H]W'3XU<VC27
MOSK]'$_Y]["S(Y#AB 0F"GLPG&GAN,U>/_\]$:-^YL?-V_^<3USEWJE])_>R
M/DE^MWPTF6U9PD0>HPAR_:5"E(H"8AI'&JJ(Q3EG$;9K>'=.R-0^X=V$]%I1
M^Q;N)Y$\_RG[PB?P!WT$&O!7HZ6G)N^70+BZW_M) :.U?K]D8K\+_,5KATW1
M1W)"FL8KS7^WZW:L(E:PG$*:FTHE3'#]_<L")C@JHC3C>50XE9JV%3PU3CB6
M3]4F4C56N$WSUOC;.0 A4 W.)(>I:>.T9W(%RZM/82U\5&_#%9)]/\3Y_@&U
M7S=5Z6[G]1C752%.]*??KP_),$LU7\$TR[03(_,<$BHQS%,J"5=93DAB7>=U
MN!Y3X[1^0!O=&&/^M<W)!;)-1OB%-2:9Q-'U#RD7_;Y09NUOBK4TOY&BURC*
MLAO4M4-\^;QPI($+3)N;,?NLP-8.\Z]>O>LN@>27-]V8756M]9HOS[XRZSC#
M,U85UN##Y%9O]7IPS]56O>+IX]51O1Z"G9JI'AXWS'6O3Q:^T!?SS-HK;7^N
MVE" ',<\S;3GD:49A4C_ ^)(:0=>)9BJ6' 5.W7RNB!O:I-:/RIOR>;E?3,-
M]5(3%\8@$RAIK'!SVR]A;^>M>T0T\&Q3:PI:]6[:8\Q.V\LA+,ZNN24R7CWR
M2S)'=<0M =CWOVUO&YA^*._-E/E5/BU7)K#NV/E^I@@2+&60%QA#Q)""#)L"
MIRI1*5*9U&@XY1)>ECDUYFE5!AN='?/[+%"VXQ?/V(7V:/=A"Q\;X0"0WRPY
M"[GCIKS9 W&0O^9PZ\!D-%Z>J%'S2:X_*]-7IM>#^&[YA=:5 9#(*:4<PP(1
M89C(E&.("&197!0TQ42Q>+9>KNG<CHF&J>%$3AMEPGUEIN,=G=?][G[1PU3)
MZM>ZVF)EVCT[)J\-&Q<[[@J/=F Z^_SVP\V9VEJFD_-2F>7?#;C=:Z'=V.(Q
M$^XJ+/UFR U39=S,N:O@.LBHN^YIUY?>^J<L[Q_64MQ^ERMZ;^HAZL]=$W7]
MQSNY>HQG.>$)B^(<LCI-(4V1.>8I("U4H81D."GBH;6W+HN?FO^V5SBJ,P"T
M%H"-"<T5P!@QO$R7Q?#8,68XT ,SI5>\KZK390];L$)=%BJ\6J4N>WC.E>IR
M>,HP\ONC7-1-!KM:L.\D7YEGO]?&?95"/M85%*H9B0E&$8]@4D0((DD2S7J4
M0DHQRA1B(N>X*\EZ9T]^EN*M/L#=0JQW8U3PHMJ+IW/PI!_XH+5V3 JPQ9XJ
MD?)$I5#2B$.D)(&8DQ2J+,DHSEB<*^%6#C<<[*$1;Y$V[N!"?Y3+Q5I+GQN^
M*UM; @V"W;SB$]BQ=BMW4.P4OP&=ZDUB6$]YS2^@/PX?+@+O/,\XPNAU@K&5
M/>K,X@C(_I3B>OO +<_-\<Z7E3G+7K^8RCOKVX4P(9=/9N>C/M29J:S@G&<Q
MC"E#)L,L@@0K C.19R*+1)S29*9G/+:TWOFT%.WRX?45",AHK;XWH-:X/G+9
MZ.RX&6J+O^6.: !, Y/963#;@V*?6Z*."/G=%[45/N[FJ",D!SNDKO</S8Q=
MW!OW^9UDYMEOZ5-IMA,-)W[>GG]^6/#YL]#38EN1\@^Z?E[5I7YF&1(185FA
M_6&S81IEF:$P!.."8<:X(BQF+ANFURHTM:W3MW2UJAODTD?3]]3X"7-M(M3S
MSR,0VL@;LX=J?OVL'V-VP\TN:QT.9=JDNF;77CF:=H0XYA@%)LJ/F[$PQM0\
MV>P7; VY 1M+NA*Z8&N+SYQ;/ZAZ3K^]4JF1,W']0'B8E.OIN<-(6C^X]E([
M;_7#HB[J^+"<ZV=431K/5[UN>;]<_: K,9,\BY*$1S#F,H%(U@U"!8:1%'J9
MRG(9(:=$74?Y4]N:[=0'OW0&_&KZ1_5M^&]=@ZF_C!V@-<0Q^\YUF.S(-B#X
M@;DU .[.I#H0/:\<ZJK#J)0Y$*!]AASZ&,=0?EG.WK4QN.^UBT3G=:<&_9MJ
MAB*,8YQ0F,0,Z[5TGD%,500E)4F<"Z&2S*H>^1D94R.V3DW0Z-DV)#&:6L9G
MGX'S/#EY BDP 0W QSXP^C("1TBDDOQO]\OO_Z'OKOGCW\C\")L?FY#H,\\=
M)]SYLF&;4&:+2X=V3CFQYMWDML<D09',M'N3YCE$1!:0IH+!'*=%%--<4C<?
MYZ+$J7W\%[9X!E80N R\G=?B%<[7W2P+4'[ &AW/;5,N21VY:8HE"(<M4VQO
M'$@^;3>HNV7;#K0.BOZP^"ZK=?V'&<K2'"=*0J4H,W4-(DARO< J,L40JFM+
MQP,.@2\*GNSQ;Z.W"4-K-6^C_7NZ._+0Q3&PY"$OD([$0U?!Z$Y"MM#X):&+
M4L<E(5L0#DC(^L9A)'2[:5UN6@Y^6+1[3FVJD&0"YSGE4*HH@ZC((V@JK< L
M+Z(BB_3?,NKB_9R5-C7/9ZLL,*VS8+D O-'7C6/.0VS'+]Z "\PM/<R^M)BU
MJ@9(Q+("Q2NKG)<X*J-8&;_/)G8W75G=\9-<OY.K\GM=I[CN,+=I@/E'T^U<
M?%Y\E:;Y8KFX?T.KLOISL62FY+$Y:?RP>'I>ZS\O33'DLM[R_KAI!!;G+)*B
MB*# 0IC=%Y/!15*8% 7#.$\SY%8K=PREI\9K_<J2)M)_:W?3PA'\LC']5] 9
M#^HV$:WYH+;_!O01 #4$8!>#*SK)C?(ZV9'OU%Z2P!P^N?=C>#7.$08L3"W/
MD(J_3B70$8;B9!W1,60/CXM9MR>^=_H1;1F^&!44F:-4@20U/>P(Q'$D8<9R
MBG/$E21.U4B/BYG:Q+0;)'$#C*:7"_>YX&H?=W(=6J-&D]@"-2A2Y#0.WN,_
MCH@:/:KCM+G'8C7.7'U-4>(_Y/IA*;9K_"9DO*VP*-L_2%D7[Y8%QW&6Y%"F
MLM!,(0DD(HU@RHHDB;.(B-RI/;*S!E,CD?:@O[&@MZ-E&A[L& $Z*RX5 _<T
M4G;<$Q3_P+3D'_J!!9<'P!>@)K.+%J]0MGD 2,<K.P]YD$]ZK)KZC;,L5RK/
M,P5S&F<0$3TTF%$&64HPSV66"XZOI\)6VD1IK]SJV2LF50X]'CD/^#6,-@#&
M5V*O*FRA5RMX1F"G3N($F&C/>#O6V;]I>!?@M\M'5B[HF2:-O?)M5=NIL>H.
M:F8L3@@WM>R22,80Q44!F:ETE\LB58DHE(HLLT?]*37@0'>LL]SEJB4IO2I?
MSZ4#27D<L_-,-O(XC-PAN&?1Z0[!?:.Z-L%US;W7&2_WCL'CC=O8G8-#CM^@
M_L%^H+;H(WREH-'["?L!YEA?84]/'E#PW$1??ZN96]0_WSX]K21O-DF_FEH:
M7=71.%<HRPB"6$411(6,()6QA$CDA A,."=6WKF3U*EYZ;6RL)GI1).A /JZ
M@T9YA[+7UOA?GN*"H!IX%FL _78)T &-C.V1=2@?'@+AL8J%VR'MJ2NQ,U+G
M*G];/VN\.M^NYNU4]7:^>6!I2^.6?UHNVC8)B_NF<'A;-7P6)P@SC&*8Q7$*
M$4DY9#C6J\T4Y7%<1'J=XQ2*<5[<U)C\<[NQTG2$<2]/>1Y;&2%,<8*@$'KE
MB!)%]+29)+ H8IG%",<YCMT*=OA#=YPR'7U\O4)KMVGE#Z[ $V"#4U_3KGG#
M+ZVROWJLU6F%BM^:G.=%CEM[T\K\@QJ;=G==P=%?3$NCY<+D*53OI-(K M'V
M=&@]%%/V/#5AO$1*3=5"I-KW1A$D::PHD8)+;M5:R$GJU!A;ZRA7)E+)]('2
MNC=>BU%_ +]<A-R!9GP".0K;M K7V 4(ZW4"Q3_97)0\/N?8@G&4>JQO'L9
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M1$!61!E4+,^1B N:1T[G+K:"IT:7MX]F-Z0"/U;E>BU-$7?EYNQ:(V[G[(;
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M_2'7#TO1A"Y):18UL8A2KL==8(B4$GI1$V/(,8D3+ADC&1E \@/5F2BE]\@
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M$D@5XC C*5)1GB4I=6I[:B=V:G2\U;J?G+$3'PO^,MJ#6GW'+3K+H;!C7O\
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M7"11^EGI"][)N6D0)W^7"[UPFK]=KIZ63<7@C_3'Q_*Q["+GXES&@J0PCIB
M>GVC(,XC#&/)(\JB!,O4JOUL:$6GQG&M+]X8"VIK@;8&M/:"#Q5H+39)FJW-
M0!MM L+-A9W=H#4<]"P'VG2PM=TAIC+DJW+!9YK0"Q#Z(.W_?V/O$&X[D7=@
MK&C<X._"?&/^WW:>7%:@:I^\WCRYJ2YN'F\:(MH\_H=1^:;_*/G33)4FA?4&
M_%@^SP5X6BT?2E:NZR=V\NN^"')Q3^^;@ =@?LF>JW(AJPKPY2,SF:YU)NR/
M<OU0_[D+BY"B.6]K#C9O *U,J):^TT1J:2ET#:K&H!N@EBM NUWQM?8^)'B1
M=%7I/YCN[-VVN3 9M-JFVI[V$5L1@$FN1U$K<4('3V7AQGC[ST5+AQ0_7C#U
M""#NQ%J/(<]?]\6O6N(/.C?=QV<XXE&2(013Q$RYF0)!$M,((HD**3!F+'=*
MQ;\@;VI>V,F^@*W.P"A]??/%/N)VBTV/. 9V9JZ#T$L;Q2/ !.^:V)?YZDT2
MCP!@TQ/QV&W#:.:37&\[S=RNUZN2/:_K',GEB7Y1(B8\RC,!*4M-!>>(F&8O
M!>1QDF<D3E":.H9_.NM@]1&-&A%J!NF_UT4[VGASVC/#N%9^HD3=1\N.M,*,
MP$B'9MM**6W?KML][(/WY1H,GU>R<]=B5/H;#-(^(0Y_D/L.7!UMP#3C"N,6
MRD55NW:WJY5^ ^OV\^QE>TD;PWFKG4-1_^<?IE[3XOZ=25N-"I'&E&I7K6"%
M]M<$A:S " J6T CQA.?"*B;*JU93\^IJK6&M-NB;!GJV ?8"^M>U]H':MIOF
M_T!K(WCGE)CL;[0O[YB]RAB&/KSX?V7X[#>]7F481]KA"C*<GK9;O.-^9F_%
MGZS1-E*\P]/?-?'_\&%KES?MEN/;[8YCTR?S7@O4/U6E:'ME;GK(SPK"2!2G
M!-(T,DGM7$)J:OKG>1KEN21IDB>S[W+%EK8;)P.T</G6^[J$^]2W&@-)5PNX
M?%Z#)9N7]\T^KMLJ9<BXV*U3 F,=>'KLM <]]6] #_H="V[ Q@9_*Y4K /2Z
M5AFBQZBKE2N VE^O7/.H@9%*;=W"DP3]YF5[29^@/VI%Z\;!LTCF!5=8P$B1
M""(14\V3K(YG2I*,X50RI[2PZU7Z?VZM OXRMH':.-<6@M</L&7HU*C#-O7E
MB=V(N0=@>0/9;X36]6J-&\+E#<:#&"]_3Q[88F:QDGQYOS!)?'?TYQNYD*I<
M5R>R(_(\X@+1 M*$QA!E$8.TX,*4:HAR(C,44Z=<%2?I4Z/I3<Y$N=ATKGJI
M0PN>>V:9^C" M88Y]K!Q&AL[V@V&>&"&[>M=5XWI-!\GA640;'X[Y3AI,&XC
MG2'@'/39&?20JUI0U^7MC+O\+$5["JI]YC8 7,48)8D44#&]ID>L$)KT!(41
M1ZE(6<0<FVU9R)P:P?5U!5ME!_6D/HNUI<?H%\' A'4"O!!1]O:XA&A<?5;N
M:_2PM@'B1#MKJUN'<<Y7^7TY_ZZ7YDTEK?>4U_Y"^P7D$1&$9QBF2E,.2HH"
M,JXASW.E9$RPRF*GN@9GI4V-9S;*:C=J41>'Y+76;D1S'F"5%X)&L>D.+B.(
M<JP!SC,*TP03E%&E?5?AMCOK#>)Q]F&W(#?Z@DYAGRC;$;DWY )3^$G( I"X
M%29>Z?N\Q%&)V\KX?<JVNVE@Q^:N,/(;_3Q:/:_JM?C[E?SWLUSPE]N?937C
MF!>11 C2K-",PB6#!,4F)3/)TB2E:4*<]C$M9$Z-N'MZ@HVBCIV;+9"V8Q7/
M^ 7FEJ/0@;^,EAY9Q0$3O^V<+>2.V];9'HB#]LX.MPYCF]OY_//Z0:Y:)[1;
M%7$9HR)+!<QRF4"$*((LBDQT;!33-%41CZ@+P1P7,S5.J54$$-R:)BMSNGH!
ME5Q]+[EK ^@3H-IQR?50!::/!J5.O0#^R'D$O)+%"5&C\L-Y<_<IX<+5UW;.
M/'XHL%]R[\^%?G:=(_ZYSJS[HE^0ZLW+;S_EBI>5_++2W\Q7<XQ0-R::"<**
M)$\9C%/"((J1J>1"8ECH51$6*>8*NU60"*KNU%CIZ,'=]I3&I+HTD16=/: V
M"-06M1VZ7$]BP[X/EGMNDQGE$4]P_0_P%4T[0^(>J+=G$)5?J05H2/A/=PH-
M*G5HUJA6Y^VR6N^U7XP2G!"4<HACF4$D,P%)'J=095QD<1S%B<K=LD6/RIG:
MA%"KJ<G #$Z3O[Y<&%? -3'T.*AVY.P!JL"LVJ9]&AV#]CB^@(3GS,_CLD;.
M^#QK\&&FY_G+AU'";TJ9_/7O<M,MQ#0*VVV0N5^NL+FT_6YFN60I1JB 5!88
M(I4ED&09UZBG^G]IAE-LU8'8FT93HYFV'=^99B#@:54^TE4Y?SF6&0I-],D3
M?3&WF-YOIN^E&T5=/\AV9#;JT 6FO8TMO89'=7]$L&O/S:D$TMVTTSK$A>OA
M\T>8WM#V2JW7:S4J"7L#<9^N_3W8/2_U]]7R>2'J":/=,I,XE5C$FI]EG$,4
MITROD_(<9CQ-XA1AF19V-6"//7UJA-LHV-2KL,\// 3M/.E=#45@ NNC<'ES
MT0(.^[3'JV 9*7W1ZB5Q2CH\:?69Y,'#>T9+ CRI;C^9[_1%;JQ4K=:S;WI(
MZXV8W^7R?D6?'DI.Y_7A8)9E<1:E&)(411 EJ:E5G5$8)SA7E#!*I-6^YEDI
MDV.IGGZ7#@T=L#Q/6MX0"DU>#N!8?Z16QI]SAO0#>HZ0_M>^$W1>PBB?MI61
MW2=N=_'05K1,.S35>E6S^7LI;Q]-'^H904*E5&D')"(%1#R-(<Y%#*E*D%(X
M37/B=(AQ0L[4/G>C)MCJ>0.TIJ!1U;7U['%<[99H'M *_.D/ 6I >]FS,'CN
M*GM<ULC-9,\:?-A#]OSE[FN26_[OY[(JC5/W>9LZ?KL0]2GLI^5:5E_HB]GV
MV 1KS)1>0Q&%$\CB2%-%)A&D1%$H>,Y3B@GGS*J*X4#Y4Z.0G@G]]/NZ"?.R
M#B98&#/,7I&QXP8H;0GX;DRQ]_N'C-/EA5)@] -34A_XGOI ZP^:*([: O"E
M ]X8 ?X1'GC[)5G@ 1AIT7;%0'BJ+',%CF>6@4.>.MI"\0J3^TO):QXSM"6+
M]FRU@(]Z1.?_\WE55J*L:_6V&QHICHI48@ZYI-B$TR20B)Q &L54Z/DEXH73
ML><%>5.;3FIU77NNG$?4S@?UB%-@XJ\UK>?76E?05S9(KQ4K8#QW6CDO<^0^
M*U8 ''99L;O-W6O=3UK]L*C9ZNWS:J5GNZ^2R_*[H:P-C[5_N:TJN:YF&/.,
M4); '.7UV:B")*$I3!DI8L:$1#BWJX9[O3)6G]6H97&;&7NUU;O^TIY6\HF6
MHN?5\L8,0&L[[#VJ*P?OLE<[PH",PW.;O/O.$KT ;QVJ5F70LZ;G;G5_O1UW
M:.S]WO&&:"07V+3Z6,@UX ]UU&*O0;3^;I:KNI)BVQ2C7.Q]0/N?VK'/RY.?
M[ ?W,R[SE0)&\Y[] -%WI#T]<9A/W=5G7#[2<C$CVF=&*,%0)22&B!&N/6@F
M89'C#&&.:.962V;GZ5/SE[LZI7\UZCF&@N\"9^<H#X8C\'1AC82S!WS48J_^
M[JZ$4;W;H\;M^[+'+QIZ!+/25- $H71[N=7O^KDF).G-R]^E,#V:OLIYLQ9_
M*)_J(T1*,,YB16$N(PY1GJ>0<:D@2_(XQ9E0-'5*6ANFQM0^_U9-T-?3Z=SV
MRE&Q/=\)C75@;AD"\X#CGVM0\GPZ-$B5D0^/KH'K\&SIJJ<-3'U8+NXU2SR:
M@ZU_2M.$58K;[W)%[V47?6?B\V:29Q&-TASR),H@2F4.&9(,<AHKA=(L2P5R
M2H6PDSLULC-J0Z,W$%KQ&_"C51W01O=-[#)8:>UO %V#IZ7^7=VFKWQTW%:T
M'1P["@P >6#.VZ+]KD:[TQJT:F]CBK]V:'_IT+X[A[9[$H8;=GZ3,BQECYND
MX0;(0=*&X^T#DSC^_5RN7[Y)O9*OLP/>?_]4?I5T;A+,?J_7:4JE21Q%D(H<
MZ74:QI"9_EP$%TE.!=/K-*MNSK8"IT9GC;Y@J_ ->/\/^.F#Z6;7: V,VHY9
M%9=0MZ,KGU@&YJEK871/<;#$QF\&PR6AXR8H6$)PD']@>]\PROE#KN[UA]L[
MU#7;3>_*ZFG9_M/4X9LO3:V5:IL4*2/!99%RF%*LB8AJ#F*9'H+_P]Z[-L>-
M8]FB?P5?;IRJ"*&'#_"!\TU^53O"9?G8JIZ86Q\R\)38G<I4DTR7-;_^ B"9
M2>438!(TY\2-Z2E+-DGLO4 N;  ;:Y,(920B:9*G3D0TS(RYT5/??+,P^TX%
MQU5=U-IJ-U(:V"]V5.4?;<\$UCIP XX@OG,"]+P ?WHY['H=DJ/2W4!3)B7!
MZ^#:I\8KG^:^BWPOGG01Z/*E(>5NX?Z+>JT?U9]WLHL%JP6*L A(E$ 9"ET(
M4/V$213#+$EQKB:@01R+;L?XWB[ST;[U 5O$]Q/0XQ=2U@59@N?68H=]1@?D
M+V_WC@SD-)2W-1HT5M_L]G@[P\&=W,XP_6!KOU_K!^.I]F;'PMIIJ]4=LC/;
MJ@X/FVP+U=W!_G;I@+O=&?[=[[_UAY,NP5 DB!$L8$#R&*(XSV N5,@;4()3
MAJ*818EM_OK1%N86R"HC7X56]F1R',#+G'PU+)[I=Q^1 2=QCT-C3ZE70S01
M>[I#Y4239V$XPXC'[YN,_,Z:W>>Y\Q>Z4UI7F.X;60I=CO-.=I2I@F7]E[</
MI3 '!Q=YC#.6<C6A9ZDN8:W(#B=2PD#FD@9Q&E%IK2Y@W^S<R&];P%%;>6/*
MV>K1?CORZZPY_4]@ZX$]!SATQF7.] .Q9R*=";KVM.L'Y8FX>$2TG4C:';0S
MS.WPL,GHW-W!/L</N'O8\N['E5Z U _ZLEX6[&6W4AAR%LJ(21C%L8IILUC"
M/) 93"/"@URDN4B<#LV<;&EN]+XSM-+[KGI?W*P<BF93I-JNM+LMV)Y&VFY-
M=A3\/'/WSL8;T%@)_FS_]+*Z>A&341=03[<VZ1KI1:?WET$OWW!=X?5>--JQ
ME)$SO5V:'E1__=MZS?\JEDNM>,5J4S/NG> ;5A=TV<D:Q"1-,RQRF,1A!!%G
M"<2A%#"4& N6B@!E3CM&HUHW-X[J3%;LU!EJBED:!<%-^;RN=.9_5:U9H1=O
MP5]%_0B(\X3=3T_;\=U/Z[^IXMN>8S>@\^$&=%X8'<*='Z,K8WC!UTMU^'$L
M_"EUXT<%]U1%^7$;&386?!;U6U(]?BG7WPO%26]>_J@$_[CZ4*S(BA6KAULM
MD6BBI@5%>93& D,F Q58AB* .,HXC%#,>)ZGZB_$HE[79&E']/9-.['XU@!_
M5/!9'^]2IH.-5K)7L:;L;%9<W1GMQM0._6!'PW[0]<RQ&EAM->C,UO7<?_FC
M0?E7L#4>W%Z&V9E8W1$;E34=FI^4$MUAV>>[ 4\81F9["9R?-WJ%M17ZK^XV
M=56K^:!ND%9UJ;[4A:1Q*I(H@E3D!")$ YB',H<\S!*4)RS(,Z?C<:X&S"T\
M_<_]+/+*6&Y"5$'*E3*]TH=7F[__WVX4Y]P[=D3G$W//='>01MX8KY7(&_-!
MS_X;\*Y8;O35?W:NC#@C'XKBJ!3H;,2D1#@4HGTZ'/R<@2([1\N<],KNO'G9
M7=)6Y;G]BY3<_*<][=A4B \749HD*4\IS*(8091@#O-<=624I@(Q'E#B6+!]
M1./F1J;=(=SFL+^CCL^8G6;'HS^K*SQS;+_F5-^Q?N$I'64>K4VE/;MI_@!=
M=WXYWYWNFD(><!]7@&A, Z=5*_( [8&TD8\V)F;Z)O&J=]C3J%+</Y)54_.J
M/RKMC5Y?A3X&KPM$ZPH;:K3:D.6]*)^J14PD"R,N89R8V!H+2'2B;)#)-,H(
M"R(>33)4^/!N;F--SP5]^%!H[1@Y[<CCY27R/'3][%=C_F-?>Z*L!U$K+%4K
MD-IZC=7-ZWG*P;1FBQ7H@04,6C,81WV^!/,8B+UX^#]C)/?9N:.% EZ-')I?
MHBL=:<&'#ZHS&@-_%_7CFO?2+!8TY6KZET=09GG054_7N\!JCLCB,)81D7;R
MB4[M6E'LI$J)+4T66QO5C]J1&RT%YYIO8H-\P'"<9 F## 4<(H(IQ%G$8<*C
MB&(1AY%PFHB/A_OTI\8/4 >_+'5)-Q^XV^;\C(RF]_R?7B4\H.FW&_@;JT'/
M[#&S@!Q0&CDCR*;EB;.#', XS!1RN7G8B+ 5_3YZ/ID3RH*42(@13YM*$)@&
M*>0!%S05B&+LE 5TMK6Y\=!.Q+[2TZYV8TN%N+TAW8V,SH-M1T*C0>B9?';H
M37"NVPJ44;GF?(N3<HR5\_O<8G?3,$YYJ^W6<:N.<K\6U;_>O-RK)QDY/8%Q
MFI @@B'%*J*,40IQ(!@,TR!+TIRPF#GMS9YI:VY\\LI4H&T%VM1!8H;G(+;C
MD9& \\PB S%S)A +-$:ECW/M34H>%H[O4X?-+=<*I_Y.:IW6_Z)/6U2+*(XD
M9Q%2*$:*-&0D(>4B@)1DE))$Y#Q.%FKF3-?NVJBO6G)Y\_OM^?L =H;> /'C
MN6B_!.Y<0^04MG9L,0)>GIFB#U1GHSE Y4.^]"@(GO1)7[?UDP1(CSI\6F'T
M^.4#9RC%JJC%)_54->VI59>;+%DCJG[[I)7W_]M\$FWY[O\2I+Q7/2$621AS
M2F,*<Q()11HBAA1S B7/):41CHG;B:F!=LPM"E'O&W*<M0SL ,OYC']8?<]T
MC ?0N !V/C3%.7HG"/KNW #M"3"NC#@-N@[+<2=( VV9=NIT'6 'DZHK'S>0
M(->E*!Y6;_6Y@?*ETZE "0F3"$/)6*+9CT*,< KS*))YB)(T#9D3^QUI9&[4
MUMIHCNK<;NK'M1Z"'+GN&):61'8E0KY9ZA@X'HJIG8-A7((YUM"T[''&U0-J
M.'>MNTK(^Z?GY?I%B%++M0O>EIKY5!!:+$W.?7?!MWK-_K4]AZ3>"+.C6-"-
MV8'4*?OWZ^Z?FUS519K2+$L9@:%)GP\3%3@E0BH2"3$)14PR;BV?Y-'.N;'/
M*X.;,T3U>BN>U^;<JTE<ZS!L(=G6@5KN0+&7T/#Y'IRGO1GUKF?F?+_?8UWU
MM9ZC*LQKKP+&UYUDA_;V!KQ^.<S1I_OU[J+&YWETN[W4RDRZ?R)MELE>@Y%*
MP4W0.V=$8'RV/IEJS 00]F5FIFCN:A7=KX(+\:0+W7U6 .IVUTMUY\-6SK$-
MFB,<9SS*(T@XH1")A$ :40&I0((E/$%1%-A&$<-,F%N H(R%/6NWM5PJ4&WH
M/P6KFWBA!L_Z2&7E)N0XL)<NC_'^L?<\?.^KPX*="^"U#SN%V %RD0,[8+!$
MKX>.F&@@M<'_H-/&%:6\#DM['5_;!_\L35]'Q\_H^[H^Z=H-PGO=U (GG(HX
MQS!&-(0H90SF.$X@H9% :9(G4>1T&F7O^7,;07;F@3^-@8-+(#;PN>[].8,R
MV9[?13RNV.Q[Y;6G3;ZFC9^TN??*P=.;>J\O&_8!WVL1\$WY8B+8)C3]*NJB
M%'P19#%-J11:X9!#E$<8XBB2,(Z2-. Q92C-'4HP7&[1ZD6>ONQ"8YW)>UY+
M4+?F@\K,)W\I5NU*DF,>]!G@[5C@2APGBO4ZM(R5-^V$6M?),I:.QPZ7T1B5
M*,XT-REG7'9[GSXL[G"?DMYR;O2UR%(7^/M2%BM6/)-E(YWU;B/NUY_%7SOQ
M8)K)(.<TABG2Q441#R#)%+,D@J0D2G$62ZLHP;WIN040.^M-R4NPM;_5LP/*
M [TBI7P8(NCLV"^7)Y_^T/9,1/,"VGZ2Z0_PB2:7@X ?:<5U&'AG9I..#YQL
M%CG,T?[L<> 3A@6=G=[B[>H@+:/[IT:*=Y%F:<95( J%C'49L"R#-)%4#1<I
M$C@F.(J=LM.M6Y[;0-%9YQ9DV@-M%W-Z@<\S\V^U@+5(^7XV6-67EIU"DML9
MP5'#5OO6)XUBG4'9#VK='^ 8XXIB\:X=+QL1F?<KKG-I%SCD$@6A@!CS$").
M0I@+%$*F:"HB+,RHFB3;A+*G6I@;$75&M@)-X+TN&FJ=_'X:R NQYQCP^%[\
M<D7&/I:YY/T1DJ@$^]O#^OM_J'L-/_P;Z1]A\V,3T)Q\ZC1QRR6GMN')Q0N'
M12&?=/F[/3T'<UX+(T0X"0(8ISA5W[34<J5!!+G(,A40YG&,K+[I2PW-[=,V
M=AYHQPPZ#G<26[LX8PS$/'_MP\!RCA<N(3%J>'"RL4FC@4LN[P_^%Z\?Z]"L
M6+'')U+^Z]U:B\$L,!91)G,$>:B3,;%.K<B$@"S-F."!1$GDE-%]J<&YT<61
MHZ!;B\&?C<U7GZ+=P]R./L9$TC.-7 ?B",=JCR/C^6SM7J,_^8#M<0@NG[(]
M<=_ C3CRXVTI>%&_)67Y(M>E4:S:'C U,3+*1)"A7)$-2V*(4)Y $H08HCC@
M/,2<Q-QI-<2BS;F1SK=:E^!CY+FHU9"K]8?4+SOCKSR3:],)EKMSXT+K>YN.
M_ "-N>#M*S1W%H]\=-<!GW$W[BS:G78'SQZ(@ZT\AUO=2*DJ:\UWU7I9Z(](
M3;AJD^_:CL*2I0G.<J[B'894Y,,$S"-"H$ T"&DJB8BM3O*>;V9NU-.W%'2F
M.@8Z%X ]SRWCP>4_J!F"E#6)V %QCC?4$WJ<H7[;YXL+34Q"$79N=JQ@>?7$
MFM>'RII?U\OEAX:K%@*A@$G.($5($8ED <2)EE>,LSS*"0]$&D\B7GW6S+D1
MD;'84>G,4P?:!4,_OUL\$]X("M#'-)[!G]I=T/H[XC30;X?,0XWYO*G_,V25
MK> >31_9KK5A \A[*86N/R8:#4T5NGY5@]17H1$LEH4QT<SM;E?\DWI_E]OK
M1+4(4)8)QBC$-.-0_4(@25$.(R237$J9,BY=AHEKC)G;8-!,B%M!WEI;:,20
M=:JJ%*I_U"R9BI60A:,^\E4=9C<L3-4-GLE_ZP9H]7WU;%I[ EZ[<@.:OM)Y
M",:=WO6ZU[Z(DIU+.G-F^3'P'97+KS)H4L8> [I]7A[EF4./Z4A1EH(??WPK
M?_.FH8D%RD@2,Y3".,XSQ;:)+D#+0AC%C,I<) '-J-L9'OO&9\FNKF=Z'+"V
M(TI?"/I.B&C-/L-[H#4>_-*:?_H4Q8 #0^ZHC7R:R,& B8\:N4-S> YIP#-&
MK9[=B*Z_JFRKMX&+U4;]W=VS:)9!JVVATSS(D PEA1&-$HCR%$.<)BE,HB1+
MLY"P*'$*(\<Q:VZ49PI#R^7ZKZJI4%!T[O2*;CN6I!VI_^S(<OI>\4RC%ZIU
M;QWK5>MNA$T:W\#..2\E;<?%>XI:WZZFS:$.^$ X+6N$#WWZT*)'S1%T-6CH
MPP;M4+'(&(ECGC&895$.$<<YS$G*84)R)EG,%7M'KE6.CC5D]6E/6M;('(P1
MC76NU72.0FG'E%? ,U6]G,9 $SH:D-Y? &E <9QS&(Q<#>=H4Q.7OSGG[F&]
MF[-7NY\3-:EZINK:QY5<ET^&5LPQ]FVIB]>_+5B>8XX1AF%,(XBPH)!$:033
M.*5"YH0IGK ]*NK<^MQ"LR;GM"D,V7/!_IBB._[GF<0[JIX)Y@2@P!C<.P#4
MJEE8'0D: 73[XZ%>P9_HA.BI3BA6H"9TLR0EX-N:.".=#!V,VYG#H>[/G.Q\
MZ&!W^T=$AS]D6)C8QIVK!UUPK9_B5.UEY 5$<!ZJX0%3O6 I> YIG 0P0C10
M0T>.8[=$;-N&YS8\;.T^S(NLKDR,M.X+N\C3!\*>AXH=N-KF5VF2E<<\25>D
M1HU8K1N?-(9UA60_JG6^?QA]J3FV:JA^T7*@.H+6LFS/>CC=C?,Y3<,D2T.8
MII)!%!,.:8A4<)LD.29!EF;2J9KCY2;G1EF=Q6:&MS77C9LL@+9CI7'A\\Q'
MG;$W1LFX?@V@2[SJ3$GV,(U*1A;-3DI#]C#L$Y##G==4%3<;,_JQ>F?&D%J3
M9)PG21"@!$,<"@)1H"LRY4D.$X'3(%(1$W++ICG;VMP(I]UZW%H+.G.'5+$^
MA;#M\MM(N'E?A3L!F8?S:5:8>*A1?:K%GU";^H+SQVM27[IIX!%84CU^6*[_
MT@JRZL?=+L&*M\67^SL&N\*UVQV[A"0ABB,5T3"MCH%"7:Y:=4.4YSP@),RC
M)'0Z(GNE07-C(Z- KK?V>INL:AR7G2_#MURO[CH[#INR0SS3G-EBU;[<@-:;
MWM:J[I6M0[V-UEXI;2^;JV/A.^YYWFN-FO:\[T@0'IP''NNY@^4)=&N*\O6A
MGX*W>[2Z\&\;A02AB+,<<QADH2)?)A-("1<P%T31LLA#BI&C/L'Y%N?&KCN#
MP2N+3<5J9V&""VA;\N68&/HFQ'/P^=$FL,-F;'&""ZU.K4Y@!\(1>0++&P>>
M !0/.K[\*IYUW4Q=1V"[![!=4&MB4;VLM@TC<(A8D/(()A'.=-G+%.(4FYKA
M&4=IFM/0JNK,=6;,C9E:+\#6C5<;7W*]KE?K6CB&? -[R(ZX_./NF<W.0GX#
M=LO[[73W%^W'KUZ"NNNP'/=TW3!3ICT]=Q5<!Z?CKGO:D')=Y=.G-5E](/J4
M1]W5L)6)H+F( Y@I#H0HT%/C@'"(,$D$RA..0NO$EN--S(WTC#Z:-A-T=KH4
M<SH*XGGN&@<:S[QTB,J@6E='X7&I974M3!,EBPR!R[$2U3DDSE::.GKCA)6D
MSAG^NE+4V2M'WN[\+.J%"O6B2&]TDER:LE YS#/UGRPF:1X(%++0JH*Q36-S
MH[U76YRB,W1[2)<P]=ULF@*F7#R7@A4#]B/.HD\("X1 3&&N!Y@LSR")\@0B
M(6DJ:1(D"5_4ZYHL)T9_V^1/07]$A*_<7W;$[6?N+-^ SV>0&V\ON0?)-+O(
MNL%Y[!_W7+?>.>[?,XR_;]>L4''O<J-U'[[HV'B]NJV;(K8FJV]]O(Y@&VJ0
M&&48434N1EK)AW,*\S@*8!IQB;"0:1P[*?E<9\[<QH#;'LFO3:*KFF HKG\4
MJTH+!_RR-)/-1L7!C9>N[#<[YIJN-SQSV^W=VX]@ZPEH70%]7W31WQ-E4$<,
M-<=%=E2*O-*D24ET'/CV:7:DIPY<:&6/@F^68BT_%*NB%I\401Q4M?BPJ?56
MTI.V[;]-O-@>SMD[28!QE&&)$<S3A$*4B!B2-!(PSDB6"RRR+'$36!O1N+F1
M=.<;!WW3P=M'4CZ(]C#T0?V81M5@5Q'><<EVS+ZV7,C]23WH>WFW=4M/J1K'
MH/'L6,6?QKO7O=SI4/A,G/0!_;BKP6,:..T:L0=H#U:.?;0Q;(SXG93_$F8H
M^B;8IC3,LPB(FL[3F,,4A8;K,209I3 A<8HR&:9$")=I_K%&YC:]O]=MN''N
M4>SLN/-:1#QSX,X\L+-O//HZY_VH-'2TH4GIY)RK^[1P]MJ!8HFD7*FPLOHB
M2J/4N-VKC9,8\PRE$*4*.12K< XG4D*.!8O2-,ME[E29Z%1#<PO-.CO!LYHZ
MFW+;@.Q-V=Z1?Q0UT7.[OSGNFY]$VXX4QL#0,S%LX5,V-AJT7O:U+R$QKI;@
MJ<:FU0F\X/*!!N"EZP?J^Q45:_1:!-_*M>QVL3\HNX]>\EG4=_*>_%#FO"N6
MFUIP8]5"9))E0H8PS6($5? 004H(@2%.*$$983QU.B(RLGUSHZ?6-K.E8X[>
MFKDB[WD$UCL1)BL. [\4*["I^.[JT\IXD[P2=F3X$SO:,X?VS=Y):MWLI0N9
MCC]UZ>=FQT^Y:<1>0??:&%='U#WTTP?C2B..;..TZHE^ #X06/34S,C[^[^5
MRIB%"DPC0E"LIIR9'C$$@01A#/,T$ %#-(S"=)0]9M/<W*:ANRW3Y^V6:6^S
M^4';? -J]\GJ!=2OW'=VQO+G[CP;<R?8>WX%RS2[STV3\]A_?N6^]0[TZ[O<
MTR1;]7/R(-X^ZD(%'U>&W#:K6JMD:YG"^_7[[V2Y4;]]($7Y#_6CN)/;/,X_
M5D7]85UN*X%7E:@J;=A"DC1(<XE@0-,8(I(',$<X@C+)4, P%UE ;#,MO5DY
MMY!VYRA@QE,MQ\1;7T&I]9PW6H%41:VB]1=(Y3#0OYA5^'*;:+U13@.Y+L%#
MZS8@6[_M<QS]O2#G670VW>Z;?'<]WCBI0EO0N=G4,S":L_=KT+D*M*_ . ON
M9"^U7ONKR]: SF-P.ZL>MT^,G47/3Y1;.]4W/Y*&F_>N.9/LZZ_MR?*%O</7
M3SGVW]BP6<U7\5VHR9.:OV0R#442PCQG9F4]AX2FN3Z.06*$\T PZC)_Z1X\
MMYF*V3!3WVECG=MD9 M6&B9Q0.((QCEG$*GI':091S!* \X3*G,492[+@X/
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M^FX,R\5UZ2([WO4,O&?&[6/>"6.I>;WV8/M[WX=)4F@'0.DE4];%CI^2$#L
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M,=>3;@)Q$(8PEZD6T$Q9D#J1V2 K9LEO_:^R-?EF>S3PU53B!GSX!_S\L<U
M<%SS&]9MKAD@GCIC:G8<IQ^N2/\8@*.G!! 72WY2"L@ L$XG@0QYV+5$VKQA
MOXOZ<<T_[@*;W;)\)K0NB0P@CB,)D8@SQ9XXAS2- DY#A(/8:LG2O>FY468_
M7:O],!OC0<_Z*[9&'#HE)T)-X'D&":5J^BYR#'.:2<@EB<(DCY(4QXOOHJ3K
MG]LM?1/\=<S)SO"&O^O8-":FOO,.QGO+KQB$; 'S-/)<;/XG#3>VL)P>8ZR?
MX+@I)HK%^U6M'OVVB?2WYPMU_>1-M< DC2F)$0SS*-5G_R3,PX1 DI,\E:&4
MF%D=;+O4T-P&C<96T!K;.\C=F&NY;W()W0L[5"-BYIE]AL)EOZ-AB<418JD$
M^]O#^OM_J$<83ODWTC_"YL=F4^/2PZ?9N;!T<;L]87O]0 4](16Y\#=BI7ZH
MM;I)[QBR_K4):Q=(T"P3",.$,QUHY@DD(160$,$#E L91$Z',BS;G1MA-"=C
M7Q_^)XT@^J-8<BT<4)>;RK'&CFTGV 4V'J#U/LTV%H/69*."U&@A;;7+;Y_T
MH?D1Q>+<0!I7!,ZR[6G%W=P .1!M<[Q]H$"PE$*7%A?->;9[\D/+*#0E@#>*
M$G>'V1:2RUC*B$(ALP2B.$H@EHQ!(K!(TCR*4S=A-ONFG3AK NF#K>6@)C^,
MG(FC3K ]Z'8$Y0=*W['/%L7V**XRNU$'^BKT)U8LBU;NLM7\&%%?V!FO<16'
M[9N?5H/8&98#56+W)PP0>%-/4*_#6U(*LV6\$#B-D)I9P2#3:8943;LP(RG$
M88IYQF)"9&JMR[;W\+G%2ZU]@&D- :8M=)#!V@?NPCSJ2C@\\T>'A+;-;*1>
M@X2#CM<5B$PEOW7PCH#=3[PHU2>Z?-%1]EJ7"%5AXE]%_=BI5.B352L.JLUS
M-Q?E!5F^5$4%- FK5_P&/ E>,!6V,^5 P9KL&:(9>TG*E[[<A?X'13[JYAH\
MEX6ZY)DL5=LJR%=XKLL;\/Q(RB?EQJ;63^P]6QNP+$3S#-F5Z-T9:;P92P#L
M1)^>T^W:OV4ZN:T3QKY2R3IUS<"2CKTJ-'>Z:(WN[-5#\^D$>48Y)UJK%PF(
MHH!!G.<99$&&<"(DXSEW*MAXIK&YL?&KRD]:&41O;W:"9.IE_E**IV+SU$J(
M""G*4GUN6Y]<:,NJ+^S"Q;$0]DSP1\']6%4;DR-S'CKW\HD6F(Q;'/%<@].6
M/K1P_:"PH<T][J'=-_'PU%^1^[B2:S4\Z%;>KDOUEVJXZM(#%Z'$6(:$0I:S
M#"*!<DAXI@) %L8DPCAF-%FLQ(,>XBX'?BY-6WTDN/E(^@;X^U:V)@+"G]2@
MK#,GS=RJ'<?M0R.G+K@<0(X.ZT3;@HW9O17YGN%@AW9GNB=\[<-27SA/%+(V
MJY&:Y1_$2H5XRR:F//HN-Z'?C?J5/:HHMHLD:;-2UHRU5;UF_VJ/B;/^<?(Q
MP\8AF)\)*9T>-UFX.<3)?B@ZZ/YA8>H]^=%DS:JXMWQ1S>C3U)_56_=N_42*
MU4+2D.44QS!,\A B&E&(8Q6XTE00DJ44)=PI4KW0WMR"5;V^UF85]PV^ =ID
M\&=CM&,2SR7([0+2$8'T/"Y<B:%S6&J)S*B1Z:4V)PU.+0'8CT]M;W,C&C.M
M*U\6?WQ;Q%F6QS++8<2B2$U]:0@)5EA*R8(8Y1'%-+#ADMTCYT876BE;UY12
M0[]M?-/#Y_R'/\QKS]_V'Y\_WK]_![[=W]Z__W;])WSHXYDDB_;BYB-M?S'?
MI_DR>X^:Y.,[-+W[OH[\R["Q^A^D+'1F;U?QOLG(T$LGRW6U*7O5R+GD*,E0
M!I4#""*"4ICC)(<,<<I8D/$X"EU&;>N6Y_9!=H:#SG)@3'>N%6\/O=WH[050
MS]_Z"2Q?P,YL\*<7X4EGM$8=V^U;GW24=P9E?[QW?X#[XE2W?JMBBT^J,;TA
MH;Z]W\43%>6"("9SE#.8IVJ"@1@A,->'!Q0:DB0J5$@3:ZF3<PW-C92VB]HZ
M%6*YL]9^0>0LK)<7F,8"RS/A;''2,XB>H>#/QE3+>==%P.Q7C,8";J(5HE,
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M**[^"M37771;'B:#C9%G0!Y*84H2N,J#^NQ^.YZ=2:=ZIN:MQ/[.S>[47%/
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M&*\$;)\WKWW<P(/"C&V>-DM]X.U42*@G))]VRIY!F% 64$A2G4:-4*RBL"2
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M"5W&\O(I66<F<@)I5#:R:WE21G("8Y^5W&X>N@/P[5$LEV\; <A%G$4R#40
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MB@'#'S545UP6*YU#L&J*GNOCA>I=;,_0E+^3FCVJ!E_]NU"O^:I>,!U^\S"
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M-W^TH4F_^'.N[G_O9Z]U7W@VC_NL8HAGH;5M]6*V7@]O%6[W(^DLP)3$G,"
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MB+)8\UM9:W4T7GPO^(8LJZ^B+IJ)AQ%[82A#DH@8)B)7PY:, UU_+(69S+E
M48 C;'54P8-M<QNHMNZ!SC^CD?5:-4N["!H?0>,D,%Z"GIM@YZ>+9H^'WK^<
MD? 3^]3SR/-_87?:9S[\Q&Z=*#?"6_>.E$GAJ0?.Y%J,W>)DV1B>H.KG:_AJ
M8N ^6%'IT^C%:B/X79-!LE[MSK5K#=2CE[PQDL/-A5H0F D9R2Q%$#&20903
M!FDFD!8D)9QBG,K<:4XZDEUS&]C;5#4C*<Q[]H-UY\!6S;DF/YPE2$?J3,M=
MM>F[R/>&6[]'MO;>O-83:3KOU*5MY[5WC"H%/3+>XV[6C63;M/MXXP)ZL,4W
M\N.'$?R'8E74XE/Q77 U5U1O>Z%FA<UI#S5'7,1Q+G$L,\A9PM6D3*<VQ)Q!
MKGZ*<YKS.$]<BD*?;\Z)CJ<J$.W&L1?PM*/.\5#RS(B-H=!8"G:F;D]K*6O'
M(S@[5$;EK0M-3DI'=N[OLXSE7>[+/SI#8:NL<[OB^O==P1:=DE5I]J!I',8P
M2;5&#F$AQ#DA,."8QP$-I+I^L1(/I*EJ;[.R8]&LU?>!F^_CH'&?Z3KM<4:Y
MU2/2B;)<9_&4NYI%.BW7H5"?33=<7EL9"]4)$Y]VJDZW6DQ9_U6O\M/;\5&T
M7](8&<V)EBFN1M5IT<$!HS,+"39/F6QQP,&E_H3?Y;9A,=YOZS7_JU@N%WF>
MAUF42QAF20I1("BD2<A@1"(AJ>148"?!SN[!<YM&=W:YA6Y;F*)$)"R+,AAR
M1""*8P%I'B,H$Q3D(D@CDJ2+9[/X\JTF9>T/K/U&_$'V1CP4JY7^\"E9:DFJ
M@=C1F&1)'""8ICA4V'$!\T17GI'J9Q9)$F#>8O=^Q7TCUS7A#S?5PO6@V<T*
MAL#@>22^^*$Y!_G[3HX:SF\?/FG@ON_2?HA^\._#6/[W8K4NB_IEJ_3+:,I1
MFJMI>QPD$.59!JG,(AA*S'(4REQRIS77_0;FQOI[NKQ%:V8%5NL:5!OZ3\%J
M?=#M>5/O:N$Y+J$>@&SWZ5X#G>=/V)1K?UPOU8M6_:^VHNHQ 62_DL>G !KU
M\S]H9%(:..7B/AV<O&[@F5R3^6'DY-L50WUP0!^46NF:T&92\6%=BN)A]>J*
M=X6Z4>>2%$0%C@1S(H3680HSB$0F(4ZB%"9A)#D)0H;MQ!G&-&IN]/-!Q>QZ
M;U=/Z@WWK(P;ZF]J\@.4^@P.X?_<5$/$7D;I1#NJFKIK/-/;UIW>GDMS(.JU
M2S>@=>K@NKYCVRIS(YYS'1'O<8^TCF'8M*=71X3RX*#JF,]V7VW])E;%NOR\
MKD7U07T;7]:*8;X5/^[_6G]0-K4OY;N-N/]+_?ER_UB4]4LG]BXIYD)P&,M(
MQ8*(,DB9KF'-]-FN/$FCU.H@R75FS(VM&T^ <06@OZ51\O\ OA$@"N+ ?MWP
MBFZYO"@[#=B^P\L^SMH-8/P RA&@/ ':E6WI3N4,:+P!C3L#9-:OZ!+[%=YI
MNF:BA=_KNFBD)+3K$3VS3'S%PR=;/;X>@/ZB\@A/&WB8D3T*OEF*.]DM:^SD
ML&@0HB0,8ABAF$$4!@1BG##]'UTW(\F0<%)Y/-/6W(:;-NU>30S 6U*6+WH6
M_0^R5!_36H+.>D!?5%3ZO"Z;>?<W\3!@JG"N ^QF "/!ZGM@::U\!6!SO,:/
M#+4%+.,>DCS3WK1')2\[?G!@TN*68?QRNYM"WZ^[\%N\*K9TOS8ILGJ%CPO^
MYN6/2N<^W'7Z9[<ZC"_J0E2WM*I+PNJ%R&@>8QQ#'/$0(II32**,P"#*4L(S
M0DGJM"_FP\BY,5K/1[U"N/42'%18T__<I+>WWFJ>^T4[K.CP5[#U&>R<!G]V
M;CL>E/3R>MC1YL_N=,]\^]/[VYFP?7;(J$SOQ=!)APB?4.^/+5[;&D7!XUX]
MQ:C#X"06E >!KH@:0Z3"6S7"4 2Y#!@G- AXZ%2DY40[<QL:#K0JM*%.(CN7
M@+4,9*^'RW<0.P2I:X4]]G'P*>VQ;>MGBGOL.WQ!WN/@\FMGPD?K0W]<;0M(
MW<DV_XLLOZRKPBPEDZ(T\\/=Y"W)!4N$P#"F-(<HCK3*8*Y^RJ(\S8B*5%.K
MHIV>[)L;"1TO$3]T+CU.%[K.OR?OF GG[,?[1R^0[ K7J<NV#H+.PQN@?6Q7
M3Z:9\(_:#YX6"<:Q\2<M+(P*\.G%B'&;N:[FU7:7L%5B?R-60A;U@J0ADS@A
M,&::W&.M^Y:R#"8IRV,6ARA+PR'%KTZT-S_:;D])M.4#AAQSO8"P'0N/B)MG
M5MU"ULM<Z(I=_-*:^^OX);,N ..E=M:I-G]*$:T+ )RJIG7IMH'1YF[#9Q$&
M61;K&EJ!S%.(!(DA3A(,*>%1@FF<XU@X18J[9\^-+OI[EXZQ70\PF8D<XS#6
M.U$<HD"Q+PFD@"E'84Q#RA@7=E7=KX1LFI+N/=# EU(1;?&LXJL+ OX70;0,
M;H<!,V&6PH@!Y*&OXP9_O>=/&[@=.G80=!VY9!BS?33B_SH\^_MZJ0];5)^*
ME?BH(K9JD0L<IVIB#'F:2O7A9AG$C*0PC=6$.,RS0$1..\IGVIH;\^U,!9VM
MX$]M+3#F.BZTG0/9[L,>"3K/'_I@U)P_?@L\1B6#<^U-2@X6CN^3A<TM[CF3
MMYP7309V6]KF?GW_*-YL7D3YM2E[9/Y"3_F6MP^E:*: *_577]JR16IP9&(1
M1A'*@U07FV()1#C6X10.H.1)*A.]^)9:A5,CVC0W,MJYM2TC=+\&RFI@7 .M
M;]U?&O? UC]PMS)_W;D(C(_V*7]C=?1YHOM)W>=]6_?_AIZSS]S\"3TX41KG
MI#WIE-LY,N9G$CW':FFRK,^1H>FG@([]Z('K$OIXX5?QO'WD^J$D3[>;^G%=
MZCI=S:PS7#"41Y2D&0Q)ED(4113F<1# 6 V\2%(J@\@I!<NRW;D-I,9LL+,;
MM(;?@)WIPV;JEOU@.8L?'UW?,_P1@'5? '"#:=S% <NVIUTX< /D8%'!\7;W
M.4,CKEKP#^ORR[K4]/FE%-^+]:9:OGP54M<\Y>UID2!@:4I3Q5.((HAH+"'%
M/(08"Y)BDF!*$]MI@7VS<R.L5K>XX/K\)&B-!SOK06>^?5#HT >7(W8_R'HF
M*VM0!YR/<D#7/JKV@_)$@?-KM!L.J8:A[106NX-V)O)U>-ADP:V[@_WX=<#=
M/ZD2TZZFQC9EG!*>)S02,-3G;1$))<1$!) 300,DXXPQJ\'!HXVS&TG&K+_S
MNNC.P,,$/EX,N_CZ)W>W[^'M9_;T]!663O?%O&HK';'S?U95I=- CUY/Z4Q3
MUV8+WY>F(NN+F>R\>7F[),J\;0II%@@F<Y3"5(84(I1(F&.$( XP1P'B&1%N
MN1UV[<YML#"%XBM0;N>"%:@V3T^ZR(HY/#LTS_<\^):+(^-#ZIN0M6$ZV[8S
M&#3+)=-DUUJAY"EK]GS;/RD;U@J0TUFN=K?[4Q.[K5LI+)U7NU%OP<NKBQ<Q
M%Y1%.(!)P'*(PC2#.$0,Q@'A62(P30D96TSL@DUSH[=.2VR7!&L$Q,87#;O4
M5W:,-W$/>&9#>\DP4H.NI[9>[=_TDR3#+.&>7#'LDEVS$PRS!'*(7ICMHP=2
M-2FUGG.E7C\3+7U1 2][V04S><ABQ,,$1@E&$*6"0"QXICHW99)320/F%$E>
M:&]N%-N9"YY%"2IML".[7H#7DCG' \TW*W9X*5.!L54QF[$6_-G^Z25.M$1H
M7"*[T.:T)&4'P $!6=XVL&Q4=RSJ=Q-KFMR!:ON7?R\4JZEYV<N[]1,I5HLX
MHBGEH822)HF:M#("\SS#D"1)3F+.PRRPDB <U/K<B*=W>G%KJ6.-*2?P[8C(
M&Z2>:>D8FD:"]_/M/\"?C;DCLM$@F,8M2>5DP;05JH: <U"P:M!#W'?Z?Q>\
M8)H7F^0H'7"]K_3:45$]:LV0)B83=^57\;!9=OJN.CNJV8RZD[T[*[U1]>9%
M_>MOZ^^B7.F_US5:RP5.&(IDJJ(L(AA$><YA+ED, YS(-)41X]A*A'\ZD^?&
MEYW7VZQ&,Q7K.0[>O+33+P'N=)YCY[S9SS5)C>T.^IU\]9"JV?5]\V(NVL%@
MZC"7]EOJ$[U*EY,=YO>">&;____=:-\-^U2-^;TC$Z5YS.Y=<4H6F;;;SB2:
M3&3(9$DJTP+;3W"9N.5A$[U7NFH+27# LS2')$YU32^>PCS&.90\0%D<$B;U
MFI%].>!73W<*/":H_JL3"MH%>+)7#^<=^4=1$[W4>UK^V@+.()<D"S&!(HA4
M<$A#!2<E#"898BG)6!:+W&5>/!S.*<HS*3A_61J!2+^HVDUX!V/E.:0YE-/<
M+\;4I"2,-Z<]BL2H<];7+4PZ)SWJW/Z<\_A%PPASJS+Y2<U?Q=?BX;&^DW]4
M3<WE19X'+,Q( !53*@*-0@8ICO6!%\0%9S054>;RQ9]M;6X,L%-^76IK0:G-
MA6L)-^H78FI2NWWWY[&VXX'1$/3,"SOPC*$WX&N'GC*V*;@^'B58@3(J19QO
M<5+*L')^GT+L;KI.,NR>_&@JM^\:4WQEZ@G(=?D7*7FUH'&0,HHDQ(*%*D*+
M$*0932#+4I3D-$]0SH;(AUFT/3>ZT2/I>D<YRES ^O8.4Q6SZ00[YO$$K6<>
MVJJ-Z02'QNZ;GJ:W-AV\M8)YL/*8 V!>5,ALVO\IBF0.P)Q2)W-YQ,"\A*?G
MY?I%B/80\J>"T&)IU+C?;DH=V2ZR!!.9100& 59!4HA32+!,H)H-)7'$F$@2
MI[/ %UN<&W/=,E9NU">F0E(M$=<L0NE-+=IHQ;E6C[R(N&6RPI@X^DY7:&V%
M92M[T+/V!K3VCIBE8 O-N'D*%UN=-E/!%H2#7 7K&P=43MP\/R\+K7E ]3+9
M[8K?U8^B_+Q>W9>$ZXPL47S74^NJ.]=+4!9'60Y#SO2B#*$0RY3 )$DE2BA#
M$EN)]@]I?&Y$U-D/RL8!0T*K]0K6VGSUMUO['0KTN7;(Y7TOGS![YJDMPJWM
M0!D/C/6ZZ#8P]H.> T,J(KH"[E 'T2/P4U4_'+T#W.H>#D3P7+5#UT=.5^-P
MH+.O*AL.?<90]4F]+KA5"/^D.U.G[NHJ)"%)2(82!/.49GKY/H$X0 (&)$I%
M&,HT3*UR.RS:FMO T*Y0[Z3Z.V,'E7DY![)=:#H2=)[)?C!J ]0G+^(QLOKD
MZ?8F5I^\Z/BA^N3E6P9FR1:KHA:?BN]:];M6;T*A>*F97JLIWN9I8\+=VR>]
MG_O?S6@;4DKR(! PDU*GRN89Q"*)818R%H1!$G$1+5;BP<3)=IF=SD98?3&X
M^6+ZIOC[<,P1<;*S%I">N8[)L^Y]8D=!GG">*(W6& ^-]6!G_G:!K^<!N+7!
MWCVS=C!\XZ;7NILQ;8[M8)@.$FV'/\F-#:NR7GS5Q^7;Z07"881SG, \B5)%
M<3B#A&8(1H)'6 I.,[LC['O/G5N(I >4HJH+1I:@E\M\.2G]+'CGN>@*2'S/
M<X>B84TD)WP_QP[JEAXSJ-_V66'_F9-\ZB<<Z;[?4_\\8&FL*3#^57P7JXV@
M+[^3?ZY+DS2VJXQ,4QQDJ8 AUM6(>"IAG@=437%8*%*6,)I8IZ]?;FYVGW!C
M,6A-UG5LC=%-8J>SKI EYA;K7:,BZ?O+_RD@.JQAC0KF5*M65X/JMDIEC=&Y
M=:G+#YEN)<K:H5=K3_9W7:L"]#NI-Z79 KF3G]:KAWM1/KT3M#:*++M3QI*G
M(L!<Z.!)Z%@J@3C+*(PIBG2Q)Q2$3OEDK@;,CK%;^SG8V:^%;;0'4!GP!+0/
M0]6!+#O%;K[H$VK?E-ZKXWD.YXD$A-SP\Z0D9&G$3Y(4<H/HM+:0XW.&L:!)
MH7M<+_G'I^=R_;TY OI;J7.[<\I52(IR2+-4S1U)@B#5^2$))R(/8AQBZ50=
M\W13<V.VK:6@Z)GJQF1G@+7CK''@\LQ..Z3Z5MX 8^=X_',9BU&9YDQSDW+*
M9;?WV</B#L>YJR@6[U=U41N]G/)Y79IHVZS@O]7JS>7+VS47BQR'C&EV2+%
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M;X14T\1[\F/!2<X#&JAO.$:Z8%1$8!ZJKSEB+*9QG$F14]LM?.?6Y_:Q:P>
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M5!B)2D4AYC&&,0UX0-.(X]1I0^@Z<Z;&!8TW,]#X SH.-:(>8.<2J'T".Z?
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M_J#5X3X!8ZHIVL6_FWV\J@[C\F>A&_Z>/V]5;V>@D(Z):R=AC_5K&\@PAK'
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M1$$1FFPX3&*( T&A2I4B-&5(<2?2N\*6J='?PW>YDM18Z$:"UW2''1V.!/+
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MUSIQ:]_KB@6TWX[Z3SY?!SO2O54G#TS+M^I6=\6J ?#WJW/ET\!QU;$&@/9
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M]DJ3U"3CT "BV&QMQR*$%$<1C$F41D2EJ>.$]TQ;4Z.9VL@^>N7'H;1C#T\
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M?+<IUYJ0C41]2J@*4 (SE,808:X@C6FF_R$11DJ'E,HZ$>9R<U.CN=IBH_?
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M+D,W:DFK/:$[^6VS9O_UV'3O;'I_;D_U:"(3F>8"LB"4.D(OAB1)N68S1&G
M8AG8%40R&75N]+456B\A^V+_][9K[NA#5C,C&*X674/K>R7H E7[%9X-2FY7
M;T8C3[LRLP'C:-5E=?,XDFH>]JO8/*[YKK=HM:O?0U$04KT9GT81ABB-!<S#
M,(>Y8 &BC$4\L:J7=&G N5%3^Z4T H.>Q'8\=!%G,PIRB9YG]CD+G-=N :8
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MBI$Q''=N%*=>S=AM/[L.8#,2\P";9^ZRZ%ZG!)^N>]T!4I,VK>O&GE6ON@-
M;%O4'=X^FH[.,=^[UU_)_UJ7[Y>DJNH]U9@&$94Q@1GA%")&,I@C%$")!)8Y
MSE,DK5(F+<:>&RTUHL//9YP#^@IJ^4&M@#5_&5O$F,-\X.R?Q\PA=KX5/@(S
MUXQF//[4K&8+S EFLW[$%<GA>_4M/JU:=^[+NJS#K#>;LJ O&QV)>;_6FVWK
MU4;AL:Q#%)I0VP7*4Y)$2019FBI?+$(II"C1D0:"9A*GC(:*^-8;LC0C/C=B
M67'B5CA_'^R]'@.(6I\1^<;7FXEE5!(AB9J5< 1U(A3$,4J@9$F8)8AQFD6+
MYR8_<T/*S5R-=2BB/Y.]$P_%2E=+!I0LM;?Q)G;+$TQCQM5'A>,$(I[G,(\5
M*]*(<)$& 4WSM+7;A]6%V-"WMEHGH#^;J1'>VF!F;L?T)O#LD9RJ=74#MDJ!
M5BO05TLONO85VV9P."X"X QI]S4!KA=M^A(!SN \63' W=/M"PC<JA4DUZO(
MCTORL AE(#,J,$1)2B 2,5,TG$80AWD449Y(&9N%31X^>6Y+MJUP0$MG7BU@
M'ZYAZKL*!,_L9:B_56F D[J.+@JP_[3)R@&<5*)?".#T!=>?O']J#X_OY.?U
MZD'W.M"-OA<THB)GNIA'JD,%,TJ@CFR&6<813N,X$T$Z]NC]])!S^U3?K<MR
M_:=]JQH#<.V/U*^';-(S]4Y<G2OZ>1O\I$7V<ZP^#(^W<_4SP[[9P?HP#$,G
MZQ?NO+)(<.-AZ,3R]4IO'-?;ABQ&0I (0QEE.41IGL \S%*884&P2&+*[(*1
M!T>;&[FT!21W0HZ*0QX&V'2!Y @VSP1CC=CXXKY#2/@IZGMRQ+<IYCND_-DB
MOH,WC3P3ZE*W=$O5Y;IZ42_3MJ:UR 5.>,)@P)@N)\YBF*<9@VF01B(2 <&<
M6QT"#0PV-^KH)2?VI!U=1'P09\.C'4?H^3[+&0V<_<&- 2)N3VJ&!ISV:,9
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MZV*IE7=7-'.[O[Q(4(ZI<OE@R%(!49AC2/,DA$@@&?$TH)QFBY7.+U6RFKF
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M)NDL#)ADRGP1H1 CJIS^),:0RB"%H61I$@4T""*K<\*W,]XD+:1)T=7L64O
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M2N'MYD3]&NPV*V;R*I@Y#7,PL&<OHM=VIJ?C39,UV'8)_GKTK=^>^M8;=6_
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MF-O<^?NJ5/(^K.K%[8;\ %2LA"Q\U"<[LH>9@^\;9<^SG7DU,OT/.RU>WZ@
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M*2=Y)&D.$QX*B((H@92@$.81EDBPG(G4*G_]S#ASHYM^E<).T+8FH6V%V3/
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MD4J'>U#Q4*SJ$WMUE3X$>Q7$LDW;=09/LU@D3/?!8YA")&D :1 B&"9!PL)
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M:Q.)"S00R='CM(9FH@,XT.AU,E&G0/8)HH9.R1P.87NIHT5DK4VR#-%&D(8
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M[_B]-]=:8L%T\[*T":7%+@W$)>-)9BJ6?N%EK-8PD<I+[6.UK'8KX<JN:FL
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M).B;%(<Z6#3!^(53:U765D57ISO.MA0.>^R^'T;N^H]5M/*CF!?_4 _M]3'
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M/<..Z]L?/CU*NP',_ /\9'G^&F5W\VACO5^?S"[GN!I6I>T"LDTZ$YU+EW[
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M:=P;2HU0-; J.@#5JJ3D'<79N[E!RT3$I$%Z7X=?90-!> ,F&^5*<I(\TR;
M>IZN<2^T-P;7@"KI &!/PYIWMT>\"85V10A(L=[$DCJ!,TY#;:6;&+-6Z=:I
MX"=$];(;M@@"S]- !V#Z-[S*'^>_AF7-K=S+L4QX\-8:YD&FVH>.;"RX7+O+
M6\.=#\27;M/2<A]%O3CG9ZI\WD#^'>#H<8[NYV^_32=*^"B9J]VV5@.YK818
M"T5J*T.9G?.ZL"88VD5-;V9H&/R<+?<.L+/K#&D2?*"84W@0F@((VH<C.(84
M610M3.$R*=<&.[NHZ<7U'A8[9\N]@ZX ^^SG=C"[XB7K0/(QMOIVNA9SHS:
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M1QC96>=PS#L[@,8I2IU?0,*OI3J&Z%=!:@9&95D'A]DZ-(HVWLB)*:F=%>X
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M^%@AX^Y](\)@&*7-SY)@!X[FTYR6,AZM,A&8J]U,//$?=320"/Z662X$:YM
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M=\J;-@-E]I+46[W2.>@91NY]'@ZM8OAWTQ"G5]/E]*21,4\>,<"AS_-D#73
M\_@ENW+ST1K$"AN=/:B@&820$)*QB14A%$FBR<)ZF;9SK<G^-]Q-B> B.R]<
MK7WR%=\N@^.1 5J-,CK:Q7F;3HH'$#?N_C0P=AZ;G*&5\SJ,S\E3J_8\J($A
M:CC%Z@!(R:2-SQ1'%8VU2HQ+"%)X\-%S&:4+O+0Y9+Z\.5H)^MYH-HR:MF\#
MF +MKPX1HJ;84%AGDX_.Y]CFPL?S='5OA(Y!S$M&Z R5O [[<WHQS+XG-;!
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MM[%DR0%-P=H82=4.2Q2*!I]5D<SK<)F\[#&(:G:/YA*(.E,)IV-IO@Q7K1(
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MU?S/.H:*Y,V##;6GJC$"E) !HN*2Y.UE$HXY=&V*M@9FY"!$N[\CHEMI^Y6
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M9I_PE]EF]42&FH(- 3D7VO!MY2\7VO]]$D$:^D%HLS$>2VD7":5A<-=421V
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MH66S?HS+Q5HRC474SJ)2TYY:)[R4)'5Q&$PT;1(ANZ@9UTD]5\// N8$<7<
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MO5/T[,9I:\<M1<MD]1):4$G1(0))VRM3?&9%"M4FS_8T3=-FU,:1^0 @'2"
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M<?G=%V1V9?H\E5IU6]]9N(>ZF1:\$G5I#$/'54$NVGB2WY$R+5R.%N[38#F
MTQ,_O+Y=I.V+<;C8/-DM+^LYKALRC,Y<D$"+2(S"RQ AF.KD18E9LU#'_0]X
M3GWN.[J!PB&B6S;@X\1XV+[;SO.;Y>7N#+]?XA_SY=7JXAMYUE?58[PNT U)
M.<\+6501ZN[1.M.O:@^7S%H,RFD[ !W#OW':,JGQL-*(QQ/7P/]*<<>V4N:G
M.M6O6M7(LK%:!= 4@H+*T4)D2D%2AA4?8M+>#+EQ!A7"?__]T^)E/*]D!.YV
MA8T[/?-29JD*>?;(BJNM H1O'1&,S]RS[)1SX[5*/$7%=$TSQTKU28 <R.*)
M+Y]_?'BUII\N\!L9Q)ORHI\OKSZ]7?R!J^L#[FRC==$''1!L9J1*0C*Z4',B
M&VP+-]9$YW[T3K/WE_8"E4/ENSP%LSN(?AX:W]NTC)-,"%T0, 8%J@0.SM5]
M5\DR+856++9Y3GZ2I&EK:\</GL?A?0<@NE6Y#[A>7VS<^U=?EE>[BDC,'Y?;
MN2WA<OUMEA,SHAINH6OWNA86?*@M[%8R-)$Q9=JD]_<BLZ^7F@.A\3!-T4Q.
M?68N?ELN4BVU65[0/R5K35]&]GKUX2K^!R:RZ;]?K7^_7/XQK\.$5F$W?O0.
MUP](:!S]E2/D.<8]]DCICU<I5: 10;\O+^:;#,SUJ[4+/HK()1A'89MRW(&K
MTRT\!6\2G2],#6K_W]L@/$W3L1;Q#C<?&UQKI;..9P%HG:UK(AAX=+7I7YC@
MI:ZG;IW=Z6[<\$@(>6CT1A3%R[1R(Z=TFY+3@77L/'$L1&2\3I<BIZ .UPNU
M$!\%B"RY5MR&G-NT6IPD<;QY%1SR15OO/#"I.(L<DD $A8*",6,44%0FM>4\
ME=N%[\^]O [^QG-*%N^#E'NOLFWXWT$<\YVJUW<F;Y5C7'A(=8F&4CF "T("
M)_<W<<$C\VU*/!^C9KI-;:VD_H.8>&\1= BCZRR(T)DI6X#YG.JBS (N6@[&
M.JV$QR1LFW[[Q^GI*\#=7\X_ ,X!3)\ZHWCG;6FY<4'R[::YG\)7\F(N=H^,
MH?"8@XW =,Z@3+80,LN .2L>.7/J(91^=*_]X!O[ LLALGW\ AN3T3T,U-NH
M4<XV.?0!4JJ[GS2WX&O)ALLR>Q=EC':\;.)^DQ:;K'IL?#4=SMP>$'$](XY,
MIS#60RZ*PMRD$P2M)205O)%)"1M&QL34>: #1?;$B,5]^#?UC+U[PP$UT\SY
M;#8%YZ"LI=^%)*#$4H)5.05\T2,6]Q+<DR,6]^'BU.*_-QQ0<"_1*$=!7JZ[
M0YF X.B/(@O4BDR?'U/\_8U8/%C\!W.Q@P#DU^7B4UU'_/O59?J\V0AY?4&^
M_K8;2OWM7:GYI.N_D;>S:(TQCF,A/ODZ*M %.F9=0AD+\]Z@XXV&+!U(\'3K
M@$\4#9]"D%WC]8E#[@( 9E%)C )LX76).^EU9"A!6,V5-YX8W*91Y$""IXVB
M3@*FP0 >3[(3A^V_?%V2YN\N"A-23%PC,%LW)R5)=!>7@.>((G(DVH?,@KG[
MF;V"9D0!+D?@9C^/-T]?"+_>]KQS[2P=" S7I$FZ9'#"UT6F&5F)J&,<LO=B
MOV^=;C%ZX^NRL0 FAA:1OUI>;$9I5$U\5_Z_Y7RQ_B>==--@K)2)IMKC(((@
M\RSJK%J30"=KC(R,.0P#H/3\MW2>=SA0KLLF3)X8+D];[%_^^CJ_W*:KZ]2K
M%!5CJB@(2F:ZS6,!;XJ%Y.O6B92(5WX <(9^7^?O@\=#J GCNP73;NYP^(3O
MRO^Y"L33];?W^)]7<R)P%J3-1EI!US6K&RGJ2@)6NWZ2*5Z'J)T9DG<_[-L[
MCPI; FTTH700%%Z?[G:P\,]7^';Q&_ZU_O@G7OR!?R?^?E[-4G;9>>M N*Q!
M,4<'C)R!)U\A!YM#JQ6< PGLW.LZ#HXMA=4O!C]@6B[ROV.XG%F;BM5.0\R!
MW%6EZ$#!<O"H.<4NF+4<E%<9"WVWI$TSMK8/W!THH'X1]_'S_')[GNRQ!"4B
MB$0L4W5!<W2F %=1V^2#+?FD@+NA;)J!LWW@[3#Q] NW-\NKR_7GS8&\CK4S
MKH[%HE]4=@BN=H$X&S"A#Y%9>TJ\W9(VS=C8/@!WH( Z0-R#6IY9$ID+IST8
M5NJJ[AS >_(-."^%)9XD&];8?&Q5W#3C6T^,IF.8/W$D^JZ4U^$B+!)^^(RX
M?C-?T.^)47=&T*YFS$G#'=>@DQ1T'B2M(*9 9(5[)K-P#R<'/QIW#OFN:2:K
MGC#*')WA?7;/?%@OT[]BS5RD.X.-[],\J._EB0\:H6-E"(DC]9K< NA=N3OH
M^3U>A'6=_5P[9>K:DWAG[<EMGU8VWNC@)6CAR9YX+L%%I2"KXETPW)A&SL)Q
M=!^]-:@*Z//R@G1^]<M_7LW7WWY;KO&Q;K,B'?.*[NF2ZQM,U9? ?!U?4:S#
M)*+E;2HL!I,X\8; T^'ONX4_3838I]&K+XCT!5_>+NISX?P/O,OKL,@;%M_C
MQ28Y=T@[X,%?-8+A'.>8?9A6Z44=BL:A.%-K+U@&^@X$$[324EK+=:.=H].:
MUIM=MT\LY$HDUVO!W:IH%BII;A@$PR@H4M&!0XK*C7><)\<P^S8C' ^C]ZR-
M[C[(_,[HMA=O!S'OCTZY^:^K5U?KS\O+^7]A_@>9F\O-??1N,VMHL]CY];=?
M_L++-%_A[Y?SA)LBUUN.2,XE+^3@.^U*W:^1("3Z8[+!Y>"9$:)-&-W^;!,O
M?>U7.4X,FTX5Z>[NQ3N'7]4E(%N4K%977[;_[8$9T<@-IJ1!&.DI-$Z.3B\9
M,$?!:Y0)$=ND#L<]Q\0[9_M2D!/!X:7X]1^NOGP)E]^6Y0-]]]5J63:,6]V:
MDN^LSL:JT&>]^G2)VU>@PV>%3$OO)!%&,X;W$:8DDX0S&"'K7->0*X3@BB+/
M+*7@BV:)M1FVWWF8<N?1]*G%P=OZ5\.#MO5)WKG"07G%P64MP1;+4F8R1=TF
MOSO:$<XZF-D'OWL',TU T(%;MJ7\>D6 -U;I@G2#(K?TBY'@BLD$.>*F]T%B
M:+.ZYAX9TZ)P(B@LQY)+!Z ZG'&WQU[D>GG^%KY<SP#V5A>-.0 WK,YSB*DN
MK&:0#/>11UZB<FVL:X/33#RN[W!P/;2;4TNZ![17U^_55_KZ--_>5_-/G^FF
M>O7^P^THDL"DS5#G$M+-I&L-FRR ,66*D^AVBFW&!_V0M(E-[>3H>2R1-)HH
M)RZ[V!SF'XOY>D=ZR8&)E"+8RAW%4X:8E8"<0H[,*\\?[J5[M,+BP<=.^\37
M#8*.97@/=NQ'O'R*E;_>%JQ8*P33%G@VBDY<5W(RETA/,GH;!'D_C9ZRCZ9]
M8AQWX72>& 'GC/G=T^2[J_5J'19YOOCT?GEQ\69Y67\X"SPK'VT!X2)IOHZD
M^5@L".5D(/9$:=L\I;0Y3^=>PLBH'$LIQH/(RU*4WZZV@WF$ML5PK&OCB0&%
M)7 B"1),4B:XZ(D[O>O(]BAGJAXCXK.=RAP EH.UY2M>SI?YPSI<KKO0F;_1
M7UROWBY^W]#UM\OEBBR98=9S%R [[VK6%\'+XJ"@K.YD$=%/] JR_V$Z#QW.
M3V^.!4P/]TR-H=ZN5E>8?[ZZK LEMDJYJ9>XFQ2^+HW(LVR3R,QI2%I12"[H
MA(%, F F#UBG8+ENLY1H?UJG3??WB/BVXMX?T'X+Z 5^JBFG+JX!XG/!^6:8
MR;5JSV(V$5U$8 )9'6ZLP)6,8&T*LH0ZXKBS0/OIPTS39=^S4DP,F!>A-=_[
MD-$*+ETB&?@Z B^3X7!6.=!2652^L,+Z=)T."SA&GP_P@C7F.+ <&7#\LNA#
M8W97;'U%W#&!?$0646?P$1,9#:T@6*8 C5!2<IZ3;>19C7V4,PTU^GC!.@X8
M/005H\95_X8U*8CYU1]X&3[AYH=U.-B;,+^LI:HXLSSH@DI!28Q<5!<CQ"02
M 5T$E:2WCK4IHSGQ0<\TG.E#JUJ"ZF"=HV^/RTZT[LZE_( []]LBR(<H.Q]"
M6Q=(B@Q0NKH7+3/P=> _7=9!NFPQN>[S+@//>J914Q^ZUQA:+^#*&\BAF4E>
M&HX9B#D2%),2G/<&-'.92R6#P4;=FJ<YX(O)[33!^31JN1?HSB<;]&1AQQ"'
MX3Z#$DJ9G4$(GFE0Q7CPA0QL42X4PX1-:B('=+Q#GFE(UZEF3@2^<[@I?\2:
MZ],/XTYP,B>,!4P=0Z(LI]#9.P8B&6^\=,HW6M1SVG.>:6AXIMK9#H(O04$?
MR8<\RQ]F?$%' B1+Q<B .0&!LP)).1VT2S*X-FNC3WW2,XTASU1)6\+P'-1T
M).=?8ZE)& E:U?5$W@7P43-(13"G,!4OVTQ3ZBGB/(?D7A=*.0'H7EXZ\/E@
M/,MD+.<0C;&@9.'@XF:JDY4>F3;:-9K$<IH#GJD^]O'0V@)$4[?5'<F2!WQX
MC[7GK&ZO7RXV<PRNPD7=$',[UB XQ[RTI %UR@Y' :ZP"#9ZSUB1,?$':X ?
M;]L[+=G3K!286&MZAT<O7F+\,7OBWA?V4YP2LR@-"FTM^&19=3 DA.P99%<B
M4\Q&$QMF!4][V.FV_74-_,>NM8Y1^ (4]>F;_RD6\9FTML3"- 19>Q5BK&5%
M,5(DD#3%PM85W_!M]+2'G6ZGXG\G16V-PEX4]1!Q;H?:O5V0F*XV[U>;%2,?
M/X?%CGF_+1=_X(I8=K=,5PLG8C9(GKHGORB0<^1\R*"U2SPP[52CI2^G/><T
M&XK./>IK#ZG_'@JW*[-5+'G!B@<L7M8=!1)<(N6(15D3"F?%R7/5M;-NG3X!
MSD^OD@> [GR*:PYFS_W"AYD1W'$,!J3+ E2)Y,SH(,&H0O\319"ILWJW/4]X
MIF4U+TDCCX#<N;Z-TE'+\O++9F79]12MU:N<YQN&W+#")I%45@YL$1H4:JP;
ML27H@C$&$:4M3=]"AY%YIK4OIU.AWJ#RHIW*?VY$=L,7SY6R45!,B\&"$C*
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MY9]XN1/DE_EZYNC,&GF$&&T"Q:6"6-_"C'#>>IM*"J><X#'.J7H<$3"]NO4
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MP[_6M0LQ_]]'WDR;CWX5ZSZRM)XE*YFKO8LI,1*I5:SNB*W/'#ID;X(HILT
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M;+E/SL1)V_'$_7B*Y0C>=P"@5SEO^DS#Q>]AGM\N?@I?R?>[V"4BE6=*:Z_
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M-H#6)Z,Q(7#STLS IEP:@)J,85.0X&DV0JFL2*J#R(/OGAO*H!O7X X33D-
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M9MN,K\V1DT\^9&,IN%QR)T@DX,M<):6CYIS(;&*=#)7:*VO82O1!ZJ,.<@N
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M<QQQG-B!V-V^L/FV+ZR[TQ>VYHG8D-?7/!([F!VUS\2D0.TI&=INSM%VZY#
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M[U;I?_^O_P]02P$"% ,4    " #O@$M4_KF7!-4<  "=$P4 $P
M    @ $     9'9A+3$R,S$R,65X,C$Q+FAT;5!+ 0(4 Q0    ( .^ 2U30
ML^UD1P,  )\)   3              "  08=  !D=F$M,3(S,3(Q97@R,S$N
M:'1M4$L! A0#%     @ [X!+5)T#G7'U!P  @20  !<              ( !
M?B   &1V82TQ,C,Q,C%E>#,Q,3$P>&LN:'1M4$L! A0#%     @ [X!+5"JN
MN)#1!P  Y2(  !<              ( !J"@  &1V82TQ,C,Q,C%E>#,Q,C$P
M>&LN:'1M4$L! A0#%     @ [X!+5"$%'"-5!0  3!8  !<
M ( !KC   &1V82TQ,C,Q,C%E>#,R,3$P>&LN:'1M4$L! A0#%     @ [X!+
M5(>ORK4[!0  Y10  !<              ( !.#8  &1V82TQ,C,Q,C%E>#,R
M,C$P>&LN:'1M4$L! A0#%     @ [X!+5&HW6(6NH 4 L$([ !
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M,C R,3$R,S%?9S$N9VEF4$L! A0#%     @ [X!+5!Q?H5GV?@  _9X  !,
M             ( !,M<' &1V82TR,#(Q,3(S,5]G,BYJ<&=02P$"% ,4
M" #O@$M4*0N15(6T P!"OP, $P              @ %95@@ 9'9A+3(P,C$Q
M,C,Q7V<S+FIP9U!+ 0(4 Q0    ( .^ 2U3$>'&UQO(! ""'%  4
M      "  0\+# !D=F$M,C R,3$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( .^
M2U0;;<I?T2P! "3>#0 4              "  0?^#0!D=F$M,C R,3$R,S%?
=<')E+GAM;%!+!08     #P / -T#   **P\    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
